"NIH Spending Categorization","Project Terms","Project Title","Public Health Relevance","Administering IC","Application ID","Award Notice Date","FOA","Project Number","Type","Activity","IC","Serial Number","Support Year","Suffix","Program Official Information","Project Start Date","Project End Date","Study Section","Subproject Number","Contact PI Person ID","Contact PI / Project Leader","Other PI or Project Leader(s)","Congressional District","Department","Primary DUNS","Primary UEI","DUNS Number","UEI","FIPS","Latitude","Longitude","Organization ID (IPF)","Organization Name","Organization City","Organization State","Organization Type","Organization Zip","Organization Country","ARRA Indicator","Budget Start Date","Budget End Date","CFDA Code","Funding Mechanism","Fiscal Year","Total Cost","Total Cost (Sub Projects)","Funding IC(s)","Direct Cost IC","InDirect Cost IC","NIH COVID-19 Response","Total Cost IC",
"Cancer; Prostate Cancer; Urologic Diseases","Address;Animals;Bone neoplasms;Cell Communication;Cells;Collaborations;Disease;Elements;Engraftment;Flow Cytometry;Fostering;Genotype;Hematopoietic;Histocompatibility Testing;Human;Image;Label;Life;Localized Disease;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of prostate;Measurement;Mesenchymal;Mesenchymal Cell Neoplasm;Metastatic Lesion;Metastatic Neoplasm to the Bone;Metastatic to;Molecular;Neoplasm Metastasis;Play;Population;Process;Regulation;Resolution;Role;Site;Supporting Cell;Technology;Testing;Time;Tissues;Transgenic Animals;Work;base;bone;bone cell;cancer cell;cancer type;cell type;in vivo;interest;neoplastic cell;tool;tumor","Bone Microenvironment Contributions to Metastatic Disease","n/a","NCI","8555538","10/12/2012 8:49:51 AM","RFA-CA-10-021","5U54CA163191-02","5","U54","CA","163191","02"," "," ","9/26/2011 12:00:00 AM","8/2/2012 12:00:00 AM","ZCA1-SRLB-3(O1)","5444","1861205","SCADDEN, DAVID T","Not Applicable","07","Unavailable","071723621","C1CPANL3EWK4","071723621","C1CPANL3EWK4","US","42.346758","-71.10256","758101","BETH ISRAEL DEACONESS MEDICAL CENTER","BOSTON","MA","Independent Hospitals","022155400","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","274218","274218"," ","192481","81737"," "," ",
"No NIH Category available","Address;Animals;Bone neoplasms;Cell Communication;Cells;Collaborations;Disease;Elements;Engraftment;Flow Cytometry;Fostering;Genotype;Hematopoietic;Histocompatibility Testing;Human;Image;Label;Life;Localized Disease;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of prostate;Measurement;Mesenchymal;Mesenchymal Cell Neoplasm;Metastatic Lesion;Metastatic Neoplasm to the Bone;Metastatic to;Molecular;Neoplasm Metastasis;Play;Population;Process;Regulation;Resolution;Role;Site;Supporting Cell;Technology;Testing;Time;Tissues;Transgenic Animals;Work;base;bone;bone cell;cancer cell;cancer type;cell type;in vivo;interest;neoplastic cell;tool;tumor","Bone Microenvironment Contributions to Metastatic Disease","n/a","NCI","8580858","2/12/2013 12:00:00 AM","RFA-CA-10-021","7U54CA163191-03","7","U54","CA","163191","03"," "," "," "," ","ZCA1-SRLB-3","5444","1861205","SCADDEN, DAVID T","Not Applicable","09","Unavailable","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","Domestic Higher Education","770304009","UNITED STATES","N","12/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","273996","273996"," ","170491","103505"," "," ",
"Genetics; Pediatric","Ablation;Angiogenic Switch;Applications Grants;Biological;Bone Development;Cartilage;Cell Death;Cell Differentiation process;Cell Survival;Cells;Chondrocytes;Collagen;Data;Disease;Environment;Enzymes;Epiphysial cartilage;Fetal Development;Fetal Growth;Generations;Genetic;Health;Hydroxylation;Hypoxia;Hypoxia Inducible Factor;In Vitro;Knowledge;Learning;Limb Bud;Malignant Neoplasms;Mediator of activation protein;Mesenchymal;Mesenchymal Differentiation;Mesenchymal Stem Cells;Mesenchyme;Metatarsal bone structure;Modeling;Molecular;Mutant Strains Mice;Organogenesis;Oxygen;Oxygen measurement, partial pressure, arterial;Phenotype;Post-Translational Protein Processing;Primordium;Process;Procollagen-Proline Dioxygenase;Protein Isoforms;Regulation;Role;Staging;Testing;Tissues;Vascular Endothelial Growth Factor A;Wild Type Mouse;Work;bone;fetal;hypoxia inducible factor 1;in vivo;insight;loss of function;mutant;stem cell biology;transcription factor;ubiquitin-protein ligase","ROLE OF HYPOXIA IN DIFFERENTIATION","n/a","NIAMS","8248070","4/20/2012 12:00:00 AM","PA-07-070","5R01AR048191-11","5","R01","AR","048191","11"," ","TYREE, BERNADETTE","4/15/2003 12:00:00 AM","3/31/2014 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","6803498","SCHIPANI, ERNESTINA ","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","603007902","SHHBRBAPSM35","603007902","SHHBRBAPSM35","US","39.780714","-86.174977","577806","INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS","INDIANAPOLIS","IN","SCHOOLS OF MEDICINE","462022915","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","233342","66627"," ","299969",
"Genetics; Osteoporosis; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Actins;Adipocytes;Adipose tissue;Adult;Aspirate substance;BMP2 gene;Bone Marrow;Bone Regeneration;Bone Tissue;Breeding;Cells;Characteristics;Chondrocytes;Clinical;Collagen;Collection;Color;Commit;Development;Exhibits;Experimental Models;FGF2 gene;Fluorescence-Activated Cell Sorting;Foundations;Fracture;Fracture Healing;Future;Ganciclovir;Gel;Goals;Grant;Hereditary Disease;Human;In Vitro;Injury;Knowledge;Label;Measures;Mesenchymal;Mesenchymal Stem Cells;Modeling;Mus;Myofibroblast;Natural regeneration;Osteoblasts;Osteogenesis;Osteoporosis;Pericytes;Phenotype;Population;Regenerative Medicine;Reporter;Research;Role;Signal Pathway;Smooth Muscle;Source;Staging;Stem cells;Stromal Cells;Suction Lipectomy;Tamoxifen;Testing;Therapeutic;Tissues;Transcription Factor AP-2 Alpha;Transgenes;Transgenic Mice;Transgenic Model;Transplantation;alpha Actin;base;bone;bone healing;in vitro testing;in vivo;in vivo Model;inhibitor/antagonist;mouse model;osteogenic;osteoprogenitor cell;progenitor;promoter;public health relevance;recombinase;regenerative;reparative medicine;research study;tissue repair;tool;transgene expression;translational study","Defining a myofibroblast/pericyte as a mesenchymal progenitor cell","
The aims of this application are focused to better identification and characterization of adult mesenchymal
progenitor cells. Our study will evaluate their ability to differentiate into mature mesenchymal lineages in vitro
and in vivo and determine the diverging point at which mesenchymal progenitor cells commit to mature
lineages and factors that can modulate this commitment. The knowledge developed in this grant will provide
the foundation for future studies aimed at use of mesenchymal progenitor cells as therapeutic tools for
osteoporosis and genetic disorders of bone.","NIAMS","8214496","3/9/2012 12:00:00 AM","PA-10-067","5R01AR055607-02","5","R01","AR","055607","02"," ","WANG, FEI","2/1/2011 12:00:00 AM","1/31/2015 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","8263348","KALAJZIC, IVO ","Not Applicable","05","DENTISTRY","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF DENTISTRY/ORAL HYGN","060305335","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","118867"," ","343867",
"Breast Cancer; Cancer","Adopted;Affect;Breast Cancer Cell;Cancer Biology;Cancer cell line;Cell Line;Cells;Clinical;Complement;Dependence;Growth Factor;Individual;Interleukin-6;JAK2 gene;Lead;Malignant Neoplasms;Measures;Mediator of activation protein;Mesenchymal;Mesenchymal Cell Neoplasm;Modeling;Monitor;Mus;Normal Cell;Pathway interactions;Pharmaceutical Preparations;Population;Process;Protocols documentation;Resistance;Signal Transduction;Stat3 Signaling Pathway;Stochastic Processes;Stromal Cells;Systems Biology;Testing;Therapeutic;Translating;autocrine;base;biochemical model;cancer cell;cancer therapy;cytokine;design;experience;extracellular;fitness;improved;in vivo;inhibitor/antagonist;malignant breast neoplasm;mathematical model;melanoma;mouse model;neoplastic cell;paracrine;research study;response;tumor;tumor progression;tumorigenesis","Variability of Cellular Responses to Growth Factors and Drugs During Tumorgenesis","n/a","NCI","8377732","5/9/2012 12:00:00 AM","RFA-CA-09-011","5U54CA148967-03","5","U54","CA","148967","03"," "," "," "," ","ZCA1-SRLB-C","6636","8605381","ALTAN-BONNET, GREGOIRE ","Not Applicable","12","Unavailable","064931884","KUKXRCZ6NZC2","064931884","KUKXRCZ6NZC2","US","40.764332","-73.955697","5079202","SLOAN-KETTERING INST CAN RESEARCH","NEW YORK","NY","Research Institutes","100656007","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM"," ","Research Centers","2012","549980","549980"," ","289995","259985"," "," ",
"Biotechnology; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Area;Bone Regeneration;Cartilage;Cell Differentiation process;Cell Therapy;Cells;Chondrocytes;Chondrogenesis;Defect;Development;Disease;Embryo;Fracture Healing;Future;Gene Silencing;Gene Targeting;Generations;Harvest;Human;Implant;In Vitro;Injection of therapeutic agent;Injury;Laboratories;Lentivirus Vector;Maintenance;Mediating;Mesenchymal;Mesenchymal Differentiation;Mesenchymal Stem Cells;Messenger RNA;MicroRNAs;Modeling;Mus;Muscle;Musculoskeletal;Musculoskeletal Development;Osteoblasts;Osteogenesis;Pathway interactions;Phenotype;Process;Proliferating;Regulation;Role;Small RNA;Smooth Muscle;Source;Staging;Staining method;Stains;Stem cells;Testing;Therapeutic Uses;Tissue-Specific Gene Expression;Tissues;Transcription Repressor/Corepressor;Transplantation;bone;cancer stem cell;cartilage cell;cartilage repair;cell type;embryo tissue;gene repression;improved;in vivo;inhibitor/antagonist;mineralization;novel;osteogenic;overexpression;prevent;repaired;research study;skeletal;stem;stem cell differentiation;tibia;tissue regeneration","Multilineage regulation of mesenchymal stem cell differentiation by microRNAs"," Bone and cartilage repair, following injury or disease, may be facilitated by the transplantation of stem/progenitor cells. Successful repair requires the generation of stable bone/cartilage cells from implanted stem cells through the process of differentiation. This project will study the roles of small regulatory RNAs (microRNAs) in controlling the differentiation pathways of stem cells towards specific cell types. This should uncover novel mechanisms that can be exploited for therapeutic use in cartilage defect repair and fracture healing.  
  
    

","NIAMS","8227821","3/6/2012 12:00:00 AM","PA-10-069","1R21AR062239-01","1","R21","AR","062239","01"," ","WANG, FEI","3/15/2012 12:00:00 AM","1/31/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","10809640","PALMER, GLYN ","HERNANDO, EVA ","12","INTERNAL MEDICINE/MEDICINE","121911077","M5SZJ6VHUHN8","121911077","M5SZJ6VHUHN8","US","40.744985","-73.978118","5998304","NEW YORK UNIVERSITY SCHOOL OF MEDICINE","NEW YORK","NY","SCHOOLS OF MEDICINE","10016","UNITED STATES","N","3/15/2012 12:00:00 AM","1/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","112500","76494"," ","188994",
"Genetics; Human Genome; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adult;Aging;Animal Model;Biochemical;Cartilage;Cells;Development;Embryo;Embryonic Development;G Protein-Coupled Receptor Signaling;Gases;Genetic;Goals;Heterotopic Ossification;Homeostasis;Human;In Vitro;Joints;Lead;Mesenchymal Differentiation;Mesenchymal Stem Cells;Molecular;Mus;Mutation;Osteoblasts;Osteogenesis;Physiology;Proteins;Skeletal Development;Skeletal system;Skeleton;System;Tissues;bone;bone mass;disabling disease;in vivo;loss of function;mature animal;osteoblast differentiation;progenitor;skeletal abnormality;smoothened signaling pathway","Hedgehog signaling in adult bone and cartilage homeostasis","n/a","NHGRI","8565555"," "," ","1ZIAHG200342-06","1","ZIA","HG","200342","06"," "," "," "," "," "," ","9416432","YANG, YINGZI ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL HUMAN GENOME RESEARCH INSTITUTE"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NHGRI"," "," "," ","348743",
"Cancer; Clinical Research; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Academic Medical Centers;Address;Architecture;Area;Award;Binding;Binding Sites;Biological Models;Bone Marrow;Cancer Model;Cell Line;Cell Proliferation;Cells;Data;Defect;Dependence;Development;Disease;Down-Regulation;Event;Exhibits;Founder Generation;Future;Herbert Irving Comprehensive Cancer Center;Human;Immunohistochemistry;In Vitro;Lasers;Lead;Lesion;Maintenance;Malignant Neoplasms;Mediating;Mentors;Mesenchymal;Mesenchymal Differentiation;Mesenchymal Stem Cells;Mesenchyme;Monitor;Mus;Musculoskeletal;Musculoskeletal Development;Oncogenes;Pathogenesis;Phenotype;Physiological;Prognostic Marker;Proliferating;RNA Interference;Regulation;Research;Research Personnel;Role;Secondary to;Signal Transduction;Small Interfering RNA;Stimulus;Testing;Therapeutic;Tissue Engineering;Tissues;Training;Transcriptional Regulation;Transgenic Mice;Translating;Tumorigenicity;Undifferentiated;Work;base;career;chromatin immunoprecipitation;design;in vivo;inhibitor/antagonist;jun Oncogene;mouse model;novel;novel diagnostics;overexpression;prevent;progenitor;promoter;sarcoma;stem cell biology;stem cell differentiation;therapeutic target;tissue regeneration;transcription factor;tumor;tumorigenesis;tumorigenic","The role of DKK1, a Wnt-Inhibitor, in Mesenchymal Differentiation/Sarcomagenesis","n/a","NCI","8208238","1/4/2012 12:00:00 AM","PA-06-512","5K08CA132986-04","5","K08","CA","132986","04"," ","PERKINS, SUSAN N","1/15/2009 12:00:00 AM","8/1/2012 12:00:00 AM","Transition to Independence Study Section (I)[NCI-I]"," ","1900840","MATUSHANSKY, IGOR ","Not Applicable","13","INTERNAL MEDICINE/MEDICINE","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","SCHOOLS OF MEDICINE","100323725","UNITED STATES","N","1/1/2012 12:00:00 AM","8/1/2012 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","157300","12584"," ","169884",
"Aging; Arthritis; Genetics; Human Genome; Osteoporosis; Pediatric; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Bone Matrix;Cartilage;Cell Differentiation process;Cell physiology;Chondrocytes;Degenerative Disorder;Degenerative polyarthritis;Development;Disease;Elements;Embryo;Embryonic Development;Ensure;Family member;Goals;Limb Development;Limb structure;Liver Stem Cell;Malignant Neoplasms;Mediating;Mesenchymal;Mesenchymal Stem Cells;Molecular;Morphogenesis;Mutation;Osteoblasts;Osteogenesis;Osteoporosis;Pathway interactions;Physical condensation;Signal Pathway;Signal Transduction;Signaling Molecule;Skeletal Development;Skeletal system;Structure;Testing;Work;age related;beta catenin;bone;human disease;intercellular communication;interest;mature animal;self-renewal;skeletal","Wnt signaling in vetebrate limb and skeletal development","n/a","NHGRI","8565533"," "," ","1ZIAHG000187-12","1","ZIA","HG","000187","12"," "," "," "," "," "," ","9416432","YANG, YINGZI ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL HUMAN GENOME RESEARCH INSTITUTE"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NHGRI"," "," "," ","813733",
"Bioengineering; Networking and Information Technology R&D; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Allografting;Behavior;Bioinformatics;Cell Communication;Cell Extracts;Cells;Chicago;Clinical;Communities;Computer software;Data;Data Analyses;Data Set;Descriptor;Development;Future;Illinois;Image;Image Analysis;Imagery;Information Technology;Institution;Instruction;Internet;Investigation;Islets of Langerhans Transplantation;Machine Learning;Measurement;Mesenchymal;Mesenchymal Stem Cells;Microscopy;Nature;Online Systems;Outcome;Performance;Property;Public Health;Research;Research Institute;Research Personnel;Resources;Services;Solutions;Stem Cell Research;Supercomputing;Techniques;Time;Transplantation;Universities;Validation;Work;analytical method;cell behavior;computing resources;data management;data sharing;design;image processing;novel;prototype;regenerative;response;statistics;stem;web services","Supercomputing and Multidimensional Data Analysis","The relevance of this project to public health is in discovering fundamental properties and relationships of mesenchymal stem cells (MSC) with respect to islet cell transplants. It is also envisioned that the information technology designed and developed under this particular project would serve as a technological prototype for inclusions of additional data sets and software from other investigators, and for providing advanced services 
to the community of researchers and practitioners working on MSC research.","NIAID","8379595","7/20/2012 12:00:00 AM","PAR-10-271","5P01AI089556-02","5","P01","AI","089556","02"," "," "," "," ","ZAI1-MFH-I","6134","11051375","MCHENRY, KENTON ","Not Applicable","27","Unavailable","052780918","F8THLJQSAF93","052780918","F8THLJQSAF93","US","25.775337","-80.209809","5221250","UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","CORAL GABLES","FL","Domestic Higher Education","331462926","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","129260","129260"," ","108319","20941"," "," ",
"Bioengineering; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Adipocytes;Animals;Biological Assay;Bone Marrow;Cartilage;Cell Culture System;Cell Differentiation process;Cell Surface Receptors;Cells;Chondrocytes;Chondrogenesis;Core Facility;Data;Extracellular Matrix;Fibroblast Growth Factor 2;Fibroblasts;Grant;Hand;Hematopoietic;Human;In Vitro;Laboratories;Location;Marrow;Mesenchymal;Mesenchymal Stem Cells;Mitotic;Oryctolagus cuniculus;Osteoblasts;Participant;Phenotype;Preparation;Procedures;Prostaglandins;Protocols documentation;Quality Control;Reagent;Regulation;Reporting;Research;Research Personnel;Research Project Grants;Role;Screening procedure;Services;Stem cells;Stress;Supplementation;Tissue Engineering;cartilage repair;cell preparation;cost effective;cytokine;design;experience;fetal bovine serum;progenitor;programs;research study","Cell Core Facility","n/a","NIAMS","8380795","7/20/2012 12:00:00 AM"," ","5P01AR053622-05","5","P01","AR","053622","05"," "," "," ","4/30/2014 12:00:00 AM","ZAR1-CHW-J","9001","7853193","SOLCHAGA, LUIS ANTONIO","Not Applicable","11","Unavailable","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","Domestic Higher Education","441061712","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","73350","73350"," ","73350","0"," "," ",
"Aging; Osteoporosis; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Age;Aging;Biological Assay;Bone Marrow;Bone Marrow Cells;C57BL/6 Mouse;Cell Culture Techniques;Cells;Collaborations;Controlled Study;Core Facility;Data;Discipline;Ensure;Faculty;Gene Expression;Goals;Impairment;Individual;Insulin-Like Growth Factor I;Laboratories;Leptin;Mesenchymal;Mesenchymal Stem Cells;Metabolic Bone Diseases;Mus;Muscle satellite cell;Musculoskeletal Diseases;Nutrient;Procedures;Production;Quality Control;Research;Research Personnel;Resources;Signal Transduction;Somatotropin;Stem Cell Research;Stem cells;Supporting Cell;System;Testing;bone loss;cost;design;interest;medical schools;multidisciplinary;programs;research facility;sound;stem;success","STEM CELL CORE","This Core Facility will provide bone marrow cells and technical support to the individual projects and thus is essential for the success of the Program Project.","NIA","8377775","4/26/2012 12:00:00 AM"," ","5P01AG036675-02","5","P01","AG","036675","02"," "," "," "," ","ZAG1-ZIJ-8","6549","1866163","ISALES, CARLOS M.","Not Applicable","12","Unavailable","966668691","N4WWJC8T2593","809593387; 966668691","JJJNQAJY5RN6; N4WWJC8T2593","US","33.471349","-81.991385","676605","AUGUSTA UNIVERSITY","AUGUSTA","GA","Domestic Higher Education","309120004","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","141473","141473"," ","94421","47052"," "," ",
"Cancer; Diabetes; Pancreatic Cancer; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adipocytes;Beta Cell;Blood Vessels;Bone Marrow;Carcinogenicity Tests;Carcinoma;Cell Differentiation process;Cells;Development;Disease Progression;Endothelial Cells;Exhibits;Health;Hyperinsulinism;Hyperplasia;In Vitro;Ischemic Stroke;Islets of Langerhans;Kidney;Malignant Neoplasms;Mesenchymal;Mesenchymal Stem Cells;Modeling;Mus;Nature;Neurons;Normal Cell;Normal tissue morphology;PDGFB gene;PDGFRA gene;PDGFRB gene;Pancreatic Endocrine Carcinoma;Pathway interactions;Patients;Pericytes;Phenotype;Population;Premalignant;Recruitment Activity;Signal Pathway;Signal Transduction;Site;Staging;Stem cells;Supporting Cell;Surface;Suspension substance;Suspensions;Testing;Time;Transgenic Mice;Tumor Angiogenesis;Tumor Burden;Xenograft procedure;adenoma;angiogenesis;base;capsule;carcinogenesis;cell type;in vivo;islet;melanoma;mouse model;neoplastic cell;neovascularization;pancreatic neoplasm;pancreatic tumorigenesis;self-renewal;stem cell population;transcriptional coactivator p75;tumor;tumor initiation;tumor progression;tumor xenograft;tumorigenesis","Multipotent mesenchymal stem cell-like cells in pancreatic tumorigenesis","PUBLIC HEALTH RELEVANCE: Mesenchymal stem cell-like cells have multipoteniality as they differentiate into various cell types including vascular cells (endothelial cells and pericytes). Therefore these cells could potentially be used for proangiogenic therapy in ischemic and stroke patients as well as be targeted in cancer to block more efficiently angiogenesis.","NCI","8165993","12/1/2011 12:00:00 AM","PA-09-210","5F32CA153524-02","5","F32","CA","153524","02"," ","JAKOWLEW, SONIA B","12/1/2010 12:00:00 AM","11/30/2012 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-A(20)L]"," ","10300709","ISACHENKO, NADEZDA ALEKSANDROVNA","Not Applicable","12","NEUROSURGERY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","59432"," "," ","59432",
"Clinical Research; Infectious Diseases; Lung; Organ Transplantation; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Acute;Allografting;Biochemical;Biological Markers;Biological Response Modifiers;Bronchiolitis Obliterans;Bronchoalveolar Lavage;Bronchoalveolar Lavage Fluid;Cell Count;Cells;Chronic;Cohort Studies;Data;Defect;Development;Dinoprostone;Donor person;Early Diagnosis;Effector Cell;Equilibrium;Event;Exhalation;Exhibits;Fibrosis;Goals;Health;Human;Immune;Inflammatory;Injury;Interleukin-13;Irrigation;Life;Lipids;Liquid substance;Lung;Lung Transplantation;Matched Case-Control Study;Measures;Mediator of activation protein;Mesenchymal;Mesenchymal Stem Cells;Myofibroblast;Outcome;Participant;Pathogenesis;Pathway interactions;Patients;Phenotype;Play;Population;Process;Prostaglandin Receptor;Prostaglandins;Pulmonary Function Test/Forced Expiratory Volume 1;Recruitment Activity;Regulation;Respiratory physiology;Role;Sampling;Signal Transduction;Stem cells;Syndrome;Synthetic Prostaglandins;T cell response;T-Cell Activation;T-Lymphocyte;Testing;Time;Transplant Recipients;Transplantation;allograft rejection;autocrine;cytokine;enzyme activity;fibrogenesis;in vivo;inhibitor/antagonist;insight;lung allograft;novel;paracrine;prospective;response;response to injury;selective expression;stem cell fate","Role of resident mesenchymal stem cells in lung allograft rejection","
Statement of Relevance
Our proposed studies will be the first to investigate lung resident mesenchymal stem cells as biomarkers of
chronic rejection in lung transplantation and provide novel mechanistic information regarding cellular and
biochemical modulators of chronic allograft rejection in human lung transplantation.","NHLBI","8268427","6/27/2012 12:00:00 AM","PA-07-070","5R01HL094622-04","5","R01","HL","094622","04"," ","EU, JERRY PC","8/1/2009 12:00:00 AM","5/31/2014 12:00:00 AM","Lung Cellular, Molecular, and Immunobiology Study Section[LCMI]"," ","7040641","LAMA, VIBHA N","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","134888"," ","382388",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human; Transplantation","Adult;Affect;Biomechanics;Bone Marrow;Bone Transplantation;Bone callus;CXC Chemokines;Cell Therapy;Cell physiology;Cells;Cessation of life;Clinical;Data;Development;Economics;Elderly;Engraftment;Environment;Foundations;Fracture;Fracture Healing;Genetically Engineered Mouse;Goals;Grant;Harvest;Healed;Homing;Hospitalization;In Vitro;Incidence;Injury;Insulin-Like Growth Factor I;Investigation;Laboratories;Lead;Ligands;Mediating;Mesenchymal;Mesenchymal Differentiation;Mesenchymal Stem Cells;Methods;Modeling;Morbidity - disease rate;Osteoblasts;Osteogenesis;Osteoporosis;Patients;Population;Procedures;Process;Property;Proto-Oncogene Proteins c-akt;Publishing;Regenerative Medicine;Regulation;Reporting;Research;Reticular Cell;Role;Seeds;Signal Pathway;Signal Transduction;Site;Soil;Speed;Staging;Stem cells;Stromal Cells;Testing;Time;Tissues;Transplantation;Transplanted tissue;United States;Vascular Endothelial Growth Factors;age related;autocrine;base;bone cell;bone morphogenic protein;bone strength;cell type;chemokine receptor;cost;fascinate;healing;improved;in vivo;injured;insight;interest;mouse model;multipotent cell;novel;novel therapeutic intervention;osteoblast differentiation;osteogenic;paracrine;progenitor;programs;public health relevance;regenerative;repaired;social;stem;tissue regeneration","Adult Multipotent Mesenchymal Stromal Cells for Fracture Repair","
PROJECT NARRATIVE- PUBLIC HEALTH RELEVANCE STATEMENT
 Non-union fractures remain a challenging clinical problem that affect approximately 600,000 people every
year in the United States. Because our elderly population is becoming larger, an increased incidence of non-
unions as consequence of poor healing and age-related worsening of osteoporosis is expected. Adult bone
marrow contains multipotent mesenchymal stromal cells (MSC) that have all the properties to become a novel
therapeutic approach to treat non-unions. The overall goal of this proposal is to understand the mechanisms
through which MSC exert their beneficial effects in fracture repair. Unraveling how MSC are capable to
respond to the fracture regenerative clue and to provide the adequate environment for tissue regeneration will
provide critical insights to develop novel MSC-based therapies to treat patients with non-unions","NIDDK","8322801","7/24/2012 12:00:00 AM","PA-10-067","5R01DK070929-08","5","R01","DK","070929","08"," ","MALOZOWSKI, SAUL N","4/5/2006 12:00:00 AM","8/31/2014 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","8184497","SPAGNOLI, ANNA ","Not Applicable","04","PEDIATRICS","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","98604"," ","304029",
"Biotechnology; Eye Disease and Disorders of Vision; Kidney Disease; Pediatric; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human; Transplantation","Address;Affect;Age;Age-Months;Animal Model;Biochemical;Blepharospasm;Bone Marrow;Cell Density;Cells;Cicatrix;Clinical;Collaborations;Confocal Microscopy;Cornea;Corneal Diseases;Corneal Injury;Corneal Stroma;Crystal Formation;Cysteamine;Cystine;Cystinosis;Data;Defect;Deposition;Deterioration;Development;Disease;Disease Progression;Drug usage;Engraftment;Epithelial;Eyedrops;Foundations;Funding;Goals;Hereditary Disease;Hour;Human;Infiltration;Inflammatory;Injection of therapeutic agent;Injury;Kidney Diseases;Knockout Mice;Knowledge;Laser Scanning Confocal Microscopy;Lysosomal Storage Diseases;Lysosomes;Measurement;Measures;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Methods;Molecular Biology;Multiple Organ Failure;Mus;Natural regeneration;Oral;Organ;Orphan;Patients;Phenotype;Photophobia;Population;Recurrence;Refractory;Renal function;Reporting;Research;Research Personnel;Staging;Systemic Therapy;Therapeutic;Therapeutic Effect;Time;Tissues;Transplantation;Umbilical cord structure;Universities;Visual;Wound Healing;aged;base;body system;immunocytochemistry;in vivo;loss of function;mouse model;novel;research study;response;response to injury;stem cell therapy","Mesenchymal Stem Cell Therapy for Corneal Cystinosis"," This study will evaluate the potential therapeutic effects of human umbilical cord mesenchymal stem cells (hUCMSC) transplantation into to the corneal stroma to treat a mouse model of corneal cystinosis. Progression of corneal cystinosis and the formation of intrastromal cystine crystals will be evaluated by quantitative in vivo confocal microscopy. Laser scanning confocal microscopy, immunocytochemistry and molecular biology will be used to evaluate differentiation of hUCMSC to mouse corneal keratocytes and their response to corneal injury.   
      

","NEI","8272241","3/26/2012 12:00:00 AM","PA-10-067","1R01EY022365-01","1","R01","EY","022365","01"," ","MCKIE, GEORGE ANN","4/1/2012 12:00:00 AM","3/31/2016 12:00:00 AM","Anterior Eye Disease Study Section[AED]"," ","9749105","SIMPSON, JENNIFER LYNNE","Not Applicable","45","OPHTHALMOLOGY","046705849","MJC5FCYQTPE6","046705849","MJC5FCYQTPE6","US","33.678042","-117.773718","577504","UNIVERSITY OF CALIFORNIA-IRVINE","IRVINE","CA","SCHOOLS OF MEDICINE","926970001","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","250000","132500"," ","382500",
"Biotechnology; Cancer; Genetics; Urologic Diseases","Antibodies;Apoptosis;Area;Biological;Biological Markers;Biological Process;Bladder;Cancer cell line;Cell Line;Cell Proliferation;Cells;Clinical;Clinical Trials;Data;Dependency;Dose;Epidermal Growth Factor Receptor;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Event;Exhibits;FGF2 gene;FGFR3 gene;Fibroblast Growth Factor;Fibroblast Growth Factor 2;Fibroblast Growth Factor Receptors;Fibroblasts;Gefitinib;Gene Expression;Gene Expression Profiling;Genes;Genomics;Goals;Growth;In Vitro;Intracellular Membranes;Laboratory Study;Lead;Learning;Ligands;Malignant Neoplasms;Malignant neoplasm of urinary bladder;Maps;Measures;Mesenchymal;Mesenchymal Cell Neoplasm;Methods;Modeling;Muscle;Mutation;Neoadjuvant Therapy;Organ;Pathway interactions;Patients;Pharmaceutical Preparations;Pharmacodynamics;Play;Pre-Clinical Model;Primary Neoplasm;Process;Protein Kinase;Research;Resistance;Risk;Role;Signal Transduction;Testing;Therapeutic;Tissues;Toxic effect;Translations;Tumor Suppressor Genes;Universities;Urogenital Cancer;Urothelial Cell;Xenograft procedure;angiogenesis;autocrine;base;cancer cell;cancer therapy;design;epithelial to mesenchymal transition;inhibitor/antagonist;mutant;neoplastic cell;novel;overexpression;paracrine;phase 2 study;preclinical study;receptor;research study;response;small molecule;therapeutic target;tissue culture;tumor","Targeting FGFR and EGFR in Bladder Cancer","RELEVANCE: Activating mutations in FGFR3, a growth-promoting receptor, occur In a large number of BCs, 
and Inhibitors of FGFR3 have already been developed for cancer therapy. The goal of this project is to 
learn how to predict which tumors will respond to these inhibitors and confirm that the level of inhibition 
achieved In patients Is sufficient to produce desirable biological effects in patients.","NCI","8230254","10/4/2012 9:58:04 AM","PAR-10-003","2P50CA091846-11","2","P50","CA","091846","11"," "," ","9/1/2011 12:00:00 AM","8/31/2017 12:00:00 AM","ZCA1-RPRB-M(O1)","6195","1862151","MCCONKEY, DAVID J","DINNEY, COLIN P.N.; SIEFKER-RADTKE, ARLENE O","09","Unavailable","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","Domestic Higher Education","770304009","UNITED STATES","N","9/19/2012 12:00:00 AM","8/31/2012 12:00:00 AM"," ","Research Centers","2012","203201","203201"," ","136910","66291"," "," ",
"Biotechnology; Breast Cancer; Cancer; Genetics; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Apoptotic;Autophagocytosis;Binding;Biogenesis;Biological Models;Biology;Breast Cancer Cell;Breast Cancer Model;Cancer Biology;Cancer Cell Growth;Cell Cycle;Cell Death;Cell Survival;Cells;Clinical;Collaborations;Data;Degenerative Disorder;Development;Dicer Enzyme;Effectiveness;Environment;Exhibits;Extracellular Matrix;Genes;Goals;Growth;Growth Factor;Housing;Human;Hypoxia;In Vitro;Inflammatory;Injury;Institutes;Insulin-Like Growth Factor I;Knowledge;Laboratories;Lead;Link;Malignant Neoplasms;Mammary Neoplasms;Mediating;Mesenchymal;Mesenchymal Differentiation;Mesenchymal Stem Cells;Messenger RNA;MicroRNAs;Modeling;Molecular;Molecular Profiling;Mus;Nutrient;Pathway interactions;Peptide Hydrolases;Pharmaceutical Preparations;Play;Primary Neoplasm;Property;Regulation;Research;Resistance;Role;Serum;Small RNA;Solid Neoplasm;Sorbus;Stem cells;Stress;Stromal Cells;Testing;Therapeutic;Tumor Burden;Tumor Suppressor Genes;Universities;Vascularization;Work;Xenograft Model;Xenograft procedure;base;cancer cell;cancer stem cell;cell growth;cytokine;deprivation;design;established cell line;improved;in vitro Model;in vivo;insight;malignant breast neoplasm;medical schools;mouse model;multidisciplinary;neoplastic cell;new therapeutic target;novel;novel therapeutic intervention;novel therapeutics;research study;response;small hairpin RNA;stem;success;therapeutic target;tumor","miRNA-mediated Stromal Cell Survival under Stress Supports  Breast Cancer Growth"," This study will give us insight into the potential role that mesenchymal stem/progenitor cells that support the growth of breast cancers.  It will also help us in identification of small RNA molecules called miRNA that are involved in the survival of the supporting stromal cells under stress and chemotherapeutic drugs, in breast cancers.  Identification of molecular pathways involved stromal cell survival may lead to identification of new therapeutic targets for resistant breast cancer.  
    

","NCI","8330756","7/31/2012 12:00:00 AM","PA-09-199","5R01CA151851-03","5","R01","CA","151851","03"," ","JHAPPAN, CHAMELLI","9/9/2011 12:00:00 AM","7/31/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","8491208","POCHAMPALLY, RADHIKA R","Not Applicable","03","NONE","928824473","X59NJBFL8BJ3","928824473","X59NJBFL8BJ3","US","32.328724","-90.175537","5390304","UNIVERSITY OF MISSISSIPPI MED CTR","JACKSON","MS","OVERALL MEDICAL","392164500","UNITED STATES","N","8/3/2012 12:00:00 AM","7/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","102713"," ","310213",
"Aging; Genetics; Osteoporosis; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Adipocytes;Adult;Age;Aging;Binding Proteins;Bone Marrow;Bone Resorption;Cell Aging;Cell Cycle;Cell Proliferation;Cell division;Cells;Chromatin Structure;Chromosomes;Collaborations;Complex;DNA Damage;Data;Databases;Deposition;Disease;Epigenetic Process;Event;Fatty acid glycerol esters;Fibroblasts;Gene Expression;Genetic;Hematopoietic stem cells;Heterochromatin;Histones;Human;Immune system;In Vitro;Kinetics;Lead;Mediating;Mesenchymal;Mesenchymal Stem Cells;Molecular;Molecular Chaperones;Mus;Nuclear;Obesity;Organelles;Orthologous Gene;Osteoblasts;Osteogenesis;Osteoporosis;Pathway interactions;Phenotype;Process;Proteins;Regulation;Relative (related person);Repression;Roentgen Rays;Role;Signal Pathway;Signal Repression;Signal Transduction;Structure;Sum;Testing;Time;Tissues;Yeasts;acrosome stabilizing factor;age related;aged;bone;bone mass;cell type;in vivo;member;mouse model;novel;osteogenic;prevent;programs;protein function;senescence;telomere","EPIGENETIC CONTROL OF OSTEOGENESIS AND SENESCENCE IN MESENCHYMAL PROGENITOR CELLS","n/a","NIA","8377714","2/16/2012 12:00:00 AM"," ","5P01AG031862-05","5","P01","AG","031862","05"," "," "," ","8/31/2013 12:00:00 AM","ZAG1-ZIJ-5","0004","6483311","ADAMS, PETER D.","Not Applicable","03","Unavailable","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","Domestic Higher Education","191046205","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","339362","339362"," ","262984","76378"," "," ",
"Biotechnology; Genetics; Lung","Age;Asthma;Bronchopulmonary Dysplasia;Cells;Cellular biology;Complex;DNA;Development;Dominant-Negative Mutation;Doxycycline;Elements;Enhancers;Epithelial Cells;Fetal Lung;Fluorescence;Functional disorder;Genes;Genetic;Growth Factor;Homeostasis;Knowledge;Lung;Lung diseases;Mesenchymal;Mesenchyme;Methodology;Mus;Pathogenesis;Pathway interactions;Play;Proteins;Publishing;Pulmonary Fibrosis;Regulatory Element;Reporter;Research;Role;Signal Pathway;Signal Transduction;Specificity;Staging;System;Testing;Tetanus Helper Peptide;Tetracyclines;Time;Trans-Activators;Transgenes;Transgenic Mice;Transgenic Organisms;dosage;in vivo;injury and repair;lung development;lung injury;lung maturation;mouse model;new therapeutic target;novel;postnatal;promoter;receptor;tool","Development of a novel genetic approach to study lung mesenchymal cell signaling"," This proposed project will develop a novel genetic approach to specifically target lung mesenchymal cells in mouse model. Successful establishment of this methodology and its application to study TGF-ï¿½ signaling in developing lung mesenchymal cells have the potential to substantially advance our research in lung mesenchymal cell biology. Moreover, these genetic tool and mouse models will help to break through the critical barrier in understanding the pathogenic mechanisms of several lung diseases including asthma and pulmonary fibrosis.    

","NHLBI","8282699","7/16/2012 12:00:00 AM","PA-10-069","5R21HL109932-02","5","R21","HL","109932","02"," ","BLAISDELL, CAROL J","8/1/2011 12:00:00 AM","7/31/2014 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","6796227","SHI, WEI ","Not Applicable","28","Unavailable","052277936","DVL1CMRMWRN9","052277936","DVL1CMRMWRN9","US","34.098065","-118.29069","1520001","CHILDREN'S HOSPITAL OF LOS ANGELES","LOS ANGELES","CA","Independent Hospitals","900276062","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","125000","75000"," ","200000",
"Autoimmune Disease; Brain Disorders; Clinical Research; Clinical Trials; Multiple Sclerosis; Neurodegenerative; Neurosciences; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Adverse effects;Affect;Age;American;Ancillary Study;Animal Experiments;Animal Model;Antibodies;Antigen-Presenting Cells;Aspirate substance;Autoimmune Diseases;Autoimmune Process;Autologous;Autologous Transplantation;B Cell Proliferation;B-Lymphocytes;Biological Assay;Blood Cells;Bone Marrow;CD8B1 gene;Cells;Clinical;Clinical Trials;Clinical assessments;Data;Department of Defense;Development;Disease;Flow Cytometry;Funding;Future;Goals;Human;Image;Immune;Immune response;Immunobiology;Immunologics;In Vitro;Infection;Inflammatory;Infusion procedures;Laboratories;Laboratory Study;Measures;Mediating;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Molecular;Monitor;Multiple Sclerosis;Myelin;Natural Killer Cells;Neurodegenerative Disorders;Participant;Pathogenesis;Patients;Phase I Clinical Trials;Procedures;Production;Property;Publishing;Relapse;Safety;Series;Severities;Stem cell transplant;T cell response;T-Lymphocyte;Testing;Time;Tissues;base;cytokine;effective therapy;experience;immunoregulation;in vivo;insight;peripheral blood;public health relevance;repaired;research study;response;sex","Immunobiology of mesenchymal stem cell transplantation in multiple sclerosis","
Project Narrative
Multiple sclerosis (MS) is a disabling neurodegenerative disease that has no cure and currently
affects approximately 400,000 Americans. This proposal details laboratory studies to be carried
out in conjunction with a Phase 1 clinical trial that will assess the MS-relevant in vivo
immunologic effects of autologous mesenchymal stem cell transplantation. This study will help
determine whether this promising procedure might be an effective therapy for the millions of
people world-wide who are affected by multiple sclerosis.","NINDS","8217181","11/24/2011 12:00:00 AM","RFA-AI-10-014","5R01NS074787-02","5","R01","NS","074787","02"," ","UTZ, URSULA","2/1/2011 12:00:00 AM","11/30/2014 12:00:00 AM","ZAI1-PA-I(S1)"," ","1905025","COHEN, JEFFREY ALAN","Not Applicable","11","INTERNAL MEDICINE/MEDICINE","135781701","M5QFLTCTSQN6","135781701","M5QFLTCTSQN6","US","41.479276","-81.680233","10000858","CLEVELAND CLINIC LERNER COM-CWRU","CLEVELAND","OH","SCHOOLS OF MEDICINE","441950001","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","265715","30529"," ","296244",
"Biotechnology; Cancer; Clinical Research; Genetics; Hematology; Rare Diseases","13q14;Benign;Biology;Bone Marrow;Bone marrow biopsy;Bortezomib;Cells;Chromosomes;Clinical Trials;DLEU2 gene;Development;Dexamethasone;Differentiation and Growth;Disease;Disease Progression;Drug resistance;Epigenetic Process;Future;Gene Targeting;Genes;Grant;Growth;Hematologic Neoplasms;In Vitro;Knockout Mice;Lead;Malignant - descriptor;Malignant Neoplasms;Mesenchymal;Mesenchymal Differentiation;Mesenchymal Stem Cells;MicroRNAs;Molecular;Monoclonal gammopathy of uncertain significance;Multiple Myeloma;Mus;Neoplasm Metastasis;Pathogenesis;Patients;Pharmaceutical Preparations;Phase;Plasma Cells;Play;Prognostic Marker;Regulation;Regulator Genes;Research Personnel;Resistance;Role;Sampling;Serum;Staging;Stromal Cells;Therapeutic;Therapeutic Agents;Transgenic Mice;Transgenic Organisms;Tumor Suppressor Proteins;base;in vivo;loss of function;mimetics;mouse model;pre-miRNA;prevent;prognostic;tumor;tumor growth;tumor progression","The role of miRNA15a and 16-1 in Multiple Myeloma"," Multiple Myeloma (MM) is the second most prevalent hematological malignancy and it remains incurable with a median survival of 3-5 years.  In many cases, MM progresses from a more benign-like stage of monoclonal gammopathy of undetermined significance (MGUS).  This grant focuses on understanding the role of specific regulators of genes called miRNA.  We will examine the role of two miRNAs, miR15a and 16-1 in the regulation of progression and dissemination in MM.  New drugs are being developed to target these miRNAs.  These new drugs will lead to a paradigm shift in the treatment of MM, where we could prevent disease progression to active MM, or revert MM to an MGUS-like stage.  
    

","NCI","8294598","5/3/2012 12:00:00 AM","PA-10-031","5R01CA154648-02","5","R01","CA","154648","02"," ","HOWCROFT, THOMAS K","7/1/2011 12:00:00 AM","5/31/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","8436435","GHOBRIAL, IRENE M.","Not Applicable","07","Unavailable","076580745","DPMGH9MG1X67","076580745","DPMGH9MG1X67","US","42.337844","-71.108337","1464901","DANA-FARBER CANCER INST","BOSTON","MA","Independent Hospitals","022155450","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","155625"," ","363125",
"Aging; Osteoporosis; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","3-Dimensional;Affect;Affinity;Aging;Alendronate;Anabolic Agents;Animal Model;Animals;Architecture;Biochemical;Bone Growth;Bone Marrow;Bone Surface;Cells;Chondrogenesis;Data;Disease;Disease model;Effectiveness;Elderly;Engraftment;Estrogens;Fracture;Fracture Healing;Glucocorticoids;Goals;Growth Factor;Home environment;Homing;Human;Immune;Impairment;Individual;Integrins;Lead;Ligands;Measures;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Methods;Modeling;Mus;Natural regeneration;Osteoblasts;Osteocytes;Osteogenesis;Osteoporosis;Patients;Pharmaceutical Preparations;Pre-Clinical Model;Process;Research;Serum;Site;Surface;Testing;Therapeutic;Time;Transplantation;Trauma;Xenograft procedure;aged;base;bone;bone loss;bone mass;bone strength;bone turnover;chemotherapy;clinical practice;hormone deficiency;juvenile animal;novel;novel strategies;osteoblast differentiation;osteogenic;parathyroid hormone (1-34);peptidomimetics;preclinical study;prevent","Directing mesenchymal stem cells to bone to augment bone formation"," Aged individuals have reduced numbers of mesenchymal stem cells (MSCs) in the bone marrow which leads to impairment of bone forming ability and subsequent bone loss (osteoporosis). MSCs are the cells that can give rise to the osteoblasts, the cells that make bone. Giving extra MSCs to patients with severe osteoporosis or delayed fracture healing would be a good therapeutic option. However, this approach was not successful due to the transplanted MSCs can not readily go to bone. Our research group has developed a novel method to guide the transplanted MSCs to bone by creating a compound with high affinity to both to the MSCs and bone. The goal of this project is to test whether we can build new bone in preclinical studies of bone loss using our lead compound, LLP2A-Ale alone, or in the combination of MSCs transplantation, to increase bone formation and if our approach has the potential to make more bones and stronger bones.   
      

","NIAMS","8294322","8/21/2012 12:00:00 AM","PA-10-067","1R01AR061366-01A1","1","R01","AR","061366","01","A","CHEN, FAYE H","9/1/2012 12:00:00 AM","8/31/2016 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","8882248","YAO, WEI ","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","047120084","TX2DAGQPENZ5","047120084","TX2DAGQPENZ5","US","38.543675","-121.729989","577503","UNIVERSITY OF CALIFORNIA AT DAVIS","DAVIS","CA","SCHOOLS OF MEDICINE","956186153","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","180000","97200"," ","277200",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Adipocytes;Adult;Aorta;Behavior;Blood;Blood Vessels;Bone Marrow;Bone Marrow Cells;CD34 gene;Cell Maintenance;Cell Proliferation;Cells;Ceramics;Characteristics;Chondrocytes;Collaborations;Data;Development;Disease;Doxycycline;Embryo;Fetal Liver;Fiber;Fluorescence;Gene Expression;Genes;Gonadal structure;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;Human;Image;Implant;In Vitro;Intermediate Filament Proteins;Label;Laboratories;Location;Maps;Marrow;Mesenchymal;Mesenchymal Stem Cells;Mesonephric structure;Methods;Modeling;Mus;Myelofibrosis;Nuclear;Oklahoma;Osteoblasts;Proteins;Regulatory Element;Role;SLAM protein;Sickle Cell Anemia;Signal Transduction;Site;Sorting - Cell Movement;Spleen;Staging;Staining method;Stains;Stem cells;Sympathetic Nervous System;Techniques;Tissue-Specific Gene Expression;Toxin;Transgenic Mice;cell type;in vivo;mouse model;nerve supply;nestin protein;novel;postnatal;progenitor;promoter;public health relevance;self-renewal;spatial relationship;stem cell niche;tissue culture;trafficking","Role of mesenchymal stem cells in the blood stem cell niche","
The spatial localization and cellular constituents forming the hematopoietic stem cell
(HSC) niche are unclear, with studies suggesting that HSC localizes either near
osteoblasts or the vasculature. Preliminary studies supporting this proposal suggest that
bona fide mesenchymal stem cells, peri-vascular and isolatable by Nestin expression,
form a unique HSC niche in the bone marrow. This proposal explores the function of this
candidate niche cell during the normal development and pathological states of bone
marrow attrition and expansion.","NHLBI","8309052","7/19/2012 12:00:00 AM","RFA-HL-09-010","5R01HL097819-04","5","R01","HL","097819","04"," ","THOMAS, JOHN","9/6/2009 12:00:00 AM","7/31/2014 12:00:00 AM","ZHL1-CSR-W(M1)"," ","2085323","FRENETTE, PAUL S","Not Applicable","14","INTERNAL MEDICINE/MEDICINE","110521739"," ","110521739"," ","US","40.851026","-73.844361","9433501","ALBERT EINSTEIN COLLEGE OF MEDICINE","BRONX","NY","SCHOOLS OF MEDICINE","104611900","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","163350"," ","410850",
"Lung; Pediatric; Rare Diseases; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Adult;Alveolar;Animals;Apert syndrome;Cartilage;Data;Defect;Disease;Distal;Dysplasia;Embryo;Epithelial;Epithelium;Exhibits;FGF10 gene;Family;Feedback;Fibroblast Growth Factor;Fibrosis;Future;Growth Factor;Health;Homeostasis;Lobe;Lung;Mediating;Mesenchymal;Mesenchymal Differentiation;Mesenchyme;Modeling;Mus;Neonatal;Patients;Phenotype;Physiological;Play;Pulmonary Emphysema;Reporting;Research Design;Respiratory physiology;Role;Signal Transduction;Smooth Muscle Myocytes;Testing;autocrine;fibroblast growth factor receptor 2b;in vivo;lung development;member;mouse model;neonatal death;novel strategies;older patient;premature;prevent;progenitor;repaired","Growth Factors in Lung Development","n/a","NHLBI","8212231","2/24/2012 12:00:00 AM","PA-07-070","5R01HL086322-05","5","R01","HL","086322","05"," ","LIN, SARA","2/1/2008 12:00:00 AM","1/31/2014 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","6949975","BELLUSCI, SAVERIO ","Not Applicable","28","Unavailable","052277936","DVL1CMRMWRN9","052277936","DVL1CMRMWRN9","US","34.098065","-118.29069","1520001","CHILDREN'S HOSPITAL OF LOS ANGELES","LOS ANGELES","CA","Independent Hospitals","900276062","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2014 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","285483","165103"," ","450586",
"Cancer; Pancreatic Cancer; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Adipocytes;Affect;Automobile Driving;Blood Vessels;Cell Differentiation process;Cell Proliferation;Cells;Cellular biology;Clinical;Data;Development;Endocrine;Endothelial Cells;Exhibits;Generations;Genetic;Healed;Health;Human;In Vitro;Injury;Islets of Langerhans;Malignant Neoplasms;Mesenchymal;Mesenchymal Stem Cells;Modeling;Mus;NGFR Protein;Natural regeneration;Nature;Neoplasm Metastasis;Nerve Growth Factor Receptors;Neuroendocrine Tumors;Neurons;Normal tissue morphology;Pancreas;Pathway interactions;Pericytes;Population;Premalignant;Production;Property;Publishing;Receptor Protein-Tyrosine Kinases;Regulation;Reporter;Role;Signal Transduction;Specimen;Stem cells;System;Testing;Tissues;Transgenic Organisms;Tumor Expansion;Xenograft Model;angiogenesis;base;cell type;diabetic patient;healing;in vivo;injured;islet;neovascularization;novel;pancreatic tumorigenesis;progenitor;public health relevance;response;self-renewal;therapeutic target;tissue regeneration;tissue repair;tumor;tumor progression;tumor xenograft;tumorigenesis;wound","Multipotential mesenchymal stem cell-like cells in pancreatic tumorigenesis","
Health Relevance
We propose MPMSC in tumors enhance angiogenesis and eventually metastases and thus provide therapeutic
targets in cancer as a response to tissue injury. On the other hand, the potential plasticity and self-renewal
capacity as well as the islet-specific properties of MPMSC offers a huge potential for clinical tissue
regeneration, for example in diabetic patients.","NCI","8245029","3/22/2012 12:00:00 AM","PA-10-067","5R01CA154383-02","5","R01","CA","154383","02"," ","MOHLA, SURESH","4/1/2011 12:00:00 AM","3/31/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-OBT-M(02)]"," ","7855732","BERGERS, GABRIELE ","Not Applicable","12","NEUROSURGERY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","113088"," ","320588",
"Diabetes; Digestive Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Address;Allogenic;Allografting;Biological Markers;Bone Marrow Aspiration;Chronic;Clinical;Clinical Trials;Coupled;Data;Dendritic Cells;Dose;Engraftment;Event;Goals;Human;Hyperglycemia;Immunity;Immunosuppression;Inflammation;Inflammatory;Instruction;Insulin;Insulin-Dependent Diabetes Mellitus;Intravenous infusion procedures;Islets of Langerhans Transplantation;Lead;Liver;Macaca fascicularis;Maintenance;Marrow;Mediating;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Metabolic Control;Modeling;Monitor;Organ Donor;Outcome;Protocols documentation;Publishing;Regulatory T-Lymphocyte;Rodent;Site;Solid;Source;T cell regulation;Testing;Time;Transplantation;Waiting Lists;allograft rejection;base;graft function;improved;intrahepatic;intravenous administration;islet;islet allograft;kidney allograft;lymph nodes;macrophage;migration;monocyte;nonhuman primate;precursor cell;programs;prospective;regenerative;response","Mesenchymal stem cell enhancement of islet engraftment and long term survival","RELEVANCE (See instmctions); 
Islet cell transplantation reverses hyperglycemia and normalizes metabolic control. However, broader application to the cure of type 1 diabetes has been limited by the requirement for chronic immunosuppression and the scarcity of organ donors. MSC delivery with the islets may limit inflammation, enhance islet revascularization and reduce the number of donors needed to achieve insulin independence. 
Furthermore, MSC administration may constitute a safe and effective way to reverse rejection episodes.","NIAID","8379596","7/20/2012 12:00:00 AM","PAR-10-271","5P01AI089556-02","5","P01","AI","089556","02"," "," "," "," ","ZAI1-MFH-I","7979","1859488","KENYON, NORMA S.","Not Applicable","27","Unavailable","052780918","F8THLJQSAF93","052780918","F8THLJQSAF93","US","25.775337","-80.209809","5221250","UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","CORAL GABLES","FL","Domestic Higher Education","331462926","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","1332288","1332288"," ","975752","356536"," "," ",
"Acute Respiratory Distress Syndrome; Clinical Research; Lung; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Acute Lung Injury;Adult Respiratory Distress Syndrome;Advisory Committees;Air;Allogenic;Alveolar;Anti-Inflammatory Agents;Anti-inflammatory;Area;California;Cardiovascular system;Carrier Proteins;Cell Therapy;Critical Care;Edema;Endotoxins;Environmental air flow;Epithelial;Functional disorder;Genes;Genetic Transcription;Goals;Grant;Growth Factor;Hepatocyte Growth Factor;Human;In Vitro;Individual;Inflammatory;Inflammatory Response;Injury;Innovative Therapy;Interleukin-10;Lead;Liquid substance;Lung;Membrane Protein Traffic;Mesenchymal;Mesenchymal Stem Cells;Methods;Modeling;Molecular Biology;Multiple Abnormalities;Mus;Nature;Pathogenesis;Patients;Permeability;Plasmids;Preparation;Property;Proteins;Pulmonary Edema;Recombinant Proteins;Research;Research Institute;Research Personnel;Resolution;Role;San Francisco;Severities;Small Interfering RNA;Sodium;Stem cells;Stimulus;Stromal Cells;Testing;Therapeutic;Therapeutic Effect;Transfection;Translations;Type II Epithelial Receptor Cell;Universities;Whole Blood;anakinra;base;clinically relevant;cytokine;improved;in vitro Model;in vivo;injured;innovation;insight;keratinocyte;lung injury;monolayer;mortality;overexpression;paracrine;programs;public health relevance;response;skills","Mesenchymal Stem Cells for Treatment of Acute Lung Injury","n/a","NHLBI","8307335","7/23/2012 12:00:00 AM","PA-06-512","5K08HL093026-05","5","K08","HL","093026","05"," ","COLOMBINI-HATCH, SANDRA","8/4/2008 12:00:00 AM","7/31/2013 12:00:00 AM","ZHL1-CSR-O(M1)"," ","9141159","LEE, JAE WOO","Not Applicable","12","ANESTHESIOLOGY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","838","Other Research-Related","2012"," "," ","NHLBI","112750","9020"," ","121770",
"Brain Disorders; Hematology; Neurosciences; Pediatric; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Stroke; Transplantation","Address;Adult;Angiogenic Factor;Animals;Antibodies;Autologous Transplantation;Behavior;Biological Assay;Blood;Blood - brain barrier anatomy;Bone Marrow;Bone Marrow Stem Cell;Bone Marrow Transplantation;Brain;Brain region;Cardiovascular Surgical Procedures;Cell Death;Cell Survival;Cells;Central Nervous System Diseases;Cerebrovascular Circulation;Data;Effectiveness;Environment;Enzyme-Linked Immunosorbent Assay;Ethical Issues;Exhibits;Exposure to;Future;Goals;Graft Rejection;Grant;Home environment;Homing;Hypoxia;In Vitro;Investigation;Ischemia;Ischemic Stroke;Journals;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Modeling;Neonatal;Neurologic;Outcome;Paper;Pathway interactions;Physical therapy;Process;Published Comment;Publishing;Rattus;Recovery;Recovery of Function;Research;Research Personnel;Sensorimotor functions;Signal Transduction;Staining method;Stains;Stem cell transplant;Stem cells;Stroke;Survival Rate;Testing;Therapeutic;Thoracic Surgical Procedures;Transplantation;Vascular Endothelial Growth Factors;Vascularization;Vibrissae;Western Blotting;Work;Writing;angiogenesis;barrel cortex;cell type;editorial;effective therapy;functional improvement;improved;in vivo;mature animal;mortality;neonatal human;neonate;neurogenesis;novel;novel strategies;novel therapeutic intervention;optical imaging;preconditioning;public health relevance;regenerative;relating to nervous system;repaired;response;stroke therapy;tissue repair","Transplantation of Pre-conditioned Bone Marrow Mesenchymal Stem Cells after Ische","
 A combination strategy will be tested to improve the cell survival quality and
regenerative capacities of transplanted bone marrow mesenchymal stem cells (BMSCs)
after rat neonatal ischemic stroke. We will address three key issues in BMSC
transplantation: 1) to promote survival of BMSCs after transplantation; 2) to promote
endogenous regenerative responses; 3) to guide and improve the repair process and
functional recovery in the whisker-barrel pathway after BMSC transplantation.","NINDS","8214596","1/27/2012 12:00:00 AM","PA-07-303","5R01NS062097-03","5","R01","NS","062097","03"," ","OWENS, DAVID F","2/1/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Developmental Brain Disorders Study Section[DBD]"," ","1948733","WEI, LING ","Not Applicable","05","ANESTHESIOLOGY","066469933","S352L5PJLMP8","066469933","S352L5PJLMP8","US","33.762977","-84.42296","2384501","EMORY UNIVERSITY","ATLANTA","GA","SCHOOLS OF MEDICINE","303224250","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","214375","117906"," ","332281",
"Biotechnology; Cancer; Genetics; Pediatric; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human","Adhesions;Adolescent;Affect;Apoptosis;Biological Assay;Biology;Bone Tissue;CDKN2A gene;Cancer Biology;Cell Adhesion;Cell Cycle Arrest;Cell Line;Cells;Cessation of life;Characteristics;Child;DNA;DNA Methylation;Data;Development;Disease;EWS-FLI1 fusion protein;Engraftment;Environment;Epigenetic Process;Ewings sarcoma;Extracellular Matrix;Family;Fibroblasts;Gene Silencing;Gene Targeting;Genes;Genetic Transcription;Goals;Growth;Human;In Vitro;Link;Maintenance;Malignant - descriptor;Malignant Neoplasms;Mediating;Mesenchymal;Mesenchymal Differentiation;Mesenchymal Stem Cells;Methylation;Modality;Modeling;Molecular;Mus;Neoplasm Metastasis;Neural Crest;Normal Cell;Oncogenes;Oncogenic;PRC1 Protein;Pathway interactions;Patients;Polycomb;Proto-Oncogenes;Repression;Research;Role;Site;Soft Tissue Neoplasms;Specific qualifier value;Stem cells;Testing;Therapeutic Intervention;Toxic effect;Tumor Suppression;Tumor Suppressor Proteins;Tumorigenicity;Xenograft procedure;base;cancer cell;cellular targeting;chromatin immunoprecipitation;clinically relevant;expression vector;human embryonic stem cell;in vivo;innovation;insight;mutant;new therapeutic target;novel;prevent;programs;promoter;public health relevance;self-renewal;senescence;stem cell differentiation;therapeutic target;transcription factor;tumor;tumor initiation;tumor progression;tumorigenesis;young adult","Investigating Oncogenic Cooperation between BMI-1 and EWS-FLI1","
PROJECT NARRATIVE
Ewing sarcoma family tumors (ET) are highly aggressive bone and soft tissue tumors that primarily affect
children, adolescents, and young adults. Novel therapies are desperately needed, particularly for patients with
metastatic disease in whom survival is rare despite aggressive, multi-modality treatment. The studies outlined
in this proposal will offer new insights into the putative stem cell origins and underlying biology of these
aggressive tumor with a goal of identifying novel stem cell pathway targets that can be exploited for therapeutic
intervention.","NCI","8256673","4/30/2012 12:00:00 AM","PA-07-070","5R01CA134604-03","5","R01","CA","134604","03"," ","AULT, GRACE S","6/10/2010 12:00:00 AM","4/30/2015 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","8554243","LAWLOR, ELIZABETH R","Not Applicable","12","PEDIATRICS","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","201275","111708"," ","312983",
"Biotechnology; Breast Cancer; Cancer; Genetics","Animal Model;Animals;Biochemical;Biological Assay;Biological Models;Breast Cancer Cell;Cancer cell line;Candidate Disease Gene;Cell Line;Cessation of life;Complex;Data;Disseminated Malignant Neoplasm;Distant;E-Cadherin;Ectopic Expression;Engineering;Epithelial;Epithelial Cells;Family;Gene Expression Profiling;Gene Targeting;Genes;Genetic;Genomics;In Vitro;Invaded;Laboratories;Lead;Lesion;Malignant Epithelial Cell;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Mass Spectrum Analysis;Mediating;Mesenchymal;Metastatic to;Methods;Methyl-CpG-Binding Protein 2;MicroRNAs;Molecular;Mouse Mammary Tumor Virus;Mus;Neoplasm Metastasis;New Agents;Oncogenes;Organ;Pathologic Processes;Phenotype;Physiological;Physiology;Play;Prevention;Primary Neoplasm;Process;Proteomics;Regulator Genes;Research;Role;Site;Staging;Testing;Therapeutic;Tissues;Transgenic Mice;Validation;Xenograft procedure;epithelial to mesenchymal transition;gene function;improved;in vivo;in vivo Model;inhibitor/antagonist;insight;interdisciplinary approach;interest;malignant breast neoplasm;migration;mouse model;neoplastic cell;novel;overexpression;public health relevance;research study;tumor;tumor progression;tumorigenesis","The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis","
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
Project Narrative/Relevance
Over 90% of cancer related deaths are due to the metastatic spread of primary tumor cells to distant
vital organs. Epithelial-mesenchymal transition (EMT) and the reverse process, MET, have been
postulated to be important processes for tumor cells to gain the ability to migrate and invade into their
surrounding tissue and to regain their epithelial phenotype to facilitate colonization once they reach
the target organs. This study will investigate how microRNAs, a novel class of genetic regulators,
regulate EMT and will provide some of the best evidence to date as to whether EMT can promote
early dissemination of tumor cells while MET may be essential for efficient colonization of distant
target organs.","NCI","8264374","3/20/2012 12:00:00 AM","PA-07-070","5R01CA141062-03","5","R01","CA","141062","03"," ","JHAPPAN, CHAMELLI","4/1/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","8327393","KANG, YIBIN ","Not Applicable","12","BIOCHEMISTRY","002484665","NJ1YPQXQG7U5","002484665","NJ1YPQXQG7U5","US","40.12273","-74.703461","6661401","PRINCETON UNIVERSITY","Princeton","NJ","SCHOOLS OF ARTS AND SCIENCES","085406000","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","201275","117932"," ","319207",
"Biotechnology; Cancer","Adaptor Signaling Protein;Adhesions;Biochemical;Biological Assay;Biological Models;Breast;Cancer cell line;Cardiovascular system;Cells;Cellular Morphology;Characteristics;Clathrin;Complex;Cytoskeleton;Data;Detection;Developmental Process;Disseminated Malignant Neoplasm;Distant;Endocytosis;Epithelial;Epithelial Cells;Equilibrium;Exocytosis;Extracellular Matrix;Family;Focal Adhesions;Future;Gel;Gelatin;Gelatinase A;Guanosine Triphosphate Phosphohydrolases;Imaging Techniques;Immunofluorescence Microscopy;In Situ;In Vitro;Individual;Intervention;Malignant Neoplasms;Mammary Neoplasms;Matrix Metalloproteinases;Mediating;Mesenchymal;Mesenchymal Cell Neoplasm;Modeling;Molecular Analysis;Monitor;Morphology;Mus;Neoplasm Metastasis;Organ;Pathway interactions;Patients;Phenotype;Population;Positioning Attribute;Primary Neoplasm;Prognostic Factor;Protein Overexpression;Proteins;RNA Interference;Recycling;Regulation;Relative (related person);Reporter;Research;Role;Scaffolding Protein;Secondary to;Signal Pathway;Signal Transduction;Site;Surveys;System;Testing;Therapeutic;Time;Tumor Cell Invasion;Tumor Cell Line;Up-Regulation;Vesicle;Xenograft procedure;cancer cell;cell motility;clinically relevant;fluorescence imaging;in vitro Model;in vivo;inhibitor/antagonist;insight;migration;mortality;mutant;neoplastic cell;novel;novel strategies;overexpression;paxillin;protein expression;rho;trafficking;tumor;tumor progression","Paxillin and Hic-5 in Coordination of Cancer Cell Invasion Mechanisms"," Tumor cell invasion and metastasis to secondary sites is the single worst prognostic factor dictating patient long-term survival.  The ability of tumor cells to switch between distinct modes of migration, called plasticity, is an important factor in the limited efficacy of invasion-directed therapeutics.  The signaling mechanisms mediating cancer cell plasticity remain poorly understood.  The proposed research will describe new roles for two closely related adhesion associated adaptor proteins, paxillin and Hic-5, in the regulation of cancer cell migration, plasticity and matrix-metalloproteinase function and thereby increase our understanding of cancer progression, malignancy and metastasis.  
    

","NCI","8216208","4/24/2012 12:00:00 AM","PA-10-067","1R01CA163296-01","1","R01","CA","163296","01"," ","SNYDERWINE, ELIZABETH G","5/1/2012 12:00:00 AM","3/31/2017 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1883199","TURNER, CHRISTOPHER E","Not Applicable","24","ANATOMY/CELL BIOLOGY","058889106","HYN3WD58HNN7","058889106","HYN3WD58HNN7","US","43.030473","-76.125697","5992619","UPSTATE MEDICAL UNIVERSITY","SYRACUSE","NY","SCHOOLS OF MEDICINE","132102306","UNITED STATES","N","5/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","123463"," ","330963",
"Chronic Liver Disease and Cirrhosis; Clinical Research; Digestive Diseases; Liver Disease","Address;Adenovirus Vector;Agonist;Apoptosis;Benign;Biological Models;Cell Count;Cell Proliferation;Cells;Chronic;Cicatrix;Cirrhosis;Cytoskeletal Proteins;Dominant-Negative Mutation;Epithelial;Erinaceidae;Etiology;Event;Fatty acid glycerol esters;Gene Expression;Genetic;Goals;Growth;Health;Hepatic;Hepatic Stellate Cell;Hepatocyte;In Vitro;Injury;Liver;Liver Dysfunction;Mediating;Mediator of activation protein;Mesenchymal;Morbidity - disease rate;Pathogenesis;Pathway interactions;Phenotype;Population;Principal Investigator;Process;Proteins;Publications;Signal Transduction;Stem cells;Toxin;Transgenic Animals;United States;epithelial to mesenchymal transition;in vivo Model;mortality;novel;regenerative;response;smoothened signaling pathway;stellate cell","Rac1 Promotes Hepatic Stellate Accumulation/Activation in Liver Injury","n/a","NIDDK","8293274","5/22/2012 12:00:00 AM","PA-06-512","5K08DK080980-04","5","K08","DK","080980","04"," ","PODSKALNY, JUDITH M,","7/22/2009 12:00:00 AM","6/30/2014 12:00:00 AM","Digestive Diseases and Nutrition C Study Section[DDK-C]"," ","8097400","CHOI, STEVE S","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Other Research-Related","2012"," "," ","NIDDK","106261","8501"," ","114762",
"Aging; Cancer; Prostate Cancer; Urologic Diseases","Address;Bone Diseases;Cessation of life;Collaborations;Complex;Distal;Epithelial Cells;Evolution;Genes;Genetic;Genetic Programming;Glucose;Glycolysis;Host Defense;Human;Hypoxia;Laboratories;Malignant neoplasm of prostate;Mesenchymal;Metabolism;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Mitochondria;Myofibroblast;Organ;Process;Production;Prostate;Prostatic Neoplasms;Regulation;Role;Signal Transduction;Stromal Cells;Tissues;Variant;angiogenesis;bone;cancer cell;cell type;driving force;effective therapy;epithelial to mesenchymal transition;information gathering;migration;mouse model;new therapeutic target;oxidation;programs;treatment strategy;tumor","Determining the Functional Contribution of Prostate Tumor Microenvironment in Bon","n/a","NCI","8555537","10/12/2012 8:49:51 AM","RFA-CA-10-021","5U54CA163191-02","5","U54","CA","163191","02"," "," ","9/26/2011 12:00:00 AM","8/2/2012 12:00:00 AM","ZCA1-SRLB-3(O1)","5443","1858925","KALLURI, RAGHU ","Not Applicable","07","Unavailable","071723621","C1CPANL3EWK4","071723621","C1CPANL3EWK4","US","42.346758","-71.10256","758101","BETH ISRAEL DEACONESS MEDICAL CENTER","BOSTON","MA","Independent Hospitals","022155400","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","287562","287562"," ","192480","95082"," "," ",
"No NIH Category available","Address;Bone Diseases;Cessation of life;Collaborations;Complex;Distal;Epithelial Cells;Evolution;Genes;Genetic;Genetic Programming;Glucose;Glycolysis;Host Defense;Human;Hypoxia;Laboratories;Malignant neoplasm of prostate;Mesenchymal;Metabolism;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Mitochondria;Myofibroblast;Organ;Process;Production;Prostate;Prostatic Neoplasms;Regulation;Role;Signal Transduction;Stromal Cells;Tissues;Variant;angiogenesis;bone;cancer cell;cell type;driving force;effective therapy;epithelial to mesenchymal transition;information gathering;migration;mouse model;new therapeutic target;oxidation;programs;treatment strategy;tumor","Determining the Functional Contribution of Prostate Tumor Microenvironment in Bon","n/a","NCI","8580857","2/12/2013 12:00:00 AM","RFA-CA-10-021","7U54CA163191-03","7","U54","CA","163191","03"," "," "," "," ","ZCA1-SRLB-3","5443","1858925","KALLURI, RAGHU ","Not Applicable","09","Unavailable","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","Domestic Higher Education","770304009","UNITED STATES","N","12/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","522160","522160"," ","290450","231710"," "," ",
"Osteoporosis","Area;Biochemical;Biological Process;Biology;Bone Development;Bone Diseases;Bone Growth;Bone Marrow;Bone Morphogenetic Proteins;Cell Differentiation process;Cell Nucleus;Cell physiology;Cells;Complex;Data;Development;Differentiation and Growth;Event;Gene Expression;Gene Targeting;Genomics;Goals;Health;Human;Investigation;Knock-out;Lead;MADH4 gene;Malignant Neoplasms;Mediating;Mesenchymal Differentiation;Mesenchymal Stem Cells;Molecular;Mus;Osteogenesis;Osteoporosis;Pathway interactions;Phosphoric Monoester Hydrolases;Phosphorylation;Physiological;Prevention;Property;Protein Dephosphorylation;Protein Serine/Threonine Phosphatase;Protein phosphatase;Proteins;Publishing;Pulmonary Hypertension;Regulation;Research;Research Proposals;Role;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Smad Proteins;Smad protein;Transducers;base;bone morphogenetic protein receptor type I;bone morphogenetic protein receptors;cell growth;human disease;insight;member;novel;novel therapeutic intervention;nucleocytoplasmic transport;osteoblast differentiation;receptor;research study;response;trafficking;transcription factor","Roles of Smad1 Dephosphorylation in Osteoblast Differentiation","n/a","NIAMS","8308683","8/4/2012 12:00:00 AM","PA-07-070","5R01AR053591-05","5","R01","AR","053591","05"," ","CHEN, FAYE H","8/1/2008 12:00:00 AM","5/31/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","6486094","FENG, XIN-HUA ","Not Applicable","09","SURGERY","051113330","FXKMA43NTV21","051113330","FXKMA43NTV21","US","29.711148","-95.39695","481201","BAYLOR COLLEGE OF MEDICINE","HOUSTON","TX","SCHOOLS OF MEDICINE","770303411","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","188179","100676"," ","288855",
"Pediatric; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Animal Model;Anterior;Area;Caliber;Cartilage;Cell Communication;Cells;Chick Embryo;Communication;Complement;Congenital Abnormality;Defect;Development;Digit structure;Elements;Embryo;Event;Foundations;Genes;Genetic;Human;Image;Imaging technology;Knowledge;Label;Laboratories;Lead;Length;Life;Ligands;Limb Bud;Limb structure;Membrane;Mesenchymal;Mesenchymal Stem Cells;Mesenchyme;Microscopy;Molecular;Monitor;Morphogenesis;Movement;Mus;Mutate;Pattern;Physical condensation;Population;Process;Proteins;Reporter;Research;Research Personnel;Resolution;Shapes;Signal Pathway;Signal Transduction;Skeletal Development;Sonic hedgehog protein;Source;Specimen;Staining method;Stains;Structure;Syndrome;Testing;Time;Tissues;base;cartilage development;cellular imaging;chondrodysplasia;human SMO protein;in vivo;malformation;novel;novel strategies;progenitor;research study;skeletal;tissue fixing;trafficking;transmission process","Vertebrate cytonemes in cell signaling and skeletal morphogenesis"," Abnormalities of the human limb are one of the most common human birth defects, yet little is known as to the cellular changes underlying these congenital malformations. The research proposed in this application will significantly advance the understanding of the underlying causes for these birth defects and help to lay the foundation for developing cellular and pharmacological based approaches for the treatment of congenital limb malformations.  
  
    

","NIAMS","8332844","8/13/2012 12:00:00 AM","PA-10-069","5R21AR062262-02","5","R21","AR","062262","02"," ","TYREE, BERNADETTE","9/15/2011 12:00:00 AM","1/7/2013 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","10597583","BARNA, MARIA ","Not Applicable","12","BIOCHEMISTRY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","9/1/2012 12:00:00 AM","1/7/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","56859","30989"," ","87848",
"Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Binding;Binding Sites;Biological Assay;Bromodeoxyuridine;Cartilage;Cartilage Diseases;Cartilage injury;Cell Differentiation process;Cell Maintenance;Cell Nucleus;Cell surface;Cells;Chondrocytes;Chondrogenesis;Clinical Treatment;Co-Immunoprecipitations;Complex;Data;Degenerative polyarthritis;Development;Differentiation Antigens;Disease;Embryo;Family;Fracture;Gel;Gene Targeting;Genes;Genetic;Goals;Histology;Immunohistochemistry;In Situ Hybridization;In Situ Nick-End Labeling;In Vitro;Injury;Ligands;Limb structure;Luciferases;Maintenance;Mediating;Membrane;Mesenchymal;Mesenchymal Stem Cells;Mesenchyme;Methodology;Methods;Mus;Mutate;Notch Signaling Pathway;Pathway interactions;Preparation;Process;Proteins;Regulation;Reverse Transcriptase Polymerase Chain Reaction;Rheumatoid Arthritis;Role;Rosa;Signal Pathway;Signal Transduction;Signaling Molecule;Staging;Staining method;Stains;Testing;Time;Tissue Engineering;Tissues;base;beta catenin;cartilage development;cartilage repair;gain of function;gamma secretase;in vitro Assay;in vivo;loss of function;mouse model;mutant;mutant mouse model;notch protein;novel;progenitor;promoter;protein complex;public health relevance;research study;skeletal;therapeutic target;tool","Notch Signaling in Cartilage Development","
Project Narrative:
We have identified the RBPJk-dependent Notch pathway as an important regulator of MPC differentiation and
chondrocyte maturation. Our proposal will determine the exact Notch signaling mechanisms responsible for
suppressing chondrogenic commitment from mesenchymal progenitor cells (MPCs) and for promoting
chondrocyte maturation. Data generated by this proposal will likely implicate specific Notch signaling
molecules as potential therapeutic targets for cartilage related injuries and diseases, as well as, provide
potential tools in MPC maintenance and expansion for use in tissue engineering applications.","NIAMS","8256561","4/13/2012 12:00:00 AM","PA-07-070","5R01AR057022-03","5","R01","AR","057022","03"," ","TYREE, BERNADETTE","7/2/2010 12:00:00 AM","4/30/2015 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","9241093","HILTON, MATTHEW J.","Not Applicable","25","ORTHOPEDICS","041294109","F27KDXZMF9Y8","041294109","F27KDXZMF9Y8","US","43.16888","-77.615939","7047101","UNIVERSITY OF ROCHESTER","ROCHESTER","NY","SCHOOL OF MEDICINE & DENTISTRY","146270140","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","216000","117720"," ","333720",
"Biodefense; Biotechnology; Digestive Diseases; Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Abdomen;Acceleration;Acute;Agonist;Animals;Apoptosis;Biological Markers;Biological Models;Blood Transfusion;Bone Marrow;Bone Marrow Transplantation;Cell Culture Techniques;Cell Death;Cell Differentiation process;Cell Proliferation;Cell Therapy;Cells;DNA Damage;Defect;Dehydration;Dose;Endothelial Cells;Enterocytes;Exposure to;Financial compensation;Goals;Growth;Growth Factor;Hematopoietic;Hemorrhage;Histopathology;Homeostasis;Hour;In Situ;Infection;Infection prevention;Inflammation Mediators;Injury;Intestinal Mucosa;Intestines;Ionizing radiation;Ligands;Lymphocyte;Macrophage Activation;Mediating;Mesenchymal;Mesenchymal Stem Cells;Modeling;Molecular Target;Mus;Natural regeneration;Organ;Plasma;Proliferating;Proteomics;Radiation;Radiation Syndromes;Radiation Toxicity;Radiation therapy;Radio;Radioprotection;Receptor Activation;Receptor Signaling;Replacement Therapy;Sepsis Syndrome;Septic Shock;Signal Pathway;Signal Transduction;Solid;Stem cells;Stromal Cells;Supporting Cell;Supportive care;Syndrome;Therapeutic;Tissue Model;Tissues;Toll-like receptors;Transplantation;Validation;base;bone morphogenetic protein 4;cell growth;cell injury;crypt cell;cytokine;gastrointestinal;gastrointestinal function;improved;intestinal crypt;irradiation;macrophage;metabolomics;microbial;pathogen;regenerative;regenerative therapy;repaired;research study;response;stem cell niche","Stem Cell-Based Therapies for Radiation-Induced Gastrointestinal Sydrome (RIGS)","Cell based therapies raise hope as transplantation of bone marrow stromal cells mitigate RIGS, 24 hrs after exposure to 18 Gy whole abdominal irradiation. Ideal therapy for RIGS would be multimodal that stimulates ISC regeneration (R-spondinl) and restores the Gl mucosal integrity; provides supportive therapy to prevent infection and dehydration; and induces repopulation ofthe intestinal and mesenchymal stem cells.","NIAID","8382571","7/27/2012 12:00:00 AM","RFA-AI-09-036","5U19AI091175-03","5","U19","AI","091175","03"," "," "," "," ","ZAI1-KS-I","6788","7274991","GUHA, CHANDAN ","Not Applicable","14","Unavailable","110521739"," ","110521739"," ","US","40.851026","-73.844361","9433501","ALBERT EINSTEIN COLLEGE OF MEDICINE","BRONX","NY","Domestic Higher Education","104611900","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","443011","443011"," ","443011","0"," "," ",
"Aging; Hematology; Osteoporosis; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adipocytes;Age-Related Bone Loss;Animals;Biological;Bone Diseases;Bone Injury;Bone Marrow;Bone Marrow Diseases;Bone Matrix;Bone Regeneration;Cell Cycle Kinetics;Cell Lineage;Cells;Characteristics;Chondrocytes;Clinical;Degenerative Disorder;Disease;Disease Progression;Fracture;Fracture Healing;Genes;Genetic;Genetically Engineered Mouse;Goals;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;Homeostasis;Image;In Vitro;Inherited;Injury;Label;Life;Longevity;Maintenance;Maps;Mesenchymal;Mesenchymal Stem Cells;Modeling;Molecular;Myxovirus;Nature;Neoplasm Metastasis;Osteoblasts;Osteocytes;Osteoporosis;Pathway interactions;Pericytes;Phenotype;Physiologic pulse;Physiological;Play;Population;Process;Proliferating;Recovery;Regulation;Reporter;Resistance;Role;Series;Site;Skeleton;Source;Specific qualifier value;Staging;Stem Cell Development;Stem cell transplant;Stem cells;Stress;Surface;Techniques;Testing;Therapeutic;Time;Tissues;Transplantation;base;bone;bone cell;bone loss;cellular targeting;clinically relevant;improved;in vivo;insight;intravital microscopy;leukemia;meetings;mouse model;nestin protein;osteogenic;osteoprogenitor cell;progenitor;promoter;regenerative;repaired;research study;response to injury;restoration;skeletal;skeletal regeneration;stem;tissue regeneration;tissue repair","Role of osteogenic stem cells in bone regeneration and repair in vivo"," Mesenchymal cell kinetics are relevant for most tissues and of particular importance in bone and bone marrow where skeletal mesenchymal cells play critical roles in regulating regenerative processes and disease progression. Bone matrix is known to turnover rapidly, but the dynamics of bone producing and remodeling cells are less well defined. We recently examined the lifespan of bone-forming osteoblasts and their source of replacement under homeostatic and injury conditions. Using newly developed genetic pulse-chase models in combination with sequential intravital microscopy, we discovered a short lifespan and unexpected dynamics of osteoblasts in vivo. Additionally, we found a population of progenitors that have the multilineage potential of MSC in vitro but have no such function in vivo. Rather, this population serves as osteolineage-restricted stem/progenitors in normal homeostasis and after bone injury. Therefore, we seek to examine the role of mature osteoblasts and their stem cells in controlling tissue regeneration and repair in physiologic circumstances. We also propose to examine the clinical benefit of osteogenic stem cells upon transplantation in bone disease conditions. The proposed experiments will elucidate: (1) the in vivo characterization of osteogenic stem cells, (2) the recovery of bone fracture by transplantation of osteogenic stem cells, and (3) the role of osteogenic stem cells in bone loss diseases. Overall, these three clinically relevant aims will further define new biological and clinical insights of osteogenic stem cells in physiological conditions.   
   
      

","NIAMS","8384424","7/27/2012 12:00:00 AM","PA-11-190","1K01AR061434-01A1","1","K01","AR","061434","01","A","WANG, FEI","8/1/2012 12:00:00 AM","7/31/2017 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","10663608","PARK, DONGSU ","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","122000","9760"," ","131760",
"Cancer; Digestive Diseases; Pancreatic Cancer; Rare Diseases","Adenocarcinoma;Adenocarcinoma Cell;Benign;Biological;Cadherins;Cell Communication;Cells;Clinical Research;Collagen;Deposition;Disease;Distant;Environment;Epithelial Cells;Evolution;Genetic;Genetically Engineered Mouse;Goals;Growth;Human;In Vitro;Individual;Knock-out;Malignant Neoplasms;Malignant neoplasm of pancreas;Mediating;Mesenchymal;Modeling;Molecular;N-Cadherin;Neoplasm Metastasis;Organ;Pancreas;Pancreatic Adenocarcinoma;Relative (related person);Role;Signal Transduction;Staging;Stromal Cells;Stromal Neoplasm;Testing;Tissues;Tumor Cell Invasion;Up-Regulation;Work;Xenograft Model;base;cancer invasiveness;cell behavior;cell motility;epithelial to mesenchymal transition;implantation;macrophage;mouse model;neoplastic cell;pancreatic neoplasm;stellate cell;tumor;tumor progression;tumorigenesis","Role of N-Cadherin in Pancreatic Tumor Microenvironment","n/a","NCI","8555506","10/12/2012 10:29:30 AM","RFA-CA-10-021","5U54CA163120-02","5","U54","CA","163120","02"," "," ","9/26/2011 12:00:00 AM","7/31/2016 12:00:00 AM","ZCA1-SRLB-3(O1)","5413","1861000","JOHNSON, KEITH R","Not Applicable","02","Unavailable","168559177","G15AG3BLLMH4","168559177","G15AG3BLLMH4","US","41.26545","-96.039767","578104","UNIVERSITY OF NEBRASKA MEDICAL CENTER","OMAHA","NE","Domestic Higher Education","681987835","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","172434","172434"," ","116117","56317"," "," ",
"Bioengineering; Nanotechnology","Adhesions;Affect;Area;Behavior;Biochemical Process;Biological;Cell Differentiation process;Cell Line;Cell physiology;Cells;Characteristics;Complex;Devices;Dimensions;Disease;Elastomers;Event;Focal Adhesions;Frequencies;Generations;Goals;Grant;Knock-out;Link;Longitudinal Studies;Measurement;Measures;Mechanics;Mesenchymal Stem Cells;Molecular;Molecular Models;Movement;Mutation;Natural regeneration;Pattern;Pharmaceutical Preparations;Play;Process;Property;Research Personnel;Role;Site;Surface;Techniques;Testing;Time;Ursidae Family;Work;base;chemical property;inhibitor/antagonist;molecular modeling;molecular scale;mutant;nanometer;research study;response;stem cell differentiation;submicron;tool","Analyses of 120nm Local Contractions Linked to Rigidity Sensing"," The purpose of the proposed work is to understand the molecular basis of newly- discovered local contractions and their role in cellular rigidity sensing. We will employ arrays of elastomer pillars with sub-micron dimensions for force measurements; examine how these local contractions are modified in cells with modified ability to sense rigidity; and study long-term differentiation in mesenchymal stem cells.    
    

","NIGMS","8222563","8/31/2012 12:00:00 AM","PA-10-067","1R01GM100282-01","1","R01","GM","100282","01"," ","NIE, ZHONGZHEN","9/1/2012 12:00:00 AM","8/31/2016 12:00:00 AM","Instrumentation and Systems Development Study Section[ISD]"," ","8377510","HONE, JAMES C","Not Applicable","13","ENGINEERING (ALL TYPES)","049179401","F4N1QNPB95M4","049179401","F4N1QNPB95M4","US","40.818766","-73.959562","1833202","COLUMBIA UNIV NEW YORK MORNINGSIDE","NEW YORK","NY","BIOMED ENGR/COL ENGR/ENGR STA","100276900","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","190000","101345"," ","291345",
"Biotechnology; HIV/AIDS; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Accounting;Adipocytes;Adult;Affect;Aging;Agriculture;Antibodies;Biological;Body Composition;Body Weight;Body Weight decreased;CCAAT-Enhancer-Binding Proteins;Cattle;Cell Cycle;Cell Differentiation Inhibition;Cell Differentiation process;Cell Line;Cell Nucleus;Cell Proliferation;Cells;Central obesity;Communication;Complementary DNA;Complex;Data;Differentiation Antigens;Dominant-Negative Mutation;Dose;Down-Regulation;EP300 gene;Fatty acid glycerol esters;Gene Targeting;Genes;Genetic Transcription;HIV;HIV Infections;Health;Human;In Vitro;Infection;Intramuscular;Investigation;Knockout Mice;Literature;Macaca;Marrow;Mediating;Mesenchymal;Mesenchymal Differentiation;Mesenchymal Stem Cells;Messenger RNA;Modeling;Molecular;Monkeys;Monoclonal Antibodies;Multipotent Stem Cells;Mus;Muscle;Mutation;Myoblasts;Myosin Heavy Chains;Nuclear Translocation;Obesity;Pathway interactions;Pharmacologic Substance;Phenotype;Phosphorylation;Physical Function;Placebos;Population;Primates;Principal Investigator;Protein Biosynthesis;Proteins;Randomized Controlled Trials;Recombinants;SIV;Signal Pathway;Signal Transduction;Skeletal Muscle;Stem cells;TCF7L2 gene;Testing;Therapeutic;Thinness;Time;Transforming Growth Factor beta;Vertebrates;beta catenin;experience;in vivo;in vivo Model;inhibitor/antagonist;insight;interest;lipid biosynthesis;mRNA Expression;multipotent cell;muscle form;myostatin;novel;oil red O;programs;protein expression;research study;sarcopenia;satellite cell;stem cell differentiation;wasting","Mechanism of Myostatin Action","
Program Director/Principal Investigator: Bhasin, Shalender
PROJECT NARRATIVE
Myostatin is being explored as an attractive target for the discovery of function promoting anabolic therapies for
conditions associated with loss of muscle mass and physical function, such as HIV-associated weight loss and
wasting, and aging. This project aims to elucidate the mechanisms by which myostatin regulates skeletal
muscle and fat mass. We will test the hypothesis that myostatin regulates mesenchymal stem cell
differentiation through activation of the TGF-beta/SMAD pathway and cross-communication of the SMAD
signal to the Wnt/beta-catenin/TCF-4 pathway and thereby modulating myogenic and adipogenic
differentiation.","NIDDK","8230647","3/8/2012 12:00:00 AM","PA-07-070","5R01DK078512-04","5","R01","DK","078512","04"," ","HAFT, CAROL R","3/9/2009 12:00:00 AM","2/28/2014 12:00:00 AM","AIDS Clinical Studies and Epidemiology Study Section[ACE]"," ","8089691","BHASIN, SHALENDER ","Not Applicable","07","Unavailable","005492160","JZ8RQC4EMDZ5","005492160","JZ8RQC4EMDZ5","US","42.337865","-71.070685","3617301","BOSTON MEDICAL CENTER","BOSTON","MA","Independent Hospitals","021182908","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","580038","201466"," ","781504",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adult;Animal Model;Area;Biological Assay;Biology;Bone Marrow;Bone Marrow Cells;Bone Regeneration;Bone Tissue;Calvaria;Cell Fraction;Cell Lineage;Cell surface;Cells;Colony-forming units;Complex;Defect;Development;Environment;Equipment;Fibroblasts;Flow Cytometry;Flushing;Genes;Genetic;Goals;Growth Factor Gene;Histology;Image;Imagery;In Vitro;Knowledge;Maps;Mesenchymal Stem Cells;Mus;Osteoblasts;Photography;Population;Positioning Attribute;Process;Proliferating;Property;Reporter;Reporter Genes;Research;Running;Skeletal Development;Skeletal bone;Specificity;System;Testing;Tetanus Helper Peptide;Therapeutic;Time;Tissues;Transgenes;Transgenic Animals;Transgenic Mice;Transgenic Organisms;Transplantation;Treatment Efficacy;Work;adult stem cell;bone;bone cell;cell type;connective tissue growth factor;experience;immunocytochemistry;in vivo;long bone;magnetic beads;member;multipotent cell;regenerative;repaired;skeletal;skeletal tissue;stem cell population;substantia spongiosa;success;tissue repair","Animal Models to Study Bone Marrow Mesenchymal Stem Cells"," Bone marrow derived mesenchymal stem cells (BMSCs) are an intensively studied adult stem cell population that retain the ability to differentiate into different skeletal cell types. Therefore, BMSCs have great therapeutic value for skeletal tissue repair. The goal of this proposal focuses on establishing animal models that would allow for the accurate identification of BMSCs in bone tissue and determining their contribution to skeletal repair.  
    

","NIAMS","8337401","8/10/2012 12:00:00 AM","PA-10-069","5R21AR060899-02","5","R21","AR","060899","02"," ","WANG, FEI","9/22/2011 12:00:00 AM","8/31/2015 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","7013213","MAYE, PETER ","Not Applicable","05","DENTISTRY","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF DENTISTRY/ORAL HYGN","060305335","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2015 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","135000","71928"," ","206928",
"Aging; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Urologic Diseases","Adult;Affect;Aging;Amino Acids;Androgen Receptor;Androgens;Body Composition;Cell Differentiation process;Cell Nucleus;Cells;Chronic Disease;Chronic Obstructive Airway Disease;Clinical Trials;Communication;Data;Development;Dose;End stage renal failure;Epithelial Cells;Family member;Fatty acid glycerol esters;Follistatin;Funding;Gene Targeting;Genetic;Grant;Growth;HIV Infections;Health;In Vitro;Individual;Investigation;Label;Ligands;Link;MADH7 gene;Malignant neoplasm of prostate;Mediating;Mediator of activation protein;Mesenchymal;Mesenchymal Differentiation;Mesenchymal Stem Cells;Molecular;Multipotent Stem Cells;Mus;Muscle;Muscle Proteins;Muscle function;Pathway interactions;Performance;Pharmacologic Substance;Phosphorylation;Physical Function;Play;Principal Investigator;Prostate;Protein Biosynthesis;Receptor Signaling;Regulation;Role;Sales;Signal Pathway;Signal Transduction;Skeletal Muscle;Societies;Stanolone;Stem cells;Stream;Supplementation;System;TCF7L2 gene;Testing;Testosterone;Transforming Growth Factor beta;Up-Regulation;Visceral;beta catenin;cancer cell;deprivation;hormone regulation;improved;in vivo;interest;lipid biosynthesis;men;multipotent cell;muscle form;muscle strength;myogenesis;myostatin;novel;older men;programs;protein degradation;public health relevance;selective androgen receptor modulator;socioeconomics;stem cell differentiation;translational study;young man","Mechanisms of Testosterone Action","
Program Director/Principal Investigator: Bhasin, Shalender
Narrative
Aging-associated limitations of physical function impose an enormous health and socioeconomic
burden on the individual and the society; therefore, there is substantial unmet need for the
development of function promoting anabolic therapies. The proposed translational studies will
elucidate the signaling mechanisms by which testosterone increases skeletal muscle mass and
provide novel leads for the discovery of more selective anabolic molecules, such as follistatin, that
might increase skeletal muscle mass and function without affecting the prostate. The proposed
project also provides an outstanding opportunity to further our understanding of hormonal regulation
of stem cell differentiation and cell fate.","NIA","8225188","2/8/2012 12:00:00 AM","PA-07-070","5R01AG037193-08","5","R01","AG","037193","08"," ","WILLIAMS, JOHN","9/30/2004 12:00:00 AM","1/31/2015 12:00:00 AM","Aging Systems and Geriatrics Study Section[ASG]"," ","8089691","BHASIN, SHALENDER ","Not Applicable","07","Unavailable","005492160","JZ8RQC4EMDZ5","005492160","JZ8RQC4EMDZ5","US","42.337865","-71.070685","3617301","BOSTON MEDICAL CENTER","BOSTON","MA","Independent Hospitals","021182908","UNITED STATES","N","2/15/2012 12:00:00 AM","1/31/2013 12:00:00 AM","866","Non-SBIR/STTR","2012"," "," ","NIA","271275","167280"," ","438555",
"Bioengineering; Diabetes; Nutrition; Obesity; Osteoporosis; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Acceleration;Adipocytes;Adipose tissue;Animal Model;Animals;Architecture;Biological;Biomedical Engineering;Biophysics;Bone Marrow;Bone Marrow Stem Cell;Cell Lineage;Cell Nucleus;Cell physiology;Cells;Cellular Structures;Chronic Disease;Cilia;Clinic;Clinical;Cytoskeleton;Development;Diabetes Mellitus;Diet;Disease;Elements;Engineering;Environment;Estrogens;Exercise;Exposure to;Fatty Liver;Fatty acid glycerol esters;Focal Adhesions;Frequencies;Goals;Health Promotion;Hour;Human;Hypertriglyceridemia;In Vitro;Inflammation;Intervention;Knowledge;Liquid substance;Liver diseases;Marrow;Mechanics;Medicine;Mesenchymal;Mesenchymal Stem Cells;Metabolic;Metabolic Diseases;Metabolism;Modeling;Molecular;Molecular Biology;Mus;Muscle;Musculoskeletal;Nonesterified Fatty Acids;Obesity;Osteogenesis;Osteopenia;Osteoporosis;Outcome;Ovariectomy;Pathologic;Pathology;Pathway interactions;Phenotype;Process;Proto-Oncogene Proteins c-akt;Recovery;Regulation;Regulatory T-Lymphocyte;Repression;Research Personnel;Rest;Schedule;Science;Signal Transduction;Stem cells;Stimulus;Strenuous Exercise;Sum;System;T-Lymphocyte Subsets;Time;Tissues;Translating;Variant;Visceral;Work;adipokines;base;bone;bone cell;design;disorder control;glucose tolerance;high risk;human disease;improved;in vivo;indexing;insulin sensitivity;lipid biosynthesis;mouse model;non-drug;prevent;progenitor;response;skeletal;stem cell differentiation;stem cell fate;stem cell population;subcutaneous;vibration","Harnessing mechanical signals to control mesenchymal stem cell fate"," This BRP is designed, through three interconnected specific aims, to better understand how low intensity vibration (LIV) effectively bias mesenchymal stem cell differentiation away from adipogenesis (fat formation) and towards osteoblastogenesis (bone formation), and to establish whether this science can translate to the clinic as a non-pharmacological intervention to suppress chronic diseases such as diabesity.   
      

","NIBIB","8371760","9/13/2012 12:00:00 AM","PAR-10-234","1R01EB014351-01A1","1","R01","EB","014351","01","A","HUNZIKER, ROSEMARIE","9/17/2012 12:00:00 AM","8/31/2015 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","1864044","RUBIN, CLINTON T","JUDEX, STEFAN ; RUBIN, JANET E","01","BIOMEDICAL ENGINEERING","804878247","M746VC6XMNH9","804878247","M746VC6XMNH9","US","40.907353","-73.128565","5992612","STATE UNIVERSITY NEW YORK STONY BROOK","STONY BROOK","NY","BIOMED ENGR/COL ENGR/ENGR STA","117943362","UNITED STATES","N","9/17/2012 12:00:00 AM","8/31/2013 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","260100","99574"," ","359674",
"Autoimmune Disease; Clinical Research; Crohn's Disease; Digestive Diseases; Immunization; Inflammatory Bowel Disease; Patient Safety; Vaccine Related","Allogenic;Anti-Tumor Necrosis Factor Therapy;Autoimmunity;Award;Basic Science;Biopsy;Bone Marrow;Cells;Chronic;Clinical Research;Clinical Trials;Colitis;Collaborations;Crohn&apos;s disease;Digestive System Disorders;Disease;Enrollment;Evaluation;Funding;Gastroenterology;Genes;Genetic;Goals;Grant;Hepatology;Immune;Immunologic Deficiency Syndromes;Inflammation;Inflammatory Bowel Diseases;Infusion procedures;Interferon Type II;Interferons;Interleukin-17;Laboratories;Lesion;Malabsorption Syndromes;Maryland;Medical;Mesenchymal;Mesenchymal Stem Cells;Molecular;Monoclonal Antibodies;Mucosal Immune Responses;Mucous Membrane;Oregon;Patients;Pharmaceutical Preparations;Pharmacologic Substance;Production;Protocols documentation;Relapse;Reporting;Research;Research Methodology;Research Personnel;Research Project Grants;Staging;Stromal Cells;Structure;Syndrome;System;Testing;Tissues;Toxic effect;Translations;Ulcerative Colitis;United States National Institutes of Health;Universities;Up-Regulation;bench to bedside;congenital immunodeficiency;conventional therapy;cytokine;effective therapy;novel;programs;response;safety study","Clinical Studies of Inflammatory Bowel Diseases","n/a","NIAID","8555860"," "," ","1ZIAAI000903-10","1","ZIA","AI","000903","10"," "," "," "," "," "," ","9691353","STROBER, WARREN ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIAID"," "," "," ","530019",
"Arthritis; Genetics","Adult;Affect;American;Binding;Binding Sites;Biochemical;Cartilage;Cartilage Diseases;Cell Maintenance;Cells;Chondrocytes;Chondrogenesis;Chromosomal Rearrangement;Commit;Complementary DNA;Complex;Conserved Sequence;Cultured Cells;DNA Sequence;DNA Sequence Rearrangement;Data;Degenerative polyarthritis;Disease;Elements;Embryo;Enhancers;Functional RNA;Gene Expression;Genes;Genetic;Genetic Enhancer Element;Goals;In Vitro;Joints;LacZ Genes;Life;Mediating;Mesenchymal;Mesenchymal Stem Cells;Molecular;Mouse, Founder, Transgenic;Mus;Pattern;Regulation;Reporter;Role;Screening procedure;Site;Skeleton;Structure;Syndrome;Testing;Therapeutic;Transact;Transcriptional Regulation;Transgenes;Transgenic Mice;Work;campomelic dysplasia;cartilage cell;chondrodysplasia;cis acting element;design;in vivo;malformation;promoter;public health relevance;skeletal dysplasia;skeletogenesis;therapeutic target;transcription factor;transcription factor USF","Transcriptional Control of Sox9","
PROJECT NARRATIVE
The goal of this project is to identify mechanisms underlying expression of Sox9, the gene for a transcription
factor required for cartilage formation. We have identified two sequences upstream of the gene that are
sufficient to activate the Sox9 promoter in cartilage cells. This project will use complementary approaches in
vitro and in vivo to test the hypothesis that these sequences are both needed and sufficient for Sox9
expression in cartilage and that they bind transcription factors, collectively referred to as chondrogenin, which
are required to activate the Sox9 gene and thereby induce chondrogenesis. The results of this study are
expected to increase understanding of the molecular regulation of chondrogenesis and to provide new DNA
sequences and factors to develop urgently needed therapies for cartilage malformation and degeneration
diseases, including the highly prevalent osteoarthritis disease.","NIAMS","8293427","6/27/2012 12:00:00 AM","PA-07-070","5R01AR060016-03","5","R01","AR","060016","03"," ","TYREE, BERNADETTE","7/20/2010 12:00:00 AM","6/30/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-K(02)]"," ","8004729","LEFEBVRE, VERONIQUE M","Not Applicable","11","OTHER BASIC SCIENCES","135781701","M5QFLTCTSQN6","135781701","M5QFLTCTSQN6","US","41.479276","-81.680233","10000858","CLEVELAND CLINIC LERNER COM-CWRU","CLEVELAND","OH","SCHOOLS OF MEDICINE","441950001","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","289616","167306"," ","456922",
"Genetics; Osteoporosis","Ablation;Address;Alleles;Binding;Bone Resorption;Bone remodeling;Cells;Commit;Cyclic AMP;Cyclic AMP-Dependent Protein Kinases;Distal;Distant;Enhancers;Equilibrium;Family;Family member;Funding;Gene Expression;Genes;Genetic Transcription;Goals;Green Fluorescent Proteins;Health;Hormones;In Vitro;Knockout Mice;Knowledge;LacZ Genes;Ligands;Mesenchymal;Mesenchymal Stem Cells;Molecular;Mouse Strains;Mus;Osteoblasts;Osteoclasts;Osteocytes;Parathyroid gland;Pathway interactions;Play;Population;Process;Production;Protein Binding;Regulatory Element;Reporter;Risk;Role;Source;Stromal Cells;Supporting Cell;TNFSF11 gene;Tamoxifen;Therapeutic Intervention;Transgenic Mice;Tumor necrosis factor receptor 11b;base;bone;bone mass;bone strength;cell type;cytokine;design;expectation;in vivo;loss of function;member;osteoblast differentiation;osteoclastogenesis;osteoporosis with pathological fracture;progenitor;protein expression;receptor;receptor expression;recombinase;small hairpin RNA;therapy development;transcription factor","Molecular Control of RANKL Gene Expression","n/a","NIAMS","8286053","6/12/2012 12:00:00 AM","PA-07-070","5R01AR049794-10","5","R01","AR","049794","10"," ","CHEN, FAYE H","9/29/2003 12:00:00 AM","6/30/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","2105531","O'BRIEN, CHARLES A","Not Applicable","02","INTERNAL MEDICINE/MEDICINE","122452563","VDFYLZPJEAV6","122452563","VDFYLZPJEAV6","US","34.751472","-92.320637","1471106","UNIV OF ARKANSAS FOR MED SCIS","LITTLE ROCK","AR","SCHOOLS OF MEDICINE","722057101","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","209088","94090"," ","303178",
"Biotechnology; Genetics; Human Genome; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Allografting;Bioinformatics;Biological;Biological Markers;Biotechnology;Blood Cells;California;Cell Separation;Cells;Clinical Trials;Collaborations;Complex;Core Facility;DNA;DNA Microarray Chip;DNA Sequencing Facility;Doctor of Philosophy;Event;Exons;Faculty;Failure;Funding;Gene Expression;Genes;Genome;Genomics;Grant;Head;Human;Immune response;Informatics;Infusion procedures;Institutes;Instruction;Islets of Langerhans Transplantation;Kidney Transplantation;Laboratories;Leadership;Letters;Mass Spectrum Analysis;Medicine;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Messenger RNA;Metric;Modeling;Molecular;Nucleic Acids;Outcome;Principal Investigator;Proteins;Proteomics;Protocols documentation;RNA;RNA Sequences;Recording of previous events;Regulation;Reperfusion Injury;Research;Research Institute;Research Personnel;Resources;Sampling;Services;Specialist;Staging;Structure;Supervision;Technology;Time;Tissues;Translational Research;Translations;Transplantation;United States National Institutes of Health;Universities;Work;base;design;experience;functional genomics;mass spectrometer;next generation;nonhuman primate;programs;regenerative;response;square foot;success;tandem mass spectrometry","Proteomics and Genomics Core","RELEVANCE (See instructions): 
It is now clear that functional genomics, the study of gene expression and its regulation in cells and tissues at the RNA level, reveals a complex picture of how critical information moves from the genome (DNA or genes) to RNA (messenger RNA) and finally to cellular proteins in response to any significant biological event, in this case, ischemia/reperfusion injury, rejection and tolerance in islet and kidney transplantation.","NIAID","8379598","7/20/2012 12:00:00 AM","PAR-10-271","5P01AI089556-02","5","P01","AI","089556","02"," "," "," "," ","ZAI1-MFH-I","7980","1880539","SALOMON, DANIEL R.","Not Applicable","27","Unavailable","052780918","F8THLJQSAF93","052780918","F8THLJQSAF93","US","25.775337","-80.209809","5221250","UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","CORAL GABLES","FL","Domestic Higher Education","331462926","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","340331","340331"," ","285198","55133"," "," ",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Adhesives;Animal Model;Biocompatible Materials;Bolus Infusion;Bone Regeneration;Bone Tissue;Cartilage;Cell Adhesion;Cell Count;Cell Survival;Cell Therapy;Cells;Clinical;Clinical Trials;Collagen;Culture Media;Defect;Drug Formulations;Engineering;Engraftment;Ethylene Glycols;Exhibits;Fibronectins;Gene Expression;Histocytochemistry;Home environment;Human;Hydrogels;Image;Immunodeficient Mouse;Immunohistochemistry;Implant;Integrin Binding;Integrin-mediated Cell Adhesion Pathway;Integrins;Intervertebral disc structure;Ligands;Luciferases;Mechanics;Mesenchymal Stem Cells;Monitor;Musculoskeletal;Osseointegration;Osteocalcin;Osteogenesis;Outcome;Peptide Hydrolases;Peptides;Pre-Clinical Model;Radial;Rattus;Recombinants;Regenerative Medicine;Reporter;Research;Signal Transduction;Source;Specificity;Stem Cell Research;Stem cells;System;Testing;Tissue Engineering;Tissues;Transplantation;Variant;Vascular Endothelial Growth Factors;Vascularization;Work;base;bone;density;ethylene glycol;improved;in vivo;injured;innovation;mimetics;novel;osteoblast differentiation;osteogenic;paracrine;promoter;receptor;repaired;self-renewal","Hydrogels for hMSC delivery & engraftment"," Mesenchymal stem cells represent a promising cell source for regenerative medicine applications. We will engineer biofunctional hydrogels to direct human mesenchymal stem cell survival, engraftment, and function. We will establish novel bioactive cell delivery vehicles that enhance stem cell survival, engraftment and bone formation for improved bone repair.   
      

","NIAMS","8368845","7/29/2012 12:00:00 AM","PA-11-260","1R01AR062368-01A1","1","R01","AR","062368","01","A","WANG, FEI","8/1/2012 12:00:00 AM","7/31/2017 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","2106898","GARCIA, ANDRES J","Not Applicable","05","ENGINEERING (ALL TYPES)","097394084","EMW9FC8J3HN4","097394084","EMW9FC8J3HN4","US","33.762977","-84.42296","676603","GEORGIA INSTITUTE OF TECHNOLOGY","ATLANTA","GA","BIOMED ENGR/COL ENGR/ENGR STA","303320415","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","82079"," ","307079",
"Biotechnology; Genetics; Neurosciences; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Acute;Anti-Inflammatory Agents;Anti-inflammatory;Apoptosis;Applications Grants;Area;Biological Models;Biophotonics;Blood Circulation;Cell Communication;Cell Survival;Cells;Cellular biology;Cessation of life;Coculture Techniques;Collaborations;Complex;Data;Disease;Disease Outcome;Distant;Endothelial Cells;Engineering;Equipment;Extracellular Protein;Gap Junctions;Gene Expression;Growth;Healed;Hematopoietic stem cells;Hindlimb;Histology;Human;Human Biology;Hypoxia;Image;In Vitro;Injection of therapeutic agent;Injury;Interdisciplinary Study;Ischemia;Lasers;Mammalian Cell;Matrix Metalloproteinases;Mediating;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Methods;MicroRNAs;Modeling;Molecular;Mus;Myocardial Infarction;Nature;Nerve;Neurons;Outcome;PECAM1 gene;Pathway interactions;Production;Proteins;RNA;RNA Interference;Recovery;Research;Site;Small Interfering RNA;Small RNA;Specific qualifier value;Staining method;Stains;Stromal Cells;System;Techniques;Testing;Tissue Model;Tissues;Transfer RNA;Transgenes;Transgenic Mice;Transplantation;Tube;Ulcer;Video Microscopy;Waxes;Western Blotting;Work;Xenograft procedure;axonal pathfinding;cell injury;cell type;cellular engineering;cellular imaging;chemokine;cytokine;design;efficacy testing;healing;in vivo;interest;mouse model;nerve stem cell;novel;overexpression;receptor;repaired;restoration;tissue repair;translational medicine;uptake;wound","Direct cell to cell transfer of microRNA for tissue repair"," Mesenchymal stem cells/stromal cells (MSC) in many tissues can rescue other cells from damage and death. Our new research shows that they can also influence target cell fate through the direct transfer of small RNA species. Our multidisciplinary research focuses on MSC-mediated microRNA transfer mechanisms and impact on differentiation and repair of target cells including hematopoietic stem cells, cells of the vasculature, and neurons. There is direct relevance to a broad range of diseases.  
    

","NIGMS","8337302","8/20/2012 12:00:00 AM","RFA-RM-10-010","5R01GM099688-02","5","R01","GM","099688","02"," ","BENDER, MICHAEL T","9/30/2011 12:00:00 AM","8/31/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-BCMB-A(51)R]"," ","1861638","NOLTA, JAN A.","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","047120084","TX2DAGQPENZ5","047120084","TX2DAGQPENZ5","US","38.543675","-121.729989","577503","UNIVERSITY OF CALIFORNIA AT DAVIS","DAVIS","CA","SCHOOLS OF MEDICINE","956186153","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","310","Non-SBIR/STTR","2012"," "," ","OD","346604","187166"," ","533770",
"Breast Cancer; Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Adenoviruses;Alleles;Biological Markers;Breast;Breast Cancer Cell;Cancer cell line;Cell Culture Techniques;Cell Line;Cell physiology;Cell surface;Cells;Competence;Development;Distant;Doxycycline;Drug resistance;Embryo;Epithelial;Epithelial Cells;Evaluation;FDA approved;Gene Expression;Genes;Homeostasis;Human;Immunodeficient Mouse;In Vitro;Knock-out;Knockout Mice;Link;Mammary gland;Mediating;Mediator of activation protein;Mesenchymal;Mesenchymal Stem Cells;Metaplastic;Modeling;Molecular;Molecular Target;Monitor;Mouse Mammary Tumor Virus;Mus;Neoplasm Metastasis;Outcome;PDGFRB gene;Pathway interactions;Pattern;Pharmaceutical Preparations;Phenotype;Play;Positioning Attribute;Process;Property;Reporter;Resistance;Role;Signal Transduction;Site;Snails;Staging;Stem cells;System;Testing;Tissues;Transgenic Organisms;Winged Helix;Work;base;cancer recurrence;cancer stem cell;cell behavior;chemotherapy;forkhead protein;functional loss;improved;in vivo;in vivo Model;inhibitor/antagonist;insight;malignant breast neoplasm;mammary epithelium;mammary gland development;mortality;novel;prognostic;programs;public health relevance;response;small hairpin RNA;spatiotemporal;stem;stem cell population;stemness;trait;transcription factor;tumor;tumor growth;tumor initiation;tumor progression;tumor xenograft;tumorigenic","Pleiotropic functions of FOXC2 in EMT, stem cells and breast cancer progression","
Relevance
Metastasis and resistance to chemotherapy are the major causes of breast cancer-related
mortality. Cancer stem cells (CSCs) play critical roles in both these processes, and we recently
found that CSCs can be generated by an epithelial-mesenchymal transition (EMT), a latent
embryonic process that has been shown to promote breast cancer progression. By using in vitro
and in vivo models, we will characterize the pleiotropic functions of FOXC2 as a central
mediator of EMT, stemness, metastatic competence and drug resistance, and the expected
results will suggest possible molecular targets that may be exploited to selectively treat
metastatic and resistant breast cancers.","NCI","8243511","3/15/2012 12:00:00 AM","PA-10-067","5R01CA155243-02","5","R01","CA","155243","02"," ","SATHYAMOORTHY, NEERAJA","3/16/2011 12:00:00 AM","2/29/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","9340088","MANI, SENDURAI AYYAVOO","Not Applicable","09","PATHOLOGY","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","211207","122500"," ","333707",
"Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adult;Angiogenic Factor;Animals;Attenuated;Back;Biological Assay;Blood Vessels;Blood capillaries;Blood flow;Bone Marrow;Bone Marrow Cells;Bone Marrow Stem Cell;Bone Marrow Transplantation;Cadherins;Caliber;Cardiac;Cells;Collecting Cell;Conditioned Culture Media;Coronary Occlusions;Coronary Vessels;Corrosion Casting;Data;Development;Disease;Endothelial Cells;Fibroblast Growth Factor;Ganciclovir;Gel;Gene Delivery;Genes;Grant;Health;Heart;Heart failure;Home environment;Hypoxia;Image;Immunologics;In Vitro;Infarction;Injection of therapeutic agent;Injury;Laboratories;LacZ Genes;Lectin;Marrow;Measures;Mediating;Mediator of activation protein;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Messenger RNA;Modeling;Molecular;Molecular Profiling;Mus;Myocardial;Myocardial Infarction;Myocardial Ischemia;Myocardium;Pathway interactions;Phosphatidylinositide 3-Kinase Inhibitor;Play;Process;Production;Proteins;Relative (related person);Reporter;Rodent;Role;Signal Transduction;Simplexvirus;Small Interfering RNA;Staining method;Stains;Stem cells;Subfamily lentivirinae;Testing;Therapeutic;Thymidine Kinase;Transplantation;Tube;Vascular Endothelial Growth Factors;Wild Type Mouse;angiogenesis;behavior influence;capillary;cell motility;cellular transduction;cytokine;density;design;hypoxia inducible factor 1;improved;in vitro Assay;in vivo;inhibitor/antagonist;injured;killings;neovascularization;neovasculature;paracrine;promoter;protective effect;repaired;suicide gene;transcription factor;vasculogenesis","Genetically Altered Mesenchymal Stem Cell; Paracrine Effect on Neovascularization","n/a","NHLBI","8236853","3/20/2012 12:00:00 AM","PA-07-070","5R01HL073219-10","5","R01","HL","073219","10"," ","WONG, RENEE P","4/1/2003 12:00:00 AM","3/31/2014 12:00:00 AM","Myocardial Ischemia and Metabolism Study Section[MIM]"," ","1870733","DZAU, VICTOR J","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","138600"," ","386100",
"Autoimmune Disease; Diabetes; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acetylcysteine;Activities of Daily Living;Adipocytes;Aftercare;Angiogenic Factor;Antioxidants;Arteries;Autologous Transplantation;Automobile Driving;Bioavailable;Biology;Blood Vessels;Blood capillaries;CXCR4 gene;Cell Lineage;Cell physiology;Cells;Comorbidity;Diabetes Mellitus;Diabetic mouse;Diet;Disease;Endothelial Cells;Epidemic;Exhibits;Functional disorder;Genetic Engineering;Goals;Healthcare;Hindlimb;Homing;Hydrogen Peroxide;Infiltration;Insulin;Ischemia;Knowledge;Light;Limb structure;Lower Extremity;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Mus;Muscle;Non-Insulin-Dependent Diabetes Mellitus;Outcome;Oxidants;Palliative Care;Participant;Pathology;Pathway interactions;Patients;Pear;Perfusion;Peripheral arterial disease;Phenotype;Population;Production;Property;Recovery;Resveratrol;Risk Factors;Role;Stem cell transplant;System;Testing;Therapeutic Intervention;Transgenic Organisms;Transplantation;Treatment Efficacy;Vascular Endothelial Growth Factors;Wild Type Mouse;Work;adipocyte differentiation;base;capillary;chemokine receptor;diabetic;diabetic patient;improved;in vivo;injured;neovascularization;novel therapeutics;overexpression;oxidant stress;paracrine;pluripotency;public health relevance;response;rosiglitazone;rosuvastatin;tetrahydrobiopterin","Mesenchymal stem cells in the treatment of hindlimb ischemia in diabetic mice","
Project Narrative
Current treatments for peripheral artery disease (PAD) are either palliative and treatment op-
tions are particularly limited in patients with the common co-morbidity of diabetes mellitus;
discovery of novel therapeutic options are an urgent matter of national health care priority.
Autologous transplantation with mesenchymal stem cells (MSC) , a pluripotent cell that par-
ticipates in post-ischemic neovascularization, holds great promise as a means to effect symp-
tomatic relief by reversing disease pathology. The proposed work will elucidate the mecha-
nisms responsible for the loss of pluripotency and therapeutic efficacy of diabetic MSC, as well
as greatly increase knowledge regarding the basic and applied vascular biology of MSC in the
treatment of lower extremity ischemia.","NHLBI","8257543","4/27/2012 12:00:00 AM","PA-07-070","5R01HL075353-08","5","R01","HL","075353","08"," ","ERSHOW, ABBY","1/1/2004 12:00:00 AM","4/30/2014 12:00:00 AM","Bioengineering, Technology and Surgical Sciences Study Section[BTSS]"," ","1962495","MESSINA, LOUIS MICHAEL","Not Applicable","02","SURGERY","603847393","MQE2JHHJW9Q8","603847393","MQE2JHHJW9Q8","US","42.277722","-71.759339","850903","UNIV OF MASSACHUSETTS MED SCH WORCESTER","WORCESTER","MA","SCHOOLS OF MEDICINE","016550002","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","159638"," ","407138",
"Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adverse effects;Animal Model;Animals;BMP2 gene;Blood Circulation;Bone Marrow;Bone Matrix;Bone Morphogenetic Proteins;Bone Transplantation;Calvaria;Cholesterol Homeostasis;Collagen;Defect;Development;Effectiveness;Embryo;Erinaceidae;Family;Fibroblasts;Fracture;Future;Gene Targeting;Goals;Healed;Human;In Vitro;Investigation;Ligands;Liver;Mediating;Mediator of activation protein;Mesenchymal;Mesenchymal Stem Cells;Modeling;Molecular;Molecular Mechanisms of Action;Mus;Neonatal;Nuclear;Organ Culture Techniques;Osteogenesis;Parents;Pathway interactions;Play;Property;Proteins;Rat-1;Rattus;Receptor Activation;Receptor Signaling;Recombinants;Relative (related person);Reporting;Role;Signal Pathway;Signal Transduction;Speed;Spinal Fusion;Stromal Cells;Structure-Activity Relationship;Testing;Tissues;analog;bone;bone cell;bone healing;clinically relevant;comparative efficacy;cost;healing;immunogenic;improved;in vitro activity;in vivo;in vivo Model;lipid biosynthesis;notch protein;novel;osteogenic;osteoprogenitor cell;receptor;response;scaffold;small molecule;smoothened signaling pathway;transcription factor","Development of Osteogenic Oxysterols for Local Bone Formation"," The studies proposed in this application will characterize a novel class of compounds that are potent stimulators of bone and bone cell formation, and will validate the ability of these molecules to stimulate bone healing alone and in combination with BMP2 in clinically relevant animal models. Results from these studies will provide important information for further development of future novel compounds that could be used for stimulating bone healing and strengthening in humans.  
    

","NIAMS","8299488","6/29/2012 12:00:00 AM","PA-10-067","5R01AR059794-02","5","R01","AR","059794","02"," ","CHEN, FAYE H","7/11/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","6711668","PARHAMI, FARHAD ","Not Applicable","33","INTERNAL MEDICINE/MEDICINE","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","SCHOOLS OF MEDICINE","900952000","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","121500"," ","346500",
"Regenerative Medicine","Adult;Attenuated;Biological Models;Blood Vessels;Bone Density;Bone Mineral Contents;Bone Regeneration;Bone Tissue;Cell Hypoxia;Cell physiology;Cells;Conflict (Psychology);Data;Development;Disease;Embryo;Embryonic Development;Fracture;Gases;Gene Expression;Genes;Glycoproteins;Health;Hypoxia;Hypoxia Inducible Factor;In Vitro;Injury;Knowledge;Lead;Literature;Mediating;Mesenchymal;Mesenchymal Stem Cells;Military Personnel;Molecular;Movement;Mus;Nutrient;Orthopedics;Osteoblasts;Osteogenesis;Oxygen;Oxygen measurement, partial pressure, arterial;Pathway interactions;Phosphorylation;Physiology;Protein Isoforms;Readiness;Regulation;Signal Pathway;Signal Transduction;Site;Skeletal Development;Stimulus;Stress Fractures;Testing;Tissue Engineering;Tissues;Trauma;arm;bone;bone cell;bone health;deprivation;in vivo;insight;long bone;novel;novel strategies;osteoblast differentiation;osteogenic;prevent;progenitor;public health relevance;repaired;skeletal;ubiquitin ligase","Regulation of sclerostin expression by hypoxia: A proposed mechanism to explain h","
Project narrative:
 As we complete our specific aims we will identify the molecular mechanisms behind cellular
oxygen sensing and elucidate how hypoxia regulates gene expression. In addition, we will examine
the ramifications of hypoxia-driven Sclerostin suppression, on signaling pathways (Wnt/ï¿½-catenin
signaling) that ultimately lead to bone formation. This project has the potential to yield new insight into
the relationship between hypoxia and bone and identify novel pathways that could be manipulated
pharmacologically to promote bone repair or even administered prophylactically to prevent bone
damage. Understanding the relationship between oxygen supply and bone cell physiology will also
have ramifications for the development of effective tissue engineering strategies for bone repair.","NIAMS","8197727","12/2/2011 12:00:00 AM","PAR-09-031","5R03AR057547-03","5","R03","AR","057547","03"," ","PANAGIS, JAMES S","4/1/2010 12:00:00 AM","11/30/2013 12:00:00 AM","ZAR1-MLB-G(M1)"," ","8508145","GENETOS, DAMIAN C","Not Applicable","03","VETERINARY SCIENCES","047120084","TX2DAGQPENZ5","047120084","TX2DAGQPENZ5","US","38.543675","-121.729989","577503","UNIVERSITY OF CALIFORNIA AT DAVIS","DAVIS","CA","SCHOOLS OF VETERINARY MEDICINE","956186153","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","50468","23112"," ","73580",
"Biotechnology; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Age;Aging;Alleles;Automobile Driving;Binding Proteins;Binding Sites;Biology;Bone Diseases;Bone Matrix;Bone Regeneration;Calcium;Cartilage;Cartilage Matrix;Cells;Cephalic;Chondrocytes;Congenital Abnormality;DNA;DNA Binding;Data;Development;Elements;Embryo;Epitopes;Event;Extracellular Matrix;Face;Fracture;Frequencies;Gene Targeting;Genome;Head;Hematopoietic System;Human;Human Genetics;Instruction;Ions;Lateral;Life;Limb structure;Maintenance;Mediating;Mesenchymal;Mesenchymal Stem Cells;Mesoderm;Minerals;Modeling;Molecular;Morphogenesis;Mouse Strains;Mus;Neural Crest;Neural Crest Cell;Online Systems;Organ;Osteoblasts;Osteoclasts;Paraxial Mesoderm;Peptides;Population;Prevalence;Process;Production;Property;Proteins;Regulation;Regulator Genes;Sequence Analysis;Signal Pathway;Signal Transduction;Skeletal Development;Skeleton;Specific qualifier value;Stem cells;Sternum;Therapeutic;Transgenic Mice;Vertebral column;base;bone;cell type;chromatin immunoprecipitation;clavicle;cranium;design;in vivo;insight;knock-down;mouse model;neural plate;progenitor;programs;repaired;repository;skeletal;skeletal disorder;skeletogenesis;transcription factor","Proect 2 - McMahon","RELEVANCE (See instructions): Defective skeletal programs are a common birth defect, and an increasing problem in aging populations. Our skeleton is synthesized by two cells type, cartilage from chondrocytes and bone from osteoblasts, under the control of three master-regulatory genes. New mouse models will identify the regulatory programs governed by each factor providing the first genome scale insights into mammalian skeletal development.","NIDDK","8564863","10/10/2012 3:10:14 PM"," ","5P01DK056246-12","5","P01","DK","056246","12"," "," ","6/1/2012 12:00:00 AM","5/31/2016 12:00:00 AM","ZDK1-GRB-7(J1)P","5975","1887350","TABIN, CLIFFORD J.","DEMAY, MARIE ; KRONENBERG, HENRY M.; MCMAHON, ANDREW P.","07","Unavailable","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","Domestic Higher Education","021201616","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","275177","275177"," ","203102","72075"," "," ",
"Cancer; Clinical Research; Pediatric; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","ACVR1 gene;Adipocytes;Adipose tissue;Birth;Blood Vessels;CCL2 gene;Caucasians;Caucasoid Race;Cell Differentiation process;Cells;Child;Cicatrix;Common Neoplasm;Data;Development;Disease;Doxycycline;Endothelial Cells;Fatty acid glycerol esters;Goals;Hemangioma;Implant;Infiltration;Inflammatory;Insulin-Like Growth Factor I;Invaded;Knowledge;Lead;Lesion;Life;Mediating;Mesenchymal;Mesenchymal Stem Cells;Molecular;Multipotent Stem Cells;Mus;Neoplasms in Vascular Tissue;Pathologic Processes;Patients;Phase;Phenotype;Physiological Processes;Population;Primary Cell Cultures;Process;Proliferating;Role;Stem cells;Testing;Time;Tissues;Transgenic Mice;angiogenesis;base;cadherin 5;cytokine;human disease;human tissue;in vivo;infancy;insight;lipid biosynthesis;macrophage;mouse model;mutant;neoplastic;novel;novel therapeutics;receptor;stem;tumor;tumor growth;vessel regression","Endothelial Plasticity in Human Disease","Hemangioma is the most common tumor effecting children, with approximately 10% of the Caucasian 
population developing some form of the disease. Despite the fact that most hemangiomas naturally regress 
over time, they can cause scarring and disfigurement of patients and many can be life threatening. Our 
proposed studies will help to understand the cause of hemangioma regression, which may lead to 
development of novel therapeutic treatments for vascular tumors and potentially other diseases.","NHLBI","8518856","8/4/2012 12:00:00 AM","PA-10-067","7R01HL112860-02","7","R01","HL","112860","02"," ","OH, YOUNGSUK","5/1/2012 12:00:00 AM","3/31/2017 12:00:00 AM","Vascular Cell and Molecular Biology Study Section[VCMB]"," ","9349015","MEDICI, DAMIAN ","Not Applicable","01","Unavailable","075710996","N876TLXYGCG4","075710996","N876TLXYGCG4","US","41.820682","-71.412855","6959701","RHODE ISLAND HOSPITAL","PROVIDENCE","RI","Independent Hospitals","029034923","UNITED STATES","N","8/3/2012 12:00:00 AM","3/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","235166","138748"," ","373914",
"Aging; Arthritis; Autoimmune Disease; Biotechnology; Clinical Research; Genetics; Regenerative Medicine","ADAMTS;Adult;Affect;Apoptosis;Appearance;Arthritis;Binding;Bioinformatics;Biological;Biological Assay;Blood Vessels;Bone Matrix;Cartilage;Cells;Cellular biology;Chondrocytes;Chondrogenesis;Collagen Type II;Degenerative polyarthritis;Development;Developmental Process;Disease;EMSA;Embryonic Development;Enzymes;Extracellular Matrix;Family;Gene Expression;Gene Targeting;Genes;Growth;HMG Domain;Homeostasis;Hypertrophy;In Vitro;Inflammatory;Joints;Knee joint;Knockout Mice;Lead;Life;Limb Development;Maintenance;Mesenchymal;Mesenchymal Stem Cells;MicroRNAs;Molecular;Molecular Target;Morphology;Movement;Mus;Nucleotides;Osteoarthrosis Deformans;Osteoblasts;Pathogenesis;Pattern;Phenotype;Physical condensation;Physiological Processes;Play;Process;Proteoglycan;Regulatory Pathway;Research;Rheumatoid Arthritis;Role;Signal Transduction;Signaling Molecule;Skeleton;Therapeutic;Therapeutic Intervention;Tissue Engineering;Tissues;Transcriptional Regulation;Transgenic Mice;Untranslated RNA;arthropathies;articular cartilage;base;bone;cartilage cell;cartilage development;early onset;extracellular;insight;interest;macromolecule;novel;novel strategies;postnatal;public health relevance;research study;scaffold;skeletal;transcription factor","The role of microRNAs in chondrogenesis and arthritis","
PROJECT NARRATIVE
 Despite substantial recent progress in understanding OA pathogenesis, disease-modifying therapies for the
most prevalent joint disease are not available. Examining the role of miR-140 in MSC and chondrocytes may
provide new insight into cartilage cell biology as well as a basis for novel approaches in tissue engineering and
therapeutic strategies for osteoarthritis.","NIAMS","8265710","5/21/2012 12:00:00 AM","PA-07-070","5R01AR050631-08","5","R01","AR","050631","08"," ","TYREE, BERNADETTE","7/1/2004 12:00:00 AM","5/31/2015 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","6983415","ASAHARA, HIROSHI ","Not Applicable","49","Unavailable","781613492","PHZJFZ32NKH4","781613492","PHZJFZ32NKH4","US","32.903152","-117.243436","7375802","SCRIPPS RESEARCH INSTITUTE","LA JOLLA","CA","Research Institutes","920371000","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","216000","194184"," ","410184",
"Biotechnology; Dental/Oral and Craniofacial Disease; Genetics; Pediatric; Pediatric Research Initiative; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Binding;Bone Development;Bone Growth;Bone Lengthening;Cartilage;Categories;Cell Separation;Cells;Characteristics;Chondrocytes;Deformity;Dental;Development;Diagnosis;Diphtheria Toxin;Doxycycline;Epiphysial cartilage;Gene Expression;Genes;Genetic;Goals;Heterogeneity;Histones;In Situ Hybridization;Kinetics;Label;Mentors;Mesenchymal;Mesenchymal Stem Cells;Modality;Monitor;Mus;Mutant Strains Mice;Osteoblasts;Osteogenesis;Phase;Physiologic pulse;Population;Proliferating;Property;Reporter;Research Project Grants;Role;Scientist;Skeletal Development;Source;Stem cells;System;Tamoxifen;Testing;Tetanus Helper Peptide;Time;Transgenic Mice;base;cDNA Arrays;cell type;craniofacial;diphtheria toxin receptor;genetic profiling;in vivo;insight;interest;nerve stem cell;nestin protein;novel;osteoblast differentiation;postnatal;progenitor;promoter;prospective;research study;self-renewal;skeletogenesis;stem;stem cell population;tool;transcription factor","Stem/progenitor cells of the chondrocyte and osteoblast lineage in vivo"," The prospective findings of this research project will give important insights into the property and the role of stem/progenitor cells in skeletal development.
This information will become a valuable tool for understanding the mechanisms of various dental and craniofacial deformities and developing novel diagnosis categories and treatment modalities.   
      

","NIDCR","8279758","2/3/2012 12:00:00 AM","PAR-09-256","1K99DE022564-01","1","K99","DE","022564","01"," ","FRIEDEN, LESLIE A","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","10879516","ONO, NORIAKI ","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","127750","10220"," ","137970",
"Aging; Cancer; Genetics; Rare Diseases","Affect;Alanine;Aspartic Acid;Biochemical;Biological;Biological Assay;Cell Line;Cells;Chromatin;Chromosome abnormality;DNA;DNA Binding;DNA Damage;DNA Double Strand Break;DNA Repair;DNA-PKcs;DNA-dependent protein kinase;Dominant-Negative Mutation;Double Strand Break Repair;Event;Exonuclease;Family;Family member;Fibroblasts;Genome;Genomics;Human;In Vitro;Interruption;Kinetics;Knockout Mice;Laboratories;Lasers;Lead;Life;Maintenance;Malignant Neoplasms;Measures;Mediating;Mesenchymal Cell Neoplasm;Mus;Mutate;Mutation;Nonhomologous DNA End Joining;Pathway interactions;Patients;Phosphorylation;Phosphorylation Site;Phosphotransferases;Play;Process;Protein Family;Recruitment Activity;Reporter;Research;Risk;Roentgen Rays;Role;Site;Study Section;Symptoms;System;Telomere Maintenance;Testing;Werner Syndrome;XRCC5 gene;age related;base;cellular imaging;early onset;endodeoxyribonuclease SceI;experience;helicase;homologous recombination;human WRN protein;in vivo;kinase inhibitor;mutant;polypeptide;protein protein interaction;repaired;research study;response;sarcoma;spatial relationship","Functions of WRN in Response to DNA Double-Strand Breaks","Werner Syndrome (WS) is an autosomal recessive condition characterized by an early onset of 
age-related symptoms. WS patients also experience an increased risk of rare non-epithelial 
cancers, especially mesenchymal neoplasms such as sarcomas. WRN, the protein defective in 
WS is involved in maintenance of genomic integrity and DNA damage repair. To understand 
the function of WRN in DNA damage response, we proposed to (i) determine the mechanism by 
which WRN is recruited to the sites of DNA damage in vivo, (ii) find out kinases that are 
responsible for WRN phosphorylation and (iii) determine the biological significance of WRN 
phosphorylation in the process of DNA double strand break repair mediated through non- 
homologous end joining and/or homologous recombination. The results obtained with these 
experiments will further elucidate the mechanism by which WRN contributes in genome 
maintenance, cancer and DNA repair.","NCI","8215807","2/23/2012 12:00:00 AM","PA-07-070","5R01CA134991-04","5","R01","CA","134991","04"," ","PELROY, RICHARD","4/1/2009 12:00:00 AM","1/31/2014 12:00:00 AM","Cancer Etiology Study Section[CE]"," ","1857780","CHEN, DAVID J","Not Applicable","30","RADIATION-DIAGNOSTIC/ONCOLOGY","800771545","YZJ6DKPM4W63","800771545","YZJ6DKPM4W63","US","32.814772","-96.841146","578404","UT SOUTHWESTERN MEDICAL CENTER","DALLAS","TX","SCHOOLS OF MEDICINE","753909105","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","201275","114727"," ","316002",
"Clinical Research; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adipocytes;Adult;Animal Model;Antibodies;Aspirate substance;Astrocytes;Bone Marrow;Cardiomyopathies;Cell Lineage;Cells;Child;Chondrocytes;Clinical Trials;Colony-forming units;Engineering;Epitopes;Fibroblasts;Freezing;Funding;Genes;Home environment;Human;Human Volunteers;Individual;Institution;Laboratories;Letters;Literature;Malignant - descriptor;Marrow;Mesenchymal;Mesenchymal Stem Cells;Methods;Mus;Muscle Cells;National Center for Research Resources;Neurons;Osteoblasts;Osteogenesis Imperfecta;Patients;Phase;Phase II Clinical Trials;Phenotype;Population;Preparation;Procedures;Protocols documentation;Rattus;Regulation;Reporting;Research;Research Personnel;Research Project Grants;Resources;Rodent;Series;Spinal cord injury;Stem cells;Stroke;Stromal Cells;Surface;Testing;Tissues;United States National Institutes of Health;Vial device;Viral Vector;adult stem cell;cell injury;cell preparation;embryonic stem cell;gene therapy;human disease;improved;interest;research study;stem","Preparation and Distribution of Adult Stem Cells","n/a","OD","8269008","6/22/2012 12:00:00 AM"," ","7P40OD011050-10","7","P40","OD","011050","10"," ","MIROCHNITCHENKO, OLEG","6/1/2003 12:00:00 AM","6/14/2013 12:00:00 AM","Comparative Medicine Review Committee[RIRG-C]"," ","1864047","PROCKOP, DARWIN JOHNSON","Not Applicable","17","NONE","835607441","HFT7XTHB6563","835607441","HFT7XTHB6563","US","30.561517","-96.274978","8266910","TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR","COLLEGE STATION","TX","SCHOOLS OF MEDICINE","778454375","UNITED STATES","N","6/1/2012 12:00:00 AM","6/14/2013 12:00:00 AM","351","Research Centers","2012"," "," ","OD","728214","338620"," ","1066834",
"Autoimmune Disease; Biotechnology; Lung; Rare Diseases","Accounting;Address;Alveolar;Apoptosis;Architecture;Biological;Biological Markers;Cataloging;Catalogs;Cells;Clinic;Collagen;Cytokeratin;Data;Deposition;Development;Diagnosis;Disease;Drug Compounding;Drug Delivery Systems;Epithelial;Epithelial Cells;Exhibits;Fibrosis;Gene Expression;Growth Factor;Hamman-Rich syndrome;Homeostasis;Human;Hyperplasia;Impaired wound healing;Instruction;Integrins;Interstitial Lung Diseases;Knowledge;Link;Lung;Lung diseases;Mediating;Mesenchymal;Methods;MicroRNAs;Normal Cell;Pathogenesis;Pathologic;Pathologic Processes;Pathway interactions;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;Phase;Play;Population;Process;Program Research Project Grants;Proteins;Pulmonary Fibrosis;Resources;Respiratory physiology;Role;Sampling;Signal Transduction;Slice;Sorting - Cell Movement;Structure of parenchyma of lung;TGFB1 gene;Testing;Tissues;Tunicamycin;Type II Epithelial Receptor Cell;alveolar type II cell;comparative;endoplasmic reticulum stress;epithelial to mesenchymal transition;extracellular;human tissue;in vitro Model;inhibitor/antagonist;molecular marker;novel;protein expression;response;response to injury","Human Cells and Tissues/Sheppard","RELEVANCE (See instructions): 
By completing the proposed aims the human tissue core will provide quality human samples that can be used for studies that address significant gaps in knowledge of the pathogenesis of IPF and aid in the development of novel therapies targeting pathologic processes including: 1) the unfolded protein response. 2) epithelial cell dependent TGFB activation and 3) epithelial to mesenchymal transition.","NHLBI","8401280","8/9/2012 12:00:00 AM","PAR-09-185","1P01HL108794-01A1","1","P01","HL","108794","01","A"," "," "," ","ZHL1-CSR-Q(M1)","7492","1859770","WOLTERS, PAUL J","Not Applicable","12","Unavailable","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","Domestic Higher Education","941432510","UNITED STATES","N","8/9/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","359468","359468"," ","229692","129776"," "," ",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Actins;Adhesions;Adhesives;Adipocytes;Adult;Biology;Blood Vessels;Cartilage;Cell Adhesion;Cell Differentiation process;Cell Lineage;Cell Proliferation;Cells;Cellular Morphology;Chondrocytes;Connective Tissue;Cues;Cytoskeleton;Degenerative Disorder;Disease;Extracellular Matrix;Fatty acid glycerol esters;Fibroblasts;Fibronectins;Foundations;Future;Goals;Grant;Healed;Homeostasis;Human;Human body;Implant;Integrins;Maintenance;Mechanics;Mesenchymal Stem Cells;Molecular;Multipotent Stem Cells;Muscle;Muscle Cells;Musculoskeletal;Osteoblasts;Osteogenesis;Osteoporosis;PPAR gamma;Pathway interactions;Physical environment;Play;Process;Regulation;Research;Research Personnel;Rest;Role;Signal Transduction;Source;Stem cells;System;Tissues;Work;adult stem cell;base;bone;calcification;daughter cell;design;extracellular;healing;injured;lipid biosynthesis;multipotent cell;novel;osteogenic;precursor cell;prevent;public health relevance;regenerative therapy;response;stem cell differentiation;stem cell fate;transcription factor","Mesenchymal Stem Cells and the Microenvironment","
PROJECT NARRATIVE (PI: Chen)
Human mesenchymal stem cells contribute to the maintenance and healing of many
musculoskeletal tissues, but they also can produce inappropriate cell lineages to exacerbate
disease, such as occurs with calcification of atherosclerotic vessels. They are now being
isolated as a promising source of stem cells for regenerative therapies, but again their utility
rests upon predictable control of their differentiation potential. This project is designed to
develop a better understanding of how adhesive and mechanical cues direct these stem cells to
differentiate into specific lineages, such that we may better design future approaches to treat or
prevent degenerative diseases.","NIGMS","8257527","4/16/2012 12:00:00 AM","PA-07-070","5R01GM074048-07","5","R01","GM","074048","07"," ","HAYNES, SUSAN R","5/1/2006 12:00:00 AM","4/30/2014 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","6130315","CHEN, CHRISTOPHER S","Not Applicable","03","BIOMEDICAL ENGINEERING","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","BIOMED ENGR/COL ENGR/ENGR STA","191046205","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","207900","124740"," ","332640",
"Breast Cancer; Cancer; Genetics","Affect;Base Sequence;Binding;Biological Assay;Breast Cancer Cell;Cancer Biology;Candidate Disease Gene;Cell Polarity;Cell-Cell Adhesion;Cells;Characteristics;Classification;Clinical;Collaborations;Computer Analysis;CpG Islands;Cytosine;Data;Data Set;Deamination;Development;Developmental Process;Disease;Epigenetic Process;Epithelial;Gene Expression;Genes;Genetic Transcription;Human;Immunohistochemistry;In Vitro;Individual;Lead;Letters;Malignant Neoplasms;Mammary Neoplasms;Maps;Mediating;Mentors;Mesenchymal;Methods;Methylation;Modification;Morbidity - disease rate;Neoplasm Metastasis;Outcome;Phenotype;Prevention;Primary Neoplasm;Process;Property;Rest;Role;Sampling;Sequence Analysis;Site;Solid Neoplasm;Specimen;Testing;Transcription Initiation;Vertebrates;activation-induced cytidine deaminase;base;cancer cell;cell behavior;chromatin immunoprecipitation;demethylation;driving force;epithelial to mesenchymal transition;experience;genome-wide;genome-wide analysis;in vivo;inhibitor/antagonist;knock-down;malignant breast neoplasm;mortality;nuclear reprogramming;prevent;promoter;therapeutic development;tumor","Epigenetic role of AID in the epithelial-mesenchymal transition in breast cancer","
NARRATIVE
Cancer is a disease in which cells abnormally multiply and spread. This is a proposal to investigate a newly
discovered mechanism that may allow cancer cells to change in ways that make it possible for them to spread
(metastasize). A better understanding of this process may lead to new ways to treat cancer and prevent
metastasis.","NCI","8336901","9/20/2012 12:00:00 AM","PAR-09-069","5K22CA163969-02","5","K22","CA","163969","02"," ","OJEIFO, JOHN O","9/21/2011 12:00:00 AM","8/31/2014 12:00:00 AM","Transition to Independence Study Section (I)[NCI-I]"," ","9618410","MUNOZ, DENISE PAULA","Not Applicable","13","Unavailable","076536184","PMDEB5ZPQQN3","076536184","PMDEB5ZPQQN3","US","37.837291","-122.26762","1514301","CHILDREN'S HOSPITAL & RES CTR AT OAKLAND","OAKLAND","CA","Independent Hospitals","946091609","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","148941","11915"," ","160856",
"Clinical Research; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Adaptor Signaling Protein;Affect;Ameloblasts;Area;Biomedical Technology;Cancer Biology;Cell Culture System;Cell Culture Techniques;Cell Maintenance;Cells;Cervical;Data;Dentin;Dentistry;Dentists;Development;Development Plans;Developmental Biology;Developmental Process;Doctor of Philosophy;Enamel Formation;Engineering;Ensure;Epithelial;Epithelium;FGFR2 gene;FRS2 gene;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Future;Generations;Goals;Growth;In Vitro;Incisor;Institutes;Instruction;Knock-out;Knockout Mice;Knowledge;Laboratories;Lesion;Light;Link;MAP Kinase Gene;Maintenance;Maxilla;Mediating;Mentors;Mesenchymal;Mesenchymal Stem Cells;Modeling;Molecular;Mus;Natural regeneration;Odontogenesis;Odontogenic Tumors;Oral;Oral Pathology;Organ;PI3K/AKT;Pathogenesis;Pathology;Pathway interactions;Phase;Phosphotransferases;Play;Postdoctoral Fellow;Prevention;Principal Investigator;Regenerative Medicine;Regulation;Reproduction;Research;Research Training;Resources;Role;Science;Scientist;Series;Signal Pathway;Signal Transduction;Stem cells;Surface;System;Techniques;Tissues;Tooth structure;Training;Training Programs;Vision;base;career;career development;college;graduate student;in vivo;insight;medical specialties;mouse development;mouse model;programs;public health relevance;reconstruction;research study;self-renewal;skills;stem;stem cell niche;tumor","Fibroblast Growth Factor signaling in odontogenic epithelial stem/progenitor cell","
7. Project Narrative
Stem cells derived from both epithelial and mesenchymal components are required for future
regeneration of whole teeth. The key for reconstruction from defined cellular and molecular
components and further elucidating the alterations in pathology depends on developing in vitro
systems that accurately recapitulate the in vivo functions. Although Fibroblast Growth Factors
(FGF) have been shown to play important roles in maintenance of the mouse incisor cervical
loop region where stem cells are thought to reside, the defined mechanism of FGF signaling is
not yet available for the odontogenic epithelial stem cells and surrounding microenvironment.
Our project is aimed at defining the FGF signaling pathways for the odontogenic epithelial stem
cells derived from mouse incisor cervical loops through an in vivo Fgfr2 tissue specific knockout
mouse model and developing in vitro sphere culture model.","NIDCR","8291917","6/7/2012 12:00:00 AM","PA-09-042","7K08DE020883-03","7","K08","DE","020883","03"," ","KING, LYNN M","7/1/2010 12:00:00 AM","7/31/2012 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","8803245","CHANG, JULIA YU FONG ","Not Applicable","17","NONE","835607441","HFT7XTHB6563","835607441","HFT7XTHB6563","US","30.561517","-96.274978","8266910","TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR","COLLEGE STATION","TX","OVERALL MEDICAL","778454375","UNITED STATES","N","7/1/2012 12:00:00 AM","7/31/2012 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","5918","473"," ","6391",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","AKT Signaling Pathway;Address;Adopted;Alkaline Phosphatase;Animal Model;Apoptosis;Apoptotic;Biocompatible Materials;Biological;Biomechanics;Bone Marrow;Bone Marrow Transplantation;Bone Regeneration;Calcium;Calvaria;Cell Culture Techniques;Cell Death;Cell Differentiation process;Cell Proliferation;Cell Survival;Cell Therapy;Cell Transplantation;Cell Transplants;Cell physiology;Cells;Characteristics;Clinical;Clinical Trials;Complex;Defect;Deposition;Development;Disease;Encapsulated;Engineering;Evaluation;Face;Family;Gel;Gelatin;Glycoproteins;Goals;Healed;Histological Techniques;Human;Imaging Techniques;In Vitro;Inflammatory;Injectable;Injury;Iron;Iron-Binding Proteins;Laboratories;Lactoferrin;Light;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Modeling;Musculoskeletal;Natural regeneration;Organ;Osteoblasts;Osteocalcin;Osteogenesis;Performance;Phenotype;Pilot Projects;Property;Rattus;Recombinants;Research;Serum;Site;Source;Staging;Stem cells;Technology;Testing;Therapeutic;Tissue Engineering;Tissues;Transferrin;Translations;Transplantation;Vascularization;base;body system;bone;design;healing;improved;in vivo;in vivo Model;injured;insight;member;osteoblast differentiation;osteogenic;osteogenic protein;osteopontin;prevent;regenerative;repository;response;self-renewal;skeletal;skeletal regeneration;stem;success;tissue regeneration;wound","Injectable Anabolic Biomaterials for Bone Regeneration"," PROJECT NARRATIVE Transplantation of bone marrow derived mesenchymal stem cells (BMSC) has great potential in tissue engineering. However, the cell based therapeutic strategies still pose significant translational challenges in terms of localized delivery: inability to retain the cells at the intended site, inability to maintain cell survival, cell proliferation, and differentiation in the altered microenvironment of the injury sit. The proposed study seeks to investigate the feasibility of developing an injectable regenerative biomaterial to serve as a cell-friendly artificial transient microenvironment at the injury site to
overcome some of these challenges associated with localized cell delivery.   
      

","NIAMS","8366964","6/12/2012 12:00:00 AM","PAR-09-031","1R03AR061575-01A1","1","R03","AR","061575","01","A","WANG, FEI","7/1/2012 12:00:00 AM","4/30/2015 12:00:00 AM","ZAR1-EHB(M1)"," ","8272967","NAIR, LAKSHMI S","Not Applicable","05","ORTHOPEDICS","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF MEDICINE","060305335","UNITED STATES","N","7/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","50000","25244"," ","75244",
"Autoimmune Disease; Biotechnology; Eye Disease and Disorders of Vision; Genetics; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Non-Human; Transplantation","Age;Alkalies;Autoimmune Diseases;Autoimmunity;Biological Preservation;Blindness;Burn injury;Cell Therapy;Cells;Characteristics;Chemical Burns;Confocal Microscopy;Congenital Abnormality;Connexin 43;Cornea;Corneal Diseases;Corneal Endothelium;Corneal Injury;Corneal Stroma;Corneal dystrophy;Defect;Differentiation Antigens;Disease;Doxycycline;Endothelial Cells;Endothelium;Epithelial Cells;Exhibits;Eye;Eye diseases;Failure;Fibroblasts;Functional disorder;Gene Mutation;Genetic;Healed;Hereditary Disease;Histology;Human;IL6 gene;Immune;Immune System Diseases;Immune response;Immunity;Immunohistochemistry;Infection;Inflammation;Inflammatory;Inflammatory Response;Injury;Interleukin-1;Keratoplasty;Knock-out;Laceration;Lead;Membrane;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Modeling;Mus;Mutation;Myofibroblast;Natural regeneration;Organ;Outcome;Pathology;Pattern;Penetrating Keratoplasty;Phenotype;Prevention;Production;Proteins;Regimen;Series;Sjogren&apos;s Syndrome;Solid;Stem cell transplant;Stem cells;Stevens-Johnson Syndrome;Surface;Syndrome;TNF gene;Tetanus Helper Peptide;Time;Trachoma;Transgenic Organisms;Transplantation;Trauma;Treatment Protocols;Vision;alternative treatment;anterior chamber;cell transformation;cell type;corneal epithelium;corneal scar;cytokine;disease phenotype;effective therapy;eye dryness;functional restoration;healing;improved;in vivo;injured;limbal;lumican;microbial;migration;mutant;postnatal;prevent;progenitor;repaired;research study;response;restoration;success;wound","Cell Therapy of Corneal Diseases with Umbilical Mesenchymal Stem Cells"," Corneal transplantation is still the most effective treatment for vision restoration of corneal blindness due to congenital gene mutation and acquired diseases such as trachoma, microbial infections, laceration, chemical burns. We are developing alternative treatment regimens using umbilical mesenchymal stem cell in lieu of corneal transplantation to ameliorate corneal diseases complicated by persistent and severe inflammation e.g., alkali burn, limbal deficiency and genetic mutation. The success of the proposed studies will lead to new strategies for treating eye diseases such as dry eye, Sjogren and Steve-Johnson syndromes, and corneal dystrophy caused by genetic mutation.     
  
    

","NEI","8536477","9/4/2012 12:00:00 AM","PA-10-067","3R01EY021768-02S1","3","R01","EY","021768","02","S","MCKIE, GEORGE ANN","9/30/2011 12:00:00 AM","8/31/2015 12:00:00 AM","Anterior Eye Disease Study Section[AED]"," ","1860239","KAO, WINSTON W","Not Applicable","01","OPHTHALMOLOGY","041064767","DZ4YCZ3QSPR5","041064767","DZ4YCZ3QSPR5","US","39.142998","-84.503581","1523902","UNIVERSITY OF CINCINNATI","CINCINNATI","OH","SCHOOLS OF MEDICINE","452210001","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","130589","41156"," ","171745",
"Biotechnology; Organ Transplantation; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Allografting;Biological Assay;Budgets;Cell model;Chicago;Clinical;Communication;Communities;Data;Data Analyses;Engraftment;Ensure;Genomics;Goals;Macaca fascicularis;Mesenchymal Stem Cells;Methods;Modeling;Organ;Outcome;Persons;Phenotype;Process;Proteomics;Protocols documentation;Publications;Reporting;Research;Sampling;Shipping;Ships;Solid;Supercomputing;Teleconferences;Testing;Transplantation;United States National Institutes of Health;Work;abstracting;base;improved;islet allograft;kidney allograft;meetings;nonhuman primate;novel;programs;regenerative;research study;tool;web site","Administrative Core","The findings from this study may provide for novel and superior methods to enhance the engraftment and long-term survival of solid organ and cellular allografts. Core A will oversee communication among the PIs, the NIH and the research community, in order to ensure high quality research that may ultimately benefit the public.","NIAID","8379593","7/20/2012 12:00:00 AM","PAR-10-271","5P01AI089556-02","5","P01","AI","089556","02"," "," "," "," ","ZAI1-MFH-I","6130","1859488","KENYON, NORMA S.","Not Applicable","27","Unavailable","052780918","F8THLJQSAF93","052780918","F8THLJQSAF93","US","25.775337","-80.209809","5221250","UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","CORAL GABLES","FL","Domestic Higher Education","331462926","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","60152","60152"," ","50407","9745"," "," ",
"Kidney Disease","Adult;Affect;Cells;Chemicals;Chimeric Proteins;Congenital Abnormality;Data;Development;Disease;Distal;Dominant-Negative Mutation;Embryo;Epithelial;Fishes;Fluorescence;Gene Expression;Genetic;Genetic Transcription;Health;Human;In Situ Hybridization;Kidney;Label;Lead;Mediating;Mesenchymal;Mesenchymal Differentiation;Methods;Monitor;Organ;Organism;Phenotype;Play;Process;Pronephric structure;Receptor Cell;Renal function;Reporter;Research Personnel;Role;Signal Transduction;System;Time;Transgenes;Transgenic Organisms;Work;Zebrafish;assay development;attenuation;beta catenin;body system;cancer stem cell;in vivo;insight;nephrogenesis;novel;receptor;response;self-renewal","Wnt signaling in zebrafish pronephric kidney development"," Wnt signaling is important in many aspects of human health, including development, disease, cancer and stem cell self-renewal. Understanding when and where Wnt signaling is happening and how it controls development in a simple fish kidney gives insights into how it acts in other organ systems, as well as how it can go awry and lead to disease in adults.  
    

","NIDDK","8367292","7/10/2012 12:00:00 AM","PA-10-110","5F32DK091998-02","5","F32","DK","091998","02"," ","MARIC-BILKAN, CHRISTINE","7/1/2011 12:00:00 AM","6/30/2013 12:00:00 AM","ZDK1-GRB-G(J1)S"," ","10580932","KAMEI, CARAMAI NANAE","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Training, Individual","2012"," "," ","NIDDK","52190"," "," ","52190",
"Clinical Research; Lung","Advisory Committees;Affect;Alveolar;Animal Model;Antioxidants;Area;Attenuated;Biology;Cell physiology;Cells;Cellular biology;Characteristics;Clinical;Data;Development;Educational Curriculum;Enzymes;Epithelial;Epithelial Cells;Extracellular Matrix;Fibrosis;Foundations;Future;Generations;Genetic Transcription;Glutathione;Goals;Health;Injury;Interstitial Lung Diseases;Investigation;K-Series Research Career Programs;Knowledge;Laboratories;Lead;Lung;Maintenance;Mediating;Mentors;Mesenchymal;Myofibroblast;NADPH Oxidase;NADPH Oxidase 1;Outcome;Oxidative Stress;Pathogenesis;Pathway interactions;Patients;Physiological;Play;Process;Reactive Oxygen Species;Reading;Research;Research Personnel;Research Proposals;Role;Science;Scientist;Signal Transduction;Source;Specimen;Stem cells;Structure;Supplementation;Technical Expertise;Transcription Factor 3;Transforming Growth Factors;Type II Epithelial Receptor Cell;Universities;base;cell type;cytokine;design;effective therapy;epithelial to mesenchymal transition;experience;improved;inhibitor/antagonist;injured;lung injury;lung repair;meetings;member;novel;oxidant stress;prevent;programs;public health relevance;repaired;stem;transcription factor","The role of reactive oxygen species in alveolar epithelial-mesenchymal transition","
Project Narrative
A mechanistic understanding of the pathogenesis of interstitial lung diseases may lead to the advent of
effective therapies that improve outcome for affected patients. This proposal seeks to determine manner by
which oxidative stress and antioxidant depletion promote abnormal lung repair and lead to fibrosis.","NHLBI","8268433","6/1/2012 12:00:00 AM","PA-09-042","5K08HL102258-03","5","K08","HL","102258","03"," ","COLOMBINI-HATCH, SANDRA","8/1/2010 12:00:00 AM","5/31/2015 12:00:00 AM","ZHL1-CSR-U(F1)"," ","9825559","VYAS-READ, SHILPA ","Not Applicable","05","PEDIATRICS","066469933","S352L5PJLMP8","066469933","S352L5PJLMP8","US","33.762977","-84.42296","2384501","EMORY UNIVERSITY","ATLANTA","GA","SCHOOLS OF MEDICINE","303224250","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","838","Other Research-Related","2012"," "," ","NHLBI","118750","9100"," ","127850",
"Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adult;Autologous;Biological;Bone Marrow;Bone Regeneration;Bone Transplantation;Bone callus;CXC Chemokines;CXCL12 gene;Cartilage;Cell Therapy;Cells;Cessation of life;Data;Elderly;Endosteal Cell;Endosteum;Engraftment;Enhancers;Formaldehyde;Fracture;Fracture Healing;Harvest;Healed;Homing;Hospitalization;In Vitro;Incidence;Individual;Laboratories;LacZ Genes;Lead;Limb structure;Mediating;Mesenchymal;Mesenchymal Stem Cells;Methods;Modeling;Molecular;Morbidity - disease rate;Mus;Nucleic Acid Regulatory Sequences;Osteoblasts;Osteogenesis;Patients;Pattern;Phase;Procedures;Process;Property;Publishing;Regulation;Regulatory Element;Reporter;Response Elements;Role;Seeds;Signal Transduction;Site;Societies;Soil;Staging;Stem cells;Stromal Cell-Derived Factor 1;Stromal Cells;Testing;Time Study;Tissues;Transgenic Mice;Transplantation;Transplanted tissue;United States;Work;base;bone;bone morphogenic protein;bone strength;cell type;chemokine receptor;economic cost;fascinate;healing;improved;in vivo;injured;interest;multipotent cell;novel;novel therapeutic intervention;osteoblast differentiation;osteogenic;paracrine;progenitor;promoter;regenerative;repaired;research study;stem;tibia;tissue regeneration","The Role of BMP2 in the Regenerative Effects of MSC in Fracture Repair"," There is a compelling need to develop novel therapies to improve fracture healing and to treat fractures that fail to heal (non-unions). The fracture healing process is impaired in 10-20% of the 6.2 million fractures occurring annually in the United States and prolonged fracture healing, especially in the elderly, correlates with increased incidence of morbidities. The studies proposed here will examine the mechanisms of the regenerative effects of mesenchymal stem cell-based therapies in promoting fracture healing.  
    

","NIAMS","8476936","6/26/2012 12:00:00 AM","PA-10-110","5F32AR060113-02","5","F32","AR","060113","02"," ","TYREE, BERNADETTE","7/1/2011 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-F10B-S(20)L]"," ","10265146","MYERS, TIMOTHY JOSEPH","Not Applicable","04","PEDIATRICS","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Training, Individual","2012"," "," ","NIAMS","58734"," "," ","58734",
"Biotechnology; Genetics; Pediatric","Architecture;Autopsy;Bacterial Infections;Biological Assay;Cell Culture Techniques;Cell Cycle Regulation;Cell Proliferation;Cell Therapy;Cells;Child;Complex;Comprehension;Defect;Development;Diagnosis;Disease;Embryo;Endothelial Cells;Endothelium;Gene Targeting;Generations;Genetic;Genetically Engineered Mouse;Growth;Health;Hematopoiesis;Hematopoietic;Homeobox Genes;Human;Immune response;Immunity;Intervention;Invaded;Knowledge;Lateral;Life;Light;Liver;Mammals;Mesenchymal;Mesenchymal Stem Cells;Mesenchyme;Mesoderm;Modeling;Molecular;Molecular Diagnosis;Molecular Genetics;Morphogenesis;Mouse Strains;Mus;Newborn Infant;Organ;Organogenesis;Pancreas;Pathogenesis;Pathway interactions;Population;Positioning Attribute;Primordium;Process;Proteins;Public Health;Relative (related person);Reporting;Research;Role;Sepsis;Spleen;Spleen Development;Staging;Stem cells;System;Testing;Tissues;Transcriptional Regulation;Transgenic Mice;Transgenic Organisms;Work;base;blood filter;cell type;established cell line;high risk;immortalized cell;mouse model;neglect;novel;prenatal;programs;reconstitution;repaired;research study","Genetic and Transcriptional Control of Spleen Development","Narrative: relevance to public health statement. 
 The complex architecture and functions of the spleen result from intimate interactions 
among different cell types: mesenchymal cells (""basic parenchyma""), invading endothelial cells and 
colonizing hematopoietic cells. In humans, the spleen has critical roles in early hematopoiesis, 
immunity and blood filtering and its absence (as in congenital asplenia, an under-diagnosed disorder 
often recognized only at autopsy) results in a high risk for life-threatening bacterial infections and 
fatal sepsis in newborns and children. Our long-term objective is to identify genetic pathways that 
control the successive stages of spleen development: morphogenesis, expansion, and influx of 
endothelial and hematopoietic cells, since these interrelated organogenetic processes are of utmost 
importance to spleen function and, as of yet, mostly unknown. We anticipate that the new knowledge 
generated from these studies will have a deep impact on the understanding of spleen function, 
including hematopoiesis and immune response. 
 In summary, the proposed work will shed light on novel genetic and molecular networks 
that underlie the ontogeny of the spleen, a neglected organ in regard to its development. Lastly, our 
studies aspire to provide a better comprehension of the pathogenesis of congenital asplenia, as we 
put forth the prerequisite basic genetic background towards prenatal molecular diagnosis of this 
condition, which results in heavily impaired immune response to deadly bacterial infections.","NICHD","8278674","5/4/2012 12:00:00 AM","PA-07-070","5R01HD061403-03","5","R01","HD","061403","03"," ","COULOMBE, JAMES N","9/15/2010 12:00:00 AM","5/31/2015 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","1980680","SELLERI, LICIA ","Not Applicable","12","ANATOMY/CELL BIOLOGY","060217502","YNT8TCJH8FQ8","060217502","YNT8TCJH8FQ8","US","40.76491","-73.955055","1514803","WEILL MEDICAL COLL OF CORNELL UNIV","NEW YORK","NY","SCHOOLS OF MEDICINE","100654805","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","199200","137448"," ","336648",
"Dental/Oral and Craniofacial Disease; Pediatric","Architecture;Beak;Birds;Branchial arch structure;Cartilage;Cell Communication;Cells;Cephalic;Cleft Lip;Complex;Congenital Abnormality;Development;Embryonic Development;Epithelial;Epithelial Cells;Exhibits;FGF8 gene;Face;Gene Expression;Genes;Genetic;Goals;Growth;Head;Health;Human;Jaw;Knowledge;Lip structure;Mesenchymal;Mesenchymal Differentiation;Molecular;Molecular Target;Morphogenesis;Mus;Mutation;Nature;Neural Crest;Organ Culture Techniques;Palate;Pathogenesis;Pathway interactions;Pattern;Process;Rodent;Secondary Palate;Shapes;Signal Pathway;Signal Transduction;Signaling Molecule;Structure;Swelling;Testing;Therapeutic;Tissues;base;bone;craniofacial;craniofacial complex;gain of function;loss of function;malformation;migration;mutant;programs;skeletal;spatiotemporal;transcription factor","Epithelial Signaling of Mammalian Facial Topology","
Craniofacial malformations resulting from genetic alterations and/or environmental insults are among
the most common forms of human birth defects. Accordingly, understanding the underlying molecular
mechanisms of epithelial signaling is of paramount importance in understanding facial morphogenesis
and pathogenesis. The overall goal of the proposed studies is to identify epithelial signals that regulate
facial morphogenesis and ultimately to establish molecular targets of therapeutics for craniofacial
anomalies.","NIDCR","8268925","4/23/2012 12:00:00 AM","PA-07-070","5R01DE019823-04","5","R01","DE","019823","04"," ","SCHOLNICK, STEVEN","5/13/2009 12:00:00 AM","4/30/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","2563587","LI, XUE SEAN","Not Applicable","07","Unavailable","076593722","Z1L9F1MM1RY3","076593722","Z1L9F1MM1RY3","US","42.340629","-71.094923","1504801","BOSTON CHILDREN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021155724","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","245025","181319"," ","426344",
"Cancer; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human","Address;Adipocytes;Area;Basement membrane;Cell Communication;Cell Differentiation process;Cell Lineage;Cells;Chemotactic Factors;Commit;Dermal;Dermis;Development;Down-Regulation;Employee Strikes;Environment;Epidermis;Epithelial Cells;Equilibrium;Funding;Hair;Hair follicle structure;Home environment;Human;Invaded;Investigation;Laboratories;Lead;Learning;Life;Ligands;Malignant - descriptor;Mediating;Melanoma Cell;Mesenchymal;Mesenchymal Stem Cells;Modeling;Neural Crest;Neurons;Notch and Wnt Signaling Pathway;Pathway interactions;Phenotype;Pigmentation physiologic function;Pigments;Plastics;Process;Property;Signal Transduction;Skin;Stem cells;Systems Biology;Testing;Tissues;Work;bone cell;cancer cell;cartilage cell;human SFRP4 protein;insight;keratinocyte;melanocyte;melanoma;neoplastic cell;notch protein;novel therapeutics;public health relevance;self-renewal;stem cell differentiation;stem cell niche;stemness;three-dimensional modeling","Cell-cell communication during melanoma development","
Public Health Relevance
We have discovered a new stem cell in human skin that has many properties in common
with malignant cells. These stem cells are located in the lower compartment of the skin,
the dermis, and can change to become melanocytes, neuronal cells, fat cells, bone cells
or cartilage cells. We plan to study how they can be maintained in the skin, what it takes
for them to migrate to the upper compartment of the skin, the epidermis, and what
triggers their change to pigment-producing melanocytes. The stem cells share many
molecules in common with melanoma cells but not with normal melanocytes, suggesting
that melanoma cells should be compared to the stem cells and not the melanocytes. As
we learn more about the stem cells, we begin to better understand how tumor cells
migrate and invade through tissues.","NCI","8251130","3/22/2012 12:00:00 AM","PA-10-067","5R01CA076674-14","5","R01","CA","076674","14"," ","SATHYAMOORTHY, NEERAJA","12/5/1997 12:00:00 AM","3/31/2016 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","2795105","HERLYN, MEENHARD F","Not Applicable","03","Unavailable","075524595","DW1XZMGNFBL4","075524595","DW1XZMGNFBL4","US","39.950872","-75.195321","9340401","WISTAR INSTITUTE","PHILADELPHIA","PA","Research Institutes","191044265","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","165480","97866"," ","263346",
"Cardiovascular; Genetics; Heart Disease; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Actins;Aorta;Aortic Aneurysm;Atherosclerosis;Attenuated;Biochemical;Biological Assay;Blood Vessels;Cardiovascular Diseases;Cell Differentiation process;Cell Fate Control;Cell Maturation;Complement;Contractile Proteins;Data;Development;Disease;Dorsal;Embryo;Embryonic Development;Gene Targeting;Genes;Genetic;Genetic Transcription;Goals;Hour;Human;Hypertension;Knockout Mice;LacZ Genes;Mediating;Mesenchymal;Mesenchymal Stem Cells;Molecular;Morphology;Muscle Contraction;Myosin Heavy Chains;Neural Crest;Nuclear;Pathogenesis;Pathway interactions;Phenotype;Play;Prevention;Process;Proteins;Publishing;Rattus;Role;Signaling Molecule;Smad Proteins;Smad protein;Smooth Muscle;Smooth Muscle Myocytes;Staging;Stem cells;Testing;Therapeutic Agents;Tissues;Transforming Growth Factors;Transgenic Mice;congenital heart disorder;human embryonic stem cell;in vivo;insight;knockout gene;mouse model;myocardin;novel;novel therapeutics;progenitor;promoter;protein expression;public health relevance;response;restenosis;therapeutic target","Smooth Muscle Differentiation and Maturation","
Project Narrative
 
Vascular smooth muscle cell differentiation is a very important process during the development of blood
vessels and it is well recognized that alterations in this process play a role in the pathogenesis and progression
of several prominent cardiovascular disease states including atherosclerosis, congenital heart diseases, aortic
aneurysm,  hypertension, and restenosis. Our proposal examining the molecular mechanisms that regulate
smooth muscle differentiation should help to identify therapeutic targets for the treatment of these diseases.","NHLBI","8249061","4/2/2012 12:00:00 AM","PA-10-067","5R01HL107526-02","5","R01","HL","107526","02"," ","REID, DIANE M","4/1/2011 12:00:00 AM","3/31/2015 12:00:00 AM","Vascular Cell and Molecular Biology Study Section[VCMB]"," ","8039541","CHEN, SHIYOU ","Not Applicable","10","PHYSIOLOGY","004315578","NMJHD63STRC5","004315578","NMJHD63STRC5","US","33.933474","-83.375853","676602","UNIVERSITY OF GEORGIA","ATHENS","GA","SCHOOLS OF VETERINARY MEDICINE","306021589","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","121250"," ","371250",
"Acute Respiratory Distress Syndrome; Hematology; Infectious Diseases; Lung; Rare Diseases; Regenerative Medicine; Septicemia; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acute Lung Injury;Address;Biological Assay;Blood;Blood Vessels;Blood capillaries;Bone Marrow;Cell Communication;Cells;Communication;Confocal Microscopy;Connexin 43;Connexins;Cytoprotection;Data;Development;Diffusion;E-Cadherin;Endothelial Cells;Endothelium;Figs - dietary;Fluorescence Resonance Energy Transfer;Focal Adhesion Kinase 1;Focal Adhesions;Goals;Hydrogen Peroxide;Image;Immunofluorescence Immunologic;Inflammation;Inflammatory;Investigation;Knowledge;Lung;Lung diseases;Mesenchymal Stem Cells;Microcirculatory Bed;Microvascular Permeability;Mitochondria;Mus;Phosphorylation;Procedures;Production;Proteins;Reporting;Research;Role;Sepsis;Signal Transduction;Small Interfering RNA;TNFRSF1A gene;Testing;Therapeutic;Therapeutic Agents;Time;Tumor Necrosis Factor-alpha;Ursidae Family;capillary;chemokine;fluorophore;follow-up;matrigel;mutant;novel;optical imaging;protective effect;receptor;response;septic;trafficking;two-photon","OPTICAL IMAGING OF MESENCHYMAL STEM CELL INTERACTIONS WITH LUNG MICROVESSELS","
PROJECT NARRATIVE
This project aims to determine fundamental mechanisms underlying interactions between
intravenously injected, bone-marrow derived mesenchymal stem cells (MSCs) and intact lung
microvessels. The findings of this research are likely to impact understanding of mechanisms of
acute lung injury and the development of relevant therapy.","NHLBI","8304979","7/18/2012 12:00:00 AM","PA-07-070","5R01HL057556-17","5","R01","HL","057556","17"," ","MOORE, TIMOTHY M","9/12/1997 12:00:00 AM","7/31/2014 12:00:00 AM","Respiratory Integrative Biology and Translational Research Study Section[RIBT]"," ","1861590","BHATTACHARYA, JAHAR ","Not Applicable","13","INTERNAL MEDICINE/MEDICINE","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","SCHOOLS OF MEDICINE","100323725","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","150975"," ","398475",
"Aging; Biotechnology; Genetics; Osteoporosis; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adipocytes;Adult;Affect;Age;Age-Related Bone Loss;Aging;Biological Assay;Bone Density;Bone Marrow;Bone remodeling;Cell Differentiation process;Cells;Characteristics;DEXA;Data;Dependence;Development;Disease Management;Elderly;Electrophoretic Mobility Shift Assay;Exhibits;Extramedullary;Fatty acid glycerol esters;Fibroblast Growth Factor 2;Fibroblast Growth Factor Receptors;Funding;Gene Expression;Genes;Genetic;Genotype;Health;Immunohistochemistry;In Vitro;Knockout Mice;Lead;Maintenance;Marrow;Mediating;Mesenchymal;Mesenchymal Stem Cells;Modeling;Molecular;Mus;Osteoblasts;Osteogenesis;Osteopenia;Pathway interactions;Patients;Peroxisome Proliferator-Activated Receptors;Phenotype;RNA;Regulation;Reporter;Reverse Transcriptase Polymerase Chain Reaction;Role;Senile Osteoporosis;Serum;Signal Pathway;Signal Transduction;Signaling Molecule;Site-Directed Mutagenesis;Stromal Cells;Testing;Transfection;Transgenes;Visual;Western Blotting;Work;aged;base;bone;bone mass;in vivo;lipid biosynthesis;novel;osteoblast differentiation;osteoclastogenesis;osteogenic;progenitor;promoter;protein expression;response;stem cell differentiation;therapeutic target;young adult","Action of Anabolic Factors on Bone Formation in Mice","n/a","NIA","8278563","5/14/2012 12:00:00 AM","PA-07-070","5R01AG021189-09","5","R01","AG","021189","09"," ","WILLIAMS, JOHN","4/15/2004 12:00:00 AM","2/28/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1864509","HURLEY, MARJA MARIE","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF MEDICINE","060305335","UNITED STATES","N","6/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","866","Non-SBIR/STTR","2012"," "," ","NIA","195076","93636"," ","288712",
"Lung; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Adult;Alveolar Cell;Alveolus;Animals;Antioxidants;Apoptosis;Area;Asbestos;Biochemical;Biodistribution;Biological Models;Bleomycin;Bone Marrow;Cell Culture Techniques;Cell Survival;Cells;Chronic;Deposition;Development;Diagnosis;Disease;Doctor of Philosophy;Engraftment;Environment;Enzymes;Equilibrium;Excision;Exposure to;Extracellular Matrix;Extracellular Space;Fibroblasts;Fibrosis;Genes;Goals;Heparin Binding;Impairment;In Vitro;Inflammatory;Injury;Knockout Mice;Knowledge;Lead;Longevity;Lung;Lung Inflammation;Lung diseases;Mediating;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Modality;Modeling;Mus;Myofibroblast;Natural regeneration;Nodule;Outcome;Oxidants;Oxidative Stress;Pathogenesis;Patients;Pharmaceutical Preparations;Play;Protein Region;Public Health;Pulmonary Fibrosis;Radiation;Reaction;Reactive Oxygen Species;Research Personnel;Role;Silicon Dioxide;Silicosis;Site;Stem cells;Structure;Structure of parenchyma of lung;Superoxide Dismutase;Testing;Therapeutic;Tissues;Translating;Transplantation;Work;adult stem cell;alveolar destruction;design;effective therapy;extracellular;improved;in vivo;induced pluripotent stem cell;injured;intravenous administration;lung development;lung injury;lung repair;migration;mimetics;outcome forecast;overexpression;particle;prevent;programs;repaired;respiratory;response;restoration;tissue regeneration;tissue repair;treatment strategy","The role of ECSODF in lung repair after silica-induces injury","n/a","NIEHS","8299125","7/1/2012 12:00:00 AM","RFA-ES-06-007","5R01ES016000-05","5","R01","ES","016000","05"," ","NADADUR, SRIKANTH","9/15/2007 12:00:00 AM","6/30/2014 12:00:00 AM","ZES1-JAB-C(R1)"," ","6437472","FATTMAN, CHERYL L","Not Applicable","18","PUBLIC HEALTH & PREV MEDICINE","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF PUBLIC HEALTH","152133320","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","NIEHS","257527","124901"," ","382428",
"Eye Disease and Disorders of Vision; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adult;Antibodies;Antigens;Applications Grants;Cataract Extraction;Cell physiology;Cells;Cellular biology;Characteristics;Chick Embryo;Cornea;Cytokine Signaling;DNA biosynthesis;Debridement;Developmental Process;Disease;Embryo;Enzyme Induction;Epiblast;Epigenetic Process;Epithelial;Epithelial Cells;Epithelium;Eye;Fibrosis;Germ Layers;Healed;Hematopoietic;Injury;Investigation;Knowledge;Link;Mediating;Mesenchymal;Mesenchymal Stem Cells;Modeling;Movement;Myofibroblast;Occupations;Paper;Phenotype;Play;Polyploidy;Population;Population Sizes;Process;Property;Proteins;Rattus;Recruitment Activity;Reporting;Role;Signal Pathway;Signal Transduction;Site;Source;Stem cells;Surface Antigens;Time;Tissues;Vimentin;Wound Healing;capsule;cell injury;cell type;corneal epithelium;corneal scar;gene repression;healing;injury and repair;lens;novel;precursor cell;progenitor;repaired;response;response to injury;tissue regeneration;transcription factor;transdifferentiation;wound","Paradigms of Wound Healing and Fibrosis in the Eye","
The knowledge gained from our studies of a novel population of progenitor cells, innate
to epithelial tissues, that upon wounding are activated to form the repair cells that
modulate the wound response, is expected to reveal novel targets for enhancing wound
repair and tissue regeneration. Furthermore, our findings that the progeny of these cells
also are a principal source of myofibroblasts, a cell type associated with fibrotic diseases
such as PCO and corneal scarring, suggest that the results of our studies also will have
a major impact on understanding of mechanisms of disease.","NEI","8328686","7/24/2012 12:00:00 AM","PA-10-067","5R01EY021784-02","5","R01","EY","021784","02"," ","ARAJ, HOUMAM H","9/30/2011 12:00:00 AM","8/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BDCN-N(02)M]"," ","1883352","MENKO, A. SUE","STEPP, MARY ANN ","03","PATHOLOGY","053284659","R8JEVL4ULGB7","053284659","R8JEVL4ULGB7","US","39.949004","-75.155569","4050801","THOMAS JEFFERSON UNIVERSITY","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191074418","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","302114","91988"," ","394102",
"Cancer; Clinical Research; Pediatric; Pediatric Research Initiative; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","ACVR1 gene;Adipocytes;Adipose tissue;Birth;Blood Vessels;CCL2 gene;Caucasians;Caucasoid Race;Cell Differentiation process;Cells;Child;Cicatrix;Common Neoplasm;Data;Development;Disease;Doxycycline;Endothelial Cells;Fatty acid glycerol esters;Goals;Hemangioma;Implant;Infiltration;Inflammatory;Insulin-Like Growth Factor I;Invaded;Knowledge;Lead;Lesion;Life;Mediating;Mesenchymal;Mesenchymal Stem Cells;Molecular;Multipotent Stem Cells;Mus;Neoplasms in Vascular Tissue;Pathologic Processes;Patients;Phase;Phenotype;Physiological Processes;Population;Primary Cell Cultures;Process;Proliferating;Role;Stem cells;Testing;Time;Tissues;Transgenic Mice;angiogenesis;base;cadherin 5;cytokine;human disease;human tissue;in vivo;infancy;insight;lipid biosynthesis;macrophage;mouse model;mutant;neoplastic;novel;novel therapeutics;receptor;stem;tumor;tumor growth","Endothelial Plasticity in Human Disease","Hemangioma is the most common tumor effecting children, with approximately 10% of the Caucasian population developing some form of the disease. Despite the fact that most hemangiomas naturally regress over time, they can cause scarring and disfigurement of patients and many can be life threatening. Our proposed studies will help to understand the cause of hemangioma regression, which may lead to development of novel therapeutic treatments for vascular tumors and potentially other diseases.","NHLBI","8272059","4/16/2012 12:00:00 AM","PA-10-067","1R01HL112860-01","1","R01","HL","112860","01"," ","OH, YOUNGSUK","5/1/2012 12:00:00 AM","6/30/2012 12:00:00 AM","Vascular Cell and Molecular Biology Study Section[VCMB]"," ","9349015","MEDICI, DAMIAN ","Not Applicable","07","DENTISTRY","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","SCHOOLS OF DENTISTRY/ORAL HYGN","021201616","UNITED STATES","N","5/1/2012 12:00:00 AM","6/30/2012 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","38320","10266"," ","48586",
"Autoimmune Disease; Biotechnology; Eye Disease and Disorders of Vision; Genetics; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Non-Human; Transplantation","Age;Alkalies;Autoimmune Diseases;Autoimmunity;Biological Preservation;Blindness;Burn injury;Cell Therapy;Cells;Characteristics;Chemical Burns;Confocal Microscopy;Congenital Abnormality;Connexin 43;Cornea;Corneal Diseases;Corneal Endothelium;Corneal Injury;Corneal Stroma;Corneal dystrophy;Defect;Differentiation Antigens;Disease;Doxycycline;Endothelial Cells;Endothelium;Epithelial Cells;Exhibits;Eye;Eye diseases;Failure;Fibroblasts;Functional disorder;Gene Mutation;Genetic;Healed;Hereditary Disease;Histology;Human;IL6 gene;Immune;Immune System Diseases;Immune response;Immunity;Immunohistochemistry;Infection;Inflammation;Inflammatory;Inflammatory Response;Injury;Interleukin-1;Keratoplasty;Knock-out;Laceration;Lead;Membrane;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Modeling;Mus;Mutation;Myofibroblast;Natural regeneration;Organ;Outcome;Pathology;Pattern;Penetrating Keratoplasty;Phenotype;Prevention;Production;Proteins;Regimen;Series;Sjogren&apos;s Syndrome;Solid;Stem cell transplant;Stem cells;Stevens-Johnson Syndrome;Surface;Syndrome;TNF gene;Tetanus Helper Peptide;Time;Trachoma;Transgenic Organisms;Transplantation;Trauma;Treatment Protocols;Vision;alternative treatment;anterior chamber;cell transformation;cell type;corneal epithelium;corneal scar;cytokine;disease phenotype;effective therapy;eye dryness;functional restoration;healing;improved;in vivo;injured;limbal;lumican;microbial;migration;mutant;postnatal;prevent;progenitor;repaired;research study;response;restoration;success;wound","Cell Therapy of Corneal Diseases with Umbilical Mesenchymal Stem Cells"," Corneal transplantation is still the most effective treatment for vision restoration of corneal blindness due to congenital gene mutation and acquired diseases such as trachoma, microbial infections, laceration, chemical burns. We are developing alternative treatment regimens using umbilical mesenchymal stem cell in lieu of corneal transplantation to ameliorate corneal diseases complicated by persistent and severe inflammation e.g., alkali burn, limbal deficiency and genetic mutation. The success of the proposed studies will lead to new strategies for treating eye diseases such as dry eye, Sjogren and Steve-Johnson syndromes, and corneal dystrophy caused by genetic mutation.     
  
    

","NEI","8328680","8/16/2012 12:00:00 AM","PA-10-067","5R01EY021768-02","5","R01","EY","021768","02"," ","MCKIE, GEORGE ANN","9/30/2011 12:00:00 AM","8/31/2015 12:00:00 AM","Anterior Eye Disease Study Section[AED]"," ","1860239","KAO, WINSTON W","Not Applicable","01","OPHTHALMOLOGY","041064767","DZ4YCZ3QSPR5","041064767","DZ4YCZ3QSPR5","US","39.142998","-84.503581","1523902","UNIVERSITY OF CINCINNATI","CINCINNATI","OH","SCHOOLS OF MEDICINE","452210001","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","337838","192568"," ","530406",
"No NIH Category available","Acute;Adult;Affect;Americas;Animal Care and Use Committees;Animals;Apoptosis;Autologous;Axotomy;Behavioral;Biological;Biological Assay;Biological Factors;Bone Marrow;Boston;Brain;Brain-Derived Neurotrophic Factor;Cell Culture Techniques;Cell Density;Cell Survival;Cells;Chronic;Cicatrix;Ciliary Neurotrophic Factor;Clinical;Coculture Techniques;Data;Demyelinations;Disease;Electrophysiology (science);Engraftment;Environment;Equipment and supply inventories;Evaluation;Event;Evolution;Extracellular Matrix;Foundations;Functional disorder;GDNF gene;Glycolates;Goals;Healthcare Systems;Human;Human Biology;Implant;In Vitro;Inflammation;Inflammatory Response;Injection of therapeutic agent;Injury;Length;Lesion;Life;Link;Lipopolysaccharides;Measures;Mediating;Mesenchymal;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Metabolic Diseases;Modeling;Molecular;Motor;Motor Neurons;Natural regeneration;Nerve;Nerve Regeneration;Neuraxis;Neurites;Neurodegenerative Disorders;Neurologic;Neuronal Plasticity;Neurons;Oligodendroglia;Outcome;Paralysed;Pathologic Processes;Pathology;Patients;Physical Medicine;Physical activity;Pilot Projects;Play;Polymers;Procedures;Process;Proteins;Protocols documentation;Publishing;Randomized;Rattus;Recovery;Recovery of Function;Regenerative Medicine;Regimen;Rehabilitation therapy;Reporting;Role;Sensory;Sensory Disorders;Site;Solid;Spinal Cord;Spinal Ganglia;Spinal cord injury;Stem cells;Students;System;Testing;Therapeutic;Therapeutic Effect;Time;Tissues;Transplantation;Traumatic Brain Injury;Treatment Effectiveness;Treatment Efficacy;Tumor Necrosis Factor-alpha;Veterans;Western Blotting;Work;adult stem cell;base;biodegradable polymer;chronic neuropathic pain;clinical application;design;effective therapy;environmental enrichment for laboratory animals;functional disability;functional improvement;human TNF protein;human stem cells;immunoregulation;in vivo;inflammatory marker;nerve stem cell;neuroprotection;nitration;novel;novel therapeutics;open wound;painful neuropathy;present value;prototype;receptor;regenerative;regenerative agent;relating to nervous system;repaired;restoration;scaffold;spinal cord repair;spinal reflex","Polymer-Stabilized Mesenchymal Stem Cells for Spinal Cord Repair","We plan to study how to use polymer scaffolds to increase the survival of transplanted adult stem cells isolated from the bone marrow to treat spinal cord injury (SCI). Because adult stem cells normally do not survive well after transplantation in the injured spinal cord, which abolishes their treatment effectiveness, understanding how to reduce their post-injection loss by using protective polymers is key for helping apply bone marrow derived stem cells to repair the spinal cord and brain following injury insult or other diseases. Because this type of stem cells can be easily prepared from people who live with SCI or other nerve disorder conditions, this kind of treatment, if successfully devised, also allows the patients to use their own stem cells as transplants so that their bodies will not reject the implanted cells.","VA","8005372","4/26/2012 12:00:00 AM","RFA-RX-10-001","1I01RX000308-01A1","1","I01","RX","000308","01","A"," ","11/1/2010 12:00:00 AM","10/31/2014 12:00:00 AM","Regenerative Rehabilitation[RRD0]"," ","8101213","TENG, YANG D.","Not Applicable","07","Unavailable","034432265","DNXEHSXERCX7","034432265","DNXEHSXERCX7","US","42.328117","-71.110686","481041","VA BOSTON HEALTH CARE SYSTEM","BOSTON","MA","Independent Hospitals","021304817","UNITED STATES","N","11/1/2010 12:00:00 AM","10/31/2014 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"No NIH Category available","Abdomen;Acute;Affect;Agonist;Bone Marrow;Bone Marrow Transplantation;Cell Survival;Cell Therapy;Cell Transplantation;Cells;Cutaneous;Endothelial Cells;Endothelial Growth Factors;Event;Exposure to;Goals;Growth Factor;Hematopoiesis;Hematopoietic;Inflammatory;Intestines;Measures;Mediating;Mesenchymal;Mesenchymal Stem Cell Transplantation;Molecular;Molecular Target;Mus;Natural regeneration;Radiation;Radiation Injuries;Radiation Syndromes;Radiation-Protective Agents;Recovery;Signal Pathway;Signal Transduction;Stem cell transplant;Stem cells;Stromal Cells;Syndrome;System;Tissues;Topical agent;Validation;Vertebrates;Wound Healing;Zebrafish;base;cell growth;gastrointestinal;inhibitor/antagonist;irradiation;macrophage;nanoparticle;novel strategies;repaired;stem cell niche;success","Stem Cell-Based Therapies for Mitigation of Acute Radiation Syndromes","RELEVANCE: The CMCR offers many deliverables, such as, intestinal stem cell growth factor, R-spondin1, TLR agonists, GSK inhibitors, Nanoparticle-NO topical agent for wound healing, and endothelial growth factors for mitigation of ARS. Cell based therapies raise hope as transplantation of bone marrow stromal cells mitigate RIGS, 24 hrs after exposure to 18 Gy whole abdominal irradiation.","NIAID","8308344","7/27/2012 12:00:00 AM","RFA-AI-09-036","5U19AI091175-03","5","U19","AI","091175","03"," ","MACCHIARINI, FRANCESCA","8/1/2010 12:00:00 AM","7/31/2015 12:00:00 AM","ZAI1-KS-I(M1)"," ","7274991","GUHA, CHANDAN ","Not Applicable","14","RADIATION-DIAGNOSTIC/ONCOLOGY","110521739"," ","110521739"," ","US","40.851026","-73.844361","9433501","ALBERT EINSTEIN COLLEGE OF MEDICINE","BRONX","NY","SCHOOLS OF MEDICINE","104611900","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","855","Non-SBIR/STTR","2012"," "," ","OD","1921116","1070542"," ","2991658",
"Bioengineering; Clinical Research; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Affect;Annual Reports;Applications Grants;Award;BMP4;Bone Matrix;California;Cell Communication;Cell Density;Cell Therapy;Cell physiology;Cells;Cellular biology;Centers for Disease Control and Prevention (U.S.);Clinical;Collagen Type I;Complex;Coupled;Cyclic AMP;Cytokeratin-14 Staining Method;Data;Dental;Dental Pulp;Dental caries;Dental crowns;Dentin;Dentin Formation;Dentists;Development;Development Plans;Developmental Biology;Discipline;Doctor of Philosophy;Drug Design;Educational workshop;Engineering;Environment;Environmental Risk Factor;Epithelial;Epithelial Cells;Epithelium;Event;FGF9 gene;Faculty;Failure;Fostering;Foundations;Funding;Future;G Protein-Coupled Receptor Signaling;G-Protein-Coupled Receptors;GTP-Binding Proteins;Goals;Growth Factor;Healed;Healthcare;Histocompatibility Testing;Hour;In Situ;Interdisciplinary Study;International;Journals;K-Series Research Career Programs;Knowledge;Lead;Learning;Ligands;Mediating;Medicine;Mentors;Mentorship;Mesenchymal;Mesenchymal Differentiation;Mesenchymal Stem Cells;Mesenchyme;Modeling;Molecular Biology;Morphology;Mus;National Institute of Dental and Craniofacial Research;Natural regeneration;Odontoblasts;Oral health;Phase;Physiological;Plant Roots;Production;Proteins;Pulp Chambers;Recurrence;Reporting;Research;Research Activity;Research Personnel;Research Training;Resources;Role;San Francisco;Schools;Scientist;Signal Pathway;Signal Transduction;Signaling Molecule;Specificity;Stem Cell Research;Stem cells;Testing;Tissue Engineering;Tissues;Tooth Cell;Tooth structure;Training;Training Support;Transgenic Mice;Tubular formation;Universities;Work;bone;career development;cell type;cost;cost effectiveness;dental genetics;experience;healing;improved;insight;keratin 5;malformation;material fatigue;member;mouse model;novel strategies;osteoblast differentiation;precursor cell;progenitor;programs;promoter;receptor;receptor function;repaired;research and development;restorative material;skills;transcription factor","Modeling Dentin by G Protein Coupled Receptor Signaling"," This K08 application will provide an optimal mentored environment and research training to direct Dr. Horst's further development as an independent clinician scientist. The proposed research plan is to determine the role of G protein signaling in guiding the development of tooth progenitor cells and the formation of the dentin-pulp complex. Completion of this project will lay the groundwork for novel strategies to guide the regeneration and repair of dentin.  
    

","NIDCR","8328604","8/17/2012 12:00:00 AM","PA-10-059","5K08DE022377-02","5","K08","DE","022377","02"," ","KING, LYNN M","9/5/2011 12:00:00 AM","8/31/2016 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","9556006","HORST, ORAPIN V","Not Applicable","12","DENTISTRY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","941432510","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","122373","9790"," ","132163",
"Biotechnology; Gene Therapy; Genetics; Neurodegenerative; Neuropathy; Neurosciences; Pain Conditions - Chronic; Pain Research; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Adult;Adverse effects;Afferent Neurons;Amputation;Analgesics;Anatomy;Animal Model;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Attention;Autologous;Behavioral;Bone Marrow;Cataloging;Catalogs;Cell Survival;Cell Therapy;Cell model;Cells;Clinical;Combined Modality Therapy;Data;Development;Dose;Electron Microscopy;Elements;Engineering;Engraftment;Ethics;Evaluation;Failure;Fatty acid glycerol esters;Gene Transfer;Genes;Genetic;Genetic Engineering;Genome;Goals;Implant;In Vitro;Injection of therapeutic agent;Interleukin-10;Lentivirus Vector;Ligation;Measures;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Modeling;Modification;Molecular;Molecular Target;Nature;Neuroglia;Neurons;Neuropathy;Pain;Pathway interactions;Patients;Peptide Signal Sequences;Peptides;Performance;Peripheral;Peripheral Nerves;Pharmaceutical Preparations;Pharmacology;Phenotype;Physiological;Process;Rattus;Reporter Genes;Research;Resistance;Route;Safety;Saline;Sensory;Site;Source;Specificity;Spinal Ganglia;Spinal nerve structure;Structure;Surgical Injuries;Surgical Replantation;Survival Rate;System;Techniques;Testing;Therapeutic;Therapy Clinical Trials;Time;Tissues;Toxic effect;Transgenes;Translating;Transplantation;Viral Vector;Virus;Work;afferent nerve;base;cellular engineering;cellular transduction;chronic neuropathic pain;chronic pain;cytokine;effective therapy;flexibility;ganglion cell;gene therapy;human subject;immunogenic;implantation;injury prevention;light microscopy;meetings;multipotent cell;nerve injury;neurotrophic factor;novel;novel strategies;pain behavior;painful neuropathy;prevent;programs;receptor;relating to nervous system;research study;response;small molecule;symposium;targeted delivery;tool;transgene expression;vector","DRG engraftment of transduced mesenchymal stem cells to treat neuropathic pain"," Chronic pain following nerve injury is common, intense in nature, and resistant to available treatments. The proposed research will develop the use of adult mesenchymal stem cells that can be derived from a patient's own bone marrow or fat, as a pain treatment. In a rat pain model, these cells will be genetically modified to  make them secrete analgesic substances, and then will be injected into the sensory nerves involved in  neuropathic pain, to develop a safe, powerful, and adaptable new technique for treating painful conditions.   
      

","NINDS","8341441","4/26/2012 12:00:00 AM","PA-11-260","1R01NS079626-01","1","R01","NS","079626","01"," ","OSHINSKY, MICHAEL L","6/1/2012 12:00:00 AM","5/31/2016 12:00:00 AM","Somatosensory and Chemosensory Systems Study Section[SCS]"," ","6198326","HOGAN, QUINN H","Not Applicable","05","ANESTHESIOLOGY","937639060","E8VWJXMMUQ67","937639060","E8VWJXMMUQ67","US","43.04575","-88.020374","46001","MEDICAL COLLEGE OF WISCONSIN","MILWAUKEE","WI","SCHOOLS OF MEDICINE","532263548","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","218750","56875"," ","275625",
"Autoimmune Disease; Biotechnology; Crohn's Disease; Digestive Diseases; Inflammatory Bowel Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adverse effects;Advisory Committees;Animal Model;Animals;Antigen Presentation;Antigen-Presenting Cells;Antigens;Atypical lymphocyte;Autoantigens;Autoimmune Diseases;Autoimmune Process;Autoimmunity;Automobile Driving;Award;Biodistribution;Biological Assay;Biomedical Engineering;Caring;Cell Communication;Cell Therapy;Cell Transplants;Cells;Chronic;Colitis;Colorectal;Crohn&apos;s disease;Dependence;Development Plans;Disease;Disease model;Engineering;Engraftment;Epithelial;Future;General Hospitals;Goals;Granuloma;Hand;Health Care Costs;Heterogeneity;Human;Image;Immune;Immune response;Immunogenetics;Immunology;Immunotherapy;Impairment;In Situ;In Vitro;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Infusion procedures;Intestines;Lesion;Lymphocyte;Lymphoid;Lymphoid Tissue;Massachusetts;Medical;Medicine;Mentored Research Scientist Development Award;Mentorship;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Methods;Modeling;Molecular;Monitor;Morbidity - disease rate;Mus;Natural Immunity;Operative Surgical Procedures;Organ;Outcome;Patients;Peripheral;Pharmaceutical Preparations;Phenotype;Population;Postdoctoral Fellow;Predisposition;Prevalence;Prevention;Process;Proteins;Radiology Specialty;Relapse;Research;Research Personnel;Research Project Grants;Self Tolerance;Stem cells;T-Lymphocyte;Testing;Therapeutic;Therapy Clinical Trials;Tissues;Training;Transplantation;Treatment Efficacy;Ulcerative Colitis;Variant;adaptive immunity;base;career development;cell type;cellular imaging;gastrointestinal;imaging modality;in vivo;medical schools;molecular imaging;molecular/cellular imaging;pre-clinical;prevent;professor;programs;public health relevance;response;stem cell fate;stem cell therapy","Peripheral Tissue Antigen Display by Mesenchymal Stem Cells","
Narrative
This is a Mentored Research Scientist Development Award application for Dr. Biju
Parekkadan a biomedical engineer by training with specialization in cell-based therapy.
He has developed new treatment approaches that harness the natural functions of
mesenchymal stem cells (MSCs) for therapy. Recently, he has discovered a new
function of MSCs that has significant relevance to the fields of autoimmunity and
transplantation. As a recently appointed postdoctoral fellow, Dr. Parekkadan submits this
five-year career development plan under the mentorship of Drs. Martin L. Yarmush, the
Helen Andrus Benedict Professor of Surgery and Bioengineering at Harvard Medical
School and the director of the Center for Engineering in Medicine, Ralph Weissleder,
Professor of Radiology at Harvard Medical School and the director of the Center for
Molecular Imaging Research at the Massachusetts General Hospital and Diane Mathis,
Professor of Immunology and Immunogenetics at Harvard Medical School. The award
includes extensive: (1) hand-on training in radiological and immunological studies of cell
transplants in vivo, (2) academic courses and seminars, and (3) guidance of a selected
advisory committee towards the future large-scale research projects.","NIDDK","8249440","3/26/2012 12:00:00 AM","PAR-09-060","5K01DK087770-03","5","K01","DK","087770","03"," ","PODSKALNY, JUDITH M,","4/1/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Digestive Diseases and Nutrition C Study Section[DDK-C]"," ","9605913","PAREKKADAN, BIJU ","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Other Research-Related","2012"," "," ","NIDDK","127750","10220"," ","137970",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute;Address;Animals;Automobile Driving;Biological Models;Biology;Bone Marrow;Bone Regeneration;CD15 Antigens;Cell Communication;Cell Count;Cell Culture Techniques;Cell Differentiation process;Cell Separation;Cell physiology;Cell surface;Cells;Cellular biology;Complex;Data;Development;Developmental Biology;Dissection;Dose;Environment;Environmental Risk Factor;Exhibits;Family;Fluorouracil;Gelatin;Goals;Harvest;Health;Hematology;Hematopoietic stem cells;Hemorrhage;Immunohistochemistry;Immunophenotyping;Implant;In Vitro;Learning;Left;Life;Maps;Marrow;Mediating;Mesenchymal;Mesenchymal Stem Cells;Methods;Modeling;Monitor;Mononuclear;Mus;Nature;Osteoblasts;Osteogenesis;PTPRC gene;Pathologic;Phenotype;Physiological;Plastics;Pluripotent Stem Cells;Population;Principal Investigator;Process;Property;Research Personnel;Stem Cell Factor;Stem cells;Stimulus;Stress;Stromal Cells;System;Testing;Time;Tissue Engineering;Transgenic Organisms;Transplantation;acute stress;base;bone;bone morphogenetic protein 2;bone morphogenetic protein 6;cell type;design;flexibility;in vivo;in vivo Bioassay;in vivo Model;innovation;osteoblast differentiation;programs;prospective;reconstitution;response;scaffold;stem cell differentiation;stem cell fate;stem cell niche;stem cell population;subcutaneous;tool","FunctionalCharacterization of the Stem Cell Niche","
Principal Investigator/Program Director (Last, First, Middle): Krebsbach, Paul H. and Taichman, Russell S
Project Narrative
A fundamental question in cellular and developmental biology is how a stem cell niche develops, and how
these niches support and maintain stem cell activity. We have pioneered the use of an in vivo model that we
will now use to functionally characterize our prospectively isolated MSCs. Our projects are designed to
understand the nature of these MSCs and how their microenvironment, including interactions with
hematopoietic stem cells (HSCs), influences their biologic activity. The overall hypothesis driving our project is
that a true mesenchymal stem cell exists within the bone marrow and the activity of this stem cell - including
interactions with hematopoietic stem cells - is dependent on its niche compartment.
PHS 398/2590 (Rev. 09/04, Reissued 4/2006) Page Continuation Format Page","NIDDK","8300198","5/24/2012 12:00:00 AM","PA-07-303","5R01DK082481-04","5","R01","DK","082481","04"," ","WRIGHT, DANIEL G","7/1/2009 12:00:00 AM","6/30/2014 12:00:00 AM","Hematopoiesis Study Section[HP]"," ","1884808","KREBSBACH, PAUL H","TAICHMAN, RUSSELL S","12","DENTISTRY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF DENTISTRY/ORAL HYGN","481091276","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","235224","125633"," ","360857",
"No NIH Category available","Acceleration;Acute;Address;Allogenic;Allografting;Amelia;Autologous;Award;Biological Markers;Biopsy;Bone Marrow Aspiration;Cell model;Chicago;Chronic;Clinical;Clinical Trials;Collaborations;Collection;Complex;Coupled;Data;Data Analyses;Diabetes Mellitus;Doctor of Philosophy;Dose;Engraftment;Experimental Designs;Gene Proteins;Genomics;Goals;Histocompatibility;Histocompatibility Testing;Hyperglycemia;Illinois;Immunity;Immunologics;Immunosuppression;Inflammation;Inflammatory;Insulin;Insulin-Dependent Diabetes Mellitus;Intravenous infusion procedures;Islets of Langerhans Transplantation;Joints;Kidney;Kidney Transplantation;Lead;Liver;Macaca fascicularis;Magnetic Resonance Imaging;Maintenance;Marrow;Mediating;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Metabolic;Metabolic Control;Methods;Modeling;Monitor;Monkeys;Mus;Organ;Organ Donor;Organ Transplantation;Outcome;Paper;Predictive Value;Process;Property;Proteomics;Protocols documentation;Publications;Publishing;Regimen;Regulatory T-Lymphocyte;Reperfusion Injury;Research;Research Institute;Research Personnel;Role;Sampling;Site;Solid;Source;Stem cell transplant;Supercomputing;Testing;Time;Tissues;Transplantation;United States National Institutes of Health;Universities;Waiting Lists;Work;allograft rejection;base;data mining;design;experience;graft function;improved;in vivo;intrahepatic;intravenous administration;islet;islet allograft;kidney allograft;liver biopsy;lymph nodes;macrophage;meetings;migration;monocyte;nonhuman primate;peripheral blood;programs;prospective;regenerative;repaired;research study;response;skin allograft;success;tool;transplantation typing","Immunomodulatory and regenerative effects of mesenchymal stem cells on allografts","n/a","NIAID","8318050","7/20/2012 12:00:00 AM","PAR-10-271","5P01AI089556-02","5","P01","AI","089556","02"," ","KRAEMER, KRISTY A","8/15/2011 12:00:00 AM","7/31/2016 12:00:00 AM","ZAI1-MFH-I(M1)"," ","1859488","KENYON, NORMA S.","Not Applicable","27","SURGERY","052780918","F8THLJQSAF93","052780918","F8THLJQSAF93","US","25.775337","-80.209809","5221250","UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","CORAL GABLES","FL","SCHOOLS OF MEDICINE","331462926","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","855","Non-SBIR/STTR","2012"," "," ","NIAID","2150368","583614"," ","2733982",
"No NIH Category available","Adult;Affect;Age-Related Bone Loss;Angiogenic Factor;Antibodies;Blood Vessels;Bone Matrix;Bone Resorption;Bone remodeling;Calcium;Cells;Development;Endothelial Cells;Equilibrium;Fracture;Funding;Future;Galactosidase;Gene Targeting;Genes;Goals;Growth Factor;Histologic;Hormonal;Hormones;Hyperparathyroidism;Hypoparathyroidism;Infusion procedures;Investigation;Kidney Diseases;Kidney Failure;Knockout Mice;Ligands;Link;Longevity;Longitudinal Studies;Marrow;Measurement;Measures;Mediating;Mesenchymal;Mesenchymal Stem Cells;Metabolism;Methodology;Methods;Minerals;Mission;Mus;Osteoblasts;Osteoclasts;Osteocytes;Osteogenesis;Osteoporosis;Parathyroid Hormone Receptor;Parathyroid gland;Pathway interactions;Patient Care;Patients;Peptides;Pericytes;Physiological;Postmenopause;Process;Production;Regulation;Research Design;Risk;Role;Secondary Hyperparathyroidism;Signal Pathway;Signal Transduction;Site;Stimulus;Surface;TNFSF11 gene;Transgenes;Vascular Endothelial Growth Factors;Veterans;Work;angiogenesis;base;bevacizumab;bone;bone loss;bone mass;calcification;cell motility;cytokine;dimer;mortality;mutant;neovascularization;osteoblast differentiation;osteogenic;overexpression;progenitor;promoter;public health relevance;receptor;receptor expression;red fluorescent protein;repaired;research study;response","Regulation of osteoblast number by PTH","n/a","VA","8195619","12/8/2011 12:00:00 AM","RFA-BX-09-008","5I01BX000514-02","5","I01","BX","000514","02"," "," ","4/1/2010 12:00:00 AM","3/31/2014 12:00:00 AM","Endocrinology B[ENDB]"," ","7747975","JILKA, ROBERT L","Not Applicable","02","Unavailable","082573742","EEMKSLSZYKJ3","082573742","EEMKSLSZYKJ3","US","34.773386","-92.289211","10006869","CENTRAL ARKANSAS VETERANS HLTHCARE SYS","NORTH LITTLE ROCK","AR","Independent Hospitals","721141709","UNITED STATES","N","4/1/2011 12:00:00 AM","3/31/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","3-Dimensional;Adenosine;Affect;Animals;Basic Science;Behavior;Biocompatible Materials;Biological;Biological Factors;Bone Marrow;Bone Morphogenetic Proteins;Bone Regeneration;Bone Tissue;Bone Transplantation;Cartilage;Cell Adhesion;Cell Culture Techniques;Cell-Matrix Junction;Cells;Connecticut;Cyclic AMP;Data;Defect;Diagnostic radiologic examination;Emulsions;Engineering;Germ Cells;Glycolates;Goals;Growth Factor;Histology;Human;Implant;In Vitro;Kinetics;Laboratories;Ligaments;Literature;Measures;Mechanics;Mesenchymal;Mesenchymal Stem Cells;Microspheres;Modeling;Molecular Biology;Monitor;Natural regeneration;Orthopedics;Oryctolagus cuniculus;Osteoblasts;Osteogenesis;Performance;Pharmaceutical Preparations;Polymers;Process;Proteins;Recombinants;Research;Research Proposals;Science;Signal Transduction;Solvents;System;Techniques;Testing;Tissues;Transplanted tissue;Universities;Work;analog;base;bone;bone healing;bone morphogenetic protein 2;cost;design;dosage;evaporation;high risk;immunogenicity;improved;in vivo;innovation;mineralization;novel;novel strategies;osteoblast differentiation;poly(lactic acid);regenerative;repaired;response;scaffold;small molecule;stem cell biology;tissue regeneration;tomography","Engineered Regeneration of Bone through a Small Molecule Cyclic Adenosine Monopho"," The laboratory has focused on developing engineered alternatives to orthopaedic tissues such as bone, cartilage, and ligament. To achieve these goals, we work with clinicians, cell biologists, and engineers from the University of Connecticut and throughout the world. The innovation of the current proposal is the use of small molecules with polymers for engineering bone tissue.  
    

","NIAMS","8330799","8/10/2012 12:00:00 AM","PA-10-069","5R21AR060480-02","5","R21","AR","060480","02"," ","WANG, FEI","9/15/2011 12:00:00 AM","8/31/2015 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","1885902","LAURENCIN, CATO T.","Not Applicable","05","ORTHOPEDICS","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF MEDICINE","060305335","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2015 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","41794","22570"," ","64364",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","3-Dimensional;Adenosine;Affect;Animals;Basic Science;Behavior;Biocompatible Materials;Biological;Biological Factors;Bone Marrow;Bone Morphogenetic Proteins;Bone Regeneration;Bone Tissue;Bone Transplantation;Cartilage;Cell Adhesion;Cell Culture Techniques;Cell-Matrix Junction;Cells;Connecticut;Cyclic AMP;Data;Defect;Diagnostic radiologic examination;Emulsions;Engineering;Germ Cells;Glycolates;Goals;Growth Factor;Histology;Human;Implant;In Vitro;Kinetics;Laboratories;Ligaments;Literature;Measures;Mechanics;Mesenchymal;Mesenchymal Stem Cells;Microspheres;Modeling;Molecular Biology;Monitor;Natural regeneration;Orthopedics;Oryctolagus cuniculus;Osteoblasts;Osteogenesis;Performance;Pharmaceutical Preparations;Polymers;Process;Proteins;Recombinants;Research;Research Proposals;Science;Signal Transduction;Solvents;System;Techniques;Testing;Tissues;Transplanted tissue;Universities;Work;analog;base;bone;bone healing;bone morphogenetic protein 2;cost;design;dosage;evaporation;high risk;immunogenicity;improved;in vivo;innovation;mineralization;novel;novel strategies;osteoblast differentiation;poly(lactic acid);regenerative;repaired;response;scaffold;small molecule;stem cell biology;tissue regeneration;tomography","Engineered Regeneration of Bone through a Small Molecule Cyclic Adenosine Monopho"," The laboratory has focused on developing engineered alternatives to orthopaedic tissues such as bone, cartilage, and ligament. To achieve these goals, we work with clinicians, cell biologists, and engineers from the University of Connecticut and throughout the world. The innovation of the current proposal is the use of small molecules with polymers for engineering bone tissue.  
    

","NIAMS","8330799","8/10/2012 12:00:00 AM","PA-10-069","5R21AR060480-02","5","R21","AR","060480","02"," ","WANG, FEI","9/15/2011 12:00:00 AM","8/31/2015 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","1885902","LAURENCIN, CATO T.","Not Applicable","05","ORTHOPEDICS","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF MEDICINE","060305335","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2015 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIMHD","112500","58041"," ","170541",
"Biotechnology; Breast Cancer; Cancer; Genetics; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Affect;Anoikis;Biological Assay;Breast Cancer Cell;Breast Carcinoma;Cancer Patient;Cardiovascular system;Cause of Death;Cell Line;Cells;Characteristics;Clinic;Data;Development;Diagnosis;Disease;Distant;Drops;Embryonic Development;Epithelial;Epithelial Cells;Event;Extracellular Matrix;Family;Functional RNA;Gene Expression;Genes;Goals;Human;Human body;In Vitro;Invaded;Lead;Life;Mammary Neoplasms;Mammary gland;Mediating;Mediator of activation protein;Medical;Mesenchymal;Metastatic to;MicroRNAs;Mus;N-Cadherin;Neoplasm Metastasis;Newly Diagnosed;Oncogenic;Patients;Phenotype;Physicians;Play;Population;Primary Neoplasm;Process;Property;Regulator Genes;Repression;Research;Research Personnel;Role;Site;Staging;Stem cells;Stimulus;Survival Rate;Testing;Time;United States;Vimentin;Woman;Wound Healing;angiogenesis;arm;cell motility;combat;epithelial to mesenchymal transition;fighting;human disease;improved;in vivo;interest;malignant breast neoplasm;mortality;neoplastic cell;novel;novel therapeutics;programs;research study;stem cell biology;trait;tumor;tumor initiation;tumor progression","miRNAs 424 and 152 as Mediators of the Mesenchymal Phenotype in Breast Cancer EMT"," The spread of breast cancer cells to other sites in the human body, a process called metastasis, is the leading cause of death for breast cancer patients. Evidence suggests that metastasis is often fueled by the same processes that occur during normal development, and recently molecules called micro-RNAs, which are small naturally occurring regulators of gene expression, have been found to contribute to both normal development and tumor progression. By better understanding how these molecules operate out-of-context, researchers and physicians can develop new therapeutics to fight the spread of breast cancer.   
      

","NCI","8395195","8/1/2012 12:00:00 AM","PA-11-111","1F31CA165617-01A1","1","F31","CA","165617","01","A","SCHMIDT, MICHAEL K","8/1/2012 12:00:00 AM","7/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-A(21)L]"," ","10867820","DRASIN, DAVID J.","Not Applicable","06","OBSTETRICS & GYNECOLOGY","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","28752"," "," ","28752",
"No NIH Category available","Adult;Affect;Age-Related Bone Loss;Angiogenic Factor;Antibodies;Blood Vessels;Bone Matrix;Bone Resorption;Bone remodeling;Calcium;Cells;Development;Endothelial Cells;Equilibrium;Fracture;Funding;Future;Galactosidase;Gene Targeting;Genes;Goals;Growth Factor;Histologic;Hormonal;Hormones;Hyperparathyroidism;Hypoparathyroidism;Infusion procedures;Investigation;Kidney Diseases;Kidney Failure;Knockout Mice;Ligands;Link;Longevity;Longitudinal Studies;Marrow;Measurement;Measures;Mediating;Mesenchymal;Mesenchymal Stem Cells;Metabolism;Methodology;Methods;Minerals;Mission;Mus;Osteoblasts;Osteoclasts;Osteocytes;Osteogenesis;Osteoporosis;Parathyroid Hormone Receptor;Parathyroid gland;Pathway interactions;Patient Care;Patients;Peptides;Pericytes;Physiological;Postmenopause;Process;Production;Regulation;Research Design;Risk;Role;Secondary Hyperparathyroidism;Signal Pathway;Signal Transduction;Site;Stimulus;Surface;TNFSF11 gene;Transgenes;Vascular Endothelial Growth Factors;Veterans;Work;angiogenesis;base;bevacizumab;bone;bone loss;bone mass;calcification;cell motility;cytokine;dimer;mortality;mutant;neovascularization;osteoblast differentiation;osteogenic;overexpression;progenitor;promoter;public health relevance;receptor;receptor expression;red fluorescent protein;repaired;research study;response","Regulation of osteoblast number by PTH","n/a","VA","8397512","3/16/2012 12:00:00 AM","RFA-BX-09-008","5I01BX000514-03","5","I01","BX","000514","03"," "," ","4/1/2010 12:00:00 AM","3/31/2014 12:00:00 AM","Endocrinology B[ENDB]"," ","7747975","JILKA, ROBERT L","Not Applicable","02","Unavailable","082573742","EEMKSLSZYKJ3","082573742","EEMKSLSZYKJ3","US","34.773386","-92.289211","10006869","CENTRAL ARKANSAS VETERANS HLTHCARE SYS","NORTH LITTLE ROCK","AR","Independent Hospitals","721141709","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"No NIH Category available","Address;Adult;Affect;Age-Related Bone Loss;Aging;Animal Model;Antioxidants;Architecture;Attenuated;Behavior;Binding;Biomedical Engineering;Bone Density;Bone Marrow;Bone Regeneration;Cell Aging;Cell Count;Cell Nucleus;Cell physiology;Cells;DNA Damage;Data;Deficiency Diseases;Degenerative Disorder;Development;Enzymes;Epigenetic Process;Event;Exons;Farnesyl Transferase Inhibitor;Fibroblasts;Fracture;Gene Expression;Gene Mutation;Genes;Genome;Gonadal Steroid Hormones;Heterochromatin;Human;In Vitro;Individual;Injury;Knowledge;Lamin Type A;Lesion;Maintenance;Marrow;Mesenchymal;Mesenchymal Stem Cells;Messenger RNA;Mission;Molecular;Nuclear;Nuclear Envelope;Nuclear Lamina;Nuclear Translocation;Osteoblasts;Osteocytes;Osteoporosis;Oxidative Stress;Patient Care;Patients;Physiological;Population;Production;Protein translocation;Proteins;RNA Splicing;Reactive Oxygen Species;Regulation;Research Design;Role;Signal Transduction;Signaling Molecule;Site;Skin;Stem cells;Stromal Cells;Superoxide Dismutase;Syndrome;TP53 gene;Testing;Therapeutic;Thick;Tissues;Translational Research;Woman;Work;age related;alpha1 Type 1 Collagen;base;biomineralization;bone;bone mass;bone quality;design;hormone deficiency;in vivo;lipid biosynthesis;men;mutant;novel;osteoblast differentiation;osteogenic;overexpression;patient population;prevent;progenitor;programs;self-renewal;senescence;transcription factor","Mechanisms of Stem Cell Self-Renewal and Aging","The VA patient population is characterized by a high number of patients suffering from age-related degenerative diseases, not just in bone, but also in other tissues. The results obtained from the proposed work will be useful for increasing our understanding of the molecular and cellular events contributing to age-related osteoporosis and the repair of bone due to fractures, injuries, or other lesions. Successful translational research by developing strategies to prevent or decrease the senescence of mesenchymal progenitors for bone, and other tissues, could provide the basis to delay the development of age-related osteoporosis and address the applicability of cellular therapies and bioengineering for bone as well as other tissues resulting from age-related degenerative diseases. The proposed studies are designed to characterize the role of alterations in the nuclear membrane lamina in stem cell senescence and bone forming potential, and how to prevent them; and thus are vital to the VA patient care mission.","VA","8246104","11/30/2011 12:00:00 AM","RFA-BX-11-001","1I01BX000952-01A2","1","I01","BX","000952","01","A"," ","10/1/2011 12:00:00 AM","9/30/2015 12:00:00 AM","Endocrinology B[ENDB]"," ","1945308","SCHILLER, PAUL CHRISTIAN","Not Applicable","24","Unavailable","079275714","U2J7L7Y9NAJ6","079275714","U2J7L7Y9NAJ6","US","25.757864","-80.214254","481022","MIAMI VA HEALTH CARE SYSTEM","MIAMI","FL","Independent Hospitals","331251624","UNITED STATES","N","10/1/2011 12:00:00 AM","9/30/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Aging; Arthritis; Genetics; Pain Conditions - Chronic; Pain Research","ADAMTS;Ablation;Address;Aging;Arthritis;BMP7 gene;CD44 Antigens;Cartilage;Cartilage injury;Cell Differentiation process;Cells;Chondrocytes;Chondrogenesis;Cleaved cell;Clinical;Complement;Complex;Consensus;Degenerative polyarthritis;Development;Disease Pathway;Effectiveness;Endocytosis;Event;Fibroblasts;Fibrosis;Focal Adhesions;Gene Expression;Genes;Heredity;Human;Hyaluronan;Hypertrophy;Injectable;Joints;Knee;Knockout Mice;Laser Microscopy;MAP3K1 gene;MAPK8 gene;Mediating;Mediator of activation protein;Mesenchymal;Mesenchymal Stem Cells;Microscopy;Modeling;Mus;Myofibroblast;Normal Cell;Obesity;PTK2 gene;Pain;Pathogenesis;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Phosphorylation;Photons;Quality of life;Research;Risk Factors;Role;Route;Signal Transduction;Small Interfering RNA;Structure;Surface;Swelling;Symptoms;TGF-beta type I receptor;Tissues;aggrecan;cartilage cell;cartilage repair;cell associated matrix;cell type;cellular targeting;effective therapy;improved;in vivo;inhibitor/antagonist;joint injury;joint stiffness;knockout gene;prevent;progenitor;receptor;repaired;response;uptake","Cartilage Degeneration and Repair By ADAMTSs and Hyaluronan Binding Proteins"," The development of agents which prevent cartilage damage in human osteoarthritis is an unmet need. Such medications should lower pain levels and markedly improve quality of life. Our research addresses the fundamental question of why and how cartilage cells at the surface of the tissue switch from being cartilage protective to cartilage destructive. The answer to this question should finally provide the cellular ""target"" needed for effective treatment.  
    

","NIAMS","8309037","4/9/2012 12:00:00 AM","PA-10-067","5R01AR057066-02","5","R01","AR","057066","02"," ","TYREE, BERNADETTE","8/1/2011 12:00:00 AM","4/30/2016 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","2503536","PLAAS, ANNA H.","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","068610245","G469A8ARUMP8","068610245","G469A8ARUMP8","US","41.875066","-87.66796","6644301","RUSH UNIVERSITY MEDICAL CENTER","CHICAGO","IL","SCHOOLS OF MEDICINE","606123833","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","240278","99574"," ","339852",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","3-Dimensional;Adenosine;Affect;Animals;Basic Science;Behavior;Biocompatible Materials;Biological;Biological Factors;Bone Marrow;Bone Morphogenetic Proteins;Bone Regeneration;Bone Tissue;Bone Transplantation;Cartilage;Cell Adhesion;Cell Culture Techniques;Cell-Matrix Junction;Cells;Connecticut;Cyclic AMP;Data;Defect;Diagnostic radiologic examination;Emulsions;Engineering;Germ Cells;Glycolates;Goals;Growth Factor;Histology;Human;Implant;In Vitro;Kinetics;Laboratories;Ligaments;Literature;Measures;Mechanics;Mesenchymal;Mesenchymal Stem Cells;Microspheres;Modeling;Molecular Biology;Monitor;Natural regeneration;Orthopedics;Oryctolagus cuniculus;Osteoblasts;Osteogenesis;Performance;Pharmaceutical Preparations;Polymers;Process;Proteins;Recombinants;Research;Research Proposals;Science;Signal Transduction;Solvents;System;Techniques;Testing;Tissues;Transplanted tissue;Universities;Work;analog;base;bone;bone healing;bone morphogenetic protein 2;cost;design;dosage;evaporation;high risk;immunogenicity;improved;in vivo;innovation;mineralization;novel;novel strategies;osteoblast differentiation;poly(lactic acid);regenerative;repaired;response;scaffold;small molecule;stem cell biology;tissue regeneration;tomography","Engineered Regeneration of Bone through a Small Molecule Cyclic Adenosine Monopho"," The laboratory has focused on developing engineered alternatives to orthopaedic tissues such as bone, cartilage, and ligament. To achieve these goals, we work with clinicians, cell biologists, and engineers from the University of Connecticut and throughout the world. The innovation of the current proposal is the use of small molecules with polymers for engineering bone tissue.  
    

","NIAMS","8502063","7/2/2012 12:00:00 AM","PA-10-069","3R21AR060480-01A1S1","3","R21","AR","060480","01","A1S","WANG, FEI","9/15/2011 12:00:00 AM","8/31/2013 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","1885902","LAURENCIN, CATO T.","Not Applicable","05","ORTHOPEDICS","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF MEDICINE","060305335","UNITED STATES","N","7/1/2012 12:00:00 AM","8/31/2012 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","6550","3537"," ","10087",
"Bioengineering; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Transplantation","Adenylate Cyclase;Adopted;Area;Autologous;Autologous Transplantation;Basic Science;Biomechanics;Blood Vessels;Bone Marrow;Capillary Endothelial Cell;Cardiac;Cardiac Myocytes;Cell Line;Cell Lineage;Cell Survival;Cells;Cicatrix;Coculture Techniques;Coronary artery;Coupled;Data;Deterioration;Development;Down-Regulation;Effectiveness;Endothelial Cells;Engineering;Engraftment;Fibroblasts;Fibrosis;Genes;Genetic;Goals;Growth;Heart failure;Human;Hypoxia;Immune;In Vitro;Infarction;Lead;Mechanics;Mesenchymal;Mesenchymal Stem Cells;Metabolic;MicroRNAs;Modification;Muscle Cells;Myocardial;Myocardial Infarction;Myocardial Ischemia;Myocardial tissue;Myocardium;Natural regeneration;Nutrient;Outcome Measure;Pathway interactions;Patients;Performance;Perfusion;Phenotype;Property;Pump;Research;Rodent Model;Smooth Muscle Myocytes;Source;Stem cells;Stretching;Therapeutic;Tissue Engineering;Tissue Grafts;Tissue Viability;Tissues;Vascular Endothelial Cell;Vascular blood supply;Ventricular;Waste Products;adenylyl cyclase 6;artery occlusion;cardiac repair;density;functional improvement;implantation;improved;in vivo;induced pluripotent stem cell;injured;insight;migration;muscle regeneration;neovascular;neovasculature;novel strategies;overexpression;preconditioning;precursor cell;progenitor;protein expression;repaired;stem cell differentiation","iPS cells-derived progenitor cells for angiomyogenesis"," This project will investigate the effectiveness of prevascularized tri-cell patch composed of endothelial cells, myocytes, and other cardiac lineage cells derived from induced pluripotent stem cells (iPSCs) for their survival and engraftment after in vivo application on infarcted hearts.  
    

","NHLBI","8325050","8/2/2012 12:00:00 AM","PA-10-067","5R01HL110740-02","5","R01","HL","110740","02"," ","LUNDBERG, MARTHA","9/1/2011 12:00:00 AM","5/31/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-VH-B(02)]"," ","8131503","WANG, YIGANG ","ASHRAF, MUHAMMAD ","01","PATHOLOGY","041064767","DZ4YCZ3QSPR5","041064767","DZ4YCZ3QSPR5","US","39.142998","-84.503581","1523902","UNIVERSITY OF CINCINNATI","CINCINNATI","OH","SCHOOLS OF MEDICINE","452210001","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","182243","103879"," ","286122",
"Digestive Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Area;Basement membrane;CD44 gene;Caco-2 Cells;Cell Cycle Arrest;Cell Line;Cell Proliferation;Cells;Characteristics;Coculture Techniques;Data;Dinoprostone;Disease;ENG gene;Environmental Risk Factor;Epithelial;Epithelial Cells;Epithelium;Exhibits;Feedback;Genes;Genetic;Goals;Health;Hematopoietic;Human;ICAM1 gene;Immune response;In Vitro;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Injury;Intestines;Knowledge;Lasers;Macrophage Activation;Mediating;Mediator of activation protein;Mesenchymal;Mesenchymal Stem Cells;Mesenchyme;Microarray Analysis;Microbe;Modeling;Molecular;Movement;Mus;Native-Born;Natural regeneration;Nature;Opportunistic Infections;Pathogenesis;Pharmaceutical Preparations;Physiological;Positioning Attribute;Process;Prostaglandin-Endoperoxide Synthase;Prostaglandins;Receptor Signaling;Relative (related person);Role;Signal Pathway;Signal Transduction;Source;Stem cells;Stromal Cells;System;Testing;Therapeutic Uses;Toll-like receptors;Vascular Cell Adhesion Molecule-1;Wild Type Mouse;Work;Wound Healing;base;cyclooxygenase 2;cytokine;human disease;in vivo;injured;injury and repair;irradiation;loss of function;macrophage;migration;monocyte;prevent;progenitor;rectal;repaired;response","RESPONSES OF INTESTINAL STEM CELLS TO EPITHELIAL INJURY","n/a","NIDDK","8266374","2/6/2012 12:00:00 AM","PA-07-070","5R01DK071619-05","5","R01","DK","071619","05"," ","CARRINGTON, JILL L","4/1/2008 12:00:00 AM","2/28/2013 12:00:00 AM","Gastrointestinal Mucosal Pathobiology Study Section[GMPB]"," ","1923960","STAPPENBECK, THADDEUS S","Not Applicable","01","PATHOLOGY","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","196020","101930"," ","297950",
"Biotechnology; Genetics; Muscular Dystrophy; Myotonic Dystrophy; Rare Diseases","Affinity;Alternative Splicing;Binding;Binding Sites;Cell Survival;Computational Technique;Conflict (Psychology);Consensus;Consensus Sequence;Coupling;DNA Sequence;Defect;Detection;Development;Disease;Effectiveness;Elements;Epilepsy;Epithelial;Event;Family;Gene Expression;Gene Expression Regulation;Gene Targeting;Genes;Genetic Transcription;Human;Link;Malignant Neoplasms;Measurement;Mental Retardation;Mesenchymal;Messenger RNA;Methodology;Methods;Mutation;Myotonic Dystrophy;Pathology;Polyadenylation;Production;Protein Family;Proteins;Protocols documentation;RNA;RNA Binding;RNA Processing;RNA Sequences;RNA Splicing;RNA-Binding Proteins;RNA-Protein Interaction;Randomized;Regulation;Role;Sampling;Severities;Severity of illness;Stem cells;Structure;Surveys;Therapeutic;Tissue-Specific Splicing;Tissues;cardiogenesis;design;epithelial to mesenchymal transition;human disease;human embryonic stem cell;neglect;novel;novel strategies;preference;programs;research study;stem cell biology;therapeutic target;tool;transcription factor","Quantitative RNA affinity landscapes: implications for development and disease"," Changes in the cellular levels of RNA binding proteins (RBPs) is a hallmark of development, cancer and disease. The global identification of RNA binding affinity landscapes is required to identify functional consequences during these important post-transcriptional temporal changes.   
      

","NIGMS","8314791","3/2/2012 12:00:00 AM","PA-11-113","1F32GM101860-01","1","F32","GM","101860","01"," ","REDDY, MICHAEL K","4/1/2012 12:00:00 AM","3/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-F08-K(20)L]"," ","10868099","LAMBERT, NICOLE J","Not Applicable","07","BIOLOGY","001425594","E2NYLCDML6V1","001425594","E2NYLCDML6V1","US","42.359476","-71.093853","4911501","MASSACHUSETTS INSTITUTE OF TECHNOLOGY","CAMBRIDGE","MA","SCHOOLS OF ARTS AND SCIENCES","021421029","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","859","Training, Individual","2012"," "," ","NIGMS","49214"," "," ","49214",
"Genetics","ATP phosphohydrolase;Adherens Junction;Adhesions;Apical;Applications Grants;Area;Binding;Biological Models;Cadherins;Caenorhabditis elegans;Cell Polarity;Cell division;Cell surface;Cells;Complement;Cues;Cytokinesis;Cytoplasm;Cytoskeleton;Data;Defect;Development;Drosophila genus;E-Cadherin;Epidermis;Epithelial;Epithelial Cells;Epithelium;Event;Family;Funding Mechanisms;Gases;Genetic;Genetic Screening;Goals;Image;In Vitro;Integrins;Kinesin;Letters;Link;Lipids;Liquid substance;Literature;Location;Mediating;Mesenchymal;Microtubules;Modeling;Molecular Genetics;Motor;Mutation;Organ;Organelles;Organism;Pathway interactions;Phenotype;Phosphatidylinositols;Positioning Attribute;Process;Research;Role;Signal Transduction;Staging;Structure;System;Testing;Tissues;Tube;Vertebrates;Work;cell cortex;daughter cell;epithelial to mesenchymal transition;genetic analysis;in vivo;mutant;novel;protein E;protein distribution;research study;rho;tissue culture","Cadherin-independent epithelial formation","  Epithelia are composed of highly polarized, adherent cells with an asymmetric distribution of proteins, lipids and organelles within the cytoplasm and at the cell surface. Epithelia perform a vital function to keep tissues, organs and cells in distinct topological compartments. This proposal seeks to establish a new model system to study epithelium formation, one that will uncover non-classical pathways for polarity and epithelialization. )  
    

","NICHD","8325563","8/13/2012 12:00:00 AM","PA-10-069","5R21HD066263-02","5","R21","HD","066263","02"," ","JAVOIS, LORETTE CLAIRE","9/1/2011 12:00:00 AM","8/31/2013 12:00:00 AM","Development - 1 Study Section[DEV1]"," ","1860974","MANGO, SUSAN E","Not Applicable","05","MICROBIOLOGY/IMMUN/VIROLOGY","082359691","LN53LCFJFL45","082359691","LN53LCFJFL45","US","42.373148","-71.118329","3212901","HARVARD UNIVERSITY","CAMBRIDGE","MA","SCHOOLS OF ARTS AND SCIENCES","021385319","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","125000","85000"," ","210000",
"Biotechnology; Clinical Research; Dental/Oral and Craniofacial Disease; Genetics; Pediatric","Adhesions;Affect;Apoptosis;Cardiac;Cell Proliferation;Cells;Chimera organism;Cleft Palate;Complex;Data;Defect;Development;Environmental Risk Factor;Epidermis;Epithelial;Epithelium;Etiology;Exhibits;Genes;Genetic;Genetic Variation;Goals;Growth;Growth Factor;Growth and Development function;Heterozygote;Human;In Situ;In Situ Hybridization;In Vitro;Interferons;Knock-out;Knockout Mice;Laboratories;Lasers;Lead;Mandible;Medial;Mediating;Mediator of activation protein;Mesenchymal;Mesenchymal Differentiation;Mesenchyme;Micrognathism;Microscopy;Modeling;Mus;Mutant Strains Mice;Mutation;Neural Crest;Neural Crest Cell;Oral;Palate;Pathway interactions;Patients;Phenotype;Play;Regulation;Research;Research Personnel;Risk;Role;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Staging;System;Testing;Time;Van der Woude syndrome;blastocyst;cleft lip and palate;craniofacial;gene function;gene interaction;in vivo;keratinocyte;knockout animal;laser capture microdissection;mutant;palatal fusion;palatal shelves;palatogenesis;programs;research study;transcription factor","The Role of IRF6 During Craniofacial Development","n/a","NIDCR","8307251","7/13/2012 12:00:00 AM","PA-06-512","5K08DE017953-05","5","K08","DE","017953","05"," ","KING, LYNN M","8/1/2008 12:00:00 AM","7/31/2013 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","8590611","GOUDY, STEVEN L.","Not Applicable","05","OTOLARYNGOLOGY","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","111775","8942"," ","120717",
"Kidney Disease; Polycystic Kidney Disease","Acute Kidney Failure;Apical;Binding Proteins;Cell Polarity;Cell division;Cells;Complex;Cytokinesis;Data;Development;Disease;Epithelial;Epithelial Cells;Epithelium;Excision;Goals;Injury;Integral Membrane Protein;Kidney;Kidney Failure;Knock-in Mouse;Laboratories;Lateral;Lead;Maintenance;Membrane;Membrane Protein Traffic;Mesenchymal;Mesenchyme;Modeling;Movement;Mus;Natural regeneration;Pathway interactions;Phosphorylation;Phosphotransferases;Play;Polycystic Kidney Diseases;Process;Protein Family;Protein Isoforms;Proteins;RNA Splicing;Recovery;Regulation;Renal function;Role;Side;Signaling Molecule;Tail;Testing;Tight Junctions;Time;Transforming Growth Factor beta;Tube;Work;apical membrane;basolateral membrane;epithelial to mesenchymal transition;in vivo;in vivo Model;nephrogenesis;overexpression;polarized cell;protein complex;public health relevance;renal epithelium;tissue culture;trafficking","Crumbs3 and Epithelial Polarity","
The goal of this work is to understand the steps that lead to polarized epithelia and kidney tube formation. The
proposal focuses on a protein called Crumbs that is crucial in this process. Proper tube formation is important
in many diseases including polycystic kidney disease and in recovery from kidney failure. Our data will
delineate the basic steps utilized by the Crumbs protein to initiate epithelial polarization.","NIDDK","8320425","7/24/2012 12:00:00 AM","PA-07-070","5R01DK069605-08","5","R01","DK","069605","08"," ","RASOOLY, REBEKAH S","2/15/2005 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-DKUS-F(02)M]"," ","2059377","MARGOLIS, BENJAMIN L","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","105239"," ","310664",
"Biotechnology; Cancer; Clinical Research; Genetics; Lung; Lung Cancer","Animals;Apical;Architecture;Cancer Etiology;Cell Communication;Cell Line;Cell Polarity;Cells;Characteristics;Complex;Disease;Distant;Dominant-Negative Mutation;Epithelial;Event;Family;Family member;Frequencies;Functional disorder;Genes;Homologous Gene;Human;In Vitro;Larva;Lung Adenocarcinoma;Malignant neoplasm of lung;Mediating;Mesenchymal;Messenger RNA;Metastasis Suppression;Metastatic to;MicroRNAs;Mus;Mutation;Neoplasm Metastasis;Oncogenic;Organ;Phenocopy;Phenotype;Prevention;Process;Property;Proteins;Regulation;Relative (related person);Repression;Subcutaneous Injections;Testing;Transcription Repressor/Corepressor;Up-Regulation;Work;cancer cell;epithelial to mesenchymal transition;improved;in vitro Model;in vivo Model;loss of function;member;mortality;neoplastic cell;promoter;protein complex;public health relevance;tumor;tumor progression","MicroRNA-200 family regulation by the apical-basal polarity complexes in EMT and","
Lung cancer is the leading cause of cancer mortality in the U.S., due mainly to the
impact of disease metastasis to distant organs. Herein we propose to work with a new
combination of in vitro and in vivo models to better understand the process of
metastasis. Specifically we plan to study how migratory and invasive characteristics of
the tumor are controlled by proteins that determine cellular architecture and cell-cell
interaction.","NCI","8325608","7/25/2012 12:00:00 AM","PA-09-042","5K08CA151651-03","5","K08","CA","151651","03"," ","PERKINS, SUSAN N","9/1/2010 12:00:00 AM","8/31/2015 12:00:00 AM","Transition to Independence Study Section (I)[NCI-I]"," ","10185817","GIBBONS, DON LYNN","Not Applicable","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","158000","12640"," ","170640",
"Hematology; Osteogenesis Imperfecta; Pediatric; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","A Mouse;Adipocytes;Adult;Affect;Area;Asses;Biology;Blood Cells;Bone Diseases;Bone Marrow;Bone Marrow Cells;Bone Marrow Stem Cell;Bone Marrow Transplantation;Bone Matrix;Bone Resorption;Bone remodeling;CD34 gene;COL1A2 gene;CXCR4 gene;Cardiovascular system;Cartilage;Cells;Characteristics;Child;Chondrocytes;Clinical Trials;Collaborations;Collagen;Collagen Diseases;Collagen Type I;Connective Tissue;Core Facility;Data;Defect;Deformity;Dentinogenesis Imperfecta;Diagnosis;Diaphyses;Disease;Doctor of Philosophy;Dysplasia;Early treatment;Experimental Designs;Fatty acid glycerol esters;Fibroblasts;Flare;Fracture;Future;Genes;Goals;Granulocyte Colony-Stimulating Factor;Growth;Healed;Hematopoietic;Hematopoietic Stem Cell Mobilization;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Hereditary Disease;Histocompatibility Testing;Hormones;Human;In Vitro;Inherited;Investigation;Knowledge;Label;Laboratories;Lead;Manuscripts;Marrow;Mentored Research Scientist Development Award;Mentors;Mesenchymal;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Methods;Minerals;Modeling;Mus;Mutation;Myofibroblast;Neonatal;Newborn Infant;Normal Cell;Osteoblasts;Osteoclasts;Osteocytes;Osteogenesis;Osteogenesis Imperfecta;Osteopenia;Parathyroid gland;Pathology;Patients;Population;Postdoctoral Fellow;Preparation;Production;Puberty;Publishing;Reporting;Research;Research Personnel;Role;Scientist;Sclera;Severities;Shapes;Side;Site;Source;Staging;Stem cells;Stromal Cells;Structural Protein;Structure;Symptoms;Techniques;Testing;Therapeutic;Tissues;Training;Transplantation;Trauma;United States National Institutes of Health;Variant;base;bone;bone strength;bone turnover;career;career development;clinical effect;enhanced green fluorescent protein;healing;hearing impairment;improved;in vivo;interest;mast cell;mouse model;novel;osteoprogenitor cell;preclinical study;prevent;progenitor;programs;reconstitution;repaired;research study;skeletal;skeletal disorder therapy;soft tissue;stem cell biology;theories","Hematopoietic Stem Cell Transplantation in Osteogenesis Imperfecta","
PROJECT NARRATIVE
We hypothesize that the primary defect in osteogenesis imperfecta lies in the HSC and that HSC
transplantation will lead to replacement of affected osteoblasts by normal cells, in turn correcting collagen
defects in bone and ameliorating and/or preventing OI pathologies. We propose to test this hypothesis using
single HSC transplantation in combination with a mouse model of OI, the oim/oim mouse. Long term, these
findings have the potential to identify HSC transplantation, and not the transplantation of MSCs or progenitor
cells, as the therapy of choice for this collagen disorder.","NIAMS","8242637","4/17/2012 12:00:00 AM","PA-09-040","5K01AR059097-03","5","K01","AR","059097","03"," ","SHARROCK, WILLIAM J","4/1/2010 12:00:00 AM","3/31/2013 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","9436812","MEHROTRA, MEENAL ","Not Applicable","01","PATHOLOGY","183710748","NHV3GTWSALA7","183710748","NHV3GTWSALA7","US","32.788289","-79.954891","7575301","MEDICAL UNIVERSITY OF SOUTH CAROLINA","CHARLESTON","SC","SCHOOLS OF MEDICINE","294074636","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","63914","5113"," ","69027",
"Arthritis; Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Affect;Animal Model;Animals;Attention;Biomimetics;Bone Marrow;Bone Regeneration;Bone Tissue;Cartilage;Cartilage injury;Cell Therapy;Chondrocytes;Complex;Computer Simulation;Defect;Degenerative polyarthritis;Elements;Engineering;Environment;Equilibrium;Event;Failure;Gelatin;Goals;Goat;Growth Factor;Hyaluronan;Implant;In Vitro;Joints;Lead;Left;Mechanics;Mesenchymal Stem Cells;Modeling;Oryctolagus cuniculus;Phase;Physiological;Porifera;Procedures;Serum;Stem cells;Stress;Structure;System;Testing;Therapeutic;Time;Tissue Engineering;Tissues;Translating;articular cartilage;base;bone;bone healing;cartilage repair;clinically relevant;novel;osteochondral repair;osteochondral tissue;repaired;success;tissue repair","Biomimetic Tissue-engineered Articular Cartilage Repair","n/a","NIAMS","8380789","7/20/2012 12:00:00 AM"," ","5P01AR053622-05","5","P01","AR","053622","05"," "," "," ","4/30/2014 12:00:00 AM","ZAR1-CHW-J","0002","8291205","CAPLAN, ARNOLD IRWIN","Not Applicable","11","Unavailable","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","Domestic Higher Education","441061712","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","73353","73353"," ","73353","0"," "," ",
"Autoimmune Disease; Genetics; Lung; Organ Transplantation; Rare Diseases; Transplantation","Alveolar;Antigen Targeting;Antigens;Applications Grants;Autoantigens;Autoimmune Diseases;Autoimmunity;Biological;Biological Markers;Bleomycin;Bronchi;Bronchioles;Bronchiolitis;Cells;Characteristics;Chimeric Proteins;Chronic;Cicatrix;Clara cell;Collagen Type V;Coupled;Data;Development;Disease;Distal;Dominant-Negative Mutation;Doxycycline;Enzymes;Epithelial;Epithelial Cells;Epithelium;Event;Family;Fibroblasts;Fibrosis;Gene Expression;Gene Silencing;Goals;Hamman-Rich syndrome;Human;In Vitro;Inflammation;Inflammatory;Injury;Interleukin-17;Journals;Knockout Mice;Link;Lung;Lung Transplantation;Lung diseases;Lymphocyte;Mediating;Medicine;Mesenchymal;Mission;Modeling;Molecular Profiling;Mus;Myofibroblast;National Heart, Lung, and Blood Institute;Organ Transplantation;Outcome;Pathogenesis;Pathology;Pathway interactions;Patients;Phosphotransferases;Predisposition;Process;Protein Isoforms;Protein Kinase;Proteins;Publishing;Pulmonary Fibrosis;Pulmonary Surfactant-Associated Protein C;RNA Interference;Reporter Genes;Research;Rodent;Role;Signal Transduction;Solid;Spindle-Shaped Fibroblast;Staging;Structure of parenchyma of lung;Survival Rate;T-Lymphocyte;Testing;Therapeutic Agents;Transplant Recipients;Transplantation;Wound Healing;airway epithelium;base;cell type;cytokine;effective therapy;epithelial to mesenchymal transition;expectation;fibrogenesis;in vivo;inhibitor/antagonist;mouse model;novel;overexpression;promoter;receptor;repaired;response;therapeutic target;tissue repair;treatment strategy","Role of IL-17 in the Induction of Epithelial to Mesenchymal Transition"," Idiopathic pulmonary fibrosis (IPF) is a fatal disease with scarring of the lungs with lung transplantation as the only known therapy. However, chronic lung rejection (obliterative bronchiolitis-OB) sets in and the transplant patients have a 50% five-year survival rate. The objective of this application is directly relevant to the mission of the National Heart, Lung and Blood Institute, by proposing the identification of interleukin-17-specific therapeutic targets to block the conversion of airway epithelial cells to scar forming cells by a process called epithelial to mesenchymal transition (EMT).    

","NHLBI","8307305","6/29/2012 12:00:00 AM","PA-10-067","5R01HL109288-02","5","R01","HL","109288","02"," ","HARABIN, ANDREA L","8/1/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","10016471","VITTAL, RAGINI ","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","603007902","SHHBRBAPSM35","603007902","SHHBRBAPSM35","US","39.780714","-86.174977","577806","INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS","INDIANAPOLIS","IN","SCHOOLS OF MEDICINE","462022915","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","140000"," ","390000",
"Biotechnology; Cancer","Adenovirus Vector;Antibodies;Architecture;Biological Assay;Bone Marrow;Cell Adhesion Molecules;Cell Line;Cells;Cellular biology;Characteristics;Collagen;Cutaneous Melanoma;Dermis;Endothelial Cells;Environment;Epidermis;Fibroblasts;Growth;Growth Factor;Healed;Human;Immunodeficient Mouse;In Vitro;Investigation;Laboratories;Lentivirus Vector;Lesion;Malignant Neoplasms;Melanoma Cell;Mesenchymal Stem Cells;Modeling;Monoclonal Antibodies;Mus;Oncogenes;Organ;Patients;Quality Control;Research;Research Personnel;Resources;Role;Screening procedure;Services;Skin;Stromal Cells;Testing;Tissues;Viral Vector;Western Blotting;Xenograft procedure;healing;in vivo;in vivo Model;interest;investigator training;keratinocyte;melanocyte;melanoma;melanoma-associated antigen;member;programs;research study;subcutaneous;three-dimensional modeling;tool;tumor;two-dimensional","Cell Biology Core","n/a","NCI","8378457","5/8/2012 12:00:00 AM"," ","5P01CA114046-05","5","P01","CA","114046","05"," "," "," ","8/31/2013 12:00:00 AM","ZCA1-GRB-P","9002","2795105","HERLYN, MEENHARD F","Not Applicable","03","Unavailable","075524595","DW1XZMGNFBL4","075524595","DW1XZMGNFBL4","US","39.950872","-75.195321","9340401","WISTAR INSTITUTE","PHILADELPHIA","PA","Research Institutes","191044265","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","177783","177783"," ","75662","102121"," "," ",
"Biotechnology; Diabetes; Gene Therapy; Genetics; Rare Diseases; Regenerative Medicine; Stem Cell Research; Transplantation","Address;Adipocytes;Adipose tissue;Adult;Age;Animal Model;Autoimmunity;Autologous;Blood Glucose;Bone Marrow;Cartilage;Cell Therapy;Cell model;Cells;Clinic;Communities;Defect;Development;Diabetes Mellitus;Disease;Dyslipidemias;Engraftment;Environment;Fatty Liver;Fatty acid glycerol esters;Fibroblasts;Foundations;Functional disorder;Future;Gene Targeting;Genes;Genetic;Graft Survival;HIV;Histology;Human;Hypertriglyceridemia;In Vitro;Individual;Inflammation;Inherited;Insulin Resistance;Laboratories;Length;Lipids;Lipodystrophy;Liver;Medical;Mesenchymal;Mesenchymal Stem Cells;Messenger RNA;Metabolic;Methods;Mitochondria;Modeling;Modification;Molecular;Mouse Strains;Mus;Mutation;National Institute of Diabetes and Digestive and Kidney Diseases;Natural regeneration;Non-Insulin-Dependent Diabetes Mellitus;Patients;Peptide Hydrolases;Phenotype;Reagent;Relative (related person);Research;Resources;Sampling;Site;Skeletal Muscle;Skin;Somatic Cell;Source;Technology;Testing;Therapeutic;Therapeutic Uses;Tissues;Transfection;Transgenes;Transplantation;Viral Vector;Work;Zinc Fingers;adipocyte differentiation;aged;blood glucose regulation;bone;c-myc Genes;cell type;embryonic stem cell;gene correction;gene therapy;improved functioning;in vivo;induced pluripotent stem cell;innovation;interest;lipid biosynthesis;mouse model;nuclease;repaired;self-renewal;senescence;stem cell therapy;telomere;therapy development;tissue regeneration;tissue repair;transcription factor;tumor","Induced pluripotent stem cell therapy for lipodystrophy"," Lipodystrophies are the result of adipose tissue degeneration as well as misdistribution and result in severe defects in lipid and glucose homeostasis. The therapeutic potential of iPS derived mesenchymal stem cells for tissue repair and regeneration is almost limitless with respect to lipodystrophy. These studies will enable the delivery of truly personalized medical treatment for lipodystrophy since the iPS cells would be eventually generated from the same individual in need of treatment.    
      

","NIDDK","8372080","9/10/2012 12:00:00 AM","PA-10-069","1R21DK094132-01A1","1","R21","DK","094132","01","A","HAFT, CAROL R","9/15/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Cellular Aspects of Diabetes and Obesity Study Section[CADO]"," ","6770158","MAJKA, SUSAN M","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","9/15/2012 12:00:00 AM","8/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","150000","84000"," ","234000",
"Autoimmune Disease; Clinical Research; Crohn's Disease; Digestive Diseases; Inflammatory Bowel Disease","Address;Anti-Inflammatory Agents;Anti-Tumor Necrosis Factor Therapy;Anti-inflammatory;Apoptosis;Attenuated;Biochemical;Cell Lineage;Cell Separation;Cells;Characteristics;Chronic;Chronic Disease;Colitis;Complement;Complication;Confocal Microscopy;Crohn&apos;s disease;Data;Deposition;Epithelial;Epithelial Cells;Extracellular Matrix;Fibroblasts;Fibrosis;Fistula;Genetic;Heart;Human;In Vitro;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Intervention;Intestinal Fibrosis;Intestines;Kidney;LacZ Genes;Lamina Propria;Lead;Liver;Mediating;Mesenchymal;Methods;Modeling;Molecular;Mouse Protein;Mus;Obstruction;Operative Surgical Procedures;Organ;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Population Heterogeneity;Process;Property;Proteins;Receptor Signaling;Recombinants;Recruitment Activity;Recurrent disease;Reporter;Role;Rosa;Shapes;Signal Pathway;Signal Transduction;Signaling Molecule;Site;Smooth Muscle Actin Staining Method;Source;Stem cells;Sulfonic Acids;Therapeutic Effect;Therapeutic Intervention;Time;Tissues;Transforming Growth Factors;Transgenic Mice;Transgenic Organisms;Treatment Efficacy;Trinitrobenzenes;Ulcerative Colitis;Wound Healing;base;bone morphogenetic protein 7;bone morphogenic protein;clinically significant;design;epithelial to mesenchymal transition;fibrogenesis;in vivo;insight;intestinal epithelium;large bowel Crohn&apos;s disease;mouse model;novel;prevent;public health relevance;receptor;research study;transcription factor;villin","Epithelial to Mesenchymal Transition and Fibrosis in Inflammatory Bowel Disease","
PROJECT NARRATIVE
Intestinal fibrosis is a major and clinically significant complication of idiopathic inflammatory bowel disease
(IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC). While fibrosis is more commonly
associated with CD, it is also sometimes seen in chronic UC. The mechanisms by which intestinal fibrosis
occurs in the setting of IBD are incompletely understood and, in the absence of a defined mechanism, it is
difficult to explore specific therapies to halt or reverse this process. Here, we propose to examine the
underlying mechanism of fibrosis in the context of IBD by evaluating the contribution of Epithelial to
Mesenchymal Transition (EMT) to intestinal fibrosis associated with a mouse model of CD. Using transgenic
mouse models with specific molecular disruption of pathways involved in fibroblast proliferation/activation and
EMT, we will attempt to understand the genetic and biochemical underpinnings of this process in intestinal
fibrosis. We will also explore the potential therapeutic efficacy of Bone Morphogenic Protein-7 (BMP-7) as a
means to boost this antifibrotic pathway.","NIDDK","8261681","4/9/2012 12:00:00 AM","PA-10-059","5K08DK087901-02","5","K08","DK","087901","02"," ","PODSKALNY, JUDITH M,","5/1/2011 12:00:00 AM","4/30/2016 12:00:00 AM","Digestive Diseases and Nutrition C Study Section[DDK-C]"," ","9915243","FLIER, SARAH NICOLE","Not Applicable","07","Unavailable","071723621","C1CPANL3EWK4","071723621","C1CPANL3EWK4","US","42.346758","-71.10256","758101","BETH ISRAEL DEACONESS MEDICAL CENTER","BOSTON","MA","Independent Hospitals","022155400","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","847","Other Research-Related","2012"," "," ","NIDDK","139390","11151"," ","150541",
"Genetics; Kidney Disease","Alleles;Apical;Caenorhabditis elegans;Cancer Etiology;Cell Line;Cell Proliferation;Cell surface;Cells;Chronic Kidney Failure;Congenital Abnormality;Cultured Cells;Defect;Disease;Drosophila genus;E-Cadherin;Embryo;Embryonic Development;Epithelial;Epithelial Cells;Epithelium;Event;Genes;Genetic;Goals;Homologous Gene;Human;Image;Image Analysis;In Vitro;Intercellular Junctions;Intestines;Kidney Diseases;Lead;Life;Ligands;Malignant Neoplasms;Mediating;Mesenchymal;Methodology;Microtubules;Molecular;Morphogenesis;Organ;Organism;PARD6A gene;Pathway interactions;Phosphotransferases;Process;Proteins;Publishing;Recruitment Activity;Renal carcinoma;Research;Role;Scaffolding Protein;Side;Staging;Structure;Surface;Testing;Travel;Tube;atypical protein kinase C;base;cell type;design;epithelial to mesenchymal transition;genetic analysis;genetic selection;in vivo;insight;mutant;polarized cell;protein function;solute;stem;tool","In vivo mechanisms of epithelial cell polarization and junction formation"," The goal of the proposed research is to determine how epithelial cells form and adhere to each other in developing organisms. Epithelial cells line the surfaces of our organs and are essential for organ formation and function. The proposed research will provide new insights into the basis of epithelial-based diseases such as kidney disease and cancer, as well as human birth defects.  
  
    

","NIGMS","8303279","6/25/2012 12:00:00 AM","PA-10-067","5R01GM098492-02","5","R01","GM","098492","02"," ","HOODBHOY, TANYA","7/18/2011 12:00:00 AM","6/30/2015 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","8470026","NANCE, JEREMY ","Not Applicable","12","ANATOMY/CELL BIOLOGY","121911077","M5SZJ6VHUHN8","121911077","M5SZJ6VHUHN8","US","40.744985","-73.978118","5998304","NEW YORK UNIVERSITY SCHOOL OF MEDICINE","NEW YORK","NY","SCHOOLS OF MEDICINE","10016","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","188000","129720"," ","317720",
"Chronic Liver Disease and Cirrhosis; Digestive Diseases; Liver Disease; Prevention; Regenerative Medicine","Acute;Adult;Bile fluid;Blood;Cell Fraction;Cells;Cessation of life;Characteristics;Chronic;Cirrhosis;Communities;Data;Development;Embryonic Development;Endothelial Cells;Environment;Epithelial;Epithelial Cells;Erinaceidae;Event;Exhibits;Failure;Gene Expression;Genes;Genetic;Glycolysis;Goals;Growth;Hepatic Stellate Cell;Hepatocyte;Human;Immune;Injury;Knowledge;Ligand Binding;Ligands;Link;Liver;Liver Cirrhosis;Liver Fibrosis;Liver Regeneration;Malignant Neoplasms;Malignant neoplasm of liver;Mediating;Mesenchymal;Mesenchyme;Mesoderm;Mesothelium;Metabolic;Metabolism;Multipotent Stem Cells;Myofibroblast;Natural regeneration;Outcome;Paracrine Communication;Pathway interactions;Phase;Phenotype;Prevention;Prevention therapy;Process;Production;Publishing;Reporting;Research;Role;Stem cells;Stress;Tissues;Transgenic Mice;Work;Wound Healing;cell type;cholangiocyte;chronic liver disease;epithelial to mesenchymal transition;fetal;fibrogenesis;human SMO protein;improved;multipotent cell;prevent;progenitor;programs;receptor;repaired;response;smoothened signaling pathway;stem;success","Hedgehog Signaling and Adult Liver Regeneration"," Liver cirrhosis and cancer are important causes of human suffering and death worldwide. Our work has identified previously-unsuspected mechanisms that control the development of these problems. These discoveries pave the way for new strategies to prevent and treat cirrhosis and liver cancer, which are the major bad outcomes of all types of chronic liver disease.   
      

","NIDDK","8366959","6/8/2012 12:00:00 AM","PA-10-067","2R01DK077794-05A1","2","R01","DK","077794","05","A","SERRANO, JOSE","4/1/2008 12:00:00 AM","3/31/2016 12:00:00 AM","Hepatobiliary Pathophysiology Study Section[HBPP]"," ","1868904","DIEHL, ANNA MAE ELIZABETH","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","7/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","123975"," ","341475",
"Arthritis; Bioengineering; Clinical Research; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Affect;Alternative Therapies;Area;Automobile Driving;Biochemical;Biocompatible;Biocompatible Materials;Bone Marrow;Cartilage;Cartilage Matrix;Cell Count;Cell Density;Cells;Cellularity;Chondrocytes;Chondrogenesis;Clinical;Defect;Degenerative Disorder;Degenerative polyarthritis;Deposition;Engineering;Exposure to;Extracellular Matrix;Gelatin;Germ Cells;Goals;Growth;Growth Factor;Healed;Human;Hydrogels;Implant;In Vitro;Mechanics;Mesenchymal Stem Cells;Methods;Microspheres;Modeling;Natural regeneration;Nature;Oryctolagus cuniculus;Patients;Peptide Hydrolases;Perfusion;Phenotype;Property;Regulation;Role;Source;Spatial Distribution;Stem cells;Supplementation;Surface;System;Techniques;Technology;Thick;Time;Tissue Engineering;Tissues;Transforming Growth Factors;Work;articular cartilage;base;cell type;clinically relevant;controlled release;crosslink;exposed human population;genipin;healing;implantation;improved;in vivo;innovation;meetings;repaired","Driving tissue formation by inductive stem cell sheet technology"," Damaged articular cartilage, which is an avascular tissue with few cells, does not have an intrinsic capacity to repair itself. We propose to engineer chondrogenic human mesenchymal stem cell (hMSC) sheets containing growth factor-laden microspheres to form cartilage and to demonstrate their potential in healing full thickness articular cartilage defects in vivo. The successful execution of the proposed work will provide the
basis for a clinically relevant tissue engineering strategy for the regeneration of damaged articular cartilage, which would be a powerful technology for advancing the treatment of patients suffering from cartilage loss or damage as is present in osteoarthritis.   
   
      

","NIAMS","8348360","7/29/2012 12:00:00 AM","PA-10-009","1R01AR063194-01","1","R01","AR","063194","01"," ","WANG, FEI","8/1/2012 12:00:00 AM","7/31/2017 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","8482366","ALSBERG, EBEN ","Not Applicable","11","BIOMEDICAL ENGINEERING","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","BIOMED ENGR/COL ENGR/ENGR STA","441061712","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","96900"," ","321900",
"Brain Disorders; Injury (total) Accidents/Adverse Effects; Injury - Trauma - (Head and Spine); Injury - Traumatic brain injury; Neurosciences; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Address;Adherens Junction;Animal Model;Animals;Area;Basic Science;Biological Assay;Biological Models;Biomedical Research;Blood - brain barrier anatomy;Blood Vessels;Bone Marrow;Cancer Center;Candidate Disease Gene;Cardiology;Cardiovascular Diseases;Cell Adhesion;Cell Communication;Cell Proliferation;Cell physiology;Cells;Chairperson;Coculture Techniques;Collaborations;Cultured Cells;Data;Disease;Doctor of Philosophy;Endothelial Cells;Environment;FDA approved;Fellowship;Future;Gene Expression;Gene Expression Microarray Analysis;Gene Expression Profile;Genes;Genomics;Goals;Health Sciences;Homing;Human;Image;In Vitro;Injury;K-18 conjugate;Knowledge;Lead;Learning;Maryland;Mediating;Medicine;Mentors;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Messenger RNA;Mission;Modality;Modeling;Mus;National Heart, Lung, and Blood Institute;Operative Surgical Procedures;Organ;Patients;Pediatric Surgical Procedures;Permeability;Phase I Clinical Trials;Positioning Attribute;Postdoctoral Fellow;Principal Investigator;Process;Production;Productivity;Property;Proteins;Publications;Published Comment;RNA;Regenerative Medicine;Research;Research Personnel;Resuscitation;Science;Scientist;Serum;Site;Stem Cell Research;Stem cells;System;Testing;Texas;Therapeutic;Therapeutic Effect;Tight Junctions;Time;Translating;Translations;Trauma;Traumatic Brain Injury;Universities;Vascular Endothelial Cell;Vascular Endothelium;Work;adult stem cell;angiogenesis;base;bench to bedside;career;career development;cell growth;cell type;clinical application;college;design;in vitro Assay;in vitro Model;in vivo;injured;knowledge base;meetings;migration;mouse model;pediatric traumatic brain injury;professor;research and development;research study;skills;stem cell biology;stem cell therapy","Systemic Effects of Bone Marrow-Derived MSCs on Vascular Stability","
7. Project Narrative
This proposal describes a therapeutic effect of human bone marrow derived mesenchymal stem
cells (MSCs) on blood vessel stability. The ultimate goal of this project is to produce a ""cell free""
treatment option derived from stem cells for the treatment of injured patients.","NHLBI","8312468","7/20/2012 12:00:00 AM","PA-09-110","5K18HL102256-02","5","K18","HL","102256","02"," ","WELNIAK, LISBETH A","9/26/2011 12:00:00 AM","7/31/2013 12:00:00 AM","ZHL1-CSR-S(F3)"," ","10036924","PATI, SHIBANI ","Not Applicable","12","Unavailable","006902498","GKT4L2JZJ622","006902498","GKT4L2JZJ622","US","37.779077","-122.446997","10004326","VITALANT ","SAN FRANCISCO","CA","Other Domestic Non-Profits","941184417","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","233","Other Research-Related","2012"," "," ","NHLBI","97987","7839"," ","105826",
"Bioengineering; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Affect;Anterior Cruciate Ligament;Area;Autologous;Behavior;Bone Marrow;Bone Regeneration;Cell Culture Techniques;Cell Lineage;Chemicals;Data;Degenerative polyarthritis;Development;Devices;Engineering;Failure;Fibrocartilages;Generations;Goals;Growth Factor;Human;Hybrids;Hydrogels;In Vitro;Knowledge;Lead;Ligaments;Literature;Melissa;Mesenchymal Stem Cells;Methods;Morphology;Natural regeneration;Nature;Operative Surgical Procedures;Orthopedics;Pathology;Patients;Porosity;Production;Property;Reporting;Research;Screening procedure;Series;Solvents;Specialist;Stress;Surgical sutures;Technology;Tendon structure;Tissue Engineering;Tissue Grafts;Tissues;Ursidae Family;Work;anterior cruciate ligament reconstruction;base;bone;cell behavior;chemical property;combinatorial;cost;design;hydrophilicity;improved;multipotent cell;osteochondral tissue;physical property;poly(ethylene glycol)diacrylate;polydimethylsiloxane;prevent;reconstruction;regenerative;sample fixation;scaffold;soft tissue;stem cell differentiation;success","Hybrid Inorganic-Organic Hydrogel Scaffolds for Osteochondral Regeneration","
PROJECT NARRATIVE
In orthopedic reconstruction, such as that of the anterior cruciate ligament (ACL), soft tissue grafts
often fail as a direct result of the failure to re-establish the osteochondral interface - a gradual
transition from fibrocartilage-like matrix to a bone-like matrix. The proposed research utilizes a
scaffold-based strategy to re-establish the vital osteochondral interface and improve reconstruction
success. New inorganic-organic scaffolds with gradient chemical and physical properties will be used
to induce a gradual transition from bone- to fibrocartilage-like matrix production by associated human
bone marrow-derived mesenchymal stem cells (MSCs).","NIBIB","8285559","3/25/2012 12:00:00 AM","PA-10-064","1R03EB015202-01","1","R03","EB","015202","01"," ","HUNZIKER, ROSEMARIE","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","8671386","GRUNLAN, MELISSA ","HAHN, MARIAH S","17","BIOMEDICAL ENGINEERING","847205572","QD1MX6N5YTN4","847205572","QD1MX6N5YTN4","US","30.588101","-96.295308","8266919","TEXAS ENGINEERING EXPERIMENT STATION","COLLEGE STATION","TX","BIOMED ENGR/COL ENGR/ENGR STA","778433577","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","50000","20956"," ","70956",
"Bioengineering; Biotechnology; Breast Cancer; Cancer; Genetics; Human Genome; Networking and Information Technology R&D","Algorithms;Antibodies;Binding Sites;Biochemistry;Biology;Biophysics;Breast Carcinoma;Cancerous;Cell Line;Cessation of life;Computational Biology;Copy Number Polymorphism;DNA;DNA Binding;DNA Sequence Rearrangement;DNA copy number;Data;Distant;Education;Engineering;Epithelial;Event;Gene Expression;Gene Expression Regulation;Gene Targeting;Genes;Genomics;Goals;Grant;Health;Human;Institution;K-Series Research Career Programs;Malignant Epithelial Cell;Malignant Neoplasms;Mentors;Mesenchymal;Methods;Microarray Analysis;Molecular;Molecular Profiling;Mus;Neoplasm Metastasis;Organ;Positioning Attribute;Postdoctoral Fellow;Primary Neoplasm;Process;Public Health;Research;Research Personnel;Research Project Grants;Research Proposals;Research Training;Snails;Training;Transcriptional Regulation;United States;United States National Library of Medicine;Universities;base;blastomere structure;career;chromatin immunoprecipitation;comparative genomic hybridization;computer science;computer studies;epithelial to mesenchymal transition;experience;functional genomics;interest;neoplastic cell;research study;tumor","Gene regulation in metastasis and new methods to analyze its microarray profiles","n/a","NLM","8324663","8/30/2012 12:00:00 AM","PA-07-297","5R00LM009770-06","5","R00","LM","009770","06"," ","YE, JANE","9/30/2010 12:00:00 AM","9/29/2014 12:00:00 AM","Biomedical Informatics, Library and Data Sciences Review Committee[BLR]"," ","8895664","ZHANG, ZHENGDONG ","Not Applicable","14","GENETICS","110521739"," ","110521739"," ","US","40.851026","-73.844361","9433501","ALBERT EINSTEIN COLLEGE OF MEDICINE","BRONX","NY","SCHOOLS OF MEDICINE","104611900","UNITED STATES","N","9/30/2012 12:00:00 AM","9/29/2014 12:00:00 AM","879","Non-SBIR/STTR","2012"," "," ","NLM","143943","95002"," ","238945",
"Contraception/Reproduction; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adopted;Affect;Architecture;Behavior;Biology;Cell Communication;Cells;ChIP-seq;Chromatin;Cues;Cyst;Data;Development;Disease;Drosophila genus;Ectopic Expression;Epithelial;Epithelial cyst;Epithelium;Event;Family;Funding;Gene Targeting;Genes;Germ Cells;Gonadal structure;Health;Homeodomain Proteins;Human;Image;Immigration;Lateral;Life;Location;Maps;Membrane;Mesenchymal;Modeling;Nature;Open Reading Frames;Pathway interactions;Population;Positioning Attribute;Production;Property;Proteins;Regenerative Medicine;Role;Running;Signal Pathway;Signal Transduction;Somatic Cell;Specific qualifier value;Spermatogenesis;Stem cells;System;Testing;Testis;Time;Tissues;Work;Zinc Fingers;cell behavior;cell motility;daughter cell;epithelial to mesenchymal transition;gain of function;interest;migration;mutant;self-renewal;stem;stem cell division;stem cell fate;stem cell niche;trafficking","Stem Cell Renewal and Differentiation in Spermatogenesis"," Potential implications for human health: There is intense interest in the circuits that guide stem cell behavior. Understanding niche-stem cell interactions is central to unraveling the circuitry necessary to use these cells in regenerative medicine. Thus,
this proposal addresses these three conceptually significant facets of stem cell-niche biology: how are niches specified, organized and function.   
      

","NIGMS","8294121","4/2/2012 12:00:00 AM","PA-10-067","2R01GM060804-13","2","R01","GM","060804","13"," ","HAYNES, SUSAN R","8/1/1999 12:00:00 AM","3/31/2016 12:00:00 AM","Cellular, Molecular and Integrative Reproduction Study Section[CMIR]"," ","1887684","DINARDO, STEPHEN FRANCIS","Not Applicable","03","ANATOMY/CELL BIOLOGY","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","4/5/2012 12:00:00 AM","3/31/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","225000","122018"," ","347018",
"Breast Cancer; Cancer","1-Phosphatidylinositol 3-Kinase;Acinus organ component;Animal Model;Apoptosis;Apoptotic;Binding;Breast;C-terminal;Cancer Patient;Cell Surface Proteins;Cell Survival;Cell physiology;Cell surface;Clinical;Complex;Data;Development;Diagnostic Neoplasm Staging;Epithelial;Epithelial Cells;Focal Adhesions;Funding;Gelatinase B;Goals;Health;Human;In Vitro;Integrins;Light;MCF10A cells;Matrix Metalloproteinase Inhibitor;Mediating;Mesenchymal;Metalloproteases;Molecular;Morphogenesis;Neoplasm Metastasis;Non-Malignant;Oncogenic;Outcome;PTK2 gene;Pathway interactions;Phenotype;Regulation;Reporting;Research Personnel;Role;Signal Transduction;Signal Transduction Pathway;Staging;Testing;Time;Tissue Inhibitor of Metalloproteinase-1;Tumor Cell Invasion;Tumor stage;Up-Regulation;base;epithelial to mesenchymal transition;human PHEMX protein;in vivo;inhibitor/antagonist;malignant breast neoplasm;matrigel;member;novel;novel strategies;outcome forecast;overexpression;transcription factor;tumor progression","A novel function of TIMP-1","n/a","NCI","8212582","3/15/2012 12:00:00 AM","PA-07-070","5R01CA089113-10","5","R01","CA","089113","10"," ","JHAPPAN, CHAMELLI","7/1/2002 12:00:00 AM","1/31/2014 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1888624","KIM, HYEONG-REH CHOI","Not Applicable","13","PATHOLOGY","001962224","M6K6NTJ2MNE5","001962224","M6K6NTJ2MNE5","US","42.35738","-83.064737","9110501","WAYNE STATE UNIVERSITY","DETROIT","MI","SCHOOLS OF MEDICINE","482024000","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2014 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","173660","87698"," ","261358",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Adhesions;Adopted;Aging;Animals;Architecture;Behavior;Biological Models;Biomimetic Materials;Cell Aging;Cell Culture Techniques;Cell Line;Cell surface;Cells;Chemicals;Chemistry;Clinical;Clinical assessments;Coculture Techniques;Data;Dental;Development;Devices;Disease;Distal;Effectiveness;Elements;Estrogens;Exhibits;Femur;Funding;Glass;Goals;Grant;Habitats;Healed;Human;Hydrogels;Imaging technology;Implant;In Vitro;Individual;Industry;Integrins;Laboratories;Legal patent;Life;Mediating;Mediator of activation protein;Medical Device;Mesenchymal;Mesenchymal Stem Cells;Messenger RNA;Methodology;Modeling;Modification;Molecular;Morphology;Mus;Normal Cell;Normal tissue morphology;Orthopedics;Osseointegration;Osteoblasts;Osteoclasts;Osteogenesis;Outcome;Patients;Phenotype;Physiology;Plastics;Production;Property;Proteins;RNA Interference;Rattus;Regulatory Pathway;Research;Role;Signal Pathway;Signal Transduction;Site;Structure;Surface;Techniques;Technology;Testing;Time;Tissues;Titania;Titanium;Work;aged;angiogenesis;autocrine;base;biomaterial interface;bone;bone healing;cell age;cell behavior;chemical property;conditioning;design;healing;implant material;improved;improved functioning;in vivo;nanoscale;new technology;novel;osteoblast differentiation;osteoprogenitor cell;paracrine;physical property;practical application;pre-clinical;public health relevance;response;stem cell differentiation;submicron;tissue culture;tissue regeneration;tissue repair;tool;vasculogenesis","Mechanisms of Cell/Surface Interaction","
This proposal addresses the clinical need for dental and orthopaedic implants that promote
rapid osseointegration and earlier loading times, particularly when placed in bone compromised
by disease or physiology of the patient. By understanding how surface morphology and
chemistry modulate cell response, materials may be developed that control cell behavior
through structural and chemical signaling, without the need for pharmacologic modification. We
propose to perform studies that determine if cell and tissue responses can be improved if the
surfaces have novel nanoscale properties including structural features as well as chemistries.
We will test effectiveness both in vitro and in vivo.","NIAMS","8249082","4/18/2012 12:00:00 AM","PA-08-052","5R01AR052102-06","5","R01","AR","052102","06"," ","PANAGIS, JAMES S","8/3/2006 12:00:00 AM","2/8/2013 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","7774437","BOYAN, BARBARA D.","Not Applicable","05","ENGINEERING (ALL TYPES)","097394084","EMW9FC8J3HN4","097394084","EMW9FC8J3HN4","US","33.762977","-84.42296","676603","GEORGIA INSTITUTE OF TECHNOLOGY","ATLANTA","GA","BIOMED ENGR/COL ENGR/ENGR STA","303320415","UNITED STATES","N","4/1/2012 12:00:00 AM","2/8/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","83503","52060"," ","135563",
"Eye Disease and Disorders of Vision; Genetics; Human Fetal Tissue; Neurosciences; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Abnormal Cell;Address;Adipocytes;Adult;Affect;Age related macular degeneration;Attenuated;Cattle;Cell Differentiation process;Cell physiology;Cells;ChIP-seq;Chondrocytes;Chromatin;Clinical Trials;Cues;Data;Development;Disease;Distal;Elements;Enhancers;Ensure;Epigenetic Process;Epiretinal Membrane;Epithelial;Epithelium;Etiology;Event;Exhibits;Exogenous Factors;Exposure to;Eye;Eye diseases;Gene Expression;Gene Expression Regulation;Generations;Genes;Histones;Human;Macular degeneration;Massachusetts;Mesenchymal;Mesenchymal Stem Cells;Metaplasia;Methods;Molecular;Molecular Conformation;Osteogenesis;Pain;Pathology;Pathway interactions;Pattern;Phenotype;Pigmentation physiologic function;Pigments;Positioning Attribute;Process;Proliferating;Proliferative Vitreoretinopathy;RNA;Regulatory Element;Reporting;Retina;Retinal Diseases;Signal Pathway;Signal Transduction;Source;Staging;Staining method;Stains;Stem cells;Structure of retinal pigment epithelium;Testing;Therapeutic;Transcriptional Regulation;Transforming Growth Factor beta;Transplantation Conditioning;Universities;Up-Regulation;Vision;Western Blotting;bone;cell type;combat;fetal;genome-wide;human embryonic stem cell;inhibitor/antagonist;knock-down;loss of function;medical schools;member;novel strategies;osteogenic;prevent;promoter;small hairpin RNA;small molecule;transcription factor","Defining the molecular mechanisms underlying human RPE plasticity"," RPE metaplasia and acquisition of abnormal fates such as bone formation is associated with a number of retinal diseases such as proliferative vitreo-retinopathy and painful conditions such as phthisical eye. Here we will address the mechanism by which this occurs, from identifying the factors that cause these changes, to understanding how those factors alter gene expression. This study has direct relevance to RPE disease, but also has implications beyond the  
retina, to diseases affecting other epithelia that similarly can exhibit metaplastic changes associated with pathology.  
    

","NEI","8219940","1/10/2012 12:00:00 AM","PA-10-067","1R01EY022079-01","1","R01","EY","022079","01"," ","NEUHOLD, LISA","2/1/2012 12:00:00 AM","1/31/2017 12:00:00 AM","Biology and Diseases of the Posterior Eye Study Section[BDPE]"," ","1882505","TEMPLE, SALLY ","Not Applicable","20","Unavailable","786575667","LLCNGSLHHLJ5","786575667","LLCNGSLHHLJ5","US","42.631984","-73.716154","10011562","REGENERATIVE RESEARCH FOUNDATION","RENSSELAER","NY","Research Institutes","121443452","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","273200","188000"," ","461200",
"Cancer","1-Phosphatidylinositol 3-Kinase;Address;Behavior;Cancer Patient;Carcinoma;Cells;Complex;Epithelial;Gene Expression;Genetic Transcription;Invaded;Lead;MAP Kinase Activation Pathway;MAP Kinase Gene;MAP Kinase Signaling Pathways;MAPK8 gene;Malignant Epithelial Cell;Malignant Neoplasms;Mediating;Mesenchymal;Mitogen-Activated Protein Kinases;Molecular;Monomeric GTP-Binding Proteins;Morphology;Mutate;Neoplasm Metastasis;Pathway interactions;Phenotype;Phosphorylation;Phosphorylation Site;Phosphotransferases;Play;Production;Property;Proteins;Recruitment Activity;Relative (related person);Research;Research Project Grants;Role;Signal Pathway;Signal Transduction;Site;Specificity;Stem cells;Tissues;Transforming Growth Factors;Tumor Cell Invasion;Work;autocrine;base;cancer cell;cancer therapy;cell behavior;cell motility;epithelial to mesenchymal transition;human FRAP1 protein;insight;mitogen-activated protein kinase p38;mortality;mutant;neoplastic cell;programs;receptor;response;tumor progression","Role of TGF-b-induced Shc-Erk MAPK signaling in epithelial-mesenchymal transition","  Tumor invasion to other tissues is the primary cause of mortality in cancer patients. TGF-2, a protein that is secreted by tumor cells, signals the tumor cells to change in morphology and behavior, and allows them to invade and spread to other tissues. The proposed research aims to better understand the molecular pathways and signals that are activated when TGF-ss acts on cells, and their roles in cancer cell behavior, cancer progression and metastasis. This work may identify new targets for cancer therapy. )  
  
    

","NCI","8366274","8/9/2012 12:00:00 AM","PA-10-110","5F32CA157109-02","5","F32","CA","157109","02"," ","JAKOWLEW, SONIA B","9/13/2011 12:00:00 AM","9/12/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-E(20)L]"," ","10432298","MUTHUSAMY, BABY PERIYANAYAKI ","Not Applicable","12","ANATOMY/CELL BIOLOGY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","941432510","UNITED STATES","N","9/13/2012 12:00:00 AM","9/12/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","52190"," "," ","52190",
"Atherosclerosis; Biotechnology; Cardiovascular; Clinical Research; Clinical Trials; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Acute myocardial infarction;Address;Adenosine;Admission activity;Aftercare;Age;Beds;Blood Vessels;Bone Marrow;Bone Marrow Cells;Cardiac;Cardiomyopathies;Catheters;Cell Adhesion;Cell Therapy;Cell-Matrix Junction;Cells;Cessation of life;Chronic;Clinical;Clinical Investigator;Clinical Protocols;Clinical Research;Clinical Research Protocols;Congestive Heart Failure;Consent;Coronary;Coronary Artery Bypass;Coronary Circulation;Coronary heart disease;Coronary sinus structure;Development;Diagnosis;Dilated Cardiomyopathy;Disease;EFRAC;Engraftment;Enrollment;Experimental Models;Ficoll;Fostering;Harvest;Healed;Heart;Heart Diseases;Heart Transplantation;Heart failure;Homing;Hospitalization;Hospitals;Infarction;Infusion procedures;Left Ventricular Dysfunction;Left Ventricular Ejection Fraction;Left Ventricular Function;Magnetic Resonance Imaging;Mediating;Medical;Medicare;Mesenchymal;Mesenchymal Stem Cells;Mononuclear;Muscle Cells;Myocardial;Myocardial Infarction;Myocardium;Natural regeneration;Operative Surgical Procedures;Organ;Patients;Placebos;Population;Preparation;Prevention;Procedures;Process;Property;Randomized;Reporting;Research Personnel;Residual state;Role;Staging;Stem cells;Structure;Testing;Time;Tissues;Training;Treatment Efficacy;United States;Ventricular Function;Viral;Work;alternative treatment;angiogenesis;cell preparation;cell type;cytokine;design;experience;healing;heart function;improved;indexing;paracrine;placebo controlled study;prevent;programs;prospective;skeletal;skills;stem cell population;three-arm study;tissue repair","Cell Therapy for Improving Cardiac Function","n/a","NHLBI","8011201","3/21/2012 12:00:00 AM","RFA-HL-06-001","5U01HL087403-05","5","U01","HL","087403","05"," ","SKARLATOS, SONIA","1/1/2007 12:00:00 AM","3/31/2014 12:00:00 AM","ZHL1-CSR-N(O1)"," ","6262599","ZHAO, DAVID X","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","349993","187247"," ","537240",
"Clinical Research; Lung; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","3-Dimensional;A549;Address;Adult;Age;Alveolar;Antigens;Architecture;Autologous;Autologous Transplantation;Autopsy;Biomedical Engineering;Blood Vessels;Bone Marrow;Cells;Clinical;Culture Media;Data;Development;Differentiation and Growth;Disease;EGF gene;Electron Microscopy;Endothelial Cells;Endothelium;Environmental Risk Factor;Epithelial;Epithelial Cells;Epithelium;Extracellular Matrix Proteins;Fibroblast Growth Factor;Fibroblasts;Future;Growth;Growth Factor;Hepatocyte;Histologic;Human;Hydrocortisone;Immune;Implant;Individual;Laboratory mice;Lung;Manuscripts;Measurement;Measures;Mechanical ventilation;Mechanics;Mesenchymal;Mesenchymal Stem Cells;Methods;Mus;Natural regeneration;Nature;Oxygen measurement, partial pressure, arterial;Patients;Perfusion;Pneumonectomy;Process;Production;Proteomics;Pulmonary Emphysema;Pulmonary Fibrosis;Reproducibility;Screening procedure;Services;Slice;Smoking History;Stromal Cells;Structure of parenchyma of lung;System;Techniques;Technology;Testing;Tissues;Transplantation;Tretinoin;Vascular Endothelial Growth Factors;Vascular Endothelium;abstracting;adult stem cell;cell type;embryonic stem cell;induced pluripotent stem cell;keratinocyte;light microscopy;lung lobe;meetings;response;scaffold;surfactant","De-Cellularized Human Lungs for Ex Vivo Lung Regeneration","
Project Narrative
There will never be enough donor lungs available to meet current and future transplantation
needs. In contrast, de-cellularization of whole cadaveric human lungs will result in an intact scaffold
that can be re-cellularized with adult stem cells, including induced pluripotent stem cells (iPS)
derived from individual patients and subsequently utilized for autologous transplantation. Our
preliminary data demonstrate that human lung can be successfully de-cellularized and re-cellularized
with both adult stem cells and with lung epithelial cells. The proposed multi-institutional collaborative
studies will utilize state-of-the-art bioengineering techniques to develop optimal methods for growing
functional lung tissue in de-cellularized cadaveric human lungs. This will provide a potentially limitless
supply of unrelated donor cadaveric lungs for use in diseases such as emphysema, pulmonary
fibrosis, and others for which there is currently no effective cure.","NHLBI","8321903","7/16/2012 12:00:00 AM","RFA-HL-11-026","5R21HL108689-02","5","R21","HL","108689","02"," ","BLAISDELL, CAROL J","8/18/2011 12:00:00 AM","7/31/2014 12:00:00 AM","ZHL1-CSR-N(M2)"," ","1931353","WEISS, DANIEL J","Not Applicable","At-Large","INTERNAL MEDICINE/MEDICINE","066811191","Z94KLERAG5V9","066811191","Z94KLERAG5V9","US","44.478216","-73.200657","8738101","UNIVERSITY OF VERMONT & ST AGRIC COLLEGE","BURLINGTON","VT","SCHOOLS OF MEDICINE","054051704","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","144222","71664"," ","215886",
"Osteoporosis; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adenoviruses;Adipocytes;Affect;Age;Alkaline Phosphatase;Antibodies;Biogenesis;Biological Assay;Blood Vessels;Bone Development;Bone Marrow;Bone Marrow Stem Cell;Bone Regeneration;Cartilage;Cell Culture Techniques;Cell Line;Cells;Chondrocytes;Clinical;Coupled;Data;Defect;Distraction Osteogenesis;Equilibrium;Extracellular Matrix;Fatty acid glycerol esters;Funding;Genes;Goals;Homeostasis;In Vitro;Infection;Marrow;Mediating;Mesenchymal;Mesenchymal Stem Cells;Molecular;Mus;Natural regeneration;Operative Surgical Procedures;Osteoblasts;Osteogenesis;Osteoporosis;Outcome;Paracrine Communication;Phenotype;Process;Receptor Signaling;Recombinant Vascular Endothelial Growth Factor;Recombinants;Resistance;Retroviridae;Role;Signal Transduction;Signaling Molecule;Skeleton;Small Interfering RNA;Stem cells;Variant;Vascular Endothelial Cell;Vascular Endothelial Growth Factor Receptor;Vascular Endothelial Growth Factor Receptor-1;Vascular Endothelial Growth Factor Receptor-2;Vascular Endothelial Growth Factors;adipocyte differentiation;angiogenesis;base;bone;bone marrow stromal stem cell;bone mass;design;disease-causing mutation;extracellular;in vivo;innovation;knock-down;lipid biosynthesis;mouse model;mutant;neutralizing antibody;osteoblast differentiation;osteoclastogenesis;postnatal;precursor cell;prevent;receptor expression;research study;skeletal tissue;stem;stem cell differentiation;substantia spongiosa;transcription factor","Biogenesis of Extracellular Matrix"," Osteoporosis is characterized by loss of bone mass and increased bone marrow fat, raising questions about how the balance between bone-forming cells and fat is regulated. This project addresses these questions in a mouse model of osteoporosis. In addition, based on the discovery that blood vessel-lining cells can be converted to bone- forming stem cells, ways of inducing such conversion during bone repair will be studied.   
   
      

","NIAMS","8370022","8/6/2012 12:00:00 AM","PA-10-067","2R01AR036819-28","2","R01","AR","036819","28"," ","TSENG, HUNG H","7/1/1985 12:00:00 AM","7/31/2017 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1888767","OLSEN, BJORN REINO","Not Applicable","07","DENTISTRY","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","SCHOOLS OF DENTISTRY/ORAL HYGN","021201616","UNITED STATES","N","8/7/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","335527","231654"," ","567181",
"Dental/Oral and Craniofacial Disease; Genetics; Neurosciences; Pediatric","Address;Affect;Ameloblasts;Anterior;Binding;Boxing;Branchial arch structure;Cadherins;Cartilage;Cell Polarity;Cells;Cephalic;Chick Embryo;Chromatin;Cleft Palate;Co-Immunoprecipitations;Complex;Congenital Abnormality;Craniofacial Abnormalities;Data;Deacetylation;Defect;Development;Dorsal;Down-Regulation;Embryo;Epigenetic Process;Epithelial;Event;Face;Family;Family member;Gene Targeting;Genes;Genetic Transcription;Goals;Histone Deacetylation;Histones;Immigration;Lead;Location;Long-Term Effects;Mesenchymal;Modification;Multipotent Stem Cells;Multiprotein Complexes;Names;Neural Crest;Neural Crest Cell;Neural tube;Neuroepithelial Cells;Neuroglia;Neurons;Odontoblasts;Osteogenesis;Peripheral Nervous System;Phase;Plants;Population;Primordium;Process;Reading;Recruitment Activity;Reporting;Repression;Role;Signal Transduction;Site;Skeleton;Smooth Muscle;Snails;Staging;Structure;Testing;Time;Tooth structure;Work;base;blastomere structure;bone;cancer cell;cancer type;cell type;craniofacial;cranium;epithelial to mesenchymal transition;face bone structure;gene discovery;homeodomain;in vivo;knock-down;loss of function;melanocyte;member;migration;palatal shelves;programs;promoter;research study","The role of PHD12 in epigenetic control of cranial neural crest EMT"," Most of the craniofacial skeleton arises from the neural crest (NC), a multipotent stem-cell-like population that migrates extensively and gives rise to an amazingly diverse set of derivatives. In addition to specific components of the craniofacial skeleton, neural crest cells also form melanocytes, neurons and glia of the peripheral nervous system, and smooth muscle. Moreover, many craniofacial abnormalities have their origin in problems at different phase of neural crest cell development ranging from initial formation, to migration or differentiation. One major contributor to craniofacial defects occurs during their departure from the neural tube, which involves a classic epithelial-to-mesenchymal transition (EMT). This application examines epigenetic role of PHD12 in NC EMT and its long term effects on formation and development of the face. Because neural crest-derived cells are involved in a variety of birth defects such as cleft palate and various types of cancer, our results on the normal mechanisms of neural crest development will provide important clues regarding the mistakes that may lead to abnormal development or loss of the differentiated state.  
    

","NIDCR","8310919","7/27/2012 12:00:00 AM","PAR-08-222","5R03DE022521-02","5","R03","DE","022521","02"," ","SCHOLNICK, STEVEN","8/2/2011 12:00:00 AM","7/31/2014 12:00:00 AM","International and Cooperative Projects - 1 Study Section[ICP1]"," ","1858016","BRONNER, MARIANNE ","STROBL MAZZULLA, PABLO HERNAN","27","NONE","009584210","U2JMKHNS5TG4","009584210","U2JMKHNS5TG4","US","34.134337","-118.126525","1073501","CALIFORNIA INSTITUTE OF TECHNOLOGY","PASADENA","CA","SCHOOLS OF ARTS AND SCIENCES","911250001","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","FIC","4813","187"," ","5000",
"Dental/Oral and Craniofacial Disease; Genetics; Neurosciences; Pediatric","Address;Affect;Ameloblasts;Anterior;Binding;Boxing;Branchial arch structure;Cadherins;Cartilage;Cell Polarity;Cells;Cephalic;Chick Embryo;Chromatin;Cleft Palate;Co-Immunoprecipitations;Complex;Congenital Abnormality;Craniofacial Abnormalities;Data;Deacetylation;Defect;Development;Dorsal;Down-Regulation;Embryo;Epigenetic Process;Epithelial;Event;Face;Family;Family member;Gene Targeting;Genes;Genetic Transcription;Goals;Histone Deacetylation;Histones;Immigration;Lead;Location;Long-Term Effects;Mesenchymal;Modification;Multipotent Stem Cells;Multiprotein Complexes;Names;Neural Crest;Neural Crest Cell;Neural tube;Neuroepithelial Cells;Neuroglia;Neurons;Odontoblasts;Osteogenesis;Peripheral Nervous System;Phase;Plants;Population;Primordium;Process;Reading;Recruitment Activity;Reporting;Repression;Role;Signal Transduction;Site;Skeleton;Smooth Muscle;Snails;Staging;Structure;Testing;Time;Tooth structure;Work;base;blastomere structure;bone;cancer cell;cancer type;cell type;craniofacial;cranium;epithelial to mesenchymal transition;face bone structure;gene discovery;homeodomain;in vivo;knock-down;loss of function;melanocyte;member;migration;palatal shelves;programs;promoter;research study","The role of PHD12 in epigenetic control of cranial neural crest EMT"," Most of the craniofacial skeleton arises from the neural crest (NC), a multipotent stem-cell-like population that migrates extensively and gives rise to an amazingly diverse set of derivatives. In addition to specific components of the craniofacial skeleton, neural crest cells also form melanocytes, neurons and glia of the peripheral nervous system, and smooth muscle. Moreover, many craniofacial abnormalities have their origin in problems at different phase of neural crest cell development ranging from initial formation, to migration or differentiation. One major contributor to craniofacial defects occurs during their departure from the neural tube, which involves a classic epithelial-to-mesenchymal transition (EMT). This application examines epigenetic role of PHD12 in NC EMT and its long term effects on formation and development of the face. Because neural crest-derived cells are involved in a variety of birth defects such as cleft palate and various types of cancer, our results on the normal mechanisms of neural crest development will provide important clues regarding the mistakes that may lead to abnormal development or loss of the differentiated state.  
    

","NIDCR","8310919","7/27/2012 12:00:00 AM","PAR-08-222","5R03DE022521-02","5","R03","DE","022521","02"," ","SCHOLNICK, STEVEN","8/2/2011 12:00:00 AM","7/31/2014 12:00:00 AM","International and Cooperative Projects - 1 Study Section[ICP1]"," ","1858016","BRONNER, MARIANNE ","STROBL MAZZULLA, PABLO HERNAN","27","NONE","009584210","U2JMKHNS5TG4","009584210","U2JMKHNS5TG4","US","34.134337","-118.126525","1073501","CALIFORNIA INSTITUTE OF TECHNOLOGY","PASADENA","CA","SCHOOLS OF ARTS AND SCIENCES","911250001","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","45183","1730"," ","46913",
"Eye Disease and Disorders of Vision; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","3T3 Cells;Adipose tissue;Adverse effects;Animals;Applications Grants;Autologous Transplantation;Biomedical Engineering;Blindness;Bone Marrow;Cattle;Cell Proliferation;Cell Therapy;Cell Transplantation;Cells;Clinical;Cornea;Corneal Diseases;Data;Development;Epithelial;Epithelial Cells;Genetic;Goals;Graft Survival;Growth;Health Hazards;Human;In Vitro;Individual;Keratoplasty;Laboratories;Ligands;Lithium Chloride;Membrane;Mesenchymal;Mesenchymal Stem Cells;Methods;Mus;Natural regeneration;Notch Signaling Pathway;Notch and Wnt Signaling Pathway;Outcome;Patients;Phenotype;Play;Population;Protocols documentation;Publishing;RNA;Regulation;Reporting;Research;Role;Serum;Signal Pathway;Signal Transduction;Source;Stem cell transplant;Stem cells;Stromal Cells;System;Testing;Toxic effect;Transcript;Translational Research;Transplantation;Transplantation Conditioning;Undifferentiated;United States Food and Drug Administration;Vision;Wound Healing;Xenobiotics;base;blind;cell growth;cell type;cellular engineering;conjunctiva;corneal epithelium;human FZD7 protein;improved;inhibitor/antagonist;innovation;knock-down;limbal;mouse model;notch protein;novel;ocular surface;progenitor;receptor;self-renewal;small hairpin RNA;small molecule;stem;stem cell population;tissue culture;transplantation typing","Ex Vivo Expansion of Human Limbal Stem Cells for Transplantation"," The goal of this proposed research is to establish an ex vivo expansion protocol for limbal stem cells, or corneal epithelial stem/progenitor cells (CESCs), in xenobiotic-free conditions for transplantation into humans and a novel bioengineering approach to increase the efficiency of expansion of functional human CESCs. Thus, the proposed research will enable the initiation of a safe and effective patient specific stem cell-based therap for limbal stem cell deficiency.   
      

","NEI","8373855","8/14/2012 12:00:00 AM","PA-11-260","1R01EY021797-01A1","1","R01","EY","021797","01","A","MCKIE, GEORGE ANN","9/1/2012 12:00:00 AM","8/31/2017 12:00:00 AM","Biology of the Visual System Study Section[BVS]"," ","9077720","DENG, SOPHIE ","Not Applicable","33","OPHTHALMOLOGY","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","SCHOOLS OF MEDICINE","900952000","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","250000","135000"," ","385000",
"Biotechnology; Cardiovascular; Food Safety; Genetics; Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Accounting;Adipocytes;Adipose tissue;Affect;Apoptosis;Arsenic;Atherosclerosis;Basic Science;Binding Proteins;Biogenesis;Blood Vessels;Brown Fat;Cardiac;Cardiovascular Diseases;Cardiovascular system;Cell Differentiation process;Cell physiology;Cells;Chronic;Chronic Disease;Data;Development;Diabetes Mellitus;Disease;Disease Progression;Dose;Environmental Hazards;Environmental Impact;Environmental Pollution;Environmental Risk Factor;Etiology;Event;Exposure to;Family;Family member;Gene Expression;Genes;Health;Human;Hypertension;Impairment;Injury;Liver;Mediating;Mesenchymal;Mesenchymal Stem Cells;Messenger RNA;Metabolic;Metabolic Diseases;MicroRNAs;Modeling;Molecular;Mus;Muscle Cells;Natural regeneration;Pathogenesis;Pathology;Peripheral;Phenotype;Physiological;Play;Population;Post-Transcriptional Regulation;Public Health;Regulation;Relative (related person);Reporting;Research;Risk;Role;Signal Transduction;Stem cells;Testing;Therapeutic Intervention;Tissues;Toxic Environmental Substances;Transcription Process;Translational Repression;Translations;Vascular Diseases;Vascular remodeling;adult stem cell;base;carcinogenesis;cardiac repair;drinking water;effective intervention;exposed human population;improved;member;men;novel;prevent;programs;protein expression;regenerative;response;stem;stem cell differentiation","Pathogenic environmental regulation of miRNA biogenesis and function"," The environmental basis of chronic diseases is a well recognized public health concern, but is mechanistically poorly understood, including exposure to arsenic in drinking water which is well known to cause significant health effects including cardiovascular and metabolic diseases in populations across the globe. The proposed studies investigate impact of arsenic exposure on miRNA, the newly discovered, small, yet powerful cellular regulators, in pathological responses in adult stem cell pools that impair regenerative or
adaptive responsive that prevent disease. This research will identify mechanisms for pathogenic arsenic effects, as well as basic understanding of regulatory mechanisms for miRNA biogenesis and function that may identify novel targets for therapeutic intervention or protection from environmentally-derived disease.    
      

","NIEHS","8395272","8/23/2012 12:00:00 AM","PA-11-113","1F32ES022134-01","1","F32","ES","022134","01"," ","HUMBLE, MICHAEL C","9/1/2012 12:00:00 AM","8/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-F10A-S(20)L]"," ","11201194","BEEZHOLD, KEVIN J","Not Applicable","18","PUBLIC HEALTH & PREV MEDICINE","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF PUBLIC HEALTH","152133320","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","113","Training, Individual","2012"," "," ","NIEHS","49214"," "," ","49214",
"Clinical Research; Lung; Rare Diseases","Address;Alveolar;Automobile Driving;Basement membrane;Binding;Biological Assay;Biological Markers;Biopsy;Bleomycin;Cells;Complex;DNA;DNA Binding;Deposition;Epithelial;Epithelial Cells;Event;Exercise;Extracellular Matrix;Fibroblasts;Fibronectins;Fibrosis;Gene Targeting;Generations;Goals;Growth Factor;Hamman-Rich syndrome;Human;Inflammation;Injury;Integrins;Laminin;Laminin Receptor;Lasers;Lead;Link;Lung;Maps;Mediator of activation protein;Mesenchymal;Modeling;Mus;Myofibroblast;Nuclear;Pathway interactions;Patients;Pattern;Peptide Hydrolases;Phosphorylation;Phosphotransferases;Process;Production;Progress Reports;Proliferating;Protein Tyrosine Kinase;Pulmonary Fibrosis;Regulation;Role;Series;Signal Pathway;Signal Transduction;Site;Source;System;Testing;Tissues;Toxic effect;Tyrosine;Uncertainty;Wound Healing;base;cell growth;chromatin immunoprecipitation;cytokine;defined contribution;design;effective therapy;epithelial to mesenchymal transition;fibrogenesis;in vivo;indium-bleomycin;injured;lung repair;mutant;promoter;public health relevance;research study;response;response to injury;therapeutic target","Epithelial Mesenchymal Transition in Pulmonary Fibrosis","
PROJECT NARRATIVE
There are currently no effective treatments to halt progression of lung scarification in patients with
pulmonary fibrosis. The goal of this application is to delineate a specific set of signals that emanate from
the prototypical wound repair cytokine, TGFï¿½1, and drive pulmonary fibrosis. If successful, the studies
should define a specific signaling pathway that could be quantified in Idiopathic Pulmonary Fibrosis
patients and serve as a basis for targeted therapy, avoiding the expected toxicities of prolonged global
inhibition of TGFï¿½1 signaling.","NHLBI","8204941","12/1/2011 12:00:00 AM","PA-07-070","5R01HL044712-21","5","R01","HL","044712","21"," ","EU, JERRY PC","1/1/1991 12:00:00 AM","12/31/2014 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1881986","CHAPMAN, HAROLD A","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","134888"," ","382388",
"Dental/Oral and Craniofacial Disease; Pediatric","Address;Affect;Antibodies;Binding;Biological Assay;Biological Models;Biology;Birds;Bromodeoxyuridine;Cell Polarity;Cell physiology;Cells;Cephalic;Chemotaxis;Cilia;Data;Data Set;Defect;Development;Dorsal;Dysmorphology;Elements;Engineering;Environment;Epithelial Cells;Etiology;Face;Fingers;Foundations;Funding;Future;Genetic Models;Goals;Grant;Growth;Head;Histone H3;In Situ Hybridization;Injection of therapeutic agent;Link;Maps;Medical center;Membrane;Mesenchymal;Methodology;Microtubules;Migration Assay;Molecular;Neural Crest;Neural Crest Cell;Neural tube;Organelles;Pattern;Pediatric Hospitals;Phase;Physical condensation;Plastic Surgical Procedures;Play;Positioning Attribute;Process;Proliferating;Proteins;Reagent;Relative (related person);Reporter;Research;Role;Sensory;Signal Transduction;Skeleton;Snails;Source;Staging;Staining method;Stains;Stress;Subfamily lentivirinae;Syndrome;Techniques;Testing;Tubulin;Work;base;cell motility;cell type;ciliopathy;craniofacial;craniofacial complex;epithelial to mesenchymal transition;gamma Tubulin;human disease;in vivo;kinetosome;knock-down;migration;molecular marker;morphogens;precursor cell;professor;progenitor;programs;research study;response;skeletal;skeletogenesis;slug;small hairpin RNA","The role of primary cilia in craniofacial development","n/a","NIDCR","8223323","12/28/2011 12:00:00 AM"," ","5R00DE019853-03","5","R00","DE","019853","03"," ","SCHOLNICK, STEVEN","2/1/2011 12:00:00 AM","1/31/2014 12:00:00 AM","NSS"," ","8403350","BRUGMANN, SAMANTHA A","Not Applicable","01","Unavailable","071284913","JZD1HLM2ZU83","071284913","JZD1HLM2ZU83","US","39.140882","-84.500494","615001","CINCINNATI CHILDRENS HOSP MED CTR","CINCINNATI","OH","Independent Hospitals","452293039","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","161115","85412"," ","246527",
"No NIH Category available","Accounting;Affect;Animals;Area;Autopsy;Behavior;Biology;Cancer Etiology;Cancer Patient;Cells;Cessation of life;Diagnosis;Disease;Disseminated Malignant Neoplasm;Distant;Elements;Engraftment;Exhibits;Fostering;Gene Mutation;Genes;Genetic;Genetic Determinism;Genetic Screening;Hypoxia;Instruction;Laboratories;Lead;Life;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of prostate;Mesenchymal;Metabolic;Metastatic Lesion;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Molecular;Myofibroblast;Neoplasm Metastasis;Organ;Patients;Pharmaceutical Preparations;Population;Prostate;Prostatic Diseases;Prostatic Neoplasms;Regulation;Role;Skeleton;System;Therapeutic;bone;bone cell;cancer cell;cell type;design;epithelial to mesenchymal transition;in vivo;insight;men;metastatic process;mortality;mouse model;neoplastic cell;new therapeutic target;preclinical study;preference;programs;stem;tumor","Stromal Regulation of Bone Metastasis","RELEVANCE (See instructions): 
Prostate cancer is the most commonly diagnosed malignancy in men in the US, with the highest rate of mortality after lung cancer. The underlying mechanism for the the 'specific' organ preferences of metastatic spread is largely unknown, particularly in the case of prostate cancer metastasizing to skeleton/bone. 
Therefore this proposal is designed to determine the impact of tumor microenvironment in the emergence of bone metastasis and identify new therapies","NCI","8338887","7/4/2012 12:00:00 AM","RFA-CA-10-021","5U54CA163191-02","5","U54","CA","163191","02"," ","MOHLA, SURESH","9/26/2011 12:00:00 AM","8/2/2012 12:00:00 AM","ZCA1-SRLB-3(O1)"," ","1858925","KALLURI, RAGHU ","SCADDEN, DAVID T","07","Unavailable","071723621","C1CPANL3EWK4","071723621","C1CPANL3EWK4","US","42.346758","-71.10256","758101","BETH ISRAEL DEACONESS MEDICAL CENTER","BOSTON","MA","Independent Hospitals","022155400","UNITED STATES","N","8/1/2012 12:00:00 AM","8/2/2012 12:00:00 AM","397","Research Centers","2012"," "," ","NCI","0","35566"," ","35566",
"Bioengineering; Biotechnology; Kidney Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Acute;Acute Kidney Failure;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Attenuated;Biological Markers;Bioreactors;Biotechnology;Blood;Blood Circulation;Canis familiaris;Cell Survival;Cell Therapy;Cell Transplantation;Cell physiology;Cell secretion;Cells;Cessation of life;Clinical;Clinical Protocols;Clinical Research;Clinical Trials;Communities;Complex;Conditioned Culture Media;Creatinine;Critical Illness;Data;Devices;Diagnostic;Dialysis procedure;Dimensions;Disease;Dose;Drug Delivery Systems;Exclusion Criteria;Functional disorder;Funding;Future;Glycocalyx;Goals;Growth;Heterogeneity;Human;Hybrids;Immune response;Immunotherapy;Injury;Intellectual Property;Investigation;Investments;Kidney;Marketing;Measures;Mesenchymal Stem Cells;Monitor;Nephrology;Organ;Patients;Pharmaceutical Preparations;Phase;Procedures;Rodent;Safety;Sentinel;Series;Severities;Simulate;Stem Cell Factor;Stem cells;Technology;Testing;Therapeutic;Therapeutic Studies;Time;Tissue Engineering;Toxicity Tests;Translating;United States National Institutes of Health;active method;animal efficacy;base;combinatorial;commercialization;design;early onset;effective therapy;efficacy testing;human study;in vivo;manufacturing process;meetings;multidisciplinary;novel therapeutics;operation;patient population;programs;prototype;quality assurance;regenerative;single molecule;success;therapy duration;tissue repair;treatment duration","Mesenchymal Stem Cell Bioreactor for the Active Treatment of Acute Renal Failure"," Sentien Biotechnologies, Inc. has developed a mesenchymal stem cell (MSC)-coated device that offers combinatorial therapeutic support to patients undergoing acute renal failure (ARF). The device delivers MSC-derived secretions of anti-inflammatory and regenerative molecules directly into the bloodstream in a dynamic and sustained manner. We now plan to develop an effective clinical protocol for the device for ARF that captures the critical components of a administering a new drug, namely (i) initiation time, (i) dose, and (iii) duration of treatment that will enable human investigation.   
   
      

","NIDDK","8251784","7/12/2012 12:00:00 AM","PA-11-096","2R44DK085766-03","2","R44","DK","085766","03"," ","MOXEY-MIMS, MARVA M","6/15/2010 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-DKUS-L(11)B]"," ","6825988","TILLES, ARNO W","PAREKKADAN, BIJU ","05","Unavailable","828970900","NDAYRDKCMBJ7","828970900","NDAYRDKCMBJ7","US","42.415247","-71.127241","10020782","SENTIEN BIOTECHNOLOGIES, INC.","Lexington","MA","Domestic For-Profits","024217998","UNITED STATES","N","7/15/2012 12:00:00 AM","6/30/2014 12:00:00 AM","847","SBIR/STTR","2012"," "," ","NIDDK"," "," "," ","773285",
"Lung; Regenerative Medicine; Stem Cell Research","3-Dimensional;Adherent Culture;Agonist;Anterior;Biology;Cell Communication;Cells;Cellular biology;Chemicals;Communities;Complex;Derivation procedure;Development;Disease;Distal;Embryo;Endocrine;Endoderm;Environment;Epithelial;Epithelium;Event;Fibroblast Growth Factor;Foundations;Generations;Genetic;Goals;Growth Factor;Hindgut;Histocompatibility Testing;Human;Human Development;In Vitro;Intestines;Liver;Lung;Lung diseases;Mechanics;Medical;Mesenchymal;Mesenchymal Stem Cells;Mesenchyme;Methods;Modeling;Molecular;Morphogenesis;Mus;Natural regeneration;Nature;Operative Surgical Procedures;Organ;Organogenesis;Organoids;Pancreas;Pathway interactions;Pattern;Pharmaceutical Preparations;Play;Pluripotent Stem Cells;Preclinical Drug Evaluation;Primitive foregut structure;Protocols documentation;Recombinant Proteins;Regulation;Reporting;SHH gene;Sampling;Signal Pathway;Signal Transduction;Source;Stem Cell Research;Stem cells;Structure;Structure of parenchyma of lung;System;Therapeutic Uses;Time;Tissues;Transplantation;Tube;Villus;Work;base;biliary tract;cell type;fetal;human disease;human tissue;in vivo;induced pluripotent stem cell;innovation;interest;loss of function;lung development;lung repair;monolayer;novel;prevent;progenitor;smoothened signaling pathway;theories;tool;translational study","Generating 3-D lung organoids in vitro from human pluripotent stem cells"," The proposed translational studies will take a fundamentally different approach to generate 3-dimensional lung tissue from human pluripotent stem cells. Development of this novel human lung model provides a stable source of human lung tissue that can be readily manipulated to study specific pathways, developmental events and lung diseases. Such studies would be challenging if not impossible if based solely on human surgical samples. The proposed studies will provide key information to support efforts to generate tissue, cells, and medical therapies for regeneration and repair of the lung, and will provide a novel reproducible method that can be used throughout the scientific community.      

","NHLBI","8354797","8/9/2012 12:00:00 AM","PA-09-248","1R21HL115372-01","1","R21","HL","115372","01"," ","LIN, SARA","8/10/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","9095766","SPENCE, JASON ","WELLS, JAMES M","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","8/10/2012 12:00:00 AM","6/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","171863","74231"," ","246094",
"Acute Respiratory Distress Syndrome; Lung; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Actins;Acute Lung Injury;Acute Renal Failure with Renal Papillary Necrosis;Acute respiratory failure;Affect;Alveolar;Alveolar Macrophages;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Apical;Beds;Biological;Biology;Bone Marrow;CD44 gene;Cell Therapy;Cell membrane;Cells;Clinical Trials;Critical Illness;Data;Development;Edema;Endothelial Cells;Endothelium;Endotoxins;Epithelial;Epithelial Cells;Epithelium;Escherichia coli;Fibroblasts;Fluid Balance;Growth;Growth Factor;Guanosine Triphosphate Phosphohydrolases;Human;Human Activities;In Vitro;Infection;Inflammation;Inflammatory;Inflammatory Response;Injury;Kidney;Liquid substance;Lung;Malignant - descriptor;Malignant Neoplasms;Mediating;Membrane;Membrane Proteins;Mesenchymal Stem Cells;Messenger RNA;Mitochondria;Modeling;Mus;Organelles;Patients;Permeability;Phenotype;Pre-Clinical Model;Protein Biosynthesis;Proteins;Pulmonary Edema;RNA Synthesis Inhibitors;Receptor Cell;Recovery of Function;Reporting;Research;Research Personnel;Resolution;Role;Safety;Sodium Channel;Stem cells;Stress Fibers;Surface;Syndrome;TNF gene;Testing;Therapeutic;Therapeutic Effect;Therapeutic Uses;Tissues;Translations;Tubular formation;Type II Epithelial Receptor Cell;antimicrobial peptide;apical membrane;cytokine;epithelial Na+ channel;in vivo;in vivo Model;injured;insight;keratinocyte growth factor;lung injury;macrophage;mortality;novel;novel strategies;novel therapeutic intervention;paracrine;pre-clinical;prevent;receptor;repaired;tissue repair;tumor growth","Human mesenchymal stem cell microvesicles for the treatment of acute lung injury"," Microvesicles released by human mesenchymal stem cells are biologically active in various pre-clinical models of acute lung injury, an important cause of acute respiratory failure in critically ill patients. The mechanism of benefit is through the transer of mRNA from the microvesicles to the injured lung epithelial and endothelial cells, leading to the expression of several proteins that can reduce lung injury and enhance repair.   
      

","NHLBI","8272406","5/2/2012 12:00:00 AM","PA-10-067","1R01HL113022-01","1","R01","HL","113022","01"," ","HARABIN, ANDREA L","5/1/2012 12:00:00 AM","4/30/2017 12:00:00 AM","Surgery, Anesthesiology and Trauma Study Section[SAT]"," ","9141159","LEE, JAE WOO","Not Applicable","12","ANESTHESIOLOGY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","136250"," ","386250",
"Biotechnology; Cancer; Clinical Research; Clinical Trials; Colo-Rectal Cancer; Digestive Diseases; Genetics; Orphan Drug; Rare Diseases","Address;Adult;Animals;Antibodies;Antineoplastic Agents;Avastin;Back;Bioinformatics;Biological Markers;Biomedical Research;C-KIT Gene;Childhood;Chronic Myeloid Leukemia;Clinic;Clinical;Clinical Research;Clinical Trials;Colorectal Cancer;Critical Pathways;Cultured Cells;Development;Disease;Disease Progression;Drug Combinations;Drug Delivery Systems;Drug Sensitization;Epidermal Growth Factor Receptor;Funding;Future;Gastrointestinal Stromal Tumors;Gastrointestinal tract structure;Gefitinib;Gene Expression;Gene-Modified;Genes;Gleevec;Goals;Human;IGF1R gene;Imatinib;Imatinib mesylate;Individual;Learning;Libraries;Malignant Neoplasms;Maps;Measures;Mesenchymal;Mesenchymal Cell Neoplasm;Modification;Molecular;Molecular Target;Mutation;Neoadjuvant Therapy;Oncogenes;Oncogenic;Oral;PDGFRB gene;Pathway interactions;Patients;Pattern;Pharmaceutical Preparations;Phase II Clinical Trials;Process;Proteins;Proto-Oncogenes;RNA Interference;Receptor Protein-Tyrosine Kinases;Regimen;Roche brand of trastuzumab;Route;Schedule;Signal Transduction;Signaling Protein;Small Interfering RNA;Testing;Therapeutic;Time;Translating;Trastuzumab;Treatment outcome;Tumor Cell Line;Validation;Work;Xenograft Model;base;bcr-abl Fusion Proteins;bevacizumab;cancer cell;cancer therapy;design;flexibility;gain of function mutation;human ZNF45 protein;improved;inhibitor/antagonist;killings;member;multimodality;neoplastic cell;network models;next generation;novel;novel therapeutics;oncology;prevent;programs;public health relevance;research study;resistance mutation;response;success;therapeutic target;tumor","The Molecular Actions of Imatinib Mesylate in GISTs","PUBLIC HEALTH RELEVANCE: Future clinical studies will need to explore schedules and combinations of treatments that optimize therapeutic results of existing agents, but at the same time novel drug able targets must also be found. The studies proposed offer an unprecedented opportunity to employ a functional approach to identify critical drug response-modifying genes that can be therapeutically targeted to improve GIST treatment outcomes with contemporary agents such as imatinib mesylate.","NCI","8282891","5/4/2012 12:00:00 AM","PA-07-070","5R01CA106588-09","5","R01","CA","106588","09"," ","TIMMER, WILLIAM C","5/1/2004 12:00:00 AM","5/31/2014 12:00:00 AM","Clinical Oncology Study Section[CONC]"," ","1891485","GODWIN, ANDREW K.","VON MEHREN, MARGARET ","03","PATHOLOGY","016060860","YXJGGNC5J269","016060860","YXJGGNC5J269","US","39.123452","-94.743946","1484303","UNIVERSITY OF KANSAS MEDICAL CENTER","KANSAS CITY","KS","SCHOOLS OF MEDICINE","661608500","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","255885","109391"," ","365276",
"Bioengineering; Biotechnology; Regenerative Medicine","Address;Allogenic;Anastomosis - action;Animals;Autologous Transplantation;Blood Vessels;Blood capillaries;Body Fluids;Bone Marrow;Buffers;Cell Culture Techniques;Cell Survival;Cell Transplants;Cells;Chemical Engineering;Consensus;Encapsulated;Endothelial Cells;Engineering;Fibrin;Gel;Histocompatibility Testing;Human;Hydrogels;Image;Implant;In Situ;In Vitro;Literature;Mesenchymal Stem Cells;Methods;Morphogenesis;Morphology;Motion;Myocardial;Myocardium;Nutrient;Oxygen;Perfusion;Reaction;Reporting;Research;Research Personnel;Rodent;Structure;Supporting Cell;System;Technology;Testing;Tissue Engineering;Tissues;Umbilical vein;Work;abstracting;aqueous;base;capillary;chemical reaction;clinically relevant;design;experience;human tissue;implantation;in vivo;innovation;interest;interstitial;poly(ethylene glycol)diacrylate;porous hydrogel;repaired;scaffold;tissue culture;two-dimensional","Modular Assembly Approach to Engineer Prevascularized Large 3D Tissue Constructs","
Project Narrative
We will develop a method to create large, porous, prevascularized tissue constructs for implantation. These
constructs can circumvent the mass transfer limitation, a major challenge that hampers creation of functional
3D tissue products of clinically relevant sizes. The resulting functional 3D tissues can replace diseased or lost
tissues of human beings.","NHLBI","8321540","7/24/2012 12:00:00 AM","RFA-HL-11-026","5R21HL108688-02","5","R21","HL","108688","02"," ","LUNDBERG, MARTHA","8/19/2011 12:00:00 AM","7/31/2014 12:00:00 AM","ZHL1-CSR-N(M2)"," ","8856351","SHEN, WEI ","Not Applicable","05","BIOMEDICAL ENGINEERING","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","BIOMED ENGR/COL ENGR/ENGR STA","554552070","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","150000","69309"," ","219309",
"Cancer; Clinical Research; Genetics; Prostate Cancer; Urologic Diseases","Alternative Splicing;Animal Model;Apoptosis;Behavior;Biological;Biological Assay;Biological Markers;Cancer Model;Cancer Patient;Cell Culture Techniques;Cell Proliferation;Cells;Clinical;Data;Decision Making;Early Diagnosis;Early treatment;Epithelial;Epithelial Cells;Event;Fibroblast Growth Factor Receptor 2;Foxes;Gene Expression;Gene Expression Regulation;Goals;Human;Imagery;In Vitro;Individual;Investigation;Malignant Neoplasms;Malignant neoplasm of prostate;Mesenchymal;Messenger RNA;Mus;Neoplasm Metastasis;Operative Surgical Procedures;Outcome;Pathologic;Patients;Pre-Clinical Model;Process;Prostate;Prostatic Neoplasms;Protein Isoforms;Proteins;RNA Splicing;RNA, Messenger, Splicing;Radical Prostatectomy;Rattus;Regulation;Reporter;Research;Role;Sampling;Testing;Tissues;Transcript;Tumorigenicity;cancer cell;cell motility;epithelial to mesenchymal transition;in vitro Model;in vivo;indium arsenide;men;novel;research study;response;therapeutic target;transcription factor;tumor progression;tumorigenesis;tumorigenic","Regulation of tumorigenesis by alternative pre-mRNA splicing"," Careful study of the regulation of gene expression in a mouse cancer model may advance our understanding of how gene expression is altered during tumorigenesis and metastasis. This investigation may identify novel biomarkers and therapeutic targets important for the early detection and treatment of prostate cancer, respectively.   
      

","NCI","8398272","9/21/2012 12:00:00 AM","PA-11-113","1F32CA165482-01A1","1","F32","CA","165482","01","A","JAKOWLEW, SONIA B","11/1/2012 12:00:00 AM","9/29/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-P(20)L]"," ","10683792","SCHAEFFER, DANEEN L.","Not Applicable","04","GENETICS","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","11/1/2012 12:00:00 AM","9/29/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","45588"," "," ","45588",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Alginates;Bioreactors;Bone Injury;Bone Regeneration;Bone Tissue;Calcium;Cell Culture Techniques;Cell Proliferation;Cells;Clinical Treatment;Coculture Techniques;Culture Media;Defect;Deposition;Development;Devices;Diffusion;Disease;Encapsulated;Endothelial Cells;Engineering;Environment;Excision;Fostering;Goals;Growth;Healed;Human;Implant;In Vitro;Investigation;Laboratories;Mechanical Stress;Mechanics;Mesenchymal Stem Cells;Methods;Nutrient;Osteocalcin;Osteogenesis;Oxygen;Perfusion;Polymers;Regenerative Medicine;Stem cells;Structure;System;Technology;Therapeutic;Tissue Engineering;Tissue Grafts;Tissues;Translating;Trauma;Tubular formation;Umbilical vein;Up-Regulation;Vascularization;base;bone;cell growth;clinical application;clinically relevant;design;fluid flow;healing;implantation;improved;in vivo;innovation;novel;osteoblast differentiation;osteopontin;oxygen transport;repaired;response;scaffold;shear stress;success;tissue culture;treatment strategy;tumor","Application of Tubular Perfusion System (TPS) Generated Prevascularized Bone Tiss","   Bone injuries resulting from trauma, tumor removal, or disease are often inadequately healed by the body's natural mechanisms. Current treatments for bone injuries have limited success. Regenerative medicine approaches often suggest successful in vitro culture of stem cells outside and rapid in vivo vascularization of the implanted tissue. To this end, we aim to develop strategies for the culture of mesenchymal stem cells, with a prevascularization network, using a novel bioreactor system.    
  
    

","NIAMS","8333407","7/16/2012 12:00:00 AM","PA-10-067","5R01AR061460-02","5","R01","AR","061460","02"," ","WANG, FEI","9/16/2011 12:00:00 AM","7/31/2015 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","8024549","FISHER, JOHN P","Not Applicable","05","BIOMEDICAL ENGINEERING","790934285","NPU8ULVAAS23","790934285","NPU8ULVAAS23","US","38.996321","-76.933629","820102","UNIV OF MARYLAND, COLLEGE PARK","COLLEGE PARK","MD","BIOMED ENGR/COL ENGR/ENGR STA","207420001","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","275883","56862"," ","332745",
"Breast Cancer; Cancer","Ablation;Basement membrane;CSPG4 gene;Cell surface;Cells;Cessation of life;Characteristics;Chondroitin Sulfate Proteoglycan;Coupled;Diagnostic Neoplasm Staging;Endothelial Cells;Evaluation;Exhibits;Fibroblasts;Fluorescence;Genetic;Genomics;Grant;Growth;Hypoxia;Imatinib;Immune;Infiltration;Inflammatory Infiltrate;Intervention;Laboratories;Lung;MAPK14 gene;Malignant Neoplasms;Mammary Neoplasms;Mediating;Mesenchymal;Mouse Protein;Mus;Mutation;Neoplasm Metastasis;PDGFRB gene;Pathway interactions;Pericytes;Phase;Platelet-Derived Growth Factor Receptor;Platelet-Derived Growth Factor beta Receptor;Play;Primary Neoplasm;Proliferating;Proteins;Reagent;Role;Snails;Sorting - Cell Movement;Staging;Systemic disease;Testing;Thymidine Kinase;Transgenic Mice;Tumor Angiogenesis;Tumor stage;Viral;angiogenesis;cancer cell;cell type;design;epithelial to mesenchymal transition;inhibitor/antagonist;malignant breast neoplasm;mitogen-activated protein kinase p38;mouse model;novel;promoter;public health relevance;receptor;recombinase;research clinical testing;slug;therapeutic target;tumor;tumor growth;tumor progression;vasculogenesis","Targeting Pericytes in Cancer","
Project Narrative:
About 80% of cancer deaths are associated with systemic disease, also known as
'metastasis'. Many studies suggest that the genetic alterations that accumulate in the
cancer cells define, in part, the metastatic potential. Nevertheless, components of the
tumor stroma, such as fibroblasts, endothelial cells, and pericytes, may play a role in
metastasis. Several studies suggest pericytes as new potential therapeutic targets to
inhibit tumor angiogenesis and subsequently tumor growth. Our proposal is designed to
functionally determine the contribution of pericytes in primary tumor growth and
metastasis, and identify new therapies to inhibit metastasis.","NCI","8210865","12/30/2011 12:00:00 AM","PA-10-067","5R01CA155370-02","5","R01","CA","155370","02"," ","MOHLA, SURESH","1/1/2011 12:00:00 AM","10/31/2012 12:00:00 AM","Developmental Therapeutics Study Section[DT]"," ","1858925","KALLURI, RAGHU ","Not Applicable","07","Unavailable","071723621","C1CPANL3EWK4","071723621","C1CPANL3EWK4","US","42.346758","-71.10256","758101","BETH ISRAEL DEACONESS MEDICAL CENTER","BOSTON","MA","Independent Hospitals","022155400","UNITED STATES","N","1/1/2012 12:00:00 AM","10/31/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","153550"," ","361050",
"Bioengineering; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Adipose tissue;Anatomy;Area;Biocompatible Materials;Blood Vessels;Blood capillaries;Bone Marrow;Bone Regeneration;Breathing;Cell Adhesion;Cell Communication;Cell Survival;Cell Therapy;Cells;Clinical;Complex;Conditioned Culture Media;Cues;Cultured Cells;Data;Development;Disease;Endothelial Cells;Engineering;Environment;Extracellular Matrix;Fibroblasts;Funding Mechanisms;Goals;Growth;Growth Factor;Hematopoietic;Hematopoietic stem cells;Hydrogels;In Vitro;Investigation;Knowledge;Location;Mechanics;Mesenchymal Stem Cells;Methods;Molecular;Mus;Natural regeneration;Nature;Outcome;Phenotype;Property;Publishing;Regenerative Medicine;Regulation;Research;Research Project Grants;Source;Staging;Stem cells;Surface;System;Testing;Therapeutic;Tissues;Tumor Stem Cells;adult stem cell;aged;base;capillary;cell type;embryonic stem cell;in vivo;innovation;insight;nerve stem cell;novel;osteogenic;paracrine;public health relevance;relating to nervous system;self-renewal;stem;stem cell biology;stem cell fate;stem cell niche;tissue repair;tool","An Artificial Perivascular Niche for Mesenchymal Stem Cells","
 Many adult stem cells reside near blood vessels in the body. This project seeks to
understand the significance and implications of that anatomic location, and to use this insight to
develop a new method to control stem cell properties outside of the body. Understanding how
blood vessels regulate stem cells, and using that knowledge to control their function, provides
the opportunity to impact bone regeneration strategies specifically, and any stem cell-based
therapy more generally.","NIDCR","8225140","2/1/2012 12:00:00 AM","PA-10-010","5R21DE021537-02","5","R21","DE","021537","02"," ","LUMELSKY, NADYA L","3/1/2011 12:00:00 AM","7/31/2013 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","2639418","PUTNAM, ANDREW J","Not Applicable","12","BIOMEDICAL ENGINEERING","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","BIOMED ENGR/COL ENGR/ENGR STA","481091276","UNITED STATES","N","3/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","150000","72002"," ","222002",
"Acute Respiratory Distress Syndrome; Biotechnology; Lung; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acute;Acute Lung Injury;Acute respiratory failure;Adherent Culture;Allogenic;Alveolar;Anti-Inflammatory Agents;Anti-inflammatory;Attenuated;Biology;Blocking Antibodies;Brain Death;Cell Therapy;Cells;Clinical;Data;Dose;Edema;Endotoxins;Epithelial;Epithelial Cells;Escherichia coli;Fluid Balance;Growth Factor;Harvest;Hepatocyte Growth Factor;Human;Hydrochloric Acid;Inflammatory;Inflammatory Response;Interferons;Interleukin-1;Interleukin-10;Intravenous;Knockout Mice;Knowledge;Life;Liquid substance;Lung;Mediating;Mesenchymal Stem Cells;Modeling;Morbidity - disease rate;Mus;Patients;Play;Pneumonia;Preparation;Pulmonary Edema;Research Proposals;Resolution;Role;Secondary to;Severities;Stimulus;TNF gene;Testing;Therapeutic;Therapeutic Effect;Therapeutic Studies;Time;Translating;Type II Epithelial Receptor Cell;Undifferentiated;United States;Work;alveolar type II cell;anakinra;base;clinically relevant;cytokine;design;improved;in vitro Model;injured;innovation;insight;keratinocyte;lung injury;mortality;mouse model;novel strategies;protective effect;research study;response;stem cell therapy","Lung Fluid Balance and Mesenchymal Stem Cells","n/a","NHLBI","8286345","6/7/2012 12:00:00 AM","PA-07-070","5R01HL051854-19","5","R01","HL","051854","19"," ","HARABIN, ANDREA L","12/1/1994 12:00:00 AM","6/30/2014 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1878543","MATTHAY, MICHAEL A.","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","134888"," ","382388",
"Genetics","Alternative Splicing;Binding;Binding Sites;Biological Assay;CD44 gene;Cell Differentiation process;Cell Line;Cells;Complementary DNA;Complex;Development;Disease;Down-Regulation;Ectopic Expression;Ensure;Epithelial;Epithelial Cells;Event;Exons;FGFR2 gene;Gene Expression;Genes;Homeostasis;Luciferases;Maintenance;Malignant Neoplasms;Mediating;Mesenchymal;Modeling;Molecular;Mutation Analysis;Names;Neoplasm Metastasis;Organ;Paracrine Communication;Pathway interactions;Pattern;Phenotype;Process;Protein Binding Domain;Protein Isoforms;Proteins;RNA;RNA Binding;RNA Interference;RNA Recognition Motif;RNA Splicing;Regulation;Role;Signal Pathway;Site;Tertiary Protein Structure;Transcript;Variant;base;cDNA Expression;cell growth;cell type;deletion analysis;epithelial to mesenchymal transition;gain of function;genetic regulatory protein;genome-wide;high throughput screening;loss of function;novel;overexpression;paralogous gene;programs;protein protein interaction;public health relevance;restoration;small molecule;tumor","Functions of Epithelial Splicing Regulatory Proteins and their role in the EMT","
PROJECT NARRATIVE
Alternative splicing is a fundamentally important process in which the same gene can generate different
proteins that have different functions, and alterations in this process are implicated in numerous diseases,
including cancer. We have identified an essential alternative splicing regulatory protein that is expressed in a
specific cell type, the epithelial cell, and which is required for development of many organs. The loss of
expression of this gene may be one process that contributes to the invasion and metastasis of many cancers.","NIGMS","8280449","6/14/2012 12:00:00 AM","PA-07-070","5R01GM088809-09","5","R01","GM","088809","09"," ","HOODBHOY, TANYA","5/1/2003 12:00:00 AM","7/31/2015 12:00:00 AM","Cancer Molecular Pathobiology Study Section[CAMP]"," ","1902860","CARSTENS, RUSS PAUL","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","7/1/2012 12:00:00 AM","7/31/2015 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","196020","117612"," ","313632",
"Neurosciences","Address;Adult;Apical;Architecture;Behavior;Binding;Cell Polarity;Cells;Centrosome;Chemotactic Factors;Cilia;Congenital Abnormality;Cues;Cytoskeleton;Data;Dorsal;Embryo;Epithelial;Erinaceidae;Esthesia;Etiology;Genetic;Genetic Research;Goals;Health;Human;Imaging Device;Incidence;Knowledge;Label;Laboratories;Liquid substance;Live Birth;Mediating;Membrane;Mesenchymal;Microtubules;Modeling;Molecular;Morphogenesis;Movement;Mus;Nature;Nerve;Neural Tube Defects;Neural tube;Neuraxis;Neuroepithelial Cells;Neurons;Nodal;Pathway interactions;Physical condensation;Population;Positioning Attribute;Process;Proteins;Regulation;Research;Research Proposals;Role;Series;Shapes;Signal Transduction;Solid;Spinal Cord;Staging;System;Techniques;Testing;Tissues;Zebrafish;base;cell motility;epithelial to mesenchymal transition;kinetosome;malformation;migration;morphogens;mutant;neural precursor cell;novel;polarized cell;relating to nervous system;retinal rods;tool","Regulation of cell polarity during neurulation","
PROJECT NARRATIVE
Neurulation is defined as a series of morphogenetic movements that result in the formation of
the neural tube, a dorsal hollow nerve cord that constitutes the rudiment of the entire adult
central nervous system. Knowledge of the mechanisms of secondary neurulation are
essential, given the high incidence of human posterior spinal cord malformations. However,
despite decades of research, the cellular and genetic basis for this type of neurulation
remains poorly understood. The goal of this research proposal is to use the various genetic
tools and labeling techniques available in the zebrafish, to investigate the mechanisms
underlying secondary neurulation. These studies will ultimately increase our understanding of
how neurulation is orchestrated and provide a molecular basis for exploring the etiology of
posterior neural tube defects in humans.","NIGMS","8307404","7/30/2012 12:00:00 AM","PA-07-070","5R01GM085290-04","5","R01","GM","085290","04"," ","HOODBHOY, TANYA","9/30/2009 12:00:00 AM","7/31/2014 12:00:00 AM","Neurogenesis and Cell Fate Study Section[NCF]"," ","9166092","BREWSTER, RACHEL MELISSA","Not Applicable","07","BIOLOGY","061364808","RNKYWXURFRL5","061364808","RNKYWXURFRL5","US","39.300978","-76.610648","820103","UNIVERSITY OF MARYLAND BALT CO CAMPUS","BALTIMORE","MD","SCHOOLS OF ARTS AND SCIENCES","212500001","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","218625","103531"," ","322156",
"No NIH Category available","Acute;Address;Adult;Allografting;Animal Model;Animals;Autologous;Biochemical;Biocompatible Materials;Cartilage;Cartilage injury;Cell Culture Techniques;Cells;Chondrocytes;Clinical;Complex;Debridement;Defect;Degenerative polyarthritis;Development;Dose;Encapsulated;Engineering;Exposure to;Family suidae;Gel;General Population;Goals;Growth Factor;Healed;Health;Human;Hyaluronic Acid;Hydrogels;Implant;In Vitro;Injury;Kinetics;Lead;Mechanics;Mesenchymal Stem Cells;Methods;Microspheres;Military Personnel;Modeling;Nature;Osteoarthrosis Deformans;Performance;Persons;Phenotype;Physical environment;Population;Process;Property;Replacement Arthroplasty;Research Personnel;Route;Societies;Stem cells;System;Techniques;Testing;Time;Tissue Engineering;Tissues;Transforming Growth Factor beta;Translating;Translations;Trauma;Veterans;Weight-Bearing state;Work;adult stem cell;articular cartilage;base;bone;cartilage regeneration;cartilage repair;clinical efficacy;clinically relevant;design;healing;imaging modality;implantation;improved;in vitro activity;in vivo;novel;osteochondral tissue;repaired;restoration;scaffold;stem cell differentiation;subcutaneous;tissue processing;treatment strategy","Cartilage repair with stem-cell laden hyaluronic acid hyrogels","Intrinsic repair of articular cartilage damage is unsatisfactory, due to its avascular nature and demanding physical environment. Military personnel suffer from cartilage damage at a higher rate than the general population, restricting active duty and leading to the development of osteoarthritis (OA) and the need for total joint replacement. The aim of this study is to evaluate novel tissue engineered construct based on a hyaluronic acid hydrogel seeded with mesenchymal stem cells. We will determine the best route towards clinical efficacy, i.e., direct formation of the engineered material within the defect, or a process where tissues are matured in vitro and then implanted. This work will dramatically improve treatment options for the military 
population suffering from acute cartilage injury and those debilitated from the ravages of progressive OA.","VA","8277528","6/21/2012 12:00:00 AM","RFA-RX-11-013","1I01RX000700-01A1","1","I01","RX","000700","01","A"," ","7/1/2012 12:00:00 AM","6/30/2016 12:00:00 AM","Regenerative Rehabilitation[RRD0]"," ","10167294","STEINBERG, DAVID ","Not Applicable","03","Unavailable","071609291","SUDELFB4VGM7","071609291","SUDELFB4VGM7","US","39.949749","-75.20114","481078","PHILADELPHIA VA MEDICAL CENTER","PHILADELPHIA","PA","Independent Hospitals","191044551","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2016 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Bioengineering; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Achievement;Animal Model;Architecture;Area;Basic Science;Bone Marrow;Cartilage;Cells;Characteristics;Chemicals;Chondrocytes;Chondrogenesis;Chondroitin Sulfates;Clinical;Clinical Trials;Collagen;Commit;Cues;Defect;Differentiation and Growth;Dimensions;Embryonic Development;Engineering;Environment;Extracellular Matrix;Extracellular Matrix Proteins;Fiber;Goals;Growth Factor;Hyaline Cartilage;In Vitro;Investigation;Joints;Knowledge;Lesion;Life;Ligaments;Mechanics;Membrane;Mesenchymal Stem Cells;Microfabrication;Microscopic;Modeling;Morphogenesis;Pattern;Physical Chemistry;Play;Property;Research;Resolution;Role;Stem cells;Structure;System;Techniques;Tendon structure;Testing;Tissue Engineering;Tissues;Work;abstracting;articular cartilage;base;cartilage repair;chemokine;density;design;histogenesis;molecular scale;nano;nanofiber;next generation;osteochondral tissue;repaired;scaffold;stem cell differentiation;three dimensional structure;two-dimensional","Structured Microenvironment for Osteochondral Histogenesis","n/a","NIAMS","8380786","7/20/2012 12:00:00 AM"," ","5P01AR053622-05","5","P01","AR","053622","05"," "," ","8/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","ZAR1-CHW-J","0001","7738508","BASKARAN, HARIHARA ","Not Applicable","11","Unavailable","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","Domestic Higher Education","441061712","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","518128","518128"," ","112538","405590"," "," ",
"Lung; Rare Diseases; Regenerative Medicine","Adult Respiratory Distress Syndrome;Alveolar;Alveolus;Animal Model;Apoptosis;Area;Attenuated;Bleomycin;Cell Death;Cell Differentiation process;Cell Line;Cell Survival;Cells;Cessation of life;Characteristics;Cicatrix;Collagen;Color;Data;Deposition;Disease;Epithelial;Epithelial Cells;Epithelium;Failure;Fibroblasts;Fibrosis;Functional disorder;Future;Gases;Goals;Hamman-Rich syndrome;Human;Hyperplasia;Injury;Lead;Literature;Lung;Lung Inflammation;Mesenchymal;Modeling;Mus;Natural regeneration;Pathogenesis;Pathway interactions;Phase;Play;Pneumonia;Population;Process;Production;Recovery;Regulation;Research;Role;Shortness of Breath;Signal Transduction;Stem cells;Transforming Growth Factors;Transgenic Mice;Transgenic Organisms;Wound Healing;alveolar epithelium;base;cell injury;cytokine;epithelial to mesenchymal transition;injured;insight;lung injury;lung repair;mouse model;novel;outcome forecast;receptor;repaired;response;response to injury;therapeutic target;therapy development","Regulation of Fibrotic Remodeling by the Alveolar Epithelium"," Idiopathic pulmonary fibrosis (IPF) is characterized by scarring of the lungs leading to progressive shortness of breath. Unfortunately, no curative treatment is available and prognosis remains extremely poor. Alveolar epithelial cells are responsible for gas exchange in the lungs and have a central role in IPF. Defining how aberrancies in this cell population impact disease processes will help to identify future targets for the development of treatments for this devastating disease.  
    

","NHLBI","8306002","6/28/2012 12:00:00 AM","PA-10-067","5R01HL105479-02","5","R01","HL","105479","02"," ","HARABIN, ANDREA L","8/1/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-CVRS-G(03)M]"," ","6900663","LAWSON, WILLIAM E","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","284216","159161"," ","443377",
"Digestive Diseases; Injury (total) Accidents/Adverse Effects; Regenerative Medicine","Address;Apoptosis;Area;Breeding;Cell Cycle Arrest;Cells;Chemotactic Factors;Control Animal;Cytoprotection;Dinoprostone;Dissection;Epithelial;Epithelial Cells;Funding;Generations;Hyaluronic Acid;Immigration;Inflammation Mediators;Injury;Intestines;Lasers;Mediating;Mesenchymal Stem Cells;Messenger RNA;Microarray Analysis;Mus;Myeloid Cells;Nature;PTGS2 gene;Pathway interactions;Physiological;Production;Radiation;Radiation Injuries;Series;Signal Transduction;Small Intestines;Source;Stem cells;Testing;Wild Type Mouse;base;cell motility;colonic crypt;intestinal crypt;intraperitoneal;macrophage;migration;monocyte;neutrophil;research study;response;response to injury;uptake;villin","Mediators of Inflammation in Intestinal Injury","n/a","NIDDK","8383778","5/14/2012 12:00:00 AM"," ","4R37DK033165-28","4","R37","DK","033165","28"," ","HAMILTON, FRANK A","4/1/1984 12:00:00 AM","5/31/2017 12:00:00 AM","NSS"," ","2419252","STENSON, WILLIAM F.","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","247500","128700"," ","376200",
"Cancer; Digestive Diseases; Pancreatic Cancer; Rare Diseases","Apoptosis;Attention;Benign;Biological Markers;Cadherins;Capillary Endothelial Cell;Cells;Chemicals;Clinic;Clinical;Clinical Research;Clinical Trials;Collagen;Collagen Type I;Combined Modality Therapy;Data;Deposition;Diagnosis;Distant;E-Cadherin;Endothelial Cells;Epithelial;Epithelial Cells;Extracellular Matrix;Growth;Human;In Vitro;Invaded;Lead;Malignant Neoplasms;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of pancreas;Mesenchymal;Methods;Modeling;Monitor;N-Cadherin;Neoplasm Metastasis;Organ;P-2;Pancreatic Adenocarcinoma;Pathway interactions;Patients;Peritoneal;Phase I Clinical Trials;Proteins;Role;Safety;Signal Pathway;Staging;Technology;Testing;Tissues;Treatment Efficacy;Tumor Angiogenesis;Tumor Biology;Tumor Cell Invasion;Unresectable;Up-Regulation;Vascular blood supply;Vascularization;base;cell behavior;cell motility;design;efficacy testing;epithelial to mesenchymal transition;gemcitabine;in vivo;inhibitor/antagonist;mouse model;neoplastic cell;outcome forecast;pancreatic cancer cells;pancreatic neoplasm;prevent;response;therapeutic target;tissue culture;tumor;tumor progression","P-2: Inhibitors of N-cahedrin in the treatment of pancreatic cancer","n/a","NCI","8381875","9/20/2012 12:00:00 AM","PAR-06-505","5P50CA127297-05","5","P50","CA","127297","05"," "," "," ","8/31/2014 12:00:00 AM","ZCA1-GRB-I","0002","1861000","JOHNSON, KEITH R","Not Applicable","02","Unavailable","168559177","G15AG3BLLMH4","168559177","G15AG3BLLMH4","US","41.26545","-96.039767","578104","UNIVERSITY OF NEBRASKA MEDICAL CENTER","OMAHA","NE","Domestic Higher Education","681987835","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Research Centers","2012","197835","197835"," ","163439","34396"," "," ",
"Genetics; Human Genome; Kidney Disease","Ablation;Address;Adult;Alleles;Alternative Splicing;Behavior;Biological Models;Cell Differentiation process;Cell Line;Cell physiology;Cells;Cellular Morphology;Data;Defect;Development;Developmental Gene;Developmental Process;Disease;Duct (organ) structure;Ectopic Expression;Epithelial;Epithelial Cells;Epithelium;Exons;Gene Expression;Gene Expression Profile;Gene Expression Regulation;Genes;Genetic Models;Health;Human;Image;In Vitro;Intercellular Junctions;Kidney;Kidney Glomerulus;Knock-out;Mesenchymal;Mesenchyme;Metanephric Diverticulum;Mus;Nephrons;Organ;Organogenesis;Play;Polyadenylation;Process;Protein Isoforms;Protein Splicing;Proteins;RNA Splicing;Regulation;Renal function;Role;Set protein;Severities;Staging;System;Technology;Time;Transcript;Tubular formation;Variant;base;cell behavior;cell injury;cell type;epithelial to mesenchymal transition;genetic regulatory protein;genome-wide;in vivo;insight;migration;nephrogenesis;novel;progenitor;programs;transcription factor;urinary","Global programs of ESRP-regulated splicing in renal development and function","
PROJECT NARRATIVE 
  
Alternative splicing allows the same gene transcript to be processed into proteins with different functions in 
different cell types, at different stages of development, and in numerous diseases.  We identified essential 
master regulators of alternative splicing that control the expression of hundreds of genes, thereby resulting in a 
distinct set of proteins forms that are specific to epithelial cells.  The kidney is a predominantly epithelial organ 
and as such the complete program of epithelial cell splicing controlled by these regulators is proposed to be 
essential for kidney development and function.  Identification of the complete program of gene regulation 
controlled by these epithelial splicing proteins will provide fundamental insights with broad applications to our 
understanding of human health and diseases.   
 
 
 ","NIDDK","8545244","9/21/2012 12:00:00 AM","PA-11-260","1R56DK097257-01","1","R56","DK","097257","01"," ","HOSHIZAKI, DEBORAH K","9/21/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Kidney Molecular Biology and Genitourinary Organ Development[KMBD]"," ","1902860","CARSTENS, RUSS PAUL","Not Applicable","03","Unavailable","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","Domestic Higher Education","191046205","UNITED STATES","N","9/21/2012 12:00:00 AM","8/31/2014 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","93750","56250"," ","150000",
"No NIH Category available","Address;Affect;Aging;Biochemical;Biological Assay;Cell Aging;Cell Communication;Cells;Clinical;Data;Dermal;Dermis;Development;Differentiation and Growth;Enzymes;Epidermis;Epithelial;Event;Exhibits;Fibroblasts;Future;Genes;Genetic;Goals;Hair follicle structure;Homeostasis;Human;Hyperplasia;Lesion;Link;Malignant - descriptor;Malignant Neoplasms;Mediator of activation protein;Mesenchymal;Mesenchyme;Molecular;Morphogenesis;Mus;Organ;Pathway interactions;Play;Predisposition;Premalignant;Role;Sampling;Signal Transduction;Skin;Skin Tissue;Testing;Tissue Sample;Tissues;Tumorigenicity;UV Radiation Exposure;UVB induced;Work;base;carcinogenesis;cell age;cell type;in vivo;keratinocyte;notch protein;paracrine;reconstitution;senescence;tongue papilla;tumor;tumorigenic","Growth differentiation control in primary keratinocytes"," Notch signaling is an important form of cell-cell communication with an essential role in development, tissue homeostasis and cancer development. Our main working hypothesis is that this pathway plays an essential role in the mesenchymal compartment of the skin, with an impact on dermal fibroblast senescence and dermal aging- associated changes, as well as on paracrine control of keratinocyte proliferation and tumor development.)  
    

","NIAMS","8238615","4/13/2012 12:00:00 AM","PA-10-067","2R01AR039190-24","2","R01","AR","039190","24"," ","BAKER, CARL","7/1/1988 12:00:00 AM","6/30/2017 12:00:00 AM","Arthritis, Connective Tissue and Skin Study Section[ACTS]"," ","1880455","DOTTO, GIAN-PAOLO ","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","260887","193709"," ","454596",
"Cancer","1-Phosphatidylinositol 3-Kinase;Address;Adhesions;Affect;Attention;Behavior;Biochemical;Carcinoma;Cell Shape;Cell Size;Cell physiology;Cells;Cessation of life;Complement;Development;Environment;Epithelial;Epithelial Cells;Epithelium;Event;Gene Expression;Genes;Genetic Transcription;Growth;Growth Factor Receptors;Health;Immune;Invaded;Investigation;Knowledge;Lead;MAP Kinase Gene;MAP Kinase Signaling Pathways;MAPK Signaling Pathway Pathway;Malignant Epithelial Cell;Malignant Neoplasms;Mediating;Mesenchymal;Mitogen-Activated Protein Kinases;Molecular;Neoplasm Metastasis;Pathway interactions;Phosphorylation;Phosphotransferases;Play;Process;Production;Protein Biosynthesis;Proteins;Recruitment Activity;Reporting;Research;Role;Signal Pathway;Signal Transduction;Specificity;Stromal Cells;Tissues;Transforming Growth Factor beta;Transforming Growth Factors;Translations;autocrine;base;cancer cell;cancer initiation;cancer therapy;cell behavior;cell motility;epithelial to mesenchymal transition;insight;migration;neoplastic cell;novel;programs;receptor;response;tumor;tumor progression;ubiquitin-protein ligase","TGF-beta-induced non-Smad signaling events and cancer cell behavior","n/a","NCI","8206855","1/4/2012 12:00:00 AM","PA-07-070","5R01CA136690-04","5","R01","CA","136690","04"," ","JHAPPAN, CHAMELLI","1/1/2009 12:00:00 AM","12/31/2013 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1871186","DERYNCK, RIK M","Not Applicable","12","ANATOMY/CELL BIOLOGY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","941432510","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","109695"," ","310970",
"Cardiovascular; Heart Disease; Regenerative Medicine","Adult;Blood Vessels;Cardiac;Cardiac Myocytes;Cell Proliferation;Cells;Cicatrix;Coronary;Coronary Vessels;DNA biosynthesis;Defect;Degenerative Disorder;Development;Dominant-Negative Mutation;Embryo;Endothelial Cells;Epicardium;Excision;Failure;Fishes;Functional disorder;Future;Goals;Healed;Heart;Heart Diseases;Heat-Shock Response;Human;In Vitro;Injury;Lead;Mammals;Mediating;Mesenchymal;Modeling;Molecular;Myocardial;Myocardium;Natural regeneration;Operative Surgical Procedures;Organ;Organism;PDGFRA gene;PDGFRB gene;Pathology;Pericytes;Platelet-Derived Growth Factor;Platelet-Derived Growth Factor Receptor;Process;Receptor Signaling;Regenerative Medicine;Research;Signal Transduction;System;Testing;Therapeutic;Time;Tissues;Transgenic Organisms;United States;Zebrafish;base;cell type;design;disability;epithelial to mesenchymal transition;healing;improved;in vivo;knock-down;mortality;neovascularization;novel therapeutic intervention;progenitor;promoter;public health relevance;regenerative;tissue regeneration","Molecular Mechanisms of  Heart Regeneration","
Narrative
 Regenerative medicine holds a great deal of promise for treating congenital and
degenerative diseases. The goal of this proposal is to determine the molecular and
cellular mechanisms of heart regeneration in zebrafish, an organism with a natural
regenerative ability. We expect the proposed research can lead to findings that may
enhance regenerative capacity in diseased human hearts in the future.
 ","NHLBI","8215709","3/7/2012 12:00:00 AM","PA-07-070","5R01HL096121-03","5","R01","HL","096121","03"," ","SCHRAMM, CHARLENE A","2/1/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","7768380","LIEN, CHING-LING E","Not Applicable","28","Unavailable","052277936","DVL1CMRMWRN9","052277936","DVL1CMRMWRN9","US","34.098065","-118.29069","1520001","CHILDREN'S HOSPITAL OF LOS ANGELES","LOS ANGELES","CA","Independent Hospitals","900276062","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","258653","143312"," ","401965",
"Biotechnology; Cancer; Digestive Diseases; Genetics; HIV/AIDS; Liver Cancer; Liver Disease; Rare Diseases; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human","Adjuvant Therapy;Age;Asians;Biliary;Binding;Biological Markers;Biosensor;Bone Marrow;Cancer Etiology;Cell Adhesion Molecules;Cell Lineage;Cells;Cessation of life;Characteristics;Chemoprevention;Classification;Clinical;Data;Diagnosis;Diagnostic;Disease;Elements;Epithelial;Epithelial Cells;Event;Family member;Future;Gene Expression;Gene Expression Profile;Gene Silencing;Genes;Genetic;Genomics;Goals;Growth;Hepatic;Hepatocyte;Heterogeneity;Human;In Vitro;Intrahepatic Cholangiocarcinoma;Lead;Link;Liver;Malignant Epithelial Cell;Malignant neoplasm of liver;Mesenchymal;Messenger RNA;MicroRNAs;Molecular;Molecular Profiling;Molecular Target;NCAM1 gene;Nature;Outcome;Pathology;Pathway interactions;Patients;Pattern;Population;Premalignant;Primary carcinoma of the liver cells;Research;Risk;Role;Signal Pathway;Signal Transduction;Staging;Stem cells;Subgroup;System;TACSTD2 gene;Testing;Tissues;Untranslated RNA;Work;advanced disease;alpha-Fetoproteins;base;beta catenin;cancer stem cell;cell growth;cell motility;cell type;chronic liver disease;clinically relevant;disease diagnosis;epithelial to mesenchymal transition;high risk;improved;in vivo Model;inhibitor/antagonist;nano-string;novel;outcome forecast;prognostic;stem;stemness;therapeutic target;trait;tumor;tumor initiation;tumorigenesis","The role of cancer stem cells in liver cancer heterogeneity and subtypes","n/a","NCI","8552871"," "," ","1ZIABC010876-05","1","ZIA","BC","010876","05"," "," "," "," "," "," ","9692181","WANG, XIN ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","807462",
"Aging; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adenovirus Vector;Aging;Agonist;Animals;Area;Biomechanics;Blood Vessels;Bone Regeneration;Bone callus;Cartilage;Cells;Chondrocytes;Chondrogenesis;Cyclic AMP-Dependent Protein Kinases;Data;Dinoprostone;EP4 receptor;Elderly;Erinaceidae;Event;Fracture;Fracture Healing;Funding;Gene Deletion;Gene Expression;Genes;Healed;Health;Histology;In Situ Hybridization;In Vitro;Knowledge;Limb structure;Maintenance;Mediating;Mesenchymal;Mesenchymal Stem Cells;Mesenchyme;Modeling;Mus;Osteogenesis;PTGS2 gene;Pathway interactions;Patients;Phenotype;Phosphorylation;Physiological;Play;Process;Prostaglandin E Receptor;Prostaglandin-Endoperoxide Synthase;Receptor Signaling;Role;Series;Signal Pathway;Signal Transduction;Staging;Technology;Testing;Translations;Work;activating transcription factor;activating transcription factor 4;aged;angiogenesis;base;bone healing;bone morphogenetic protein 2;cyclooxygenase 2;cyclopamine;gain of function;healing;human WFDC2 protein;human disease;improved;in vivo;insight;loss of function;novel;novel therapeutic intervention;older patient;progenitor;programs;receptor expression;repaired;research study;skeletal;smoothened signaling pathway;translational study","Cyclooxygenases in Skeletal Repair","
Project Narrative
Fracture healing, which is necessary for maintenance of skeletal integrity, typically efficiently occurs, but is
compromised in certain conditions, including aging. This proposal investigates the role of a key gene,
cyclooxygenase-2, and its expression and function during key processes of fracture healing. Insights gained
from this work will enhance the understanding and treatment of fractures in patients with compromised healing,
and has particular potential to improve bone repair in the elderly.","NIAMS","8286051","6/4/2012 12:00:00 AM","PA-07-070","5R01AR048681-09","5","R01","AR","048681","09"," ","WANG, FEI","4/16/2003 12:00:00 AM","6/30/2014 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1880536","O'KEEFE, REGIS J","ZHANG, XINPING ","25","ORTHOPEDICS","041294109","F27KDXZMF9Y8","041294109","F27KDXZMF9Y8","US","43.16888","-77.615939","7047101","UNIVERSITY OF ROCHESTER","ROCHESTER","NY","SCHOOL OF MEDICINE & DENTISTRY","146270140","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","213840","116543"," ","330383",
"Breast Cancer; Cancer; Genetics","Actins;Adherens Junction;Binding;Biochemical;Biological;Biological Process;Breast Cancer Cell;Cadherins;Cell Nucleus;Cell membrane;Cell physiology;Cell-Cell Adhesion;Cells;Data;E-Cadherin;EGF gene;Endocytosis;Ensure;Epidermal Growth Factor Receptor;Epithelial;Epithelial Cells;Epithelium;Event;Focal Adhesions;Generations;Genes;Genetic Transcription;Growth;Growth Factor;Growth Factor Receptors;Human;In Vitro;Life;Lipids;Lymph;Lysosomes;Malignant Neoplasms;Maps;Mesenchymal;Modification;Morphogenesis;N-Cadherin;Neoplasm Metastasis;Nuclear Translocation;Organ;Pathway interactions;Patients;Phenotype;Phosphatidylinositol 4,5-Diphosphate;Phosphatidylinositol Phosphates;Phosphatidylinositols;Phosphotransferases;Play;Post-Translational Protein Processing;Process;Protein Isoforms;RNA Splicing;Receptor Signaling;Regulation;Role;Second Messenger Systems;Signal Pathway;Signal Transduction;Sorting - Cell Movement;Specificity;Transcriptional Activation;Tumor Cell Biology;Variant;adhesion receptor;base;cell motility;epithelial to mesenchymal transition;in vivo Model;malignant breast neoplasm;migration;nexin;outcome forecast;protein protein interaction;public health relevance;receptor;second messenger;src-Family Kinases;trafficking;tumor progression;tumorigenesis","PI Signaling Role in Epithelial/Mesenchymal Transition","
Cancers of epithelial origin represent at least 80% of all human cancers and are often the most difficult to cure.
The life threatening aspect of epithelial cancer is metastasis and this process is dependent upon the loss of
epithelial cell organization a process that is controlled by the E-cadherin receptor. E-cadherin holds epithelial
cells together and suppresses growth and metastasis. When E-cadherin is lost epithelial cancers are free to
metastasize or migrate to different organs. We have discovered a signaling pathway that regulates both E-
cadherin's ability to hold cells together and also the loss of E-cadherin from epithelial cancers.","NCI","8250252","7/6/2012 12:00:00 AM","PA-07-070","5R01CA104708-08","5","R01","CA","104708","08"," ","WOODHOUSE, ELIZABETH","7/2/2004 12:00:00 AM","3/31/2015 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","6228781","ANDERSON, RICHARD A.","Not Applicable","02","PHARMACOLOGY","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","SCHOOLS OF MEDICINE","537151218","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","194203","94188"," ","288391",
"Clinical Research; Diabetes; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Accounting;Adopted;Affect;Animals;Attention;Biological Assay;Blood Glucose;Blood Vessels;Bone Marrow;Bone Marrow Transplantation;Cell Aging;Cell Cycle Progression;Cell Proliferation;Cell physiology;Cells;Cellular biology;Cerebrovascular Disorders;Coronary Arteriosclerosis;Development;Diabetes Mellitus;Diabetic Angiopathies;Diagnosis;Diagnostic;Epigenetic Process;Functional disorder;Gene Expression;Gene Expression Profile;Growth;Health Care Costs;Hematopoietic;Hematopoietic stem cells;Human;Hyperglycemia;Hypoxia;Impaired wound healing;Impairment;In Vitro;Injury;Ischemia;Lead;Memory;Mesenchymal;Mesenchymal Stem Cells;Modeling;Pathway interactions;Patients;Peripheral Vascular Diseases;Phenotype;Population;Principal Investigator;Process;Public Health;Reactive Oxygen Species;Recovery;Role;Screening procedure;Severities;Signal Transduction;Stem cells;Therapeutic;Transgenic Mice;Transgenic Model;Transgenic Organisms;Translating;United States;Work;Wound Healing;angiogenesis;bone;clinically relevant;diabetic;diabetic patient;human FRAP1 protein;human disease;in vivo;innovation;neovascular;neovascularization;non-diabetic;novel;progenitor;public health relevance;response;stem;stem cell population;tool;trafficking;vasculogenesis","Progenitor Cell Dysfunction and Impaired Neovascularization in Diabetes","
Project Narrative
Diabetes is a major public health concern in the United States, accounting for 180 billion dollars in annual
health costs. Diabetes-induced impairments in new blood vessel growth greatly increase the severity of the
sequelae caused by various ischemic processes, including coronary artery disease, cerebrovascular disease,
peripheral vascular disease and impaired wound healing. Recovery from ischemic injury requires new blood
vessel growth, termed neovascularization, and requires functional participation by stem and progenitor cells.
There is growing evidence that diabetes directly impairs progenitor cell function and impairs
neovascularization. This proposal takes an innovative approach to elucidate this dysfunction and find new
ways to approach diagnosis and treatment of diabetic vascular complications.","NIDDK","8272667","4/2/2012 12:00:00 AM","PA-07-070","5R01DK074095-09","5","R01","DK","074095","09"," ","JONES, TERESA L Z","9/30/2005 12:00:00 AM","4/30/2014 12:00:00 AM","Surgery, Anesthesiology and Trauma Study Section[SAT]"," ","7053106","GURTNER, GEOFFREY C","BROWNLEE, MICHAEL A","18","SURGERY","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","341854","127342"," ","469196",
"No NIH Category available","Accounting;Automobile Driving;Biological;Biological Markers;Biological Process;Biometry;Cancer Biology;Cancer Center;Cell Line;Cessation of life;Clinical;Clinical Research;Clinical Trials;Collaborations;Complex;Databases;Development;Diagnostic;Discipline;Disease;Distant;Early Diagnosis;Engineering;Epithelial;Evaluation;Ewings sarcoma;Future;G-Protein-Coupled Receptors;Genetic;Goals;Head and neck structure;Health;Human;Image;Individual;Institution;Intervention;Intramural Research Program;Investigation;Knowledge;Laboratories;Lead;Light;Location;Lung;Malignant Neoplasms;Malignant Peripheral Nerve Sheath Tumor;Measures;Medical Oncology;Mesenchymal Cell Neoplasm;Metastatic Neoplasm to the Lung;Metastatic/Recurrent;Michigan;Molecular;Necrosis;Neoplasm Metastasis;Nonprofit Organizations;Operative Surgical Procedures;Outcome;Paraffin Tissue;Pathology;Patients;Pediatric Oncology;Pharmaceutical Preparations;Phase;Pilot Projects;Positron-Emission Tomography;Prevention;Process;Radiation Oncology;Radiation therapy;Radiosurgery;Recurrence;Research;Research Infrastructure;Research Personnel;Research Project Grants;Resources;Retroperitoneal Space;Secure;Signaling Pathway Gene;Site;Specialist;Surgical Oncology;Surgical margins;Survival Rate;Testing;Therapeutic;Tissue Microarray;Tissues;Toxic effect;Translational Research;Translations;Universities;Validation;Xenograft procedure;base;career;chemotherapy;clinically relevant;cost;experience;improved;in vivo Model;innovation;irradiation;mortality;new therapeutic target;novel;novel therapeutic intervention;osteosarcoma;performance site;pre-clinical;programs;response;sarcoma;scaffold;soft tissue;therapeutic target;treatment strategy;tumor","SARC Sarcoma SPORE","RELEVANCE: Currently, there are limited programs that have the capability to provide the infrastructure for collaboration on translational research for sarcoma. Because sarcoma is a relatively uncommon disease, this SARC Sarcoma SPORE will provide the infrastructure for translational research to develop and test the feasibility of cancer relevant interventions in humans and/or determine the biological basis for observations made in individuals with sarcoma.","NCI","8336997","9/26/2012 12:00:00 AM","PAR-10-003","1U54CA168512-01","1","U54","CA","168512","01"," ","AGARWAL, RAJEEV K","9/26/2012 12:00:00 AM","8/31/2017 12:00:00 AM","ZCA1-RPRB-7(M1)"," ","10486730","POLLOCK, RAPHAEL E.","Not Applicable","12","Unavailable","186146911","G9GQJWPKUZP9","186146911","G9GQJWPKUZP9","US","42.316954","-83.681817","10021144","SARC","Ann Arbor","MI","Other Domestic Non-Profits","481059484","UNITED STATES","N","9/26/2012 12:00:00 AM","8/31/2013 12:00:00 AM","397","Research Centers","2012"," "," ","NCI","2200015","99985"," ","2300000",
"Breast Cancer; Cancer; Clinical Research; Genetics; Stem Cell Research","Address;Adherens Junction;Binding Sites;Breast;Breast Cancer Cell;Cancer Patient;Cause of Death;Cell Line;Cell model;Cells;Characteristics;Colon Carcinoma;DNA Binding;Data;Disease;Disease Outcome;Distal;Distant;Down-Regulation;E-Cadherin;Embryonic Development;Epithelial;Epithelial Cells;Epithelium;Event;Family;Family member;Feedback;GKLF protein;Gene Expression Profile;Gene Expression Profiling;Gene Targeting;Genes;Genetic;Genetic Transcription;Genome;Growth;Human;In Vitro;Life;Maintenance;Mammary Tumorigenesis;Mammary gland;Mediating;Mesenchymal;Metastatic to;Modality;Modeling;Molecular;Neoplasm Metastasis;Normal tissue morphology;Pathway interactions;Phenotype;Platelet Factor 4;Primary Lesion;Primary Neoplasm;Process;Property;Proteins;Regulation;Relative (related person);Reporting;Repression;Signal Transduction;Site;Snails;Specific qualifier value;Stem cells;Testing;Transforming Growth Factors;Transgenic Model;Tumor Cell Invasion;Tumor Suppressor Proteins;Work;Xenograft procedure;base;chromatin immunoprecipitation;epithelial to mesenchymal transition;in vivo;induced pluripotent stem cell;insight;malignant breast neoplasm;mammary epithelium;mammary gland development;member;migration;mouse model;neoplastic cell;novel;overexpression;pluripotency;prevent;therapeutic target;transcription factor;tumor;tumor progression","KLF4 regulation of epithelial/mesenchymal transition in breast cancer"," Disseminated disease is the primary cause of death in breast cancer patients and identifying the molecular mechanism(s) that control formation and growth of metastases is critical for developing life-saving treatment modalities.  The studies proposed will determine how KLF4, a protein that controls the activity of genes, regulates the ability of breast cells to migrate out of a primary tumor and form metastases in another site.  The pathways used by KLF4 that are identified through this work may then serve as useful therapeutic targets to prevent breast cancer metastasis.  
    

","NCI","8286855","5/1/2012 12:00:00 AM","PA-10-067","5R01CA154384-02","5","R01","CA","154384","02"," ","WOODHOUSE, ELIZABETH","7/1/2011 12:00:00 AM","4/30/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1924151","KERI, RUTH A.","Not Applicable","11","PHARMACOLOGY","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","SCHOOLS OF MEDICINE","441061712","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","118275"," ","325775",
"Bioengineering; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Adipose tissue;Adult;Allogenic;Autologous;Biocompatible Materials;Biological Assay;Biology;Biomedical Engineering;Blood Vessels;Bone Development;Bone Marrow;Bone Marrow Aspiration;Bone Substitutes;Bone Tissue;Bone Transplantation;Caliber;Calvaria;Cell Density;Cell Lineage;Cell physiology;Cells;Chronic Disease;Clinical;Communities;Connexin 43;Data;Defect;Dermal;Development;Dimensions;Dose;Endothelial Cells;Engineering;Excision;Flow Cytometry;Fluorescence;Fluorescence-Activated Cell Sorting;Goals;Gold;Growth Factor;Healed;Hematopoiesis;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Histology;Homeostasis;Human;Hydroxyapatites;Immunohistochemistry;In Vitro;Mechanics;Mediating;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Modality;Modeling;Molecular;Morbidity - disease rate;Natural regeneration;Nerve;Nude Rats;Operative Surgical Procedures;Osteoblasts;Osteocalcin;Osteogenesis;Outcome;Outcome Measure;Outpatients;Platelet-Derived Growth Factor;Polystyrenes;Population;Procedures;Reporting;Shapes;Site;Smooth Muscle Actin Staining Method;Spectroscopy, Fourier Transform Infrared;Stem cells;Stromal Cells;Structure;Surgeon;Testing;Tissue Engineering;Tissues;Translations;Transplantation;Trauma;Tubular formation;Vascular Endothelial Growth Factors;Vascularization;Work;analog;angiogenesis;base;bone;bone healing;bone sialoprotein;clinical practice;clinically significant;computerized;controlled release;expectation;healing;immunocytochemistry;improved;in vivo;novel;osteogenic;osteopontin;pathogen;reconstruction;scaffold;skeletal;stem;tissue culture;transmission process;tumor","Engineering of Vascularized Bone","
Project Narrative
Bone grafts are critically needed in surgical procedures to reconstruct skeletal
defects resulting from trauma, chronic diseases, tumor removal and congenital
anomalies. Autologous bone grafts are the clinical gold standard, but necessitate
donor site trauma and morbidity; allogeneic or xenogeneic grafts are associated
with immunorejection, pathogen transmission and suboptimal healing and
synthetic materials such as hydroxyapatite suffer from poor integration. In this
proposal, we have engineered vascularized bone grafts from the combined
actions of vascular progenitor cells and bone progenitor cells; the vascularized
bone grafts can be tailored to any shape and dimension, and integrate with host's
existing bone, thus providing an improved treatment modality for bone defects.","NIDCR","8308943","6/28/2012 12:00:00 AM","PA-07-279","5R01DE018248-04","5","R01","DE","018248","04"," ","LUMELSKY, NADYA L","9/25/2009 12:00:00 AM","5/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-B(03)M]"," ","1866984","MAO, JEREMY J","Not Applicable","13","DENTISTRY","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","SCHOOLS OF DENTISTRY/ORAL HYGN","100323725","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","353334","203527"," ","556861",
"Cancer; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Affect;Bone Marrow;CCL21 gene;CSF3 gene;CXCL12 gene;Carcinoma;Cell Differentiation process;Cell Proliferation;Cell Transplantation;Cell surface;Cells;Clinical;Diagnostic;Epithelial;Extracellular Matrix Degradation;Fibroblasts;Gene Proteins;Genes;Genetic Models;Goals;Granulocyte Colony-Stimulating Factor;Growth;Hematopoietic stem cells;Homing;Image;In Vitro;Lead;Lewis Lung Carcinoma;Longitudinal Studies;Lymphoid;Macrophage Colony-Stimulating Factor;Malignant Neoplasms;Mesenchymal;Mesenchymal Stem Cells;Methods;Modeling;Molecular Profiling;Morphology;Mus;Myofibroblast;Neoplasm Metastasis;Outcome;Pathology;Patients;Pericytes;Platelet-Derived Growth Factor;Play;Population;Production;Proteins;Proto-Oncogene Proteins c-sis;RNA;Role;Small Interfering RNA;Solid;Solid Neoplasm;Source;Stromal Neoplasm;Testing;Tissues;Transforming Growth Factor beta;Transplantation;Tumor Angiogenesis;Tumor Biology;Tumorigenicity;base;cell stroma;chemokine;cytokine;gain of function;improved;in vivo;insight;loss of function;macrophage;migration;monocyte;monocyte colony stimulating factor;neoplastic cell;neovascularization;novel;population based;prognostic;public health relevance;reconstitution;research study;therapeutic target;transdifferentiation;tumor;tumor growth;tumor progression;tumorigenesis","Hematopoietic Stem Cell-Derived Carcinoma Associated Fibroblasts in Tumor","
NARRATIVE
Our goal is to determine how hematopoietic stem cell (HSC) carcinoma associated fibroblasts (CAFs) and their
circulating fibroblast precursors (CFPs) directly influence tumor progression and identify mechanisms that
regulate the contribution of these cells to tumor. Findings from these studies will lead to a better understanding
of basic tumor biology as well as identify novel potential therapeutic targets based on HSC-derived CFP/CAF
participation in tumor microenvironment. Furthermore, these studies have the potential to lead to the
identification of unique cancer associated molecular signatures that may prove useful for stratifying patients
and predicting metastasis and clinical outcomes, eventually leading to improved diagnostic and prognostic
values.","NCI","8217145","2/24/2012 12:00:00 AM","PA-10-067","5R01CA148772-02","5","R01","CA","148772","02"," ","MUFSON, R ALLAN","2/1/2011 12:00:00 AM","1/31/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","7775909","LARUE, AMANDA C.","Not Applicable","01","PATHOLOGY","183710748","NHV3GTWSALA7","183710748","NHV3GTWSALA7","US","32.788289","-79.954891","7575301","MEDICAL UNIVERSITY OF SOUTH CAROLINA","CHARLESTON","SC","SCHOOLS OF MEDICINE","294074636","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","53950"," ","261450",
"Cardiovascular; Heart Disease; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Actin-Binding Protein;Adult;Anterior;Apoptosis;Biological Assay;Blood;CD44 gene;Cardiac;Cell Lineage;Cell Survival;Cell physiology;Cell-Matrix Junction;Complex;Congenital Heart Defects;Data;Defect;Degenerative Disorder;Development;Developmental Process;Dorsal;Double Outlet Right Ventricle;Embryo;Embryonic Heart;Engraftment;Event;Exhibits;Extracellular Matrix Proteins;Focal Adhesion Kinase 1;Funding;Future;Gene Silencing;Genetic Models;Glycosaminoglycans;Growth;Guanosine Triphosphate Phosphohydrolases;Heart;Heart Atrium;Heart Septal Defects;Human;Hyaluronan;Individual;Inferior;Integrin Signaling Pathway;Integrins;Knockout Mice;Lateral;Lead;Left;Link;Mesenchymal;Mesenchymal Stem Cells;Metabolism;Mitral Valve;Modeling;Molecular;Morphogenesis;Mus;Muscle;Muscle Cells;Mutate;Mutation;Organ;PTPRC gene;Pathogenesis;Pattern;Phenotype;Phosphorylation;Phosphotransferases;Play;Primordium;Process;Production;Proteins;Publishing;Regulation;Role;Signal Pathway;Signal Transduction;Site;Source;Stem cells;Structure;System;Testing;Time;Tissues;Tricuspid valve structure;Tubular formation;Ventricular;Ventricular septum;Work;atrioventricular septal defect;base;cardiogenesis;caspase-3;extracellular;filamin;hyaluronan synthase 1;insight;intercellular communication;periostin;reconstruction;vector","Mucopolysaccharide Metabolism in Cardiac Anomalies"," The proposed studies will identify the mechanisms by which matricellular proteins periostin and CCN1, based on their reciprocal expression patterns and null phenotypes, have key regulatory roles in the formation of the atrioventricular septal complex required for the AV junction remodelling into an adult heart phenotype.   
      

","NHLBI","8373590","6/19/2012 12:00:00 AM","PA-11-260","2R01HL033756-28A1","2","R01","HL","033756","28","A","SCHRAMM, CHARLENE A","4/1/1987 12:00:00 AM","5/31/2016 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","1873251","MARKWALD, ROGER R","Not Applicable","01","ANATOMY/CELL BIOLOGY","183710748","NHV3GTWSALA7","183710748","NHV3GTWSALA7","US","32.788289","-79.954891","7575301","MEDICAL UNIVERSITY OF SOUTH CAROLINA","CHARLESTON","SC","SCHOOLS OF MEDICINE","294074636","UNITED STATES","N","6/19/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","118750"," ","368750",
"Genetics; Lung; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adult;Alveolar;Animal Model;Apoptosis;Area;Asthma;Bone Marrow;Bone Marrow Cells;Bone Marrow Transplantation;Cell Differentiation process;Cell Survival;Cell physiology;Cells;Chimera organism;Chromosomes;Chronic;Chronic Obstructive Airway Disease;DNA;Deposition;Development;Disease;Disease Management;Enzymes;Epithelial;Epithelial Cells;Extracellular Matrix;Fatal Outcome;Fibroblasts;Fibrosis;Gene Expression;Gene Expression Profile;Gene Expression Regulation;Hamman-Rich syndrome;Health;Human;Inflammatory;Injury;Interstitial Lung Diseases;Knockout Mice;Length;Lung;Lung diseases;Maintenance;Mediator of activation protein;Mesenchymal;Mesenchymal Stem Cells;Molecular Analysis;Multienzyme Complexes;Mus;Myofibroblast;Pathogenesis;Patients;Phenotype;Play;Population;Process;Progressive Disease;Pulmonary Fibrosis;Recruitment Activity;Regulation;Research Project Grants;Resistance;Role;Signal Transduction;Site;Somatic Cell;Source;Stem cells;Telomerase;Telomerase RNA Component;Telomere Length Maintenance;Testing;Tissues;Transcription factor genes;Wild Type Mouse;base;cytokine;effective therapy;indium-bleomycin;injured;insight;lung injury;neoplastic cell;novel;precursor cell;progenitor;reconstitution;telomerase reverse transcriptase;telomere","A novel telomerase expressing lung fibroblast phenotype","
Project Narrative:
This research project will analyze the role of an enzyme complex called telomerase in chronic fibrotic lung
diseases, such as in various interstitial lung diseases, including idiopathic pulmonary fibrosis. This enzyme is
responsible for maintaining the length of telomeres, repeated pieces of DNA at the ends of chromosomes, but
it is unknown why this enzyme is expressed at high levels in diseased lungs. This project will attempt to
clarify the importance of this enzyme in the development of fibrotic lung disease and thus provide new insights
into many of these diseases that currently lack an effective cure or therapy. It is hoped that attainment of
the study's objectives will provide new ideas for effective treatment and management of these diseases.","NHLBI","8225216","2/24/2012 12:00:00 AM","PA-07-070","5R01HL077297-08","5","R01","HL","077297","08"," ","EU, JERRY PC","7/5/2004 12:00:00 AM","2/28/2013 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1861132","PHAN, SEM H","Not Applicable","12","PATHOLOGY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","124865"," ","372365",
"Asthma; Clinical Research; Genetics; Infant Mortality/ (LBW); Lung; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal - Neonatal Respiratory Distress Syndrome; Perinatal Period - Conditions Originating in Perinatal Period","Accounting;Actins;Adhesions;Alveolar;Alveolus;Aspirate substance;Asthma;Biological Markers;Birth Weight;Bronchopulmonary Dysplasia;C57BL/6 Mouse;Cell Differentiation process;Cell Proliferation;Cells;Chemicals;Child;Childhood Asthma;Cicatrix;Clinical;Collagen;Coupled;Data;Deposition;Development;Diagnosis;Disease;Dominant-Negative Mutation;Effector Cell;Enzyme-Linked Immunosorbent Assay;Extracellular Matrix Proteins;Fiber;Fibroblast Growth Factor;Fibroblasts;Fibrosis;Gender;Gene Expression;Gestational Age;Glycogen Synthase Kinases;Growth Factor Overexpression;Human;Hyperoxia;In Vitro;Incidence;Individual;Infant;Knock-out;Knockout Mice;Lead;Lung;Measures;Mesenchymal;Mesenchymal Differentiation;Mesenchyme;Messenger RNA;Methods;Modeling;Molecular;Mus;Myofibroblast;NADPH Oxidase;Neonatal;Odds Ratio;Outcome;Pathogenesis;Phenotype;Phosphorylation;Pilot Projects;Plasminogen Inactivators;Play;Premature Infant;Protein Isoforms;Proteins;Receptor Signaling;Retroviral Vector;Role;Signal Transduction;Small Interfering RNA;Smooth Muscle Actin Staining Method;Staining method;Stains;Stromal Cells;Structure;T cell factor 4;Testing;Transforming Growth Factors;Vascular Endothelial Cell;Work;connective tissue growth factor;in vivo;inhibitor/antagonist;insight;interstitial;lung injury;migration;muscle hypertrophy;mutant;overexpression;periostin;premature;prevent;programs;protein expression;public health relevance;receptor binding;respiratory smooth muscle;response","Mechanisms of Airway Smooth Muscle Hypertrophy","
Project Narrative
Prematurity and bronchopulmonary dyplasia (BPD) are increasingly common causes of asthma in older
children. This application seeks to understand the cellular and molecular mechanisms underlying the
development of BPD, focusing on the role of mesenchymal stromal cells and their differentiation into
myofibroblasts, the key effector cell in lung scarring. Insight provided from the proposed studies may lead to
new methods to diagnose, prevent and treat BPD, a common precedent to childhood asthma.","NHLBI","8250317","6/9/2012 12:00:00 AM","PA-10-067","5R01HL079339-07","5","R01","HL","079339","07"," ","BLAISDELL, CAROL J","7/24/2006 12:00:00 AM","6/30/2016 12:00:00 AM","Lung Cellular, Molecular, and Immunobiology Study Section[LCMI]"," ","2479071","HERSHENSON, MARC B.","Not Applicable","12","PEDIATRICS","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","138750"," ","388750",
"Aging; Biotechnology; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Accounting;Address;Anatomy;Animal Model;Apoptosis;Area;Autologous;Bioluminescence;Biopsy;Blood Vessels;Bone Marrow;Cardiac;Cardiac Myocytes;Cell Death;Cell Size;Cell Therapy;Cells;Cessation of life;Chronic;Cicatrix;Clinical;Congestive Heart Failure;Coronary Arteriosclerosis;Depressed mood;Development;Disease;Drug Formulations;EFRAC;Family suidae;Fluorescence;Functional disorder;Growth Factor;Head;Heart;Heart Diseases;Heart failure;Human;Image;Immunohistochemistry;Infarction;Injection of therapeutic agent;Ischemia;Label;Lead;Left;Left Ventricular Mass;Left Ventricular Remodeling;Mass Spectrum Analysis;Mesenchymal;Mesenchymal Stem Cells;Mining;Modeling;Muscle Cells;Myocardial;Myocardial Infarction;Myocardial Ischemia;Myocardial Reperfusion;Myocardial perfusion;Myocardium;Natural regeneration;Nuclear;PET/CT scan;Patients;Perfusion;Phenotype;Physiological;Prevalence;Prevention strategy;Proliferating;Proteins;Proteomics;Relative (related person);Reperfusion Therapy;Reporter;Rest;Role;Source;Staging;Stem cells;Therapeutic Intervention;Time;Tissue Sample;Tissues;Translations;Vasodilation;Ventricular;Work;adult stem cell;base;cardiac repair;cell preparation;cell type;cellular imaging;comparative;density;end stage disease;heart dimension/size;improved;improved functioning;in vivo;innovation;insight;liquid chromatography mass spectrometry;novel strategies;paracrine;preclinical study;prevent;release factor;repaired;stem cell differentiation;stem cell fate;stem cell therapy;stressor;success","Chronic Adaptations to Myocardial Ischemia","
This project is highly relevant to the contemporary management of the vast majority of patients following reper-
fused myocardial infarction as well as chronic coronary artery disease where LV systolic function is mildly de-
pressed without symptomatic heart failure. Demonstrating a beneficial effect of stem cell therapies on myocar-
dial regeneration could change our current treatment paradigm which focuses on advanced end-stage disease
to one that employs cell based therapy to prevent the progression of asymptomatic LV systolic dysfunction to
clinical heart failure.
 ","NHLBI","8204904","11/18/2011 12:00:00 AM","PA-10-067","5R01HL055324-12","5","R01","HL","055324","12"," ","SCHWARTZ, LISA","8/1/1996 12:00:00 AM","11/30/2014 12:00:00 AM","Myocardial Ischemia and Metabolism Study Section[MIM]"," ","1882750","CANTY, JOHN M","Not Applicable","26","INTERNAL MEDICINE/MEDICINE","038633251","LMCJKRFW5R81","038633251","LMCJKRFW5R81","US","42.892284","-78.859403","5992614","STATE UNIVERSITY OF NEW YORK AT BUFFALO","AMHERST","NY","SCHOOLS OF MEDICINE","142282567","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","279129","163290"," ","442419",
"Cancer; HIV/AIDS; Rare Diseases","Antigens;Carcinoma;Childhood;Clinic;Collaborations;Epithelial;Equipment;Gastrointestinal Stromal Tumors;Goals;KDR gene;Malignant Neoplasms;Malignant mesothelioma;Mesenchymal;Methods;Proteins;Soft Tissue Neoplasms;Specimen;Succinate Dehydrogenase;Tissue Donations;Tissues;Tumor Biology;Vascular Endothelial Growth Factor Receptor-2;insight;melanoma;novel diagnostics;tumor","Immunohistochemical analysis of tumors","n/a","NCI","8553178"," "," ","1ZIABC011427-01","1","ZIA","BC","011427","01"," "," "," "," "," "," ","11592663","MIETTINEN, MARKKU ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","251384",
"Aging; Biotechnology; Eye Disease and Disorders of Vision; Genetics; Neurodegenerative; Neurosciences; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adipocytes;Affinity;Animal Model;Antibodies;Aqueous Humor;Astrocytes;Bone Marrow;Brain;Cell Culture System;Cells;Coculture Techniques;Complex;Conditioned Culture Media;Crystalline Lens;Data;Defect;Development;Disease;Endocytosis;Excision;Exhibits;Exposure to;Eye;Fractionation;Functional disorder;Gel;Gene Expression;Genes;Genetic;Glaucoma;Goals;Growth Factor;Human;Impairment;Inflammation;Interleukin-11;Interleukin-6;Investigation;Knockout Mice;LIF gene;Lead;MAP Kinase Signaling Pathways;MAPK14 gene;MAPK8 gene;Maintenance;Mass Spectrum Analysis;Measures;Mediating;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Molecular;Mus;Mutate;N-terminal;Nervous system structure;Neurodegenerative Disorders;Optic Nerve;Osteoblasts;Osteogenesis;Pathway Analysis;Peripheral;Platelet-Derived Growth Factor;Play;Protein Analysis;Protein Family;Proteins;Proteomics;Ranvier&apos;s Nodes;Rattus;Retinal;Retinal Ganglion Cells;Role;Schwann Cells;Signal Pathway;Signal Transduction;Spinal Cord;Structure;Subgroup;System;Testing;Thick;Tissues;Trabecular meshwork structure;Transgenic Animals;Transplantation;Visual evoked cortical potential;Wild Type Mouse;X-Ray Computed Tomography;axon guidance;bone;extracellular;improved;in vivo;insight;interest;member;myelination;myocilin;neuronal cell body;neuroprotection;neurotrophic factor;novel;osteogenic;regenerative;retrograde transport;sciatic nerve;stem cell differentiation;substantia spongiosa;transcription factor","Molecular Mechanisms Of Glaucoma","n/a","NEI","8556817"," "," ","1ZIAEY000318-15","1","ZIA","EY","000318","15"," "," "," "," "," "," ","6570952","TOMAREV, STANISLAV I","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL EYE INSTITUTE"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NEI"," "," "," ","949683",
"Pediatric; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Biological Assay;Blood Vessels;Cell Count;Cell Separation;Cells;Child;Communication;Cryopreserved Cell;DNA;Endothelial Cells;Equipment and supply inventories;Female;Funding;Future;Genomics;Goals;Growth;Hemangioma;Histology;Human;Immunophenotyping;Infant;Instruction;Liquid substance;Mails;Mesenchymal Stem Cells;Molecular;Newborn Infant;Nitrogen;Normal Cell;Phase;Population;Program Research Project Grants;Proliferating;RNA;Research Personnel;Resources;Reverse Transcriptase Polymerase Chain Reaction;Sampling;Skin;Specimen;Stem cells;Strawberry nevus;System;Telephone;Testing;Tissue Banking;Tissue Banks;Tissues;Training;Umbilical Cord Blood;Work;base;cell bank;cell type;clinical care;in vivo;penis foreskin;prevent;programs;success;tool;tumor;web site","Core B: Hemangioma Cell and Tissue Core","n/a","NIAMS","8379599","8/9/2012 12:00:00 AM"," ","5P01AR048564-09","5","P01","AR","048564","09"," "," ","9/15/2003 12:00:00 AM"," ","ZAR1-EHB-F","6392","1917530","BISCHOFF, JOYCE E.","Not Applicable","07","Unavailable","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","Domestic Higher Education","021201616","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","139546","139546"," ","83221","56325"," "," ",
"Genetics; Human Genome; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human","Algorithms;Antibodies;Area;Biological;Budgets;Cells;Chad;Chromatin;Communities;Complex;Cytosine;DNA;DNA Methylation;Data;Data Collection;Data Set;Development;Disease;Elements;Enhancers;Ensure;Epigenetic Process;Epitope Mapping;Epitopes;Equipment;Future;Genes;Genome;Genomics;Goals;Gold;Hand;Health;Histones;Human;Human Genome;Institutes;Karyotype;Location;Maps;Medical;Mesenchymal Stem Cells;Methods;Methylation;Modification;Nature;Nucleotides;Pathway interactions;Pattern;Phase;Phenotype;Population;Process;Production;Proteins;Quality Control;Reading;Reagent;Reference Standards;Research;Research Infrastructure;Research Personnel;Resolution;Site;Stem cells;Technology;Tissue Banking;Tissue Banks;Tissues;Transcript;Variant;Work;bisulfite;cell population study;cell preparation;cell type;chromatin modification;chromatin protein;comparative;cost;cost effective;data mining;digital;embryonic stem cell;epigenomics;functional genomics;genome-wide;histone modification;human embryonic stem cell;imprint;insight;programs;promoter;research study;scale up;stem cell biology;tool","Production sequencing of reference human epigenomes","n/a","NIEHS","8311844","8/2/2012 12:00:00 AM","RFA-RM-07-013","5U01ES017155-05","5","U01","ES","017155","05"," ","TYSON, FREDERICK L","9/29/2008 12:00:00 AM","9/30/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-CB-P(50)R]"," ","2301556","BERNSTEIN, BRADLEY EVAN","MEISSNER, ALEXANDER ","07","Unavailable","623544785","H5G9NWEFHXN4","623544785","H5G9NWEFHXN4","US","42.363318","-71.087781","10021177","BROAD INSTITUTE, INC.","CAMBRIDGE","MA","Research Institutes","021421027","UNITED STATES","N","7/1/2012 12:00:00 AM","9/30/2013 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","OD","2783487","402585"," ","3186072",
"Aging; Genetics; Human Genome; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Age;Age of Onset;Aging;Biological Assay;Cell Aging;Cell Line;Cell model;Cells;Chronic;DNA Damage;Data;Deoxyribonuclease I;Disease;Double Strand Break Repair;Elements;Endothelial Cells;Fibroblasts;Genetic;Genome;Genomic Instability;Goals;Health;Healthcare;Human;Individual;Insertional Mutagenesis;L1 Elements;Lead;Longevity;Malignant Neoplasms;Mesenchymal Stem Cells;Messenger RNA;Molecular;Monkeys;Mutagenesis;Mutation;Normal Cell;Older Population;Pathway interactions;Population;Process;Property;Reporter;Reporting;Somatic Cell;Specificity;Staining method;Stains;Stem cells;Surveys;Testing;Tissues;Umbilical vein;Variant;Western Blotting;Whole Organism;adult stem cell;age group;aged;comparative;design;endonuclease;human adult stem cell;human stem cells;human tissue;mutant;prevent;research study;response;tissue culture","L 1 element as an inrinsic factor of mammalian aging","n/a","NIA","8220917","2/2/2012 12:00:00 AM","PA-06-001","5K01AG030074-05","5","K01","AG","030074","05"," ","GUO, MAX","3/15/2008 12:00:00 AM","12/31/2013 12:00:00 AM","Biological Aging Study Section[NIA-B]"," ","8610738","BELANCIO, VICTORIA PEREPELITSA","Not Applicable","01","PUBLIC HEALTH & PREV MEDICINE","053785812","XNY5ULPU8EN6","053785812","XNY5ULPU8EN6","US","29.935453","-90.123916","8424601","TULANE UNIVERSITY OF LOUISIANA","NEW ORLEANS","LA","SCHOOLS OF PUBLIC HEALTH","701185665","UNITED STATES","N","3/1/2012 12:00:00 AM","12/31/2013 12:00:00 AM","866","Other Research-Related","2012"," "," ","NIA","105923","8474"," ","114397",
"No NIH Category available","Adenoviruses;Animals;Base of the Brain;Biological Markers;Biometry;Brain Neoplasms;Clinic;Clinical;Clinical Trials;Combined Modality Therapy;Development;Diagnosis;Diagnostic Imaging;Evaluation;Genetic;Glioblastoma;Goals;Institution;Interdisciplinary Study;Investments;Malignant neoplasm of brain;Mesenchymal Stem Cells;Molecular;Molecular Biology;Molecular Diagnosis;Molecular Epidemiology;Molecular Genetics;Monitor;Neurocognitive;Oncolytic;Oncolytic viruses;Operative Surgical Procedures;Outcome;Pathology;Patient Care;Patients;Pediatrics;Public Health;Radiation Oncology;Radiation Therapy Oncology Group;Research;Research Infrastructure;Research Training;Resistance;Resources;Signal Transduction Inhibitor;Testing;Therapeutic;Tissue Procurements;Training Support;Translating;Translational Research;University of Texas M D Anderson Cancer Center;Ursidae Family;base;career development;effective therapy;improved;inhibitor/antagonist;innovation;insight;neuro-oncology;novel;patient population;programs;response;small molecule;statistics;temozolomide;therapy development;tumor","SPORE in Brain Cancer","n/a","NCI","8332730","8/22/2012 12:00:00 AM","PAR-06-505","5P50CA127001-05","5","P50","CA","127001","05"," ","ARNOLD, JULIA T","9/1/2008 12:00:00 AM","8/31/2013 12:00:00 AM","ZCA1-GRB-I(J1)"," ","1871070","YUNG, W K ALFRED","Not Applicable","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","397","Research Centers","2012"," "," ","NCI","1573476","726524"," ","2300000",
"Genetics","Adult;Area;Benign;Biostatistics Core;Blue Nevus;Candidate Disease Gene;Cell Line;Cells;Cicatrix;Common Blue Nevus;Communication;Complementary DNA;Deposition;Dermis;Development;Disease;Ectoderm;Epithelial;Etiology;Event;Fibroblasts;Foundations;Gene Expression;Genes;Goals;Hair follicle structure;Hamartoma;Human;Immunodeficient Mouse;K-Series Research Career Programs;Lead;Lesion;Location;Malignant Neoplasms;Melanocytic nevus;Mesenchymal;Mesoderm;Modeling;Molecular;Natural regeneration;Neonatal;Neoplasm Metastasis;Neuroectoderm;Nevus;Phenotype;Positioning Attribute;Principal Investigator;Research Personnel;Sebaceous Glands;Services;Signal Transduction;Skin;Structure;System;Testing;Transcript;cell type;keratinocyte;melanocyte;migration;new therapeutic target;overexpression;reconstitution;research study;tumor","Understanding molecular mechanisms underlying the formation of the blue nevus and","These experiments aim to uncover basic molecular mechanisms regulating mesenchymal-epithelial interactions important for mammalian skin and hair follicle development. The information obtained in these studies has the potential to reveal novel therapeutic targets for epidermal and pigmentary disorders.","NIAMS","8376531","6/27/2012 12:00:00 AM","RFA-AR-08-002","5P30AR057217-04","5","P30","AR","057217","04"," "," "," "," ","ZAR1-KM-D","6447","9661601","CASTELO-SOCCIO, LESLIE A","Not Applicable","03","Unavailable","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","Domestic Higher Education","191046205","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM"," ","Research Centers","2012","29537","29537"," ","18461","11076"," "," ",
"Aging; Arthritis; Bioengineering; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Affect;Age;Biochemical;Biocompatible Materials;Biopolymers;Caliber;Cartilage;Cartilage Matrix;Cartilage injury;Cells;Chondrocytes;Chondrogenesis;Chondroitin Sulfates;Clinical;Collagen;Collagen Fiber;Contralateral;Data;Defect;Degenerative polyarthritis;Development;Dimensions;Engineering;Environment;Ethylene Glycols;Exhibits;Extracellular Matrix;Fiber;Fibrocartilages;Gel;Gene Expression;Goals;Histology;Hyaline Cartilage;Hydrogels;Immunohistochemistry;In Vitro;Joints;Lead;Lesion;Limb structure;Mechanics;Mesenchymal Stem Cells;Methacrylates;Methods;Nude Rats;Operative Surgical Procedures;Outcome Measure;Pain;Play;Prevalence;Process;Production;Property;Proteoglycan;Rattus;Relative (related person);Research;Role;Scanning Electron Microscopy;Structure;System;Techniques;Tissue Engineering;Tissues;Translating;Translations;Trauma;Water;articular cartilage;base;bone;caprolactone;cartilage repair;cell type;design;ethylene glycol;implant material;implantation;in vivo;interest;nanofiber;nanoscale;patient population;polymerization;repaired;scaffold;subcutaneous;tissue repair","Chondroitin sulfate-fiber hydrogels for cartilage tissue engineering","n/a","NIA","8204411","12/30/2011 12:00:00 AM","PA-07-002","5F31AG033999-03","5","F31","AG","033999","03"," ","WILLIAMS, JOHN","1/1/2010 12:00:00 AM","3/31/2012 12:00:00 AM","Special Emphasis Panel[ZRG1-F10-S(20)L]"," ","9534768","COBURN, JEANNINE ","Not Applicable","07","BIOMEDICAL ENGINEERING","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","1/1/2012 12:00:00 AM","3/31/2012 12:00:00 AM","866","Training, Individual","2012"," "," ","NIA","18674"," "," ","18674",
"Biotechnology; Breast Cancer; Cancer; Genetics","Accounting;Address;Affect;Applications Grants;Biochemical;Biogenesis;Biological Markers;Breast Cancer Cell;Breast Cancer Model;Breast Carcinoma;Cancer Etiology;Cell Adhesion Molecules;Cells;Cessation of life;Clinical;Computer Analysis;Data;Development;Developmental Process;Diagnosis;Disease;Distant;Down-Regulation;E-Cadherin;Epithelial;Epithelial Cells;Evaluation;Functional RNA;Future;Gene Targeting;Genomics;Goals;Human;Individual;Investigation;Knowledge;Laboratories;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Mammary gland;Mediating;Mesenchymal;Messenger RNA;MicroRNAs;Molecular;Molecular Genetics;Molecular Profiling;Mus;Names;Neoplasm Metastasis;Oncogenic;Pathogenesis;Pathologic Processes;Patients;Play;Primary Neoplasm;Process;Property;Proteins;RNA Sequence Analysis;RNA Sequences;Regulation;Reporting;Research;Research Subjects;Role;Site;Stem cells;Therapeutic;Therapeutic Intervention;Transcript;Tumor Cell Invasion;Up-Regulation;Work;base;cancer cell;cell type;in vivo;leukemia inhibitory factor receptor;malignant breast neoplasm;metastatic process;migration;neoplastic cell;novel;novel strategies;outcome forecast;overexpression;promoter;receptor function;research study;therapeutic target;transcription factor;tumor;tumor progression","Regulation of metastasis and epithelial-mesenchymal transition by microRNAs","  MicroRNAs are beginning to be implicated in tumor progression and metastasis, and they act by suppressing the expression of target genes. In this grant application, we will study the regulation of tumor metastasis and epithelial-mesenchymal transition by specific microRNAs and their target genes. These studies will reveal the molecular mechanisms underlying malignant progression and new targets for therapeutic intervention.   
      

","NCI","8395824","7/16/2012 12:00:00 AM","PA-10-067","1R01CA166051-01A1","1","R01","CA","166051","01","A","JHAPPAN, CHAMELLI","8/1/2012 12:00:00 AM","5/31/2017 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","9385371","MA, LI ","Not Applicable","09","RADIATION-DIAGNOSTIC/ONCOLOGY","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","8/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","120350"," ","327850",
"Aging; Eye Disease and Disorders of Vision","Adhesions;Anterior;Antibodies;Blindness;Cataract;Cataract Extraction;Cell Adhesion Molecules;Cell-Cell Adhesion;Complication;Crystalline Lens;Data;Developed Countries;Development;Disease;E-Cadherin;Epithelial;Epithelial Cells;Event;Extracapsular;Eye;Fibrosis;Funding;Gelatinase A;Gelatinase B;Goals;Grant;Lead;Link;Matrix Metalloproteinase Inhibitor;Matrix Metalloproteinases;Mediating;Mediator of activation protein;Mesenchymal;Modeling;Molecular;Mus;Mutant Strains Mice;Myofibroblast;North America;Nuclear Translocation;Operative Surgical Procedures;Organ;Pathway interactions;Play;Prevention;Rattus;Recombinants;Research;Role;Signal Pathway;Signal Transduction;Smooth Muscle Actin Staining Method;Testing;Therapeutic;Tissues;Transforming Growth Factor beta;Wild Type Mouse;Work;cost;design;epithelial to mesenchymal transition;in vivo Model;inhibitor/antagonist;lens;lens transparency;morphogens;mouse model;myocardin;prevent;research study;transcription factor;treatment strategy","Role of MMPs in TGFbeta-induced Cataract Formation","
Loss of transparency of the lens, or cataract, is the leading cause of blindness worldwide
despite the availability of effective surgery in developed countries. Extracapsular
cataract extraction is the most frequently performed surgical procedure in North
America, costing over 3.5 billion dollars each year, and can frequently lead to
complications such as the development of secondary cataract (posterior capsular
opacification (PCO). Thus, an understanding of the cellular and molecular mechanisms
regulating the normal and pathological differentiation of the lens is necessary in order to
develop therapeutic strategies for the treatment and/or prevention of cataracts. In the
proposed research we will investigate the cell signaling mechanisms responsible for two
fibrotic cataracts, anterior subcapsular cataracts (ASC) and PCO and further determine
how these mechanisms can be inhibited. Specifically we will focus on those pathways
mediated by transforming growth factor beta (TGFï¿½) and the matrix metalloproteinases
(MMPs) since both of have been implicated in these cataracts. Ultimately, it is hoped
that the data obtained from the proposed studies will lead to therapeutic strategies for
mitigating cataract formation.","NEI","8323802","8/8/2012 12:00:00 AM","PA-10-067","5R01EY017146-07","5","R01","EY","017146","07"," ","ARAJ, HOUMAM H","3/1/2006 12:00:00 AM","8/31/2013 12:00:00 AM","Anterior Eye Disease Study Section[AED]"," ","8363724","WEST-MAYS, JUDITH A","Not Applicable","n/a","Unavailable","207510108","Q7EMP68DMNM5","207510108","Q7EMP68DMNM5","CA","43.233408","-79.94964","4997001","MCMASTER UNIVERSITY","HAMILTON","ON","Unavailable","L8S 4K1","CANADA","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","224686","17975"," ","242661",
"Pain Conditions - Chronic; Pain Research; Pediatric","Adolescent;Adverse effects;Affect;Binding;Biochemical;Biomedical Research;Blood Vessels;Cartilage;Cartilaginous exostosis;Cells;Child;Chondrocytes;Chondrogenesis;Communities;Defect;Deformity;Degenerative polyarthritis;Developmental Process;Disease;EXT1 gene;EXT2 gene;Elements;Epiphysial cartilage;Erinaceidae;Exostoses;Family;Family member;Fatigue;Genes;Genetic;Growth;Heparitin Sulfate;Hereditary Multiple Exostoses;Impairment;Incidence;Infiltration;Life;Malignant - descriptor;Malignant Bone Neoplasm;Mesenchymal;Mesenchymal Differentiation;Methods;Molecular;Motion;Mus;Mutation;Nerve compression syndrome;Operative Surgical Procedures;Organ;Pain;Palliative Care;Pathogenesis;Patients;Physiological Processes;Procedures;Production;Protein Binding;Proteins;Proteoglycan;Reporter;Role;Severities;Signal Pathway;Signal Transduction;Signaling Protein;Stem cells;Structure;Syndrome;Tendon structure;Testing;Therapeutic;Tissues;base;bone;drug candidate;early onset;effective therapy;glycosyltransferase;in vitro Model;in vivo;insight;interest;liquid chromatography mass spectrometry;loss of function mutation;mutant;neglect;prevent;research study;skeletal;skeletal dysplasia;sulfation;translational medicine;tumor","Pathogenic Mechanisms in Hereditary Multiple Exostoses Syndrome","  Hereditary Multiple Exostoses (HME) is a serious disease that affects about 1 in 20,000 children and an adolescent, causes growth retardation, continuous pain, limited mobility and fatigue, and is associated with bone malignant tumors. There are no cures or effective treatments at the moment, and this project thus aims to identify the mechanisms of pathogenesis and test a specific therapeutic treatment to prevent formation of tumor-like bone (exostosis) typical of this disease.  
  
    

","NIAMS","8294622","5/29/2012 12:00:00 AM","PA-10-067","5R01AR061758-02","5","R01","AR","061758","02"," ","TYREE, BERNADETTE","7/1/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-C(04)M]"," ","1880414","PACIFICI, MAURIZIO ","KOYAMA, EIKI ","03","Unavailable","073757627","G7MQPLSUX1L4","073757627","G7MQPLSUX1L4","US","39.946629","-75.196611","1499101","CHILDREN'S HOSP OF PHILADELPHIA","PHILADELPHIA","PA","Independent Hospitals","191462305","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","305954","206519"," ","512473",
"Bioengineering; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Address;Adipose tissue;Adult;Apoptosis;Autologous Transplantation;Biological;Bone Development;Bone Marrow;Bone Regeneration;Bone Tissue;Bone Transplantation;Bone callus;Bone necrosis;Cartilage;Cells;Chondrocytes;Chondrogenesis;Clinical;Data;Defect;Development;Developmental Process;Encapsulated;Engineering;Event;Excision;Extracellular Matrix Proteins;Failure;Fracture;Fracture Healing;Genetic;Goals;Gold;Healed;Health;Histologic;Human;Hydrogels;Impaired wound healing;In Vitro;Label;Matrilysin;Matrix Metalloproteinases;Mechanics;Mesenchymal Stem Cells;Molecular;Multipotent Stem Cells;Mus;Musculoskeletal;Natural regeneration;Operative Surgical Procedures;Osteogenesis;Osteotomy;Outcome;Pathway interactions;Phenotype;Procedures;Process;Productivity;Property;Protocols documentation;Research;Research Proposals;Series;Skeleton;Spinal Fusion;Stem cells;System;Techniques;Technology;Testing;Time;Tissue Engineering;Tissue Grafts;Tissues;Translating;Translations;Transplantation;Trauma;United States;Vascularization;Work;base;bone;bone quality;career;clinical application;clinically relevant;design;healing;improved;in vivo;in vivo Model;intramembranous bone formation;long bone;meetings;mineralization;mouse model;new technology;poly(ethylene glycol)diacrylate;repaired;response;scaffold;skills;success;tibia;tumor","Tissue engineering application of endochondral ossification for bone regeneration"," Presently there is no adequate bone graft technology that allows for correction of large segmental defects that occur in response to trauma, gunshot and artillery wounds, and that occur upon tumor removal. The success of this project may have widespread and immediate impact on human health by developing a cartilage template that will promote bone regeneration through the process of endochondral ossification. This project will investigate the in vivo molecular mechanism and quality of bone regeneration from a cartilage graft in the first aim, and then develop a tissue engineering strategy that uses a biologically modified scaffold to promote cartilage formation from mesenchymal stem cells in the second aim.   
      

","NIAMS","8256413","2/27/2012 12:00:00 AM","PA-11-113","1F32AR062469-01","1","F32","AR","062469","01"," ","WANG, FEI","3/1/2012 12:00:00 AM","2/28/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-F10B-S(20)L]"," ","10219305","BAHNEY, CHELSEA SHIELDS","Not Applicable","12","ORTHOPEDICS","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","846","Training, Individual","2012"," "," ","NIAMS","49214"," "," ","49214",
"Clinical Research; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Smoking and Health; Tobacco","Accidents;Address;Adverse effects;Affect;Animal Model;Basic Science;Behavior;Bone Regeneration;Carbon Monoxide;Cell Differentiation process;Cell model;Cell physiology;Cells;Cellular biology;Chondrocytes;Chondrogenesis;Chronic;Cigarette Smoker;Clinical;Development;Disease;Embryo;Exposure to;Fibroblasts;Fracture;Fracture Healing;Healed;Human;Hypoxia;Hypoxia Inducible Factor;Hypoxia-Inducible Factor Pathway;In Vitro;Injury;Investigation;Limb structure;Link;Mentors;Mesenchymal Stem Cells;Modeling;Morbidity - disease rate;Mus;Nicotine;Operative Surgical Procedures;Orthopedics;Outcome;Oxygen;Pathway interactions;Patient Outcomes Assessments;Patients;Procollagen-Proline Dioxygenase;Repeat Surgery;Research Personnel;Role;Series;Signal Pathway;Signal Transduction;Site;Skeleton;Smoker;Smoking;Staging;Surgeon;Testing;Tobacco;Tobacco smoke;Toxic effect;Toxin;Trauma;Work;bone;bone healing;bone loss;cigarette smoking;clinically relevant;disability;experience;healing;high risk;in vivo;in vivo Model;inhibitor/antagonist;interest;non-smoker;repaired;response;skills;skills training;tibia","Is impaired fracture healing in smokers related to CO exposure?"," Smoking is associated with impaired fracture healing, yet the causative toxins in tobacco smoke have not been identified. This proposal seeks to test the hypothesis that smoking cigarettes impairs the ability of cells to sense low oxygen states, which is required for induction of endochondral bone repair. Thus, in the presence of carbon monoxide, mesenchymal stem cells may fail to respond to hypoxic conditions which under normal circumstances would drive terminal differentiation to hypertrophic chondrocytes. Restoring the cellular response to hypoxia could have important consequences for those fracture patients at high risk for nonunion and poor outcome after injury.   
   
      

","NIAMS","8280994","9/19/2012 12:00:00 AM","PA-11-193","1K08AR062591-01","1","K08","AR","062591","01"," ","PANAGIS, JAMES S","9/19/2012 12:00:00 AM","8/31/2015 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","10133065","WIXTED, JOHN ","Not Applicable","02","ORTHOPEDICS","603847393","MQE2JHHJW9Q8","603847393","MQE2JHHJW9Q8","US","42.277722","-71.759339","850903","UNIV OF MASSACHUSETTS MED SCH WORCESTER","WORCESTER","MA","SCHOOLS OF MEDICINE","016550002","UNITED STATES","N","9/19/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","82822","6626"," ","89448",
"Basic Behavioral and Social Science; Behavioral and Social Science; Bioengineering; Lung","Adhesions;Adhesives;Asthma;Attention;Biological Models;Breathing;Cell Adhesion Molecules;Cell Communication;Cell Line;Cells;Chemicals;Chemotaxis;Chronic Obstructive Airway Disease;Coffee;Complex;Comprehension;Data;Duct (organ) structure;Epithelial;Event;Fibrosis;Functional disorder;Goals;Growth;Heterogeneity;Human;Immigration;Individual;Lead;Libraries;Link;Logic;Lung;Measures;Mechanical Stress;Mechanical ventilation;Mechanics;Mesenchymal;Microscopy;Molecular;Morphogenesis;Motion;Natural regeneration;Phase;Physiology;Play;Population;Preclinical Drug Evaluation;Role;Source;Staging;Stress;Suggestion;System;Testing;base;bean;body system;cancer cell;cell motility;epithelial to mesenchymal transition;injury and repair;lung development;men who have sex with men;migration;molecular scale;monolayer;new technology;novel;prototype;public health relevance;repaired;research study;stable cell line;stem cell biology;tumor progression","Mechanics of Monolayer Migration","
PROJECT NARRATIVE
Recent technical and conceptual advances from our team1-13 lead to the suggestion that mechanics of the cel-
lular monolayer in the lung, and in other organ systems as well, may be dominated by a change of state called
the jamming transition. This new perspective leads logically to important new questions. In normal physiology,
for example, do cellular monolayers tend to form solidlike aggregated sheets -with excellent barrier function
and with little possibility of cell invasion or escape- because constituent cells are jammed? In pathophysiol-
ogy, do certain cell populations become fluidlike and permissive of paracellular leak, transformation, invasion
or cell escape because they become unjammed? To answer these questions, our interdisciplinary team will
test the jamming hypothesis in well-characterized endothelial and epithelial monolayer systems. And to test
the limits of applicability of the jamming hypothesis, we will study four well-characterized stable cell lines pre-
and post-EMT. These experimental studies will be made possible by an enabling new technology that we pro-
pose to develop: Monolayer Stress Microscopy.","NHLBI","8253706","3/23/2012 12:00:00 AM","PAR-07-352","5R01HL107561-02","5","R01","HL","107561","02"," ","NOEL, PATRICIA","4/6/2011 12:00:00 AM","3/31/2016 12:00:00 AM","Respiratory Integrative Biology and Translational Research Study Section[RIBT]"," ","1887476","FREDBERG, JEFFREY J","Not Applicable","07","PUBLIC HEALTH & PREV MEDICINE","149617367","UNVDZNFA8R29","149617367","UNVDZNFA8R29","US","42.335241","-71.102433","3212904","HARVARD SCHOOL OF PUBLIC HEALTH","BOSTON","MA","SCHOOLS OF PUBLIC HEALTH","021156028","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","430381","187916"," ","618297",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Affect;Cell Differentiation process;Cell physiology;Cells;Complement;Complex;Development;Functional disorder;Genetic;Heart;Histocompatibility Testing;Homeostasis;In Vitro;Injury;Intervention;Lung;Maintenance;Marrow;Mediating;Mesenchymal;Methods;Organ;Participant;Pattern;Physiological;Play;Population;Process;Regenerative Medicine;Regulatory Pathway;Research Personnel;Role;Science;Specific qualifier value;Stem cells;Stress;Stromal Cells;Time;Tissues;base;cell type;in vivo;in vivo Model;progenitor;repaired;small molecule;stromal progenitor","Microenvironmental control of progenitors in organ dysfunction and repair","n/a","NHLBI","8264178","5/9/2012 12:00:00 AM","RFA-HL-09-004","5U01HL100402-04","5","U01","HL","100402","04"," ","BLAISDELL, CAROL J","9/30/2009 12:00:00 AM","4/30/2016 12:00:00 AM","ZHL1-CSR-J(S1)"," ","1861205","SCADDEN, DAVID T","KIM, CARLA F.","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","1017893","213444"," ","1231337",
"Clinical Research; Lung; Rare Diseases","Acute Lung Injury;Address;Adenosine;Adenosine A2B Receptor;Alveolar;Alveolar Macrophages;Antibodies;Cessation of life;Chronic;Chronic lung disease;Clinical Data;Clinical Treatment;Clinical Trials;Data;Development;Diagnosis;Disease;Drug Delivery Systems;Epithelial;Epithelial Cells;Exhibits;Fibrosis;Funding;Generations;Genetic;Goals;Grant;Hamman-Rich syndrome;Human;In Vitro;Inflammation;Inflammatory;Interleukin-6;Interstitial Lung Diseases;Irrigation;Knowledge;Laboratories;Lead;Liquid substance;Lung;Lung diseases;Mediating;Mediator of activation protein;Mesenchymal;MicroRNAs;Modeling;Mus;Myofibroblast;Patients;Play;Process;Production;Property;Pulmonary Fibrosis;Receptor Signaling;Role;Signal Pathway;Signal Transduction;Signaling Molecule;Staging;Testing;Therapeutic;Therapeutic Agents;Time;Tissues;Wound Healing;design;epithelial to mesenchymal transition;in vivo;insight;lung injury;macrophage;mouse model;neutralizing antibody;novel;novel therapeutics;pre-clinical;protective effect;repaired;research study;response;therapy development","Adenosine Signaling and Lung Fibrosis"," Pulmonary fibrosis is a component of many interstitial lung diseases and there are few treatment options for this disorder. Idiopathic pulmonary fibrosis (IPF) is a particularly deadly form of fibrotic interstitial lung disease often leading to death within three to five years following diagnosis. This proposal examines the mechanisms by which the signaling molecule adenosine regulates pulmonary fibrosis and conducts preclinical analysis of the efficacy of neutralizing IL-6 antibodies in fibrosis models in mice. Knowledge obtained from these studies could lead to new therapeutic options for patients suffering from deadly fibrotic lung disorders.  
    

","NHLBI","8302209","6/10/2012 12:00:00 AM","PA-10-067","5R01HL070952-10","5","R01","HL","070952","10"," ","EU, JERRY PC","7/1/2002 12:00:00 AM","6/30/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-CVRS-G(03)M]"," ","1964108","BLACKBURN, MICHAEL R","Not Applicable","09","BIOCHEMISTRY","800771594","ZUFBNVZ587D4","800771594","ZUFBNVZ587D4","US","29.798149","-95.369119","578417","UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON","HOUSTON","TX","SCHOOLS OF MEDICINE","770305400","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","123645"," ","373645",
"Breast Cancer; Cancer; Genetics; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","1-Phosphatidylinositol 3-Kinase;Address;Bioinformatics;Biological;Biological Assay;Breast Cancer Model;Cancer Patient;Cell Count;Cell Cycle Checkpoint;Cells;Chemotherapy-Oncologic Procedure;Clinic;Clinical Trials;DNA Repair;DNA Repair Pathway;DNA copy number;Development;Endocrine;Epithelial;Family;Genes;Genetically Engineered Mouse;Genomics;Grant;Hormonal;Human;In Vitro;Investigation;Laboratories;Mammary gland;Mesenchymal;Messenger RNA;MicroRNAs;Modeling;Mus;Mutation;Pathway interactions;Patients;Phase;Phenotype;Pre-Clinical Model;Property;Radiation Induced DNA Damage;Recurrence;Regimen;Relapse;Relative (related person);Reporter;Resistance;Role;Signal Pathway;Signal Transduction;Snails;Stem cells;Testing;Therapeutic;Transplantation;chemotherapy;conventional therapy;epithelial to mesenchymal transition;improved;in vivo;inhibitor/antagonist;malignant breast neoplasm;member;mortality;mouse model;neoplastic cell;notch protein;novel;overexpression;pre-clinical;public health relevance;research study;response;self-renewal;small hairpin RNA;standard of care;therapeutic target;therapy development;transcription factor;tumor","Therapeutic Targeting of Breast Cancer Tumor Initiating Cells","
Project)Narrative)
Despite recent improvements in mortality for breast cancer patients, it is still not known why many patients
relapse even after an initial response to conventional endocrine and/or chemotherapies. To effectively target
breast cancer tumor initiating cells thought to be responsible for intrinsic therapeutic resistance and recurrence,
we have identified preclinical mouse models that develop claudin-low/spindloid tumors, where the bulk of the
tumors cells appear to be tumor initiating cells. These now provide novel models for the elucidation of critical
signaling pathways and therapeutics required to eliminate these cells. )","NCI","8209289","12/30/2011 12:00:00 AM","PA-07-070","5R01CA148761-03","5","R01","CA","148761","03"," ","WATSON, JOANNA M","3/17/2010 12:00:00 AM","12/31/2014 12:00:00 AM","Cancer Molecular Pathobiology Study Section[CAMP]"," ","7353752","ROSEN, JEFFREY MARK","PEROU, CHARLES M.","09","ANATOMY/CELL BIOLOGY","051113330","FXKMA43NTV21","051113330","FXKMA43NTV21","US","29.711148","-95.39695","481201","BAYLOR COLLEGE OF MEDICINE","HOUSTON","TX","SCHOOLS OF MEDICINE","770303411","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","394937","96738"," ","491675",
"Arthritis; Autoimmune Disease; Biotechnology; Patient Safety; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Adult;Adverse effects;Affect;Allogenic;American;Animal Model;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Arthritis;Attenuated;Atypical lymphocyte;Autologous;Businesses;Cell Therapy;Cells;Clinical;Clinical Trials;Collagen Arthritis;Data;Disease;Disease Outcome;Dose;Ensure;Goals;Healed;Home environment;Homeostasis;Human;Immune;Immune response;Inflammatory;Inflammatory Response;Intellectual Property;Investigational Drugs;Joints;Lead;Legal patent;Life Expectancy;Literature;Marketing;Medical;Mesenchymal Stem Cells;Methodology;Methods;Modeling;Monitor;Mus;Outcome;Patients;Pharmaceutical Preparations;Phenotype;Preparation;Regimen;Research;Rheumatoid Arthritis;Series;Severities;Site;Stem cells;Testing;Therapeutic;Tissues;Toxic effect;Treatment Efficacy;Tumorigenicity;Universities;Work;base;cell preparation;falls;follow-up;functional disability;healing;human disease;human tissue;improved;joint destruction;new technology;phase 1 study;phase 2 study;public health relevance;repaired;response;safety testing;stem cell therapy;success;tissue repair","The First Locally Acting Anti-Inflammatory Stem Cell-Based Therapy for Rheumatoid"," Public Health Relevance: Millions of Americans suffer from rheumatoid arthritis (RA) every year. It is a debilitating disease associated with progressive join destruction, functional disability, and decreased life expectancy. This study aims to advance the first anti-inflammatory mesenchymal stem cell (MSC)-based product for the treatment of rheumatoid arthritis. Unlike any of the currently available anti-inflammatory medications, MSCs used in this therapy are anticipated to go to the affected sites, to directly treat the inflammatio, and to promote repair of the affected joints. By going to work directly at the inflamed tissues it s expected that the adverse effects of conventional anti-inflammatory medications will be avoided. The new technology used in the preparation of the MSC-product (MSC2) being tested here overcomes the major obstacle of current MSC-based therapy by ensuring a consistently effective and reproducible anti-inflammatory MSC phenotype.   
      

","NIAMS","8312110","9/21/2012 12:00:00 AM","PA-10-122","1R43AR061902-01A1","1","R43","AR","061902","01","A","MAO, SU-YAU","9/21/2012 12:00:00 AM","8/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-T(12)B]"," ","1872415","BETANCOURT, ALINE ","Not Applicable","52","Unavailable","080059354"," ","080059354"," ","US","29.92324","-90.11171","10027777","COMMENCE BIO, INC.","SAN DIEGO","CA","Domestic For-Profits","921917007","UNITED STATES","N","9/21/2012 12:00:00 AM","8/30/2013 12:00:00 AM","846","SBIR/STTR","2012"," "," ","NIAMS"," "," "," ","352102",
"Aging; Bioengineering; Cardiovascular; Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","3-Dimensional;Activities of Daily Living;Affect;Age;Aging;Anatomy;Animal Experimentation;Animals;Autologous;Autologous Bone Marrow Transplantation;Binding;Biochemical;Biological;Biological Models;Blocking Antibodies;Bone Marrow;Caliber;Cardiac;Cardiac Myocytes;Cardiovascular system;Cell Communication;Cell Proliferation;Cell Transplantation;Cell physiology;Cells;Clinical Research;Clinical Trials;Coculture Techniques;Communication;Complex;Control Animal;Cues;Dependency;Endothelial Cells;Environment;Event;Gene Expression;Gene Silencing;Goals;Heart;Human;Hydrostatic Pressure;Immigration;Instruction;Length;Liquid substance;Mechanics;Mediating;Mentors;Mesenchymal Stem Cells;Modeling;Molecular;Muscle Contraction;Myocardial;Myocardial Infarction;Myocardium;Notch Signaling Pathway;Outcome;Patients;Phenotype;Process;Property;Publishing;Regenerative Medicine;Reperfusion Therapy;Research;Role;Smooth Muscle Myocytes;Source;Stem cell transplant;Stem cells;Stimulus;Structure;System;Testing;Therapeutic;Tissue Engineering;Tissues;Vascular Endothelial Growth Factors;adult stem cell;age effect;age related;angiogenesis;improved;in vitro Model;juvenile animal;migration;regenerative;response;shear stress;tissue regeneration;tissue repair;two-dimensional","Project 1 - Cardiovascular and Regenerative Medicine","RELEVANCE (See instructions): 
An inherent challenge in the use of autologous adult stem cell sources for myocardial infarction is a potential 
decrease in number or functional capacity of the available stem cells as a function of age. This proposal 
investigates the dependency of donor age on mesenchymal stem cell-dependent angiogenic processes 
using a differential approach that progressively increases the complexity of the in vitro model systems.","NIGMS","8466849","7/26/2012 12:00:00 AM","PAR-09-079","1P20GM103629-01A1","1","P20","GM","103629","01","A"," "," "," ","ZRR1-RI-B(01)","8391","7795775","AHSAN, TABASSUM ","Not Applicable","01","Unavailable","053785812","XNY5ULPU8EN6","053785812","XNY5ULPU8EN6","US","29.935453","-90.123916","8424601","TULANE UNIVERSITY OF LOUISIANA","NEW ORLEANS","LA","Domestic Higher Education","701185665","UNITED STATES","N","8/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Research Centers","2012","284859","284859"," ","201019","83840"," "," ",
"Biotechnology; Genetics","3&apos; Untranslated Regions;Alternative Splicing;Angiopoietin-1;Biological Assay;CD44 gene;Candidate Disease Gene;Cell Nucleus;Cell Proliferation;Cell Surface Proteins;Cell surface;Cells;Collaborations;Custom;Development;Disease;Exons;Extracellular Matrix;Family;Feedback;Gene Expression;Gene Expression Regulation;Genes;Genome;Grant;Homing;Institutes;Knowledge;Lentivirus Vector;Libraries;Ligands;Link;MEKs;Malignant Neoplasms;Mammalian Cell;Measurement;Mesenchymal;Messenger RNA;MicroRNAs;Modification;Monitor;Nuclear;Pathway interactions;Plant Roots;Polyadenylation;Post-Transcriptional Regulation;Process;Proliferating;Protein Isoforms;Proteins;Public Health;RNA Splicing;RNA-Binding Proteins;Ras Signaling Pathway;Recycling;Regulation;Reporter;Reporter Genes;Reporting;Retroviral Vector;Ribonucleases;SRC-associated p68 protein;Signal Pathway;Signal Transduction;Site;Staging;Stem cells;Structure;Subfamily lentivirinae;Surface;System;Testing;Untranslated Regions;Validation;Variant;angiogenesis;angiogenin;base;cancer stem cell;cell motility;epithelial to mesenchymal transition;extracellular;inhibitor/antagonist;interest;loss of function;member;neoplastic cell;public health relevance;receptor;small hairpin RNA;tau Proteins;tumor;vector","Regulation of mRNA Processing","
Relevance to Public Health
Alternative RNA splicing is a central aspect of most normal and disease processes.
Little is known about the factors and pathways that regulate alternative RNA splicing.
We propose to study how alternative splicing of CD44 is regulated by the Ras signaling
pathway. These studies will both increase our knowledge of mechanisms controlling
alternative splicing and as well the factors that control CD44 activity in diseases such as
cancer.","NIGMS","8325075","8/27/2012 12:00:00 AM","PA-07-070","5R01GM034277-28","5","R01","GM","034277","28"," ","BENDER, MICHAEL T","12/1/1984 12:00:00 AM","5/31/2014 12:00:00 AM","Molecular Genetics B Study Section[MGB]"," ","7355826","SHARP, PHILLIP A","Not Applicable","07","MISCELLANEOUS","001425594","E2NYLCDML6V1","001425594","E2NYLCDML6V1","US","42.359476","-71.093853","4911501","MASSACHUSETTS INSTITUTE OF TECHNOLOGY","CAMBRIDGE","MA","ORGANIZED RESEARCH UNITS","021421029","UNITED STATES","N","9/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","325156","214146"," ","539302",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Actomyosin;Adhesions;Adhesives;Adipocytes;Area;Autologous;Biomechanics;Cell Adhesion;Cell Culture Techniques;Cell Differentiation process;Cell Lineage;Cell Shape;Cell-Matrix Junction;Cells;Chronic;Complex;Cues;Culture Media;Cultured Cells;Cutaneous;Cytoskeleton;Development;Differentiation Antigens;Disease;Ethylene Glycols;Extracellular Matrix;Fibronectins;Focal Adhesions;Future;Gene Expression;Gold;Human;Hydrogels;In Vitro;Lasers;Lead;Left Ventricular Dysfunction;Link;Masks;Mechanics;Mesenchymal Stem Cells;Motor;Myosin Type II;Neurons;Oligonucleotides;Osteoblasts;Osteogenesis;Osteogenesis Imperfecta;Pathway interactions;Pattern;Peptides;Physiological;Plasma;Property;Protein Array;Proteins;Regenerative Medicine;Research;Resistance;Role;Scanning;Shapes;Site;Source;Stem cells;Structural Protein;Surface;Testing;Ulcer;Work;base;cell behavior;cell type;crosslink;density;design;ethylene glycol;experience;extracellular;genetic regulatory protein;human disease;immunocytochemistry;improved;in vivo;insight;interest;lipid biosynthesis;lithography;migration;monolayer;multipotent cell;nanoscale;poly(ethylene glycol)diacrylate;research study;stem cell differentiation;stem cell therapy;surface coating;two-dimensional;virtual","Directing Stem Cell Differentiation on Biologically Inspired Micropatterned Surfa"," Although human mesenchymal stem cells (hMSCs) have shown great promise in regenerative medicine, a better understanding of the factors that influence hMSC differentiation is needed to improve future therapies. Materials based approaches that attempt to mimic biomechanical cues received by hMSCs in vivo have not been able to achieve complete lineage-specific hMSC differentiation in vitro. The proposed research will attempt to achieve more complete lineage-specific differentiation of hMSCs by culturing these cells on biologically inspired micropatterned surfaces, providing insight on stem cell mechanobiology that can greatly improve the design of stem cell therapies.   
      

","NIGMS","8396136","8/9/2012 12:00:00 AM","PA-11-113","1F32GM103194-01","1","F32","GM","103194","01"," ","OKITA, RICHARD T","8/9/2012 12:00:00 AM","6/30/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F15-P(20)L]"," ","11171977","SHUKLA, ANITA ","Not Applicable","02","BIOMEDICAL ENGINEERING","050299031","K51LECU1G8N3","050299031","K51LECU1G8N3","US","29.720685","-95.393732","9291001","RICE UNIVERSITY","HOUSTON","TX","BIOMED ENGR/COL ENGR/ENGR STA","770051827","UNITED STATES","N","8/9/2012 12:00:00 AM","6/30/2013 12:00:00 AM","859","Training, Individual","2012"," "," ","NIGMS","44766"," "," ","44766",
"Acute Respiratory Distress Syndrome; Lung; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human; Transplantation","Acute Disease;Acute Lung Injury;Acute respiratory failure;Address;Adult;Alveolar;Angiopoietins;Animal Model;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Bone Marrow;Cell Line;Cell Therapy;Cell physiology;Cell secretion;Cells;Characteristics;Chorion;Cicatrix;Critical Illness;Data;Development;Effectiveness;Endothelium;Endotoxins;Engraftment;Enzyme-Linked Immunosorbent Assay;Epithelial;Epithelium;Escherichia coli;Fetal Tissues;Fibroblast Growth Factor;Fibrosis;Future;Granulocyte-Macrophage Colony-Stimulating Factor;Growth;Growth Factor;Hematopoietic;Human;Infection;Inflammatory;Injury;Investigation;Knowledge;Liquid substance;Lung;Measures;Mediating;Mesenchymal;Mesenchymal Stem Cells;Mesenchyme;Modeling;Morphology;Mus;Nature;Organ;Outcome;Paracrine Communication;Patients;Phenotype;Placenta;Preparation;Production;Pulmonary Edema;Regenerative Medicine;Research;Source;Stem cells;Stromal Cells;Testing;Therapeutic;Therapeutic Use Study;Therapeutic Uses;Time;Transforming Growth Factor beta;Treatment Effectiveness;Treatment Efficacy;Type II Epithelial Receptor Cell;United States National Institutes of Health;base;blastomere structure;cell type;clinically relevant;cost;cytokine;fetal;fetal stem cell;human embryonic stem cell;human stem cells;improved;injured;lung development;lung injury;mouse model;novel;paracrine;placental stem cell;potency testing;programs;repaired;restoration;tissue regeneration","Stromal Stem Cells of Human Placenta for the Treatment of Acute Lung Injury"," Novel sources of multipotent, highly therapeutically effective patient-specific stem cells are in great need. The placenta is a potential source of fetal stem cells. Few studies involving placental stem cells for therapeutic use have been conducted. We plan to develop a research program, with support from NIH that will enable us to obtain a therapeutic product based upon use of placental stromal cells for the treatment of acute disorders like Acute Lung Injury. Cells will be selected from placentas upon their paracrine activity and tested in animal models of Acute Lung Injury and in isolated ex vivo human lungs. This study will further contribute to the advances in knowledge and to the potential for regenerative medicine using stem cell derived from the placenta. Upon completion, this project will provide novel abundant, non-controversial and inexpensive source of therapeutically active fetal stem cells, available for use in humans within very short period of time, which will determine its outstanding future commercial potential.      

","NHLBI","8251414","7/30/2012 12:00:00 AM","PA-11-096","1R43HL108327-01A1","1","R43","HL","108327","01","A","HARABIN, ANDREA L","8/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-CVRS-H(11)B]"," ","10485858","VITERI, FERNANDO ","Not Applicable","11","Unavailable","003454586"," ","003454586"," ","US","37.921269","-122.309327","10026197","PLASALUS, LLC","EL CERRITO","CA","Domestic For-Profits","945302207","UNITED STATES","N","8/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","838","SBIR/STTR","2012"," "," ","NHLBI"," "," "," ","178706",
"Bioengineering; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Accounting;Address;Adverse effects;Affect;Amino Acids;Animal Model;Animals;Apoptosis;Biological;Biomedical Engineering;Bone Marrow;Cardiac;Cardiac Myocytes;Cell Differentiation process;Cell Lineage;Cell Maturation;Cell Proliferation Regulation;Cell Survival;Cell physiology;Cells;Cellular biology;Characteristics;Chemicals;Cicatrix;Clinical;Collaborations;Cues;Development;Engraftment;Evaluation;Family;Gene Expression;Goals;Growth;Growth Factor;Healed;Health Care Costs;Heart;Heart failure;Hospitalization;Human;Hypertrophy;Hypoxia;In Vitro;Infarction;Injectable;Injection of therapeutic agent;Injury;Insulin-Like Growth Factor I;Kinetics;Legal patent;Measures;Mechanics;Mesenchymal;Mesenchymal Stem Cells;Modeling;Molecular;Mus;Muscle;Muscle Cells;Myocardial Infarction;Myocardial Ischemia;Myocardium;Natural regeneration;Neonatal;Outcome;Pathologic;Pathway interactions;Patients;Peptides;Physiological;Physiology;Prevention;Primary idiopathic dilated cardiomyopathy;Pump;Rattus;Recovery;Recovery of Function;Recruitment Activity;Research;Shipping;Ships;Somatomedins;Staging;Stem cells;Stress;System;Techniques;Technology;Tertiary Protein Structure;Testing;Time;Tissue Engineering;Tissues;United States;Variant;Ventricular;Ventricular Function;Work;abstracting;base;cardiac repair;cellular engineering;design;disability burden;functional gain;healing;hypertensive heart disease;improved;in vivo;member;migration;mortality;muscle regeneration;novel;novel strategies;novel therapeutics;physical property;prevent;progenitor;prohormone;public health relevance;repaired;scaffold;stem;stem cell differentiation;stem cell population;three-dimensional modeling;tissue regeneration","Cardiac Regeneration through Growth Factor Eluting Microrod Scaffolds","
Project Narrative
Heart failure is a common condition carrying a high burden of disability and mortality. Current estimates are
that heart failure accounts for approximately one million hospitalizations and
$10 billion in health care costs in the United States per year. The main underlying causes of heart failure are
ischemic heart disease, hypertension and idiopathic dilated cardiomyopathy, whose common pathophysiologic
characteristic is an inadequate mass of functional myocytes. This proposal develops and tests a novel
therapeutic 3D eluting microrod scaffold (MRS) system to deliver a natural cardiac growth factor for aiding in
the regeneration and recovery of damaged cardiac muscle in culture and animal models.","NHLBI","8294454","6/25/2012 12:00:00 AM","PAR-06-504","5R01HL090523-04","5","R01","HL","090523","04"," ","LUNDBERG, MARTHA","9/1/2010 12:00:00 AM","5/31/2014 12:00:00 AM","ZEB1-OSR-D(M1)S"," ","7579967","GOLDSPINK, PAUL H","Not Applicable","05","PHYSIOLOGY","937639060","E8VWJXMMUQ67","937639060","E8VWJXMMUQ67","US","43.04575","-88.020374","46001","MEDICAL COLLEGE OF WISCONSIN","MILWAUKEE","WI","SCHOOLS OF MEDICINE","532263548","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","285269","69470"," ","354739",
"Biotechnology; Cancer; Complementary and Alternative Medicine; Digestive Diseases; Genetics; Pancreatic Cancer; Prevention; Rare Diseases","Adverse effects;Animal Model;Biochemical Pathway;Biological;Biological Availability;Cancer Etiology;Cancer Patient;Cell Survival;Cells;Cessation of life;Clinical Data;Curcumin;DNA Binding;Data;Development;Diagnosis;Dinoprostone;Disease;Down-Regulation;Drug resistance;E-Cadherin;Epithelial;Future;Gene Expression;Genistein;In Vitro;Induction of Apoptosis;Investigation;Isoflavones;Laboratories;Lead;Link;Malignant Neoplasms;Malignant neoplasm of pancreas;Mediating;Mesenchymal;Metabolism;MicroRNAs;Mission;Modality;Molecular;Names;Neoplasm Metastasis;Oncogenes;Outcome;PTEN gene;PTGS2 gene;Pancreas;Pathway interactions;Patients;Phenotype;Plant Roots;Plasma;Prevention;Publications;Publishing;Recurrence;Regulation;Resistance;Role;Signal Pathway;Signal Transduction;Staging;Testing;Therapeutic;Time;Tissues;Transgenic Animals;Transgenic Organisms;United States;United States National Institutes of Health;Up-Regulation;Vascular Endothelial Growth Factors;Work;Xenograft procedure;analog;angiogenesis;base;cancer stem cell;carcinogenesis;cell type;chemotherapeutic agent;conditioning;design;epithelial to mesenchymal transition;gemcitabine;improved;in vivo;insight;killings;migration;notch protein;novel;novel strategies;pancreatic cancer cells;pre-clinical;prevent;stem;tumor;tumor progression;volunteer","Prevention of Tumor Progression by a Novel Approach","  This project is focused on elucidating the mechanism of Epithelial-to-Mesenchymal Transition (EMT) in gemcitabine-resistant (GR) pancreatic cancer (PC) cells related to the regulation of miR-21 and its targets, and further investigate the mechanism(s) by which ""natural agents"" such as curcumin and our novel synthetic analog (CDF) of curcumin could effectively kill EMT-type cells alone or in combination with conventional chemotherapeutic agents. We will examine the molecular mechanism in vitro and will also test our hypothesis in vivo using xenograft and K-ras transgenic animal model by assessing whether CDF or curcumin alone or in combination with conventional therapeutics could be useful for the prevention of tumor progression and/or treatment. Our proposed investigation is highly relevant to the mission of NCI, NIH and is likely to have a significant impact toward saving lives of patients diagnosed with PC in the immediate future.  
    

","NCI","8279237","4/18/2012 12:00:00 AM","PA-10-067","5R01CA154321-02","5","R01","CA","154321","02"," ","PERLOFF, MARJORIE","7/1/2011 12:00:00 AM","4/30/2016 12:00:00 AM","Chemo/Dietary Prevention Study Section[CDP]"," ","7020611","SARKAR, FAZLUL H.","Not Applicable","13","PATHOLOGY","001962224","M6K6NTJ2MNE5","001962224","M6K6NTJ2MNE5","US","42.35738","-83.064737","9110501","WAYNE STATE UNIVERSITY","DETROIT","MI","SCHOOLS OF MEDICINE","482024000","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","207500","107900"," ","315400",
"Aging; Arthritis; Bioengineering; Biotechnology; Clinical Research; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta - Non-Human; Transplantation","Adult;Affect;American;Anabolism;Animal Model;Arthritis;Biocompatible Materials;Biological Process;Biology;Blood Cells;Bone Marrow;Bone Tissue;Canis familiaris;Cartilage;Cells;Complement;Data;Data Set;Defect;Degenerative polyarthritis;Embryonic Development;Encapsulated;Endothelial Cells;Engineering;Equus caballus;FDA approved;Family suidae;Future;Glycolates;Goals;Gold;Growth Factor;Harvest;Healed;Hematopoietic;Human;Image Analysis;Immune;Immune Tolerance;Implant;In Vitro;Investigation;Joints;Knee;Lead;Length;Life;Ligaments;Mechanics;Mesenchymal;Mesenchymal Stem Cells;Microspheres;Modeling;Muscle;Musculoskeletal;Nanotechnology;Natural regeneration;Nature;Nerve Regeneration;Neurons;Orthopedic Surgery procedures;Orthopedics;Oryctolagus cuniculus;Patients;Preparation;Production;Property;Publishing;Qualifying;Quality of life;Rattus;Relative (related person);Research;Research Personnel;Risk;Signal Transduction;Skin;Source;Stem cells;Structure;Techniques;Technology;Tendon structure;Testing;Tissue Engineering;Tooth structure;Transforming Growth Factors;Translational Research;Trauma;Umbilical Cord Blood;Umbilical cord structure;United States;Veins;Wound Healing;base;bone;bone morphogenetic protein 2;clinical application;controlled release;cost;design;disability;experience;healing;immunogenicity;immunoregulation;improved;in vivo;innovation;interfacial;joint injury;nanoparticle;new technology;novel;osteochondral tissue;osteogenic;repaired;scaffold;spatiotemporal;statistics;stem cell biology;treatment strategy","Gradient-based strategy for osteochondral regeneration","Narrative 
Osteoarthritis (OA) is the most common form of arthritis, affecting approximately 21 million Americans at an annual cost of over $60 billion. Given the severely impaired quality of life and the limitations of current treatments, there is an urgent need to explore new treatment strategies for the steadily growing number of OA patients. Toward that end, the proposed research will produce a continuous osteochondral tissue to heal defects in joints ravaged by arthritis and trauma.","NIAMS","8235065","3/28/2012 12:00:00 AM","PA-07-070","5R01AR056347-03","5","R01","AR","056347","03"," ","WANG, FEI","4/1/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","8258971","DETAMORE, MICHAEL S.","Not Applicable","02","ENGINEERING (ALL TYPES)","076248616","SSUJB3GSH8A5","076248616","SSUJB3GSH8A5","US","38.951659","-95.266091","1484302","UNIVERSITY OF KANSAS LAWRENCE","LAWRENCE","KS","BIOMED ENGR/COL ENGR/ENGR STA","660457552","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","182291","81921"," ","264212",
"Aging; Cardiovascular; Clinical Research; Genetics; Lung; Prevention; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Address;Aging;Alzheimer&apos;s Disease;Animal Model;Anti-Inflammatory Agents;Anti-inflammatory;Biology;Bleomycin;Blood Vessels;Bone Marrow;Cardiovascular Diseases;Cause of Death;Cells;Collaborations;Complex;Coupled;Coupling;Development;Disease;Endocytic Vesicle;Eukaryotic Cell;Exhibits;Failure;Financial compensation;Gene Expression;Generations;Genes;Genetic;Goals;Hamman-Rich syndrome;Health;Heart;Heart failure;Human;Immune;Inflammation Mediators;Injury;Interstitial Lung Diseases;Knowledge;Lung;Lung Transplantation;Lung diseases;Malignant Neoplasms;Mediating;Mesenchymal Stem Cells;MicroRNAs;Minnesota;Mitochondria;Modeling;Molecular;Molecular Profiling;Mus;Muscle Cells;Myocardial Ischemia;National Heart, Lung, and Blood Institute;Organ;Organelles;Parkinson Disease;Patients;Phase I Clinical Trials;Prevention;Production;Pulmonary Circulation;Regulation;Reperfusion Injury;Research;Research Personnel;Right Ventricular Function;Right Ventricular Hypertrophy;Role;Safety;Therapeutic;Time;Transfer RNA;United States National Institutes of Health;Universities;Vascular Diseases;Ventricular;Ventricular Remodeling;Vesicle;coping;effective therapy;experience;human data;human study;interdisciplinary approach;knowledge base;lung injury;macrophage;mitochondrial dysfunction;multidisciplinary;origen;outcome forecast;pressure;prevent;programs;pulmonary arterial hypertension;response;stem cell biology","RV/PA Recoupling by Bone Marrow Derived Mesenchymal Stem Cells"," Idiopathic pulmonary fibrosis and pulmonary arterial hypertension are lethal diseases for which no successful treatment is available. Bone marrow derived mesenchymal stem cells (MSC) are multi-potent cells that have the capacity to ameliorate lung injury. In this application we propose the hypothesis that MSCs are capable of inducing immune regulation by releasing anti inflammatory mediators (TSG-6), endosomal vesicles called exosomes in which they shuttle micro RNAs, and transfer mitochondria to other cells. Micro RNAs are powerful regulators of the expression of genes and Mitochondria are one of the most complex organelles found in eukaryotic cells and mitochondrial dysfunction has also been implicated in aging, cancer, Parkinson's, Alzheimer's, cardiovascular, and lung diseases.   
      

","NHLBI","8353089","8/20/2012 12:00:00 AM","RFA-HL-12-021","1R01HL114795-01","1","R01","HL","114795","01"," ","MOORE, TIMOTHY M","9/1/2012 12:00:00 AM","6/30/2017 12:00:00 AM","ZHL1-CSR-H(M1)"," ","1870700","ORTIZ, LUIS ALBERTO","Not Applicable","18","PUBLIC HEALTH & PREV MEDICINE","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF PUBLIC HEALTH","152133320","UNITED STATES","N","9/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","437450","216536"," ","653986",
"Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","ATP phosphohydrolase;Allogenic;Animal Model;Bioenergetics;Blood Vessels;Blood flow;Buffers;Cardiac;Cell Differentiation process;Cell Transplantation;Cells;Clinical Trials;Congestive Heart Failure;Contracts;Coronary Arteriosclerosis;Coronary Stenosis;Coronary artery;Coronary heart disease;Creatine Kinase;Diagnostic;Energy Metabolism;Engraftment;Etiology;Family suidae;Functional disorder;Growth Factor;Heart;Heart Transplantation;Hypertrophy;Infarction;Ischemia;Lead;Left;Left Ventricular Hypertrophy;Left Ventricular Remodeling;Left ventricular structure;Magnetic Resonance Imaging;Measures;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Methods;Modality;Modeling;Molecular Profiling;Muscle Cells;Myocardial;Myocardial Contraction;Myocardial Infarction;Myocardial perfusion;Myocardium;Natural regeneration;Oxidative Stress;Pathway interactions;Patients;Performance;Perfusion;Post-Translational Protein Processing;Pre-Clinical Model;Production;Protein Family;Proteins;Proteomics;Reporting;Research;Safety;Secondary to;Severities;Signal Pathway;Stem cell transplant;Stem cells;Stress;System;Systole;Therapeutic;Time;Ventricular;base;clinically relevant;comparative;data acquisition;density;design;follow-up;functional outcomes;improved;in vivo;interest;liquid chromatography mass spectrometry;pressure;prevent;protein expression;repaired;research study;response;sex","Bioenergetics in Hypertrophied and Remodeled Left Ventricle"," The inner layers of the left ventricular wall (ENDO) are the most susceptible to oxidative stresses. Using our recently established NMR methods, this set of experiments will for the first time, examine whether the ENDO lower ATP production capacity via creatine kinase (CK) and ATPase results in the ENDO vulnerability in LVH hearts. Using swine models of LVH secondary to pressure overload or post-infarction LV remodeling as well as the quantitative proteomics method, these studies will also examine whether the functional beneficial effects of the cell transplantation are associated with the improvement of ATP production capacity via both CK and ATPase, which are accompanied by the changes in the protein expression profile of the recipient myocardium particularly the growth factors family proteins and proteins involved in energy metabolism. The findings of the experiments will elucidate for the first time, the transmural gradient of ATP turnover rate via CK and ATPase in the in vivo LVH hearts with or without stem cell transplantation; and will advance our understanding of the mechanisms of cellular therapy in myocardial repair that lead to better diagnostic and therapeutic modalities for CHF patients.   
   
      

","NHLBI","8385977","8/10/2012 12:00:00 AM","PA-10-067","1R01HL114120-01A1","1","R01","HL","114120","01","A","WONG, RENEE P","8/10/2012 12:00:00 AM","5/31/2016 12:00:00 AM","Cardiac Contractility, Hypertrophy, and Failure Study Section[CCHF]"," ","1895907","ZHANG, JIANYI ","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","SCHOOLS OF MEDICINE","554552070","UNITED STATES","N","8/10/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","468008","199207"," ","667215",
"Biotechnology; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute;Acute myocardial infarction;Adult;Animal Model;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Antihypertensive Agents;Antioxidants;Apoptosis;Apoptotic;Attenuated;Blood Vessels;Blood capillaries;Bone Marrow;Brain;Cardiac;Cardiac Myocytes;Cardiovascular Diseases;Cardiovascular Physiology;Cardiovascular system;Cell Survival;Cell Therapy;Chronic;Endothelial Cells;Enzymes;Fibrosis;Functional disorder;Funding;Gene Delivery;Genes;Genetic;Genetically Modified Animals;Glycogen Synthase Kinase 3;Goals;Grant;Growth;Healed;Heart;Heart Hypertrophy;Heart failure;Human;Hypertrophy;Hypotension;Hypoxia;Infarction;Inflammation;Injury;Ischemia;Ischemic Stroke;Isoproterenol;Kallikrein-Kinin System;Kidney;Kidney Diseases;Kininogenase;Kininogens;Kinins;Knockout Mice;Mediating;Mesenchymal Stem Cell Transplantation;Mesenchymal Stem Cells;Mitogen-Activated Protein Kinases;Modeling;Modification;Molecular;Myocardial;Myocardial Infarction;Myocardial Ischemia;Myocardium;Natural regeneration;Nitric Oxide;Norway;Organ;Prevention;Property;Proteins;Proteolysis;Rattus;Reactive Oxygen Species;Regimen;Regulation;Renal function;Reperfusion Therapy;Research;Resistance;Rodent;Role;Signal Pathway;Signal Transduction;Stem cells;Testing;Therapeutic;Tissue Kallikrein;Transgenic Mice;Tube;Vascular Endothelial Growth Factors;Ventricular Remodeling;angiogenesis;base;blood pressure regulation;capillary;cardiac repair;cell type;chemokine;cytokine;healing;heme oxygenase-1;human tissue;implantation;improved;innovation;insight;migration;neovascularization;novel;novel therapeutics;overexpression;paracrine;pressure;prevent;receptor;repaired;stem cell therapy","Regulation and Function of Tissue Kallikrein","n/a","NHLBI","8281655","5/15/2012 12:00:00 AM","PA-07-070","5R01HL029397-29","5","R01","HL","029397","29"," ","GAO, YUNLING","7/1/1986 12:00:00 AM","5/31/2014 12:00:00 AM","Hypertension and Microcirculation Study Section[HM]"," ","1887486","CHAO, JULIE ","Not Applicable","01","BIOCHEMISTRY","183710748","NHV3GTWSALA7","183710748","NHV3GTWSALA7","US","32.788289","-79.954891","7575301","MEDICAL UNIVERSITY OF SOUTH CAROLINA","CHARLESTON","SC","SCHOOLS OF MEDICINE","294074636","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","117563"," ","365063",
"Aging; Atherosclerosis; Biotechnology; Cardiovascular; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","3&apos; Untranslated Regions;Advisory Committees;Age;Aging;Animal Experiments;Aorta;Arterial Fatty Streak;Atherosclerosis;Back;Basic Science;Binding;Binding Sites;Bioinformatics;Biological Assay;Biology;Blood Vessels;Calcified;Calcium;Cardiac;Cardiology;Cardiovascular system;Cells;Chemicals;Cholesterol;Clinical Research;Collagen;Complex;Computational Biology;Data;Development;Development Plans;Diet;Doctor of Philosophy;Down-Regulation;Elements;Endothelium;Enzymes;Faculty;Fatty acid glycerol esters;Functional disorder;Funding;Genes;Genetic Enhancer Element;Grant;Grant Review;Hares;Hepatic;Hypoxia;Inflammation;Injection of therapeutic agent;Injury;Institutes;Instruction;Journals;K-Series Research Career Programs;LDL Cholesterol Lipoproteins;Laboratories;Lipids;Liver;Luciferases;Measures;Mediating;Medicine;Mentors;Mentorship;Mesenchymal;Mesenchymal Stem Cells;MicroRNAs;Microbiology;Molecular;Molecular Biology;Mus;Mutagenesis;Myofibroblast;NIH 3T3 Cells;Oils;Osteoblasts;Osteogenesis;Pathogenesis;Pathway interactions;Phenotype;Phosphoric Monoester Hydrolases;Plasma;Production;Promoter Regions;Proteins;Regenerative Medicine;Regulation;Research;Research Support;Risk Factors;Rodent;Running;Scientist;Senior Scientist;Silicon Dioxide;Site-Directed Mutagenesis;Smooth Muscle;Smooth Muscle Myocytes;Staining method;Stains;Stem cells;Testing;Therapeutic;Thoracic aorta;Tissues;Training;United States National Institutes of Health;Universities;Vascular Smooth Muscle;Wages;Western Blotting;Writing;age related;angiogenesis;base;bone;calcification;career development;cholesterol biosynthesis;feeding;middle age;new therapeutic target;novel;osteogenic;post-doctoral training;programs;research study;response;responsible research conduct;senescence;stem cell differentiation;symposium;transcription factor","Mechanisms for miR-30e Regulated Atherogenic Pathways with Age"," This career development award provides Dr. Shehadeh, a research faculty, with salary and research support to pursue a career development plan aimed at making her an independent research scientist studying mechanisms for interrogating atherogenic pathways with age. Dr. Shehadeh will be mentored by two senior scientists at the University of Miami and conduct research using a promising new molecule (microRNA) to reduce atherogenic burden with age and investigate mechanisms for this treatment.   
      

","NIA","8300301","9/21/2012 12:00:00 AM","PA-11-190","1K01AG040468-01A1","1","K01","AG","040468","01","A","KOHANSKI, RONALD A","9/30/2012 12:00:00 AM","8/31/2015 12:00:00 AM","Biological Aging Study Section[NIA-B]"," ","8303933","SHEHADEH, LINA A","Not Applicable","27","INTERNAL MEDICINE/MEDICINE","052780918","F8THLJQSAF93","052780918","F8THLJQSAF93","US","25.775337","-80.209809","5221250","UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","CORAL GABLES","FL","SCHOOLS OF MEDICINE","331462926","UNITED STATES","N","9/30/2012 12:00:00 AM","8/31/2013 12:00:00 AM","866","Other Research-Related","2012"," "," ","NIA","112775","9022"," ","121797",
"Biotechnology; Cancer; Clinical Research; Genetics; Pediatric; Rare Diseases","Affect;Age;Award;Boston;Cancer Model;Cell Line;Clinical;Clinical Oncology;Collaborations;Connective Tissue;Consultations;Dana-Farber Cancer Institute;Development;Embryology;Environment;Exhibits;Family;Family member;Funding;Gene Expression;Gene Family;Genes;Genetic;Genetic Variation;Glycolysis;Goals;Growth;HMGA Proteins;HMGA1 gene;Hematology;Human;In Vitro;International;Investigation;Knowledge;Laboratories;Lesion;Lipoma;Malignant - descriptor;Malignant Neoplasms;Mediating;Mentors;Mentorship;Mesenchymal Cell Neoplasm;Messenger RNA;Metabolic;Metabolic Diseases;Metabolism;MicroRNAs;Mitochondria;Modeling;Molecular;Molecular Target;Mus;Muscle;Myoblasts;Nutrient;Oncogenes;Oncogenic;Organ;Output;Oxidative Phosphorylation;Pathway interactions;Pediatric Hospitals;Pelvis;Physicians;Process;Production;Proteins;RNA Processing;RNA-Binding Proteins;Regulation;Research;Research Training;Resources;Rhabdomyosarcoma;Role;Scientist;Soft Tissue Neoplasms;Structure;Syndrome;Testing;Therapeutic;Tissues;Training;Transgenic Mice;Translations;Tumor Suppressor Genes;Tumor Suppressor Proteins;cancer cell;cancer therapy;career;clinically relevant;fibrosarcoma;genetically modified cells;glucose uptake;in vivo;inhibitor/antagonist;insulin sensitivity;mRNA Expression;meetings;member;metabolomics;mouse model;muscle metabolism;neoplastic;oncology;osteosarcoma;overexpression;sarcoma;skills;soft tissue;stem cell biology;success;therapeutic target;tumor;tumor progression;tumorigenesis;uptake","Metabolic roles for Lin28-let-7 miRNA pathway in sarcoma tumorigenesis"," Sarcoma represents both a clinical challenge, given their genetic diversity, and an opportunity, given the dramatic success of targeted molecular therapies in some sarcomas. LIN28A and LIN28B are cancer- promoting proteins that block the proper production of let-7; an important family of tumor suppressive microRNAs. Though LIN28A and B are expressed in a variety of human sarcomas, their roles in this context are undefined. Lin28a transgenic mice that we have developed in our lab display overgrowth, possess profoundly altered metabolism, and develop soft-tissue tumors. I will investigate the role of Lin28s and their microRNA target, let-7, in sarcoma development with a particular focus on analyzing how Lin28 causes metabolic changes in cancer. Since it is thought that cancer cells must re-structure their metabolism to gain a selective growth advantage, the Lin28 let-7 pathway could potentially be targeted to reverse the metabolic changes that are essential for cancer development.   
    

","NCI","8296550","7/6/2012 12:00:00 AM","PA-10-059","5K08CA157727-02","5","K08","CA","157727","02"," ","JAKOWLEW, SONIA B","7/5/2011 12:00:00 AM","8/31/2012 12:00:00 AM","Transition to Independence Study Section (I)[NCI-I]"," ","10414551","ZHU, HAO ","Not Applicable","07","Unavailable","076593722","Z1L9F1MM1RY3","076593722","Z1L9F1MM1RY3","US","42.340629","-71.094923","1504801","BOSTON CHILDREN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021155724","UNITED STATES","N","7/1/2012 12:00:00 AM","8/31/2012 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","31861","2549"," ","34410",
"Arthritis; Bioengineering; Biotechnology; Complementary and Alternative Medicine; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adhesives;Animals;Area;Arthritis;Autologous;Biomechanics;Bioreactors;Carbodiimides;Cartilage;Cell Culture Techniques;Cells;Chondrocytes;Collagen;Defect;Degenerative polyarthritis;Engineering;Ensure;Failure;Fibrin Tissue Adhesive;Goals;Goat;Growth Factor;Harvest;Histology;Hyaluronan;Image;Immunochemistry;Implant;In Vitro;Joints;Lateral;Length;Life;Magnetic Resonance Imaging;Maps;Measures;Mechanics;Mesenchymal Stem Cells;Methods;Modeling;Nude Mice;Omega-3 Fatty Acids;Operative Surgical Procedures;Organ Culture Techniques;Oryctolagus cuniculus;Outcome;Paste substance;Pre-Clinical Model;Procedures;Production;Property;Prosthesis;Replacement Arthroplasty;Sheep;Site;Surface;Testing;Thick;Tissue Engineering;Tissues;Variant;adhesive polymer;alternative treatment;articular cartilage;base;bone;calcium phosphate;cartilage repair;density;design;follow-up;implant material;implantation;in vivo;in vivo Model;repaired;scaffold;sound;stem;tissue repair","Total Joint Resurfacing","n/a","NIAMS","8380791","7/20/2012 12:00:00 AM"," ","5P01AR053622-05","5","P01","AR","053622","05"," "," "," ","4/30/2014 12:00:00 AM","ZAR1-CHW-J","0003","1860065","DENNIS, JAMES E","Not Applicable","11","Unavailable","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","Domestic Higher Education","441061712","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","68118","68118"," ","68118","0"," "," ",
"Assistive Technology; Bioengineering; Biotechnology; Digestive Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Abdomen;Accounting;Adipose tissue;Affinity;Animal Model;Autologous;Binding;Biocompatible;Biocompatible Materials;Bioprosthesis device;Blood Vessels;Caring;Cell Therapy;Cells;Cellular Infiltration;Clinical Trials;Data;Dermal;Devices;Distress;Failure;Fascia;Fibroblasts;Foreign Bodies;Fracture;Goals;Healed;Hernia;Infection prevention;Injury;Inpatients;Left;Letters;Life;Link;Mediating;Mesenchymal Stem Cells;Myocardial;Operative Surgical Procedures;Pain;Patients;Peptide Synthesis;Peptides;Phase;Phenotype;Process;Production;Protocols documentation;Recurrence;Secure;Series;Site;Stem cells;Sterilization;Stromal Cells;Surgeon;Suture Techniques;Technology;Testing;Time;Tissues;United States;Ursidae Family;Vascularization;Visceral;adult stem cell;biomaterial compatibility;cost;design;follow-up;healing;immunogenic;improved;in vivo;interest;manufacturing process;meetings;novel;paracrine;point of care;prevent;prototype;repaired;research study;response;scale up;soft tissue;tissue repair","Delivery of Adipose Derived Stem Cells for Healing Surgical Hernia Repairs"," Improving the rate of healing after surgical hernia repair will reduce pain, discomfort and follow-up care. The use of adult stem cells in soft tissue healing represents a potential improvement for surgical procedures. This proposal will develop a novel bioprosthetic for the local retention of cells to improve healing rates and reduce recurrence of incisional hernia repairs.   
      

","NIGMS","8392845","8/27/2012 12:00:00 AM","PA-11-096","2R44GM099488-03","2","R44","GM","099488","03"," ","COLE, ALISON E","9/10/2011 12:00:00 AM","8/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-SBIB-V(12)B]"," ","9809509","LAMB, BRUCE ","Not Applicable","04","Unavailable","078296854","YJQ6K1QMS488","078296854","YJQ6K1QMS488","US","35.366248","-79.429394","10031812","AFFINERGY, LLC","DURHAM","NC","Domestic For-Profits","277094650","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","859","SBIR/STTR","2012"," "," ","NIGMS"," "," "," ","913033",
"Bioengineering; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human","Affect;Anastomosis - action;Animal Model;Antigen-Presenting Cells;Area;Blood Circulation;Blood Vessels;Cardiovascular Diseases;Cause of Death;Cell Therapy;Cells;Cessation of life;Characteristics;Collagen;Collagen Fibril;Collagen Type I;Development;Endothelial Cells;Engineering;Extracellular Matrix;Genetic;Germ Cells;Goals;Health;Home environment;Human;Implant;In Situ;In Vitro;Integrin Binding;Mechanics;Mesenchymal Stem Cells;Modeling;Modification;Mus;Natural regeneration;Peripheral;Physiological;Population;Property;Signal Transduction;Site;Skin;Source;Stem cells;Structure;Supporting Cell;Testing;Therapeutic;Thick;Tissue Engineering;Tissue Grafts;Tissues;Transplantation;Umbilical Cord Blood;United States;Vascular blood supply;Wound Healing;base;behavior influence;cell behavior;cell type;cost;density;design;human subject;improved;in vivo;interest;mouse model;novel;progenitor;repaired;stem cell differentiation;success;therapeutic angiogenesis;wound","Engineering Collagen Matrices that Modulzate in vivo Vessel Formation","n/a","NHLBI","8321541","8/20/2012 12:00:00 AM","PA-08-021","5F30HL096350-04","5","F30","HL","096350","04"," ","CARLSON, DREW E","9/1/2009 12:00:00 AM","5/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F15-N(20)L]"," ","9509814","CRITSER, PAUL JOHN","Not Applicable","07","PEDIATRICS","603007902","SHHBRBAPSM35","603007902","SHHBRBAPSM35","US","39.780714","-86.174977","577806","INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS","INDIANAPOLIS","IN","SCHOOLS OF MEDICINE","462022915","UNITED STATES","N","9/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Training, Individual","2012"," "," ","NHLBI","32043"," "," ","32043",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adipocytes;Animals;Biochemical;Biology;Bone Marrow;Bone Marrow Cells;CSF1 gene;Calvaria;Cell Count;Cell Culture Techniques;Cell Line;Cells;Coculture Techniques;Cost Savings;Densitometry;Dual-Energy X-Ray Absorptiometry;Engineering;Freezing;Functional disorder;Genotype;Goals;Hormones;Image;In Vitro;Laboratories;Macrophage Colony-Stimulating Factor;Marrow;Mesenchymal Stem Cells;Modeling;Mus;Musculoskeletal;Musculoskeletal Diseases;Osteoblasts;Osteoclasts;Parathyroid gland;Phenotype;Preparation;Protocols documentation;RNA;Rattus;Research;Research Personnel;Resolution;Services;Skeleton;Spleen;Stem cells;Stromal Cells;TNFSF11 gene;Techniques;Technology;Training;Universities;Variant;adipocyte differentiation;base;bone;bone cell;cell bank;college;fetal;interest;investigator training;medical schools;member;oncostatin M;progenitor;skeletal","CELL CORE","The relevance of the Cell Core is based on its ability to consistently provide cells of
high quality and of the appropriate genotype and phenotype. This results in uniformity of function, cost
savings and most importantly, lowers the threshold for new investigators to explore the skeletal biology of
their models and for an expansion of investigative efforts by current Center members.","NIAMS","8376753","9/18/2012 11:20:22 AM","RFA-AR-08-003","5P30AR046032-14","5","P30","AR","046032","14"," "," ","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","ZAR1-CHW-G","7270","1883490","HOROWITZ, MARK C","Not Applicable","03","Unavailable","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","Domestic Higher Education","065208327","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Research Centers","2012","189759","189759"," ","117689","72070"," "," ",
"Biotechnology; Cancer; Clinical Research; Clinical Trials; Ovarian Cancer; Rare Diseases; Regenerative Medicine","Autoantibodies;Bioinformatics;Biological;Biological Assay;Biological Markers;Biometry;Cell Line;Clinical Trials;Data;Data Analyses;Development;Dose;Early Diagnosis;Effectiveness;Genes;In Vitro;Instruction;Malignant neoplasm of ovary;Measures;Mesenchymal Stem Cells;Mutation;Pathway interactions;Phase;Phase I Clinical Trials;Phase II Clinical Trials;Proteins;Research;Sample Size;Signal Transduction;Systems Biology;Toxic effect;University of Texas M D Anderson Cancer Center;Vascular Endothelial Growth Factors;Xenograft Model;angiogenesis;data management;design;high throughput screening;implementation trial;improved;in vivo;notch protein;predictive modeling;research study;response;statistics;stem cell therapy;tumor","Biostatistics, Bioinformatics and Systems Biology (BBSB) Core","The BBSB Core provides support to the Projects and Cores of the SPORE. This support includes designing 
in vivo and in vitro experiments and analyzing results obtained, designing new clinical trials, assisting in the conduct of and analyzing results from ongoing trials, supplying analysis and interpretation of high-throughput assays, combining results across assays, and helping interpret results in terms of component pathways.","NCI","8380491","9/4/2012 12:00:00 AM","PAR-08-020","5P50CA083639-13","5","P50","CA","083639","13"," "," "," "," ","ZCA1-RPRB-M","7772","6215880","ATKINSON, E NEELY","Not Applicable","09","Unavailable","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","Domestic Higher Education","770304009","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Research Centers","2012","287346","287346"," ","287346","0"," "," ",
"Bioengineering; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Adhesions;Alginates;Award;Biocompatible Materials;Biology;Bone Regeneration;Bone Tissue;Cell Adhesion;Cell Transplants;Cells;Collagen;Dental;Dentistry;Extracellular Matrix;Face;Fibronectins;Fluorescence Resonance Energy Transfer;Gel;Hydrogels;In Vitro;Laminin;Lead;Ligand Binding;Ligands;Mechanics;Mesenchymal Stem Cells;Molecular Weight;Oral;Osteogenesis;Patients;Peptides;Phenotype;Plastics;Polymers;Population;Property;Publications;Research;Role;Screening procedure;Specificity;Staging;Stem cells;Structure;Synthetic Peptide Libraries;System;Techniques;Testing;Tissues;Traction;base;bone;cell type;craniofacial;crosslink;density;design;in vivo;nanoscale;novel strategies;osteoblast differentiation;osteoprogenitor cell;physical property;receptor;repaired;single cell analysis;success","Polymeric Matrices with Defined Cell Adhesion","RELEVANCE: 
There are many situations in which new bone is required in dentistry to repair or reconstruct facial or oral 
structures. This project aims to develop biodegradable plastics that can increase the amount and rate at 
which new bone can be created in our bodies by stimulating stem cells to become bone-forming cells. It will 
increase our basic understanding of bone biology, may lead to new approaches to help patients who require 
large volumes of bone tissue, and may also be widely useful in forming other body tissues as well.","NIDCR","8231337","1/30/2012 12:00:00 AM"," ","5R37DE013033-15","5","R37","DE","013033","15"," ","LUMELSKY, NADYA L","8/1/1998 12:00:00 AM","2/28/2014 12:00:00 AM","NSS"," ","8116883","MOONEY, DAVID J","Not Applicable","05","ENGINEERING (ALL TYPES)","082359691","LN53LCFJFL45","082359691","LN53LCFJFL45","US","42.373148","-71.118329","3212901","HARVARD UNIVERSITY","CAMBRIDGE","MA","GRADUATE SCHOOLS","021385319","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","245025","162782"," ","407807",
"Autoimmune Disease; Diabetes; Diagnostic Radiology; Digestive Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Acute Liver Failure;Alginates;Amino Acids;Antibodies;Apoptosis;Arginine;Attention;Biocompatible;Cell Line;Cell Survival;Cell Therapy;Cell physiology;Cells;Chemicals;Clinic;Clinical;Color;Contrast Media;Crosslinker;Detection;Diabetic mouse;Discrimination;Disease;Encapsulated;Environment;Firefly Luciferases;Goals;Hemophilia A;Human;Image;Imagery;In Vitro;Individual;Insulin;Insulin-Dependent Diabetes Mellitus;Islet Cell;Islets of Langerhans;Islets of Langerhans Transplantation;Label;Libraries;Life;Lipids;Liposomes;Magnetic Resonance;Magnetic Resonance Imaging;Malignant Neoplasms;Measures;Membrane;Mesenchymal;Mesenchymal Stem Cells;Metals;Methods;Microencapsulations;Monitor;Mus;Parkinson Disease;Patients;Peptides;Physiological;Population;Production;Reporting;Signal Transduction;Source;Staging;Stem cells;Streptozocin;Techniques;Testing;Therapeutic immunosuppression;Time;Toxic effect;Treatment Protocols;Validation;base;capsule;cell capsule;design;functional status;glycemic control;in vivo;insulin secretion;insulinoma;islet;mouse model;pre-clinical;preclinical study;prevent;public health relevance;remote sensing;small molecule libraries;success","DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing","
Islet transplantation (ITx) has received considerable attention in recent years for treatment of Type 1 Diabetes
Melitus (T1DM). This proposal is focused on the production of immunoprotective islet cell capsules which are
appropriate for treatment and allow MR monitoring of the pH these islets using biodegradable CEST contrast
agents.","NIBIB","8323997","8/6/2012 12:00:00 AM","PA-10-067","5R01EB012590-03","5","R01","EB","012590","03"," ","LIU, CHRISTINA","9/22/2010 12:00:00 AM","8/31/2014 12:00:00 AM","Medical Imaging Study Section[MEDI]"," ","1858847","MCMAHON, MICHAEL T","Not Applicable","07","Unavailable","155342439","DKMDCB5HNBL7","155342439","DKMDCB5HNBL7","US","39.298451","-76.594323","2370003","HUGO W. MOSER RES INST KENNEDY KRIEGER","BALTIMORE","MD","Research Institutes","212051832","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","216270","131925"," ","348195",
"Autoimmune Disease; Crohn's Disease; Digestive Diseases; Inflammatory Bowel Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human; Transplantation","Acute;Adoptive Transfer;Affect;Allogenic;Animal Model;Antigens;Attenuated;Autoimmunity;Bone Marrow;Cells;Chemical Injury;Chronic;Clinical;Colitis;Collagen Arthritis;Colon;Crohn&apos;s disease;Data;Development;Disease;Disease Progression;Effector Cell;Enteral;Etiology;Experimental Autoimmune Encephalomyelitis;Future;Generations;Genetic;Histopathology;Home environment;Homing;Human;Immune;Immune response;Immune system;Immunologic Techniques;Immunosuppressive Agents;In Vitro;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Inflammatory disease of the intestine;Injury;Interleukin-10;Investigation;Laboratories;Lamina Propria;Lymphoid;Lymphoid Tissue;Major Histocompatibility Complex;Mediating;Medical;Mesenchymal Stem Cells;Mesentery;Modeling;Molecular;Mus;Nature;Operative Surgical Procedures;Oral Administration;Oral mucous membrane structure;Patients;Poison;Population;Positioning Attribute;Production;Rattus;Rectal Administration;Regulation;Regulatory T-Lymphocyte;Reporting;Small Intestines;Stem cells;T-Lymphocyte;T-Lymphocyte Subsets;Testing;Therapeutic Agents;Tissues;Treatment Efficacy;Ulcerative Colitis;Work;allograft rejection;attenuation;bone;cost;cytokine;in vitro activity;in vivo;lymph nodes;mouse model;novel therapeutics;prevent;public health relevance;response;trafficking","Regulation of Chronic Colitis by Mesenchymal Stem Cells","Public Health Relevance: Currently, there are only a handful of medical treatments available for treating the inflammatory bowel diseases (IBD; Crohn's disease; ulcerative colitis) with only a few new therapies projected to be available in the near future. Thus, there is a clear need for the development of additional therapeutic agents to treat patients with IBD. A new and exciting therapy that has shown promise in animal models of chronic inflammatory diseases such as autoimmune encephalomyelitis, allograft rejection, collagen-induced arthritis and graft vs. host disease is treatment with bone marrow-derived mesenchymal stem cells (MSCs). Unfortunately, no attempt has been made to evaluate the therapeutic efficacy of these immune-modifying stem cells in animal models of chronic intestinal inflammation. Because large numbers of MSCs can be grown in the laboratory, we are now in a position to evaluate the therapeutic efficacy of human or mouse MSCs in a well-characterized, mouse model of chronic colitis. In addition to providing a better understanding of how (and where) MSCs to suppress intestinal inflammation, data obtained from the proposed studies may identify new therapeutic strategies that could be used to treat patients with IBD.","NIDDK","8289961","6/14/2012 12:00:00 AM","PA-10-067","1R01DK091269-01A1","1","R01","DK","091269","01","A","HAMILTON, FRANK A","6/15/2012 12:00:00 AM","5/31/2016 12:00:00 AM","Gastrointestinal Mucosal Pathobiology Study Section[GMPB]"," ","1861062","GRISHAM, MATTHEW B","Not Applicable","19","MICROBIOLOGY/IMMUN/VIROLOGY","609980727","E4Z2NUYUMHF9","609980727","E4Z2NUYUMHF9","US","33.568999","-101.884244","8285902","TEXAS TECH UNIVERSITY HEALTH SCIS CENTER","LUBBOCK","TX","SCHOOLS OF MEDICINE","794306271","UNITED STATES","N","6/15/2012 12:00:00 AM","5/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","110110"," ","327610",
"Bioengineering; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adipocytes;Affect;Aging;Applications Grants;Bed rest;Binding;Bone Marrow;CCAAT-Enhancer-Binding Proteins;Cell Lineage;Cells;Consensus;Data;Disinhibition;Environment;Estrogens;Event;Evolution;Exercise;Fatty acid glycerol esters;Food;Functional disorder;Goals;Grant;Health;Individual;Intracellular Accumulation of Lipids;Investigation;Laboratories;Link;Lipids;Locomotion;Marrow;Mechanical Stimulation;Mechanics;Mesenchymal Stem Cells;Morphology;Mus;Muscle Cells;Nature;Nuclear;Osteoblasts;Osteogenesis;Output;Pathologic;Pathway interactions;Peroxisome Proliferator-Activated Receptors;Phenotype;Phosphorylation;Production;Proteins;Proto-Oncogene Proteins c-akt;Regimen;Regulation;Reporter;Repression;Resistance;Signal Transduction;Skeleton;Source;Stimulus;TSC2 gene;Testing;Time;Transactivation;Work;adipokines;adiponectin;aged;aging population;bone;bone mass;human FRAP1 protein;insight;integrin-linked kinase;lipid biosynthesis;osteogenic;osteoprogenitor cell;prevent;progenitor;public health relevance;receptor;response;sedentary;senescence;skeletal;stem cell differentiation;transcription factor","Mechanical Control of Mesenchymal Stem Cell Lineage Allocation","
Rubin: Narrative
 Evolution has led to interrelationships between bone and fat together to allow individuals to move to
food sources (skeleton necessary for locomotion), and store energy (as fat). Clearly our nation's health is
impacted by counterproductive ""activities"" -lack of exercise and caloric excess. Indeed, as the presence of
mechanical information prevents emergence of adipocytes from the marrow, exercise may be considered a
way to prevent bone marrow senescence as ""old"" bone marrow mimics unloading with increased fat. As
such, understanding the mechanisms by which mechanical input controls lineage selection is highly
relevant to an aging population, and should have high importance for understanding the pathophysiology
behind the decreased osteoprogenitor pool and how to reverse it.
 Consensus building now needs to be a targeted goal, examining the basics of how exercise impacts
these relationships by defining the fate of mesenchymal stem cells. We propose here a focused
investigation of how loading cells can affect lineage selection when that lineage is already directed toward
fat (as would be seen in non-exercising individuals, or aged individuals). We seek insights into the type of
mechanical input (how much and for how long), and the targets, beginning with ï¿½-catenin, but considering
other factors which determine lineage selection, and what strained cells become. We will examine
proximal nodes in strain activation of ï¿½-catenin and investigate alternative effectors of mechanical strain.
We will look at direct effects to prevent adipogenesis (inhibition of PPARï¿½ expression) and indirect ï¿½-
catenin inhibition of PPARï¿½ responses.","NIAMS","8271289","4/20/2012 12:00:00 AM","PA-07-070","5R01AR056655-03","5","R01","AR","056655","03"," ","SHARROCK, WILLIAM J","5/1/2010 12:00:00 AM","4/30/2015 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1897246","RUBIN, JANET E","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","194400","93312"," ","287712",
"Cancer; Genetics; Rare Diseases","Address;Aging;Apoptosis;Apoptotic;Binding;Biological Assay;Bone Tissue;Bone neoplasms;Cell Line;Cell Proliferation;Cells;DNA Binding;Data;EMSA;Elements;Equilibrium;Future;Genes;Genetic Transcription;Goals;Growth;Homeostasis;Life Cycle Stages;Literature;Malignant Bone Neoplasm;Mesenchymal Stem Cells;Mitotic;Molecular;Mus;Mutagenesis;NF-kappa B;Neoplasms;Osteoblasts;Osteocytes;Play;Proliferating;Regulation;Reporter;Repression;Response Elements;Role;Signal Transduction;base;bone;bone cell;cytokine;expression vector;inhibitor/antagonist;insight;loss of function;novel;osteoblast differentiation;osteosarcoma;p65;promoter","Regulation of apoptosis in osteoblasts by Runx2 and NFkB","
Despite the importance of apoptosis in bone homeostasis, its regulation in osteoblasts
remains elusive. In this proposal we will determine the specific role of the Runx2/Bax
axis in regulation of apoptosis in osteoblasts and get an insight on the role of NF-kB as a
modulator of the Runx2/Bax apoptotic axis.","NIAMS","8299020","5/7/2012 12:00:00 AM","PAR-09-031","5R03AR061515-02","5","R03","AR","061515","02"," ","WANG, FEI","7/1/2011 12:00:00 AM","5/31/2014 12:00:00 AM","ZAR1-EHB(M1)"," ","8868556","ELISEEV, ROMAN ","Not Applicable","25","ORTHOPEDICS","041294109","F27KDXZMF9Y8","041294109","F27KDXZMF9Y8","US","43.16888","-77.615939","7047101","UNIVERSITY OF ROCHESTER","ROCHESTER","NY","SCHOOL OF MEDICINE & DENTISTRY","146270140","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","50000","27250"," ","77250",
"Antimicrobial Resistance; Bioengineering; Biotechnology; Breast Cancer; Cancer; Emerging Infectious Diseases; Infectious Diseases; Lung; Lung Cancer; Regenerative Medicine","A549;Accounting;Address;Adopted;Anti-Bacterial Agents;Antibiotics;Arginine;Bacteria;Behavior;Biocompatible Materials;Biological Assay;Breast Carcinoma;Cancer cell line;Cancerous;Carcinoma;Cell membrane;Cell surface;Cells;Charge;Development;Drug Delivery Systems;Electron Microscopy;Electrostatics;Erythrocytes;Exhibits;Extracellular Matrix;Extravasation;Foundations;Gel;Human;Hydrogels;Immune;Immune response;Implant;Infection;Injectable;Lipids;Liposomes;Membrane;Mesenchymal Stem Cells;Molecular;Multi-Drug Resistance;Nosocomial Infections;Patients;Peptides;Pseudomonas aeruginosa;Recovery;Relative (related person);Site;Solutions;Spectrum Analysis;Sterility;Structure;Surface;Syringes;Tissue Engineering;Tissues;Wound Healing;aqueous;bacterial resistance;base;cancer cell;cell killing;cytotoxic;cytotoxicity;design;drug resistant bacteria;implantation;killings;lung Carcinoma;methicillin resistant Staphylococcus aureus;mouse model;novel;wound","Development of antibacterial agents and materials","n/a","NCI","8553099"," "," ","1ZIABC011314-03","1","ZIA","BC","011314","03"," "," "," "," "," "," ","11592582","SCHNEIDER, JOEL ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","551535",
"Cancer; Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human; Transplantation","Adult;Blood Cells;Blood Platelets;Bone Marrow;CD34 gene;Cells;Coculture Techniques;Coupled;Disadvantaged;Dose;Engraftment;Erythrocytes;Failure;Hematologic Neoplasms;Hematopoiesis;Hematopoietic;Hemorrhage;Homing;Infection;Leukocytes;Liquid substance;Mesenchymal Stem Cells;Methods;Mononuclear;Oxygen;Patients;Phase I Clinical Trials;Recovery;Resources;Suspension Culture;System;Testing;Therapeutic;Transplant Recipients;Transplantation;Umbilical Cord Blood;Umbilical Cord Blood Transplantation;base;experience;fighting;graft failure;improved;migration;prevent;progenitor;reconstitution;success","Cord Blood Expansion and Homing to Improve Engraftment","Slow recovery of white blood cells to fight infection, platelets to prevent bleeding and red cells to carry oxygen represent major obstacles to wider use of cord blood transplantation. Project 1 seeks to overcome these barriers by improving the expansion of cord blood cells, and by directing their migration to the bone marrow, before their transplantation into patients. If successful, this strategy will improve the survival of cord blood transplant patients.","NCI","8555381","10/12/2012 11:51:22 AM","PAR-09-025","5P01CA148600-02","5","P01","CA","148600","02"," "," ","9/22/2011 12:00:00 AM","8/31/2016 12:00:00 AM","ZCA1-RPRB-J(J1)","5302","1866037","SHPALL, ELIZABETH J","Not Applicable","09","Unavailable","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","Domestic Higher Education","770304009","UNITED STATES","N","9/17/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","534406","534406"," ","425160","109246"," "," ",
"Biotechnology; Cardiovascular; Clinical Research; Cystic Fibrosis; Genetics; Heart Disease; Lung; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute Kidney Failure;Adult;Allogenic;Alveolar Macrophages;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Antigen Presentation;Attenuated;Bacteria;Bone Marrow;Bone Marrow Transplantation;Breathing;Cardiovascular Diseases;Carrier Proteins;Cell Count;Cell Therapy;Cells;Characteristics;Chloride Ion;Chlorides;Chronic;Clinical Research;Cystic Fibrosis;Cystic Fibrosis Transmembrane Conductance Regulator;Destinations;Disease Progression;Epithelial;Equilibrium;Functional disorder;Genes;Genetic;Graft Rejection;Heart Diseases;Hematological Disease;Hematopoiesis;Hematopoietic;Hereditary Disease;Histocompatibility Testing;Homeostasis;Immune Tolerance;Immune response;Immune system;Immunity;Immunosuppression;Infarction;Infection;Inflammation;Inflammation Mediators;Inflammatory;Inflammatory Response;Injury;Intervention;Lead;Left Ventricular Function;Lung;Lung diseases;MHC Class I Genes;Macrophage Activation;Meniscus structure of joint;Mesenchymal;Mesenchymal Stem Cells;Methods;Molecular Profiling;Morbidity - disease rate;Mucous body substance;Mutation;Myeloid Cells;Myocardial Ischemia;Natural Immunity;Natural regeneration;Neutrophil Infiltration;Outcome;Pathway interactions;Patient Care;Phagocytosis;Phase;Pneumonia;Production;Pseudomonas aeruginosa;Recruitment Activity;Resolution;Respiratory physiology;Source;Spinal cord injury;Stem cells;Stimulus;Stroke;Tendinitis;Therapeutic;Therapeutic Effect;Time;Tissues;airway epithelium;cell type;chemokine;clinical application;combat;cystic fibrosis patients;cytokine;graft vs host disease;immune activation;improved;innovation;macrophage;mortality;neutrophil;pathogen exposure;patient population;pre-clinical;prevent;public health relevance;reconstitution;regenerative;response;stem cell therapy","Cell Based Therapies for Cystic Fibrosis","
Narrative
Cystic fibrosis (CF) patients have mutations in the gene encoding the chloride transport protein CFTR which
when defective in the airway epithelium results in significant pulmonary morbidity and eventual mortality. The
morbidities are associated with inefficient resolution of pulmonary infection with Pseudomonas aeruginosa and
the ensuing inflammatory response. The question is what is responsible for this over-zealous response to
bacteria burden and why can't the immune system resolve the infection efficiently. Although dysfunctional
airway clearance, mucous plugging and epithelial chemokine production are major contributors to CF
pulmonary disease, the inability to of the innate immune response to efficiently clear bacteria and ""turn-off"" the
resounding inflammation is still a prominent question. Cell-based therapies such as bone marrow
transplantation and mesenchymal stem cells have the potential to be developed as alternative therapeutic
strategies combating the genetic anomaly and the disease progression in cystic fibrosis through the ability to
enhance the host's ""self"" immunity enabling efficient infection and inflammation resolution.","NHLBI","8264750","3/26/2012 12:00:00 AM","PA-09-248","5R21HL104362-02","5","R21","HL","104362","02"," ","BANKS-SCHLEGEL, SUSAN P","6/1/2011 12:00:00 AM","3/31/2014 12:00:00 AM","Lung Cellular, Molecular, and Immunobiology Study Section[LCMI]"," ","1900527","BONFIELD, TRACEY L","Not Applicable","11","PEDIATRICS","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","SCHOOLS OF MEDICINE","441061712","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","125000","71250"," ","196250",
"Breast Cancer; Cancer; Lung; Lung Cancer","Cancer Patient;Caring;Cell physiology;Cells;Data;Development;Diagnostic Neoplasm Staging;Distant;Epithelial;Genes;Goals;Human;Laboratories;Lung;Malignant Neoplasms;Malignant neoplasm of lung;Mediating;Medical;Mesenchymal;Metastatic Neoplasm to Lymph Nodes;Modeling;Neoplasm Metastasis;Organ;Pathway interactions;Patients;Pattern;Play;Primary Neoplasm;Process;Regulation;Role;Site;Solid Neoplasm;Work;cancer cell;implantation;malignant breast neoplasm;neoplastic cell;novel;novel therapeutics;tumor;tumor progression","Mechanisms in development and regulation of metastasis in lung cancer","n/a","NCI","8553011"," "," ","1ZIABC011160-04","1","ZIA","BC","011160","04"," "," "," "," "," "," ","9692477","KWONG, KING ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","80972",
"Cardiovascular; Diagnostic Radiology; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adult;Animal Model;Animals;Canis familiaris;Cardiac;Cardiac Myocytes;Cardiomyopathies;Cardiovascular Diseases;Cardiovascular Physiology;Cardiovascular system;Cells;Clinical;Clinical Trials;Echocardiography;Engraftment;Funding;Goals;Heart;Histology;Infarction;Magnetic Resonance Imaging;Measurement;Mesenchymal Stem Cells;Microspheres;Modeling;Motivation;Myocardial Infarction;One-Step dentin bonding system;Outcome;Pathway interactions;Patients;Phase;Physiological;Physiology;Program Research Project Grants;Research;Research Personnel;Rodent;Role;Source;Stem cells;Surgical Models;Techniques;Tissues;Translating;United States National Institutes of Health;Universities;Washington;Work;base;cell injury;clinically relevant;embryonic stem cell;functional improvement;improved;in vivo;pre-clinical;repaired;stem cell therapy;tissue preparation","Outcomes Core","The long term goal of this Core is to assist investigators in this project to study how stem cells and 
embryonic stem cell-derived cardiomyocytes improve cardiac function so that eventually, these cells can be 
potentially used as treatment for patients with ischemic cardiomyopathy.","NHLBI","8380427","6/8/2012 12:00:00 AM"," ","5P01HL094374-03","5","P01","HL","094374","03"," "," "," "," ","Heart, Lung, and Blood Program Project Study Section[HLBP]","8560","6770872","MINAMI, ELINA ","Not Applicable","07","Unavailable","605799469","HD1WMN6945W6","605799469","HD1WMN6945W6","US","47.660049","-122.31441","9087701","UNIVERSITY OF WASHINGTON","SEATTLE","WA","Domestic Higher Education","981951016","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","363165","363165"," ","218774","144391"," "," ",
"Cancer; Clinical Research; Genetics; Prostate Cancer; Urologic Diseases","Alternative Splicing;American Cancer Society;Behavior;Cells;Data;Disease;Distant;Epithelial;Epithelial Cells;Exons;Fibroblast Growth Factor Receptor 2;Gene Expression;Goals;Health;Human;Image;Malignant neoplasm of prostate;Mammals;Mesenchymal;Metastatic to;Molecular Profiling;Neoplasm Metastasis;New York;Outcome;Patients;Primary Neoplasm;Process;Property;Prostate;Prostate carcinoma;Prostatic Neoplasms;Protein Isoforms;RNA Splicing;Rattus;Regulation;Reporter;Reporting;Signal Transduction;System;Technology;Testing;Therapeutic;Time;Transcript;Tumor Markers;Vertebrates;Work;fitness;in vivo;killings;men;mouse model;neoplastic cell;novel;programs;therapeutic target;tumor;tumor progression;tumorigenesis","Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors","
The potential significance of our application to human health is underscored by
the magnitude of prostate cancer as a health problem, which The American
Cancer Society (ACS) predicts will afflict ~200,000 men and will kill >25,000 in
the US alone. In addition, prostate cancer presents the clinician and the patient
with unique problems in terms of choosing among therapeutic options and
predicting eventual outcomes (see New York Times 26 February article ""A
Review of Prostate Cancer Leaves Men in a Muddle""). The work proposed here
should identify useful markers of tumor behavior and perhaps even targets for
novel therapies.","NCI","8196869","11/18/2011 12:00:00 AM","PA-07-070","5R01CA127727-04","5","R01","CA","127727","04"," ","SNYDERWINE, ELIZABETH G","12/1/2008 12:00:00 AM","11/30/2013 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1869178","GARCIA-BLANCO, MARIANO A.","Not Applicable","04","GENETICS","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","112714"," ","313989",
"Facioscapulohumeral Muscular Dystrophy; Genetics; Muscular Dystrophy; Neurosciences; Rare Diseases; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human","Adult;Alleles;Binding Sites;Biological;Cells;Characteristics;Chromatin;Chromatin Structure;Chromosomes, Human, Pair 4;Clinical;Collaborations;Complex;Contracts;D4Z4;DNA;DNA Methylation;DNA Sequence;Data;Development;Disease;Distal;ES Cell Line;Embryonic Development;Enhancers;Epigenetic Process;Facioscapulohumeral Muscular Dystrophy;Fibroblasts;Functional disorder;Genetic;Genetic Enhancer Element;Genetic Transcription;Goals;Haplotypes;In Vitro;Lead;Mesenchymal Stem Cells;Methyl-CpG-Binding Protein 2;Modification;Myoblasts;Myopathy;Pathogenesis;Pathogenicity;Pathology;Patients;Process;RNA;RNA Binding;RNA Processing;Repression;Role;Structure;Testing;Transcript;Transcriptional Silencer Elements;Undifferentiated;Variant;base;chromatin protein;embryonic stem cell;established cell line;histone modification;human embryonic stem cell;insight;knock-down","The Genetic and Epigenetic Basis for FSHD","The significance of these studies is that identifying the genetic and epigenetic conditions required for 
FSHD will provide fundamental insight into the pathophysiology of FSHD as well as providing new avenues for interventional therapies.","NINDS","8376790","2/28/2012 12:00:00 AM"," ","5P01NS069539-03","5","P01","NS","069539","03"," "," "," "," ","Neurological Sciences and Disorders B Study Section[NSD-B]","6882","6828192","VAN DER MAAREL, SILVERE M","Not Applicable","07","Unavailable","078200995","HMSNCM57QNR5","078200995","HMSNCM57QNR5","US","47.628707","-122.330795","861001","FRED HUTCHINSON CANCER RESEARCH CENTER","SEATTLE","WA","Research Institutes","981094433","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","176228","176228"," ","176228","0"," "," ",
"Breast Cancer; Cancer","Address;Adenocarcinoma;Affect;Apoptosis;Behavior;Biochemistry;Biological;Biological Assay;Biological Process;Breast;Cancer Etiology;Cell Culture Techniques;Cell physiology;Cells;Cellular biology;Cessation of life;Development;Differentiation and Growth;Disease;Ductal;Ductal Epithelial Cell;Dysplasia;Environment;Epithelial;Epithelial Cells;Epithelial-Stromal Communication;Epithelium;Equilibrium;Extracellular Matrix;Extracellular Matrix Degradation;Functional disorder;Funding;Genes;Genomic Instability;Goals;Growth;Growth Factor;Health;Hyperplasia;Lead;Lesion;Life;Lupus erythematosus cell;MMP3 gene;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Matrix Metalloproteinase Inhibitor;Matrix Metalloproteinases;Mechanics;Mediator of activation protein;Mesenchymal;Metalloproteases;Methods;Modeling;Molecular;Morphogenesis;Mus;Mutate;Myoepithelial cell;Neoplasms;Normal tissue morphology;Pathogenesis;Pathologic;Pathologic Processes;Pathway interactions;Phenotype;Play;Premalignant;Process;Research;Role;Series;Signal Pathway;Signal Transduction;Stem cells;Stromal Cells;Stromelysin 1;Structure-Activity Relationship;System;Testing;Therapeutic Intervention;Tissue Inhibitor of Metalloproteinase-1;Tissues;Transgenic Organisms;Transplantation;Trees;Woman;Women&apos;s Health;base;cell behavior;cellular imaging;epithelial to mesenchymal transition;genetic manipulation;human MMP14 protein;in vivo;in vivo Model;inhibitor/antagonist;insight;intercellular communication;malignant breast neoplasm;mammary epithelium;mammary gland development;mutant;neoplastic;neoplastic cell;novel;overexpression;reconstitution;research study;response;tumor;tumor progression","Role of metalloproteinases in mammary gland remodeling","n/a","NCI","8269085","5/22/2012 12:00:00 AM","PA-07-070","5R01CA057621-20","5","R01","CA","057621","20"," ","SNYDERWINE, ELIZABETH G","4/15/1993 12:00:00 AM","9/29/2013 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1869452","WERB, ZENA ","BISSELL, MINA ","12","ANATOMY/CELL BIOLOGY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","6/1/2012 12:00:00 AM","9/29/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","386555","119619"," ","506174",
"Biotechnology; Clinical Research; Genetics; Kidney Disease; Polycystic Kidney Disease","Accounting;Actins;Acute Renal Failure with Renal Papillary Necrosis;Adherens Junction;Alleles;Apoptosis;Binding;Biochemical;Biochemistry;Biological;Cadherins;Cell Adhesion;Cell Polarity;Cell Proliferation;Cell surface;Cell-Cell Adhesion;Cells;Cilia;Complement;Complex;Cyst;Cystic kidney;Cytoskeleton;Data;Defect;Development;Disease;Distal;E-Cadherin;Embryo;Epithelial;Event;Extracellular Domain;Failure;Family;Family member;Gene Expression Profile;Gene Expression Profiling;Genes;Genetic;Genetic Transcription;Goals;Guanosine Triphosphate Phosphohydrolases;Health;Human;Immunohistochemistry;Individual;Investigation;Kidney;Kidney Diseases;Knock-out;Laboratories;Lead;Light;Link;Mediating;Mesenchymal;Mesenchyme;Metanephric Diverticulum;Methods;Molecular;Morphogenesis;Mus;Mutant Strains Mice;Mutate;Natural regeneration;Nephrology;Nephrons;Newborn Infant;Oligonucleotide Microarrays;Organ;Partner in relationship;Pathogenesis;Pathway interactions;Penetrance;Phenocopy;Phenotype;Physicians;Play;Polycystic Kidney Diseases;Proteins;Recovery;Regulation;Research Personnel;Research Proposals;Reverse Transcriptase Polymerase Chain Reaction;Role;Scientist;Signal Pathway;Signal Transduction;Staging;Surface;Testing;Therapeutic;Tissues;Transcriptional Regulation;Transduction Gene;Transgenic Mice;Translating;Western Blotting;adhesion receptor;career;catenin p120ctn protein;cell motility;cell type;clinically relevant;comparative;design;epithelial to mesenchymal transition;experience;improved;in vivo;interest;mouse model;mutant;nephrogenesis;novel;recombinase;repaired;rho;tool;tumor progression","The Role of p120 Catenin in Metanephric Kidney Development","n/a","NIDDK","8294847","7/16/2012 12:00:00 AM","PA-06-512","5K08DK081668-05","5","K08","DK","081668","05"," ","RANKIN, TRACY L","7/15/2008 12:00:00 AM","6/30/2014 12:00:00 AM","Kidney, Urologic and Hematologic Diseases D Study Section[DDK-D]"," ","1892253","MARCIANO, DENISE K","Not Applicable","30","INTERNAL MEDICINE/MEDICINE","800771545","YZJ6DKPM4W63","800771545","YZJ6DKPM4W63","US","32.814772","-96.841146","578404","UT SOUTHWESTERN MEDICAL CENTER","DALLAS","TX","SCHOOLS OF MEDICINE","753909105","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","847","Other Research-Related","2012"," "," ","NIDDK","137500","11000"," ","148500",
"Biotechnology; Hematology; Infectious Diseases; Lung; Septicemia","Acute Lung Injury;Animal Model;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Apoptosis;Automobile Driving;Bacteria;Biological;Biological Assay;Bone Marrow;Carbon Monoxide;Cell Communication;Cell Therapy;Cell surface;Cells;Cessation of life;Coculture Techniques;Complex;Conditioned Culture Media;Death Rate;Diagnosis;Disease;Early treatment;Effector Cell;Event;Exposure to;Failure;Fibroblasts;Functional disorder;Gases;Goals;Harvest;Hematopoietic;Heme;Home environment;Homeostasis;Homing;Hour;Human;Hypotension;Hypoxia;Immune;Immune Cell Activation;Immune response;Immune system;Infection;Inflammation;Inflammatory;Inflammatory Response;Injury;Invaded;Knockout Mice;Laboratories;Lead;Ligation;Lung;Lymphocyte;Mediator of activation protein;Medical;Mesenchymal;Molecular;Mus;Organ;Organ Survival;Organism;Outcome;Oxygenases;Patients;Phagocytes;Phagocytosis;Process;Property;Pulmonary Circulation;Puncture procedure;Refractory;Resolution;Respiratory Failure;Role;Sepsis;Septic Shock;Severities;Site;Staging;Stromal Cells;Therapeutic;Time;Transgenic Mice;antimicrobial;base;conditioning;heme oxygenase-1;improved;improved functioning;in vivo;innovation;insight;lung injury;macrophage;microbial;microorganism;monocyte;neutrophil;novel;novel strategies;novel therapeutics;overexpression;paracrine;pathogen;pre-clinical;prevent;response;tissue repair","Mesenchymal Stromal Cell Conditioning by Carbon Monoxide","RELEVANCE (See instmctions): 
Sepsis is a medical condition caused by an underlying infection that leads to an inflammatory process throughout the body. Although there have been intense efforts to improve the treatment of sepsis, death rates remain high in patients with this disease. This project will investigate new approaches to treating sepsis, using cell s (mesenchymal stromal cells) as a therapy, and we will also discover ways to improve the function of these cells for therapeutic benefit using the gas carbon monoxide.","NHLBI","8380530","8/8/2012 12:00:00 AM","PAR-09-185","5P01HL108801-02","5","P01","HL","108801","02"," "," "," "," ","ZHL1-PPG-A","5937","1915712","PERRELLA, MARK A","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","484703","484703"," ","303771","180932"," "," ",
"Brain Cancer; Brain Disorders; Cancer; Clinical Research; Clinical Trials; Genetics; Neurosciences; Orphan Drug; Rare Diseases","Adult;Angiogenesis Inhibitors;Area;BAY 54-9085;Biological Assay;Biological Markers;Candidate Disease Gene;Clinic;Clinical;Clinical Trials;Complement;Data;Data Set;Databases;Diagnosis;Ensure;Extracellular Matrix;Formalin;Future;Gene Expression;Genes;Glioblastoma;Histopathology;MGMT gene;Malignant neoplasm of brain;Medicine;Mesenchymal;Mesenchymal Differentiation;Meta-Analysis;Methylation;Microarray Analysis;Mining;Mitogen-Activated Protein Kinases;Molecular;Molecular Profiling;Newly Diagnosed;Outcome;Pathway interactions;Patients;Pattern;Phase;Phase III Clinical Trials;Phenotype;Phosphorylation;Primary Brain Neoplasms;Progression-Free Survivals;RNA;Radiation;Radiation Therapy Oncology Group;Radiation therapy;Randomized;Recurrence;Refractory;Regimen;Resistance;Sampling;Signal Transduction;Staging;Statistical Models;Survival Rate;Techniques;Testing;Therapeutic;Therapeutic Agents;Time;Tissues;University of Texas M D Anderson Cancer Center;Validation;angiogenesis;base;bevacizumab;chemotherapy;cohort;college;design;efficacy testing;improved;inclusion criteria;inhibitor/antagonist;insight;molecular marker;next generation;novel;novel therapeutics;outcome forecast;overexpression;phase 3 study;promoter;prospective;research clinical testing;response;response marker;standard care;standard of care;temozolomide;treatment response;trial comparing;tumor","Prediction of Chemoradiation response in Glioblastoma to individualize Therapy","n/a","NCI","8380394","8/22/2012 12:00:00 AM","PAR-06-505","5P50CA127001-05","5","P50","CA","127001","05"," "," "," "," ","ZCA1-GRB-I","0003","2081378","ALDAPE, KENNETH D","Not Applicable","09","Unavailable","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","Domestic Higher Education","770304009","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Research Centers","2012","376610","376610"," ","257646","118964"," "," ",
"Autoimmune Disease; Clinical Research; Genetics; Lung; Rare Diseases","Accounting;Address;Alveolar;Animal Model;Apoptosis;Architecture;Biologic Characteristic;Biological Assay;Biology;Candidate Disease Gene;Cell Proliferation;Cell surface;Cells;Cellular biology;Characteristics;Collagen;Cytokeratin;Data;Deposition;Development;Diagnosis;Dinoprostone;Disease;E-Cadherin;Epithelial;Epithelial Cells;Fibroblasts;Fibrosis;Fingerprint;Future;Gene Expression;Genes;Genetic;Genomics;Growth Factor;Hamman-Rich syndrome;Human;Hyperplasia;Immunohistochemistry;Impaired wound healing;In Vitro;Interstitial Lung Diseases;Investigation;Knowledge;Lead;Lung;Lung diseases;Mediator of activation protein;Mesenchymal;Messenger RNA;Metalloproteases;Methods;MicroRNAs;Normal Cell;Outcome;Pathogenesis;Pathway interactions;Patients;Phenotype;Physiological;Play;Population;Process;Proliferating;Prostaglandins;Proteins;RNA;Research Proposals;Respiratory physiology;Reverse Transcriptase Polymerase Chain Reaction;Role;Sorting - Cell Movement;Source;Surface;Technology;Testing;Time;Type II Epithelial Receptor Cell;alveolar type II cell;cell type;endoplasmic reticulum stress;epithelial to mesenchymal transition;in vitro Assay;new technology;novel;public health relevance;research study;response to injury","Analysis of Alveolar Type II cells in Normal and Fibrotic Human Lung","
PROJECT NARRATIVE
 Idiopathic pulmonary fibrosis, the most common form of lung fibrosis, is a deadly disease with average
survival of three years. This proposal applies novel technologies to purify and characterize alveolar type II
cells and type II cell subtypes (CD15+) from the lungs of patients with idiopathic pulmonary fibrosis. Following
purification, the unique biological characteristics of IPF type II cells and CD15+ type II cells will be established.
By broadly analyzing the unique biology of IPF type II cells, these studies have the potential to identify
unsuspected causes of Idiopathic pulmonary fibrosis and could lead to the development of new therapies that
favorably modulate outcomes of this devastating disease.","NHLBI","8249365","3/23/2012 12:00:00 AM","PA-10-069","5R21HL104422-02","5","R21","HL","104422","02"," ","EU, JERRY PC","4/1/2011 12:00:00 AM","3/31/2013 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1859770","WOLTERS, PAUL J","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","125000","68125"," ","193125",
"Breast Cancer; Cancer","Address;Adherens Junction;Affect;Antibodies;Apoptosis;Binding;Biological;Biological Assay;Bone Morphogenetic Proteins;Breast;Breast Cancer Cell;Breast Carcinoma;Cancer Patient;Cancer cell line;Cell Migration Pathway;Cell Polarity;Cell Surface Receptors;Cell surface;Cells;Distant;E-Cadherin;Egtazic Acid;Epithelial;Epithelial Cells;Genes;Growth;Growth Factor;Human;In Vitro;Intercellular Junctions;Invaded;Ligands;Luciferases;Lung;Maintenance;Malignant Neoplasms;Mammary Tumorigenesis;Mediating;Mediator of activation protein;Membrane;Mesenchymal;Modeling;Monitor;Mus;Nature;Neoplasm Metastasis;Normal tissue morphology;Ovarian;Ovary;Pancreas;Pathway interactions;Patients;Phosphorylation;Play;Predisposition;Primary Neoplasm;Process;Production;Prostate;Proteins;Regulation;Reporter;Role;Signal Pathway;Signal Transduction;Site;Source;Staging;Structure;Survival Rate;Transforming Growth Factor beta Receptors;Transforming Growth Factors;Tumor Promoters;Tumor Suppressor Proteins;angiogenesis;anticancer research;base;basolateral membrane;cancer cell;cell growth;cell motility;epithelial to mesenchymal transition;in vivo;malignant breast neoplasm;mouse model;mutant;overexpression;polarized cell;promoter;receptor;tumor;tumor progression;tumorigenesis;wound","Role of TGF beta receptor III localization in breast cancer progression"," We have demonstrated that a cell surface receptor for the transforming growth factor-2 (TGF-2), the type III TGF-2 receptor (T2RIII), is able to suppress cancer progression in a broad spectrum of human cancers, including cancers of the breast, lung, ovary, pancreas and prostate, by decreasing the ability of the cancer cells to migrate, invade and spread to distant sites. As T2RIII can mediate these effects both through regulation of TGF-2 signaling as well as through TGF-2 signaling-independent mechanisms, a more precise understanding of the role of the T2RIII in mammary carcinogenesis is required to target both T2RIII and the TGF-2 signaling pathway for the treatment of human breast cancer.  
    

","NCI","8337521","8/1/2012 12:00:00 AM","PA-10-110","5F32CA157030-02","5","F32","CA","157030","02"," ","JAKOWLEW, SONIA B","9/30/2011 12:00:00 AM","9/29/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-E(20)L]"," ","10452031","MEYER, ALISON ","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","9/30/2012 12:00:00 AM","9/29/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","53942"," "," ","53942",
"Cancer; Clinical Research; Dental/Oral and Craniofacial Disease; Rare Diseases","Accounting;Aggressive behavior;Animal Model;Apoptotic;Behavior;Biological;Biological Markers;Biological Markers;Biology;Cancer Biology;Carcinoma;Cell Proliferation;Cell Survival;Cessation of life;Characteristics;Complex;Data;Development;Developmental Biology;Diagnosis;Disease;Embryonic Development;Ensure;Environment;Epithelial;Equilibrium;Family;Family member;Goals;Grant;Human;Immigration;Invaded;Knowledge;Laboratories;Ligands;Malignant Neoplasms;Malignant neoplasm of pancreas;Mediating;Mediator of activation protein;Mentorship;Mesenchymal;Modeling;Molecular;Mouth Neoplasms;Mus;Neoplasm Metastasis;Neural Crest;Neuroblastoma;Neurotrophic Tyrosine Kinase Receptor Type 2;Oral cavity;Pathogenesis;Patients;Phenotype;Physiologic Neovascularization;Play;Predictive Value;Process;Public Health;Receptor Protein-Tyrosine Kinases;Research;Research Personnel;Research Proposals;Research Training;Resistance;Resources;Role;Scientist;Signal Transduction;Stem cells;System;Testing;Training Programs;Tumor Biology;Tumor Cell Invasion;Tumor-Derived;United States;Up-Regulation;Work;adverse outcome;base;career;career development;epithelial to mesenchymal transition;experience;imaging modality;innovation;insight;malignant mouth neoplasm;migration;mouth squamous cell carcinoma;neoplastic cell;novel;overexpression;programs;public health relevance;receptor;research study;skills;success;therapeutic target;therapy resistant;tumor;tumor progression","Critical Role of TrkB for Invasion and Metastasis of Oral Cancer","n/a","NIDCR","8286070","6/13/2012 12:00:00 AM","PA-06-512","5K08DE019185-04","5","K08","DE","019185","04"," ","KING, LYNN M","7/1/2009 12:00:00 AM","6/30/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","9163623","KUPFERMAN, MICHAEL ","Not Applicable","09","SURGERY","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","100000","8000"," ","108000",
"Cancer","AKT inhibition;Accounting;Address;Adhesions;Affect;Aneuploidy;Apoptosis;Architecture;Attention;Automobile Driving;Back;Behavior;Binding;Carcinoma;Cell Cycle Arrest;Cell Line;Cell physiology;Cells;Chromosomal translocation;Clinical;Complex;Cytogenetics;Data;Disease;Distant;Environment;Epithelial;Etiology;Family;Goals;Growth;Heterogeneity;Histology;Human;Human Cell Line;Immigration;In Vitro;Induction of Apoptosis;Intermediate Filaments;Investigation;Karyotype;Knowledge;Laboratories;Learning;Lung;Malignant - descriptor;Malignant Fibrous Histiocytoma;Malignant Neoplasms;Mesenchymal;Modeling;Molecular;Molecular Profiling;Mus;Neoplasm Metastasis;Outcome;Pathway interactions;Patients;Phosphorylation;Phosphotransferases;Preclinical Testing;Process;Property;Proto-Oncogene Proteins c-akt;Recurrence;Regulation;Research;Resistance;Role;Sampling;Secondary to;Signal Pathway;Signal Transduction;Structural Protein;Therapeutic;Tissues;Translating;Tumor Markers;Undifferentiated;Vimentin;Xenograft Model;Xenograft procedure;abstracting;base;cancer cell;cell motility;epithelial to mesenchymal transition;fibrosarcoma;improved;in vivo;interest;leiomyosarcoma;migration;mouse model;neoplastic cell;novel;novel therapeutic intervention;outcome forecast;pre-clinical;protein kinase C kinase;sarcoma;soft tissue;stem;treatment center;tumor;tumorigenic","AKT-Vimentin interaction; a potential role in soft tissue sarcoma progression and","
Project Narrative
Soft tissue sarcoma is a form of malignancy that occurs anywhere in the body and is
ultimately lethal to approximately 50% of those afflicted, usually secondary to
uncontrollable local or distant tumor recurrence especially in the subset of complex
Karyotype high grade pleomorphic sarcomas. The process of dissemination is not
adequately controlled due to our lack of knowledge of pertinent molecular pathways
driving the proliferation and dissemination of this disease. This research focuses on one
such pathway which appears to be particularly active in soft tissue sarcoma (the AKT
regulation of vimentin expression and function) which may ultimately prove to be
relevant as a potential point of soft tissue sarcoma therapeutic vulnerability.","NCI","8249120","4/11/2012 12:00:00 AM","PA-07-070","5R01CA138345-04","5","R01","CA","138345","04"," ","AULT, GRACE S","7/1/2009 12:00:00 AM","4/30/2014 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1886387","BARELI, MENASHE ","Not Applicable","09","BIOLOGY","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","108689"," ","309964",
"Genetics; Hematology; Regenerative Medicine; Transplantation","Address;Adipocytes;Adult;Architecture;Atrophic;Biological Models;Blood;Bone Marrow;Bone Marrow Transplantation;Cancer Patient;Cell Communication;Cell Line;Cell Maintenance;Cell physiology;Cell surface;Cells;Characteristics;Chondrocytes;Clinical;Coculture Techniques;Development;Disease;Engraftment;Epithelial;Exhibits;Fluorescence;Gene Expression;Genes;Genetically Engineered Mouse;Growth;Hematological Disease;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;Histones;Homeostasis;Human;Immune;Immune system;In Vitro;Infection;Injection of therapeutic agent;Integrins;Kidney;Label;Lead;Life;Location;Maintenance;Malignant - descriptor;Malignant Neoplasms;Maps;Mesenchymal;Mesenchymal Stem Cells;Minority-Serving Institution;Morbidity - disease rate;Mouse Strains;Natural regeneration;Non-Malignant;Nude Mice;Operative Surgical Procedures;Osteoblasts;Patients;Phenotype;Population;Population Heterogeneity;Productivity;Property;Proteins;Puberty;Publications;Recovery;Recruitment Activity;Relapse;Reporter;Research;Research Personnel;Role;Signal Pathway;Signal Transduction;Skin;Sorting - Cell Movement;Stem Cell Factor;Stem cell transplant;Stem cells;Structure;Students;T-Cell Development;T-Lymphocyte;TACSTD2 gene;Testing;Thymic Tissue;Thymic epithelial cell;Thymus Gland;Time;Tissues;Training;Transgenic Mice;Transgenic Model;Translations;Transplantation;United States National Institutes of Health;adaptive immunity;adult stem cell;base;bone;cancer therapy;capsule;design;fighting;functional loss;immune function;improved;in vivo;inhibitor/antagonist;mouse model;novel;pluripotency;postnatal;premature;progenitor;reconstitution;response;self-renewal;stem cell population;treatment strategy","Development and Maintenance of Thymic Epithelial Microenvironments"," In paradox to the critical importance of the thymus in the development of T cells required for adaptive immunity, the thymus undergoes profound atrophy relatively early in life. Thymic degeneration is evident starting at puberty in humans and contributes to a significant loss of T cell function and the capacity to fight infection. Bone marrw transplants, while potentially curative for many forms of cancer and non-malignant blood disorders, often result in potentially lethal infections and malignant relapse, due to a prolonged loss of T cell function resulting from damage to the thymus induced by pre-transplant therapies. This study addresses a critical unmet clinical need to enhance thymic reconstitution through the identification of adult stem cells capable of reforming functional thymic tissue that may be used in treatment strategies to both minimize damage and hasten recovery of thymic function following BMT or other cytoablative therapies.   
      

","NIAID","8338776","8/9/2012 12:00:00 AM","PAR-08-026","9SC1AI104994-05","9","SC1","AI","104994","05"," ","PRABHUDAS, MERCY R","8/15/2012 12:00:00 AM","7/31/2016 12:00:00 AM","ZGM1-MBRS-9(SC)"," ","6514194","PEZZANO, MARK ","Not Applicable","10","BIOLOGY","603503991","L952KGDMSLV5","603503991","L952KGDMSLV5","US","40.818677","-73.950702","1605017","CITY COLLEGE OF NEW YORK","NEW YORK","NY","SCHOOLS OF ARTS AND SCIENCES","100367207","UNITED STATES","N","8/15/2012 12:00:00 AM","7/31/2013 12:00:00 AM","859","Other Research-Related","2012"," "," ","NIGMS","250000","132500"," ","382500",
"Cancer; Contraception/Reproduction; Hematology; Pediatric; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adult;Biochemistry;Blood Cells;Cells;Commit;Conceptus;Core-Binding Factor;Development;Embryo;Endothelial Cells;Endothelium;Erinaceidae;Erythroid;Erythropoiesis;Event;Fetal Development;Fetus;Goals;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;In Vitro;Labyrinth;Mesenchymal;Mus;Myelogenous;Names;Placenta;Principal Investigator;Research;Resource Sharing;Signal Transduction;Site;Source;Stem cells;To specify;Zebrafish;allantois;cell type;granulocyte;leukemia virus;progenitor;programs;stem;transcription factor;virus core","Biochemistry of Leukemia Virus Core Binding Factor","n/a","NHLBI","8197838","11/17/2011 12:00:00 AM","PA-07-070","5R01HL091724-19","5","R01","HL","091724","19"," ","BAI, C BRIAN","8/10/1993 12:00:00 AM","3/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-HEME-B(02)M]"," ","1870514","SPECK, NANCY ","Not Applicable","03","ANATOMY/CELL BIOLOGY","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","12/1/2011 12:00:00 AM","3/31/2013 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","142313"," ","389813",
"Cancer","Actins;Adhesions;Affect;Biochemical;Bundling;Bypass;Cell Communication;Cell Culture System;Cell-Matrix Junction;Cells;Characteristics;Clinical;Clinical Data;Collaborations;Cytoskeleton;Data;Databases;Development;Disease;Distal;Extracellular Matrix;Fibroblasts;Funding;Goals;Homing;Human;In Vitro;Integrins;Lead;Link;Malignant Neoplasms;Mechanics;Mesenchymal;Modification;Molecular;Play;Process;Property;Protein-Lysine 6-Oxidase;Proteins;Proteomics;Regulation;Renal Cell Carcinoma;Renal carcinoma;Research Personnel;Resources;Role;Sampling;Signal Pathway;Signal Transduction;Site;Stretching;Stromal Cells;Stromal Change;Stromal Neoplasm;Structure;System;Testing;Time;Tissues;Tumor Cell Invasion;Up-Regulation;cancer cell;clinically relevant;crosslink;in vivo;neoplastic cell;novel therapeutic intervention;outcome forecast;paracrine;periostin;permissiveness;physical property;prevent;stem;tumor;tumor progression;tumorigenesis;tumorigenic","3D-Adhesion Stromagenesis in Cancer Permissiveness","  Results stemming from this study will facilitate uncovering some of the mechanisms responsible for the tumor fueling vicious cycle which maintains stroma activation and in turn incites tumor progression. The study will emphasize the clinical relevance of assessing the progression of mesenchymal stroma, and it could reveal possible targets to prevent stroma progression and consequently stall tumorigenesis.   
      

","NCI","8292558","4/12/2012 12:00:00 AM","PA-10-067","2R01CA113451-06A1","2","R01","CA","113451","06","A","MOHLA, SURESH","7/1/2006 12:00:00 AM","3/31/2017 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","7852640","CUKIERMAN, EDNA ","Not Applicable","02","Unavailable","064367329","FF1XVJMDYVR1","064367329","FF1XVJMDYVR1","US","40.066764","-75.092751","1190002","RESEARCH INST OF FOX CHASE CAN CTR","PHILADELPHIA","PA","Research Institutes","191112434","UNITED STATES","N","4/12/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","137882","107893"," ","245775",
"Biotechnology; Breast Cancer; Cancer; Clinical Research; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Affect;Applications Grants;Behavior;Biological Assay;Biological Markers;Bone Marrow;Breast Cancer Cell;Cancer Patient;Cancer cell line;Cause of Death;Cells;Cessation of life;Chemicals;Coculture Techniques;Collection;Data Set;Development;Drug Kinetics;Estrogen Receptors;Future;Gene Expression;Gene Expression Profile;Genes;Goals;Growth;Home environment;Human;Immunohistochemistry;In Vitro;Interferon Activation;Interferon Type I;Interferons;Label;Luciferases;Malignant Neoplasms;Mammary Neoplasms;Measures;Mentorship;Mesenchymal Stem Cells;Meta-Analysis;Molecular Profiling;NOD/SCID mouse;Neoplasm Metastasis;Pathway Analysis;Pathway interactions;Patients;Pharmaceutical Preparations;Physicians;Predictive Value;Property;RANTES;RNA Interference;Research;Reverse Transcriptase Polymerase Chain Reaction;Sampling;Scientist;Signal Transduction;Site;Slide;Specimen;Staging;Testing;Tissue Microarray;Training;Tumor-Derived;United States;Wound Healing;Xenograft Model;career development;cell motility;chemokine;in vivo;inhibitor/antagonist;knock-down;laser capture microdissection;mRNA Expression;malignant breast neoplasm;migration;mortality;novel;overexpression;protein expression;small molecule;transcription factor;tumor;tumor growth","Targeting Metastasis Induced by Mesenchymal Stem Cells in the Tumor Stroma","
PROJECT NARRATIVE
The purpose of this grant application is to support my career development activities towards a highly trained
independent physician-scientist. Metastasis is the major cause of death from breast cancer and with the
mentorship of experts of the field I will undergo training and conduct research on how breast cancer cells
acquire metastatic properties under the influence of certain non-cancerous cells that surround them. We will
also investigate whether that metastatic acquisition can be blocked by targeted chemicals opening the
possibility of developing drugs against breast cancer metastasis.","NCI","8335484","8/20/2012 12:00:00 AM","PA-10-059","5K08CA158149-02","5","K08","CA","158149","02"," ","JAKOWLEW, SONIA B","9/20/2011 12:00:00 AM","8/31/2016 12:00:00 AM","Transition to Independence Study Section (I)[NCI-I]"," ","10522717","CHATTOPADHYAY, SHRIKANTA ","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","164829","13186"," ","178015",
"Bioengineering; Biotechnology; Genetics","Animals;Attenuated;Biological Assay;Biomechanics;Bone Resorption;Bone remodeling;Cell Line;Cell model;Cells;Collaborations;Data;Dissection;Down-Regulation;ERG gene;Equilibrium;Event;Exercise;Felis catus;Frequencies;Gene Expression Profile;Gene Expression Regulation;Gene Silencing;Gene Targeting;Generations;Genes;Goals;Grant;Guanosine Triphosphate Phosphohydrolases;Hand;Harvest;Hour;In Vitro;Knockout Mice;Laboratories;MAPK3 gene;Marrow;Mature Bone;Measurable;Mechanical Stimulation;Mechanics;Membrane Lipids;Membrane Microdomains;Mesenchymal Stem Cells;Microarray Analysis;Molecular;Mus;Nature;Nitric Oxide;Nuclear Translocation;Osteoblasts;Osteogenesis;Pathway interactions;Pattern;Phenotype;Positioning Attribute;Process;Publishing;Regulation;Role;Signal Pathway;Signal Transduction;Skeleton;Small Interfering RNA;Speed;Stromal Cells;TNFSF11 gene;Testing;Time;Transgenic Mice;Tumor necrosis factor receptor 11b;WISP1 gene;Work;authority;bone;bone cell;caveolin 1;cellular targeting;design;experience;fluid flow;in vivo;insight;instrumentation;knock-down;mouse model;novel;osteoblast differentiation;osteoclastogenesis;promoter;research study;response;skeletal;tool","Biophysical Regulation of Bone Remodeling","
Narrative for Rubin grant:
The role of exercise to generate a functionally sufficient skeleton involves control of the
differentiation of mesenchymal stem cells along the osteoblast lineage. The signaling cascades
initiated by mechanical stimulation of bone cells confer a cellular phenotype that is both anti-
catabolic and pro-anabolic. Work proposed here seeks to understand the loading induced signals
and responses that result in this phenotype, thereby bringing novel insights into the mechanisms
by which the loaded response is generated.","NIAMS","8287697","6/28/2012 12:00:00 AM","PA-07-070","5R01AR042360-16","5","R01","AR","042360","16"," ","SHARROCK, WILLIAM J","6/1/1993 12:00:00 AM","6/30/2014 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1897246","RUBIN, JANET E","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","192456","92379"," ","284835",
"Diabetes; Nutrition; Obesity; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adipocytes;Adipose tissue;Animals;Applications Grants;Biology;Blood Vessels;Body fat;CCAAT-Enhancer-Binding Proteins;Cardiovascular Diseases;Cells;Data;Developmental Process;Diabetes Mellitus;Diet;Dominant-Negative Mutation;FABP4 gene;Fatty Acids;Fatty acid glycerol esters;Funding;Genetic;Genetic Transcription;Glucose;Goals;Health;Hyperplasia;Hypertrophy;Immune Sera;Insulin;Laboratories;Lipids;Malignant Neoplasms;Marrow;Measurement;Mediating;Medical;Mesenchymal;Mesenchymal Stem Cells;Metabolic;Metabolism;Modeling;Molecular;Multipotent Stem Cells;Mus;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Osteoblasts;Osteocalcin;Pathway interactions;Peroxisome Proliferator-Activated Receptors;Physiological;Process;Proteins;Recycling;Regulation;Research;Resistance;Risk;Role;Series;Serum;Signal Pathway;Signal Transduction;Systems Biology;Testing;Transgenic Mice;Translations;Triglycerides;United States;Visceral;Weight Gain;Work;adipocyte differentiation;adiponectin;base;bone mass;extracellular;farmer;glucose metabolism;human FABP4 protein;human FRAP1 protein;human FZD4 protein;in vivo;inhibitor/antagonist;insight;lipid biosynthesis;lipid metabolism;mTOR protein;member;novel;progenitor;programs;promoter;receptor;research study;substantia spongiosa","Roles for Wnt signaling in adipose tissue","
Project Narrative
Obesity and weight gain are associated with diabetes and many other medical problems
including cardiovascular disease and certain cancers. Obesity is characterized by an
increase in adipose tissue due to increase in size of existing fat cells, and recruitment of
new progenitors. Wnt signaling is involved in both of these processes; however, the
mechanisms are not well understood. Thus, the proposed research will provide
important insights into adipocyte and whole body metabolism, and potentially provide
insight into the medical problems of obesity and type II diabetes, two major health risks
in the United States.","NIDDK","8284216","5/17/2012 12:00:00 AM","PA-07-070","5R01DK062876-09","5","R01","DK","062876","09"," ","HAFT, CAROL R","2/1/2003 12:00:00 AM","6/30/2014 12:00:00 AM","Cellular Aspects of Diabetes and Obesity Study Section[CADO]"," ","1888062","MACDOUGALD, ORMOND A","Not Applicable","12","PHYSIOLOGY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","230324","117995"," ","348319",
"Biotechnology; Cancer; Dental/Oral and Craniofacial Disease; Genetics; Osteoporosis; Regenerative Medicine; Transplantation","Address;Adjuvant;Adjuvant Therapy;Adult;Affect;Allografting;American;Animal Model;Autologous Transplantation;Biocompatible Materials;Biological Markers;Bone Tissue;Bone Transplantation;Calvaria;Cancer Patient;Cell Transplants;Cells;Child;Cicatrix;Collaborations;Collagen;Congenital Abnormality;Data;Defect;Diagnosis;Disease;Femur;Fibrosis;Foreign Bodies;Foreign-Body Reaction;Fracture;Gene Deletion;Gene Expression;Genetic;Genetic Models;Genetic Recombination;Head;Healed;Histology;Hormones;Image;Immunologist;Inflammation;Inflammatory;Injury;Isogenic transplantation;Knowledge;Life;Malignant Neoplasms;Mediating;Mesenchymal;Mesenchymal Stem Cells;Messenger RNA;Modeling;Mus;Musculoskeletal;Natural regeneration;Nature;Operative Surgical Procedures;Oral;Oral cavity;Osteoblasts;Osteogenesis;Osteoporosis;Parathyroid gland;Patients;Periosteal Cell;Periosteum;Pharmaceutical Preparations;Phase;Placebos;Process;Recombinants;Reconstructive Surgical Procedures;Recruitment Activity;Refractory;Risk;Role;Scientist;Signal Transduction;Site;Stromal Cells;Surface;Systemic Therapy;TNFSF11 gene;Tamoxifen;Teriparatide;Testing;Tissue Engineering;Tissues;Transcript;Transgenic Mice;Transplantation;Trauma;Undifferentiated;Vascular Endothelial Growth Factors;Vascularization;abstracting;angiogenesis;base;bone;bone loss;bone morphogenetic protein 2;cancer surgery;cell type;cellular targeting;craniofacial;craniofacial complex;craniomaxillofacial;gain of function;graft healing;healing;hormone therapy;intramembranous bone formation;loss of function;malignant mouth neoplasm;mouse model;osteogenic;osteoprogenitor cell;preclinical study;prevent;programs;recombinase;reconstruction;regenerative;repaired;response;skeletogenesis;success;vasculogenesis","PTH Effects of Craniofacial Allografts","
Project Narrative
Although approximately 100,000 bone grafts are performed each year to regenerated bone lost due to
trauma or disease that are craniomaxillofacial in nature, the long-term results of these reconstructions
are poor due to the overwhelming tissue fibrosis and scarring that occurs following surgery. This
inflammatory, foreign body response to the grafted biomaterial remains one of the great challenges
in treating patients with birth defects, traumatic injuries or cancers in the head and mouth. Recently,
we have observed remarkable effects of the osteoporosis drug teriparatide (recombinant parathyroid
hormone, PTH) in treating patients with fracture non-unions and animal models of bone grafting, in
which the drug appears to resolve the fibrotic tissue and prevent the foreign body reaction. Here we
propose to formally demonstrate that PTH has these effects and could be used as an adjuvant
therapy during craniomaxillofacial reconstructive surgery.","NIDCR","8522518","8/24/2012 12:00:00 AM","RFA-DE-09-001","3R01DE019902-04S1","3","R01","DE","019902","04","S","LUMELSKY, NADYA L","6/15/2009 12:00:00 AM","5/31/2014 12:00:00 AM","ZDE1-RW(11)"," ","1939533","SCHWARZ, EDWARD M.","GAZIT, DAN ","25","ORTHOPEDICS","041294109","F27KDXZMF9Y8","041294109","F27KDXZMF9Y8","US","43.16888","-77.615939","7047101","UNIVERSITY OF ROCHESTER","ROCHESTER","NY","SCHOOL OF MEDICINE & DENTISTRY","146270140","UNITED STATES","N","9/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","245180","40875"," ","286055",
"Bioengineering; Biotechnology; Cancer; Regenerative Medicine","1-Carboxyglutamic Acid;Academia;Amino Acids;Automobile Driving;Basic Science;Behavior;Biocompatible Coated Materials;Biocompatible Materials;Biological Assay;Biological Availability;Biotechnology;Blood capillaries;Buffers;Caliber;Catheters;Cell Survival;Cells;Charge;Chronic;Complex;Data;Disease;Drug Delivery Systems;Drug Formulations;Electrostatics;Encapsulated;Face;Family;Family member;Gel;Government;Heavy Metals;Hereditary Disease;Hydrogels;Hydrogen Bonding;Hydrophobicity;Industry;Injectable;Injection of therapeutic agent;Intramuscular Injections;Ionic Strengths;Ions;Length;Life;Manuscripts;Mechanics;Mesenchymal Stem Cells;Metalloproteases;Methods;Molecular;Mus;Needles;Neutrons;Peptide Conformation;Peptides;Physiological;Play;Property;Proteins;Prunella vulgaris;Publishing;RNA;Recovery;Relative (related person);Saline;Sodium Chloride;Solutions;Spatial Distribution;Spectrum Analysis;Structure;Subcutaneous Injections;Syringes;Temperature;Therapeutic;Therapeutic Agents;Tissue Engineering;Transmission Electron Microscopy;Viscosity;Water;Weight;Width;Work;Wound Healing;Zinc;aqueous;base;beta pleated sheet;capillary;clinical application;crosslink;design;enantiomer;experience;hydrophilicity;implantation;interest;intravenous injection;nanoscale;novel;response;self assembly;small molecule;surgery material;tool","Design and Utility of Novel Proteinaceous Biomaterials","n/a","NCI","8553098"," "," ","1ZIABC011313-03","1","ZIA","BC","011313","03"," "," "," "," "," "," ","11592582","SCHNEIDER, JOEL ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","1286913",
"Biotechnology; Osteoporosis; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Affect;Age;Area;Atrophic;Attention;BMP2 gene;Biological;Blood Circulation;Blood Vessels;Bone Density;Bone Marrow;Bone Regeneration;Bone remodeling;Cell Therapy;Cell Transplants;Cells;Clinical;Clinical Research;Complex;Coupling;Data;Defect;Development;Disease;Economic Burden;Ectopic Expression;Engineering;Fracture;Genetic Engineering;Growth Factor;Healed;Healthcare;Home environment;Homing;Impaired wound healing;Injury;Integrins;Lead;Long-Term Effects;Lung;Mediating;Mesenchymal Stem Cells;Methods;Modality;Modeling;Molecular Medicine;Morbidity - disease rate;Multiple Fractures;Musculoskeletal System;Natural regeneration;Nature;Osteoblasts;Osteogenesis;Osteoporosis;Outcome Study;Pathology;Patients;Peripheral;Population;Recombinants;Regenerative Medicine;Role;Signal Pathway;Signal Transduction;Skeleton;Source;Stem cells;Stimulus;Testing;Therapeutic;Tissues;Transplantation;Treatment Efficacy;United States;Vascular Endothelial Growth Factors;Vascular blood supply;Vascular remodeling;angiogenesis;bone;bone healing;bone morphogenetic protein 2;effective therapy;healing;hypoxia inducible factor 1;improved;in vivo;mouse model;novel;novel therapeutic intervention;osteogenic;overexpression;pre-clinical;preclinical study;progenitor;regenerative;self-renewal;skeletal;stem cell therapy;tissue regeneration;tissue repair;treatment strategy","Targeted Stem Cell Therapy Coupling Angiogenesis and Osteogenesis for Bone Defect","  A major problem in skeletal defects is non-union of bone fractures. The potential of bone marrow- derived mesenchymal stem cells (MSC) in regenerative medicine is increasingly gaining attention especially for diseases affecting the skeleton since MSC are the progenitor cells for bone-forming osteoblasts, and bone is the natural niche for MSC in the body. Thus, development of strategies to optimally use MSC should realize their potential in non-union bone defects, which are difficult to treat.  
  
    

","NIAMS","8293090","8/30/2012 12:00:00 AM","PA-10-067","5R01AR060948-02","5","R01","AR","060948","02"," ","WANG, FEI","9/1/2011 12:00:00 AM","8/31/2016 12:00:00 AM","Gene and Drug Delivery Systems Study Section[GDD]"," ","6379862","PONNAZHAGAN, SELVARANGAN ","Not Applicable","07","PATHOLOGY","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","SCHOOLS OF MEDICINE","352940001","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","104625"," ","329625",
"Bioengineering; Biotechnology; Dental/Oral and Craniofacial Disease; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Alginates;American;Biochemical;Biocompatible Materials;Biological Assay;Biopolymers;Bone Marrow;Bone Morphogenetic Proteins;Bone Regeneration;Bone Tissue;Cell Count;Cells;Cephalic;Charge;Clinical;Collagen;Communities;Congenital Abnormality;Connective Tissue;Cues;Defect;Development;Dextrans;Disease;Effectiveness;Encapsulated;Engineering;Environment;Excision;Exhibits;Gene Expression;Gene Silencing;Genes;Goals;Green Fluorescent Proteins;Growth;Growth Factor;Healed;Human;Hydrogels;Implant;Injectable;Injury;Lead;Life;Location;Measures;Mechanics;Medicine;Mesenchymal Stem Cells;Messenger RNA;Natural regeneration;Nude Rats;Operative Surgical Procedures;Orthopedics;Osteogenesis;Pathway interactions;Polyethyleneimine;Polymers;Polysaccharides;Population;Proliferating;Proteins;RNA;RNA Interference;RNA Sequences;Reporter Genes;Research;Reverse Transcriptase Polymerase Chain Reaction;Ribonucleases;Signal Pathway;Site;Source;Staining method;Stains;Stem cells;Supplementation;System;Technology;Testing;Therapeutic;Time;Tissue Engineering;Tissues;Trauma;Work;base;bone;bone healing;bone morphogenetic protein 2;chordin;clinically relevant;craniofacial;design;dextran;effective therapy;healing;implantation;improved;in vivo;mineralization;novel;novel strategies;osteogenic;protein degradation;regenerative;repaired;response;scaffold;tissue regeneration","Controlled, Sustained Delivery of siRNA to hMSCs for Enhanced Bone Regeneration"," Treating bone defects incurred by mililons of Americans each year, especially those occurring in the craniofacial region, remains a significant chalenge to the orthopaedics community as there are few viable options for those that exhibit problematic healing. We propose to engineer biopolymer systems for the delivery of siRNA to mesenchymal stem cells to silence the expresion of bone morphogenetic protein (BMP) antagonists and thereby increase their osteogenic response. The results from this proposal will represent a significant advance for osteogenic tissue regeneration for healing bone defects, provide an increased understanding of stem cell diferentiation decision pathways, and lead to the development of a platform technology for the effective delivery of siRNA that may hold promise for many applications in regenerative and therapeutic medicine.    
      

","NIDCR","8521781","8/8/2012 12:00:00 AM","PA-10-009","1R56DE022376-01A1","1","R56","DE","022376","01","A","LUMELSKY, NADYA L","8/9/2012 12:00:00 AM","7/31/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","8482366","ALSBERG, EBEN ","Not Applicable","11","BIOMEDICAL ENGINEERING","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","BIOMED ENGR/COL ENGR/ENGR STA","441061712","UNITED STATES","N","8/9/2012 12:00:00 AM","7/31/2014 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","225000","120969"," ","345969",
"Autoimmune Disease; Crohn's Disease; Digestive Diseases; Inflammatory Bowel Disease","Abdominal Pain;Acute;Affect;Anchorage-Independent Growth;Animal Model;Antigens;Apoptosis;Area;Binding;Biological Process;Blood Vessels;Body Weight Changes;Cell Adhesion;Cell Line;Cell Proliferation;Cells;Chemicals;Chronic;Citrobacter rodentium;Clinical;Clinical Data;Co-Immunoprecipitations;Colitis;Colon;Colorectal;Colorectal Cancer;Complementary DNA;Complex;Data;Defect;Development;Epithelial;Epithelial Cells;Epithelium;Feces;Fistula;Genetic;Guanine;Guanine Nucleotide Exchange Factors;Healed;Heart;Homeostasis;Immune system;Impaired wound healing;In Vitro;Infection;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Injury;Intestines;Link;Maps;Mesenchymal;Modeling;Molecular;Molecular Analysis;Monitor;Mucous Membrane;Mus;Nature;Oxidative Stress;Pathogenesis;Pathology;Pathway interactions;Patients;Phenotype;Phosphoric Monoester Hydrolases;Physicians;Play;Process;Protein phosphatase;Proteins;RNA;Research Personnel;Resistance;Rho-associated kinase;Risk;Role;Sampling;Scientist;Severities;Severity of illness;Signal Pathway;Signal Transduction;Sodium Dextran Sulfate;Surface;Testing;Tight Junctions;Tissues;Trauma;United States;Wound Healing;Yeasts;cancer cell;carcinogenesis;cell growth;cell motility;corneal epithelium;epithelial to mesenchymal transition;experience;healing;human disease;in vivo;injury and repair;intestinal epithelium;knock-down;microorganism;migration;pathogen;prevent;programs;repaired;research study;response to injury;yeast two hybrid system","The Role of BVES in Intestinal Repair Programs and Inflammatory Bowel Disease","n/a","NIDDK","8453603","9/18/2012 12:00:00 AM","PA-11-110","1F30DK096718-01A1","1","F30","DK","096718","01","A","PODSKALNY, JUDITH M,","9/18/2012 12:00:00 AM","9/17/2016 12:00:00 AM","ZDK1-GRB-2(O1)S"," ","10637946","PARANG, BOBAK ","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","9/18/2012 12:00:00 AM","9/17/2013 12:00:00 AM","847","Training, Individual","2012"," "," ","NIDDK","26232"," "," ","26232",
"Breast Cancer; Cancer; Clinical Research","Accounting;Affect;Binding Proteins;Biochemical;Biological Models;CDK2 gene;Cancer Patient;Cell Cycle Checkpoint;Cell Cycle Proteins;Cells;Cessation of life;Cleaved cell;Clinic;Cyclin E;Cytoplasm;Development;Diagnosis;ERBB2 gene;Effectiveness;Elastases;Epithelial;Epithelial Cells;Estrogen Antagonists;Estrogen Receptors;Event;Funding;Generations;Goals;Human;Laboratories;Lead;Length;Link;Maintenance;Malignant Neoplasms;Mammary Neoplasms;Mammary Tumorigenesis;Mammary gland;Mediating;Mesenchymal;Molecular;Molecular Weight;Neoplasm Metastasis;Oncogenes;Outcome;Pathway interactions;Patients;Phenotype;Phosphotransferases;Physiological;Population;Process;Progesterone Receptors;Protein Isoforms;Proteins;Proteolytic Processing;Recurrence;Relative (related person);Research;Resistance;Role;Signal Pathway;Signal Transduction Pathway;System;Testing;Therapeutic;Time;Transgenic Animals;Transgenic Mice;Translating;Woman;Work;attenuation;cancer initiation;cancer therapy;clinically relevant;design;effective therapy;epithelial to mesenchymal transition;in vivo;innovation;malignant breast neoplasm;mammary epithelium;mouse model;neoplastic cell;new therapeutic target;novel;outcome forecast;overexpression;pre-clinical;programs;public health relevance;treatment strategy;triple-negative invasive breast carcinoma;tumor;tumor initiation;tumor progression;tumorigenesis","Proeolytic Processing of Cyclin E in Breast Cancer","
Project Narrative: The information gained through the proposed studies could have tremendous clinical
relevance for patients with triple negative breast cancer. We already know that LMW-E expression correlates
with poor TNBC patient outcome; elucidating how the LMW-E expression can also alter the cytoplasmic signal
transduction pathways which could then lead to EMT and tumorigenesis, will open novel avenues of cancer
therapy that can take advantage of treatment strategies targeting LMW-E. As such, a targeted and
personalized therapy can be justified for those patients who currently do not have such treatment strategies
available to them.","NCI","8207212","11/16/2011 12:00:00 AM","PA-10-067","5R01CA087548-11","5","R01","CA","087548","11"," ","HILDESHEIM, JEFFREY","8/1/2001 12:00:00 AM","11/30/2015 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","1859727","KEYOMARSI, KHANDAN ","Not Applicable","09","RADIATION-DIAGNOSTIC/ONCOLOGY","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","181340","105177"," ","286517",
"Breast Cancer; Cancer; Genetics; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Animals;Antineoplastic Agents;Apoptosis;Appearance;Area;Back;Behavior;Biological;Breast Cancer Cell;Cells;Chimeric Proteins;Connective Tissue;Distant;Distant Metastasis;Embryo;Embryonic Development;Epithelial;Epithelial Cells;Event;Fatty acid glycerol esters;Gene Proteins;Genes;Growth;Health;Heart;Implant;Knock-in Mouse;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Mammary gland;Manuscripts;Mesenchymal;Micrometastasis;Minority;Mouse Strains;Mus;Natural regeneration;Nature;Neoplasm Metastasis;Neoplastic Epithelial Cell;Normal Cell;Normal tissue morphology;Population;Primary Neoplasm;Process;Proliferating;Publications;Reagent;Research;Resistance;Screening procedure;Seeds;Series;Signal Transduction;Site;Snails;Stem cells;Tamoxifen;Testing;Text;Tissues;Tumor Stem Cells;Work;anticancer research;cancer cell;cancer stem cell;cell motility;empowered;epithelial to mesenchymal transition;experience;implantation;mortality;neoplastic cell;novel;programs;regenerative;research study;self-renewal;slug;success;telomerase reverse transcriptase;trait;transcription factor;transdifferentiation;tumor;tumor progression;tumorigenic","Catalytic Subunit of the Telomerase Gene Hest2","
Project Narrative
 While being responsible for ~90% of cancer related mortality, the process of cancer-cell metastasis
remains poorly understood; many of its steps are now being revealed by studying cell-biological changes that
occur during early embryonic development. These changes also impart to cancer cells an ability to regenerate
themselves, yielding ""cancer stem cells"" that can seed new tumors. The ability to produce large numbers of
such cancer stem cells, as described in the proposed research, may present an opportunity to develop novel
anti-cancer drugs that are able to eliminate tumors by eliminating the stem cells that allow tumors to grow back
after initially successful treatments.","NCI","8196876","11/17/2011 12:00:00 AM","PA-07-070","5R01CA078461-13","5","R01","CA","078461","13"," ","MOHLA, SURESH","9/30/1999 12:00:00 AM","11/30/2013 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1891586","WEINBERG, ROBERT A","Not Applicable","07","Unavailable","120989983","JVKKKWN2N5N3","120989983","JVKKKWN2N5N3","US","42.363304","-71.087734","1742101","WHITEHEAD INSTITUTE FOR BIOMEDICAL RES","CAMBRIDGE","MA","Research Institutes","021421025","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","271155","257597"," ","528752",
"Cancer; Colo-Rectal Cancer; Digestive Diseases","Adenocarcinoma Cell;Alternative Splicing;Animal Model;Azoxymethane;CD44 gene;Carcinogens;Cell Differentiation process;Cell Line;Cells;Colon;Colon Adenocarcinoma;Colon Carcinoma;Colonic Neoplasms;Colorectal Cancer;Colorectal Neoplasms;Data;Diagnostic Neoplasm Staging;Differentiation Antigens;Differentiation and Growth;Distant;E-Cadherin;Enterocytes;Epithelial;Epithelial Cells;Equilibrium;Gastrointestinal tract structure;Genes;Genetic Transcription;Goals;Growth;HCT116 Cells;Human;Immunocompromised Host;Intestines;Maintenance;Malignant Neoplasms;Mediating;Mesenchymal;Mus;Natural regeneration;Neoplasm Metastasis;Oncogenic;Organ;PTK6 gene;Patients;Phenotype;Phosphotransferases;Play;Property;Protein Isoforms;Protein Tyrosine Kinase;Proteins;Proto-Oncogene Proteins c-akt;RNA Binding;RNA-Binding Proteins;Rectal Adenocarcinoma;Regulation;Reporting;Resistance;Role;SRC-associated p68 protein;STAT3 gene;Sampling;Signal Transduction;Staging;Survival Rate;Testing;Tissue Microarray;Tissues;Tumor Cell Line;Tumor stage;Vimentin;Xenograft Model;cancer cell;cancer initiation;cell motility;colon cancer cell line;epithelial to mesenchymal transition;human protein tyrosine kinase brk;in vivo;intestinal epithelium;lymph nodes;neoplastic cell;overexpression;therapeutic target;transcription factor;tumor;tumor initiation;tumor progression;tumorigenesis","Functions of Protein Tyrosine Kinase 6 in the Gastrointestinal Tract"," PTK6 is a tyrosine kinase that is expressed in the gastrointestinal tract where it regulates normal growth and differentiation, but recent studies indicate that it also contributes to colon tumorigenesis. Colon cancers become deadly after they undergo the epithelial mesenchymal transition (EMT) and metastasize, and the goal of this study is to understand functions of PTK6 in maintaining the epithelial phenotype of colon tumor cells. The proposed studies will clarify the roles for PTK6 in regulating the EMT and colon tumor metastases, and will allow us to determine if PTK6 should be targeted in colon cancer.   
      

","NIDDK","8294285","3/15/2012 12:00:00 AM","PA-10-067","2R01DK044525-18","2","R01","DK","044525","18"," ","HAMILTON, FRANK A","5/1/1993 12:00:00 AM","3/31/2017 12:00:00 AM","Clinical, Integrative and Molecular Gastroenterology Study Section[CIMG]"," ","1877184","TYNER, ANGELA L","Not Applicable","07","BIOCHEMISTRY","098987217","W8XEAJDKMXH3","098987217","W8XEAJDKMXH3","US","41.880316","-87.687597","577703","UNIVERSITY OF ILLINOIS AT CHICAGO","Chicago","IL","SCHOOLS OF MEDICINE","606124305","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","123283"," ","340783",
"Kidney Disease; Organ Transplantation; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Allografting;Animal Model;Anti-Inflammatory Agents;Anti-inflammatory;Aspirate substance;Autoimmune Diseases;Autologous;Bioinformatics;Biological Markers;Biopsy;Bone Marrow;Clinical Trials;Cytokine Suppression;Data;Data Analyses;Data Set;Dendritic Cells;Development;Diabetes Mellitus;Dialysis procedure;Dose;Event;Experimental Models;Fibrosis;Frequencies;Genomics;Goals;Growth Factor;Heart Transplantation;Human;Hypertension;Immune response;Immunosuppression;Immunosuppressive Agents;Infiltration;Inflammatory;Injury;Instruction;Interferon Type II;Interleukin-10;Interleukin-2;Ischemia;Kidney Failure;Kidney Transplantation;Macaca fascicularis;Machine Learning;Mesenchymal Stem Cells;Modeling;Mus;Musculoskeletal;Natural regeneration;Necrosis;Obesity;Organ Transplantation;Outcome;Outcome Measure;Papio;Population;Predictive Value;Preparation;Prevalence;Production;Property;Protocols documentation;Regimen;Reperfusion Injury;Reporting;Reproducibility;Sample Size;Sampling;Schedule;Signal Transduction;Skin;Source;T cell regulation;T-Lymphocyte;Testing;The Sun;TimeLine;Tissues;Transforming Growth Factor beta;Transplantation;Vascular Endothelial Growth Factors;bone morphogenetic protein 7;clinical application;comparative efficacy;design;efficacy testing;functional outcomes;graft vs host disease;improved;islet;islet allograft;kidney allograft;monocyte;neutrophil;nonhuman primate;novel;pandemic disease;peripheral blood;pre-clinical;predictive modeling;prevent;primary outcome;progenitor;programs;regenerative;repaired;response;secondary outcome;statistics;symposium;tumor","Mesenchymal stem cell enhancement of organ allograft repair and long term surviva","RELEVANCE (See instructions): 
 
With the pandemic of obesity, renal failure, increasing in prevalence due to the increasing obesity-related rates of diabetes and hypertension, and the need for kidney transplants are increasing. Despite improvements in renal transplant sun/ival, long-term transplant loss is a serious problem requiring additional transplants or return to dialysis. Mesenchymal stem cells may be able to prevent graft loss by suppressing the body's immune responses and providing nourishing, regenerative signals to the transplanted kidney.","NIAID","8379591","7/20/2012 12:00:00 AM","PAR-10-271","5P01AI089556-02","5","P01","AI","089556","02"," "," "," "," ","ZAI1-MFH-I","6129","2785335","BARTHOLOMEW, AMELIA M.","Not Applicable","27","Unavailable","052780918","F8THLJQSAF93","052780918","F8THLJQSAF93","US","25.775337","-80.209809","5221250","UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","CORAL GABLES","FL","Domestic Higher Education","331462926","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","871951","871951"," ","730692","141259"," "," ",
"No NIH Category available","Address;Behavior;Bioinformatics;Bone Marrow;Cells;DNA;DNA Methylation;Decitabine;Fibroblasts;Gene Expression;Germ-Free;Growth;Helicobacter;Human;Link;Malignant Neoplasms;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of liver;Malignant neoplasm of pancreas;Mesenchymal Stem Cells;Methylation;Molecular;Mus;Myofibroblast;Pancreas;Patients;Pattern;Phase I Clinical Trials;Physiological;Predisposition;Prevention;Primary carcinoma of the liver cells;Research Personnel;Role;Signal Transduction;Solid Neoplasm;Staging;TLR4 gene;Universities;Work;base;commensal microbes;human tissue;in vivo;malignant stomach neoplasm;microbiome;mouse model;programs;promoter;therapy design;tumor;tumor growth;tumor progression","Myofibroblasts in Gastrointestinal Cancers","This study will address the origins and importance of stromal fibroblasts in gastric cancer, liver cancer and pancreatic cancer with a particular focus on the role of commensal bacteria, DNA methylation and the origins of stromal fibroblasts. Understanding how cancer fibroblasts arise and the ways in which they contribute to the growth of tumors will clarify the utility and proper design of therapies targeted to the stroma.","NCI","8337299","8/31/2012 12:00:00 AM","RFA-CA-10-021","5U54CA163111-02","5","U54","CA","163111","02"," ","MOHLA, SURESH","9/22/2011 12:00:00 AM","7/31/2016 12:00:00 AM","ZCA1-SRLB-3(O1)"," ","1873597","WANG, TIMOTHY CRAGIN","Not Applicable","13","PATHOLOGY","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","SCHOOLS OF MEDICINE","100323725","UNITED STATES","N","9/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","397","Research Centers","2012"," "," ","NCI","315113","189068"," ","504181",
"Cancer; Prevention","American;Apical;Basic Science;Behavior;Biological Models;Cancer Etiology;Carcinoma;Cell Differentiation process;Cell Polarity;Cell-Cell Adhesion;Cells;Cellular Morphology;Characteristics;Defect;Disseminated Malignant Neoplasm;Embryo;Endocytosis;Epithelial;Epithelial Cells;Goals;Individual;Invaded;Investigation;Lead;Left;Ligands;Malignant - descriptor;Malignant Neoplasms;Mediating;Mesenchymal;Mind;Molecular;Morbidity - disease rate;Morphogenesis;Neoplasm Metastasis;Organ;Organogenesis;Pharmaceutical Preparations;Phenocopy;Play;Process;Property;Proteins;Protocols documentation;Radiation;Research;Role;Sensory;Series;Signal Pathway;Signal Transduction;Site;Therapeutic;Tissues;Zebrafish;abstracting;base;cell fate specification;lateral line;malformation;mortality;mutant;neoplastic cell;notch protein;novel therapeutics;prevent;stem cell division;therapy design;tumor;ubiquitin-protein ligase","Investigation of the role of Mind bomb in epithelial morphogenesis","
Project Narrative
Metastasis is a series of process that tumor cells lose their stationary epithelial characteristics and
acquire migratory mesenchymal characteristics. More than 500,000 Americans lost their lives to
metastatic cancer in 2008. Understanding the molecular mechanisms for the acquisition of highly
invasive characteristics will contribute to developing therapeutic protocols for preventing and
treating cancers.","NICHD","8479467","8/27/2012 12:00:00 AM","PA-11-197","4R00HD062561-02","4","R00","HD","062561","02"," ","JAVOIS, LORETTE CLAIRE","9/1/2010 12:00:00 AM","6/30/2013 12:00:00 AM","NSS"," ","9710938","MATSUDA, MIHO ","Not Applicable","10","ANATOMY/CELL BIOLOGY","623946217"," ","623946217"," ","US","40.738771","-74.190235","714201","UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL","NEWARK","NJ","SCHOOLS OF MEDICINE","071032757","UNITED STATES","N","9/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","134438","79318"," ","213756",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","3-Dimensional;Address;Animal Model;Blood;Blood Cells;Blood Vessels;Bone Marrow;Cell Communication;Cell Culture System;Cells;Complement;Cues;Development;Disease;Drops;Extracellular Matrix;Hematopoiesis;Hematopoietic stem cells;Human;Human Biology;Hybrids;In Vitro;Individual;Lead;Location;Mesenchymal Stem Cells;Microfluidics;Modeling;Normal tissue morphology;Organ;Osteoblasts;Pathology;Patients;Phenotype;Play;Preclinical Drug Evaluation;Process;Production;Published Comment;Rodent Model;Role;Stem cells;Structure;System;Techniques;Technology;Therapeutic;Time;Tissues;base;cell assembly;cell associated matrix;cell type;design;hematopoietic tissue;improved;in vitro Model;in vivo;insight;osteoprogenitor cell;reconstitution;stem cell differentiation;stem cell niche;success;three-dimensional modeling;tool","Building the Hematopoietic Stem Cell Niche","
PROJECT NARRATIVE
The production of blood cells (hematopoiesis) is a continuous, critical activity of stem cell
in the body, and its dysregulation has severe repercussions. This project will lead to a
better understanding of this process by developing new culture models of human
hematopoiesis, and it is expected these models will provide insight on current therapies
using blood stem cells, could lead to the production of human blood cells that could be
used to treat patients, and may also improve our understanding of diseases involving
blood cell production.","NIBIB","8328560","6/20/2012 12:00:00 AM","RFA-HL-11-025","5R01EB014703-02","5","R01","EB","014703","02"," ","HUNZIKER, ROSEMARIE","9/15/2011 12:00:00 AM","7/31/2015 12:00:00 AM","ZHL1-CSR-N(M1)"," ","8116883","MOONEY, DAVID J","SCADDEN, DAVID T; WEITZ, DAVID A; WESTERVELT, ROBERT M","05","NONE","082359691","LN53LCFJFL45","082359691","LN53LCFJFL45","US","42.373148","-71.118329","3212901","HARVARD UNIVERSITY","CAMBRIDGE","MA","BIOMED ENGR/COL ENGR/ENGR STA","021385319","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","527858","227319"," ","755177",
"Breast Cancer; Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Animals;B-Lymphocytes;Biology;Breast;CCL3 gene;CCL4 gene;CXCL12 gene;CXCL13 gene;Cells;Cessation of life;Clinic;Clinical;Clinical Trials;Cytotoxic Chemotherapy;Disease;Distant;ERBB2 gene;Environment;Epithelial;Equilibrium;Evaluation;Generations;Genes;Genetic Heterogeneity;Goals;Growth;Heterogeneity;Histology;Human;ITGAM gene;Immune;Immune Targeting;Immunity;Infiltration;Laboratories;Lead;Lung;Malignant - descriptor;Malignant Neoplasms;Mesenchymal;Microarray Analysis;Myelogenous;Myeloid Cells;Neoplasm Metastasis;Outcome;Patients;Phase;Phenotype;Play;Process;Property;Proteins;RANTES;Recruitment Activity;Recurrence;Regulatory T-Lymphocyte;Research;Research Personnel;Role;Sampling;Site;Stem cells;Subgroup;Suppressor-Effector T-Lymphocytes;T-Lymphocyte;Time;Translating;Treatment Efficacy;Tumor Cell Line;Tumor-Associated Process;United States;Woman;cDNA Arrays;cancer cell;cancer stem cell;chemokine;chemotherapy;cytokine;cytotoxic;epithelial to mesenchymal transition;immunoregulation;inhibitor/antagonist;macrophage;malignant breast neoplasm;monocyte;neoplastic cell;novel strategies;programs;small molecule;triple-negative invasive breast carcinoma;tumor;tumor eradication;tumor growth","Targeting the Infiltrating Immune Cells in Claudin-low and Basal-type Tumors","Breast cancer is the most common malignancy in women in the United States and the second leading cause 
of malignant death. We have found that a new subtype, claudin-low, are heavily infiltrated with immune cells, 
which are critical to the growth of these tumors. The current project seeks to understand how these immune 
cells regulate tumor growth and to target immune and tumor cells as a novel approach to therapy.","NCI","8389742","9/14/2012 12:00:00 AM","PAR-10-003","2P50CA058223-19A1","2","P50","CA","058223","19","A"," ","8/5/1997 12:00:00 AM","8/31/2017 12:00:00 AM","ZCA1-RPRB-0(M1)","6444","1865906","SERODY, JONATHAN S","Not Applicable","04","Unavailable","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","Domestic Higher Education","275995023","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","210435","210435"," ","210435","0"," "," ",
"Cancer; Dental/Oral and Craniofacial Disease; Prevention; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","AKT inhibition;Accounting;Acute;Animal Disease Models;Animal Model;Apoptosis;Attenuated;Bone Marrow;Bone Matrix;Bone Resorption;Bone Transplantation;Bone necrosis;Calcium Channel;Cell Differentiation process;Cell Survival;Cell Therapy;Cells;Chronic;Complication;Cytosol;Dental;Deposition;Endocytic Vesicle;Endocytosis;Enzymes;Extracellular Space;Goals;Healed;Human;In Vitro;Inflammation;Ions;Jaw;Label;Life;Link;Lipids;Liquid substance;Location;Lytic Metastatic Lesion;Malignant neoplasm of prostate;Measures;Mesenchymal Stem Cells;Mesoderm;Metastatic Neoplasm to the Bone;Modeling;Monomeric GTP-Binding Proteins;Multiple Myeloma;Necrosis;Neoplasm Metastasis;Neural Crest;Nitrogen;Operative Surgical Procedures;Oral;Osteoclasts;Osteoporosis;Outcome;Paget&apos;s Disease;Pathway interactions;Phase;Phosphorylation;Population;Preventive;Process;Production;Protein Isoprenylation;Proteins;Rattus;Relative (related person);Signal Pathway;Signaling Protein;Site;Specificity;Stem cells;Stromal Cells;Surrogate Markers;Transplantation;base;bisphosphonate;bone;bone turnover;cancer cell;cellular imaging;cofactor;cytotoxic;design;effective therapy;farnesyl pyrophosphate;geranylgeranyl pyrophosphate;healing;improved;in vivo;insight;isoprenoid;long bone;malignant breast neoplasm;mandible/maxilla;mevalonate;microbial;orofacial;osteogenic;osteoprogenitor cell;prenylation;prevent;rho;senescence;trafficking;tumor;uptake","Intracellular trafficking of Bisphosphonates in bone mesenchymal Stem Cells","  Bisphosphonate is an effective therapy for bone complications associated with cancer metastasis but a major complication is jaw bone necrosis. We want to understand how jaw bone stem cells readily succumb to effects of bisphosphonate so the complication of jaw necrosis can be prevented.                          
   
      

","NIDCR","8356486","8/29/2012 12:00:00 AM","PAR-11-083","1R21DE022826-01","1","R21","DE","022826","01"," ","WAN, JASON","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-K(80)S]"," ","7618421","AKINTOYE, SUNDAY O","Not Applicable","03","DENTISTRY","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF DENTISTRY/ORAL HYGN","191046205","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","150000","90000"," ","240000",
"Aging; Biotechnology; Cancer; Genetics","Accounting;Address;Aging;Antibodies;Biological;Biological Process;Biology;Buffers;Cells;Cellular biology;Coculture Techniques;Coupled;Data;Defect;Dermal;Dermatologic;Dermatology;Development;Disease;Doxycycline;EGF gene;Epidermis;Epithelial;Event;FGF7 gene;Feedback;Fibroblasts;Gene Expression;Gene Targeting;Goals;Growth;Hair;Hair follicle structure;Healthcare;Homeostasis;Human;Hyperplasia;Inflammatory;Knowledge;LATS2 gene;Malignant - descriptor;Malignant Neoplasms;Measures;Mediating;Mesenchymal;Messenger RNA;MicroRNAs;Mouse Cell Line;Nail plate;Neoplasm Metastasis;Office Visits;Pathologic;Pathway interactions;Patients;Pattern;Phorbol Esters;Play;Premalignant;Process;RNA;Regulation;Regulatory Element;Research;Role;Signal Pathway;Signal Transduction;Skin;Skin Aging;Skin Carcinogenesis;Small RNA;Solutions;System;Testing;Therapeutic;Therapeutic Intervention;Tissues;Transgenic Mice;Translating;Validation;Wound Healing;base;biological adaptation to stress;career;cell behavior;cell motility;epithelial to mesenchymal transition;folliculogenesis;in vivo;inhibitor/antagonist;insight;keratinocyte;mRNA Expression;malignant breast neoplasm;migration;mouse model;new technology;novel;novel therapeutic intervention;overexpression;prevent;promoter;repaired;response;self-renewal;skin disorder;stem cell biology;therapeutic target;tool","The role of microRNA miR-31 in skin biology","  The development of new therapeutic approaches has been invigorated by the discovery of small RNA molecules that can regulate gene expression and many important biological processes including all the major dermatological diseases. These small RNA molecules, called microRNAs, are formidable therapeutic targets and tools due to their size and mechanism of action. We have identified the microRNA miR-31 as potential prime candidate for therapeutic interventions due to its expression pattern, impact on events in the skin such as hair growth, its association with skin carcinogenesis, skin aging, and aberrant growth in many inflammatory disorders.    
    

","NIAMS","8307326","6/4/2012 12:00:00 AM","PA-10-067","5R01AR061474-02","5","R01","AR","061474","02"," ","BAKER, CARL","8/1/2011 12:00:00 AM","5/31/2016 12:00:00 AM","Arthritis, Connective Tissue and Skin Study Section[ACTS]"," ","9459347","ANDL, THOMAS ","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","126000"," ","351000",
"Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Transplantation","Adult;Back;Bioinformatics;Cell Nucleus;Cell Transplantation;Cells;Clinical;Cloning;Data;Development;Epigenetic Process;Event;Gene Combinations;Gene Expression;Genes;Genetic;Genome;Hematopoietic;Human;Individual;Knock-in Mouse;Lead;Mesenchymal;Modeling;Modification;Myelogenous;Myeloid Cells;Oocytes;Patients;Phenotype;Process;Somatic Cell;Staging;System;Testing;Tissues;Trans-Activators;Undifferentiated;base;comparative;egg;embryonic stem cell;human embryonic stem cell;insight;novel;novel strategies;nuclear transfer;overexpression;pluripotency;regenerative therapy;research study;self-renewal","ES Cell-Specific Genes and Reprogramming of Human Somatic Cells","n/a","NIGMS","8381277","8/20/2012 12:00:00 AM","RFA-GM-08-003","5P01GM081629-05","5","P01","GM","081629","05"," "," ","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","ZGM1-GDB-8","0003","2096141","SLUKVIN, IGOR I.","Not Applicable","02","Unavailable","012420082","W6Q8XJV41Z98","012420082","W6Q8XJV41Z98","US","43.072813","-89.407457","10023197","MORGRIDGE INSTITUTE FOR RESEARCH, INC.","MADISON","WI","Research Institutes","537151119","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","387040","387040"," ","311517","75523"," "," ",
"Digestive Diseases","Address;Adhesions;Anatomy;Architecture;Automobile Driving;Cell Polarity;Cell Shape;Characteristics;Congenital Abnormality;DNA Sequence Rearrangement;Data;Development;Embryo;Endoderm;Endoderm Cell;Epithelial;Epithelium;Etiology;Event;Figs - dietary;Gastrocoele;Gastrointestinal Neoplasms;Gastrointestinal tract structure;Gene Expression;Gene Expression Profile;Homeostasis;Human;Individual;Intestines;Knowledge;Left;Life;Link;MAPK8 gene;Mediating;Mesenchymal;Modeling;Molecular;Morphogenesis;Organ;Pathway interactions;Pattern;Physiological;Play;Process;Radial;Reagent;Research;Rho-associated kinase;Role;Rotation;Side;Signal Transduction;Staging;Tissues;Tube;Work;Xenopus;Xenopus laevis;fascinate;gain of function;insight;intercalation;molecular asymmetry;novel;polarized cell;public health relevance;spatiotemporal;transcription factor","Pitx2 and Wnt/PCP signaling in left-right asymmetric gut morphogenesis","
Project Narrative
 The proposed work will illuminate the currently unknown etiology of common digestive
organ birth defects, such as intestinal malrotation, narrowing or occlusion of the digestive tract,
and congenital short bowel. The results of this research will also have significant, broad
implications for the interrelationship of Pitx2 and Wnt signaling in the morphogenesis of multiple
symmetric and asymmetric organs, and in the epithelial-mesenchymal transitions that drive
development, maintain gut epithelial homeostasis, and underlie metastatic progression in
tumors of the digestive and other epithelia.","NIDDK","8286415","6/7/2012 12:00:00 AM","PA-07-070","5R01DK085300-03","5","R01","DK","085300","03"," ","CARRINGTON, JILL L","7/1/2010 12:00:00 AM","6/30/2015 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","1928197","NASCONE-YODER, NANETTE M","Not Applicable","02","VETERINARY SCIENCES","042092122","U3NVH931QJJ3","042092122","U3NVH931QJJ3","US","35.832653","-78.645194","578204","NORTH CAROLINA STATE UNIVERSITY RALEIGH","RALEIGH","NC","SCHOOLS OF VETERINARY MEDICINE","276950001","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","215325","99464"," ","314789",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adverse effects;Autologous;BMP2 gene;Biological;Biological Models;Biomimetics;Bone Morphogenetic Proteins;Bone Regeneration;Bone Transplantation;Calvaria;Cells;Clinical;Complement;Cyst;Defect;Development;Dose;Down-Regulation;Elements;Employment;Environment;Epidermal Growth Factor;Exhibits;Feedback;Fracture;Goals;Gold;Growth Factor;Healed;In Vitro;Marrow;Mechanics;Mediating;Mesenchymal Stem Cells;Methods;Modality;Modeling;Morbidity - disease rate;Natural regeneration;Osteoblasts;Osteogenesis;Pathway interactions;Physiological;Proteins;RNA Interference;Research;Signal Transduction;Site;Small Interfering RNA;Spinal Fusion;Stem cells;System;Testing;Therapeutic;Tibial Fractures;Tissues;Transplanted tissue;Vesicle;Viral;base;bone;healing;in vivo;inhibitor/antagonist;long bone;maxillofacial;non-viral gene delivery;novel;osteoblast differentiation;osteogenic;osteoinductive factor;osteoprogenitor cell;polyarginine;protein expression;relating to nervous system;repaired;scaffold;uptake","Combined Effect of Noggin Suppression and Nell-1 on Bone Regeneration","  This research will contribute to the development of alternative therapeutic strategies that can effectively complement BMP activity in clinical situations where maximal bone regeneration is required.  
    

","NIAMS","8306999","6/29/2012 12:00:00 AM","PA-10-067","5R01AR060213-02","5","R01","AR","060213","02"," ","WANG, FEI","7/25/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","9370659","LEE, MIN ","Not Applicable","33","DENTISTRY","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","900952000","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","121500"," ","346500",
"Biotechnology; Cancer; Genetics; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Benign;Biological Process;Cancer Control;Cell Cycle;Cell Nucleus;Cells;Development;Diagnosis;Epigenetic Process;Event;Family;Functional RNA;Gene Expression;Gene Expression Regulation;Genes;Genetic Transcription;Genomics;Human;Instruction;Investigation;Malignant - descriptor;Malignant Neoplasms;Mediating;Mesenchymal Stem Cells;MicroRNAs;Normal Cell;Nuclear;Oncogenes;Pathway interactions;Process;Promoter Regions;Proteins;RNA;RNA Interference;RNA Processing;RNA chemical synthesis;Regulation;Role;Small RNA;Somatic Cell;Source;Staging;Stress;Testing;Transcriptional Regulation;Variant;cancer cell;embryonic stem cell;human DICER1 protein;in vivo;insight;malignant phenotype;neoplastic cell;overexpression;research study;response","Cancer and Gene Regulation by Non-coding RNAs","RELEVANCE (See Instructions): Decreases in miRNA regulation are commonly observed in malignant cells. This probably confers plasticity to cancer cells permitting a greater range of developmental states and more diverse responses to stresses. Integrating the current understanding of miRNA regulation into the chain of events in vivo that results in a malignant cell is important. A greater understanding of the roles in cancer of the large family of non-coding RNAs could provide new opportunities for diagnosis and treatment.","NCI","8299784","10/4/2012 10:38:41 AM","PAR-09-025","2P01CA042063-26A1","2","P01","CA","042063","26","A"," ","5/1/1997 12:00:00 AM","5/31/2017 12:00:00 AM","ZCA1-RPRB-O(J1)","6428","7355826","SHARP, PHILLIP A","Not Applicable","07","Unavailable","001425594","E2NYLCDML6V1","001425594","E2NYLCDML6V1","US","42.359476","-71.093853","4911501","MASSACHUSETTS INSTITUTE OF TECHNOLOGY","CAMBRIDGE","MA","Domestic Higher Education","021421029","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","818083","818083"," ","279981","538102"," "," ",
"Aging; Biotechnology; Clinical Research; Genetics; Human Genome; Osteoporosis","Adopted;Archives;Bioinformatics;Biometry;Bone Density;Bone Marrow;Bone Resorption;Candidate Disease Gene;Caucasians;Caucasoid Race;Cells;Clinical;Complex;DNA Microarray Chip;Diagnostic;Disease;Environmental Risk Factor;Ethnic group;Expressed Sequence Tags;Female;Future;Gender;Gene Expression Profile;Gene Proteins;Genes;Genetic;Genetic Polymorphism;Genome;Genomics;Genotype;Heritability;Human;Human Genome;Human Subject Research;Individual;Mediator of activation protein;Medical;Medicine;Mesenchymal Stem Cells;Messenger RNA;Metabolic Bone Diseases;Molecular;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis;Pathway interactions;Phenotype;Pilot Projects;Population;Preventive Intervention;Proteins;Proteome;Proteomics;Public Health;RUNX1 gene;Recruitment Activity;Risk;Sampling;Scanning;Specificity;Staging;Technology;Variant;Woman;base;bone;bone cell;design;functional genomics;gene discovery;gene function;high risk;insight;male;men;molecular marker;monocyte;nano;novel;novel strategies;peripheral blood;protein expression;success;therapeutic target;tool","Genomic Convergence for Female Osteoporosis Risk Genes","n/a","NIAMS","8537002","9/5/2012 12:00:00 AM","RFA-OD-06-003","3P50AR055081-06S1","3","P50","AR","055081","06","S","SHARROCK, WILLIAM J","9/7/2007 12:00:00 AM","7/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-HOP-U(40)R]"," ","6616034","DENG, HONG-WEN ","Not Applicable","01","BIOSTATISTICS & OTHER MATH SCI","053785812","XNY5ULPU8EN6","053785812","XNY5ULPU8EN6","US","29.935453","-90.123916","8424601","TULANE UNIVERSITY OF LOUISIANA","NEW ORLEANS","LA","SCHOOLS OF PUBLIC HEALTH","701185665","UNITED STATES","N","9/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Research Centers","2012"," "," ","NIAMS","99668","50332"," ","150000",
"Aging; Biotechnology; Clinical Research; Genetics; Human Genome; Osteoporosis","Adopted;Archives;Bioinformatics;Biometry;Bone Density;Bone Marrow;Bone Resorption;Candidate Disease Gene;Caucasians;Caucasoid Race;Cells;Clinical;Complex;DNA Microarray Chip;Diagnostic;Disease;Environmental Risk Factor;Ethnic group;Expressed Sequence Tags;Female;Future;Gender;Gene Expression Profile;Gene Proteins;Genes;Genetic;Genetic Polymorphism;Genome;Genomics;Genotype;Heritability;Human;Human Genome;Human Subject Research;Individual;Mediator of activation protein;Medical;Medicine;Mesenchymal Stem Cells;Messenger RNA;Metabolic Bone Diseases;Molecular;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis;Pathway interactions;Phenotype;Pilot Projects;Population;Preventive Intervention;Proteins;Proteome;Proteomics;Public Health;RUNX1 gene;Recruitment Activity;Risk;Sampling;Scanning;Specificity;Staging;Technology;Variant;Woman;base;bone;bone cell;design;functional genomics;gene discovery;gene function;high risk;insight;male;men;molecular marker;monocyte;nano;novel;novel strategies;peripheral blood;protein expression;success;therapeutic target;tool","Genomic Convergence for Female Osteoporosis Risk Genes","n/a","NIAMS","8537002","9/5/2012 12:00:00 AM","RFA-OD-06-003","3P50AR055081-06S1","3","P50","AR","055081","06","S","SHARROCK, WILLIAM J","9/7/2007 12:00:00 AM","7/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-HOP-U(40)R]"," ","6616034","DENG, HONG-WEN ","Not Applicable","01","BIOSTATISTICS & OTHER MATH SCI","053785812","XNY5ULPU8EN6","053785812","XNY5ULPU8EN6","US","29.935453","-90.123916","8424601","TULANE UNIVERSITY OF LOUISIANA","NEW ORLEANS","LA","SCHOOLS OF PUBLIC HEALTH","701185665","UNITED STATES","N","9/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Research Centers","2012"," "," ","OD","199335","100665"," ","300000",
"Aging; Bioengineering; Clinical Research; Nutrition; Osteoporosis; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Affect;Amino Acids;Animal Experimentation;Apoptosis;Apoptotic;Area;Award;Basic Science;Biology;Bone Marrow;CCAAT-Enhancer-Binding Protein-beta;Cell physiology;Cells;Cellular Stress;Chronic Disease;Clinical;Data;Data Analyses;Down-Regulation;Endocrinologist;Endoplasmic Reticulum;Environment;Exercise;Faculty;Fatty acid glycerol esters;Figs - dietary;Fracture Healing;Funding;Goals;Harvest;Health;Hydrogen Peroxide;In Vitro;International;Knowledge;Laboratories;Lead;Marrow;Mechanics;Mentors;Mentorship;Mesenchymal Stem Cells;Microscopy;Modeling;Molecular;Molecular Biology;Molecular Chaperones;Morbidity - disease rate;Mus;Obesity;Osteogenesis;Osteoporosis;Paraplegia;Physicians;Postmenopausal Osteoporosis;Process;Proteins;Regulation;Repression;Research;Research Personnel;Resistance;Risk;Role;Running;Scientist;Signal Transduction;Stretching;Techniques;Testing;Training;Tunicamycin;Work;Writing;aging population;analog;arm;base;bone;bone health;bone mass;bone strength;bone turnover;career;combat;endoplasmic reticulum stress;feeding;frailty;improved;in vivo;investigator training;lipid biosynthesis;meetings;mortality;novel;osteogenic;prevent;research study;resistant strain;response;skeletal;skills;stem cell differentiation;stem cell fate;stressor;substantia spongiosa;transcription factor","Role of C/EBPbeta in mechanical regulation of MSC potential"," Exercise-based therapies increase bone strength and offer non-pharmacologic strategies to combat osteoporosis, a condition which carries significant morbidity and mortality in our aging population. The goal of this proposal is to characterize the mechanisms by which exercise/ mechanical signals repress mesenchymal stem cell (MSC) adipogenesis, thus improving MSC potential for osteogenic differentiation and resistance to cellular stress.   
      

","NIAMS","8224427","3/27/2012 12:00:00 AM","PA-10-059","1K08AR062097-01","1","K08","AR","062097","01"," ","SHARROCK, WILLIAM J","4/1/2012 12:00:00 AM","6/30/2017 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","9161853","STYNER, MAYA SHALEV","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","4/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","112513","9001"," ","121514",
"Biotechnology; Cancer; Genetics; Lung; Lung Cancer; Prevention","Adult;Affect;Alleles;Animal Model;Animals;Apoptosis;Apoptotic;Applications Grants;Area;Biochemistry;Biological;Biological Assay;Biological Process;Biology;Cancer Control;Cell Proliferation;Cells;Cellular biology;Chromatin;Collaborations;Colon Carcinoma;Complex;Data;Development;Developmental Process;Diagnosis;Doxycycline;E2F1 gene;Embryonic Development;Family;Floor;Functional RNA;Funding;Gene Expression;Gene Expression Regulation;Gene Targeting;Genes;Genomics;Grant;Growth;Human;Institutes;Instruction;Investigation;Lead;Lentivirus Vector;Lung Neoplasms;Maintenance;Malignant Neoplasms;Malignant neoplasm of lung;Mediating;Mesenchymal;Mesenchymal Differentiation;Messenger RNA;Methods;MicroRNAs;Modeling;Molecular;Molecular Genetics;Mus;Mutant Strains Mice;Oncogenes;Pathway interactions;Performance;Play;Polycomb;Post-Translational Protein Processing;Process;Progress Reports;Proteins;RNA;RNA Sequences;Regulation;Research;Retinoblastoma Genes;Retinoblastoma Protein;Role;Screening procedure;Site;Small Interfering RNA;Small RNA;Syndrome;System;Technology;Testing;Therapeutic;Time;Tissues;Tumor Suppression;Tumor Suppressor Proteins;Work;base;chromatin modification;gain of function;gene function;in vivo;insight;loss of function;mouse model;mutant;nanoparticle;novel;osteosarcoma;programs;research study;small hairpin RNA;tumor;tumor progression;tumorigenesis;vector","Cancer and Gene Regulation by the pRB/E2F Pathway","RELEVANCE (See instructions): 
It is well established that cancer development involves disruption of the regulatory mechanisms that control cell proliferation, apoptosis and terminal differentiation. The pRb tumor suppressor plays a key role in each of these processes. This research is directed at understanding the mechanistic basis for pRb's biological roles and it has the potential to provide new opportunities for diagnosis and treatment.","NCI","8299786","10/4/2012 10:38:44 AM","PAR-09-025","2P01CA042063-26A1","2","P01","CA","042063","26","A"," ","5/1/1997 12:00:00 AM","5/31/2017 12:00:00 AM","ZCA1-RPRB-O(J1)","6430","1964403","LEES, JACQUELINE A.","Not Applicable","07","Unavailable","001425594","E2NYLCDML6V1","001425594","E2NYLCDML6V1","US","42.359476","-71.093853","4911501","MASSACHUSETTS INSTITUTE OF TECHNOLOGY","CAMBRIDGE","MA","Domestic Higher Education","021421029","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","238438","238438"," ","238438"," "," "," ",
"Biotechnology; Cancer; Dental/Oral and Craniofacial Disease; Genetics; Osteoporosis; Regenerative Medicine; Transplantation","Address;Adjuvant;Adjuvant Therapy;Adult;Affect;Allografting;American;Animal Model;Autologous Transplantation;Biocompatible Materials;Biological Markers;Bone Tissue;Bone Transplantation;Calvaria;Cancer Patient;Cell Transplants;Cells;Child;Cicatrix;Collaborations;Collagen;Congenital Abnormality;Data;Defect;Diagnosis;Disease;Femur;Fibrosis;Foreign Bodies;Foreign-Body Reaction;Fracture;Gene Deletion;Gene Expression;Genetic;Genetic Models;Genetic Recombination;Head;Healed;Histology;Hormones;Image;Immunologist;Inflammation;Inflammatory;Injury;Isogenic transplantation;Knowledge;Life;Malignant Neoplasms;Mediating;Mesenchymal;Mesenchymal Stem Cells;Messenger RNA;Modeling;Mus;Musculoskeletal;Natural regeneration;Nature;Operative Surgical Procedures;Oral;Oral cavity;Osteoblasts;Osteogenesis;Osteoporosis;Parathyroid gland;Patients;Periosteal Cell;Periosteum;Pharmaceutical Preparations;Phase;Placebos;Process;Recombinants;Reconstructive Surgical Procedures;Recruitment Activity;Refractory;Risk;Role;Scientist;Signal Transduction;Site;Stromal Cells;Surface;Systemic Therapy;TNFSF11 gene;Tamoxifen;Teriparatide;Testing;Tissue Engineering;Tissues;Transcript;Transgenic Mice;Transplantation;Trauma;Undifferentiated;Vascular Endothelial Growth Factors;Vascularization;abstracting;angiogenesis;base;bone;bone loss;bone morphogenetic protein 2;cancer surgery;cell type;cellular targeting;craniofacial;craniofacial complex;craniomaxillofacial;gain of function;graft healing;healing;hormone therapy;intramembranous bone formation;loss of function;malignant mouth neoplasm;mouse model;osteogenic;osteoprogenitor cell;preclinical study;prevent;programs;recombinase;reconstruction;regenerative;repaired;response;skeletogenesis;success;vasculogenesis","PTH Effects of Craniofacial Allografts","
Project Narrative
Although approximately 100,000 bone grafts are performed each year to regenerated bone lost due to
trauma or disease that are craniomaxillofacial in nature, the long-term results of these reconstructions
are poor due to the overwhelming tissue fibrosis and scarring that occurs following surgery. This
inflammatory, foreign body response to the grafted biomaterial remains one of the great challenges
in treating patients with birth defects, traumatic injuries or cancers in the head and mouth. Recently,
we have observed remarkable effects of the osteoporosis drug teriparatide (recombinant parathyroid
hormone, PTH) in treating patients with fracture non-unions and animal models of bone grafting, in
which the drug appears to resolve the fibrotic tissue and prevent the foreign body reaction. Here we
propose to formally demonstrate that PTH has these effects and could be used as an adjuvant
therapy during craniomaxillofacial reconstructive surgery.","NIDCR","8269970","5/23/2012 12:00:00 AM","RFA-DE-09-001","5R01DE019902-04","5","R01","DE","019902","04"," ","LUMELSKY, NADYA L","6/15/2009 12:00:00 AM","5/31/2014 12:00:00 AM","ZDE1-RW(11)"," ","1939533","SCHWARZ, EDWARD M.","GAZIT, DAN ","25","ORTHOPEDICS","041294109","F27KDXZMF9Y8","041294109","F27KDXZMF9Y8","US","43.16888","-77.615939","7047101","UNIVERSITY OF ROCHESTER","ROCHESTER","NY","SCHOOL OF MEDICINE & DENTISTRY","146270140","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","289436","61595"," ","351031",
"Bioengineering; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adult;Cell Differentiation process;Cell secretion;Coculture Techniques;Complex;Cues;Development;Developmental Biology;Dose;Embryo;Embryonic Development;Engineering;Environment;Failure;Figs - dietary;Future;Goals;Growth Factor;Healed;In Vitro;Individual;Knock-out;Knowledge;Lead;Ligaments;Maintenance;Mechanical Stimulation;Mechanics;Mesenchymal Stem Cells;Modeling;Morbidity - disease rate;Motivation;Mus;Muscle;Muscle Cells;Muscle Fibers;Myoblasts;Natural regeneration;Operative Surgical Procedures;Outcome;Outcome Study;Outcomes Research;Patients;Play;Process;Production;Public Health;Role;Rupture;Schedule;Signal Transduction;Site;Staging;Stem cells;System;Tendon structure;Time;Tissue Engineering;Tissues;Transforming Growth Factors;Translating;Work;base;growth differentiation factor 5;healing;in vivo;injured;innovation;novel;progenitor;reconstruction;repaired;scaffold;stem;tissue regeneration","Identification of Muscle-Derived Soluble and Mechanical Cues to Direct Differenti","
Project Narrative
This proposal is highly relevant to the improvement of public health as we envision that
in the long-term, successful outcomes will enable innovative and efficient approaches to
regenerating functional tendon. Thus, millions of patients that undergo surgical
procedures for the repair or reconstruction of such tissues will ultimately benefit from this
work.","NIAMS","8265942","4/13/2012 12:00:00 AM","PAR-09-031","5R03AR061036-02","5","R03","AR","061036","02"," ","WANG, FEI","4/1/2011 12:00:00 AM","3/31/2014 12:00:00 AM","ZAR1-EHB(M1)"," ","9345044","KUO, CATHERINE K.","Not Applicable","07","ENGINEERING (ALL TYPES)","073134835","WL9FLBRVPJJ7","073134835","WL9FLBRVPJJ7","US","42.423895","-71.1092","8422701","TUFTS UNIVERSITY MEDFORD","Boston","MA","BIOMED ENGR/COL ENGR/ENGR STA","021111817","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","50000","23206"," ","73206",
"Biotechnology; Cardiovascular; Diagnostic Radiology; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Area;Biology;Bone Marrow Cell Transplantation;Bone Marrow Stem Cell;Cardiac;Cell Adhesion Molecules;Cell Survival;Cell Therapy;Cell Transplantation;Cell Transplants;Cells;Clinical;Clinical Management;Clinical Trials;Decision Making;Disease;Echocardiography;Engraftment;Environment;Future;Goals;Heart Diseases;Histologic;Image;Imaging Techniques;Individual;Integrins;Investigation;Left;Mesenchymal Stem Cells;Metabolism;Modeling;Molecular Target;Myocardial;Myocardial Infarction;Myocardium;Natural regeneration;Nuclear;Patient Selection;Perfusion;Play;Protocols documentation;Rattus;Residual state;Role;Signaling Molecule;Stem cells;Testing;Therapeutic;Time;Tissues;Transplantation;Treatment Efficacy;Up-Regulation;Wit;Work;base;cell type;design;functional improvement;functional outcomes;improved;injured;innovation;insight;molecular imaging;novel strategies;public health relevance;regenerative;repaired;stem cell therapy;success;therapy outcome","Imaging of the Myocardial Microenvironment to Facilitate Stem Cell Engraftment","
Project Narrative / Relevance
 Cardiac stem cell therapy is condsidered to be a very promising approach for repair of damaged
myocardium, but the benefit in clinical trials is currently still variable. In this proposal, molecular imaging
techniques are introduced which aim at improving cell therapy by providing information about myocardial
microenvironmental conditions which are most suitable for stem cell engraftment. Such biologic imaging
strategies have the potential to guide individual therapeutic decisions, and are thus highly relevant to optimize
the benefit of stem cell therapy in the clinical management of heart disease.","NHLBI","8527319","9/6/2012 12:00:00 AM","PA-07-070","3R01HL092985-03S2","3","R01","HL","092985","03","S","ADHIKARI, BISHOW B","1/15/2010 12:00:00 AM","12/31/2014 12:00:00 AM","Medical Imaging Study Section[MEDI]"," ","8742846","ABRAHAM, MARIA ROSELLE","WAHL, RICHARD LEO","07","RADIATION-DIAGNOSTIC/ONCOLOGY","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","9/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","16088","10296"," ","26384",
"Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adult;Affect;Biological Markers;Biology;Blood;Bone Marrow;Cell Aging;Cell Cycle;Cells;Characteristics;Dental;Dentin;Disease;Doxycycline;Employee Strikes;Exhibits;Genetic;Homeostasis;Human;Immunohistochemistry;In Situ Hybridization;Incisor;Intestines;Label;Lead;Life;Location;Maintenance;Mesenchymal Stem Cells;Modeling;Molar tooth;Morphogenesis;Mus;Odontoblasts;Pathway interactions;Pattern;Play;Population;Production;Reporter;Role;Series;Signal Pathway;Signal Transduction;Stem cells;Supernumerary Tooth;Techniques;Telomerase;Testing;Therapeutic;Tissues;Tooth structure;Transgenic Organisms;bone;cell type;embryonic stem cell;gain of function;genetic manipulation;improved;induced pluripotent stem cell;mouse model;postnatal;prevent;prospective;regenerative;self renewing cell;self-renewal;stem cell population;tissue regeneration;tool","The role of mTert-expressing stem cells in tooth formation and renewal"," A lack of definitive dental stem cell markers has hampered our understanding of the self- renewal and differentiation potential of these cells as well as thei prospective role in tissue regeneration. We have developed a unique mouse model that allows us to investigate the role of telomerase-expressing stem cells in tooth biology. Results from this study will identify and functionally characterize a discrete population of dental stem cells which may ultimately lead to improved therapeutic treatment options for diseases affecting teeth.   
      

","NIDCR","8386043","9/3/2012 12:00:00 AM","PA-11-261","1R21DE022420-01A1","1","R21","DE","022420","01","A","LUMELSKY, NADYA L","9/3/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-A(02)M]"," ","8640716","CARLONE, DIANA LYNN","Not Applicable","07","Unavailable","076593722","Z1L9F1MM1RY3","076593722","Z1L9F1MM1RY3","US","42.340629","-71.094923","1504801","BOSTON CHILDREN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021155724","UNITED STATES","N","9/3/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","150000","111000"," ","261000",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Adipose tissue;Affinity;Allogenic;Animal Model;Aspirate substance;Attention;Autologous;Bacteriophages;Binding;Biocompatible;Biocompatible Materials;Biological;Bone Marrow;Bone Morphogenetic Proteins;Bone Transplantation;Cell Count;Cells;Chemistry;Clinic;Clinical;Clinical Trials;Collagen;Defect;Dose;Filler;Frequencies;Goals;Growth Factor;Healed;Implant;In Vitro;Libraries;Life;Link;Liquid substance;Marketing;Mature Bone;Mesenchymal Stem Cells;Modeling;Oryctolagus cuniculus;Osteogenesis;Outcome;Peptides;Phage Display;Phase;Phenotype;Process;Production;Proteins;Radial;Running;Safety;Signaling Molecule;Site;Specificity;Stem cells;Sterilization;Technology;Testing;Therapeutic;Therapeutic Effect;Tissues;Treatment Efficacy;biomaterial compatibility;bone;bone healing;bone morphogenetic protein 2;bone morphogenetic protein 6;bone morphogenetic protein 7;cell growth;cell type;comparative efficacy;cost;cost effective;healing;improved;manufacturing process;manufacturing scale-up;medical implant;osteogenic;programs;protein aminoacid sequence;prototype;research study;scaffold;scale up","Peptide conjugation for Co-Delivery of Growth Factors and Stem Cells"," Stem cells and growth factors provide valuable therapies for a variety of indications, and co-delivery of stem cells with growth factors produces a greater therapeutic effect than delivery of either stem cells or growth factors alone. In this application, we propose to develop a biomaterial that can bind and retain both growth factors and stem cells.  
    

","NIGMS","8250588","6/29/2012 12:00:00 AM","PA-11-096","2R44GM077753-04","2","R44","GM","077753","04"," ","COLE, ALISON E","9/1/2006 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-IMST-M(13)B]"," ","8613208","NAIR, SHRIKUMAR AMBUJAKSHAN","Not Applicable","04","Unavailable","078296854","YJQ6K1QMS488","078296854","YJQ6K1QMS488","US","35.366248","-79.429394","10031812","AFFINERGY, LLC","DURHAM","NC","Domestic For-Profits","277094650","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","859","SBIR/STTR","2012"," "," ","NIGMS"," "," "," ","747725",
"Biotechnology; Cardiovascular; Diagnostic Radiology; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Area;Biology;Bone Marrow Cell Transplantation;Bone Marrow Stem Cell;Cardiac;Cell Adhesion Molecules;Cell Survival;Cell Therapy;Cell Transplantation;Cell Transplants;Cells;Clinical;Clinical Management;Clinical Trials;Decision Making;Disease;Echocardiography;Engraftment;Environment;Future;Goals;Heart Diseases;Histologic;Image;Imaging Techniques;Individual;Integrins;Investigation;Left;Mesenchymal Stem Cells;Metabolism;Modeling;Molecular Target;Myocardial;Myocardial Infarction;Myocardium;Natural regeneration;Nuclear;Patient Selection;Perfusion;Play;Protocols documentation;Rattus;Residual state;Role;Signaling Molecule;Stem cells;Testing;Therapeutic;Time;Tissues;Transplantation;Treatment Efficacy;Up-Regulation;Wit;Work;base;cell type;design;functional improvement;functional outcomes;improved;injured;innovation;insight;molecular imaging;novel strategies;public health relevance;regenerative;repaired;stem cell therapy;success;therapy outcome","Imaging of the Myocardial Microenvironment to Facilitate Stem Cell Engraftment","
Project Narrative / Relevance
 Cardiac stem cell therapy is condsidered to be a very promising approach for repair of damaged
myocardium, but the benefit in clinical trials is currently still variable. In this proposal, molecular imaging
techniques are introduced which aim at improving cell therapy by providing information about myocardial
microenvironmental conditions which are most suitable for stem cell engraftment. Such biologic imaging
strategies have the potential to guide individual therapeutic decisions, and are thus highly relevant to optimize
the benefit of stem cell therapy in the clinical management of heart disease.","NHLBI","8207204","12/22/2011 12:00:00 AM","PA-07-070","5R01HL092985-03","5","R01","HL","092985","03"," ","ADHIKARI, BISHOW B","1/15/2010 12:00:00 AM","12/31/2014 12:00:00 AM","Medical Imaging Study Section[MEDI]"," ","8742846","ABRAHAM, MARIA ROSELLE","WAHL, RICHARD LEO","07","RADIATION-DIAGNOSTIC/ONCOLOGY","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","301496","187667"," ","489163",
"Bioengineering; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute;Address;Adipose tissue;Affinity;Animal Model;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Apoptosis;Attenuated;Autologous;Autologous Transplantation;Binding;Blood Vessels;Bone Marrow;Burn injury;Cell Transplants;Cells;Cellular Infiltration;Cessation of life;Chemistry;Chronic;Clinical;Collagen;Cultured Cells;Deposition;Dermal;Dermis;Devices;Diabetes Mellitus;Extracellular Matrix;Family suidae;Fibroblasts;Goals;Granulation Tissue;Growth Factor;Harvest;Healed;Healthcare Systems;Histology;Hospitalization;Hypertrophic Cicatrix;Immune;Immune response;Implant;Infection;Infiltration;Inflammation;Inflammatory Response;Left;Life;Link;Marketing;Measures;Mechanics;Medical;Mesenchymal Stem Cells;Operative Surgical Procedures;Outcome;Pain;Patients;Peptides;Phage Display;Pharmaceutical Preparations;Phase;Phenotype;Procedures;Process;Property;Proteins;Relative (related person);Reporting;Risk;Safety;Screening procedure;Skin;Skin Substitutes;Societies;Specificity;Stem cells;Surgical sutures;Tensile Strength;Testing;Time;Tissues;Treatment Efficacy;Varicose Ulcer;Vascularization;Wound Healing;attenuation;biomaterial compatibility;burn therapy;cost;foot;healing;implantation;improved;in vivo;meetings;mortality;neovascularization;point of care;pre-clinical;protein aminoacid sequence;prototype;research study;success;wound","Peptide-coated skin substitutes for the treatment of burn injuries and wounds","n/a","NIGMS","8312066","6/29/2012 12:00:00 AM","PA-11-096","1R43GM101759-01","1","R43","GM","101759","01"," ","COLE, ALISON E","7/1/2012 12:00:00 AM","9/14/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-T(12)B]"," ","9809509","LAMB, BRUCE ","Not Applicable","04","Unavailable","078296854","YJQ6K1QMS488","078296854","YJQ6K1QMS488","US","35.366248","-79.429394","10031812","AFFINERGY, LLC","DURHAM","NC","Domestic For-Profits","277094650","UNITED STATES","N","7/1/2012 12:00:00 AM","9/14/2014 12:00:00 AM","859","SBIR/STTR","2012"," "," ","NIGMS"," "," "," ","306524",
"Bioengineering; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Adherent Culture;Adipocytes;Apoptosis;Arthritis;Back;Behavior;Biocompatible Materials;Biological Assay;Biomedical Engineering;Cardiac;Cell Proliferation;Cell Survival;Cell Transplants;Cells;Chondrocytes;Data;Defect;Development;Developmental Biology;Dyes;Encapsulated;Engineering;Goals;Healed;Home environment;Human;Human Activities;Hydrogels;Image;Implant;In Vitro;Joints;Label;Lead;Ligaments;Mechanics;Mesenchymal Stem Cells;Metabolism;Methods;Microscopic;Modality;Molecular;Mus;Muscle;Musculoskeletal;Natural regeneration;Neurons;Nude Rats;Organ;Osteoblasts;Outcome Assessment;Pancreas;Photobleaching;Population;Proliferating;Proteins;Quantum Dots;Rattus;Regenerative Medicine;Relative (related person);SCID Mice;Signal Transduction;Stem cells;System;Tail;Technology;Tendon structure;Testing;Time;Tissue Engineering;Tissues;Veins;Wound Healing;bone;cytotoxicity;healing;improved;in vivo;osteochondral tissue;public health relevance;response;scaffold;tissue regeneration;tool","Tracking stem cells in engineered tissue and organs in vivo and in real time","
Project Narrative:
This project has the potential to demonstrate a viable method for labeling stem
cells and tracking the development of regenerating tissue in vivo and in real time.
It also has a potential to contribute to our understanding of the engineered
osteochondral interface that is of critical value in bioengineered replacement of
arthritic joints.","NIBIB","8319267","8/20/2012 12:00:00 AM","PAR-06-504","5R01EB009663-04","5","R01","EB","009663","04"," ","HUNZIKER, ROSEMARIE","9/15/2009 12:00:00 AM","8/31/2014 12:00:00 AM","ZEB1-OSR-D(M1)S"," ","1866984","MAO, JEREMY J","Not Applicable","13","DENTISTRY","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","SCHOOLS OF DENTISTRY/ORAL HYGN","100323725","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","348477","199338"," ","547815",
"Aging; Arthritis; Bioengineering; Biotechnology; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","3-Dimensional;Adipose tissue;Adult;Affect;Age;Anatomy;Architecture;Arthritis;Biochemical;Biocompatible Materials;Biological;Biological Assay;Biological Availability;Biology;Bioreactors;Blood Circulation;Bone Marrow;Bone necrosis;Cartilage;Catabolism;Cells;Chondrocytes;Complex;Degenerative polyarthritis;Development;Dimensions;Disease;Effector Cell;Endothelium;Evaluation;Exposure to;Future;Health;Histocompatibility Testing;Histologic;Housing;Image;In Vitro;Individual;Inflammation;Inflammatory;Injury;Investigation;Joints;Lesion;Maintenance;Mechanics;Mesenchymal Stem Cells;Modality;Modeling;Molecular;Monitor;Osteolysis;Osteopenia;Outcome;Pathogenesis;Perfusion;Pharmaceutical Preparations;Phenotype;Physiological;Population;Printing;Readiness;Reporter;Role;Safety;Sampling;Simulate;Source;Structure;Synovial Membrane;System;Technology;Testing;Therapeutic;Tissues;Toxicology;adult stem cell;articular cartilage;base;bone;bone quality;culture plates;cytokine;design;design and construction;improved;in vitro Model;microsystems;osteochondral tissue;osteogenic;promoter;response;scaffold","3-D Osteochondral Micro-tissue to Model Pathogenesis of Osteoarthritis"," Osteoarthritis, a degenerative joint disease that affects up to 15% of adults, is initiated by degeneration of the articular cartilage that covers the joint surfac. Development of disease modifying drugs for osteoarthritis requires a clear understanding of the underlying mechanisms, responsible for the failed interaction between cartilage and bone. This proposal aims to establish an in vitro 3-dimensional microsystem based on adult stem cells to simulate this bone-cartilage interface, which may be used in the future to identify and test candidate therapeutics for osteoarthritis.   
      

","NCATS","8415187","7/24/2012 12:00:00 AM","RFA-RM-12-001","1U18TR000532-01","1","U18","TR","000532","01"," ","SUTHERLAND, MARGARET L","7/24/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BST-N(50)R]"," ","1858712","TUAN, ROCKY S","Not Applicable","18","ORTHOPEDICS","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","7/24/2012 12:00:00 AM","6/30/2013 12:00:00 AM","350","Other Research-Related","2012"," "," ","OD","61087","55269"," ","116356",
"Aging; Arthritis; Bioengineering; Biotechnology; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","3-Dimensional;Adipose tissue;Adult;Affect;Age;Anatomy;Architecture;Arthritis;Biochemical;Biocompatible Materials;Biological;Biological Assay;Biological Availability;Biology;Bioreactors;Blood Circulation;Bone Marrow;Bone necrosis;Cartilage;Catabolism;Cells;Chondrocytes;Complex;Degenerative polyarthritis;Development;Dimensions;Disease;Effector Cell;Endothelium;Evaluation;Exposure to;Future;Health;Histocompatibility Testing;Histologic;Housing;Image;In Vitro;Individual;Inflammation;Inflammatory;Injury;Investigation;Joints;Lesion;Maintenance;Mechanics;Mesenchymal Stem Cells;Modality;Modeling;Molecular;Monitor;Osteolysis;Osteopenia;Outcome;Pathogenesis;Perfusion;Pharmaceutical Preparations;Phenotype;Physiological;Population;Printing;Readiness;Reporter;Role;Safety;Sampling;Simulate;Source;Structure;Synovial Membrane;System;Technology;Testing;Therapeutic;Tissues;Toxicology;adult stem cell;articular cartilage;base;bone;bone quality;culture plates;cytokine;design;design and construction;improved;in vitro Model;microsystems;osteochondral tissue;osteogenic;promoter;response;scaffold","3-D Osteochondral Micro-tissue to Model Pathogenesis of Osteoarthritis"," Osteoarthritis, a degenerative joint disease that affects up to 15% of adults, is initiated by degeneration of the articular cartilage that covers the joint surfac. Development of disease modifying drugs for osteoarthritis requires a clear understanding of the underlying mechanisms, responsible for the failed interaction between cartilage and bone. This proposal aims to establish an in vitro 3-dimensional microsystem based on adult stem cells to simulate this bone-cartilage interface, which may be used in the future to identify and test candidate therapeutics for osteoarthritis.   
      

","NCATS","8415187","7/24/2012 12:00:00 AM","RFA-RM-12-001","1U18TR000532-01","1","U18","TR","000532","01"," ","SUTHERLAND, MARGARET L","7/24/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BST-N(50)R]"," ","1858712","TUAN, ROCKY S","Not Applicable","18","ORTHOPEDICS","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","7/24/2012 12:00:00 AM","6/30/2013 12:00:00 AM","350","Other Research-Related","2012"," "," ","NCATS","188913","44481"," ","233394",
"Lung","Address;Affect;Alveolar;Animal Model;Bleomycin;Bone Marrow;Cell Culture Techniques;Cells;Cessation of life;Chronic Disease;Cicatrix;Clinical;Coculture Techniques;Collagen;Collagen Gene;Collagen Type I;Complication;Consensus;Data;Deposition;Development;Diagnosis;Disease;Embryonic Development;Epithelial;Epithelial Cell Proliferation;Epithelial Cells;Equilibrium;Extracellular Matrix;Family;Fibrillar Collagen;Fibroblasts;Fibrosis;Goals;Hamman-Rich syndrome;Helix-Turn-Helix Motifs;Human;Injury;Investigation;Lead;Learning;Lung;Measures;Medical;Mesenchymal;Morbidity - disease rate;Mus;Myofibroblast;Pathway interactions;Phenotype;Play;Process;Proteins;Pulmonary Fibrosis;Recovery;Recruitment Activity;Regulation;Research;Role;Signal Transduction;Signaling Molecule;Source;System;Techniques;Testing;Therapeutic;Therapeutic Intervention;Time;Tissues;Work;cell behavior;cell type;design;fibrogenesis;human disease;interstitial;migration;novel;programs;repaired;therapeutic target;transcription factor;tumor progression","Function of epithelial-mesenchymal transition during pulmonary fibrosis"," Despite years of research, pulmonary fibrosis remains a devastating problem without good therapy. The function of epithelial cells during fibrosis remains poorly characterized but emerging evidence suggests that they have a critical role. With greater understanding into the relatively unexplored function of epithelial cells, a new paradigm for the progression of fibrosis may emerge with the potential for novel therapies.   
      

","NHLBI","8290684","5/15/2012 12:00:00 AM","PA-10-067","1R01HL108904-01A1","1","R01","HL","108904","01","A","HARABIN, ANDREA L","5/15/2012 12:00:00 AM","3/31/2017 12:00:00 AM","Special Emphasis Panel[ZRG1-CVRS-G(02)M]"," ","2054274","KIM, KEVIN KEEWOUN","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","5/15/2012 12:00:00 AM","3/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","138750"," ","388750",
"Bioengineering; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Adult;Autologous;Bone Regeneration;Cartilage;Cell Transplants;Cells;Chemicals;Clinical;Coupled;Culture Media;Defect;Degenerative polyarthritis;Dose;Drug Formulations;Encapsulated;Engineering;Environment;Foundations;Gelatin;Germ Cells;Goals;Growth Factor;Hydrogels;Implant;In Vitro;Injectable;Insulin-Like Growth Factor I;Kinetics;Mechanics;Mesenchymal Stem Cells;Modeling;Natural regeneration;Nature;Oryctolagus cuniculus;Pain;Population;Process;Progress Reports;Public Health;Research Project Grants;Staging;Stem cell transplant;Stem cells;Testing;Time;Tissues;Transforming Growth Factors;Translations;Transplantation;articular cartilage;bone;cartilage regeneration;combinatorial;density;experience;implantation;in vivo;in vivo Model;novel;novel strategies;oligo(poly(ethylene glycol)fumarate);osteochondral tissue;osteogenic;public health relevance;repaired;scaffold;tissue regeneration","Injectable Cellular Composites for Cartilage Engineering","
Relevance to Public Health
Due to the limited natural ability of cartilage tissue to repair itself, damage to articular cartilage
and underlying bone often leads to significant clinical problems that afflict millions of people
worldwide, including pain, limited mobility and osteoarthritis. No strategies currently exist that
are consistently successful in treating cartilage defects of this nature. The project described in
this proposal aims to develop novel injectable, bilayered, degradable materials that can be
implanted as a vehicle for the concurrent delivery of bioactive molecules and adult derived stem
cells to promote regeneration of damaged cartilage tissue.","NIAMS","8289677","6/2/2012 12:00:00 AM","PA-07-070","5R01AR048756-08","5","R01","AR","048756","08"," ","WANG, FEI","4/1/2003 12:00:00 AM","6/30/2015 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","1864036","MIKOS, ANTONIOS G.","KASPER, FRED KURTIS","02","BIOMEDICAL ENGINEERING","050299031","K51LECU1G8N3","050299031","K51LECU1G8N3","US","29.720685","-95.393732","9291001","RICE UNIVERSITY","HOUSTON","TX","BIOMED ENGR/COL ENGR/ENGR STA","770051827","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","216000","104816"," ","320816",
"Biotechnology; Cardiovascular; Diagnostic Radiology; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Area;Biology;Bone Marrow Cell Transplantation;Bone Marrow Stem Cell;Cardiac;Cell Adhesion Molecules;Cell Survival;Cell Therapy;Cell Transplantation;Cell Transplants;Cells;Clinical;Clinical Management;Clinical Trials;Decision Making;Disease;Echocardiography;Engraftment;Environment;Future;Goals;Heart Diseases;Histologic;Image;Imaging Techniques;Individual;Integrins;Investigation;Left;Mesenchymal Stem Cells;Metabolism;Modeling;Molecular Target;Myocardial;Myocardial Infarction;Myocardium;Natural regeneration;Nuclear;Patient Selection;Perfusion;Play;Protocols documentation;Rattus;Residual state;Role;Signaling Molecule;Stem cells;Testing;Therapeutic;Time;Tissues;Transplantation;Treatment Efficacy;Up-Regulation;Wit;Work;base;cell type;design;functional improvement;functional outcomes;improved;injured;innovation;insight;molecular imaging;novel strategies;public health relevance;regenerative;repaired;stem cell therapy;success;therapy outcome","Imaging of the Myocardial Microenvironment to Facilitate Stem Cell Engraftment","
Project Narrative / Relevance
 Cardiac stem cell therapy is condsidered to be a very promising approach for repair of damaged
myocardium, but the benefit in clinical trials is currently still variable. In this proposal, molecular imaging
techniques are introduced which aim at improving cell therapy by providing information about myocardial
microenvironmental conditions which are most suitable for stem cell engraftment. Such biologic imaging
strategies have the potential to guide individual therapeutic decisions, and are thus highly relevant to optimize
the benefit of stem cell therapy in the clinical management of heart disease.","NHLBI","8527039","8/31/2012 12:00:00 AM","PA-07-070","3R01HL092985-03S1","3","R01","HL","092985","03","S","ADHIKARI, BISHOW B","1/15/2010 12:00:00 AM","12/31/2014 12:00:00 AM","Medical Imaging Study Section[MEDI]"," ","8742846","ABRAHAM, MARIA ROSELLE","WAHL, RICHARD LEO","07","RADIATION-DIAGNOSTIC/ONCOLOGY","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","9/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","16088","10296"," ","26384",
"Regenerative Medicine","Address;Adverse effects;Affect;Animal Model;Animals;Biochemical;Bone Regeneration;Bone Resorption;Cells;Cervical;Clinical;Cyst;Data;Defect;Development;Dose;Down-Regulation;FDA approved;Fracture;Genetic;Growth Factor;Healed;Human;Knockout Mice;Laboratories;Lead;Life;Mediating;Mesenchymal Stem Cells;Methods;Modeling;Molecular;Mus;Operative Surgical Procedures;Osteogenesis;Pathology;Peroxisome Proliferator-Activated Receptors;Publishing;RNA Interference;Recombinants;Reporter;Research;Research Personnel;Rodent;Role;Safety;Signal Transduction;Solutions;Swelling;Testing;Therapeutic;Up-Regulation;Wnt proteins;base;bone;bone growth factor;bone healing;bone loss;bone morphogenetic protein 2;cost;gain of function;healing;improved;in vivo;inhibitor/antagonist;innovation;interest;lipid biosynthesis;loss of function;nonhuman primate;novel;osteogenic;repaired;skeletal;skeletal regeneration;small hairpin RNA;standard of care","Wnt and PPARy Signaling in Nell-1 and BMP2 Mediated Bone Regeneration"," Non-healing bone defects are addressed in over 2.2 million surgical cases worldwide each year. Bone Morphogenetic Protein2 (BMP2), the most commonly used bone growth factor, has significant adverse effects including formation of poor quality, fatty
bone. Our innovative solution uses NELL-1, a novel bone forming molecule to inhibit fatty bone formation and to improve the efficacy of BMP2-based bone regeneration therapies.   
      

","NIAMS","8387489","6/28/2012 12:00:00 AM","PA-11-260","1R01AR061399-01A1","1","R01","AR","061399","01","A","WANG, FEI","7/1/2012 12:00:00 AM","5/31/2017 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","7123123","SOO, CHIA ","Not Applicable","33","ORTHOPEDICS","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","SCHOOLS OF MEDICINE","900952000","UNITED STATES","N","7/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","121500"," ","346500",
"Cardiovascular; Genetics; Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Embryonic - Non-Human; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Animals;Attention;Canis familiaris;Cardiac;Cardiac Myocytes;Cardiovascular system;Cause of Death;Cell Culture Techniques;Cell Therapy;Cells;Chromosomes;Complex;Conditioned Culture Media;Data;Derivation procedure;Development;Ensure;Gene Transfer Techniques;Generations;Genes;Genetic;Goals;Human;Human Resources;In Vitro;Individual;Marrow;Mesenchymal Stem Cells;Methods;Modification;Myocardial Infarction;Phenotype;Plasmids;Pluripotent Stem Cells;Preparation;Production;Protocols documentation;Quality Control;Reporter;Reporting;Research Personnel;Stem cells;Stromal Cells;Sum;System;Testing;Training;Training Programs;Transfection;Translating;Transplantation;Undifferentiated;Vascular Endothelial Growth Factor Receptor-2;Work;base;cardiac repair;cell type;cost effective;embryonic stem cell;experience;human embryonic stem cell;in vivo;induced pluripotent stem cell;large scale production;progenitor;programs;repaired;research study;scale up;tool","Stem Cell Core","The goal of this program is to develop stem cell based therapies for myocardial infarction, the number one 
cause of death in the U.S. However, the culture of stem cells is technically challenging, and so we need a 
centralized Stem Cell Core for the scaled production of stem cells and stem cell-derived heart muscle cells.","NHLBI","8380425","6/8/2012 12:00:00 AM"," ","5P01HL094374-03","5","P01","HL","094374","03"," "," "," "," ","Heart, Lung, and Blood Program Project Study Section[HLBP]","8559","2090328","LAFLAMME, MICHAEL ALAN","Not Applicable","07","Unavailable","605799469","HD1WMN6945W6","605799469","HD1WMN6945W6","US","47.660049","-122.31441","9087701","UNIVERSITY OF WASHINGTON","SEATTLE","WA","Domestic Higher Education","981951016","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","300136","300136"," ","180805","119331"," "," ",
"Injury (total) Accidents/Adverse Effects; Osteoporosis; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Amputation;Biomechanics;Bone Growth;Bone Regeneration;Bone callus;Bone remodeling;Cell Lineage;Cells;Chondrocytes;Collagen;Congenital Disorders;Defect;Development;Discipline;Disease;Epiphysial cartilage;Exhibits;Foundations;Fracture;Fracture Healing;Future;Generations;Genes;Genetic;Goals;Hand;Histopathology;Homing;In Vitro;Inherited;Knowledge;Loss of Heterozygosity;Lovastatin;Mesenchymal Stem Cells;Modeling;Molecular;Molecular Target;Mus;Nature;Neurofibromatoses;Operative Surgical Procedures;Osteoblasts;Osteoclasts;Pathway interactions;Patients;Pre-Clinical Model;Process;Property;Pseudarthrosis;Research Design;Resolution;Role;Signal Transduction;Site;Skeleton;Staging;Structure;Syndrome;Testing;Work;base;bone;bone cell;bone healing;bone quality;calcification;cell type;comparative;improved;in vivo;leukemia;loss of function;mineralization;mouse model;neurofibroma;new therapeutic target;novel;novel strategies;novel therapeutic intervention;osteoblast differentiation;osteoclastogenesis;palliative;pre-clinical;prevent;repaired;skeletal disorder;skeletal tissue;sound;therapeutic target;tool","Bone Pseudoarthrosis Dissected through the Generation of New Mouse Models","
NARRATIVE
The studies proposed in this application aim at characterizing the molecular defects of NF1 bone
pseudoarthrosis by the generation of new mouse models, subsequently used as pre-clinical models to test the
corrective effect of various pharmacological agents on bone healing.","NIAMS","8290410","7/13/2012 12:00:00 AM","PA-07-070","5R01AR055966-04","5","R01","AR","055966","04"," ","WANG, FEI","7/1/2009 12:00:00 AM","6/30/2014 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","8359228","ELEFTERIOU, FLORENT ","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","213840","114404"," ","328244",
"No NIH Category available","Address;Binding;Biological Assay;C-terminal;Cells;Cilia;Data;Defect;Dermal;Dermatologic;Development;Disease;Drug or chemical Tissue Distribution;Epidermis;Epithelial;Epithelium;Event;Funding;Growth Factor;Guanosine Triphosphate Phosphohydrolases;Hair;Hair follicle structure;Human;Immune;Immune system;Immunologics;Immunoproliferative Disorders;Infiltration;Inflammatory;Integrin Binding;Integrin Signaling Pathway;Integrins;Laminin;Measures;Mediating;Mesenchymal;Modeling;Molecular;Molecular Profiling;Morphogenesis;Mus;PDGFRB gene;PTK2 gene;Pathology;Pathway interactions;Peptide Signal Sequences;Phenotype;Point Mutation;Process;Production;Psoriasis;Role;Signal Transduction;Skin;Specificity;Staging;System;T-Lymphocyte Subsets;Testing;Transgenic Mice;United States;Work;Wound Healing;appendage;cytokine;human disease;in vivo;interleukin 20;interleukin-22;keratinocyte;mutant;overexpression;response;skin disorder;tongue papilla;tool","Laminins in the Skin","
NARRATIVE SUMMARY
Advances derived from this funding cycle have led to advances in our understanding of how
laminins control epithelial mesenchymal interactions during hair development. The proposed
studies in the first Aim will determine the sequence of events which occur in the early events of
hair formation. This proposal also presents preliminary data of a highly promising model of
immunoproliferative skin disease resembling the human disease psoriasis. The studies
proposed in the second Aim will determine the cellular and molecular interactions, as well as the
triggering factors which precipitate epidermal proliferation and immune infiltration in this model.","NIAMS","8257146","4/30/2012 12:00:00 AM","PA-07-070","5R01AR047223-13","5","R01","AR","047223","13"," ","BAKER, CARL","8/1/2000 12:00:00 AM","4/30/2014 12:00:00 AM","Arthritis, Connective Tissue and Skin Study Section[ACTS]"," ","1885225","MARINKOVICH, MATT PETER","Not Applicable","18","DERMATOLOGY","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","213840","129827"," ","343667",
"Assistive Technology; Atherosclerosis; Bioengineering; Biotechnology; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Hematology; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Angiography;Angioplasty;Apoptosis;Area;Atherosclerosis;Autologous;Balloon Angioplasty;Blood;Blood Platelets;Blood Vessels;Caliber;Cardiology;Cardiovascular system;Cell Differentiation process;Cell Proliferation;Cell Therapy;Cellular biology;Clinical;Coronary;Coronary Angiography;Coronary Arteriosclerosis;Coronary artery;Coronary heart disease;Data;Deposition;Development;Down-Regulation;Drug Controls;Endothelial Cells;Engineering;Family suidae;Fibrinogen;Functional disorder;Gene Expression;Gene Transduction Agent;Genes;Goals;Growth;Heart;Histology;Human;Hyperlipidemia;Hyperplasia;In Vitro;Inflammatory;Injury;Insulin-Like Growth Factor I;Interferons;Interleukin-12;Investigation;Laboratories;Legal patent;Lipids;Mediator of activation protein;Mesenchymal Stem Cells;Metals;Mitogens;Modeling;Molecular Biology;Optics;Outcome;PTEN gene;Pathology;Patients;Percutaneous Transluminal Coronary Angioplasty;Pharmaceutical Preparations;Phosphoric Monoester Hydrolases;Positioning Attribute;Prevention;Procedures;Receptor Cell;Research;Resolution;Role;Signal Transduction;Signaling Molecule;Site;Smooth Muscle Myocytes;Stem cells;Stenosis;Stents;Symptoms;TNF gene;Testing;Therapeutic;Thick;Thrombosis;Transduction Gene;Transgenes;Translating;Ulcer;Vascular Diseases;Vascular Endothelial Growth Factors;cell growth;cytokine;gene therapy;in vivo;intercellular communication;intima media;novel;overexpression;phase 1 study;prevent;receptor expression;repaired;response to injury;restenosis;shear stress;stem cell differentiation;tomography;transgene expression;vector;vector control","MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIA"," Re-narrowing of coronary arteries in the heart after balloon angioplasty or placement of stents is serious problem. This is primarily due to uncontrolled growth of smooth muscle cells at the site of injury due to balloon angioplasty or the placement of stent in coronary artery. Another major problem is the deposition of platelets that develop thrombosis. In this project we proposed to deliver autologous mesenchymal stem cells together with a novel gene at the site of injury in the heart of atherosclerotic pig during these procedures to prevent the re-narrowing of the coronary arteries and keep them patent for longer period. The goal is to test the hypothesis that the administration of stem cells with gene therapy is superior to drug-eluting stents. The proposed studies will provide conceptual support of our hypothesis and position us to translate our investigation into a clinical phase 1 study for the delivery of stem cells with the novel gene in patients with coronary artery disease.  
  
    

","NHLBI","8257841","11/25/2011 12:00:00 AM","PA-10-067","1R01HL112597-01","1","R01","HL","112597","01"," ","KINDZELSKI, ANDREI L","12/1/2011 12:00:00 AM","11/30/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-VH-B(02)]"," ","8153099","AGRAWAL, DEVENDRA K.","Not Applicable","02","OTHER BASIC SCIENCES","053309332","NH64NT271S93","053309332","NH64NT271S93","US","41.26545","-96.039767","1943701","CREIGHTON UNIVERSITY","OMAHA","NE","SCHOOLS OF MEDICINE","681780133","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","440672","196099"," ","636771",
"Cardiovascular; Kidney Disease; Osteoporosis","Affect;Age;Animal Model;Animals;Antibodies;Aorta;Architecture;Arteries;Attenuated;Biochemical;Biomechanics;Blood Pressure;Blood Vessels;Bone Diseases;Bone Tissue;Bone necrosis;Bone remodeling;Calcitriol;Calcium;Cardiovascular Abnormalities;Cardiovascular Diseases;Cardiovascular system;Chronic Kidney Failure;Clinical;Clinical Data;Clinical Practice Guideline;Development;Dialysis patients;Disease;Disease Progression;Dose;Down-Regulation;Elderly;Epidemic;Fracture;Functional disorder;General Population;Goals;Growth Factor;Growth Factor Inhibition;Health;Heart;Heart Diseases;Histology;Homeostasis;Human;In Vitro;Incidence;Incubated;Individual;Injection of therapeutic agent;Innate Bone Remodeling;International;Jaw;Left;Left Ventricular Hypertrophy;Left Ventricular Mass;Link;Measures;Mediating;Mediator of activation protein;Mesenchymal;Mesenchymal Stem Cells;Metabolic Bone Diseases;Metabolism;Minerals;Modeling;Morbidity - disease rate;Names;Osteogenesis;Osteoid;Pathogenesis;Patients;Pharmaceutical Preparations;Phenotype;Phosphorus;Phosphorylation;Plasma;Prevention;Protein Tyrosine Kinase;Public Health;Rattus;Renal function;Research;Research Proposals;Risk Factors;Safety;Secondary Hyperparathyroidism;Series;Serum;Side;Smooth Muscle Myocytes;Staging;Stem cells;Syndrome;Testing;Thick;Time;Tissues;Toxic effect;Translating;United States;Up-Regulation;Vascular Diseases;Vascular Endothelial Growth Factor Receptor;Vascular Endothelial Growth Factors;Vascular calcification;Work;Zoledronic Acid;angiogenesis;bevacizumab;bisphosphonate;body system;bone;bone cell;bone loss;bone mass;bone morphogenetic protein 2;bone morphogenic protein;bone turnover;calcification;calcium intake;coronary artery calcification;density;design;drug market;drug mechanism;effective therapy;human disease;improved;in vivo;indexing;inhibitor/antagonist;innovation;mineralization;mortality;novel;osteogenic;pre-clinical;prevent;public health relevance;receptor;research study;response;skeletal","Bisphosphonates in the treatment of chronic kidney disease-mineral bone disease","
In patients with chronic kidney disease there is abnormal bone and hardening of the
arteries. Both of these problems may be linked. The purpose of this study is to
determine if a commonly used group of drugs, bisphosphonates, may help both bone
and heart/blood vessel disease and determine the mechanism the drugs work.","NIAMS","8233931","3/3/2012 12:00:00 AM","PA-07-070","5R01AR058005-03","5","R01","AR","058005","03"," ","SHARROCK, WILLIAM J","4/1/2010 12:00:00 AM","2/28/2015 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1901988","MOE, SHARON M","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","603007902","SHHBRBAPSM35","603007902","SHHBRBAPSM35","US","39.780714","-86.174977","577806","INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS","INDIANAPOLIS","IN","SCHOOLS OF MEDICINE","462022915","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","216000","116640"," ","332640",
"Contraception/Reproduction; Genetics; Infant Mortality/ (LBW); Infertility; Neurosciences; Pediatric; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","26S proteasome;Ablation;Acrosome;Adult;Affect;Alleles;Anencephaly;Apoptosis;Attenuated;Biological Assay;C57BL/6 Mouse;CDKN1C gene;CHEK2 gene;Cell Cycle;Cell Differentiation process;Cell Lineage;Cell Proliferation;Cell Survival;Cells;Checkpoint kinase 1;Cleaved cell;Collaborations;Congenital Abnormality;Cyclin-Dependent Kinases;DNA;DNA Damage;DNA damage checkpoint;Defect;Development;Embryo;Embryonic Development;Endometrium;Ensure;Enzymes;Event;Excision;Fertility;Fertilization in Vitro;Folic Acid;Gene Deletion;Gene Expression;Genes;Genetic;Genetic Transcription;Genome;Giant Cells;Goals;Government;Human;Human Development;Implant;In Vitro;Infertility;Inner Cell Mass;Institution;Laboratories;Life;Link;Mammals;Mediator of activation protein;Mesenchymal;Mesenchymal Stem Cells;Mitogens;Mitosis;Mitotic Cell Cycle;Modeling;Molecular;Morula;Mus;Mutagenesis;Nervous system structure;Neural Tube Closure;Northern Blotting;Organ;Organism;Organogenesis;Partner in relationship;Pattern;Penetration;Placenta;Play;Polyploidy;Pre-Eclampsia;Premature Birth;Proliferating;Protein Kinase;Proteins;RNA;Reporting;Reproduction;Research;Reverse Transcriptase Polymerase Chain Reaction;Role;Scheme;Signal Pathway;Site;Specific qualifier value;Sperm Penetration;Spermatocytes;Staging;Stem cells;Transgenic Mice;Zona Pellucida;blastocyst;blastomere structure;cyclin-dependent kinase inhibitor 1B;egg;embryo cell;embryo stage 2;embryonic stem cell;in vivo;inhibitor/antagonist;male;monolayer;mouse development;natural Blastocyst Implantation;preimplantation;premature;prevent;progenitor;programs;prospective;proto-oncogene protein kfgf;relating to nervous system;research study;response;self-renewal;sperm cell;transcription factor;trophoblast;zygote","Gene Expression At The Beginning Of Mammalian Development","n/a","NICHD","8553843"," "," ","1ZIAHD000507-17","1","ZIA","HD","000507","17"," "," "," "," "," "," ","9930856","DEPAMPHILIS, MELVIN ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NICHD"," "," "," ","793077",
"Cancer; Genetics; Hematology; Rare Diseases","Alleles;Archives;Attenuated;Benign;Binding;Biology;Bone Diseases;Bone Marrow;Bone neoplasms;Bortezomib;CDH1 gene;Cadherins;Carcinoma;Cell Adhesion;Cell Line;Cell Proliferation;Cells;Clinical;Code;Complex;Consensus Sequence;DNA Modification Process;DNA Sequence;Data;Derivation procedure;Disease;Disease Progression;Down-Regulation;Drug resistance;E-Cadherin;Enhancers;Event;Exhibits;Extracellular Matrix;Extramedullary;Foundations;Gene Expression;Gene Expression Profile;Gene Expression Profiling;Gene Frequency;Gene Mutation;Genes;Genetic;Genetic Polymorphism;Genetic Transcription;Goals;Growth;Homologous Gene;In Vitro;Interleukin-9;Length;Lesion;Link;Longitudinal Studies;Luciferases;Lytic Metastatic Lesion;Magnetic Resonance Imaging;Malignant Neoplasms;Measures;Mediating;Mesenchymal Stem Cells;Messenger RNA;Molecular;Monoclonal gammopathy of uncertain significance;Multiple Myeloma;Mutation;N-Cadherin;Natural History;Neoplasm Metastasis;Nuclear;Nucleotides;Osteoblasts;Osteolytic;Pathogenesis;Pathway interactions;Patients;Plasma Cells;Plasmin;Protein Isoforms;Proteins;Publishing;Quality of life;Recombinants;Regulation;Resistance;Role;SCID-hu Mice;Sampling;Signal Transduction;Site;Solid Neoplasm;Staging;TCF Transcription Factor;Therapeutic;Tissues;Tumor Suppressor Proteins;Up-Regulation;Variant;Western Blotting;Work;Wound Healing;angiogenesis;base;beta catenin;bone;cell growth;chemotherapy;chromatin immunoprecipitation;epithelial to mesenchymal transition;gain of function;improved;in vivo;innovation;insight;lenalidomide;loss of function;malignant breast neoplasm;mouse model;neoplastic cell;novel;novel therapeutic intervention;osteoblast differentiation;overexpression;programs;promoter;syndecan;therapeutic target;transcription factor;tumor;tumor growth;tumor progression","Tumor Cell-Microenvironment Interactions in the Molecular Pathogenesis of Multipl","Deregulation of Wnt/Beta-catenin signaling is central to myeloma biology and pathogenesis, so it may provide molecular therapeutic targets. Myeloma tumors aberrantly produce molecules that disrupt specific aspects of the Beta-catenin signaling axis, leading to enhanced tumor growth and bone destruction early in the disease and greater cell proliferation and metastases later in the disease. By thoroughly investigating the Beta-catenin signaling axis in myeloma. Project 3 will provide the framework for innovative therapeutic strategies.","NCI","8555168","10/12/2012 8:54:39 AM"," ","5P01CA055819-18","5","P01","CA","055819","18"," "," ","6/5/2000 12:00:00 AM","8/31/2014 12:00:00 AM","ZCA1-RPRB-J(M1)P","5113","3166467","SHAUGHNESSY, JOHN DAMIAN","Not Applicable","02","Unavailable","122452563","VDFYLZPJEAV6","122452563","VDFYLZPJEAV6","US","34.751472","-92.320637","1471106","UNIV OF ARKANSAS FOR MED SCIS","LITTLE ROCK","AR","Domestic Higher Education","722057101","UNITED STATES","N","9/11/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","406054","406054"," ","280179","125875"," "," ",
"Assistive Technology; Atherosclerosis; Bioengineering; Biotechnology; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Hematology; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Angiography;Angioplasty;Apoptosis;Area;Atherosclerosis;Autologous;Balloon Angioplasty;Blood;Blood Platelets;Blood Vessels;Caliber;Cardiology;Cardiovascular system;Cell Differentiation process;Cell Proliferation;Cell Therapy;Cellular biology;Clinical;Coronary;Coronary Angiography;Coronary Arteriosclerosis;Coronary artery;Coronary heart disease;Data;Deposition;Development;Down-Regulation;Drug Controls;Endothelial Cells;Engineering;Family suidae;Fibrinogen;Functional disorder;Gene Expression;Gene Transduction Agent;Genes;Goals;Growth;Heart;Histology;Human;Hyperlipidemia;Hyperplasia;In Vitro;Inflammatory;Injury;Insulin-Like Growth Factor I;Interferons;Interleukin-12;Investigation;Laboratories;Legal patent;Lipids;Mediator of activation protein;Mesenchymal Stem Cells;Metals;Mitogens;Modeling;Molecular Biology;Optics;Outcome;PTEN gene;Pathology;Patients;Percutaneous Transluminal Coronary Angioplasty;Pharmaceutical Preparations;Phosphoric Monoester Hydrolases;Positioning Attribute;Prevention;Procedures;Receptor Cell;Research;Resolution;Role;Signal Transduction;Signaling Molecule;Site;Smooth Muscle Myocytes;Stem cells;Stenosis;Stents;Symptoms;TNF gene;Testing;Therapeutic;Thick;Thrombosis;Transduction Gene;Transgenes;Translating;Ulcer;Vascular Diseases;Vascular Endothelial Growth Factors;cell growth;cytokine;gene therapy;in vivo;intercellular communication;intima media;novel;overexpression;phase 1 study;prevent;receptor expression;repaired;response to injury;restenosis;shear stress;stem cell differentiation;tomography;transgene expression;vector;vector control","MESENCHYMAL STEM CELLS IN THE PREVENTION OF THROMBOSIS AND NEOINTIMAL HYPERPLASIA"," Re-narrowing of coronary arteries in the heart after balloon angioplasty or placement of stents is serious problem. This is primarily due to uncontrolled growth of smooth muscle cells at the site of injury due to balloon angioplasty or the placement of stent in coronary artery. Another major problem is the deposition of platelets that develop thrombosis. In this project we proposed to deliver autologous mesenchymal stem cells together with a novel gene at the site of injury in the heart of atherosclerotic pig during these procedures to prevent the re-narrowing of the coronary arteries and keep them patent for longer period. The goal is to test the hypothesis that the administration of stem cells with gene therapy is superior to drug-eluting stents. The proposed studies will provide conceptual support of our hypothesis and position us to translate our investigation into a clinical phase 1 study for the delivery of stem cells with the novel gene in patients with coronary artery disease.  
  
    

","NHLBI","8402772","2/3/2012 12:00:00 AM","PA-10-067","3R01HL112597-01S1","3","R01","HL","112597","01","S","KINDZELSKI, ANDREI L","12/1/2011 12:00:00 AM","11/30/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-VH-B(02)]"," ","8153099","AGRAWAL, DEVENDRA K.","Not Applicable","02","OTHER BASIC SCIENCES","053309332","NH64NT271S93","053309332","NH64NT271S93","US","41.26545","-96.039767","1943701","CREIGHTON UNIVERSITY","OMAHA","NE","SCHOOLS OF MEDICINE","681780133","UNITED STATES","N","2/6/2012 12:00:00 AM","11/30/2012 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","38899","12356"," ","51255",
"Biotechnology; Cancer; Genetics; Lung; Lung Cancer","Acetylation;Address;American;Architecture;Biomedical Research;Breast;Breast Cancer Cell;Carcinoma;Cell-Cell Adhesion;Cells;ChIP-seq;Characteristics;Clinical;Colorectal;Complex;Data;Detection;Diagnosis;Diagnostic Neoplasm Staging;Disease;Distant;Ensure;Epigenetic Process;Gene Activation;Gene Expression;Gene Expression Microarray Analysis;Gene Targeting;Genes;Genetic Transcription;Goals;HDAC3 gene;Health;Histone H3;Histones;Human;Invaded;Laboratories;Lead;Link;Liver;Lung;Lysine;Maintenance;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of lung;Mediating;Mediator of activation protein;Mesenchymal;Modeling;Modification;Morphogenesis;Morphology;NF-kappa B;Neoplasm Metastasis;Newly Diagnosed;Non-Small-Cell Lung Carcinoma;Outcome;PCAF gene;Patients;Phenotype;Play;Polycomb;Process;Prostate;Proteins;Recruitment Activity;Regulation;Retinoids;Role;Seeds;Site;Snails;Staging;Stem cells;System;TNF gene;Thyroid Hormone Receptor;Time;Tumor Tissue;Tumor stage;United States;Work;bone;cancer cell;cancer initiation;cancer stem cell;epigenomics;epithelial to mesenchymal transition;genome-wide analysis;histone deacetylase 3;melanoma;migration;mouse model;new therapeutic target;novel;outcome forecast;p65;prevent;promoter;protein complex;protein expression;slug;stem;transcription factor;tumor;tumor progression","Role of IKK in NSCLC: Modulation of SMRT and NF-kappaB","
Project Narrative:
A major focus in biomedical research is to understand how cancer cells invade healthy cells and metastasize
to distant sites. Lung cancer in particular is more prone to aggressive forms of the disease that are difficult to
treat effectively and have a poor clinical prognosis. Non-small cell lung cancer (NSCLC) is the most common
form of lung cancer. The 5-year mean survival for patients suffering from stage III lung cancer is less than
30%. Poor clinical prognosis for NSCLC is directly associated with late-stage diagnosis and high propensity
for metastasis to liver and bone. For the last several years our laboratory has been working on a transcription
factor called nuclear factor-kappa B (NF-ï¿½B). NF-ï¿½B is a protein complex that is found in almost all human
cells. In non-cancerous cells NF-ï¿½B is tightly regulated, however, cancer cells have found ways to elevate the
activity of NF-ï¿½B. Although it is known that cancer cells enhance NF-ï¿½B activity, the reasons for this are not
fully understood. Our laboratory has discovered that NF-ï¿½B is one of the master-switch transcription factors
required to induce phenotypic changes in cells referred to as epithelial to mesenchymal transition (EMT). EMT
is a critical step in cancer metastasis. For the first time, our laboratory can demonstrate that following the
induction of EMT, NF-ï¿½B is required to orchestrate changes associated with the induction and maintenance of
cancer stem cells. Cancer stem cells are believed to act as a ""seed"" which is able to reestablish malignant
disease. This proposal will identify critical EMT-induced genes that are required for induction and maintenance
of cancer stem cells. The overall goal of this project is use these newly identified gene products as novel
therapeutic targets for detection and treatment of NSCLC.","NCI","8317725","8/13/2012 12:00:00 AM","PA-07-070","5R01CA104397-09","5","R01","CA","104397","09"," ","JOHNSON, RONALD L","4/19/2004 12:00:00 AM","8/31/2014 12:00:00 AM","Cancer Molecular Pathobiology Study Section[CAMP]"," ","1889852","MAYO, MARTY W","Not Applicable","05","BIOCHEMISTRY","065391526","JJG6HU8PA4S5","065391526","JJG6HU8PA4S5","US","38.034207","-78.512346","1526402","UNIVERSITY OF VIRGINIA","CHARLOTTESVILLE","VA","SCHOOLS OF MEDICINE","229044195","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","179217","90823"," ","270040",
"Atherosclerosis; Biotechnology; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Nutrition; Obesity; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Affect;Aftercare;Age;Agonist;Animals;Aorta;Apolipoprotein E;Bone Marrow;C57BL/6 Mouse;Calcified;Calcium;Cell Culture Techniques;Cell Line;Cells;Cholesterol;Chondroblast;Cloning;Collagen Fiber;Corticotropin;Data;Data Reporting;Detection;Dexamethasone;Diet;Dose;Elastin Fiber;Endocrinology;Enzymes;Event;Fasting;Fatty acid glycerol esters;Fibronectins;Fluorochrome;Foundations;Future;Genotype;Glucocorticoids;Glucose;Heart;Hematopoietic stem cells;Hormones;Human;Hydroxyapatites;Hyperactive behavior;Hyperglycemia;Image Analysis;Immunoblotting;Immunofluorescence Immunologic;In Vitro;Inbred WKY Rats;Inflammatory;Injection of therapeutic agent;Integrins;Investigation;Journals;Label;Lesion;Leukocytes;Lipids;Lipofuscin;Manuscripts;Measures;Mediating;Mediator of activation protein;Melanocortin 2 Receptor;Membrane;Mesenchymal;Mesenchymal Stem Cells;Metabolic;Metabolic syndrome;Metabolism;Methods;Minerals;Modeling;Molecular;Mus;Nature;Obesity;Osteogenesis;Pathway interactions;Pattern;Peptides;Play;Population;Pro-Opiomelanocortin;Process;Production;Proprotein Convertase 1;Prostaglandin D2;Proteins;Protocols documentation;Rattus;Regulation;Relative (related person);Reporting;Research;Resistance;Role;Signal Transduction;Source;Staining method;Stains;Stress;Stromal Cells;Study models;Sudan;Surface;System;Techniques;Time;Training;Valsalva sinus;Vascular calcification;Vimentin;age related;ascending aorta;bone;established cell line;experience;feeding;hypercholesterolemia;hypothalamic-pituitary-adrenal axis;improved;in vivo;insight;macrophage;melanocortin receptor;mineralization;novel;osteoblast differentiation;osteogenic;progenitor;prostaglandin R2 D-isomerase;protein expression;receptor;release of sequestered calcium ion into cytoplasm;research study;response;soft tissue;success","Stress Hormones and Chondrogenic Vascular Calcification","n/a","NHLBI","8528166","8/17/2012 12:00:00 AM","PA-07-297","4R00HL091116-03","4","R00","HL","091116","03"," ","CARLSON, DREW E","9/1/2009 12:00:00 AM","5/31/2015 12:00:00 AM","NSS"," ","8840795","EVANS, JODI FRANCES","Not Applicable","04","Unavailable","065937856","ELGEEPUTTZM4","065937856","ELGEEPUTTZM4","US","40.741744","-73.642726","5618301","NYU WINTHROP HOSPITAL","MINEOLA","NY","Independent Hospitals","115013957","UNITED STATES","N","8/17/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","191946","57054"," ","249000",
"Biotechnology; Cancer; Clinical Research; Dental/Oral and Craniofacial Disease; Rare Diseases","Ablation;Accounting;Address;Antibodies;Area;Automobile Driving;Behavior;Biometry;Bypass;Carcinoma;Cell Line;Cells;Cessation of life;Cetuximab;Clinical;Combined Modality Therapy;Communities;Data;Dependence;Detection;Diagnostic Neoplasm Staging;Disease;Drug resistance;E-Cadherin;Epidermal Growth Factor Receptor;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Epigenetic Process;Epithelial;Feedback;Fibroblasts;Gene Expression;Goals;Green Fluorescent Proteins;Growth;Head and neck structure;Heterogeneity;Human;IL8 gene;In Vitro;Individual;Interleukin-6;International;Laboratories;Learning;Life;Malignant Epithelial Cell;Malignant Neoplasms;Mediating;Mentorship;Mesenchymal;Modeling;Molecular;Neoplasm Metastasis;Outcome;Pathway interactions;Patients;Pattern;Pharmacology;Phenotype;Play;Production;Public Health;Receptor Inhibition;Research;Resistance;Role;Scientist;Selection for Treatments;Signal Pathway;Signal Transduction;Specificity;Surgical Oncologist;Survivors;System;Testing;Thymidine Kinase;Tissue Engineering;Tissue Microarray;Training;Transforming Growth Factors;Tumor stage;Tumor-Derived;Viral;Work;Xenograft Model;Xenograft procedure;aggressive therapy;anticancer research;base;cancer therapy;career;cellular imaging;chemotherapy;clinical efficacy;connective tissue growth factor;disability;epithelial to mesenchymal transition;human tissue;imaging modality;improved;in vitro Model;in vivo Model;innovation;malignant mouth neoplasm;meetings;mouth squamous cell carcinoma;neoplastic cell;novel;outcome forecast;promoter;response;responsible research conduct;self-renewal;stem cell biology;suicide gene;trait;tumor;tumor growth;tumor progression","Targeting mesenchymal-like cells in oral cancer to overcome cetuximab resistance"," OSCC is a major public health issue in the US, accounting for approximately 36,000 annual cases and 8000 deaths as well as severe treatment-related disabilities in many survivors. The applicant's preliminary data support that MLSP cells contribute to aggressive clinical behavior and drug resistance in these tumors. This proposal pursues the mechanisms underlying these MLSP-mediated effects in order to improve outcomes for OSCC patients.   
      

","NIDCR","8354347","8/7/2012 12:00:00 AM","PA-11-193","1K08DE022842-01","1","K08","DE","022842","01"," ","KING, LYNN M","9/1/2012 12:00:00 AM","8/31/2017 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","10079279","BASU, DEVRAJ ","Not Applicable","03","OTOLARYNGOLOGY","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","123850","9908"," ","133758",
"Cancer; Digestive Diseases; Genetics; Liver Cancer; Liver Disease; Pancreatic Cancer; Rare Diseases","Address;Allografting;Biological Assay;Cancerous;Carcinoma;Cells;DNA;DNA Methylation;Data;Decitabine;Epithelial;Epithelial Cells;Gene Expression;Genes;Genetic;Growth;Human;Laboratories;Lead;Link;Liver Fibrosis;Maintenance;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of gastrointestinal tract;Malignant neoplasm of liver;Maps;Measures;Mediating;Mesenchymal Stem Cells;Methylation;Methyltransferase Gene;Modeling;Molecular;Molecular Profiling;Mus;Myofibroblast;Neoplasm Metastasis;Nitrosamines;Pancreatic carcinoma;Pharmaceutical Preparations;Pharmacodynamics;Phase I Clinical Trials;Primary carcinoma of the liver cells;Role;Stomach;Stomach Carcinoma;Stromal Cells;Testing;base;cancer therapy;cancer type;cell stroma;chemical carcinogenesis;clinically relevant;in vivo;insight;mouse model;prevent;promoter;research study;response;therapeutic target;tumor;tumor progression;wound","Targeting Cancer-Associated Myofibroblasts by DNA Hypomethylation","Our study will address the role of myofibroblasts in pancreatic and hepatocellular carcinomas, with a 
particular focus on DNA methylation in these stromal cells as a target for anti-cancer therapy. Since these 
difficult to treat cancer types contain large numbers of tumor-promoting myofibroblasts, understanding how 
such cells promote cancer and how they can be inhibited with specific drugs is highly clinically relevant.","NCI","8555378","10/12/2012 12:13:02 PM","RFA-CA-10-021","5U54CA163111-02","5","U54","CA","163111","02"," "," ","9/22/2011 12:00:00 AM","7/31/2016 12:00:00 AM","ZCA1-SRLB-3(O1)","5299","1891538","TYCKO, BENJAMIN ","Not Applicable","13","Unavailable","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","Domestic Higher Education","100323725","UNITED STATES","N","9/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","207074","207074"," ","140574","66500"," "," ",
"Breast Cancer; Cancer","Behavior;Breast;Breast Cancer Cell;Cancer Biology;Cells;Chemotactic Factors;Chemotaxis;Complex;Coupled;Cyclic AMP;Dictyostelium;Disseminated Malignant Neoplasm;Epithelial;Head;Hematopoietic;Heterotrimeric GTP-Binding Proteins;Human;Inflammation;Mammalian Cell;Mesenchymal;Neoplasm Metastasis;Phosphatidylinositols;Phosphotransferases;Production;Resistance;Role;Signal Pathway;Signal Transduction;Sirolimus;Tail;Tissues;Work;ameboid movement;angiogenesis;cancer cell;cell motility;chemokine;insight;interest;malignant breast neoplasm;migration;neutrophil;programs;tumor progression","CHEMOTACTIC SIGNALS REGULATING HUMAN NEUTROPHIL AND BREAST METASTATIC MIGRATION","n/a","NCI","8553049"," "," ","1ZIABC011216-04","1","ZIA","BC","011216","04"," "," "," "," "," "," ","6815042","PARENT, CAROLE ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","924268",
"Osteoporosis","Affect;Alleles;Bone Development;Bone Marrow;Bone Matrix;Bone remodeling;Cells;Development;Disease;Doxycycline;Embryonic Development;Excision;Genetic;Goals;Homeostasis;Individual;Lead;Light;Mesenchymal;Mus;Osteoblasts;Osteogenesis;Osteoporosis;Pathway interactions;Phenotype;Public Health;Regulation;Role;Signal Pathway;Signal Transduction;Staging;Testing;WNT Signaling Pathway;bone;bone mass;cell type;notch protein;novel;novel therapeutic intervention;osteoblast differentiation;progenitor;public health relevance","Elucidating the Relationship Between Notch and WNT Signaling in Bone Formation","
Project Narrative:
Osteoporosis is a major public health problem affecting approximately 75 million individuals worldwide.
Findings from these studies may lead to novel therapeutic approaches to the treatment of this disease.","NIAMS","8264958","4/12/2012 12:00:00 AM","PA-10-110","5F32AR060674-02","5","F32","AR","060674","02"," ","TYREE, BERNADETTE","4/1/2011 12:00:00 AM","3/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-F10B-S(20)L]"," ","10442996","KARNER, COURTNEY MICHAEL","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Training, Individual","2012"," "," ","NIAMS","52190"," "," ","52190",
"Bioengineering; Biotechnology; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adhesions;Adhesives;Affect;Antibodies;Biotin;Blood Circulation;Bone Marrow;Cardiac;Cardiac Myocytes;Cardiac Output;Cardiovascular Diseases;Cell Adhesion;Cell Adhesion Molecules;Cell Communication;Cell Survival;Cell Therapy;Cell surface;Cells;Cessation of life;Characteristics;Chemicals;Clinical;Congestive Heart Failure;Connective Tissue;Data;Defect;Deterioration;Development;Disease;Endothelial Cells;Endothelium;Engineering;Engraftment;Ethics;Extravasation;Glycoproteins;Goals;Heart;Home environment;Homing;Human;In Vitro;Infarction;Inflammation;Injection of therapeutic agent;Integrins;Intercellular adhesion molecule 1;Lead;Leukocytes;Ligands;Literature;Mediating;Mesenchymal Stem Cells;Methods;Modeling;Modification;Molecular;Mus;Myocardial Infarction;Myocardium;Natural regeneration;P-Selectin;P-selectin ligand protein;Play;Property;Quality of life;Role;Selectins;Simulate;Site;Source;Stem cells;Streptavidin;Surface;Tail;Therapeutic;Tissues;Vascular Cell Adhesion Molecule-1;Vascular Endothelium;Veins;Work;Wound Healing;cell type;design;improved;improved functioning;in vivo;interest;migration;mouse model;novel strategies;paracrine;public health relevance;receptor;repaired;research study;response;shear stress;sialyl Lewis a;stem cell therapy;surface coating;trafficking","Engineered Induction of a Stem Cell Homing Response","
The aim of this proposal is to engineer the surface of mesenchymal stem cells to enhance
their trafficking efficiency to sites of cardiovascular disease, and improve the homogeneity
of the homing response without affecting their native properties, including their ability to
transmigrate through vascular endothelium and capacity for multi-lineage differentiation.
The development of this novel approach will have broad implications for wound repair and
treatment of many tissues where cell based therapies is appropriate. Potential benefits for
treatment of ischemic tissue following myocardial infarction include increased cardiac output
leading to increased survival and improved quality of life.","NHLBI","8269745","5/20/2012 12:00:00 AM","PA-07-070","5R01HL095722-03","5","R01","HL","095722","03"," ","YANG, YU-CHUNG","6/1/2010 12:00:00 AM","5/31/2015 12:00:00 AM","Intercellular Interactions Study Section[ICI]"," ","9036629","KARP, JEFFREY MICHAEL","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","286349","129590"," ","415939",
"Bioengineering; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Affect;Alternative Therapies;Anastomosis - action;Angiogenic Factor;Architecture;Basal lamina;Biological Models;Biological Preservation;Blood Vessels;Blood capillaries;Caliber;Cell Culture Techniques;Cell Survival;Cells;Cellularity;Clinical;Complex;Defect;Dimensions;Endothelial Cells;Engineering;Ethylene Glycols;Excision;Extracellular Matrix;Fibrin;Fractals;Future;Gene Expression;Goals;Health;Histocompatibility Testing;Histology;Human;Immune;Immune response;Immunohistochemistry;Implant;Liquid substance;Mesenchymal Stem Cells;Methods;Microfilaments;Modeling;Morphology;Necrosis;Nerve;Nerve Tissue;Nutrient;Organ;Patients;Penetration;Perfusion;Peripheral Nerves;Phenotype;Physiological;Procedures;Process;Proliferating;Property;Prostaglandins I;Proteins;Protocols documentation;Pulsatile Flow;Rattus;Research;Research Personnel;Shapes;Source;Stress;Structure of parenchyma of lung;Surgical Anastomosis;System;Techniques;Technology;Thick;Tissue Engineering;Tissues;Translating;Transplantation;Vascular System;Vascularization;Waiting Lists;Western Blotting;Work;base;capillary;capillary bed;cooking;crosslink;ethylene glycol;experience;fluid flow;immunogenic;immunogenicity;implantation;in vivo;preconditioning;public health relevance;regenerative;regenerative therapy;scaffold;shear stress;tissue regeneration;two-dimensional;vascular bed","3D Acellular Vascular Beds: Characterization and Re-endothelialization","
CLINICAL AND HEALTH RELEVANCE
As the organ wait list continues to exceed the number of donors each year, the need for alternative therapies
to transplantation is becoming increasingly important. Yet, researchers have demonstrated that a vascular
connection is necessary in order to maintain viability in tissues beyond 100-200 microns thick. To date, there
is no effective manner in which to recreate this vascular connection. The goal of our proposed research is to
develop three-dimensional vascular beds from natural tissues, which can ultimately be used in scaffolds for
tissue engineering applications requiring immediate vascularization or which can be used as stand-alone
grafts for necrotic tissues in the body. To create the vascular construct we will use a decellularization
procedure, which we have previously developed to accurately preserve the intricate micro-architecture of
peripheral nerve, to remove the immunogenic cellular components from highly vascularized lung tissue and to
simultaneously preserve the microvessel extracellular matrix. The vascular bed will be subsequently re-
endothelialized with human mesenchymal stem cells (MSCs) that have been transdifferentiated into an
endothelial cell phenotype. MSCs offer great potential for clinical translational because they are immune-
privileged or they can be isolated from the patient. In addition, decellularized tissues offer clinical
opportunities; in fact, most examples of current scaffold-based regenerative therapies utilize natural, acellular
tissues (e.g., SIS products from Cook Biotech, AlloDerm from LifeCell, and Avance from AxoGen; note: the
Avance nerve graft is based on the PI's decellularization processes for nerve tissue).","NIBIB","8240978","3/26/2012 12:00:00 AM","PA-10-010","5R21EB013358-02","5","R21","EB","013358","02"," ","HUNZIKER, ROSEMARIE","4/1/2011 12:00:00 AM","12/31/2012 12:00:00 AM","Bioengineering, Technology and Surgical Sciences Study Section[BTSS]"," ","1921325","SCHMIDT, CHRISTINE E","Not Applicable","10","BIOMEDICAL ENGINEERING","170230239","V6AFQPN18437","170230239","V6AFQPN18437","US","30.308138","-97.764903","578403","UNIVERSITY OF TEXAS, AUSTIN","AUSTIN","TX","BIOMED ENGR/COL ENGR/ENGR STA","787595316","UNITED STATES","N","4/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","4671","374"," ","5045",
"Bioengineering; Biotechnology; Breast Cancer; Cancer; Ovarian Cancer; Rare Diseases","Address;Adhesions;Affect;Apoptotic;Artificial Heart;Ascites;Automobile Driving;Basic Science;Behavior;Biochemical Genetics;Biochemical Pathway;Biological Assay;Biological Markers;Biomechanics;Bone Morphogenetic Proteins;Breast;Cancer Model;Cancer cell line;Cancerous;Cell Line;Cell Mobility;Cell division;Cell membrane;Cell model;Cells;Cellular biology;Characteristics;Clinical;Cytoskeleton;Data Analyses;Development;Diagnosis;Diagnostic;Diffusion;Disease;Disseminated Malignant Neoplasm;Environment;Epithelial;Epithelial Cell Proliferation;Epithelial Cells;Extracellular Matrix;Genetic Determinism;Goals;Heterogeneity;Hour;Human;Image;Immigration;In Vitro;Integrins;Lateral;Ligands;MDA MB 231;Magnetism;Malignant Neoplasms;Malignant neoplasm of ovary;Mammary Gland Parenchyma;Measurement;Measures;Mechanics;Mediating;Membrane;Mesenchymal;Methodology;Microscope;Migration Assay;Modeling;Mus;Nanotechnology;Neoplasm Metastasis;Ovarian;Ovarian Tissue;Pathogenesis;Patients;Process;Property;Rheology;S-Phase Fraction;Signal Transduction;Signal Transduction Pathway;Specimen;Staging;System;Time;Tissues;Translations;Tumor Biology;Tumorigenicity;abstracting;bioimaging;cancer cell;cancer therapy;cell motility;data acquisition;epithelial to mesenchymal transition;high throughput screening;indexing;inhibin;insight;instrument;magnetic beads;malignant breast neoplasm;member;metastatic process;migration;neoplastic cell;neuronal cell body;prognostic;prototype;receptor;response;software development;tool;treatment effect;tumor;tumor progression","Array Microscope Assay for Cancer Cell Mechanics","Array Microscope Assay for Cancer Cell Mechanics Narrative We will develop a high throughput force assay system validated on cancer cell lines and on ex-vivo tumor specimens. This powerful system will be ready to be used for discovery of biochemical and genetic determinants of cancer cell metastatic properties to better understand the basic science, diagnosis and treatment of cancer.","NCI","8333396","8/20/2012 12:00:00 AM","RFA-CA-10-004","5R33CA155618-02","5","R33","CA","155618","02"," ","KNOWLTON, JOHN R","9/15/2011 12:00:00 AM","8/31/2014 12:00:00 AM","ZCA1-SRLB-V(M1)"," ","6113930","SUPERFINE, RICHARD ","Not Applicable","04","PHYSICS","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF ARTS AND SCIENCES","275995023","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","250721","58388"," ","309109",
"Bioengineering; Biotechnology; Brain Cancer; Brain Disorders; Cancer; Genetics; Lymphoma; Networking and Information Technology R&D; Rare Diseases","Address;Algorithms;Binding;Bioinformatics;Biological;Biomedical Computing;Biomedical Research;Budgets;Communities;Computational Biology;Computers;Consumption;DNA;DNA-Binding Proteins;Data;Data Analyses;Data Set;Dissection;Environment;Equipment;Faculty;Funding;Future;Genome;Glioma;Grant;High Performance Computing;Hour;Investigation;Investments;Lymphoma;Mesenchymal;Methodology;Mission;Nature;New York;Performance;Phenotype;Process;Recruitment Activity;Research;Research Infrastructure;Research Personnel;Role;Running;Shapes;Software Tools;Specificity;System;Systems Biology;Titan;United States National Institutes of Health;Universities;base;combinatorial;gene discovery;gene interaction;malignant phenotype;melanoma;novel;programs;success","High-performance compute cluster for biomedical computing","n/a","OD","8334997","7/31/2012 12:00:00 AM","PAR-11-228","1S10OD012351-01","1","S10","OD","012351","01"," ","LEVY, ABRAHAM","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-BST-F(30)I]"," ","7827402","CALIFANO, ANDREA ","Not Applicable","13","MISCELLANEOUS","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","SCHOOLS OF MEDICINE","100323725","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","351","Other Research-Related","2012"," "," ","OD","2000000"," "," ","2000000",
"Cancer; Genetics","Binding;Bromodomain;Carcinoma;Cell Cycle Progression;Cell Line;Chromatin;Communities;Complex;DNA Polymerase II;Embryo;Ensure;Epithelial;Etiology;Event;Genes;Genetic Transcription;Histones;In Vitro;Lead;Malignant Neoplasms;Mediating;Mesenchymal;Modeling;Molecular;Molecular Mechanisms of Action;Nature;Neoplasm Metastasis;Pattern;Phosphorylation;Phosphotransferases;Primary Neoplasm;Proteins;Publishing;Recruitment Activity;Regulation;Reporting;Stem cells;TAF7 gene;Time;Transcription Elongation;Transcription Initiation;Virus Diseases;base;genetic regulatory protein;in vivo;insight;interest;novel;promoter;therapeutic target;transcription factor TFIIH;transcription termination;tumor;tumor growth","Brd4 is an atypical kinase that regulates transcription","n/a","NCI","8553141"," "," ","1ZIABC011381-02","1","ZIA","BC","011381","02"," "," "," "," "," "," ","11199937","SINGER, DINAH S.","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","538148",
"No NIH Category available","Ablation;Adult;Area;Arteries;Automobile Driving;Blood Vessels;Cells;Data;Development;Disease;Embryo;Environment;Epicardium;Epithelial;Event;Future;Gastrointestinal tract structure;Goals;Health;Heart;Human;Injury;Invaded;Label;Lead;Mesenchymal;Mesothelium;Modeling;Morphogenesis;Natural regeneration;Omentum;Organ;Organogenesis;Pattern;Pattern Formation;Phenotype;Play;Process;Property;Regulation;Role;Smooth Muscle;Source;Stem cells;Structure;Surface;Therapeutic procedure;Transgenic Mice;Transplantation;Variant;Vascularization;cell preparation;cell type;injured;mouse model;regenerative;repaired","Serosal Mesothelium and Vascularization of the Gut","
Development of the major blood vessels of the gut is not understood. Our studies will
determine the source of blood vessels in the embryonic gut and how the pattern of
formation is regulated. These studies will form the background for future analysis of
abnormal blood vessel formation in development and disease.","NIDDK","8298628","6/25/2012 12:00:00 AM","PA-07-070","5R01DK083234-04","5","R01","DK","083234","04"," ","CARRINGTON, JILL L","8/1/2009 12:00:00 AM","7/31/2014 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","3223271","BADER, DAVID M","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","213172","119376"," ","332548",
"Bioengineering; Biotechnology; Chronic Liver Disease and Cirrhosis; Digestive Diseases; Liver Disease; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Acetaminophen;Achievement;Acute;Acute Kidney Failure;Acute Liver Failure;Address;Ally;Animal Model;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Artificial Liver;Bioreactors;Biotechnology;Blood;Businesses;Canis familiaris;Cell Count;Cell Survival;Cell physiology;Cell secretion;Cells;Chronic;Clinic;Clinical;Commit;Complex;Critical Illness;Data;Development;Devices;Dose;Drug Delivery Systems;Engineering;Environment;Fiber;Functional disorder;Funding;Germ Cells;Glycocalyx;Goals;Hepatocyte;Hepatology;Human;Hybrids;Image;Imaging Device;Immune response;Inflammation;Inflammatory;Injection of therapeutic agent;Investments;Letters;Liver;Liver Failure;Marketing;Medical;Membrane;Mesenchymal Stem Cells;Methods;Modeling;Monitor;Nutrient;Organ;Organ failure;Patients;Phase;Plant Roots;Poisoning;Positron-Emission Tomography;Procedures;Property;Rattus;Simulate;Small Business Innovation Research Grant;Stem cells;Subcutaneous Injections;Technology;Testing;Therapeutic;Therapy Clinical Trials;Time;Tissue Engineering;Translating;Transplantation;base;bioimaging;chronic liver disease;clinical efficacy;clinically relevant;combinatorial;commercialization;cost;effective therapy;in vivo;injured;liver transplantation;mortality;operation;patient population;pre-clinical;programs;prototype;regenerative;repaired;single molecule;tissue repair;tool","Cellular Device for the Treatment of Acute Liver Failure"," Biotechnologies Inc. has developed an extracorporeal device that has the potential to offer unparalleled support to patients undergoing acute liver failure. Th Sentien device delivers to the patient a broad-spectrum array of secreted factors from mesenchymal stem cells. Collectively, these factors protect the injured organ from inflammation and promote endogenous repair programs. This combinatorial approach to liver therapy is distinguishable from the competition and promises to become a disruptive technology. Sentien now seeks funding to finalize its pre-clinical development by creating optimized cellular coatings and performing subsequent in vivo testing in large animal models of liver failure. At the end of these studies, Sentien expects to have sufficient evidence of pre-clinical efficacy to motivate initial trials of this device in humans.   
   
      

","NIDDK","8313302","3/12/2012 12:00:00 AM","PA-11-096","1R43DK093285-01A1","1","R43","DK","093285","01","A","DENSMORE, CHRISTINE L","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-DKUS-A(10)B]"," ","6825988","TILLES, ARNO W","PAREKKADAN, BIJU ","05","Unavailable","828970900","NDAYRDKCMBJ7","828970900","NDAYRDKCMBJ7","US","42.415247","-71.127241","10020782","SENTIEN BIOTECHNOLOGIES, INC.","Lexington","MA","Domestic For-Profits","024217998","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","SBIR/STTR","2012"," "," ","NIDDK"," "," "," ","307888",
"Biotechnology; Genetics; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","3-Dimensional;Address;Adult;Allogenic;Animals;Autologous;Bolus Infusion;Canis familiaris;Cell Count;Cell Line;Cells;Characteristics;Communication;Complementary DNA;Connexin 43;Connexins;Coupled;Data;Dermis;Diffuse;Diffusion;Dimensions;Effectiveness;Exposure to;Extracellular Space;Fluorescence;Gap Junctions;Gene Silencing;Gene Targeting;Genes;Giant Cells;Green Fluorescent Proteins;Heart;High Pressure Liquid Chromatography;Hour;Human;Image;Immune response;In Vitro;Injection of therapeutic agent;Knowledge;Length;Measures;Mediating;Membrane Proteins;Mesenchymal Stem Cells;Messenger RNA;Modeling;Monitor;Nude Mice;Organ;Pacemakers;Pathway interactions;Penetration;Permeability;Pharmaceutical Preparations;Positioning Attribute;Problem Solving;Proteins;Protocols documentation;RNA chemical synthesis;Relative (related person);Reverse Transcriptase Polymerase Chain Reaction;Site;Small Interfering RNA;Source;System;Tail;Testing;Therapeutic;Therapeutic Agents;Time;Tissues;Veins;Western Blotting;base;cell motility;cell type;clinical application;density;design;fluorescence imaging;gap junction channel;heart cell;in vivo;inhibitor/antagonist;lucifer yellow;mathematical model;monolayer;patch clamp;public health relevance;research study;small molecule;three-dimensional modeling;time use;tumor","SiRNA therapeutics: Gap junction delivery in vitro and in vivo","
Project Narrative
Small interfering RNA (siRNA) targets a single protein reducing its expression. As such it has great potential as
a highly selective drug. However systems for its in vivo delivery are not optimal. The present application
investigates the ability of the immuno-privileged adult mesenchymal stem cell (MSC) as well as other cell types
to deliver small interfering RNA (siRNA) to a target cell or tissue. The basis of this cell based delivery is the
gap junction channel. These channels connect the intracellular compartments of coupled cells and allow
transfer of small molecules without entry into the extracellular space. We have already established that cells
that make connexins (the building block of gap junctions) can transfer siRNAs. This application asks whether
cells can serve as a delivery system for siRNA. By a combination of experiment and mathematical modeling
we seek to determine the ability of cellular delivery of siRNA to penetrate tissues in vitro and in vivo.","NIGMS","8330252","8/27/2012 12:00:00 AM","PA-07-070","5R01GM088180-03","5","R01","GM","088180","03"," ","NIE, ZHONGZHEN","9/1/2010 12:00:00 AM","8/31/2014 12:00:00 AM","Intercellular Interactions Study Section[ICI]"," ","1891199","BRINK, PETER R","COHEN, IRA S; MATHIAS, RICHARD T","01","PHYSIOLOGY","804878247","M746VC6XMNH9","804878247","M746VC6XMNH9","US","40.907353","-73.128565","5992612","STATE UNIVERSITY NEW YORK STONY BROOK","STONY BROOK","NY","SCHOOLS OF MEDICINE","117943362","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","261565","149092"," ","410657",
"No NIH Category available"," ","Investigation of the role of Mind bomb in epithelial morphogenesis","Project Narrative
Metastasis is a series of process that tumor cells lose their stationary epithelial characteristics and
acquire migratory mesenchymal characteristics. More than 500,000 Americans lost their lives to
metastatic cancer in 2008. Understanding the molecular mechanisms for the acquisition of highly
invasive characteristics will contribute to developing therapeutic protocols for preventing and
treating cancers. __SpecificAimsTextDelimiter__ 
10. SPECIFIC AIM
Metastasis is a series of process that tumor cells lose their stationary epithelial characteristics
and acquire migratory mesenchymal characteristics(1-5). Tumor cells lose original epithelial
characteristics such as strong cell-cell adhesion, leave a primary site of the tumor and invade into
the adjacent tissues. However, molecular mechanisms critical to change the cellular
characteristics are NOT well understood. Although multiple signaling pathways are involved in the
cancer metastasis(6-11), growing evidence suggests that one of the critical signaling cascades
for the acquisition of highly invasive characteristics is Notch signaling(12-20). Notch signaling
plays a well-characterized role in cell fate specifications, stem cell renewal, and cell differentiation.
However, the role of Notch signaling, determining the invasive cell characteristics remains poorly
understood. Our long-term goal is to elucidate the molecular mechanism by which Notch
signaling and its modulators regulate the invasive cell properties, thus serving as a
necessary prerequisite to developing new therapeutic protocols for treating and preventing
metastatic cancers. The specific target of our study is Mind bomb (Mib), a E3 ubiquitin ligase for
the Notch ligand, Delta. Mib ubiquitinates Delta and promotes Delta endocytosis, which is essential
for effective Notch signaling. Our hypothesis is that; Mind bomb (Mib) plays a critical role in
epithelial morphogenesis not only by promoting Notch signaling but also by interacting with
additional proteins that directly regulate epithelial cell polarity independently of Notch
signaling. Our hypothesis is based on the following observations. First, in addition to aberrant cell
fate decisions, mib mutants show morphological malformations. Second, a loss of Notch
manipulation does not completely phenocopy morphological defects in mib mutants. It suggests
that changes in mib mutants may not only be due to morphological changes accompanied with
aberrant cell fate changes following loss of Notch signaling. Third, recent studies in our lab indicate
that Mib interacts with Epb4.1l5, a critical regulator of cell polarity formation. The zebrafish is an
excellent vertebrate model system to visualize the behavior of individual cells. In this study, we
focus on the sensory organ, the posterior lateral line (pLL). During pLL morphogenesis,
migratory mesenchymal cells acquire more stationary epithelial cell characteristics. It
seems an ideal model system to investigate how these two processes, Notch-mediated cell fate
decision and epithelial morphogenesis, are regulated by Mib.
The specific aims are to:
1. Define the Notch -dependent and -independent function of Mib in pLL morphogenesis:
We will perform morphological and molecular characterization of pLL organogenesis in mib
mutants. We will investigate how Mib contributes to pLL morphogenesis in Notch-dependent and
Notch-independent manners.
2. Characterize molecular mechanism of the Notch-independent Mib function in epithelial
morphogenesis: We will focus on the investigation of Notch-independent Mib function. To
understand the molecular mechanism of this Mib function, we will focus on the interactions
between Mib and Epb4.1l5, a protein that regulates apical-basal polarity in epithelial cells.
More than 500,000 Americans lost their lives to metastatic cancer in 2008, because current drug
and radiation treatments are only partially effective or too toxic to be used safely(21). Thus, new
rationally designed therapies are urgently needed to control, cure and prevent invasive
malignancies. In this proposed study, we use the zebrafish lateral line as a model system to
understand the molecular mechanisms by which mesenchymal cells acquire epithelial cell
characteristics. We believe that the successful completion of our basic research proposed here will
be applicable to understanding the mechanisms by which stationary epithelial cells acquire the
property of highly malignant carcinoma in our bodies. It will lead to new therapies that effectively
prevent and eliminate invasive forms of cancers.","NICHD","8711843","8/14/2013 12:00:00 AM","PA-11-197","6R00HD062561-03","6","R00","HD","062561","03"," ","JAVOIS, LORETTE CLAIRE","9/1/2010 12:00:00 AM","8/31/2015 12:00:00 AM","NSS"," ","9710938","MATSUDA, MIHO ","Not Applicable","10","ANATOMY/CELL BIOLOGY","078795851","QHHJD3X516J9","078795851","QHHJD3X516J9","US"," "," ","10034169","RBHS-NEW JERSEY MEDICAL SCHOOL","NEWARK","NJ","SCHOOLS OF MEDICINE","071032757","UNITED STATES","N","7/1/2013 12:00:00 AM","8/31/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","22166","13078"," ","35244",
"Aging; Cancer; Genetics; Prostate Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Urologic Diseases","American;Androgen Receptor;Androgens;Automobile Driving;Award;Biochemistry;Biological;C-KIT Gene;CD44 gene;Cancer Biology;Cell physiology;Cells;Cellular biology;ChIP-on-chip;Data;Dependency;Development;Development Plans;Dyes;Environment;Enzymes;Epigenetic Process;Epithelial Cells;Event;Exhibits;Foundations;Gene Expression;Gene Expression Regulation;Gene Targeting;Genes;Genetic Transcription;Histones;Human;Hypoxia;In Vitro;Invaded;Lentivirus Vector;Lesion;Link;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Mentors;Mesenchymal;Modality;Modeling;Molecular Biology;Monitor;Mus;Neoplasm Metastasis;Neurosecretory Systems;PKH 26;Phase;Phenotype;Play;Positioning Attribute;Property;Prostate;Prostate Adenocarcinoma;Prostate Neuroendocrine Neoplasm;Prostatic Neoplasms;Proteins;Recruitment Activity;Regulation;Research;Resistance;Resources;Role;Signal Transduction;Stem Cell Factor;Stem cells;System;Technology;Testing;Therapeutic;Transcript;Work;cancer cell;cancer stem cell;career;career development;demethylation;design;embryonic stem cell;epithelial to mesenchymal transition;hormone therapy;hypoxia inducible factor 1;in vivo Model;matrigel;men;novel;novel therapeutics;outcome forecast;programs;promoter;protein expression;research study;self-renewal;slug;small hairpin RNA;therapy resistant;transcription factor;tumor;tumor progression;tumor xenograft;tumorigenesis","Role of Jmjd1a in hypoxia-induced EMT and prostate cancer stem cells"," The proposed studies will characterize the role of epigenetic control, by histone demethylase - Jmj1a - in hypoxia-induced EMT, and the implication of this new regulatory axis to prostate cancer stem cells and normal prostate stem cells. Because EMT and stem cell-like phenotypes are tightly associated with tumor progression, metastasis, poor prognosis and therapeutic resistance, our proposed studies offer novel mechanisms driving the progression of human prostate cancer, with implications for targeted therapy and monitoring.    

","NCI","8309461","8/2/2012 12:00:00 AM","PA-10-063","5K99CA154888-02","5","K99","CA","154888","02"," ","SCHMIDT, MICHAEL K","8/1/2011 12:00:00 AM","7/31/2013 12:00:00 AM","Institutional Training and Education Study Section (F)[NCI-F]"," ","10300476","QI, JIANFEI ","Not Applicable","49","Unavailable","020520466","PHMKYKKJLQS1","020520466","PHMKYKKJLQS1","US","32.903503","-117.243803","1180101","SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE","LA JOLLA","CA","Research Institutes","920371005","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","99680","7974"," ","107654",
"No NIH Category available","Address;Adult;Cell Culture Techniques;Cell Differentiation process;Cell Proliferation;Cells;Cilia;Code;Complex;Data;Development;Duct (organ) structure;Embryonic Development;Endocrine;Epithelial;Epithelial Cells;Epithelium;Erinaceidae;GLI2 gene;Gene Targeting;Genes;Islets of Langerhans;Mesenchymal;Names;Nature;Organ;Organogenesis;Pancreas;Pathway interactions;Play;Principal Investigator;Research;Role;Staging;Time;Transcription Coactivator;Transgenic Mice;appendage;cell type;design;embryonic stem cell;human SMO protein;novel;programs;research study;smoothened signaling pathway","Effects of Hedgehog Signaling on Pancreas Organogenesis","n/a","NIDDK","8265841","2/8/2012 12:00:00 AM","PA-07-070","5R01DK060533-10","5","R01","DK","060533","10"," ","SATO, SHERYL M","3/1/2003 12:00:00 AM","2/28/2014 12:00:00 AM","Cellular Aspects of Diabetes and Obesity Study Section[CADO]"," ","6796101","HEBROK, MATTHIAS ","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","207952","109862"," ","317814",
"Cancer; HIV/AIDS","Blood;Blood Vessels;Cancer Center Support Grant;Cancer Immunology Science;Cells;Comprehensive Cancer Center;Critical Pathways;Development;Doctor of Medicine;Doctor of Philosophy;Epithelial Cells;Extracellular Matrix;Faculty;Family;Fibroblasts;Fostering;Foundations;Funding;Goals;HIV Infections;Homeostasis;Immune;Immunity;Lymphatic;Malignant Neoplasms;Mesenchymal;Molecular;Organ;Pathway interactions;Patients;Peer Review Grants;Physiological Processes;Population;Prevention;Publications;Publishing;Research Support;Stromal Cells;Therapeutic;Tissues;Virus Diseases;base;cell type;combat;human cancer mouse model;insight;medical schools;mouse model;neoplastic cell;novel;novel strategies;preclinical study;programs;tumor;tumorigenesis","Cancer, Immunology, Microenvir","n/a","NCI","8388358","10/12/2012 2:36:25 PM","PAR-11-005","2P30CA082103-14","2","P30","CA","082103","14"," "," ","8/5/1999 12:00:00 AM","5/31/2017 12:00:00 AM","Cancer Centers Study Section (A)[NCI-A]","6389","2446782","MCCORMICK, FRANK PATRICK","Not Applicable","12","Unavailable","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","Domestic Higher Education","941432510","UNITED STATES","N","9/19/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Research Centers","2012","146","146"," ","93","53"," "," ",
"Neurosciences; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adhesions;Adrenergic Receptor;Angiopoietin-1;Antibodies;Apoptosis;Applications Grants;Biological;Biological Assay;Biology;Blood Circulation;Blood Vessels;Bone Marrow;CSF1R gene;CXCL12 gene;Cell Adhesion Molecules;Cells;Circadian Rhythms;Cisplatin;Collaborations;Data;Denervation;Dichloromethylene Diphosphonate;Endothelium;Engineering;Fc Immunoglobulins;Funding;Genes;Granulocyte Colony-Stimulating Factor;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;Homing;ITGAM gene;Immunology;In Vitro;Institutes;Lead;Lesion;Liposomes;Marrow;Mediating;Mesenchymal Stem Cells;Methods;Modeling;Molecular;Mus;Natural regeneration;Nature;Nerve;Neurons;Neuropathy;Norepinephrine;Pathway interactions;Peritoneal;Procedures;Recovery;Regulation;Regulatory Pathway;Research;Role;SLAM protein;Signal Transduction;Stem Cell Factor;Stem cell transplant;Stem cells;Stromal Cells;Sympathetic Nervous System;System;Testing;Time;Toxin;Transfusion;Transplantation;Tyrosine 3-Monooxygenase;base;cellular targeting;chemotherapy;clinically relevant;cytokine;genome-wide;in vivo;macrophage;monocyte;nestin protein;neuroprotection;neurotoxicity;neurotrophic factor;novel;progenitor;promoter;public health relevance;receptor expression;receptor function;relating to nervous system;self-renewal;stem;stem cell niche;trafficking","Mechanisms mediating hematopoietic stem and progenitor cell trafficking","
Studies conducted under this project have revealed that the bone marrow niche consists
of the paring of the two stem cells, mesenchymal and hematopoietic, that inhabit the
marrow. Here, we will explore further the hypothesis that the retention of hematopoietic
stem and progenitor cells in the niche is regulated by differing signals from the
sympathetic nervous system and macrophages.","NIDDK","8307238","7/24/2012 12:00:00 AM","PA-07-303","5R01DK056638-12","5","R01","DK","056638","12"," ","WRIGHT, DANIEL G","3/1/2000 12:00:00 AM","7/31/2014 12:00:00 AM","Hematopoiesis Study Section[HP]"," ","2085323","FRENETTE, PAUL S","Not Applicable","14","INTERNAL MEDICINE/MEDICINE","110521739"," ","110521739"," ","US","40.851026","-73.844361","9433501","ALBERT EINSTEIN COLLEGE OF MEDICINE","BRONX","NY","SCHOOLS OF MEDICINE","104611900","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","135581"," ","341006",
"Biotechnology; Cancer; Clinical Research; Dental/Oral and Craniofacial Disease; Infectious Diseases; Orphan Drug; Rare Diseases","Address;Antibodies;Candidate Disease Gene;Cetuximab;Cisplatin;Clinical;Collaborations;DNA Repair Pathway;Data;Data Set;Databases;Disease;Distant Metastasis;Distress;Double Strand Break Repair;Epidermal Growth Factor Receptor;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Formalin;Funding;Gene Expression;Gene Expression Profile;Grant;Head and Neck Squamous Cell Carcinoma;Human Papillomavirus;Immunohistochemistry;In Vitro;Individual;Instruction;Lung;Malignant Epithelial Cell;Mesenchymal;Meta-Analysis;Outcome;Paraffin Embedding;Pathway interactions;Patients;Phase;Phase III Clinical Trials;Physicians;Population;Postoperative Period;Prognostic Marker;Proteins;Proteomics;Radiation Therapy Oncology Group;Randomized;Regimen;Relapse;Research Personnel;Resistance;Signal Pathway;Signal Transduction;Societies;Source;Specialized Program of Research Excellence;Specimen;Telomerase;Testing;Therapeutic;Tissues;Toxic effect;Validation;XRCC5 gene;base;candidate marker;clinical application;clinical practice;combat;design;epithelial to mesenchymal transition;experience;genome-wide;improved;in vitro Model;novel;novel marker;pre-clinical;preference;programs;randomized trial;receptor expression;resistance mechanism;response;response marker;therapeutic target;tumor;working group","Markers and therapeutic strategies for overcoming chemoradiotherapy resistance","RELEVANCE (See instructions): 
This project has the potential to directly advance the treatment of HNSCC in several ways. Identification of 
predictive markers for rational selection of better suited therapy for individual patients with defined tumor 
features will improve tumor control while reducing unnecessary patient distress and the financial burden to 
patients and society. Furthermore, markers and mechanisms of resistance to CRT will be identified and 
strategies for overcoming it will be developed.","NCI","8338880","7/12/2012 12:00:00 AM"," ","5R01CA168484-02","5","R01","CA","168484","02"," ","BERNHARD, ERIC J","9/26/2011 12:00:00 AM","7/31/2016 12:00:00 AM","ZCA1-RPRB-O(M1)"," ","1894553","HEYMACH, JOHN V","Not Applicable","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","184572","105498"," ","290070",
"Genetics; Kidney Disease","Adipocytes;Adult;Age;Age-Months;Albumins;Albuminuria;Animals;Apoptosis;B-Lymphocytes;Biochemistry;Biology;Blood Urea Nitrogen;Cell Lineage;Cell physiology;Cells;Cellular Structures;ChIP-seq;Child;Chronic Kidney Failure;Clinical Treatment;Commit;Core Facility;Cues;Defect;Development;Disease Progression;Distal convoluted renal tubule structure;Duct (organ) structure;Early identification;Education;Embryo;Ensure;Epithelial;Epithelium;Event;Exhibits;Faculty;Failure;Funding;Future;Gene Expression;Gene Targeting;Genes;Genome;Goals;Grant;Histology;In Vitro;Investigation;Investments;Kidney;Kidney Diseases;Kidney Failure;Laboratories;Life;Mediating;Medical;Mentors;Mesenchymal;Mesenchyme;Metabolic;Metanephric Diverticulum;Metanephric structure;Molecular;Molecular Biology;Monitor;Morphogenesis;Mus;N-Cadherin;National Institute of Diabetes and Digestive and Kidney Diseases;Nephrons;Organogenesis;Osteoblasts;Participant;Pathologist;Pathology;Pathway interactions;Pattern;Performance;Phenotype;Physical condensation;Physiological;Population;Positioning Attribute;Postdoctoral Fellow;Prevalence;Process;Protein Family;Proteins;Proteinuria;RNA;Regulation;Renal function;Reporter;Research;Research Personnel;Response Elements;Role;Scientist;Signal Pathway;Signal Transduction;Staging;Syndrome;Techniques;Time;Tissue Differentiation;Tissues;Training;Transcript;Transcriptional Regulation;Transfection;Tubular formation;Undifferentiated;Vascularization;Work;blastema;career;cell type;cytokine;design;epithelial to mesenchymal transition;in vivo;interstitial cell;kidney cell;mesangial cell;migration;nephrogenesis;novel;podocyte;postnatal;progenitor;protein expression;research study;transcription factor;wasting","Regulation of Podocyte Differentiation by the Transcription Factor EBF1"," We have identified the transcriptional regulator Early B Cell Factor 1 (Ebf1) as a completely novel key participant in renal development and podocyte function. Currently an estimated 11.5 percent of adults ages 20 or older have physiological evidence of chronic kidney disease, while congential nephritic syndrome has a prevalence of 16 per 100,000 children. Investigation into the mechanisms underlying Ebf1's role in disease progression will be instrumental to increasing the potential for more effective clinical treatments
for management of renal disorders effecting podocytes.      

","NIDDK","8383289","7/6/2012 12:00:00 AM","PA-11-197","1K99DK093711-01A1","1","K99","DK","093711","01","A","RANKIN, TRACY L","7/15/2012 12:00:00 AM","4/30/2014 12:00:00 AM","Kidney, Urologic and Hematologic Diseases D Study Section[DDK-D]"," ","10218218","FRETZ, JACKIE ","Not Applicable","03","ORTHOPEDICS","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","7/15/2012 12:00:00 AM","4/30/2013 12:00:00 AM","847","Other Research-Related","2012"," "," ","NIDDK","83333","6667"," ","90000",
"No NIH Category available","Adipocytes;Adverse effects;Aging;Animals;Automobile Driving;Binding;Bone Marrow;Bone Resorption;Cells;Communities;Data;Disease;Dose;Enhancers;Estrogens;Event;Fatty acid glycerol esters;Femoral Fractures;Fracture;General Population;Growth;Homeostasis;Human;Immobilization;Implant;Injury;Laboratories;Lead;Lipids;Malignant Neoplasms;Marrow;Measures;Mediating;Mesenchymal Stem Cells;Nodule;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis;Osteoporosis prevention;PPAR gamma;Pathway interactions;Peroxisome Proliferator-Activated Receptors;Pharmaceutical Preparations;Population;Proteins;Rattus;Relative (related person);Reporter;Repression;Risk;Role;Signal Pathway;Signal Transduction;Signaling Molecule;Small Interfering RNA;Stem cells;Steroids;Stimulus;Surface;Testing;Therapeutic;Therapeutic Agents;Tumor Necrosis Factor-alpha;Ubiquitin;Veterans;Work;beta catenin;bisphosphonate;bone;bone loss;bone mass;bone morphogenetic protein 2;cell type;cost;design;human TNF protein;in vivo;innovation;lipid biosynthesis;mimetics;mineralization;novel;novel therapeutics;osteogenic;osteosarcoma;prevent;progenitor;receptor;small molecule;transcription factor","Mechanisms by which LMP-1 Regulates Lineage Commitment in Mesenchymal Stem Cells","Osteoporosis manifested by low bone mass and increased risk of fragility fractures is an increasing problem within the aging Veteran population. Osteoporosis can be accelerated by aging, steroid treatment, and immobilization from traumatic injuries. It is estimated that there ar over 2 million fractures costing $17 billion dollars per year in the US. By 2025, annual fractures and costs are projected to increase by 50%. Although several drugs are available to slow bone loss and one to increase bone mass, most have been found to have side effects (estrogen-cancer, bisphosphonates-implant loosening/femur fractures, PTH-osteosarcoma in rats). No osteoporosis treatment consistently and safely increases bone formation over the long term. This VA MERIT proposal seeks to confirm and utilize a key observation that a small protein, LMP-1, influences the pool of cells that form bone and fat driving them towards bone formation rather than fat formation. Successful completion of this proposal will lead to a new paradigm for preventing and/or treating osteoporosis.","VA","8332604","3/26/2012 12:00:00 AM","RFA-BX-11-014","1I01BX001764-01","1","I01","BX","001764","01"," "," ","4/1/2012 12:00:00 AM","3/31/2016 12:00:00 AM","Endocrinology B[ENDB]"," ","9523595","TITUS, FRANCES LOUISA","Not Applicable","04","Unavailable","824835805","JN4QJ2LB2S13","824835805","JN4QJ2LB2S13","US","33.801554","-84.309778","481023","VETERANS HEALTH ADMINISTRATION","DECATUR","GA","Independent Hospitals","300334004","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Dental/Oral and Craniofacial Disease; Neurosciences; Regenerative Medicine; Stem Cell Research","Address;Adult;Afferent Neurons;Animal Model;Autologous;Biochemical Markers;Biological Models;Biomedical Research;Bone Regeneration;Callithrix;Callithrix jacchus jacchus;Cartilage;Cell Differentiation process;Cell Lineage;Cell Maintenance;Cell Therapy;Cell Transplantation;Cell model;Cells;Cephalic;Clinical;Complex;Cranial Nerves;Cues;Dental;Dental Pulp;Dentin;Dentistry;Dentists;Development;Electrophysiology (science);Embryo;Embryonic Development;Epithelial;Epithelium;Event;Face;Flow Cytometry;Future;Gene Expression;Generations;Genes;Goals;Human;Human Development;In Vitro;Investigation;Laboratories;Mandible;Maxilla;Meckel&apos;s cartilage;Mesenchymal;Mesenchymal Differentiation;Mesenchyme;Modeling;Molecular;Molecular Profiling;Multipotent Stem Cells;Natural regeneration;Neural Crest;Neural Crest Cell;Neurons;Odontoblasts;Osteoblasts;Patients;Peripheral;Peripheral Nerves;Peripheral Nervous System;Phenotype;Play;Pluripotent Stem Cells;Population;Pregnancy;Primates;Research;Research Proposals;Role;Safety;Schwann Cells;Scientist;Signal Pathway;Signal Transduction;Somatic Cell;Sorting - Cell Movement;Source;Specific qualifier value;Stem cells;Structure;Structure of trigeminal ganglion;Testing;Tissue Transplantation;Tooth structure;Training;Translational Research;bone;career;cell motility;cell type;clinical application;extracellular;face bone structure;immunocytochemistry;in vivo;induced pluripotent stem cell;innovation;nonhuman primate;osteogenic;regenerative;relating to nervous system;stem;stem cell population;therapy development;tissue regeneration","Establishment of Marmoset iPS-derived Cranial Neural Crest Cells"," Induced pluripotent stem (iPS) cells are a new and exciting source of cells useful to develop stem cell populations that will promote the regeneration of tissues and structures in the body through cell or tissue transplantation. Cranial neural crest (CNC) stem cells are an ideal population to develop from iPS cells due to their known critical role in contributing to the proper formation of cranial-facial cartilage, bone, teeth, and the cranial peripheral nervous system during vertebrate development. The planned studies will develop and characterize CNC stem cells from iPS cells of the common marmoset (Callithrix jacchus); a non-human primate model useful for developing and evaluating stem cell based therapies.  
    

","NIDCR","8256468","5/31/2012 12:00:00 AM","PA-11-110","1F30DE022494-01","1","F30","DE","022494","01"," ","FRIEDEN, LESLIE A","8/1/2012 12:00:00 AM","7/31/2015 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","10223012","FARNSWORTH, STEVEN ","Not Applicable","21","PHYSIOLOGY","800772162","C3KXNLTAAY98","800772162","C3KXNLTAAY98","US","29.513082","-98.577731","578418","UNIVERSITY OF TEXAS HLTH SCIENCE CENTER","SAN ANTONIO","TX","SCHOOLS OF MEDICINE","782293901","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","29912"," "," ","29912",
"Biotechnology; Cancer; Genetics; Ovarian Cancer; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","ABCB1 gene;Adhesions;Advanced Malignant Neoplasm;Affect;Apoptosis;Bioinformatics;Cancer Diagnostics;Cancer Patient;Carboplatin;Cell physiology;Cells;Clinic;Detection;Diagnostic;Drug resistance;E-Cadherin;Embryo;Epithelial;Epithelial Cells;Exhibits;Family;Family member;Gene Expression;Genes;Growth;HMGA2 gene;Human;In Vitro;Malignant Neoplasms;Malignant neoplasm of ovary;Mesenchymal;Messenger RNA;MicroRNAs;Modeling;Molecular Profiling;Monitor;Multidrug Resistance Gene;Mutation;Neoplasm Metastasis;Nucleotides;Oncogenic;Paclitaxel;Patients;Pharmaceutical Preparations;Phenotype;Primary Neoplasm;Process;Property;Proteins;RNA;Resistance;Role;Severity of illness;Small RNA;Staging;Stem cells;Taxane Compound;Testing;Translating;Tumor Necrosis Factor Ligand Superfamily Member 6;base;blastomere structure;cancer cell;cancer therapy;cell type;chemotherapy;design;epithelial to mesenchymal transition;human disease;improved;in vivo;mouse model;neoplastic cell;prevent;response;self-renewal;taxane;tool;transcription factor;tumor progression","The Role of MicroRNAs in Tumor Progression","
Narrative
Micro (mi)RNAs are small RNA molecules that target various messenger RNAs in cells so that they cannot be
translated into proteins and it has become clear that miRNAs are key players in regulating differentiation
processes and cancer. This proposal is aimed at defining the function of the two miRNA families, let-7 and
miR-200 and their targets in cancer progression. The results of this study have the potential to improve cancer
diagnostics and treatment through detection of miRNA targets and modulating the expression of miRNAs
and/or their targets in human cancers.","NCI","8267742","5/10/2012 12:00:00 AM","PA-07-070","5R01CA149356-12","5","R01","CA","149356","12"," ","JHAPPAN, CHAMELLI","7/1/2000 12:00:00 AM","4/30/2015 12:00:00 AM","Development - 1 Study Section[DEV1]"," ","6483309","PETER, MARCUS E.","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","005436803","KG76WYENL5K1","005436803","KG76WYENL5K1","US","41.896017","-87.616602","6144650","NORTHWESTERN UNIVERSITY AT CHICAGO","CHICAGO","IL","SCHOOLS OF MEDICINE","606114579","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","190038","82139"," ","272177",
"Autoimmune Disease; Cancer; Lung; Lung Cancer; Orphan Drug; Rare Diseases","1-Phosphatidylinositol 3-Kinase;Accounting;Adenocarcinoma;Alveolar;American;Asbestos;Asbestos-related lung injury;Automobile Driving;Behavior;Binding;Biochemical;Cancer Etiology;Cell Proliferation;Cell Surface Receptors;Cell membrane;Cell surface;Cells;Cessation of life;Characteristics;Chronic Obstructive Airway Disease;Chronic lung disease;Clathrin;Data;Development;Disease;Disease Progression;Disease model;Distant;E-Cadherin;Endocytosis;Endosomes;Enzymes;Epithelial;Fibroblasts;Fibrosis;Grant;Hamman-Rich syndrome;Hyperplasia;Inflammatory;Joints;Leukocyte Elastase;Link;Lung;Lung Adenocarcinoma;Lung Neoplasms;Malignant Neoplasms;Malignant neoplasm of lung;Mediating;Mesenchymal;Modeling;Movement;Mus;Myofibroblast;N-Cadherin;National Heart, Lung, and Blood Institute;Nature;Neoplasm Metastasis;Organ;Outcome;Pathway interactions;Patients;Peptide Hydrolases;Phenotype;Process;Production;Proteins;Pulmonary Fibrosis;Reporting;Risk;Serine Protease;Therapeutic;adenoma;advanced disease;antimicrobial drug;cancer cell;cell behavior;design;epithelial to mesenchymal transition;expression cloning;in vivo;insulin receptor substrate 1 protein;mortality;mouse model;neoplastic cell;neutrophil;neutrophil elastase inhibitor;new therapeutic target;novel;receptor;research study;therapeutic target;tumor;tumor growth","""Neutrophil Elastase Links Idiopathic Pulmonary Fibrosis and Lung Cancer"""," Lung cancer and idiopathic pulmonary fibrosis are ""linked,"" diseases, meaning that patients with IPF are at an increased risk to subsequently develop lung cancer. The outcomes for both of these diseases are dismal, with combined mortality reaching nearly 200,000 American lives each year. We have identified an inflammatory cell derived protein called neutrophil elastase that promotes disease progression in both IPF and lung cancer. The purpose of this proposal is to establish neutrophil elastase as a legitimate therapeutic target for patients with lung cancer and/or pulmonary fibrosis.    

","NHLBI","8302284","6/15/2012 12:00:00 AM","PA-10-067","7R01HL108979-02","7","R01","HL","108979","02"," ","HARABIN, ANDREA L","7/15/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","6786529","HOUGHTON, A MCGARRY","Not Applicable","07","Unavailable","078200995","HMSNCM57QNR5","078200995","HMSNCM57QNR5","US","47.628707","-122.330795","861001","FRED HUTCHINSON CANCER RESEARCH CENTER","SEATTLE","WA","Research Institutes","981094433","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","178600"," ","428600",
"Arthritis; Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Adipose tissue;Adult;Affect;American;Anatomy;Arthralgia;Arthritis;Autologous Transplantation;Biochemical;Biocompatible Materials;Biological;Biomechanics;Cartilage;Cartilage Matrix;Cell Culture Techniques;Cells;Chemicals;Chondrogenesis;Clinical;Communities;Core Facility;Defect;Degenerative polyarthritis;Development;Differentiation and Growth;Disease;Ear;Elastic Cartilage;Engineering;Extracellular Matrix;Functional disorder;Future;Gene Expression;Goals;Growth;Harvest;Head and neck structure;Histologic;Human;Implant;In Situ;In Vitro;Infiltration;Inflammation;Injury;Joint repair;Joints;Maintenance;Measures;Mechanics;Medical;Mesenchymal Stem Cells;Methods;Modeling;Molds;Molecular;Molecular Profiling;Monitor;Morbidity - disease rate;Morphology;Natural regeneration;Nose;Nucleic Acids;Operative Surgical Procedures;Orthopedics;Oryctolagus cuniculus;Pathology;Patients;Performance;Phase;Phenotype;Plastic Surgical Procedures;Plastics;Procedures;Process;Property;Protein Analysis;Proteins;Proteome;Proteomics;Quality Control;Reaction;Reconstructive Surgical Procedures;Risk;Risk Factors;Safety;Sampling;Shapes;Small Business Innovation Research Grant;Spatial Distribution;Stem cells;Synovial Membrane;Technology;Testing;Time;Tissue Engineering;Tissues;Toxic effect;Trachea;Trauma;Treatment Cost;Ultraviolet Rays;Weight-Bearing state;Work;articular cartilage;base;bone;cartilage allograft;cartilage development;cartilage repair;crosslink;disability;economic impact;immunogenic;implantation;improved;in vivo;insight;joint injury;long bone;macrophage;meetings;novel;physical process;protein expression;reconstruction;repaired;scaffold;success;tissue repair","A crosslinked cartilage-derived matrix for cartilage tissue engineering","  The goal of this Phase I SBIR project is to develop a novel tissue engineered scaffold consisting of processed articular cartilage extracellular matrix that has been cross-linked so it can maintain a pre-defined anatomical shape. The ability of this porous, biologically active scaffold to support cartilaginous tissue formation will be tested using
human adipose-derived or mesenchymal stem cells in long-term in vitro culture. Additionally, cartilaginous tissue growth and the host immunological reaction to the biomaterial will be monitored in an in vivo rabbit cartilage repair defect model. The ultimate goal of this project is o develop engineered tissues for treating cartilage defects in orthopaedic and/or reconstructive surgery applications.   
   
      

","NIAMS","8312139","9/16/2012 12:00:00 AM","PA-11-096","1R43AR061916-01A1","1","R43","AR","061916","01","A","WANG, FEI","9/17/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-S(10)B]"," ","9717208","ESTES, BRADLEY T","Not Applicable","04","Unavailable","783502466","G9RMDCWJYGL3","783502466","G9RMDCWJYGL3","US","36.008773","-78.944327","10010326","CYTEX THERAPEUTICS INC.","DURHAM","NC","Domestic For-Profits","277043048","UNITED STATES","N","9/17/2012 12:00:00 AM","8/31/2014 12:00:00 AM","846","SBIR/STTR","2012"," "," ","NIAMS"," "," "," ","299327",
"Cancer; Colo-Rectal Cancer; Digestive Diseases; Genetics","5&apos; Untranslated Regions;Address;Apoptosis;Binding;Binding Sites;Biological Assay;Cancer Etiology;Cancerous;Cells;Cessation of life;Colon;Colon Carcinoma;Colonic Neoplasms;Colorectal Cancer;Colorectal Neoplasms;Complex;Cultured Cells;Dominant-Negative Mutation;Down-Regulation;E-Cadherin;Epithelial;Fibroblasts;Fractionation;Free Energy;Gene Expression;Gene Targeting;Genetic Transcription;HT29 Cells;Health;In Vitro;Injection of therapeutic agent;Intervention;Knowledge;Liver;MAPK8 gene;Malignant Neoplasms;Measures;Mesenchymal;Messenger RNA;Methods;Molecular;Mus;Mutate;Mutation;Neoplasm Metastasis;Normal tissue morphology;Nude Mice;Oncogene Activation;Polyribosomes;Prevention;Primary Neoplasm;Process;Proteins;Publications;Reagent;Reverse Transcription;Role;Site-Directed Mutagenesis;Slug protein;Staining method;Stains;Structure;Testing;Tissues;Transcription Factor AP-1;Transcription Repressor/Corepressor;Translational Repression;Translations;Tumor Cell Invasion;Tumor Suppressor Proteins;Tumor Tissue;Tumor-Suppressor Gene Inactivation;United States;Up-Regulation;Work;base;c-myc Genes;cancer cell;chromatin immunoprecipitation;design;epithelial to mesenchymal transition;implantation;in vivo;inhibitor/antagonist;insight;knock-down;lymph nodes;mutant;neoplastic cell;novel;novel therapeutics;prevent;promoter;slug;translation assay;tumor progression","The role of Pdcd4 in colorectal tumor progression","
Project Narrative
Colorectal cancer is the second most fatal cancer in the United States, largely due to invasion and metastasis
to the liver and lymph nodes. In this proposal, we intend to understand the effects of a novel tumor suppressor,
Pdcd4, on colon tumor metastasis and the molecular mechanism involved in this process. This work will
provide a comprehensive understanding of how Pdcd4 modulates colon tumor progression and holds great
promise for novel interventions for preventing and treating colon cancer.","NCI","8197127","12/1/2011 12:00:00 AM","PA-07-070","5R01CA129015-04","5","R01","CA","129015","04"," ","JHAPPAN, CHAMELLI","1/1/2009 12:00:00 AM","11/30/2013 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","8737920","YANG, HSIN-SHENG ","Not Applicable","06","PHARMACOLOGY","939017877","H1HYA8Z1NTM5","939017877","H1HYA8Z1NTM5","US","38.042307","-84.458748","2793601","UNIVERSITY OF KENTUCKY","LEXINGTON","KY","SCHOOLS OF MEDICINE","405260001","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","93593"," ","294868",
"Cancer; Digestive Diseases","Activins;Address;Affect;Biological;Biological Assay;Biology;Bone Morphogenetic Proteins;CD44 gene;Cancer cell line;Cathepsins B;Cell Adhesion Molecules;Cells;Complex;Data;Development;Dominant-Negative Mutation;E-Cadherin;Epithelial;Epithelial Cells;Epithelial-Stromal Communication;Esophageal;Esophageal Neoplasms;Esophageal Squamous Cell;Esophageal Squamous Cell Carcinoma;Esophagus;Event;Family;Fibroblast Growth Factor;Fibroblasts;Fibrous capsule of kidney;Generations;Genetic Recombination;Goals;Grant;Growth;Hematopoiesis;Homeostasis;In Vitro;Invaded;Investigation;MMP9 gene;Maintenance;Malignant Neoplasms;Malignant Squamous Cell Neoplasm;Malignant neoplasm of esophagus;Matrilysin;Mediating;Mesenchymal;Modeling;N-Cadherin;Nodal;Property;Receptor Signaling;Reporting;Role;Signal Pathway;Signal Transduction;System;Tissue Microarray;Tissue Recombination;Transforming Growth Factors;Tumor Promoters;Tumor Suppressor Proteins;Tumor Tissue;Undifferentiated;Work;Xenograft Model;Xenograft procedure;activin A;autocrine;base;equilibration disorder;human embryonic stem cell;in vivo;keratinocyte;member;mouse model;neoplastic cell;novel;outcome forecast;overexpression;pluripotency;receptor;response;small hairpin RNA;stemness;tumor;tumorigenesis;tumorigenic","Mechanisms of epithelial-mesenchymal crosstalk during esophageal cell invasion"," We established a three-dimensional organotypic culture model using esophageal keratinocytes expressing dominant-negative mutant E-cadherin and TGF2 receptor and demonstrated fibroblast-dependent esophageal cell invasion mediated by cathepsin B and the CD44-MMP9 axis. We observe high levels of pSmad2 in the absence of functional E-cadherin and T2RII in our model as well as in tumor tissues leading us to hypothesize that Activin A signaling, which intersects with TGF2 signaling at the level of Smad2 and Smad3, is activated. The overaching hypothesis of this proposal is that invading keratinocytes undergo epithelial- mesenchymal transition in response to autocrine Activin A signaling resulting in the observed cell invasion and tumorigenesis which we will address in vitro and in vivo using state-of-the-art xenograft models. !   
      

","NIDDK","8239843","8/27/2012 12:00:00 AM","PAR-09-230","1R03DK091491-01A1","1","R03","DK","091491","01","A","PODSKALNY, JUDITH M,","8/28/2012 12:00:00 AM","7/31/2014 12:00:00 AM","Digestive Diseases and Nutrition C Study Section[DDK-C]"," ","7797423","ANDL, CLAUDIA D","Not Applicable","05","SURGERY","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","8/28/2012 12:00:00 AM","7/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","50000","28000"," ","78000",
"Cardiovascular; Diabetes; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","ACVRL1 gene;Activin Receptor;Aorta;Arteries;Arteriovenous malformation;BMP2 gene;BMP4;Biochemical;Blood Vessels;Bone Morphogenetic Proteins;Cardiovascular Diseases;Cell Differentiation process;Cell Lineage;Cell Maturation;Cells;Characteristics;Commit;Data;Development;Diabetes Mellitus;Diabetic Angiopathies;Disease;Endothelial Cells;Endothelium;Genetic;Growth;Heart;Heart Diseases;Hereditary Disease;Hereditary hemorrhagic telangiectasia;In Vitro;Knowledge;Lead;Link;Manuscripts;Mesenchymal Stem Cells;Modeling;Molecular;Morbidity - disease rate;Multipotent Stem Cells;Mus;Mutation;Osteogenesis;Pathology;Patients;Play;Population;Prevention;Prevention strategy;Protein Inhibition;Proteins;Regulation;Role;Signal Transduction;Small Interfering RNA;Staging;Stem cells;Syndrome;Testing;Therapeutic;Therapeutic Uses;Transgenic Mice;Translating;Vascular Diseases;Vascular calcification;Work;angiogenesis;diabetic;in vivo;inhibitor/antagonist;matrix Gla protein;mortality;mouse model;multipotent cell;osteogenic;precursor cell;progenitor;receptor;response","Molecular Mechanisms of Matrix GLA Protein (MGP)"," Our studies are relevant to the treatment of disease of the heart and vessels such as hardening of the arteries, which is common in patients with diabetes, and hereditary hemorrhagic telangiectasia, a hereditary disease. Our studies focus on factors called bone morphogenetic proteins and their inhibitors, which are important in regulating the heart and vessels. Understanding how these factors work may lead to new strategies for prevention and treatment.   
      

","NHLBI","8292985","3/2/2012 12:00:00 AM","PA-10-067","2R01HL081397-06A1","2","R01","HL","081397","06","A","SRINIVAS, POTHUR R","4/24/2006 12:00:00 AM","3/31/2017 12:00:00 AM","Vascular Cell and Molecular Biology Study Section[VCMB]"," ","6184443","BOSTROM, KRISTINA I","Not Applicable","33","INTERNAL MEDICINE/MEDICINE","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","SCHOOLS OF MEDICINE","900952000","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","135000"," ","385000",
"Arthritis; Bioengineering; Regenerative Medicine","Address;Adult;Aging;Arthritis;Biochemical;Biomechanics;Cartilage;Cartilage Matrix;Cell Death;Cell Proliferation;Chondrocytes;Chondrogenesis;Conditioned Culture Media;Development;Developmental Biology;Disease;Embryo;Embryonic Development;Engineering;Gene Expression;Goals;Growth;Homeostasis;Human;Hyaline Cartilage;Immunology;Inflammation;Inflammatory;Inflammatory Response Pathway;Insulin-Like Growth Factor Binding Protein 5;Insulin-Like Growth Factor II;Joint repair;Knowledge;Lead;Mediating;Mesenchymal Stem Cells;Methods;Modeling;Muscle;Muscle Cells;Natural regeneration;Orthopedics;Pain;Physical environment;Physiological;Prevalence;Production;Property;Regulation;Research;Resistance;Role;Seeds;Signal Pathway;Signal Transduction;Silk;Site;Societies;Solutions;Stimulus;TNF gene;Technology;Testing;Tissue Engineering;Tissues;United States;Work;cartilage regeneration;cell growth;cell type;clinical application;cytokine;disability;effective therapy;improved;insight;interdisciplinary approach;joint destruction;meetings;novel;novel strategies;physical property;public health relevance;repaired;response;scaffold;tissue repair","Muscle Cell-Enhanced Cartilage Tissue Engineering","
Muscle cell-enhanced cartilage tissue engineering
Narrative:
Arthritis, characterized by inflammation and joint destruction, is a leading cause of disability in our ever-aging
society. However, effective treatment options for this prevailing disease still remain limited. We propose a
novel strategy to engineer stable cartilage tissue that is resistant to inflammation by utilizing muscle cells.
Thus, our research aspires to meet the critical need for improving cartilage regeneration and joint repair
technology, which may ultimately be developed as an effective treatment method for arthritis.","NIAMS","8298608","6/12/2012 12:00:00 AM","PA-10-009","5R01AR059106-03","5","R01","AR","059106","03"," ","WANG, FEI","9/1/2010 12:00:00 AM","6/30/2015 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","6840443","ZENG, LI ","Not Applicable","07","ANATOMY/CELL BIOLOGY","039318308","C1F5LNUF7W86","039318308","C1F5LNUF7W86","US","42.349907","-71.061712","8422704","TUFTS UNIVERSITY BOSTON","BOSTON","MA","SCHOOLS OF MEDICINE","021111901","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","222677","144740"," ","367417",
"Cancer; Ovarian Cancer; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Adverse effects;Animal Model;Autologous;Beds;Behavior;Biodistribution;Bone Marrow;CD44 gene;Cell Communication;Cells;Characteristics;Chemosensitization;Clinical;Collaborations;Combination Drug Therapy;Data;Development;Dose;Elements;Engraftment;Exhibits;Extracellular Matrix;Gene-Modified;Goals;Growth Factor;Home environment;Homing;Human;Inflammation Mediators;Instruction;Interferon-beta;Malignant Neoplasms;Malignant neoplasm of ovary;Mediating;Mesenchymal Stem Cells;Modeling;Mus;Ovarian Carcinoma;Patients;Phase I Clinical Trials;Pre-Clinical Model;Production;Proliferating;Proteins;Reaction;Recruitment Activity;Refractory;Role;Route;Schedule;Signal Transduction;Solid Neoplasm;Staging;Stem cell transplant;Stromal Cells;Testing;Therapeutic;Tissues;Toxic effect;University of Texas M D Anderson Cancer Center;Wound Healing;Xenograft procedure;cancer cell;cancer therapy;cell motility;cellular engineering;chemotherapy;cytokine;interest;intraperitoneal;neoplastic cell;novel;ovarian neoplasm;paracrine;pre-clinical;receptor;repaired;response;stem cell population;subcutaneous;therapeutic gene;treatment strategy;tumor;tumor growth;tumor xenograft","P5 - Gene-modified MSCs for Controlling Ovarian Cancer","n/a","NCI","8380487","9/4/2012 12:00:00 AM","PAR-08-020","5P50CA083639-13","5","P50","CA","083639","13"," "," "," "," ","ZCA1-RPRB-M","7770","7722857","MARINI, FRANK C","Not Applicable","09","Unavailable","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","Domestic Higher Education","770304009","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Research Centers","2012","186856","186856"," ","186856","0"," "," ",
"Bioengineering; Biotechnology; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Adipose tissue;Affinity;Age;Animal Model;Animals;Antibodies;Area;Aspirate substance;Autologous;Binding;Biocompatible;Blood Platelets;Blood Vessels;Bone Growth;Bone Marrow;Bone Marrow Stem Cell;Bone Regeneration;Calvaria;Cell Adhesion;Cell Count;Cell Proliferation;Cell Separation;Cells;Clinic;Clinical;Containment;Data;Defect;Elasticity;Fiber;Frequencies;Goals;Gold;Growth Factor;Harvest;Healed;Immune response;Implant;Link;Measures;Mesenchymal Stem Cells;Modeling;Modification;Operative Surgical Procedures;Oral;Osseointegration;Osteogenesis;Outcome;Peptides;Phage Display;Pharmaceutical Preparations;Phase;Phenotype;Process;Proliferating;Rattus;Safety;Screening procedure;Shapes;Site;Solutions;Specificity;Stem cells;Surface;Surgeon;Surgical Flaps;Technology;Testing;Therapeutic;Time;Tissues;Titania;Titanium;Tumor Tissue;adult stem cell;biomaterial compatibility;bone;cell motility;cell type;craniofacial;craniomaxillofacial;cranium;design;healing;implantation;improved;in vivo;macrophage;novel;osteogenic;prevent;protein aminoacid sequence;reconstruction;restoration;scaffold;success","Novel coatings on titanium implants for the delivery of stem cells"," Calvarial reconstruction continues to present challenges for surgeons. One proposed solution is the use of adult stem cells to augment bone regeneration; however, the use of stem cells has been limited by the low frequency of the cells in tissue. In this application, we propose to develop a titanium implant that can capture and retain adult stem cells to improve clinical outcomes.   
   
      

","NIDCR","8392335","8/15/2012 12:00:00 AM","PA-11-096","1R43DE022487-01A1","1","R43","DE","022487","01","A","LUMELSKY, NADYA L","8/15/2012 12:00:00 AM","7/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-K(11)]"," ","9971977","DARBY, MARTYN ","Not Applicable","04","Unavailable"," "," "," "," ","US","35.366248","-79.429394","10002709","AFFINERGY ,INC","RESEARCH TRIANGLE PARK","NC","Domestic For-Profits","277094650","UNITED STATES","N","8/15/2012 12:00:00 AM","7/31/2014 12:00:00 AM","121","SBIR/STTR","2012"," "," ","NIDCR"," "," "," ","149771",
"Bioengineering; Cancer","3-Dimensional;Accounting;Address;Affect;Antineoplastic Agents;Blood Circulation;Caliber;Cells;Colorectal Cancer;Complex;Development;Distant;Drops;Endothelial Cells;Epithelial;Event;Extravasation;Fibrin;Fibroblasts;Gel;Grant;Growth Factor;Human;Hypoxia;In Vitro;Investigation;Lead;Left;Life;Liquid substance;Liver;Mesenchymal;Microcirculation;Microfabrication;Microfluidics;Modeling;Neoplasm Metastasis;Normal Cell;Nutrient;Organ;Oxygen;Patients;Pattern;Pericytes;Permeability;Pharmacotherapy;Phenotype;Positioning Attribute;Process;Research Personnel;Resolution;Resources;Role;Route;Simulate;Site;Source;Stress;Stromal Cells;Survival Rate;System;Technology;Testing;Therapeutic;Tissue Engineering;Tissue Grafts;Transforming Growth Factor beta;Transforming Growth Factors;Tumor Biology;Tumor-Derived;United States National Institutes of Health;Validation;Vascular blood supply;arteriole;base;cancer cell;flexibility;fluid flow;improved;in vitro Model;innovation;interstitial;lymphatic circulation;macrophage;metastatic process;migration;neoplastic cell;novel;novel strategies;novel therapeutics;pressure;response;shear stress;skills;tumor;tumor progression;venule;wasting","A 3-D in vitro platform of tumor metastasis (PQ24)"," The central objective of our application is to create a high-throughput platform of 3-D human tumor spheroids perfused by human microvessels that mimics the early events of metastasis including epithelial mesenchymal transition (EMT) and intravasation. The flexible platform will provide new opportunities to study underlying mechanisms of metastasis, and thus new therapeutic options.   
      

","NCI","8384796","8/17/2012 12:00:00 AM","RFA-CA-11-011","1R01CA170879-01","1","R01","CA","170879","01"," ","GREENSPAN, EMILY J","8/20/2012 12:00:00 AM","6/30/2016 12:00:00 AM","ZCA1-SRLB-9(M1)"," ","1912012","GEORGE, STEVEN CARL","HUGHES, CHRISTOPHER C. W.; LEE, ABRAHAM P.; WATERMAN, MARIAN L","45","BIOMEDICAL ENGINEERING","046705849","MJC5FCYQTPE6","046705849","MJC5FCYQTPE6","US","33.678042","-117.773718","577504","UNIVERSITY OF CALIFORNIA-IRVINE","IRVINE","CA","BIOMED ENGR/COL ENGR/ENGR STA","926970001","UNITED STATES","N","8/20/2012 12:00:00 AM","6/30/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","224892","113283"," ","338175",
"Clinical Research; Digestive Diseases; Genetics; Pediatric; Perinatal Period - Conditions Originating in Perinatal Period","Address;Area;Award;Basic Science;Biological Markers;Cell Death;Cells;Clinical;Complement;Country;Data;Defect;Development;Developmental Biology;Ensure;Environment;Epithelial;Epithelial Cells;Epithelium;Erinaceidae;Ethics;Etiology;Event;Faculty;Failure;Fibroblast Growth Factor;Foundations;Funding;Gene Expression;Genetic Models;Goals;Growth;Growth and Development function;Human;Individual;Institution;Intervention;Intestinal Atresia;Intestinal Obstruction;Intestines;Iron;Large Intestine;Lead;Leadership;Mammalian Genetics;Mentors;Mentorship;Mesenchymal;Mesenchyme;Mesoderm;Molecular;Mus;Mutagenesis;Mutation;Neonatal;Obstruction;Operative Surgical Procedures;Patients;Positioning Attribute;Radial;Research;Research Personnel;Resolution;Resources;Role;Scientist;Short Bowel Syndrome;Signal Transduction;Small Intestines;Solutions;Surgeon;Testing;Time;Tissues;Training;Tube;United States;Universities;Wages;Wisconsin;career;career development;critical developmental period;directed attention;insight;interest;meetings;mutant;novel;postnatal;programs;receptor;regenerative therapy;smoothened signaling pathway;therapy development","Role of Fgfr2IIIb in epithelial mesenchymal signaling in intestinal development","Statement of Relevance 
We anticipate that the research proposed will provide novel and critically important insights into the molecular mechanisms that stimulate radial and longitudinal growth of the intestinal mesoderm during normal development and unveil opportunities for intervention in short gut patients in the postnatal period.","NIDDK","8249462","3/26/2012 12:00:00 AM","PA-09-042","5K08DK087854-03","5","K08","DK","087854","03"," ","PODSKALNY, JUDITH M,","5/1/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Digestive Diseases and Nutrition C Study Section[DDK-C]"," ","9498133","NICHOL, PETER F","Not Applicable","02","SURGERY","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","SCHOOLS OF MEDICINE","537151218","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Other Research-Related","2012"," "," ","NIDDK","149650","11972"," ","161622",
"Aging; Bioengineering; Biotechnology; Osteoporosis; Regenerative Medicine; Transplantation","Address;Adhesives;Animal Model;Binding;Biocompatible Materials;Biological Availability;Biology;Bone Regeneration;Bone Screws;Bone Tissue;Bone Transplantation;Cell Culture Techniques;Cells;Clinical;Clinical Research;Collagen;Defect;Dental Implants;Development;Disease;Dose;Engineering;Estrogens;Ethylene Glycols;Fibronectins;Fracture;Goals;Health Care Costs;Human;Hydrogels;Immunohistochemistry;Implant;In Vitro;Integrins;Kinetics;Ligands;Mechanics;Mesenchymal Stem Cells;Modeling;Monitor;Mus;Occupational;Orthopedics;Osseointegration;Osteogenesis;Osteoporosis;Outcome;Peptide Hydrolases;Peptides;Performance;Play;Polymers;Porifera;Postmenopause;Procedures;Proteins;Radial;Rattus;Recombinants;Replacement Arthroplasty;Research;Role;Specificity;Stainless Steel;Structure;Surface;Technology;Testing;Translations;Transplanted tissue;Trauma;Work;base;bone;bone loss;bone morphogenetic protein 2;bone prosthesis;cellular engineering;clinical application;clinically relevant;density;disability;ethylene glycol;fluorescence imaging;implant coating;improved;in vivo;innovation;insight;mineralization;nanoengineering;novel;osteoblast differentiation;osteogenic;receptor;reconstruction;repaired;response;sample fixation;scaffold;socioeconomics;tumor","Osseo-reparative, integrin-specific materials"," Biomaterials play crucial roles in the treatment of bone deficiencies, but their performance is significantly limited by poor integration into bone and bone
formation. We will engineer novel implant coatings and bone grafts that enhance implant-bone integration and bone repair. These materials will improve bone reconstruction procedures compared to present-day approaches.   
      

","NIAMS","8304544","7/29/2012 12:00:00 AM","PA-10-067","1R01AR062920-01","1","R01","AR","062920","01"," ","PANAGIS, JAMES S","8/1/2012 12:00:00 AM","7/31/2017 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","2106898","GARCIA, ANDRES J","Not Applicable","05","ENGINEERING (ALL TYPES)","097394084","EMW9FC8J3HN4","097394084","EMW9FC8J3HN4","US","33.762977","-84.42296","676603","GEORGIA INSTITUTE OF TECHNOLOGY","ATLANTA","GA","BIOMED ENGR/COL ENGR/ENGR STA","303320415","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","109150"," ","334150",
"Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human; Transplantation","Adult;Animals;Apoptosis;Biological Assay;Biological Preservation;CD34 gene;Cell Aging;Cell Count;Cells;Collection;Colony-Forming Units Assay;Colony-forming units;Cryopreservation;Development;Disease;Engraftment;Exhibits;Flow Cytometry;Freezing;Genotype;Hematopoietic;Hematopoietic Neoplasms;Hematopoietic stem cells;Human;Immune;Immunotherapy;Investigation;Kinetics;Life;Lymphocyte;Maps;Measures;Membrane;Mesenchymal Stem Cells;Methods;Metric;Modeling;Monitor;Mononuclear;National Heart, Lung, and Blood Institute;Outcome Study;Phase;Process;Quality Control;Recovery;Regenerative Medicine;Reporting;Risk;Site;Source;Staining method;Stains;Stem cell transplant;Temperature;Testing;Therapeutic Uses;Time;Transplantation;Umbilical Cord Blood;United States Food and Drug Administration;Variant;Whole Blood;annexin A5;biobank;caspase-3;cell age;clinical application;clinically relevant;experience;functional disability;improved;monocyte;pathogen;programs;standard measure;transmission process","Post thaw assessment of umbilical cord blood","
Project Narrative
Umbilical cord blood units are used to treat a variety of diseases including blood cancer.
This project develops assays that permit a doctor to determine if the unit is of sufficient
quality that it can be used for therapeutic purposes.","NHLBI","8261833","4/9/2012 12:00:00 AM","RFA-HL-12-004","1R21HL112653-01","1","R21","HL","112653","01"," ","WAGNER, ELIZABETH","4/15/2012 12:00:00 AM","3/31/2014 12:00:00 AM","ZHL1-CSR-P(F2)"," ","1876735","HUBEL, ALLISON ","Not Applicable","05","ENGINEERING (ALL TYPES)","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","BIOMED ENGR/COL ENGR/ENGR STA","554552070","UNITED STATES","N","4/15/2012 12:00:00 AM","3/31/2013 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","75000","39000"," ","114000",
"Biotechnology; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Adopted;Allogenic;Apoptotic;Autologous;Biogenesis;Bone Marrow;Bone Marrow Cells;Cardiac;Cardiac Myocytes;Cell Survival;Cell Therapy;Cells;Coculture Techniques;Coronary Arteriosclerosis;Cytoprotection;Data;Development;Dissection;Embryo;Engraftment;Environment;Heart;Heart Diseases;Implant;In Vitro;Infarction;Ischemia;Lasers;Mediating;Mesenchymal Stem Cells;MicroRNAs;Molecular;Myocardial;Myocardial Infarction;Myocardial Ischemia;Myocardium;Natural regeneration;Neonatal;Organ;Pathway interactions;Phenotype;Pilot Projects;Regulation;Reporting;Research;Role;Series;Signal Pathway;Signal Transduction;Stem cells;System;Techniques;Therapeutic;Tissues;Transduction Gene;Transplantation;Up-Regulation;adult stem cell;base;cardiac repair;cell type;cellular engineering;clinical application;genetic manipulation;in vivo;member;neovascularization;novel;overexpression;paracrine;public health relevance;repaired;stem cell differentiation;stem cell population;suicide gene;transdifferentiation;vasculogenesis","Wnt11 signaling in stem cell survival and cardiac regeneration","
Narrative
Coronary artery disease is the most common cause of heart infarction. The cell based therapy using stem
cells to cure the infarcted heart appears to be a promising approach. However, several recent studies
question the potential of in vivo effect of cell therapy, with low rates of implanted cell survival and
engraftment being the suggested causes. The proposed research will attempt myocardial repair by genetic
manipulation of stem cells prior to transplantation into infarcted heart in order to increase stem cell survival
and engraftment in ischemic microenvironment, and enhances regeneration of infarcted myocardium.","NHLBI","8279226","5/27/2012 12:00:00 AM","PA-07-070","5R01HL105176-03","5","R01","HL","105176","03"," ","ADHIKARI, BISHOW B","9/10/2010 12:00:00 AM","5/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-CVRS-C(02)M]"," ","8250530","XU, MEIFENG ","ASHRAF, MUHAMMAD ; JONES, WALTER KEITH","01","PATHOLOGY","041064767","DZ4YCZ3QSPR5","041064767","DZ4YCZ3QSPR5","US","39.142998","-84.503581","1523902","UNIVERSITY OF CINCINNATI","CINCINNATI","OH","SCHOOLS OF MEDICINE","452210001","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","141075"," ","388575",
"Aging; Arthritis; Bioengineering; Injury (total) Accidents/Adverse Effects; Pain Conditions - Chronic; Pain Research; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Affect;Animal Model;Anti-Inflammatory Agents;Anti-inflammatory;Arthritis;Articular Range of Motion;Biological;Caring;Cartilage;Cartilage injury;Cells;Chondrogenesis;Clinical;Complex;Defect;Degenerative polyarthritis;Deposition;Development;Environment;Goals;Healed;Human;Immunocompromised Host;In Situ;Incidence;Inflammation;Inflammatory;Instruction;Interleukin-1;Joints;Lead;Mediating;Mentors;Mesenchymal Stem Cells;Modeling;Monitor;Musculoskeletal;Natural regeneration;Operative Surgical Procedures;Oryctolagus cuniculus;Outcome;Pain;Pathogenesis;Phase;Play;Population;Process;Proliferating;Quality of life;Rattus;Regenerative Medicine;Reporter;Role;Secondary to;Shapes;Signal Transduction;Site;Stem cells;Surgical Injuries;TNF gene;Time;Tissue Engineering;Training Support;Transplantation;Trauma;Tumor Necrosis Factor-alpha;Work;articular cartilage;base;cartilage regeneration;cartilage repair;clinical application;cytokine;healing;improved;in vivo;injured;injury and repair;interest;joint injury;osteochondral tissue;post-doctoral training;regenerative;repaired;success;tissue regeneration;tool","Facilitating cartilage regeneration by heterogeneous progenitor cells","RELEVANCE (See instructions); 
Because articular cartilage has very limited capacity for self-repair, injuries following trauma persist and can 
ultimately lead to osteoarthritis (OA). The resulting pain and reduced range of joint motion can severely 
impair quality of life. The studies described in this proposal should add to our understanding of factors that 
limit cell-based cartilage repair. Overcoming these factors will help improve repair outcomes and reduce the 
incidence of post-traumatic OA.","NIAMS","8333207","8/14/2012 12:00:00 AM"," ","5R00AR057105-03","5","R00","AR","057105","03"," ","WANG, FEI","7/1/2009 12:00:00 AM","8/31/2014 12:00:00 AM","NSS"," ","8557978","PORTER, RYAN MICHAEL","Not Applicable","07","Unavailable","071723621","C1CPANL3EWK4","071723621","C1CPANL3EWK4","US","42.346758","-71.10256","758101","BETH ISRAEL DEACONESS MEDICAL CENTER","BOSTON","MA","Independent Hospitals","022155400","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","141078","105896"," ","246974",
"Breast Cancer; Cancer; Prostate Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Urologic Diseases","Address;Adenocarcinoma;Adult;Angiogenesis Inhibitors;Blood;Blood Circulation;Blood Vessels;Bone Marrow;Bone Marrow Ablation;Breast Carcinoma;Cell Line;Cells;Clinic;Clinical Research;Clinical Trials;Clone Cells;Dissection;Drug resistance;Drug usage;Employee Strikes;Endothelial Cells;Endothelium;Engraftment;Genes;Goals;Heterogeneity;Homing;Human;Knowledge;Laboratories;Lasers;Mammary Neoplasms;Mesenchymal Stem Cells;Molecular;Molecular Profiling;Mouse Mammary Tumor Virus;Mus;Myeloid Cells;Neoplasm Metastasis;Neoplasms;Neoplasms in Vascular Tissue;Nutrient;Oxygen;PECAM1 gene;Prostate carcinoma;Prostatic Neoplasms;Stem cells;Testing;Transgenic Mice;Tumor Biology;antiangiogenesis therapy;base;bone;calcification;cancer therapy;cell type;design;feeding;mineralization;mouse model;neoplastic cell;novel;progenitor;programs;tumor;tumor progression","Tumor endothelial cell abnormalities","RELEVANCE (See InstrucUons): 
Anti-angiogenesis is based on the principle that tumors can be shrunk by using drugs to target the blood 
vessels feeding them with blood, oxygen, and nutrients. But our basic knowledge of tumor blood vessels Is 
severely limited. Our study will better characterize the biology of tumor-specific blood vessels with the longterm 
goal of using this new knowledge towards the rational design of anti-angiogenic therapies.","NCI","8325609","8/8/2012 12:00:00 AM","PA-07-297","5R00CA140708-05","5","R00","CA","140708","05"," ","MOHLA, SURESH","9/1/2009 12:00:00 AM","8/31/2014 12:00:00 AM","NSS"," ","9560372","DUDLEY, ANDREW CARL","Not Applicable","04","PHYSIOLOGY","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","168243","80757"," ","249000",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Active Sites;Affinity;Animals;Bacteria;Bacterial Proteins;Basic Science;Beta-N-Acetylglucosaminidase;Binding;Biocompatible Materials;Biological;Bone Marrow;Cell Line;Cells;Cellular biology;Coiled-Coil Domain;Collagen;DDR2 gene;Data;Dendritic Cells;Development;Differentiation and Growth;Enzymes;Escherichia coli;Evaluation;Fibrillar Collagen;Film;Fostering;Generations;Growth;Higher Order Chromatin Structure;Human;Hydroxyproline;Implant;In Vitro;Inflammatory Response;Integrins;Length;Matrix Metalloproteinases;Mechanics;Mediating;Mesenchymal Stem Cells;Methodology;Modification;Molecular;Morphology;Mus;Osteoblasts;Porifera;Property;Proteins;Receptor Cell;Recombinants;Signal Transduction;Site;Specificity;Stem cells;Streptococcus pyogenes;Structure;System;Tissue Engineering;Variant;Work;animal tissue;base;bone;crosslink;design;experience;genetic manipulation;human stem cells;in vitro testing;in vivo;large scale production;macrophage;novel strategies;osteogenic;product development;protein degradation;public health relevance;receptor;response;scaffold;stem cell differentiation;subcutaneous;tool;triple helix","Biomaterial Applications of Recombinant Bacterial Collagens","
There is a need for well-defined standardized collagen proteins amenable to easy sequence
modifications and large scale production for biomedical and biomaterial applications. The
development of a bacterial collagen system to incorporate biologically active sites and to form
well-defined hierarchical structures would revolutionize the use of this important protein in both
fundamental and applied studies.","NIBIB","8323975","8/6/2012 12:00:00 AM","PA-10-067","5R01EB011620-03","5","R01","EB","011620","03"," ","HUNZIKER, ROSEMARIE","9/30/2010 12:00:00 AM","8/31/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","2059300","KAPLAN, DAVID L.","BRODSKY, BARBARA M","07","ENGINEERING (ALL TYPES)","073134835","WL9FLBRVPJJ7","073134835","WL9FLBRVPJJ7","US","42.423895","-71.1092","8422701","TUFTS UNIVERSITY MEDFORD","Boston","MA","BIOMED ENGR/COL ENGR/ENGR STA","021111817","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","212543","111702"," ","324245",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","3-Dimensional;Adverse effects;Allografting;Autologous;Autologous Transplantation;Biochemical;Biocompatible Materials;Bone Regeneration;Bone Tissue;Bone Transplantation;Cadaver;Cell Adhesion;Cell Culture Techniques;Cells;Chemistry;Clinical;Complex;Cues;Defect;Development;Engineering;Environment;Excision;Extracellular Matrix;Gene Expression Regulation;Goals;Growth;Harvest;Homing;Human;Hydrogels;Infection;Knowledge;Laboratories;Lead;Malignant Neoplasms;Mesenchymal Stem Cells;Methods;Nanotopography;Operative Surgical Procedures;Pathway interactions;Plague;Polymers;Preparation;Process;Prosthesis;Recruitment Activity;Research;Risk;Scheme;Site;Stem cells;Structure;Sulfhydryl Compounds;Surface;Surgeon;System;Techniques;Testing;Time;Tissue Engineering;Tissues;Transplanted tissue;Trauma;Work;base;bone;cell motility;design;disease transmission;high risk;implantation;improved;interest;osteogenic;photopolymerization;protein expression;research study;scaffold;self-renewal;stem cell differentiation;tissue regeneration","Hydrogel Scaffolds with Engineered Dynamically Tunable Topographies for hMSC Diff"," The aim of this proposal is to engineer an improved, bioactive bone graft material for repairing bone defects resulting from congenital anomalies, trauma, infection and cancer. My approach is to investigate the mechanisms for how cells respond to dynamic biophysical cues, such as topography. The results of the proposed research will lead to the creation of improved 3-dimensional synthetic matrices that will act as scaffolds to recruit cells from surrounding tissues and promote natural bone regeneration.  
    

","NIAMS","8333062","7/18/2012 12:00:00 AM","PA-10-110","5F32AR061923-02","5","F32","AR","061923","02"," ","WANG, FEI","9/1/2011 12:00:00 AM","8/16/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F10B-S(20)L]"," ","10755879","MAGIN, CHELSEA M","Not Applicable","02","ENGINEERING (ALL TYPES)","007431505","SPVKK1RC2MZ3","007431505","SPVKK1RC2MZ3","US","40.027599","-105.251595","1199902","UNIVERSITY OF COLORADO","Boulder","CO","BIOMED ENGR/COL ENGR/ENGR STA","803031058","UNITED STATES","N","9/1/2012 12:00:00 AM","8/16/2013 12:00:00 AM","846","Training, Individual","2012"," "," ","NIAMS","50465"," "," ","50465",
"Biotechnology; Clinical Research; Dental/Oral and Craniofacial Disease; Genetics; Pediatric; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adenovirus Vector;Adenoviruses;Area;BMP2 gene;Birth trauma;Bone Morphogenetic Proteins;Bone Regeneration;Calvaria;Cell Line;Cells;Critical Pathways;Data;Defect;Differentiation Antigens;Elements;Engineering;Evaluation;Excision;Experimental Designs;Goals;Healed;In Vitro;Individual;Infection;Literature;MADH4 gene;Malignant Neoplasms;Mandible;Measures;Mediation;Mesenchymal Stem Cells;Modality;Modeling;Morbidity - disease rate;Mus;Natural regeneration;Osteoblasts;Osteocalcin;Osteogenesis;Pathway interactions;Patients;Phenotype;Pluripotent Stem Cells;Protein Family;RNA;Recombinants;Reverse Transcriptase Polymerase Chain Reaction;Role;Signal Transduction;Site;Skeleton;Small Interfering RNA;Source;Staging;Stem cells;Technology;Testing;Transfection;Weight-Bearing state;base;beta catenin;bone;bone healing;bone morphogenetic protein 2;bone morphogenetic protein 9;craniofacial;craniofacial repair;experience;healing;in vivo;osteoblast differentiation;osteogenic;promoter;skeletal;trafficking","Differential Effects of BMPs on the Healing of Craniofacial Defects","
PROJECT NARRATIVE
Large defects from birth, trauma or cancer resection require almost a limitless source of
bone, which cannot be supplied by autogenous donor sites without serious morbidity. A
means of providing large quantities of bone would be to transfer engineered, pluripotent
stem cells that could induce bony regeneration. The project characterized herein has
relevance to patients with skeletal deficiencies of the craniofacial skeleton.","NIDCR","8310813","7/31/2012 12:00:00 AM","PA-09-042","5K08DE020140-04","5","K08","DE","020140","04"," ","KING, LYNN M","9/25/2009 12:00:00 AM","8/31/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","9037313","REID, RUSSELL R.","Not Applicable","01","SURGERY","005421136","ZUE9HKT2CLC9","005421136","ZUE9HKT2CLC9","US","41.789554","-87.601172","1413601","UNIVERSITY OF CHICAGO","CHICAGO","IL","SCHOOLS OF MEDICINE","606372612","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","115894","9272"," ","125166",
"Arthritis; Bioengineering; Biotechnology; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Alkaline Phosphatase;Architecture;Biomimetics;Bioreactors;Bone Regeneration;Calcium;Caliber;Cartilage;Cell Culture Techniques;Cells;Characteristics;Clinical;Collagen Type I;Collagen Type II;Defect;Degenerative polyarthritis;Deposition;Development;Differentiation Antigens;Engineering;Extracellular Matrix;Fiber;Generations;Glycosaminoglycans;Goals;Growth Factor;Histocompatibility Testing;Histology;Hybrids;Implant;In Situ;In Vitro;Measures;Mesenchymal Stem Cells;Modeling;Monitor;Natural regeneration;Oryctolagus cuniculus;Pain;Perfusion;Poly-5;Polymers;Property;Research;Research Project Grants;Signal Transduction;Stem cells;Technology;Tissue Engineering;Tissues;articular cartilage;biodegradable polymer;bone;caprolactone;cartilage regeneration;density;implant material;implantation;in vivo;injured;innovation;nanofiber;novel;novel strategies;osteoblast differentiation;osteochondral repair;osteochondral tissue;osteogenic;repaired;scaffold;shear stress","Flow Perfusion Bioreactor Fabrication of Bioactive Polymer/ECM Hybrid Constructs","
Project Narrative
A significant clinical need exists for novel implant materials capable of promoting the repair and regeneration of
injured or compromised tissues, such as damaged articular cartilage. Indeed, as cartilage has a limited natural
capacity to repair itself, damage to articular cartilage and underlying bone often leads to considerable clinical
problems that afflict million of people worldwide, including pain, limited mobility and osteoarthritis. The research
project presented in this proposal seeks to apply advanced cell culture technologies to fabricate biologically
active implant materials that can promote cells within the recipient to regenerate or repair specific damaged
tissues, in this case articular cartilage and underlying bone.","NIAMS","8234157","3/26/2012 12:00:00 AM","PA-07-070","5R01AR057083-04","5","R01","AR","057083","04"," ","WANG, FEI","4/1/2009 12:00:00 AM","3/31/2014 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","1864036","MIKOS, ANTONIOS G.","Not Applicable","02","BIOMEDICAL ENGINEERING","050299031","K51LECU1G8N3","050299031","K51LECU1G8N3","US","29.720685","-95.393732","9291001","RICE UNIVERSITY","HOUSTON","TX","BIOMED ENGR/COL ENGR/ENGR STA","770051827","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","213840","103051"," ","316891",
"Dental/Oral and Craniofacial Disease; Genetics; Orphan Drug; Pediatric; Pediatric Research Initiative; Rare Diseases","Ablation;Address;Age;Ameloblasts;Apical;Bone Development;Bone Matrix;Cartilage;Cell Lineage;Cells;Chondroblast;Chondrocytes;Cleidocranial Dysplasia;Collagen Type I;Complex;Dendrites;Dental Enamel;Dental Research;Dentin;Deposition;Development;Disease;Dysplasia;Embryo;Embryonic Development;Fibroblasts;Foundations;Gene Deletion;Gene Expression;Genes;Genetic;Health;Homeostasis;Human;Individual;Knock-out;Knockout Mice;Lead;Left;Link;Maintenance;Mesenchymal Stem Cells;Mesenchyme;Modeling;Molecular;Morphology;Mus;Mutation;Odontoblasts;Odontogenesis;Oral;Osteoblasts;Osteoclasts;Osteocytes;Osteogenesis;Osteopenia;Perinatal;Phase;Phenotype;Play;Process;Property;Reporting;Research;Role;Skeletal Development;Skeleton;Staging;Supernumerary Tooth;System;Testing;Therapeutic;Tissues;Tooth Germ;Tooth structure;Transgenic Mice;Transgenic Model;Transgenic Organisms;Variant;bone;cell type;clavicle;clinical application;craniofacial;in vivo;inhibitor/antagonist;intramembranous bone formation;long bone;malformation;mineralization;mouse model;novel;novel diagnostics;novel therapeutics;osteogenic;overexpression;postnatal;promoter;recombinase;skeletal;skeletal abnormality;skeletal dysplasia;skeletogenesis;tool;transcription factor","Osteoblast and Odontoblast Specific Regulatory Action of Runx2 for Bone and Tooth"," These studies will contribute to our knowledge of how bone and tooth formation occurs normally, and also has the potential for development of novel therapeutics regarding dentin remodeling, and individuals with genetic or non-hereditary skeletal and craniofacial dysplasias.   
      

","NIDCR","8316770","6/14/2012 12:00:00 AM","PA-11-110","1F30DE022693-01","1","F30","DE","022693","01"," ","FRIEDEN, LESLIE A","7/1/2012 12:00:00 AM","6/30/2017 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","10086604","ADHAMI, MITRA D","Not Applicable","07","ANATOMY/CELL BIOLOGY","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","SCHOOLS OF MEDICINE","352940001","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","48032"," "," ","48032",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Address;Behavior;Binding;Biological;Biological Assay;Biomedical Engineering;Bioreactors;Cell Culture Techniques;Cells;Cicatrix;Connective Tissue;Cultured Cells;Deposition;Development;Disease;Encapsulated;Engineering;Environment;Environmental Risk Factor;Evaluation;Extracellular Matrix;Fatigue;Fibroblasts;Frequencies;Gel;Gene Expression;Gene Proteins;Health;Heparin Binding;Human;Hydrogels;In Situ;Individual;Injectable;Injection of therapeutic agent;Insect Proteins;Insecta;Investigation;Laboratories;Lamina Propria;Living Standards;Mechanical Stimulation;Mechanical Stress;Mechanics;Mesenchymal Stem Cells;Methodology;Methods;Modeling;Natural regeneration;Occupational;Operative Surgical Procedures;Organ;Oryctolagus cuniculus;Outcome;Phenotype;Pliability;Production;Productivity;Property;Proteins;Recombinants;Recovery;Regenerative Medicine;Research;Resistance;Rheology;Sampling;Stretching;Techniques;Testing;Tissue Engineering;Tissues;United States;Voice;Voice Disorders;Western Blotting;Work;base;cell type;comparative;cost;design;elastomeric;in vivo;interest;method development;novel;polypeptide;programs;protein expression;resilience;resilin;scaffold;social;sound;success;teacher;tissue regeneration;vocal cord","Highly resilient, hydrophilic bioelastomers for engineering vocal fold tissue","PROJECT NARRATIVE 
Impaired voice production holds significant implications for individual health and wellness, social and 
occupational function, and societal productivity. In this program, we will develop novel materials for treating 
vocal fold diseases, based on the protein resilin, which demonstrates key properties similar to those of the 
vocal fold - excellent recovery after stretch at high frequencies. The development of this novel material, as 
well as methods to characterize and culture materials at high frequencies, offers a comprehensive approach 
for mechanically demanding regenerative medicine applications.","NIDCD","8295660","3/16/2012 12:00:00 AM","PA-10-009","1R01DC011377-01A1","1","R01","DC","011377","01","A","SHEKIM, LANA O","3/20/2012 12:00:00 AM","2/28/2017 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","7551443","KIICK, KRISTI L","Not Applicable","At-Large","ENGINEERING (ALL TYPES)","059007500","T72NHKM259N3","059007500","T72NHKM259N3","US","39.677657","-75.757204","2076701","UNIVERSITY OF DELAWARE","NEWARK","DE","BIOMED ENGR/COL ENGR/ENGR STA","197160099","UNITED STATES","N","3/20/2012 12:00:00 AM","2/28/2013 12:00:00 AM","173","Non-SBIR/STTR","2012"," "," ","NIDCD","352561","137295"," ","489856",
"Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human; Stem Cell Research - Nonembryonic - Non-Human","Autologous;Benchmarking;Biology;Bispecific Antibodies;Bone Marrow;Bone Marrow Transplantation;Cell Separation;Cells;Centers of Research Excellence;Chronic;Climate;Clinical;Clinical Trials;Coculture Techniques;Collaborations;Commit;Dermatology;Development;Dimensions;Endothelial Cells;Equilibrium;Evaluation;Fertilization;Fibroblasts;Flow Cytometry;Fostering;Foundations;Funding;Goals;Grant;Healed;Hematology;Hematopoietic stem cells;Housing;Human;Image;Immunohistochemistry;Impaired wound healing;Injury;Institution;International;Islet Cell;Islets of Langerhans;Knowledge;Lead;Leadership;Link;Medical center;Medicine;Mentors;Mentorship;Mesenchymal Stem Cells;Modality;Modeling;Molecular;Muscle;Operative Surgical Procedures;Pathology;Pilot Projects;Principal Investigator;Recruitment Activity;Research;Research Activity;Research Infrastructure;Research Personnel;Resources;Rodent;Scientist;Skin;Stem cells;Surgical Flaps;Therapeutic;Tissues;Training;United States National Institutes of Health;Wages;Work;base;career;cytokine;functional restoration;healing;injured;injury and repair;interdisciplinary approach;macrophage;molecular marker;multidisciplinary;novel;novel strategies;progenitor;skills;stem cell biology;success;therapeutic target;tissue regeneration;tissue repair","New Approaches to Tissue Repair","n/a","NIGMS","8255485","6/8/2012 12:00:00 AM","RFA-RR-07-001","8P20GM103414-10","8","P20","GM","103414","10"," ","GOROSPE, RAFAEL","9/30/2003 12:00:00 AM","4/30/2013 12:00:00 AM","ZRR1-RI-6(01)"," ","1864507","FALANGA, VINCENT ","Not Applicable","02","Unavailable","625899281"," ","625899281"," ","US","41.833856","-71.435325","7071801","ROGER WILLIAMS HOSPITAL","PROVIDENCE","RI","Independent Hospitals","029084735","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","859","Research Centers","2012"," "," ","NIGMS","1344958","940019"," ","2284977",
"Dental/Oral and Craniofacial Disease; Osteoporosis; Pediatric","Accounting;Address;Affect;Anatomy;Award;BMP4;Biological Assay;Birds;Bone Density;Bone Growth;Bone Morphogenetic Proteins;Bone Regeneration;Bone necrosis;Bone remodeling;Candidate Disease Gene;Cartilage;Cells;Cephalic;Chimera organism;Clinical;Complex;Congenital Abnormality;Deposition;Development;Disease;Ducks;Embryo;Engineering;Epithelium;Event;Extracellular Matrix;Face;Fibroblast Growth Factor;Foundations;Gene Expression;Genes;Goals;In Vitro;Injury;Jaw;Learning;Length;Mandible;Mediating;Mesenchymal;Mesenchyme;Methods;Molecular;Natural regeneration;Neural Crest;Nuclear;Osteoclasts;Osteocytes;Osteogenesis;Osteoid;Osteoporosis;Pathway interactions;Phenotype;Population;Process;Publications;Publishing;Quail;Regulation;Regulator Genes;Research;Signal Transduction;Skeleton;System;TNFSF11 gene;Techniques;Testing;Time;Tissues;Transforming Growth Factor beta;Transplantation;Trauma;Variant;Work;base;bone;clinically relevant;craniofacial;design;in vivo;injured;interest;loss of function;member;mineralization;novel;osteogenic;premature;prevent;programs;public health relevance;repaired;research study;skeletal","Mesenchymal Regulation of Osteogenesis","
PROJECT NARRATIVE
How do cells learn when and where to make bone? Answering this question is important for preventing and
treating birth defects, as well as for devising new therapies to repair or regenerate bones affected by injury or
disease. The goal of this project is to identify genes and embryonic events that control bone formation.","NIDCR","8246295","3/8/2012 12:00:00 AM","PA-07-070","5R01DE016402-07","5","R01","DE","016402","07"," ","SCHOLNICK, STEVEN","9/28/2004 12:00:00 AM","3/31/2015 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","6279502","SCHNEIDER, RICHARD A","Not Applicable","12","ORTHOPEDICS","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","247500","134888"," ","382388",
"Aging; Osteoporosis; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Acute;Age;Aging;Attenuated;BMP6 gene;Binding;Biological Assay;Biology;Bone Marrow Cells;Bone Resorption;Cell Differentiation process;Cell Survival;Cells;Cellular Assay;Chronic;Clinical Research;Collaborations;Conditioned Culture Media;Coupled;Coupling;Data;Defect;Estrogens;Gene Expression;Goals;Health;Human;In Vitro;Knowledge;Laboratories;Lead;Location;Mediating;Menopause;Mesenchymal Stem Cells;Molecular;Molecular Biology;Mus;Nodule;Osteoblasts;Osteoclasts;Osteogenesis;Phase;Phosphorylation;Physiology;Play;Positioning Attribute;Postmenopause;Process;Production;Recruitment Activity;Regulation;Reporting;Research;Research Personnel;Resort;Role;SPHK1 enzyme;Site;Sphingosine;Staging;Stromal Cells;TNFSF11 gene;Testing;Transforming Growth Factor beta;Work;age effect;aged;aging population;bone;bone loss;bone metabolism;bone morphogenetic protein 6;bone turnover;c-myc Genes;cell motility;design;effective therapy;expectation;in vivo;in vivo Model;insight;migration;mineralization;mouse model;neutralizing antibody;novel;osteoblast differentiation;osteoclastogenesis;progenitor;response;skeletal;sphingosine 1-phosphate;stem cell differentiation;transcription factor USF","REGULATION OF BONE FORMATION BY OSTEOCLASTS","A crucial question in bone biology is how osteoblasts are recruited to a resorption site and how the amount
of bone laid down is controlled. Studies have implicated osteoclasts as important modulators of bone
formation. Understanding the mechanisms by which osteoclasts influence osteoblast recruitment,
differentiation, and survival will likely lead to more effective theapies to selectively promote bone formation.","NIA","8377402","6/20/2012 12:00:00 AM"," ","5P01AG004875-29","5","P01","AG","004875","29"," "," "," "," ","ZAG1-ZIJ-8","8375","3131924","OURSLER, MERRY JO","Not Applicable","01","Unavailable","006471700","Y2K4F9RPRRG7","006471700","Y2K4F9RPRRG7","US","44.022374","-92.465881","4976101","MAYO CLINIC ROCHESTER","ROCHESTER","MN","Other Domestic Non-Profits","559050001","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","289137","289137"," ","191355","97782"," "," ",
"Brain Cancer; Brain Disorders; Cancer; Clinical Research; Clinical Trials; Neurosciences; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Adenovirus Infections;Adenoviruses;Aftercare;Animal Disease Models;Animal Model;Applications Grants;Biological;Bone Marrow;Brain Neoplasms;Clinical;Clinical Research;Clinical Trials;Cytolysis;DNA Repair Pathway;Data;Disease;Doctor of Medicine;Engineering;Enrollment;Fiber;Future;Generations;Genes;Glioma;Goals;Grant;Human;Immune;In Situ;Injection of therapeutic agent;Institutional Review Boards;MGMT gene;Malignant Glioma;Malignant Neoplasms;Malignant neoplasm of brain;Mediating;Mesenchymal Stem Cells;Modification;Molecular;Mus;Oncolytic;Oncolytic viruses;Operative Surgical Procedures;Pathway interactions;Patient Care;Patients;Pattern;Phase I Clinical Trials;Property;Proteins;RGD (sequence);Reaction;Recurrence;Resistance;Rest;Sampling;Schedule;Site;Specimen;Stem cells;Testing;Therapeutic;Therapeutic Agents;Translating;Tropism;United States National Institutes of Health;Viral;Virus;Virus Diseases;base;bone;cdc Genes;chemotherapeutic agent;clinical application;effective therapy;human subject;improved;in vivo;killings;member;neoplastic cell;oncolysis;pre-clinical;preclinical study;programs;repaired;standard of care;success;temozolomide;translational study;tumor;tumor eradication","Tropism Enhanced Oncolytic Adenovirus for the treatment of Brain Tumors","n/a","NCI","8380390","8/22/2012 12:00:00 AM","PAR-06-505","5P50CA127001-05","5","P50","CA","127001","05"," "," "," "," ","ZCA1-GRB-I","0001","3142143","FUEYO, JUAN ","Not Applicable","09","Unavailable","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","Domestic Higher Education","770304009","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Research Centers","2012","264692","264692"," ","181081","83611"," "," ",
"Dental/Oral and Craniofacial Disease; Neurosciences; Pediatric","Abnormal Cell;Actomyosin;Adhesions;Affect;Behavior;Behavior Control;Biology;Biosensor;Cadherins;Cartilage;Cell-Cell Adhesion;Cells;Cellular Morphology;Chronic;Conflict (Psychology);Congenital Abnormality;Cytoskeleton;Development;Disease;Embryonic Development;Environment;Epithelial;Event;F-Actin;Family;Fibrosis;Future;Image;Immigration;Inflammation;Lead;Life;Literature;Location;Modeling;Molecular;Monomeric GTP-Binding Proteins;Morphology;Neoplasm Metastasis;Neural Crest;Neural Crest Cell;Neural tube;Neuroglia;Neurons;Pathologic Processes;Pathology;Pathway interactions;Peripheral Nervous System;Pigments;Play;Process;Reporting;Role;Signal Pathway;Signal Transduction;Staging;Structure;Structure of primordial sex cell;Testing;Time;Tissues;Work;Zebrafish;bone;cadherin-6;cell behavior;cell motility;craniofacial;epithelial to mesenchymal transition;gain of function;in vivo;inhibitor/antagonist;intercellular communication;migration;neuroepithelium;plasmid DNA;research study;rho;rho GTP-Binding Proteins;small molecule;spatiotemporal;tumor progression","Mechanisms of Neural Crest EMT"," Improper development of neural crest cell (NCC) derived structures, including craniofacial bone and cartilage, leads to a class of birth defects called neurocristopathies. To populate their targets NCCs must become migratory, which involves undergoing epithelial to mesenchymal transition (EMT). EMTs are important events in development that also drive pathologies such as fibrosis, chronic inflammation, and cancer metastasis. The experiments proposed here have the potential to explain how specific molecules control these critical events and inform therapies in diseases involving EMT and abnormal cell migration.  
    

","NIDCR","8386827","5/18/2012 12:00:00 AM","PA-10-108","5F31DE022232-02","5","F31","DE","022232","02"," ","FRIEDEN, LESLIE A","7/1/2011 12:00:00 AM","6/30/2013 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","10750293","CLAY, MATTHEW ROBERT","Not Applicable","02","ZOOLOGY","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","SCHOOLS OF ARTS AND SCIENCES","537151218","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","32472"," "," ","32472",
"Clinical Research; Genetics; Stem Cell Research","AIDS/HIV problem;Address;Adherence;Africa;African;Automation;Benchmarking;Biocompatible Materials;Bioinformatics;Biological;Blood;California;Cell Line;Cells;Central Africa;Communicable Diseases;Community Outreach;Cryopreservation;DNA;Development;Disease;Elements;Ensure;Ethics;Evaluation;Exercise;Faculty;Generations;Genomics;Guidelines;Health;Hematology;Human;Hypertension;Industry;Informatics;Institutes;Institution;International;Knowledge;Lead;Malignant Neoplasms;Mesenchymal Stem Cells;Methods;National Cancer Institute;Nucleic Acids;Outcome;Pathology;Pharmacogenomics;Phase;Plague;Population;Preparation;Process;Protocols documentation;Quality Control;Records;Regenerative Medicine;Research Infrastructure;Resource Development;Retrieval;Safety;Sampling;Science;Scientist;Services;Shipping;Ships;Societies;South Africa;Specimen;Stem Cell Development;Stem cells;System;Temperature;Testing;Training;Universities;biobank;human subject;induced pluripotent stem cell;meetings;novel strategies;operation;programs;quality assurance;repository;sample collection;scale up;skills;social","Development of stem cell, blood & DNA bio repositories to facilitate studies on H","Creation of a full scale biorespository (biobank) will be an important part of scientific capacity building on the African continent and will support large scal genomic studies that will be performed on the continent. These studies and supporting infrastructure are necessary to address the health needs of the continent that is plagued with infectious disease such as HIV/AIDS as well as an ever increasing burden of non-communicable diseases such as Hypertension and cancer. Biorepositories will serve to preserve human samples, harmonize sample collection efforts, a training center for African scientists and a community outreach portal to educate the public about the implications of biobanking and genomics for the health of African populations.","NHGRI","8432104","8/14/2012 12:00:00 AM","RFA-RM-12-003","1UH2HG007092-01","1","UH2","HG","007092","01"," ","PETERSON, JANE","8/15/2012 12:00:00 AM","7/31/2013 12:00:00 AM","ZHG1-HGR-P(M3)"," ","11294414","ABAYOMI, AKIN EMMANUEL","Not Applicable","n/a","Unavailable","569118040","C6CHDMTANVS3","569118040","C6CHDMTANVS3","SF","-33.916667","18.6","10001610","STELLENBOSCH UNIVERSITY TYGERBERG CAMPUS","CAPE TOWN"," ","Unavailable","8000","SOUTH AFRICA","N","8/15/2012 12:00:00 AM","7/31/2013 12:00:00 AM","310","Non-SBIR/STTR","2012"," "," ","OD","115000","5403"," ","120403",
"Cancer; Clinical Research","Activins;Address;Affect;Autocrine Communication;Biological;Biological Assay;Cells;Chronic;Data;Development;Disease;Dominant-Negative Mutation;E-Cadherin;E-Cadherin Staining Method;Embryonic Development;Epithelial;Epithelial Cells;Epithelial-Stromal Communication;Epithelium;Esophageal;Esophageal Squamous Cell;Esophagus;Fibroblasts;Fibrous capsule of kidney;Gastrointestinal Diseases;Goals;Growth;Homeostasis;In Vitro;Investigation;Knowledge;Maintenance;Malignant Squamous Cell Neoplasm;Mediating;Mesenchymal;Mission;Modeling;Oncogenic;Paracrine Communication;Pathogenesis;Play;Public Health;Regulation;Reporting;Research;Role;Signal Pathway;Signal Transduction;Signaling Molecule;System;TGFB1 gene;Testing;Tissue Recombination;Transforming Growth Factors;Tumor Tissue;United States National Institutes of Health;Xenograft Model;Xenograft procedure;activin A;autocrine;base;in vivo;in vivo Model;innovation;insight;keratinocyte;member;mouse model;neoplastic cell;novel;novel strategies;overexpression;paracrine;receptor;response;small hairpin RNA;tumorigenesis","The role of Activin A signaling in esophageal cell invasion"," The proposed research is relevant to public health because the identification of signaling pathways regulating epithelial-mesenchymal transition and esophageal keratinocyte invasion will advance our understanding of the pathogenesis of gastrointestinal disease and mechanisms of regulating homeostasis. This study will determine the role of Activin A autocrine and paracrine signaling in the induction of cell invasion in vitro and in vivo models. The proposed research is relevant to the part of NIHï¿½s mission that pertains to reducing the suffering of those affected by chronic and costly diseases.   
      

","NIDDK","8271120","3/12/2012 12:00:00 AM","PA-10-067","1R01DK094900-01","1","R01","DK","094900","01"," ","CARRINGTON, JILL L","7/1/2012 12:00:00 AM","6/30/2017 12:00:00 AM","Clinical, Integrative and Molecular Gastroenterology Study Section[CIMG]"," ","7797423","ANDL, CLAUDIA D","Not Applicable","05","SURGERY","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","111179"," ","328679",
"Bioengineering; Lung; Rare Diseases","Active Sites;Alveolar;Apoptosis;Apoptotic;Appearance;Attenuated;Biochemical;Biomechanics;Bleomycin;Cell Survival;Cells;Characteristics;Chronic;Chronic Disease;Clinical;Cues;Deposition;Dinoprostone;Disease;Employee Strikes;Endothelin-1;Epithelial;Epithelial Cells;Extracellular Matrix;Fibroblasts;Fibrosis;Focal Adhesion Kinase 1;Hamman-Rich syndrome;In Vitro;Injury;Intervention;Liver Fibrosis;Lung;Lung Compliance;Lung diseases;Maintenance;Mechanics;Mediating;Mediator of activation protein;Mesenchymal;Modeling;Mus;Myofibroblast;Outcome;Pathogenesis;Pathologic;Pathologic Processes;Pathway interactions;Patients;Phenotype;Phosphotransferases;Physical environment;Physiological;Plasmin;Plastics;Production;Property;Proteolysis;Pulmonary Fibrosis;Recurrence;Regulation;Resistance;Resolution;Role;Severities;Signal Transduction;Stimulus;Structure of parenchyma of lung;Tissues;Wound Healing;behavior influence;cell behavior;effective therapy;fibrogenesis;human TGFB1 protein;improved;in vivo;injured;mortality;novel;novel strategies;outcome forecast;physical property;repaired;response","Mesenchymal Cell Fate Determination by Extracellular Matrix Stiffness"," The proposed studies will enhance our fundamental understanding of myofibroblast fate regulation in physiologic and pathologic wound healing and facilitate identification of novel anti-fibrotic targets for intervention in pulmonary fibrosis.    

","NHLBI","8307799","6/29/2012 12:00:00 AM","PA-10-067","5R01HL105489-02","5","R01","HL","105489","02"," ","HARABIN, ANDREA L","8/1/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","7823113","HOROWITZ, JEFFREY C","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","276613","114733"," ","391346",
"Bioengineering; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Transplantation","3-Dimensional;Adverse effects;Area;Attention;Autologous;Biocompatible;Biocompatible Materials;Biological;Bone Regeneration;Bone Transplantation;Cadaver;Calvaria;Cell Adhesion;Cells;Cellular Infiltration;Clinical;Cues;Defect;Deposition;Development;Engineering;Epitopes;Excision;Extracellular Matrix;Future;Growth Factor;Home environment;Human;Hydrogels;Immigration;In Vitro;Infection;Injectable;Invaded;Laboratories;Malignant Neoplasms;Mesenchymal Stem Cells;Minerals;Modification;Movement;Natural regeneration;Operative Surgical Procedures;Osteogenesis;Pathway interactions;Patients;Plague;Platelet-Derived Growth Factor;Polymers;Preparation;Process;Prosthesis;Rattus;Recruitment Activity;Research;Risk;Scheme;Signal Transduction;Site;Sulfhydryl Compounds;Surgeon;System;Techniques;Testing;Tissue Engineering;Tissues;Transplanted tissue;Trauma;Work;allogenic bone transplantation;base;bone;bone mass;bone repair material;cell motility;controlled release;crosslink;design;disorder risk;implantation;improved;in vivo;injured;migration;neuronal cell body;osteogenic;photopolymerization;polymerization;protein aminoacid sequence;public health relevance;repaired;scaffold;success;technique development;tissue regeneration;tool","Osteogenic Hydrogel Niches to Promote hMSC Migration and Differentiation","
PROJECT NARRATIVE
The Anseth Group aims to develop synthetic materials for repairing bone defects resulting from
congenital anomalies, trauma, infection, and cancer. Our approach is to create 3-dimensional
matrices that will act as scaffolds to recruit cells from surrounding tissues and promote natural
bone regeneration processes, creating an improved and bioactive bone graft material.","NIDCR","8197724","11/10/2011 12:00:00 AM","PA-10-067","5R01DE016523-07","5","R01","DE","016523","07"," ","LUMELSKY, NADYA L","5/1/2005 12:00:00 AM","11/30/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-C(03)M]"," ","1860511","ANSETH, KRISTI S.","Not Applicable","02","ENGINEERING (ALL TYPES)","007431505","SPVKK1RC2MZ3","007431505","SPVKK1RC2MZ3","US","40.027599","-105.251595","1199902","UNIVERSITY OF COLORADO","Boulder","CO","BIOMED ENGR/COL ENGR/ENGR STA","803031058","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","237500","110527"," ","348027",
"Cancer","Actins;Address;Affect;Aging;Antibodies;Binding;Biological Assay;Cell Surface Receptors;Cell physiology;Cells;Chondrogenesis;Cicatrix;Collagen;Collagen Type II;Connective Tissue;Connective Tissue Diseases;Cues;Cytoskeleton;Defect;Deposition;Detergents;Development;Differentiation Antigens;Disease;Disease Outcome;Disease Progression;Environment;Extracellular Matrix;Extracellular Matrix Proteins;Fibronectins;Fibrosis;Foundations;Goals;Heparin;Homeostasis;Individual;Integrin Binding;Integrins;Lead;Malignant Neoplasms;Maps;Mass Spectrum Analysis;Measures;Mechanics;Mediating;Mesenchymal Stem Cells;Molecular Analysis;Molecular Conformation;Molecular Probes;Morphogenesis;Pathology;Process;Property;Proteins;Reaction;Recombinant Proteins;Recombinants;Role;Signal Transduction;Small Interfering RNA;Structure;Testing;Tissue Differentiation;Tissues;Wound Healing;base;cell growth;crosslink;deoxycholate;design;dimer;human disease;improved;in vitro Model;insight;mutant;novel;physical state;polyacrylamide gels;polymerization;prevent;receptor;research study;treatment strategy;tumorigenesis","Molecular Analysis of Extracellular Matrix Assembly"," Most, if not all, human diseases involve perturbations in the extracellular matrix, the network of proteins that organizes cells into tissues. The proposed studies will provide novel information about how a normal matrix is assembled and how changes in the tissue environment affect assembly and contribute to developmental defects and disease. Knowing the protein interactions that determine matrix structure and control matrix functions, we will be better able to design and develop new treatments and strategies for dealing with ECM defects in fibrosis, connective tissue diseases, and cancer.   
      

","NCI","8303935","4/23/2012 12:00:00 AM","PA-10-067","1R01CA160611-01A1","1","R01","CA","160611","01","A","MOHLA, SURESH","5/1/2012 12:00:00 AM","3/31/2017 12:00:00 AM","Intercellular Interactions Study Section[ICI]"," ","8171084","SCHWARZBAUER, JEAN E","Not Applicable","12","BIOCHEMISTRY","002484665","NJ1YPQXQG7U5","002484665","NJ1YPQXQG7U5","US","40.12273","-74.703461","6661401","PRINCETON UNIVERSITY","Princeton","NJ","SCHOOLS OF ARTS AND SCIENCES","085406000","UNITED STATES","N","5/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","117972"," ","325472",
"Aging; Osteoporosis; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human; Transplantation","Accounting;Address;Affect;Biological Assay;Bone Marrow;Bone Marrow Cells;Bone Resorption;C57BL/6 Mouse;Cells;Ceramics;Complement;Complement 1q;Complement 3;Complement Activation;Complement Factor D;Complement Receptor;Complement component C1;Complex;Equilibrium;Estrogens;Goals;Hematopoietic;Hematopoietic stem cells;Homeostasis;Human;Immune;Immunology;Implant;In Vitro;Knockout Mice;Laboratories;Lead;Link;Mediating;Mesenchymal Stem Cells;Methods;Modeling;Mus;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis;Ovariectomy;Pathway interactions;Postmenopausal Osteoporosis;Postmenopause;Production;Regulation;Role;Signal Transduction;Stem cells;Structure;Testing;Time;Tissues;Transplantation;Umbilical Cord Blood;Wild Type Mouse;X-Ray Computed Tomography;base;bone;bone loss;bone turnover;cell type;clinically relevant;complement deficiency;complement system;cytokine;deprivation;dosage;drug development;effective therapy;implantation;in vivo;inhibitor/antagonist;interest;novel;novel strategies;osteogenic;prevent;progenitor;receptor;research study;skeletal;transcription factor","Complement and Osteoporosis"," This project will study the role of complement in regulating bone turnover in osteoporosis, which has the potential of opening up complement as a new target for developing novel, effective therapies against osteoporosis.   
      

","NIAMS","8293594","9/13/2012 12:00:00 AM","PA-10-067","1R01AR061564-01A1","1","R01","AR","061564","01","A","SHARROCK, WILLIAM J","9/15/2012 12:00:00 AM","1/7/2013 12:00:00 AM","Innate Immunity and Inflammation Study Section[III]"," ","6571178","LIN, FENG C","DENNIS, JAMES E","11","PATHOLOGY","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","SCHOOLS OF MEDICINE","441061712","UNITED STATES","N","9/15/2012 12:00:00 AM","1/7/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","300410","87278"," ","387688",
"Bioengineering; Biotechnology; Cardiovascular; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adolescent;Adult;Animal Model;Benchmarking;Biological;Bioprosthesis device;Bioreactors;Caliber;Cardiovascular system;Cells;Childhood;Clinical Trials;Culture Media;Data;Deposition;Dermal;Development;Diffusion;Engineering;Exhibits;Failure;Feedback;Fibrin;Fibroblasts;Funding;Gel;Generations;Goals;Growth;Heart Valves;Hematopoietic;Human;Implant;In Vitro;Infiltration;Life;Mechanics;Mesenchymal Stem Cells;Modeling;Monitor;Nutrient;Operative Surgical Procedures;Patients;Performance;Phenotype;Physiologic pulse;Plant Roots;Polymers;Positioning Attribute;Property;Pulmonary artery structure;Pulmonary valve structure;Pump;Radial;Research;Seeds;Sheep;Silicones;Smooth Muscle Actin Staining Method;Stretching;Stroke Volume;Surface;Technology;Tensile Strength;Testing;Thinness;Tissue Engineering;Tissues;Translating;Transplantation;Tube;United States;United States National Institutes of Health;Validation;Variant;aortic valve;aortic valve replacement;design;human tissue;implantation;improved;interest;mortality;operation;pre-clinical;preimplantation;pressure;public health relevance;pulmonary valve replacement;success;valve replacement","Tissue-engineered pulmonic valve grown from human cells for pediatric patients","
Narrative
In the United States alone, over 95,000 valve replacement surgeries are now performed annually according to
the AHA. While mechanical and bioprosthetic heart valves have made a dramatic impact since their
introduction in the 1960's, the 10-year mortality after replacement is still 30-55%. The need is particularly great
for pediatric patients, since these valves do not have the capacity to grow. Thus, there is great interest in
developing a new generation of tissue-engineered heart valves, and this research is aimed at the design and
testing of a completely biological living valve replacement.","NHLBI","8527302","9/7/2012 12:00:00 AM","PA-10-067","3R01HL107572-02S1","3","R01","HL","107572","02","S","BLAISDELL, CAROL J","4/1/2011 12:00:00 AM","3/31/2016 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","1964940","TRANQUILLO, ROBERT T","Not Applicable","05","BIOMEDICAL ENGINEERING","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","BIOMED ENGR/COL ENGR/ENGR STA","554552070","UNITED STATES","N","9/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","27707","10039"," ","37746",
"Bioengineering; Pediatric; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human; Transplantation","Acceleration;Address;Adipocytes;Adipose tissue;Adopted;Advanced Development;Affect;Age;Animals;Appearance;Area;Award;Biochemical;Bioluminescence;Blood;Blood Vessels;Bone Marrow;Boston;Burn injury;Carcinoma;Cell Differentiation process;Cells;Clinical;Collagen;Confocal Microscopy;Congenital Abnormality;Data;Development;Diabetes Mellitus;Endocrinology;Engineering;Excision;Fatty acid glycerol esters;Fibrin;Filler;Generations;Goals;Hour;Human;Image;Immunofluorescence Immunologic;Implant;In Situ;In Vitro;Individual;Injury;Intramuscular;Knowledge;Label;Letters;Location;Luciferases;Mastectomy;Mesenchymal Stem Cells;Mus;Muscle Cells;Natural regeneration;Organ;Outcome;Patients;Pediatric Hospitals;Phase;Phenotype;Plastics;Population;Process;Publishing;Reconstructive Surgical Procedures;Recruitment Activity;Regenerative Medicine;Research;Site;Specificity;Staining method;Stains;Stem cells;Stimulus;Strawberry nevus;System;Techniques;Technology;Testing;Therapeutic;Time;Tissue Engineering;Tissues;Translating;Undifferentiated;Vascularization;base;blood perfusion;design;experience;implantation;improved;in vivo;in vivo Model;interest;lipid biosynthesis;matrigel;postnatal;research study;scale up;subcutaneous;success;tissue regeneration;tissue repair;tumor","Engineering vascularized tissue in vivo using postnatal progenitor cells","This is an enabling technology that can be applied to regeneration of tissues/prgans wherein functional blood 
vessels are essential. This proposal will focus on formation of adipose tissue, but it will be applicable to 
many aspects of regenerative medicine, including tissue-engineering and in situ therapeutic vascularization.","NIBIB","8315990","7/13/2012 12:00:00 AM","PA-11-197","5R00EB009096-04","5","R00","EB","009096","04"," ","HUNZIKER, ROSEMARIE","8/15/2009 12:00:00 AM","7/31/2014 12:00:00 AM","NSS"," ","9319578","MELERO-MARTIN, JUAN M","Not Applicable","07","Unavailable","076593722","Z1L9F1MM1RY3","076593722","Z1L9F1MM1RY3","US","42.340629","-71.094923","1504801","BOSTON CHILDREN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021155724","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","140426","103915"," ","244341",
"Biotechnology; Stem Cell Research","Albumins;Biological Assay;Carbohydrates;Categories;Cell Culture Techniques;Cell Differentiation process;Cell Proliferation;Cell Therapy;Cells;Collagen;Crowding;Culture Media;Cytochrome P450;Deposition;Development;Drug toxicity;Endoderm;Enzymes;Evaluation;Exhibits;Extracellular Matrix;Fibroblast Growth Factor;Ficoll;Funding;Glycogen;Goals;Government;Hepatic;Hepatocyte;In Vitro;Indocyanine Green;Industrialization;Laminin;Legal patent;Lipids;Liver parenchyma;Low-Density Lipoproteins;Measures;Mesenchymal Stem Cells;Metabolism;Methodology;Methods;Monitor;Output;Persons;Phase;Pluripotent Stem Cells;Preclinical Drug Evaluation;Production;Property;Protocols documentation;Reagent;Reporter;Research;Resources;Screening procedure;Small Business Innovation Research Grant;Staging;Staining method;Stains;Stem cells;System;Technology;Testing;Therapeutic Studies;Toxicity Tests;Toxicology;Urea;Work;abstracting;activin A;base;cell type;drug discovery;improved;improved functioning;in vivo;induced pluripotent stem cell;macromolecule;meetings;new technology;novel;oncostatin M;phase 1 study;phase 2 study;sample fixation;scale up;tissue culture;two-dimensional;uptake","A Novel Method to Improve Function of SC-Derived Hepatocytes"," Primorigen Biosciences, Inc. SBIR ","NIGMS","8314618","6/11/2012 12:00:00 AM","PA-11-096","1R43GM101858-01","1","R43","GM","101858","01"," ","MAAS, STEFAN","8/1/2012 12:00:00 AM","11/30/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-IMST-K(14)B]"," ","9786398","MONSMA, SCOTT ALLEN","Not Applicable","02","Unavailable","782932177"," ","782932177"," ","US","43.058641","-89.47536","10009928","PRIMORIGEN BIOSCIENCES, INC.","MADISON","WI","Domestic For-Profits","537191289","UNITED STATES","N","8/1/2012 12:00:00 AM","11/30/2013 12:00:00 AM","859","SBIR/STTR","2012"," "," ","NIGMS"," "," "," ","328224",
"Aging; Estrogen; Osteoporosis; Prevention; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Affect;Age;Animals;Biological Assay;Bone Diseases;Bone Resorption;Cell Communication;Cell Differentiation process;Cell Lineage;Cells;Drops;Endocrine;Equilibrium;Estradiol;Estrogen Receptors;Estrogen Replacements;Estrogens;Evolution;Family;Follicle Stimulating Hormone Receptor;Genes;Glycoproteins;Gonadal Steroid Hormones;Green Fluorescent Proteins;Health;Hormones;Human;Immune;In Vitro;Knock-out;Knockout Mice;Ligands;Longitudinal Studies;Macrophage Colony-Stimulating Factor;Mediating;Menopause;Mesenchymal Stem Cells;Minerals;Modeling;Monitor;Mus;Organ;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis prevention;Pattern;Physiologic calcification;Pituitary Gland;Pituitary Hormones;Postmenopausal Osteoporosis;Production;Protein Isoforms;RNA Splicing;Regulation;Relative (related person);Reproduction;Screening procedure;Signal Transduction;Skeleton;Source;Steroid Receptors;Steroids;System;TNFSF11 gene;Testing;Thyroid Hormones;Thyrotropin Receptor;Ursidae Family;Variant;Woman;Work;bone;bone cell;bone loss;bone mass;bone turnover;hydrocortisone receptor;improved;in vivo;insight;interest;knockout animal;mouse model;osteoblast differentiation;precursor cell;prevent;receptor;receptor expression;response;species difference;stem cell differentiation","Regulation of Human Bone Turnover by FSH","n/a","NIAMS","8264381","5/12/2012 12:00:00 AM","PA-07-070","5R01AR055208-05","5","R01","AR","055208","05"," ","CHEN, FAYE H","7/3/2008 12:00:00 AM","5/31/2014 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1881296","BLAIR, HARRY C.","Not Applicable","18","PATHOLOGY","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","209088","107680"," ","316768",
"Breast Cancer; Cancer; Clinical Research","Adjuvant Therapy;Affect;Biological;Bone Marrow;Breast;Breast Cancer Cell;CXCL12 gene;Cancer Patient;Cell Survival;Distant;ERBB2 gene;Fibroblasts;Goals;Grant;IGF1 gene;In Vitro;Knowledge;Literature;Lung;Malignant neoplasm of prostate;Mammary Neoplasms;Mediating;Mesenchymal Stem Cells;Metastatic Neoplasm to the Bone;Modeling;Neoplasm Metastasis;Organ;Pathway interactions;Phase;Population;Primary Neoplasm;Relapse;Resistance;Role;Seeds;Signal Transduction;Solid Neoplasm;Source;Structure of parenchyma of lung;Tamoxifen;Testing;base;bone;cancer cell;cytokine;in vivo;insight;macrophage;malignant breast neoplasm;novel;response;tumor","MECHANISMS OF SRC ACTIVATION AND ITS ROLE IN LATENT BONE METASTASIS OF BREAST AND","RELEVANCE (See instfuctions): 
Metastasis represents a major threat to the lives of cancer patients. Although most solid tumors can be 
surgically removed, metastatic relapses may occur to various distant organs with variable latency, and 
usually accompanied with resistance to adjuvant therapies. Our long-term goal is to understand the 
biological mechanism underlying metastasis, and to uncover novel therapies.","NCI","8337360","9/5/2012 12:00:00 AM","PA-09-036","5R00CA151293-03","5","R00","CA","151293","03"," ","MOHLA, SURESH","9/1/2010 12:00:00 AM","8/31/2014 12:00:00 AM","NSS"," ","10168466","ZHANG, XIANG ","Not Applicable","09","ANATOMY/CELL BIOLOGY","051113330","FXKMA43NTV21","051113330","FXKMA43NTV21","US","29.711148","-95.39695","481201","BAYLOR COLLEGE OF MEDICINE","HOUSTON","TX","SCHOOLS OF MEDICINE","770303411","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","171841","69688"," ","241529",
"Bioengineering; Biotechnology; Cardiovascular; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Adolescent;Adult;Animal Model;Benchmarking;Biological;Bioprosthesis device;Bioreactors;Caliber;Cardiovascular system;Cells;Childhood;Clinical Trials;Culture Media;Data;Deposition;Dermal;Development;Diffusion;Engineering;Exhibits;Failure;Feedback;Fibrin;Fibroblasts;Funding;Gel;Generations;Goals;Growth;Heart Valves;Hematopoietic;Human;Implant;In Vitro;Infiltration;Life;Mechanics;Mesenchymal Stem Cells;Modeling;Monitor;Nutrient;Operative Surgical Procedures;Patients;Performance;Phenotype;Physiologic pulse;Plant Roots;Polymers;Positioning Attribute;Property;Pulmonary artery structure;Pulmonary valve structure;Pump;Radial;Research;Seeds;Sheep;Silicones;Smooth Muscle Actin Staining Method;Stretching;Stroke Volume;Surface;Technology;Tensile Strength;Testing;Thinness;Tissue Engineering;Tissues;Translating;Transplantation;Tube;United States;United States National Institutes of Health;Validation;Variant;aortic valve;aortic valve replacement;design;human tissue;implantation;improved;interest;mortality;operation;pre-clinical;preimplantation;pressure;public health relevance;pulmonary valve replacement;success;valve replacement","Tissue-engineered pulmonic valve grown from human cells for pediatric patients","
Narrative
In the United States alone, over 95,000 valve replacement surgeries are now performed annually according to
the AHA. While mechanical and bioprosthetic heart valves have made a dramatic impact since their
introduction in the 1960's, the 10-year mortality after replacement is still 30-55%. The need is particularly great
for pediatric patients, since these valves do not have the capacity to grow. Thus, there is great interest in
developing a new generation of tissue-engineered heart valves, and this research is aimed at the design and
testing of a completely biological living valve replacement.","NHLBI","8242099","3/26/2012 12:00:00 AM","PA-10-067","5R01HL107572-02","5","R01","HL","107572","02"," ","BLAISDELL, CAROL J","4/1/2011 12:00:00 AM","3/31/2016 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","1964940","TRANQUILLO, ROBERT T","Not Applicable","05","BIOMEDICAL ENGINEERING","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","BIOMED ENGR/COL ENGR/ENGR STA","554552070","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","438314","218430"," ","656744",
"Biotechnology; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Biogenesis;Birth;Blood Vessels;Bone Marrow;Cardiac;Cardiac Myocytes;Cell Proliferation;Cell Therapy;Cells;Clinical Trials;Conditioned Culture Media;Data;Deterioration;Development;Down-Regulation;Employee Strikes;Endothelial Cells;Endothelium;Fibroblasts;Functional disorder;Future;Gene Expression;Gene Targeting;Granulation Tissue;Heart;Heart failure;Histologic;Human;Infarction;Injection of therapeutic agent;Intramuscular;Knowledge;Lead;Link;MRL/MpJ Mouse;Mediating;Mesenchymal Stem Cells;Modeling;Molecular;Mus;Muscle;Myocardial;Myocardial Infarction;Myocardial Ischemia;Myocardium;Natural regeneration;Pathway interactions;Phenotype;Population;Porifera;Pre-Clinical Model;Reagent;Regulation;Relative (related person);Role;Signal Pathway;Signal Transduction;Stem cells;Therapeutic;Therapeutic Intervention;Tissue Model;Tissues;Transcript;Treatment Efficacy;Wound Healing;Wounds and Injuries;base;cardiac repair;diabetic;fetal;human SFRP4 protein;improved;improved functioning;member;migration;novel;older patient;paracrine;preclinical study;reconstitution;regenerative;regenerative therapy;repaired;research study;self-renewal;stem;stem cell population;tool;transdifferentiation;wound","Creating Super Stem Cells for Cardiac and Wound Repair","n/a","NHLBI","8242088","3/5/2012 12:00:00 AM","PA-07-303","5R01HL088424-05","5","R01","HL","088424","05"," ","THOMAS, JOHN","4/1/2008 12:00:00 AM","3/31/2014 12:00:00 AM","Myocardial Ischemia and Metabolism Study Section[MIM]"," ","1924237","YOUNG, PAMPEE P","Not Applicable","05","PATHOLOGY","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","222750","115599"," ","338349",
"No NIH Category available","Acute Renal Failure with Renal Papillary Necrosis;Allogenic;Bilateral;Biological Markers;CXCL12 gene;CXCR4 gene;Cardiac Surgery procedures;Chronic;Chronic Kidney Failure;Clinical;Complex;Complication;Crush Injury;Development;Diagnosis;Diagnostic;Dialysis procedure;Disease;Disease model;Dose;Dyes;Early Diagnosis;Goals;Homing;Injury;Ischemia;Kidney;Laboratories;Mediating;Mesenchymal Stem Cells;Monitor;Morbidity - disease rate;Nephrectomy;Nephrotoxic;Operative Surgical Procedures;Patients;Pharmaceutical Preparations;Phase I Clinical Trials;Prevention;Public Health;Rattus;Recovery;Recovery of Function;Renal function;Reperfusion Therapy;Research;Resistance;Resources;Sepsis;Serum;Shock;Stem cells;Stromal Cell-Derived Factor 1;Stromal Cells;Study Section;Technology;Testing;Therapeutic;Time;Trauma;Treatment Cost;Up-Regulation;Urine;Veterans;Work;base;chemokine;combat;design;high risk;injured;mortality;noninvasive diagnosis;novel;novel diagnostics;paracrine;prevent;receptor;stem cell therapy;tool;urinary","SDF-1:  A Diagnostic and Therapy-Specific Biomarker of AKI and CKD","A growing number of veterans require dialysis for the treatment of acute kidney injury (AKI) sustained during surgery, trauma, crush injuries, sepsis or 
from nephrotoxic dyes and drugs. The associated morbidity and mortality remains high and functional recovery, if it occurs, may take from days to weeks, thus consuming enormous resources. It is imperative that more effective therapeutic tools be developed to help prevent and combat this disease, which is the goal of this proposal.","VA","8259054","12/7/2011 12:00:00 AM","RFA-BX-09-008","5I01BX000391-03","5","I01","BX","000391","03"," "," ","4/1/2010 12:00:00 AM","3/31/2014 12:00:00 AM","Nephrology[NEPH]"," ","9586668","WESTENFELDER, CHRISTOF ","Not Applicable","02","Unavailable","009094756","YYULHSE8AL99","009094756","YYULHSE8AL99","US","40.777624","-111.93104","481089","VA SALT LAKE CITY HEALTHCARE SYSTEM","SALT LAKE CITY","UT","Independent Hospitals","841480001","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Bioengineering; Biotechnology; Regenerative Medicine","Adipose tissue;Animals;Biochemical;Biochemistry;Biocompatible Materials;Biological Markers;Bone Regeneration;Bone Tissue;Cell Differentiation process;Cell Survival;Cell physiology;Cells;Clinical;Collaborations;Collagen;Collection;Computer software;Data;Defect;Deposition;Detection;Development;Engineering;Equilibrium;Extracellular Matrix;Fatty acid glycerol esters;Fluorescence;Fracture;Funding;Goals;Growth;Histocompatibility Testing;Human;Image;Implant;In Vitro;Knowledge;Light;Mammary gland;Mesenchymal Stem Cells;Metabolic;Methods;Monitor;Morphology;Natural regeneration;Operative Surgical Procedures;Optical Methods;Optics;Osteoporosis;Outcome;Pathway interactions;Patients;Play;Process;Property;Proteins;Public Health;Reconstructive Surgical Procedures;Reporting;Research;Research Personnel;Resolution;Resources;Role;Sampling;Signal Transduction;Silk;Source;Staining method;Stains;Stem cells;Structure;System;Technology;Testing;Time;Tissue Engineering;Tissues;United States National Institutes of Health;Validation;Work;base;bone;bone engineering;cell growth;experience;functional status;imaging modality;implantation;in vivo;innovation;instrumentation;light scattering;mouse model;non-invasive monitor;novel;osteogenic;reconstruction;repaired;scaffold;soft tissue;spectroscopic imaging;stem cell biology;tissue regeneration;tissue repair;tool","Optical monitoring of engineered tissues","n/a","NIBIB","8286938","4/27/2012 12:00:00 AM","PAR-06-504","5R01EB007542-04","5","R01","EB","007542","04"," ","HUNZIKER, ROSEMARIE","5/1/2009 12:00:00 AM","4/30/2015 12:00:00 AM","ZEB1-OSR-D(O1)S"," ","2442066","GEORGAKOUDI, IRENE ","Not Applicable","07","ENGINEERING (ALL TYPES)","073134835","WL9FLBRVPJJ7","073134835","WL9FLBRVPJJ7","US","42.423895","-71.1092","8422701","TUFTS UNIVERSITY MEDFORD","Boston","MA","BIOMED ENGR/COL ENGR/ENGR STA","021111817","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2015 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","214107","108457"," ","322564",
"Aging; Osteoporosis; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adult;Affect;Aging;Alleles;BMP2 gene;BMP4;BMP7 gene;Bone Marrow;Bone Marrow Transplantation;Bone Morphogenetic Proteins;Bone Regeneration;Bone Resorption;Bone remodeling;Cells;Data;Defect;Disease;Embryonic Development;Excision;Fracture;Fracture Healing;Health;Homeostasis;Individual;Knockout Mice;LacZ Genes;Life;Limb Development;Limb structure;Maintenance;Maps;Mediating;Mesenchymal Stem Cells;Mus;Osteoblasts;Osteoclasts;Osteogenesis;Osteopenia;Osteoporosis;Participant;Pathological fracture;Pattern;Phenotype;Play;Population;Prevalence;Regulation;Reporter;Risk;Role;Signal Pathway;Signal Transduction;Site;Skeletal Development;Skeleton;Staining method;Stains;Stromal Cells;Therapeutic Agents;Visual;Work;base;bone;bone mass;bone morphogenetic protein 2;improved;interest;mature animal;osteoblast differentiation;osteogenic;osteoprogenitor cell;postnatal;programs;research study;skeletal","BMP-2 Regulation of Bone Homeostasis","
Project Narrative
Bone remodeling occurs throughout adult life, and requires that osteoblasts (bone
forming cells) and osteoclasts (bone removing cells) work in concert to maintain bone
mass. Osteopenia results when new bone formation cannot keep pace with bone
resorption, leading to a weakened skeleton, increased risk of fracture, and osteoporosis,
an incapacitating disease of increased prevalence with aging. As changes in BMP
activity in adult bone have been associated with osteoporosis and in the reduced ability
to heal fractures that occur with aging (Badley, 1995; Enomoto-Iwamoto et al., 1998;
Mundy et al., 1999; Rountree et al., 2004; Styrkarsdottir et al., 2003), and our data
identify BMP2 as key to normal BMP activity in adults, we believe developing a greater
understanding of the way BMP2 regulates bone homeostasis is highly relevant to
improving the health of the aging US population.","NIAMS","8302456","7/27/2012 12:00:00 AM","PA-07-070","5R01AR055904-04","5","R01","AR","055904","04"," ","CHEN, FAYE H","8/6/2009 12:00:00 AM","7/31/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1944055","ROSEN, VICKI ","Not Applicable","07","DENTISTRY","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","SCHOOLS OF DENTISTRY/ORAL HYGN","021201616","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","213840","148619"," ","362459",
"Genetics; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human","Address;Affect;Area;Behavior;Biogenesis;Biological Models;Cell Line;Cell Nucleus;Cells;Cellular biology;Chimeric Proteins;Chromatin;Code;Coupled;DNA Replication Inhibition;DNA biosynthesis;Elements;Embryo;Functional RNA;Gene Cluster;Gene Expression;Gene Expression Regulation;Genes;Genome;Goals;Health;Hereditary Disease;Histones;Human;Life;Link;Mesenchymal Stem Cells;Messenger RNA;Molecular;Nuclear;Nuclear Envelope;Nuclear Structure;Patients;Play;Positioning Attribute;Process;Proteins;RNA;RNA Interference;RNA Processing;Recruitment Activity;Regulation;Research Proposals;Role;S Phase;Severities;Signal Transduction;Site;Small Nuclear Ribonucleoproteins;Somatotype;Spinal Muscular Atrophy;Structure;System;Time;Trans-Activators;Transcription Process;U2 small nuclear RNA;adult stem cell;embryonic stem cell;human embryonic stem cell;interest;mRNA Precursor;mutant;scaffold;self organization;stem cell differentiation","Mechanisms of Nuclear Body Biogenesis","PUBLIC HEALTH RELEVANCE: In proposed project we seek to uncover mechanisms of how nuclear structures form within the cell nucleus and how they contribute to genome function. Specifically, we will explore how gene expression and nuclear substructures mutually affect each other and how defective formation of nuclear bodies contributes to genetic disease. In addition, we will investigate the role of a nuclear body in coordination of gene expression during differentiation of human embryonic and adult stem cells.","NIGMS","8296631","2/13/2012 12:00:00 AM","PA-10-067","5R01GM090156-02","5","R01","GM","090156","02"," ","CARTER, ANTHONY D","7/5/2011 12:00:00 AM","2/29/2016 12:00:00 AM","Nuclear and Cytoplasmic Structure/Function and Dynamics Study Section[NCSD]"," ","9765486","DUNDR, MIROSLAV ","Not Applicable","10","ANATOMY/CELL BIOLOGY","069501252","V913TCT2SFZ9","069501252","V913TCT2SFZ9","US","42.298939","-87.860781","1402201","ROSALIND FRANKLIN UNIV OF MEDICINE & SCI","NORTH CHICAGO","IL","SCHOOLS OF MEDICINE","600643037","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","189000","103005"," ","292005",
"Arthritis; Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Absorbable Implants;Address;Adult;Antibodies;Appearance;Architecture;Award;Benchmarking;Bio-Base;Biological Markers;Biomechanics;Biomedical Engineering;Caliber;Cartilage;Cartilage Matrix;Chondrocytes;Chondrogenesis;Collagen;Collagen Arthritis;Collagen Fibril;Collagen Type II;Collagen Type IX;Collagen Type XI;Complex;Defect;Dorsal;Electron Microscopy;Engineering;Enzyme-Linked Immunosorbent Assay;Event;Extracellular Matrix;Fibrillar Collagen;Fingerprint;Foundations;Future;Goals;Growth;Healed;Human;Hyaline Cartilage;Knowledge;Mass Spectrum Analysis;Measures;Mesenchymal Stem Cells;Methodology;Methods;Minor;Molecular;Molecular Profiling;Monitor;National Institute of Arthritis and Musculoskeletal and Skin Diseases;Nude Mice;Outcome Measure;Pain;Pathway interactions;Pattern;Peptides;Phenotype;Polymers;Property;Protein Chemistry;Proteomics;Shock;Stem cells;Structure;Techniques;Time;Tissue Engineering;Tissues;Transplantation;Western Blotting;articular cartilage;base;biodegradable polymer;crosslink;density;fibrillogenesis;healing;in vivo;indexing;joint function;molecular assembly/self assembly;public health relevance;response;sound;subcutaneous;tool","Collagen Assembly in Tissue-Engineered Cartilage","
NARRATIVE
 The ability of cartilage to act as a shock absorber depends on the quality of the collagen
heterofibrillar network that frames cartilage. In arthritis, this collagen network is broken down leading
to a loss of normal joint function and severe pain. The goal of this study is to develop and
authenticate a biomarker to monitor if this collagen heterofibrillar network assembled in bioengineered
cartilage is typical of normal cartilage.","NIAMS","8234165","3/28/2012 12:00:00 AM","PA-07-070","5R01AR057025-03","5","R01","AR","057025","03"," ","WANG, FEI","4/1/2010 12:00:00 AM","3/31/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","8151274","FERNANDES, RUSSELL J","Not Applicable","07","ORTHOPEDICS","605799469","HD1WMN6945W6","605799469","HD1WMN6945W6","US","47.660049","-122.31441","9087701","UNIVERSITY OF WASHINGTON","SEATTLE","WA","SCHOOLS OF MEDICINE","981951016","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","194400","108864"," ","303264",
"Bioengineering; Dental/Oral and Craniofacial Disease; Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Autologous;Bilateral;Biological Assay;Bioluminescence;Blood;Blood Clot;Blood Vessels;Blood capillaries;Blood coagulation;Bone Regeneration;Bone Transplantation;Calvaria;Cell Survival;Cell Therapy;Cell Transplants;Cells;Characteristics;Chemicals;Coagulation Process;Coculture Techniques;Data;Defect;Development;Engineering;Exhibits;Fibrin;Fibrinogen;Fracture;Functional Imaging;Gel;Head and Neck Cancer;Healed;Human;Hypoxia;Image;Implant;Injectable;Intervention;Ionic Strengths;Lasers;Life;Light;Link;Measures;Mechanics;Mesenchymal Stem Cells;Methods;Modeling;Monitor;Operative Surgical Procedures;Osteogenesis;Participant;Patients;Perfusion;Persons;Phenotype;Population;Proliferating;Property;Proteins;Quality of life;Radiation therapy;Regenerative Medicine;Relative (related person);Research;Rodent;Site;Speed;Stem cells;Stromal Cells;Structure;Supporting Cell;Testing;Thrombin;Tissue Engineering;Tissue Grafts;Tissues;Transplantation;Vascularization;bone;bone healing;capillary;clinical application;cost effective;density;experience;healing;imaging modality;implantation;improved;in vitro Assay;in vivo;innovation;mineralization;molecular marker;neovascularization;novel;osteogenic;osteoprogenitor cell;physical property;public health relevance;repaired;response;soft tissue;stem;success;tissue repair;tomography;tumor;vasculogenesis","Cell delivery for irradiated bone defects","
Narrative
The development of new cell delivery strategies that accelerate tissue formation and function upon
implantation will greatly improve the quality of life for those who suffer from nonhealing tissue defects. We seek
to determine if engineered fibrin gels possessing increased stiffness can promote vascularization and bone
formation by transplanted vessel- and bone-forming cells.","NIDCR","8231275","1/27/2012 12:00:00 AM","PAR-07-418","5R03DE021704-02","5","R03","DE","021704","02"," ","LUMELSKY, NADYA L","3/1/2011 12:00:00 AM","2/28/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","12359562","LEACH, J. KENT","Not Applicable","03","BIOMEDICAL ENGINEERING","047120084","TX2DAGQPENZ5","047120084","TX2DAGQPENZ5","US","38.543675","-121.729989","577503","UNIVERSITY OF CALIFORNIA AT DAVIS","DAVIS","CA","BIOMED ENGR/COL ENGR/ENGR STA","956186153","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","75000","40375"," ","115375",
"Diabetes; Genetics; HIV/AIDS; Nutrition; Obesity","2,4-thiazolidinedione;Address;Adipocytes;Adipose tissue;Apple;Body Weight;Body fat;Boxing;Brown Fat;Cell model;Cultured Cells;Development;Developmental Gene;Diabetes Mellitus;Diet;Disease;Eating;Energy Metabolism;Equilibrium;Fatty acid glycerol esters;Food Energy;Gene Expression Profile;Genes;Genetically Engineered Mouse;Glucose;Glypican;Grant;Health;Heterogeneity;Homeostasis;Human;In Vitro;Insulin Resistance;Knock-out;Lead;Light;Lipids;Measures;Mesenchymal Stem Cells;Metabolic;Metabolic syndrome;MicroRNAs;Mus;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Pathway interactions;Pattern;Pear;Peripheral;Play;Process;Regulation;Relative (related person);Research;Risk;Role;Shapes;Site;Thiazolidinediones;Transcriptional Regulation;Visceral;Waist-Hip Ratio;embryonic stem cell;homologous recombination;in vivo;insight;research study;response;subcutaneous;trait","Developmental Genes and the Origin of Fat","
7. Project Narrative:
 Accumulation of excess visceral fat (central or ""apple-shaped"" obesity) is associated with increased risk of
type 2 diabetes and metabolic syndrome, whereas accumulation of subcutaneous adipose (peripheral or ""pear-
shaped"" obesity) does not have such a risk. Recently, we have demonstrated that certainly fundamental
developmental genes may play a role in this process. In this study we will determine the role of these genes in
adipocyte determination and differential function of adipocytes from visceral and subcutaneous depots through
studies over-expressing or knocking out there expression in preadipocytes in culture and in genetically
engineered mice in vivo.","NIDDK","8230677","2/29/2012 12:00:00 AM","PA-07-070","5R01DK082659-04","5","R01","DK","082659","04"," ","HAFT, CAROL R","3/15/2009 12:00:00 AM","2/28/2014 12:00:00 AM","Integrative Physiology of Obesity and Diabetes Study Section[IPOD]"," ","1863670","KAHN, C RONALD","Not Applicable","07","Unavailable","071723084","UUUMQVGJNNX1","071723084","UUUMQVGJNNX1","US","42.346758","-71.10256","2133701","JOSLIN DIABETES CENTER","BOSTON","MA","Research Institutes","022155306","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","353763","215189"," ","568952",
"Nutrition; Obesity; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adipocytes;Adipose tissue;Adult;Affect;Animal Model;Area;Biochemistry;Blood;Candidate Disease Gene;Cell Count;Cell Size;Cell model;Cells;Chemical Exposure;Chemicals;Development;Disease;Dose;Endocrine Disruptors;Environmental Risk Factor;Epidemic;Ethers;Event;Exposure to;Fatty acid glycerol esters;Fetus;Genes;Health;Health Care Costs;Human;Individual;Knowledge;Life;Measures;Mediating;Mesenchymal Stem Cells;Metabolic;Molecular;Multipotent Stem Cells;Mus;Obesity;Oral;PPAR gamma;Pathway interactions;Perinatal;Pharmaceutical Preparations;Phenotype;Process;Public Health;Publishing;Research;Research Design;Resistance;Risk Assessment;Role;Route;Staging;Stem cells;Subfamily lentivirinae;Testing;Time;Work;bisphenol A;cost;critical period;exposed human population;in vivo;innovation;insight;lipid biosynthesis;mother nutrition;novel;postnatal;prenatal;prenatal exposure;programs;small hairpin RNA;stem cell differentiation;stem cell fate;tributyltin","Is bisphenol A diglycidyl ether (BADGE) and obesogen?"," Obesity is a major public health problem. We propose to elucidate how maternal and early life programming of adipose tissue development is influenced by the endocrine disrupting chemical, bisphenol A diglycidyl ether (BADGE). The successful completion of this research will make important contributions to understanding the developmental programming of obesity, how obesogens affect this process, and what is the contribution of altered stem cell programming.  
    

","NIEHS","8229713","1/10/2012 12:00:00 AM","PA-10-069","1R21ES021020-01","1","R21","ES","021020","01"," ","HEINDEL, JERROLD","1/10/2012 12:00:00 AM","12/31/2013 12:00:00 AM","Integrative and Clinical Endocrinology and Reproduction Study Section[ICER]"," ","1900163","BLUMBERG, BRUCE ","Not Applicable","45","ANATOMY/CELL BIOLOGY","046705849","MJC5FCYQTPE6","046705849","MJC5FCYQTPE6","US","33.678042","-117.773718","577504","UNIVERSITY OF CALIFORNIA-IRVINE","IRVINE","CA","SCHOOLS OF ARTS AND SCIENCES","926970001","UNITED STATES","N","1/10/2012 12:00:00 AM","12/31/2012 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","NIEHS","150000","74492"," ","224492",
"Bioengineering; Dental/Oral and Craniofacial Disease; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Animal Model;Animals;Binding;Biochemical;Biological Assay;Biomimetics;Blood Vessels;Bone Marrow;Bone Regeneration;Bone Tissue;Caliber;Calvaria;Cells;Cephalic;Clinical;Complex;Defect;Detection;Dextrans;Differentiation and Growth;Engineering;Evaluation;Extracellular Matrix;Fluorescence;Funding;Generations;Healed;Image;Image Analysis;Imagery;Imaging technology;Impaired wound healing;Implant;In Vitro;Indium;Institutes;Laser Scanning Microscopy;Life;Mediating;Mesenchymal Stem Cells;Modality;Modeling;Molecular;Monitor;Morphology;Mus;Natural regeneration;Osseointegration;Osteogenesis;Patients;Production;Property;Proteins;Protocols documentation;Qualitative Evaluations;Quantitative Evaluations;Research;Resolution;Risk;Role;Series;Signal Transduction;Stem cells;System;Techniques;Technology;Testing;Texas;Therapeutic;Time;Tissue Engineering;Tissues;Transgenic Animals;Transgenic Mice;Translational Research;Universities;base;bone;bone healing;cell motility;design;dextran;efficacy testing;flexibility;healing;imaging modality;improved;in vivo;intravenous injection;intravital microscopy;magnetic field;nanofiber;public health relevance;regenerative;repaired;scaffold;second harmonic;skeletal;spatial relationship;stem cell niche;success;tissue regeneration;tissue repair;tool","Intravital imaging of nanofiber-mediated skeletal repair","
Project Narrative
Nanofiber holds great promise in tissue repair and regeneration due to its versatility in
creating an integrated platform for stem cell manipulations. The project will use state-of-
the-art imaging technology to define the important elements in the design of nanofibers
for bone repair and regeneration.","NIDCR","8250384","3/9/2012 12:00:00 AM","PA-10-069","5R21DE021513-02","5","R21","DE","021513","02"," ","LUMELSKY, NADYA L","4/4/2011 12:00:00 AM","3/31/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","7845877","ZHANG, XINPING ","Not Applicable","25","ORTHOPEDICS","041294109","F27KDXZMF9Y8","041294109","F27KDXZMF9Y8","US","43.16888","-77.615939","7047101","UNIVERSITY OF ROCHESTER","ROCHESTER","NY","SCHOOL OF MEDICINE & DENTISTRY","146270140","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","125000","68125"," ","193125",
"Biotechnology; Breast Cancer; Cancer; Clinical Research; Genetics; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Affect;Area;Autoimmune Diseases;Biological Models;Biological Process;CCL22 gene;CXCL12 gene;Cell physiology;Cells;Development;Disease;Disseminated Malignant Neoplasm;Feedback;Fibrosis;Gene Targeting;Growth;Histocompatibility Testing;Homeostasis;Immunologic Surveillance;In Vitro;Late Promoters;Malignant Neoplasms;Malignant neoplasm of liver;Mammary Neoplasms;Mediating;Mediator of activation protein;Mesenchymal Stem Cells;MicroRNAs;Neoplasm Metastasis;Outcome;Pathologic Processes;Pathway interactions;Pattern;Play;Process;Production;Regulation;Regulatory T-Lymphocyte;Repression;Role;Signal Pathway;Staging;Stem cells;Testing;Transforming Growth Factor beta;Transgenic Mice;Up-Regulation;base;cancer cell;cancer therapy;chemokine;cytokine;human disease;immune function;in vivo;malignant breast neoplasm;mouse model;novel;stem;tumor;tumor progression;tumor xenograft;tumorigenesis","The role of TGF-beta in tumorigenesis","
As a critical cytokine regulating many cellular activities, TGF-ss is involved in the pathological
processes of many types of human diseases, such as autoimmune disease, cancer, and
fibrosis. A better understanding of the mechanisms associated with TGF-ss action in various
cell/tissue types, will help the development of better therapies for those diseases.","NCI","8301004","5/1/2012 12:00:00 AM","PA-07-070","5R01CA151541-03","5","R01","CA","151541","03"," ","JHAPPAN, CHAMELLI","6/7/2010 12:00:00 AM","4/30/2015 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1861012","WANG, XIAO-FAN ","Not Applicable","04","PHARMACOLOGY","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","110450"," ","311725",
"Cancer; Hematology; Orphan Drug; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Animal Disease Models;Animal Model;BMP4;Biological Assay;Biology;CXCR4 gene;Cell Maturation;Cells;Cytoplasmic Granules;Defect;Development;Disease;Disease Progression;Drug Delivery Systems;Employee Strikes;Extramedullary;Extramedullary Hematopoiesis;Failure;Funding;Gelatinase B;Gene Expression;Growth Factor;Hematopoiesis;Hematopoietic;Immunoelectron Microscopy;Inflammatory;Investigation;JAK2 gene;Lead;Marrow;Megakaryocytes;Mesenchymal Stem Cells;Mus;Myelofibrosis;Natural History;Neutrophil Activation;Osteoblasts;P-Selectin;Patients;Peptide Hydrolases;Pharmaceutical Preparations;Primary Myelofibrosis;Proliferating;Proteins;Research;SELP gene;Signaling Molecule;Site;Sorting - Cell Movement;Stem cells;Stimulus;Testing;Thrombin;Transplantation;chemokine;design;drug development;improved;in vivo;inhibitor/antagonist;loss of function;metallothionein III;mouse model;neutrophil;prevent;receptor;research study;response;stem;treatment strategy;von Willebrand Factor","Mouse Models of Myelofibrosis","The beneficial of the majority of drugs that inhibit JAK2 tested in PMF patients up to now are modest, highlighting the importance to identify new treatment strategies for this disease. By using the Gatallow animal model, this study has the potential to further increase our understanding of the patho-biology of PMF and to identify additional targets against which more effective drugs for the treatment of PMF patients can be designed.","NCI","8377874","8/17/2012 12:00:00 AM","PAR-09-025","5P01CA108671-06","5","P01","CA","108671","06"," "," ","7/1/2006 12:00:00 AM"," ","ZCA1-RPRB-J","5374","1962023","MIGLIACCIO, ANNA RITA F","Not Applicable","13","Unavailable","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","Domestic Higher Education","100296574","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","369749","369749"," ","246581","123168"," "," ",
"Bioengineering; Biotechnology; Dental/Oral and Craniofacial Disease; Nanotechnology; Regenerative Medicine","Anabolism;Animals;Artificial nanoparticles;Biochemistry;Biocompatible Materials;Bone Cements;Bone Marrow;Bone Regeneration;Bone Tissue;Calvaria;Categories;Cephalic;Ceramics;Charge;Chemistry;Chondroitin Sulfates;Clinic;Clinical;Clinical Research;Colloids;Data;Defect;Electrostatics;Engineering;Environment;Filler;Foundations;Future;Gel;Glycosaminoglycans;Goals;Growth Factor;Hydrogels;Hydroxyapatites;In Vitro;Institutes;Lead;Liquid substance;Liver Regeneration;Medical;Mesenchymal Stem Cells;Metals;Mission;Modeling;Molds;Musculoskeletal;Natural regeneration;Necrosis;Operative Surgical Procedures;Osteogenesis;Paste substance;Pharmaceutical Preparations;Polymers;Polymethyl Methacrylate;Property;Publishing;Qualifying;Rattus;Relative (related person);Research;Research Personnel;Rheology;Signal Transduction;Site;Solid;Stress;Surface;Surgeon;Technology;Testing;Tissue Engineering;Tissues;Vascular Endothelial Growth Factors;Weight-Bearing state;base;bone;bone morphogenetic protein 2;cohesion;commercialization;controlled release;craniofacial;design;in vivo;innovation;nanoparticle;novel;osteochondral tissue;osteogenic;polysulfated glycosaminoglycan;prototype;reconstruction;repaired;scaffold;stem cell differentiation;three dimensional structure;tissue regeneration","Integrative colloidal gels for cranial defect repair","  Reconstruction of craniofacial bone currently relies on materials that require surgical placement and that do not adequately facilitate regeneration of native bone. There is an urgent need to identify new materials that enable reconstruction of bone in general and the proposed research will investigate a unique pseudoplastic biomaterial for conducting rapid bone regeneration.  
    

","NIDCR","8239401","2/24/2012 12:00:00 AM","PA-10-067","1R01DE022472-01A1","1","R01","DE","022472","01","A","LUMELSKY, NADYA L","3/1/2012 12:00:00 AM","2/29/2016 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","8432919","BERKLAND, CORY ","Not Applicable","02","ENGINEERING (ALL TYPES)","076248616","SSUJB3GSH8A5","076248616","SSUJB3GSH8A5","US","38.951659","-95.266091","1484302","UNIVERSITY OF KANSAS LAWRENCE","LAWRENCE","KS","BIOMED ENGR/COL ENGR/ENGR STA","660457552","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","250000","109154"," ","359154",
"Biotechnology; Cardiovascular; Genetics; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Affect;Area;Blood Vessels;Bone Marrow;Cardiac;Cardiac Myocytes;Cell Survival;Cell Therapy;Cells;Cellular biology;Coronary Arteriosclerosis;Data;Development;Endothelial Cells;Engineering;Environment;Evaluation;Event;Extracellular Fluid;Fibrosis;Foundations;Functional RNA;Functional disorder;Gap Junctions;Gene Targeting;Genetic Engineering;Heart;Heart failure;Infarction;Ischemia;Mediating;Mediator of activation protein;Mesenchymal Stem Cells;Messenger RNA;MicroRNAs;Molecular;Molecular Biology;Myocardial;Myocardial Infarction;Myocardial Ischemia;Myocardial perfusion;Myocardium;Natural regeneration;Pathology;Play;Positioning Attribute;Proteins;Reperfusion Injury;Research;Role;Staging;Stem cell transplant;Stem cells;Techniques;Testing;Therapeutic;Tissues;Translational Repression;Transplantation;Untranslated RNA;Up-Regulation;Ventricular Remodeling;adult stem cell;angiogenesis;base;cardiac repair;cell injury;design;experience;extracellular;improved;in vivo;insight;molecular imaging;novel therapeutics;overexpression;regenerative;repaired;stem cell biology;stem cell therapy;tissue repair;transcription factor","MicroRNA as mediators of angiogenesis & ischemic myocardial repair"," Coronary artery disease is the most common cause of heart infarction. The cell-based therapy is a putative treatment for end-stage heart failure to use stem cells for regeneration and as vehicle for transfer of cardioprotective and regenerative small noncoding RNA to the host damaged cells for repair.   
      

","NHLBI","8333130","7/12/2012 12:00:00 AM","PA-11-260","1R01HL114654-01","1","R01","HL","114654","01"," ","LUNDBERG, MARTHA","7/12/2012 12:00:00 AM","4/30/2017 12:00:00 AM","Special Emphasis Panel[ZRG1-CVRS-K(02)M]"," ","8250530","XU, MEIFENG ","ASHRAF, MUHAMMAD ","01","PATHOLOGY","041064767","DZ4YCZ3QSPR5","041064767","DZ4YCZ3QSPR5","US","39.142998","-84.503581","1523902","UNIVERSITY OF CINCINNATI","CINCINNATI","OH","SCHOOLS OF MEDICINE","452210001","UNITED STATES","N","7/12/2012 12:00:00 AM","4/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","361686","181110"," ","542796",
"Biotechnology; Brain Disorders; Clinical Research; Genetics; Hydrocephalus; Neurosciences; Pediatric; Rare Diseases","Affect;Biological Assay;Biology;Brain;Breeding;Candidate Disease Gene;Cerebellar malformation;Cerebellum;Clinical;Congenital Abnormality;Custom;Dandy-Walker Syndrome;Defect;Development;Developmental Gene;Diagnosis;Diagnostic;Disease;Electroporation;Embryo;Family;Future;Gene Transfer Techniques;Genes;Genetic Heterogeneity;Goals;Growth Factor;Head;Human;Hydrocephalus;In Vitro;Informatics;Lasers;Lead;Lip structure;Live Birth;Meningeal;Meninges;Mesenchymal;Mesenchyme;Methods;Molecular;Molecular Biology;Motor;Mus;Neurodevelopmental Disorder;Pathogenesis;Pathway interactions;Patients;Phenocopy;Phenotype;Posterior Fossa;RNA Interference;Regulation;Role;Scientist;Signal Pathway;Signal Transduction;Signaling Molecule;Slice;System;Testing;Transgenic Mice;Ventricular;Walkers;base;brain malformation;brain pathway;clinical phenotype;cohort;computerized data processing;design;developmental genetics;gene discovery;gene interaction;genome-wide;improved;in vivo;innovation;interdisciplinary approach;malformation;mouse model;mutant;neurodevelopment;novel;prognostic;programs;research study;tool;transcription factor","Congenital brain malformations caused by aberrant head mesenchymal signaling"," This application develops and implements innovative interdisciplinary approaches to identify and characterize the developmental and genetic disruptions that cause Dandy-Walker malformation spectrum birth defects. Dandy-Walker malformation spectrum birth defects are structural birth defects of the developing cerebellum of the brain. They are common, affecting approximately 1/3000 live births and cause intellectual and motor delays and hydrocephalus. Through gene discovery, we aim to develop badly needed effective diagnostic and prognostic tools for affected families.   
   
      

","NINDS","8458757","9/4/2012 12:00:00 AM","PA-11-085","1R01NS080390-01A1","1","R01","NS","080390","01","A","RIDDLE, ROBERT D","9/15/2012 12:00:00 AM","5/31/2017 12:00:00 AM","Developmental Brain Disorders Study Section[DBD]"," ","7138301","MILLEN, KATHLEEN JOYCE","Not Applicable","07","Unavailable","048682157","SZ32VTCXM799","048682157","SZ32VTCXM799","US","47.663628","-122.283919","1531401","SEATTLE CHILDREN'S HOSPITAL","SEATTLE","WA","Independent Hospitals","981053901","UNITED STATES","N","9/15/2012 12:00:00 AM","5/31/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","236315","222136"," ","458451",
"Bioengineering; Biotechnology; Genetics; Regenerative Medicine","Adhesives;Affect;Apoptosis;Atomic Force Microscopy;Behavior;Biochemistry;Biological Assay;Biological Process;Biophysics;Cell Count;Cell Culture Techniques;Cell physiology;Cells;Chromosome Mapping;Complex;Cytoskeleton;DNA biosynthesis;Development;Drug Delivery Systems;Environment;Event;Feedback;Fibroblasts;Fluorescence Microscopy;Focal Adhesions;Future;Gene Expression;Gene Expression Regulation;Genes;Genetic;Goals;Health;Hour;Image;Individual;Knowledge;Life;Link;Measures;Mechanics;Medical Technology;Mesenchymal Stem Cells;Messenger RNA;Methods;Molecular;Monitor;Nature;Neoplasm Metastasis;Output;Pattern;Pharmacotherapy;Physiologic pulse;Positioning Attribute;Process;Signal Transduction;Staging;Stimulus;Structure;Surface;Techniques;Testing;Time;Tissue Engineering;Tissues;Transcript;Transcriptional Regulation;United States National Institutes of Health;Work;cancer therapy;cantilever;design;experience;improved;insight;light microscopy;regenerative;regenerative therapy;research study;response;stem cell differentiation;therapeutic target;transcription factor;tumor;tumor progression","Towards a molecular mechanism for mechanosensitive gene regulation"," Tumor progression and stem cell differentiation are cellular processes that are affected by the mechanical microenvironment a cell finds itself in, though how a cell senses and interprets mechanical information in its microenvironment is not well understood. The proposed work will advance our knowledge of this sensing process, identifying key parts that could serve as targets for drug therapies and informing how to design engineered tissues for regenerative therapies.   
      

","NIGMS","8317223","4/5/2012 12:00:00 AM","PA-11-113","1F32GM101911-01","1","F32","GM","101911","01"," ","SAKALIAN, MICHAEL","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-F05-P(20)L]"," ","10887323","RICCA, BENJAMIN L","Not Applicable","13","BIOMEDICAL ENGINEERING","124726725","GS3YEVSS12N6","124726725","GS3YEVSS12N6","US","37.870295","-122.268133","577502","UNIVERSITY OF CALIFORNIA BERKELEY","BERKELEY","CA","BIOMED ENGR/COL ENGR/ENGR STA","947101749","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","859","Training, Individual","2012"," "," ","NIGMS","49214"," "," ","49214",
"Genetics; Nutrition; Obesity; Pediatric","Address;Adipocytes;Affect;Age;Animals;Antioxidants;Birth;Cell Lineage;Chromatin;DNA Methylation;Data;Desire for food;Development;Diabetes Mellitus;Diet;Elderly;Embryo;Energy Metabolism;Environment;Epigenetic Process;Event;Exhibits;Fatty Acids;Fatty acid glycerol esters;Female;Fetus;Fostering;Gene Expression;Genes;Genome;Growth and Development function;Health;Human;Incidence;Inflammation;Insulin Resistance;Lead;Life;Link;Measures;Mediating;Mesenchymal Stem Cells;Messenger RNA;Metabolic;Microarray Analysis;Modification;Mothers;Neonatal;Newborn Infant;Obesity;Oxidative Stress;Placenta;Plasma;Play;Polyunsaturated Fatty Acids;Predisposition;Pregnancy;Pregnant Women;Process;Rattus;Risk;Rodent;Role;Saturated Fatty Acids;Staging;Testing;Time;Tissues;United States;Up-Regulation;Woman;adipocyte differentiation;blastocyst;chromatin remodeling;embryo/fetus;feeding;fetal;high risk;histone modification;lipid biosynthesis;offspring;postnatal;preimplantation;prenatal exposure;prevent;programs;public health relevance;pup","Mechanisms by which Obesity in Pregnancy Leads to Obesity in Offspring","
Narrative
Maternal obesity significantly increases fetal and neonatal adiposity and offspring of obese mothers have a
very high risk of developing obesity in later life. This application will address the mechanisms underlying this
phenomenon and determine if a diet enriched with antioxidants will prevent the development of obesity in the
offspring. Since the incidence of obesity is rapidly increasing in the United States, these studies will have great
impact on health.","NIDDK","8265968","2/23/2012 12:00:00 AM","PA-07-070","5R01DK078761-03","5","R01","DK","078761","03"," ","SILVA, CORINNE M","3/1/2010 12:00:00 AM","2/28/2015 12:00:00 AM","Pregnancy and Neonatology Study Section[PN]"," ","1950535","SIMMONS, REBECCA A","Not Applicable","03","PEDIATRICS","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","123255"," ","328680",
"Bioengineering; Diagnostic Radiology; Regenerative Medicine","Animal Model;Animals;Binding;Biochemical;Biology;Biomedical Engineering;Biopsy;Bone Growth;Cartilage;Cells;Chicago;Chondrogenesis;Clinical;Collagen;Data;Defect;Development;Diffusion;Disease;Elasticity;Engineering;Enzyme-Linked Immunosorbent Assay;Extracellular Matrix;Fatty acid glycerol esters;Feedback;Future;GAG Gene;Goals;Growth;Histological Techniques;Human;Image;Imagery;Imaging Techniques;Implant;In Vitro;Injury;Knowledge;Length;Magnetic Resonance Elastography;Magnetic Resonance Imaging;Maps;Measures;Mechanics;Medicine;Mesenchymal Stem Cells;Methods;Microscopic;Monitor;Morphogenesis;Morphology;Mus;Natural regeneration;Optics;Organ;Osteogenesis;Pathway interactions;Perfusion;Phase;Procedures;Process;Property;Prosthesis;Proteoglycan;Protocols documentation;Regenerative Medicine;Relaxation;Resolution;Sampling;Scientist;Staging;Structure;System;Techniques;Temperature;Time;Tissue Differentiation;Tissue Engineering;Tissue Grafts;Tissue Sample;Tissues;Universities;Viscosity;Water;Weight;Work;base;bone;cancer therapy;density;design;imaging modality;implantation;in vivo;lipid biosynthesis;mouse model;physical property;public health relevance;restoration;scaffold;success;tissue regeneration;tool;water diffusion","MR Monitoring of Engineered Tissues","
Narrative
The objective of this study is to develop new techniques for monitoring engineered chondrogenic tissues using
magnetic resonance imaging and magnetic resonance elastography. Magnetic resonance imaging provides
three dimensional views of developing tissue at all stages of growth without the need to sacrifice the animal or
to biopsy the tissue. Magnetic resonance elastography gives a direct measure of the strength and stiffness of
regenerating tissue: critical information needed to guide the design of new methods of tissue engineering and
to assess the success of tissue implants for restoring tissue damaged by disease, injury or cancer treatment.","NIBIB","8232120","2/28/2012 12:00:00 AM","PAR-06-504","5R01EB007537-04","5","R01","EB","007537","04"," ","HUNZIKER, ROSEMARIE","5/1/2009 12:00:00 AM","2/28/2014 12:00:00 AM","ZEB1-OSR-D(J1)S"," ","1903069","MAGIN, RICHARD L","Not Applicable","07","ENGINEERING (ALL TYPES)","098987217","W8XEAJDKMXH3","098987217","W8XEAJDKMXH3","US","41.880316","-87.687597","577703","UNIVERSITY OF ILLINOIS AT CHICAGO","Chicago","IL","BIOMED ENGR/COL ENGR/ENGR STA","606124305","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","275739","77521"," ","353260",
"Clinical Research; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Affect;Allergic Reaction;Allogenic;Animals;Antibodies;Antigen-Presenting Cells;Antigens;Autoimmune Diseases;Biology;Blast Cell;Bone Marrow;Bone Marrow Transplantation;CCL8 gene;CCR5 gene;CXCL10 gene;CXCL11 gene;CXCR3 gene;Cancer Vaccines;Cell Therapy;Cells;Clinical;Clinical Protocols;Clinical Trials;Coculture Techniques;Complement;Degenerative Disorder;Disease;Disease model;Exposure to;Graft Rejection;Health;Human;IRF1 gene;Immune;Immune System Diseases;Immune Tolerance;Immune response;Immunosuppression;Immunosuppressive Agents;In Vitro;Inflammation;Inflammatory;Injection of therapeutic agent;Interferon Type I;Interferons;Interleukin-1;Interleukin-11;Interleukin-12;Interleukin-2;Lead;Ligands;Lymphocyte;Malignant Neoplasms;Mediating;Mesenchymal Stem Cells;Modeling;Molecular;Mus;Nitric Oxide;Organ Transplantation;Pattern;Production;Property;RANTES;Reaction;Recruitment Activity;Regulation;Reporting;Role;Skin;Splenocyte;Stem Cell Research;Stem cells;System;T-Cell Proliferation;T-Cell Receptor;T-Lymphocyte;TNF gene;Testing;Transplantation;Up-Regulation;Vaccine Design;adult stem cell;cancer immunotherapy;chemokine;chemokine receptor;clinical application;cytokine;embryonic stem cell;graft vs host disease;human NOS2A protein;in vivo;inhibitor/antagonist;mRNA Stability;prevent;public health relevance;response","Immunosuppression by Adult Stem Cells","
PUBLIC HEALTH RELEVANCE: One of the most important properties of mesenchymal stem cells is
their high potency in suppressing immune reactions, which can be involved in many diseases such
autoimmune disorders, allergic reactions, rejection of transplants and graft-versus-host disease
associated with bone marrow transplantation. It is likely that the very first clinical application of stem cell
research will be the use of mesenchymal stem cells to treat immune disorders. Therefore, the proposed
studies are expected to have enormous relevance to human health.","NIGMS","8220982","2/2/2012 12:00:00 AM","PA-07-070","5R01GM866889-03","5","R01","GM","866889","03"," ","DUNSMORE, SARAH","2/10/2010 12:00:00 AM","1/31/2014 12:00:00 AM","Innate Immunity and Inflammation Study Section[III]"," ","1884701","SHI, YUFANG ","Not Applicable","06","GENETICS","617022384"," ","617022384"," ","US","40.526695","-74.470817","714203","UNIV OF MED/DENT NJ-R W JOHNSON MED SCH","PISCATAWAY","NJ","SCHOOLS OF MEDICINE","088548021","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","198000","105558"," ","303558",
"Kidney Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Agonist;Biomedical Engineering;Cell physiology;Cells;Cellular biology;Collection;Ectopic Expression;Employee Strikes;Epithelium;Equilibrium;Event;Failure;Future;Gene Expression;Gene Targeting;Genes;Health;Homeostasis;Individual;Kidney;Lead;Lung;Malignant Neoplasms;Mediating;Mesenchymal;Mesenchyme;Molecular;Nephroblastoma;Organ;Pancreas;Pattern;Phenotype;Play;Population;Process;Renal tubule structure;Rest;Role;Side;Signal Pathway;Signal Transduction;Stem cells;Testing;Tissues;Tubular formation;Undifferentiated;cell type;design;interest;mutant;nephrogenesis;prevent;progenitor;research study;response;transcription factor","The role of Wnt signaling in kidney tubule formation","n/a","NIDDK","8299642","6/18/2012 12:00:00 AM","PA-07-070","5R01DK080004-05","5","R01","DK","080004","05"," ","HOSHIZAKI, DEBORAH K","9/2/2008 12:00:00 AM","6/30/2013 12:00:00 AM","Urologic and Kidney Development and Genitourinary Diseases Study Section[UKGD]"," ","8710161","CARROLL, THOMAS JOSEPH","Not Applicable","30","INTERNAL MEDICINE/MEDICINE","800771545","YZJ6DKPM4W63","800771545","YZJ6DKPM4W63","US","32.814772","-96.841146","578404","UT SOUTHWESTERN MEDICAL CENTER","DALLAS","TX","SCHOOLS OF MEDICINE","753909105","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","196020","111731"," ","307751",
"Genetics; Osteogenesis Imperfecta; Rare Diseases","Affect;Autophagocytosis;Autophagosome;Binding;Cartilage;Cells;Collagen Type I;Complex;Contracture;Data;Defect;Deformity;Diagnostic tests;Disease;Extracellular Matrix;Family;Fibroblasts;Fracture;Functional disorder;Genes;Genetic;Genetic Counseling;Goals;Golgi Apparatus;Growth;Homeostasis;Hsp47 protein;Human;Inherited;Instruction;Joints;Knockout Mice;Knowledge;Ligaments;Link;Maintenance;Maps;Mesenchymal;Molecular;Molecular Chaperones;Molecular Target;Mus;Mutation;Organelles;Osteogenesis;Osteogenesis Imperfecta;Outcome;Pain;Pathogenesis;Pathway interactions;Phenotype;Principal Investigator;Process;Proteins;Research;Role;Skeleton;Stress;Tendon structure;Testing;Tissues;Type I Procollagen;Work;base;bone;exome;improved;in vivo;insight;loss of function mutation;mineralization;novel;programs;skeletal;skeletal disorder;trafficking","Project 2. FKBP10 CHAPERONE COMPLEX AND TRAFFICKING AND ORGANELLE DYSFUNCTION IN","n/a","NICHD","8380628","7/10/2012 12:00:00 AM","RFA-HD-10-006","5P01HD070394-02","5","P01","HD","070394","02"," "," "," "," ","ZHD1-DSR-Y","6322","7354258","LEE, BRENDAN ","Not Applicable","09","Unavailable","051113330","FXKMA43NTV21","051113330","FXKMA43NTV21","US","29.711148","-95.39695","481201","BAYLOR COLLEGE OF MEDICINE","HOUSTON","TX","Domestic Higher Education","770303411","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","325196","325196"," ","325196","0"," "," ",
"Cancer; Digestive Diseases; Genetics; Infectious Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Advisory Committees;Affect;Benign;Biology;Carcinoma in Situ;Cell Culture Techniques;Cell Fate Control;Cell Line;Cells;Characteristics;Complex;Coupled;Cues;Cyclin D1;Data;Development;Disease;Disease Progression;Dominant-Negative Mutation;Dysplasia;Epithelial;Epithelial Cells;Esophageal;Esophageal Diseases;Esophageal Squamous Cell Carcinoma;Esophagus;Future;Genetic;Genetically Engineered Mouse;Goals;Growth;Heterogeneity;Histocompatibility Testing;Homeostasis;Human;Human Papillomavirus;Image;Intervention;Keratin;Knockout Mice;Knowledge;Laboratories;Lead;Life;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of esophagus;Mediating;Mentors;Mesenchymal;Mission;Modeling;Molecular;Morphology;Mus;Mutation;NOTCH1 gene;Nature;Oncogene Proteins;Outcome;Pathogenesis;Pathway interactions;Prevention;Primary Neoplasm;Public Health;Regulation;Research;Resistance;Role;Shapes;Signal Transduction;Skin;Squamous Differentiation;Squamous cell carcinoma;Staging;Stem cells;System;Testing;Time;Tissues;Training;Transforming Growth Factors;Transgenic Mice;Transgenic Organisms;Transplantation;Tumor Biology;Tumor Suppressor Proteins;base;cancer stem cell;carcinogenesis;epithelial to mesenchymal transition;experience;gain of function;human disease;imaging modality;in vivo;innovation;insight;keratinocyte;loss of function;molecular imaging;mouse model;neoplastic cell;notch protein;novel;novel strategies;prevent;research study;response;senescence;trait;transcription factor;tumor;tumor progression","Integrative mouse pathobiology: GI epithelial biology and genetics"," (provided by applicant): The proposed research is relevant to public health because detailed understanding of the regulatory mechanisms of esophageal squamous differentiation and esophageal cancer stem cells by Notch will fundamentally advance the fields of Notch signaling and esophageal epithelial biology and tumor biology, and provide a platform for new avenues of translational biologically based applications for therapy of esophageal  squamous cell carcinoma. Thus, proposed research is relevant to the part of NIH's mission that pertains to developing fundamental knowledge that will help to reduce the burdens of human diseases through the power of mouse pathobiology.    
    

","OD","8327700","5/14/2012 12:00:00 AM","PAR-09-053","8K26OD011179-02","8","K26","OD","011179","02"," ","MIROCHNITCHENKO, OLEG","9/3/2011 12:00:00 AM","6/30/2016 12:00:00 AM","ZRR1-CM-2(01)"," ","7132013","NAKAGAWA, HIROSHI ","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","351","Other Research-Related","2012"," "," ","OD","94099","7528"," ","101627",
"Cancer; Lung; Lung Cancer","Accounting;Adenocarcinoma;Aftercare;Angiogenesis Inhibitors;Angiogenic Factor;Animals;Antibodies;Behavior;Biological;Biological Markers;Blood Vessels;Cancer Center;Cancer Etiology;Cancer Patient;Cancer cell line;Cell Communication;Cell Line;Cessation of life;Chest;Clinical;Clinical Research;Conditioned Culture Media;Cytotoxic agent;Data;Databases;Development;Disease;Disease-Free Survival;Dose;Enrollment;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Epithelial;Epithelial Cells;Excision;Fibroblasts;Growth;Head and neck structure;Health;Hepatocyte Growth Factor;Immunocompetent;In Vitro;Knowledge;Large Cell Carcinoma;Malignant - descriptor;Malignant neoplasm of lung;Medical Oncology;Mesenchymal;Mitogens;Modeling;Molecular;Molecular Abnormality;Molecular Profiling;Neoplasm Metastasis;Non-Small-Cell Lung Carcinoma;Operative Surgical Procedures;Outcome;Patient Selection;Patients;Primary Neoplasm;Prognostic Marker;Quality of life;Regimen;Relapse;Resectable;Resistance;Risk Factors;Role;Smooth Muscle Myocytes;Squamous cell carcinoma;Staging;Stromal Cells;Testing;Therapeutic;Therapeutic Agents;Therapeutic Effect;Tumor Burden;Tumorigenicity;United States;Vascular Endothelial Growth Factors;Woman;Xenograft Model;angiogenesis;base;cancer therapy;cell stroma;epithelial to mesenchymal transition;follow-up;hepatoma cell;hepatoma-derived growth factor;improved;in vivo Model;inhibitor/antagonist;men;mortality;mouse model;neutralizing antibody;neutralizing monoclonal antibodies;new therapeutic target;novel;overexpression;prospective;research study;response;success;therapeutic target;treatment strategy;tumor;tumor growth;tumor progression;tumor xenograft","HDGF: a novel biomarker and therapetic target of lung cancer","
Project Narrative
Hepatoma-derived growth factor (HDGF) is a novel molecule important for lung cancer progression. This study
will evaluate the role of HDGF as a prognostic marker for identifying lung cancer patients likely to recurr or
metastatize after curative surgical treatment. We will also evaluate our newly developed neutralizing
monoclonal anti-HDGF antibodies for their utility as therapeutic agents in lung cancer treatment.","NCI","8250458","4/13/2012 12:00:00 AM","PA-07-070","5R01CA126818-05","5","R01","CA","126818","05"," ","WANG, WENDY","7/14/2008 12:00:00 AM","4/30/2014 12:00:00 AM","Cancer Biomarkers Study Section[CBSS]"," ","1866789","MAO, LI ","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","188435911","Z9CRZKD42ZT1","188435911","Z9CRZKD42ZT1","US","39.291412","-76.624753","820104","UNIVERSITY OF MARYLAND BALTIMORE","BALTIMORE","MD","SCHOOLS OF MEDICINE","212011508","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","259075","131561"," ","390636",
"No NIH Category available","Affect;Architecture;Basement membrane;Cells;Choristoma;Collagen;Cues;Data;Defect;Development;Diffusion;Duct (organ) structure;Ductal;Elements;Engineering;Epithelial;Epithelial Cells;Event;Extracellular Matrix;Family member;Gene Expression;Genes;Goals;Growth;Growth Factor;Hyperplasia;Lead;Location;Lung;Malignant - descriptor;Mammary gland;Membrane Proteins;Mesenchymal;Modeling;Morphogenesis;Neoplasms;Pattern;Peptide Hydrolases;Play;Positioning Attribute;Process;Publishing;Relative (related person);Research;Resolution;Role;Series;Signal Transduction;Site;Structure;Subgroup;Techniques;Testing;Tissues;Transforming Growth Factors;Translating;Trees;Work;autocrine;base;collecting tubule structure;density;in vivo;insight;lithography;mammary gland development;morphogens;physical property;research study;response;tumor","Spatial patterning of branching morphogenesis","n/a","NIGMS","8260558","4/16/2012 12:00:00 AM","PA-07-070","5R01GM083997-05","5","R01","GM","083997","05"," ","HOODBHOY, TANYA","5/1/2008 12:00:00 AM","4/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-ICI-D(01)Q]"," ","8741240","NELSON, CELESTE M","Not Applicable","12","ENGINEERING (ALL TYPES)","002484665","NJ1YPQXQG7U5","002484665","NJ1YPQXQG7U5","US","40.12273","-74.703461","6661401","PRINCETON UNIVERSITY","Princeton","NJ","BIOMED ENGR/COL ENGR/ENGR STA","085406000","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","186219","95143"," ","281362",
"Cardiovascular; Heart Disease","Ablation;Actins;Affect;Age;Arrhythmia;Baculoviruses;Binding;COS-7 Cell;Cardiac Myocytes;Cells;Collagen;Congenital Heart Defects;Contractile Proteins;Coronary Vessels;Cytokinesis;Defect;Embryonic Development;Epithelial;Exhibits;Failure;Fibroblasts;Filament;Gel;Head;Heart;In Situ;Kinetics;Maintenance;Mediating;Mesenchymal;Microfilaments;Modeling;Morphogenesis;Motor;Motor Activity;Mus;Muscle Contraction;Myocardial;Myosin ATPase;Myosin Type II;Property;Proteins;Right ventricular structure;Role;Role Concepts;Skeletal Muscle Myosins;Slide;Small Interfering RNA;Time;Transgenic Mice;Ventricular;blebbistatin;cardiogenesis;cell cortex;constriction;crosslink;in vivo;mouse development;mutant;non-muscle myosin;novel;paralogous gene;promoter;recombinase;research study;restoration;retinal rods","The Role of Nonmuscle Myosin II-B In Vivo","n/a","NHLBI","8557930"," "," ","1ZIAHL004228-18","1","ZIA","HL","004228","18"," "," "," "," "," "," ","9694358","ADELSTEIN, ROBERT ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL HEART, LUNG, AND BLOOD INSTITUTE"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NHLBI"," "," "," ","425242",
"Aging; Biotechnology; Cancer; Gene Therapy; Genetics; Prevention; Prostate Cancer; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Urologic Diseases","Address;Adenovirus Vector;Adenoviruses;Adipose tissue;Antitumor Response;Apoptosis;Autologous;Bioluminescence;Bone Marrow;Cancer Patient;Cell Differentiation process;Cell Therapy;Cells;Clinical;Clinical Research;Clinical Trials;Cytokine Gene;Data;Detection;Development;Disease;Distant Metastasis;Dose;Effectiveness;Effector Cell;Endothelial Cells;Enzymes;Firefly Luciferases;Gene Delivery;Goals;Growth;Half-Life;Image;Immune;Infection;Innovative Therapy;Interferon-beta;Interferons;Link;Luc Gene;Macular degeneration;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Medicine;Mesenchymal Stem Cells;Metastatic to;Methods;Modality;Modeling;Monitor;Morbidity - disease rate;Mus;Neoplasm Metastasis;Oncogenes;Patients;Phenotype;Population;Probability;Prostate;Prostate Cancer therapy;Prostatic Neoplasms;Publishing;Reaction;Recombinant Cytokines;Recombinant Proteins;Recruitment Activity;Renilla;Reporter;Resources;Role;S Phase Arrest;Secondary to;Signal Transduction;Site;Staging;Structure of base of prostate;Systemic Therapy;Techniques;Testing;Therapeutic;Time;Toxic effect;Toxicology;Transgenic Model;Translating;Viral Vector;Work;antiangiogenesis therapy;antitumor agent;base;chemokine;clinical application;college;cytokine;cytokine therapy;design;effective therapy;gene therapy;immune activation;immunogenic;immunogenicity;immunoregulation;improved;in vivo;insight;intravenous administration;neoplastic cell;novel;novel strategies;novel therapeutics;outcome forecast;pigment epithelium-derived factor;pre-clinical;prevent;research study;response;sensor;success;tool;tumor;tumor growth;tumor progression;tumorigenesis;vector","Preventing prostate cancer progression by ASC delivery of PEDF and IFNb"," Developing new approaches for preventing prostate cancer progression is highly relevant to prostate cancer patients, as there are no effective treatments for the advanced stages of the disease. Our overall objective is to examine the potential of developing more effective cell-based gene therapies for preventing prostate cancer progression using adipose-derived mesenchymal stem cells (ASCs) as cellular vehicles. We propose that expression of antitumor cytokine gene therapies (PEDF or IFN-?) from ASCs will be effective in preventing prostate tumor progression and in enhancing recruitment and activation of microenvironment immune effector cells that will aid in reducing tumor growth.   
      

","NCI","8289223","3/19/2012 12:00:00 AM","PAR-09-162","1R21CA153165-01A1","1","R21","CA","153165","01","A","SCHWARTZ, ELENA IVAN","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-OBT-A(55)R]"," ","1857598","FIGUEIREDO, MARXA L","Not Applicable","14","PHARMACOLOGY","800771149","MSPWVMXXMN76","800771149","MSPWVMXXMN76","US","29.243715","-94.856994","578406","UNIVERSITY OF TEXAS MED BR GALVESTON","GALVESTON","TX","GRADUATE SCHOOLS","775555302","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","119190","59360"," ","178550",
"Aging; Cancer; Prostate Cancer; Urologic Diseases","Address;Aspirate substance;Autopsy;Biopsy;Blood;Bone Marrow;Cells;Clinic;Clinical;Collection;Consent;Ensure;Human;Individual;Informatics;Leukocytes;Malignant neoplasm of prostate;Mesenchymal;Metastatic Neoplasm to the Bone;Michigan;Pathologist;Pathology;Patient Participation;Process;Prostate;Research Infrastructure;Resources;Sampling;Serum;Tissue Banking;Tissue Banks;Tissues;Translational Research;Universities;human biological material;neoplastic cell;operation;programs;quality assurance","Human Sample Acquisition Core (HSAC)","This TMEN will be focused on the mechanisms that regulate dormancy of skeletal metastases in prostate 
cancer. This core will oversee the operations of the entire Program to ensure that it moves forward in a 
direction that addresses this important clinical problem.","NCI","8555284","10/12/2012 2:13:10 PM","RFA-CA-10-021","5U54CA163124-02","5","U54","CA","163124","02"," "," ","9/16/2011 12:00:00 AM","7/31/2016 12:00:00 AM","ZCA1-SRLB-3(O1)","5209","1871046","PIENTA, KENNETH J.","Not Applicable","12","Unavailable","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","Domestic Higher Education","481091276","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","137802","137802"," ","88619","49183"," "," ",
"Aging; Bioengineering; Nutrition; Obesity; Osteoporosis; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adipocytes;Adipose tissue;Adolescence;Adult;Age;Aging;Alkaline Phosphatase;Animals;Biological Assay;Body Composition;Bone Marrow;Bone Marrow Stem Cell;Bone Marrow Transplantation;Bone Tissue;Candidate Disease Gene;Cell Culture Techniques;Cell Line;Cells;Cerebral Palsy;Child;Clinic;Diabetes Mellitus;Diet;Disease;Elderly;Environment;Exercise;Fatty acid glycerol esters;Female;Femur;Flow Cytometry;Foundations;Frequencies;Funding;Genes;Genetic Models;Glucose tolerance test;Health;Human;In Vitro;Incidence;Intervention;Label;Left;Leptin;Life Style;Liver;Marrow;Measurement;Measures;Mechanics;Mesenchymal Stem Cells;Metabolic;Metabolism;Modeling;Mouse Strains;Mus;Muscle;Musculoskeletal;Musculoskeletal System;Nonesterified Fatty Acids;Obesity;Osteogenesis;Osteoporosis;Ovariectomy;Pathogenesis;Pathway interactions;Phenotype;Population;Predisposition;Process;Production;Protocols documentation;RNA;Research;Reverse Transcriptase Polymerase Chain Reaction;Role;Series;Serum;Signal Transduction;Stem cells;System;Time;Tissues;Transgenic Organisms;Translating;Transplantation;Triglycerides;Visceral;Work;abdominal fat;base;bone;bone cell;bone loss;design;feeding;immunocytochemistry;improved;in vivo;intraperitoneal;lipid biosynthesis;male;mineralization;non-drug;oil red O;osteogenic;respiratory;response;sedentary;stem cell differentiation;stem cell population;subcutaneous;substantia spongiosa;tibia;young adult","Augmentation of Trabecular Bone by Low Magnitude Strain","
Augmentation of Trabecular Bone by Low Magnitude Strain
This work will investigate the mechanisms behind the anabolic potential of extremely low-
magnitude mechanical signals, and how they strengthen both bone and muscle. Research over the
last period of funding has also shown that these signals markedly suppress adiposity, by
influencing the differentiation pathway of mesenchymal stem cells rather than elevating the
animal's metabolism, indicating a previously unrecognized mechanical means of the regulating
fat and bone production. This research will provide the foundation to translate this work to the
clinic as a safe, non-pharmacologic, intervention for the control of osteoporosis and obesity.","NIAMS","8317301","7/30/2012 12:00:00 AM","PA-07-070","5R01AR043498-12","5","R01","AR","043498","12"," ","SHARROCK, WILLIAM J","12/1/1996 12:00:00 AM","8/31/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1864044","RUBIN, CLINTON T","Not Applicable","01","BIOMEDICAL ENGINEERING","804878247","M746VC6XMNH9","804878247","M746VC6XMNH9","US","40.907353","-73.128565","5992612","STATE UNIVERSITY NEW YORK STONY BROOK","STONY BROOK","NY","SCHOOLS OF MEDICINE","117943362","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","232363","97434"," ","329797",
"Breast Cancer; Cancer; Genetics; Human Genome; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adherens Junction;Architecture;Area;Biological;Biological Models;Biological Process;Breast;Breast Cancer Model;Cancer Center;Cell model;Cells;Chromatin;Clinic;Clinical;Code;Collaborations;Colon Carcinoma;Complex;Core Facility;Development;Doctor of Medicine;E-Cadherin;ERBB2 gene;Environment;Epigenetic Process;Epithelial Cells;Faculty;Fellowship;Functional RNA;Gene Expression;Gene Expression Profiling;Genes;Genetically Engineered Mouse;Genome;Genomics;Goals;Heart;Hospitals;Human;Human Characteristics;Institution;Knowledge;Laboratories;Learning;Link;Malignant Neoplasms;Malignant neoplasm of pancreas;Mammary Neoplasms;Mammary gland;Mediating;Medical center;Medicine;Mentors;Mentorship;Mesenchymal;Methodist Church;Modeling;Modification;Molecular;Molecular and Cellular Biology;Multiprotein Complexes;Mus;Neoadjuvant Therapy;Pathway interactions;Phenotype;Play;Postdoctoral Fellow;Process;Property;Proteins;RNA;Radiation;Regulation;Research;Research Institute;Research Personnel;Research Training;Resistance;Resources;Rice;Role;Screening procedure;Solid;Source;Stem Cell Research;Stem cells;Stimulus;Subgroup;Testing;Texas;Therapeutic;Tight Junctions;Training;Transcript;Transcriptional Regulation;Translating;Universities;Walking;Work;aggressive therapy;calin;cancer cell;cancer genomics;cancer stem cell;career;chemotherapy;claudin 3;clinically relevant;college;combat;conventional therapy;epithelial to mesenchymal transition;graduate student;improved;insight;malignant breast neoplasm;mammalian genome;mammary gland development;medical schools;mouse model;neoplastic cell;pre-clinical;programs;skills;stem cell population;therapy resistant;tumor;tumor progression;tumorigenesis","The Role of Long Non-coding RNAs in EMT and Cancer Stem Cells","    
   
Completing the goals of this proposal will enhance our understanding of the molecular mechanisms that regulate cancer stem cells (CSCs). This will be critical for devising new treatments that selectively target these aggressive and therapy-resistant cancer cells. This will enable us to ultimately translate these findings into the clinic in order to sensitize tumors to conventional therapies by targeting critical regulation of EMT/CSC- pathways by long non-coding RNA mediated epigenetic mechanisms.   
   
      

","NCI","8384595","9/4/2012 12:00:00 AM","PA-11-197","1K99CA166815-01A1","1","K99","CA","166815","01","A","SCHMIDT, MICHAEL K","9/5/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Institutional Training and Education Study Section (F)[NCI-F]"," ","10320387","HERSCHKOWITZ, JASON I","Not Applicable","09","ANATOMY/CELL BIOLOGY","051113330","FXKMA43NTV21","051113330","FXKMA43NTV21","US","29.711148","-95.39695","481201","BAYLOR COLLEGE OF MEDICINE","HOUSTON","TX","SCHOOLS OF MEDICINE","770303411","UNITED STATES","N","9/5/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","153663","12293"," ","165956",
"Bioengineering; Biotechnology; Clinical Research; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Adult;Advisory Committees;Apoptosis;Area;Award;Binding;Biocompatible Materials;Biological;Biological Preservation;Biology;Biomedical Engineering;Biomimetics;Blood Vessels;Bone Marrow;CD44 gene;Cell Adhesion Molecules;Cell Culture Techniques;Cell Signaling Process;Cell Surface Receptors;Cells;Chemicals;Chicago;Clinical Treatment;Complex;Dental;Dental Care;Dental Pulp;Dentin;Dentistry;Dentition;Deposition;Development;Embryo;Embryonic Development;Endodontics;Endothelial Cells;Engineering;Ensure;Epithelial Cells;Excision;Extracellular Matrix;Goals;Healed;Health Care Costs;Healthcare;Human;Hyaluronan;Hyaluronic Acid;Hydrogels;Illinois;In Vitro;Infection;Inflammation Process;Inflammatory;Interdisciplinary Study;Laboratories;Lead;Leukocytes;Literature;Longevity;Measures;Mechanics;Medical;Medicine;Mentors;Mesenchymal Stem Cells;Messenger RNA;Methods;Modality;Molecular;Molecular Genetics;Muscle Cells;Natural regeneration;Nerve Endings;Odontoblasts;Oral health;Plant Roots;Population;Preparation;Procedures;Process;Production;Proteins;Pulp Canals;Reaction;Regenerative Medicine;Regulation;Reporting;Research;Research Personnel;Role;Root Canal Therapy;Science;Scientist;Signal Transduction;Stem cells;Stress;Structure;Surgical Injuries;System;Techniques;Therapeutic;Tissue Engineering;Tissues;Tooth Extraction;Tooth Loss;Tooth structure;Training;Treatment Protocols;Universities;analog;base;biomineralization;bone;college;cost;design;embryonic stem cell;gene function;healing;maxillofacial;morphogens;novel;novel strategies;novel therapeutic intervention;novel therapeutics;outcome forecast;permanent tooth;postnatal;progenitor;programs;public health relevance;regenerative;repaired;response;restorative material;scaffold;skills;soft tissue;stem;stressor;success","A Novel Approach for Biomaterials Assisted Regeneration of Pulp-Dentin Complex","
The proposed research will lead to development of a novel endodontic technique to regenerate dental pulp tissue and
form reparative dentin, using a special biological substrate for proliferation and differentiation of progenitor pulp stem
cells/mesenchymal stem cells to tissue-engineer the pulp-dentin complex. Ideally, the new material will also provide novel
treatment of root formation in immature permanent dentition, and have uses in other maxillofacial structures.","NIDCR","8240446","5/22/2012 12:00:00 AM","PA-10-059","5K08DE019514-02","5","K08","DE","019514","02"," ","KING, LYNN M","7/1/2011 12:00:00 AM","6/30/2016 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","9309296","ALAPATI, SATISH B","Not Applicable","07","DENTISTRY","098987217","W8XEAJDKMXH3","098987217","W8XEAJDKMXH3","US","41.880316","-87.687597","577703","UNIVERSITY OF ILLINOIS AT CHICAGO","Chicago","IL","SCHOOLS OF DENTISTRY/ORAL HYGN","606124305","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","126010","10081"," ","136091",
"Biotechnology; Injury (total) Accidents/Adverse Effects; Injury - Trauma - (Head and Spine); Neurodegenerative; Neurosciences; Regenerative Medicine; Spinal Cord Injury; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Address;Amyotrophic Lateral Sclerosis;Animal Model;Astrocytes;Autologous;Back;Basic Science;Biological Markers;Bone Marrow;Carbohydrates;Cardiovascular Diseases;Cell Culture Techniques;Cell physiology;Cells;Clinical;Clinical Trials;Crowding;Culture Media;Deposition;Diabetes Mellitus;Differentiation and Growth;Disease;Disease model;Environment;Evaluation;Extracellular Matrix;Goals;Government;Harvest;Human;In Vitro;Investments;Legal patent;Limb structure;Measures;Mesenchymal Stem Cells;Methodology;Methods;Metric;Modeling;Motor;Neurodegenerative Disorders;Outcome;Parkinson Disease;Patients;Persons;Phase;Phenotype;Plastics;Population;Property;Protocols documentation;Publishing;Rattus;Research;Sensory;Skeleton;Small Business Innovation Research Grant;Solutions;Spinal cord injury;Techniques;Technology;Testing;Therapeutic;Therapeutic Effect;Time;Transplantation;Work;aqueous;base;cell type;clinical application;clinically relevant;design;human stem cells;improved;in vivo;interest;macromolecule;new technology;novel;phase 1 study;phase 2 study;pre-clinical research;preclinical study;relating to nervous system;research and development;spinal cord and brain injury;stem cell differentiation;therapeutic effectiveness","A Novel Method to Improve Proliferation and Neural Induction of Human MSCs"," The last two decades have seen an overwhelming amount of basic and preclinical research demonstrating the therapeutic promise of human mesenchymal stem cells (hMSCs) for neurodegenerative diseases, spinal cord and brain injuries, cardiovascular diseases, diabetes mellitus, and diseases of the skeleton. In most of these studies, treatment with hMSCs results in substantial functional benefit and these pre-clinical studies have led to the initiation of a number of clinical trials worldwide. To obtain sufficient hMSCs for these autologous clinical applications, the hMSCs must be harvested from the patient and quickly expanded in vitro before transplantation back to the patient. Recent studies suggest that neural induction of hMSCs (NI-hMSCs) prior to transplantation could provide a significant advantage over naive hMSC in treatment of animal models of spinal cord injury (SCI). Furthermore, recent studies by our collaborators reveal that the hMSCs expanded using standard cell culturing conditions lose their ability to generate NI-hMSCs after 4 passages, far short of the estimated expansion required to generate sufficient cell populations for clinical therapy. To address this problem, we have devised a proprietary, patent-pending cell culturing technology to effectively recreate native biophysical properties of the cellular microenvironment that encourages cells to secrete and remodel extracellular matrix (ECM) using their own endogenous machinery as a solution for increasing proliferation rates and maintaining differentiation capacity over a sufficient number of passages to generate the cells needed for therapeutic applications.   
   
      

","NINDS","8315667","5/4/2012 12:00:00 AM","PA-11-096","1R43NS079001-01","1","R43","NS","079001","01"," ","FERTIG, STEPHANIE","5/15/2012 12:00:00 AM","5/14/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-ETTN-G(13)B]"," ","10132025","GARCIA, BRADLEY H.","Not Applicable","02","Unavailable","782932177"," ","782932177"," ","US","43.058641","-89.47536","10009928","PRIMORIGEN BIOSCIENCES, INC.","MADISON","WI","Domestic For-Profits","537191289","UNITED STATES","N","5/15/2012 12:00:00 AM","5/14/2014 12:00:00 AM","853","SBIR/STTR","2012"," "," ","NINDS"," "," "," ","344715",
"Aging; Biotechnology; Cancer; Complementary and Alternative Medicine; Prevention; Prostate Cancer; Urologic Diseases","Adenocarcinoma;Angiogenesis Inhibitors;Animals;Applications Grants;Cancer Cell Growth;Cancer Etiology;Cancer Patient;Cell Culture System;Cell Culture Techniques;Cell Proliferation;Cells;Cessation of life;Chemoprevention;Chemopreventive Agent;Clinic;Development;Diagnosis;Disease;Distant;Distant Metastasis;Endothelial Cells;Epithelial;Event;Fibroblasts;Funding;Grant;Growth;Health;Hepatoprotective Agent;Human;Hypoxia;Lesion;Lung;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Mesenchymal;Metabolism;Metastatic Neoplasm to the Bone;Milk Thistle;Molecular;Mus;Neoplasm Metastasis;Oral;Osteoblasts;Osteoclasts;Outcome;Phase I Clinical Trials;Phase II Clinical Trials;Pre-Clinical Model;Prevention;Preventive;Preventive Intervention;Process;Prostate;Prostate Cancer therapy;Public Health;Research;SCID Mice;Secondary to;Seeds;Site;Testing;Therapeutic Intervention;Time;Toxic effect;Transgenic Organisms;Treatment Efficacy;Tumor Angiogenesis;Tumor Tissue;United States;Work;Xenograft Model;abstracting;angiogenesis;base;bone;cancer cell;cancer therapy;dietary supplements;epithelial to mesenchymal transition;in vivo;men;migration;mouse model;neoplastic cell;novel;pre-clinical;prostate cancer prevention;silibinin;tissue/cell culture;tool;tumor;tumor growth;tumor progression","Prostate Cancer Prevention and Treatment by Silibinin","
Project Narrative
Prostate cancer is second leading cause of cancer-related deaths in United States, and
thus is an important public health issue. Use of chemopreventive agents seems to be
more effective approach for the control of prostate cancer as it has long latent period of
development; sometimes over decade from precursor lesions to full blown disease.
Current grant proposal focuses on the development of one such agent, namely silibinin,
which is already consumed extensively in the United States and world-wide as a dietary
supplement and used in the clinic as a hepatoprotective agent. This compound has not
shown any toxicity in animal studies as well as in humans. The outcomes of our
proposed research will provide a mechanism-based agent for the prevention and
therapeutic intervention of prostate cancer in humans.","NCI","8212511","2/24/2012 12:00:00 AM","PA-07-070","5R01CA102514-09","5","R01","CA","102514","09"," ","MALONE, WINFRED F","7/9/2003 12:00:00 AM","1/31/2014 12:00:00 AM","Chemo/Dietary Prevention Study Section[CDP]"," ","1865330","AGARWAL, RAJESH ","Not Applicable","06","PHARMACOLOGY","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF PHARMACY","800452570","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","399","Non-SBIR/STTR","2012"," "," ","NCI","210780","111713"," ","322493",
"Digestive Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acids;Antral;Basic Science;Bioinformatics;Biology;Cells;Cellular biology;Clinical;Decision Making;Development;Embryo;Epithelial;Epithelial Cells;Epithelium;Erinaceidae;Gastric Parietal Cells;Gastrointestinal tract structure;Goals;Homeostasis;Image;Inflammation;Inflammatory;Interferon Type II;Intestines;Joints;LacZ Genes;Mediating;Mesenchymal;Michigan;Mus;Pathology;Pathway interactions;Pattern;Peptides;Phenotype;Population;Program Research Project Grants;Public Health;Reporter;Research Personnel;Role;Signal Pathway;Signal Transduction;Stem Cell Development;Stem cells;Stomach;Techniques;Time;Universities;cytokine;medical schools;meetings;morphogens;mouse model;progenitor;response;smoothened signaling pathway","Cellular Decisions of Differentiation in the GI Tract","n/a","NIDDK","8298432","8/1/2012 12:00:00 AM"," ","5P01DK062041-10","5","P01","DK","062041","10"," ","CARRINGTON, JILL L","9/15/2002 12:00:00 AM","7/31/2013 12:00:00 AM","ZDK1-GRB-9(M1)P"," ","1936411","MERCHANT, JUANITA L.","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","876506","409176"," ","1285682",
"Aging; Cancer; Prostate Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation; Urologic Diseases","Accounting;Adenocarcinoma;Adult;Androgen Receptor;Androgens;Area;Benign Prostatic Hypertrophy;Binding;Biological Assay;Biological Models;Cancer Etiology;Carcinoma;Cell Line;Cell physiology;Cells;Cessation of life;Characteristics;Commit;Complex;Cytokeratin-8 Staining Method;Data;Dependence;Development;Disease;Disseminated Malignant Neoplasm;Epithelial;Epithelial Cells;Epithelium;Event;Functional disorder;Gene Mutation;Genetic;Genetic Transcription;Goals;Growth;Heterogeneity;Histologic;Human;In Vitro;Lead;Lung;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of prostate;Measures;Mesenchymal;Metastatic to;Modeling;Mus;Neoplasm Metastasis;Neoplasm Transplantation;Null Lymphocytes;Outcome;PTEN gene;Pathologic Processes;Pathology;Pathway interactions;Patients;Peptide Signal Sequences;Phase;Phenotype;Play;Polycomb;Population;Preventive;Primary Neoplasm;Probability;Property;Prostate;Prostate Adenocarcinoma;Prostate carcinoma;Prostatic;Proto-Oncogene Proteins c-akt;Regulation;Research Support;Resistance;Role;Signal Transduction;Spindle-Cell Carcinomas;Staging;Stem cells;Structure;TP53 gene;Testing;Therapeutic;Tissue Array Analysis;Tissues;Transforming Growth Factor beta;Transitional Cell Carcinoma;Transplantation;Tumor Initiators;Tumor Stem Cells;Tumor Suppressor Proteins;base;bone;cancer cell;cancer stem cell;cell transformation;epithelial to mesenchymal transition;established cell line;in vivo;inhibitor/antagonist;insight;lymph nodes;malignant neurologic neoplasms;men;mouse model;mutant;neoplastic cell;progenitor;prognostic indicator;promoter;self-renewal;slug;stem;stem cell population;therapy development;tumor;tumor progression;tumorigenic","Tumor stem cells and metastatic outcomes in mouse models of prostate cancer","n/a","NCI","8552837"," "," ","1ZIABC010802-06","1","ZIA","BC","010802","06"," "," "," "," "," "," ","9692485","KELLY, KATHLEEN ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","788424",
"Biotechnology; Cancer; Genetics; Rare Diseases","1-Phosphatidylinositol 3-Kinase;Actins;BRAF gene;Cancer Model;Cell Line;Cell Polarity;Clinical Trials;DNA Sequence Rearrangement;Data;Development;Disease;Distant;Epithelial;Event;Fibronectins;Follicular thyroid carcinoma;GTP-Binding Proteins;Gene Expression Profile;Genes;Genetic;Goals;Human;In Vitro;Incidence;Inhibitory Concentration 50;Invaded;Knockout Mice;Maintenance;Malignant Neoplasms;Malignant neoplasm of thyroid;Mediating;Mesenchymal;Molecular Profiling;NF-kappa B;Neoplasm Metastasis;Oncogenes;Oncogenic;PDPK1 gene;PTCH gene;PTEN gene;Papillary;Papillary thyroid carcinoma;Pathway interactions;Patients;Pattern;Phenotype;Phosphorylation;Phosphotransferases;Primary Neoplasm;Process;Processed Genes;Proteins;Proto-Oncogene Proteins c-akt;Public Health;RET Oncogene;Receptor Protein-Tyrosine Kinases;Regulation;Reporting;Role;Series;Signal Pathway;Signal Transduction;Signaling Molecule;Staging;Survival Rate;Testing;Thyroid Gland;Transgenic Model;United States;Validation;Vimentin;Xenograft Model;base;cancer cell;cancer diagnosis;cancer genetics;cell motility;cytotoxic;epithelial to mesenchymal transition;impression;in vivo;in vivo Model;inhibitor/antagonist;interest;kinase inhibitor;member;migration;mutant;novel;osteopontin;overexpression;p21 activated kinase;prevent;programs;research study;tumor;tumor growth;tumor progression","p21 Activated Kinases and EMT in Thyroid Cancer","n/a","NCI","8378702","4/19/2012 12:00:00 AM"," ","5P01CA124570-05","5","P01","CA","124570","05"," "," "," ","4/29/2013 12:00:00 AM","ZCA1-GRB-S","0004","6184325","RINGEL, MATTHEW D","Not Applicable","03","Unavailable","832127323","DLWBSLWAJWR1","832127323","DLWBSLWAJWR1","US","40.003166","-83.034278","6218701","OHIO STATE UNIVERSITY","COLUMBUS","OH","Domestic Higher Education","432101016","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","273762","273762"," ","195452","78310"," "," ",
"Chronic Liver Disease and Cirrhosis; Diabetes; Digestive Diseases; Genetics; Hepatitis; Liver Disease; Nutrition; Obesity","Acetylation;Amino Acids;Apoptosis;C-terminal;Cardiovascular Diseases;Cellular Stress;Chronic;Cirrhosis;Complex;DNA Binding;Data;Development;Diet;Disease;Disease Progression;E-Cadherin;Energy Intake;Epithelial;FGR gene;Family member;Fatty Liver;Gene Targeting;Genes;Genetic;Genetic Transcription;Glucose Intolerance;Hepatic;Hepatocyte;Histone Deacetylase;Hormones;Hyperglycemia;Inflammation;Inflammatory;Injury to Liver;Insulin;Insulin Resistance;Knock-out;Lead;Leptin deficiency;Lipid Mobilization;Lipids;Liver;Liver Failure;Liver diseases;Mesenchymal;Metabolic;Metabolic Pathway;Metabolism;Modeling;Molecular;Mus;N-terminal;Neoplasm Metastasis;Non-Insulin-Dependent Diabetes Mellitus;Nutrient;Obese Mice;Obesity;Outcome;Overnutrition;Oxidative Stress;Pathway interactions;Phosphorylation;Physiological Adaptation;Post-Translational Protein Processing;Predisposition;Prevalence;Primary carcinoma of the liver cells;Process;Property;Pyruvate Kinase;Risk Factors;Role;Snails;Stress;Testing;Transcriptional Activation;Transcriptional Regulation;Work;Zinc Fingers;base;cell type;chromatin remodeling;epithelial to mesenchymal transition;fatty acid oxidation;improved;lipid biosynthesis;lipid metabolism;non-alcoholic;non-alcoholic fatty liver;nonalcoholic steatohepatitis;novel;overexpression;oxidation;prevent;promoter;uptake","Transcriptional Regulation of Metabolism"," The prevalence of obesity is increasing rapidly. Obesity is associated with nonalcoholic fatty liver diseases (NAFLD). NAFLD leads to nonalcoholic steatohepatitis (NASH), cirrhosis, hepatocellular carcinoma, and type 2 diabetes. Unfortunately, the underlying mechanism of obesity-induced NAFLD is unclear, which limits our ability to treat these diseases. In this study, we will establish a novel concept that a ""hepatocellular stress- Snail2 vicious cycle"" drives NAFLD progression. Thus, the outcome is expected to lead to a new treatment for NAFLD, NASH, cirrhosis, and type 2 diabetes by breaking this cycle.   
      

","NIDDK","8369507","9/18/2012 12:00:00 AM","PA-11-260","1R01DK094014-01A1","1","R01","DK","094014","01","A","PAWLYK, AARON C","9/19/2012 12:00:00 AM","6/30/2016 12:00:00 AM","Cellular Aspects of Diabetes and Obesity Study Section[CADO]"," ","6675852","RUI, LIANGYOU ","Not Applicable","12","PHYSIOLOGY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","9/19/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","245079","136019"," ","381098",
"Alcoholism; Chronic Liver Disease and Cirrhosis; Digestive Diseases; Hepatitis; Liver Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Substance Abuse","Acute;Acute Alcoholic Hepatitis;Adult;Alcohol consumption;Alcohol-Induced Disorders;Alcoholic Liver Diseases;Alcoholic beverage heavy drinker;Alcohols;Biological Markers;Cell Cycle;Cells;Cessation of life;Chronic;Cirrhosis;Data;Disease Progression;Embryonic Development;Epithelial;Erinaceidae;Figs - dietary;Funding;Gene Expression;Gene Targeting;Genes;Genetic Predisposition to Disease;Growth;Health;Hepatic;Hepatocyte;Individual Differences;Injury;Knowledge;Life;Ligands;Link;Liver;Liver Dysfunction;Liver Fibrosis;Liver Regeneration;Liver diseases;Mediating;Mesenchymal;Modeling;Mus;Myofibroblast;Natural regeneration;Neoplasm Metastasis;Organ;Outcome;Pathway interactions;Pentoxifylline;Play;Population;Predisposition;Primary carcinoma of the liver cells;Process;Recombinants;Recovery;Recurrence;Relative (related person);Research;Residual state;Risk;Role;Signal Transduction;Snails;Steatohepatitis;Stem cells;Stimulus;Stress;TNF gene;Tissues;Tumor Necrosis Factor-alpha;Up-Regulation;Work;alcohol exposure;cholangiocyte;chronic alcohol ingestion;cytokine;embryo tissue;epithelial to mesenchymal transition;experience;fibrogenesis;human TNF protein;improved;injured;liver repair;migration;morphogens;new therapeutic target;novel;oval cell;prevent;progenitor;programs;receptor;regenerative;repaired;smoothened signaling pathway;transcription factor;tumor","TNF Alpha and Recovery from Alchoholic Liver Injury","
The results will clarify the relative significance of EMT/MET, and some of the mechanisms that regulate these
processes, in controlling the divergent outcomes of ALD. This, in turn, might identify novel genetic
susceptibility factors for alcohol-related cirrhosis, new biomarkers for ALD progression, and novel therapeutic
targets for this common liver disease.","NIAAA","8306351","7/10/2012 12:00:00 AM","PA-07-070","5R37AA010154-17","5","R37","AA","010154","17"," ","GAO, PETER","8/1/1994 12:00:00 AM","7/31/2014 12:00:00 AM","Hepatobiliary Pathophysiology Study Section[HBPP]"," ","1868904","DIEHL, ANNA MAE ELIZABETH","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","273","Non-SBIR/STTR","2012"," "," ","NIAAA","234139","131118"," ","365257",
"Diabetes; Nutrition; Obesity; Pediatric; Prevention","5&apos;-AMP-activated protein kinase;Acetylesterase;Activities of Daily Living;Adipocytes;Adult;Affect;Affinity;Aging;American;Antidiabetic Drugs;Attenuated;Barker Hypothesis;Birth;Catalytic Domain;Cell Differentiation process;Cells;Child;Country;Cultured Cells;Data;Development;Developmental Biology;Diabetes Mellitus;Diet;Down-Regulation;EP300 gene;Embryo;Energy Metabolism;Ensure;Environment;Epidemic;Event;Fatty acid glycerol esters;Fetal Development;Fetus;Fibroblasts;Fibrosis;Gene Expression;Glucose;Health;Histones;Impairment;Incidence;Insulin;Insulin Resistance;Intervention;Intramuscular;Knockout Mice;Knowledge;Laboratories;Life;Link;Location;Mediating;Mediator of activation protein;Mesenchymal;Mesenchymal Stem Cells;Messenger RNA;Metabolic;Metabolism;Metformin;Methodology;Molecular;Mus;Muscle;Muscle Cells;Muscle Development;Muscle Fibers;Muscle function;Neonatal;Non-Insulin-Dependent Diabetes Mellitus;Nuclear Receptors;Obese Mice;Obesity;Pathway interactions;Peripheral;Peroxisome Proliferator-Activated Receptors;Pharmaceutical Preparations;Phosphorylation;Physiological;Pregnant Women;Protein Isoforms;Proteins;Regulation;Role;Signal Pathway;Signal Transduction;Skeletal Muscle;Staging;Staining method;Stains;Stress;Teenagers;Testing;Tissues;Transforming Growth Factors;United States;Universities;Woman;Work;Wyoming;adenylate kinase;animal facility;attenuation;child bearing;clinical application;density;experience;fatty acid oxidation;fetal;fetal programming;fibrogenesis;glucose uptake;in vivo;laboratory facility;lipid biosynthesis;mouse model;muscle form;muscle strength;myogenesis;novel;offspring;paracrine;pregnant;prevent;public health relevance;stem cell differentiation;transcription factor","Maternal Obesity affects AMP-Kinase in Muscle Cell Differentiation","
AMP-Activated Protein Kinase in Cell Differentiation during Muscle Development Affected by Maternal Obesity
Min Du Developmental Biology Group and Center for the Study of Fetal Programming, University of Wyoming, Laramie, WY
82071
The United States is experiencing an obesity epidemic which increasingly involves women of child bearing years. 18-35% of
pregnant American women are clinically obese, a condition which affects fetal development with long-term consequences for
offspring health, including pre-disposition to obesity and Type 2 diabetes. The underlying mechanisms are poorly defined. The
objectives of proposed studies are to explore mechanisms associated with impairment of fetal skeletal muscle development due
to maternal obesity. Knowledge obtained will allow us to further explore fetal skeletal muscle development due to maternal
obesity and other maternal physiological stresses. Molecular mediators identified are targets for interventions to ensure proper
skeletal muscle development in fetuses of obese women. Due to the importance of skeletal muscle for lifelong activities and its
close association with obesity and Type 2 diabetes, such intervention will help the increasing number of obese pregnant women
in this country to deliver healthy children.","NICHD","8306744","7/13/2012 12:00:00 AM","PA-10-067","5R01HD067449-03","5","R01","HD","067449","03"," ","RAITEN, DANIEL J","9/27/2010 12:00:00 AM","7/31/2015 12:00:00 AM","Pregnancy and Neonatology Study Section[PN]"," ","8916581","DU, MIN ","Not Applicable","05","VETERINARY SCIENCES","041485301","XRJSGX384TD6","041485301","XRJSGX384TD6","US","46.732476","-117.162915","9082001","WASHINGTON STATE UNIVERSITY","PULLMAN","WA","EARTH SCIENCES/RESOURCES","991641060","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","159360","78883"," ","238243",
"Bioengineering; Biotechnology; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Adult;Affect;Architecture;Automobile Driving;Behavior;Biocompatible;Biological Models;Biomedical Engineering;Blood Circulation;Body part;Bone Marrow;Burn Trauma;Burn injury;Calgranulin A;Cancer Biology;Cell Differentiation process;Cells;Cellular biology;Chemical Engineering;Chemistry;Chemotactic Factors;Chemotaxis;Cicatrix;Clinical;Collaborations;Complex;Complex Mixtures;Connective Tissue;Contracts;Contracture;Cutaneous;Data;Databases;Dermal;Dermatology;Development;Devices;Dissection;Dorsal;Ear;Elastic Fiber;Electrons;Environment;Epidermis;Epithelial;Esthetics;Excision;Exhibits;Faculty;Fertilization;Fibroblasts;Fostering;Generations;Genotype;Goals;Growth Factor;Hair follicle structure;Healed;Health;Human;Image;Immunohistochemistry;Implant;Infiltration;Injury;Interleukin-2;Joint Ventures;Laser Surgery;Lasers;Lead;Location;MRL/MpJ Mouse;Maintenance;Mammals;Measures;Medical;Mesenchymal;Mesenchymal Stem Cells;Mesenchyme;Methods;Microfluidic Microchips;Microfluidics;Microspheres;Modeling;Molecular Profiling;Mouse Strains;Mus;Natural regeneration;Operative Surgical Procedures;Outcome;Pathology;Phenotype;Physics;Physiologic pulse;Plastic Surgical Procedures;Platelet-Derived Growth Factor;Polymer Chemistry;Polyurethanes;Population;Process;Production;Proteins;Proteome;Proteomics;Publishing;Qualifying;Recruitment Activity;Relative (related person);Reporting;Research;Research Personnel;Resolution;S100A8 gene;Screening procedure;Seasons;Series;Signal Transduction;Signaling Molecule;Signaling Protein;Site;Skin;Source;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization;Staging;Stem cells;Structure;Study models;System;Talents;Techniques;Testing;Thick;Thymosin;Tissue Engineering;Tissues;Transplantation;Two-Dimensional Gel Electrophoresis;Ulcer;Universities;Validation;Work;Wound Healing;appendage;base;blastema;cell behavior;cell motility;comparative;controlled release;coping;design;elastomeric;flexibility;healing;human SFRP4 protein;innovation;interest;medical schools;migration;morphogens;multidisciplinary;novel;novel strategies;polyurethane foam;progenitor;prospective;protein profiling;reconstruction;regenerative;release factor;repaired;response;restoration;scaffold;skin regeneration;stem cell biology;stem cell population;success;tissue regeneration;two-dimensional;wound","Skin Regeneration with Stem Cells and Scaffolds","NARRATIVE 
 Wounds and burns frequently scar and fail to regenerate the original architecture of the skin. 
Certain strains of mice heal skin much better in some regions of their body, and part of this may be due 
to differences in their circulating stem cells or the way they are recruited to the wound. This is a study to 
identify the cell signals that differ between normal healing and regeneration, to see how they affect the 
behavior of stem cells, and to devise a temporary, synthetic scaffold that can deliver these regenerative 
signals to restore skin structure and function.","NIAMS","8291439","7/10/2012 12:00:00 AM","PA-07-070","5R01AR056138-04","5","R01","AR","056138","04"," ","BAKER, CARL","9/1/2009 12:00:00 AM","6/30/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","1869024","DAVIDSON, JEFFREY M.","GUELCHER, SCOTT A; NANNEY, LILLIAN B; OPALENIK, SUSAN RENEE","05","PATHOLOGY","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","419397","234862"," ","654259",
"Biotechnology; Cardiovascular; Clinical Research; Heart Disease; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Accounting;Address;Allogenic;Autologous;Award;Biopsy;Bone Marrow;Cardiac;Cardiomyopathies;Cardiovascular system;Catheters;Cell Differentiation process;Cell Proliferation;Cell Therapy;Cell surface;Cells;Cellular Morphology;Cessation of life;Clinical;Clinical Research;Clinical Trials;Clinical Trials Data Monitoring Committees;Congestive Heart Failure;Data;Diamond;Dilated Cardiomyopathy;Disease;Doctor of Philosophy;EFRAC;Enrollment;FDA approved;Fibrosis;Grant;Growth;Hares;Heart;Heart Transplantation;Heart failure;In Vitro;Individual;Injection of therapeutic agent;Investigation;Lead;Magnetic Resonance Imaging;Measures;Mesenchymal Stem Cells;Myocardial perfusion;N-octanoylglucosylamine;National Heart, Lung, and Blood Institute;Natural regeneration;Outcome;Patients;Perfusion;Phase;Phenotype;Pilot Projects;Preparation;Primary idiopathic dilated cardiomyopathy;Randomized;Research;Research Personnel;Safety;Scientific Advances and Accomplishments;Shapes;Skeletal Myoblasts;Specialized Center;Stem cells;System;Testing;Tissues;Ventricular Remodeling;base;cell type;comparative;design;disability;experience;improved;innovation;insight;interest;novel strategies;pre-clinical;regenerative;repaired;stem cell therapy;sudden cardiac death","Stem Cells for Dilated Cardiomyopathy"," This clinical study will address a significant clinical need, namely the investigation of new and promising therapies for heart failure, one of the leading causes of cardiovascular death and disability. The proposed studies will elucidate new mechanisms of repair and regeneration of heart tissue.  
    

","NHLBI","8300026","7/1/2012 12:00:00 AM","PA-10-067","5R01HL110737-02","5","R01","HL","110737","02"," ","BUXTON, DENIS B","7/15/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Myocardial Ischemia and Metabolism Study Section[MIM]"," ","1893621","HARE, JOSHUA M","Not Applicable","27","INTERNAL MEDICINE/MEDICINE","052780918","F8THLJQSAF93","052780918","F8THLJQSAF93","US","25.775337","-80.209809","5221250","UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","CORAL GABLES","FL","SCHOOLS OF MEDICINE","331462926","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","457941","193324"," ","651265",
"No NIH Category available","Address;Animal Model;Area;Automobile Driving;Biological Models;Biomechanics;Blood Vessels;CREB1 gene;Cell physiology;Cells;Chronic;Clinical;Collagen;Colorado;Communication;Complex;Development;Disease;Disease susceptibility;Elastin;Epoprostenol;Evolution;Functional disorder;Genomics;Goals;Health Sciences;Heart Diseases;Hereditary Disease;Human;Hypoxia;Inflammation;Inflammatory;Investigation;Laboratories;Lead;Lung;Lung diseases;Mesenchymal Stem Cells;Modeling;Molecular;Morbidity - disease rate;Myelogenous;PTEN gene;Pathogenesis;Performance;Peroxisome Proliferator-Activated Receptors;Phosphoric Monoester Hydrolases;Play;Process;Pulmonary Heart Disease;Pulmonary Hypertension;Recording of previous events;Recruitment Activity;Research;Research Personnel;Robin bird;Role;Signal Pathway;Signal Transduction;Stem cells;Techniques;Technology;Tissues;Transgenic Mice;Universities;Vascular Cell Adhesion Molecule-1;Vascular remodeling;Work;animal tissue;biomechanical engineering;cell growth;constriction;effective therapy;experience;hemodynamics;inhibitor/antagonist;innovation;insight;interest;laser capture microdissection;member;monocyte;mortality;mouse model;novel;novel therapeutics;professor;programs;successful intervention;tool;vasoconstriction","Adaptations to Hypoxia","Pulmonary hypertension (PH) complicates the clinical course of many chronic heart and lung diseases. Its' presence significantly increases the morbidity and mortality of the underlying disease. Current treatments are non-specific and often unsuccessful because mechanisms leading to the development of PH remain unclear. 
Our goal is to better understand the disease process, ultimately allowing for successful intervention.","NHLBI","8293020","6/30/2012 12:00:00 AM"," ","5P01HL014985-39","5","P01","HL","014985","39"," ","MOORE, TIMOTHY M","4/1/1996 12:00:00 AM","6/30/2014 12:00:00 AM","Heart, Lung, and Blood Program Project Study Section[HLBP]"," ","1862827","STENMARK, KURT R.","Not Applicable","06","INTERNAL MEDICINE/MEDICINE","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","1562559","713068"," ","2070976",
"Biotechnology; Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Actins;Acute;Address;Adhesions;Affect;Binding;Blood flow;Cell Lineage;Cell Nucleus;Cell membrane;Cell physiology;Cells;Cellular Stress;Color;Complex;Cysteine;Cytoskeletal Proteins;Cytoskeleton;Development;Disease;Dissociation;Dyes;Dystrophin;Elasticity;Erythrocytes;Erythropoiesis;Exhibits;F-Actin;Fluorescence;Fluorescent Probes;Health;Hematopoietic;Homology Modeling;Human;In Situ;Kinetics;Knockout Mice;Label;Lamins;Ligands;Liquid substance;Maps;Marrow;Mass Spectrum Analysis;Measures;Membrane;Mesenchymal Stem Cells;Methodology;Methods;Modification;Molecular;Molecular Conformation;Mus;Nonmuscle Myosin Type IIA;Nuclear;Null Lymphocytes;Peptides;Pliability;Population;Process;Protein Conformation;Protein Family;Protein Isoforms;Proteins;Proteome;Proteomics;RNA Interference;Recombinants;Relaxation;Science;Shotguns;Signal Transduction;Simulate;Site;Solutions;Spectrin;Staging;Stem cells;Stress;Stress Fibers;Stretching;Structural Protein;Structure;Surface;System;Temperature;Tertiary Protein Structure;Testing;Time;Translations;Urea;Vimentin;cell motility;cellular engineering;clinically relevant;exon skipping;filamin;fluorescence imaging;fluorophore;improved;inhibitor/antagonist;insight;interest;membrane skeleton;mutant;non-muscle myosin;novel;novel therapeutics;protein folding;protein structure;shear stress;single molecule;skeletal","Cytoskeletal Pliability within Cells under Stress: RBCs and Marrow-derived SCs","n/a","NHLBI","8294419","6/30/2012 12:00:00 AM","PA-07-070","5R01HL062352-13","5","R01","HL","062352","13"," ","QASBA, PANKAJ","5/10/1999 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-HEME-C(02)M]"," ","1923930","DISCHER, DENNIS E.","Not Applicable","03","ENGINEERING (ALL TYPES)","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","BIOMED ENGR/COL ENGR/ENGR STA","191046205","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","198000","103763"," ","301763",
"Bioengineering; Biotechnology; Regenerative Medicine","3-Dimensional;Address;Affect;Angiogenic Factor;Animal Model;Anterior;Architecture;Autologous Transplantation;Biocompatible Materials;Biological;Blood Vessels;Bone Growth;Bone Regeneration;Bone Tissue;Caring;Cells;Clinical;Coupled;Defect;Development;Drug Formulations;Encapsulated;Evaluation;Generations;Goals;Growth Factor;Harvest;Heating;Human;Hydrogels;Implant;In Situ;In Vitro;Infiltration;Injectable;Injection of therapeutic agent;Kinetics;Laboratories;Lead;Length of Stay;Mechanics;Mesenchymal Stem Cells;Methodology;Methods;Modality;Modeling;Molds;Musculoskeletal;Nature;Operative Surgical Procedures;Orthopedics;Oryctolagus cuniculus;Osteogenesis;Patients;Performance;Polyesters;Polymers;Porosity;Process;Recovery;Research;Retrieval;Shapes;Sheep;Site;Solid;Specific qualifier value;Staging;System;Techniques;Testing;Time;Tissue Engineering;Tissues;Translations;Transplantation;Vascular Endothelial Growth Factors;Vascularization;Vertebral column;Work;base;biodegradable polymer;bone;bone morphogenetic protein 2;caprolactone;cell motility;clinical application;clinically relevant;crosslink;design;implantation;in vivo;in vivo Model;minimally invasive;novel;osteogenic;osteoinductive factor;poly(propylene fumarate);pre-clinical;public health relevance;reconstruction;regenerative;scaffold;skeletal;skeletal regeneration;vertebra body","Injectable and Preformed Osteoinductive Biodegradable Composites","
Project Narrative
The novel biodegradable polymeric composite scaffolds to be developed in this project will offer new treatment
options for skeletal defects of various size and shape. The biomaterial will provide biological reconstruction of
the defect site by inducing bone formation following either implantation of preformed scaffolds or injection of in
situ polymerizable formulations. These two application modalities offer distinct advantages. The preformed
scaffolds allow precise control over scaffold geometry and internal architecture, while the injectable scaffolds
utilize minimally invasive surgical techniques that can lead to shortened hospital stay and faster recovery for
patients. The degradable nature of the biomaterial will not require implant retrieval, saving them time, expense,
and inconvenience.","NIBIB","8261873","3/7/2012 12:00:00 AM","PA-10-067","5R01EB003060-07","5","R01","EB","003060","07"," ","HUNZIKER, ROSEMARIE","9/30/2003 12:00:00 AM","2/28/2015 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","2126013","YASZEMSKI, MICHAEL J","LU, LICHUN ","01","Unavailable","006471700","Y2K4F9RPRRG7","006471700","Y2K4F9RPRRG7","US","44.022374","-92.465881","4976101","MAYO CLINIC ROCHESTER","ROCHESTER","MN","Other Domestic Non-Profits","559050001","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","365819","211078"," ","576897",
"Cardiovascular; Genetics; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adult;Animals;Apoptosis;Back;Bone Marrow;Bone Marrow Stem Cell;Calcium Signaling;Cardiac;Cardiac Myocytes;Cell Cycle;Cell Death;Cell Proliferation;Cells;Cessation of life;Characteristics;Cicatrix;Development;Engraftment;Environment;Exercise;Flow Cytometry;Funding Opportunities;Future;Genetic;Genetic Transcription;Genetically Engineered Mouse;Heart;Heart Hypertrophy;Heart failure;Hematopoietic stem cells;Histology;Home environment;Knock-in Mouse;Label;Mediating;Medical;Mesenchymal Stem Cells;Methods;Mitosis;Mitotic;Modeling;Morphologic artifacts;Muscle Cells;Myocardial Infarction;Myocardium;Natural regeneration;Organ;Physiological;Play;Population;Process;Proto-Oncogene Protein c-kit;Relative (related person);Reporter;Research;Research Personnel;Research Proposals;Role;Social Problems;Source;Stem cells;System;Tamoxifen;Techniques;Tissues;Toxin;Transgenes;Vascular blood supply;base;cardiac repair;career;fetal;in vivo;in vivo regeneration;injured;killings;mouse model;novel;pressure;progenitor;recombinase;regenerative;repaired;stem cell population;stem cell therapy","Functional relevance of cardiac regeneration by c-kit positive stem cells","
Project Narrative
Heart failure is a growing medical problem for which current medical therapies offer no cure. Cardiac stem cell
therapy holds promise to repair the underlying problem of heart failure, myocardial infarction and death. This
proposal will study endogenous cardiac repair, determine the extent of it and assess its relevance for cardiac
function.
 ","NHLBI","8278085","6/4/2012 12:00:00 AM","PA-11-197","1K99HL112852-01","1","K99","HL","112852","01"," ","CARLSON, DREW E","6/4/2012 12:00:00 AM","3/31/2014 12:00:00 AM","ZHL1-CSR-P(F1)"," ","10911776","VAN BERLO, JOHANNES (JOP) ","Not Applicable","01","Unavailable","071284913","JZD1HLM2ZU83","071284913","JZD1HLM2ZU83","US","39.140882","-84.500494","615001","CINCINNATI CHILDRENS HOSP MED CTR","CINCINNATI","OH","Independent Hospitals","452293039","UNITED STATES","N","6/4/2012 12:00:00 AM","3/31/2013 12:00:00 AM","837","Other Research-Related","2012"," "," ","NHLBI","121660","9733"," ","131393",
"Cancer","Affect;Apoptosis;Binding;Biological;Biological Assay;Biological Process;Carcinoma;Cell Communication;Cell Survival;Cells;Clinic;Coculture Techniques;Combined Modality Therapy;Data;Desmoplastic;Drug Delivery Systems;Electron Microscopy;Engineering;Extravasation;Fibroblasts;Homing;Immunoblotting;Immunofluorescence Immunologic;In Vitro;Lead;Life;Malignant Neoplasms;Malignant neoplasm of pancreas;Mammary Neoplasms;Mass Spectrum Analysis;Mediating;Mediator of activation protein;Mesenchymal Stem Cells;Methods;Modification;Molecular Biology;Mus;Neoplasm Metastasis;Neuropilin-1;Organ;Pathway interactions;Penetration;Peptides;Pharmaceutical Preparations;Phenotype;Prevention;Primary Neoplasm;Process;Proteomics;Role;Signal Transduction;System;Technology;Testing;Time;Tissues;Toxic effect;Tracer;Transgenic Mice;Tumor Tissue;Vascular Endothelial Growth Factors;base;cancer therapy;cell motility;cellular imaging;in vivo;intravital microscopy;neoplastic cell;novel;pancreatic neoplasm;protein expression;receptor;subcutaneous;treatment strategy;tumor;tumor progression;tumor xenograft;uptake","The role of fibroblasts in the activities of tissue penetrating peptides","  Mechanistic studies to understand the exceptional tumor tissue and cell penetration of our iRGD peptide will be performed in view of carcinoma-associated fibroblast functions. Novel biological functions of iRGD that modify tumor microenvironment and lead to metastasis inhibition will also be explored. The project may result in a technology that enables targeting of clinically challenging desmoplastic cancers, and a comprehensive anti- cancer strategy that destroys existing tumors and inhibits metastasis simultaneously.   
      

","NCI","8276585","3/29/2012 12:00:00 AM","PA-10-067","1R01CA167174-01","1","R01","CA","167174","01"," ","FU, YALI","4/1/2012 12:00:00 AM","3/31/2017 12:00:00 AM","Drug Discovery and Molecular Pharmacology Study Section[DMP]"," ","10430708","SUGAHARA, KAZUKI ","Not Applicable","49","Unavailable","020520466","PHMKYKKJLQS1","020520466","PHMKYKKJLQS1","US","32.903503","-117.243803","1180101","SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE","LA JOLLA","CA","Research Institutes","920371005","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","236310","170999"," ","407309",
"Bioengineering; Biotechnology; Cardiovascular; Heart Disease; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Ablation;Accounting;Action Potentials;Adenoviruses;Adult;Affect;Animal Model;Animals;Arrhythmia;Canis familiaris;Cardiac;Cardiac Myocytes;Catheters;Cell Line;Cell Therapy;Cells;Cessation of life;Clinical Trials;Computer Simulation;Coronary;Devices;Engineering;Frequencies;Functional disorder;Generations;Genes;Genetic;Goals;Head;Health;Heart;Heart Rate;Human;In Situ;In Vitro;Individual;Infarction;Intervention;Ion Channel;Ions;Kinetics;Knowledge;Lead;Ligation;Membrane Potentials;Mesenchymal Stem Cells;Modality;Modeling;Modification;Morbidity - disease rate;Muscle Cells;Mutate;Myocardial Infarction;Outcome;Pathway interactions;Patients;Pharmaceutical Preparations;Prevention;Prevention therapy;Property;Refractory;Research;Site;Site-Directed Mutagenesis;Specificity;Speed;Stress;System;Tail;Techniques;Testing;Text;Tissues;Ventricular;Ventricular Tachycardia;Viral;Viral Vector;base;density;design;gene therapy;improved;in vivo;innovation;mathematical model;mortality;mutant;novel;novel strategies;overexpression;premature;prevent;research study;statistics;sudden cardiac death","Novel ion channel approaches to reentrant arrythymias","
Project Narrative
Cardiac arrhythmias remain a major disabler and killer of US citizens and current drug
and device therapies are inconsistently effective and often create further problems. We
propose to use the techniques of gene and cell therapy to deliver novel genes to the
heart that will target sites of arrhythmia generation with high selectivity and efficacy and
offer a safer modality of treatment","NHLBI","8274331","5/28/2012 12:00:00 AM","PA-07-070","7R01HL094410-04","7","R01","HL","094410","04"," ","LATHROP, DAVID A","7/15/2009 12:00:00 AM","5/31/2014 12:00:00 AM","Electrical Signaling, Ion Transport, and Arrhythmias Study Section[ESTA]"," ","1871841","COHEN, IRA S","Not Applicable","01","PHYSIOLOGY","804878247","M746VC6XMNH9","804878247","M746VC6XMNH9","US","40.907353","-73.128565","5992612","STATE UNIVERSITY NEW YORK STONY BROOK","STONY BROOK","NY","SCHOOLS OF MEDICINE","117943362","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","542256","190208"," ","732464",
"Aging; Arthritis; Bioengineering; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","1 year old;3-Dimensional;Acute;Address;Affect;Age-Years;Aging;American;Biochemical;Biological Models;Bone Marrow;Caliber;Cartilage;Cells;Cellular Morphology;Chondrocytes;Chondrogenesis;Chronic;Clinical;Collection;Connective Tissue;Cues;Defect;Degenerative polyarthritis;Development;Elderly;Environment;Ethylene Glycols;Exhibits;Extracellular Matrix;Fiber;Fibroblasts;Functional disorder;Gene Expression;Goals;Healed;Histology;Human;Hydrogels;In Vitro;Interleukin-1;Interleukins;Joints;Laboratories;Lesion;Marrow;Mesenchymal Stem Cells;Methods;Modeling;Musculoskeletal;Operative Surgical Procedures;Osteoarthrosis Deformans;Osteoblasts;Pathogenesis;Pathologic;Phenotype;Physical activity;Play;Polyethylene Glycols;Population;Procedures;Process;Production;Property;Public Health;Rattus;Reporting;Risk Factors;Rodent Model;Role;Scanning Electron Microscopy;Structure;Surface;Swelling;System;Time;Tissue Engineering;Translating;United States;Weight-Bearing state;Work;arthropathies;articular cartilage;base;caprolactone;cartilage development;cartilage regeneration;cartilage repair;density;design;ethylene glycol;healing;in vivo;insight;morphometry;nanoindentation;nanoscale;new technology;novel;physical property;public health relevance;regenerative;repaired;research study;restoration;scaffold;stem cell fate;two-dimensional","Fibrous-Hydrogel Composites for Cartilage Repair in an Osteoarthritic Environment","
Project Narrative
Load bearing joint surfaces do not heal spontaneously and over time small cartilage lesions progress to full
blown osteoarthritis which adversely affects the lives of 60% of people over 55 years of age. The aims of this
proposal seek to develop a novel technology platform for the treatment of cartilage defects both in a healthy
joint and in the context of a diseased joint environment.","NIA","8197972","11/25/2011 12:00:00 AM","PA-09-207","5F30AG034807-02","5","F30","AG","034807","02"," ","JOSEPH, LYNDON","12/1/2010 12:00:00 AM","11/30/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F10B-S(20)L]"," ","9569003","GIBSON, MATTHEW AVERY","Not Applicable","07","BIOMEDICAL ENGINEERING","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","BIOMED ENGR/COL ENGR/ENGR STA","212182680","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","866","Training, Individual","2012"," "," ","NIA","47232"," "," ","47232",
"Biotechnology; Chronic Liver Disease and Cirrhosis; Digestive Diseases; Genetics; Liver Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Ablation;Adult;Alleles;Animals;Apoptosis;Behavior;Cell Culture System;Cell Proliferation;Cell Therapy;Cell Transplantation;Cell Transplants;Cells;Chromosomal Stability;Chronic;Conditioned Culture Media;Disease;Future;Gene Expression;Gene Expression Profile;Genes;Genetic;Goals;Growth;Hepatocyte;Human;Immune;In Vitro;Injury;Intestines;Knock-out;Knockout Mice;Life;Liver;Liver Failure;Liver Regeneration;Liver diseases;Location;Mesenchymal Stem Cells;Methodology;Methods;Modeling;Mus;Natural regeneration;Nude Mice;Organ;Organ Transplantation;Organoids;Pancreas;Pathway interactions;Patients;Pattern;Phenotype;Play;Prevention;Primary Cell Cultures;Progenitor Cell Engraftment;Regimen;Reporting;Research;Role;Safety;Simulate;Source;Stem cells;Surface Antigens;System;Target Populations;Testing;Therapeutic;Tissues;Transplantation;bile duct;chronic liver disease;conditioning;enzyme deficiency;in vivo;intrahepatic;liver function;liver repair;liver transplantation;novel;preconditioning;prevent;progenitor;regenerative;self-renewal;stem;stem cell niche;tumor","Regenerative Capacity of Adult Liver Progenitor Cells"," Intrahepatic stem cells play an important role in the ability of the liver to regenerate during disease and damage, especially chronic injury. Until recently, the precise identity and location of this cell remained unknown, but now others and we have found methods to isolate these cells from both mice and humans. The relevance of the proposed studies is that they will open up the possibility of manipulating their behavior in chronic liver disease and using them for transplantation.   
	      

","NIDDK","8313047","2/28/2012 12:00:00 AM","PA-11-110","1F30DK095514-01","1","F30","DK","095514","01"," ","PODSKALNY, JUDITH M,","4/1/2012 12:00:00 AM","3/31/2017 12:00:00 AM","ZDK1-GRB-2(J1)S"," ","10986953","TARLOW, BRANDEN D","Not Applicable","03","PEDIATRICS","096997515","NPSNT86JKN51","096997515","NPSNT86JKN51","US","45.499316","-122.688464","6297007","OREGON HEALTH & SCIENCE UNIVERSITY","PORTLAND","OR","SCHOOLS OF MEDICINE","972393098","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Training, Individual","2012"," "," ","NIDDK","47232"," "," ","47232",
"Bioengineering; Diagnostic Radiology; Osteoporosis; Regenerative Medicine; Transplantation","3-Dimensional;Allografting;Autologous Transplantation;Biochemical;Biological Markers;Bone Regeneration;Bone Substitutes;Bone Tissue;Bone Transplantation;Brain imaging;Cell Differentiation process;Cell physiology;Cells;Characteristics;Clinical;Collagen;Complex;Compressive Strength;Cytoskeleton;Data;Deposition;Development;Engineering;Environmental Risk Factor;Extracellular Matrix;Fluorescence;Fracture;Future;Generations;Growth;Growth and Development function;Human;Image;Imaging Techniques;Implant;In Vitro;Ionizing radiation;Laboratories;Light-Scattering Spectroscopy;Magnetic Resonance Imaging;Measurement;Measures;Mechanics;Mesenchymal Stem Cells;Metabolic;Methodology;Methods;Molecular Biology Techniques;Monitor;Natural regeneration;Operative Surgical Procedures;Optics;Osteoblasts;Osteogenesis;Osteoporosis;Outcome;Oxidative Stress;Patients;Penetration;Procedures;Process;Property;Publishing;Reconstructive Surgical Procedures;Research;Resolution;Signal Transduction;Silk;Site;Source;Spinal Fusion;Structure;Surgical complication;Techniques;Technology;Tensile Strength;Testing;Theoretical model;Time;Tissue Engineering;Tissues;Work;X-Ray Computed Tomography;absorption;base;bone;bone imaging;fluorescence imaging;implantation;improved;in vivo;light scattering;mineralization;minimally invasive;multi-photon;repaired;scaffold;second harmonic;skeletal;tissue regeneration","Non-invasive optical biomarkers to quantify engineered bone tissue development"," The proposed research will provide a set of non-invasive optical techniques to assess bone structure and function, which will improve the efficiency by which tissue engineering techniques are refined to develop functional bone substitutes. For the millions of patients that undergo surgical procedures that involve bone repair, this research will also provide a means to evaluate regeneration with greater resolution than traditional imaging techniques without the use of ionizing radiation.  
    

","NIAMS","8490507","8/10/2012 12:00:00 AM","PA-10-110","5F32AR061933-02","5","F32","AR","061933","02"," ","WANG, FEI","8/1/2011 12:00:00 AM","7/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F14-A(20)L]"," ","10745125","QUINN, KYLE PATRICK","Not Applicable","07","ENGINEERING (ALL TYPES)","073134835","WL9FLBRVPJJ7","073134835","WL9FLBRVPJJ7","US","42.423895","-71.1092","8422701","TUFTS UNIVERSITY MEDFORD","Boston","MA","BIOMED ENGR/COL ENGR/ENGR STA","021111817","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Training, Individual","2012"," "," ","NIAMS","49214"," "," ","49214",
"Cancer; Dental/Oral and Craniofacial Disease; Prevention; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Animal Model;Animals;Biochemistry;Blood Vessels;Bone Injury;Bone Marrow;Bone Regeneration;Bone remodeling;Cancer Survivor;Cell Cycle Arrest;Cellular biology;Combined Modality Therapy;Complication;Data;Development;Equilibrium;Event;Face;Genetic;Goals;Head and Neck Cancer;Healed;Human;Hyperbaric Oxygen;Hypoxia;Hypoxia Inducible Factor;Imaging technology;Immunohistochemistry;In Vitro;Incidence;Jaw;Life;Life Expectancy;Malignant Neoplasms;Mandible;Mesenchymal Stem Cells;Mesoderm;Methods;Modeling;Molecular;Morbidity - disease rate;Multimodal Imaging;Necrosis;Neural Crest;Osteoblasts;Osteoclasts;Osteogenesis;Osteoradionecrosis;Outcome;Pathogenesis;Population;Positron-Emission Tomography;Predisposition;Preventive;Process;Property;Quality of life;Radiation;Radiation Tolerance;Radiation therapy;Rattus;Recovery;Role;Scientist;Signal Transduction;Site;Staining method;Stains;Stem cells;Survival Rate;System;Tooth Loss;Work;bone;bone cell;bone healing;cancer cell;cancer radiation therapy;cancer therapy;career development;healing;hypoxia inducible factor 1;improved;in vivo;irradiation;long bone;mandible/maxilla;orofacial;osteogenic;osteoprogenitor cell;prevent;regenerative;senescence;skeletal;standard of care;tissue regeneration","Complications of Jaw Osteoradionecrosis in Cancer Management","Radiotherapy is a standard of care for head and neck cancers. It is often complicated by jaw osteoradionecrosis because bone cells needed for tissue regeneration become damaged by radiation. We will use stem cells and animal systems to understand mechanisms promoting jaw necrosis and how to prevent them. The goal is to improve quality of life of cancer survivors.","NCI","8353798","9/17/2012 12:00:00 AM","PAR-09-069","1K22CA169089-01","1","K22","CA","169089","01"," ","OJEIFO, JOHN O","9/17/2012 12:00:00 AM","8/31/2015 12:00:00 AM","Transition to Independence Study Section (I)[NCI-I]"," ","7618421","AKINTOYE, SUNDAY O","Not Applicable","03","DENTISTRY","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF DENTISTRY/ORAL HYGN","191046205","UNITED STATES","N","9/17/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","181800","14544"," ","196344",
"Cancer; Genetics; Neuroblastoma; Neurosciences; Pediatric; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Ablation;Affect;Antibodies;Apoptosis;Attention;Bone Marrow;CXCR4 gene;Cell Line;Cells;Coculture Techniques;Collaborations;Cytotoxic agent;Disease;Drug resistance;Drug usage;Drug-sensitive;Environment;Epigenetic Process;Failure;Gene Expression;Genes;Genetic;Human;IL6 gene;Immune;In Vitro;Interleukin-6;JAK2 gene;Lead;MYCN gene;Malignant Childhood Neoplasm;Malignant Neoplasms;Mediating;Mesenchymal Stem Cells;Mononuclear;Multi-Drug Resistance;Mus;Neuroblastoma;Normal Cell;Only Child;Osteoblasts;Pathway interactions;Patients;Phagocytes;Pharmaceutical Preparations;Play;Pre-Clinical Model;Primary Neoplasm;Recurrence;Research;Research Personnel;Resistance;Role;STAT3 gene;Sampling;Staging;Stromal Cells;Testing;Therapeutic;Transgenic Mice;Transgenic Model;base;chemotherapeutic agent;chemotherapy;clinically relevant;cytokine;drug sensitivity;high risk;improved;in vivo;inhibitor/antagonist;lenalidomide;macrophage;monocyte;mouse model;neoplastic cell;neuroblastoma cell;research study;resistance mechanism;response;tumor;tumorigenic","Targeting IL-6/IL-6R/STAT3 in EMDR in Neuroblastoma","n/a","NCI","8555321","10/12/2012 2:29:35 PM","RFA-CA-10-021","5U54CA163117-02","5","U54","CA","163117","02"," "," ","9/20/2011 12:00:00 AM","7/31/2016 12:00:00 AM","ZCA1-SRLB-3(O1)","5242","8756967","DECLERCK, YVES A","Not Applicable","28","Unavailable","052277936","DVL1CMRMWRN9","052277936","DVL1CMRMWRN9","US","34.098065","-118.29069","1520001","CHILDREN'S HOSPITAL OF LOS ANGELES","LOS ANGELES","CA","Independent Hospitals","900276062","UNITED STATES","N","9/20/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","253723","253723"," ","163692","90031"," "," ",
"Aging; Genetics; Human Genome","Age;Aging;Binding;Biochemical;Biochemical Genetics;Biochemistry;Biological Models;Cell Aging;Cell Proliferation;Cells;Cellular biology;Chemicals;Chromatin;Chromatin Structure;Complement;Complex;Computer Simulation;DNA Sequence;Deposition;Development;Diabetes Mellitus;Disease;Enzymes;Epigenetic Process;Eukaryota;Event;Face;Gene Activation;Gene Silencing;Generations;Genes;Genomics;Goals;Heterochromatin;Histone H3;Histone H3.3;Histones;Homologous Gene;Human;In Vitro;Laboratories;Lead;Ligands;Link;Longevity;Mammals;Mediating;Mediator of activation protein;Mesenchymal Stem Cells;Methodology;Modeling;Molecular;Molecular Chaperones;Mus;Mutagenesis;Neurodegenerative Disorders;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Organelles;Orthologous Gene;Osteogenesis;Pharmaceutical Preparations;Phenotype;Play;Post-Translational Protein Processing;Process;Production;Proteins;Reagent;Regulation;Roentgen Rays;Role;Screening procedure;Sirtuins;Site;Structure;Testing;Tissues;Transcriptional Activation;Variant;Yeasts;base;cell age;chromatin protein;design;dimer;functional group;in vitro Assay;in vivo;inhibitor/antagonist;insight;mutant;programs;scaffold;senescence;small molecule;yeast protein","STRUCTURAL BASIS FOR EPIGENETICS IN AGING AND LONGEVITY","n/a","NIA","8377708","2/16/2012 12:00:00 AM"," ","5P01AG031862-05","5","P01","AG","031862","05"," "," "," ","8/31/2013 12:00:00 AM","ZAG1-ZIJ-5","0001","1866999","MARMORSTEIN, RONEN ","Not Applicable","03","Unavailable","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","Domestic Higher Education","191046205","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","351497","351497"," ","280609","70888"," "," ",
"Biotechnology; Breast Cancer; Cancer; Genetics","1p34;3&apos; Untranslated Regions;Affect;Animal Model;Breast Cancer Cell;Breast Cancer Treatment;Cancer cell line;Cells;Cellular Assay;Cessation of life;Chromosomes;Clinical;Development;Disease;Distant;Embryonic Development;Epithelial;Epithelial Cells;Event;Exhibits;Gametogenesis;Gene Expression;Genes;Genetic;Genetic Epistasis;Genetic Screening;Goals;Human;In Vitro;Laboratories;Loss of Heterozygosity;Maintenance;Malignant Neoplasms;Mammary gland;Mediating;Mediator of activation protein;Mesenchymal;MicroRNAs;Molecular;Molecular Profiling;Mus;Neoplasm Metastasis;Outcome;Pathway interactions;Play;Primary Carcinoma;Primary Neoplasm;Prognostic Marker;RNA Interference;Regulation;Relapse;Role;Sampling;Signal Pathway;Site;Snails;Testing;Therapeutic;Transplantation;Tumor Angiogenesis;Tumor Cell Invasion;Tumor Suppressor Proteins;Xenograft Model;Xenograft procedure;base;cell growth;genome-wide;in vitro Assay;in vivo;insight;lymph nodes;malignant breast neoplasm;mouse model;mutant;neoplastic cell;outcome forecast;prognostic;programs;promoter;public health relevance;research study;senescence;small hairpin RNA;therapeutic target;transcription factor;tumor;tumor growth;tumor xenograft;tumorigenesis;vector","Defining the Molecular Mechanisms of KLF17 Regulation and Function in EMT","
PUBLIC ABSTRACT
This proposal studies transcription factor KLF17 in tumor maintenance, epithelial-
mesenchymal transition (EMT) and metastasis. Tumor spread from a primary site to
distant sites is responsible for most cancer death. EMT plays a critical role in tumor
spread. Currently there are few prognostic markers and therapeutics for metastatic
disease. KLF17 was recently discovered in my laboratory to be involved in EMT by a
genome-wide RNAi screen. Elucidation of the molecular mechanisms of KLF17 in EMT
and metastasis will provide potential prognostic marker and therapeutics for the
treatment of this deadly disease.","NCI","8215813","3/15/2012 12:00:00 AM","PA-07-070","5R01CA148759-03","5","R01","CA","148759","03"," ","AULT, GRACE S","4/1/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Cancer Genetics Study Section[CG]"," ","8334157","HUANG, QIHONG ","Not Applicable","03","Unavailable","075524595","DW1XZMGNFBL4","075524595","DW1XZMGNFBL4","US","39.950872","-75.195321","9340401","WISTAR INSTITUTE","PHILADELPHIA","PA","Research Institutes","191044265","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","209657","129990"," ","339647",
"No NIH Category available","Address;American;Androgens;Aneuploidy;Applications Grants;Area;Biochemical;Biopsy Specimen;Body part;Cancer Etiology;Cancer Model;Cancer Patient;Cell Culture Techniques;Cell membrane;Cell surface;Cells;Cessation of life;Characteristics;Clinical;Collagen Type I;Collection;DNA Damage;DU145;Data;Diagnosis;Disease;Down-Regulation;Drug Industry;E-Cadherin;Elderly;Environmental Risk Factor;Epithelial;Epithelial Cells;Event;Excision;Experimental Models;Failure;Fibroblasts;Future;Generations;Genomic Instability;Goals;Grant;Growth;Health;Hemopexin;Hormonal;Hospitals;Human;Hypoxia;Immunohistochemistry;In Vitro;Indolent;Inflammation;Invaded;LNCaP;Lead;Life;Malignant Neoplasms;Malignant neoplasm of prostate;Matrix Metalloproteinase Inhibitor;Matrix Metalloproteinases;Mediating;Membrane;Mesenchymal;Metastatic Neoplasm to the Lung;Metastatic Prostate Cancer;Mission;Mitochondria;Modeling;Molecular;Morbidity - disease rate;Neoplasm Metastasis;Non-Visceral;Normal tissue morphology;Operative Surgical Procedures;Outcomes Research;Oxidases;Pathologic;Pathway interactions;Patient observation;Patients;Pharmaceutical Preparations;Pharmacologic Substance;Phenotype;Pilot Projects;Play;Primary Neoplasm;Process;Prostate;Publishing;Radiation therapy;Radical Prostatectomy;Reactive Oxygen Species;Research;Research Project Grants;Role;Scientist;Series;Shapes;Signal Pathway;Site;Skin Cancer;Source;Specimen;Staging;Superoxides;Survival Rate;Time;Tissues;Up-Regulation;Validation;Veterans;Work;base;cDNA Arrays;cancer cell;cancer diagnosis;cancer therapy;cancer type;chemotherapy;deprivation;docetaxel;epithelial to mesenchymal transition;human MMP14 protein;in vivo;men;metastatic process;mortality;novel;novel strategies;outcome forecast;pressure;prevent;public health relevance;research study;small hairpin RNA;tool;treatment strategy;tumor;tumor growth;tumor progression","Reversibility of Epithelial-Mesenchymal Transition in Prostate Cancer","7. Project Narrative 
 Prostate cancer is the major visceral (non skin) cancer diagnosis (20% of all cancers) 
and a leading cause of morbidity and mortality among men. It is the second leading cause 
of cancer mortality among American men. Prostate cancer is especially prominent among 
elderly veterans, with more than 11,000 new cases diagnosed per year in VA hospitals 
(VA Central Office data). Although surgery and radiation therapy are effective in early 
stage prostate cancer, treatment options are limited for patients with metastatic disease 
who become unresponsive to hormonal (androgen deprivation) therapy. The recent 
introduction of Taxotere chemotherapy for metastatic prostate cancer only prolongs 
survival by 2 to 3 months. 
 In order to develop new approaches to the treatment of advanced prostate cancer, it is 
essential that scientists better understand basic mechanisms leading cancers to spread 
from the prostate gland to other parts of the body (metastasis). Over the past few years, it 
has been recognized that cancer cells in the prostate gland begin to change their shape 
and become more aggressive over time. This change is called, ""epithelial-to- 
mesenchymal transition"", abbreviated as EMT. It is widely recognized that EMT may 
represent an important mechanism leading to metastasis. Hence, it is critical that we 
understand the details of how molecules working inside cancer cells produce EMT and 
metastasis. Once we understand how these molecules lead cancer cells to spread around 
the body, the pharmaceutical industry will be able to develop drugs to counteract these 
molecules and stop cancer metastasis. This approach will open up new avenues for the 
control of metastatic prostate cancer. 
 The goal of this grant application is to identify the molecules involved in cancer EMT 
and to show that interfering with these molecules will stop cancer cells from being able to 
invade surrounding normal tissues and metastasize around the body. We have recently 
published an article demonstrating the discovery of a new pathway by which prostate 
cancer cells become more invasive and capable of metastasis. The current grant will work 
on demonstrating the detailed molecules involved in prostate cancer EMT and begin to 
show that experimental drugs can interfere with this process of cancer dissemination. If 
successful, our research will encourage pharmaceutical companies to develop new drugs 
based on the experimental approaches that we hope to develop during this grant. These 
new drugs will be very beneficial to veterans with advanced prostate cancer. 
 This research project will also help to determine which of these ""cancer molecules"" are 
increased in prostate cancer biopsy specimens from patients who will or will not develop 
disseminated cancer in the future. Based on identifying dangerous ""cancer molecules"" in 
a patient prostate biopsy specimen, clinical doctors may be able to say which patients 
need aggressive forms of treatment to prevent metastasis or in the absence of ""cancer 
molecules"", which patients can be managed conservatively by watchful waiting rather 
than surgery (radical prostatectomy) or radiation therapy. 
 The outcome of this research will therefore be very relevance to veterans health and the 
mission of the VA.","VA","8195852","12/1/2011 12:00:00 AM","RFA-BX-09-001","5I01BX000352-03","5","I01","BX","000352","03"," "," ","10/1/2009 12:00:00 AM","9/30/2013 12:00:00 AM","Oncology A[ONCA]"," ","1978886","ZUCKER, STANLEY ","Not Applicable","03","Unavailable","008209124","ZQZKMKZWMXF3","008209124","ZQZKMKZWMXF3","US","40.89979","-73.306754","481063","NORTHPORT VA MEDICAL CENTER","NORTHPORT","NY","Independent Hospitals","117682200","UNITED STATES","N","10/1/2011 12:00:00 AM","9/30/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Bioengineering; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Adipose tissue;Allogenic;Allografting;Antioxidants;Biological;Biological Models;Biological Sciences;Biology;Bone Marrow;Cell Differentiation process;Cell Proliferation;Cell physiology;Cells;Chondrogenesis;Clinical;Clinical Research;Collaborations;Development;Devices;Electrons;Embryonic Structures;Endothelial Cells;Engineering;Engraftment;Gene Expression;Generations;Genes;Goals;Healed;Histology;Institutes;Knowledge;Lasers;Length;Life;Link;Measures;Mediating;Mesenchymal Stem Cells;Methods;Microscopy;Molecular;Nitrogen;Nodule;Operative Surgical Procedures;Osteogenesis;Outcome Study;Oxidation-Reduction;Oxygen;Phenotype;Physics;Plasma;Property;Proteins;Publishing;Reactive Nitrogen Species;Reactive Oxygen Species;Regenerative Medicine;Regulation;Reporting;Signal Pathway;Signal Transduction;Stem cells;System;Technology;Testing;Time;Tissue Engineering;Tissues;United States;Universities;Vascular Graft;Vascularization;Work;Wound Healing;adult stem cell;base;cancer cell;healing;implantation;improved;in vivo;insight;new technology;novel strategies;osteogenic;precursor cell;public health relevance;scaffold;stem cell biology;stem cell differentiation;stem cell fate;tissue regeneration;tissue repair;tool;transcription factor;treatment duration;vascular tissue engineering","Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation","
PROJECT NARRATIVE:
The purpose of this project is to explore and develop biological applications of Non-Thermal Plasma for use in
tissue engineering and regenerative medicine. Our preliminary studies and other published reports indicate
that this new technology can significantly influence the fate of adult stem cells and promote their proliferation,
commitment and differentiation. Results generated from the proposed studies will provide improved methods
for tissue repair and regeneration with direct applicability to both clinical research and surgical procedures.","NIBIB","8240982","2/22/2012 12:00:00 AM","PAR-10-142","5R01EB013011-02","5","R01","EB","013011","02"," ","HUNZIKER, ROSEMARIE","4/1/2011 12:00:00 AM","1/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-BST-E(51)R]"," ","8663349","FREEMAN, THERESA A","FRIDMAN, GREGORY ","03","ORTHOPEDICS","053284659","R8JEVL4ULGB7","053284659","R8JEVL4ULGB7","US","39.949004","-75.155569","4050801","THOMAS JEFFERSON UNIVERSITY","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191074418","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","266459","80709"," ","347168",
"Bioengineering; Biotechnology; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adhesions;Affect;Age;Alkaline Phosphatase;Animal Model;Biomedical Engineering;Biomimetics;Bone Regeneration;Canis familiaris;Cartilage;Cells;Cereals;Clinic;Clinical;Collagen Fibril;Deposition;Disease;Extracellular Matrix;Failure;Fiber;Fibroblasts;Gene Expression;Glycolates;Goals;Guided Tissue Regeneration;Healed;Health;Human;Implant;In Vitro;Individual;Injury;Knowledge;Lead;Length;Ligaments;Maintenance;Mechanics;Meniscus structure of joint;Mesenchymal Stem Cells;Minerals;Modeling;Morphology;Nanostructures;Nanotechnology;Operative Surgical Procedures;Orthopedic Surgery procedures;Orthopedic Surgical Procedures;Osteoblasts;Patients;Population;Property;Quality of life;Rattus;Research;Rotator Cuff;Shoulder;Site;Stress;Tendon structure;Testing;Thick;United States Food and Drug Administration;Universities;Variant;Washington;anterior cruciate ligament reconstruction;base;biocompatible polymer;biodegradable polymer;biomineralization;bone;bone healing;calcium phosphate;cell motility;clinically relevant;clinically significant;density;design;ductile;healing;improved;in vivo;injury and repair;multidisciplinary;nanofiber;novel;programs;public health relevance;repaired;response;scaffold;scleraxis;soft tissue;supraspinatus muscle","Nanofiber Scaffolds with Gradations in Mineral Content for Rotator Cuff Repair","
NARRATIVE
We will design, fabricate, and validate a novel class of scaffolds based on electrospun nanofibers and with
continuous gradations in mineral content for rotator cuff repair - that is, surgical reattachment of the torn
tendons to their bony insertions. It is a clinically significant problem that affects approximately 30% of the
population over the age of 60. The current failure rates range from 30% to 94%. Reducing these failure rates
will have a major impact on shoulder function in these patients. This research will improve the health and
quality of life for individuals afflicted with rotator cuff injuries, having significant impact on the treatment of
diseases at rotator cuff and other soft tissue-to-bone interfaces (e.g., anterior cruciate ligament reconstruction).","NIAMS","8227988","6/18/2012 12:00:00 AM","PA-08-052","7R01AR060820-02","7","R01","AR","060820","02"," ","PANAGIS, JAMES S","4/1/2011 12:00:00 AM","3/31/2016 12:00:00 AM","Nanotechnology Study Section[NANO]"," ","8586579","XIA, YOUNAN ","GALATZ, LEESA M; THOMOPOULOS, STAVROS ","05","ENGINEERING (ALL TYPES)","097394084","EMW9FC8J3HN4","097394084","EMW9FC8J3HN4","US","33.762977","-84.42296","676603","GEORGIA INSTITUTE OF TECHNOLOGY","ATLANTA","GA","BIOMED ENGR/COL ENGR/ENGR STA","303320415","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","291383","153559"," ","444942",
"Asthma; Clinical Research; Hematology; Lung; Pain Research; Pediatric; Prevention; Rare Diseases; Sickle Cell Disease; Sleep Research","Apnea;Asthma;Biological;Child;Chronic;Clinical;Clinical Data;Cohort Studies;Collaborations;Comorbidity;Complex;Correlative Study;Data;Disease;Enrollment;Evaluation;Evolution;Fibrosis;Foundations;Functional disorder;Future;Goals;Hospitalization;Hypersensitivity skin testing;Incidence;Individual;Laboratories;Lead;Length;Longitudinal Studies;Lung;Lung diseases;Measures;Mesenchymal Stem Cells;Morbidity - disease rate;Mus;Myofibroblast;Natural History;Obstructive Lung Diseases;Opioid;Outcome;Oxygen;Pain;Pathogenesis;Patients;Pattern;Phenotype;Polysomnography;Pulmonary Fibrosis;Pulmonary function tests;Recording of previous events;Research Design;Research Personnel;Respiratory physiology;Risk Factors;Scientist;Sickle Cell;Sickle Cell Anemia;Sleep;Sleep Apnea Syndromes;Smooth Muscle Actin Staining Method;Symptoms;Testing;Therapeutic Human Experimentation;Time;Transgenic Organisms;Translational Research;Work;acute chest syndrome;airborne allergen;airway obstruction;base;burden of illness;cohort;early childhood;follow-up;indexing;insight;mortality;mouse model;nocturnal Hypoxemia;pre-clinical;prevent;prospective;public health relevance;vaso-occlusive pain","Asthma and Nocturnal Hypoxemia in Sickle Cell Anemia II","
PROJECT NARRATIVE
Pulmonary complications are a leading cause of morbidity and mortality in sickle cell disease; yet, the natural
history, risk factors and underlying mechanisms of progressive lung disease are poorly defined. The overall
goal of this proposal is to identify the laboratory and clinical determinants of how lung disease progresses from
normal in early childhood to asthma and later to a severe lung disease that requires oxygen","NHLBI","8317689","8/10/2012 12:00:00 AM","PA-07-070","5R01HL079937-07","5","R01","HL","079937","07"," ","BLAISDELL, CAROL J","8/25/2005 12:00:00 AM","7/31/2014 12:00:00 AM","Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section[IRAP]"," ","6122799","DEBAUN, MICHAEL R.","STRUNK, ROBERT ","05","PEDIATRICS","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","9/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","574164","107019"," ","681183",
"Alcoholism; Biotechnology; Genetics; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Substance Abuse","Accidents;Acute;Admission activity;Adolescent;Affect;Alcohol abuse;Alcohol consumption;Alcohols;Antioxidants;Attenuated;Automobile Driving;Binding;Biological Assay;Biology;Blood alcohol level measurement;Bone callus;Boxing;Cell Culture Techniques;Cell Differentiation process;Cells;Chondrocytes;Chronic;Data;Disease;Environment;Exhibits;Family;Fracture;Fracture Healing;Gene Expression;Gene Silencing;Gene Targeting;Genes;Goals;Healed;Homeostasis;Human;Impairment;In Vitro;Inflammatory;Injury;Innovative Therapy;Knowledge;Laboratories;Lead;Link;Measures;Mediating;Mesenchymal Stem Cells;Metabolism;Methods;Molecular;Morbidity - disease rate;Mus;Orthopedics;Osteoblasts;Osteogenesis;Osteopenia;Oxidative Stress;Pathology;Pathway interactions;Patients;Phase;Play;Process;Reporting;Research;Risk;Risk Factors;Rodent;Rodent Model;Role;Signal Pathway;Signal Transduction;Site;Small Interfering RNA;Techniques;Testing;Therapeutic;Time;Tissues;Transgenic Animals;Trauma;Up-Regulation;Work;alcohol abuse therapy;alcohol effect;alcohol exposure;base;binge drinking;bone;bone cell;bone healing;bone health;catalase;cell type;cofactor;combat;healing;in vitro Model;in vivo;interest;mouse model;novel;repaired;stem cell differentiation;transcription factor;young adult","The Effects of Alcohol-Induced Oxidative Stress on Bone Fracture Repair"," Alcohol use is known to be detrimental to bone health and perturb fracture healing, yet it is unknown how alcohol exhibits these effects. This study proposes to discover the mechanism behind alcohol's actions on bone and fracture repair biology, eventually leading to preventative and therapeutic treatments of alcohol- induced osteopenia and fracture malunion.   
      

","NIAAA","8314285","3/15/2012 12:00:00 AM","PA-11-111","1F31AA021308-01","1","F31","AA","021308","01"," ","OROSZ, ANDRAS","4/1/2012 12:00:00 AM","3/31/2015 12:00:00 AM","Biomedical Research Study Section[AA-1]"," ","10526601","ROPER, PHILIP ","Not Applicable","07","SURGERY","791277940","RFRPFMNR8LA5","791277940","RFRPFMNR8LA5","US","41.86527","-87.833383","4689203","LOYOLA UNIVERSITY CHICAGO","MAYWOOD","IL","SCHOOLS OF MEDICINE","601533328","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","273","Training, Individual","2012"," "," ","NIAAA","28957"," "," ","28957",
"Bioengineering; Dental/Oral and Craniofacial Disease; Digestive Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Abbreviations;Acinar Cell;Address;Affect;Alanine;Artificial Organs;Atomic Force Microscopy;Basement membrane;Binding;Binding Sites;Biological Assay;Biopolymers;Cell Density;Cell Differentiation process;Cell Line;Cell-Matrix Junction;Cells;Characteristics;Chemicals;Chemistry;Collagen Type IV;Complex;Data;Detection;Differentiation Antigens;Elasticity;Embryo;Engineering;Environment;Epithelial;Epithelial Cells;Ethylene Glycols;Ethylene Oxide;Extracellular Matrix;Future;Gel;Generations;Goals;Green Fluorescent Proteins;Growth;Human;Hydrogels;Implant;In Vitro;Isoleucine;Knowledge;Life;Lysine;Maintenance;Mammary gland;Mechanics;Mesenchymal Stem Cells;Methacrylates;Morphogenesis;Mus;Natural regeneration;Organ;Patients;Play;Polyethylene Glycols;Polymerase Chain Reaction;Property;Quality of life;Rattus;Regulation;Resistance;Role;Saliva;Salivary;Salivary Glands;Series;Signal Transduction;Site;Sjogren&apos;s Syndrome;Stem cells;Symptoms;Testing;Tissue Differentiation;Tissue Engineering;Tissues;Valine;Work;Xerostomia;base;blastomere structure;crosslink;density;design;ethylene glycol;extracellular;immunocytochemistry;in vivo;lithography;man;matrigel;novel;salivary acinar cell;sarcoma;scaffold;stem;stem cell differentiation;success","Extracellular Scaffold Elasticity and Binding Sites in Acinar Differentiation"," This project will identify the necessary elastic and cell binding characteristics of a cellular scaffold to promote acinar differentiation. These results will provide a framework for future identification of other factors that influence acinar generation in a future proposal. These studies will eventually make possible the engineering of an artificial scaffold to alleviate symptoms in patients suffering from Sjogren's syndrome and other causes of salivary hypofunction, or dry mouth.  
    

","NIDCR","8257739","11/16/2011 12:00:00 AM","PA-10-069","1R21DE021841-01A1","1","R21","DE","021841","01","A","LUMELSKY, NADYA L","12/1/2011 12:00:00 AM","11/30/2013 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","1923774","LARSEN, MELINDA ","Not Applicable","20","BIOLOGY","152652822","NHH3T1Z96H29","152652822","NHH3T1Z96H29","US","42.666488","-73.798445","5992604","STATE UNIVERSITY OF NEW YORK AT ALBANY","ALBANY","NY","SCHOOLS OF ARTS AND SCIENCES","122220001","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","150000","78000"," ","228000",
"Brain Cancer; Brain Disorders; Cancer; Genetics; Neurosciences; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Animals;Apoptosis;Biology;Brain Neoplasms;Cells;ChIP-on-chip;Clinical;DNA Damage;Data;EGFR inhibition;Excision;Foundations;Gene Expression;Gene Targeting;Genetic Transcription;Glioblastoma;Glioma;Growth;Human;Laboratories;Link;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of brain;Mediating;Mesenchymal Stem Cells;Molecular;Mus;Neonatal;Newly Diagnosed;Oncogenic;Pathway interactions;Phenotype;Play;Pluripotent Stem Cells;Property;Publishing;Receptor Protein-Tyrosine Kinases;Recurrence;Relative (related person);Resistance;Role;Signal Pathway;Signal Transduction;Site;Somatic Cell;Stem Cell Development;Stem cells;Testing;Therapeutic;Tumor Cell Line;Tumor Stem Cells;Xenograft procedure;c-myc Genes;cancer cell;cancer stem cell;cancer therapy;clinically relevant;effective therapy;in vivo;inhibitor/antagonist;medulloblastoma;meetings;migration;neoplastic;neoplastic cell;nerve stem cell;novel;novel therapeutics;overexpression;precursor cell;relating to nervous system;research study;stem;stem cell biology;stemness;transcription factor;tumor;tumor growth;tumor xenograft;tumorigenesis","Brain Cancer Stem Cell Reprogramming by c-Met"," Glioblastoma is a very aggressive and almost universally fatal brain tumor. Malignant stem-like cells are believed to be responsible for the resistance of glioblastoma to current therapies. This project will identify new therapeutic vulnerabilities of glioblastoma stem cells by determining how they are supported and regulated by the receptor tyrosine kinase c-Met and reprogramming transcription factors.   
      

","NINDS","8303038","4/30/2012 12:00:00 AM","PA-10-067","1R01NS073611-01A1","1","R01","NS","073611","01","A","FOUNTAIN, JANE W","5/15/2012 12:00:00 AM","4/30/2017 12:00:00 AM","Clinical Neuroimmunology and Brain Tumors Study Section[CNBT]"," ","1878757","LATERRA, JOHN J","Not Applicable","07","Unavailable","155342439","DKMDCB5HNBL7","155342439","DKMDCB5HNBL7","US","39.298451","-76.594323","2370003","HUGO W. MOSER RES INST KENNEDY KRIEGER","BALTIMORE","MD","Research Institutes","212051832","UNITED STATES","N","5/15/2012 12:00:00 AM","4/30/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","218750","134750"," ","353500",
"Bioengineering; Biotechnology; Genetics; Regenerative Medicine","Address;Adipose tissue;Allogenic;Animal Model;Area;Attention;Biological;Biology;Biomechanics;Bioreactors;Bone Marrow;Cartilage;Cell Differentiation process;Cell Proliferation;Cell Therapy;Cell physiology;Cell surface;Cell-Cell Adhesion;Cells;Cellular biology;Chondrocytes;Cicatrix;Clinical;Clinical Trials;Custom;DNA Microarray Chip;Data;Development;Devices;Disease;Engineering;Environment;Experimental Designs;Extracellular Matrix;Fatty acid glycerol esters;Fibroblasts;Future;Gene Expression;Genes;Genomics;Genotype;Goals;Growth;Human;Immune;Immunohistochemistry;Immunophenotyping;Institution;Knowledge;Laboratories;Laboratory culture;Lamina Propria;Larynx;Literature;Living Donors;Measures;Mechanical Stimulation;Mechanics;Mediating;Mesenchymal;Molecular Profiling;Muscle;Myoblasts;Natural regeneration;Osteoblasts;Outcome;Patients;Phonation;Physiological;Polymerase Chain Reaction;Property;Quality of life;Regenerative Medicine;Research;Residencies;Risk;Signal Transduction;Simulate;Source;Stimulus;Stretching;Stromal Cells;Testing;Therapeutic;Time;Tissue Engineering;Tissues;Transcript;Universities;Wisconsin;Work;base;bone;cell behavior;cell transformation;cell type;conventional therapy;design;effective therapy;human subject;immunoregulation;improved;in vivo;innovation;repaired;response;simulation;stem cell biology;therapy development;vibration;vocal cord","Identification of Biomechanically Valid Cell Therapeutics for Vocal Fold Scar"," The goal of this research is to identify optimal cell source(s) for vocal fold scarring therapeutics. To this end, we will evaluate mesenchymal stromal cells (MSC) in a context which simulates the biomechanical forces of the human larynx. Study findings will advance knowledge of cell response to phonation-like vibration and inform the design of biomechanically relevant treatment for vocal fold regeneration prior to a clinical trial.  
   
      

","NIDCD","8456381","8/3/2012 12:00:00 AM","PA-11-111","1F31DC012973-01","1","F31","DC","012973","01"," ","SKLARE, DAN","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","ZDC1-SRB-R(36)"," ","11263602","BARTLETT, REBECCA S","Not Applicable","02","NONE","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","SCHOOLS OF MEDICINE","537151218","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","173","Training, Individual","2012"," "," ","NIDCD","31032"," "," ","31032",
"Bioengineering; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Aging;Allografting;Attention;Autologous Transplantation;Biodegradable microsphere;Biological Assay;Biomechanics;Blood Vessels;Bone Marrow;Bone Regeneration;Bone Substitutes;Bone Tissue;Bone Transplantation;Cell Proliferation;Cell Survival;Cells;Clinical;Coculture Techniques;Confocal Microscopy;Defect;Deformity;Dental;Development;Devices;Equilibrium;Excision;Exhibits;Failure;Fracture;Gene Expression;Generations;Histology;Human;Immunofluorescence Microscopy;Implant;In Vitro;Infiltration;Marketing;Measures;Mechanics;Mesenchymal Stem Cells;Microspheres;Modeling;Natural regeneration;Nutrient;Operative Surgical Procedures;Oral;Orthopedic Surgery procedures;Orthopedics;Oryctolagus cuniculus;Osteoclasts;Osteogenesis;Performance;Periodontal Diseases;Population;Porosity;Process;Property;Recovery of Function;Reverse Transcriptase Polymerase Chain Reaction;Seeds;Sodium Chloride;Solutions;Staining method;Stains;Stem cells;Surface;Techniques;Testing;Tissue Engineering;Tooth Diseases;Trauma;United States;Vascular blood supply;Vascularization;Weight-Bearing state;Work;alternative treatment;angiogenesis;base;bone;bone healing;bone loss;cell type;clinically relevant;design;improved;in vivo;maxillofacial;mineralization;neovascularization;novel;oral surgery specialty;oxygen transport;peripheral blood;repaired;scaffold;tissue regeneration;tumor","Optimal Biodegradable Scaffolds and Progenitor Cells for Effective Bone Regenerat","Bone replacement and repair in oral/maxillofacial and orthopaedic surgery represent a multi-billion dollar market, which is rapidly expanding due to increasing demand and improving treatment options. Scaffold-based bone regeneration, the most promising treatment option on the horizon, is substantially limited by insufficient vascularization. This study will develop a novel technique for enhanced scaffold-based bone regeneration and vascularization through the development of pre-vascularized, biodegradable and optimally-designed scaffolds.","NIDCR","8366803","8/30/2012 12:00:00 AM","PA-11-110","5F30DE022477-02","5","F30","DE","022477","02"," ","FRIEDEN, LESLIE A","9/1/2011 12:00:00 AM","8/31/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","9210471","AMINI, AMI R","Not Applicable","05","ORTHOPEDICS","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF MEDICINE","060305335","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","48032"," "," ","48032",
"No NIH Category available","Adult;Aftercare;Amputation;Animals;Apical;Autologous;Back;Bone Marrow;Bone Regeneration;Cell Separation;Cell Therapy;Cells;Cellularity;Clinical;Clinical Research;Clinical Treatment;Clinical Trials;Data;Dental;Dental Pulp;Dental crowns;Dentin;Endodontically-Treated Tooth;Endodontics;Environment;Excision;Failure;Family suidae;Flow Cytometry;Foundations;Future;Gene Expression;Gene Expression Profile;Goals;Growth Factor;Gutta-Percha;Harvest;Health;Histology;Human;Immunohistochemistry;Implant;In Vitro;Light;Mesenchymal Stem Cells;Methods;Miniature Swine;Modality;Modeling;Molecular Profiling;Mus;Natural regeneration;Odontoblasts;Organ;Outcome;Plant Roots;Plants;Procedures;Process;Production;Property;Protocols documentation;Pulp Canals;Pulp Chambers;Research;Reverse Transcriptase Polymerase Chain Reaction;Root Canal Therapy;Rubber;SCID Mice;Services;Simulate;Source;Stem cells;Structure;Study models;System;Technology;Testing;Therapeutic;Time;Tissue Engineering;Tissues;Tooth structure;United States;Vascularization;Western Blotting;Work;angiogenesis;base;cell growth;clinical application;cost;craniofacial;craniofacial repair;deciduous tooth;human stem cells;in vivo;injured;nerve supply;organ regeneration;prospective;public health relevance;regenerative;repaired;research study;scaffold;stem cell therapy;subcutaneous;success;tissue regeneration;tongue papilla","Stem Cell Based Therapy for Regenerative Endodontics ","n/a","NIDCR","8568895","10/31/2012 12:00:00 AM","PA-07-070","7R01DE019156-06","7","R01","DE","019156","06"," ","LUMELSKY, NADYA L","8/1/2008 12:00:00 AM","11/30/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-K(09)F]"," ","1936352","HUANG, GEORGE T.J","Not Applicable","09","DENTISTRY","941884009","X1M1PN3KG3E7","941884009","X1M1PN3KG3E7","US","35.139758","-90.033697","578302","UNIVERSITY OF TENNESSEE HEALTH SCI CTR","MEMPHIS","TN","SCHOOLS OF DENTISTRY/ORAL HYGN","381034903","UNITED STATES","N","9/17/2012 12:00:00 AM","11/30/2012 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","226628","113314"," ","339942",
"Bioengineering; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adipose tissue;Basic Science;Biocompatible Materials;Biological;Bone Development;Bone Marrow;Bone Morphogenetic Proteins;Bone Regeneration;Bone Tissue;Calcium;Calcium ion;Cartilage;Cells;Connecticut;Data;Defect;Development;Devices;Diagnostic radiologic examination;Disadvantaged;Dose;Dose-Limiting;Emulsions;Engineering;FDA approved;Food Additives;Glycolic-Lactic Acid Polyester;Goals;Growth Factor;Histology;Human;Hydrogen Peroxide;Implant;In Vitro;Laboratories;Lead;Ligaments;Literature;Measures;Mechanics;Mesenchymal Stem Cells;Microspheres;Modeling;Molecular;Molecular Biology;Monitor;Natural regeneration;Orthopedics;Oryctolagus cuniculus;Osteogenesis;Oxygen;Penetration;Performance;Peroxides;Polymers;Property;Research;Research Personnel;Research Proposals;Science;Signal Transduction;Solubility;Solvents;Source;Stem cells;Surface;Techniques;Testing;Tissue Engineering;Tissues;Universities;Vascular Endothelial Growth Factors;Vascularization;angiogenesis;base;bone;bone healing;bone morphogenetic protein 2;calcium hydroxide;clinical application;controlled release;cost;design;evaporation;high risk;immunogenicity;improved;in vivo;innovation;laurencin;melting;mineralization;novel;novel strategies;osteogenic;poly(lactide);regenerative;response;scaffold;stem cell biology;tissue regeneration;tomography","Enhanced Osteoinduction and Angioinduction via Polymer/CaO2 Bone Tissue Engineeri"," The Laurencin laboratory has focused on developing tissue engineering strategies for the regeneration of orthopaedic tissues such as bone, cartilage, and ligament. To achieve these goals, we collaborate with experts from a wide range of scientific fields including clinicians, cell and molecular biologists, and engineers from the University of Connecticut and around the world. The innovation of the current proposal is the development of controlled release composite scaffolds that can induce angiogenesis and osteogenesis without the need for exogenous growth factors.   
      

","NIAMS","8386342","6/19/2012 12:00:00 AM","PA-10-069","1R21AR062771-01A1","1","R21","AR","062771","01","A","WANG, FEI","7/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","1885902","LAURENCIN, CATO T.","Not Applicable","05","ORTHOPEDICS","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF MEDICINE","060305335","UNITED STATES","N","7/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","135000","71150"," ","206150",
"Bioengineering; Biotechnology; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Temporomandibular Muscle/Joint Disorder (TMJD)","ALCAM gene;Adult;Attention;BMP7 gene;Biocompatible Materials;Biodegradable microsphere;Biological Assay;Biomimetics;Bone Marrow;Cartilage;Cartilage injury;Cell Density;Cells;Chemotaxis;Chemotaxis Induction;Chitosan;Chondrogenesis;Clinic;Clinical;Collagen;Collagen Type I;Data;Defect;Developmental Biology;ENG gene;Eating;Encapsulated;Engineering;Exhibits;Fibroblast Growth Factor 2;Fibrocartilages;Gene Expression;Glycosaminoglycans;Goals;Growth Factor;Healed;Helium;Histocytochemistry;Hyaline Cartilage;Hyaluronic Acid;Hydrogels;In Situ;In Vitro;Ions;Joints;Kinetics;Knee;Mandible;Mandibular Condyle;Mesenchymal Stem Cells;Methods;Microscopy;Microspheres;Morphogenesis;Natural regeneration;Oryctolagus cuniculus;Patients;Phase;Platelet-Derived Growth Factor;Population;Population Heterogeneity;Production;Research;Resolution;SOX9 protein;Signal Transduction;Source;Staging;Stem cells;Structure;Surface;Synovial Cell;Synovial Membrane;Temporomandibular Joint;Testing;Tissues;Translating;articular cartilage;base;bone healing;cartilage regeneration;cell motility;controlled release;crosslink;design;healing;in vitro Assay;in vitro testing;in vivo;innovation;nano;nanoscale;osteochondral tissue;response;success;therapy development","Mandibular Cartilage Regeneration In Situ by Endogenous Stem Cell Recruitment"," Temporomandibular joint articular cartilage injuries do not heal, resulting in joint degeneration that interferes with speaking and eating. Our goal is to engineer cartilage regeneration by using biomaterials and growth factors to mimic the signaling cascade that occurs during successful healing. Our approach is innovative because it will instruct the patient's own stem cells to regenerate mandibular cartilage, and it will be easy to translate to the clinic to treat patients with temporomandibular joint cartilage injuries.   
      

","NIDCR","8425503","8/27/2012 12:00:00 AM","PA-11-197","1K99DE023123-01","1","K99","DE","023123","01"," ","FRIEDEN, LESLIE A","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","9505813","VANDEN BERG-FOELS, WENDY S.","Not Applicable","01","ANATOMY/CELL BIOLOGY","183710748","NHV3GTWSALA7","183710748","NHV3GTWSALA7","US","32.788289","-79.954891","7575301","MEDICAL UNIVERSITY OF SOUTH CAROLINA","CHARLESTON","SC","SCHOOLS OF MEDICINE","294074636","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","83333","6667"," ","90000",
"Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Adult;American;Animals;Apoptosis;Biological Assay;Bone Marrow;Bone Marrow Cells;Bone Marrow Stem Cell;Budgets;Cardiac;Cardiac Myocytes;Cell Death;Cell Survival;Cell Therapy;Cell surface;Cells;Centers of Research Excellence;Computer software;Conditioned Culture Media;Consult;Country;Critical Care;Cultured Cells;Data;Epitopes;Experimental Designs;Gel;Grant;Growth;Health Sciences;Heart;Human;Hypoxia;Immunocompetent;Immunodeficient Mouse;Infarction;Inhibition of Apoptosis;Injection of therapeutic agent;Injury;Intramuscular;Intravenous;Journals;Letters;Magnetism;Marrow;Mass Spectrum Analysis;Medicine;Mesenchymal Stem Cells;Molecular;Molecular Profiling;Mononuclear;Mus;Myocardial Infarction;Myocardium;NGFR Protein;Natural regeneration;Necrosis;Neonatal;Oxygen;Patients;Persons;Phenotype;Population;Principal Investigator;Procedures;Proteins;Proteomics;Publications;Radiolabeled;Rattus;Recovery;Reporting;Route;STAT3 gene;Serum;Serum-Free Culture Media;Sorting - Cell Movement;Stem cells;Tail;TdT-Mediated dUTP Nick End Labeling Assay;Techniques;Testing;Time;Tissues;Universities;Veins;base;compare effectiveness;design;experience;heart preservation;paracrine;programs;radiotracer;repaired;research study;respiratory;stem;tandem mass spectrometry;transcription factor;transcriptional coactivator p75","Factors Responsible for Cardiac Preservation Conferred by Adult Marrow Stem Cells","n/a","NHLBI","8208026","12/9/2011 12:00:00 AM","PA-07-070","5R01HL085210-05","5","R01","HL","085210","05"," ","WONG, RENEE P","1/10/2008 12:00:00 AM","12/31/2013 12:00:00 AM","Myocardial Ischemia and Metabolism Study Section[MIM]"," ","8452175","SPEES, JEFFREY L","Not Applicable","At-Large","INTERNAL MEDICINE/MEDICINE","066811191","Z94KLERAG5V9","066811191","Z94KLERAG5V9","US","44.478216","-73.200657","8738101","UNIVERSITY OF VERMONT & ST AGRIC COLLEGE","BURLINGTON","VT","SCHOOLS OF MEDICINE","054051704","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","222750","112489"," ","335239",
"Biotechnology; Eye Disease and Disorders of Vision; Gene Therapy; Genetics; Neurodegenerative; Neurosciences; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Animal Model;Area;Autologous;Back;Blindness;Blood Vessels;Bone Marrow;CXCR4 gene;Cell Adhesion Molecules;Cell Survival;Cell Therapy;Cells;Cessation of life;Clinic;Clinical;Clinical Trials;Development;Disease;Dose;Effectiveness;Encapsulated;Ethics;Eye;Genetic;Growth Factor;Homing;Human;Injection of therapeutic agent;Intravenous;Left;Light;Mediator of activation protein;Medicine;Mesenchymal Stem Cells;Methods;Modeling;Modification;Molecular;Mus;Mutation;Nature;Neurodegenerative Disorders;Pathology;Patients;Photoreceptors;Play;Process;Public Health;Rattus;Research;Research Proposals;Retina;Retinal;Retinal Degeneration;Risk;Rodent Model;Role;Route;Running;Safety;Social Impacts;Staging;Stem cells;Stromal Cell-Derived Factor 1;Structure;Surgeon;Testing;Therapeutic Effect;Time;Translations;Treatment Protocols;Vision;autocrine;base;chemokine;college;cytokine;effective therapy;experience;gene therapy;implantation;intravenous administration;intravenous injection;intravitreal injection;lens;novel strategies;paracrine;photoreceptor degeneration;protective effect;regenerative;repaired;response;stem cell biology;stem cell therapy;subretinal injection","Development of non-invasive cell-based therapy for retinal degeneration and assoc","
PROJECT NARRATIVE
Retinal degeneration and associated ocular vascular pathology are the leading course of irreversible blindness
in the USA, there is no effective treatment yet. We propose to develop non-invasive cell-based therapy to
preserve vision and limit the pathological vascular modification by systemic administration of multipotent bone
marrow derived stem cells (MSCs) in rodent models for retinal degeneration. The MSCs have great potential for
clinic as autologous cells to rescue vision and stabilize/repair ocular vascular pathology.","NEI","8207846","12/2/2011 12:00:00 AM","PA-10-067","5R01EY020488-03","5","R01","EY","020488","03"," ","NEUHOLD, LISA","1/1/2011 12:00:00 AM","12/31/2015 12:00:00 AM","Biology and Diseases of the Posterior Eye Study Section[BDPE]"," ","9882546","WANG, SHAOMEI ","Not Applicable","28","Unavailable","075307785","NCSMA19DF7E6","075307785","NCSMA19DF7E6","US","34.076546","-118.380008","1225501","CEDARS-SINAI MEDICAL CENTER","LOS ANGELES","CA","Independent Hospitals","900481804","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","250000","167500"," ","417500",
"Cancer; Clinical Research; Hematology; Orphan Drug; Pediatric; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Acute Lymphocytic Leukemia;Address;Affect;Binding;Biological Models;Blast Cell;Bone Marrow;Cell Survival;Cells;Chemotherapy-Oncologic Procedure;Clinical;Clinical Trials;Coculture Techniques;Complex;Data;Development;Disease remission;Drug Delivery Systems;Drug resistance;Drug-sensitive;Event;Foundations;Funding;Future;Genetic;Genetically Engineered Mouse;Hematopoiesis;Hematopoietic;Human;Hypoxia;Hypoxia Inducible Factor;Image;Imaging Techniques;In Vitro;Label;Leukemic Cell;Marrow;Mediating;Mediator of activation protein;Mesenchymal Stem Cells;Metabolic Marker;Metabolic Pathway;Metabolism;Modeling;Molecular;Monitor;Mus;Optical reporter;Osteoblasts;Pathway interactions;Patients;Pimonidazole;Positron-Emission Tomography;Prodrugs;Proteins;Relapse;Resistance;Risk;Role;Sampling;Signal Pathway;Signal Transduction;Small Interfering RNA;Staging;Stem cells;Stromal Cells;Testing;Therapeutic;Time;Translating;Up-Regulation;Xenograft Model;base;chemokine;chemokine receptor;chemotherapeutic agent;chemotherapy;imaging probe;improved;in vivo;inhibitor/antagonist;knock-down;leukemia;novel;public health relevance;tool;transcription factor","Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia","
Narrative
Studies proposed here will for the first time investigate hypoxia as an essential
component of the leukemic microenvironment and determine downstream mediators of
chemoresistance. Our preliminary evidence strongly suggests that targeting hypoxia
may be feasible and may render leukemic cells drug sensitive. We anticipate that
understanding of the complex interactions between ALL cells and their
microenvironment will provide mechanism-based rationale for eliminating resistant ALL
progenitor cells and provide the foundation for future clinical trials with HIF-1ï¿½ inhibitors
and hypoxia-activated pro-drugs.","NCI","8220724","1/1/2012 12:00:00 AM","PA-10-067","5R01CA155056-02","5","R01","CA","155056","02"," ","FORRY, SUZANNE L","2/1/2011 12:00:00 AM","12/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-DTCS-A(81)S]"," ","7847414","KONOPLEVA, MARINA Y","Not Applicable","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","245016","81838"," ","326854",
"No NIH Category available"," ","Mesenchymal Regulation of Jaw Bone Length"," What controls the length of bone? Answering this question is important for preventing and treating birth defects, as well as for devising new therapies to repair or regenerate bones affected by injury or disease. The goal of this project is to identify genes and embryonic events that determine jaw length.     
    

","NIDCR","8692496","7/3/2013 12:00:00 AM","PA-10-059","7K08DE021705-03","7","K08","DE","021705","03"," ","KING, LYNN M","9/1/2011 12:00:00 AM","8/31/2016 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","9547956","BUMANN, ERIN EALBA","Not Applicable","12","DENTISTRY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF DENTISTRY/ORAL HYGN","481091276","UNITED STATES","N","7/1/2013 12:00:00 AM","8/31/2013 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","24599","1968"," ","26567",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adipose tissue;Adult;Affect;Affinity;Antibodies;Area;Aspirate substance;Autologous;Binding;Biocompatible Materials;Biodegradation;Biological;Biological Assay;Biomechanics;Blood Vessels;Bone Marrow;Bone Transplantation;Cell Separation;Cell Therapy;Cells;Clinical;Collagen;Complex;Defect;Development;Devices;Drug Formulations;Elements;Engineering;Evaluation;Fee-for-Service Plans;Fostering;Fracture;Frequencies;Gene Expression;Goals;Gold;Growth Factor;Harvest;Histology;Implant;Liquid substance;Manuals;Mesenchymal Stem Cells;Modeling;Mononuclear;Multipotent Stem Cells;Operating Rooms;Operative Surgical Procedures;Organ Transplantation;Orthopedic Surgery procedures;Orthopedics;Oryctolagus cuniculus;Osteogenesis;Palpation;Patients;Peptide Synthesis;Peptides;Phage Display;Pharmaceutical Preparations;Phase;Population;Process;Protocols documentation;Publishing;Reagent;Rest;Safety;Screening procedure;Series;Speed;Spinal Fusion;Stem cells;Sterilization;Surgeon;System;Technology;Testing;Tissue Engineering;Tissues;United States;Vertebral column;Work;adult stem cell;biomaterial compatibility;bone;bone healing;clinical practice;cost;design;flexibility;immunogenicity;implantation;improved;innovation;osteogenic;point of care;protein aminoacid sequence;prototype;repaired;research study;scaffold;scale up;self-renewal;tricalcium phosphate","Development of an adipose-derived stem cell isolation matrix"," Bone grafting is widely used in orthopaedic surgery to treat fractures and large bone defects and to achieve spinal fusions. However, harvesting a bone graft from patients is associated with a significant number of complications and often provides an inadequate amount of tissue. While alternatives to bone grafts have shown promise, there is still room for considerable improvement. Therefore, a device that could directly isolate progenitor cells from complex biological fluids, and then be used at point-of-care in the operating room, would be of significant clinical benefit.   
   
      

","NIGMS","8312104","6/29/2012 12:00:00 AM","PA-11-096","2R44GM093462-02A1","2","R44","GM","093462","02","A","MAAS, STEFAN","7/15/2010 12:00:00 AM","6/30/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-IMST-M(13)B]"," ","9971977","DARBY, MARTYN ","Not Applicable","04","Unavailable","078296854","YJQ6K1QMS488","078296854","YJQ6K1QMS488","US","35.366248","-79.429394","10031812","AFFINERGY, LLC","DURHAM","NC","Domestic For-Profits","277094650","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","859","SBIR/STTR","2012"," "," ","NIGMS"," "," "," ","807976",
"Cancer; Clinical Research; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Adoptive Transfer;Bone Marrow;Cancer Biology;Cancer Model;Cells;Chemotactic Factors;Coculture Techniques;Data;Disease;Event;Fibroblasts;Genetic;Grant;Growth Factor;Home environment;Human;Immune;Immune response;In Vitro;Infiltration;Investigation;Kinetics;Knowledge;Lymphangiogenesis;Lymphatic vessel;Macrophage Colony-Stimulating Factor;Malignant Neoplasms;Malignant neoplasm of cervix uteri;Malignant neoplasm of prostate;Malignant neoplasm of thyroid;Mediating;Memorial Sloan-Kettering Cancer Center;Mentors;Mesenchymal Stem Cells;Modeling;Mus;Mutation;Myofibroblast;Neoplasm Metastasis;Oncogenic;Papillary;Papillary thyroid carcinoma;Pathogenesis;Patients;Peptide Hydrolases;Pericytes;Phenotype;Population;Proteins;Radioactive Iodine;Recruitment Activity;Refractory;Research;Research Personnel;Role;Scientist;Staging;Stromal Neoplasm;Structure;Testing;Thyroid Gland;Training;Transgenic Mice;Tumor Angiogenesis;Tumor Promoters;Tumor-Derived;Undifferentiated;anaplastic thyroid cancer;angiogenesis;cancer cell;cancer initiation;cancer therapy;chemokine;density;macrophage;malignant breast neoplasm;monocyte;mouse model;outcome forecast;progenitor;public health relevance;research study;skills;thyroid neoplasm;tumor;tumor growth;tumor progression;tumorigenesis","Papillary thyroid cancer and tumor-associated macrophages","
Project Narrative
The results of these investigations will help identify potential mechanisms of thyroid cancer pathogenesis
through recruitment and interactions of host immune cells. This knowledge and understanding can then be
used to develop new targets for cancer therapy for patients whose disease has not responded to traditional
treatments.","NCI","8324656","8/8/2012 12:00:00 AM","PAR-09-050","5K08CA133183-03","5","K08","CA","133183","03"," ","PERKINS, SUSAN N","9/1/2010 12:00:00 AM","6/28/2013 12:00:00 AM","Transition to Independence Study Section (I)[NCI-I]"," ","9062643","RYDER, MABEL ","Not Applicable","12","Unavailable","064931884","KUKXRCZ6NZC2","064931884","KUKXRCZ6NZC2","US","40.764332","-73.955697","5079202","SLOAN-KETTERING INST CAN RESEARCH","NEW YORK","NY","Research Institutes","100656007","UNITED STATES","N","9/1/2012 12:00:00 AM","6/28/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","157300","12584"," ","169884",
"Aging; Arthritis; Biotechnology; Genetics; Prevention","Adult;Affect;Age;Aging;Antibodies;Binding;Binding Sites;Biological;Biological Assay;Biological Factors;Bone Marrow;Cartilage;Cell Differentiation process;Cell physiology;Cells;Chondrocytes;Chromatin;Chronic;Complementary DNA;Crossbreeding;DNA Binding Domain;DNA Methylation;Data;Degenerative polyarthritis;Development;Disease Progression;Electrophoretic Mobility Shift Assay;Epigenetic Process;Exhibits;Functional disorder;Gene Expression;Gene Targeting;Genetic;Genetic Predisposition to Disease;Goals;Histopathology;Human;Immunohistochemistry;Joints;Laser Scanning Cytometry;Lead;Maintenance;Mechanics;Mesenchymal Stem Cells;Molecular;Molecular Target;Mus;Mutation;Older Population;Osteoarthrosis Deformans;Pathogenesis;Patients;Peptide Hydrolases;Phenotype;Physiological;Prevention strategy;Preventive;Proteins;Research;Risk Factors;Skeletal Development;Stem cells;Stromal Cells;Structure;Synovial Cell;Synovial Membrane;Testing;Therapeutic;Tissues;Transgenic Mice;Weight-Bearing state;age related;arthropathies;articular cartilage;base;bone;cell type;chromatin immunoprecipitation;cytokine;disability;histone modification;improved;innovation;insight;joint injury;mature animal;member;middle age;mouse model;novel;nuclear factors of activated T-cells;overexpression;prevent;promoter;proteinase In;transcription factor","Transcription Factor NFAT1 Deficiency and Osteoarthritis"," The major goal of this project is to explore the molecular and cellular mechanisms by which transcription factor NFAT1 deficiency causes osteoarthritic joint degeneration. Successful completion of the proposed studies may provide new insights into the etiopathogenesis of osteoarthritis and could lead to improved strategies for prevention and treatment of osteoarthritis.  
    

","NIAMS","8298582","5/14/2012 12:00:00 AM","PA-10-067","5R01AR059088-02","5","R01","AR","059088","02"," ","TYREE, BERNADETTE","7/11/2011 12:00:00 AM","5/31/2016 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","2093862","WANG, JINXI ","Not Applicable","03","ORTHOPEDICS","016060860","YXJGGNC5J269","016060860","YXJGGNC5J269","US","39.123452","-94.743946","1484303","UNIVERSITY OF KANSAS MEDICAL CENTER","KANSAS CITY","KS","SCHOOLS OF MEDICINE","661608500","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","112500"," ","337500",
"Aging; Biotechnology; Genetics; Osteoporosis","3&apos; Untranslated Regions;Adipocytes;Aging;Basic Science;Bioinformatics;Bone Density;Bone Matrix;Bone Resorption;Bone remodeling;Cell Communication;Cell Line;Cell Lineage;Cell Shape;Cells;Characteristics;Clinical Research;Code;Collagen Fibril;Commit;Cysteine;Disease;Equilibrium;Extracellular Matrix;Functional RNA;Gene Expression;Genes;Genetic Polymorphism;Glycoproteins;Goals;Haplotypes;Health;Hormones;Human;Human Activities;In Vitro;Individual;Innate Bone Remodeling;Knock-in Mouse;Knowledge;Maintenance;Malignant Neoplasms;Mammals;Marrow;Mechanics;Mediating;Mesenchymal Stem Cells;Messenger RNA;MicroRNAs;Modification;Molecular;Mus;Mutation;Obesity;Osteoblasts;Osteoclasts;Osteogenesis;Osteonectin;Osteopenia;Osteoporosis;Parathyroid gland;Pathology;Phenotype;Play;Process;Property;Proteins;RNA Stability;Regulation;Risk;Role;Signal Transduction;Single Nucleotide Polymorphism;Skeleton;Therapeutic Intervention;Tissues;Trans-Activators;Transcript;Translational Repression;Translations;Untranslated Regions;Work;bone;bone loss;bone mass;bone turnover;cell behavior;hormone therapy;in vivo;knock-down;lipid biosynthesis;migration;novel;osteoblast differentiation;osteoclastogenesis;response;skeletal;substantia spongiosa","Function and Regulation of Osteonectin in Bone","
Project Narrative
This project focuses on understanding the regulation of a bone matrix protein that is critical for the
maintenance of bone mass. This protein is called osteonectin or SPARC, and polymorphisms in the gene
coding for this protein are associated with bone density in humans. Information obtained from these studies
could be used to identify novel targets for therapeutic intervention in the treatment of osteoporosis, and may be
used to identify individuals at risk for developing osteoporosis.","NIAMS","8286072","6/7/2012 12:00:00 AM","PA-07-070","5R01AR044877-14","5","R01","AR","044877","14"," ","CHEN, FAYE H","8/1/1998 12:00:00 AM","6/30/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1878695","DELANY, ANNE M","Not Applicable","05","OTHER BASIC SCIENCES","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF MEDICINE","060305335","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","213840","115474"," ","329314",
"Biotechnology; Genetics; Muscular Dystrophy; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Affect;Age;Amino Acids;Binding;Binding Proteins;Bone Density;Cardiomyopathies;Cell Nucleus;Cells;Chromatin;Chromosome Structures;DNA Crosslinking;Data;Defect;Development;Disease;Drosophila genus;Drosophila inturned protein;Emery-Dreifuss Muscular Dystrophy;Engineering;Environment;Family;Family member;Female;Functional disorder;Gene Expression Regulation;Genes;Genetic;Genetic Transcription;Gonadal structure;Homeostasis;Human;Immunohistochemistry;Interphase;Investigation;Lamins;Maintenance;Mesenchymal Stem Cells;Mitosis;Molecular;Molecular Genetics;Morphogenesis;Mutation;Myopathy;Nuclear;Nuclear Envelope;Nuclear Lamina;Ovarian;Ovary;Pathology;Phenotype;Phylogenetic Analysis;Production;Property;Proteins;Regulation;Regulatory Pathway;Role;Signal Transduction;Site;Site-Directed Mutagenesis;Somatic Cell;Stem cells;Structure;Surface;Tertiary Protein Structure;Tissues;Transactivation;Transcriptional Regulation;Variant;Work;abstracting;barrier-to-autointegration factor;human disease;insight;loss of function;mutant;novel;prevent;protein folding;public health relevance;research study;stem cell niche;stem cell population;tool;transcription factor","The role of LEM domain proteins in nuclear function","
PROJECT NARRATIVE
The integrity and organization of the nucleus depends upon the function of the nuclear lamina, a
protein meshwork that underlies the nuclear envelope. Alterations in nuclear lamina
components cause several human diseases that are associated with tissue-restricted pathology,
such as Emery-Dreifuss muscular dystrophy, myocardial diseases and bone density disorders,
even though nuclear lamina proteins are found in all cells. Using genetic and molecular
approaches in Drosophila, we will determine the function of one class of nuclear lamina
proteins, the LEM domain proteins to provide insights into mechanisms of human disease of the
nuclear lamina.","NIGMS","8274838","5/14/2012 12:00:00 AM","PA-07-070","5R01GM087341-03","5","R01","GM","087341","03"," ","AINSZTEIN, ALEXANDRA M","6/1/2010 12:00:00 AM","5/31/2014 12:00:00 AM","Development - 1 Study Section[DEV1]"," ","1898349","GEYER, PAMELA K.","Not Applicable","02","BIOCHEMISTRY","062761671","Z1H9VJS8NG16","062761671","Z1H9VJS8NG16","US","41.662689","-91.547715","3972901","UNIVERSITY OF IOWA","IOWA CITY","IA","SCHOOLS OF MEDICINE","522421320","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","193050","90761"," ","283811",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adipose tissue;Adult;Affect;Affinity;Antibodies;Area;Aspirate substance;Autologous;Binding;Biocompatible Materials;Biodegradation;Biological;Biological Assay;Biomechanics;Blood Vessels;Bone Marrow;Bone Transplantation;Cell Separation;Cell Therapy;Cells;Clinical;Collagen;Complex;Defect;Development;Devices;Drug Formulations;Elements;Engineering;Evaluation;Fee-for-Service Plans;Fostering;Fracture;Frequencies;Gene Expression;Goals;Gold;Growth Factor;Harvest;Histology;Implant;Liquid substance;Manuals;Mesenchymal Stem Cells;Modeling;Mononuclear;Multipotent Stem Cells;Operating Rooms;Operative Surgical Procedures;Organ Transplantation;Orthopedic Surgery procedures;Orthopedics;Oryctolagus cuniculus;Osteogenesis;Palpation;Patients;Peptide Synthesis;Peptides;Phage Display;Pharmaceutical Preparations;Phase;Population;Process;Protocols documentation;Publishing;Reagent;Rest;Safety;Screening procedure;Series;Speed;Spinal Fusion;Stem cells;Sterilization;Surgeon;System;Technology;Testing;Tissue Engineering;Tissues;United States;Vertebral column;Work;adult stem cell;biomaterial compatibility;bone;bone healing;clinical practice;cost;design;flexibility;immunogenicity;implantation;improved;innovation;osteogenic;point of care;protein aminoacid sequence;prototype;repaired;research study;scaffold;scale up;self-renewal;tricalcium phosphate","Development of an adipose-derived stem cell isolation matrix"," Bone grafting is widely used in orthopaedic surgery to treat fractures and large bone defects and to achieve spinal fusions. However, harvesting a bone graft from patients is associated with a significant number of complications and often provides an inadequate amount of tissue. While alternatives to bone grafts have shown promise, there is still room for considerable improvement. Therefore, a device that could directly isolate progenitor cells from complex biological fluids, and then be used at point-of-care in the operating room, would be of significant clinical benefit.   
   
      

","NIGMS","8516754","9/10/2012 12:00:00 AM","PA-11-096","3R44GM093462-02A1S1","3","R44","GM","093462","02","A1S","MAAS, STEFAN","7/15/2010 12:00:00 AM","6/30/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-IMST-M(13)B]"," ","9971977","DARBY, MARTYN ","Not Applicable","04","Unavailable","078296854","YJQ6K1QMS488","078296854","YJQ6K1QMS488","US","35.366248","-79.429394","10031812","AFFINERGY, LLC","DURHAM","NC","Domestic For-Profits","277094650","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","859","SBIR/STTR","2012"," "," ","NIGMS"," "," "," ","202432",
"Bioengineering; Biotechnology; Dental/Oral and Craniofacial Disease; Digestive Diseases; Infectious Diseases","Acinar Cell;Agonist;Amylases;Apical;Autoimmune Diseases;Binding;Biological;Blood Vessels;Cancer Etiology;Cell Differentiation process;Cell Survival;Cells;Chemical Engineering;Chemicals;Complex;Deglutition;Dental caries;Development;Differentiation and Growth;Dryness;Ectodermal Dysplasia;Engineering;Epithelial;Exhibits;Extracellular Matrix;Extracellular Matrix Proteins;Fibrin;Food;Functional disorder;Gene Delivery;Gene Transfer;Growth;Growth Factor;Head and Neck Cancer;Head and neck structure;Hereditary Disease;Human;Hybrids;Hydrogels;Individual;Infection;Lead;Link;Mastication;Mesenchymal Stem Cells;Modeling;Molecular;Oral cavity;Oral health;Parotid Gland;Patients;Periodontal Diseases;Physiology;Play;Process;Production;Property;Research Personnel;Role;Saliva;Salivary;Salivary Glands;Signal Pathway;Sjogren&apos;s Syndrome;Structure;Subfamily lentivirinae;Survival Rate;Syndrome;Tertiary Protein Structure;Therapeutic;Tight Junctions;Wound Healing;Xerostomia;base;cell growth;experience;extracellular;gene therapy;irradiation;keratinocyte;keratinocyte growth factor;matrigel;microbial;multidisciplinary;particle;polymerization;protein expression;response;restoration;restorative treatment;saliva secretion;salivary acinar cell;scaffold;three dimensional structure;tumor","The Use of Fibrin Hydrogels to Build an Artificial Salivary Gland"," Proper salivary gland function is critical for oral health. Autoimmune disorders (such as Sjï¿½gren's syndrome), genetic diseases (such as ectodermal dysplasia), and irradiation therapies (for head and neck cancers) cause salivary gland dysfunction and lead to severe dryness of the oral cavity. This project aims to create functional salivary acinar structures (using modified fibrin hydrogels), which could contribute to the construction of a transplantable artificial salivary gland.   
   
      

","NIDCR","8390949","7/16/2012 12:00:00 AM","RFA-DE-12-004","1R01DE022971-01","1","R01","DE","022971","01"," ","BURGOON, PENNY W","7/16/2012 12:00:00 AM","6/30/2016 12:00:00 AM","ZDE1-MH(14)"," ","8441141","BAKER, OLGA JULIANA","ANDREADIS, STELIOS THEOHARIS","26","DENTISTRY","038633251","LMCJKRFW5R81","038633251","LMCJKRFW5R81","US","42.892284","-78.859403","5992614","STATE UNIVERSITY OF NEW YORK AT BUFFALO","AMHERST","NY","SCHOOLS OF DENTISTRY/ORAL HYGN","142282567","UNITED STATES","N","7/16/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","250000","114075"," ","364075",
"Biotechnology; Cancer; Genetics; Hematology; Rare Diseases","Affect;Alleles;Allogenic;Animal Model;Arkansas;Binding;Biological Models;Biotechnology;Bone Marrow;Bortezomib;Cell Culture Techniques;Cell Line;Cell Nucleus;Cell Therapy;Cell membrane;Cell surface;Cells;Clinical;Clinical Trials;Collaborations;Core Facility;Data;Development;Disease;E-Cadherin;Equipment;Gene Expression Profiling;Genetic;Genomics;Growth;Heterogeneity;Immunoprecipitation;In Vitro;Institutes;Investigation;Knowledge;Laboratories;Malignant Neoplasms;Medical;Mesenchymal Stem Cells;Molecular;Molecular Genetics;Molecular and Cellular Biology;Multiple Myeloma;N-Cadherin;Natural Killer Cells;Newly Diagnosed;Nuclear;Osteoblasts;Osteoclasts;Pathway interactions;Patients;Preparation;Proteins;Proteomics;Protocols documentation;Public Health;Relapse;Research;Research Institute;Research Project Grants;Resource Sharing;Resources;Risk;Role;Sampling;Science;Services;Source;Stratification;Subcellular Fractions;Subgroup;Techniques;Technology;Testing;Therapeutic Studies;Translating;Universities;Variant;Work;base;beta catenin;chromatin immunoprecipitation;clinical material;clinical practice;data mining;experience;in vitro Model;in vivo;in vivo Model;lenalidomide;mutant;neoplastic cell;novel;osteoblast differentiation;patient population;predictive modeling;programs;promoter;protein expression;research study;success;syndecan;therapy development;tool;transcription factor","Genomics and Proteomics","The relevance of this Core to the public health derives from its role in advancing the overall objective of this program project: understanding MM growth in the context of its interaction with the bone marrow ME in order to translate and exploit this knowledge into smarter MM growth control in patients.","NCI","8555174","10/12/2012 8:54:39 AM"," ","5P01CA055819-18","5","P01","CA","055819","18"," "," ","6/5/2000 12:00:00 AM","8/31/2014 12:00:00 AM","ZCA1-RPRB-J(M1)P","5117","3166467","SHAUGHNESSY, JOHN DAMIAN","Not Applicable","02","Unavailable","122452563","VDFYLZPJEAV6","122452563","VDFYLZPJEAV6","US","34.751472","-92.320637","1471106","UNIV OF ARKANSAS FOR MED SCIS","LITTLE ROCK","AR","Domestic Higher Education","722057101","UNITED STATES","N","9/11/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","481216","481216"," ","332041","149175"," "," ",
"Biotechnology; Cancer; Digestive Diseases; Infectious Diseases; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Apoptosis;Bone Marrow;Bone Marrow Stem Cell;Bone Marrow Transplantation;Bypass;CXCL12 gene;CXCR4 gene;Cancer Biology;Cancer Etiology;Cancer Model;Carcinogens;Carcinoma;Cell Culture Techniques;Cell Differentiation process;Cell fusion;Cells;Characteristics;Chronic;Data;Disease Progression;Dysplasia;Engraftment;Epithelial;Epithelial Cells;Evaluation;Event;Future;Gastric Adenocarcinoma;Gastric mucosa;Gene Mutation;Goals;Grant;Growth;Helicobacter;Helicobacter Infections;Home environment;Homing;In Vitro;Infection;Inflammation;Injury;Laboratories;Light;Link;Luciferases;Malignant - descriptor;Malignant Neoplasms;Marrow;Mesenchymal Stem Cells;Metaplasia;Modeling;Mus;Neoplasm Metastasis;Peripheral;Play;Population;Property;Reporter;Role;Stem cells;Stomach;Stromal Cell-Derived Factor 1;Supporting Cell;Surface;System;Technology;Testing;Time;Tissues;Transplantation;Work;base;cancer cell;cancer initiation;cancer prevention;cancer stem cell;cancer therapy;cell injury;cell type;cellular imaging;in vivo;malignant stomach neoplasm;mouse model;novel;novel strategies;prevent;promoter;receptor expression;recombinase;research study;stability testing;stem cell population;tumor","Stem Cells and Gastric Cancer","n/a","NCI","8206700","12/30/2011 12:00:00 AM"," ","5R01CA119061-07","5","R01","CA","119061","07"," ","MOHLA, SURESH","2/15/2006 12:00:00 AM","12/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-ONC-U(90)S]"," ","1888620","HOUGHTON, JEANMARIE ","Not Applicable","02","INTERNAL MEDICINE/MEDICINE","603847393","MQE2JHHJW9Q8","603847393","MQE2JHHJW9Q8","US","42.277722","-71.759339","850903","UNIV OF MASSACHUSETTS MED SCH WORCESTER","WORCESTER","MA","SCHOOLS OF MEDICINE","016550002","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","129149","83301"," ","212450",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Activities of Daily Living;Address;Age;Autologous;Bioreactors;Blood Circulation;Blood Vessels;Blood capillaries;Bone Marrow;Bone Tissue;Build-it;Cartilage;Cells;Complex;Disease;Embryonic Development;Engineering;Foundations;Funding;Generations;Goals;Grant;Growth;Heart Diseases;Hour;Human;Human body;Immunosuppression;Implant;In Situ;In Vitro;Life;Liver;Liver Dysfunction;Liver diseases;Lung diseases;Mediating;Mesenchymal Stem Cells;Metabolic;Methodology;Microcirculatory Bed;Modeling;National Institute of Biomedical Imaging and Bioengineering;Natural regeneration;Nutrient;Organ;Organ Transplantation;Organ failure;Oxygen;Patients;Pattern;Peptides;Perfusion;Phenotype;Physiological;Population;Problem Solving;Role;Seeds;Source;Staging;Stem cells;Sterility;Structure;System;Therapeutic;Tissue Engineering;Tissues;Transplantation;United States;United States National Institutes of Health;Vascular System;Vascularization;Waiting Lists;arteriole;base;bone;capillary;ex vivo perfusion;implantation;in vivo;novel;novel strategies;progenitor;public health relevance;scaffold;stem cell technology;success;technique development;tissue regeneration;transplantation medicine;vascular bed;venule","Inside-Out Tissue Engineering for Organ Fabrication","
Project Narrative
 Tissue engineering holds the promise to create new organs but progress has been limited by poor
vascularization of tissue constructs and ineffective re-integration of these tissues into the systemic circulation.
To address this problem, we have developed a novel approach to engineer organ-level constructs by using
pre-existing, explanted microcirculatory beds as an autologous scaffold for tissue regeneration. Our initial
results demonstrate that viable microcirculatory beds can be maintained ex vivo, seeded with progenitor cells,
and transfected to produce therapeutic peptides - all critical initial steps toward generating vascularized organ-
level constructs.","NIBIB","8249854","4/5/2012 12:00:00 AM","PA-07-070","5R01EB005718-03","5","R01","EB","005718","03"," ","HUNZIKER, ROSEMARIE","6/1/2010 12:00:00 AM","3/31/2014 12:00:00 AM","Bioengineering, Technology and Surgical Sciences Study Section[BTSS]"," ","7053106","GURTNER, GEOFFREY C","LONGAKER, MICHAEL T","18","SURGERY","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","216270","130281"," ","346551",
"Bioengineering; Biotechnology; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Transplantation","Address;Allografting;Autologous Transplantation;Binding;Binding Proteins;Biocompatible Materials;Biological;Bone Matrix;Bone Regeneration;Bone Substitutes;Bone Transplantation;Capsid;Cell Adhesion;Cell-Matrix Junction;Cells;Cephalic;Chemistry;Clinical;Collagen;Coupled;Coupling;Development;Disadvantaged;Disease;Engineering;Goals;Healed;Hydroxyapatites;Immune response;Implant;In Vitro;Laboratories;Logic;Mechanics;Mesenchymal Stem Cells;Metals;Methods;Minerals;Modeling;Morbidity - disease rate;Natural regeneration;Operative Surgical Procedures;Organ Transplantation;Osteogenesis;Pain;Peptides;Phase;Polymers;Property;Protein Binding;Proteins;Rattus;Recombinants;Reporting;Research;Risk;Site;Solid;Source;Surface;Technology;Testing;Time;Tissue Engineering;Tissues;Transplanted tissue;Viral;Viral Vector;Virus;Work;Xenograft procedure;adeno-associated viral vector;allogenic bone transplantation;aspartyl-glycyl-glutamyl-alanine;bone;bone morphogenic protein;calcium phosphate;cell behavior;cost;gene therapy;healing;implantation;improved;in vivo;mimetics;nanoparticulate;new technology;osteoblast differentiation;osteogenic;osteoinductive factor;pathogen;polycaprolactone;public health relevance;regenerative;response;scaffold;success;tool","Enhanced coupling of bone regenerative peptides to hydroxyapatite-containing biom","
Project Narrative
Work to improve options for healing and regenerating bone continues due to the lack of an optimal 
treatment regime.  This proposal addresses this concern by focusing on a method that could be adapted 
to new technologies and those already in place, since hydroxyapatite(in one form or another) is widely 
used not only in bone grafting procedures but also as a coating for metal implants.  This research, 
focusing on the E7 domain as a delivery tool specific to HA, could be used to facilitate longer and more 
reliable tethering of any number of bioactive peptides and proteins to HA containing biomaterials.        
 ","NIDCR","8153104","3/22/2012 12:00:00 AM","PA-10-108","5F31DE021613-02","5","F31","DE","021613","02"," ","FRIEDEN, LESLIE A","3/1/2011 12:00:00 AM","2/28/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","10461285","CULPEPPER, BONNIE K","Not Applicable","07","BIOMEDICAL ENGINEERING","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","BIOMED ENGR/COL ENGR/ENGR STA","352940001","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","37403"," "," ","37403",
"Biotechnology; Cancer; Clinical Research; Gene Therapy; Genetics; Hematology; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Achievement;Allogeneic Bone Marrow Transplantation;Apoptosis;Autologous;Behavior;Biological;Bone Marrow;CD34 gene;Cell Line;Cells;Characteristics;Chickens;Clinical Protocols;Clinical Trials;Clonal Evolution;Codon Nucleotides;Complementary DNA;Complex;Development;Disease;Elongation Factor;Engraftment;Fanconi&apos;s Anemia;Gagging;Gene Transfer;Genes;Genomic Instability;Goals;Hematopoietic;Hematopoietic System;Hematopoietic stem cells;Hereditary Disease;Hetastarch;Hour;Human;In Vitro;Insulator Elements;Interferon Type II;Knockout Mice;Lentivirus Vector;Malignant Neoplasms;Mediating;Mesenchymal Stem Cells;Modeling;Modification;Monitor;Mus;Myelogenous;Myeloproliferative disease;Pancytopenia;Patients;Phosphoglycerate Kinase;Plasmids;Predisposition;Process;Protocols documentation;Recombinants;Regimen;Role;Series;Siblings;Squamous cell carcinoma;Stem cells;Technology;Testing;Time;Toxic effect;Transgenes;Translations;Transplantation;Viral;Work;base;env Gene Products;env Genes;gene correction;gene therapy;human stem cells;improved;in vivo;insight;lymphoblast;novel;particle;progenitor;promoter;public health relevance;stem;transduction efficiency;transgene expression;vector","Genetic Therapy for Fanconi Anemia","
NARRATIVE
Achievement of these goals will permit the translation of this basic work to the development of clinical protocols
for effective viral mediated gene correction of Fanconi anemia. On a broader basis, these studies should
provide insight into the biological behavior of hematopoietic stem cells and the ability to manipulate them ex
vivo prior to transplantation and engraftment.","NCI","8215658","1/9/2012 12:00:00 AM","PA-10-067","5R01CA155294-02","5","R01","CA","155294","02"," ","FORRY, SUZANNE L","2/1/2011 12:00:00 AM","12/31/2015 12:00:00 AM","Therapeutic Approaches to Genetic Diseases Study Section[TAG]"," ","1962260","CLAPP, DAVID W","HANENBERG, HELMUT ; YANG, FENG-CHUN ","07","PEDIATRICS","603007902","SHHBRBAPSM35","603007902","SHHBRBAPSM35","US","39.780714","-86.174977","577806","INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS","INDIANAPOLIS","IN","SCHOOLS OF MEDICINE","462022915","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","207500","112050"," ","319550",
"Bioengineering; Biotechnology; Gene Therapy; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Adult;Affect;Architecture;Area;Award;Binding;Biocompatible Materials;Biological;Cartilage;Cell Culture Techniques;Cell Differentiation process;Cells;Clinical;Complex;Conditioned Culture Media;Confocal Microscopy;Defect;Development;Diffusion;Disease;Engineering;Fiber;Filament;Gene Delivery;Gene Transfer;Genes;Goals;Growth Factor;Healed;Heterogeneity;Histocompatibility Testing;Histology;Human;Immobilization;Immunohistochemistry;Implant;Incubated;Individual;Injury;Lead;Lentivirus Vector;Life;Ligaments;Lysine;Mediating;Mesenchymal Stem Cells;Methods;Monitor;Muscle;Musculoskeletal;Musculoskeletal Diseases;Natural regeneration;Operative Surgical Procedures;Orthopedics;Pain;Patients;Pattern;Performance;Periosteum;Phenotype;Physiological;Polymers;Property;Regenerative Medicine;Research;Research Personnel;Research Proposals;Site;Skin;Source;Specific qualifier value;Stem cells;Structure;Subfamily lentivirinae;Techniques;Tendon structure;Testing;Tissue Engineering;Tissues;United States;Virus;Work;autocrine;bone;bone morphogenetic protein 2;bone morphogenetic protein 6;caprolactone;cell type;density;design;disability;enhanced green fluorescent protein;experience;genetically modified cells;healing;implant material;innovation;osteochondral tissue;osteogenic;overexpression;particle;programs;repaired;scaffold;skeletal tissue;transcription factor;transgene expression;viral gene delivery","Spatially Controlled Gene Delivery of Morphogenetic Factors from Woven Scaffolds","
Inadequate implant materials for healing or replacing diseased or damaged orthopedic tissues are a leading
cause of pain and suffering in the United States. This work is focused on developing enhanced methods for
engineering living tissues with superior biological properties and complex architectures that more closely mimic
natural tissues. This will result in the ability to create living tissues that alleviate human suffering, discomfort,
and disability.","NIAMS","8249080","4/2/2012 12:00:00 AM","PAR-09-031","5R03AR061042-02","5","R03","AR","061042","02"," ","WANG, FEI","4/1/2011 12:00:00 AM","3/31/2014 12:00:00 AM","ZAR1-EHB(M1)"," ","7781708","GERSBACH, CHARLES A.","Not Applicable","04","BIOMEDICAL ENGINEERING","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","BIOMED ENGR/COL ENGR/ENGR STA","277054673","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","50000","26050"," ","76050",
"Aging; Clinical Research; Diagnostic Radiology; Nutrition; Obesity; Osteoporosis","Abdomen;Abdominal Mass;Address;Adipocytes;Adipose tissue;Affect;Age;Aging;Ancillary Study;Animal Model;Area;Body Composition;Body fat;Bone Density;Bone Marrow;Bone Resorption;Cell model;Clinical;Data;Elderly;Environment;Fatty acid glycerol esters;Filler;Fracture;Glucocorticoids;Hip region structure;Hormone replacement therapy;Human;Infiltration;Knowledge;Link;Magnetic Resonance Spectroscopy;Marrow;Measurement;Measures;Mesenchymal Stem Cells;Muscle;Neck;Obesity;Observational Study;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis;Participant;Pathway interactions;Pharmaceutical Preparations;Predisposition;Prevalence;Principal Investigator;Process;Recording of previous events;Reporting;Research;Research Project Grants;Risk;Role;Scanning;Site;Spinal Fractures;Stem cells;Testing;Thigh structure;Translating;Vertebral Bone;Vertebral column;Visceral;Woman;X-Ray Computed Tomography;abdominal fat;aging gene;autocrine;base;bisphosphonate;bone;bone imaging;bone loss;bone preservation;bone turnover;cohort;cost;cost effective;density;design;insight;meetings;novel strategies;novel therapeutic intervention;osteogenic;paracrine;prevent;public health relevance;spine bone structure;subcutaneous;substantia spongiosa","Bone Marrow Adiposity, Bone and Body Composition","
PROJECT NARRATIVE
This study will determine if higher levels of fat in the bone marrow in older adults are associated with reduced
bone density and size, and will assess the relationship between marrow fat and other types of body fat,
including total and abdominal fat. A better understanding of the process underlying the accumulation of
marrow fat with age and osteoporosis may provide new targets for treatments to prevent bone loss.","NIAMS","8241609","4/2/2012 12:00:00 AM","PA-07-070","5R01AR057819-03","5","R01","AR","057819","03"," ","CHEN, FAYE H","4/1/2010 12:00:00 AM","9/30/2014 12:00:00 AM","Neurological, Aging and Musculoskeletal Epidemiology Study Section[NAME]"," ","7332763","SCHWARTZ, ANN V","LI, XIAOJUAN ","12","PUBLIC HEALTH & PREV MEDICINE","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","4/1/2012 12:00:00 AM","9/30/2014 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","485857","98576"," ","584433",
"Bioengineering; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","American;Animals;Area;Autologous;Biological;Biomechanics;Blood;Blood Platelets;Bone Marrow;Bone callus;Calculi;Cells;Cicatrix;Clinical Treatment;Coagulation Process;Collagen;Combined Modality Therapy;Data;Defect;EGF gene;Engineering;Family;Fibroblast Growth Factor 2;Flexor;Generations;Growth Factor;Healed;Healthcare;Housing;Human;Implant;In Situ;In Vitro;Inferior;Injury;Insulin-Like Growth Factor I;Lead;Ligaments;Maintenance;Mechanics;Medicine;Mesenchymal Stem Cells;Metabolic;Modeling;Mus;Natural regeneration;Orthopedics;Oryctolagus cuniculus;Osteogenesis;Patients;Performance at work;Phenotype;Plasma;Platelet-Derived Growth Factor;Proliferating;Property;Quality of life;Rattus;Recovery of Function;Rotator Cuff;Source;Specimen;Stem cells;Structure;Tendon Injuries;Tendon structure;Testing;Time;Tissue Engineering;Tissues;United States;Vascular Endothelial Growth Factors;achilles tendon;clinical application;cost;healing;implantation;improved;in vivo;injured;innovation;ligament injury;progenitor;regenerative;repaired;restoration;self-renewal;stem cell differentiation;treatment effect","A tissue specific approach to enhance tendon repair"," Using a combination of tendon stem cells (TSCs), platelet-rich plasma (PRP), and engineered tendon matrix (ETM), this project aims to enhance repair of acutely injured tendons. The results of this study may lead to a new effective clinical treatment for injured tendons, thus benefiting millions of tendon injury patients in the United States alone. In addition, this study will serve as a ""stepping-stone"" for investigating healing problems of other types of injured tendons, including flexor and rotator cuff tendons.  
    

","NIAMS","8239703","6/11/2012 12:00:00 AM","PA-10-069","1R21AR060920-01A1","1","R21","AR","060920","01","A","WANG, FEI","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","7596791","WANG, JAMES H-C.","Not Applicable","18","ORTHOPEDICS","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","112500","57938"," ","170438",
"Aging; Osteoporosis","Affect;Affinity;Aging;Alkaline Phosphatase;American;Amino Acids;Anabolic Agents;Apoptosis;Binding;Binding Proteins;Bone Density;C-terminal;Caspase;Cell Differentiation process;Cell Proliferation;Cell division;Complex;Crystallization;Crystallography;Cystine;Data;Development;Disease;Docking;Embryo;Extracellular Domain;Extracellular Matrix Proteins;Fibroblasts;Fracture;Genes;Health;Human;Knowledge;LDL-Receptor Related Protein 1;Link;Mammalian Cell;Mediating;Medical;Mesenchymal Stem Cells;Molecular;Molecular Conformation;Morbidity - disease rate;Mutation;Names;Osteoblasts;Osteoclasts;Osteocytes;Osteogenesis;Osteoporosis;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Play;Postmenopause;Proteins;Reporting;Role;Sclerosis;Signal Transduction;Site;Skeleton;Solutions;Structure;Surface Plasmon Resonance;Syndrome;Teriparatide;Therapeutic;Van Buchem disease;Vascular Endothelial Cell;Woman;Xenopus;angiogenesis;base;bone;bone mass;bone morphogenetic protein 6;bone morphogenetic protein receptors;bone quality;cell motility;cyr61 protein;design;insight;lipoprotein receptor related protein 5;men;mineralization;mutant;protein complex;public health relevance;receptor;receptor binding;small molecule","Structure of Sclerostin Protein Complexes","
PROJECT NARRATIVE
Orally effective drugs that build bone are required for the treatment of osteoporosis. By determining the
structures of complexes of sclerostin (a bone inhibitory protein) with other proteins with which it interacts, we
will be able to obtain the information that will allow the design of such drugs. This effort will greatly help
women and men with osteoporosis and osteoporosis-related fractures.","NIAMS","8232023","3/26/2012 12:00:00 AM","PA-10-069","5R21AR060869-02","5","R21","AR","060869","02"," ","CHEN, FAYE H","4/1/2011 12:00:00 AM","3/31/2013 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1865616","KUMAR, RAJIV ","Not Applicable","01","Unavailable","006471700","Y2K4F9RPRRG7","006471700","Y2K4F9RPRRG7","US","44.022374","-92.465881","4976101","MAYO CLINIC ROCHESTER","ROCHESTER","MN","Other Domestic Non-Profits","559050001","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","112500","64913"," ","177413",
"Bioengineering; Biotechnology; Breast Cancer; Cancer; Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Urologic Diseases","3-Dimensional;Adipocytes;Adipose tissue;Biocompatible Materials;Blood Circulation;Blood Vessels;Bone Marrow;Bone Marrow Neoplasms;Bone Marrow Stem Cell;Breast;Cancer Biology;Cell Culture Techniques;Cells;Cessation of life;Development;Discontinuous Capillary;Distant;Engineering;Engraftment;Goals;Growth;Growth and Development function;Hematopoietic stem cells;Human;Image;Implant;In Vitro;Location;Lung;Malignant Neoplasms;Malignant neoplasm of prostate;Mammary Neoplasms;Marrow;Mediating;Mesenchymal Stem Cells;Metastatic Neoplasm to the Bone Marrow;Microfluidics;Modeling;Molecular;Mus;Neoplasm Metastasis;Osteoblasts;Pharmaceutical Preparations;Positioning Attribute;Preparation;Process;Prostate;Prostatic Neoplasms;Public Health;Recruitment Activity;Research;Research Personnel;Simulate;Site;Skin;Stromal Cells;System;Technology;Therapeutic;Tissue Engineering;Tissue Model;Training;Tumor Biology;Undifferentiated;Universities;analog;bone;cancer cell;carcinogenesis;chemokine;improved;in vivo;leukemia;malignant breast neoplasm;microchip;microsystems;migration;neoplastic cell;oncology;osteogenic;prevent;scaffold;therapeutic target;tumor;tumor growth","Elucidating Essential Components of Bone Marrow Metastasis","    
   
Tumor cell metastasis is an insidious phenomenon that causes 90% of cancer-associated death and the bone marrow has been recognized as a prime and early metastatic site of numerous tumors. The objective of proposed research is to elucidate essential stromal components of bone marrow niche that are the linchpin of a tumor metastasis using engineered bone marrow tissue models. The results of this study are expected to directly improve public health by providing alternative therapeutic strategies for preventing bone marrow metastasis.   
      

","NCI","8383166","8/3/2012 12:00:00 AM","PA-11-197","1K99CA163671-01A1","1","K99","CA","163671","01","A","SCHMIDT, MICHAEL K","8/3/2012 12:00:00 AM","7/31/2014 12:00:00 AM","Institutional Training and Education Study Section (F)[NCI-F]"," ","10507782","LEE, JUNGWOO ","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","8/3/2012 12:00:00 AM","7/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","82733","6619"," ","89352",
"Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Affect;Area;Biochemical;Biology;Cell Maintenance;Cell Proliferation;Cell model;Cells;Characteristics;Clinical;Complex;Development;Equilibrium;Event;Exhibits;Genetic;Goals;Growth;Growth Disorders;Homeostasis;Human;Malignant Neoplasms;Mesenchymal Stem Cells;Modeling;Molecular;Mus;Muscle satellite cell;Mutate;Mutation;PTEN gene;Pathway interactions;Population;Postdoctoral Fellow;Proliferating;Proto-Oncogene Proteins c-akt;Regulation;Research;Rest;Rhabdomyosarcoma;Role;Running;Signal Pathway;Signal Transduction;Sirolimus;Skeletal Muscle;Stem cells;Techniques;Tissues;Tumor Stem Cells;Tumor Suppressor Proteins;Work;base;cancer stem cell;cancer therapy;design;drug discovery;exhaustion;experience;fight against;human FRAP1 protein;improved;insight;novel;repaired;research study;sarcoma;self-renewal;stem cell biology;stem cell fate;tool;tumor;tumor growth","PI3K-mTOR signaling in stem cells, tissue homeostasis, and cancer"," The growth of some tumors may be driven by a sub-population of cells that exhibit stem cell characteristics, such as being able to proliferate and self-renew. For other cancers, mutation in a rare stem cell could be the tumor-initiating event. Thus, understanding the molecular regulation of both normal and tumor stem cells has broad clinical implications in the ongoing fight against cancer. In this proposal, we investigate the molecular mechanisms by which normal stem cells are regulated, and ask how deregulation of these mechanisms causes tissue growth disorders and cancer. By better understanding the biology of normal and tumor stem cells, we can more rationally design cancer therapies.  
    

","NCI","8330769","8/9/2012 12:00:00 AM","PA-08-165","5R21CA161121-02","5","R21","CA","161121","02"," ","WATSON, JOANNA M","9/9/2011 12:00:00 AM","8/31/2013 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","7691254","GUERTIN, DAVID A","Not Applicable","02","ANATOMY/CELL BIOLOGY","603847393","MQE2JHHJW9Q8","603847393","MQE2JHHJW9Q8","US","42.277722","-71.759339","850903","UNIV OF MASSACHUSETTS MED SCH WORCESTER","WORCESTER","MA","SCHOOLS OF MEDICINE","016550002","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","130500","84173"," ","214673",
"Aging; Bioengineering; Biotechnology; Pain Conditions - Chronic; Pain Research; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Affect;Aging;American;Area;Back Pain;Biomechanics;Biomedical Engineering;Biomedical Research;Biomimetics;Cell Lineage;Cell Proliferation;Cells;Chitosan;Clinical;Complex;Deterioration;Development;Devices;Disadvantaged;Doctor of Philosophy;Elderly;Engineering;Evaluation;Exhibits;Extracellular Matrix;Gelatin;Gene Expression;Goals;Growth;Histology;Hyaluronan;Hydrogels;Immune response;Immunohistochemistry;Implant;In Vitro;Incidence;Intervertebral disc structure;Knowledge;Laboratories;Life Expectancy;Life Style;Mechanics;Mesenchymal Stem Cells;Methodology;Methods;Natural regeneration;Pain;Pathology;Patients;Phenotype;Production;Proliferating;Quality of life;Recovery;Recruitment Activity;Research;Research Personnel;Research Project Grants;Research Proposals;Rodent Model;Signal Transduction;Signaling Molecule;Solutions;Spinal;Spinal Fusion;Spinal nerve structure;Stem cells;Structure;Symptoms;Talents;Testing;Tissue Engineering;Tissues;Training;Work;age related;aging population;cell motility;crosslink;disc regeneration;effective therapy;experience;implantation;improved;in vivo;intervertebral disk degeneration;novel;novel therapeutics;nucleus pulposus;nutrition;physical conditioning;repaired;scaffold;skills;stem cell differentiation;subcutaneous;tissue regeneration;treatment strategy","Biphasic Intervertebral Disc Regeneration using Biomimetic Scaffolds","The goal of this research project is to develop a new therapeutic strategy for the treatment of age-related back pain, which affects almost 12 million people per year. This research project will use bioengineering to pursue the development of materials and methods to imitate the intervertebral disc (IVD) and facilitate tissue regeneration. In order for advances in treatments of IVD degeneration to take place, strategies must be developed that better promote native tissue formation to ultimately treat the problems associated with IVD degeneration rather than conventional clinical approaches, which focus only on relieving the symptoms.","NIA","8300439","7/26/2012 12:00:00 AM","PA-11-111","1F31AG040929-01A1","1","F31","AG","040929","01","A","MURTHY, MAHADEV","7/26/2012 12:00:00 AM","7/25/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F10B-S(20)L]"," ","10757599","WHATLEY, BENJAMIN R.","Not Applicable","03","BIOMEDICAL ENGINEERING","042629816","H2BMNX7DSKU8","042629816","H2BMNX7DSKU8","US","34.684286","-82.812554","1626401","CLEMSON UNIVERSITY","CLEMSON","SC","BIOMED ENGR/COL ENGR/ENGR STA","296340001","UNITED STATES","N","7/26/2012 12:00:00 AM","7/25/2013 12:00:00 AM","866","Training, Individual","2012"," "," ","NIA","42232"," "," ","42232",
"Cardiovascular; Clinical Research; Heart Disease; Lung; Sleep Research","Achievement;Area;Arrhythmia;Asthma;Atherosclerosis;Awareness;Bacterial Pneumonia;Biology;Biomedical Research;Blood;Blood Vessels;Cardiac Myocytes;Cardiovascular system;Cell surface;Cellular biology;Childhood;Clinical;Communities;Coupled;Cystic Fibrosis;Databases;Disadvantaged;Education;Endothelial Cells;Environment;Epidemiology;Evaluation;Exposure to;Faculty;Foundations;Funding;Goals;Health;Health Professional;Heart;Heart failure;Host Defense;Hypoxia;Immunology;Institution;Laboratories;Lead;Leukocytes;Lung;Measurable;Measures;Medical;Medical Students;Medicine;Mentors;Mesenchymal Stem Cells;Natural Immunity;Outcome;Population;Preparation;Process;Publications;Records;Recruitment Activity;Request for Proposals;Research;Research Activity;Research Personnel;Research Proposals;Research Training;Residencies;Respiratory Muscles;Rewards;Science;Sleep;Sleep Apnea Syndromes;Sleep Disorders;Social Interaction;Structure;Students;System;Time;Training;Training Programs;Transplantation;Tuberculosis;Underrepresented Minority;Universities;Work;abstracting;angiogenesis;base;career;career development;design;experience;falls;graduate student;health disparity;improved;instrument;interest;lectures;medical schools;meetings;peer;population based;posters;programs;respiratory;role model;skills;social;stem cell biology;symposium;undergraduate student","CWRU Short-Term Heart Lung and Blood Research Opportunities Program","
PROJECT NARRATIVE
 The CWRU Short-Term Heart Lung and Blood Research Opportunities program will provide key
support for underrepresented minority and disadvantaged undergraduate and medical students in research
education in order to expose students to biomedical challenges in cardiovascular, pulmonary, hematologic and
sleep research. This experience, coupled with additional activities will strengthen their confidence as
researchers, bolster their competiveness for subsequent graduate and medical programs, and encourage
students to continue academic research.","NHLBI","8277375","5/25/2012 12:00:00 AM","RFA-HL-10-013","5R25HL103152-03","5","R25","HL","103152","03"," ","MEADOWS, TAWANNA","6/1/2010 12:00:00 AM","5/31/2015 12:00:00 AM","ZHL1-CSR-H(M2)"," ","2424126","CHANCE, MARK R","Not Applicable","11","NEUROSCIENCES","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","SCHOOLS OF MEDICINE","441061712","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Other Research-Related","2012"," "," ","NHLBI","150047","12004"," ","162051",
"Bioengineering; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Acute;Address;Adhesions;Adhesives;Affect;Apoptosis;Area;Behavior;Biocompatible Materials;Biological;Biological Models;Biomedical Engineering;Blood;Bone Regeneration;Cell Communication;Cell Proliferation;Cell Surface Receptors;Cell Survival;Cell surface;Cells;Cessation of life;Chronic;Communication;Computer software;Cues;Cytokine Signaling;Data;Defect;Dependence;EGF gene;Electronics;Engineering;Environment;Epidermal Growth Factor Receptor;Equilibrium;Fibronectins;Funding;Goals;Grant;Growth;Growth Factor;Growth Factor Receptors;Healed;Human;Immigration;Inflammatory;Institutes;Integrins;Internet;Laboratories;Learning;Ligands;Location;Mails;Massachusetts;Mediating;Mesenchymal Stem Cells;Modality;Molecular;Natural regeneration;Nature;Outcome;Paper;Pathway interactions;Pattern;Phenotype;Play;Polymers;Production;Publications;Receptor Activation;Receptor Signaling;Relative (related person);Research Personnel;Role;Science;Signal Pathway;Signal Transduction;Site;Source;Stimulus;Surface;System;Techniques;Technology;Telephone;Testing;Tissue Engineering;Tissues;Undifferentiated;Universities;Visit;Work;adhesion receptor;autocrine;base;cell behavior;cell type;clinical application;clinically relevant;data sharing;extracellular;graduate student;healing;in vivo;insight;meetings;migration;novel;prevent;receptor;receptor internalization;response;scaffold;skin regeneration;stem cell differentiation;stem cell population;tissue regeneration;wound","Bioengineering Polymers for Parsing Cell Responses","n/a","NIDCR","8270346","5/11/2012 12:00:00 AM","PA-07-070","5R01DE019523-13","5","R01","DE","019523","13"," ","LUMELSKY, NADYA L","9/1/1999 12:00:00 AM","5/31/2014 12:00:00 AM","Intercellular Interactions Study Section[ICI]"," ","1893068","GRIFFITH, LINDA G","Not Applicable","07","ENGINEERING (ALL TYPES)","001425594","E2NYLCDML6V1","001425594","E2NYLCDML6V1","US","42.359476","-71.093853","4911501","MASSACHUSETTS INSTITUTE OF TECHNOLOGY","CAMBRIDGE","MA","BIOMED ENGR/COL ENGR/ENGR STA","021421029","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","265207","77500"," ","342707",
"Biotechnology; Cancer","Adult;Biological;Biological Models;Breast;Cancer Cell Growth;Cancer Patient;Carcinoma;Cell Survival;Cell model;Cell physiology;Cells;Complex;Data;Data Set;Development;Developmental Process;Epidermis;Epithelial;Epithelial Cells;Family;Family member;Functional disorder;Funding;Gene Expression;Gene Targeting;Generations;Genetic Transcription;Genotoxic Stress;Goals;Human;Knock-out;Knockout Mice;Laboratories;Lead;Malignant Neoplasms;Mammary gland;Mesenchymal;Metabolic;Metabolic stress;Metabolism;Mus;Normal Cell;Organ;Pathway interactions;Play;Predisposition;Process;Prostate;Protein Family;Proteins;Proteomics;Regulation;Relative (related person);Role;Signal Pathway;Signal Transduction;Skin;Stimulus;Stratum Basale;Stress;Structure;Testing;Therapeutic;Time;Tissues;Translating;Tumor Suppression;Tumor Suppressor Proteins;base;cancer therapy;chromatin immunoprecipitation;design;expectation;genetically modified cells;in vivo Model;insight;mouse model;novel;overexpression;protein complex;protein p73;public health relevance;response;stoichiometry;tumor;tumorigenesis;ubiquitin-protein ligase","p63 and p73 Signaling in Cell Growth and Cancer","
NARRATIVE
 While p53 has been extensively characterized as a tumor suppressor, it has
been more difficult to determine if its family members, p63 and p73 play a similar role. In
the proposed studies, we will employ genetically engineered cell and mouse model
systems to determine the roles of p63 and p73 in cell metabolism and survival as well as
epithelial-mesenchymal crosstalk and transition, and to discover how these roles are
deregulated during tumorigenesis. It is essential to decipher the role of these proteins in
both normal cell function and during tumorigenesis in order to design more effective anti-
cancer therapies that will target the majority of human tumors that have a defective p53
family signaling axis.","NCI","8196710","11/18/2011 12:00:00 AM","PA-07-070","5R01CA105436-08","5","R01","CA","105436","08"," ","WATSON, JOANNA M","3/1/2004 12:00:00 AM","11/30/2014 12:00:00 AM","Cancer Molecular Pathobiology Study Section[CAMP]"," ","1938512","PIETENPOL, JENNIFER A","Not Applicable","05","BIOCHEMISTRY","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","194203","108753"," ","302956",
"Bioengineering; Cardiovascular; Genetics; Heart Disease; Heart Disease - Coronary Heart Disease; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute myocardial infarction;Autologous;Azacitidine;Back;Blood Vessels;Bone Marrow;Cardiac Myocytes;Cardiovascular system;Cell Therapy;Cells;Chemicals;Chronic;Clinic;Clinical;DNA Methylation;Data;Development;Endothelial Cells;Enzymes;Epigenetic Process;Fibrosis;G9a histone methyltransferase;Gene Expression;Genes;Genetic;Goals;Heart failure;Histone Acetylation;Histones;Human;In Vitro;Lysine;Mediating;Mediator of activation protein;Mesenchymal Stem Cells;Mesoderm;Methylation;Methyltransferase;MicroRNAs;Modeling;Modification;Molecular;Mus;Muscle Cells;Myocardial;Myocardial Ischemia;Myocardium;Natural regeneration;Patients;Pharmaceutical Preparations;Phenotype;Physiological;Plastics;Principal Investigator;Process;Property;Quality of life;Regenerative Medicine;Role;Smooth Muscle Myocytes;Somatic Cell;Stem cells;Testing;Therapeutic;Transferase;Transplantation;Treatment Efficacy;Trichostatin A;Valproic Acid;Vascular Endothelial Cell;Vascularization;Ventricular Function;arginyl-glycyl-aspartyl-serine;cell type;chromatin remodeling;diabetic;embryonic stem cell;histone modification;human HDAC1 protein;improved;in vivo;inhibitor/antagonist;interest;myogenesis;nanofiber;neovasculature;paracrine;progenitor;programs;promoter;regenerative;repaired;research study;small molecule;tissue repair","Epigenetic Modulation of EPC for Cardiomyogenesis","n/a","NHLBI","8380886","4/30/2012 12:00:00 AM","PAR-10-285","5P01HL108795-02","5","P01","HL","108795","02"," "," "," "," ","Heart, Lung, and Blood Program Project Study Section[HLBP]","7448","6897813","LOSORDO, DOUGLAS W","Not Applicable","07","Unavailable","005436803","KG76WYENL5K1","005436803","KG76WYENL5K1","US","41.896017","-87.616602","6144650","NORTHWESTERN UNIVERSITY AT CHICAGO","CHICAGO","IL","Domestic Higher Education","606114579","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","364978","364978"," ","239330","125648"," "," ",
"Aging; Clinical Research; Genetics; Human Genome; Osteoporosis","African;Aging;Alleles;Apoptosis;Binding;Biological;Biological Models;Bone Density;Caucasians;Caucasoid Race;Cells;Cellular biology;Clinical;Clinical Data;DNA;DNA Resequencing;Data;Equipment and supply inventories;Ethnic group;Etiology;European;Fracture;Gene Expression;Genes;Genetic;Genetic Polymorphism;Genetic Variation;Genomics;Genotype;Goals;Growth;Haplotypes;Health;Human;In Vitro;Inbred Strains Mice;Individual;Inherited;Life;Life Style;Ligands;Linkage Disequilibrium;Maintenance;Medical;Mesenchymal Stem Cells;Modeling;Molecular;Osteoblasts;Osteocytes;Osteogenesis;Osteoporosis;Osteoporosis prevention;Pathway interactions;Pattern;Pharmacogenomics;Play;Population;Population Genetics;Predisposition;Proteins;Public Health;Regulation;Regulatory Element;Research;Risk;Role;Sampling;Signal Pathway;Signal Transduction;Signaling Pathway Gene;Signaling Protein;Site;Testing;Tobago;Transcriptional Regulation;Variant;Woman;base;bone cell;bone health;bone loss;bone mass;caucasian American;cohort;disorder risk;drug development;experience;gene interaction;genetic analysis;genetic association;genetic variant;genome wide association study;insight;men;novel;older men;osteoporosis with pathological fracture;promoter;public health relevance;receptor;research study;response;skeletal;tool;trait","Wnt Genes and Skeletal Aging: From the Population to the Cell","
Osteoporosis is a major clinical and global public health problem. In sharp contrast to
our understanding of the etiology and prevention of osteoporosis in women, there is
a paucity of information about bone health in men. Our proposed study seeks to identify
inherited genetic variations responsible for bone loss and osteoporosis in men.","NIA","8313948","8/15/2012 12:00:00 AM","PA-07-070","5R01AG033618-03","5","R01","AG","033618","03"," ","JOSEPH, LYNDON","9/1/2010 12:00:00 AM","8/31/2014 12:00:00 AM","Neurological, Aging and Musculoskeletal Epidemiology Study Section[NAME]"," ","7117951","ZMUDA, JOSEPH M.","Not Applicable","18","PUBLIC HEALTH & PREV MEDICINE","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF PUBLIC HEALTH","152133320","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","866","Non-SBIR/STTR","2012"," "," ","NIA","356905","220750"," ","577655",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Embryonic - Non-Human","AKT1 gene;Address;Anterior;Blood;Cell Line;Cells;Conditioned Culture Media;Decision Making;Development;Endoderm;Family member;Gene Targeting;Intestines;Liver;Lung;MAP Kinase Gene;Mesoderm;Modeling;Molecular;Muscle;Nodal;PI3K/AKT;Pancreas;Pathway interactions;Pattern;Phosphotransferases;Refractory;Regenerative Medicine;Regulation;Role;Serine;Signal Pathway;Signal Transduction;Snails;Source;Staging;Therapeutic;Threonine;Thyroid Gland;Transforming Growth Factor beta;activin A;beta catenin;bone;cell type;epithelial to mesenchymal transition;human embryonic stem cell;in vivo;inhibitor/antagonist;research study;self-renewal;stem cell differentiation;stem cell fate;transcription factor","Control of Early hESC Fate Determination","n/a","NIGMS","8382718","8/6/2012 12:00:00 AM","RFA-GM-08-003","5P01GM085354-05","5","P01","GM","085354","05"," "," ","8/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","ZGM1-GDB-8","0001","7691455","DALTON, STEPHEN ","Not Applicable","10","Unavailable","004315578","NMJHD63STRC5","004315578","NMJHD63STRC5","US","33.933474","-83.375853","676602","UNIVERSITY OF GEORGIA","ATHENS","GA","Domestic Higher Education","306021589","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","319679","319679"," ","216731","102948"," "," ",
"Aging; Injury (total) Accidents/Adverse Effects","Acceleration;Accounting;Age;Aging;Binding;Biological;Biomechanics;Bone Regeneration;Cells;Child;Clinical;Complication;Elderly;Event;Foundations;Fracture;Fracture Healing;Gene Expression;Gene Targeting;Genetic;Healed;Histologic;Immunohistochemistry;Investigation;Ligands;Measurement;Mesenchymal;Modeling;Molecular;Morbidity - disease rate;Mus;Muscle;Octogenarian;Osteoblasts;Osteogenesis;Pathway interactions;Patients;Property;Role;Signal Pathway;Signal Transduction;Societies;Source;Testing;Therapeutic Effect;Tibial Fractures;Tissues;Work;aged;aging population;base;bone healing;cost;healing;improved;mortality;mouse model;muscle regeneration;notch protein;progenitor;receptor;recombinase","Role of Notch signaling in fracture healing as a function of aging"," Fragility fractures represent a significant cause of morbidity in the elderly. These fractures take much longer to heal and with greater morbidity than fractures in the young. The work proposed in this study using a mouse model will investigate whether increasing Notch signaling can be used to promote healing of fractures in geriatric patients.  
  
    

","NIA","8313898","7/13/2012 12:00:00 AM","RFA-AG-11-007","5R03AG040670-02","5","R03","AG","040670","02"," ","WILLIAMS, JOHN","8/15/2011 12:00:00 AM","7/31/2014 12:00:00 AM","ZAG1-ZIJ-9(M1)"," ","10542748","AHN, JAIMO ","HANKENSON, KURT DAVID","03","ORTHOPEDICS","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","866","Non-SBIR/STTR","2012"," "," ","NIA","50000","30000"," ","80000",
"Aging; Biotechnology; Genetics; Osteoporosis; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adverse effects;Age;Alkaline Phosphatase;Alleles;Alternative Splicing;American;Anabolic Agents;Back;Biological Assay;Biology;Bone Density;Bone Tissue;Calvaria;Cell Culture Techniques;Cells;Chromosome Mapping;Clinical;Complex;Data;Data Analyses;Development;Dissection;Drug Delivery Systems;Event;FDA approved;Fracture;Future;Gene Expression;Gene Proteins;Genes;Genetic;Genetic Variation;Genome;Goals;Green Fluorescent Proteins;Harvest;Health Care Costs;Hip Fractures;Homeostasis;Human;In Vitro;Inbred Strain;Introns;Knowledge;Laboratory mice;Life;Maps;Marrow;Measurement;Measures;Mesenchymal Stem Cells;Messenger RNA;Methods;Minerals;Mining;Molecular;Molecular Genetics;Mouse Strains;Mus;Nodule;Obesity;Osteoblasts;Osteogenesis;Osteoporosis;Partner in relationship;Pathway interactions;Patients;Pattern;Pharmaceutical Preparations;Phenotype;Play;Population;Process;Property;Protein Isoforms;Public Health;Publications;Quantitative Genetics;RNA;RNA Splicing;Reporting;Research Design;Resources;Risk;Role;Sampling;Site;Sorting - Cell Movement;Spinal Fractures;Staining method;Stains;Surgeon;Techniques;Technology;Teriparatide;Therapeutic;Time;Transgenic Mice;United States;Walking;Woman;aged;base;bone;bone health;bone loss;combat;drug development;exon skipping;in vivo;men;mineralization;molecular dynamics;osteoblast differentiation;osteoporosis with pathological fracture;osteoprogenitor cell;programs;public health relevance;young adult","Genetics of Osteoblast Differentiation","
Relevance to Public Health
It is predicted that currently 43.7 million Americans over the age of 50 already have or are at serious risk of
developing osteoporosis. Based on a recent surgeon general's report, in the United States there are over 1.5
million osteoporotic fractures each year, including 280,000 hip fractures and 500,000 vertebral fractures. Two
out of every 10 women and 3 out of every 10 men who suffer a fracture of the hip will die within 1 year of that
fracture, half will never return to their previous living situation, and 70-80% will never walk again unaided. The
annual direct health care costs for treatment of osteoporosis in the United States is over $18.3 billion.
Increasing evidence shows that proper differentiation of mesenchymal stem cells (MSCs) into functional
osteoblasts plays a key role in bone health and homeostasis. Studies in both mouse and human have shown
that with age, the number of osteoblasts in marrow decreases and the degree of marrow adiposity increases.
One of the most promising therapeutic avenues for the treatment of osteoporosis is the development of
anabolic agents which promote osteoblast function. Currently, only a single osteoblast promoting drug is
approved by the FDA (teriparatide), but this compound carries significant risks and is thus indicated for use for
no more than two years. In order to better understand the genetic bases of osteoporosis and to develop new
treatments, we must understand the process of osteoblast differentiation from both a molecular and genetic
perspective, which is the goal of this proposal.","NIAMS","8241082","4/12/2012 12:00:00 AM","PA-10-069","5R21AR060981-02","5","R21","AR","060981","02"," ","CHEN, FAYE H","3/15/2011 12:00:00 AM","2/28/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","9827653","HIBBS, MATTHEW AARON","ACKERT-BICKNELL, CHERYL LYNNE","02","Unavailable","042140483","XR6LMXNKDJJ1","042140483","XR6LMXNKDJJ1","US","44.385065","-68.267533","7096501","JACKSON LABORATORY","BAR HARBOR","ME","Research Institutes","046091523","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","135000","107595"," ","242595",
"Alcoholism; Chronic Liver Disease and Cirrhosis; Digestive Diseases; Genetics; Liver Disease; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Substance Abuse","Alcohols;Animal Model;Cell Fate Control;Cells;Cirrhosis;Collaborations;Complex;Development;Disease;Dominant-Negative Mutation;EZH2 gene;Epigenetic Process;Gene Silencing;Goals;Hepatic Fibrogenesis;Hepatic Stellate Cell;International;Knock-out;Laboratories;Liver;Liver Cirrhosis;Liver Fibrosis;Mediating;Mesenchymal;Methyl-CpG-Binding Protein 2;Modality;Molecular;Patients;Peroxisome Proliferator-Activated Receptors;Polycomb;Regulation;Repression;Research;Testing;inhibitor/antagonist;lipid biosynthesis;man;methylcobalamin-coenzyme M methyltransferase;mouse model;novel;novel therapeutic intervention;novel therapeutics;problem drinker;promoter;restoration;therapeutic target;transdifferentiation","Epigenetic regulation of alcoholic liver fibrosis","n/a","NIAAA","8316432","8/3/2012 12:00:00 AM","PAR-08-004","5U01AA018663-03","5","U01","AA","018663","03"," ","GAO, PETER","9/1/2010 12:00:00 AM","8/30/2015 12:00:00 AM","Biomedical Research Study Section[AA-1]"," ","2105294","TSUKAMOTO, HIDEKAZU ","Not Applicable","37","PATHOLOGY","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF MEDICINE","900894304","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","273","Non-SBIR/STTR","2012"," "," ","NIAAA","379843","96674"," ","455261",
"Bioengineering; Biotechnology; Clinical Research; Lung; Regenerative Medicine","Air;Alveolar;Alveolus;Area;Blood Vessels;Blood capillaries;Cell Communication;Cells;Clinical;Development;Devices;Drug Delivery Systems;Endothelial Cells;Engineering;Epithelial;Evaluation;Exposure to;Foundations;Gases;Goals;Growth;Hydrogels;Industry;Infant;Injury;Investigation;Knowledge;Learning;Length;Liquid substance;Lung;Mechanics;Membrane;Mesenchymal;Methods;Microfabrication;Microfluidics;Mus;Newborn Infant;Nutrient;Organ;Oxygen;Pathologic;Perfusion;Physiological;Polyethylene Terephthalates;Population;Reporting;Research;Research Personnel;Resistance;Semiconductors;Severity of illness;Siloxanes;Structure;Structure of parenchyma of lung;Study models;Supplementation;Surface;System;Techniques;Technology;Testing;Tissue Engineering;Tissues;Travel;Vascularization;Work;base;biocompatible polymer;capillary;design;drug testing;experience;fetal;lithography;lung development;microchip;mortality;novel;premature;programs;prototype;respiratory;scaffold;scale up;three-dimensional modeling","Tissue Engineering a Novel Alveolar-Capillary Interface Within Microchannels","n/a","NIBIB","8305974","8/20/2012 12:00:00 AM","PA-06-512","5K08EB008126-04","5","K08","EB","008126","04"," ","ERIM, ZEYNEP","8/15/2009 12:00:00 AM","7/31/2013 12:00:00 AM","ZEB1-OSR-E(M1)S"," ","8509224","ABDULLAH, FIZAN ","Not Applicable","07","SURGERY","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","286","Other Research-Related","2012"," "," ","NIBIB","162125","12970"," ","175095",
"Breast Cancer; Cancer","Actins;Adult;Basement membrane;Binding;Blood Circulation;Cancer Patient;Clinical;Collagen;Data;Dipeptidyl Peptidases;Distant Metastasis;Embryo;Endothelium;Epithelial;Extracellular Matrix;Extracellular Matrix Degradation;Family;Family member;Gelatinases;Genetic;Goals;Human;Image;Invaded;Malignant Epithelial Cell;Mammary Neoplasms;Matrix Metalloproteinases;Mediating;Membrane;Mesenchymal;Modeling;Molecular;Morphogenesis;Mus;Neoplasm Metastasis;Outcome;Peptide Hydrolases;Play;Process;Regulation;Research;Role;Serine Protease;Skin Neoplasms;Testing;Time;Tissues;Tumor Cell Invasion;Tumor Tissue;Work;Wound Healing;base;cancer cell;in vivo;malignant breast neoplasm;neoplastic cell;novel;response;transcription factor;tumor;tumor progression","Regulation of Tumor Invasion by Twist1","  The proposed research aims to determine the regulation and function of a key protease in invadopodia- mediated matrix degradation and tumor metastasis. We believe that this work could uncover a novel regulatory machinery of tumor invasion and provide new targets for anti-metastasis therapy.   
      

","NCI","8342751","7/9/2012 12:00:00 AM","PA-11-260","1R01CA168689-01","1","R01","CA","168689","01"," ","WOODHOUSE, ELIZABETH","9/1/2012 12:00:00 AM","6/30/2017 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","8858419","YANG, JING ","Not Applicable","52","PHARMACOLOGY","804355790","UYTTZT6G9DT1","804355790","UYTTZT6G9DT1","US","32.881785","-117.236973","577507","UNIVERSITY OF CALIFORNIA, SAN DIEGO","LA JOLLA","CA","SCHOOLS OF MEDICINE","920930621","UNITED STATES","N","9/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","114125"," ","321625",
"Breast Cancer; Cancer","Animals;Antibodies;Automobile Driving;Behavior;Biological;Blood Circulation;Breast Cancer Cell;Breast Carcinoma;CSF3 gene;Carcinoma;Cells;Chemotactic Factors;Complex;Disseminated Malignant Neoplasm;Endocrine;Enzyme-Linked Immunosorbent Assay;Epithelial;Extravasation;Human;Implant;Laboratories;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Mesenchymal;Mus;Myeloid Cells;Nature;Neoplasm Metastasis;Organ;Paracrine Communication;Pathogenesis;Play;Primary Neoplasm;Production;Recruitment Activity;Relapse;Research;Role;Signal Transduction;Snails;Source;Spleen;Splenectomy;Splenomegaly;Stromal Cells;Testing;Tumor Volume;cancer cell;cell stroma;cell type;extracellular;implantation;in vivo;macrophage;malignant state;monocyte;neoplastic cell;neutrophil;paracrine;programs;release factor;success;trait;transcription factor;tumor;tumor progression","Stromal Cell Recruitment and the Pathogenesis of Metastasis","n/a","NCI","8555485","10/12/2012 2:15:43 PM","RFA-CA-10-021","5U54CA163109-02","5","U54","CA","163109","02"," "," ","9/23/2011 12:00:00 AM","7/31/2016 12:00:00 AM","ZCA1-SRLB-3(O1)","5394","1891586","WEINBERG, ROBERT A","Not Applicable","07","Unavailable","001425594","E2NYLCDML6V1","001425594","E2NYLCDML6V1","US","42.359476","-71.093853","4911501","MASSACHUSETTS INSTITUTE OF TECHNOLOGY","CAMBRIDGE","MA","Domestic Higher Education","021421029","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","205263","205263"," ","152681","52582"," "," ",
"Biotechnology; Contraception/Reproduction; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Urologic Diseases","Adult;Adverse effects;Age;Aging;Animal Model;Biological Models;Blood Vessels;Cell Nucleus;Cell Therapy;Cells;Cesarean section;Child;Childbirth;Clinical;Clinical Trials;Complex;Conditioned Culture Media;Cytokine Receptors;Data;Development;Diabetes Mellitus;Diffuse;Dose;Elastic Fiber;Elastin;Elastin Fiber;Elderly woman;Epidemic;Fascia;Fecal Incontinence;Female;Functional disorder;Future;Genitourinary system;Goals;Growth Factor;Home environment;Homeostasis;Homing;Immunohistochemistry;Incidence;Incontinence;Infusion procedures;Injection of therapeutic agent;Injury;Intervention;Investigation;Knockout Mice;Label;Link;Lower urinary tract;Mediating;Membrane;Mesenchymal Stem Cells;Methods;Monoamine Oxidase;Mus;Muscle Cells;Nylons;Obesity;Operative Surgical Procedures;Organ;Outcome;Outcome Study;Pattern;Pelvic Floor Disorders;Pelvic floor structure;Pelvis;Placebos;Population;Postpartum Period;Pregnancy;Prevalence;Process;Property;Protein-Lysine 6-Oxidase;Proteins;Ptosis;Rattus;Recovery;Recovery of Function;Research;Reverse Transcriptase Polymerase Chain Reaction;Risk;Risk Factors;Role;Saline;Simulate;Site;Small Interfering RNA;Smooth Muscle;Staging;Stem cells;Stress Urinary Incontinence;Striated Muscles;Structure;System;Systemic Therapy;Tail;Testing;Time;Tissues;Transfection;Translating;Up-Regulation;Urethra;Urodynamics;Vaginal delivery procedure;Validation;Veins;Woman;base;chemokine;chemokine receptor;crosslink;cytokine;experience;improved;injured;innovation;knock-down;lifetime risk;migration;morphometry;mouse model;obesity risk;operation;paracrine;parity;prevent;public health relevance;pup;receptor;regenerative;repaired;reproductive;research study;stem cell therapy;tissue repair","Stem Cell Homing for Treatment of Female Pelvic Floor Disorders","Narrative 
 Up to half the women in the U.S. experience female pelvic floor disorders: stress urinary incontinence, 
fecal incontinence, and pelvic organ prolapse, but little is known about their pathophysiology and few 
nonsurgical treatments are available. In this project, we will use an animal model to determine if homing of 
adult mesenchymal stem cells could provide a possible nonsurgical treatment or preventative option. We 
will explore the possibility of making this therapy noncellular to avoid complications of cell therapy. This 
research is of high significance for development of improved therapies for female pelvic floor disorders.","NICHD","8290072","6/18/2012 12:00:00 AM","PA-07-070","5R01HD059859-03","5","R01","HD","059859","03"," ","PARROTT, ESTELLA C","8/16/2010 12:00:00 AM","6/30/2015 12:00:00 AM","Urologic and Kidney Development and Genitourinary Diseases Study Section[UKGD]"," ","6659273","DAMASER, MARGOT S","Not Applicable","11","OTHER BASIC SCIENCES","135781701","M5QFLTCTSQN6","135781701","M5QFLTCTSQN6","US","41.479276","-81.680233","10000858","CLEVELAND CLINIC LERNER COM-CWRU","CLEVELAND","OH","SCHOOLS OF MEDICINE","441950001","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","199200","113544"," ","312744",
"Biotechnology; Brain Cancer; Brain Disorders; Cancer; Genetics; Rare Diseases","Accounting;B-Cell Lymphomas;Biological Assay;Biology;Brain Neoplasms;Cell Culture Techniques;Cells;Characteristics;DNA;DNA Repair;DNA biosynthesis;Drosophila genus;Enzymes;Event;Genes;Genetic Recombination;Glioblastoma;Goals;Growth;Human;Human Genome;Length;Loss of Heterozygosity;Mammalian Cell;Mesenchymal;Mobile Genetic Elements;Monitor;Mus;Neurons;Phase;Primary Neoplasm;RNA;Retrotransposition;Retrotransposon;Reverse Transcription;Role;Telomerase;Telomerase RNA Component;Telomerase inhibition;Telomere Maintenance;Testing;Yeasts;gene function;mouse genome;neoplastic cell;novel;repaired;sarcoma;small hairpin RNA;telomere;tumor;tumor growth;tumorigenesis","Mechanisms of subtelomere recombination in telomerase deficient tumors"," Telomere maintenance can occur without telomerase and 10% of human tumors lack telomerase activity. These additional mechanisms can also contribute to telomere maintenance in tumors expressing telomerase and likely are selected in tumors inhibited for telomerase. These studies are relevant to understanding tumorigenesis that occurs in the absence of telomerase, including human sarcomas and potentially certain types of brain tumors. )  
    

","NCI","8320132","8/1/2012 12:00:00 AM","PA-10-063","5K99CA154889-02","5","K99","CA","154889","02"," ","SCHMIDT, MICHAEL K","8/15/2011 12:00:00 AM","10/31/2012 12:00:00 AM","Institutional Training and Education Study Section (F)[NCI-F]"," ","6415205","MORRISH, TAMMY A","Not Applicable","07","BIOCHEMISTRY","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","8/1/2012 12:00:00 AM","10/31/2012 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","124850","9988"," ","134838",
"Aging; Biotechnology; Cancer; Prostate Cancer; Urologic Diseases","Affect;Animal Model;Biological;Biological Markers;Biology;Carcinoma;Cell Lineage;Cells;Clinical;Drug Delivery Systems;Ectopic Expression;Epithelial;Epithelium;Evaluation;Fibroblast Growth Factor Receptor 1;Genetic Recombination;Genetically Engineered Mouse;Glean;Human;Knock-out;Lesion;Link;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Mesenchymal;Modeling;Molecular;Neoplasm Metastasis;Outcome;Patients;Primary Neoplasm;Principal Investigator;Property;Prostate;Reagent;Relative (related person);Role;Sampling;Signal Pathway;Signal Transduction;Specimen;Stem cells;Testing;Tissue Microarray;Tissue Model;Transgenic Model;Work;base;cancer initiation;design;experience;human tissue;improved;in vivo;knowledge base;mouse model;novel;programs;tumor growth;tumor progression","Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion","n/a","NCI","8334481","9/7/2012 12:00:00 AM","RFA-CA-08-018","5U01CA141497-04","5","U01","CA","141497","04"," ","MARKS, CHERYL L","9/9/2009 12:00:00 AM","8/31/2014 12:00:00 AM","ZCA1-SRLB-Q(M1)"," ","1922205","ITTMANN, MICHAEL M","Not Applicable","09","PATHOLOGY","051113330","FXKMA43NTV21","051113330","FXKMA43NTV21","US","29.711148","-95.39695","481201","BAYLOR COLLEGE OF MEDICINE","HOUSTON","TX","SCHOOLS OF MEDICINE","770303411","UNITED STATES","N","9/7/2012 12:00:00 AM","8/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","441777","236351"," ","671170",
"Breast Cancer; Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","African;African American;Aggressive behavior;Attenuated;Behavior;Biological Assay;Biology;Breast Cancer Cell;CD44 gene;Cancer Patient;Cancer cell line;Caucasians;Caucasoid Race;Cell Line;Cells;Clinical;Complex;Data;Diagnosis;Disease;Drug Design;ERBB2 gene;Effectiveness;Estrogen receptor negative;Event;Fluorescence-Activated Cell Sorting;Fresh Tissue;Gelatinase B;Genes;Goals;HRAS gene;Human;Immunohistochemistry;In Vitro;MAP Kinase Gene;MAPK3 gene;MMP9 gene;Malignant - descriptor;Mammary Neoplasms;Mammary gland;Mediating;Mesenchymal;Metastatic Neoplasm to the Breast;Molecular;N-Cadherin;Nuclear;Nuclear Pore Complex Proteins;Nude Mice;Oncogenic;Outcome;Oxidative Stress;PECAM1 gene;Paraffin Embedding;Pathway interactions;Patients;Pharmaceutical Preparations;Play;Population;Postmenopause;Premenopause;Property;Reporting;Role;Signal Transduction;Small Interfering RNA;Snails;Sorting - Cell Movement;Stem cells;Testing;Therapeutic;Time;Tissue Sample;Tumor Biology;Tumor Volume;Undifferentiated;Vascular Endothelial Growth Factors;Vimentin;Western Blotting;Woman;Xenograft procedure;aldehyde dehydrogenase 1;angiogenesis;base;cancer stem cell;cell motility;cell type;chemotherapy;clinical practice;design;embryonic stem cell;epithelial to mesenchymal transition;health disparity;in vivo;mRNA Expression;malignant breast neoplasm;matrigel;mortality;new therapeutic target;progesterone receptor negative;protein expression;self-renewal;slug;small hairpin RNA;triple-negative invasive breast carcinoma;tumor;tumor initiation;tumor progression;tumorigenic","Targeting pERK1/2 in Human Mammary Cancer Stem Cells"," This project will test the effectiveness of phospho-ERK1/2 targeting in human mammary cancer stem cells isolated from African American and Caucasian patients. Mammary cancer stem cells will be isolated from the discarded fresh tissue samples from patient and their ability to form tumors in Nude mice will be tested before and after inhibition of ERK1/2 signaling. Our studies if validated by our preliminary data may provide unique approach to clinical practice by designing therapeutic drugs to specifically target pERK1/2 in mammary cancer stem cells, which are highly stable and provide key oncogenic trigger.  
  
    

","NCI","8299474","7/12/2012 12:00:00 AM","PAR-08-026","5SC1CA165865-02","5","SC1","CA","165865","02"," ","CHUNG, DAVYD W","7/11/2011 12:00:00 AM","6/30/2016 12:00:00 AM","ZGM1-MBRS-7(CG)"," ","8146804","PERVIN, SHEHLA ","Not Applicable","44","INTERNAL MEDICINE/MEDICINE","785877408","PFBDNBDS57H3","785877408","PFBDNBDS57H3","US","33.924399","-118.307924","489501","CHARLES R. DREW UNIVERSITY OF MED & SCI","LOS ANGELES","CA","SCHOOLS OF MEDICINE","900593051","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","396","Other Research-Related","2012"," "," ","NIGMS","200000","82000"," ","282000",
"Arthritis; Autoimmune Disease","Actins;Adhesions;Affect;Behavior;Binding;Cadherins;Cartilage;Cathepsins;Cell Adhesion;Cell Adhesion Molecules;Cells;Chimera organism;Cytoplasmic Tail;Cytoskeletal Modeling;Dorsal;Enzymes;Extracellular Matrix;Fibroblasts;Fibronectins;Fluorescence Microscopy;Genetic Transcription;Human;Hyperplasia;In Vitro;Inflammation;Integrins;Joints;Life;Matrix Metalloproteinases;Mediating;Membrane;Mesenchymal;Molecular;Movement;PTK2 gene;Pain;Platelet-Derived Growth Factor;Play;Population;Process;Production;Protein Biosynthesis;Rheumatoid Arthritis;Role;SCID Mice;Stimulus;Structure;Swelling;Synovial Cell;Synovial Membrane;Tissues;Traction;Work;cadherin-11;cell fixing;cell motility;cellular imaging;in vivo;joint injury;knock-down;macrophage;membrane-type matrix metalloproteinase;migration;public health relevance;trafficking","Synovial Cadherin in Rheumatoid Arthritis","n/a","NIAMS","8296043","6/26/2012 12:00:00 AM","PA-07-070","5R01AR048114-10","5","R01","AR","048114","10"," ","MAO, SU-YAU","7/1/2002 12:00:00 AM","6/30/2013 12:00:00 AM","Arthritis, Connective Tissue and Skin Study Section[ACTS]"," ","1860775","BRENNER, MICHAEL B.","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","188179","134862"," ","323041",
"Hematology; Human Fetal Tissue; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Adult;Autologous Transplantation;Biological Assay;Blood;Cell Separation;Cell Transplantation;Cells;Colony-Forming Units Assay;Development;Embryo;Erythroid;Fetal Tissues;Fluorescence-Activated Cell Sorting;Goals;Hematopoietic;Hematopoietic stem cells;Hemoglobinopathies;Immunodeficient Mouse;Immunology;Institution;Instruction;Lymphoid;Measures;Mesenchymal;Methods;Myelogenous;Neonatal;Patients;Placenta;Research;Research Institute;Scientist;Services;Skin;Sorting - Cell Movement;Specimen;Structure of thyroid parafollicular cell;Supporting Cell;Teratoma;Testing;Tissues;Transplantation;Work;cell type;fetal;human fetus tissue;human tissue;in vivo;induced pluripotent stem cell;meetings;programs;reconstitution;systems research","Cell Transplantation and Analysis Core","RELEVANCE (See instructions): 
This core provides services critical to accomplishing the research goals of the overall program project that aims to develop new methods of treating hemoglobinopathies using genetically correcting patient cells to generate hematopoietic stem cells for autologous transplantation.","NIDDK","8381530","8/17/2012 12:00:00 AM","PAR-10-266","5P01DK088760-02","5","P01","DK","088760","02"," "," "," "," ","ZDK1-GRB-6","6462","1889366","MUENCH, MARCUS O","Not Applicable","12","Unavailable","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","Domestic Higher Education","941432510","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","182698","182698"," ","182698","0"," "," ",
"Genetics; Human Genome; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human","Acetylation;Aging;Biological Models;Cell Lineage;Cells;Chromosomes;Cytosine;DNA Methylation;Data;Data Analyses;Databases;Development;Endoderm;Enhancers;Epigenetic Process;Event;Fibroblasts;Gene Expression;Gene Silencing;Genetic Transcription;Genome;Histones;Human;Human Development;Human Genome;Individual;Informatics;Maps;Mesenchymal;Mesoderm;Methods;Methylation;Modification;Nucleotides;Organogenesis;Pathway interactions;Pattern;Play;Process;Proteins;Quality Control;Reading;Regenerative Medicine;Regulation;Research Design;Research Personnel;Resolution;Resources;Role;Site;Solutions;Technology;Therapeutic Agents;Tissues;Transcription Process;Undifferentiated;Validation;Visualization software;Whole-Genome Shotgun Sequencing;bisulfite;blastomere structure;cell type;chromatin modification;high throughput technology;histone modification;human disease;human embryonic stem cell;human embryonic stem cell line;improved;insight;novel;programs;promoter;trophoblast","The San Diego Epigenome Center","n/a","NIEHS","8546648","9/21/2012 12:00:00 AM","RFA-RM-07-013","3U01ES017166-05S1","3","U01","ES","017166","05","S","TYSON, FREDERICK L","9/29/2008 12:00:00 AM","6/30/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-CB-P(50)R]"," ","7066003","REN, BING ","Not Applicable","52","Unavailable","627922248","ESJQL5U9JYM3","627922248","ESJQL5U9JYM3","US","32.881785","-117.236973","2384603","LUDWIG INSTITUTE  FOR CANCER RES  LTD","LA JOLLA","CA","Research Institutes","920930660","UNITED STATES","N","9/21/2012 12:00:00 AM","6/30/2013 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","OD","255643","123703"," ","379346",
"Autoimmune Disease; Clinical Research; Clinical Trials; Lung; Rare Diseases","Address;Biochemical;Biological Markers;Biology;Bleomycin;Breathing;Carbon Monoxide;Cell Death;Cell Proliferation;Cessation of life;Clinical;Clinical Trials;Connective Tissue;Deposition;Development;Disease;Disease Progression;Dose;Effectiveness;Epithelial;Epithelial Cells;Fibroblasts;Fibrosis;Gene Expression Profile;Genes;Genomics;Goals;Hamman-Rich syndrome;Human;Individual;Inhalation Exposure;Interstitial Lung Diseases;Lung;Mesenchymal;Modeling;Molecular;Mononuclear;Mus;Pathogenesis;Pathway interactions;Patients;Peripheral Blood Mononuclear Cell;Phase III Clinical Trials;Physiological;Prognostic Marker;Proteins;Relative (related person);Reporting;Research Personnel;Respiratory Failure;Role;Staging;Structure;Testing;Therapeutic Agents;abstracting;base;clinically relevant;design;experience;novel;peripheral blood;phase 2 study;prevent;response","Phase II Study of Inhales Carbon Monoxide for the Treatment of Idiopathic Pulmona","n/a","NHLBI","8149936","8/13/2012 12:00:00 AM","RFA-HL-10-003","5U01HL105371-02","5","U01","HL","105371","02"," ","EU, JERRY PC","9/24/2010 12:00:00 AM","6/30/2014 12:00:00 AM","ZHL1-CSR-H(S1)"," ","1864413","CHOI, AUGUSTINE M","GARCIA, JOE G. N.","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","1591292","308908"," ","1900200",
"Clinical Research; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute;Adult;Aftercare;Alkaline Phosphatase;Allogenic;Animals;Antibody Formation;Autologous;Biochemical;Biological;Biological Assay;Biology;Cell Line;Cell Transplantation;Cell physiology;Cells;Chromosomes;Clinical;Dermal;Disease;Doctor of Philosophy;Doxycycline;Environment;Equus caballus;Exhibits;Fibroblasts;Flexor;Flow Cytometry;Gene Expression Profile;Generations;Genetic;Haplotypes;Histology;Human;Image;Immune;Immune response;Immunohistochemistry;Immunology;Infiltration;Inflammatory Response;Injection of therapeutic agent;Injury;Investigation;Knowledge;Laboratories;Laboratory Research;Learning;Lentivirus Vector;Lesion;Leukocytes;MHC Class I Genes;Magnetic Resonance Imaging;Mentors;Mesenchymal Stem Cells;Methods;Mixed Lymphocyte Culture Test;Modeling;Molecular;Molecular Profiling;Morphology;Mus;Orthopedics;Pathologic;Phase;Phase Transition;Pluripotent Stem Cells;Preparation;Property;Qualifying;RNA;Records;Regenerative Medicine;Research;Research Personnel;Sample Size;Scientist;Serum;Specialty Boards;Staging;Staining method;Stains;Stem cells;Surgeon;System;Techniques;Tendinitis;Tendon structure;Teratoma;Testing;Therapeutic;TimeLine;Tissues;Toll-like receptors;Training;Training Programs;Transplantation;Ultrasonography;Universities;Veterinarians;Viral;Work;c-myc Genes;career;cell type;clinically relevant;cytokine;expectation;fetal;graduate student;immunogenic;in vivo;in vivo Model;in vivo regeneration;induced pluripotent stem cell;insight;knowledge base;molecular marker;regenerative;repaired;research study;response;skills;stem cell biology;stem cell therapy;tissue regeneration","Equine iPS cells and their ability to enhance tendon regeneration in vivo"," The proposed research plan would generate and characterize equine induced pluripotent stem (iPS) cells including their ability to stimulate or decrease an immune response. The immune properties and regenerative potential of iPS cells would then be compared to mesenchymal stem cells (MSCs) using the well established equine model of tendonitis. The knowledge gained though the completion of these studies would provide immediately relevant, clinically applicable information for determining which stem cell type should be applied therapeutically for the treatment of tendonitis in people.   
   
      

","NIAMS","8298839","4/26/2012 12:00:00 AM","PA-11-193","1K08AR060875-01A1","1","K08","AR","060875","01","A","WANG, FEI","5/1/2012 12:00:00 AM","4/30/2017 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","8470764","SCHNABEL, LAUREN VIRGINIA","Not Applicable","23","OTHER CLINICAL SCIENCES","872612445","G56PUALJ3KT5","872612445","G56PUALJ3KT5","US","42.434772","-76.463216","1514802","CORNELL UNIVERSITY","ITHACA","NY","SCHOOLS OF VETERINARY MEDICINE","148502820","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","90188","6989"," ","97177",
"Aging; Estrogen; Osteoporosis; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Accounting;Adult;Affect;Aging;Androgens;Apoptosis;Apoptotic;Attenuated;Biological Preservation;Bone Density;Cells;Chemosensitization;Equilibrium;Estradiol;Estrogen Receptors;Estrogens;Experimental Models;Goals;Gonadal Steroid Hormones;Health;Hormonal;Hormones;Human;In Vitro;Lead;Ligands;Longevity;Mechanical Stimulation;Mediating;Mesenchymal;Molecular;Mus;Osteoblasts;Osteogenesis;Osteoporosis;Parathyroid gland;Periosteum;Population;Postmenopausal Osteoporosis;Primates;Property;Regulation;Relative (related person);Research;Rodent;Site;Skeleton;Surface;Testing;Therapeutic Effect;Therapeutic Intervention;Time;Undifferentiated;Woman;attenuation;bone;bone mass;bone strength;in vivo;men;novel therapeutic intervention;osteoblast differentiation;progenitor;sex;skeletal;therapeutic target","HORMONAL CONTROL OF PERIOSTEAL EXPANSION","n/a","NIAMS","8220988","2/26/2012 12:00:00 AM","PA-07-070","5R01AR054447-05","5","R01","AR","054447","05"," ","CHEN, FAYE H","4/1/2008 12:00:00 AM","8/14/2013 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","7752388","KOUSTENI, STAVROULA ","Not Applicable","13","INTERNAL MEDICINE/MEDICINE","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","SCHOOLS OF MEDICINE","100323725","UNITED STATES","N","2/1/2012 12:00:00 AM","8/14/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","188179","114789"," ","302968",
"Acute Respiratory Distress Syndrome; Lung; Orphan Drug; Rare Diseases","Acute Lung Injury;Address;Adult Respiratory Distress Syndrome;Alveolar;Apoptosis;Apoptotic;Biological;Blood capillaries;Cell Death;Cell Differentiation process;Cells;Clinical;Deposition;Development;Diffuse;Epithelial;Epithelial Cells;Epithelium;Extracellular Matrix;Family member;Fibroblasts;Fibrosis;Functional disorder;Genes;Genetic;Grant;Hour;In Vitro;Inflammatory;Injury;Liquid substance;Lung;Mesenchymal;Molecular;Mus;Myofibroblast;Outcome;Pathway interactions;Patients;Process;Proteins;Pulmonary Fibrosis;Reporting;Research;Role;Signal Pathway;Supportive care;United States;Ventilator;animal data;base;capillary;human TGFB1 protein;human data;improved;in vivo;injury and repair;lung injury;mortality;mouse model;novel therapeutics;prevent;repaired;tissue repair","Mechanisms of alveolar epithelial apoptosis during acute lung injury","From a clinical perspective, mortality in ARDS is unacceptably high despite improved supportive care and
ventilatory strategies. In vitro, animal and human data implicate TGF-31 action on alveolar epithelial cells as
of primary importance in alveolar injury and repair. Our study has the potential to determine the role of TGF-
31 signaling pathway in epithelial apoptosis that may provide the rationale for the development of novel
therapeutic strategies.","NHLBI","8376675","3/19/2012 12:00:00 AM"," ","5P01HL071643-09","5","P01","HL","071643","09"," "," ","8/1/2003 12:00:00 AM"," ","Heart, Lung, and Blood Program Project Study Section[HLBP]","5093","1949914","CHANDEL, NAVDEEP S","Not Applicable","07","Unavailable","005436803","KG76WYENL5K1","005436803","KG76WYENL5K1","US","41.896017","-87.616602","6144650","NORTHWESTERN UNIVERSITY AT CHICAGO","CHICAGO","IL","Domestic Higher Education","606114579","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","354540","354540"," ","232485","122055"," "," ",
"Genetics; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Address;Beryllium;Cell Fraction;Cell Therapy;Cell physiology;Cells;Chromatin;Complex;DNA Methylation;Data;Early Diagnosis;Elements;Epigenetic Process;Event;Future;Genes;Heterogeneity;Indium;Knock-in Mouse;Knowledge;Lead;Light;Medical Research;Modeling;Modification;Molecular;Monitor;Patients;Pattern;Population;Preclinical Drug Evaluation;Process;Proviruses;Reporter;Research;Resources;Role;Somatic Cell;Staging;Stem Cell Research;System;Techniques;Time;base;c-myc Genes;cellular transduction;clinical application;epithelial to mesenchymal transition;gain of function;histone modification;induced pluripotent stem cell;innovation;loss of function;novel;novel marker;pluripotency;post-doctoral training;programs;research study;tool","Utilizing single cell approaches to decipher the mechanism underlying somatic cel"," The discovery that terminally differentiated cells can change their fate to become ES-like cells (i.e. reprogramming process) provides an invaluable resource for drug screening, medical research, and patient specific cell-based therapy. The proposed research will shed light on the mechanisms that define the ""true"" reprogramming process.  
    

","NIGMS","8255664","1/12/2012 12:00:00 AM","PA-11-113","1F32GM099153-01A1","1","F32","GM","099153","01","A","JANES, DANIEL E","2/1/2012 12:00:00 AM","1/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-F05-A(20)L]"," ","10721916","BOUGANIM, YOSEPH DAVID","Not Applicable","07","Unavailable","120989983","JVKKKWN2N5N3","120989983","JVKKKWN2N5N3","US","42.363304","-71.087734","1742101","WHITEHEAD INSTITUTE FOR BIOMEDICAL RES","CAMBRIDGE","MA","Research Institutes","021421025","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","859","Training, Individual","2012"," "," ","NIGMS","53942"," "," ","53942",
"Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Affect;Binding;Biological Models;Bone Marrow;Cell Communication;Cell physiology;Cells;Chemicals;Complex;Disease;Disease model;Dysmyelopoietic Syndromes;Genes;Goals;Hematological Disease;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;Human;Image;Imaging Techniques;Mediator of activation protein;Mesenchymal;Methods;Modeling;Molecular;Mus;Progenitor Cell Engraftment;RNA Processing;Research;Resolution;Screening procedure;Stem cells;Syndrome;System;Technology;Testing;Zebrafish;base;clinical application;data exchange;in vivo Model;insight;mouse model;osteoprogenitor cell;public health relevance;stem","Stem Cell Engagement of the Niche","
Narrative
The overall goal of this proposal is to define the basis for a mouse model of the human
blood disease, myelodyplasia and to identify compounds that might positively affect the
bone marrow. We will use a unique combination of mouse and zebrafish model systems
examined by molecular, chemical and imaging techniques.","NHLBI","8323133","7/20/2012 12:00:00 AM","RFA-HL-09-010","5R01HL097794-04","5","R01","HL","097794","04"," ","THOMAS, JOHN","9/5/2009 12:00:00 AM","7/31/2014 12:00:00 AM","ZHL1-CSR-W(M1)"," ","1861205","SCADDEN, DAVID T","Not Applicable","05","ANATOMY/CELL BIOLOGY","082359691","LN53LCFJFL45","082359691","LN53LCFJFL45","US","42.373148","-71.118329","3212901","HARVARD UNIVERSITY","CAMBRIDGE","MA","SCHOOLS OF ARTS AND SCIENCES","021385319","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","492610","81631"," ","574241",
"Cancer; Diagnostic Radiology","Area;Biomedical Engineering;Chairperson;Comprehensive Cancer Center;Decision Making;Development;Funding;Grant;Image;Lung;Malignant Neoplasms;Malignant neoplasm of pancreas;Mediating;Metastatic Neoplasm to the Bone;Methodology;Monitor;Organization and Administration;Pathway interactions;Pilot Projects;Process;Radiation Oncology;Radiology Specialty;Renal carcinoma;Research;Research Infrastructure;Research Personnel;Resources;Scientist;System;Treatment Efficacy;base;cancer therapy;cost;epithelial to mesenchymal transition;high reward;high risk;hypoxia inducible factor 1;imaging modality;in vivo Cellular and Molecular Imaging Centers;innovative technologies;insight;intravital microscopy;melanoma;molecular imaging;multimodality;programs;trend;tumor progression","Developmental Fund","The developmental projects that we have selected will enable outstanding investigators to incorporate 
molecular imaging to provide new perspectives and insights into their research. These developmental 
projects, if successful, will provide advances in the discovery and treatment of cancer.","NCI","8555373","10/12/2012 8:17:45 AM","PAR-09-157","5P50CA103175-07","5","P50","CA","103175","07"," "," ","8/10/2003 12:00:00 AM","7/31/2016 12:00:00 AM","ZCA1-SRLB-9(M1)","5294","6215429","JAFFEE, ELIZABETH M.","Not Applicable","07","Unavailable","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","Domestic Higher Education","212182680","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","123160","123160"," ","78759","44401"," "," ",
"Genetics; Human Genome; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human","Acetylation;Aging;Biological Models;Cell Lineage;Cells;Chromosomes;Cytosine;DNA Methylation;Data;Data Analyses;Databases;Development;Endoderm;Enhancers;Epigenetic Process;Event;Fibroblasts;Gene Expression;Gene Silencing;Genetic Transcription;Genome;Histones;Human;Human Development;Human Genome;Individual;Informatics;Maps;Mesenchymal;Mesoderm;Methods;Methylation;Modification;Nucleotides;Organogenesis;Pathway interactions;Pattern;Play;Process;Proteins;Quality Control;Reading;Regenerative Medicine;Regulation;Research Design;Research Personnel;Resolution;Resources;Role;Site;Solutions;Technology;Therapeutic Agents;Tissues;Transcription Process;Undifferentiated;Validation;Visualization software;Whole-Genome Shotgun Sequencing;bisulfite;blastomere structure;cell type;chromatin modification;high throughput technology;histone modification;human disease;human embryonic stem cell;human embryonic stem cell line;improved;insight;novel;programs;promoter;trophoblast","The San Diego Epigenome Center","n/a","NIEHS","8311845","8/2/2012 12:00:00 AM","RFA-RM-07-013","5U01ES017166-05","5","U01","ES","017166","05"," ","TYSON, FREDERICK L","9/29/2008 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-CB-P(50)R]"," ","7066003","REN, BING ","Not Applicable","52","Unavailable","627922248","ESJQL5U9JYM3","627922248","ESJQL5U9JYM3","US","32.881785","-117.236973","2384603","LUDWIG INSTITUTE  FOR CANCER RES  LTD","LA JOLLA","CA","Research Institutes","920930660","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","OD","3061686","546593"," ","3218417",
"Biotechnology; Genetics","Acetylation;Adhesions;Affect;Algorithms;Apoptosis;Apoptotic;Behavior;Biochemical;Bioinformatics;Bioreactors;Cell Line;Cells;Chinese Hamster Ovary Cell;DNA Microarray Chip;Data;Development;Diagnostic;Disease;Environment;Epithelial;Event;Genes;Glucose;Growth;Growth Factor Gene;HDAC2 gene;Hela Cells;Hemagglutinin;Hepatocyte Growth Factor;Histone Deacetylation;Histones;Human;Lead;Link;MDCK cell;Malignant Neoplasms;Mammalian Cell;Membrane;Mesenchymal;MicroRNAs;Microarray Analysis;Molecular;Morphology;Nutrient;Oxidative Stress;Phase;Phenotype;Physiological;Process;Production;Promoter Regions;Property;Proteins;Reactive Oxygen Species;Reduced Glutathione;Role;Sampling;Sialyltransferases;Suspension Culture;Suspension substance;Suspensions;Techniques;Therapeutic;Time;Transfection;Up-Regulation;Vaccine Production;Virus;Work;base;cell behavior;deprivation;egg;improved;influenzavirus;member;overexpression;tool","Identification of genes related to spcific properties of mammalian cells","n/a","NIDDK","8553669"," "," ","1ZIADK075080-01","1","ZIA","DK","075080","01"," "," "," "," "," "," ","9415718","SHILOACH, JOSEPH ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIDDK"," "," "," ","315595",
"Aging; Clinical Research; Contraception/Reproduction; Injury (total) Accidents/Adverse Effects; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Urologic Diseases","Acute;Affect;Age;Aging;Animal Model;Apoptotic;Birth;Birth trauma;CXCR4 gene;Chemokine (C-C Motif) Receptor 1;Child;Childbirth;Clinical;Communities;Coughing;Data;Development;Diabetes Mellitus;E-Selectin;Elderly woman;Environment;Epidemiologic Studies;Equilibrium;Evaluation;Exertion;Extravasation;Female;Functional disorder;Future;Generations;Genetic;Head;Hematopoietic Stem Cell Mobilization;Homing;Human;Inflammatory;Injection of therapeutic agent;Injury;Insulin-Like Growth Factor I;Interferons;Interleukin-2;Investigation;Ischemia;Lower urinary tract;Maternal Age;Measurable;Measures;Mediating;Medical;Mesenchymal Stem Cells;Modeling;Mothers;Mus;Obesity;Organ;Outcome;Outcome Measure;Pathway interactions;Pattern;Pelvic floor structure;Pelvis;Play;Postpartum Women;Pregnancy;Prevalence;Process;Rattus;Recommendation;Recovery;Recovery of Function;Recurrence;Reporting;Research Personnel;Risk;Risk Factors;Role;Secondary to;Severities;Signal Transduction;Simulate;Sneezing;Stem cells;Stress Urinary Incontinence;Stromal Cell-Derived Factor 1;Testing;Therapeutic;Time;Tissues;Trauma;Urethra;Urinary Incontinence;Urine;Vagina;Vaginal delivery procedure;Vascular Cell Adhesion Molecule-1;Vascular Endothelial Growth Factors;Woman;Wood material;advanced maternal age;age effect;aged;cytokine;fetal;high risk;injured;migration;monocyte chemoattractant protein-3;paracrine;pressure;prospective;public health relevance;receptor;research study;response;social;social implication;stem cell therapy","Tissue recovery in the pathophysiology of stress urinary incontinence","
 Stress Urinary Incontinence (SUI) presents a large social, medical and personal burden. Development
of SUI is strongly associated with pregnancy, maternal age, vaginal delivery and aging. This study is directed
at understanding the mechanisms mediating the balance between injury and recovery and the role of
mesenchymal stem cells in recovery and to evaluate the effect of aging on the balance and response to stem
cell therapy.","NIDDK","8234163","11/7/2011 12:00:00 AM","PA-10-059","5K08DK090134-02","5","K08","DK","090134","02"," ","RANKIN, TRACY L","3/1/2011 12:00:00 AM","11/30/2014 12:00:00 AM","ZDK1-GRB-G(O2)M"," ","8753364","HIJAZ, ADONIS K","Not Applicable","11","UROLOGY","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","SCHOOLS OF MEDICINE","441061712","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","847","Other Research-Related","2012"," "," ","NIDDK","137500","11000"," ","148500",
"Lung","Basement membrane;CD44 Antigens;Cell surface;Cells;Data;Deposition;Development;Epithelial Cells;Extracellular Matrix;FDA approved;Fibroblasts;Fibrosis;Funding;Gases;Gene Expression Profile;Genomics;Glycosaminoglycans;Hamman-Rich syndrome;Hyaluronan;Injury;Interstitial Pneumonia;Invaded;Label;Laboratories;Lead;Lung;Lung Inflammation;Lung diseases;Medical;Mesenchymal;Mesothelium;Molecular;Morbidity - disease rate;Mus;Myofibroblast;Pathologic;Phenotype;Population;Principal Investigator;Production;Pulmonary Fibrosis;Regulation;Relative (related person);Role;Signal Pathway;Smooth Muscle Actin Staining Method;Source;Testing;Transgenes;Transgenic Mice;Work;alveolar epithelium;base;extracellular;hyaluronan synthase 1;lung injury;mortality;mouse model;novel;overexpression;programs;promoter;receptor","Matrix Regulation of Pulmonary Fibrosis"," Severe pulmonary fibrosis a major cause of morbidity and mortality for which there are no FDA-approved medical therapies. The hallmark of severe fibrosis is the relentless deposition of extracellular matrix in the gas exchanging regions of the lung. Understanding how matrix regulates fibrosis could lead to new therapies.    

","NHLBI","8302195","7/12/2012 12:00:00 AM","PA-10-067","5R01HL060539-15","5","R01","HL","060539","15"," ","GAIL, DOROTHY","9/30/1997 12:00:00 AM","6/30/2013 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","11701410","LIANG, CAROL JIURONG","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","8/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","142500"," ","392500",
"Cancer; Dental/Oral and Craniofacial Disease; Genetics; Neuroblastoma; Neurosciences; Pediatric; Rare Diseases","Accounting;Area;Binding;Body part;Cartilage;Cells;Cephalic;Colon;Congenital Abnormality;Congenital Heart Defects;DNA Methyltransferase 3B;Defect;Development;Disease;Embryology;Embryonic Development;Epigenetic Process;Face;Genes;Goals;Heart;Homologous Gene;Lead;Malignant Neoplasms;Molecular Biology Techniques;Mutation;Neural Crest;Neural Crest Cell;Neural tube;Neuroblastoma;Neurofibromatoses;Pattern;Peripheral Nervous System;Pheochromocytoma;Play;Population;Public Health;Regulation;Role;Skin;Transcriptional Regulation;cancer type;cleft lip and palate;craniofacial;epithelial to mesenchymal transition;insight;melanoma;migration;public health relevance","Epigenetic Regulation in Cranial Neural Crest Development","
Relevance to Public Health
The neural crest cells are involved in a variety of birth defects and cancers such
as cleft lip and palate, heart defects, colon disease and neuroblastoma. Neural
crest related defects account for as much as one third of all congenital birth
defects.","NIDCR","8292969","7/11/2012 12:00:00 AM","PA-10-108","5F31DE021643-03","5","F31","DE","021643","03"," ","FRIEDEN, LESLIE A","9/9/2010 12:00:00 AM","7/1/2013 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","10439936","HU, NA ","Not Applicable","27","NONE","009584210","U2JMKHNS5TG4","009584210","U2JMKHNS5TG4","US","34.134337","-118.126525","1073501","CALIFORNIA INSTITUTE OF TECHNOLOGY","PASADENA","CA","SCHOOLS OF ARTS AND SCIENCES","911250001","UNITED STATES","N","9/1/2012 12:00:00 AM","7/1/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","32123"," "," ","32123",
"HIV/AIDS; Hematology; Pediatric; Pediatric AIDS; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acquired Immunodeficiency Syndrome;Architecture;Binding;Blood;Bone Marrow;Bone Marrow Transplantation;Cells;Defect;Disease;Dysmyelopoietic Syndromes;Dysplasia;Functional disorder;Generations;Genetic;Genetically Engineered Mouse;Grant;HIV;HIV Infections;Hematopoiesis;Hematopoietic;Hematopoietic System;Host Defense;Individual;Learning;Longevity;Maintenance;Marrow;Mesenchymal;Molecular;Morbidity - disease rate;Mouse Strains;Natural regeneration;Organ;Pathway interactions;Physiologic pulse;Population;Population Sizes;Production;Proliferating;Staging;Stem cells;System;Tissues;Variant;Work;base;cytopenia;meetings;novel;progenitor;research study","Mechanisms of Hematopoiesis in AIDS"," This proposal focuses on defining how the structural components of the bone marrow contribute to the healthy and diseased function of the hematopoietic or blood forming stem cells. It is intended to provide novel opportunities for intervening to overcome defects in blood formation associated with myelodysplasia.  
  
    

","NHLBI","8528891","9/15/2012 12:00:00 AM","PA-12-100","3R01HL044851-22S1","3","R01","HL","044851","22","S","THOMAS, JOHN","10/1/2012 12:00:00 AM","9/30/2013 12:00:00 AM"," "," ","1861205","SCADDEN, DAVID T","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","10/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","187359","109045"," ","296404",
"Dental/Oral and Craniofacial Disease; Genetics; Neurosciences; Pediatric","Adrenal Glands;Cell Culture Techniques;Cell Maintenance;Cells;Chondrocytes;Chondrogenesis;Chromaffin Cells;Complex;Congenital Abnormality;Congenital Disorders;Defect;Development;Distant;Dorsal;Embryo;Embryonic Structures;Family;Gene Targeting;Genetic Transcription;Heart;Human;Lead;Life Expectancy;Light;Link;Maintenance;Malignant Neoplasms;Molecular;Multipotent Stem Cells;Mus;Neural Crest;Neural Crest Cell;Neural tube;Neuroglia;Neurons;Outcome;Peripheral Nervous System;Play;Process;Proteins;Regulation;Research;Role;Site;Skeleton;Staging;Stem cells;Testing;Time;Tissues;Xenopus;cell type;craniofacial;epithelial to mesenchymal transition;insight;malformation;melanocyte;promoter;skeletal;skeletal tissue;stem cell population;transcription factor","SoxE regulation of Neural Crest Development"," Chondrogenesis is an essential vertebrate specific process that when improperly regulated can lead to skeletal malformation and birth defects causing a significant reduction in life expectancy. The craniofacial skeleton is derived from a special group of multipotent stem cells called the neural crest. SoxE transcription factors are key regulators of this cell type, and the proposed research will shed important light on their regulation and function.  
    

","NIDCR","8386824","7/19/2012 12:00:00 AM","PA-10-110","5F31DE021922-02","5","F31","DE","021922","02"," ","FRIEDEN, LESLIE A","9/1/2011 12:00:00 AM","8/31/2015 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","10584988","NORDIN, KARA M","Not Applicable","07","BIOCHEMISTRY","160079455","EXZVPWZBLUE8","160079455","EXZVPWZBLUE8","US","42.049695","-87.678657","6144601","NORTHWESTERN UNIVERSITY","Chicago","IL","SCHOOLS OF ARTS AND SCIENCES","606114579","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","35398"," "," ","35398",
"No NIH Category available","Address;Affect;Animal Model;Basic Science;Bone Marrow;Bone Marrow Transplantation;CD34 gene;Cells;Chromatin;Clinical;Clinical Trials;Cooley&apos;s anemia;Development;Engraftment;Future;Gene Transduction Agent;Gene Transfer;Genomics;Globin;Goals;Greece;Hematological Disease;Hematopoietic Stem Cell Mobilization;Hemoglobinopathies;Hereditary Disease;Human Genome;Individual;Lead;Lentivirus Vector;Mesenchymal;Minority;Mus;New York;Palliative Care;Patients;Primates;Program Research Project Grants;Regimen;Research Personnel;Safety;Services;Sickle Cell Anemia;Site;Stem cells;Talents;Technology;Thalassemia;abstracting;beta Thalassemia;conditioning;gene correction;gene therapy;gene therapy clinical trial;induced pluripotent stem cell;novel;programs;tool development;vector","Stem Cell Gene Therapy for Hemoglobinopathies","n/a","NHLBI","8282781","4/28/2012 12:00:00 AM"," ","5P01HL053750-18","5","P01","HL","053750","18"," ","QASBA, PANKAJ","9/1/1996 12:00:00 AM","3/31/2015 12:00:00 AM","Heart, Lung, and Blood Program Project Study Section[HLBP]"," ","1870735","STAMATOYANNOPOULOS, GEORGE ","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","605799469","HD1WMN6945W6","605799469","HD1WMN6945W6","US","47.660049","-122.31441","9087701","UNIVERSITY OF WASHINGTON","SEATTLE","WA","SCHOOLS OF MEDICINE","981951016","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","1616724","767120"," ","2383844",
"Breast Cancer; Cancer; Genetics; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Affect;Antigens;Antineoplastic Agents;Biological Models;Biological Products;Breast Cancer Cell;Breast Carcinoma;Cell Line;Cells;Characteristics;Clear Cell;Complex;Cytotoxic T-Lymphocytes;Data;Embryo;Epithelial;Genes;Goals;Hemagglutinin;Human;Immune;Immune response;Immune system;Immunotherapy;In Vitro;Knowledge;Malignant Epithelial Cell;Mediating;Mesenchymal;Minor;Modeling;Molecular Target;Monitor;Mus;Patients;Peptides;Phenotype;Population;Proteins;Resistance;Stem cells;System;T-Cell Receptor;T-Lymphocyte;Transgenes;Transgenic Mice;Tumor Antigens;Viral;Viral Proteins;base;cancer cell;cancer stem cell;chemotherapy;cytotoxic;immunogenic;improved;in vivo;killings;malignant breast neoplasm;neoplastic cell;novel;perforin;promoter;response;success;transcription factor;triple-negative invasive breast carcinoma;tumor","Mechanisms of Immune-mediated Tumor Cell Destruction","n/a","NCI","8552632"," "," ","1ZIABC010012-17","1","ZIA","BC","010012","17"," "," "," "," "," "," ","9692491","SAYERS, THOMAS ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","324588",
"Lung","Alveolar;Apoptosis;Autophagocytosis;Award;Biology;Cells;Cellular biology;Collaborations;Complement;Conscious;Data;Development;Developmental Cell Biology;Developmental Process;Discipline;Disease;Distal;Environment;Epithelial;Epithelium;Event;Faculty;Funding;Genetic;Goals;Grant;Health;Injury;Lung;Lung diseases;Mesenchymal;Mission;Molecular;Molecular Biology;Participant;Pathogenesis;Pulmonary Surfactants;Research;Research Personnel;Science;Scientist;Series;Stress;Structure of respiratory epithelium;Students;Time;Tissues;Travel;Underrepresented Minority;United States National Institutes of Health;Woman;abstracting;airway epithelium;base;design;innovation;interest;lung development;lung repair;meetings;posters;professor;programs;surfactant;symposium","FASEB SRC: The Lung Epithelium in Health & Disease","The 2012 FASEB Summer Research Conference, ""Lung Epithelium in Health and Diseaseâ, is the primary forum for discussion of pulmonary epithelial science. Cutting edge topics that will be discussed in this 7th iteration of the meeting will include stem cell biology, metabolomics, genomics and the role of autophagy, protein misfolding, epigenetics, and microRNAs in lung disease. The objective of the meeting is to stimulate meaningful discussion, facilitate collaboration and establish new research directions and is important to the public health because it is designed to translate cutting edge concepts from the bench to the bedside.","NHLBI","8398679","6/29/2012 12:00:00 AM","PA-10-071","1R13HL116023-01","1","R13","HL","116023","01"," ","LIN, SARA","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","ZHL1-CSR-G(M1)"," ","1917566","MCCORMACK, FRANCIS XAVIER","Not Applicable","08","Unavailable","074816851","CLHCSTHHSX25","074816851","CLHCSTHHSX25","US","39.014166","-77.099455","2604901","FEDERATION OF AMER SOC FOR EXPER BIOLOGY","BETHESDA","MD","Other Domestic Non-Profits","208143998","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Other Research-Related","2012"," "," ","NHLBI","15000","0"," ","15000",
"No NIH Category available","26S proteasome;Biochemical Genetics;Cell physiology;Cells;Complex;Congenital Abnormality;Data;Disease;Dorsal;Embryo;Embryonic Development;Equilibrium;Foundations;Future;Generations;Germ Layers;Goals;In Vitro;Investigation;Malignant Neoplasms;Mediating;Mesenchymal;Messenger RNA;Methods;Modeling;Molecular;Organ;Pattern;Pattern Formation;Phosphorylation;Phosphotransferases;Play;Principal Investigator;Proteins;Proteolysis;Regulation;Research;Research Personnel;Role;Signal Transduction;Stem cells;Testing;Tissues;Ubiquitin-mediated Proteolysis Pathway;Work;Xenopus;base;beta catenin;in vivo;insight;loss of function;mutant;neoplastic;novel;prevent;research study;tissue regeneration","Regulation of beta-catenin proteolysis in dorsal-ventral patterning","
Molecular mechanisms controlling the formation of dorsal-ventral axis formation represent a
fundamental challenge of early embryogenesis. Our proposed studies will focus on the role of
ubiquitin-mediated proteolysis in dorsoventral patterning formation. The results of the proposed studies
will be broadly implicated in preventing congenital malformation, regulating stem cell function and
managing neoplastic diseases.","NICHD","8264155","4/18/2012 12:00:00 AM","PA-10-064","5R03HD064617-02","5","R03","HD","064617","02"," ","MUKHOPADHYAY, MAHUA","5/15/2011 12:00:00 AM","4/30/2013 12:00:00 AM","Developmental Biology Study Section[CHHD-C]"," ","6478287","ZHU, ZHENGLUN ","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","50000","39250"," ","89250",
"Bioengineering; Biotechnology; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Alkaline Phosphatase;Allografting;Alveolar Bone Loss;Amino Acids;BMP2 gene;Back;Binding;Biocompatible Materials;Blood Transfusion;Bone Matrix;Bone Regeneration;Bone Transplantation;Cattle;Cell Adhesion;Cell Surface Receptors;Clinical;Collagen;Congenital Disorders;Coupling;Defect;Dental;Dental Implants;Disease;Environment;Goals;Gold;Harvest;Human;Hydroxyapatites;Implant;In Vitro;Injury;Integrins;Lesion;Measures;Mesenchymal Stem Cells;Methods;Minerals;Modeling;Morbidity - disease rate;Operative Surgical Procedures;Oral cavity;Orthopedics;Osteocalcin;Osteogenesis;Outcome;Patients;Peptides;Performance;Periodontal Diseases;Phase I Clinical Trials;Procedures;Process;Proteins;Rattus;Recombinant Proteins;Recombinants;Regenerative Medicine;Relative (related person);Reporting;Research;Role;Site;Staging;Sterilization;Surface;Technology;Tooth Loss;Tooth structure;Transplanted tissue;Trauma;United States;Wit;Work;Xenograft procedure;allogenic bone transplantation;alveolar bone;aspartyl-glycyl-glutamyl-alanine;bone;bone healing;bone morphogenic protein;bone xenograft;cost;craniofacial;in vivo;mimetics;novel;osteoblast differentiation;osteoinductive factor;osteoprogenitor cell;polycaprolactone;polyglutamate;recombinant peptide;regenerative;response;scaffold;subcutaneous;synthetic peptide;targeted delivery;time interval","Targeted delivery of osteoinductive molecules to biologic HA in bone grafts"," Alveolar bone loss occurs due to a number of conditions and there is a need to regain this lost bone either for tooth retention or tooth replacement by dental implants. Autogenous bone, often considered the gold standard for regenerative procedures, requires harvesting from the patient and increased morbidity; therefore allograft bone can be used as a substitute but due to processing and sterilization procedures it may have lost important proteins that help in bone formation. By developing a method of anchoring these important proteins back to this commercially available bone we hope to increase the regenerative capacity of allograft bone comparable to the level of autogenous bone.   
      

","NIDCR","8396921","7/25/2012 12:00:00 AM","PA-11-113","1F32DE022997-01","1","F32","DE","022997","01"," ","FRIEDEN, LESLIE A","12/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","11182649","BAIN, JENNIFER L","Not Applicable","07","DENTISTRY","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","SCHOOLS OF DENTISTRY/ORAL HYGN","352940001","UNITED STATES","N","12/1/2012 12:00:00 AM","11/30/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","70742"," "," ","70742",
"Bioengineering; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Affect;Americas;Amniotic Fluid;Anatomy;Animal Disease Models;Animal Model;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Area;Bathing;Beds;Blood Circulation;Blood Vessels;Bone Marrow;Burn injury;Cell Therapy;Cells;Centers for Disease Control and Prevention (U.S.);Clinical;Contralateral;Contusions;Crush Injury;Development;Disease;Dose;Environment;Evaluation;Event;Exhibits;Fracture;Functional disorder;Gene Expression;Harvest;Hematopoietic;Hemorrhage;Histologic;Homing;Human;Immune;In Vitro;Injection of therapeutic agent;Injury;Institutes;Laboratories;Lead;Life;Limb structure;Malignant - descriptor;Measurement;Mediating;Medicine;Mesenchymal Stem Cells;Modeling;Multiple Trauma;Mus;Muscle;Muscle function;Musculoskeletal Diseases;Operative Surgical Procedures;Organ;Pharmacologic Substance;Physiological;Population;Process;Rattus;Recovery;Recovery of Function;Regenerative Medicine;Reporting;Residencies;Selectins;Site;Skeletal Muscle;Small Business Technology Transfer Research;Solutions;Stem cells;Syndrome;Technology;Teratoma;Testing;Therapeutic;Time;Tissues;Trauma;United States;adult stem cell;amniotic fluid derived stem cell;base;cell motility;cost;disability;forest;improved;injured;new technology;novel;novel strategies;pre-clinical;regenerative;relating to nervous system;repaired;research study;stem cell population","ASC101 Enhancement of Regenerative Capacity of Amniotic Fluid-derived Stem Cells"," A variety of injuries, such as crush injuries, burns, circulation blockage, fractures, hemorrhage, severely bruised muscles, surgery and other trauma lead to devastating tissue damage with potential loss of limb or life. To address the complexity of the events underlying the pathophysiology of these injuries we will explore the therapeutic potential of a cell-based approach. We will utilize a novel type of stem cell exhibiting multilineage differentiation potential in combination with a novel technology that can enhance the migration of cells to the site of damage. The potential for broad therapeutic application of this combination approach underscores the importance of these proposed studies.  
  
    

","NHLBI","8253016","8/15/2012 12:00:00 AM","PA-11-097","1R41HL112461-01","1","R41","HL","112461","01"," ","MITCHELL, PHYLLIS","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE-B]"," ","7817102","MILLER, LEONARD P","SOKER, SHAY ","49","Unavailable","617462234","NJG4X7NZ4BM1","617462234","NJG4X7NZ4BM1","US","33.146662","-117.343472","10008420","TARGAZYME, INC.","CARLSBAD","CA","Domestic For-Profits","920114402","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","839","SBIR/STTR","2012"," "," ","NHLBI"," "," "," ","156754",
"Bioengineering; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human; Transplantation","Adult;Age;Aging;Alginates;Animal Model;Arthritis;Blood Vessels;Bone Density;Bone Marrow;Bone Matrix;Bone Regeneration;Bone Tissue;Cell Communication;Cell Proliferation;Cell physiology;Cells;Cephalic;Chitosan;Complex;Defect;Dental;Dentures;Disease;Encapsulated;Esthetics;Fiber;Fibrin;Fracture;Gold;Growth Factor;Harvest;Healed;Health;Human;Implant;In Vitro;Injectable;Knowledge;Lesion;Mandible;Maryland;Maxilla;Mechanics;Mesenchymal Stem Cells;Microspheres;Minerals;Molds;Musculoskeletal;Operative Surgical Procedures;Orthopedics;Osteogenesis;Osteoporosis;Paste substance;Patients;Peptides;Population;Prevalence;Procedures;Property;Psychological reinforcement;Quality of life;RGD (sequence);Regenerative Medicine;Reporting;Research;Resistance;Risk;Shapes;Side;Source;Stem cells;Stress;System;Teenagers;Testing;Time;Tissue Engineering;Umbilical cord structure;Universities;Weight-Bearing state;bone;bone engineering;calcium phosphate;cell growth;cost;craniofacial;density;design;healing;human embryonic stem cell;improved;in vivo;interdisciplinary approach;knowledge base;mandible/maxilla;meetings;minimally invasive;novel;oral surgery specialty;reconstruction;regenerative;scaffold;tissue regeneration","Human Embryonic Stem Cells in Calcium Phosphate Constructs for Bone Regeneration"," Despite the high promise of human embryonic stem cells (hESCs), there has been no report on hESC seeding with injectable calcium phosphate constructs for bone regeneration. The proposed research will investigate hESCs for bone tissue engineering via novel injectable calcium phosphate scaffolds for the first time, and establish ground-breaking knowledge on hESC guidance via peptide-calcium phosphate cement scaffold to enhance hESC function and bone regeneration in animal model. The novel hESC-calcium phosphate construct is expected to have a wide range of craniofacial and orthopedic applications, with greatly enhanced bone regeneration capability to improve the health and quality of life for millions of people.   
   
      

","NIDCR","8281745","2/16/2012 12:00:00 AM","PA-10-069","1R21DE022625-01","1","R21","DE","022625","01"," ","LUMELSKY, NADYA L","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","Oral, Dental and Craniofacial Sciences Study Section[ODCS]"," ","2093590","XU, HUAKUN ","Not Applicable","07","NONE","188435911","Z9CRZKD42ZT1","188435911","Z9CRZKD42ZT1","US","39.291412","-76.624753","820104","UNIVERSITY OF MARYLAND BALTIMORE","BALTIMORE","MD","SCHOOLS OF DENTISTRY/ORAL HYGN","212011508","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","125000","66875"," ","191875",
"Bioengineering; Biotechnology; Cardiovascular; Diagnostic Radiology; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Affect;Autologous;Behavior;Biological Models;Blood Vessels;Blood flow;Cardiovascular Diseases;Cell Culture Techniques;Cell Cycle Kinetics;Cell physiology;Cells;Characteristics;Clinical Trials;Development;Disease;Endothelial Cells;Engraftment;Event;Foot Ulcer;Gastrocnemius Muscle;Goals;Gold;Growth;Hydrogels;Image;Imagery;Imaging Techniques;In Situ;In Vitro;Injectable;Injection of therapeutic agent;Ischemia;Kinetics;Label;Lead;Limb Salvage;Limb structure;Lower Extremity;Measurement;Measures;Medical;Mesenchymal Stem Cells;Methods;Modeling;Monitor;Muscle;Muscle Cells;Muscle function;Myopathy;Optics;Pain;Patients;Pericytes;Peripheral arterial disease;Positioning Attribute;Procedures;Process;Property;Rattus;Reperfusion Therapy;Resolution;Role;Safety;Signal Transduction;Skeletal Muscle;Solutions;Specificity;Stem cells;Structure;System;Therapeutic;Time;Tissues;Toxic effect;Ultrasonography;United States;Vascularization;Work;absorption;biomaterial compatibility;blood vessel visualization;cell behavior;cell motility;cytokine;functional improvement;in vivo;interdisciplinary approach;interest;muscle regeneration;nanoparticle;neovascularization;particle;plasmonics;stem cell population;stem cell therapy;surface coating;tissue regeneration;vasculogenesis","Nanotracer Development to Track Stem Cell Therapy"," Early clinical trials in patients with peripheral arterial disease resulting in critical limb ischemia have demonstrated the safety of autologous stem cell therapies and suggested modest improvements in reperfusion and limb salvage. A major challenge to the development of clinically applied stem cell therapy remains the lack of efficient stem cell tracking methods and in vivo visualization of neovascularization. Therefore, the overall goal of the current proposal is to quantify blood vessel growth kinetics and function in vivo using
nanotracer-enhanced, high-resolution combined ultrasound and photoacoustic (US/PA) imaging.   
      

","NIBIB","8276260","4/27/2012 12:00:00 AM","PA-11-148","1R01EB015007-01","1","R01","EB","015007","01"," ","ATANASIJEVIC, TATJANA","5/1/2012 12:00:00 AM","4/30/2016 12:00:00 AM","Nanotechnology Study Section[NANO]"," ","1950710","SUGGS, LAURA J","Not Applicable","10","BIOMEDICAL ENGINEERING","170230239","V6AFQPN18437","170230239","V6AFQPN18437","US","30.308138","-97.764903","578403","UNIVERSITY OF TEXAS, AUSTIN","AUSTIN","TX","BIOMED ENGR/COL ENGR/ENGR STA","787595316","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","285180","119560"," ","404740",
"No NIH Category available","Address;Adult;Applications Grants;Arthritis;Autologous;Biochemical;Biological;Biology;Biomedical Engineering;Bioreactors;Cartilage;Cartilage Matrix;Cell Differentiation process;Cells;Centers of Research Excellence;Chondrocytes;Chondrogenesis;Clinical;Coculture Techniques;Collagen;Collagen Fiber;DNA;DNA Fingerprinting;Data;Defect;Degenerative polyarthritis;Deposition;Development;Device or Instrument Development;Devices;Dose;Electron Microscopy;Engineering;Environment;Extracellular Matrix;Face;Fiber;GAG Gene;Goals;Growth Factor;Healed;Health;Histology;Hospitals;Image;Image Analysis;Implant;In Vitro;Injury;Interdisciplinary Study;Joints;Knee;Knee joint;Laboratories;Limb structure;Literature;Mechanics;Medical;Medical center;Mentors;Mesenchymal Stem Cells;Methodology;Military Personnel;Miniature Swine;Modeling;Natural regeneration;Operative Surgical Procedures;Orthopedics;Outcome;Patients;Population;Process;Production;Property;Qualifying;Regenerative Medicine;Rehabilitation therapy;Replacement Arthroplasty;Reporting;Research;Rhode Island;Risk;Sampling;Scheme;Stimulus;System;Techniques;Testing;Tissue Engineering;Tissues;Translating;Translations;Transplantation;Trauma;Universities;Veterans;Wages;Weight-Bearing state;Work;adult stem cell;articular cartilage;base;biomaterial compatibility;bone;cartilage repair;cell growth;cost;design;engineering design;experience;functional restoration;healing;implantation;improved;in vivo;innovation;interest;novel;prevent;primary outcome;programs;repaired;secondary outcome;skeletal;stem cell differentiation;success","Design of an Engineered Cartilage Biocomposite for Joint Rehabilitation","This project aims to develop a transplantable biocomposite to restore cartilage of a traumatized joint. Limb trauma in young veterans often results in loss of cartilage tissue function that leads to severe arthritis and osteoarthritis. Total national cost of arthritis was $81 billion in medical costs and $47 billion in lost wages in 2003. US veterans face increased risks of arthritis compared with non-veterans due to orthopedic injuries at the military. Over the five-year CDA-2 program, Dr. Bilgen aims to develop an implantable biocomposite for cartilage repair using adult stem cells and a bioreactor that can apply mechanical stimuli on the growing tissue, which mimics the mechanical environment in the knee joint. The broader impact is that the developed techniques are anticipated to treat degenerative joint diseases and prevent joint replacement surgeries, thus impacting nearly half of the population.","VA","8203276","2/14/2012 12:00:00 AM","RFA-RX-11-009","1IK2RX000760-01","1","IK2","RX","000760","01"," "," ","4/1/2012 12:00:00 AM","3/31/2017 12:00:00 AM","Career Development Program - Panel I[RRD8]"," ","10194380","BILGEN, BAHAR ","Not Applicable","02","Unavailable","182465745","GEANJU535YZ7","182465745","GEANJU535YZ7","US","41.833894","-71.433949","10018779","PROVIDENCE VA  MEDICAL CENTER","PROVIDENCE","RI","Independent Hospitals","029084734","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2017 12:00:00 AM","999","Other","2012"," "," "," "," "," "," "," ",
"No NIH Category available","Adult;Affect;Androgen Receptor;Androgen Response Element;Animal Model;Asthma;Atrophic;Binding;Binding Sites;Burn injury;Cell Culture Techniques;Cell Nucleus;Cell physiology;Cells;Chronic Obstructive Airway Disease;Commit;Communities;DNA;DNA Binding;DNA Sequence;Data;Denervation;Disease;Disuse Atrophy;Event;Fiber;Future;Gene Expression;Genes;Genetic Transcription;Hypertrophy;Immobilization;Immunohistochemistry;Injury;Knock-out;Knowledge;Ligand Binding;Ligands;Mediating;Medical;Mesenchymal Stem Cells;Messenger RNA;Molecular;Muscle;Muscle Fibers;Muscular Atrophy;Myoblasts;Nandrolone;Nerve;Nuclear Translocation;Paralysed;Pharmaceutical Preparations;Play;Proliferating;Proteolysis;Quality of life;Recovery;Response Elements;Role;Sequence Analysis;Signal Transduction;Site;Skeletal Muscle;Soldier;Speed;Spinal cord injury;Stroke;TCF Transcription Factor;Testing;Time;Transgenic Mice;Up-Regulation;Veterans;activating transcription factor;cell type;daughter cell;functional restoration;improved;inhibitor/antagonist;mRNA Stability;mouse model;muscle form;notch protein;overexpression;prevent;promoter;receptor;research study;restoration;satellite cell;self-renewal;tissue repair;transcription factor","Notch and Wnt signaling in protection by nandrolone against disuse atrophy","Muscle loss affects veterans with diverse medical conditions that include stroke, spinal cord injury, COPD, asthma and rheumatological disease. It also affects wounded soldiers during recovery from burns and/or immobilization resulting from their injuries. Knowledge that improves treatments to preserve or restore function of these veterans holds the potential to significantly improve the speed of their recovery, and, possibly, their quality of life and community function and integration. Medications that prevent muscle atrophy or promote restoration of muscle mass after illness or injury are not available. Knowledge regarding molecular and cellular processes that might be targets for future medications is thus highly relevant to veterans.","VA","8202501","2/10/2012 12:00:00 AM","RFA-RX-11-001","1I01RX000533-01A1","1","I01","RX","000533","01","A"," ","4/1/2012 12:00:00 AM","3/31/2016 12:00:00 AM","Spinal Cord Injury/Disorders & Neuropathic Pain[RRDA]"," ","6486155","CARDOZO, CHRISTOPHER ","Not Applicable","13","Unavailable","040077133","CZ6LSS7VPWY1","040077133","CZ6LSS7VPWY1","US","40.86905","-73.903112","481060","JAMES J PETERS VA  MEDICAL CENTER","BRONX","NY","Independent Hospitals","104683904","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2016 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Biotechnology; Cardiovascular; Clinical Research; Clinical Trials; Heart Disease; Heart Disease - Coronary Heart Disease; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Acute;Acute myocardial infarction;Adult;Age;Allogenic;Animal Model;Area;Autologous;Autologous Transplantation;Biological Preservation;Bone Marrow;CSF3 gene;Cardiac;Cardiac Myocytes;Cardiomyopathies;Cardiovascular Diseases;Cardiovascular system;Cell Therapy;Cell Transplantation;Cells;Chronic;Clinical;Clinical Trials;Clinical Trials Network;Communities;Diagnosis;Dose;Endothelial Cells;Engraftment;Functional disorder;Germ Layers;Heart failure;Homing;Hospitals;Human;Image;Infarction;Infusion procedures;Lead;Left Ventricular Function;Mechanics;Mesenchymal Stem Cells;Mononuclear;Morbidity - disease rate;Multi-Institutional Clinical Trial;Myocardial;Myocardial tissue;Myocardium;National Heart, Lung, and Blood Institute;Natural regeneration;Ohio;Outcome;Patients;Phase;Population;Pre-Clinical Model;Preparation;Prevention;Rattus;Recovery;Relative (related person);Reperfusion Therapy;Research Personnel;Risk Assessment;Role;Signal Transduction;Site;Skeletal Myoblasts;Smooth Muscle Myocytes;Stem cell transplant;Stem cells;Stromal Cell-Derived Factor 1;Testing;Therapeutic Studies;Therapy Clinical Trials;Time;Tissues;Translating;Transplantation;Universities;animal data;base;cell preparation;cell type;clinical practice;functional improvement;gene therapy;improved;injured;interest;mortality;novel strategies;patient safety;percutaneous coronary intervention;placebo controlled study;pre-clinical;programs;randomized trial;stem cell population;stem cell therapy;success;sudden cardiac death;tertiary care;vasculogenesis","Northeast Ohio Center for Cardiovascular Cell Therapy Research","n/a","NHLBI","8009507","3/22/2012 12:00:00 AM","RFA-HL-06-001","5U01HL087314-05","5","U01","HL","087314","05"," ","SKARLATOS, SONIA","1/1/2007 12:00:00 AM","3/31/2014 12:00:00 AM","ZHL1-CSR-N(O1)"," ","8606741","ELLIS, STEPHEN ","Not Applicable","11","INTERNAL MEDICINE/MEDICINE","135781701","M5QFLTCTSQN6","135781701","M5QFLTCTSQN6","US","41.479276","-81.680233","10000858","CLEVELAND CLINIC LERNER COM-CWRU","CLEVELAND","OH","SCHOOLS OF MEDICINE","441950001","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","284084","154825"," ","438909",
"No NIH Category available","Adult;Affect;Age;Allogenic;Aryl Hydrocarbon Receptor;Behavior;Bone Growth;Bone Regeneration;Carbon Monoxide;Cardiac;Cardiac Myocytes;Cardiovascular Diseases;Cartilage;Cells;Cephalic;Characteristics;Chondrocytes;Chronic;Development;Disease;Dorsal;Embryonic Development;Embryonic Stem Cell Transplantation;Engraftment;Exhibits;Fracture;Gene Expression;General Population;Germ Layers;Growth Factor;Healed;Hemoglobin concentration result;Human;Hypoxia;In Vitro;Knowledge;Life;Mechanics;Mesenchymal Stem Cells;Mus;Myocardial;Natural regeneration;Nature;Neural Crest;Neural tube;Nicotine;Organ;Osteogenesis;Pathology;Patients;Periodontal Diseases;Periodontal Ligament;Phenotype;Pluripotent Stem Cells;Population;Process;Proteins;Protocols documentation;Reporting;Research Project Grants;Risk Factors;Smoke;Smoker;Smoking;Source;Stem cells;Teratoma;Therapeutic Uses;Tissues;Tobacco Use Cessation;Veterans;adult stem cell;base;bone healing;cartilage repair;cigarette smoking;embryonic stem cell;healing;human embryonic stem cell;human tissue;immunogenic;implantation;improved;in vivo;induced pluripotent stem cell;nestin protein;non-smoker;oral tissue;pluripotency;programs;regenerative;regenerative therapy;response;skeletal;stem cell differentiation;stem cell population;tissue oxygenation;tissue regeneration;tissue repair;transcriptional coactivator p75;vasoconstriction","Effect of Smoking on Adult Stem Cell Differentiation","The pluripotent nature of PDL stem cells allows for regenerative therapies for various pathologies. It is unclear whether cigarette smoking affects endogenous stem cells. Since oral tissues are first to come in contact with smoking, this is a unique opportunity to examine the effect of smoking on the viability and regenerative potential of this unique population of pluripotent stem cell. A 1997 study comparing veteran and nonveteran smoking found 35% of all veterans were current smokers compared to 28% of the general population and 77% had smoked during their lifetime compared to 49% of the general population. This is later confirmed by Spigel's study (2007) and a VA report on National Smoking and Tobacco Use Cessation Program directive. Our proposal will add new knowledge of the effect of smoking on the viability and regenerative potential of adult stem cell.","VA","8141929","1/18/2012 12:00:00 AM","RFA-BX-10-006","1I01BX001227-01","1","I01","BX","001227","01"," "," ","1/1/2012 12:00:00 AM","12/31/2014 12:00:00 AM","Cellular and Molecular Medicine[CAMM]"," ","1877781","CHEUNG, HERMAN S","Not Applicable","24","Unavailable","079275714","U2J7L7Y9NAJ6","079275714","U2J7L7Y9NAJ6","US","25.757864","-80.214254","481022","MIAMI VA HEALTH CARE SYSTEM","MIAMI","FL","Independent Hospitals","331251624","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human","Address;Adhesives;Affect;Affinity Chromatography;Anabolism;Attention;Automobile Driving;Binding;Biochemical;Biological Assay;Blood;Bone Marrow;Bone Marrow Diseases;CD34 gene;CD44 gene;CSF3 gene;Cell Adhesion Molecules;Cell Differentiation process;Cell surface;Cells;Clinical;Collaborations;Complication;Cues;Custom;Development;Elements;Engineering;Erythroid;Failure;Far-Western Blotting;Flow Cytometry;Fucose;Fucosidase;Glycobiology;Glycoside Hydrolases;Goals;Growth;Hematopoiesis;Hematopoietic;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Human;In Vitro;Infection;Instruction;Lectin;Leukocytes;Licensing;Life;Ligands;Lipids;Malignant Neoplasms;Marrow;Measures;Mediating;Mesenchymal Stem Cells;Metabolic;Modification;Morbidity - disease rate;Myelogenous;Myeloproliferation;Neuraminidase;Neutropenia;Polysaccharides;Process;Production;Property;Proteins;Reaction;Recovery;Regimen;Research;Secondary to;Sialic Acids;Source;Specific qualifier value;Staging;Stem cells;Stromal Cells;Structure;Surface;Techniques;Therapeutic Uses;To specify;Umbilical Cord Blood;Variant;Western Blotting;base;cancer therapy;combinatorial;glycosyltransferase;granulocyte;in vitro activity;in vivo;inhibitor/antagonist;lactosamine;leukemia;mortality;peripheral blood;progenitor;programs;receptor;scaffold;stem;structural biology","FUNCTION OF LACTOSAMINYL GLYCANS IN EARLY HEMATOPOIETIC AND MYELOPOIETIC CELLS","RELEVANCE (See instructions): 
Low levels of white blood cells can result In life-threatening infections. Deficiency of white blood cells is a common complication of cancer therapy and can also occur with bone marrow diseases. Information obtained from this research effort will provide important information on how white blood cells are made, and should pave the way for new treatments to increase white blood cell production when needed.","NHLBI","8376509","5/31/2012 12:00:00 AM","RFA-HL-10-026","5P01HL107146-02","5","P01","HL","107146","02"," "," "," "," ","ZHL1-CSR-H","6916","1899770","SACKSTEIN, ROBERT ","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","788188","788188"," ","441562","346626"," "," ",
"Genetics; Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human","Adult;BMP4;Blood;Blood Cell Count;Blood Cells;Bone Marrow;Bone Marrow Cells;CD34 gene;Cell Culture Techniques;Cell Line;Cell surface;Cells;Characteristics;Clonal Expansion;Clonal Hematopoietic Stem Cell;DNA Transposons;Data;Derivation procedure;Development;Disease;ES Cell Line;ES01;Exhibits;Fibroblasts;Functional disorder;Funding;Gene Mutation;Genes;Genetic Models;Hematological Disease;Hematopoietic;Hematopoietic stem cells;Human;Inherited;Investigation;Laboratories;Lead;Leukocytes;Link;Marrow;Mesenchymal Stem Cells;Methodology;Methods;Modeling;Molecular Profiling;Mutate;Mutation;PTPRC gene;Paper;Patients;Phosphatidylinositols;Pluripotent Stem Cells;Process;Proteins;Protocols documentation;Publishing;Reporting;Research;Retroviral Vector;Role;Sickle Cell Anemia;Signal Pathway;Somatic Cell;Somatic Mutation;Stromal Cells;System;Testing;Tissues;Umbilical Cord Blood;Virus;base;blastocyst;cell type;clinical application;developmental genetics;embryonic stem cell;human embryonic stem cell;human stem cells;improved;induced pluripotent stem cell;notch protein;novel;peripheral blood;pluripotency;postnatal human;prospective;public health relevance;rat Piga protein;stem;success;vector","Directed hematopoietic differentiation of human pluripotent stem cells","
This study focuses on hematopoietic differentiation from human pluripotent stem cells.
We will establish a novel prospective model using human stem cells to better understand
clonal dominance and other puzzling pathophysiology of paroxysmal nocturnal
hemoglobinuria (PNH), which has not been adequately answered by existing models.
This study will also help us to establish a universal method to study dozens of other
somatic blood diseases as well as inherited blood diseases such as sickle cell anemia.","NHLBI","8320184","8/1/2012 12:00:00 AM","PA-08-043","5R01HL073781-09","5","R01","HL","073781","09"," ","THOMAS, JOHN","9/1/2003 12:00:00 AM","8/31/2014 12:00:00 AM","Hematopoiesis Study Section[HP]"," ","6713373","CHENG, LINZHAO ","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","254227","162705"," ","416932",
"Facioscapulohumeral Muscular Dystrophy; Genetics; Muscular Dystrophy; Neurosciences; Rare Diseases; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Affect;Alleles;Area;Autologous Transplantation;Binding;Binding Sites;Biological Assay;Biopsy;Cell Culture Techniques;Cell Line;Cells;Chromatin;Chromatin Structure;Cis-Acting Sequence;Collaborations;D4Z4;DNA Methylation;Data;Dependovirus;Development;Disease model;Engineering;Enhancers;Epigenetic Process;Facioscapulohumeral Muscular Dystrophy;Fibroblasts;Functional disorder;Gene Expression;Gene Expression Profile;Genes;Genetic Recombination;Genetic Transcription;Genome Stability;Genotype;Goals;Haplotypes;Histocompatibility Testing;Histones;Human;Individual;LacZ Genes;Length;Lentivirus Vector;Mediating;Mesenchymal Stem Cells;Methylation;Modeling;Modification;Mus;Muscle;Muscle Cells;Mutate;Mutation;Myoblasts;NOD/SCID mouse;Nuclear;Nucleic Acid Regulatory Sequences;Parents;Pathogenesis;Pathway interactions;Patients;Pattern;Phenotype;Population;Process;Protocols documentation;Publications;Publishing;RNA;Regulation;Repression;Retrotransposition;Role;Signal Transduction;Skeletal Myoblasts;Skin;Teratoma;Testing;Therapeutic Intervention;Tissues;Toxic effect;Transcript;Transcriptional Regulation;Transcriptional Silencer Elements;Transfection;Transgenic Mice;Transplantation;Variant;cell type;design;dosage;embryonic antigen;embryonic stem cell;human embryonic stem cell;induced pluripotent stem cell;member;programs;promoter;research study;stem cell technology;therapeutic target;transcription factor;treatment strategy;vector","FSH-Patient Derived IPS Cells to Study the Developmental Regulation of DUX4 Trans","The significance of these studies is that an understanding of normal and pathogenic developmental 
patterns of DUX4 transcriptional regulation will provide a model for disease pathophysiology and help identify therapeutic targets for treatment.","NINDS","8376796","2/28/2012 12:00:00 AM"," ","5P01NS069539-03","5","P01","NS","069539","03"," "," "," "," ","Neurological Sciences and Disorders B Study Section[NSD-B]","6885","1939329","MILLER, DANIEL G","Not Applicable","07","Unavailable","078200995","HMSNCM57QNR5","078200995","HMSNCM57QNR5","US","47.628707","-122.330795","861001","FRED HUTCHINSON CANCER RESEARCH CENTER","SEATTLE","WA","Research Institutes","981094433","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","241818","241818"," ","241818","0"," "," ",
"Cardiovascular; Diabetes; Hypertension; Nutrition; Obesity; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acids;Adipocytes;Adipose tissue;Agonist;Animal Model;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Attenuated;Blood Pressure;Blood Vessels;Bone Marrow;Cardiovascular Diseases;Cells;Clinical;Cytochrome P450;Data;Development;Diabetes Mellitus;Diet;Event;Fatty acid glycerol esters;Functional disorder;Gene Deletion;Health;Heme;Homeostasis;Hyperglycemia;Hypertension;In Vitro;Inflammatory;Injury;Insulin Resistance;Interleukin-6;Lead;Life Expectancy;Link;Mediating;Mesenchymal Stem Cells;Metabolic syndrome;Molecular;Mus;Nonesterified Fatty Acids;Obesity;Oxygenases;Pathway interactions;Patients;Phenotype;Plasma;Production;Proteins;Quality of life;Reactive Oxygen Species;Regulation;Resistance;Risk Factors;Role;Signal Transduction;Stem cells;System;Testing;Tissue Expansion;Translating;Up-Regulation;Vascular Diseases;Weight Gain;adipokines;adiponectin;base;cytokine;expectation;feeding;fighting;glucose uptake;heme oxygenase-2;hormone regulation;improved;inhibitor/antagonist;insight;lipid biosynthesis;novel;overexpression;prevent;response;therapeutic development","HO-EET Regulation of Adipocyte- Vascular Interactions","Understanding the cellular and molecular mechanisms governing adipocyte-vascular interactions will lead to the development of therapeutic strategies to fight vascular dysfunction and hypertension seen in obesity with the expectation that this will result in improving the quality of life and life expectancy of the obese, insulin resistant patients.","NHLBI","8376615","3/21/2012 12:00:00 AM"," ","5P01HL034300-27","5","P01","HL","034300","27"," "," "," "," ","Heart, Lung, and Blood Program Project Study Section[HLBP]","6733","1882782","ABRAHAM, NADER G.","Not Applicable","17","Unavailable","041907486","WK63UJ11C2H7","041907486","WK63UJ11C2H7","US","41.086078","-73.784459","5948901","NEW YORK MEDICAL COLLEGE","VALHALLA","NY","Domestic Higher Education","105951524","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","409018","409018"," ","405032","3986"," "," ",
"Diabetes; Neurosciences; Nutrition; Obesity","2,4-thiazolidinedione;Adipocytes;Adipose tissue;Agonist;Amino Acids;Artificial Sweeteners;Blood Vessels;Carbohydrates;Cells;Cultured Cells;Cyclic AMP;Data;Development;Endocrine;Fatty Acids;Fatty acid glycerol esters;G-Protein-Coupled Receptors;Glucocorticoid Receptor;Hydrocortisone;Hydroxybutyrates;Hyperplasia;Hypertrophy;In Vitro;Insulin;Insulin-Like Growth Factor I;Knockout Mice;Ligands;Light;Lipolysis;Literature;Mediating;Mesenchymal Stem Cells;Metabolic;Metabolic syndrome;Metabolism;Mus;Non-Insulin-Dependent Diabetes Mellitus;Nutrient;Obesity;Phosphodiesterase Inhibitors;Phosphorylation;Play;Process;Receptor Activation;Regulation;Repression;Research;Research Personnel;Research Proposals;Role;Saccharin;Sensory Receptors;Serum;Signal Pathway;Signal Transduction;Small Intestines;Succinates;Sweetening Agents;Taste Perception;Testing;Thiazolidinediones;Tongue;Volatile Fatty Acids;Work;adipocyte differentiation;base;fetal;improved;in vivo;insight;lipid biosynthesis;long chain fatty acid;nutrition;preference;programs;receptor;response;sterol esterase;sweet taste perception;tongue papilla","Role of Sweet Taste Receptors in Adipocyte Differentiation and Metabolism"," The proposed research will increase our understanding of how activation of sweet taste receptors by artificial sweeteners (e.g. saccharin) and naturally occurring metabolites regulates expansion of white fat through effects on both development and metabolism of fat cells. Understanding these processes may provide insights into the increase in adipocyte number and size that occurs with obesity, and also shed light on how obesity predisposes to metabolic complications such as type II diabetes.   
      

","NIDDK","8329028","5/24/2012 12:00:00 AM","PA-10-152","1R01DK095705-01","1","R01","DK","095705","01"," ","HAFT, CAROL R","6/1/2012 12:00:00 AM","3/31/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-EMNR-E(02)M]"," ","1888062","MACDOUGALD, ORMOND A","Not Applicable","12","PHYSIOLOGY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","6/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","212500","112748"," ","325248",
"Biotechnology; Neurosciences; Patient Safety; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Address;Adult;Animals;Astrocytes;Astrocytoma;Biochemical;Biological Assay;Biological Models;Biotechnology;Cell Culture System;Cell Culture Techniques;Cell Differentiation process;Cell Line;Cell Survival;Cells;Chemical Engineering;Chemicals;Development;Drug toxicity;Engineering;Environment;Environmental Health;Evaluation;Exposure to;Extracellular Matrix;Glial Fibrillary Acidic Protein;Goals;Growth;Health;Homeostasis;Human;Human body;Immunofluorescence Immunologic;In Vitro;Individual;MAP Kinase Gene;Mesenchymal Stem Cells;Methods;Nature;Neurons;Organ;Osteocalcin;Outcome;Outcome Study;Pathway interactions;Performance;Pharmaceutical Preparations;Phase;Play;Poison;Property;Research;Resources;Role;Safety;Screening procedure;Series;Signal Pathway;Staging;Stem cells;Techniques;Technology;Testing;Tissues;Toxic effect;Toxicology;Transformed Cell Line;Transport Process;Work;adult stem cell;base;biochip;cell behavior;cell type;combinatorial;cytotoxicity;drug candidate;drug discovery;environmental chemical;high throughput screening;human adult stem cell;human stem cells;in vivo;nerve stem cell;nestin protein;response;self-renewal;stem cell biology;stem cell differentiation;stem cell fate;stem cell niche;tool;toxicant","High-Throughput Platform for Identifying Stem Cell Toxicity","  The proposed effort impacts human health by understanding the critical differences that chemical toxicants (e.g., drugs, environmental chemicals, etc.) have on human adult stem cells in relation to non-stem cells. A wealth of information on specific responses of different human adult stem cells will be obtained as a result of exposure to various known chemical toxicants. In addition, a new high-throughput screening tool will be developed for predictive human toxicology. This work will facilitate the use of stem cells in environmental health screening and in early-stage drug toxicity screening because of the critical role self-renewing stem cells play in the health of an individual.  
    

","NIEHS","8217894","1/1/2012 12:00:00 AM","PA-10-067","1R01ES020903-01","1","R01","ES","020903","01"," ","REINLIB, LESLIE J","12/23/2011 12:00:00 AM","10/31/2015 12:00:00 AM","Instrumentation and Systems Development Study Section[ISD]"," ","1883175","DORDICK, JONATHAN S.","SCHAFFER, DAVID V","20","ENGINEERING (ALL TYPES)","002430742","U5WBFKEBLMX3","002430742","U5WBFKEBLMX3","US","42.731447","-73.683872","6910301","RENSSELAER POLYTECHNIC INSTITUTE","TROY","NY","BIOMED ENGR/COL ENGR/ENGR STA","121803590","UNITED STATES","N","12/23/2011 12:00:00 AM","10/31/2012 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","NIEHS","397016","127967"," ","524983",
"No NIH Category available","Address;Ambystoma;Behavior;Candidate Disease Gene;Cell Differentiation process;Cells;Characteristics;Congenital Abnormality;Data;Defect;Development;Dominant-Negative Mutation;Dorsal;Embryonic Development;Epithelial;Genes;Goals;Growth;Human;Image;Image Analysis;Lateral;Learning;Libraries;Life;Ligands;Limb Bud;Limb Development;Limb structure;Measurement;Mesenchymal;Mesenchyme;Microscopy;Molecular;Morphogenesis;Mus;Mutant Strains Mice;Natural regeneration;Pattern;Play;Population;Primordium;Process;Retroviral Vector;Role;Shapes;Signal Transduction;Staging;Technology;Testing;Time;Tissues;behavior influence;cell behavior;cell motility;cell type;design;directional cell;extracellular;interest;malformation;migration;public health relevance;reconstruction;regenerative;two-photon","Lineage and cell migration in patterning the limb primordium","
Narrative:
We are studying the contribution of lineage and cell migration to the pattering of the limb bud. Congenital limb
malformations are among the most common human birth defects, many, if not most, of which are attributable to
defects in the proper establishment of the limb pattern. Moreover, the general lessons we learn about the
integration of cellular behavior and extracellular signaling in organizing the limb, will serve as paradigms for
understanding these processes during embryogenesis.","NICHD","8291903","4/18/2012 12:00:00 AM","PA-07-070","5R01HD045499-08","5","R01","HD","045499","08"," ","JAVOIS, LORETTE CLAIRE","8/10/2005 12:00:00 AM","5/31/2015 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","1887350","TABIN, CLIFFORD J.","Not Applicable","07","GENETICS","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","SCHOOLS OF MEDICINE","021201616","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","265883","175351"," ","441234",
"Biotechnology; Cancer; Genetics","11q22;Apoptosis;Cancer Cell Growth Regulation;Cell Death;Cell Proliferation;Cell Proliferation Regulation;Cell physiology;Cells;Contact Inhibition;Cyclin E;Data;Development;Drosophila genus;Epithelial;Gene Expression;Gene Expression Regulation;Gene Targeting;Genetic;Genetic Transcription;Goals;Homologous Gene;Human;Human Chromosomes;Human Development;Inhibition of Apoptosis;Malignant Neoplasms;Malignant neoplasm of liver;Malignant neoplasm of prostate;Mammalian Cell;Mediating;Mesenchymal;MicroRNAs;Molecular;Mutation;Neurofibromatosis 2;Oncogene Proteins;Oncogenes;Oncogenic;Organ Size;PRDM4 gene;Pathway interactions;Phosphorylation Inhibition;Play;Protein Kinase;Proteins;Regulation;Role;Signal Pathway;Testing;Tumor Suppressor Proteins;Work;cIAP1 protein;member;mutant;novel;protein function;public health relevance;response;transcription factor;tumorigenesis","Regulation and function of the YAP transcription co-activator oncoprotein","n/a","NCI","8215749","3/15/2012 12:00:00 AM","PA-07-070","5R01CA132809-05","5","R01","CA","132809","05"," ","WATSON, JOANNA M","4/8/2008 12:00:00 AM","2/28/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-ICI-D(01)Q]"," ","1883101","GUAN, KUN-LIANG ","Not Applicable","52","PHARMACOLOGY","804355790","UYTTZT6G9DT1","804355790","UYTTZT6G9DT1","US","32.881785","-117.236973","577507","UNIVERSITY OF CALIFORNIA, SAN DIEGO","LA JOLLA","CA","SCHOOLS OF MEDICINE","920930621","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","109695"," ","310970",
"Biotechnology; Breast Cancer; Cancer","Adjuvant;Antineoplastic Agents;Bone Marrow;Bone Marrow Cells;Breast Cancer Cell;Cancer cell line;Cell Culture System;Cell Culture Techniques;Cell Line;Cells;Cessation of life;Characteristics;Clinical;Communities;Data;Development;Diagnosis;Disease;Drug Delivery Systems;Drug Kinetics;Drug resistance;Drug usage;Endothelium;Frequencies;Heterogeneity;Human;Human Cell Line;Hypoxia;Image Analysis;Imaging Techniques;In Vitro;Lead;Lung;Malignant Neoplasms;Mammary Neoplasms;Measures;Mesenchymal Stem Cells;Methods;Modeling;Molecular;Monitor;Mus;Neoplasm Metastasis;New Agents;Osteoblasts;Outcome;Oxygen measurement, partial pressure, arterial;Patients;Pharmaceutical Preparations;Physiological;Physiology;Postoperative Period;Primary Neoplasm;Proliferating;Prostate;Recurrence;Recurrent Malignant Neoplasm;Recurrent disease;Relapse;Relative (related person);Reporter;Research;Risk;Sampling;Signal Pathway;Signal Transduction;Site;Solid;Specimen;Stromal Cells;System;Technology;Testing;Time;Translations;Treatment Protocols;Tumor Subtype;Xenograft procedure;anticancer research;cancer cell;cancer therapy;cancer type;cell type;chemotherapy;cost;cytokine;cytotoxicity;drug development;drug efficacy;drug testing;imaging modality;improved;in vivo;innovation;malignant breast neoplasm;molecular imaging;mortality;mouse model;neoplastic cell;optical imaging;outcome forecast;prevent;response;self-renewal;tumor","Modeling Therapy of Disseminated Cancer Cells in Bone Marrow (PQ 17)"," This research will develop an improved approach for testing potential new drugs against breast cancer cells in bone marrow, a common site of metastatic disease. Our approach can be used for many other types of cancer, so this research will lead to better therapies for multiple patients.   
      

","NCI","8374192","8/17/2012 12:00:00 AM","RFA-CA-11-011","1R01CA170198-01","1","R01","CA","170198","01"," ","ALLEY, MICHAEL C","9/1/2012 12:00:00 AM","6/30/2016 12:00:00 AM","ZCA1-SRLB-9(M1)"," ","1974298","LUKER, GARY D","TAKAYAMA, SHUICHI ","12","RADIATION-DIAGNOSTIC/ONCOLOGY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","9/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","247933","130693"," ","378626",
"Biotechnology; Genetics; Human Genome; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","3T3-L1 Cells;Accounting;Adipocytes;Affect;Area;Bioinformatics;Biological Assay;Biological Markers;Cardiovascular Diseases;Cell Count;Cell Differentiation process;Cell Line;Cell Nucleus;Cell Proliferation;Cells;Code;Computing Methodologies;Data;Data Set;Development;Diabetes Mellitus;Disease;Epigenetic Process;Event;Expressed Sequence Tags;Foundations;Functional RNA;Future;Gene Expression Profile;Gene Expression Regulation;Genes;Genetic Transcription;Genome;Genomics;Grant;Human;Human Genome;Light;Mammals;Mesenchymal Stem Cells;Methods;Molecular;Molecular Biology;Mus;Non-Insulin-Dependent Diabetes Mellitus;Northern Blotting;Obesity;Play;Process;Proteins;Public Health;RNA;RNA Processing;RNA analysis;Regulation;Reporting;Research;Role;Signal Transduction;Solid;Staging;Structure;Time;Transcript;Untranslated RNA;Validation;chromatin remodeling;experience;genome-wide;human disease;knock-down;lipid biosynthesis;mammalian genome;mouse genome;novel;precursor cell","Long Non-coding RNAs in Adipogenesis"," Adipocytes have many implications for human diseases. Aberration in fat cell number leads to obesity, which is rapidly becoming a serious public health problem around the world, and is related to other common diseases, such as type II diabetes and cardiovascular diseases. Adipogenesis is the process that generates adipocytes from precursor cells, which involves a cascade of signaling events leading to regulation of genes that play roles in cell proliferation and differentiation. In this grant, we will identify and examine long noncoding RNAs (lncRNAs), which are increasingly found to be associated with various key functions in the cell. However, their roles in adipogenesis are completely unclear.  
    

","NIDDK","8227004","12/2/2011 12:00:00 AM","PA-10-069","1R21DK094207-01","1","R21","DK","094207","01"," ","HAFT, CAROL R","12/5/2011 12:00:00 AM","11/30/2013 12:00:00 AM","Cellular Aspects of Diabetes and Obesity Study Section[CADO]"," ","7856818","TIAN, BIN ","Not Applicable","10","BIOCHEMISTRY","623946217"," ","623946217"," ","US","40.738771","-74.190235","714201","UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL","NEWARK","NJ","SCHOOLS OF MEDICINE","071032757","UNITED STATES","N","12/5/2011 12:00:00 AM","11/30/2012 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","125000","70000"," ","195000",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adhesions;Adolescent;Adult;Age;Aging;Anabolism;Animal Model;Animals;Appearance;Attenuated;Autologous;Behavior;Biological;CD Antigens;Cell Separation;Cell Size;Cell Surface Receptors;Cell Survival;Cell Therapy;Cell-Matrix Junction;Cells;Cellular Morphology;Characteristics;Clinical;Coculture Techniques;Conditioned Culture Media;Development;Extracellular Matrix;Family suidae;Flow Cytometry;Fluorescence;Fluorescence-Activated Cell Sorting;Foundations;Human;In Vitro;Integrins;Intervertebral disc structure;Laminin;Maintenance;Mesenchymal Stem Cells;Messenger RNA;Methods;Microscopy;Molecular;Molecular Profiling;Morphology;Natural regeneration;Pain;Pathology;Patients;Pattern;Phenotype;Play;Population;Protein Biosynthesis;Proteins;Proteoglycan;Protocols documentation;Rat-1;Rattus;Receptor Cell;Role;Signaling Molecule;Sorting - Cell Movement;Spinal Cord;Stem cells;Technology;Testing;Tissues;Translations;Work;age effect;aged;animal tissue;base;behavior measurement;cell type;design;disc regeneration;human tissue;implantation;in vivo;interest;intervertebral disk degeneration;mRNA Expression;molecular marker;molecular phenotype;notochord;novel;nucleus pulposus;precursor cell;protein expression;public health relevance;receptor;regenerative;regenerative therapy;spine bone structure;therapeutic target","Developing Immature Nucleus Pulposus Cells for Regenerative Therapy","
NARRATIVE
Intervertebral disc degenerative disorders and resulting pain may be associated with aging- or pathology-
related cell loss, and changes in cell phenotype. Cellular therapies for biologically-driven regeneration of
intervertebral disc are of great interest, whereby disc cells from human patients or progenitor cells are used to
generate new matrix in vitro or following re-implantation in vivo. This project will use a cell sorting technology
to identify a population of disc cells which retain characteristics of an immature cell phenotype, and to
investigate the key contributors or therapeutic targets for maintaining this immature cell-like phenotype and
matrix synthesis during cell regeneration.","NIAMS","8315906","8/9/2012 12:00:00 AM","PA-07-070","5R01AR057410-04","5","R01","AR","057410","04"," ","WANG, FEI","9/28/2009 12:00:00 AM","8/31/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","7624497","CHEN, JUN ","Not Applicable","04","ORTHOPEDICS","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","149688","83825"," ","233513",
"Osteoporosis","AXIN2 protein;Ablation;Affect;Attention;Binding Proteins;Biological Process;Bone Diseases;Bone Marrow;Bone Matrix;Bone Resorption;Bone remodeling;Cells;Complex;Development;Disease;Ensure;Equilibrium;Fostering;Fracture;Genetic Transcription;Growth Factor;Homeodomain Proteins;Homeostasis;Hormones;Human;In Vitro;Investigation;Knowledge;LDL-Receptor Related Protein 1;Lead;Malignant Neoplasms;Mediating;Mesenchymal Stem Cells;Molecular;Morbidity - disease rate;Mus;Mutation;Osteoblasts;Osteoclasts;Osteocytes;Osteogenesis;Osteoporosis;Pharmaceutical Preparations;Phenotype;Physiological;Physiological Processes;Physiology;Play;Prevention;Process;Protein Kinase;Regulation;Research;Research Proposals;Risk;Role;Signal Pathway;Signal Transduction;Skeletal Development;Syndrome;Therapeutic;Transcription Repressor/Corepressor;Transforming Growth Factor beta;Transgenic Mice;Two-Hybrid System Techniques;Ubiquitin;Work;Yeasts;bone;bone mass;cytokine;design;drug discovery;gain of function;improved;in vivo;insight;lipoprotein receptor related protein 5;loss of function;loss of function mutation;mineralization;mortality;mouse model;osteoblast differentiation;programs;public health relevance;receptor;response;scaffold;selective expression;skeletal disorder","Role of TGIF in Wnt-Induced Bone Formation","
Wnt signaling fosters osteoblast proliferation and differentiation, and perturbations of this signaling pathway
affect bone homeostasis, resulting in bone disorders in human. We discovered that a physiological function of
the homeodomain protein TGIF is to ensure proper osteoblast cell fate determination in response to Wnt
signaling. We believe that functional characterization of his newly discovered regulator of bone formation will
open a new field of investigation both in terms of understanding the mechanisms that regulate osteoblasts and
their bone matrix-secreting activity and in terms of drug discovery with the hope to improve the treatment of
osteoporosis and other low bone mass syndromes.","NIAMS","8293431","6/29/2012 12:00:00 AM","PA-10-067","5R01AR059070-04","5","R01","AR","059070","04"," ","CHEN, FAYE H","9/10/2010 12:00:00 AM","6/30/2015 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","9977356","ATFI, AZEDDINE ","Not Applicable","03","BIOCHEMISTRY","928824473","X59NJBFL8BJ3","928824473","X59NJBFL8BJ3","US","32.328724","-90.175537","5390304","UNIVERSITY OF MISSISSIPPI MED CTR","JACKSON","MS","SCHOOLS OF MEDICINE","392164500","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","216000","106920"," ","322920",
"Arthritis; Bioengineering; Clinical Research; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Adult;Affect;American;Area;Arthritis;Basic Science;Benchmarking;Biological;Biology;Biomedical Engineering;Biotechnology;Bone Growth;Bone Regeneration;Calcium;Cartilage;Cartilage Diseases;Center for Translational Science Activities;Centers of Research Excellence;Chondrocytes;Clinical;Core Facility;Crystal Formation;Degenerative polyarthritis;Discipline;Disease;Engineering;Environment;Equipment;Extramural Activities;Faculty;Fatty acid glycerol esters;Funding;Generations;Genes;Goals;Grant;Harvest;Health;Hospitals;Housing;Joints;Laboratories;Life;Mechanics;Medicine;Mentors;Mentorship;Mesenchymal Stem Cells;Molecular;Molecular Biology;Molecular Medicine;Orthopedics;Pathway interactions;Peer Review;Pharmacology;Phase;Physiology;Pilot Projects;Prevalence;Prevention;Prevention strategy;Principal Investigator;Recruitment Activity;Research;Research Infrastructure;Research Personnel;Research Project Grants;Rhode Island;Scientist;Side;Skeletal Development;Stem cells;Tissue Engineering;Tissues;Training Programs;Translational Research;United States National Institutes of Health;Universities;Ursidae Family;Vision;Work;aged;arthropathies;articular cartilage;base;career;cost;disability;human FRAP1 protein;interdisciplinary approach;long bone;medical schools;meetings;member;molecular imaging;multidisciplinary;novel strategies;programs;public health relevance;repaired;role model;skeletal;success","COBRE for Skeletal Health and Repair","PUBLIC HEALTH RELEVANCE (provided by applicant): Cartilage and joint diseases, a research focus of our COBRE, are a leading cause of disability nationally, affecting an estimated 46.4 million U.S. citizens -more than one in every five adults aged 18 or older. The alarming figures of cartilage and joint diseases are compounded by the enormous costs we bear for arthritis treatment, its complications and the resulting disability. The prevalence of the join disease rates illustrates the significance for research, treatment, and prevention of these debilitating diseases.","NIGMS","8337517","9/10/2012 12:00:00 AM","PAR-09-180","9P20GM104937-06","9","P20","GM","104937","06"," ","LIU, YANPING","9/10/2007 12:00:00 AM","8/31/2017 12:00:00 AM","ZRR1-RI-B(01)"," ","1882224","CHEN, QIAN ","Not Applicable","01","Unavailable","075710996","N876TLXYGCG4","075710996","N876TLXYGCG4","US","41.820682","-71.412855","6959701","RHODE ISLAND HOSPITAL","PROVIDENCE","RI","Independent Hospitals","029034923","UNITED STATES","N","9/10/2012 12:00:00 AM","8/31/2013 12:00:00 AM","859","Research Centers","2012"," "," ","NIGMS","2281323","614805"," ","2192326",
"Breast Cancer; Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","AMD3100;Academia;Address;Affinity;Amines;Animal Model;Attention;Attenuated;Binding;Biological Assay;Biological Availability;Bone Marrow;CXC Chemokines;Cancer Etiology;Cancerous;Carrageenan;Cells;Cessation of life;Chemicals;Clinic;Clinical;Cyclic AMP;Dependency;Development;Disease;Disseminated Malignant Neoplasm;Distant;Dose;Drug Kinetics;Edema;Endothelium;Fibrosis;Foundations;Growth;High Pressure Liquid Chromatography;Homing;Human;In Vitro;Industry;Inflammation;Intervention;Lead;Lesion;Life Extension;Ligands;Liver;Long-Term Effects;Lung;Malignant Neoplasms;Maps;Marketing;Matrigel Invasion Assay;Mesenchymal Stem Cells;Modeling;Morbidity - disease rate;Neoplasm Metastasis;Oral;Organ;Outcome;Pattern;Pharmaceutical Preparations;Physiology;Plasma;Play;Process;Pyrimidine;Quantitative Structure-Activity Relationship;Research;Role;Screening procedure;Signal Transduction;Site;Solid Neoplasm;Specificity;Stem cells;Stromal Cell-Derived Factor 1;Stromal Neoplasm;Structure;Testing;Therapeutic;Time;Tissues;Toxic effect;Transgenic Organisms;Transplantation;analog;base;chemokine receptor;design;drug candidate;improved;in vivo;in vivo Model;inhibitor/antagonist;lymph nodes;macrophage;malignant breast neoplasm;matrigel;metabolic abnormality assessment;metastatic process;mortality;mouse model;neoplastic cell;novel;programs;research clinical testing;scaffold;small molecule;tumor","Development of anti-CXCR4 compounds to block breast cancer metastasis","  The intended outcome of this proposal is the development of orally available, safe, small molecules that will attenuate breast cancer metastasis in vivo by blocking a specific function of CXCR4 whilst demonstrating a sufficient pharmacokinetic and specificity profile to merit advancement into human clinical evaluation.  
    

","NCI","8250523","3/9/2012 12:00:00 AM","PA-10-067","1R01CA165306-01","1","R01","CA","165306","01"," ","FU, YALI","3/9/2012 12:00:00 AM","2/28/2017 12:00:00 AM","Drug Discovery and Molecular Pharmacology Study Section[DMP]"," ","1874950","SHIM, HYUNSUK ","Not Applicable","05","RADIATION-DIAGNOSTIC/ONCOLOGY","066469933","S352L5PJLMP8","066469933","S352L5PJLMP8","US","33.762977","-84.42296","2384501","EMORY UNIVERSITY","ATLANTA","GA","SCHOOLS OF MEDICINE","303224250","UNITED STATES","N","3/9/2012 12:00:00 AM","2/28/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","237794","127646"," ","365440",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","3-Dimensional;Adopted;Adult;Animals;Architecture;Autologous;Binding;Biocompatible Materials;Biomedical Engineering;Bioreactors;Cartilage;Cell Survival;Cells;Chemicals;Chondrocytes;Chondrogenesis;Complex;Coupled;Coupling;Cues;Data;Degenerative polyarthritis;Deposition;Development;Diffusion;Disease;Doctor of Philosophy;Embryo;Encapsulated;Engineering;Environment;Extracellular Matrix;Funding;Future;Gel;Gene Expression;Growth;Growth Factor;Healed;Health;Hyaluronic Acid;Hydrogels;Hydrolysis;In Vitro;Incidence;Investigation;Joints;K22 Award;Laboratories;Lead;Mechanics;Mesenchymal Stem Cells;Methods;Modeling;Molecular;Motion;Orthopedic Surgery procedures;Orthopedics;Pathologist;Patients;Pattern;Physiological;Process;Production;Property;Publications;Regimen;Research;Research Project Grants;Signal Transduction;Skeletal Development;Slide;Staging;Structure;Surface;Surgeon;System;Techniques;Testing;Tissue Engineering;Tissues;Trauma;United States National Institutes of Health;Variant;Weight-Bearing state;Work;abstracting;articular cartilage;base;career;cartilage development;cartilage regeneration;cartilage repair;clinically relevant;conditioning;crosslink;density;design;healing;implantation;in vivo;innovation;joint injury;joint loading;novel;novel strategies;preconditioning;receptor;receptor binding;repaired;response;scaffold;subcutaneous","Engineering Developmental Microenvironments: Cartilage Formation and Maturation","
Project Narrative
This project develops a clinically-relevant approach to cartilage repair using MSC-laden hydrogels with temporally
controlled structures subjected to physiologic mechanical conditioning to mimic the developmental paradigm of
tissue formation and maturation that occurs from the embryo to adulthood. This biomaterial system provides
receptor-matrix interactions, controlled mechanics, and tailored degradation profiles to enhance the differentiation of
encapsulated MSCs and the accumulation and distribution of formed extracellular matrix (ECM). If successful, this
approach would surmount a major hurdle in cartilage tissue engineering to provide a more structurally relevant ECM
with enhanced mechanical properties to support the intense loads found in the joint. This cartilage tissue
engineering technique could aid in the treatment of millions of patients afflicted with debilitating cartilage loss and
degeneration due to trauma or disease.","NIBIB","8223126","3/8/2012 12:00:00 AM","PA-07-279","5R01EB008722-04","5","R01","EB","008722","04"," ","HUNZIKER, ROSEMARIE","4/13/2009 12:00:00 AM","2/28/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","7261809","BURDICK, JASON A","MAUCK, ROBERT L","03","BIOMEDICAL ENGINEERING","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","BIOMED ENGR/COL ENGR/ENGR STA","191046205","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","251688","126654"," ","378342",
"Biotechnology; Clinical Research; Gene Therapy; Genetics; Osteogenesis Imperfecta; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Achievement;Adipose tissue;Affect;Alleles;Antibodies;Base Pairing;Biological Assay;CD34 gene;COL1A1 gene;COL1A2 gene;Cartilage;Cell Line;Cells;Cessation of life;Chromosome abnormality;Clinical;Collagen Diseases;Collagen Fibril;Collagen Gene;Collagen Type I;Deformity;Dependovirus;Development;Disease;Dominant-Negative Mutation;Exons;Fracture;Frequencies;Gene Expression Regulation;Gene Targeting;Gene Transduction Agent;Genes;Genetic Recombination;Genetic Transcription;Goals;Human;Human Cell Line;In Vitro;Individual;Inherited;Insertional Mutagenesis;Internal Ribosome Entry Site;Knock-out;Lead;Left;Location;Measures;Mediating;Medical Genetics;Mentors;Mesenchymal Stem Cells;Messenger RNA;Methods;Modification;Mus;Mutate;Mutation;Neonatal;Oncogene Activation;Osteogenesis Imperfecta;Patients;Polyadenylation;Process;Processed Genes;Procollagen;Production;Proteins;RNA;RNA Splicing;Recovery;Research;Research Personnel;Sequence Homologs;Single Nucleotide Polymorphism;Site;Southern Blotting;Stem cells;Structure;System;Testing;Training Programs;Universities;Variant;Viral Genes;Washington;Work;adeno-associated viral vector;arm;bone;career;cell type;effective therapy;embryonic stem cell;gene therapy;homologous recombination;improved;in vivo;insight;keratinocyte;magnetic beads;mutant;novel;novel therapeutic intervention;null mutation;prevent;programs;promoter;research study;training project;transcription termination;treatment strategy;vector","Gene targeting with AAV vectors for the treatment of Osteogenesis Imperfecta","n/a","NIAMS","8315912","8/17/2012 12:00:00 AM","PA-06-512","7K08AR053917-05","7","K08","AR","053917","05"," ","CHEN, FAYE H","9/1/2008 12:00:00 AM","12/31/2013 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","8366382","DEYLE, DAVID R","Not Applicable","01","Unavailable","006471700","Y2K4F9RPRRG7","006471700","Y2K4F9RPRRG7","US","44.022374","-92.465881","4976101","MAYO CLINIC ROCHESTER","ROCHESTER","MN","Other Domestic Non-Profits","559050001","UNITED STATES","N","9/1/2012 12:00:00 AM","12/31/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","112625","9010"," ","121635",
"Breast Cancer; Cancer","Biopsy;Blood Circulation;Bone Marrow;Bone Marrow Neoplasms;Breast;Carcinoma;Cells;Clinical;Defect;Development;Endocrine;Epithelial;Growth;Human;Implant;Indolent;Interruption;Malignant Neoplasms;Mammary Neoplasms;Marrow;Mediating;Mediator of activation protein;Mesenchymal;Modality;Molecular;Mus;Myofibroblast;Neoplasm Metastasis;Operative Surgical Procedures;Paracrine Communication;Pathogenesis;Physiological;Primary Neoplasm;Process;Reagent;Recruitment Activity;Research;Research Project Grants;Residual state;Role;Signal Transduction;Specimen;Stem cells;Stromal Cells;Surveys;Tissues;Wound Healing;Xenograft Model;breast surgery;cancer cell;carcinogenesis;cytokine;malignant breast neoplasm;neoplastic cell;neutralizing antibody;novel;osteopontin;peripheral blood;pre-clinical;precursor cell;progenitor;research study;response;stromal progenitor;tumor;tumor growth;tumor xenograft","Recruitment of Stromal Cells to Mammary Tumors","n/a","NCI","8374814","3/26/2012 12:00:00 AM"," ","5P01CA080111-14","5","P01","CA","080111","14"," "," "," "," ","ZCA1-GRB-S","8264","1941097","BROWN, MYLES A","Not Applicable","07","Unavailable","120989983","JVKKKWN2N5N3","120989983","JVKKKWN2N5N3","US","42.363304","-71.087734","1742101","WHITEHEAD INSTITUTE FOR BIOMEDICAL RES","CAMBRIDGE","MA","Research Institutes","021421025","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","252197","252197"," ","218236","33961"," "," ",
"Eye Disease and Disorders of Vision","Adverse effects;Basement membrane;Biology;Cataract;Cataract Extraction;Cell surface;Cells;Cicatrix;Communication;Data;Development;Embryo;Epithelial;Epithelial Cells;Epithelium;Excision;Extracapsular;Extracellular Matrix;Extracellular Matrix Proteins;Eye;Fibronectins;Gene Expression;Grant;Integrins;Investigation;Lens Fiber;Ligands;Mediating;Molecular;Molecular Target;Myofibroblast;Operative Surgical Procedures;Outcome;Pathogenesis;Pathway interactions;Patients;Phenotype;Play;Prevention;Process;Proteins;Regulation;Relative (related person);Role;Signal Pathway;Signal Transduction;Staging;Testing;Tissues;Vesicle;Visual;Work;base;capsule;cell behavior;epithelial to mesenchymal transition;fiber cell;insight;lens;lens capsule;prevent;transdifferentiation","The Influence of Capsule Composition on Lens Biology"," The lens capsule is an understudied, but crucial regulator of lens biology. This application seeks to understand the molecular mechanisms underlying its fundamental role in both the regulation of normal lens biology and the conversion of lens epithelial cells to myofibroblasts, a main component of scar tissue. This work will provide fundamental insights into the pathogenesis of after-cataract (posterior capsular opacification), the major side effect of cataract surgery. This will allow us to identify additional molecular targets to prevent this condition which could result in better final visual outcomes for patients.  
      

","NEI","8399302","9/18/2012 12:00:00 AM","PA-10-067","2R01EY015279-09","2","R01","EY","015279","09"," ","ARAJ, HOUMAM H","12/1/2003 12:00:00 AM","3/31/2014 12:00:00 AM","Biology of the Visual System Study Section[BVS]"," ","2189960","DUNCAN, MELINDA K","Not Applicable","At-Large","BIOLOGY","059007500","T72NHKM259N3","059007500","T72NHKM259N3","US","39.677657","-75.757204","2076701","UNIVERSITY OF DELAWARE","NEWARK","DE","SCHOOLS OF ARTS AND SCIENCES","197160099","UNITED STATES","N","9/30/2012 12:00:00 AM","3/31/2014 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","250000","132500"," ","382500",
"Cardiovascular; Clinical Research; Heart Disease; Pediatric","Binding;Biological Models;Cardiac;Cardiovascular system;Cells;Child;Cilia;Complex;Congenital Heart Defects;Defect;Detection;Development;Extracellular Fluid;Gastrula;Gene Expression;Genes;Genetic;Handedness;Heart;Heparan Sulfate Proteoglycan;Human;Lateral;Lead;Left;Mesoderm;Modeling;Molecular;Molecular Genetics;Morbidity - disease rate;Morphogenesis;Mus;Nodal;Organ;Organogenesis;Pathway interactions;Pattern;Play;Positioning Attribute;Process;Role;Side;Structure;System;Testing;Tube;Vertebrates;Vesicle;Zebrafish;base;cilium biogenesis;congenital heart disorder;epithelial to mesenchymal transition;fibroglycan;fluid flow;improved;malformation;mortality;precursor cell;public health relevance","Establishing Left-Right Asymmetry in Vertebrates","
PROJECT NARRATIVE/RELEVANCE
Abnormalities in left-right development often lead to complex congenital heart defects with significant
associated morbidity and mortality but little is known about the molecular anomalies that cause these defects.
Understanding the mechanisms that regulate left-right development in model vertebrate systems will advance
our ability to understand, detect, and treat human cardiovascular malformations.","NICHD","8212159","3/6/2012 12:00:00 AM","PA-09-042","5K08HD062638-03","5","K08","HD","062638","03"," ","JAVOIS, LORETTE CLAIRE","2/1/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Developmental Biology Study Section[CHHD-C]"," ","9241039","ARRINGTON, CAMMON ","Not Applicable","02","PEDIATRICS","009095365","LL8GLEVH6MG3","009095365","LL8GLEVH6MG3","US","40.76776","-111.832926","514002","UNIVERSITY OF UTAH","SALT LAKE CITY","UT","SCHOOLS OF MEDICINE","841128930","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","865","Other Research-Related","2012"," "," ","NICHD","126999","10078"," ","137077",
"Lung; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adult;Alveolar Duct;Basal Cell;Bromodeoxyuridine;Cell Lineage;Cells;Chronic lung disease;Data;Development;Distal;Embryo;Epithelial;Goals;Growth Factor;Health;Hyperplasia;Injury;Lung;Maintenance;Malignant neoplasm of lung;Mesenchyme;Modality;Molecular;Monitor;Naphthalene;Natural regeneration;Pathway interactions;Phenotype;Predisposing Factor;Process;Publishing;Role;Signal Transduction;Smooth Muscle Myocytes;Stem cells;Therapeutic;WNT Signaling Pathway;airway epithelium;bronchial epithelium;epithelial to mesenchymal transition;fibroblast growth factor 10;improved;lung development;paracrine;precursor cell;progenitor;repaired;response;stem cell niche","Lung regeneration and the stem cell niche","
Health relevance:
Remodeling of the airway epithelium is a common pathological feature in chronic lung disease and a
predisposing factor in the development of lung cancer. Accordingly, understanding cellular and
molecular mechanisms of epithelial maintenance and repair are fundamental to the development of
improved therapeutic modalities for the treatment of chronic lung disease. We hypothesize that after
epithelial injury, the surrounding non-epithelial cells get reprogrammed to contribute, directly and
indirectly be secreting growth factors, to the epithelial repair.","NHLBI","8230583","2/8/2012 12:00:00 AM","PA-07-070","5R01HL092967-04","5","R01","HL","092967","04"," ","BLAISDELL, CAROL J","3/1/2009 12:00:00 AM","2/28/2014 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","9220162","DE LANGHE, STIJN PIET JOHAN","Not Applicable","01","Unavailable","076443019","VLQKFEEJ3NE9","076443019","VLQKFEEJ3NE9","US","39.738343","-104.942796","5720901","NATIONAL JEWISH HEALTH","DENVER","CO","Independent Hospitals","802062761","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","138600"," ","386100",
"Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Alleles;Biology;Blood Vessels;Blood capillaries;Cell Therapy;Cells;Clinic;Clinical;Data;Defect;Dental;Dental Pulp;Dentin;Dentin Formation;Dentinogenesis;Development;Disease;Embryo;Embryonic Development;Endothelial Cells;Endothelium;Evaluation;Event;Experimental Models;Gene Mutation;Generations;Goals;Human;Human Development;Immunodeficient Mouse;In Vitro;Inherited;Knowledge;Laboratories;Lead;Link;Mediating;Mesenchymal Stem Cells;Metabolic;Molecular;Nutrient;Odontoblasts;Organ;Osteoblasts;Osteogenesis;Oxygen;Patients;Phenotype;Physiological;Play;Pluripotent Stem Cells;Process;Proto-Oncogene Proteins c-akt;Regenerative Medicine;Research Design;Retinal;Role;Signal Pathway;Signal Transduction;Source;Staining method;Stains;Stem Cell Research;Stem cells;Structure;Testing;Tetracyclines;Tissue Engineering;Tissues;Tooth structure;Translations;Vascular Endothelial Cell;Vascular Endothelial Growth Factor Receptor-1;Vascular Endothelial Growth Factors;Vascular Endothelium;Vascularization;Work;base;capillary;cell determination;clinical application;design;human FZD4 protein;in vivo;receptor;research study;stem;stem cell differentiation;stem cell fate;tissue regeneration;vasculogenesis","Mechanisms of dental pulp stem cell differentiation into functional endothelium"," The dental pulp is a readily accessible source of stem cells that are suitable for tissue regeneration. One of the critical limitations to tissue engineering is the absolute requirement of appropriate vascularization to provide oxygen and nutrients for cells engaged in the making of new tissues. This project is centered on the study of mechanisms involved in the determination of the vasculogenic fate of dental pulp stem cells. The ability of controlling the processes that regulate the differentiation of stem cells into blood vessels constitutes a major step forward towards the use of stem cell-based therapies in patients that need tissue regeneration.  
  
    

","NIDCR","8279195","6/8/2012 12:00:00 AM","PA-10-067","5R01DE021410-02","5","R01","DE","021410","02"," ","LUMELSKY, NADYA L","7/1/2011 12:00:00 AM","6/30/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-B(03)S]"," ","6876822","NOR, JACQUES EDUARDO","Not Applicable","12","DENTISTRY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF DENTISTRY/ORAL HYGN","481091276","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","225000","124875"," ","349875",
"Biotechnology; Cardiovascular; Clinical Research; Clinical Trials; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Adipocytes;Adipose tissue;Adopted;Aftercare;Autologous;Biodistribution;Bone Marrow;Bone Marrow Stem Cell;Cardiac;Cardiomyopathies;Cardiovascular Diseases;Cardiovascular system;Cell Therapy;Cell physiology;Cells;Chronic;Clinical;Clinical Research;Clinical Trials;Community Health Centers;Comparative Study;Conduct Clinical Trials;Controlled Clinical Trials;Development;Doctor of Philosophy;Double-Blind Method;Enrollment;FDA approved;Goals;Harvest;Hearing;Heart;Heart Diseases;Heart failure;Hospitals;Infarction;Infusion procedures;Injection of therapeutic agent;Institutes;Intermittent Claudication;Leadership;Light;Louisiana;Maps;Medical center;Medicine;Mesenchymal Stem Cells;Methods;Monitor;Mononuclear;Multimedia;Myocardial Infarction;Myocardial Ischemia;N-octanoylglucosylamine;Online Systems;Outcome;Patient Recruitments;Patients;Perfusion;Physician Executives;Placebos;Population;Principal Investigator;Procedures;Program Development;Protocols documentation;Randomized;Randomized Clinical Trials;Randomized Controlled Clinical Trials;Recruitment Activity;Regimen;Reporter Genes;Research;Role;Safety;Source;Staging;Stem Cell Research;Stem cells;Technology;Testing;Texas;Therapeutic Studies;United States;Universities;Work;adult stem cell;aldehyde dehydrogenases;arm;cell type;control trial;experience;head-to-head comparison;high risk;improved;innovation;insight;meetings;patient population;percutaneous coronary intervention;point of care;preclinical study;precursor cell;regenerative;skills;stem cell therapy;technique development","Cardiovascular Cell Therapy Research Network","The goal of our proposal is to advance cell therapy by conducting a comparative study of multiple cell types 
to help identify the most effective cell types in heart failure and by introducing cell therapy into a new, large 
patient population (NSTEMI patients). Also, our cell tracking studies will provide mechanistic insight into the 
benefits of cell therapy. We hope to achieve these aims by continuing to be part of the CCTRN II.","NHLBI","8288947","3/13/2012 12:00:00 AM","RFA-HL-12-026","2UM1HL087365-06","2","UM1","HL","087365","06"," ","SKARLATOS, SONIA","1/1/2007 12:00:00 AM","2/28/2019 12:00:00 AM","ZHL1-CSR-O(F2)"," ","1887369","WILLERSON, JAMES T.","PERIN, EMERSON CARVALHO","07","Unavailable","086987831","ET52YPHJ2JR3","086987831","ET52YPHJ2JR3","US","29.798149","-95.369119","951201","TEXAS HEART INSTITUTE","HOUSTON","TX","Research Institutes","772250345","UNITED STATES","N","3/15/2012 12:00:00 AM","2/28/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","600169","263148"," ","863317",
"Cancer; Lung; Lung Cancer; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adverse effects;Alveolar;Antioxidants;Bone Marrow;Breathing;CSF3 gene;Cell Separation;Cells;Chest;Clara cell-specific protein;Data;Dose;Dose-Limiting;Endothelial Cells;Female;Fibroblasts;Fibrosis;Ganciclovir;Hamman-Rich syndrome;Hematopoietic Stem Cell Mobilization;Histopathology;Human;Hydrogen Peroxide;Intercellular adhesion molecule 1;Label;Lesion;Liposomes;Lung;Malignant neoplasm of esophagus;Malignant neoplasm of lung;Malignant neoplasm of thorax;Manganese Superoxide Dismutase;Manuscripts;Marrow;Measures;Mediating;Mesenchymal Stem Cells;Methods;Mitochondria;Molecular;Mus;Myofibroblast;Naphthalene;Nebulizer;Non-Small-Cell Lung Carcinoma;Patients;Plasmids;Proliferating;Protocols documentation;Pulmonary Fibrosis;Pump;Radiation;Radiation Protection;Radiation therapy;Recurrence;Research;Retreatment;Signal Transduction;Simplexvirus;Stem cells;Stromal Cells;Superoxides;Techniques;Testing;Therapeutic Intervention;Thymidine Kinase;Time;Toxic effect;Toxin;Transgenic Mice;Up-Regulation;Vascular Cell Adhesion Molecule-1;catalase;gene therapy;improved;irradiation;macrophage;male;migration;mouse model;progenitor;research study;uptake","Mechanism of Irradiation Pulmonary Fibrosis","n/a","NCI","8270375","5/9/2012 12:00:00 AM","PA-07-070","5R01CA119927-12","5","R01","CA","119927","12"," ","PRASANNA, PAT G","7/1/2008 12:00:00 AM","5/31/2013 12:00:00 AM","Radiation Therapeutics and Biology Study Section[RTB]"," ","1865781","GREENBERGER, JOEL S","Not Applicable","18","RADIATION-DIAGNOSTIC/ONCOLOGY","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","186604","96101"," ","282705",
"Aging; Biotechnology; Genetics; Osteoporosis","3&apos; Untranslated Regions;Address;Adult;Adverse effects;Affect;Age;Aging;Alkaline Phosphatase;Biological;Biological Assay;Biological Preservation;Bone Resorption;Cell Line;Cells;Characteristics;Chemicals;Deposition;Disease;Disease Progression;Dose;Drug Delivery Systems;Environment;Equilibrium;Family;Fireflies;Firefly Luciferases;Fracture;Gene Expression;Generations;Genes;Goals;Health;Hematopoiesis;Human;In Vitro;Incidence;Individual;Inhibitory Concentration 50;Institutes;Large T Antigen;Libraries;Luc Gene;Maintenance;Malignant Neoplasms;Mediating;Mesenchymal Stem Cells;Messenger RNA;Morbidity - disease rate;Morphogenesis;Morphology;Mus;Organ;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis;Pharmaceutical Preparations;Phenotype;Physiological;Population;Prevention;Process;Property;Proteins;Refractory;Renilla Luciferases;Reporter;Series;Simian virus 40;Skeletal system;Skeleton;Source;Specificity;Technology;Testing;Therapeutic;Transcript;United States;Untranslated Regions;Zinc Fingers;base;bone;bone loss;bone mass;cost;cytotoxic;design;high throughput screening;in vivo;inhibitor/antagonist;interest;member;mineralization;mortality;novel;null mutation;osteoblast differentiation;osteogenic;postnatal;prevent;promoter;public health relevance;response;skeletal;skeletal disorder;small hairpin RNA;small molecule;therapeutic target","Schnurri-3 Inhibitors: specific inducers of adult bone formation","
Project Narrative
Osteoporosis is a debilitating disease of the skeletal system that currently affects over 10 million individuals in
the United States. Disease progression results in an increased incidence of fracture that results in serious
health consequences and will present an expanding source of morbidity and mortality in an aging global
population. While a few classes of medications are available to either prevent bone loss or increase bone
formation in the setting of osteoporosis or cancer, current therapeutics are far from ideal due to toxic side
effects, intolerance, or prohibitive cost. The ultimate goal of this proposal is to develop mechanism-based
treatments to prevent bone loss and to increase anabolic bone formation.
2 
 ","NIMH","8259713","3/30/2012 12:00:00 AM","PAR-09-129","5R03MH094204-02","5","R03","MH","094204","02"," ","YAO, YONG","4/21/2011 12:00:00 AM","3/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-BST-F(50)R]"," ","1871771","GLIMCHER, LAURIE HOLLIS","Not Applicable","07","MICROBIOLOGY/IMMUN/VIROLOGY","149617367","UNVDZNFA8R29","149617367","UNVDZNFA8R29","US","42.335241","-71.102433","3212904","HARVARD SCHOOL OF PUBLIC HEALTH","BOSTON","MA","SCHOOLS OF PUBLIC HEALTH","021156028","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","310","Non-SBIR/STTR","2012"," "," ","OD","25000","15375"," ","40375",
"Bioengineering; Biotechnology; Clinical Research; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Actins;Adhesions;Affect;Age;Aging;Allografting;Animal Model;Atomic Force Microscopy;Autologous Transplantation;Biocompatible;Biocompatible Materials;Bone Regeneration;Bone Tissue;Bone Transplantation;Calcineurin;Calcium;Cell Adhesion;Cell Culture Techniques;Cell Proliferation;Cells;Characteristics;Cytoskeleton;Defect;Disease;Environment;Exposure to;Extracellular Matrix;Focal Adhesion Kinase 1;Genetic Engineering;Goals;Health;Histologic;Human;Human Characteristics;Hydroxyapatites;Immune;Implant;In Vitro;Injury;Integrins;Lead;Mesenchymal Stem Cells;Mitogen-Activated Protein Kinases;Molds;Morbidity - disease rate;Mus;Musculoskeletal;Nanotechnology;Nanotopography;Operative Surgical Procedures;Orthopedics;Osteogenesis;Pathology;Pathway interactions;Phenotype;Phospholipase C;Polymers;Polystyrenes;Population;Protocols documentation;Regulation;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Site;Source;Staging;Surface;Therapeutic;Tissue Engineering;Transgenic Animals;adult stem cell;aged;bone;bone loss;electron beam lithography;fluid flow;in vivo;inhibitor/antagonist;insight;nanoscale;novel;novel strategies;novel therapeutic intervention;osteogenic;polybromo;research study;response;scaffold;shear stress;stem cell differentiation;surface coating;tricalcium phosphate;wasting","Biophysical signals, biomaterial surface characteristics and hMSC differentiation","
Project Narrative
As the aged population increases the need for novel therapeutic approaches to musculoskeletal pathology will
also increase. Tissue engineering exploiting adult stem cells is one such approach. This project will develop
novel musculoskeletal tissue engineering protocols combining nanotechnology, adult stem cells and
biophysical forces that will lead to strategies to replace bone loss to disease, injury and aging.","NIAMS","8231561","3/5/2012 12:00:00 AM","PA-07-070","5R01AR054937-04","5","R01","AR","054937","04"," ","WANG, FEI","4/1/2009 12:00:00 AM","2/28/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","1865703","DONAHUE, HENRY J","Not Applicable","10","ORTHOPEDICS","129348186","TNKGNDAWB445","129348186","TNKGNDAWB445","US","40.26536","-76.625873","1524204","PENNSYLVANIA STATE UNIV HERSHEY MED CTR","HERSHEY","PA","SCHOOLS OF MEDICINE","170332360","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","217800","113782"," ","331582",
"Aging; Biotechnology; Cancer; Clinical Research; Estrogen; Prostate Cancer; Urologic Diseases","Ablation;Adipose tissue;African American;Age;American;Androgen Receptor;Androgens;Biological Markers;Cancer Cell Growth;Cancer Patient;Cells;Charcoal;Clinical;Clonal Expansion;Conditioned Culture Media;Development;Disease;Disease Progression;Ectopic Expression;Enzymes;Estrogen Receptor beta;Estrogens;Ethnic group;European;Genes;Gonadal structure;Growth;Hormones;In Vitro;Incidence;Injection of therapeutic agent;Instruction;Lead;Link;Malignant neoplasm of prostate;Mediating;Mesenchymal Stem Cells;Nature;Neoplasm Metastasis;Nude Mice;Obesity;Outcome;PC3 cell line;Patients;Play;Preventive;Production;Prostatic Neoplasms;Protein Isoforms;Race;Receptor Signaling;Recruitment Activity;Recurrence;Resistance;Role;Sampling;Signal Pathway;Signal Transduction;Small Interfering RNA;Source;Specimen;Stem cells;Testing;Testosterone;Therapeutic;Tissue Microarray;Transactivation;Tumor-Derived;Up-Regulation;adverse outcome;base;cDNA Arrays;cancer cell;cancer risk;cohort;deprivation;design;expression vector;health disparity;in vivo;innovation;interest;men;mortality;neoplastic cell;novel;overexpression;prognostic indicator;research study;response;scaffold;small hairpin RNA;therapeutic target;tumor;tumor growth;tumor progression","Estrogen-ERbeta Axis In Disparity of Prostate Cancer","RELEVANCE (See Instructions): The discovery of alternate signaling pathways that may lead to androgen resistance and aggressive PC growth in AA-men, would be of crucial importance. A crucial role of estrogen-ERP signaling axis in PC progression and the contribution of adipose stem cell derived estrogens on growth and metastasis of PC cells, will provide new clues for understanding the disproportionate incidence and mortality due to PC in African American natients and will rifilineate novel theraneutic strategies that can be easily implemented.","NCI","8328901","9/18/2012 12:00:00 AM","PAR-09-161","5U01CA149204-02","5","U01","CA","149204","02"," ","MOHLA, SURESH","9/6/2011 12:00:00 AM","8/31/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-OBT-A(50)R]"," ","2200940","ABDEL-MAGEED, ASIM B","Not Applicable","01","UROLOGY","053785812","XNY5ULPU8EN6","053785812","XNY5ULPU8EN6","US","29.935453","-90.123916","8424601","TULANE UNIVERSITY OF LOUISIANA","NEW ORLEANS","LA","SCHOOLS OF MEDICINE","701185665","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","227207","114739"," ","299290",
"Clinical Research; Infant Mortality/ (LBW); Lung; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal - Neonatal Respiratory Distress Syndrome; Perinatal Period - Conditions Originating in Perinatal Period","Actins;Alveolar;Alveolus;Area;Aspirate substance;Bioinformatics;Biological Markers;Biology;Bronchopulmonary Dysplasia;Cell Proliferation;Cells;Childhood;Childhood Asthma;Chronic lung disease;Clinical;Clinical Investigator;Clinical Research;Collagen;Confidence Intervals;Coupled;Data;Deposition;Development;Disease;Doctor of Medicine;Dysplasia;Enrollment;Enzyme-Linked Immunosorbent Assay;Experimental Designs;Extracellular Matrix Proteins;Fellowship;Fiber;Fibroblast Growth Factor;Fibrosis;Gene Expression;Genes;Goals;Growth Factor Overexpression;Health;Immunoblotting;Incidence;Infant;Informed Consent;Lasers;Lung;Measures;Medicine;Mentors;Mentorship;Mesenchymal;Messenger RNA;Methods;Michigan;Microscopy;Modeling;Mus;Myofibroblast;NADPH Oxidase;Neonatal;Odds Ratio;Outcome;Paper;Pathogenesis;Patients;Phenotype;Pilot Projects;Plasminogen Activator;Play;Premature Infant;Proteins;Public Health Schools;Publishing;Pulmonology;Regression Analysis;Research;Research Personnel;Role;Sampling;Signal Transduction;Smooth Muscle Actin Staining Method;Stromal Cells;Supervision;Testing;Training;Training Programs;Transforming Growth Factors;Translating;Universities;Vascular Endothelial Cell;Work;base;biobank;career;connective tissue growth factor;experience;human tissue;improved;inhibitor/antagonist;insight;lung injury;mRNA Expression;overexpression;patient oriented research;periostin;programs;protein expression;receptor binding;response;skills;statistics","Mesenchymal stromal cells and bronchopulmonary dysplasia","
Project Narrative
This application seeks to train Antonia P. Popova MD in the methods and approaches needed to perform
patient-oriented research in pediatric pulmonology. Specifically, Dr. Popova will focus on bronchopulmonary
dyplasia (BPD), a chronic lung disease of premature infants which is an increasingly common cause of
childhood asthma. The proposed training program, which includes coursework in the School of Public Health
Clinical Research Masters Program and University of Michigan Center for Computational Medicine and
Bioinformatics, will enable Dr. Popova to become an independent investigator, and ultimately improve health
outcomes in premature infants.","NHLBI","8319337","6/29/2012 12:00:00 AM","PA-10-060","5K23HL109149-02","5","K23","HL","109149","02"," ","COLOMBINI-HATCH, SANDRA","8/12/2011 12:00:00 AM","6/30/2016 12:00:00 AM","ZHL1-CSR-X(M1)"," ","10500910","POPOVA, ANTONIA PETROVA","Not Applicable","12","PEDIATRICS","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","837","Other Research-Related","2012"," "," ","NHLBI","134604","10200"," ","144804",
"Brain Disorders; Neurosciences; Stroke","Address;Adult;Affect;Animal Model;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Applications Grants;Attenuated;Autologous;Bone Marrow;Bone Marrow Cells;Brain;Brain Injuries;Cell Fraction;Cell Separation;Cell Therapy;Cells;Clinical Trials;Conditioned Culture Media;Cytoprotection;Data;Effectiveness;Erythroid Cells;Funding;Graft Rejection;Harvest;Hypoxia;In Vitro;Infarction;Inflammation Mediators;Inflammatory;Inflammatory Response;Infusion procedures;Injury;Insulin-Like Growth Factor I;Interleukin-10;Ischemic Stroke;Knockout Mice;Laboratories;Lead;Lesion;Lymphoid Cell;Mediating;Mesenchymal Stem Cells;Microglia;Modeling;Mononuclear;Myeloid Cells;Neurologic;Neurons;Outcome;Oxidative Stress;Pathway interactions;Patients;Population;Population Heterogeneity;Public Health;Rattus;Recombinants;Recovery;Risk;Stem cells;Stroke;Testing;Therapeutic;Thrombolytic Therapy;Time;United States National Institutes of Health;Up-Regulation;cell type;cytokine;disability;functional outcomes;improved;in vitro Model;in vivo Model;injured;ischemic lesion;macrophage;neurological recovery;neuroprotection;neurotoxicity;neutralizing antibody;novel strategies;novel therapeutic intervention;preclinical study;prevent;protective effect;public health relevance;release factor;research study;response;safety testing;stroke recovery","Cytoprotection with Autologous Mononuclear Cells for Stroke","
Stroke is the leading cause of adult disability but there is only one approved therapy with
limited effectiveness for this devastating condition. Cellular therapy is a promising new
approach to improve stroke recovery. This application proposes to define underlying
mechanisms by which autologous bone marrow mononuclear cells improve outcome after
stroke. The data from these proposed experiments are essential to better develop this new
therapeutic approach to enhance recovery from stroke.","NINDS","8242031","2/10/2012 12:00:00 AM","PA-10-067","5R01NS071127-02","5","R01","NS","071127","02"," ","BOSETTI, FRANCESCA","4/1/2011 12:00:00 AM","2/29/2016 12:00:00 AM","Brain Injury and Neurovascular Pathologies Study Section[BINP]"," ","8949812","SAVITZ, SEAN I","Not Applicable","09","NEUROLOGY","800771594","ZUFBNVZ587D4","800771594","ZUFBNVZ587D4","US","29.798149","-95.369119","578417","UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON","HOUSTON","TX","SCHOOLS OF MEDICINE","770305400","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","218750","109375"," ","328125",
"Bioengineering; Dental/Oral and Craniofacial Disease; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Age;Alginates;Animal Model;Animal Testing;Area;Biomimetics;Blood Vessels;Bone Density;Bone Marrow;Bone Regeneration;Bone Tissue;Cartilage;Cell Differentiation process;Cell Proliferation;Cell Survival;Cell physiology;Cells;Cephalic;Chitosan;Clinical;Collagen;Defect;Dental;Dentures;Deposition;Development;Elderly;Encapsulated;Engineering;Evaluation;FDA approved;Fatty acid glycerol esters;Fiber;Fracture;Fracture Fixation;Frequencies;Generations;Grant;Growth Factor;Health;Hydrogels;Hydroxyapatites;Implant;In Situ;In Vitro;Injectable;Injection of therapeutic agent;Legal patent;Lesion;Location;Mandible;Manuscripts;Maryland;Maxilla;Maxillary Ridge Augmentations;Mechanics;Mesenchymal Stem Cells;Minerals;Molds;Motion;Musculoskeletal;Operative Surgical Procedures;Orthopedics;Osteogenesis;Paste substance;Population;Procedures;Process;Proliferating;Property;Psychological reinforcement;Quality of life;Rattus;Recording of previous events;Reporting;Research;Resistance;Scientist;Seeds;Severities;Shapes;Stem cells;Stress;Structure;Surface;System;Techniques;Testing;Time;Tissue Engineering;Tissues;Universities;Weight-Bearing state;abstracting;aging population;base;bone;bone engineering;bone healing;calcium phosphate;cell growth;cost;craniofacial;density;dicalcium phosphate anhydrous;improved;in vivo;interdisciplinary approach;meetings;minimally invasive;nano;nanoapatite;news;novel;osteogenic;reconstruction;relating to nervous system;repaired;scaffold;tetracalcium phosphate;tool","Injectable and Strong Nano-Apatite/Stem Cell Scaffolds for Bone Regeneration","
Project Narrative
 Seven million people suffer bone fractures annually in the U.S. Musculoskeletal conditions cost $215
billion/year. These numbers are increasing as the population ages. This project will develop the first
generation of injectable, strong, tough, macroporous, bone mineral-mimicking nano-apatite scaffolds with stem
cell and multiple growth factor delivery, and will study bone regeneration in animal models. Potential
applications include dental, craniofacial and orthopedic repairs. They include maxillary and mandibular
reconstruction and minimally-invasive surgeries such as filling and strengthening osteoporotic bone lesions,
with greatly enhanced bone healing and regeneration to improve the health and quality of life for millions of
people.","NIDCR","8209173","12/21/2011 12:00:00 AM","PA-07-070","5R01DE014190-10","5","R01","DE","014190","10"," ","DRUMMOND, JAMES","4/1/2003 12:00:00 AM","1/31/2014 12:00:00 AM","Oral, Dental and Craniofacial Sciences Study Section[ODCS]"," ","2093590","XU, HUAKUN ","Not Applicable","07","DENTISTRY","188435911","Z9CRZKD42ZT1","188435911","Z9CRZKD42ZT1","US","39.291412","-76.624753","820104","UNIVERSITY OF MARYLAND BALTIMORE","BALTIMORE","MD","SCHOOLS OF DENTISTRY/ORAL HYGN","212011508","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","184736","92368"," ","277104",
"HIV/AIDS; Hematology; Pediatric; Pediatric AIDS; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acquired Immunodeficiency Syndrome;Architecture;Binding;Blood;Bone Marrow;Bone Marrow Transplantation;Cells;Defect;Disease;Dysmyelopoietic Syndromes;Dysplasia;Functional disorder;Generations;Genetic;Genetically Engineered Mouse;Grant;HIV;HIV Infections;Hematopoiesis;Hematopoietic;Hematopoietic System;Host Defense;Individual;Learning;Longevity;Maintenance;Marrow;Mesenchymal;Molecular;Morbidity - disease rate;Mouse Strains;Natural regeneration;Organ;Pathway interactions;Physiologic pulse;Population;Population Sizes;Production;Proliferating;Staging;Stem cells;System;Tissues;Variant;Work;base;cytopenia;meetings;novel;progenitor;research study","Mechanisms of Hematopoiesis in AIDS"," This proposal focuses on defining how the structural components of the bone marrow contribute to the healthy and diseased function of the hematopoietic or blood forming stem cells. It is intended to provide novel opportunities for intervening to overcome defects in blood formation associated with myelodysplasia.  
  
    

","NHLBI","8308396","4/19/2012 12:00:00 AM","PA-10-067","5R01HL044851-22","5","R01","HL","044851","22"," ","THOMAS, JOHN","2/1/1991 12:00:00 AM","4/30/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-AARR-J(02)M]"," ","1861205","SCADDEN, DAVID T","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","306064","180606"," ","486670",
"Biotechnology; Genetics; Pediatric","Alleles;Amino Acid Motifs;Cell Proliferation;Cells;DNA-Binding Proteins;Development;Embryo;Embryonic Development;Epithelial;Essential Amino Acids;Family;Funding;Gene Family;Gene Targeting;Genes;Genetic;Goals;Grant;Homozygote;Human Development;Individual;Knock-in Mouse;Left;Mammals;Mediating;Mesenchymal;Molecular Genetics;Movement;Mus;Muscle Development;Mutant Strains Mice;Mutate;Mutation;Natural regeneration;Nuclear;Phenotype;Phosphorylation;Phosphotransferases;Physiology;Play;Post-Translational Protein Processing;Post-Translational Regulation;Process;Protein Family;Proteins;Reagent;Role;Skeletal Muscle;Snails;Staging;Testing;Transcription Repressor/Corepressor;Work;Zinc Fingers;beta-Transducin Repeat-Containing Proteins;gastrulation;gene repression;genetic analysis;in vivo;multicatalytic endopeptidase complex;muscle regeneration;mutant;public health relevance;ubiquitin ligase","Genetic Analysis of Snail Superfamily Genes in Mice","n/a","NICHD","8302414","5/25/2012 12:00:00 AM","PA-07-070","5R01HD034883-16","5","R01","HD","034883","16"," ","COULOMBE, JAMES N","1/1/1998 12:00:00 AM","6/30/2014 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","1878555","GRIDLEY, THOMAS HOOKER","Not Applicable","01","Unavailable","071732663","MAYKB1LWD5U9","071732663","MAYKB1LWD5U9","US","43.652614","-70.27474","4757601","MAINEHEALTH","PORTLAND","ME","Independent Hospitals","041023175","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","205147","115909"," ","321056",
"Aging; Clinical Research; Osteoporosis","Address;Arthroplasty;Biochemical;Biochemical Markers;Biopsy;Bone Density;Bone Formation Stimulation;Bone Resorption;Bone Surface;Bone remodeling;Cells;Clinical;Data;Degenerative polyarthritis;Ethics;Evaluation;Femur;Finite Element Analysis;Fracture;Hip Fractures;Hip region structure;Hormones;Human;Hypoparathyroidism;Incidence;Investigation;Location;Measures;Mesenchymal;Morbidity - disease rate;Neck;Osteoblasts;Osteogenesis;Osteoporosis;Outcome;Parathyroid gland;Patients;Pharmaceutical Preparations;Placebos;Population;Principal Investigator;Procedures;Protocols documentation;Research Personnel;Risk;Sampling;Skeleton;Specimen;Structure;Teriparatide;Thick;Time;Vertebral column;Zoledronic Acid;base;bisphosphonate;bone;bone strength;bone turnover;density;disability;high risk;hip bone;hip replacement arthroplasty;improved;indexing;interest;mortality;precursor cell;prevent;public health relevance;response","Early effects of PTH on the proximal femur","
Teriparatide is a potent osteoporosis medication that helps prevent fractures, however, we know little about its
effect on the hip. We will evaluate hip bone samples from patients treated with teriparatide before undergoing
hip replacement. The information will help us understand how teriparatide might help reduce hip fracture risk.","NIAMS","8242642","3/13/2012 12:00:00 AM","PA-07-070","5R01AR059204-03","5","R01","AR","059204","03"," ","CHEN, FAYE H","5/1/2010 12:00:00 AM","2/28/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1893920","COSMAN, FELICIA ","Not Applicable","20","Unavailable","157119244","JH3AAWA12273","157119244","JH3AAWA12273","US","42.686129","-73.729346","5966009","HELEN HAYES HOSPITAL","MENANDS","NY","Independent Hospitals","122042893","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","236244","132326"," ","368570",
"Genetics; Lung","A549;Address;Adult;Affect;Animals;BMP4;Biochemical;Cause of Death;Cell Differentiation process;Cell Line;Cell Nucleus;Cells;Communications Personnel;Complex;Data;Defect;Development;Distal;Embryo;Epithelial;Epithelial Cells;Epithelium;Fibroblast Growth Factor;Future;Gases;Gene Deletion;Gene Expression;Genes;Genetic;Genetic Models;Goals;Growth;Human;Letters;Lung;Lung diseases;Mammals;Mediating;Mesenchymal;Methods;Modeling;Molecular;Morbidity - disease rate;Morphogenesis;Mosaicism;Mus;Nuclear;Partner in relationship;Pathway interactions;Pattern;Play;Process;Publications;Reagent;Regulation;Reporter;Role;Scheme;Signal Pathway;Signal Transduction;Signal Transduction Pathway;System;Techniques;Therapeutic Intervention;Transfection;Transgenic Mice;Transgenic Organisms;Type I Epithelial Receptor Cell;Work;adenoviral-mediated;airway epithelium;cell motility;design;experience;human disease;in vivo;inhibitor/antagonist;neonate;novel;receptor;research study;success","Regulation of Airway Morphogenesis and Differentiation by Wnt Signaling","n/a","NHLBI","8197381","11/17/2011 12:00:00 AM","PA-07-070","5R01HL087825-05","5","R01","HL","087825","05"," ","BLAISDELL, CAROL J","12/10/2007 12:00:00 AM","7/31/2013 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1865475","MORRISEY, EDWARD E","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","12/1/2011 12:00:00 AM","7/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","300604","172847"," ","473451",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","3-Dimensional;Address;Adult;Age;Air;Animals;Anosmia;Area;Basal Cell;Binding Proteins;Biological Assay;Brain;Breast;Cells;Clinic;Communication;Complex;Conditioned Culture Media;Confocal Microscopy;Coulter counter;Data;Development;Differentiation and Growth;Duct (organ) structure;Environment;Epithelial;Epithelial Cells;Epithelium;ErbB Receptor Family Protein;ErbB4 gene;Event;Exhibits;Fibroblasts;Gases;Generations;Gland;Goals;Growth;Growth Factor;Immunohistochemistry;In Vitro;Injury;Knock-out;Knockout Mice;Knowledge;Laboratories;Lamina Propria;Life;Lung;Measures;Mesenchymal;Mesenchyme;Metaplasia;Methods;Modeling;Mus;Natural regeneration;Neuregulins;Neurons;Olfactory Epithelial Cell;Olfactory Epithelium;Organism;Phenotype;Population;Process;Proteins;Recombinant Proteins;Recombinants;Regenerative Medicine;Regulation;Research;Rest;Seeds;Services;Signal Pathway;Signal Transduction;Smell Perception;Source;Staining method;Stains;Stem cells;Supporting Cell;System;Testing;Therapeutic;Time;Tissues;Work;adult stem cell;cell type;design;in vitro Assay;in vitro Model;in vivo;insight;methyl bromide;model design;novel;null mutation;pneumocyte;progenitor;receptor;regenerative therapy;repaired;research study;respiratory;response;stem;stem cell biology;stem cell differentiation;surfactant;tissue regeneration;tissue repair;tool","Regulation of epitheliopoiesis in the olfactory epithelium by Neuregulin signalin","The ability to harness the power of adult stem cells is crucial to the progression of regenerative therapies, both those specific to olfaction, such as anosmia (the loss of smell), as well as for expansion of a general understanding that can be applied to other mammalian tissues. Understanding how Nrg1 influences differentiation of the OE will not only characterize a novel signaling pathway in olfactory epitheliopoiesis, but will also serve as a 
gateway to study the effect of other mesenchymal signals in the OE. These findings will be critical for designing therapeutic methods to manipulate stem cell differentiation in the clinic.","NIDCD","8316487","12/5/2011 12:00:00 AM","PA-11-111","1F31DC012470-01","1","F31","DC","012470","01"," ","SKLARE, DAN","12/5/2011 12:00:00 AM","12/4/2013 12:00:00 AM","Communication Disorders Review Committee[CDRC]"," ","10802162","GILBERT, MELISSA ANN","Not Applicable","07","ANATOMY/CELL BIOLOGY","039318308","C1F5LNUF7W86","039318308","C1F5LNUF7W86","US","42.349907","-71.061712","8422704","TUFTS UNIVERSITY BOSTON","BOSTON","MA","SCHOOLS OF MEDICINE","021111901","UNITED STATES","N","12/5/2011 12:00:00 AM","12/4/2012 12:00:00 AM","173","Training, Individual","2012"," "," ","NIDCD","37954"," "," ","37954",
"Cancer; Genetics; Pediatric; Rare Diseases","Acceleration;Address;Adult;Alleles;Apoptosis;Behavior;Bone Diseases;Bone neoplasms;Cell Proliferation;Cells;Cytogenetics;Development;Developmental Process;Disease;Down-Regulation;Elderly;Gene Expression;Gene Expression Profile;Genes;Genetic;Genetic Models;Goals;Health;Hereditary Malignant Neoplasm;Hereditary Retinoblastoma;Histology;Homeostasis;Human;In Vitro;Lead;Li-Fraumeni Syndrome;Link;Malignant - descriptor;Malignant Bone Neoplasm;Malignant Neoplasms;Measures;Mesenchymal Stem Cells;Modeling;Molecular;Mus;Mutate;Mutation;Neoplasm Metastasis;Notch Signaling Pathway;Osteoblasts;Pathogenesis;Pathway interactions;Patients;Penetrance;Phenotype;Play;Population;Publishing;Regulation;Reporting;Role;Rothmund-Thomson syndrome;Sampling;Signal Transduction;Stress;Syndrome;TP53 gene;Testing;Therapeutic;Time;Tissues;Translating;Tumor Suppressor Genes;Up-Regulation;Werner Syndrome;Work;Xenograft procedure;base;bone cell;cell type;clinical application;gain of function;helicase;in vivo;in vivo Model;loss of function;mouse model;mutant;notch protein;novel strategies;novel therapeutics;osteoblast differentiation;osteoclastogenesis;osteoprogenitor cell;osteosarcoma;p53 Signaling Pathway;skeletal;success;tool;tumor;tumorigenesis;unpublished works","Skeletal genetic pathways of Notch and p53 in the pathogenesis of osteosarcoma","
Project Narrative:
 Understanding how the genetic factors and pathways function in tumorigenesis have broad implications for
health and disease. Specifically, we will understand how those factors interact in the formation and spread of
bone tumors. The overall goal of this project is to translate findings to consequential therapies for bone
disease.","NIAMS","8303280","7/28/2012 12:00:00 AM","PAR-09-031","5R03AR061565-02","5","R03","AR","061565","02"," ","SHARROCK, WILLIAM J","9/1/2011 12:00:00 AM","8/31/2014 12:00:00 AM","ZAR1-EHB(M1)"," ","9734472","TAO, JIANNING ","Not Applicable","09","GENETICS","051113330","FXKMA43NTV21","051113330","FXKMA43NTV21","US","29.711148","-95.39695","481201","BAYLOR COLLEGE OF MEDICINE","HOUSTON","TX","SCHOOLS OF MEDICINE","770303411","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","50000","28250"," ","78250",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Adipose tissue;Affinity;Animal Model;Antibodies;Aspirate substance;Autologous;Benchmarking;Binding;Biocompatible Materials;Biological;Biological Assay;Bone Marrow;Bone Morphogenetic Proteins;Bone Regeneration;Bone Transplantation;Calvaria;Caring;Cell Separation;Cell Therapy;Cells;Clinical;Complex;Contracts;Defect;Degenerative polyarthritis;Development;Devices;Disease;Elements;Engineering;Ensure;Filtration;Fostering;Fracture;Gold;Growth Factor;Harvest;Human;Implant;Libraries;Ligaments;Liquid substance;Manufacturer Name;Mediating;Mesenchymal Stem Cells;Methods;Modeling;Mutagenesis;Operating Rooms;Organ Transplantation;Orthopedic Surgery procedures;Orthopedics;Osteogenesis;Patients;Peptide Hydrolases;Peptide Synthesis;Peptides;Phage Display;Pharmaceutical Preparations;Phase;Physicians;Polystyrenes;Population;Preparation;Property;Proteins;Rattus;Research;Rest;Safety;Sampling;Screening procedure;Seed Implantation;Series;Site;Small Business Innovation Research Grant;Solid;Spinal Fusion;Stem cells;Sterilization;System;Technology;Tendon structure;Testing;Therapeutic;Tissue Engineering;Tissues;Transplanted tissue;Work;adult stem cell;biomaterial compatibility;bone;bone healing;cell type;commercialization;cost effective;design;design and construction;experience;flexibility;improved;in vivo;innovation;multipotent cell;osteoinductive factor;point of care;product development;programs;protein aminoacid sequence;prototype;research study;scale up;tissue repair","Point of Care Adult Stem Cell Isolation"," Bone grafting is widely used in orthopedic surgery to treat fractures and large bone defects and to achieve spinal fusions. However, harvesting a bone graft from patients is associated with a significant number of complications and often provides an inadequate amount of tissue. While alternatives to bone grafts have shown promise, there is still room for considerable improvement. Therefore, a device, like the one proposed in this SBIR application, that could isolate adult stem cells efficiently and quickly in the operating room would be of significant clinical benefit in a number of clinical indications.  
    

","NIAMS","8326622","9/14/2012 12:00:00 AM","PA-10-050","5R44AR054229-04","5","R44","AR","054229","04"," ","WANG, FEI","8/1/2007 12:00:00 AM","2/28/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-M(10)B]"," ","9971977","DARBY, MARTYN ","Not Applicable","04","Unavailable","078296854","YJQ6K1QMS488","078296854","YJQ6K1QMS488","US","35.366248","-79.429394","10031812","AFFINERGY, LLC","DURHAM","NC","Domestic For-Profits","277094650","UNITED STATES","N","9/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","846","SBIR/STTR","2012"," "," ","NIAMS"," "," "," ","958831",
"Bioengineering; Biotechnology; Brain Cancer; Brain Disorders; Cancer; Genetics; Human Genome; Neurosciences; Rare Diseases","Academic Medical Centers;Affect;Agreement;Algorithms;Animals;Applications Grants;B-Lymphocytes;Binding;Biomedical Computing;Blood Vessels;Brain;Brain Neoplasms;Cell Culture System;Central Nervous System Neoplasms;Clinical;Collection;Communities;Computer Analysis;DNA Binding;Data;Development;Discipline;Disease;Dissection;Engineering;Epigenetic Process;Failure;Gene Expression Profile;Gene Silencing;Genes;Genetic;Genetic Programming;Genomics;Glioblastoma;Glioma;Gliomagenesis;Goals;Human;Invaded;Malignant - descriptor;Malignant Glioma;Malignant Neoplasms;Medicine;Mesenchymal;Modeling;Molecular Profiling;Mus;Outcome;Pathogenesis;Pathway interactions;Phenotype;Process;Proteins;Research Infrastructure;Research Personnel;Role;Series;Source;Systems Biology;Technology;Testing;The Cancer Genome Atlas;Therapeutic Intervention;Transcription Repressor/Corepressor;Tumor Angiogenesis;Work;angiogenesis;anticancer research;base;cancer genome;computerized tools;design;genome-wide;malignant phenotype;outcome forecast;programs;protein complex;public health relevance;reconstruction;research study;therapeutic target;tool;trait;transcription factor;tumor;tumorigenesis","Computational analysis of Human High Grade Gliomas","
High-grade gliomas (also known as glioblastoma mutiforme) are the fastest growing type of central
nervous system tumors in humans. They are invariably associated with a bad prognosis. Recently, two
intrinsic capabilities of glioblastoma multiforme have been recognized as key traits of malignancy, the
ability to invade adjacent normal brain and produce new blood vessels. There is general agreement that
the current failures in the treatment of high-grade gliomas are mostly caused by lack of effective tools
against these features of aggressive brain tumors. This grant proposal uses cutting-edge computational
technologies recently developed at Columbia University Medical Center to exploit microarray expression
profiles from a large collection of primary glioblastoma multiforme and identify the key genetic master
regulators responsible for the most aggressive attributes of malignant gliomas (""the mesenchymal
signature""). We will perform a series of state-of-the-art experiments in cell culture systems and
experimental animals to validate the predictions made by the new algorithms. We anticipate that the
identification of the master genetic programs directing the most aggressive features of malignant gliomas
will offer the best possible targets for therapeutic intervention.","NINDS","8327774","8/8/2012 12:00:00 AM","PAR-08-184","5R01NS061776-04","5","R01","NS","061776","04"," ","FOUNTAIN, JANE W","9/1/2009 12:00:00 AM","8/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-CB-J(02)M]"," ","6189067","IAVARONE, ANTONIO ","Not Applicable","13","NEUROLOGY","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","SCHOOLS OF MEDICINE","100323725","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","296272","178831"," ","475103",
"Genetics","1,2-diacylglycerol;Adaptor Signaling Protein;Affect;Animal Model;Area;Binding;Binding Proteins;Biochemical;Biogenesis;Biological;Biological Process;Brain;Bypass;C-terminal;Cardiac;Cell Line;Cell membrane;Cells;Centrosome;Charge;Complex;Cytoplasmic Granules;Diacylglycerol Kinase;Diglycerides;Electrons;Electrostatics;Endoplasmic Reticulum;Enzymes;Epigenetic Process;Event;Failure;Gene Structure;Generations;Genes;Genome;Genomics;Germ Lines;Health;Hereditary Disease;Kinesin;Link;Lipids;Male Contraceptive Agents;Male Infertility;Malignant Neoplasms;Mediator of activation protein;Meiosis;Mesenchymal Stem Cells;Methylation;Microtubules;Mitochondria;Mitochondrial RNA;Motor;Movement;Nature;Nuclear;Organelles;Pathway interactions;Phenotype;Phosphatidate Phosphatase;Phosphatidic Acid;Play;Process;Production;Proteins;RNA;RNA Interference;RNA Processing;Regulation;Reporting;Research;Role;Signal Transduction;Small RNA;Source;Spermatocytes;Spermatogenesis;Structure;Surface;Therapeutic;Tissues;Transcript;Transmembrane Domain;Work;base;cancer type;extracellular;imprint;member;novel;piRNA;research study;response;sensor;tool development;trafficking","Regulation of RNA processing on the mitochondrial surface by lipid signaling"," Mobilization of transposons can cause genetic diseases including cancer. piRNAs, the third type of RNAi discovered, function to maintaining genome integrity by suppressing transposon mobilization and performing germ-line imprinting. We have found that mitochondria play a role in generation of piRNAs via the action of a signaling enzyme anchored on the mitochondrial surface. We propose to increase our understanding of how a signal generated on the mitochondrial surface regulates this process, which may involve controlling how mitochondria and the RNA structures traffic through the cell on microtubules. If successful, the proposed research could facilitate the development of tools to broadly manipulate the epigenetic structure of genes and thus control their expression, might identify some causes of male infertility, and will present a potential therapeutic opportunity for a male contraceptive. It may also be important more broadly, as piRNAs are now being reported in many tissues.   
      

","NIGMS","8372464","8/20/2012 12:00:00 AM","PA-11-260","1R01GM100109-01A1","1","R01","GM","100109","01","A","BENDER, MICHAEL T","9/1/2012 12:00:00 AM","8/31/2016 12:00:00 AM","Membrane Biology and Protein Processing Study Section[MBPP]"," ","1879382","FROHMAN, MICHAEL A.","Not Applicable","01","PHARMACOLOGY","804878247","M746VC6XMNH9","804878247","M746VC6XMNH9","US","40.907353","-73.128565","5992612","STATE UNIVERSITY NEW YORK STONY BROOK","STONY BROOK","NY","SCHOOLS OF MEDICINE","117943362","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","190000","108459"," ","298459",
"Bioengineering; Cardiovascular; Clinical Research; Nutrition; Patient Safety; Stem Cell Research","Beds;Blood Vessels;Caliber;Carbon Dioxide;Cardiac Output;Cardiovascular system;Cell Density;Cells;Computers;Contracts;Development;Diabetes Mellitus;Disease;Drug toxicity;Effectiveness;Electrodes;Electromagnetics;Endothelial Cells;Endothelium;Evaluation;Exercise;Fiber;Fibroblasts;Gases;Glucose;Heart failure;Human;Hydrogels;Inflammatory;Laboratories;Liquid substance;Measurement;Measures;Mechanical Stimulation;Mechanics;Mediating;Mesenchymal Stem Cells;Metabolic;Metabolism;Methodology;MicroRNAs;Microcirculatory Bed;Microfabrication;Microfluidics;Monitor;Muscle;Muscle Contraction;Muscle Fibers;Muscle function;Muscular Dystrophies;Myopathy;Nutrient;Organ;Outcome;Oxygen;Oxygen Consumption;Partial Pressure;Performance;Perfusion;Peripheral arterial disease;Pharmaceutical Preparations;Phase;Physiologic Monitoring;Physiological;Production;Property;Pulsatile Flow;Pump;Relative (related person);Research;Resistance;Role;Running;Screening procedure;Severities;Severity of illness;Simulate;Skeletal Muscle;Smooth Muscle Myocytes;Stimulus;System;Techniques;Testing;Thick;Tissues;Toxic effect;Toxicity Tests;Toxin;U-Series Cooperative Agreements;Vasoconstrictor Agents;Vasodilator Agents;Venous;Venous system;cerivastatin;design;drug candidate;drug testing;fatty acid metabolism;glucose metabolism;in vivo;induced pluripotent stem cell;metabolomics;muscle engineering;muscle form;muscular system;pressure;research study;response;sarcopenia;scaffold;uptake;vascular bed","Circulatory system and integrated muscle tissue for drug and tissue toxicity","  This project will provide new methodology to examine the function of human skeletal muscle in the laboratory and to test the effectiveness and toxicity of drugs. We expect that the results of this project will facilitate the screening of candidate drugs o treat disorders of skeletal muscle and blood vessels.   
      

","NCATS","8415349","7/24/2012 12:00:00 AM","RFA-RM-11-022","1UH2TR000505-01","1","UH2","TR","000505","01"," ","TAGLE, DANILO A","7/24/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BST-N(50)R]"," ","1879807","TRUSKEY, GEORGE A","Not Applicable","04","BIOMEDICAL ENGINEERING","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","BIOMED ENGR/COL ENGR/ENGR STA","277054673","UNITED STATES","N","7/24/2012 12:00:00 AM","6/30/2013 12:00:00 AM","350","Non-SBIR/STTR","2012"," "," ","OD","298365","0"," ","298365",
"Bioengineering; Cardiovascular; Clinical Research; Nutrition; Patient Safety; Stem Cell Research","Beds;Blood Vessels;Caliber;Carbon Dioxide;Cardiac Output;Cardiovascular system;Cell Density;Cells;Computers;Contracts;Development;Diabetes Mellitus;Disease;Drug toxicity;Effectiveness;Electrodes;Electromagnetics;Endothelial Cells;Endothelium;Evaluation;Exercise;Fiber;Fibroblasts;Gases;Glucose;Heart failure;Human;Hydrogels;Inflammatory;Laboratories;Liquid substance;Measurement;Measures;Mechanical Stimulation;Mechanics;Mediating;Mesenchymal Stem Cells;Metabolic;Metabolism;Methodology;MicroRNAs;Microcirculatory Bed;Microfabrication;Microfluidics;Monitor;Muscle;Muscle Contraction;Muscle Fibers;Muscle function;Muscular Dystrophies;Myopathy;Nutrient;Organ;Outcome;Oxygen;Oxygen Consumption;Partial Pressure;Performance;Perfusion;Peripheral arterial disease;Pharmaceutical Preparations;Phase;Physiologic Monitoring;Physiological;Production;Property;Pulsatile Flow;Pump;Relative (related person);Research;Resistance;Role;Running;Screening procedure;Severities;Severity of illness;Simulate;Skeletal Muscle;Smooth Muscle Myocytes;Stimulus;System;Techniques;Testing;Thick;Tissues;Toxic effect;Toxicity Tests;Toxin;U-Series Cooperative Agreements;Vasoconstrictor Agents;Vasodilator Agents;Venous;Venous system;cerivastatin;design;drug candidate;drug testing;fatty acid metabolism;glucose metabolism;in vivo;induced pluripotent stem cell;metabolomics;muscle engineering;muscle form;muscular system;pressure;research study;response;sarcopenia;scaffold;uptake;vascular bed","Circulatory system and integrated muscle tissue for drug and tissue toxicity","  This project will provide new methodology to examine the function of human skeletal muscle in the laboratory and to test the effectiveness and toxicity of drugs. We expect that the results of this project will facilitate the screening of candidate drugs o treat disorders of skeletal muscle and blood vessels.   
      

","NCATS","8415349","7/24/2012 12:00:00 AM","RFA-RM-11-022","1UH2TR000505-01","1","UH2","TR","000505","01"," ","TAGLE, DANILO A","7/24/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BST-N(50)R]"," ","1879807","TRUSKEY, GEORGE A","Not Applicable","04","BIOMEDICAL ENGINEERING","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","BIOMED ENGR/COL ENGR/ENGR STA","277054673","UNITED STATES","N","7/24/2012 12:00:00 AM","6/30/2013 12:00:00 AM","350","Non-SBIR/STTR","2012"," "," ","NCATS","331032","340266"," ","671298",
"Clinical Research; Contraception/Reproduction; Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adhesions;Affect;Animals;Ascaridil;Autologous;Benign;Blood;Blood Cells;Bone Marrow;Bone Marrow Cells;Bone Marrow Transplantation;CD34 gene;Cell Culture Techniques;Cell Separation;Cell physiology;Cell surface;Cells;Chimerism;Clinical;Derivation procedure;Development;Digestion;Disease;Endometrial;Endometrial Stromal Cell;Endometrium;Endothelial Cells;Engraftment;Epithelial Cells;Exhibits;Female;Fertilization;Fetus;Fluorescent in Situ Hybridization;Gland;Granulocyte Colony-Stimulating Factor;Green Fluorescent Proteins;HIV-1;Habitual Abortion;Hematopoietic;Hemorrhage;Heterogeneity;Human;Hysterotomy;Immune;Immune Tolerance;Immunohistochemistry;Infertility;Label;Lentivirus Vector;Leukocytes;Literature;MCAM gene;Macaca;Macaca mulatta;Malignant - descriptor;Mesenchymal Stem Cells;Microchimerism;Modeling;Natural Killer Cells;PTPRC gene;Pathology;Patients;Peripheral Blood Stem Cell;Placenta;Play;Pregnancy;Primary Cell Cultures;Primates;Protocols documentation;Reporting;Reproduction;Role;Sampling;Sorting - Cell Movement;Source;Staining method;Stains;Stem cell transplant;Stem cells;Stromal Cells;T-Lymphocyte;Testing;Tissues;Transplant Recipients;Transplantation;Undifferentiated;Update;Uterus;Woman;Y Chromosome;base;cell type;cohort;endometriosis;human AMID protein;implantation;improved;interest;male;nonhuman primate;novel;progenitor;stem cell niche","Endometrial Derivation in a Human and Macaque Chimeric Bone Marrow Model","n/a","NICHD","8554001"," "," ","1ZIAHD008925-01","1","ZIA","HD","008925","01"," "," "," "," "," "," ","11593512","WOLFF, ERIN ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NICHD"," "," "," ","41066",
"Clinical Research; Dental/Oral and Craniofacial Disease; Pediatric","Accounting;Address;Adolescent;Affect;Anatomy;Award;Basic Science;Beak;Biological Assay;Biology;Birds;Bone Development;Bone Regeneration;Bone necrosis;California;Candidate Disease Gene;Cells;Chimera organism;Clinical;Complex;Congenital Abnormality;Data;Dental Enamel;Dentists;Deposition;Development;Disease;Ducks;Dysplasia;Embryo;Event;Exhibits;Face;Faculty;Family;Foundations;Gelatinase A;Genes;Goals;Grant;Human;Hyperplasia;Indium;Injury;Jaw;Length;Loeys-Dietz Syndrome;Manuscripts;Mentors;Mesenchymal;Mesenchyme;Methods;Micrognathism;Molecular;Mus;Mutate;Mutation;Natural regeneration;Neural Crest;Nuclear;Operative Surgical Procedures;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis;Paget&apos;s Disease;Pathway interactions;Play;Population;Process;Publishing;Quail;Regulation;Research;Research Personnel;Role;San Francisco;Scientist;Shapes;Signal Transduction;Skeleton;Specific qualifier value;Staging;Syndrome;System;TGF-beta type I receptor;TNFSF11 gene;Techniques;Testing;Time;Tissues;Transforming Growth Factor beta;Transplantation;Trauma;Tumor necrosis factor receptor 11b;Universities;Work;Writing;authority;base;bone;craniofacial;design;in vivo;injured;loss of function;malformation;member;mineralization;novel;osteogenic;prevent;programs;public health relevance;repaired;research study;skeletal;skills;treatment strategy","Mesenchymal Regulation of Jaw Bone Length","
PROJECT NARRATIVE
What controls the length of bone? Answering this question is important for preventing and treating birth
defects, as well as for devising new therapies to repair or regenerate bones affected by injury or disease. The
goal of this project is to identify genes and embryonic events that determine jaw length. 
 ","NIDCR","8238334","8/3/2012 12:00:00 AM","PA-10-059","5K08DE021705-02","5","K08","DE","021705","02"," ","KING, LYNN M","9/1/2011 12:00:00 AM","6/30/2013 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","9547956","BUMANN, ERIN EALBA","Not Applicable","12","DENTISTRY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","941432510","UNITED STATES","N","9/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","92901","6759"," ","99660",
"No NIH Category available","Accounting;Amino Acids;Binding;Biological Assay;Blood Vessels;Bone Injury;Bone Marrow;Bone Regeneration;CXC Chemokines;CXCL5 gene;Calvaria;Caring;Cell model;Cells;Chemotaxis;Commit;Conflict (Psychology);Country;Cysteine;Data;Defect;Enzyme-Linked Immunosorbent Assay;Event;Face;Family;Fostering;Fracture;Freedom;Generations;Granulation Tissue;Head;Healed;Health;Hearing;Homologous Gene;Human;IL8 gene;Immigration;In Vitro;Indium;Inflammatory;Injury;Interruption;Knockout Mice;Knowledge;Limb structure;Mediating;Mesenchymal Stem Cells;Messenger RNA;Middle East;Military Personnel;Mitogen-Activated Protein Kinases;Modeling;Morbidity - disease rate;Mus;Osteoblasts;Osteogenesis;Pathway interactions;Peptides;Phase;Phenotype;Physical condensation;Play;Process;Production;Proteins;Rehabilitation therapy;Research Proposals;Resources;Reverse Transcriptase Polymerase Chain Reaction;Role;Signal Pathway;Signal Transduction;Site;Small Interfering RNA;Sports;Stromal Cells;Subgroup;Technology;Time;Trauma;Traumatic Brain Injury;Up-Regulation;Vascular blood supply;Veterans;Visual;angiogenesis;beta catenin;bone;bone healing;cell motility;chemokine;combat;cranium;disability;experience;expression vector;healing;in vitro Model;in vivo;intramembranous bone;leucylarginine;migration;operation;osteogenic;overexpression;paracrine;primitive cell;protein kinase D;public health relevance;receptor;repaired;restoration","Role of Angiogenic CXC Chemokines in Intramembranous Bone Repair","RELEVANCE TO VETERANS HEALTH 
The current research proposal is every relevant to the care of veterans who have 
experienced traumatic injury in active combat theaters. Characterization of the types of 
combat injuries observed in Operation Enduring Freedom (OEF) and Operation Iraqi 
Freedom (OIF) has shown that traumatic bone injury is a prevalent problem. In fact the 
types of combat injuries observed in Operation Enduring Freedom (OEF) and Operation 
Iraqi Freedom (OIF) has shown that 26% of all extremity wounds are fractures (Owens 
BD, Kragh, Jr JF, Macaitis J, Svoboda SJ, Wenke JC. Characterization of extremity 
wounds in Operation Iraqi Freedom and Operation Enduring Freedom. J Orthop 
Trauma 21:254-257, 2007). Head and face trauma accounts for 2% - 20% of combat 
injuries depending on the theater of Middle East conflict. Thus traumatic bone injury is 
found to be associated with active military campaigns. In those traumatic bone injuries 
that either heal slowly or do not heal, or in the case of facial and skull bone injuries that 
could also have attendant visual or hearing deficits or traumatic brain injury, increased 
morbidity, long-term rehabilitation, and even long-term disabilities are faced by such 
veterans that take a toll on the veterans themselves, their families, and the financial 
resources of the country. It is important to understand the early events in bone repair. 
These events include the generation of new bone forming cells called osteoblasts from 
more primitive cells from bone marrow (e.g. mesenchymal stem cells), and the 
restoration of new blood supply to bone. Re-establishing blood supply to bone by a 
process called angiogenesis (the sprouting of new blood vessels from existing blood 
vessels after injury) is necessary and critical for bone repair to occur. Knowledge of these 
key elements in bone repair may help to develop and deliver therapies that would hasten 
bone healing to restore bone to pre-morbid levels of strength and soundness.","VA","8258197","12/6/2011 12:00:00 AM","RFA-BX-08-002","5I01BX000170-04","5","I01","BX","000170","04"," "," ","4/1/2009 12:00:00 AM","3/31/2013 12:00:00 AM","Endocrinology B[ENDB]"," ","9443584","YAMAGUCHI, DEAN T","Not Applicable","33","Unavailable","066689118","DL46AKJ5YD48","066689118","DL46AKJ5YD48","US","34.104809","-118.41105","481012","VA GREATER LOS ANGELES HEALTHCARE SYSTEM","LOS ANGELES","CA","Independent Hospitals","900731003","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Breast Cancer; Cancer; Genetics","Address;Adult;Adverse effects;Affect;Alleles;Animals;Birth;Breast Cancer Cell;Cancer cell line;Cause of Death;Cell Lineage;Cells;Chemotherapy-Oncologic Procedure;Complex;DNA Binding;DNA-Binding Proteins;Deacetylase;Distant;Distant Metastasis;Drug Delivery Systems;E-Cadherin;Epithelial;Epithelial Cells;Event;Extravasation;Fibroblasts;Funding;Gene Expression;Gene Targeting;Genes;Goals;Half-Life;Health;ITGA5 gene;In Vitro;Integrins;Internal Ribosome Entry Site;Investigation;Knock-out;Knockout Mice;Label;Link;Literature;Location;Lung;Macrophage Colony-Stimulating Factor;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Maps;Mediating;Mesenchymal;Modeling;Molecular;Molecular Target;Mouse Mammary Tumor Virus;Mus;N-terminal;Neoplasm Metastasis;Nucleosomes;Organ;PEA3;Paclitaxel;Phenotype;Phosphorylation;Phosphorylation Inhibition;Phosphorylation Site;Phosphotransferases;Play;Polyomavirus;Primary Neoplasm;Process;Protein Dephosphorylation;Proteins;Recording of previous events;Recruitment Activity;Regulation;Reporter;Reporting;Research Personnel;Resistance;Role;Serine;Site;Subfamily lentivirinae;System;Tamoxifen;Testing;Transcription Coactivator;Transgenes;Treatment Efficacy;Virus;Work;cancer cell;cancer therapy;carcinogenesis;chemotherapy;ductal breast carcinoma;epithelial to mesenchymal transition;experience;gene repression;in vivo;insight;malignant breast neoplasm;migration;mortality;mouse model;neoplastic cell;nuclear receptor coactivator 1;overexpression;promoter;sensor;stability testing;stress-activated protein kinase 1;transcription factor;tumor;tumor growth;twist protein","The Role of SRC-1 in Breast Cancer","  Metastasis is the major cause of death in breast cancer as well as other cancers. Twist is a DNA-binding protein that promotes metastasis by altering gene expression. This project will define the in vivo role of Twist in breast cancer cell phenotypic changes and metastasis, evaluate the target value and side effects of Twist inactivation in animal cancer therapy, test possible synergistic effects of combined Twist inactivation and chemotherapy on breast cancer metastasis in mouse models, and investigate new strategies to reduce Twist protein level and function in breast cancer cells.   
      

","NCI","8295580","4/9/2012 12:00:00 AM","PA-10-067","2R01CA112403-06A1","2","R01","CA","112403","06","A","JHAPPAN, CHAMELLI","9/1/2006 12:00:00 AM","3/31/2017 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1870226","XU, JIANMING ","Not Applicable","09","ANATOMY/CELL BIOLOGY","051113330","FXKMA43NTV21","051113330","FXKMA43NTV21","US","29.711148","-95.39695","481201","BAYLOR COLLEGE OF MEDICINE","HOUSTON","TX","SCHOOLS OF MEDICINE","770303411","UNITED STATES","N","4/9/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","172353","97379"," ","269732",
"Bioengineering; Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Adhesions;Adhesives;Adsorption;Affect;Alloys;Applications Grants;Area;Atomic Force Microscopy;Binding;Biocompatible Materials;Biological Assay;Bone Tissue;Cell Adhesion;Cell Communication;Cell Culture Techniques;Cell physiology;Cell surface;Cell-Cell Adhesion;Cells;Chemicals;Chemistry;Clinic;Clinical;Collagen Type I;Complex;Cultured Cells;Data;Dental;Deposition;Detection;Development;Diffusion;Distant;Drug Formulations;Economics;Electron Probe Microanalysis;Engineering;Environment;Exhibits;Extracellular Matrix;Fibronectins;Film;Fluorescence Microscopy;Foundations;Functional disorder;Gene Expression;Genes;Goals;Heparin Binding;Hour;Immunofluorescence Microscopy;Implant;In Vitro;Institution;Interleukin-11;International;Investigation;Knowledge;Laminin;Laser Scanning Confocal Microscopy;Libraries;Life;Liquid substance;Location;Marketing;Measurement;Mechanics;Membrane Proteins;Mesenchymal Stem Cells;Messenger RNA;Metals;Microscopy;Modeling;Molecular Conformation;Morphology;Orthopedics;Osseointegration;Osteoblasts;Osteocalcin;Osteogenesis;Outcome;Oxides;Peer Review;Physiology;Plasma;Population;Procedures;Process;Prosthesis;Protein Conformation;Proteins;Publications;RGD (sequence);Research;Research Activity;Roentgen Rays;Scanning Electron Microscopy;Science;Scientist;Screening procedure;Serum;Spectrometry;Spectroscopy, Fourier Transform Infrared;Spectrum Analysis;Staging;Stem cells;Stimulus;Surface;Surface Properties;TNF gene;TNFSF11 gene;Techniques;Technology;Testing;Therapeutic;Thick;Tissue Engineering;Tissue Model;Tissues;Titania;Titanium;Training;Transcript;Translating;Vitronectin;base;bone healing;cell behavior;cell motility;cell type;cold temperature;combinatorial;graduate student;hip replacement arthroplasty;human tissue;implant material;improved;in vivo;interest;metal oxide;migration;nano;nanostructured;novel;osteogenic;osteopontin;protein distribution;public health relevance;scaffold;stem cell differentiation;symposium;vapor","Combinatorial Metal Oxide Substrates to Enhance Osteogenic Stem Cell Functions","
Project Narrative
With a U.S. Prosthetic Implant market of about $1 billion a year and growing at a rate of 10% a
year, any improvement in osseointegration and life of the prosthetic implant will have a drastic
economic effect, especially if one takes into consideration that up to 30% of the implants in
procedures such as hip replacement do not show appropriate osseointegration. The proposed
project aims to improve the number of candidate biomaterials screened for improved
osseointegration by investigating the effect of the material surface properties and protein
adsorption on osteogenic mesenchymal stem cell behavior, using state of the art surface
characterization and gene expression technologies.","NIGMS","8213444","2/22/2012 12:00:00 AM","PAR-08-027","5SC2GM089642-03","5","SC2","GM","089642","03"," ","OKITA, RICHARD T","2/1/2010 12:00:00 AM","1/31/2014 12:00:00 AM","ZGM1-MBRS-X(CH)"," ","7752488","RAMIREZ-VICK, JAIME E","Not Applicable","98","ENGINEERING (ALL TYPES)","175303262","GZRNJ1GZDBM1","175303262","GZRNJ1GZDBM1","US","18.202288","-66.577983","578704","UNIVERSITY OF PUERTO RICO MAYAGUEZ","MAYAGUEZ","PR","BIOMED ENGR/COL ENGR/ENGR STA","006819000","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2014 12:00:00 AM","859","Other Research-Related","2012"," "," ","NIGMS","74250","30226"," ","104476",
"Cardiovascular; Genetics; Heart Disease; Heart Disease - Coronary Heart Disease","A Mouse;Ablation;Address;Affect;Attenuated;Award;Biological Models;Biological Process;Cardiac;Cell Adhesion;Cell Proliferation;Cells;Coronary;Coronary Vessels;Coronary artery;Coronary heart disease;Data;Defect;Development;Embryo;Epicardium;Epithelial;Genes;Genetic;Genotype;Heart;In Vitro;Label;Ligands;Link;Mediator of activation protein;Membrane;Mesenchymal;Methodology;Molecular;Monitor;Morphogenesis;Mus;Mutant Strains Mice;Mutation;Myocardial;Myocardium;Nuclear Receptors;Nuclear Translocation;Pathway interactions;Pattern;Phenotype;Proteins;RXR;Retinoid Receptor;Retinoids;Role;Signal Transduction;System;Testing;Therapeutic Intervention;Tissues;Transgenic Mice;Ventricular;Wild Type Mouse;cell fate specification;cell motility;cell transformation;cell type;in vivo;insight;mortality;novel;recombinase;time use;transcription factor;two-dimensional","Genetic Ablation of Epicardial Function in the Mouse","n/a","NHLBI","8228081","12/30/2011 12:00:00 AM","PA-07-070","5R01HL065484-10","5","R01","HL","065484","10"," ","SCHRAMM, CHARLENE A","7/1/2002 12:00:00 AM","12/31/2013 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","2095823","RUIZ-LOZANO, PILAR ","Not Applicable","18","PEDIATRICS","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","146012"," ","393512",
"Breast Cancer; Cancer","Biopsy;Blood Circulation;Bone Marrow;Bone Marrow Neoplasms;Breast;Carcinoma;Cells;Clinical;Defect;Development;Endocrine;Epithelial;Growth;Human;Implant;Indolent;Interruption;Malignant Neoplasms;Mammary Neoplasms;Marrow;Mediating;Mediator of activation protein;Mesenchymal;Modality;Molecular;Mus;Myofibroblast;Neoplasm Metastasis;Operative Surgical Procedures;Paracrine Communication;Pathogenesis;Physiological;Primary Neoplasm;Process;Reagent;Recruitment Activity;Research;Research Project Grants;Residual state;Role;Signal Transduction;Specimen;Stem cells;Stromal Cells;Surveys;Tissues;Wound Healing;Xenograft Model;breast surgery;cancer cell;carcinogenesis;cytokine;malignant breast neoplasm;neoplastic cell;neutralizing antibody;novel;osteopontin;peripheral blood;pre-clinical;precursor cell;progenitor;research study;response;stromal progenitor;tumor;tumor growth;tumor xenograft","Recruitment of Stromal Cells to Mammary Tumors","n/a","NCI","8374812","3/26/2012 12:00:00 AM"," ","5P01CA080111-14","5","P01","CA","080111","14"," "," "," "," ","ZCA1-GRB-S","8263","1891586","WEINBERG, ROBERT A","Not Applicable","07","Unavailable","120989983","JVKKKWN2N5N3","120989983","JVKKKWN2N5N3","US","42.363304","-71.087734","1742101","WHITEHEAD INSTITUTE FOR BIOMEDICAL RES","CAMBRIDGE","MA","Research Institutes","021421025","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","293849","293849"," ","254280","39569"," "," ",
"Genetics; Lung; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Alveolar;Alveolar Process;Alveolus;Anatomy;Area;Basement membrane;Blood Vessels;Candidate Disease Gene;Cell Lineage;Cells;Complex;Cuboidal Cell;Data;Development;Distal;Epithelial;Epithelial Cells;Exhibits;Gases;Gene Expression;Gene Expression Profiling;Genes;Goals;Homeostasis;In Vitro;Individual;Injury;Lead;Life;Liquid substance;Literature;Lung;Maps;Mesenchymal;Metabolism;Modeling;Modification;Molecular Profiling;Outcome;Pathway interactions;Phenotype;Play;Proliferating;Regulation;Regulator Genes;Role;Squamous Cell;Statistical Methods;Stem cells;Surface;System;Testing;Therapeutic;Therapeutic Agents;Time;Transgenic Organisms;Type I Epithelial Receptor Cell;alveolar epithelium;base;cell type;data modeling;fetal;immunoregulation;in vivo;insight;interstitial;lung development;lung injury;lung repair;mRNA Expression;novel;novel diagnostics;novel therapeutics;podoplanin;precursor cell;repaired;research study;response;surfactant;transcription factor","ALVEOLAR EPITHELIAL CELL FATES: MAPPING AND REGULATION","n/a","NHLBI","8374756","4/30/2012 12:00:00 AM"," ","5P01HL024075-32","5","P01","HL","024075","32"," "," "," "," ","ZHL1-PPG-S","5075","1862822","DOBBS, LELAND GEORGE","Not Applicable","12","Unavailable","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","Domestic Higher Education","941432510","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM"," ","Non-SBIR/STTR","2012","464869","464869"," ","300886","163983"," "," ",
"Biotechnology; Breast Cancer; Cancer; Genetics","Address;Award;Breast Cancer Cell;Breast Cancer Model;Breast Cancer Treatment;Cancer cell line;Cells;Combined Modality Therapy;Data;Development;Disease;Distant Metastasis;E-Cadherin;Functional RNA;Genetic;Genetically Engineered Mouse;Genomics;Goals;Histologic;Knockout Mice;Lung;Malignant - descriptor;Malignant Neoplasms;Mediating;Mesenchymal;MicroRNAs;Micrometastasis;Modeling;Molecular Genetics;Mus;Names;Neoplasm Metastasis;Oncogenic;Pathogenesis;Phase;Play;Primary Neoplasm;Research;Role;Screening procedure;Testing;Therapeutic;Tumor Angiogenesis;Tumor Cell Invasion;Vascular Endothelial Growth Factors;Work;angiogenesis;base;cancer therapy;macrophage;malignant breast neoplasm;mortality;mouse model;neoplastic cell;overexpression;programs;research study;tumor","Role of microRNAs in malignant progression","RELEVANCE (See Inslruclions): 
90% of cancer-related mortality is caused by metastasis. Current cancer treatments can control many 
primary tumors but do little to stop the metastatic spread. Not only does this study Illuminate the genetic and 
molecular basis of tumor metastasis, but it also has Implications for breast cancer treatment.","NCI","8323981","8/16/2012 12:00:00 AM","PA-07-297","5R00CA138572-05","5","R00","CA","138572","05"," ","JHAPPAN, CHAMELLI","9/24/2010 12:00:00 AM","6/30/2014 12:00:00 AM","NSS"," ","9385371","MA, LI ","Not Applicable","09","RADIATION-DIAGNOSTIC/ONCOLOGY","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","9/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","152832","88643"," ","241475",
"Bioengineering; Biotechnology; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adhesions;Adhesives;Adipose tissue;Affect;Anatomic Sites;Apoptosis;Articular Range of Motion;Autologous;BMP-12;Biomechanics;Canis familiaris;Cell Proliferation;Cell Therapy;Cell surface;Cells;Characteristics;Clinical;Coculture Techniques;Connective Tissue;Dense Connective Tissue;Environment;Extracellular Matrix;Failure;Fibrin;Fibroblast Growth Factor;Fibroblast Growth Factor 2;Fibroblasts;Flexor;Goals;Growth Factor;Hand;Healed;Health Care Costs;Heparin;In Vitro;Inflammation;Inflammatory;Injury;Knee;Lead;Ligaments;Location;Mechanics;Mesenchymal Stem Cells;Methods;Modeling;Natural regeneration;Operative Surgical Procedures;Outcome;Pilot Projects;Polymers;Process;Production;Property;Rehabilitation therapy;Rotator Cuff;Rupture;Site;Solutions;Staging;Stem cells;Study Section;Surface;Surgical sutures;Synovial Cell;System;Tendon Injuries;Tendon structure;Testing;Therapeutic;Time;Tissues;Transplantation;United States;Up-Regulation;Upper Extremity;adult stem cell;articular cartilage;base;cell growth;cell motility;clinical care;clinically relevant;cost;cytokine;digital;disability;healing;improved;in vivo;injured;ligament injury;migration;musculoskeletal injury;nanofiber;novel;platelet-derived growth factor BB;prevent;reconstruction;repaired;research study;scaffold;soft tissue;stem cell therapy;success;translational study","Enhanced Tendon Healing through Growth Factor and Cell Therapies"," Treatment of musculoskeletal injuries results in 30 billion dollars in healthcare costs in the United States each year. Approximately half of these injuries involve tendons and ligaments. Growth factor- and cell- based therapy has the potential to improve healing for a broad range of connective tissue injuries. Our long-term goal is to apply growth factor and cell therapy solutions in order to positively affect the clinical outcomes of tendon repair.   
      

","NIAMS","8457419","9/13/2012 12:00:00 AM","PA-11-260","1R01AR062947-01A1","1","R01","AR","062947","01","A","WANG, FEI","9/15/2012 12:00:00 AM","8/31/2017 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1874281","GELBERMAN, RICHARD H","SAKIYAMA-ELBERT, SHELLY ELESE; THOMOPOULOS, STAVROS ","01","ORTHOPEDICS","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","9/15/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","386397","158772"," ","545169",
"Acute Respiratory Distress Syndrome; Biotechnology; Clinical Research; Lung; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acute;Acute Lung Injury;Acute respiratory failure;Adult Respiratory Distress Syndrome;Advisory Committees;Alveolar;Anti-Inflammatory Agents;Anti-inflammatory;Attenuated;Bacterial Pneumonia;Biology;Bleomycin;CD15 Antigens;California;Cardiovascular system;Cell Therapy;Cell surface;Clinical;Commit;Critical Care;Critical Illness;Data;Dose;Endotoxins;Epithelial;Equilibrium;Escherichia coli;Extravascular Lung Water;Gene Combinations;Genes;Goals;Growth;Growth Factor;Hepatocyte Growth Factor;Inflammatory;Inflammatory Response;Interleukin-10;Intravenous;K-Series Research Career Programs;Knockout Mice;Light;Liquid substance;Lung;Measures;Medicine;Mentors;Mesenchymal Stem Cells;Methods;Microarray Analysis;Modeling;Molecular;Mus;Pathway interactions;Patients;Permeability;Pneumonia;Population;Postdoctoral Fellow;Production;Proteins;Research;Research Institute;Research Personnel;Respiratory Failure;San Francisco;Scientist;Severities;Signal Pathway;Small Interfering RNA;Stimulus;Supportive care;TLR4 gene;TNF gene;Testing;Therapeutic Effect;Therapeutic Studies;TimeLine;Tissue-Specific Gene Expression;Universities;alveolar epithelium;anakinra;base;career;improved;improved functioning;inhibitor/antagonist;injured;interest;knowledge base;lung injury;mortality;mouse model;novel;programs;protective effect;research study;response;stage-specific embryonic antigen 4;stem cell population;stem cell therapy","Cell Based Therapy for Experimental Acute Lung Injury","n/a","NHLBI","8307927","7/25/2012 12:00:00 AM","PA-06-512","5K08HL092059-04","5","K08","HL","092059","04"," ","COLOMBINI-HATCH, SANDRA","1/1/2009 12:00:00 AM","7/31/2014 12:00:00 AM","ZHL1-CSR-O(O1)"," ","8229431","GUPTA, NAVEEN ","Not Applicable","49","Unavailable","781613492","PHZJFZ32NKH4","781613492","PHZJFZ32NKH4","US","32.903152","-117.243436","7375802","SCRIPPS RESEARCH INSTITUTE","LA JOLLA","CA","Research Institutes","920371000","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","838","Other Research-Related","2012"," "," ","NHLBI","118750","9500"," ","128250",
"Aging; Arthritis; Bioengineering; Biotechnology; Gene Therapy; Genetics; Pain Conditions - Chronic; Pain Research","Adherent Culture;Adult;Affect;Age;American;Animals;Anterior Cruciate Ligament;Antibodies;Appearance;Arthritis;Biological Assay;Biology;Bioluminescence;Bone Resorption;Cartilage;Cells;Chondrocytes;Chronic;Clinical Treatment;Collagen;Coupled;Cultured Cells;Degenerative polyarthritis;Disease;Disease Progression;Down-Regulation;Effectiveness;Engineering;Environment;Excision;Exostoses;Experimental Models;Female;Future;Gene Expression;Gene Proteins;Gene Targeting;Gene Transfer;Goals;Hip Osteoarthritis;Human;Image;In Vitro;Intra-Articular Injections;Joints;Knee;Knee Osteoarthritis;Lead;Life;Lung;Mechanics;Medial meniscus structure;Mediating;Mesenchymal Stem Cells;Modeling;Operative Surgical Procedures;Osteoarthrosis Deformans;Osteoblasts;Osteogenesis;Pathogenesis;Pathology;Penetration;Prevalence;Production;Proteins;Rattus;Recombinant adeno-associated virus (rAAV);Recombinants;Regulation;Reporter Genes;Research;Reverse Transcriptase Polymerase Chain Reaction;Reverse Transcription;Rheumatoid Arthritis;Role;Sclerosis;Serotyping;Signal Pathway;Signal Transduction;Societies;Symptoms;Synovial Membrane;System;Testing;Therapeutic;Time;Tissues;Transgenes;Transgenic Mice;Trauma;Up-Regulation;Western Blotting;adeno-associated viral vector;aggrecan;airway epithelium;articular cartilage;beta catenin;bone;cell type;cellular transduction;cost;design;digital imaging;effective therapy;functional disability;gene therapy;improved;in vivo;inhibitor/antagonist;monolayer;mouse model;postnatal;transduction efficiency;vector","In Vivo Gene Therapy for Treatment of Osteoarthritis","Project Narrative 
The goal of this proposed research is to identify mechanisms that regulate disease progression in osteoarthritic 
joints. Approximately 80% of adults show some radiographic evidence of osteoarthritis, a major contributor to 
functional impairment and reduced independence, after the age of age of 65. This study may lead to a less 
invasive and less traumatic, gene therapy-based approach to treatment of this debilitating disease.","NIAMS","8300235","6/30/2012 12:00:00 AM","PA-09-210","5F32AR056936-03","5","F32","AR","056936","03"," ","WANG, FEI","8/1/2010 12:00:00 AM","7/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F10B-S(20)L]"," ","9289651","MASON, JEFFREY B.","Not Applicable","03","VETERINARY SCIENCES","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF VETERINARY MEDICINE","191046205","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Training, Individual","2012"," "," ","NIAMS","57734"," "," ","57734",
"Aging; Bioengineering; Biotechnology; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","3-Dimensional;Affect;Aging;Animal Model;Animals;Antibodies;Architecture;Biocompatible Materials;Biological Assay;Bone Growth;Bone Matrix;Bone Regeneration;Calvaria;Cell Culture Techniques;Cells;Characteristics;Clinic;Clinical;Data;Defect;Dental;Dental Implants;Deposition;Dose;Edentulous Mouth;Effectiveness;Elderly;Enzyme-Linked Immunosorbent Assay;Face;Fibroblast Growth Factor 2;Flow Cytometry;Future;Gene Expression;Goals;Growth Factor;Healed;Health;Hematoxylin and Eosin Staining Method;Histological Techniques;Histology;Human;Immunohistochemistry;Implant;In Vitro;Infiltration;Knockout Mice;Lead;Life Style;Measures;Mesenchymal Stem Cells;Modeling;Mus;Odontogenesis;Orthopedics;Osteoblasts;Osteogenesis;Patients;Phase;Ploidies;Recruitment Activity;Reporter;Research;Risk;Scheme;Site;Specificity;Stem cells;System;Technology;Testing;Time;Transgenic Mice;Translating;Translations;Work;age related;aged;bone;bone healing;bone morphogenetic protein 2;calcification;controlled release;design;face bone structure;healing;implantation;in vitro testing;in vivo;injured;meetings;miniaturize;mouse model;nano;novel;older patient;osteoprogenitor cell;progenitor;research study;response;sample fixation;scaffold","Modulated release of growth factors for stimulating progenitors in aging bone","  Our long-term goal is to achieve rapid healing, integration and sustained fixation of dental and orthopaedic implants, particularly for injured elderly patients that heal more slowly and with less consistency. Towards this goal we propose to study the combined delivery of fibroblast growth factor-2 (FGF-2) and bone morphogenetic protein-2 (BMP-2) as a means of rejuvenating aged osteoprogenitors. We will develop a 3-D polyelectrolyte multi-layer coated biomaterials growth factor delivery system that can modulate release of multiple growth factors and overcome problems with existing systems.   
    

","NIDCR","8236277","3/22/2012 12:00:00 AM","PA-10-009","1R01DE021103-01A1","1","R01","DE","021103","01","A","LUMELSKY, NADYA L","6/1/2012 12:00:00 AM","5/31/2017 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","1947524","KUHN, LIISA TIINA","Not Applicable","05","DENTISTRY","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF DENTISTRY/ORAL HYGN","060305335","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","250000","124577"," ","374577",
"Bioengineering; Biotechnology; Cardiovascular; Clinical Research; Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","3-Dimensional;Adult;Allografting;Architecture;Arteries;Autologous;Behavior;Binding;Biochemical;Biodegradation;Biological;Bioreactors;Blood;Cardiac;Cardiovascular Diseases;Cell Differentiation process;Cell Shape;Cells;Child;Coagulation Process;Collagen;Cues;Data;Devices;Elastases;Elements;Endocarditis;Engineering;Environment;Extracellular Matrix;Failure;Family suidae;Gel;Glucose;Glycosaminoglycans;Goals;Growth Factor;Heart;Heart Valve Diseases;Heart Valves;Histologic;Homeostasis;Human;In Vitro;Infiltration;Life;Literature;Mechanics;Mesenchymal Stem Cells;Molds;Natural regeneration;Operative Surgical Procedures;Patients;Pentas;Phenotype;Physiological;Plant Roots;Preparation;Procedures;Property;Public Health;Reporting;Risk;Science;Seeds;Shapes;Signal Transduction;Silicone Elastomers;Source;Stem cells;Structure;Surgeon;Surgical Flaps;System;Tannic Acid;Testing;Time;Tissue Engineering;Tissues;analog;aortic valve;biodegradable polymer;biomaterial compatibility;calcification;conditioning;crosslink;design;heart valve replacement;hemodynamics;implantation;improved;in vivo;innovation;interstitial cell;pericardial sac;pressure;public health relevance;reconstruction;response;scaffold;stem cell differentiation;tissue support frame","Tissue Engineered Aortic Heart Valves:  Scaffolds and Stem Cells","
Heart valves are flap-like tissues inside the heart chambers that open and close every second of the
cardiac cycle to allow blood to flow through the heart. Diseased heart valves are routinely replaced by
surgery, but available artificial devices are less than optimal and fail within 15-20 years after
implantation, mostly because they are made of non-living materials. New and improved devices are
needed for more than 300,000 patients every year. We are developing living materials comprised of
layers of tissue scaffolds to which we add the own patients' cells and shape the entire device in the
form of a natural heart valve. This tissue engineered device has the potential to adapt and remodel
with the patient, and thus will have a global impact by treating cardiovascular diseases in adults and
children.","NHLBI","8215809","2/6/2012 12:00:00 AM","PA-07-070","5R01HL093399-03","5","R01","HL","093399","03"," ","LUNDBERG, MARTHA","3/1/2010 12:00:00 AM","1/31/2014 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","7664907","SIMIONESCU, DAN TEODOR","Not Applicable","03","BIOMEDICAL ENGINEERING","042629816","H2BMNX7DSKU8","042629816","H2BMNX7DSKU8","US","34.684286","-82.812554","1626401","CLEMSON UNIVERSITY","CLEMSON","SC","BIOMED ENGR/COL ENGR/ENGR STA","296340001","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","261466","94978"," ","356444",
"Cancer; Clinical Research; Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Non-Human; Transplantation","Binding;Blood Cells;Blood Platelets;Bone Marrow;CD34 gene;Cell physiology;Cell surface;Cells;Clinical;Coculture Techniques;Commit;Complement;Data;Defect;Disadvantaged;Dose;E-Selectin;Engraftment;Failure;Fucosyltransferase;Funding;Generations;Goals;Grant;Hematologic Neoplasms;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;Hemorrhage;Hereditary Disease;Home environment;Homing;Immunodeficient Mouse;Infusion procedures;Laboratories;Lead;Liquid substance;Marrow;Megakaryocytes;Membrane Glycoproteins;Mesenchymal Stem Cells;Modification;Mononuclear;Morbidity - disease rate;Mus;Outcome;Patients;Population;Recombinants;Reporting;Research;Research Personnel;Resources;Safety;Selectins;Siblings;Staging;Stem cells;Surface;Suspension Culture;System;Testing;Time;Transplant Recipients;Transplantation;Umbilical Cord Blood;Umbilical Cord Blood Transplantation;base;cost;decision research;design;extracellular;high risk;improved;in vivo;innovation;neutrophil;progenitor;public health relevance;reconstitution;research clinical testing;research study;stem cell niche;sugar;trend","Hematopoietic Progenitor Cells - Cord Blood","
Project Narrative/Relevance
Umbilical cord blood is being used increasingly for many patients with high-risk hematological
malignancies and genetic disorders who do not have a bone marrow donor, but is associated
with a longer time to engraftment compared to marrow. The expansion of cord blood in the
laboratory prior to infusion appears to shorten time to engraftment; additionally the treatment of
the cord blood with a sugar molecule prior to infusion appears to improve its ability to home to
the bone marrow quickly. Both these strategies will be explored in the grant thereby making the
transplant safer for patients in terms of infectious and bleeding complications and will thus
improve survival.","NCI","8213736","2/24/2012 12:00:00 AM","PA-07-070","5R01CA061508-18","5","R01","CA","061508","18"," ","MERRITT, WILLIAM D","9/17/1993 12:00:00 AM","1/31/2015 12:00:00 AM","Clinical Oncology Study Section[CONC]"," ","1866037","SHPALL, ELIZABETH J","SIMMONS, PAUL JOHN","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","251594","58370"," ","309964",
"Biotechnology; Genetics","Affect;Amino Acids;Autologous;Biological Assay;Bone Morphogenetic Proteins;Cell Culture Techniques;Cephalic;Chest;Chimeric Proteins;Complex;Defect;Dermal;Dose;Extracellular Matrix;Fibroblasts;Gene Expression;Gene Proteins;Gene Transfer;Genes;Genetic Transcription;Goals;Healed;Health;Human;In Vitro;LIM Domain;Lead;Length;Mandible;Maps;Mediating;Mesenchymal Stem Cells;Methods;Mitogen-Activated Protein Kinases;Modeling;Mus;Muscle;Nodule;Nuclear;Oryctolagus cuniculus;Osteogenesis;Pathway interactions;Peptides;Physiologic calcification;Play;Process;Protein Fragment;Protein Splicing;Proteins;RNA Interference;Rattus;Recombinant Proteins;Role;Signal Transduction;Site;Tertiary Protein Structure;Variant;Vertebral column;Yeasts;adenoviral-mediated;base;bone;bone healing;bone morphogenetic protein 2;clinically relevant;healing;implantation;improved;in vivo;in vivo Model;inhibitor/antagonist;kinase inhibitor;mineralization;myogenesis;novel;osteoblast differentiation;osteogenic;overexpression;programs;promoter;research study;scaffold;synthetic peptide;transcription factor;yeast two hybrid system","LMP and Bone Healing","
Project Narrative
Bone healing is complex process involving a number of different factors. Although the delivery of BMPs as
recombinant proteins can induce local bone formation and healing of bone defects, we have demonstrated
previously that local gene transfer of BMPs results in more rapid and efficient bone healing. We have shown
that gene transfer of the LIM Mineralization Protein (LMP) can induce osteogenesis and bone formation as or
more efficiently than BMP-2. The goals of this proposal are to identify the domains in LMP required for
osteogenesis, to begin to examine the mechanisms through which LMP is able to induce osteogenesis and to
examine the ability of the LMP-based domains to induce bone formation in vivo following gene and protein-
transduction mediated delivery. The successful completion of the proposal experiments will lead to a better
understanding of the pathways important for induction of osteogenesis by LMP and will result in clinically
relevant approaches to stimulate new bone formation using LMP peptides.","NIAMS","8305710","7/27/2012 12:00:00 AM","PA-07-070","7R01AR051456-05","7","R01","AR","051456","05"," ","WANG, FEI","9/10/2008 12:00:00 AM","8/31/2013 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1888670","ROBBINS, PAUL D.","Not Applicable","18","Unavailable","148230662","MGUCX773RNJ8","148230662","MGUCX773RNJ8","US","26.933813","-80.128954","10005569","SCRIPPS FLORIDA","JUPITER","FL","Research Institutes","334585284","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","209088","194919"," ","404007",
"Cardiovascular; Genetics; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute myocardial infarction;American;Animal Model;Autologous;Azacitidine;Back;Blood Vessels;Bone Marrow;Cardiac;Cardiac Myocytes;Cardiovascular system;Cell Differentiation process;Cell Therapy;Cells;Chemical Modifier;Chemicals;Chronic;Clinic;Clinical;Coronary heart disease;DNA Methylation;Data;Development;Endothelial Cells;Epigenetic Process;Gene Expression;Genes;Goals;HDAC1 gene;Health;Heart;Heart Diseases;Heart failure;Histone Acetylation;Histones;In Vitro;Left Ventricular Function;Life;Mediating;Mediator of activation protein;Mesenchymal Stem Cells;Mesoderm;Methylation;Modeling;Modification;Molecular;Morbidity - disease rate;Mus;Muscle Cells;Myocardial;Myocardial Infarction;Myocardial Ischemia;Myocardial tissue;Myocardium;Natural regeneration;Patients;Phenotype;Plastics;Property;Quality of life;Regenerative Medicine;Role;Smooth Muscle Myocytes;Somatic Cell;Stem cells;Testing;Therapeutic;Tissues;Transplantation;Treatment Efficacy;Trichostatin A;United States;Valproic Acid;Vascular Endothelial Cell;Vascularization;cardiac repair;cell type;chromatin remodeling;embryonic stem cell;histone modification;improved;in vivo;inhibitor/antagonist;injured;interest;mortality;multipotent cell;myogenesis;neovasculature;novel;paracrine;progenitor;promoter;public health relevance;regenerative;repaired;research study;small molecule;tissue repair","Reprogramming of endothelial cells for improved cardiomyogenicity in vivo","
Project Narrative
 Heart disease is a leading cause of morbidity and mortality amongst Americans. Our studies, if
successful, will generate a novel set of well-controlled experimental evidence supporting the increased
potential for regeneration of the heart when endothelial progenitor cells are treated with 5'Azacytidine,
Trichostatin A and valproic acid. Most importantly, our results may significantly improve an existing
cellular therapy and improve the lives of the over 16 milion patients in the United States living with
coronary heart disease.
!","NHLBI","8263030","4/23/2012 12:00:00 AM","PA-10-110","5F32HL107093-02","5","F32","HL","107093","02"," ","MEADOWS, TAWANNA","5/1/2011 12:00:00 AM","7/14/2012 12:00:00 AM","Special Emphasis Panel[ZRG1-F10A-S(20)L]"," ","8081464","THAL, MELISSA ANN","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","005436803","KG76WYENL5K1","005436803","KG76WYENL5K1","US","41.896017","-87.616602","6144650","NORTHWESTERN UNIVERSITY AT CHICAGO","CHICAGO","IL","SCHOOLS OF MEDICINE","606114579","UNITED STATES","N","5/1/2012 12:00:00 AM","7/14/2012 12:00:00 AM","837","Training, Individual","2012"," "," ","NHLBI","12995"," "," ","12995",
"Genetics; Human Genome; Stem Cell Research","Adult;Affect;Biology;Biopsy Specimen;Cell Count;Cell Culture Techniques;Cell Fraction;Cell Proliferation;Cell Separation;Cell Therapy;Cells;Chromatin;Chromosomal Stability;Chromosomes;Commit;DNA;DNA Methylation;DNA Sequence;Deoxyribonucleases;Development;Differentiation Antigens;Disease model;Elderly;Embryo;Epigenetic Process;Epithelial Cells;Equilibrium;Event;Gene Expression;Genes;Genetic Transcription;Genomics;Germ Layers;Global Change;Heterogeneity;Human;Hypersensitivity;In Vitro;Mesenchymal;Modification;Mutation;Needles;Nucleic Acids;Oncogenic;Pattern;Population;Procedures;Process;Production;Punch Biopsy;RNA analysis;RNA methylation;Regenerative Medicine;Reporting;Repression;Retroviral Vector;Site;Somatic Cell;Staging;Surface Antigens;System;Variant;Vertebral column;Virus;base;embryonic stem cell;epigenomics;histone modification;human disease;human embryonic stem cell;induced pluripotent stem cell;interest;novel;overexpression;pluripotency;programs;research study;response;stem;tool;transcription factor;vector","Project 1: Early Events in Reprogramming Somatic Cells","n/a","NIGMS","8381785","9/24/2012 12:00:00 AM","RFA-GM-11-005","5P01GM099130-02","5","P01","GM","099130","02"," "," "," "," ","ZGM1-GDB-8","8711","1901955","WEISSMAN, SHERMAN MORTON","Not Applicable","18","Unavailable","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","Domestic Higher Education","943052004","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","582999","582999"," ","576642","6357"," "," ",
"Dental/Oral and Craniofacial Disease; Digestive Diseases; Neurosciences; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acinar Cell;Adult;Apoptosis;Architecture;Atrophic;Biopsy;Cell Communication;Cell Fate Control;Cell Lineage;Cell Maintenance;Cell Surface Receptors;Cell physiology;Cells;Clinical;Communication;Denervation;Development;Embryo;Epithelial;Epithelial Cells;Epithelium;Extracellular Matrix;Future;Gland;Growth;Head and Neck Cancer;Knowledge;Label;Maintenance;Mediating;Mesenchymal;Mesenchyme;Morphogenesis;Mus;Mutation;Natural regeneration;Nerve;Neurons;Organ;Organogenesis;Parasympathectomy;Pathology;Pathway interactions;Patients;Pluripotent Stem Cells;Population;Radiation;Salivary;Salivary Glands;Series;Signal Transduction;Staging;Stem cells;Therapeutic;Tissues;Transplantation;Undifferentiated;Venus;Xerostomia;base;cell type;gland development;improved;in vivo;injured;irradiation;nerve stem cell;nerve supply;neurotrophic factor;organ regeneration;progenitor;receptor;regenerative therapy;repaired;stem;tissue regeneration;transcription factor","Neuronal and Progenitor/Stem Cell Function During Salivary Gland Development","n/a","NIDCR","8553349"," "," ","1ZIADE000722-05","1","ZIA","DE","000722","05"," "," "," "," "," "," ","9693104","HOFFMAN, MATTHEW ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIDCR"," "," "," ","872392",
"Digestive Diseases; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Adult;Apoptosis;Architecture;Biological Assay;Biology;Candidate Disease Gene;Cell Count;Cell Cycle;Cell Proliferation;Cell surface;Cells;Coculture Techniques;DNA Damage;Development;Epithelial;Fibroblasts;G-Protein-Coupled Receptors;Gastrointestinal Diseases;Gene Expression;Gene Expression Profile;Goals;In Situ;In Vitro;Inflammatory;Injury;Intestines;Leucine-Rich Repeat;Mesenchymal;Mitosis;Modeling;Molecular;Molecular Profiling;Mus;Natural regeneration;Neoplasms;Pathway interactions;Phase;Phosphotransferases;Population;Principal Investigator;Process;Proliferating;Radiation Injuries;Regenerative Medicine;Role;Signal Pathway;Small Intestines;Solid;Sorting - Cell Movement;Stem cells;System;Testing;Time;Tissues;Villus;base;cytotoxic;in vivo;insight;intestinal crypt;intestinal epithelium;notch protein;novel;novel marker;progenitor;public health relevance;regenerative;research study;response;restoration;self-renewal;stem;stem cell differentiation;stem cell fate","Isolation and Characterization of Intestinal Stem Cells Using Novel Markers  (RP)","n/a","NIDDK","8328967","8/20/2012 12:00:00 AM","RFA-DK-08-010","5U01DK085508-04","5","U01","DK","085508","04"," ","CARRINGTON, JILL L","9/30/2009 12:00:00 AM","8/31/2014 12:00:00 AM","ZDK1-GRB-8(O1)S"," ","8710262","HOUCHEN, COURTNEY WAYNE","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","878648294","GY8NMUZQXVS7","878648294","GY8NMUZQXVS7","US","35.480049","-97.494195","1524003","UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR","OKLAHOMA CITY","OK","SCHOOLS OF MEDICINE","731043609","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","247466","118784"," ","336650",
"Bioengineering; Biotechnology; Cancer; Genetics; Lymphoma; Rare Diseases","Alternative Splicing;Behavior;Blood Vessels;Breast Cancer Cell;Carcinoma;Cause of Death;Cells;Data;Development;Disease;Distant;Gene Expression;Goals;Growth Factor;Lymphatic vessel;Lymphoma;Malignant - descriptor;Malignant Neoplasms;Measures;Metric;Modeling;Neoplasm Metastasis;Neuraxis;Organ;Phenotype;Primary Neoplasm;RNA Interference;Regulation;Regulatory Pathway;Research;Resistance;Screening procedure;Signaling Pathway Gene;System;Therapeutic Intervention;Xenograft procedure;cell behavior;cell motility;chemotherapy;epithelial to mesenchymal transition;in vivo;mammary epithelium;mathematical model;migration;mortality;neoplastic cell;novel;programs;response;stem;therapy resistant;tumor;tumor progression","Migration Networks","The major causes of death from cancer stem from the spread of the disease from the primary tumor to distant organs. To identify new ways to interfere with cancer dissemination, the status of many cell regulatory systems will be measured and correlated mathematically with changes that cells undergo during cancer progression. The resulting mathematical models can uncover new connections between cell regulation and metastic behavior for the development of new therapies to treat the disease.","NCI","8375826","4/18/2012 12:00:00 AM","RFA-CA-09-011","5U54CA112967-08","5","U54","CA","112967","08"," "," ","4/17/2012 12:00:00 AM","2/28/2015 12:00:00 AM","ZCA1-SRLB-C","6516","1941644","GERTLER, FRANK B","Not Applicable","07","Unavailable","001425594","E2NYLCDML6V1","001425594","E2NYLCDML6V1","US","42.359476","-71.093853","4911501","MASSACHUSETTS INSTITUTE OF TECHNOLOGY","CAMBRIDGE","MA","Domestic Higher Education","021421029","UNITED STATES","N","4/17/2012 12:00:00 AM","2/28/2013 12:00:00 AM"," ","Research Centers","2012","374840","374840"," ","374840","0"," "," ",
"Dental/Oral and Craniofacial Disease; Genetics","Adherens Junction;Affect;Ameloblasts;Animal Model;Apoptosis;Biomedical Engineering;Cadherins;Cell Adhesion;Cell Culture Techniques;Cell Death;Cell Differentiation process;Cells;Chemicals;Coculture Techniques;Collaborations;Complex;Defect;Dental;Dental Enamel;Dental Pulp;Dental crowns;Dentin;Development;Disease;Embryo;Environment;Epidermis;Epithelial Cells;Epithelium;Failure;Family;Food;Gene Mutation;Genes;Germ;Goals;Hair;Hair follicle structure;Hereditary Disease;Human;Human Genetics;In Vitro;Incisor;Knockout Mice;Life;Limb structure;Mastication;Mesenchymal;Mesenchyme;Molar tooth;Molecular;Mus;Nuclear;Odontoblasts;Oral;Organ;Physical condensation;Process;Proteins;Role;Signal Transduction;Skin;Staging;Structure;Surface;Temperature;Tight Junctions;Time;Tissues;Tooth Germ;Tooth structure;Zinc Fingers;bone;cell type;craniofacial;in vivo;induced pluripotent stem cell;member;mutant;novel;novel strategies;overexpression;protein function;regenerative;repaired;transcription factor","Oral and Craniofacial Development and Disease","n/a","NIDCR","8553347"," "," ","1ZIADE000720-06","1","ZIA","DE","000720","06"," "," "," "," "," "," ","9415015","YAMADA, YOSHIHIKO ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIDCR"," "," "," ","842722",
"Eye Disease and Disorders of Vision","Affect;Alleles;Anabolism;Binding;Biochemical;Biological Assay;Cell surface;Cells;Chondroitin Sulfates;Clinical;Communication;Conjunctival Epithelium;Defect;Development;Diagnosis;Disease;Dry Eye Syndromes;Epithelial;Epithelium;Etiology;Extracellular Space;Eye Abnormalities;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Future;Genes;Genetic Models;Glycosaminoglycans;Goals;Heparin;Heparitin Sulfate;Human;Human Development;Inorganic Sulfates;Intervention;Knock-out;Lacrimal gland structure;Lead;Mediating;Medical Research;Mesenchymal;Mesenchyme;Modification;Molecular;Morphogenesis;Movement;Mus;Pathway interactions;Pattern;Process;Receptor Gene;Regulation;Role;Signal Pathway;Signal Transduction;Structure;Study models;System;Testing;Unspecified or Sulfate Ion Sulfates;Work;base;gland development;human disease;insight;lacrimal;mutant;polysulfated glycosaminoglycan;research study;response;sulfation","Regulation of FGF signaling in lacrimal gland development","
PROJECT NARRATIVE
This project investigates the mechanism of FGF signaling in lacrimal gland development. It is expected to
contribute to our understanding of this important pathway in human development and disease, and inform
future development of clinical interventions to treat dry eye syndrome.","NEI","8206828","12/9/2011 12:00:00 AM","PA-07-070","5R01EY018868-04","5","R01","EY","018868","04"," ","MCKIE, GEORGE ANN","1/1/2009 12:00:00 AM","12/31/2012 12:00:00 AM","Anterior Eye Disease Study Section[AED]"," ","6859793","ZHANG, XIN ","Not Applicable","07","GENETICS","603007902","SHHBRBAPSM35","603007902","SHHBRBAPSM35","US","39.780714","-86.174977","577806","INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS","INDIANAPOLIS","IN","SCHOOLS OF MEDICINE","462022915","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","190080","102643"," ","292723",
"Aging; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adolescent;Adult;Age;Aging;Basal lamina;Cell Proliferation;Cell physiology;Cells;Data;Deterioration;Disease;Disintegrins;Equilibrium;Exhibits;Fatty acid glycerol esters;Genes;Genetic Transcription;Germ Cells;Goals;Injury;Investigation;Knockout Mice;Laminin Receptor;Life;Link;Longevity;Mesenchymal;Metalloproteases;Methodology;Molecular;Mus;Muscle;Muscle rehabilitation;Myoblasts;Myogenic Regulatory Factors;Names;Natural regeneration;Obesity;Pathway interactions;Pattern;Performance;Phase;Phenotype;Proliferating;Publishing;Regulation;Regulatory Element;Reporting;Role;Skeletal Muscle;Skeletal Muscle Satellite Cells;Staging;Stem cells;Surface;Tissues;Transgenic Mice;Viral;age group;age related;base;expression vector;human ITGA7 protein;improved;in vivo;insight;muscle aging;nestin protein;overexpression;progenitor;protein expression;rehabilitation strategy;repaired;sarcopenia;satellite cell;self-renewal;therapy design;transcription factor","Myogenic Stem Cell Function in Aging Skeletal Muscle","n/a","NIA","8223257","2/21/2012 12:00:00 AM","PA-07-070","5R01AG021566-10","5","R01","AG","021566","10"," ","WILLIAMS, JOHN","9/30/2002 12:00:00 AM","2/28/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-L(07)M]"," ","1878018","YABLONKA-REUVENI, ZIPORA ","Not Applicable","07","ANATOMY/CELL BIOLOGY","605799469","HD1WMN6945W6","605799469","HD1WMN6945W6","US","47.660049","-122.31441","9087701","UNIVERSITY OF WASHINGTON","SEATTLE","WA","SCHOOLS OF MEDICINE","981951016","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2015 12:00:00 AM","866","Non-SBIR/STTR","2012"," "," ","NIA","195076","109243"," ","304319",
"Kidney Disease; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adult;Affect;American;Biochemical;Blood;Blood Pressure;Body Fluids;Caring;Cell Communication;Cell physiology;Cells;Chronic Kidney Failure;Clinic;Clinical;Complement;Complex;Cues;DNA Binding;Data Set;Development;Duct (organ) structure;Epithelial;Event;Family;Future;Genetic;Genetic Models;Genomics;Goals;Healthcare;Homeostasis;Individual;Kidney;Kidney Diseases;Length;Life;Maintenance;Mediating;Mesenchymal;Mesenchyme;Metanephric Diverticulum;Mining;Modeling;Molecular;Morphogenesis;Mus;Nephrons;Organ;Pathway interactions;Pattern;Physiological;Population;Positioning Attribute;Process;Recording of previous events;Renal function;Research;Risk;Role;Signal Pathway;Signal Transduction;Stem cells;Structure;System;Vesicle;Water;Work;body system;clinically relevant;design;fetal;kidney repair;man;nephrogenesis;notch protein;novel therapeutics;podocyte;progenitor;programs;repaired;response;salt balance;wasting","Cell Interactions in Development of the Mammalian Kidney","n/a","NIDDK","8326239","8/31/2012 12:00:00 AM","PA-07-070","7R37DK054364-15","7","R37","DK","054364","15"," ","HOSHIZAKI, DEBORAH K","9/1/1998 12:00:00 AM","8/31/2013 12:00:00 AM","Development - 1 Study Section[DEV1]"," ","1862596","MCMAHON, ANDREW P.","Not Applicable","37","OTHER BASIC SCIENCES","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF MEDICINE","900894304","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","379163","242664"," ","621827",
"No NIH Category available","Affect;Benign;Biological Markers;Biology;Brain-Derived Neurotrophic Factor;Clinical;Enzymes;Epithelial Cells;Extracellular Matrix;Focal Adhesion Kinase 1;Funding;Gene Expression;Gene Targeting;Genes;Growth;Growth Factor;Human;Localized Malignant Neoplasm;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Mentors;Metastatic Neoplasm to the Bone;Molecular;Neoplasm Metastasis;Nuclear;Prostate;Proteins;Publications;Reactive Oxygen Species;Research Personnel;Serum;Signal Pathway;Signal Transduction;Signaling Molecule;Specimen;Stromal Neoplasm;Tissues;Translating;Translations;bone;cancer cell;clinical practice;epithelial to mesenchymal transition;heparanase;heparin proteoglycan;mitochondrial DNA mutation;next generation;novel;perlecan;programs;response;tumor;tumor progression","Prostate Cancer Bone Metastasis:  Biology and Targeting","n/a","NCI","8305770","8/9/2012 12:00:00 AM"," ","5P01CA098912-09","5","P01","CA","098912","09"," ","MOHLA, SURESH","9/17/2003 12:00:00 AM","7/31/2014 12:00:00 AM","ZCA1-GRB-S(O1)"," ","1877206","CHUNG, LELAND W.K.","Not Applicable","28","Unavailable","075307785","NCSMA19DF7E6","075307785","NCSMA19DF7E6","US","34.076546","-118.380008","1225501","CEDARS-SINAI MEDICAL CENTER","LOS ANGELES","CA","Independent Hospitals","900481804","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","1295575","254354"," ","1549929",
"Dental/Oral and Craniofacial Disease; Neurosciences; Nutrition; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human; Stem Cell Research - Nonembryonic - Non-Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Non-Human","Adult;Affect;Alleles;Appearance;Asses;Autocrine Communication;Birth;Brain;Cell Differentiation process;Cells;Complement;Cranial Nerves;Data;Development;Diet;Eating;Embryonic Development;Epithelial;Epithelial Cells;Epithelium;Erinaceidae;Event;Goals;Health;Ligands;Mediating;Mesenchymal;Mesenchyme;Modeling;Molecular;Molecular Genetics;Morphogenesis;Mus;Nerve;Organ;Pathway interactions;Pattern;Pharmaceutical Preparations;Process;Production;Proteins;Receptor Cell;Regulation;Repression;Role;Signal Pathway;Signal Transduction;Source;Staging;Surface;Taste Bud Cell;Taste Buds;Taste Perception;Testing;Tissues;Tongue;Type II Epithelial Receptor Cell;Variant;autocrine;base;human SMO protein;insight;precursor cell;preference;promoter;research study;response;sensory system;tongue papilla;tool","Tissue interactions in taste bud development"," Our sense of taste is mediated by taste buds on the tongue surface, and we use this sensory system to make key dietary decisions which impact our health, i.e., what to eat and what to avoid. In this application we will investigate how taste buds are established, with the long-term goal of understanding how taste bud development affects dietary choices of adults.   
   
      

","NIDCD","8365412","6/20/2012 12:00:00 AM","PA-11-260","1R01DC012675-01","1","R01","DC","012675","01"," ","SULLIVAN, SUSAN L","7/1/2012 12:00:00 AM","6/30/2017 12:00:00 AM","Somatosensory and Chemosensory Systems Study Section[SCS]"," ","1863736","BARLOW, LINDA A","Not Applicable","06","BIOLOGY","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","173","Non-SBIR/STTR","2012"," "," ","NIDCD","212500","90882"," ","303382",
"Cancer","Actins;Biochemical;Biological;Biological Assay;Cancer Patient;Cause of Death;Cells;Cellular Morphology;Data;Employee Strikes;Epithelial;Exhibits;Family member;Filament;Future;Goals;Hand;Human;Immigration;Label;Lead;Malignant Epithelial Cell;Malignant Neoplasms;Mesenchymal;Microfilaments;Migration Assay;Modeling;Molecular;Mutate;Nature;Neoplasm Metastasis;Patients;Phenotype;Play;Process;Protein Binding Domain;Protein Family;Proteins;RNA Cap-Binding Proteins;Recruitment Activity;Regulation;Role;Site;Structure;Testing;Time;Tissues;Tumor Cell Invasion;Vimentin;Wound Healing;Yeasts;base;cancer cell;cancer therapy;cell motility;fibrosarcoma;improved;migration;movie;mutant;neoplastic cell;polarized cell;polymerization;research study;scaffold;tumor;yeast two hybrid system","The Role of CARMIL2 in Cell Migration and Invasion"," The main cause of death in patients with cancer is the invasion of body tissues by metastasizing tumor cells. This proposal explores the molecular basis by which cells polarize and assemble cytoskeletal networks to drive migration and invasion during tumor metastasis. Completion of this proposal will provide an improved understanding of metastasis and aid in the search for new cancer therapies.   
      

","NCI","8396161","8/1/2012 12:00:00 AM","PA-11-110","1F30CA171595-01","1","F30","CA","171595","01"," ","DAMICO, MARK W","8/1/2012 12:00:00 AM","7/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-P(09)L]"," ","9589115","LANIER, MICHAEL HUNTER","Not Applicable","01","ANATOMY/CELL BIOLOGY","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","28427"," "," ","28427",
"Bioengineering; Biotechnology; Digestive Diseases; Liver Disease; Regenerative Medicine","Architecture;Artificial Organs;Biocompatible Materials;Biology;Blood Vessels;Cardiac;Cells;Centrifugation;Clinical;Communities;Development;Disease model;Endothelial Cells;Engineering;Engraftment;Exhibits;Extracellular Matrix;Face;Fibroblasts;Future;Hepatocyte;Human;Immune response;In Vitro;Indium;Knowledge;Label;Liver;Mesenchymal;Methods;Microscopy;Modeling;Molds;Morphogenesis;Movement;Nature;Necrosis;Organ;Organ Transplantation;Organ failure;Patients;Pattern;Pharmacologic Substance;Poison;Polymers;Population;Process;Research;Role;Signal Transduction;Stromal Cells;Structure;System;Techniques;Technology;Testing;Time;Tissue Engineering;Tissues;Transplantation;Work;angiogenesis;base;bile canaliculus structure;cell type;density;design;drug development;human tissue;in vivo;novel;novel strategies;public health relevance;scaffold;systems research;time use;tool","Micropatterned scaffold-free liver tissue","
Project Narrative
Artificially engineered tissues (e.g., liver) could serve as organ-substitutes for clinical transplantation as well as
test systems for research and pharmaceutical development. Here, we will develop novel engineering tools to
study how nature organizes different types of ""cellular building blocks"" in building three-dimensional tissues.
This knowledge could be applied in building functional tissues for human therapies.
)","NIDDK","8223683","2/15/2012 12:00:00 AM","PA-10-110","5F32DK091007-02","5","F32","DK","091007","02"," ","PODSKALNY, JUDITH M,","2/5/2011 12:00:00 AM","9/3/2012 12:00:00 AM","ZDK1-GRB-2(O1)S"," ","10443301","STEVENS, KELLY R","Not Applicable","07","MISCELLANEOUS","001425594","E2NYLCDML6V1","001425594","E2NYLCDML6V1","US","42.359476","-71.093853","4911501","MASSACHUSETTS INSTITUTE OF TECHNOLOGY","CAMBRIDGE","MA","SCH ALLIED HEALTH PROFESSIONS","021421029","UNITED STATES","N","2/5/2012 12:00:00 AM","9/3/2012 12:00:00 AM","847","Training, Individual","2012"," "," ","NIDDK","34573"," "," ","34573",
"Biotechnology; Breast Cancer; Cancer; Genetics; Regenerative Medicine","Adult;Aftercare;Biological Assay;CXCR6 gene;Cells;Coculture Techniques;Colorectal;Conditioned Culture Media;Diagnosis;Disease;Embryonic Development;Epithelial;Epithelial Cells;Exhibits;Gene Expression;Gene Targeting;Homeostasis;Immunoblotting;Investigation;Kidney;Knowledge;Lead;Malignant Neoplasms;Mammalian Cell;Mammary gland;Mediating;Mesenchymal;Microarray Analysis;Mus;Neoplasm Metastasis;Nude Mice;Ovary;Pathway interactions;Pattern;Phenotype;Process;Property;Prostate;Recombinant Proteins;Regulation;Reverse Transcriptase Polymerase Chain Reaction;Signal Transduction;Stem cells;Subcutaneous Injections;Testing;Transfection;Wnt proteins;base;beta catenin;cancer type;chemokine receptor;embryo tissue;embryonic stem cell;expression vector;frizzled related protein-1;human SFRP4 protein;human embryonic stem cell;malignant breast neoplasm;matrigel;novel;research study;tumor;tumorigenic","R-spondins, Secreted Frizzled-Related Proteins and the Regulation of Wnt Signali","n/a","NCI","8552646"," "," ","1ZIABC010251-17","1","ZIA","BC","010251","17"," "," "," "," "," "," ","9692479","RUBIN, JEFFREY ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","498109",
"Digestive Diseases; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Adult;Apoptosis;Architecture;Biological Assay;Biology;Candidate Disease Gene;Cell Count;Cell Cycle;Cell Proliferation;Cell surface;Cells;Coculture Techniques;DNA Damage;Development;Epithelial;Fibroblasts;G-Protein-Coupled Receptors;Gastrointestinal Diseases;Gene Expression;Gene Expression Profile;Goals;In Situ;In Vitro;Inflammatory;Injury;Intestines;Leucine-Rich Repeat;Mesenchymal;Mitosis;Modeling;Molecular;Molecular Profiling;Mus;Natural regeneration;Neoplasms;Pathway interactions;Phase;Phosphotransferases;Population;Principal Investigator;Process;Proliferating;Radiation Injuries;Regenerative Medicine;Role;Signal Pathway;Small Intestines;Solid;Sorting - Cell Movement;Stem cells;System;Testing;Time;Tissues;Villus;base;cytotoxic;in vivo;insight;intestinal crypt;intestinal epithelium;notch protein;novel;novel marker;progenitor;public health relevance;regenerative;research study;response;restoration;self-renewal;stem;stem cell differentiation;stem cell fate","Isolation and Characterization of Intestinal Stem Cells Using Novel Markers  (RP)","n/a","NIDDK","8499783","8/22/2012 12:00:00 AM","RFA-DK-08-010","3U01DK085508-04S1","3","U01","DK","085508","04","S","CARRINGTON, JILL L","9/30/2009 12:00:00 AM","8/31/2014 12:00:00 AM","ZDK1-GRB-8(O1)S"," ","8710262","HOUCHEN, COURTNEY WAYNE","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","878648294","GY8NMUZQXVS7","878648294","GY8NMUZQXVS7","US","35.480049","-97.494195","1524003","UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR","OKLAHOMA CITY","OK","SCHOOLS OF MEDICINE","731043609","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","24321","11674"," ","35995",
"Autoimmune Disease; Clinical Research; Crohn's Disease; Digestive Diseases; Inflammatory Bowel Disease","Acute;Adhesions;Bacteria;Cell Communication;Cells;Characteristics;Chronic;Crohn&apos;s disease;Development;Endothelial Cells;Epigenetic Process;Fibroblasts;Funding;Future;Gastrointestinal tract structure;Gene Expression;Genomics;Human;Immune;Immune response;Immunity;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Inflammatory disease of the intestine;Intestinal Mucosa;Intestines;Investigation;Knowledge;Laboratories;Leukocytes;Ligands;Maintenance;Mediating;Mediator of activation protein;Mesenchymal;Microbial Genetics;Modification;Molecular;Mucosal Immunity;Mucositis;Mucous Membrane;Natural Immunity;Pathogenesis;Pathway interactions;Permeability;Play;Process;Production;Regulation;Role;Signal Pathway;Stimulus;Testing;Therapeutic Intervention;Ulcerative Colitis;absorption;angiogenesis;base;cell type;cytokine;histone modification;immune activation;microbial;novel;public health relevance;receptor;receptor expression;response;synergism","Cell interactions in the inflammed intestinal mucosa","
PROJECT NARRATIVE
This proposal aims at understanding the role of two types of intestinal cells, the fibroblasts and endothelial
cells, in gut inflammation. Specifically, the proposal will investigate how these cells respond to bacteria
normally present in the intestine, and how this response contributes to mechanisms of inflammation. The
results may allow the development of new ways to control acute and chronic intestinal inflammation.","NIDDK","8244462","3/21/2012 12:00:00 AM","PA-07-070","5R01DK050984-13","5","R01","DK","050984","13"," ","HAMILTON, FRANK A","9/30/1995 12:00:00 AM","3/31/2015 12:00:00 AM","Gastrointestinal Mucosal Pathobiology Study Section[GMPB]"," ","1877095","FIOCCHI, CLAUDIO ","Not Applicable","11","OTHER BASIC SCIENCES","135781701","M5QFLTCTSQN6","135781701","M5QFLTCTSQN6","US","41.479276","-81.680233","10000858","CLEVELAND CLINIC LERNER COM-CWRU","CLEVELAND","OH","SCHOOLS OF MEDICINE","441950001","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","111957"," ","317382",
"Arthritis; Genetics","Affect;Alleles;Antibodies;Binding;Binding Sites;Birds;Cartilage;Cells;Chick Embryo;Chickens;Chondrocytes;Chondrogenesis;Collagen;Competence;Complex;DNA Binding;Degenerative polyarthritis;Development;Electrophoretic Mobility Shift Assay;Enhancers;Environment;Epiphysial cartilage;Family member;Fibroblasts;Gene Expression;Goals;Hypertrophy;Knowledge;Lead;Light;Limb Bud;Link;Luciferases;Mediating;Mesenchymal;Mesoderm;Mus;Mutation;Nucleic Acid Regulatory Sequences;Play;Publishing;Reagent;Reporter;Reporter Genes;Role;Signal Transduction;Somites;Techniques;Transfection;Transgenes;Transgenic Mice;Work;articular cartilage;cell type;embryo tissue;in vivo;programs;public health relevance;small hairpin RNA;transcription factor;transgene expression","Identification of the transcriptional regulators of chondrocyte hypertrophy","
The course of cartilage degradation in osteoarthritis (OA) involves an activation of the chondrocyte
hypertrophy program in the affected cartilage, suggesting that activation of the chondrocyte
maturation program could play a key role in progression of cartilage destruction in OA. The goal of
this proposal is to elucidate the factors that control chondrocyte hypertrophy in the hope that this
knowledge will lead to the development of reagents that could block this program in articular cartilage
and thereby slow the progression of OA.","NIAMS","8248083","4/9/2012 12:00:00 AM","PA-07-070","5R01AR055552-03","5","R01","AR","055552","03"," ","TYREE, BERNADETTE","4/1/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1899368","LASSAR, ANDREW BRUCE","Not Applicable","07","BIOCHEMISTRY","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","SCHOOLS OF MEDICINE","021201616","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","216000","150120"," ","366120",
"Dental/Oral and Craniofacial Disease; Genetics; Neurosciences; Pediatric","Adopted;Animal Model;Animals;Behavior;Biochemical;Biological Models;Cartilage;Cells;Cephalic;Congenital Abnormality;Congenital Disorders;Development;Disease;Embryo;Evolution;Face;Family;Gene Expression Profile;Genes;Genetic;Genome;Goals;Heat-Shock Response;Individual;Libraries;Link;Maintenance;Malignant Neoplasms;Messenger RNA;Neural Crest;Neural Crest Cell;Neuroglia;Peripheral Nerves;Pigments;Play;Population;Process;Proteins;Regulation;Regulator Genes;Relative (related person);Role;Signal Pathway;Skeleton;Small RNA;Snails;Sorting - Cell Movement;Staging;Stem cells;Structure;System;Tissues;Transcriptional Regulation;Transgenic Organisms;Vertebrates;Work;Zebrafish;bone;cell behavior;cell type;craniofacial;epithelial to mesenchymal transition;genome-wide;insight;next generation;novel;pluripotency;progenitor;promoter;response;self-renewal;stem cell population;tool;transcription factor","Unbiased discovery of Novel  Regulators of the Cranial Neural Crest","  Neural crest (NC) cells make extensive contributions to craniofacial structures and are of central importance to understanding many congenital disorders. Our studies will provide essential insights into the regulation of proteins playing central roles in both NC development and disease processes.  
  
    

","NIDCR","8312510","7/30/2012 12:00:00 AM","PA-10-069","5R21DE022150-02","5","R21","DE","022150","02"," ","SCHOLNICK, STEVEN","8/4/2011 12:00:00 AM","7/31/2013 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1925874","LABONNE, CAROLE ","Not Applicable","07","BIOCHEMISTRY","160079455","EXZVPWZBLUE8","160079455","EXZVPWZBLUE8","US","42.049695","-87.678657","6144601","NORTHWESTERN UNIVERSITY","Chicago","IL","SCHOOLS OF ARTS AND SCIENCES","606114579","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","125000","65625"," ","190625",
"Cancer","3-Dimensional;Address;Attention;Basement membrane;Breast;Cancer Cell Growth;Cancerous;Carcinoma;Cell physiology;Cells;Collagen;Complement;Data;Development;Elastin;Enzymes;Epithelial;Epithelial Cells;Event;Extracellular Matrix;Extracellular Matrix Degradation;Family;Family member;Gene Family;Growth;Growth and Development function;Health;Human;In Vitro;Invaded;Knock-out;Link;Malignant Neoplasms;Matrix Metalloproteinases;Membrane;Mesenchymal;Metalloproteases;Metalloproteinase Gene;Molecular Genetics;Morphogenesis;Neoplasm Metastasis;Neoplastic Epithelial Cell;Normal Cell;Normal tissue morphology;Participant;Peptide Hydrolases;Phenotype;Play;Population;Proteoglycan;Regulation;Relative (related person);Role;Series;Staging;Structure;Structure-Activity Relationship;System;Tissues;Work;base;cancer cell;cell behavior;cell growth;cell type;collagenase 3;human MMP14 protein;in vivo;insight;interstitial;member;membrane-type matrix metalloproteinase;metalloenzyme;neoplastic;neoplastic cell;novel therapeutic intervention","Function of the Membrane Type Matrix Metalloproteinase","n/a","NCI","8271318","5/25/2012 12:00:00 AM","PA-07-070","5R01CA071699-15","5","R01","CA","071699","15"," ","WOODHOUSE, ELIZABETH","6/11/1997 12:00:00 AM","5/31/2013 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1899079","WEISS, STEPHEN J","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","206344","98715"," ","305059",
"Neurosciences; Regenerative Medicine; Rehabilitation; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Affect;American;Auditory;Biological;Birds;Cell Line;Cell Proliferation;Cell Shape;Cell physiology;Cells;Cellular biology;Communication impairment;Development;Ear;Ear Diseases;Elderly;Elements;Embryo;Epithelial;Equilibrium;Event;Functional disorder;Generations;Goals;Growth;Hair Cells;Healed;Hearing;Human;In Vitro;Individual;Intercellular Junctions;Investigation;Knowledge;Labyrinth;Lead;Mammals;Mechanics;Mesenchymal;Molecular;Natural regeneration;Neurology;Pathway interactions;Production;Recovery;Research;Rodent;Sensorineural Hearing Loss;Sensory Hair;Signal Transduction;Stem cells;Testing;Tissues;Vertebrates;base;cancer cell;cell behavior;equilibration disorder;experience;falls;hair cell regeneration;healing;hearing impairment;improved;progenitor;regenerative;repaired;response;scale up;therapeutic development;therapy development","Growth and Regeneration in the Inner Ear","n/a","NIDCD","8288600","6/19/2012 12:00:00 AM","PA-07-127","5R01DC000200-28","5","R01","DC","000200","28"," ","FREEMAN, NANCY","12/1/1988 12:00:00 AM","11/30/2013 12:00:00 AM","Auditory System Study Section[AUD]"," ","1863777","CORWIN, JEFFREY T","Not Applicable","05","NEUROSCIENCES","065391526","JJG6HU8PA4S5","065391526","JJG6HU8PA4S5","US","38.034207","-78.512346","1526402","UNIVERSITY OF VIRGINIA","CHARLOTTESVILLE","VA","SCHOOLS OF MEDICINE","229044195","UNITED STATES","N","7/1/2012 12:00:00 AM","11/30/2013 12:00:00 AM","173","Non-SBIR/STTR","2012"," "," ","NIDCD","318059","164688"," ","482747",
"Biotechnology; Clinical Research; Diabetes; Genetics; Human Genome; Infant Mortality/ (LBW); Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal Period - Conditions Originating in Perinatal Period; Prevention; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human","Adult;Age;Aging;Biological;Biological Assay;Birth Weight;CD34 gene;Cardiovascular Diseases;Cessation of life;Chronic;Chronic Disease;Commit;Cytosine;DNA Methylation;Data Set;Development;Disease;Disease Resistance;Disease susceptibility;Endothelial Cells;Environment;Epigenetic Process;Evaluation;Event;Exposure to;Fetal Development;Fetal Growth;Fetal Growth Retardation;Future;Gender;Gene Expression;Gene Expression Regulation;Generations;Genes;Genomics;Gestational Age;Hematopoietic;Human;Individual;Infant;Informatics;Institution;Lead;Leukocytes;Life;Lymphocyte;Marker Discovery;Memory;Mesenchymal Stem Cells;Metabolic Pathway;Methylation;Modification;Molecular;Neonatal;Non-Insulin-Dependent Diabetes Mellitus;Onset of illness;Pattern;Phenotype;Population;Predisposition;Process;Recurrence;Regulation;Research;Resolution;Resources;Risk;Sampling;Site;Stem cells;Stress;Structure;Technology;Tissues;Transcript;Umbilical Cord Blood;Umbilical cord structure;Umbilical vein;Validation;Veins;Vulnerable Populations;age related;bisulfite;body system;cell type;design;epigenomics;fetal;genome-wide;human disease;in utero;insight;interest;meetings;neonate;normal aging;novel;peripheral blood;premature;prevent;progenitor;public health relevance;tissue processing;trait","Genome-wide DNA Methylation Profiles Associated with Abnormal Intrauterine Growth","Project Narrative 
Infants born at the extremes of birth weight (i.e. the smallest and largest) are more likely to development type 2 diabetes and other age-related diseases as adults(1). Understanding the contribution of intrauterine conditions to chronic adult disease may lead to the discovery of markers that can be used to identify individuals at risk and may help to prevent chronic disease and premature death.","NICHD","8301705","6/12/2012 12:00:00 AM","RFA-RM-08-017","5R01HD063791-04","5","R01","HD","063791","04"," ","ILEKIS, JOHN V","9/10/2009 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-GGG-M(53)R]"," ","9614788","HUGHES EINSTEIN, FRANCINE ","GREALLY, JOHN ; MONTAGNA, CRISTINA ","14","OBSTETRICS & GYNECOLOGY","110521739"," ","110521739"," ","US","40.851026","-73.844361","9433501","ALBERT EINSTEIN COLLEGE OF MEDICINE","BRONX","NY","SCHOOLS OF MEDICINE","104611900","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","OD","203371","0"," ","203371",
"Biotechnology; Clinical Research; Diabetes; Genetics; Human Genome; Infant Mortality/ (LBW); Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal Period - Conditions Originating in Perinatal Period; Prevention; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human","Adult;Age;Aging;Biological;Biological Assay;Birth Weight;CD34 gene;Cardiovascular Diseases;Cessation of life;Chronic;Chronic Disease;Commit;Cytosine;DNA Methylation;Data Set;Development;Disease;Disease Resistance;Disease susceptibility;Endothelial Cells;Environment;Epigenetic Process;Evaluation;Event;Exposure to;Fetal Development;Fetal Growth;Fetal Growth Retardation;Future;Gender;Gene Expression;Gene Expression Regulation;Generations;Genes;Genomics;Gestational Age;Hematopoietic;Human;Individual;Infant;Informatics;Institution;Lead;Leukocytes;Life;Lymphocyte;Marker Discovery;Memory;Mesenchymal Stem Cells;Metabolic Pathway;Methylation;Modification;Molecular;Neonatal;Non-Insulin-Dependent Diabetes Mellitus;Onset of illness;Pattern;Phenotype;Population;Predisposition;Process;Recurrence;Regulation;Research;Resolution;Resources;Risk;Sampling;Site;Stem cells;Stress;Structure;Technology;Tissues;Transcript;Umbilical Cord Blood;Umbilical cord structure;Umbilical vein;Validation;Veins;Vulnerable Populations;age related;bisulfite;body system;cell type;design;epigenomics;fetal;genome-wide;human disease;in utero;insight;interest;meetings;neonate;normal aging;novel;peripheral blood;premature;prevent;progenitor;public health relevance;tissue processing;trait","Genome-wide DNA Methylation Profiles Associated with Abnormal Intrauterine Growth","Project Narrative 
Infants born at the extremes of birth weight (i.e. the smallest and largest) are more likely to development type 2 diabetes and other age-related diseases as adults(1). Understanding the contribution of intrauterine conditions to chronic adult disease may lead to the discovery of markers that can be used to identify individuals at risk and may help to prevent chronic disease and premature death.","NICHD","8301705","6/12/2012 12:00:00 AM","RFA-RM-08-017","5R01HD063791-04","5","R01","HD","063791","04"," ","ILEKIS, JOHN V","9/10/2009 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-GGG-M(53)R]"," ","9614788","HUGHES EINSTEIN, FRANCINE ","GREALLY, JOHN ; MONTAGNA, CRISTINA ","14","OBSTETRICS & GYNECOLOGY","110521739"," ","110521739"," ","US","40.851026","-73.844361","9433501","ALBERT EINSTEIN COLLEGE OF MEDICINE","BRONX","NY","SCHOOLS OF MEDICINE","104611900","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","34229","156816"," ","191045",
"Cancer; Genetics","Binding;Biochemical;Biological Assay;Biological Process;Cancer Biology;Cell Proliferation;Cell-Cell Adhesion;Cells;Complex;Development;Disabled Persons;Disease;Elements;Embryonic Development;Epithelial;Extracellular Matrix;Family;Fibrosis;Genes;Genetic Translation;Goals;Growth Factor;Heterogeneous-Nuclear Ribonucleoproteins;Human;Hypoxia;In Vitro;Indium;Inflammation;Interleukin-2;Knowledge;Maintenance;Malignant Neoplasms;Maps;Mediating;Mesenchymal;Messenger RNA;Modeling;Molecular;Neoplasm Metastasis;Nucleotides;Nutrient;Pathway interactions;Phenotype;Phosphorylation;Phosphotransferases;Post-Translational Protein Processing;Prevention;Process;Property;Protein Biosynthesis;Protein Isoforms;Protein Kinase;Proteins;Proteomics;RNA-Protein Interaction;Receptor Signaling;Regulation;Regulatory Pathway;Regulon;Ribonucleoproteins;Role;Signal Transduction;Site;Structure;System;Techniques;Testing;Therapeutic;Tissues;Transcript;Transforming Growth Factor beta;Translational Activation;Translational Regulation;Translations;Tumor Angiogenesis;Untranslated Regions;Up-Regulation;Validation;autocrine;cancer cell;cell growth;cohort;cytokine;deprivation;design;human EEF1A1 protein;in vitro Model;in vivo;insight;messenger ribonucleoprotein;migration;neoplastic cell;novel;public health relevance;response;tumor;tumor progression;tumorigenesis","TGF-regulated EMT","
Narrative
The epithelial-mesenchymal transition (EMT) is a fundamental process during normal embryonic development
but it can also be aberrantly re-activated in a variety of diseases including fibrosis and cancer. TGFï¿½ is one of
the growth factors implicated in EMT. The successful pursuit of the studies proposed herein will elucidate the
molecular mechanism through which TGFï¿½ mediates EMT and will provide insight into the design of strategies
and therapeutics aimed at its prevention in pathological situations.","NCI","8206542","12/30/2011 12:00:00 AM","PA-10-067","5R01CA154663-03","5","R01","CA","154663","03"," ","KNOWLTON, JOHN R","1/1/2011 12:00:00 AM","12/31/2015 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","6449999","HOWE, PHILIP H","Not Applicable","01","BIOCHEMISTRY","183710748","NHV3GTWSALA7","183710748","NHV3GTWSALA7","US","32.788289","-79.954891","7575301","MEDICAL UNIVERSITY OF SOUTH CAROLINA","CHARLESTON","SC","SCHOOLS OF MEDICINE","294074636","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","98563"," ","306063",
"Dental/Oral and Craniofacial Disease; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Apical;Biological Assay;Bone Marrow;Boxing;Canis familiaris;Cell Differentiation process;Cell physiology;Cells;Characteristics;Complex;Dental;Dental Cementum;Dental Pulp;Dentin;Development;Developmental Process;Embryo;Enzymes;Epigenetic Process;Event;Female;Gene Activation;Gene Expression;Gene Silencing;Gene Targeting;Genes;Genetic Screening;Genetic Transcription;Hereditary Disease;Histone H3;Histones;Human;Human Genetics;Immunodeficient Mouse;Immunoprecipitation;Implant;In Vitro;Incisor;Inherited;Link;Luciferases;Lysine;Mandible;Maxilla;Mesenchymal Stem Cells;Methylation;Modification;Molecular;Molecular Biology;Molecular Genetics;Mutation;Natural regeneration;Nature;Nodule;Ocular orbit;Odontoblasts;Osteoblasts;Patients;Pattern;Periodontal Ligament;Plant Roots;Play;Polymerase Chain Reaction;Population;Property;Public Health;Regulation;Reporter;Role;Stem cells;Structure;Syndrome;Testing;Time;Tissues;Tooth structure;Transcriptional Activation;Ubiquitination;Work;base;bone;chromatin immunoprecipitation;chromatin modification;craniofacial;demethylation;forkhead protein;gene repression;histone modification;human disease;improved;in vivo;inhibitor/antagonist;insight;knock-down;loss of function;male;novel;novel strategies;postnatal human;programs;promoter;public health relevance;repaired;self-renewal;small hairpin RNA;small molecule;stem cell differentiation;tissue regeneration;tissue repair;tongue papilla","Molecular Regulation of Human Dental Stem Cell Properties","
Relevance to Public Health Statement
 Human postnatal dental stem cells are unique precursor populations which are isolated tooth. These cells
are capable of differentiating into dentin/bone-like forming cells. When implanted into immunodeficient mice,
dental stem cells can form dentin- or cement-like mineralized tissues. Although dental stem cells may present
promising application prospects in tooth regeneration and repair, currently, molecular regulation of their fate is
poorly understood. Histone demethylases are newly-identified enzymes that remove histone methyl marks
associated with gene activation or repression. While they have been implicated in developmental processes and
human diseases, it is largely unknown whether and how histone demethylases play a critical role in dental stem
cell function. In this application, we propose to examine how chromatin modification by histone demethylases
regulates gene expression and dental stem cell differentiation using molecular and genetic approaches. Our
results may provide new insights into the molecular biology of human dental stem cells. Moreover, because
demethylases, being enzymes, can be readily targeted by small molecule inhibitors, our work may help to
develop novel strategies for improving dental and craniofacial tissue regeneration and repair.","NIDCR","8246418","3/30/2012 12:00:00 AM","PA-07-070","5R01DE016513-09","5","R01","DE","016513","09"," ","LUMELSKY, NADYA L","5/1/2005 12:00:00 AM","4/30/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-C(03)M]"," ","2234578","WANG, CUN-YU ","Not Applicable","33","DENTISTRY","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","900952000","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","235125","126968"," ","362093",
"Bioengineering; Injury (total) Accidents/Adverse Effects; Injury - Trauma - (Head and Spine); Neurodegenerative; Neurosciences; Regenerative Medicine; Rehabilitation; Spinal Cord Injury; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Adult;Afferent Neurons;Axon;Biocompatible Materials;Biological;Biological Assay;Biological Models;Biology;Biomedical Engineering;Cells;Chemistry;Chronic;Complex;Coupling;Data;Development;Devices;Diagnosis;Embryo;Engineering;Environment;Evaluation;Exhibits;Fiber;Funding;Goals;Grant;Hippocampus (Brain);Human;Human body;Hybrids;Implant;In Vitro;Journals;Laboratories;Legal patent;Locomotor Recovery;Manuscripts;Mechanoreceptors;Mesenchymal Stem Cells;Microelectrodes;Modeling;Molecular and Cellular Biology;Motor;Motor Neurons;Muscle;Muscle Fibers;Myelin Basic Proteins;Myopathy;Myosin Heavy Chains;Nanotechnology;Natural regeneration;Neonatal;Nervous system structure;Neuroglia;Neurologic;Neuromuscular Junction;Neurons;Neurotransmitters;Oligodendroglia;Outcome;Pain;Population;Preparation;Prevention;Production;Progress Reports;Prosthesis;Protein Isoforms;Publications;Ranvier&apos;s Nodes;Rattus;Reflex action;Rehabilitation therapy;Research;Research Project Grants;Sarcomeres;Schwann Cells;Screening procedure;Serum;Spinal Cord;Spinal cord damage;Spinal cord injury;Stem cells;Structure;Surface;Synapses;System;Systems Biology;Techniques;Technology;Testing;Toxicology;Work;base;cell type;design;drug discovery;fetal stem cell;human stem cells;improved;in vitro Model;in vivo;information processing;innovation;myelination;nerve supply;new technology;next generation;orthotics;prototype;public health relevance;research study;satellite cell;solid state;spinal reflex;stretch reflex;symposium;synaptic function","An In Vitro Model of Stem Cell Innervation of Myotubes","
Project Narrative
The goal of this project is to engineer a system to model one of the most fundamental motor circuits in the
human body, the spinal reflex arc. We will use nanotechnology and microelectronics in combination with
biomedical engineering techniques to build this hybrid biological/non-biological system. Potential benefits
include prevention, diagnosis, and treatment of developmental abnormalities in the spinal cord, rehabilitation of
chronic neurological/muscle disorders and accompanying pain, and new strategies for prosthetic and orthotic
design and evaluation.","NINDS","8217190","2/7/2012 12:00:00 AM","PA-10-009","5R01NS050452-07","5","R01","NS","050452","07"," ","OWENS, DAVID F","9/23/2005 12:00:00 AM","1/31/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-ETTN-F(02)M]"," ","1959212","HICKMAN, JAMES J","Not Applicable","07","MISCELLANEOUS","150805653","RD7MXJV7DKT9","150805653","RD7MXJV7DKT9","US","28.587878","-81.200337","513805","UNIVERSITY OF CENTRAL FLORIDA","ORLANDO","FL","ORGANIZED RESEARCH UNITS","328263231","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","281209","120309"," ","401518",
"Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research","Address;Adhesions;Alkanesulfonates;Animals;Binding;Biological;Biological Assay;Biological Process;Biomimetics;Biotechnology;Cell Adhesion;Cell Differentiation process;Cell Line;Cell surface;Cells;Charge;Chemical Engineering;Chemistry;Clinical;Communities;Culture Media;Defect;Derivation procedure;Development;Embryo;Environment;Extracellular Matrix;Goals;Growth;Growth Factor;Heparin;Heparitin Sulfate;Human;In Vitro;Integrins;Knowledge;Label;Lead;Learning;Maintenance;Mediating;Medical;Mesenchymal Stem Cells;Methods;Mission;Modification;Molecular;Molecular Probes;Mus;Natural regeneration;Nature;Osteoblasts;Patients;Phase;Phenotype;Pluripotent Stem Cells;Polymers;Positioning Attribute;Property;Proteomics;Protocols documentation;Public Health;RGD (sequence);Receptor Cell;Recombinant Proteins;Research;Research Design;Resistance;Serum;Side;Solid;Somatic Cell;Stem cells;Sterilization;Structure;Subcellular Fractions;Substrate Interaction;Support System;Supporting Cell;Surface;System;Testing;Thick;Undifferentiated;United States National Institutes of Health;Vertebral column;Xeno;abstracting;base;bone;chemical property;clinical application;clinically relevant;craniofacial;density;design;extracellular;heparin proteoglycan;human disease;human embryonic stem cell;human tissue;induced pluripotent stem cell;innovation;matrigel;novel;phosphonate;physical property;pluripotency;regenerative therapy;research study;self-renewal;skeletal;stem;stem cell biology;stem cell differentiation;stem cell fate;success;sugar;synthetic biology;therapeutic development;tool","Dissecting Self-renewal Mechanisms of iPS Cells on Defined Synthetic Substrates"," The proposed research is relevant to public health because we will determine how to generate of patient- specific puripotent stem cells (iPS) in fully defined and xenogeneic-free conditions that can be differentiated to osteoblasts capable of regenerating clinically relevant skeletal defects. Our innovation is derived from our so- called synthetic biology approach where synthetic PMEDSAH takes on biological functions; for example, supporting cell adhesion, enabling self-renewal and heparin-like binding of growth factors. Because we will derive patient-matched stem cells in completely defined and xengeneic free conditions we will positively impact both the understanding of basic stem cell biology and contribute to the development of consistent and safe regenerative therapies. As such, successful completion of the projects should enable new horizons important to the mission of the NIH.  
    

","NIDCR","8240773","2/28/2012 12:00:00 AM","PA-10-067","2R01DE016530-06","2","R01","DE","016530","06"," ","LUMELSKY, NADYA L","4/1/2005 12:00:00 AM","3/31/2017 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1884808","KREBSBACH, PAUL H","Not Applicable","12","DENTISTRY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF DENTISTRY/ORAL HYGN","481091276","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","249495","133959"," ","383454",
"Biotechnology; Cardiovascular; Genetics; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute;Adopted;Aftercare;Anoxia;Apoptotic;Attenuated;Behavior;Bioenergetics;Blood;Blood Vessels;Cardiac;Cardiac Function Study;Cardiac Myocytes;Cell Survival;Cell Therapy;Cell physiology;Cells;Characteristics;Combined Modality Therapy;Coronary artery;Cytoprotection;Data;Development;Echocardiography;Electron Microscopy;Engraftment;Experimental Animal Model;Exposure to;Financial compensation;Flow Cytometry;Gene Expression;Gene Proteins;Gene Targeting;Genes;Genetic Transcription;Goals;Growth;Growth Factor Gene;Hypoxia;Hypoxia Inducible Factor;Image;Immunochemistry;In Vitro;Infarction;Injection of therapeutic agent;Lentivirus Vector;Ligation;Maintenance;Mediating;Mediator of activation protein;Mesenchymal Stem Cells;MicroRNAs;Molecular;Molecular Biology;Molecular Profiling;Myocardial;Myocardial Infarction;Myocardial Ischemia;Natural regeneration;Oxygen;Patients;Phenotype;Property;Proteomics;Recovery of Function;Regional Blood Flow;Role;Signal Transduction;Stem cell transplant;Stem cells;Techniques;Time;Transplantation;Untranslated Regions;angiogenesis;base;cardiac repair;cell type;density;design;heart cell;heart preservation;improved;in vitro Model;in vivo;indexing;interdisciplinary approach;neoplastic cell;novel;novel strategies;novel therapeutic intervention;overexpression;paracrine;public health relevance;repaired;response;restoration;self-renewal;stem cell therapy;therapeutic angiogenesis;therapeutic effectiveness;treatment strategy","Angiomyogenesis with HIF-1a responsive microRNAs","
Narrative
 This proposal is designed to investigate angiomyogenic and paracrine behavior of stem cells
reprogrammed by manipulation of HIF-1ï¿½ responsive microRNAs (HRMs) using our novel approach of
treating the cells with intermittent multiple short cycles of anoxia/reoxygenation. We anticipate improved
angiomyogenic response in the infarcted heart after treatment with reprogrammed stem cells. Our proposal will
be the first to elucidate the mechanistic participation of HRMs in paracrine behavior, angiomyogenic potential
and cytoprotection.","NHLBI","8212062","12/22/2011 12:00:00 AM","PA-10-067","5R01HL106190-02","5","R01","HL","106190","02"," ","ADHIKARI, BISHOW B","2/1/2011 12:00:00 AM","11/30/2016 12:00:00 AM","Vascular Cell and Molecular Biology Study Section[VCMB]"," ","11422658","HABEEBAHMED, RAFEEQ ","Not Applicable","01","PATHOLOGY","041064767","DZ4YCZ3QSPR5","041064767","DZ4YCZ3QSPR5","US","39.142998","-84.503581","1523902","UNIVERSITY OF CINCINNATI","CINCINNATI","OH","SCHOOLS OF MEDICINE","452210001","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","403922","199084"," ","603006",
"Hematology; Neurosciences; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","AMD3100;Ablation;Adrenergic Receptor;Adult;Animals;Antibodies;Aspirate substance;Biological Assay;Blocking Antibodies;Bone Marrow;Bone Marrow Cell Transplantation;Bone Marrow Cells;Bone Marrow Transplantation;Burn injury;CSF1R gene;CXCL12 gene;Cell Line;Cell Transplants;Cells;Coculture Techniques;Data;Dependence;Development;Dichloromethylene Diphosphonate;Engraftment;Enzyme-Linked Immunosorbent Assay;Erythropoiesis;Extracellular Fluid;FDA approved;Filgrastim;Flow Cytometry;Genes;Genetic;Genetic Models;Granulocyte Colony-Stimulating Factor;Granulocyte Colony-Stimulating Factor Receptors;Harvest;Hematinics;Hematological Disease;Hematopoiesis;Hematopoietic;Hematopoietic Stem Cell Mobilization;Hematopoietic stem cells;High Dose Chemotherapy;Injury;Intermediate Filament Proteins;Island;Lead;Lipopolysaccharides;Liposomes;Literature;Macrophage Colony-Stimulating Factor;Maintenance;Malignant Neoplasms;Mediating;Mediator of activation protein;Medical;Mesenchymal Stem Cells;Monoclonal Antibodies;Mus;Myocardial Infarction;Nerve Degeneration;Patients;Population;Production;Protein Array;Regulation;Relative (related person);Reporting;Retrieval;Role;Signal Transduction;Site;Stem cells;Stromal Cells;Surgical Models;Sympathectomy;Sympathetic Nervous System;Testing;Transgenic Mice;Transplantation;Umbilical Cord Blood;chemokine;clinically relevant;cytokine;improved;in vivo;in vivo Model;macrophage;monocyte;mouse model;nestin protein;peripheral blood;public health relevance;receptor;reconstitution;relating to nervous system;research study;stem;stem cell niche;tissue repair","Maintenance of the Hematopoietic Stem Cell Niche Monocytes and Macrophages","n/a","NHLBI","8209164","12/30/2011 12:00:00 AM","PA-08-021","5F30HL099028-03","5","F30","HL","099028","03"," ","MITCHELL, PHYLLIS","1/12/2010 12:00:00 AM","7/12/2012 12:00:00 AM","Special Emphasis Panel[ZRG1-F10A-S(20)L]"," ","8776379","CHOW, ANDREW ","Not Applicable","13","INTERNAL MEDICINE/MEDICINE","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","SCHOOLS OF MEDICINE","100296574","UNITED STATES","N","1/12/2012 12:00:00 AM","7/12/2012 12:00:00 AM","839","Training, Individual","2012"," "," ","NHLBI","17417"," "," ","17417",
"Biotechnology; Breast Cancer; Cancer; Estrogen; Genetics","AKT3 gene;Adjuvant;Aggressive behavior;Aromatase Inhibitors;Biological;Breast Cancer Cell;Breast Carcinoma;CREB1 gene;Cell Survival;Cell model;Data;Drug resistance;Endocrine;Estrogen Antagonists;Estrogens;Exhibits;Gene Expression;Gene Expression Profiling;Genes;Goals;Hormones;In Vitro;Link;Malignant Epithelial Cell;Malignant Neoplasms;Mediating;Microarray Analysis;Mitogen-Activated Protein Kinases;Molecular;Molecular Target;Morphology;Neoplasm Metastasis;Pathway Analysis;Pathway interactions;Pattern;Phenotype;Phosphotransferases;Play;Process;Proto-Oncogene Proteins c-akt;Publishing;Regulation;Research;Resistance;Resistance development;Role;Signal Pathway;Signal Transduction;System;Tamoxifen;Testing;Therapeutic;Therapeutic Agents;Therapeutic Intervention;Transcription Factor AP-1;Transcriptional Regulation;Up-Regulation;Xenograft procedure;base;cancer cell;design;drug development;effective therapy;epithelial to mesenchymal transition;gene function;hormone therapy;in vivo;insight;malignant breast neoplasm;malignant phenotype;molecular marker;mouse model;novel;prognostic indicator;prospective;resistance mechanism;response;slug;small hairpin RNA;therapeutic development;tool;transcription factor;tumor;tumor progression;tumorigenesis","MEK5-Erk5 in breast cancer resistance","
NARRATIVE
While endocrine therapies, such as the anti-estrogen tamoxifen and the aromatase inhibitors, are important
tools in the treatment of ER(+) breast carcinoma in the adjuvant and metastatic setting some tumors ultimately
progresses to hormone-independence and resistance. Here we examine the role and mechanisms of the novel
MEK5-Erk5 mitogen-activated protein kinase pathway in the regulation of cell survival and therapeutic
resistance of breast cancer cells. We further examine the role of MEK5-Erk5 signaling in the progression of
breast cancer cells to an ERï¿½-negative and epithelial-to-mesenchymal transition phenotype. The research in
this proposal is about understanding mechanisms of resistance and developing strategies to target and treat
breast cancer progression.","NCI","8260576","4/26/2012 12:00:00 AM","PA-07-070","5R01CA125806-03","5","R01","CA","125806","03"," ","FORRY, SUZANNE L","7/1/2010 12:00:00 AM","4/30/2015 12:00:00 AM","Basic Mechanisms  of Cancer Therapeutics Study Section[BMCT]"," ","1900866","BUROW, MATTHEW E.","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","053785812","XNY5ULPU8EN6","053785812","XNY5ULPU8EN6","US","29.935453","-90.123916","8424601","TULANE UNIVERSITY OF LOUISIANA","NEW ORLEANS","LA","SCHOOLS OF MEDICINE","701185665","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","212648","88305"," ","300953",
"Cancer; Clinical Research; Pediatric; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human","Address;Age;Age-Years;Angiogenesis Inhibitors;Animal Model;Basic Science;Behavior;Benign;Birth;Blood Vessels;Cell Proliferation;Cells;Child;Common Neoplasm;Data;Development;Differentiation and Growth;Drug Delivery Systems;Endothelial Cells;European;Exhibits;FDA approved;Family;Goals;Growth;Health;Hemangioma;Human;Immune;Immunodeficient Mouse;In Vitro;Infant;Knowledge;Lead;Lesion;Life;Life Cycle Stages;Measures;Mesenchymal Stem Cells;Modeling;Molecular;Mus;Neoplasms in Vascular Tissue;Newborn Infant;Normal Cell;Normal tissue morphology;Paper;Pathway interactions;Pediatric Neoplasm;Pericytes;Pharmaceutical Preparations;Phase;Process;Proliferating;Property;Research;Role;Signal Transduction;Smooth Muscle Myocytes;Specimen;Stem cells;Strawberry nevus;Testing;Translating;Tumor Angiogenesis;Vascular Endothelial Growth Factor B;Vascular Endothelial Growth Factors;base;cell growth;cell type;clinical application;early childhood;in vivo;infancy;insight;novel;prevent;self-renewal;small hairpin RNA;stem cell differentiation;tissue regeneration;tissue repair;transcription factor;tumor","Blood vessel assembly from multipotent hemangioma-derived stem cells","
Project Narrative:
This proposal will study stem cells isolated from a common childhood tumor known as infantile
hemangioma. We hope to understand how and why these stem cells have become disrupted, such
that instead of following a normal healthy pathway to become normal cells and tissue, the
hemangioma-derived stem cells form a mass of disorganized blood vessels that grows dramatically
during infancy. The results from this study may lead to new, fast-acting and safe treatments for
children with endangering hemangiomas. In addition, the studies may provide fundamental insights
into the behavior of human vascular progenitor cells which could then be applied to strategies to use
such progenitor cells for tissue repair and regeneration, and specifically to build healthy vascular
networks.","NHLBI","8248244","4/4/2012 12:00:00 AM","PA-07-070","5R01HL096384-04","5","R01","HL","096384","04"," ","MCDONALD, CHERYL","4/1/2009 12:00:00 AM","3/31/2014 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","1917530","BISCHOFF, JOYCE E.","Not Applicable","07","Unavailable","076593722","Z1L9F1MM1RY3","076593722","Z1L9F1MM1RY3","US","42.340629","-71.094923","1504801","BOSTON CHILDREN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021155724","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","183150"," ","430650",
"Hematology","Acute;Address;Advisory Committees;Affect;Anesthesia procedures;Antithrombin III;Apoptosis;Area;Attenuated;Biochemistry;Biological Markers;Biomedical Research;Bleomycin;Carbon Black;Cell Survival;Cellular biology;Characteristics;Chemicals;Cicatrix;Coagulation Process;Collagen;Data;Deposition;Development;Disease;Ensure;Environment;Excision;Exhibits;Factor Xa;Faculty;Fibrin;Fibrinolysis;Fibrinolytic Agents;Fibrosis;Health Sciences;Hemorrhage;Hirudin;Hirudins;Human;Immunologics;In Vitro;Injury;Laboratories;Light;Link;Lung;Mediating;Mentors;Mentorship;Mesenchymal;Mesothelial Cell;Mesothelium;Modeling;Molecular;Molecular Biology Techniques;Mus;Operative Surgical Procedures;Pathogenesis;Pathway interactions;Patients;Peptide Hydrolases;Phenotype;Phosphorylation;Plasminogen Activator Inhibitor 1;Pleura;Pleural;Pleural Mesothelial Cell;Postdoctoral Fellow;Principal Investigator;Process;Protein Chemistry;Proteinase-Activated Receptors;Proteins;Publications;Reporting;Research;Research Personnel;Research Project Grants;Resistance;Risk;Role;Signal Pathway;Signal Transduction;Sirolimus;Smooth Muscle Actin Staining Method;TFPI;Techniques;Texas;Thrombin;Tight Junctions;Tissues;Training Programs;Universities;Work;abstracting;base;career;cell motility;design;human FRAP1 protein;in vivo;inhibitor/antagonist;interest;mTOR Inhibitor;mouse model;new therapeutic target;novel;professor;programs;repaired;response","The role of coagulation cascade proteases in pleural fibrosis","
This project addresses new potential mechanisms and therapies for the treatment of pleural fibrosis. In this
project we will determine the role of coagulation cascade proteases in mesenchymal transition and their
contribution to the progression of pleural fibrosis. We also propose new potential therapies for the treatment
of this disease.","NHLBI","8367874","7/18/2012 12:00:00 AM","RFA-HL-12-030","1K01HL115466-01","1","K01","HL","115466","01"," ","COLOMBINI-HATCH, SANDRA","8/1/2012 12:00:00 AM","6/30/2017 12:00:00 AM","ZHL1-CSR-F(M1)"," ","10012756","TUCKER, TORRY ALLE","Not Applicable","01","NONE","800772337","FPCUDWBE7DX2","800772337","FPCUDWBE7DX2","US","32.415607","-95.211889","578420","UNIVERSITY OF TEXAS HLTH CTR AT TYLER","TYLER","TX","OVERALL MEDICAL","757083154","UNITED STATES","N","8/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","837","Other Research-Related","2012"," "," ","NHLBI","102000","8160"," ","110160",
"Aging; Biotechnology; Clinical Research; Genetics; Osteoporosis; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Accounting;Address;Affect;Age;Antibodies;Biochemical;Biology;Blood specimen;Bone Density;Bone Marrow;Bone Resorption;Candidate Disease Gene;Caucasians;Caucasoid Race;Cell Nucleus;Cells;China;Cluster Analysis;Complement;Complex;Cytoskeleton;Cytosol;DNA;DNA Microarray Chip;Detection;Diagnosis;Diagnostic;Disease;Dissection;Epidemiologic Studies;Epidemiology;Etiology;Female;Foundations;Fracture;Funding;Gender;Gene Proteins;Genes;Genetic;Genetic Polymorphism;Genome;Genomics;Goals;Grant;Health;Heritability;Hydrophobicity;In Vitro;Informatics;Ions;Isoelectric Point;Link;Liquid Chromatography;Membrane;Membrane Proteins;Mesenchymal Stem Cells;Messenger RNA;Metabolic Pathway;Molecular;Molecular Genetics;Molecular Profiling;Molecular Weight;Nebraska;Negative Finding;Nuclear;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis;Outcome;Pathway interactions;Peptides;Phenotype;Population;Positioning Attribute;Prevention;Principal Investigator;Prognostic Marker;Property;Protein Precursors;Proteins;Proteome;Proteomics;Public Health;Recruitment Activity;Risk;Sampling;Scanning;Science;Specificity;TNFRSF5 gene;Testing;Tobacco;Trauma;United States National Institutes of Health;Validation;Variant;Western Blotting;Woman;Work;base;bone;bone loss;bone mass;bone metabolism;cohort;design;functional genomics;genetic linkage;genetic pedigree;genome wide association study;genome-wide;hip bone;in vivo;innovation;insight;mRNA Expression;male;men;monocyte;mortality;multidisciplinary;nano;novel;osteoclastogenesis;osteogenic;osteoporosis with pathological fracture;peripheral blood;precursor cell;programs;protein expression;research study;sex;tandem mass spectrometry;two-dimensional","Identification of Proteins Important for Male Osteoporosis","
 RELEVANCE
 Osteoporosis is a disease with severe bone loss and a significantly
increased risk of low trauma fractures. Male osteoporosis, compared with
female osteoporosis, has higher mortality rate upon fractures. This project
aims to identify proteins that are important to male osteoporosis. The findings
will provide essential scientific basis for effective prevention, diagnosis and
treatment of the disease.","NIAMS","8324932","8/21/2012 12:00:00 AM","PA-07-070","5R01AR057049-05","5","R01","AR","057049","05"," ","SHARROCK, WILLIAM J","9/18/2009 12:00:00 AM","7/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-HOP-T(02)M]"," ","6616034","DENG, HONG-WEN ","Not Applicable","01","BIOSTATISTICS & OTHER MATH SCI","053785812","XNY5ULPU8EN6","053785812","XNY5ULPU8EN6","US","29.935453","-90.123916","8424601","TULANE UNIVERSITY OF LOUISIANA","NEW ORLEANS","LA","SCHOOLS OF PUBLIC HEALTH","701185665","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","410358","202957"," ","613315",
"Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","AMD3100;Acute myocardial infarction;Age;Anti-Inflammatory Agents;Anti-inflammatory;Biomechanics;Bone Marrow;Bone Marrow Aspiration;Bone Regeneration;Bone callus;CSF3 gene;CXCR4 Receptors;Cartilage;Cell Count;Cell Differentiation process;Cell Separation;Cells;Collection;Colony-Forming Units Assay;Complex;Complication;Deformity;Disease;Engraftment;Flow Cytometry;Fracture;Fracture Healing;General Anesthesia;Goals;Granulocyte Colony-Stimulating Factor;Growth Factor;Healed;Hematopoietic Stem Cell Mobilization;Hematopoietic stem cells;Home environment;Homing;Impaired wound healing;In Vitro;Inflammatory;Injury;Intervention;Label;Laboratories;Life Style;Ligaments;Measures;Mechanics;Mesenchymal Stem Cells;Minerals;Modeling;Molecular;Mus;Musculoskeletal;Myocardial;Natural regeneration;Osteogenesis;Pain;Pharmaceutical Preparations;Population;Process;Recovery;Shapes;Signal Transduction;Site;Smoking;Source;Stem cells;Stromal Cell-Derived Factor 1;Tendon structure;Testing;Therapeutic;Time;Tissues;Transplantation;Vascular Endothelial Growth Factors;Work;angiogenesis;base;body system;bone;bone healing;cell motility;cell preparation;chemokine;cost effective;cytokine;density;effective therapy;healing;improved;in vivo;mortality;paracrine;peripheral blood;progenitor;receptor;repaired;response;scaffold;stem;tissue regeneration","Rapid mobilization of endogenous progenitor cells for bone healing"," Rapid pharmacological mobilization of endogenous cell populations into PB, as an effective strategy to enhance tissue regeneration, would circumvent current complications associated with progenitor cell isolation, in vitro manipulation and subsequent delivery. This has significant implications for our current cell based strategies for bone regeneration, and could be extended as a simple and cost effective therapy for the treatment of damage in other musculoskeletal tissues such as cartilage, ligament and tendon, and beyond bone for the repair of other organ systems.   
      

","NIAMS","8301916","3/23/2012 12:00:00 AM","PA-10-069","1R21AR061604-01A1","1","R21","AR","061604","01","A","WANG, FEI","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","2117693","YELLOWLEY-GENETOS, CLARE E","Not Applicable","03","VETERINARY SCIENCES","047120084","TX2DAGQPENZ5","047120084","TX2DAGQPENZ5","US","38.543675","-121.729989","577503","UNIVERSITY OF CALIFORNIA AT DAVIS","DAVIS","CA","SCHOOLS OF VETERINARY MEDICINE","956186153","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","112500","60610"," ","173110",
"Aging; Biotechnology; Cancer; Clinical Research; Genetics; Prostate Cancer; Urologic Diseases","Address;Adoptive Transfer;Area;Attenuated;Basal lamina;Biological;Biological Models;Biology;Bone Marrow Transplantation;CD14 gene;CD34 gene;Cancer Biology;Cancer Patient;Candidate Disease Gene;Carcinoma;Categories;Cell Line;Cell physiology;Cells;Cessation of life;Clinical Data;Coculture Techniques;Data;Development;Disease Progression;Dominant-Negative Mutation;Engineering;Epithelial;Epithelial Cells;Epithelium;Evolution;Exhibits;Fibroblast Growth Factor 2;Fibroblasts;Gene Expression;Gene Expression Profile;Genes;Growth Factor;Health;Human;In Vitro;LNCaP;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of prostate;Marrow;Mesenchymal;Mitogen-Activated Protein Kinases;Molecular Profiling;Mus;Myofibroblast;Neoplasm Metastasis;Pathway interactions;Phenotype;Premalignant;Procedures;Process;Property;Prostate;Recruitment Activity;Role;Signal Pathway;Signal Transduction;Smooth Muscle;Stem cells;Stromal Cells;Tamoxifen;Thrombospondin 1;Tissue Microarray;Tissue-Specific Gene Expression;Transforming Growth Factor beta;Transgenic Mice;Transgenic Model;Work;Xenograft Model;Xenograft procedure;angiogenesis;cell type;connective tissue growth factor;hepsin;in vitro Model;in vivo Model;interest;notch protein;novel;overexpression;pre-clinical;progenitor;protein expression;receptor;research study;response;stromal progenitor;therapeutic target;tumor;tumor progression;tumorigenesis","Mesenchymal Derived Growth Factors in Prostatic Cancer","
This project will provide pre-clinical data to help determine the recruitment and tumor-regulatory biology of the
cancer stromal microenvironment. Data gained will help identify whether targeting TGF-1 induced biology
can be used as a strategic approach for the treatment of prostate cancer via its microenvironment.","NCI","8299438","7/19/2012 12:00:00 AM","PA-07-298","5R01CA058093-19","5","R01","CA","058093","19"," ","MOHLA, SURESH","9/30/1992 12:00:00 AM","7/31/2014 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1858147","ROWLEY, DAVID R","Not Applicable","09","ANATOMY/CELL BIOLOGY","051113330","FXKMA43NTV21","051113330","FXKMA43NTV21","US","29.711148","-95.39695","481201","BAYLOR COLLEGE OF MEDICINE","HOUSTON","TX","SCHOOLS OF MEDICINE","770303411","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","170519","91228"," ","261747",
"Biotechnology; Cardiovascular; Clinical Research; Heart Disease; Orphan Drug; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Accounting;Address;Advanced Development;Autologous;Award;Biology;Biopsy;Bone Marrow;Cardiac;Cardiomyopathies;Cardiovascular system;Catheters;Cell Proliferation;Cell Therapy;Cell surface;Cells;Cellular Morphology;Cessation of life;Cicatrix;Clinical;Clinical Research;Clinical Trials;Clinical Trials Design;Coculture Techniques;Combined Modality Therapy;Congestive Heart Failure;Data;Databases;Diamond;Dilated Cardiomyopathy;Disease;Dose;Drug Formulations;EFRAC;Enrollment;Experimental Models;Family suidae;Fibrosis;Foundations;Functional disorder;Growth;Health;Heart;Heart Transplantation;Heart failure;Human;Image;In Vitro;Individual;Injection of therapeutic agent;Institutes;Investigation;Lead;Left Ventricular Function;Measures;Mesenchymal Stem Cells;Methods;Modeling;Myocardial Ischemia;N-octanoylglucosylamine;National Heart, Lung, and Blood Institute;Outcome;Patient Selection;Patients;Perfusion;Phase;Phenotype;Preparation;Primary idiopathic dilated cardiomyopathy;Program Development;Property;Randomized;Randomized Clinical Trials;Relative (related person);Role;Safety;Solid;Specialized Center;Stem cells;System;Testing;Therapeutic;Tissues;Treatment Efficacy;Ventricular Remodeling;Work;base;cell type;clinically relevant;design;disability;experience;heart function;improved;injured;innovation;insight;novel;novel strategies;novel therapeutic intervention;novel therapeutics;patient population;pre-clinical;programs;research study;safety testing;skills;stem cell therapy;sudden cardiac death","Cell Based Therapy for Non-Ischemic Dilated Cardiomyopathy","This clinical study will address a significant clinical need, namely the investigation of new and promising cellbased 
therapies for heart dysfunction due to non-ischemic heart failure (Idiopathic Dilated Cardiomyopathy). 
The proposed phase l/ll randomized clinical trial will elucidate new insights into the clinical role of cell-based 
therapy for the treatment of this important disorder that is one of the leading causes of cardiovascular death 
and disability in the USA","NHLBI","8288406","3/23/2012 12:00:00 AM","RFA-HL-12-026","1UM1HL113460-01","1","UM1","HL","113460","01"," ","SKARLATOS, SONIA","3/23/2012 12:00:00 AM","2/28/2019 12:00:00 AM","ZHL1-CSR-O(F2)"," ","1893621","HARE, JOSHUA M","Not Applicable","27","INTERNAL MEDICINE/MEDICINE","052780918","F8THLJQSAF93","052780918","F8THLJQSAF93","US","25.775337","-80.209809","5221250","UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","CORAL GABLES","FL","SCHOOLS OF MEDICINE","331462926","UNITED STATES","N","3/23/2012 12:00:00 AM","2/28/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","481532","234012"," ","715544",
"Bioengineering; Regenerative Medicine","Acute;Affect;American;Animal Model;Atrophic;Autologous;Biocompatible Materials;Biological;Biomechanics;Cattle;Cell Culture Techniques;Cell Therapy;Cellular Infiltration;Cicatrix;Collagen;Complex;Contralateral;Data;Defect;Development;Disease;Drug Formulations;Extracellular Matrix;Extracellular Matrix Proteins;Fatty acid glycerol esters;Fibroblasts;Funding;Gel;Goals;Growth Factor;Hepatocyte Growth Factor;Histologic;Human;Hyaluronic Acid;Hydrogels;Immune response;Implant;In Vitro;Individual;Injection of therapeutic agent;Injury;Lamina Propria;Larynx;Lead;Maintenance;Medical;Mesenchymal Stem Cells;Methodology;Modeling;Motivation;Mucous Membrane;Natural regeneration;Normal tissue morphology;Occupations;Operative Surgical Procedures;Oryctolagus cuniculus;Pathology;Patients;Performance;Permeability;Phase;Porosity;Prevention;Procedures;Process;Proliferating;Property;Protein Biosynthesis;Proteins;Quality of life;Rattus;Regenerative Medicine;Reporting;Research;Research Personnel;Saline;Sample Size;Simulate;Staging;Surgical Management;System;Techniques;Testing;Therapeutic;Time;Tissue Engineering;Tissues;Treatment Efficacy;Voice;Voice Disorders;Voice Quality;Wound Healing;base;biomaterial compatibility;career;embryonic stem cell;improved;in vivo;injured;innovation;novel;novel therapeutic intervention;prevent;public health relevance;reconstruction;repaired;research study;restoration;scaffold;stem;treatment effect;vibration;viscoelasticity;vocal cord;vocalis muscle;wound","Xenogeneic scaffolds for the repair of acute vocal fold lamina propria injury","
NARRATIVE STATEMENT
 Each year, an estimated 3-9% of Americans suffer from some kind of voice
disorders, which adversely affect the communicative abilities, quality of life, and even
the careers of individuals relying on a healthy, functional voice for their occupations.
Despite the recent advances in phonosurgical approaches and therapeutic strategies, vocal
fold lamina propria defects, such as vocal fold scarring, atrophy and sulcus vocalis,
remain to be among the most clinically challenging disorders, due to the vulnerability of
the vocal fold lamina propria to scar tissue formation and the difficulties to effectively
replace the lamina propria. The proposed research explores the potential of an innovative
tissue engineering scaffold to facilitate the functional reconstruction of the injured vocal
fold lamina propria, and could contribute to the development of effective surgical
management for such voice disorders.","NIDCD","8274723","5/17/2012 12:00:00 AM","PAR-07-287","5R03DC011145-03","5","R03","DC","011145","03"," ","SHEKIM, LANA O","6/1/2010 12:00:00 AM","5/31/2014 12:00:00 AM","ZDC1-SRB-Y(53)"," ","10255650","XU, CHET CHE","Not Applicable","30","OTOLARYNGOLOGY","800771545","YZJ6DKPM4W63","800771545","YZJ6DKPM4W63","US","32.814772","-96.841146","578404","UT SOUTHWESTERN MEDICAL CENTER","DALLAS","TX","SCHOOLS OF MEDICINE","753909105","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","173","Non-SBIR/STTR","2012"," "," ","NIDCD","96800","56991"," ","153791",
"Biotechnology; Cardiovascular; Clinical Research; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Acute;Adipose tissue;Adult;Affect;Allogenic;Animal Model;Animals;Autologous;Biological;Biological Assay;Biological Response Modifier Therapy;Bioluminescence;Biopsy;Biotechnology;Bone Marrow;Cardiac;Cardiac Myocytes;Cardiovascular Diseases;Cause of Death;Cell Culture Techniques;Cell Survival;Cells;Centers for Disease Control and Prevention (U.S.);Clinical;Clinical Trials;Communities;Data Set;Development;Disease;Echocardiography;Endothelial Cells;Engraftment;Ensure;Flow Cytometry;Freezing;Future;Goals;Growth Factor;Healed;Health;Heart;Heart Diseases;Histology;Human;Hypoxia;Immunologics;In Vitro;Infarction;Injection of therapeutic agent;Injury;Ischemia;Left;Legal patent;Leukocytes;Licensing;Liquid substance;Long-Term Effects;Marketing;Measurement;Measures;Medical center;Mesenchymal Stem Cells;Methods;Migration Assay;Modification;Mononuclear;Mus;Myoblasts;Myocardial Infarction;Myocardium;Names;Natural regeneration;Nitrogen;Nutrient;Organ;Outpatients;Patients;Persons;Phase;Pilot Projects;Prevalence;Procedures;Process;Publishing;Recombinants;Research Personnel;Research Proposals;Resistance;Rome;Safety;Sampling;Series;Serum;Simulate;Skeletal Muscle;Source;Starvation;Stem cells;Surface;Technology;Testing;Time;Tube;United States;Universities;Variant;adult stem cell;cell type;commercialization;design;fetal bovine serum;healing;impression;improved;in vivo;manufacturing process;migration;mouse model;paracrine;phase 2 study;potency testing;protein expression;regenerative;repaired;response;safety testing;scale up;success","Characterization and Potency of Optimized Cardiosphere-derived Stem Cell Method","Cardiovascular disease is the No. 1 cause of death in the United States. Cardiosphere-derived stem cells, 
isolated from a personï¿½s own heart using Capricorï¿½s patented technology, can alleviate and reverse many effects 
of the disease. The cardiosphere technology has the potential to affect many lives, to provide a possible cure for 
the disease or halt its progression, and to improve the health of the Nation.","NHLBI","8265926","2/29/2012 12:00:00 AM","PA-08-050","5R44HL095203-03","5","R44","HL","095203","03"," ","BUXTON, DENIS B","9/1/2009 12:00:00 AM","8/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-CVS-K(10)B]"," ","10187917","SMITH, RACHEL RUCKDESCHEL","Not Applicable","33","Unavailable","625221820","RWZSK9ADN236","625221820","RWZSK9ADN236","US","34.07292","-118.372813","10011850","CAPRICOR, INC.","BEVERLY HILLS","CA","Domestic For-Profits","902112606","UNITED STATES","N","3/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","837","SBIR/STTR","2012"," "," ","NHLBI"," "," "," ","425410",
"Bioengineering; Biotechnology; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","3-Dimensional;Address;Adult;Alginates;American;American Heart Association;Animal Model;Area;Biocompatible Materials;Biological Products;Biomedical Engineering;Biotechnology;Calcium;Carbonates;Cardiac;Cardiovascular Diseases;Cell Differentiation process;Cell Survival;Cell Therapy;Cells;Cellular Structures;Clinical Trials;Coupling;Data;Development;Differentiation and Growth;Engineering;Environment;Evaluation;Fiber;Fibrosis;Film;Future;Genetic;Goals;Growth;Growth Factor;Heart;Human;Hybrids;In Vitro;Incidence;Injection of therapeutic agent;Kinetics;Knowledge;Left;Legal patent;Life;Mainstreaming;Mechanics;Mesenchymal Stem Cells;Methods;Modeling;Morphology;Muscle;Muscle Cells;Myoblasts;Myocardial;Myocardial Infarction;Necrosis;Oxygen;Pancreas;Pattern;Peptide Signal Sequences;Peroxides;Polymers;Printing;Problem Solving;Property;Recording of previous events;Research;Severities;Skeletal Myoblasts;Soft Tissue Injuries;Spinal cord injury;Stem cells;Structure;System;Technology;Testing;Therapeutic;Tissue Engineering;Tissues;Toxic effect;United States National Institutes of Health;Ventricular;Work;base;biodegradable polymer;bone;career;copolymer;copolymer 1;cyclopropane;design;elastomeric;experience;improved;in vivo;injured;interest;meetings;nanoparticle;neural patterning;novel;particle;polymerization;public health relevance;repaired;scaffold;stem;stem cell differentiation;stem cell therapy;success;synthetic tissue scaffolding;tissue regeneration;tissue repair","Bio-printing stem cell based and oxygen releasing grafts for myocardial repair","
An estimated 80,000,000 American adults (one in three) have one or more types of
cardiovascular disease (CVD); 7,900,000 have a history of myocardial infarction (American
Heart Association). Stem cell therapy is a promising approach for myocardial infarction repair,
and the use of stem cells to repair a damaged heart is now mainstream in current cardiac
research. The proposed project will improve current stem cell therapy for myocardial infarct by
providing cells with a stable delivery vehicle and an amenable local environment that enhances
and regulates their proliferation and differentiation for cell-based tissue regeneration and repair.","NHLBI","8270024","5/2/2012 12:00:00 AM","PAR-08-027","5SC2HL107235-03","5","SC2","HL","107235","03"," ","LUNDBERG, MARTHA","8/1/2010 12:00:00 AM","12/31/2013 12:00:00 AM","ZGM1-MBRS-5(NP)"," ","6262033","BOLAND, THOMAS ","Not Applicable","16","ENGINEERING (ALL TYPES)","132051285","Q6D2KKKRKG73","132051285","Q6D2KKKRKG73","US","31.849559","-106.433857","578405","UNIVERSITY OF TEXAS EL PASO","EL PASO","TX","BIOMED ENGR/COL ENGR/ENGR STA","799680001","UNITED STATES","N","5/1/2012 12:00:00 AM","12/31/2013 12:00:00 AM","837","Other Research-Related","2012"," "," ","NHLBI","99000","35317"," ","134317",
"Diabetes; Kidney Disease","Active Sites;Animals;Cells;Characteristics;Collagen Type IV;Complications of Diabetes Mellitus;Data;Development;Diabetes Mellitus;Diabetic Nephropathy;Diabetic mouse;Epithelial;Epithelial Cells;Epithelium;Fibronectins;Fibrosis;Genetic;Genetic Transcription;Glucose;Heterozygote;In Vitro;Injury;Insulin-Dependent Diabetes Mellitus;Kidney;Kidney Diseases;Mediating;Mediator of activation protein;Mesenchymal;Metabolic Control;Metformin;Mus;Normal Cell;Pathogenesis;Pathway interactions;Phosphorylation;Phosphotransferases;Protein Isoforms;Proteins;Ribosomal Protein S6 Kinase;Role;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Sirolimus;Site;Tissues;Transcriptional Regulation;Transforming Growth Factor beta;Transforming Growth Factors;Translations;Tubular formation;Tumor Suppressor Proteins;Work;cell injury;diabetic;human FRAP1 protein;human TSC2 protein;in vivo;interstitial;kidney cortex;mTOR Inhibitor;novel therapeutics;prevent;protein expression;response;sensor","Tubular epithelial cell injury"," Metabolic control of diabetes remains the most effective approach to prevent the development diabetic complications including diabetic nephropathy. However, achieving euglycemia is difficult and may be associated with complications. Understanding cellular mechanisms that contribute to the pathogenesis and progression of diabetic nephropathy may help develop adjunct therapy to prevent or even reverse this complication of diabetes. Interstitial fibrosis is a prominent feature of diabetic nephropathy. We have evidence that AMPK, an energy sensor in cells and tissues, regulate matrix protein accumulation and other mesenchymal features of tubular epithelial cells in diabetes. We wish to explore the role of this kinase and identify its mechanisms of action. The studies may result in the identification of new therapeutic strategies to treat diabetic nephropathy. Specifically, the work may demonstrate the utility of AMPK activators to prevent diabetic complications not only in type 2 but also in type1 diabetes.   
      

","NIDDK","8440131","9/21/2012 12:00:00 AM","PA-11-260","2R01DK033665-24","2","R01","DK","033665","24"," ","PARSA, AFSHIN","12/1/1984 12:00:00 AM","8/31/2016 12:00:00 AM","Pathobiology of Kidney Disease Study Section[PBKD]"," ","1898637","ABBOUD, HANNA E","Not Applicable","21","INTERNAL MEDICINE/MEDICINE","800772162","C3KXNLTAAY98","800772162","C3KXNLTAAY98","US","29.513082","-98.577731","578418","UNIVERSITY OF TEXAS HLTH SCIENCE CENTER","SAN ANTONIO","TX","SCHOOLS OF MEDICINE","782293901","UNITED STATES","N","9/24/2012 12:00:00 AM","8/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","107663"," ","325163",
"Assistive Technology; Atherosclerosis; Bioengineering; Cardiovascular; Diagnostic Radiology; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acoustics;Acute;Address;Allogenic;Angioplasty;Anticoagulants;Aorta;Area;Arterial Fatty Streak;Arterial Injury;Arteries;Autologous;Automobile Driving;Blood Vessels;Cardiovascular system;Catheters;Cell Communication;Cell Survival;Cells;Chronic;Clinical;Coagulation Process;Collaborations;Complex;Contrast Media;Coronary;Coronary Arteriosclerosis;Coronary artery;Data;Drug Delivery Systems;Effectiveness;Electrostatics;Endothelium;Energy-Generating Resources;Event;FDA approved;Frequencies;Gases;Glycocalyx;Goals;Grant;Healed;Hyperplasia;In Vitro;Injury;Intervention;Lead;Link;Lipids;Mediating;Medicine;Mesenchymal Stem Cells;Methods;Microbubbles;Microbubbles Ultrasound Contrast Medium;Modeling;Morbidity - disease rate;Motion;Natural regeneration;Oryctolagus cuniculus;Outcome;Particle Size;Patients;Pharmaceutical Preparations;Physics;Physiological;Play;Procedures;Radiation;Research;Role;Safety;Stem cells;Stents;Surface;System;Technology;Testing;Therapeutic;Thrombosis;Time;Tissues;Translating;Treatment Efficacy;Ultrasonography;Universities;absorption;base;clinical application;clinically relevant;design;efficacy testing;falls;healing;improved;in vivo;injured;interest;molecular imaging;mortality;multidisciplinary;novel;particle;percutaneous coronary intervention;prevent;radiation effect;repaired;research study;restenosis;restoration;scaffold;sound;tool","Vascular endoluminal cellular paving using acoustic radiation force"," Percutaneous intervention with stents has made a major impact in the treatment of symptomatic atherosclerotic blockages in the coronary arteries. One of the current issues with these vascular scaffolds is the slow healing and tissue integration, in particular with drug coated stents, requiring prolonged treatment with blood thinners. The current application explore a novel way of paving the inside of the stent-treated arteries with progenitor cells, using acoustic energy generated by a catheter inside the vessel, harnessed to selectively push the cells to their target. The progenitor cells will then have the potential to regenerate the normal endothelial lining of healthy arteries, thus preventing clot formation inside the stent, and at the same time inhibit the tissue ingrowth associated with restenosis. This is an entirely new concept, and we will develop the cellular paving method from the bench top to a translational model emulating the proposed clinical application.  
  
    

","NHLBI","8240691","12/30/2011 12:00:00 AM","PA-10-069","1R21HL102531-01A1","1","R21","HL","102531","01","A","LEE, ALBERT","1/1/2012 12:00:00 AM","12/31/2013 12:00:00 AM","Vascular Cell and Molecular Biology Study Section[VCMB]"," ","9829325","TOMA, CATALIN ","Not Applicable","18","INTERNAL MEDICINE/MEDICINE","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","125000","64375"," ","189375",
"No NIH Category available","1,25 (OH) vitamin D;Alternative Splicing;Binding;Biological;Biological Assay;Biology;Bone Development;Bone Marrow;Bone Regeneration;Cartilage;Cells;Chondrocytes;Chondrogenesis;Complement Factor D;Data;Defect;Degenerative polyarthritis;Diagnostic radiologic examination;Disease;Evaluation;Event;Family;Funding;Gene Activation;Gene Expression;Genes;Growth Factor;Hepatocyte Growth Factor;Human;Image;Introns;Knock-out;Lead;Length;Luciferases;Maintenance;Mediating;Mesenchymal Stem Cells;Messenger RNA;Methodology;Modality;Modeling;Modification;Nude Rats;Osteoblasts;Osteogenesis;Osteoporosis;Outcome Study;Pathway interactions;Play;Population;Process;Production;Protein Isoforms;RNA Splicing;Rattus;Receptor Gene;Regulation;Relative (related person);Response Elements;Role;Sampling;Skeleton;Small Interfering RNA;Stem cells;Tail;Techniques;Testing;Time;Tissue-Specific Gene Expression;Tissues;Transactivation;Up-Regulation;Validation;Variant;Veterans;Viral;Vitamin D;Vitamin D3 Receptor;Western Blotting;Work;Xenograft Model;base;bone;bone healing;bone metabolism;cartilage development;cartilage repair;cell type;digital;effective therapy;expectation;frailty;in vivo;lipid biosynthesis;member;novel therapeutics;osteoblast differentiation;osteogenic;osteoprogenitor cell;promoter;receptor;receptor expression;repaired;response;stem cell differentiation;stem cell therapy;transcription factor;vector;vertebra body","Human Osteoprogenitor Control by Hepatocyte Growth Factor and Vitamin D","Osteoporosis and osteoarthritis are major causes of frailty in the veteran population. A greater understanding of the regulation of human bone marrow-derived stem cell differentiation and bone and cartilage biology could eventually lead to more effective therapies for these diseases. Specifically, our methodology and information could open the way to facilitate stem cell therapy for veterans with osteoporosis and potentially with cartilage repair in osteoarthritis. Because of the potential for adding new bone to a weakened skeleton, such therapy would be a significant addition to present therapies, which are directed mainly at preserving bone. Because of the problems with cartilage loss/damage in osteoarthritis, understanding the regulation of stem cell differentiation into cartilage-forming cells could also add to present therapies. The work proposed will provide a detailed understanding of how vitamin D and its receptor interact with growth factors and other molecules to guide the stem cells into respective mature cell types that could eventually be used for new therapies.","VA","8334112","8/23/2012 12:00:00 AM","RFA-BX-11-014","1I01BX001529-01A1","1","I01","BX","001529","01","A"," ","7/1/2012 12:00:00 AM","6/30/2016 12:00:00 AM","Endocrinology B[ENDB]"," ","9473574","HOWARD, GUY ","Not Applicable","24","Unavailable","079275714","U2J7L7Y9NAJ6","079275714","U2J7L7Y9NAJ6","US","25.757864","-80.214254","481022","MIAMI VA HEALTH CARE SYSTEM","MIAMI","FL","Independent Hospitals","331251624","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Aging; Diabetes; Hematology; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adipocytes;Affect;Age;Aging;Agonist;Agriculture;B cell differentiation;B-Cell Development;B-Lymphocytes;Bexarotene;Blood;Bone Marrow;Bone Marrow Cells;Bone Marrow Suppression;Bone Resorption;C57BL/6 Mouse;Cell Adhesion Molecules;Cell Count;Cell Culture Techniques;Cell Differentiation process;Cell Survival;Cells;Data;Dose;Elements;Environment;Environmental Exposure;Environmental Pollution;Equilibrium;Exposure to;Fatty acid glycerol esters;Fracture;Genes;Health;Hematopoietic;Histology;House Dust;Human;Immune;In Vitro;Knowledge;Laboratories;Lead;Life;Literature;Liver;Longitudinal Studies;Lymphocyte;Lymphoid;Lymphopoiesis;Mammals;Marines;Measurable;Measures;Mesenchymal Stem Cells;Molecular;Myelogenous;Non-Insulin-Dependent Diabetes Mellitus;Organ;Osteoblasts;Osteogenesis;Patients;Peroxisome Proliferator-Activated Receptors;Pesticides;Phenotype;Physiology;Plastics;Premature aging syndrome;Prevalence;Production;RXR;Resources;Risk;Serum;Serum Markers;Source;Stomas;Stromal Cells;Supporting Cell;System;Techniques;Therapeutic;Therapeutic Effect;Wood material;adipocyte differentiation;adipokines;base;bone;bone loss;chemokine;cytokine;design;in vivo;knock-down;morphometry;mouse model;osteoblast differentiation;osteogenic;phthalates;pollutant;progenitor;receptor;rosiglitazone;senescence;stem cell differentiation;tributyltin","Environmental PPAR Agonists Accelerate Aging of Bone and Impair Lymphopoiesis","PUBLIC HEALTH RELEVANCE: We hypothesize that exposure to environmental contaminants can lead to premature aging of bone. Here we propose that engagement of a protein receptor, called the peroxisome proliferator activated receptor, by contaminants in plastics alters the differentiation of cells in the bone marrow. The resulting accumulation of fat in the bone, reminiscent of aging, will cause the loss of cells that support formation of new bone and that support formation of new immune cells. Understanding the molecular mechanisms leading to altered bone marrow cell differentiation and its impact on immune cell formation will allow us to minimize the detrimental effects of contaminant exposure and the unintended effects of therapeutics that also target this receptor.","NIEHS","8319569","8/29/2012 12:00:00 AM","PA-09-207","5F30ES019394-03","5","F30","ES","019394","03"," ","HUMBLE, MICHAEL C","9/1/2010 12:00:00 AM","8/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-F10B-S(20)L]"," ","10193399","BAKER, AMELIA RACHEL HAAS","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","604483045","FBYMGMHW4X95","604483045","FBYMGMHW4X95","US","42.336234","-71.070647","894901","BOSTON UNIVERSITY MEDICAL CAMPUS","BOSTON","MA","SCHOOLS OF MEDICINE","021182841","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","113","Training, Individual","2012"," "," ","NIEHS","47232"," "," ","47232",
"Bioengineering; Cancer; Hematology; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","AMD3100;Actins;Adherence;African American;American Cancer Society;Apoptosis;Autologous Stem Cell Transplantation;Biological Assay;Biological Models;Biomechanics;Bone Marrow;Bone Marrow Stem Cell;CXCR4 Signaling Pathway;CXCR4 gene;Cell Communication;Cell Lineage;Cell membrane;Cells;Cessation of life;Coculture Techniques;Computer Simulation;Data;Development;Diagnosis;Disease;Disease remission;Drug resistance;Evolution;Feedback;G-Protein-Coupled Receptors;Goals;Graph;Growth;Hematopoietic Neoplasms;High Dose Chemotherapy;Hydrogels;Lead;Link;Malignant Neoplasms;Mathematics;Measures;Mechanics;Mesenchymal Stem Cells;Modeling;Multiple Myeloma;Myosin ATPase;Outcome;Pathway interactions;Patients;Phenotype;Plasma Cells;Play;Population;Property;Protocols documentation;Publications;RNA Interference;Recurrent disease;Role;Signal Pathway;Signal Transduction;Stem cells;Stream;Stromal Cells;System;Therapeutic Agents;Tissues;United States;base;biological systems;cancer cell;cancer stem cell;cell type;computerized data processing;cytokine;improved;inhibitor/antagonist;mathematical model;novel;novel therapeutics;outcome forecast;research study;stem cell niche;tool;treatment response;tumorigenesis","Modelling the Growth of the MIC Niche at the System Level"," Multiple myeloma is currently an incurable disease even with recently developed novel therapeutic agents and high dose chemotherapy with autologous stem cell transplantation, and is the second most common hematological cancer in the United States. It represents 10% of hematopoietic malignancies and is the most common hematopoietic malignancy in African Americans. About 14,400 cases are diagnosed annually with nearly 11,200 deaths (American Cancer Society). Through integrated in-silico and experimental analyses, we will fully explore the mechanisms how Multiple Myeloma stem cell (imitating cell) fate is regulated by cell-cell feedback signaling and in turn predict the treatment response in the
niche.   
      

","NCI","8286603","4/18/2012 12:00:00 AM","PAR-11-203","1U01CA166886-01","1","U01","CA","166886","01"," ","LI, JERRY","5/1/2012 12:00:00 AM","4/12/2013 12:00:00 AM","ZEB1-OSR-C(J1)S"," ","9035518","ZHOU, XIAOBO ","Not Applicable","09","Unavailable","185641052","XJUCJAYJWYV1","185641052","XJUCJAYJWYV1","US","29.705786","-95.40227","10005742","METHODIST HOSPITAL RESEARCH INSTITUTE","HOUSTON","TX","Other Domestic Non-Profits","77030","UNITED STATES","N","5/1/2012 12:00:00 AM","4/12/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","309505","153050"," ","462555",
"Biotechnology; Brain Cancer; Brain Disorders; Cancer; Clinical Research; Clinical Trials; Genetics; Immunization; Neurosciences; Orphan Drug; Prevention; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Non-Human; Vaccine Related","Accounting;Adult;Affinity;Anaplastic astrocytoma;Antigen Targeting;Antigens;Autoimmune Process;Autoimmunity;Brain;Brain Neoplasms;CD8B1 gene;Cause of Death;Cell surface;Cells;Cessation of life;Child;Clinical;Clinical Trials;Complementary DNA;DNA;Data;Dendritic Cells;Epidermal Growth Factor;Epitopes;Figs - dietary;Genes;Glioblastoma;Health;Heterogeneity;Human;Immune response;Immunocompetent;Immunologics;Immunotherapeutic agent;Immunotherapy;Inbreeding;Lead;Length;Libraries;Malignant - descriptor;Medical;Mesenchymal Stem Cells;Messenger RNA;Minority;Modeling;Molecular;Molecular Target;Mus;MutS DNA mismatch-binding protein;Mutation;Natural regeneration;Normal Cell;Oncogenic;Pathway interactions;Patients;Peptide Vaccines;Phase I Clinical Trials;Phase II Clinical Trials;Phase III Clinical Trials;Physiologic pulse;Predisposition;Preparation;Primary Brain Neoplasms;Property;Proteins;Protocols documentation;Quality-Adjusted Life Years;RNA;RNA library;Radiation;Recurrence;Resistance;Reverse Transcriptase Polymerase Chain Reaction;Risk;Safety;Sorting - Cell Movement;Source;Techniques;Testing;Therapeutic;Toxic effect;Transgenic Organisms;Translating;Translations;Transplantation;Tumor Antigens;Tumor Stem Cells;United States;Vaccination;Vaccines;base;chemotherapy;conventional therapy;epidermal growth factor receptor VIII;immunogenicity;innovation;melanoma;neoplastic cell;nerve stem cell;novel;phase 1 study;relating to nervous system;response;self-renewal;tumor;vaccination strategy","RNA-based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells","n/a","NCI","8270511","5/14/2012 12:00:00 AM","PA-07-070","5R01CA135272-05","5","R01","CA","135272","05"," ","TIMMER, WILLIAM C","8/1/2008 12:00:00 AM","5/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-BDCN-A(05)M]"," ","3160894","SAMPSON, JOHN H.","Not Applicable","04","SURGERY","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","289840","162311"," ","452151",
"Biotechnology; Pain Conditions - Chronic; Pain Research; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adoption;Adult;Animal Model;Animals;Back Pain;Behavior;Biological Response Modifier Therapy;Biomechanics;Bone necrosis;Cartilage;Cell Culture Techniques;Cell Nucleus;Cell Therapy;Cell physiology;Cells;Chondrocytes;Chronic low back pain;Clinical;Coculture Techniques;Collagen;Data;Degenerative polyarthritis;Developmental Process;Disease;Drug Formulations;Ensure;Environment;Equilibrium;Fibrin;Functional disorder;Future;Gene Expression;Goals;Gold;Grant;Growth Factor;Healed;Hypertrophy;Hypoxia;Immune response;In Vitro;Inflammation;Inflammatory;Injection of therapeutic agent;Injury;Intervertebral disc structure;Lead;Matrix Metalloproteinases;Mechanics;Mesenchymal Stem Cells;Methods;Modeling;Motion;Musculoskeletal;Needles;Nutrient;Operative Surgical Procedures;Osteoporosis;Outpatients;Pain;Patients;Phenotype;Physical condensation;Physiological;Pre-Clinical Model;Procedures;Process;Production;Property;Proteoglycan;Proteolysis;Rattus;Rejuvenation;Research;Safety;Signal Transduction;Source;Spinal;Spinal Fusion;Spinal Injections;Stem cells;Structure;System;Techniques;Testing;Therapeutic;Therapeutic Effect;Therapeutic Intervention;Tissue Engineering;Tissues;Translations;United States National Institutes of Health;Water;bone;cell behavior;cell type;cytokine;density;deprivation;disability;disc regeneration;healing;improved;in vivo;injured;intervertebral disk degeneration;minimally invasive;novel;nucleus pulposus;preclinical study;prevent;repaired;resilience;response;restoration;spine bone structure;stem cell differentiation;stem cell therapy;therapy design;therapy development;three dimensional structure;treatment strategy;trend","Structured co-culture of stem cells and chondrocytes for spinal disc repair"," The goals of this new R21 application are to: 1) optimize a stem cell therapy for intervertebral disc degeneration; and 2) demonstrate disease modifying activity in a small animal model. This research will have substantial impact by providing a minimally- invasive therapy for the management of patients with the most common and costly musculoskeletal condition - chronic low back pain. The proposed therapeutic approach may also have future applications for treatment of cartilage and bone conditions, such as osteoarthritis and osteonecrosis.   
      

","NIAMS","8354655","7/1/2012 12:00:00 AM","PA-11-261","1R21AR063357-01","1","R21","AR","063357","01"," ","WANG, FEI","7/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","1931928","LOTZ, JEFFREY C.","Not Applicable","12","ORTHOPEDICS","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","7/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","112500","61313"," ","173813",
"Atherosclerosis; Cardiovascular; Diabetes; Heart Disease; Nutrition; Obesity; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Animal Model;Animals;Antioxidants;Area;Arterial Fatty Streak;Atherosclerosis;Award;Biochemistry;Biology;Blood Vessels;Cardiac;Cardiac Death;Cardiology;Cardiovascular Diseases;Cardiovascular Pathology;Cardiovascular Physiology;Cardiovascular system;Cellular biology;Centers of Research Excellence;Chemicals;Clinical;Clinical Trials;Confocal Microscopy;Core Facility;Development;Diabetes Mellitus;Diabetes prevention;Diabetic mouse;Echocardiography;Environment;Epidemiology;Extramural Activities;Faculty;Flow Cytometry;Foam Cells;Fostering;Foundations;Funding;Future;Glucose;Goals;Grant;Heart;Heart failure;Hyperglycemia;Image;Image Cytometry;Imaging Techniques;Individual;Infarction;Inflammation;Inflammatory;Injury;Intervention;Investigation;Knockout Mice;Laboratories;Measurement;Mediating;Mentors;Mentorship;Mesenchymal Stem Cells;Metabolism;Methodology;MicroRNAs;Modality;Modeling;Molecular;Molecular Biology;Molecular Chaperones;Monitor;Myocardial;NF-kappa B;Obesity;Oxidation-Reduction;Oxidative Stress;Pharmaceutical Preparations;Phase;Physiology;Postdoctoral Fellow;Principal Investigator;Proteins;Records;Regulation;Research;Research Infrastructure;Research Personnel;Research Project Grants;Research Support;Resources;Role;Science;Scientist;Signal Transduction;Smooth Muscle Myocytes;Stem Cell Research;Stem cell transplant;Stem cells;Stress;Students;Sum;Sustainable Development;Talents;Techniques;Technology;Testing;Time;Tissue Sample;Tissues;Training;Transgenic Organisms;United States National Institutes of Health;Universities;Work;atherogenesis;cardiac repair;cardiovascular imaging;career;diabetic;diabetic cardiomyopathy;experience;flexibility;functional improvement;graduate student;in vivo;interest;macrophage;member;novel therapeutics;peer;premature;prevent;programs;response;senescence;stem cell biology;success","Center of Excellence in Diabetes and Obesity Research","n/a","NIGMS","8301646","6/18/2012 12:00:00 AM","PAR-07-229","8P20GM103492-05","8","P20","GM","103492","05"," ","CANTO, MARIA TERESA","9/26/2008 12:00:00 AM","7/31/2013 12:00:00 AM","Research Centers in Minority Institutions and Institutional Development Award Review Committee[RIRG-M]"," ","1885223","BHATNAGAR, ARUNI ","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","057588857","E1KJM4T54MK6","057588857","E1KJM4T54MK6","US","38.185212","-85.660469","4679701","UNIVERSITY OF LOUISVILLE","LOUISVILLE","KY","SCHOOLS OF MEDICINE","402920001","UNITED STATES","N","7/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","859","Research Centers","2012"," "," ","NIGMS","1493474","716868"," ","2210342",
"Arthritis; Bioengineering; Biotechnology; Clinical Research; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Acute;Address;Adult;Affect;Allografting;Arthralgia;Arthroscopic Surgical Procedures;Biologic Characteristic;Biological Assay;Biology;Bioreactors;Bone Marrow;Cartilage;Cell Hypoxia;Cell Survival;Cells;Characteristics;Chemicals;Clinical;Collagen Type II;Confocal Microscopy;Degenerative polyarthritis;Development;Down-Regulation;Effectiveness;Engineering;Environment;Excision;Exhibits;Fibrocartilages;Future;Genes;Genetic Transcription;Goals;Grant;Growth;Homeostasis;Human;Hypoxia;Immune response;Injury;Intervention;Knee joint;Knowledge;Lead;Link;Magnetic Resonance Imaging;Measures;Mediating;Meniscus structure of joint;Mesenchymal Stem Cells;Metabolic;Metabolic Pathway;Metabolism;Methods;Microscopic;Modeling;Molecular;Molecular Biology;Operative Surgical Procedures;Orthopedics;Oxygen;Oxygen measurement, partial pressure, arterial;Pain;Particulate;Pathogenesis;Pathology;Patients;Phenotype;Physicians;Population;Primary Cell Cultures;Procedures;Process;Production;Property;Proteoglycan;Research Training;Reverse Transcriptase Polymerase Chain Reaction;Role;Scientist;Signal Transduction;Stem cells;Surgeon;System;Techniques;Technology;Testing;Time;Tissue Differentiation;Tissue Engineering;Tissues;Training;Transplantation;Up-Regulation;Vascular blood supply;aggrecan;articular cartilage;base;career;design;disability;effective therapy;expectation;experience;hypoxia inducible factor 1;improved;information gathering;knee pain;knee replacement arthroplasty;novel;overexpression;particle;premature;programs;repaired;restoration;scaffold;scleraxis;skills;stem cell differentiation;success;tissue regeneration;training project;transcription factor","Impact of Oxygen Tension on Human Meniscus Tissue Engineering","
Project Narrative
Patients with meniscus deficiency experience joint pain and exhibit progressive
degenerative joint disease. The aims of this proposal investigate the impact of hypoxia,
HIF-1a signaling, and particulate oxygen generating systems on the differentiation of
human bone marrow derived stem cells seeded onto human meniscus scaffolds
compared with normal meniscus tissue standards. These studies will improve our
understanding of human meniscus biology and will support the development of effective
bioreactor cultivation approaches for engineering a functional tissue engineered
meniscus replacement.","NIAMS","8238126","4/2/2012 12:00:00 AM","PA-09-042","5K08AR059172-03","5","K08","AR","059172","03"," ","WANG, FEI","4/1/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","9412471","FERGUSON, CRISTIN M","Not Applicable","06","SURGERY","937727907","SN7KD2UK7GC5","937727907","SN7KD2UK7GC5","US","36.103147","-80.260787","9021205","WAKE FOREST UNIVERSITY HEALTH SCIENCES","WINSTON-SALEM","NC","SCHOOLS OF MEDICINE","271570001","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","81931","6554"," ","88485",
"Aging; Arthritis; Genetics","Address;Adenoviruses;Affect;Aging;Arthritis;Binding Sites;Biological Assay;Biomechanics;Bone remodeling;Cartilage;Cell Differentiation process;Cell Survival;Cell physiology;Cells;Cellularity;Chondrocytes;Collagen;Complex;Cyclin D1;Data;Defect;Degenerative polyarthritis;Development;Disease;Elderly;Enhancers;Etiology;Evolution;Excision;FOS gene;Gene Deletion;Gene Expression;Genes;Genetic;Goals;HMGB2 gene;Homeostasis;Human;In Vitro;Intra-Articular Injections;Joints;Knee;Knee joint;Knock-out;Lead;Lesion;Lubrication;Maps;Matrix Metalloproteinases;Medial meniscus structure;Mesenchymal Stem Cells;Molecular;Monitor;Mus;Osteoarthrosis Deformans;Pathogenesis;Pathway interactions;Pattern;Phase;Phenotype;Population;Prevention;Preventive;Process;Proteins;Regulation;Relative (related person);Research;Risk Factors;Role;Site;Structure;Surface;Therapeutic;Time;Tissue Engineering;Wild Type Mouse;age related;aggrecanase;arthropathies;articular cartilage;bcl-1 Genes;cartilage cell;chromatin immunoprecipitation;chromatin protein;congenic;disability;early onset;in vivo;insight;joint function;knock-down;notch protein;overexpression;recombinase;response","HMGB2 in cartilage homeostasis, aging and osteoarthritis","
7. PROJECT NARRATIVE
Osteoarthritis represents the most prevalent joint disease and is a major cause of disability. Disease-modifying
therapies are not available and this is in part related to an incomplete understanding of pathogenetic
mechanisms. Specifically, osteoarthritic lesions begin at the articular cartilage surface which is important in
biomechanical function and joint lubrication and then progress to larger lesions with complete loss of cartilage.
Information on the causes of the initial cartilage surface defects is very limited. Our preliminary studies show
that the chromatin protein HMGB2 is exclusively expressed in the superficial zone of articular cartilage from
human and murine joints. With advancing age there is a reduction and loss of HMGB2 expression that is
followed by loss of cartilage cells and the onset of degenerative changes in the cartilage surface. These
observations suggest that HMGB2 is a critical factor for maintaining the integrity of the cartilage surface and
that its aging-related loss is a central pathogenetic mechanism in osteoarthritis. The proposed research has
the potential to identify new avenues for the prevention and treatment of osteoarthritis.","NIAMS","8277985","6/28/2012 12:00:00 AM","PA-07-070","5R01AR056026-04","5","R01","AR","056026","04"," ","TYREE, BERNADETTE","7/1/2009 12:00:00 AM","6/30/2014 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1864057","LOTZ, MARTIN K","Not Applicable","49","Unavailable","781613492","PHZJFZ32NKH4","781613492","PHZJFZ32NKH4","US","32.903152","-117.243436","7375802","SCRIPPS RESEARCH INSTITUTE","LA JOLLA","CA","Research Institutes","920371000","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","213840","192242"," ","406082",
"Bioengineering; Biotechnology; Cardiovascular; Diagnostic Radiology; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute myocardial infarction;Adult;Affect;Animals;Anterior Descending Coronary Artery;Apoptosis;Attenuated;Binding;Biocompatible Materials;Bioenergetics;Biological Preservation;Bone Marrow;Cardiac;Cardiac Myocytes;Cell Transplants;Cell physiology;Cells;Characteristics;Chemicals;Clinical;Congestive Heart Failure;Data;Deterioration;Development;Distal;Endoderm;Endothelial Cells;Endothelium;Engraftment;Family suidae;Fibrin;Functional disorder;Growth Factor;Health;Heart;Heart Hypertrophy;Heart failure;Hepatocyte;Hypertrophy;Infarction;Injury;Ischemia;Label;Lead;Left;Left Ventricular Dysfunction;Left Ventricular Function;Left Ventricular Remodeling;Left ventricular structure;Ligation;Literature;Magnetic Resonance;Magnetic Resonance Imaging;Measures;Mechanics;Mesenchymal Stem Cells;Mesoderm;Methods;Modeling;Muscle Cells;Myocardial;Myocardial Infarction;Myocardial dysfunction;Myocardium;Natural regeneration;Neuroectoderm;Oxidative Phosphorylation;Oxygen;Patients;Performance;Perfusion;Phosphocreatine;Population;Proliferating;Radial;Radioactive;Reperfusion Therapy;Reporting;Route;Severities;Shapes;Site;Smooth Muscle;Smooth Muscle Myocytes;Stem cell transplant;Stem cells;Stress;Structure of left gastric vein;Surface;Testing;Time;Transplantation;Ventricular;base;blood flow measurement;cytokine;deoxymyoglobin;follow-up;functional improvement;hemodynamics;improved;inorganic phosphate;intravenous drip;mouse model;neovascularization;novel;paracrine;prevent;progenitor;repaired;research study;response;spectroscopic imaging;transdifferentiation","Stem Cells For Myocardial Repair: A Large Bore Magnet Study","
Post-infarction left ventricular remodeling including hypertrophy and chamber dilation occurs to compensate for
loss of contractile myocardium. After a period stable hypertrophy myocardial dysfunction can develop and may
ultimately lead to overt congestive heart failure (CHF) that is a most significant clinical problem. This proposal
will examine whether a PEGylated fibrin patch based stem cell transplantation can provide a new regeneration
therapy for heart failure patients.","NHLBI","8277096","6/13/2012 12:00:00 AM","PA-07-070","5R01HL095077-04","5","R01","HL","095077","04"," ","BUXTON, DENIS B","6/16/2009 12:00:00 AM","3/18/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-CVS-D(02)M]"," ","1895907","ZHANG, JIANYI ","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","SCHOOLS OF MEDICINE","554552070","UNITED STATES","N","6/1/2012 12:00:00 AM","3/18/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","311423","163222"," ","474645",
"Cancer; Clinical Research; Lung; Lung Cancer","Automobile Driving;Blood Vessels;Cancer Etiology;Cancer Model;Catalytic Domain;Cause of Death;Cell Proliferation;Cells;Cessation of life;Clinical;Collagen;Common Neoplasm;Data;Development;Dipeptidyl Peptidases;Endopeptidases;Endothelial Cells;Epithelial;Extracellular Matrix;Fibroblasts;Fibrosis;Gene Expression Profile;Generations;Goals;Growth;Homeostasis;Human;Immune;In Vitro;Inflammatory;Inflammatory Infiltrate;Integrins;Kinetics;Knock-in Mouse;Lead;Lung;Lung Neoplasms;Malignant Neoplasms;Malignant neoplasm of lung;Mediating;Mediator of activation protein;Mesenchymal;Modeling;Mus;Mutation;Myofibroblast;Neoplasm Metastasis;Neoplastic Cell Transformation;Operative Surgical Procedures;Peptide Hydrolases;Pericytes;Play;Population;Process;Public Health;Reporter;Role;Series;Signal Transduction;Smooth Muscle Actin Staining Method;Solid Neoplasm;Specimen;Stromal Cells;Structure;System;Testing;Tissues;Trans-Activators;Transplantation;Tumor Markers;Tumor Promotion;Tumor-Derived;Vascularization;Wound Healing;Xenograft procedure;angiogenesis;base;cancer cell;cancer genetics;cis acting element;fibroblast-activating factor;in vivo;inhibitor/antagonist;man;mouse model;mutant;neoplastic cell;novel;novel therapeutic intervention;promoter;protein expression;public health relevance;research study;tumor;tumor growth;tumor initiation;tumor progression;tumorigenesis","Fibroblast Activation Protein in the Tumor Microenvironment in Lung Cancer","
Project Narrative
As the second leading cause of death, cancer presents a major public health problem. Lung cancer is the second most
common cancer and the leading cause of cancer deaths. Therefore, there is an urgent need to develop new treatments
for lung cancer. We now know that the tumor microenvironment plays a critical role in driving neoplastic transformation
and tumor progression. We have obtained evidence that targeting a protease restricted to mesenchymal derived stromal
cells, which are prevalent in a wide variety of solid tumors, inhibits tumor growth. The proposed experiments will define
the mechanisms that lead to the expression of this protease in tumors and the mechanisms by which it promotes tumor
growth. These studies are likely to lead to the clinical development of new anti-tumor therapies that target stromal cells.","NCI","8214619","3/15/2012 12:00:00 AM","PA-07-070","5R01CA141144-03","5","R01","CA","141144","03"," ","MOHLA, SURESH","4/1/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1864184","PURE', ELLEN ","Not Applicable","03","Unavailable","075524595","DW1XZMGNFBL4","075524595","DW1XZMGNFBL4","US","39.950872","-75.195321","9340401","WISTAR INSTITUTE","PHILADELPHIA","PA","Research Institutes","191044265","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207066","93234"," ","300300",
"Biotechnology; Cardiovascular; Injury (total) Accidents/Adverse Effects; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adrenal Glands;Affect;Aftercare;Androgen Receptor;Apoptotic;Aromatase;Blood Pressure;Blood Vessels;Blood Volume;Blood flow;Bone Marrow;CCAAT-Enhancer-Binding Proteins;Cardiac;Cardiac Myocytes;Cardiac Output;Cardiovascular system;Cell Therapy;Cells;Depressed mood;Development;Diestrus;Endoplasmic Reticulum;Endothelial Cells;Estrogen Receptors;Estrogens;Estrus;Event;Female;Flutamide;Free Radicals;Functional disorder;Funding;GRP78 gene;Gender;Genetic;Gonadal Steroid Hormones;Health;Heart;Heat shock proteins;Hemorrhage;Hepatocyte;Homologous Protein;Hormonal;Hypoxia;Incidence;Inflammatory;Infusion procedures;Injury;Kupffer Cells;Left;Liver;Lung;Maintenance;Mesenchymal Stem Cells;Messenger RNA;Metestrus;Mitochondria;Modeling;Modification;Molecular;Morbidity - disease rate;Myocardium;Organ;Organ failure;Pathogenesis;Performance;Predisposition;Production;Proestrus;Proteins;Rattus;Recovery;Resuscitation;Sepsis;Signal Transduction;Signaling Molecule;Small Intestines;Staging;Stress;Techniques;Testosterone;Trauma;Up-Regulation;Ventricular;activating transcription factor;cytochrome c;endoplasmic reticulum stress;glucose-regulated proteins;hemodynamics;improved;male;molecular chaperone GRP78;mortality;novel;prevent;protein expression;pulmonary function;receptor downregulation;receptor expression;repaired;response;stem cell therapy;stress protein;transcription factor","Maintenance of Organ Function Following Injury","
PROJECT RELEVANCE
We will examine the mechanisms by which the use of female sex hormones after trauma will improve cell and
organ functions and decrease the lethality from infectious complications. We will use state-of-the-art molecular
techniques and cell-based therapy to delineate the mechanisms involved in injury pathogenesis. The funding
will help to develop gender-specific therapy. Such therapy should prevent organ dysfunction after injury and
reduce morbidity and mortality from subsequent sepsis in male and female trauma victims.","NIGMS","8217201","7/25/2012 12:00:00 AM","PA-07-070","5R01GM039519-26","5","R01","GM","039519","26"," ","SOMERS, SCOTT D","2/1/1988 12:00:00 AM","7/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-SBIB-E(02)M]"," ","2419504","CHAUDRY, IRSHAD H","Not Applicable","07","SURGERY","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","SCHOOLS OF MEDICINE","352940001","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","272178","122480"," ","394658",
"Autoimmune Disease; Brain Disorders; Multiple Sclerosis; Neurodegenerative; Neurosciences; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Adjuvant;Adult;Animal Model;Autoimmune Diseases;Autoimmune Process;Automobile Driving;B-Lymphocytes;Biological Assay;Bone Marrow;Brain;Cell Therapy;Cells;Central Nervous System Diseases;Cerebral Ischemia;Chronic;Clinical;Coculture Techniques;Conditioned Culture Media;Cytokine Suppression;Degenerative Disorder;Delayed Hypersensitivity;Demyelinating Diseases;Demyelinations;Disease;Disease Progression;Epitopes;Experimental Autoimmune Encephalomyelitis;Failure;Flow Cytometry;Functional disorder;Goals;Human;Immune;Immune response;Immunization;Immunohistochemistry;Immunologics;In Vitro;Infiltration;Inflammation;Inflammatory;Lesion;Lipoproteins;Lumbar spinal cord structure;Marrow;Mediating;Mesenchymal Stem Cells;Modeling;Mononuclear;Multiple Sclerosis;Mus;Myelin;Myelin Proteins;Myelin Sheath;Natural Killer Cells;Natural regeneration;Nerve Degeneration;Neuraxis;Neurologic;Neurons;Oligodendroglia;Organ;Paralysed;Peptides;Peripheral;Phenotype;Population;Process;Production;Recovery of Function;Regulation;Regulatory T-Lymphocyte;Relapse;Research;Stem cells;Stromal Cells;Symptoms;System;T cell response;T-Cell Proliferation;T-Lymphocyte;T-Lymphocyte Subsets;Therapeutic;Time;Traumatic Brain Injury;autoreactive T cell;axonal degeneration;cell type;clinical remission;cytokine;effective therapy;human stem cells;in vivo;motor deficit;mouse model;myelin degeneration;myelination;neurotrophic factor;oligodendrocyte lineage;prevent;public health relevance;relating to nervous system;remyelination;repaired;stem;success","Immunomodulatory mechanisms of human stem cells from bone marrow","
PROJECT NARRATIVE
 Multiple Sclerosis (MS) is an immune-mediated disease of the central nervous system characterized by
inflammation and loss of myelin that supports neuronal conduction. Despite years of extensive research there
is a distinct lack of highly effective treatments for the management of MS as the search for a cure remains
ongoing. This proposal will characterize a potential cell-based therapy using human stem/progenitor cells from
bone marrow to modulate immune responses so as to prevent damage and promote repair in an animal model
of MS.","NINDS","8227980","3/22/2012 12:00:00 AM","PA-10-110","5F32NS073282-02","5","F32","NS","073282","02"," ","UTZ, URSULA","3/1/2011 12:00:00 AM","2/28/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F03A-F(20)L]"," ","8610867","ROBINSON, ANDREW PATRICK","Not Applicable","07","MICROBIOLOGY/IMMUN/VIROLOGY","005436803","KG76WYENL5K1","005436803","KG76WYENL5K1","US","41.896017","-87.616602","6144650","NORTHWESTERN UNIVERSITY AT CHICAGO","CHICAGO","IL","SCHOOLS OF MEDICINE","606114579","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","853","Training, Individual","2012"," "," ","NINDS","53942"," "," ","53942",
"No NIH Category available","Adhesions;Adipocytes;Adult;Aging;Agreement;Alternative Therapies;Animal Model;Blood Vessels;Bone Marrow Cells;Cardiac;Cardiac Myocytes;Cell Lineage;Cell Therapy;Cell-Matrix Junction;Cells;Cessation of life;Chondroblast;Clinical;Data;Development;Disease;Ectoderm;Embryo;Endoderm;Extracellular Matrix;Fatty acid glycerol esters;Gene Expression;Germ Layers;Gland;Goals;Graft Rejection;Health;Heart;Heart Transplantation;Heart failure;Hepatocyte;Human;Immunocompromised Host;In Vitro;Intestines;Marrow;Mesenchymal Stem Cells;Mesoderm;Microarray Analysis;Mononuclear;Mus;Muscle;Myocardial;Myocardial Infarction;Myocardium;Natural regeneration;Nerve;Nerve Fibers;Osteoblasts;Outcome Study;Paper;Plastics;Population;Positioning Attribute;Procedures;Property;Reliance;Reporting;Research;Retrieval;Signal Transduction;Source;Stem Cell Development;Stem cells;Surveys;System;Teratoma;Testing;Therapeutic;Tissues;Transplantation;Umbilical Cord Blood;Umbilical cord structure;Veterans;age related;angiogenesis;base;bone;clinical application;heart function;human embryonic stem cell;implantation;improved;in vivo;innovation;mouse model;novel therapeutic intervention;public health relevance;reconstruction;repaired;self-renewal;tissue regeneration","Use of umbilical cord as a unique stem cell source for tissue regeneration","As the US population is aging, so too is the US veteran population. According to the 2003 National Survey of Veteran Enrollees' Health and Reliance on VA, 47% of veterans were 65 years or older. Myocardial infarction (MI), as an age-related disease, is one of the leading causes of heart failure and death in the US. Currently, the best option for completely restoring cardiac function after a large MI is heart transplantation. However, it is limited by donor availability and transplant rejection. Recently, regeneration of infracted myocardium by injecting stem cells has been proposed as an alternative therapy. If the proposed studies confirm that umbilical cord blood contains a large number of embryonic- like stem cells that can be isolated by ECM adhesion procedures, and that can selectively differentiate into cardiomyocytes in vitro and reconstruct myocardium in vivo after MI, it will facilitate development of novel therapeutic approaches for cell-based regeneration to treat post-MI veteran.","VA","8196326","12/1/2011 12:00:00 AM","RFA-BX-09-008","5I01BX000580-02","5","I01","BX","000580","02"," "," ","10/1/2010 12:00:00 AM","9/30/2013 12:00:00 AM","Cellular and Molecular Medicine[CAMM]"," ","7939180","CHEN, XIAO-DONG ","Not Applicable","21","Unavailable","078493228","RRFHKE8Z71R7","078493228","RRFHKE8Z71R7","US","29.508404","-98.581006","481157","SOUTH TEXAS VETERANS HEALTH CARE SYSTEM","SAN ANTONIO","TX","Independent Hospitals","782294404","UNITED STATES","N","10/1/2011 12:00:00 AM","9/30/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Address;Antibodies;BMP2 gene;Back;Belief;Blood Vessels;Bone Regeneration;Bone Tissue;Cartilage;Cell Differentiation process;Cell Line;Cells;Clinical;Coculture Techniques;Commit;Congenital Abnormality;Data;Development;Distraction Osteogenesis;Endothelial Cells;Endothelium;Excision;Extracellular Matrix;Feedback;Fracture;Galactosidase;Gene Targeting;Genes;Genetic Recombination;Growth Factor;Healed;Impaired wound healing;Injury;Laboratories;Lead;Malignant Neoplasms;Mediating;Mesenchymal Stem Cells;Modeling;Molecular;Morbidity - disease rate;Morphogenesis;Mus;Natural regeneration;Operative Surgical Procedures;Orthopedics;Osteoblasts;Osteogenesis;Osteotomy;Phase;Play;Population;Procedures;Process;Production;Proteins;Recruitment Activity;Relative (related person);Role;Site;Source;Testing;Tissues;Transgenes;Transgenic Mice;Trauma;Vascular Endothelial Growth Factor Receptor;Vascular Endothelial Growth Factor Receptor-1;Vascular Endothelial Growth Factor Receptor-2;Vascular Endothelial Growth Factors;Vascular Endothelium;Vascular blood supply;Work;angiogenesis;bone;bone healing;bone morphogenetic protein 2;cell growth;distraction;functional status;healing;innovation;osteogenic;paracrine;receptor-mediated signaling;regenerative;repaired;research study;selective expression;skeletal;skeletal injury;small hairpin RNA;vasculogenesis","Role of Angiogenesis in Distraction Osteogenesis"," Distraction osteogenesis (DO) is one of most dramatic examples of a successfully used clinical procedure for the augmentation of lost bone due to congenital deformity, cancer or trauma and it is often used to promote bone healing in cases of non unions after fracture. Unlike normal fracture repair that goes through an avascular cartilage phase DO is characterized by robust vascular tissue formation and primarily bone formation. The objective of this proposal is to determine how vascular tissue formation helps to promote bone repair in situations of impaired healing.  
    

","NIAMS","8321521","8/9/2012 12:00:00 AM","PA-10-067","5R01AR056637-02","5","R01","AR","056637","02"," ","WANG, FEI","9/1/2011 12:00:00 AM","8/31/2016 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1863111","GERSTENFELD, LOUIS CHARLES","Not Applicable","07","ORTHOPEDICS","604483045","FBYMGMHW4X95","604483045","FBYMGMHW4X95","US","42.336234","-71.070647","894901","BOSTON UNIVERSITY MEDICAL CAMPUS","BOSTON","MA","SCHOOLS OF MEDICINE","021182841","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","143325"," ","368325",
"Biotechnology; Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human; Transplantation","Adjuvant;Adult;Air;Allogenic;Automation;Biological Assay;Birth;Blood;Blood specimen;Burn injury;Bypass;Cardiovascular Diseases;Cell Therapy;Chairperson;Childbirth;Collection;Companions;Coupled;DNA;DNA purification;Data;Detection;Diabetes Mellitus;Diagnostic tests;Disease;Explosion;Freezing;Funding;Funding Agency;Genes;Genetic screening method;Goals;Gold;HLA-A gene;HLA-B Antigens;HLA-C Antigens;High Prevalence;Hydration status;International;Letters;Lymphoid;Mails;Malignant Neoplasms;Marrow;Masks;Medicine;Mesenchymal Stem Cells;Methods;Microarray Analysis;National Heart, Lung, and Blood Institute;Neurodegenerative Disorders;Outcome;Preparation;Procedures;Process;Recovery;Research;Resolution;Resource Development;Risk;Role;Sampling;Seminal;Sensitivity and Specificity;Series;Shipping;Ships;Solutions;Source;Specimen;Spinal cord injury;Stem cells;System;Technology;Teflon;Thalassemia;Therapeutic;Tissues;Touch sensation;Trauma;Umbilical Cord Blood;Umbilical cord structure;Validation;Water;Work;abstracting;base;cohort;cost;diabetes mellitus therapy;embryo tissue;feeding;genetic analysis;genotyping technology;nervous system disorder;novel;novel strategies;patient population;programs;prospective;prototype;scale up;stem cell therapy;type I and type II diabetes;working group","High-Throughput HLA-Typing: on Raw, Unpurified Cord Blood Samples","
Project Narrative.
It is clear that stem cell therapy will revolutionize medicine in the 21st century. Much remains to be discovered,
but a strong argument can be made that enriched umbilical cord blood (UCB) will emerge as the one source of
stem cells that is practical and safe-enough to be scaled-up to the national-level, in support of treatment of
multiple common diseases: lymphoid cancers and thalassemias at present, and if the current explosion of
research is on track, the treatment of high-prevalence diseases such as Type 1 & Type 2 Diabetes,
neurodegenerative diseases and traumatic tissue damage, such as spinal cord injury and burns. For each of those
current and possible treatment indications, the enriched UCB stem cells must be delivered along with HLA-
Typing as the corresponding Companion Genetic Test. The goal of this R21 is to demonstrate feasibility of very
high throughput HLA-Typing, directly from raw UCB samples, as the new standard for Companion Genetic
Testing to support the processing and delivery of that stem cell therapy. Based on other funding sources,
GenUSA is already in the process of obtaining FDA approval of its core microarray technology. If approved, that
underlying FDA 510(k) application could be leveraged to seek follow-on FDA approval of the Companion Genetic
Test developed in this R21-R33 series.","NHLBI","8262309","4/9/2012 12:00:00 AM","RFA-HL-12-004","1R21HL112664-01","1","R21","HL","112664","01"," ","WAGNER, ELIZABETH","4/15/2012 12:00:00 AM","3/31/2014 12:00:00 AM","ZHL1-CSR-P(F2)"," ","1885659","HOGAN, MICHAEL E.","Not Applicable","03","Unavailable","141832860","SGB5JFXZH469","141832860","SGB5JFXZH469","US","32.182617","-110.9202","10002951","GENOMICS USA, INC.","TUCSON","AZ","Domestic For-Profits","857135245","UNITED STATES","N","4/15/2012 12:00:00 AM","3/31/2013 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","75000","30000"," ","105000",
"Brain Cancer; Brain Disorders; Cancer; Neurosciences; Rare Diseases","Address;Alleles;Animals;Binding;Binding Proteins;Biological;Biological Assay;Brain;Brain Neoplasms;Brain imaging;Carcinoma;Cells;Cessation of life;Data;Diagnosis;Dimerization;Disease;Disease Outcome;Doxycycline;Epithelial;Failure;Gene Expression;Generations;Glioblastoma;Glioma;Goals;Growth;Human;Image;Imaging Techniques;In Vitro;Individual;Label;Malignant - descriptor;Malignant Neoplasms;Mediating;Mediator of activation protein;Mesenchymal;Modeling;Neoplasm Metastasis;Oncogenes;Outcome;Patients;Pattern;Phenotype;Protein Isoforms;Proteins;Proteomics;Proto-Oncogene Proteins c-akt;Regulation;Repression;Research;Residual state;Resistance;Role;Signal Transduction;Simulate;Stem cells;TWIST1 gene;Techniques;Testing;Therapeutic;Time;Tissues;Translating;Treatment outcome;Tumor Cell Invasion;Up-Regulation;Xenograft Model;angiogenesis;dimer;human TWIST1 protein;implantation;improved;in vitro testing;in vivo;innovation;novel;public health relevance;relating to nervous system;therapeutic target;tumor;tumor initiation;tumor progression","TWIST1 as a target for inhibition of glioma invasion","
Relevance
The lack of significant improvement in treatment outcomes for patients with
glioblastoma (GBM) for over 30 years is due largely to our failure to address the
problem of GBM cell invasion into the brain. TWIST1 is a putative oncogene
which promotes carcinoma invasion and metastasis through activation of
epithelial mesenchymal transition (EMT). We have now confirmed TWIST1 as a
critical mediator of GBM invasion and malignancy and here will establish for the
first time the therapeutic relevance of a TWIST1 signaling network through
POSTN and Akt, in turn regulated by TWIST1 binding partners. By
demonstrating the impact of this novel pro-invasive network in GBM invasion we
will validate the importance of EMT related mechanisms for GBM, also expected
to have great relevance for a much larger group of invasive carcinomas. This
paradigm shift is expected to revolutionize our understanding of invasion in GBM,
accelerate discovery of therapeutic targets, and translate into significant
improvements in GBM patient outcomes.","NCI","8244998","11/18/2011 12:00:00 AM","PA-10-067","5R01CA136808-02","5","R01","CA","136808","02"," ","WOODHOUSE, ELIZABETH","3/18/2011 12:00:00 AM","11/30/2015 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1905210","ROSTOMILY, ROBERT C","Not Applicable","07","NEUROSURGERY","605799469","HD1WMN6945W6","605799469","HD1WMN6945W6","US","47.660049","-122.31441","9087701","UNIVERSITY OF WASHINGTON","SEATTLE","WA","SCHOOLS OF MEDICINE","981951016","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","136950"," ","344450",
"Atherosclerosis; Cardiovascular; Climate-Related Exposures and Conditions; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acetylcholine;Acute;Admission activity;Adult;Affect;Air;Air Pollution;Animals;Antioxidants;Aorta;Arrhythmia;Atherosclerosis;Automobile Exhaust;Biological Markers;Blood Cells;Blood Pressure;Blood Vessels;Bone Marrow;Breathing;Cardiotoxicity;Cardiovascular Diseases;Cardiovascular Pathology;Cardiovascular system;Cell Count;Cell Death;Cell Survival;Cell physiology;Cells;Cessation of life;Chronic;Coagulation Process;Coal;Defect;Deposition;Development;Endothelium;Epidemiologic Studies;Event;Exposure to;Flow Cytometry;Fossil Fuels;Free Radicals;Functional disorder;Generations;Goals;Health;Heart Arrest;Heart failure;Hematopoietic;Hematopoietic stem cells;Homing;Hospitals;Human;Inflammation;Inflammatory Response;Injury;Intervention;Ischemic Stroke;Lead;Location;Maintenance;Measures;Mediator of activation protein;Mesenchymal Stem Cells;MicroRNAs;Mus;Myocardial;Myocardial Infarction;Myocardial Ischemia;Oxidation-Reduction;Oxidative Stress;Paper;Particulate;Particulate Matter;Plants;Plasma;Population;Reaction;Relaxation;Reporting;Risk;Smoke;Steel;Stem cells;Stroke;Symptoms;Testing;Thrombosis;Time;Toxic effect;Ultrafine;Unstable angina;Wood material;Wound Healing;air filter;angiogenesis;atherogenesis;base;cardiovascular disorder risk;cardiovascular risk factor;cell growth;human tissue;insight;novel;particle;peripheral blood;prevent;repaired;research study;response;tissue repair;young adult","Endothelial Progenitor Cells and Particulate Air Pollution"," Exposure to particulate matter (PM) air pollution is strongly correlated with the initiation and progression of atherosclerosis, increased thrombosis, myocardial infarction, and stroke. These cardiovascular pathologies are characterized by a dysfunctional endothelium and its inefficient repair by pluripotent cells or endothelial progenitor cells (EPCs). Thus in this proposal, we test the hypothesis that the cardiotoxicity resulting from PM exposure is a consequence of PM-induced deficits in EPC number or function.  
    

","NIEHS","8337749","7/10/2012 12:00:00 AM","PA-10-067","5R01ES019217-02","5","R01","ES","019217","02"," ","NADADUR, SRIKANTH","9/23/2011 12:00:00 AM","4/30/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-CVRS-C(02)M]"," ","8911484","O'TOOLE, TIMOTHY E","BHATNAGAR, ARUNI ; POPE, ARDEN ","03","INTERNAL MEDICINE/MEDICINE","057588857","E1KJM4T54MK6","057588857","E1KJM4T54MK6","US","38.185212","-85.660469","4679701","UNIVERSITY OF LOUISVILLE","LOUISVILLE","KY","SCHOOLS OF MEDICINE","402920001","UNITED STATES","N","6/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","NIEHS","371452","184368"," ","555820",
"Genetics; Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute;Anemia;Angiopoietin-1;Animals;Blood;Bone Marrow;Bone Marrow Purging;Bone Marrow Transplantation;Breeding;CXCL12 gene;Cells;Chemotherapy-Oncologic Procedure;Collaborations;Commit;Complex;Dichloromethylene Diphosphonate;Disease;Disease model;Erythroblasts;Erythroid;Erythroid Progenitor Cells;Erythropoiesis;Flow Cytometry;Fluorouracil;Generations;Genes;Genetic;Genetic Models;Hematocrit procedure;Hematopoiesis;Hematopoietic stem cells;Hemolysis;Hereditary Disease;Homeostasis;In Vitro;Integrins;Interleukin-4;Island;Knock-in Mouse;Knowledge;Lead;Liposomes;Macrophage Colony-Stimulating Factor;Marrow;Mesenchymal Stem Cells;Modeling;Molecular;Mononuclear;Mus;Mutate;Nature;Oklahoma;Pathogenesis;Phagocytes;Phenylhydrazines;Play;Polycythemia;Polycythemia Vera;Population;Production;Recovery;Role;Seminal;Sickle Cell Anemia;Signal Transduction;Specificity;Spleen;Staging;Stem Cell Factor;Stress;Structure;Testing;Thalassemia;Therapeutic;Time;Transgenic Mice;Transgenic Model;Transgenic Organisms;Vascular Cell Adhesion Molecule-1;abstracting;adhesion receptor;base;chemotherapy;embryonic stem cell;erythroid differentiation;in vivo;insight;irradiation;macrophage;mouse model;nestin protein;novel;overexpression;phenylhydrazine;postnatal;receptor;reconstitution;stem;stem cell niche","In vivo function of macrophage in healthy and diseased erythropoiesis","
!
!
Our in vivo preliminary studies reveal that bone marrow macrophages promote terminal erythroid
maturation. Here, we will characterize some key molecular mechanisms using macrophage-specific
genetic deletion and manipulate macrophage numbers to gain insight on their function in healthy and
diseased erythropoiesis.","NHLBI","8417074","9/25/2012 12:00:00 AM","RFA-HL-12-033","1R01HL116340-01","1","R01","HL","116340","01"," ","KLAUZINSKA, MALGORZATA","9/26/2012 12:00:00 AM","6/30/2016 12:00:00 AM","ZHL1-CSR-O(S1)"," ","2085323","FRENETTE, PAUL S","Not Applicable","14","INTERNAL MEDICINE/MEDICINE","110521739"," ","110521739"," ","US","40.851026","-73.844361","9433501","ALBERT EINSTEIN COLLEGE OF MEDICINE","BRONX","NY","SCHOOLS OF MEDICINE","104611900","UNITED STATES","N","9/26/2012 12:00:00 AM","6/30/2013 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","267057","167500"," ","434557",
"Breast Cancer; Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Animal Model;Antigen-Presenting Cells;Apoptosis;BRCA1 gene;Bone Marrow;Breast;Bystander Effect;Cells;Development;ERBB2 gene;Endothelial Cells;Erinaceidae;Fibroblasts;Grant;Health;Hereditary Breast Carcinoma;Human;IL8 gene;IL8RA gene;In Vitro;Inflammation;Inflammatory;Inherited;Laboratories;Lead;Link;Malignant - descriptor;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Mediating;Mesenchymal Stem Cells;Mus;Neoplasm Metastasis;Oncogenes;Outcome;Pathway interactions;Play;Population;Property;Radiation therapy;Recruitment Activity;Regulation;Relapse;Resistance;Role;Signal Transduction;Stem cells;Testing;Therapeutic Intervention;Tissues;Tumor Necrosis Factor Ligand Superfamily Member 6;Tumor Stem Cells;Woman;Xenograft Model;aldehyde dehydrogenases;cancer stem cell;carcinogenesis;chemokine;chemotherapy;effective therapy;improved;inhibitor/antagonist;injury and repair;malignant breast neoplasm;mouse model;neoplastic cell;notch protein;novel strategies;repaired;self-renewal;small molecule;stem cell niche;tumor;tumor growth;tumorigenesis","Regulation of Breast Stem Cells by the Microenvironment","
There is increasing evidence that many human cancers, including breast cancer, are driven by a small
population of cells that displays stem cell properties. These properties include self-renewal which drives
tumorigenesis and differentiation which generates the tumor bulk. Recent in vitro and animal model studies
have shown that cancer stem cells, including those of the breast, are relatively resistant to radiation therapy
and chemotherapy. There is considerable evidence that the microenvironment regulates normal mammary
development as well as tumor growth and metastasis. Since cancer stem cells may drive tumorigenesis and
metastasis as well as contributing to treatment resistance and relapse, the development of novel strategies to
target this cell population may lead to improved outcomes for women with advanced breast cancer.","NCI","8277829","5/1/2012 12:00:00 AM","PA-07-070","5R01CA101860-09","5","R01","CA","101860","09"," ","SATHYAMOORTHY, NEERAJA","9/1/2004 12:00:00 AM","5/31/2014 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1872561","WICHA, MAX S.","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","158379","86316"," ","244695",
"Genetics; Infant Mortality/ (LBW); Lung; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal - Neonatal Respiratory Distress Syndrome; Perinatal Period - Conditions Originating in Perinatal Period","Address;Adult;Alveolar;Bleomycin;Bronchopulmonary Dysplasia;Cell Lineage;Cell surface;Cells;Chronic Disease;Communication;Data;Development;Differentiation and Growth;Epithelial;Epithelium;Exhibits;Family;Genes;Genetic;Health;Human Genome;Hyperoxia;Injury;Lesion;Ligand Binding;Lung;Lung diseases;Mediating;Mediator of activation protein;Mesenchymal;Mesenchyme;Mesoderm Cell;Messenger RNA;Modeling;Morphogenesis;Mus;Neonatal;Newborn Infant;Pathogenesis;Pathway interactions;Phenotype;Physiological;Play;Primordium;Principal Investigator;Protein Family;Pulmonary Fibrosis;Receptor Protein-Tyrosine Kinases;Resistance;Role;SHH gene;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Signaling Molecule;Specificity;Suggestion;Transforming Growth Factors;base;genetic manipulation;in vivo;indium-bleomycin;lung development;lung injury;neonatal lung injury;novel;polypeptide;programs;receptor;response;tool","Mechanism of Lung Development and Injury","
Project Narrative:
This project will use specific genetic tools to study the role of TGF-ï¿½ during lung
development and in pathogenesis of neonatal and adult chronic diseases.","NHLBI","8259435","4/30/2012 12:00:00 AM","PA-07-070","5R01HL095349-04","5","R01","HL","095349","04"," ","LIN, SARA","5/1/2009 12:00:00 AM","4/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-RES-B(02)M]"," ","1876418","MINOO, PARVIZ MINOO","Not Applicable","37","PEDIATRICS","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF MEDICINE","900894304","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","153450"," ","400950",
"Digestive Diseases; Genetics; Infant Mortality/ (LBW); Lung; Pediatric; Perinatal Period - Conditions Originating in Perinatal Period; Rare Diseases","Abdomen;Affect;Anterior;Biology;Birth;Candidate Disease Gene;Cells;Congenital Abnormality;Congenital Heart Defects;Congenital diaphragmatic hernia;Cytogenetics;Data;Defect;Development;Embryo;Factor Analysis;Gene Expression Profile;Genes;Genetic;Genetic Transcription;Gonadal structure;Heart;Hot Spot;Human;Investigation;Lobar;Lobe;Location;Lung;Mediating;Mesenchymal;Modeling;Molecular;Morbidity - disease rate;Morphogenesis;Mus;Mutant Strains Mice;Mutation;Newborn Infant;Nonsense Mutation;Normal tissue morphology;Pathogenesis;Pathway interactions;Patients;Pattern;Phenotype;Play;Population;Respiratory Diaphragm;Retinoic Acid Receptor;Role;Secondary to;Signal Transduction;Signaling Pathway Gene;Structure;Testing;Time;Tretinoin;apoAI regulatory protein-1;base;cofactor;cohort;lung development;mortality;mouse model;mutant;neonate;transcription factor","Transcription Factor Analysis in a Congenital Diaphragmatic Hernia Model","n/a","NHLBI","8150629","4/26/2012 12:00:00 AM","PA-07-070","4R01HL085459-03","4","R01","HL","085459","03"," ","LIN, SARA","7/1/2009 12:00:00 AM","1/31/2015 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","7142157","ACKERMAN, KATE G.","Not Applicable","25","PEDIATRICS","041294109","F27KDXZMF9Y8","041294109","F27KDXZMF9Y8","US","43.16888","-77.615939","7047101","UNIVERSITY OF ROCHESTER","ROCHESTER","NY","SCHOOL OF MEDICINE & DENTISTRY","146270140","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","225000","122625"," ","347625",
"Autoimmune Disease; Brain Disorders; Dental/Oral and Craniofacial Disease; Genetics; Multiple Sclerosis; Neurodegenerative; Neurosciences","Active Sites;Adult;Affect;Afferent Neurons;Animal Model;Axon;Basement membrane;Behavior Disorders;Biological;Caliber;Cell Adhesion;Cell Surface Receptors;Cells;Cerebellum;Collaborations;Collagen Type IV;Corticospinal Tracts;Defect;Development;Disease;Embryo;Endothelial Cells;Epiblast;Epithelial;Extracellular Matrix;Extracellular Matrix Proteins;Family;Fiber;Genes;Glycoproteins;Goals;Hereditary Disease;Hindlimb;Integral Membrane Protein;Knockout Mice;Laminin;Membrane;Membrane Proteins;Meninges;Mesenchymal;Molecular Conformation;Morphogenesis;Motor;Multiple Sclerosis;Mus;Muscle Cells;Mutation;Myelin;NID gene;Neuraxis;Neurites;Neurons;Nidogen;Oligodendroglia;Organ;Patients;Phenotype;Play;Process;Proteins;Purkinje Cells;Role;Sensory;Spinal Cord;Spinal Cord Tract;Structure;Structure-Activity Relationship;Tissues;Transgenes;Transgenic Mice;Transgenic Organisms;Tremor;Tumor Cell Invasion;Wild Type Mouse;dorsal column;dysmyelination;granule cell;implantation;in vivo;laminin-1;membrane assembly;migration;mouse model;myelination;perlecan;scaffold;tissue repair","Basement Membranes and Associated Protein Factors In Development and Disease","n/a","NIDCR","8553324"," "," ","1ZIADE000485-24","1","ZIA","DE","000485","24"," "," "," "," "," "," ","9415015","YAMADA, YOSHIHIKO ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIDCR"," "," "," ","817936",
"Aging; Eye Disease and Disorders of Vision","Address;Affect;Behavior;Biological Availability;Blindness;Cataract;Cataract Extraction;Cell Differentiation process;Cell Polarity;Cells;Complication;Country;Cues;Cytoskeleton;Development;Differentiation and Growth;Epithelial;Epithelial Cells;Excision;Family;Fiber;Fibroblast Growth Factor;Funding;Goals;Growth;Growth Factor;In Vitro;Intraocular lens implant device;Knowledge;Laboratories;Lens Fiber;Ligands;Mesenchymal;Molecular;Natural regeneration;Operative Surgical Procedures;Optics;Pathway interactions;Pattern;Phenotype;Plastics;Problem Solving;Property;Research;Residual state;Risk;Role;Signal Pathway;Signal Transduction;Structure;System;Transgenic Organisms;Translating;Vision;Visual Acuity;capsule;cell behavior;cell growth;cost;effective therapy;fiber cell;in vivo;killings;lens;lens capsule;lens morphogenesis;lens regeneration;member;novel;prevent;programs;resilience","Lens differentiation and cataract:a role for Wnt-Fz/PCP signaling"," With approximately 20 million people affected, clouding of the lens (cataract) is the most common cause of blindness in the world today. Although surgery can initially be very effective in restoring sight, in the longer term complications are common and often result in the development of a secondary cataract. A central aim in our laboratory is to devise molecular strategies that (i) prevent the aberrant lens cell behavior that occurs after surgery, and (ii) promote normal patterns of lens cell growth and differentiation so that lens clarity is maintained.  
    

","NEI","8235977","12/13/2011 12:00:00 AM","PA-10-067","2R01EY003177-30","2","R01","EY","003177","30"," ","ARAJ, HOUMAM H","9/30/1991 12:00:00 AM","11/30/2012 12:00:00 AM","Special Emphasis Panel[ZRG1-BDCN-H(02)M]"," ","1965966","MCAVOY, JOHNSTON W","LOVICU, FRANK JAMES","n/a","Unavailable","752389338","CRPQN9NU7X28","752389338","CRPQN9NU7X28","AS","-33.86785","151.207323","8178701","UNIVERSITY OF SYDNEY","SYDNEY"," ","Unavailable","2006","AUSTRALIA","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","182237","14579"," ","196816",
"Osteoporosis","Ablation;Adipocytes;Adult;Affect;Anabolism;Binding;Bone Development;Bone Growth;Cell Differentiation process;Cell Line;Cell Proliferation;Cells;Chondrocytes;Chondrogenesis;Commit;Complex;Cues;Data;Defect;Dependency;Embryo;Embryonic Development;Equilibrium;Fibroblasts;Fracture;Future;Genes;Homeostasis;In Vitro;Inhibition of Cell Proliferation;Life;Limb structure;Mediating;Mesenchymal;Modeling;Molecular;Mus;Mutation;Osteoblasts;Osteogenesis;Osteoporosis;Proliferating;Recruitment Activity;Regulation;Research;Role;Signal Pathway;Signal Transduction;Skeletal Development;Skeleton;System;Testing;Therapeutic;Transactivation;base;bone;bone cell;bone mass;bone morphogenetic protein 2;demineralization;in vivo;in vivo Model;mature animal;mutant;osteoblast differentiation;osteoclastogenesis;osteogenic;overexpression;prevent;programs;public health relevance;skeletogenesis","Smad4/B-Catenin Signaling Cross-Talk for Osteoblastogenesis","
 Therapeutic options for stimulating bone formation in subjects with bone demineralization,
such as osteoporosis, are limited. This research will study an interaction between two
molecules that determine how bone forming cells replicate or differentiate to produce new bone.
Results will allow us to better understand how bone forming cells proliferate and function in
adult animals, and will disclose new ways to stimulate bone formation that may be used in the
future to discover new treatments for people with low bone mass and fractures.","NIAMS","8213516","2/28/2012 12:00:00 AM","PA-07-070","5R01AR056678-03","5","R01","AR","056678","03"," ","CHEN, FAYE H","2/1/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1884054","CIVITELLI, ROBERTO ","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","216000","112320"," ","328320",
"Cancer; Prevention","Adverse effects;Agonist;Anti-Inflammatory Agents;Anti-inflammatory;Biology;Breast;Chemopreventive Agent;Colon Carcinoma;Cyclooxygenase Inhibitors;Development;Dithiolthione;Epithelial;Extramural Activities;Faculty;Hydrogen Sulfide;Inflammation;LOX gene;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of prostate;Mediating;Mesenchymal;Modeling;Myocardial Infarction;Nitric Oxide;Nucleoside Diphosphate Kinase A;Outcome;Oxidation-Reduction;PTGS2 gene;Pathway interactions;Patients;Peptides;Pharmaceutical Preparations;Property;Protein Phosphatase 2A Regulatory Subunit PR53;Proteins;Radiation;Research;Risk;Signal Transduction;Stomach;Stroke;Superoxides;Thiones;Thrombosis;Toxic effect;Tumor Suppressor Proteins;Ulcer;anethole;cancer prevention;cancer therapy;cancer type;chemotherapy;dithiol;improved;inhibitor/antagonist;mimetics;novel;novel strategies;prevent;tumor","Properties of redox modified NSAIDs in cancer prevention and treatment","n/a","NCI","8552886"," "," ","1ZIABC010899-05","1","ZIA","BC","010899","05"," "," "," "," "," "," ","9692213","WINK, DAVID ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","261104",
"Cardiovascular; Heart Disease; Pediatric; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adopted;Blood Vessels;Cardiac;Cardiac Myocytes;Cells;Coronary;Data;Differentiation and Growth;EDN2 gene;Embryo;Endocardium;Enzymes;Epicardium;Epithelial;Fetal Heart;Foundations;Future;Genes;Goals;Heart;Heart failure;Hematocrit procedure;Knock-out;Lead;Mesenchymal;Mesothelium;Myocardial;Myocardial Infarction;Myocardial tissue;Myocardium;Phenotype;Planet Mars;Population;Regenerative Medicine;Role;Signal Transduction;Smooth Muscle;Source;Stem cells;Testing;Therapeutic Uses;Tretinoin;abstracting;cardiogenesis;defined contribution;fetal;heart function;interest;interstitial;multipotent cell;novel;postnatal;progenitor;research study;transcription factor","Epicardial Contribution to the Developing and Postnatal Heart","
Project Narrative
The epicardium is a sheet of cells that covers heart muscle tissue. Recently, there has been
increased interest in epicardium because of its role in forming the blood vessels of the fetal
heart, and the potential that this activity can be reactivated in the mature heart. We have found
that epicardium can also form heart muscle cells. The overall goal of this proposal is to define
the cells and signals that the epicardium contributes to the developing and postnatal heart.
These experiments will prepare the foundation for future studies on potential therapeutic uses
of epicardium as a source of cells and signals to treat heart failure.","NHLBI","8207246","12/30/2011 12:00:00 AM","PA-07-070","5R01HL094683-04","5","R01","HL","094683","04"," ","SCHRAMM, CHARLENE A","1/1/2009 12:00:00 AM","7/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-CVS-D(02)M]"," ","2107930","PU, WILLIAM TSWENCHING","Not Applicable","07","Unavailable","076593722","Z1L9F1MM1RY3","076593722","Z1L9F1MM1RY3","US","42.340629","-71.094923","1504801","BOSTON CHILDREN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021155724","UNITED STATES","N","1/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","183150"," ","430650",
"No NIH Category available","Biological;Bioluminescence;Biometry;Cancer Center;Core Facility;Cyclin D1;Diagnostic;Endothelial Cells;Epithelial Cells;Esophageal;Esophageal Neoplasms;Esophageal Squamous Cell;Facility Designs;Fibroblasts;Fostering;Foundations;Genetic;Genetically Engineered Mouse;Image;Immunodeficient Mouse;Instruction;Interdisciplinary Study;Malignant Neoplasms;Malignant Squamous Cell Neoplasm;Malignant neoplasm of esophagus;Mesenchymal;Modeling;Molecular;Molecular Biology;Morphology;Mutation;Pathogenesis;Patients;Pennsylvania;Process;Protein p53;Research;Resistance;Resources;Role;Services;Site;Squamous Cell;Staging;Therapeutic;Time;Translating;Translations;Tumor Cell Invasion;Tumor Suppressor Genes;Universities;carcinogenesis;erbB Genes;experience;in vivo;innovation;insight;medical schools;novel;novel therapeutics;outcome forecast;programs;therapeutic development;translational medicine;tumor;tumorigenesis","Mechanisms of esophageal carcinogenesis","RELEVANCE (See instructions): Esophageal squamous cell cancer is common worldwide and carries with it a dismal prognosis. As a result, this Program Project seeks to develop and characterize innovative models that phencopy this cancer and translate the findings into translational medicine with new, exciting diagnostics and therapeutics.","NCI","8322189","8/8/2012 12:00:00 AM"," ","5P01CA098101-09","5","P01","CA","098101","09"," ","SATHYAMOORTHY, NEERAJA","8/15/2003 12:00:00 AM","6/30/2014 12:00:00 AM","ZCA1-RPRB-O(J1)P"," ","1868587","RUSTGI, ANIL K","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","1127559","477943"," ","1605502",
"Biotechnology; Cancer; Genetics","Acetylation;Address;Affect;Biochemical;Biological;Biological Assay;Cell Communication;Cell-Free System;Cells;Chromatin;Complex;Cultured Cells;DNA Damage;Development;Dominant-Negative Mutation;Epithelial;Event;Failure;Family member;Fibroblasts;Gene Expression;Gene Targeting;Genes;Genetic;Genetic Transcription;Genomics;Histone Deacetylation;Human;In Vitro;Life;Link;Malignant Neoplasms;Mesenchymal;Methodology;Modification;Molecular;Mono-S;Mus;Nature;Normal Cell;Oncogene Activation;Oncogenic;Patients;Performance;Phenotype;Physiological;Play;Protein p53;Proteins;Regulation;Relative (related person);Repression;Role;Signal Transduction;Signal Transduction Pathway;Staging;Stress;Suggestion;System;TP53 gene;Therapeutic;Time;Tissues;Tumor Suppressor Genes;Tumor Suppressor Proteins;Ubiquitin;Ubiquitination;Work;base;cancer cell;cancer therapy;density;follow-up;genetic manipulation;histone modification;improved;in vivo;insight;interest;malignant state;neoplastic cell;novel;overexpression;prevent;promoter;protein protein interaction;research study;response;success;transcription factor;tumor;tumorigenesis","Functional analysis of the p53 tumor suppressor","n/a","NCI","8278422","7/30/2012 12:00:00 AM"," ","5R37CA040099-28","5","R37","CA","040099","28"," ","WATSON, JOANNA M","8/15/1985 12:00:00 AM","7/30/2013 12:00:00 AM","NSS"," ","9153082","OREN, MOSHE ","Not Applicable","n/a","Unavailable","600048466","NPJ8YBLFTKX6","600048466","NPJ8YBLFTKX6","IS","31.896944","34.818611","9116201","WEIZMANN INSTITUTE OF SCIENCE","REHOVOT"," ","Unavailable","7610001","ISRAEL","N","8/1/2012 12:00:00 AM","7/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","202918","16233"," ","219151",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Autocrine Communication;Biological Assay;Biological Models;Cell Communication;Cell Nucleus;Cells;Data Reporting;Dermal;Development;Disease;Engineering;Epidermis;Epithelial;Etiology;Fibroblasts;Goals;Growth;Growth Disorders;Hair;Hair Cells;Hair follicle structure;Knowledge;Knowledge acquisition;Maintenance;Mediating;Membrane Proteins;Mesenchymal;Mission;Molecular;Mus;Natural regeneration;Nature;Organ;Pathway interactions;Pigmentation physiologic function;Pigments;Population;Prevention approach;Protein Binding;Proteins;Public Health;Regulation;Reporter;Research;Role;Signal Transduction;Signaling Molecule;Skin;Sorting - Cell Movement;Staging;Stem cells;Structure;Testing;Tissue Engineering;Transplantation;Wnt proteins;Work;base;design;in vivo;innovation;interest;melanocyte;mouse model;novel;novel strategies;postnatal;self-renewal;skin disorder;stem;stem cell biology;tissue regeneration;tongue papilla;treatment strategy","Coordinated Regulation of Hair Growth and Pigmentation by Dermal Papilla Cells"," The proposed research is relevant to public health because understanding of the molecular mechanisms that regulate stem cell activities in hair follicle holds
the key to develop the effective strategies for the treatment of hair growth disorders and the regeneration of hair follicles for transplanted skin. Thus, the proposed research is relevant to th part of NIH's mission that pertains to developing fundamental knowledge that will aid in the design of innovative approaches for promotion of healthy hair growth.   
   
      

","NIAMS","8288505","7/29/2012 12:00:00 AM","PAR-09-031","1R03AR062788-01","1","R03","AR","062788","01"," ","BAKER, CARL","8/1/2012 12:00:00 AM","7/31/2015 12:00:00 AM","ZAR1-EHB(M1)"," ","10833520","ZHANG, YUHANG ","Not Applicable","01","NONE","041064767","DZ4YCZ3QSPR5","041064767","DZ4YCZ3QSPR5","US","39.142998","-84.503581","1523902","UNIVERSITY OF CINCINNATI","CINCINNATI","OH","SCHOOLS OF PHARMACY","452210001","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","50000","28500"," ","78500",
"Pediatric","Address;Amphibia;Anterior;Back;Biological Models;Biology;Carcinoma;Cardiac Myocytes;Cells;Conceptions;Conceptus;Congenital Abnormality;DNA Sequence Rearrangement;Development;Embryo;Embryonic Development;Endoderm;Endoderm Cell;Epiblast;Event;Fertilization;Foundations;Generations;Genetic;Germ Cells;Goals;Head;Heart;Human;Human Development;In Situ Hybridization;Injection of therapeutic agent;Inner Cell Mass;Iontophoresis;Knock-out;Left;Link;Mammals;Mesoderm;Molecular;Molecular Genetics;Mus;Myocardial;Neoplasm Metastasis;Organism;Organogenesis;Pattern;Play;Population;Pregnancy;Primitive Streaks;Primitive foregut structure;Procedures;Process;Research;Research Personnel;Role;Shapes;Signal Transduction;Signaling Molecule;Staging;Structure;Tail;Techniques;Testing;Tissue Recombination;Tissues;Translating;Vertebrates;Visceral;anticancer research;base;blastocyst;cardiogenesis;embryo tissue;epithelial to mesenchymal transition;implantation;improved;mouse development;natural Blastocyst Implantation;preimplantation;research study;spatial relationship;sperm cell","Visceral Endoderm Fate and Signals in Mammalian Development","n/a","NIGMS","8269778","5/25/2012 12:00:00 AM","PA-07-070","5R01GM087130-05","5","R01","GM","087130","05"," ","HOODBHOY, TANYA","7/1/2008 12:00:00 AM","5/31/2014 12:00:00 AM","Development - 1 Study Section[DEV1]"," ","8870847","RIVERA-PEREZ, JAIME A.","Not Applicable","02","ANATOMY/CELL BIOLOGY","603847393","MQE2JHHJW9Q8","603847393","MQE2JHHJW9Q8","US","42.277722","-71.759339","850903","UNIV OF MASSACHUSETTS MED SCH WORCESTER","WORCESTER","MA","SCHOOLS OF MEDICINE","016550002","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","209058","134843"," ","343901",
"Bioengineering; Genetics","Accounting;Address;Aliquot;Biochemical;Biological;Biological Assay;Biology;Cardiac Myocytes;Cell Differentiation process;Cells;Cellular Structures;Characteristics;Complement;Data;Data Analyses;Development;Disease;Epithelial;Exhibits;Flow Cytometry;Funding;Gene Expression;Gene Expression Profile;Genes;Genome;Heterogeneity;Human body;Image;In Vitro;Individual;Kinetics;Lead;Life;Malignant Neoplasms;Maps;Measurement;Measures;Mesenchymal;Messenger RNA;Methods;MicroRNAs;Microfluidics;Mission;Modeling;Molecular Profiling;Monitor;Natural regeneration;Nature;Noise;Nucleic Acids;Pathway Analysis;Phenotype;Population;Population Heterogeneity;Proteins;Regulator Genes;Reporter;Research Project Grants;Resolution;Sampling;Solutions;Specific qualifier value;Statistical Distributions;Stratification;Surface;System;Systems Biology;Techniques;Technology;Time;Tissues;Transcript;Work;base;cancer stem cell;cell assembly;cell type;cellular imaging;clinically relevant;improved;induced pluripotent stem cell;insight;mRNA Expression;malignant breast neoplasm;member;network models;novel;promoter;protein expression;research study;single cell analysis;technology development;tool","Project 3","n/a","NIGMS","8517253","9/1/2012 12:00:00 AM","PAR-10-200","2P50GM076547-06A1","2","P50","GM","076547","06","A"," "," "," ","ZGM1-CBCB-3(SB)","7183","2407157","HOOD, LEROY E","Not Applicable","07","Unavailable","135646524","SMK9PCMKXED6","135646524","SMK9PCMKXED6","US","47.622042","-122.337243","4106301","INSTITUTE FOR SYSTEMS BIOLOGY","SEATTLE","WA","Research Institutes","981095263","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Research Centers","2012","402295","402295"," ","223497","178798"," "," ",
"Cancer","Animals;Biological Assay;Blood;Blood Vessels;Carcinoma;Cell Communication;Cell Line;Cell physiology;Cells;Cessation of life;Chick Embryo;Clinical;Colon Carcinoma;Complement;Databases;Distal;Down-Regulation;Embryo;Evaluation;Event;Exhibits;Extravasation;Fibroblast Growth Factor 2;Fibroblasts;Gelatinase B;Goals;Health;Human;In Vitro;Individual;Inflammatory;Intervention;Knowledge;Laboratories;Link;Malignant Epithelial Cell;Malignant Neoplasms;Matrix Metalloproteinases;Measurement;Mesenchymal;Modeling;Modification;Molecular;Molecular Analysis;Monitor;Mus;Neoplasm Metastasis;Organ;Outcome;Pancreatic carcinoma;Pathologic Processes;Physiological;Population;Primary Neoplasm;Procedures;Process;Property;Prostate carcinoma;Proteins;Proteomics;Reporting;Research;Role;Site;Stromal Invasion;Survival Rate;Testing;Tissues;Tumor Cell Invasion;Variant;angiogenesis;cancer type;chorioallantoic membrane;comparative;congenic;fibrosarcoma;in vivo;insight;intravital microscopy;mouse model;neoplastic cell;novel;repository;tumor","A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis","n/a","NCI","8259169","5/22/2012 12:00:00 AM","PA-07-070","5R01CA129484-05","5","R01","CA","129484","05"," ","AULT, GRACE S","8/5/2008 12:00:00 AM","5/31/2014 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1886517","QUIGLEY, JAMES P","Not Applicable","49","Unavailable","781613492","PHZJFZ32NKH4","781613492","PHZJFZ32NKH4","US","32.903152","-117.243436","7375802","SCRIPPS RESEARCH INSTITUTE","LA JOLLA","CA","Research Institutes","920371000","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","180142"," ","381417",
"Dental/Oral and Craniofacial Disease","Affect;Animal Model;Biological;Biological Process;Bite Force;Cells;Cephalic;Complex;Data;Defect;Dental;Dental Papilla;Dental Sac;Dental crowns;Dentition;Development;Embryonic Development;Epithelial;Epithelium;Feedback;Foundations;Gene Targeting;Genetic Transcription;Growth Factor;Jaw;Knowledge;Lead;Mediating;Mesenchymal;Mesenchyme;Modeling;Molecular;Morphogenesis;Mus;Natural regeneration;Neural Crest;Neuraxis;Oral health;Organogenesis;Physiological;Plant Roots;Play;Process;Quality of life;Regulation;Research;Research Design;Role;Signal Pathway;Signal Transduction;Smad4 Protein;Stem cells;Structure;Testing;Tissues;Tooth root structure;Tooth structure;activator 1 protein;bone;common treatment;craniofacial;design;malformation;mutant;nuclear factor 1;programs;research study","THE MOLECULAR REGULATORY MECHANISM OF TOOTH ROOT DEVELOPMENT"," Dental roots are crucial for oral health because they provide anchorage for our dentition, transmit occlusal force to the jaw bone and send bio-feedback to our central nervous system. Despite recent advancements in research on the regulation of early tooth development, we still have limited knowledge of the regulatory mechanism of root development. Our research program is designed to further our understanding of how aberrant growth factor signaling networks may adversely affect cell fate determination, tissue-tissue interactions and cause root development defects.   
      

","NIDCR","8387673","7/19/2012 12:00:00 AM","PA-11-260","1R01DE022503-01A1","1","R01","DE","022503","01","A","SCHOLNICK, STEVEN","7/19/2012 12:00:00 AM","6/30/2017 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","6378298","CHAI, YANG ","Not Applicable","37","DENTISTRY","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","900894304","UNITED STATES","N","7/19/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","242500","155200"," ","397700",
"Biotechnology; Eye Disease and Disorders of Vision; Genetics","Address;Age;Biochemical;Biochemical Genetics;Biochemical Pathway;Biology;Cell Culture System;Cell Culture Techniques;Cell Cycle Arrest;Cell Proliferation;Cells;Cellular biology;Complex;Cultured Cells;Defect;Development;Developmental Process;Disease;Embryo;Evaluation;Event;Eye;Eye Development;Eye diseases;Fostering;Genes;Genetic;Germ Lines;Goals;Government;Health;Human;Hyperplasia;Laboratories;Lead;Left;Malignant Neoplasms;Mammalian Cell;Mesenchymal;Mitogens;Molecular;Molecular Abnormality;Mus;Nuclear Protein;Pathogenesis;Pathologic Processes;Pathology;Pathway interactions;Pericytes;Persons;Phenotype;Physiological Processes;Platelet-Derived Growth Factor Receptor;Play;Positioning Attribute;Progress Reports;Proteins;Regulation;Rewards;Role;Signal Transduction;Site;Staging;Stimulus;Therapeutic Intervention;Tumor Suppressor Genes;Tumor Suppressor Proteins;Vascular System;Work;base;blind;in vivo;insight;interest;member;mouse model;p19ARF;prevent;promoter;receptor expression;research study;stem;tumor;vessel regression","ARF Controls Vascular Regression During Eye Development","n/a","NEI","8336897","8/10/2012 12:00:00 AM","PA-07-070","5R01EY014368-12","5","R01","EY","014368","12"," ","SHEN, GRACE L","8/1/2003 12:00:00 AM","7/31/2014 12:00:00 AM","Anterior Eye Disease Study Section[AED]"," ","1879886","SKAPEK, STEPHEN X","Not Applicable","30","PEDIATRICS","800771545","YZJ6DKPM4W63","800771545","YZJ6DKPM4W63","US","32.814772","-96.841146","578404","UT SOUTHWESTERN MEDICAL CENTER","DALLAS","TX","SCHOOLS OF MEDICINE","753909105","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","240000","141586"," ","381586",
"Dental/Oral and Craniofacial Disease; Neurosciences; Nutrition; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Address;Adult;Affect;Alleles;Anterior;Automobile Driving;Birth;Cell physiology;Cells;Complex;Development;Diet;Disease;Embryo;Epithelial;Epithelium;Erinaceidae;Fungiform Papilla;Genetic;Genetic screening method;Health;Image;In Vitro;Individual;Knock-out;Knowledge;Life;Life Style;Link;Mediating;Mesenchymal;Mesenchyme;Mitosis;Molecular;Molecular Genetics;Monitor;Morphogenesis;Mus;Nature;Neurons;Organ;Papillary;Phase;Play;Population;Pregnancy;Process;Property;Receptor Cell;Regulation;Role;Sense Organs;Signal Pathway;Signal Transduction;Signaling Molecule;Specific qualifier value;Staging;Stem cells;Structure;System;Taste Buds;Taste Perception;Technology;Testing;Time;Tissues;To specify;Tongue;Wild Type Mouse;appendage;cell behavior;cell type;in vivo;insight;molecular marker;morphogens;postnatal;progenitor;research study;sensory system;tongue papilla;tool","Characterizing the essential role of sonic hedgehog in taste bud development"," Molecular mechanisms governing taste bud formation is limited. Proper organization of taste bud is essential as this alters individual's taste perception, ultimately affecting diet, lifestyle and health. Studies in this proposal will address the essential role of a secreted signaling molecule, Sonic hedgehog in taste organ morphogenesis and will represent a significant contribution to the limited knowledge of molecular signals regulating the development of this important sensory system. Further, understanding the genesis of embryonic taste organs will thus provide insight into mature taste system function.  
  
    

","NIDCD","8284315","6/6/2012 12:00:00 AM","PAR-10-055","5R03DC011141-02","5","R03","DC","011141","02"," ","SULLIVAN, SUSAN L","7/1/2011 12:00:00 AM","6/30/2014 12:00:00 AM","ZDC1-SRB-Q(68)"," ","10188946","THIRUMANGALATHU, SHOBA ","Not Applicable","06","BIOLOGY","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","173","Non-SBIR/STTR","2012"," "," ","NIDCD","100000","53000"," ","153000",
"Contraception/Reproduction; Estrogen; Genetics; Pediatric; Urologic Diseases","Adult;Age;Androgen Receptor;Androgens;Animals;Applications Grants;Bilateral;Blood Circulation;Cell Differentiation process;Cell Proliferation;Cell division;Cells;Congenital Abnormality;Cryptorchidism;Defect;Development;Estradiol;Estrogens;Exhibits;G-Protein-Coupled Receptors;Gene Expression;Gene Targeting;Genes;Histology;Human;In Vitro;Incidence;Insulin;LH Receptors;Leucine-Rich Repeat;Mediating;Mesenchymal;Messenger RNA;Molecular;Mus;Muscle Cells;Mutant Strains Mice;Nerve;Notch Signaling Pathway;Organ Culture Techniques;Pathway interactions;Peptides;Phase;Phenotype;Play;Process;Recovery;Relaxin;Role;Scrotum;Serum;Siblings;Signal Pathway;Signal Transduction;Staging;System;Testis;Testosterone;cremaster muscle;insight;knockout animal;leydig interstitial cell;male;morphometry;myogenesis;notch protein;postnatal;prevent;testosterone replacement therapy","The Mechanism of Cryptorchidism in LH Receptor Knockout Animals","n/a","NICHD","8245103","3/19/2012 12:00:00 AM","PA-07-070","5R01HD057501-05","5","R01","HD","057501","05"," ","TAYMANS, SUSAN","4/1/2008 12:00:00 AM","3/31/2015 12:00:00 AM","Integrative and Clinical Endocrinology and Reproduction Study Section[ICER]"," ","2220008","LEI, ZHENMIN ","Not Applicable","03","OBSTETRICS & GYNECOLOGY","057588857","E1KJM4T54MK6","057588857","E1KJM4T54MK6","US","38.185212","-85.660469","4679701","UNIVERSITY OF LOUISVILLE","LOUISVILLE","KY","SCHOOLS OF MEDICINE","402920001","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2015 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","192456","86056"," ","278512",
"Cancer; Immunization; Lung; Lung Cancer; Vaccine Related","Adenocarcinoma;Aftercare;Antigens;Avidity;BCL1 Oncogene;Bladder;Boxing;Brachyury protein;CD8-Positive T-Lymphocytes;CD8B1 gene;Cancer Patient;Cancer Vaccine Related Development;Cell Line;Cells;Cessation of life;Characteristics;Chitosan;Clinical;Clinical Research;Clinical Trials;Colon Carcinoma;Colorectal Cancer;Computer Simulation;Computers;Cytolysis;Data;Databases;Development;Disease;Down-Regulation;Drug resistance;Embryonic Development;Epidermal Growth Factor Receptor;Epithelial;Epitopes;Exhibits;Expressed Sequence Tags;Family;Future;Gene Expression;Goals;Heating;Hematopoietic Neoplasms;Human;Image;Immune;Immune response;Immune system;Immunity;Immunotherapeutic agent;Immunotherapy;In Vitro;Injection of therapeutic agent;Interleukin-12;Kidney;Lung;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant neoplasm of prostate;Measures;Mediating;Mesenchymal;Mesoderm;Mining;Molecular;Monitor;Mus;Natural Killer Cells;Neoplasm Metastasis;Nodule;Normal tissue morphology;Ovary;Phase;Phenotype;Phosphotransferases;Play;Polysaccharides;Population;Poxviridae;Primary Neoplasm;Process;Property;Prostate carcinoma;Proteins;Recombinant Vaccines;Recombinants;Regulation;Regulatory T-Lymphocyte;Resistance;Reverse Transcription;Role;Serum;Small Intestinal Neoplasm;Squamous cell carcinoma;Stomach;T cell response;T-Cell Receptor;T-Lymphocyte;Testing;Testis;Therapeutic;Therapeutic Intervention;Thyroid Gland;Time;Tissues;Toxic effect;Transcription factor genes;Translations;Treatment Efficacy;Tumor Antigens;Tumor Cell Line;Tumor Tissue;Up-Regulation;Uterus;Vaccination;Vaccine Therapy;Vaccines;Xenograft Model;Yeasts;base;cancer cell;cancer immunotherapy;cancer therapy;cell motility;cytokine;design;epithelial to mesenchymal transition;immune function;in vivo;inhibitor/antagonist;killings;lung Carcinoma;mRNA Differential Displays;member;mouse model;neoplastic cell;novel;overexpression;preclinical study;prevent;protein expression;selective expression;small molecule;stemness;therapeutic target;tool;transcription factor;tumor;tumor progression;vaccine efficacy;vector","Strategies for Cancer Vaccine Development:  Preclinical Studies","n/a","NCI","8552894"," "," ","1ZIABC010944-05","1","ZIA","BC","010944","05"," "," "," "," "," "," ","2407138","SCHLOM, JEFFREY ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","612693",
"Acute Respiratory Distress Syndrome; Biotechnology; Lung; Pediatric; Perinatal Period - Conditions Originating in Perinatal Period; Prevention; Rare Diseases; Smoking and Health; Tobacco","Acinus organ component;Agonist;Alveolar;Chronic lung disease;Complex;Development;Down-Regulation;Epithelial;Exposure to;Fetus;Fibroblasts;Homeostasis;Immunohistochemistry;In Vitro;Injury;Life;Lung;Mesenchymal;Mesenchyme;Modeling;Molecular;Molecular Target;Myofibroblast;Newborn Infant;Nicotine;PPAR gamma;Paracrine Communication;Pathway interactions;Perinatal;Perinatal Exposure;Peroxisome Proliferator-Activated Receptors;Phenotype;Pregnancy;Preventive;Pulmonary function tests;Reverse Transcriptase Polymerase Chain Reaction;Risk;Signal Pathway;Signal Transduction;Smoke;Structure;Technology;Testing;Therapeutic;Time;Translating;Up-Regulation;Work;alveolar homeostasis;base;functional genomics;in utero;in vivo;in vivo Model;injury and repair;innovation;interstitial;laser capture microdissection;lung development;lung injury;maternal cigarette smoking;medical complication;metabolomics;novel;parathyroid hormone-related protein;prevent;respiratory;transdifferentiation","Fibroblast Cell Signaling in Utero Nicotine-Induced Lung Injury","n/a","NICHD","8309208","7/24/2012 12:00:00 AM","PA-07-070","5R01HD051857-05","5","R01","HD","051857","05"," ","ILEKIS, JOHN V","9/30/2008 12:00:00 AM","7/31/2014 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","6717879","REHAN, VIRENDER K","Not Applicable","43","Unavailable","069926962","LTJVF4QSFCP9","069926962","LTJVF4QSFCP9","US","33.834898","-118.292983","2543101","LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER","TORRANCE","CA","Research Institutes","905022006","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","201960","67734"," ","269694",
"Genetics; Lung; Pediatric; Pediatric Research Initiative; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Birth;CCL4 gene;Cardiac;Cleft Palate;Congenital Heart Defects;Data;Defect;Development;Differentiation and Growth;Embryo;Embryology;Epithelial;Epithelium;Fetal Lung;Fibroblast Growth Factor;Gene Targeting;Genetic;Genetic Epistasis;Germ Lines;Growth;Kidney;Lateral;Limb Development;Link;Lung;Mammals;Mediating;Mesenchymal;Mesenchyme;Mesoderm;Modeling;Molecular;Morphogenesis;Mus;Mutant Strains Mice;Pathway interactions;Pattern;Primitive foregut structure;Role;Series;Signal Pathway;Signal Transduction;Structure of parenchyma of lung;System;Testing;Tissues;Work;Xenopus;Zinc Fingers;cardiogenesis;craniofacial;human stem cells;innovation;lung basal segment;lung development;mutant;nephrogenesis;perinatal health;progenitor;research study;transcription factor","Osr transcription factors regulate embryonic lung development"," A better understanding of lung development will have a significant impact on perinatal health and facilitate efforts to direct the differentiation of lung
tissue from human stem cells. Despite recent progress there are a number of critical unanswered questions that remain in our understanding of embryonic lung development. This proposal addresses some of these and tests the hypothesis that Osr zinc finger transcription factors regulate a signaling cascade linking early foregut patterning, pulmonary specification and lung bud growth into a unified molecular pathway.      

","NHLBI","8343489","8/8/2012 12:00:00 AM","PA-10-067","1R01HL114898-01","1","R01","HL","114898","01"," ","LIN, SARA","8/10/2012 12:00:00 AM","6/30/2017 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","6951546","ZORN, AARON M","Not Applicable","01","Unavailable","071284913","JZD1HLM2ZU83","071284913","JZD1HLM2ZU83","US","39.140882","-84.500494","615001","CINCINNATI CHILDRENS HOSP MED CTR","CINCINNATI","OH","Independent Hospitals","452293039","UNITED STATES","N","8/10/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","132500"," ","382500",
"Asthma; Lung; Pediatric; Perinatal Period - Conditions Originating in Perinatal Period; Prevention; Smoking and Health; Tobacco","Acetylation;Address;Affect;Agonist;Asthma;Cells;Childhood Asthma;DNA;Data;Development;Differentiation and Growth;Environmental Risk Factor;Epidemic;Epigenetic Process;Exposure to;Female;Fetal Lung;Gender;Generations;Gonadal structure;Knowledge;Lead;Lung;Mediating;Mesenchymal Differentiation;Methylation;Molecular;Molecular Target;Nicotine;Organ;PPAR gamma;Pathogenesis;Pathway interactions;Perinatal Exposure;Phenotype;Physiological;Predisposition;Pregnancy;Prevalence;Preventive Intervention;Public Health;Rat-1;Rattus;Respiratory physiology;Risk;Signal Pathway;Smoking;Structure;Suggestion;Tissues;arm;base;disorder prevention;grandchild;in utero;innovation;lung development;male;maternal cigarette smoking;novel;offspring;prevent;rosiglitazone;trait;transmission process","In Utero Nicotine Exposure & Transgenerational Transmission of Asthma"," Childhood asthma is a major public health problem worldwide with maternal smoking during pregnancy as a significant contributor to this ever growing epidemic. In addition, there is emerging evidence for transgenerational transmission of asthma risk following exposure to maternal smoke during pregnancy. The studies proposed in this application aim to examine the molecular basis underlying the increased transgenerational asthma risk following in utero exposure to maternal smoke and are likely to provide pivotal molecular data that can have significant impact on understanding the pathogenesis of, and devising new treatments for, childhood asthma.   
      

","NICHD","8398879","7/2/2012 12:00:00 AM","PA-11-261","1R21HD071731-01A1","1","R21","HD","071731","01","A","RAJU, TONSE N","7/5/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-CVRS-G(03)]"," ","6717879","REHAN, VIRENDER K","Not Applicable","43","Unavailable","069926962","LTJVF4QSFCP9","069926962","LTJVF4QSFCP9","US","33.834898","-118.292983","2543101","LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER","TORRANCE","CA","Research Institutes","905022006","UNITED STATES","N","7/5/2012 12:00:00 AM","6/30/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","150000","59360"," ","209360",
"Bioengineering; Dental/Oral and Craniofacial Disease","Actins;Address;Adhesions;Adhesiveness;Area;Biochemical;Cell Adhesion;Cell Adhesion Molecules;Cell Surface Extensions;Cell physiology;Cells;Cellular Morphology;Cellular biology;Chimera organism;Collagen;Complex;Cytoskeletal Modeling;Cytoskeletal Proteins;Cytoskeleton;Development;Disease;Environment;Extracellular Matrix;Fibroblasts;Fluorescence;Fluorescence Recovery After Photobleaching;Goals;Health;Human Development;Hydrogels;Image;Immigration;Integrins;Kinetics;Knock-out;Knowledge;Lateral;Life;Link;Malignant Neoplasms;Mediating;Mesenchymal;Microscopy;Microtubules;Molecular;Molecular Biology;Myosin ATPase;Myosin Type II;Nonmuscle Myosin Type IIA;Normal Cell;Phase;Physiological;Play;Process;Protein Dynamics;Protein Isoforms;Proteins;Regulation;Role;Signal Pathway;Signal Transduction;Speed;Structure;Subcellular structure;Time;Tissue Engineering;Vinculin;blebbistatin;cell motility;extracellular;in vivo;migration;molecular dynamics;mutant;novel strategies;paxillin;prevent;programs;receptor;research study;tissue culture;two-dimensional","Cell-Matrix Interactions and Migration","n/a","NIDCR","8553326"," "," ","1ZIADE000524-22","1","ZIA","DE","000524","22"," "," "," "," "," "," ","9415013","YAMADA, KENNETH ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIDCR"," "," "," ","574793",
"Genetics; Pediatric; Rare Diseases; Spina Bifida","Actins;Affect;Anterior;Behavior;Behavior Control;Biochemical;Biological Assay;Cells;Congenital Abnormality;Cytoskeleton;DNA Resequencing;DNA Sequence Rearrangement;Data;Defect;Development;Drosophila genus;Embryo;Embryonic Organizers;Ethylnitrosourea;Event;Foundations;Gene Proteins;Genes;Genetic;Genetic Models;Genetic Screening;Germ Layers;Goals;Health;Induced Mutation;Left;Ligands;Link;Maps;Mediating;Molecular Genetics;Morphogenesis;Movement;Mus;Mutation;Neoplasm Metastasis;Neural Tube Closure;Neural Tube Defects;Neural tube;Organ;Pathway interactions;Phenotype;Primitive Streaks;Process;Regulation;Reporter;Role;Signal Transduction;Single Nucleotide Polymorphism Map;Situs Inversus;System;Technology;Tertiary Protein Structure;Testing;Tissues;Transgenic Organisms;base;cell behavior;cell motility;cofilin;embryo tissue;epithelial to mesenchymal transition;extracellular;gastrulation;mutant;neoplastic cell;neural plate;notch protein;novel;research study;response;tool;tumor","Isolation of Novel Mutations Affecting the Mouse Embryo","n/a","NICHD","8301701","5/25/2012 12:00:00 AM","PA-07-070","5R37HD035455-15","5","R37","HD","035455","15"," ","JAVOIS, LORETTE CLAIRE","7/1/1998 12:00:00 AM","6/30/2013 12:00:00 AM","Genetics of Health and Disease Study Section[GHD]"," ","1885388","ANDERSON, KATHRYN V","Not Applicable","12","Unavailable","064931884","KUKXRCZ6NZC2","064931884","KUKXRCZ6NZC2","US","40.764332","-73.955697","5079202","SLOAN-KETTERING INST CAN RESEARCH","NEW YORK","NY","Research Institutes","100656007","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","365245","328355"," ","693600",
"Cancer; Genetics; Pediatric","3-Dimensional;Adhesives;Adopted;Agonist;Basement membrane;Blood Vessels;Cancer Cell Growth;Cells;Chronic;Collagen Type I;Defect;Development;Disease;Embryo;Endothelial Cells;Epithelial;Epithelial Cells;Event;Family;Generations;Growth Factor;Healed;Health;Imaging Device;In Vitro;Inflammatory;Invaded;Knock-out;Knockout Mice;Legal patent;Link;MMP14 gene;MT2-MMP;Matrix Metalloproteinases;Membrane;Mesenchymal;Modeling;Molecular;Molecular Biology Techniques;Morphogenesis;Mus;Neoplasm Metastasis;Outcome;Pathologic;Phenotype;Play;Principal Investigator;Proteolysis;Regulation;Role;Series;Structure;Testing;Therapeutic Intervention;Tissues;Transcription Repressor/Corepressor;Transgenic Mice;Transgenic Organisms;Ursidae Family;Vascular Endothelial Growth Factors;Zinc Fingers;angiogenesis;cohort;gastrulation;healing;in vivo;insight;interstitial;membrane-type matrix metalloproteinase;neovascularization;novel;novel therapeutic intervention;postnatal;precursor cell;programs;trafficking;tumorigenesis;vasculogenesis","Matrix Metalloproteinase-Dependent Angiogenesis"," Angiogenesis, or the development of new blood vessels, plays critical roles in health and disease. For example, in the absence of angiogenesis, wounds cannot heal while the pathologic activation of angiogenesis promotes cancer cell growth and metastasis. The outlined project uses sophisticated molecular biology techniques, cutting-edge imaging tools and novel mouse (transgenic/knockout) models to identify the key molecules that regulate blood vessel formation. The characterization of the pro- and anti-angiogenic molecules that control blood vessel formation will have important implications for the development of new therapeutic interventions.    
    

","NCI","8326050","7/13/2012 12:00:00 AM","PA-10-067","5R01CA088308-12","5","R01","CA","088308","12"," ","SNYDERWINE, ELIZABETH G","7/6/2000 12:00:00 AM","7/31/2016 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","1899079","WEISS, STEPHEN J","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201488","111826"," ","313314",
"Biotechnology; Dental/Oral and Craniofacial Disease; Genetics; Pediatric","Ameloblasts;Back;Biochemical;Cells;Cilia;Cities;DNA Binding Domain;DNA Microarray Chip;DNA-Binding Proteins;Data;Defect;Dental;Development;Elements;Embryonic Development;Epithelial;Epithelium;Erinaceidae;Fluorescence Polarization;Gene Expression;Gene Family;Gene Targeting;Genes;Genetic;Goals;Head;Health Sciences;Homeobox;Immunoprecipitation;Incisor;Institutes;Knowledge;Mandible;Maps;Measures;Mesenchymal;Methodology;Molecular;Molecular Genetics;Morphogenesis;Mus;Mutant Strains Mice;Mutation;Natural regeneration;Odontoblasts;Oral;P-Cadherin;Pattern;Play;Process;Program Development;Proteins;Regulation;Reverse Transcriptase Polymerase Chain Reaction;Role;Salivary Glands;Signal Transduction;Signaling Molecule;Small Interfering RNA;Staging;Surface Plasmon Resonance;Technology;Testing;Texas;Therapeutic;Tooth structure;Transactivation;Transcription factor genes;Transcriptional Activation;Transfection;Winged Helix;Yeasts;amelogenin;base;craniofacial;feeding;gain of function;islet;loss of function;neonate;oral cavity epithelium;promoter;research study;transcription factor;yeast two hybrid system","Mechanisms of FoxJ1 Tooth Morphogenesis","n/a","NIDCR","8246305","3/7/2012 12:00:00 AM","PA-07-070","7R01DE018885-04","7","R01","DE","018885","04"," ","SCHOLNICK, STEVEN","7/1/2009 12:00:00 AM","7/31/2012 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-K(09)S]"," ","1892917","AMENDT, BRAD A","Not Applicable","17","GENETICS","835607441","HFT7XTHB6563","835607441","HFT7XTHB6563","US","30.561517","-96.274978","8266910","TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR","COLLEGE STATION","TX","OVERALL MEDICAL","778454375","UNITED STATES","N","4/1/2012 12:00:00 AM","7/31/2012 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","103482","48119"," ","151601",
"Breast Cancer; Cancer; Complementary and Alternative Medicine; Genetics; Nutrition","Adverse effects;Affect;American;Anchorage-Independent Growth;Animal Testing;Anthracenes;Antibody Therapy;Antioxidants;Antiviral Agents;Apoptosis;Aromatic Polycyclic Hydrocarbons;Benzo(a)pyrene;Binding;Biological Assay;Breast;Breast Cancer Cell;Cancer Etiology;Cancer cell line;Carcinogenesis Mechanism;Carcinogens;Cardiovascular Diseases;Cardiovascular system;Cause of Death;Cell Line;Cell Proliferation;Cell physiology;Cells;Clinic;Complement Factor B;Complex;Consumption;Cytoplasm;DNA Damage;Data;Development;Diabetes Mellitus;Dietary Factors;Disease;Disease Progression;Drug resistance;ERBB2 gene;Environmental Carcinogens;Environmental Exposure;Epidemiologic Studies;Epigallocatechin Gallate;Epigenetic Process;Epithelial;Epithelial Cells;Exposure to;Factor V;Family;Gene Activation;Genes;Genetic;Green tea;Growth;Heavy Metals;Human;Immune response;Immunity;In Vitro;Incidence;Individual;Inflammatory Response;JUN gene;Lead;Lung diseases;Maintenance;Malignant Neoplasms;Mammary Neoplasms;Mammary Tumorigenesis;Mammary gland;Mediating;Mesenchymal;Microarray Analysis;Morbidity - disease rate;Mouse Mammary Tumor Virus;Mus;Mutation;NF-kappa B;Neoplastic Cell Transformation;Normal tissue morphology;Nuclear Family;Obesity;Oncogenes;Oxidative Stress;Pathogenesis;Pathway Analysis;Pathway interactions;Patients;Phenotype;Phosphotransferases;Play;Pleural effusion disorder;Property;Rattus;Reporting;Resistance;Roche brand of trastuzumab;Rodent;Role;Signal Transduction;Signal Transduction Pathway;Specimen;Sprague-Dawley Rats;TNFRSF5 gene;Testing;Tissues;Transactivation;Transcription Factor AP-1;Transgenic Mice;Translating;Trastuzumab;Tumor Burden;Tumor Cell Line;Tumor-Derived;Virus Diseases;Woman;Xenograft Model;cigarette smoking;dimethylbenzanthracene;drinking;early onset;epithelial to mesenchymal transition;gallocatechol;in vivo;inhibitor/antagonist;mRNA Expression;malignant breast neoplasm;malignant phenotype;mouse model;mutant;neoplastic cell;overexpression;p65;polyphenol;pre-clinical;promoter;public health relevance;pulmonary function;research clinical testing;transcription factor;tumor;tumorigenesis","Roles of NF-kB/Rel in the pathogenesis of breast cancer","n/a","NCI","8211012","3/20/2012 12:00:00 AM","PA-07-070","5R01CA129129-05","5","R01","CA","129129","05"," ","JOHNSON, RONALD L","4/1/2008 12:00:00 AM","1/31/2015 12:00:00 AM","Cancer Molecular Pathobiology Study Section[CAMP]"," ","1896578","SONENSHEIN, GAIL E.","Not Applicable","07","BIOCHEMISTRY","039318308","C1F5LNUF7W86","039318308","C1F5LNUF7W86","US","42.349907","-71.061712","8422704","TUFTS UNIVERSITY BOSTON","BOSTON","MA","SCHOOLS OF MEDICINE","021111901","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2015 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","207383","124588"," ","331971",
"Dental/Oral and Craniofacial Disease; Genetics; Pediatric; Pediatric Research Initiative; Prevention","Alleles;Area;Auditory;Binding;Biochemical;Biology;Cephalic;Cleft Lip;Cleft Palate;Congenital Abnormality;Defect;Development;Dimerization;Disease;Dorsal;Drug Delivery Systems;Ectoderm;Epithelium;Face;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Gene Targeting;Growth Factor;Human;Individual;Laboratories;Lead;Mesenchymal;Mesenchyme;Mus;Mutagenesis;Mutant Strains Mice;Mutation;Neural Crest;Neural Crest Cell;Organ;Palate;Pathway interactions;Phenotype;Play;Point Mutation;Population;Prevention;Process;Proteins;Role;Series;Signal Pathway;Signal Transduction;Tissues;base;bone;cell motility;cell type;craniofacial;migration;mutant;neoplastic;novel;prevent;receptor;relating to nervous system;response;skeletal disorder","FGF Signaling Pathways and Craniofacial Development"," Craniofacial developmental diseases including cleft lip or palate are the most prevalent birth defects in the human population worldwide. The major aims of this proposal are to identify mechanisms controlled by FGF signaling that underlie normal development of the midface. We will identify downstream FGF intracellular signaling pathways that are critical in midline development, investigate how FGFs signal in the epithelium and in neural crest cells, and analyze the development of the frontonasal process in FGF receptor mutants.   
   
      

","NIDCR","8343550","7/11/2012 12:00:00 AM","PA-10-067","1R01DE022778-01","1","R01","DE","022778","01"," ","SCHOLNICK, STEVEN","7/11/2012 12:00:00 AM","4/30/2017 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1898203","SORIANO, PHILIPPE M","Not Applicable","13","ANATOMY/CELL BIOLOGY","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","SCHOOLS OF MEDICINE","100296574","UNITED STATES","N","7/11/2012 12:00:00 AM","4/30/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","370498","256224"," ","626722",
"Biotechnology; Brain Cancer; Brain Disorders; Cancer; Neurosciences; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","ADP ribosylation;Affect;Angiogenesis Inhibitors;Apoptosis;Apoptotic;Asses;Attenuated;Binding Sites;Bioluminescence;Boston;Brain;Brain Neoplasms;Caspase;Cell Death;Cell Death Inhibition;Cell Line;Cell Proliferation;Cell Survival;Cell Therapy;Cells;Cessation of life;Cetuximab;Clinical Data;Clinical Trials;Collaborations;Combined Modality Therapy;Cytotoxic Chemotherapy;Cytotoxic agent;Death Domain;Death Receptor 5;Deposition;Diagnostic;Diphtheria Toxin;Down-Regulation;EGF gene;Effectiveness;Embryo;Engineering;Epidermal Growth Factor Receptor;Exotoxins;G Cells;Glioblastoma;Glioma;Half-Life;Homing;Hospitals;Human;Human Engineering;Image;Immunotoxins;Implant;In Vitro;Interleukin-13;Laboratories;Lentivirus Vector;Ligands;Malignant - descriptor;Mammalian Cell;Mediating;Mesenchymal Stem Cells;Modeling;Molecular Weight;Monoclonal Antibodies;Mus;Nature;Netherlands;Pathology;Pathway interactions;Peptide Elongation Factor 2;Pharmacodynamics;Plasmids;Primary Brain Neoplasms;Proliferating;Protein Biosynthesis;Protein Isoforms;Proto-Oncogene Proteins c-akt;Pseudomonas;Radiation therapy;Receptor Signaling;Research;Resistance;Signal Pathway;Signal Transduction;Site;Stem cells;TNFRSF10A gene;TNFSF10 gene;Testing;Therapeutic;Therapy Clinical Trials;Time;Toxin;Transplantation;Treatment Efficacy;Tumor Necrosis Factor-alpha;Universities;Variant;Work;adult stem cell;base;brain tissue;cancer therapy;cell killing;combinatorial;cytokine;cytotoxic;death receptor-4;design;human TNFRSF10A protein;in vivo;innovation;interleukin-13 receptor;intravital fluorescence microscopy;intravital microscopy;killings;mouse model;mutant;nanobodies;neoplastic cell;nerve stem cell;neurosurgery;novel;optical imaging;overexpression;pre-clinical;public health relevance;receptor;stem cell fate;stem cell therapy;targeted delivery;therapeutic protein;time use;tomography;tumor;tumor growth","Developing diagnostic and therapeutic stem cells for cancer therapy","
Narrative
In this proposal we will engineer human mesenchymal stem cells (MSC) to express
targeted therapeutic proteins directed against overexpressed receptors in glioma cells.
Two different combinatorial therapy approaches based on targeting cell proliferation and
death pathways in glioma cells will be explored. The developed agents and strategies
will be designed to be clinically translatable and should have a major impact in
developing efficient therapies for brain tumors.","NCI","8211001","2/23/2012 12:00:00 AM","PA-07-070","5R01CA138922-03","5","R01","CA","138922","03"," ","FORRY, SUZANNE L","3/18/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Developmental Therapeutics Study Section[DT]"," ","8586528","SHAH, KHALID A","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","201275","153023"," ","354298",
"Biotechnology; Cancer; Gene Therapy; Genetics; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acute;Animal Model;Animals;Antineoplastic Agents;Antiviral Agents;Apoptosis;Binding;CXCL12 gene;Cell Cycle;Cell membrane;Cells;Characteristics;Chemicals;Clinical;Clinical Trials;Clinical Trials Design;Cytolysis;Data;Decitabine;Development;Development Plans;Dichloroacetate;Disease;Energy Metabolism;Engineering;Future;GTPase-Activating Proteins;Gene Delivery;Gene Expression;Generations;Genes;Giant Cells;Goals;Growth;Herpesvirus 1;Human Herpesvirus 2;Immune system;Immunity;In Vitro;Induction of Apoptosis;Laboratories;Malignant - descriptor;Malignant Neoplasms;Mediating;Membrane Fusion;Mesenchymal Stem Cells;Modeling;Natural Immunity;Normal Cell;Oncolytic;Oncolytic viruses;Outcome;Pathway interactions;Patients;Pharmaceutical Preparations;Phase;Play;Preclinical Testing;Property;Proteins;Ras Signaling Pathway;Regimen;Resistance;Role;Route;S Phase;Simplexvirus;Staging;Testing;Therapeutic;Toxic effect;Toxicology;Translating;Treatment Efficacy;Tumor Tissue;Viral;Virus;Virus Diseases;Virus Replication;Work;abstracting;base;cancer therapy;cell killing;chemotherapy;clinical application;design;gemcitabine;gene therapy;improved;in vivo;killings;mutant;neoplastic cell;novel;preclinical study;ras GTPase-Activating Proteins;success;trafficking;tumor","Development of an HSV-2 based oncolytic virus","
Project Narrative
Using viruses to kill tumor cells has shown considerable promise in the laboratory and in early clinical trials.
Yet several obstacles must be overcome before this strategy gains acceptance as a safe and potent form of
cancer therapy. The applicant has constructed a virus from herpes simplex virus type 2, called FusOn-H2,
which has produced encouraging antitumor activity in animal tumor models. He now propose to develop and
test different strategies for improving FusOn-H2 virotherapy, with the long-term goal of translating this
treatment into a clinically feasible option for patients with malignant sold tumors.","NCI","8528758","9/7/2012 12:00:00 AM","PA-07-070","3R01CA132792-05S1","3","R01","CA","132792","05","S","OGUNBIYI, PETER","12/1/2008 12:00:00 AM","11/30/2013 12:00:00 AM","Developmental Therapeutics Study Section[DT]"," ","7740876","ZHANG, XIAOLIU ","Not Applicable","18","BIOLOGY","036837920","QKWEF8XLMTT3","036837920","QKWEF8XLMTT3","US","29.721486","-95.338112","1449402","UNIVERSITY OF HOUSTON","HOUSTON","TX","SCHOOLS OF ARTS AND SCIENCES","772042610","UNITED STATES","N","8/1/2012 12:00:00 AM","11/30/2012 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","15243","7602"," ","22845",
"Biodefense; Clinical Research; Clinical Trials; Emerging Infectious Diseases; Hematology; Infectious Diseases; Orphan Drug; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Acute Lung Injury;Adenosine;Adenovirus Infections;Adverse effects;Agonist;Antithymoglobulin;Attenuated;Autoimmune hemolytic anemia;Blood Platelets;Bone Marrow;Bone Marrow Transplantation;Busulfan;Cells;Cessation of life;Child;Chimerism;Clinical;Clinical Treatment;Clinical Trials;Collaborations;Combination Drug Therapy;Cooperative Research and Development Agreement;Cytomegalovirus;Data;Development;Dialysis procedure;Disease;Drug Formulations;Eligibility Determination;Engraftment;Erythropoiesis;Goals;Graft Rejection;Hematopoietic;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Hemorrhage;Homing;Homologous Transplantation;Immune;Immunologic Deficiency Syndromes;Immunology;Immunosuppressive Agents;Infection;Infusion procedures;Inherited;Ischemia;Journals;Kidney Failure;Laboratories;Leukocyte Adhesion Deficiency;Link;Lymphoid;MabCampath;Malignant - descriptor;Malignant Neoplasms;Meninges;Mesenchymal Stem Cells;Modeling;Morbidity - disease rate;Mus;Myelogenous;Neutropenia;Non-Malignant;Osteomyelitis;Outcome;Overdose;Paper;Patients;Pharmaceutical Preparations;Pharmacologic Substance;Platelet Transfusion;Property;Prophylactic treatment;Protocols documentation;Publishing;Regimen;Regulatory T-Lymphocyte;Relative (related person);Reporting;Research Personnel;Risk;Role;Salvage Therapy;Sepsis;Severities;Siblings;Sirolimus;Skin Transplantation;Skin graft;Source;Stem cells;Study models;T-Lymphocyte;Therapeutic;Therapeutic Clinical Trial;Thinking;Time;Tissue Model;Toxic effect;Transfusion;Transplantation;Umbilical Cord Blood;Universities;Vertebral column;Virginia;Whole-Body Irradiation;Work;X-Linked Severe Combined Immunodeficiency;base;blood product;conditioning;drug mechanism;drug testing;follow-up;forest;graft failure;graft vs host disease;granulocyte;high risk;immune function;improved;interest;mortality;preclinical study;prevent;receptor","Clinical Trials of Allogeneic Transplantation for Inherited Immune Deficiencies","n/a","NIAID","8555916"," "," ","1ZIAAI000989-06","1","ZIA","AI","000989","06"," "," "," "," "," "," ","9413707","KANG, ELIZABETH ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIAID"," "," "," ","423763",
"Bioengineering; Cancer; Cardiovascular; Clinical Research; Diagnostic Radiology; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute;Adrenergic Agents;Angioplasty;Apoptosis;Apoptotic;Area;Binding;Bioluminescence;Biometry;Cardiac;Cardiac Myocytes;Cardiology;Cardiomyopathies;Cardiotoxicity;Cardiovascular Diseases;Cardiovascular system;Cell Culture Techniques;Cell Death;Cells;Cellular biology;Chemotherapy-Oncologic Procedure;Clinical;Clinical Trials;Coronary Artery Bypass;Coronary heart disease;Cytolysis;Cytoprotection;Developed Countries;Diagnosis;Disease;Doxorubicin;Environment;Fibroblasts;Foundations;Functional disorder;Funding;Future;Goals;Growth Factor;Heart;Heart failure;Human;Image;Imagery;Imaging Techniques;Imaging technology;In Vitro;Infarction;Instruction;Ischemia;Label;Lead;Left Ventricular Dysfunction;Magnetic Resonance;Magnetic Resonance Imaging;Magnetism;Medical;Mentors;Mesenchymal Stem Cells;Methodology;Modeling;Molecular;Monitor;Morbidity - disease rate;Mus;Muscle Cells;Myocardial;Myocardial Infarction;Myocarditis;Myocardium;Necrosis;Operative Surgical Procedures;Outcome;Patient Care;Penetration;Pharmaceutical Preparations;Phosphatidylserines;Physiological;Populations at Risk;Positioning Attribute;Principal Investigator;Proteins;Recovery of Function;Research;Research Proposals;Resolution;Signal Transduction;Stem cell transplant;Stem cells;Symptoms;Syndrome;Testing;Therapeutic;Time;Tissues;Training;Treatment Protocols;Viral;Work;abstracting;adrenergic;allograft rejection;alpha-1 adrenergic receptors;annexin A5;career;career development;chemotherapy;clinically relevant;cohort;experience;extracellular;frontier;heart allograft;heart cell;improved;in vivo;insight;interest;iron oxide;malignant breast neoplasm;molecular imaging;mortality;novel;novel diagnostics;oxidative damage;particle;prevent;professor;programs;response;single photon emission computed tomography;skills;stem cell therapy","Cardiac Magnetic Resonance to Detect Apoptosis in Vivo using Magnetic Labeling.","n/a","NHLBI","8293239","6/5/2012 12:00:00 AM","PA-06-512","5K08HL097022-04","5","K08","HL","097022","04"," ","CARLSON, DREW E","8/15/2009 12:00:00 AM","6/30/2014 12:00:00 AM","ZHL1-CSR-O(M1)"," ","9020432","DASH, RAJESH ","Not Applicable","18","INTERNAL MEDICINE/MEDICINE","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","837","Other Research-Related","2012"," "," ","NHLBI","112450","8996"," ","121446",
"Aging; Arthritis; Bioengineering; Regenerative Medicine; Stem Cell Research","Address;Adult;Affect;Animal Model;Arthritis;Biology;Bioluminescence;Bone Marrow;Cardiovascular system;Cartilage;Cartilage injury;Cells;Chondrocytes;Chondrogenesis;Clinical Research;Clinical Research Curriculum Award;Data;Degenerative polyarthritis;Development;Dexamethasone;Dinoprostone;Embryo;Embryonic Development;Erinaceidae;Exogenous Factors;FGF2 gene;Funding;Gene Expression Profile;Generations;Goals;Grant;Health Sciences;Hospitals;Human;Hyaline Cartilage;Hypoxia;Image;In Vitro;Insulin-Like Growth Factor I;Joints;Luciferases;Mechanics;Mentors;Mesenchymal Stem Cells;Mesenchyme;Molecular Profiling;Morbidity - disease rate;Orthopedic Surgery procedures;Orthopedics;Outcome;Pluripotent Stem Cells;Population;Regenerative Medicine;Relative (related person);Reporting;Research;Research Personnel;Staging;Surface;Surface Antigens;Telomerase;Testing;Tissues;Training;Training Activity;Transforming Growth Factor beta;Tretinoin;United States;United States National Institutes of Health;Work;Writing;Xenograft Model;Xenograft procedure;articular cartilage;base;bone;career development;cartilage cell;cartilage regeneration;cartilage repair;design;early embryonic stage;improved;in vivo;induced pluripotent stem cell;innovation;knowledge base;lipid mediator;luminescence;meetings;mortality;novel;novel therapeutic intervention;osteogenic;progenitor;regenerative;repaired;restoration;skills;stem cell biology;stem cell differentiation","Generation of human chondroprogenitor cells for cartilage restoration"," Degenerative joint disease or osteoarthritis (OA) is a group of mechanical abnormalities involving degradation of joints, including articular cartilage and subchondral bone. According to the National Arthritis Data Workgroup, OA affected 26.9 million adults in 2005 in the United States, and the number is projected to increase up to 40% by 2030, therefore making joint surface restoration a priority. This application is highly relevant to the field of health science because it's designed to develop new therapeutic approaches for cartilage restoration, which in turn will reduce morbidity and mortality from degenerative joint disease.  
    

","NIAMS","8304960","6/27/2012 12:00:00 AM","PA-10-056","5K01AR061415-02","5","K01","AR","061415","02"," ","TYREE, BERNADETTE","7/20/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","10660951","EVSEENKO, DENIS ","Not Applicable","33","ORTHOPEDICS","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","SCHOOLS OF MEDICINE","900952000","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","107638","8611"," ","116249",
"Biotechnology; Breast Cancer; Cancer; Genetics; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Bioreactors;Bone Marrow;Bone Marrow Cells;Breast Cancer Cell;Cancer cell line;Cell Line;Cell Separation;Cell Survival;Cells;Clinical;Coculture Techniques;Computer Simulation;Cues;Data;Disseminated Malignant Neoplasm;Environment;Enzymes;Fluorescence;Future;Gene Targeting;Genes;Genetic Transcription;Goals;Growth;Human;Imagery;Immunohistochemistry;Immunotherapy;In Vitro;Label;Learning;Luciferases;MCF7 cell;Malignant Neoplasms;Maps;Marrow;Measurement;Measures;Mediator of activation protein;Mesenchymal Stem Cells;Messenger RNA;Metabolic;Metastatic Neoplasm to the Bone;Methodology;Microdissection;Modeling;Molecular;Mus;NF-kappa B;NOD/SCID mouse;Neoplasm Metastasis;Paracrine Communication;Pathway interactions;Pharmaceutical Preparations;Pharmacotherapy;Phase;Radiation therapy;Resistance;Sampling;Signal Pathway;Signal Transduction;Site;Specimen;Staging;Stromal Cells;Stromal Neoplasm;Testing;Time;Touch sensation;Transcript;Variant;Workplace;Xenograft Model;bone;cancer cell;candidate marker;carcinogenesis;cell motility;cell type;in vivo;malignant breast neoplasm;novel;novel strategies;research study;response;small hairpin RNA;therapeutic development;three-dimensional modeling;tumor;tumorigenic","Cell-Specific Transcription in Cancer Microenvironment in vitro and in vivo"," Bone metastases cause much of the suffering of advanced breast cancer.  It is believed that the cancer cells change the bone marrow environment to make it more hospitable.  This proposal seeks to measure for the first time which genes are turned on in normal bone marrow cells (stromal cells) by breast cancer cells that are touching them as this occurs.  We will then identify how the cancer cells within growing tumors in mice change their own gene transcription in response to the molecular cues from adjacent bone marrow cells.  We will test whether some of these signals have arisen in bone specimens containing breast cancer.  Learning this information will guide us in selecting drugs to treat metastatic breast cancer that interrupt specific responses of the stromal cells to the cancer cells and vice versa.  
    

","NCI","8236326","7/9/2012 12:00:00 AM","PA-10-067","1R01CA154728-01A1","1","R01","CA","154728","01","A","SATHYAMOORTHY, NEERAJA","7/9/2012 12:00:00 AM","4/30/2017 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1867541","STEINMAN, RICHARD A","Not Applicable","18","INTERNAL MEDICINE/MEDICINE","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","7/9/2012 12:00:00 AM","4/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","212297","111456"," ","323753",
"Bioengineering; Digestive Diseases; Human Fetal Tissue; Liver Disease; Regenerative Medicine; Stem Cell Research","3-Dimensional;Activities of Daily Living;Address;Admixture;Adult;Affect;Albumins;Architecture;Area;Biocompatible Materials;Biological Assay;Biology;Blood Coagulation Factor VII;Blood Vessel Tissue;Blood Vessels;Cardiac;Cardiac Myocytes;Cell Line;Cell Survival;Cell physiology;Cells;Cellular biology;Cytochrome P450;Deposition;Development;Dimensions;Drug Approval Processes;Drug Costs;Drug Industry;Drug toxicity;Endothelial Cells;Engineering;Enzymes;Extracellular Matrix;Failure;Fibroblasts;Fostering;Foundations;Generations;Goals;Hepatic;Hepatic Stellate Cell;Hepatocyte;Human;In Situ;In Vitro;Ink;Lead;Legal patent;Life;Liver;Liver diseases;Maintenance;Marketing;Measurable;Mesenchymal Stem Cells;Metabolic;Metabolism;Methods;Modeling;Molecular Conformation;Neurons;Pharmaceutical Preparations;Phase;Physiology;Play;Polymers;Positioning Attribute;Printing;Process;Production;Protocols documentation;Regimen;Research;Risk;Role;Screening procedure;Shapes;Smooth Muscle;Smooth Muscle Myocytes;Solutions;Source;Speed;Staging;Stem cells;Structure;System;Technology;Therapeutic;Time;Tissue Engineering;Tissue Microarray;Tissue Model;Tissues;Toxic effect;Toxicology;base;cell type;cost;density;drug development;drug discovery;drug metabolism;human embryonic stem cell;human tissue;improved;in vivo;induced pluripotent stem cell;innovation;instrument;liver function;liver-specific protein;metabolic abnormality assessment;novel;post-market;pressure;programs;prototype;safety testing;scaffold;stem;success;theories;tool","Generation of Three-Dimensional, Bioprinted, Functional Human Liver Tissue","  The goal of this project is to develop small-scale living 3-dimensional (3D) liver tissues, using a renewable source of functional liver cells, in a format compatible with current methods. Organovo's patent-pending bioprinting platform enables fabrication of 3D human tissues using cells as building blocks, without the use of synthetic or native tissue-derived biomaterials or scaffolding, yielding a tissue in vitro that recapitulates native tissue architecture and biology. The human liver tissues generated by this project have the potential to substantially improve the drug development process by providing a superior model of liver biology and liver toxicology. This effort could greatly reduce the cost of drug development by reducing the number of late stage drug failures thus the overall cost of drugs as well.   
   
      

","NIDDK","8312779","3/19/2012 12:00:00 AM","PA-11-096","1R43DK095584-01","1","R43","DK","095584","01"," ","DENSMORE, CHRISTINE L","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-IMST-M(13)B]"," ","11021172","PRESNELL, SHARON COLLINS","Not Applicable","52","Unavailable","809425114"," ","809425114"," ","US","32.895696","-117.19255","10018425","ORGANOVO, INC.","SAN DIEGO","CA","Domestic For-Profits","921212245","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","SBIR/STTR","2012"," "," ","NIDDK"," "," "," ","290053",
"Biodefense; Emerging Infectious Diseases; Genetics; Infectious Diseases; Injury (total) Accidents/Adverse Effects","Adrenergic Antagonists;Adrenergic Receptor;Adrenergic beta-Antagonists;Algorithms;Animal Model;Animals;Apoptosis;Architecture;Area;Biological Assay;Biological Markers;Biology;Biometry;Burn injury;CREB1 gene;Cell Proliferation;Cells;Clinic;Clinical;Clinical Sciences;Complex;Critical Pathways;Cytokine Gene;Data;Development;Dose;Evaluation;Failure;Fibroblast Growth Factor;Foundations;Gene Expression;Genes;Genetic;Glean;HSPB1 gene;Harvest;Healed;Health Benefit;Human;Impaired wound healing;Individual;Inflammation;Injury;Interleukins;Intervention;Investigation;Ionizing radiation;JUN gene;Leadership;Lesion;MAP Kinase Gene;MAP2K1 gene;MAPK1 gene;MAPK14 gene;MAPK3 gene;MAPK8 gene;Measures;Mesenchymal Stem Cells;Methods;Metric;Modeling;Molecular;Molecular Biology;Molecular Profiling;Mus;NF-kappa B;Nuclear Warfare;Operative Surgical Procedures;Outcome;Pathway interactions;Patients;Pattern;Pharmaceutical Preparations;Phase;Proteins;Public Health;Qualifying;RNA;ROC Curve;Radiation;Radiation Injuries;Radiobiology;Safety;Sampling;Science;Skin;Skin Tissue;Statistical Methods;Surface;Surgical wound;Testing;Time;Tissues;Trauma;Vascular Endothelial Growth Factors;Work;Wound Healing;Wounds and Injuries;abstracting;activating transcription factor;adverse outcome;base;beta-adrenergic receptor;cost;cytokine;healing;human data;improved;in vivo;injured;interest;irradiation;keratinocyte;mouse model;multidisciplinary;novel therapeutic intervention;programs;protein expression;public health relevance;repaired;response;success;tissue repair;wound","Molecular mechanisms and novel therapeutic approaches to combined radiation and b","
Public Health Relevance
In a nuclear warfare or terrorist incident, combined injury by radiation and burn wounding
is likely. We will provide a better mechanistic understanding of the molecular biology
behind healing of combined injury wounds, and will test a non-invasive assay for wound
healing success and a potential therapy to improve healing. All of this would be of
considerable public health benefit in such a scenario.","NIAID","8531403","8/21/2012 12:00:00 AM"," ","3R33AI080604-04S1","3","R33","AI","080604","04","S","DICARLO-COHEN, ANDREA L","7/15/2008 12:00:00 AM","2/28/2014 12:00:00 AM","NSS"," ","1973299","ROCKE, DAVID M.","ISSEROFF, ROSLYN R.","03","PUBLIC HEALTH & PREV MEDICINE","047120084","TX2DAGQPENZ5","047120084","TX2DAGQPENZ5","US","38.543675","-121.729989","577503","UNIVERSITY OF CALIFORNIA AT DAVIS","DAVIS","CA","SCHOOLS OF MEDICINE","956186153","UNITED STATES","N","8/21/2012 12:00:00 AM","2/28/2013 12:00:00 AM","855","Non-SBIR/STTR","2012"," "," ","NIAID","73955","39916"," ","113871",
"Aging; Clinical Research; Diabetes; Osteoporosis; Prevention; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Adipocytes;Adverse effects;Affect;Age;Aging;Alkaline Phosphatase;Antioxidants;Apoptosis;Biochemical;Biological Assay;Blood Circulation;Blood Vessels;Bone Density;Bone Marrow;Bromodeoxyuridine;Cell Proliferation;Cells;DNA Nucleotidylexotransferase;Development;Diabetes Mellitus;Differentiation Antigens;Discontinuous Capillary;Early treatment;Elderly;Endocrine;Enzymes;Extracellular Matrix;Failure;Fatty acid glycerol esters;Female;Fluorescence-Activated Cell Sorting;Fracture;Functional disorder;Future;Generations;Glucose;Hip Fractures;Hip region structure;Hormonal;Human;In Vitro;Incubated;Individual;Investigation;Knowledge;Label;Marrow;Measures;Mediating;Mesenchymal Stem Cells;Metabolic;Methods;Modeling;Morbidity - disease rate;Musculoskeletal;Non-Insulin-Dependent Diabetes Mellitus;Osteoblasts;Osteogenesis;Outcomes Research;Oxidative Stress;Oxidative Stress Induction;Pathogenesis;Pathway interactions;Persons;Physiological;Population;Postmenopause;Prevention;Process;Production;Public Health;Reactive Oxygen Species;Research;Risk;Role;Serum;Skeleton;Speed;Staining method;Stains;System;Targeted Research;Testing;Time;Transferase;Translating;Undifferentiated;Woman;aging population;bone;bone quality;catalyst;diabetic;disability;effective intervention;enzyme activity;frailty;glucose tolerance;high risk;impaired glucose tolerance;indexing;innovation;mRNA Expression;mineralization;mortality;novel;oil red O;osteoblast differentiation;osteogenic;precursor cell;premature;prevent;research study;skeletal;therapeutic target","Glycemic derangement and osteogenic cells:A model of Premature skeletal aging"," The proposed research is relevant to public health because identifying the pathogenesis of skeletal failure in T2DM will speed the discovery of effective strategies for hip fracture prevention in the aging, diabetic population. This research is also expected to stimulate future exploration into the role of hormonal, metabolic and musculoskeletal dysregulation in the development of disability and frailty with age.  
  
    

","NIA","8313922","7/17/2012 12:00:00 AM","RFA-AG-11-007","5R03AG040695-02","5","R03","AG","040695","02"," ","WILLIAMS, JOHN","8/15/2011 12:00:00 AM","1/31/2016 12:00:00 AM","ZAG1-ZIJ-9(M1)"," ","10110321","MOSELEY, KENDALL ","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","8/1/2012 12:00:00 AM","1/31/2016 12:00:00 AM","866","Non-SBIR/STTR","2012"," "," ","NIA","50000","31000"," ","81000",
"Aging; Bioengineering; Clinical Research; Complementary and Alternative Medicine; Diagnostic Radiology; Estrogen; Nutrition; Obesity; Osteoporosis; Prevention; Rehabilitation","Address;Adherence;Adipocytes;Adverse effects;Affect;Age;Aging;Alternative Therapies;American;Animal Model;Biomechanics;Bone Density;Bone Marrow;Bone Resorption;Cells;Competence;Data;Diagnosis;Disease;Distal;Double-Blind Method;Down-Regulation;Dual-Energy X-Ray Absorptiometry;Electronics;Elements;Equilibrium;Estrogens;Exercise;Failure;Fatty acid glycerol esters;Feedback;Fracture;Frequencies;Gender;Gene Expression;Hip region structure;Human;Image;Intervention;Laboratories;Life Style;Magnetic Resonance Imaging;Maintenance;Marrow;Measurement;Measures;Mechanical Stimulation;Mechanics;Menopause;Mesenchymal Stem Cells;Methodology;Methods;Modeling;Monitor;Nuclear Hormone Receptors;Obesity;Osteoblasts;Osteocytes;Osteogenesis;Osteoporosis;Outcome;Patients;Peripheral;Peroxisome Proliferator-Activated Receptors;Pharmaceutical Preparations;Placebos;Play;Postmenopause;Predisposition;Prevalence;Prevention;Property;Protocols documentation;Public Health;Radial;Randomized;Relative (related person);Reporting;Resolution;Risk Factors;Sheep;Signaling Molecule;Site;Staging;Stromal Cells;Tissues;Vertebral column;Woman;Work;aged;base;bone;bone loss;bone mass;bone strength;cohort;cost;density;effective therapy;follow-up;imaging modality;improved;insight;lipid biosynthesis;lumbar vertebra bone structure;magnetic resonance spectroscopic imaging;men;osteogenic;peer;prophylactic;randomized placebo controlled trial;response;sedentary;skeletal;skeletal disorder;spectroscopic imaging;spine bone structure;substantia spongiosa;tibia;treatment response;vibration;young woman","Osteoporosis treatment response assessed by micromechanical modeling of MRI data."," Osteoporosis and low bone mass are major public health issues affecting a significant portion of older Americans, in particular women after menopause. While effective drug treatment is now available, it is expensive, associated with significant side effects and indicated only at a late stage of the disease at which point it is no longer reversible Mechanical stimulation is a new, entirely noninvasive form of nonpharmacologic intervention, but its effect in terms of conferring bone strength is not known. By evaluating changes in bone mechanical competence in early postmenopausal women undergoing mechanical stimulation via image-based computational biomechanics, this project focuses on prevention rather than treatment.   
      

","NIAMS","8297424","6/11/2012 12:00:00 AM","PA-10-067","2R01AR055647-05","2","R01","AR","055647","05"," ","LESTER, GAYLE E","9/7/2007 12:00:00 AM","8/31/2017 12:00:00 AM","Special Emphasis Panel[ZRG1-DTCS-U(81)S]"," ","1862421","WEHRLI, FELIX W","Not Applicable","03","RADIATION-DIAGNOSTIC/ONCOLOGY","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","287133","145058"," ","432191",
"Biotechnology; Cardiovascular; Genetics; Heart Disease; Nutrition; Obesity","Adipose tissue;Adult;Alleles;Animals;Binding;Binding Proteins;Biopsy;Body Temperature;Brown Fat;Burn injury;Calories;Cardiovascular Diseases;Cell Culture System;Cell Culture Techniques;Cells;Characteristics;Cytoplasm;Development;Diet;Down-Regulation;EF Hand Motifs;EF-Hand Domain;Ear;Eating;Embryo;Energy Intake;Energy Metabolism;Energy Metabolism Pathway;Fatty acid glycerol esters;Fiber;Fibroblasts;Gene Expression;Gene Expression Profile;Generations;Genes;Genetic Models;Genetically Engineered Mouse;Genus Hippocampus;Glycerol;Glycerol-3-Phosphate Dehydrogenase;Grant;Heart;Heating;Homeostasis;Human;Image;In Vitro;Indirect Calorimetry;Inner mitochondrial membrane;Lead;Location;Maintenance;Measures;Mediating;Mesenchymal Stem Cells;Metabolic;Metabolism;Mitochondria;Molecular Genetics;Mus;Muscle;Muscle Cells;Muscle Contraction;Muscle Fatigue;Muscle function;Mutant Strains Mice;Mutation;Myocardial;Myocardium;Obesity;Oxidoreductase;Pathway interactions;Phenotype;Physical Endurance;Physical activity;Physiologic Thermoregulation;Physiological;Physiological Processes;Physiology;Play;Predisposition;Production;Property;Proteins;Regulation;Resistance;Respiration;Role;SV40 T Antigens;Sarcoplasmic Reticulum;Skeletal Muscle;Stress;Structure;System;Testing;Thermogenesis;Tissues;Up-Regulation;Work;base;design;diabetic;diabetic patient;energy balance;extracellular;in vivo;inorganic phosphate;insulin sensitivity;mitochondrial uncoupling protein;mutant;novel;null mutation;nutrition;oxidation;protein expression;public health relevance;research study;response;subcutaneous","Molecular Genetics of Thermogenesis","
The efficiency of energy metabolism, defined as the ability to rapidly produce energy in
response to a cellular requirement, is profoundly important for many physiological
processes, such as excitation-contraction of heart and skeletal muscle. Consequently,
the inefficient production of ATP in the muscle of diabetic patients can lead to
cardiovascular disease. Through our studies of mutant mice we have identified a protein
called SLC25A25 that is important for the achieving maximal metabolic efficiency, which
when inactivated causes extreme muscle fatigue. We found major reductions of
Slc25a25 gene expression in skeletal muscle biopsies from obese and type 2 diabetic
humans that correlate with insulin sensitivity. In this proposal using genetically
engineered mice we will test the hypothesis that SLC25A25 functions by supporting the
energy requirements for muscle function and body temperature regulation.","NIDDK","8305096","4/30/2012 12:00:00 AM","PA-07-070","5R01DK089641-35","5","R01","DK","089641","35"," ","LAUGHLIN, MAREN R","5/1/2010 12:00:00 AM","4/30/2014 12:00:00 AM","Integrative Physiology of Obesity and Diabetes Study Section[IPOD]"," ","1912664","MYNATT, RANDALL LEE","YOUNG, MARTIN E","06","NONE","611012324","MWYVQTQ32ME5","611012324","MWYVQTQ32ME5","US","30.404354","-91.122411","577909","LSU PENNINGTON BIOMEDICAL RESEARCH CTR","BATON ROUGE","LA","ORGANIZED RESEARCH UNITS","708084124","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","285803","104182"," ","389985",
"Biotechnology; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Affect;Agonist;American;Animals;Area;Autologous;Award;Cardiac;Cardiac Myocytes;Cardiomyopathies;Cardiomyoplasty;Cardiovascular system;Catheterization;Cell Communication;Cell Cycle;Cell Proliferation;Cell Survival;Cell Therapy;Cells;Cessation of life;Chronic;Cicatrix;Clinical;Clinical Data;Clinical Trials;Coculture Techniques;Connexin 43;Data;Disease;Disease Progression;Engraftment;Exhibits;Experimental Models;Family suidae;Fibrosis;Functional disorder;Funding;Gap Junctions;Genetic;Glean;Healed;Health;Heart;Heart failure;Hospitalization;Human;Image;Immunohistochemistry;In Vitro;Infarction;Injection of therapeutic agent;Investigation;Label;Left Ventricular Dysfunction;Link;Longitudinal Studies;Magnetic Resonance Imaging;Measurement;Mediating;Mesenchymal Stem Cells;Modeling;Modification;Molecular;Motion;Muscle Cells;Myocardial;Myocardial Infarction;Myocardial Ischemia;Myocardium;Natural regeneration;Patients;Phosphotransferases;Process;Property;Recurrence;Research;Risk;Role;Safety;Series;Somatotropin-Releasing Hormone;Staging;Stem cells;System;Testing;Therapeutic;Tissues;Translating;Ventricular Remodeling;Work;base;cardiac repair;cell type;cellular engineering;clinical efficacy;clinically relevant;common treatment;design;disability;follow-up;functional improvement;healing;hemodynamics;improved;in vivo;injured;innovation;insight;intercellular communication;knowledge base;myocardial infarct sizing;novel;overexpression;patient population;pre-clinical;preclinical study;pressure;programs;regenerative;repaired;response;restoration;sudden cardiac death;translational approach","Cellular Cardiomyoplasty for Chronic Heart Failure"," This preclinical study will address a significant clinical need, namely the investigation of mechanisms of action of new and promising cell-based therapies for heart dysfunction due to heart attack. This is one of the leading causes of cardiovascular death and disability. The proposed studies will elucidate new mechanistic insights for enhancing the clinical efficacy and safety of cell-based therapy for the treatment of this common and important disorder.    
      

","NHLBI","8392856","7/23/2012 12:00:00 AM","PA-10-067","2R01HL084275-06","2","R01","HL","084275","06"," ","BUXTON, DENIS B","7/5/2007 12:00:00 AM","5/31/2017 12:00:00 AM","Myocardial Ischemia and Metabolism Study Section[MIM]"," ","1893621","HARE, JOSHUA M","Not Applicable","27","INTERNAL MEDICINE/MEDICINE","052780918","F8THLJQSAF93","052780918","F8THLJQSAF93","US","25.775337","-80.209809","5221250","UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","CORAL GABLES","FL","SCHOOLS OF MEDICINE","331462926","UNITED STATES","N","7/23/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","132500"," ","382500",
"Biotechnology; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adult;Apoptosis;Autophagocytosis;Bone Marrow;Cardiac;Cardiac Myocytes;Cause of Death;Cell Death;Cell Nucleus;Cell Therapy;Cells;Cessation of life;Complex;Country;Cyclin D1;Cytosol;Development;Dominant-Negative Mutation;Down-Regulation;Enzymes;Exhibits;Funding;Glycogen Synthase Kinase 3;Growth;Heart;Heart Hypertrophy;Heart failure;Hypertrophy;Injection of therapeutic agent;Injury;Intervention;Investigation;Ischemia;Knock-in Mouse;Knowledge;Laboratories;Lead;Left;Location;Mediating;Medical;Mesenchymal Stem Cells;Molecular;Mus;Muscle Cells;Myocardial;Myocardial Infarction;Myocardial Ischemia;Myocardial Reperfusion;Myocardium;Nuclear;Pathway interactions;Phosphorylation;Phosphotransferases;Physiological;Play;Protein Biosynthesis;Protein Isoforms;Protein-Serine-Threonine Kinases;Recovery;Recovery of Function;Regulation;Reperfusion Injury;Reperfusion Therapy;Role;Stress;TSC2 gene;Up-Regulation;Work;angiogenesis;heart cell;human FRAP1 protein;improved;in vivo;mTOR protein;mitochondrial dysfunction;mouse model;novel;precursor cell;pressure;prevent;public health relevance;stem cell differentiation;stem cell therapy;transcription factor","Regulation of myocardial growth and death by GSK-3","
PROJECT NARRATIVE:
Despite recent progress in medical therapy, heart failure is one of the most common causes of death in
western countries. Understanding the molecular mechanism mediating growth and death of cardiac muscle is
fundamentally important and potentially leads to better medical treatment for heart failure. This laboratory has
been working on an enzyme termed glycogen synthase kinase-3, which plays an essential role in regulating
growth and death of cardiomyocytes. Although this enzyme in the heart exists as two distinct forms, namely
alpha and beta isoforms, the function of each form is not well understood. We will investigate the function of
each isoform during heart failure, ischemic heart disease and stem cell differentiation, using genetically
modified mice and mouse models of heart failure and ischemia/reperfusion injury. The knowledge obtained
from this investigation should be useful for the development of better treatment for heart failure, ischemic injury
and stem cell therapy.
 ","NHLBI","8254462","3/6/2012 12:00:00 AM","PA-07-070","5R01HL067724-12","5","R01","HL","067724","12"," ","BUXTON, DENIS B","9/30/2000 12:00:00 AM","2/28/2014 12:00:00 AM","Cardiac Contractility, Hypertrophy, and Failure Study Section[CCHF]"," ","6354902","SADOSHIMA, JUNICHI ","Not Applicable","10","ANATOMY/CELL BIOLOGY","623946217"," ","623946217"," ","US","40.738771","-74.190235","714201","UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL","NEWARK","NJ","SCHOOLS OF MEDICINE","071032757","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","222750","124740"," ","347490",
"Breast Cancer; Cancer","Biological Process;Breast;Cell Line;Cell Proliferation;Cell-Cell Adhesion;Cells;Cessation of life;Common Neoplasm;Cyclic AMP;Cyclic AMP-Dependent Protein Kinases;Data;Dermis;Developed Countries;Development;Disease;Duct (organ) structure;Ductal;Embryo;Epidermis;Epithelial;Epithelial Cells;Epithelium;Failure;Fatty acid glycerol esters;Functional disorder;Gene Expression;Genes;Goals;Growth Factor;Hair follicle structure;Human;Knowledge;Laboratories;Limb Bud;Mammary Neoplasms;Mammary gland;Mediating;Mesenchymal;Mesenchyme;Morbidity - disease rate;Morphogenesis;Mus;Neoplasm Metastasis;Nipples;Pathogenesis;Pathway interactions;Phenocopy;Primary Neoplasm;Process;Publishing;Series;Signal Pathway;Signal Transduction;Skeleton;Skin;Source;Staging;System;Tissues;Tumor Cell Invasion;Woman;Work;analog;bone morphogenetic protein 4;bone morphogenetic protein receptors;cell motility;cost;defined contribution;improved;in vivo;insight;malignant breast neoplasm;mammary epithelium;mammary gland development;metastatic process;mortality;mutant;overexpression;parathyroid hormone-related protein;premature;promoter;receptor;soft tissue;tumor progression","PTHrP in Mammary Development","
8. PROJECT NARRATIVE
 Breast cancer is the most common neoplasm afflicting women in the US and other developed
countries. This disease causes much suffering, is responsible for a large number of premature deaths and
costs the US economy a great amount each year. The source of most morbidity and mortality from breast
cancer is not the primary tumor itself, which can be removed surgically, but rather metastases to the skeleton
and soft tissues. Therefore understanding the mechanisms related to tissue invasion and metastases are
crucial for better therapy. Normal mammary development relies on many processes such as the modulation of
cell adhesion, cell proliferation, cell migration and matrix remodeling that are common to tumor invasion and
the metastatic cascade. This is particularly true of embryonic mammary development, which involves the
invasion of the nascent mammary epithelial ducts from one stromal compartment and into another. Our
preliminary data suggest that the initiation of embryonic ductal proliferation may rely on interactions between
PTHrP, Wnt and BMP signaling. All three of these growth factor pathways are also involved in breast cancer
pathogenesis. Therefore, we believe that understanding how PTHrP modulates mesenchymal Wnt and BMP
signaling to regulate embryonic mammary development may ultimately help us to understand the metastatic
process better.","NIDDK","8282942","6/27/2012 12:00:00 AM","PA-10-067","5R01DK055501-13","5","R01","DK","055501","13"," ","SATO, SHERYL M","9/30/1999 12:00:00 AM","6/30/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1872589","WYSOLMERSKI, JOHN J","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","198000","129690"," ","327690",
"Cancer; Lung; Smoking and Health; Tobacco","Acetylcysteine;Acrolein;Affect;Agonist;Alkylation;Amino Acids;Antioxidants;Biochemical;Cell Line;Cells;Cysteine;Cytoskeleton;Data;Development;Disseminated Malignant Neoplasm;Disulfides;Dose;E-Cadherin;EGF gene;Enzymes;Epithelial;Epithelial Cells;Event;Exposure to;Family member;Fibrosis;Glutathione;Growth Factor;Hamman-Rich syndrome;Human;Hydrogen Peroxide;In Vitro;Individual;Leucine;Lung;Malignant Epithelial Cell;Malignant neoplasm of lung;Mass Spectrum Analysis;Measures;Mediating;Mesenchymal;Methods;Modeling;Modification;Molecular;Molecular Conformation;Mutate;Neoplasm Metastasis;Non-Small-Cell Lung Carcinoma;Oxidants;Oxidation-Reduction;Oxidative Stress;Pathway interactions;Phenotype;Phosphorylation;Physiological;Plasmids;Platelet-Derived Growth Factor;Protein Dephosphorylation;Protein Kinase;Protein Tyrosine Kinase;Proteins;Regulation;Relative (related person);Reporting;Rest;Signal Pathway;Signal Transduction;Site;Smoke;Sorting - Cell Movement;Stimulus;Testing;Tetrachlorodibenzodioxin;Vimentin;Zinc;Zinc deficiency;base;cancer cell;cell transformation;cell type;cigarette smoke-induced;cigarette smoking;cigarette smoking;in vivo;inhibitor/antagonist;oxidation;prevent;receptor;receptor binding;src-Family Kinases","Oxidative activation of Src in smoke-induced epithelial mesenchymal transition"," Src is an enzyme that is critical to the transformation of normal epithelial cells into other cell types that are associated with fibrosis and metastatic cancer. Cigarette smoking can cause this transformation and our results suggest that oxidizing and alkylating compounds in smoke are the cause of Src activation and cell transformation. We will investigate how Src is activated at a molecular level and whether this kind of activation also
causes prolonged Src activity.   
   
      

","NIEHS","8383384","8/30/2012 12:00:00 AM","PA-11-261","1R21ES020942-01A1","1","R21","ES","020942","01","A","NADADUR, SRIKANTH","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Xenobiotic and Nutrient Disposition and Action Study Section[XNDA]"," ","1887462","FORMAN, HENRY JAY","Not Applicable","37","NONE","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","OTHER SPECIALIZED SCHOOLS","900894304","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","NIEHS","150000","96000"," ","246000",
"Biodefense; Genetics; Injury (total) Accidents/Adverse Effects","Adrenergic Antagonists;Adrenergic Receptor;Adrenergic beta-Antagonists;Algorithms;Animal Model;Animals;Apoptosis;Architecture;Area;Biological Assay;Biological Markers;Biology;Biometry;Burn injury;CREB1 gene;Cell Proliferation;Cells;Clinic;Clinical;Clinical Sciences;Complex;Critical Pathways;Cytokine Gene;Data;Development;Dose;Evaluation;Failure;Fibroblast Growth Factor;Foundations;Gene Expression;Genes;Genetic;Glean;HSPB1 gene;Harvest;Healed;Health Benefit;Human;Impaired wound healing;Individual;Inflammation;Injury;Interleukins;Intervention;Investigation;Ionizing radiation;JUN gene;Leadership;Lesion;MAP Kinase Gene;MAP2K1 gene;MAPK1 gene;MAPK14 gene;MAPK3 gene;MAPK8 gene;Measures;Mesenchymal Stem Cells;Methods;Metric;Modeling;Molecular;Molecular Biology;Molecular Profiling;Mus;NF-kappa B;Nuclear Warfare;Operative Surgical Procedures;Outcome;Pathway interactions;Patients;Pattern;Pharmaceutical Preparations;Phase;Proteins;Public Health;Qualifying;RNA;ROC Curve;Radiation;Radiation Injuries;Radiobiology;Safety;Sampling;Science;Skin;Skin Tissue;Statistical Methods;Surface;Surgical wound;Testing;Time;Tissues;Trauma;Vascular Endothelial Growth Factors;Work;Wound Healing;Wounds and Injuries;abstracting;activating transcription factor;adverse outcome;base;beta-adrenergic receptor;cost;cytokine;healing;human data;improved;in vivo;injured;interest;irradiation;keratinocyte;mouse model;multidisciplinary;novel therapeutic intervention;programs;protein expression;public health relevance;repaired;response;success;tissue repair;wound","Molecular mechanisms and novel therapeutic approaches to combined radiation and b","
Public Health Relevance
In a nuclear warfare or terrorist incident, combined injury by radiation and burn wounding
is likely. We will provide a better mechanistic understanding of the molecular biology
behind healing of combined injury wounds, and will test a non-invasive assay for wound
healing success and a potential therapy to improve healing. All of this would be of
considerable public health benefit in such a scenario.","NIAID","8332261","2/27/2012 12:00:00 AM"," ","5R33AI080604-04","5","R33","AI","080604","04"," ","DICARLO-COHEN, ANDREA L","7/15/2008 12:00:00 AM","2/28/2014 12:00:00 AM","NSS"," ","1973299","ROCKE, DAVID M.","ISSEROFF, ROSLYN R.","03","PUBLIC HEALTH & PREV MEDICINE","047120084","TX2DAGQPENZ5","047120084","TX2DAGQPENZ5","US","38.543675","-121.729989","577503","UNIVERSITY OF CALIFORNIA AT DAVIS","DAVIS","CA","SCHOOLS OF MEDICINE","956186153","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","855","Non-SBIR/STTR","2012"," "," ","OD","242550","130573"," ","373123",
"Bioengineering; Nanotechnology; Regenerative Medicine","Academy;Adhesions;Adult;Affect;Air;Alloys;American;Apoptosis;Applications Grants;Biocompatible Materials;Biological;Biological Assay;Biomedical Engineering;Blood;Body Fluids;Chemicals;Clinical;Clinical Trials;Cobalt;Couples;Deposition;Development;Devices;Diamond;Dinoprostone;Dislocations;Endotoxins;Exhibits;Experimental Designs;Failure;Finite Element Analysis;Friction;Future;Goals;Hardness;Hip region structure;Hour;Human;Implant;In Vitro;Industry;Interleukin-1;Interleukin-6;Investigation;Joints;Knee;Lead;Life;Liquid substance;Measures;Mechanics;Mesenchymal Stem Cells;Metals;Methods;Modeling;Motion;NIH Program Announcements;Nanotechnology;New Zealand;Operative Surgical Procedures;Orthopedics;Oryctolagus cuniculus;Osseointegration;Osteolysis;Outcome Study;Pain;Particle Size;Polyethylenes;Property;Protocols documentation;Rattus;Recurrence;Replacement Arthroplasty;Research;Resistance;Route;Services;Simulate;Sterility;Structure;Surface;Surgeon;TNF gene;Testing;Thick;Time;Tissues;Titania;Titanium;Universities;Weight-Bearing state;biomaterial compatibility;bone;clinically relevant;cytokine;cytotoxicity;design;hip replacement arthroplasty;implant coating;implantable device;improved;in vivo;knee replacement arthroplasty;macrophage;nano;nanostructured;particle;research study;response;restoration;sample fixation;statistics;substantia spongiosa;success;tool;vapor","Bioengineering Research Partnership in Total Joint Replacements","
PROJECT NARRATIVE
We propose the use of nanotechnology approaches for controlling interfaces between the hip
and knee implants and the surrounding tissues. The primary focus of this grant application is to
improve the fixation, durability and osseointegration for long-term success of Total Joint
Replacements and lower the need for recurrent multiple surgical procedures. Also, development
of new nanotechnology tools and methods will lead to a new class of functionalized
nanostructured surfaces for titanium and cobalt chrome alloys for use in biomedical implant
industry. One benefit of the diamond-diamond components will be reductions in overall device
size that will ultimately allow for a clinically less-invasive route to joint restoration and longer
implant lifetime in vivo.","NIAMS","8291149","6/13/2012 12:00:00 AM","PAR-07-352","5R01AR056665-04","5","R01","AR","056665","04"," ","PANAGIS, JAMES S","7/1/2009 12:00:00 AM","6/30/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-B(03)M]"," ","6490731","VOHRA, YOGESH K.","Not Applicable","07","PHYSICS","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","SCHOOLS OF ARTS AND SCIENCES","352940001","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2015 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","128304","59661"," ","187965",
"Bioengineering; Biotechnology; Neurosciences; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adult;Advanced Development;Alzheimer&apos;s Disease;Amyotrophic Lateral Sclerosis;Astrocytes;Behavior;Biochemical;Biocompatible Materials;Biomechanics;Brain;Cell Adhesion;Cell Fate Control;Cell Lineage;Cell physiology;Cells;Cessation of life;Commit;Complex;Cues;Cytoskeleton;Data;Decision Making;Development;Disease;Dominant-Negative Mutation;Environment;Enzymes;Event;Exhibits;Exposure to;Extracellular Matrix;Fatty acid glycerol esters;Focal Adhesions;Future;Genes;Goals;Growth Factor;Hippocampus (Brain);Hour;In Vitro;Knowledge;Learning;Life;Measurement;Mechanics;Memory;Mesenchymal Stem Cells;Modeling;Molecular;Myosin Type II;Neurodegenerative Disorders;Neuronal Differentiation;Neurons;Organism;Parkinson Disease;Play;Population;Process;Property;Proteins;Rattus;Regenerative Medicine;Retroviral Vector;Role;Science;Signal Pathway;Signal Transduction;Stem cells;Surface;System;Time;Tissue Engineering;Tissues;Traction;Variant;Work;adhesion receptor;bone;cell behavior;cell type;design;in vivo;innovation;insight;interest;migration;morphogens;nerve stem cell;neurodevelopment;neurogenesis;non-muscle myosin;relating to nervous system;response;rho GTP-Binding Proteins;self-renewal;stem;stem cell biology;stem cell differentiation;stem cell fate;stem cell niche;tool;transcription factor;translational medicine","Mechanisms of Neural Stem Cell Mechanoregulation","
 PROJECT NARRATIVE
Adult neural stem cells (NSCs) are a population of cells in the adult brain that have the ability to renew
themselves throughout life and give rise to a variety of cell types, including neurons. NSCs are of tremendous
interest for both their potential role in neural development and disease and because they may be harnessed in
various ways to treat neurodegenerative disease (e.g., Alzheimer's, Parkinson's, and Lou Gehrig's Diseases).
The goal of this proposal is to understand mechanisms through which biomechanical inputs from the cellular
microenvironment influence NSC neurogenesis in vitro and in vivo, which we expect will significantly add to our
understanding of NSC biology and help inform the design of tissue engineering and regenerative medicine
strategies to treat disease.","NINDS","8297995","4/20/2012 12:00:00 AM","PA-10-067","1R01NS074831-01A1","1","R01","NS","074831","01","A","OWENS, DAVID F","5/1/2012 12:00:00 AM","4/30/2017 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","2242041","SCHAFFER, DAVID V","KUMAR, SANJAY ","13","ENGINEERING (ALL TYPES)","124726725","GS3YEVSS12N6","124726725","GS3YEVSS12N6","US","37.870295","-122.268133","577502","UNIVERSITY OF CALIFORNIA BERKELEY","BERKELEY","CA","BIOMED ENGR/COL ENGR/ENGR STA","947101749","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","218750","110029"," ","328779",
"Biotechnology; Cancer; Gene Therapy; Genetics; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Acute;Animal Model;Animals;Antineoplastic Agents;Antiviral Agents;Apoptosis;Binding;CXCL12 gene;Cell Cycle;Cell membrane;Cells;Characteristics;Chemicals;Clinical;Clinical Trials;Clinical Trials Design;Cytolysis;Data;Decitabine;Development;Development Plans;Dichloroacetate;Disease;Energy Metabolism;Engineering;Future;GTPase-Activating Proteins;Gene Delivery;Gene Expression;Generations;Genes;Giant Cells;Goals;Growth;Herpesvirus 1;Human Herpesvirus 2;Immune system;Immunity;In Vitro;Induction of Apoptosis;Laboratories;Malignant - descriptor;Malignant Neoplasms;Mediating;Membrane Fusion;Mesenchymal Stem Cells;Modeling;Natural Immunity;Normal Cell;Oncolytic;Oncolytic viruses;Outcome;Pathway interactions;Patients;Pharmaceutical Preparations;Phase;Play;Preclinical Testing;Property;Proteins;Ras Signaling Pathway;Regimen;Resistance;Role;Route;S Phase;Simplexvirus;Staging;Testing;Therapeutic;Toxic effect;Toxicology;Translating;Treatment Efficacy;Tumor Tissue;Viral;Virus;Virus Diseases;Virus Replication;Work;abstracting;base;cancer therapy;cell killing;chemotherapy;clinical application;design;gemcitabine;gene therapy;improved;in vivo;killings;mutant;neoplastic cell;novel;preclinical study;ras GTPase-Activating Proteins;success;trafficking;tumor","Development of an HSV-2 based oncolytic virus","
Project Narrative
Using viruses to kill tumor cells has shown considerable promise in the laboratory and in early clinical trials.
Yet several obstacles must be overcome before this strategy gains acceptance as a safe and potent form of
cancer therapy. The applicant has constructed a virus from herpes simplex virus type 2, called FusOn-H2,
which has produced encouraging antitumor activity in animal tumor models. He now propose to develop and
test different strategies for improving FusOn-H2 virotherapy, with the long-term goal of translating this
treatment into a clinically feasible option for patients with malignant sold tumors.","NCI","8196839","12/1/2011 12:00:00 AM","PA-07-070","5R01CA132792-05","5","R01","CA","132792","05"," ","WELCH, ANTHONY R","12/1/2008 12:00:00 AM","11/30/2013 12:00:00 AM","Developmental Therapeutics Study Section[DT]"," ","7740876","ZHANG, XIAOLIU ","Not Applicable","18","BIOLOGY","036837920","QKWEF8XLMTT3","036837920","QKWEF8XLMTT3","US","29.721486","-95.338112","1449402","UNIVERSITY OF HOUSTON","HOUSTON","TX","SCHOOLS OF ARTS AND SCIENCES","772042610","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","201275","100638"," ","301913",
"Bioengineering; Biotechnology; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","3-Dimensional;Adhesions;Affinity;Agonist;Animals;Attenuated;Autocrine Communication;Biocompatible Materials;Biological;Biological Assay;Blood Circulation;Blood Vessels;Bone Growth;Bone Regeneration;Calvaria;Cell Adhesion;Cell Communication;Cells;Cephalic;Chimera organism;Chronic;Clinical;Cutaneous;Data;Defect;Development;Dorsal;Dorsal Skinfold Window Chamber Model;Dose;Drug Delivery Systems;Encapsulated;Endothelial Cells;Endothelium;Family;Figs - dietary;G-Protein-Coupled Receptors;Glycolates;Growth;Harvest;Healed;Homing;Immunohistochemistry;Implant;In Vitro;Inflammation;Inflammatory;Injection of therapeutic agent;Kinetics;Label;Left;Leukocytes;Life Expectancy;Lipids;Marrow;Measures;Medical;Mesenchymal Stem Cells;Methods;Microspheres;Modeling;Mus;Natural regeneration;Oral;Organ;Organ Transplantation;Osteoblasts;Osteoclasts;Osteogenesis;Osteoid;Outcome;Paracrine Communication;Pathologic;Patients;Pericytes;Pharmaceutical Preparations;Population;Rattus;Receptor Signaling;Recombinants;Regulation;Relative (related person);Resolution;Role;Signal Transduction;Site;Smooth Muscle Myocytes;Stem cells;Supporting Cell;TNF gene;Tail;Testing;Therapeutic;Tissue Engineering;Tissue Grafts;Tissues;Transplantation;Veins;Waiting Lists;angiogenesis;base;biodegradable polymer;bone;bone cell;bone healing;clinical application;craniofacial;cytokine;density;edg-3 Protein;gain of function;healing;implantation;in vivo;inflammatory modulation;inorganic phosphate;loss of function;migration;monocyte;osteoblast differentiation;osteoprogenitor cell;prevent;progenitor;receptor;reconstruction;research study;response;restoration;scaffold;skeletal injury;tissue regeneration;tissue repair;tomography","Therapeutic S1P Drug Targets for Cranial Bone Repair","
Project Narrative
The replacement or restoration of function to traumatized, damaged, or lost organs and tissues is an
increasingly significant clinical problem. It is estimated that only 24,422 received organ transplants of a
possible 79,512 patients on the transplantation wait list in 2002. In addition, it is currently estimated that over
1.5 million skeletal injuries alone will require tissue graft reconstruction in the US each year, and these
numbers will continue to grow as the life expectancy of the population increases. Thus, the development of
effective strategies to harness inflammation for revascularization and regeneration of osseous tissue defects is
a significant medical need.","NIDCR","8268316","9/11/2012 12:00:00 AM","RFA-DE-09-001","7R01DE019935-04","7","R01","DE","019935","04"," ","LUMELSKY, NADYA L","6/5/2009 12:00:00 AM","4/30/2014 12:00:00 AM","ZDE1-RW(11)"," ","2108099","BOTCHWEY, EDWARD A.","Not Applicable","05","ENGINEERING (ALL TYPES)","097394084","EMW9FC8J3HN4","097394084","EMW9FC8J3HN4","US","33.762977","-84.42296","676603","GEORGIA INSTITUTE OF TECHNOLOGY","ATLANTA","GA","BIOMED ENGR/COL ENGR/ENGR STA","303320415","UNITED STATES","N","8/24/2012 12:00:00 AM","4/30/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","245025","110700"," ","355725",
"Biotechnology; Clinical Research; Hematology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Acceleration;Acute;Affect;American;Antibodies;Area;Aspirate substance;Autologous;Beds;Biomedical Engineering;Biopsy;Biopsy Specimen;Blinded;Bone Marrow;Bone Marrow Cells;Bone Marrow Stem Cell;Carbon Dioxide;Caring;Cartilage;Cell Count;Cell Therapy;Cells;Chronic;Clinical;Clinical Trials;Compression Bandage;Dermal;Diabetic ulcer;Direct Costs;Double-Blind Method;Effectiveness;Elastic Fiber;Elastin;Endothelium;Epithelial;Fatty acid glycerol esters;Fibrin;Fibrin Tissue Adhesive;Fibrinogen;Fibrosis;Flow Cytometry;Gel;Generations;Goals;Growth;Growth Factor;Growth Factor Receptors;Healed;Human;Hypertension;Immigration;Impaired wound healing;In Vitro;Infection;Institution;Investigational Drugs;Keratin;Knowledge;Lead;Leg;Leg Ulcer;Life;Lower Extremity;Measurement;Mesenchymal Stem Cells;Methods;Molecular Profiling;Mus;Muscle;New Drug Approvals;Outcome;Pain;Pathogenesis;Patients;Pilot Projects;Polymers;Protease Inhibitor;Publishing;Quality of life;Randomized;Receptor Signaling;Reporting;Research;Signal Transduction;Skin;Staining method;Stains;Stem cells;Surface;Syringes;System;Testing;Thigh structure;Thrombin;Tissue Engineering;Tissues;Topical application;Varicose Ulcer;Veins;Venous;Work;Wound Healing;arm;base;bone;c-myc Genes;computerized;experience;healing;improved;innovation;migration;molecular marker;novel;polymerization;prognostic;public health relevance;repaired;response;stem cell therapy;success;therapy development;wound","Treatment of venous ulcers with autologous cultured bone marrow stem cells","
NARRATIVE
 Chronic wounds, such as those that are called venous ulcers and are caused by abnormal veins, are very
common. They cause pain, infection, and loss of independence. We have developed a way to isolate, grow,
and expand stem cells from the patient's own bone marrow and to deliver millions of these cells to the wound
using a novel cell delivery system. This research will test the value and effectiveness of this stem cell treatment
in these difficult to heal leg ulcers.","NIAMS","8248607","3/30/2012 12:00:00 AM","PA-10-067","5R01AR060342-02","5","R01","AR","060342","02"," ","TSENG, HUNG H","4/1/2011 12:00:00 AM","3/31/2016 12:00:00 AM","Arthritis, Connective Tissue and Skin Study Section[ACTS]"," ","1864507","FALANGA, VINCENT ","Not Applicable","02","Unavailable","625899281"," ","625899281"," ","US","41.833856","-71.435325","7071801","ROGER WILLIAMS HOSPITAL","PROVIDENCE","RI","Independent Hospitals","029084735","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","143775"," ","368775",
"Aging; Osteoporosis","Affect;Age;Aging;Aging-Related Process;Alkaline Phosphatase;Antioxidants;Apoptosis;Apoptotic;BMP6 gene;Body fat;Bone Marrow;Bone Marrow Cells;Bone Resorption;Cell Culture Techniques;Cell Death;Cells;Cessation of life;Clinical;Clinical Markers;Coculture Techniques;Communication;Conditioned Culture Media;Cysteine Protease;Data;Dentin;Development;Disease;Dose;Elderly;Glutathione;Goals;Growth;Hair;Hepatocyte;Homeostasis;Human;Knock-out;Knockout Mice;Kyphosis deformity of spine;Lead;Link;Literature;Liver;Longevity;Macrophage Colony-Stimulating Factor;Measures;Mediating;Mesenchymal Stem Cells;Mitochondria;Modeling;Molecular;Molecular Target;Mus;NADP;Organism;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis;Oxidative Stress;Peptide Hydrolases;Play;Premature aging syndrome;Production;Proteins;Relative (related person);Respiration;Role;Signal Transduction;Slice;Small Interfering RNA;Stress;System;TNFSF11 gene;Tumor necrosis factor receptor 11b;Urine;Wild Type Mouse;age related;bone;bone loss;bone morphogenetic protein 6;bone turnover;caspase-2;copper zinc superoxide dismutase;deoxypyridinoline;macrophage;male;mineralization;mouse model;osteoclastogenesis;oxidation;platelet-derived growth factor BB;precursor cell;prevent;public health relevance;release factor;research study;substantia spongiosa;trait;urinary","The role of caspase-2 in osteoblast-osteoclast interactions","
8. Project Narrative
Osteoporosis is a debilitating disease that causes severe bone loss in the elderly. This study will help elucidate
molecular mechanisms underlying cell death of osteoclasts that are involved in bone resorption. Identification
of molecular targets regulating cell death of osteoclasts will help facilitate the creation of new strategies to treat
osteoporosis.","NIA","8261167","2/8/2012 12:00:00 AM","PA-10-107","5F30AG039948-02","5","F30","AG","039948","02"," ","WILLIAMS, JOHN","4/1/2011 12:00:00 AM","3/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-F10B-S(20)L]"," ","10585877","CALLAWAY, DANIELLE ARDEN","Not Applicable","21","ANATOMY/CELL BIOLOGY","800772162","C3KXNLTAAY98","800772162","C3KXNLTAAY98","US","29.513082","-98.577731","578418","UNIVERSITY OF TEXAS HLTH SCIENCE CENTER","SAN ANTONIO","TX","SCHOOLS OF MEDICINE","782293901","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","866","Training, Individual","2012"," "," ","NIA","47232"," "," ","47232",
"Diabetes; Genetics; Nutrition; Obesity","Accounting;Acyltransferase;Adipocytes;Adipose tissue;Adolescent;Adult;Age;Animals;Binding;Biological;Biopsy;Body Composition;Body Weight;Cell Differentiation process;Cell Line;Cell physiology;ChIP-seq;Chromatin Structure;Comorbidity;Coupled;Databases;Development;Developmental Gene;Diabetes Mellitus;Diet;Disease;Drug Delivery Systems;EP300 gene;Embryo;Endoplasmic Reticulum;Enhancers;Environment;Epidemic;Epidemiology;Epigenetic Process;Epoxide hydrolase;Epoxy Compounds;Etiology;Fatty Acids;Fatty acid glycerol esters;Fibroblasts;Gene Deletion;Gene Expression;Gene Expression Profile;Gene Targeting;Genes;Genetic;Genetic Variation;Genomics;Golgi Apparatus;Growth;Health;Heterogeneity;Human;Hydrolase;Inbred Mouse;Inbreeding;Individual;Inherited;Life;Link;Lipase;Lipids;Measurement;Mediator of activation protein;Mesenchymal Stem Cells;Mesoderm;Metabolic;Modeling;Molecular;Mus;Neonatal;Non-Insulin-Dependent Diabetes Mellitus;Nutritional status;Obesity;Pathway interactions;Persons;Phenotype;Population;Predisposition;Regulation;Role;Scientist;Signal Transduction;Testing;Tissue Expansion;Transcript;Variant;Vascularization;Weight Gain;angiogenesis;base;bisulfite;cell growth;energy balance;feeding;glucose uptake;imprint;in utero;knockout gene;lipid biosynthesis;mRNA Expression;male;member;metabolomics;mouse model;new therapeutic target;non-genetic;obesity treatment;programs;promoter;protein expression;research study;therapeutic target;uptake","Epigenetic mechanisms and genes that regulate adipose tissue expansion"," Scientists have shown that factors such as genetics and the environment interact to determine a person's susceptibility to developing diseases such as obesity and diabetes; however, very little is known about the molecular pathways that are involved in these interactions. Therefore, we are studying a mouse model in where all of the individuals are genetically identical to understand the basis for these alterations. We have identified several genes that are associated with variations in obesity and propose to study how one these genes, mesoderm specific transcript, functions in order to determine whether it could be used as drug target for the treatment of obesity.  
    

","NIDDK","8300079","4/17/2012 12:00:00 AM","PA-10-067","5R01DK090361-02","5","R01","DK","090361","02"," ","HAFT, CAROL R","7/15/2011 12:00:00 AM","1/11/2013 12:00:00 AM","Cellular Aspects of Diabetes and Obesity Study Section[CADO]"," ","8040810","KOZA, ROBERT A","Not Applicable","06","NONE","611012324","MWYVQTQ32ME5","611012324","MWYVQTQ32ME5","US","30.404354","-91.122411","577909","LSU PENNINGTON BIOMEDICAL RESEARCH CTR","BATON ROUGE","LA","ORGANIZED RESEARCH UNITS","708084124","UNITED STATES","N","5/1/2012 12:00:00 AM","1/11/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","47557","22828"," ","70385",
"Biotechnology; Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Acute;Address;Area;Bioinformatics;Biological Assay;Bone Morphogenetic Proteins;Cells;Chronic;Cutaneous;Dermatology;Development;Epithelial;Family;Gene Targeting;Goals;Hair follicle structure;In Vitro;Instruction;Keratin;Lead;Malignant Neoplasms;Mesenchymal;Methods;Microarray Analysis;Modems;Molecular;Molecular Profiling;Mus;Neoplasms;Neoplastic Cell Transformation;Neoplastic Processes;Nude Mice;Pathway interactions;Patients;Phenotype;Population;Process;Regulation;Research;Research Personnel;Reverse Transcriptase Polymerase Chain Reaction;Role;Signal Pathway;Signal Transduction;Skin;Skin Neoplasms;Sorting - Cell Movement;Stem cells;Study models;Technology;Testing;Training;Transgenic Mice;Transgenic Organisms;Tumor Stem Cells;Tumor Suppressor Proteins;Tumor-Derived;Undifferentiated;Work;base;bone morphogenetic protein receptors;cancer prevention;cancer stem cell;cancer therapy;carcinogenesis;career;career development;improved;in vivo;insight;neoplastic;novel strategies;prevent;progenitor;recombinase;reconstitution;skin disorder;skin regeneration;stem;stem cell biology;stem cell division;therapy development;tumor;type IA bone morphogenetic protein receptor","Molecular control of normal and neoplastic skin stem cells","n/a","NIAMS","8292907","6/12/2012 12:00:00 AM","PA-06-001","5K01AR056771-04","5","K01","AR","056771","04"," ","BAKER, CARL","7/1/2009 12:00:00 AM","6/30/2014 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","8651312","SHAROV, ANDREY ","Not Applicable","07","Unavailable","604483045","FBYMGMHW4X95","604483045","FBYMGMHW4X95","US","42.336234","-71.070647","894901","BOSTON UNIVERSITY MEDICAL CAMPUS","BOSTON","MA","Domestic Higher Education","021182841","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","115025","9202"," ","124227",
"No NIH Category available","Adhesions;Adhesives;Autoimmune Diseases;B-Cell Development;B-Lymphocytes;Blood;Bone Marrow;CXCR4 gene;Cell Communication;Cell Count;Cell Lineage;Cell Surface Receptors;Cells;Chemotactic Factors;Defect;Development;Discontinuous Capillary;Hematopoietic;Human;Immature B-Lymphocyte;Immigration;Immune System Diseases;Immune system;Immunoglobulin Genes;Immunologic Deficiency Syndromes;Individual;Integrins;Interleukin 7 Receptor;Interleukin-7;Laboratories;Ligands;Light;Lipids;Lymphocyte;Lymphoid;Lymphopenia;Mediating;Mesenchymal;Microanatomy;Microscope;Microscopy;Modeling;Molecular;Movement;Mus;Organ;Photons;Positioning Attribute;Process;Proteins;Protocols documentation;Role;Signal Transduction;Sphingosine;Sphingosine-1-Phosphate Receptor;Staging;Stromal Cells;Systems Development;Testing;Vaccine Design;Work;cell motility;cell type;cytokine;in vivo;insight;intravital microscopy;migration;multi-photon;novel therapeutics;pathogen;progenitor;receptor;receptor coupling;research study;sphingosine 1-phosphate;trafficking","Control of B-lineage cell migration during differentiation in bone marrow"," Defects in B cell development are major causes of immunological diseases. By investigating where and how B cells migrate and position within bone marrow we may develop new therapeutic strategies against devastating immunodeficiencies.   
   
      

","NIAID","8531469","8/21/2012 12:00:00 AM","PA-10-067","1R56AI098996-01","1","R56","AI","098996","01"," ","MILLER, LARA R","9/1/2012 12:00:00 AM","12/31/2013 12:00:00 AM","Cellular and Molecular Immunology - B Study Section[CMIB]"," ","10398962","PEREIRA, JOAO ","Not Applicable","03","MICROBIOLOGY/IMMUN/VIROLOGY","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","9/1/2012 12:00:00 AM","12/31/2013 12:00:00 AM","855","Non-SBIR/STTR","2012"," "," ","NIAID","250000","165209"," ","415209",
"Bioengineering; Clinical Research; Regenerative Medicine","3-Dimensional;Acoustics;Air;Apoptosis;Area;Basement lamina;Basement membrane;Behavior;Biocompatible Materials;Biological;Biological Assay;Biology;Biomechanics;Cell Line;Cell Proliferation;Cells;Clinical;Coculture Techniques;Complex;Development;Disease;Dysphonia;Engineering;Environment;Enzymes;Epithelial;Epithelium;Extracellular Matrix;Extracellular Matrix Proteins;Fibroblasts;Future;Gene Proteins;Goals;Histology;Immune;Immunoblotting;Immunohistochemistry;Immunologics;In Vitro;Individual;Infiltration;Kinetics;Label;Lamina Propria;Liquid substance;Measures;Membrane;Mesenchymal;Metabolic;Methodology;Modeling;Molecular and Cellular Biology;Morphogenesis;Mucous Membrane;Natural regeneration;Output;Performance;Phenotype;Physiological;Polysaccharides;Population;Production;Property;Proteomics;Refractory;Research;Series;Squamous Cell;Stem cells;Stratification;Stress;Structure;System;Techniques;Testing;Therapeutic;Tissue Engineering;Tissues;Transcriptional Regulation;Trauma;Voice;Work;base;cell behavior;cell motility;cell type;clinical application;human tissue;improved;in vitro Model;in vivo;keratinocyte;keratinocyte differentiation;novel;public health relevance;reconstitution;research study;restoration;scaffold;success;tissue regeneration;tissue repair;tool;vocal cord","Regeneration of Multi-layered Vocal Fold Mucosa","
PROJECT NARRATIVE
 The vocal fold mucosa is a complex biological structure that underpins normal voice production. The
proposed research is focused on the optimization of a multi-layered vocal fold mucosa substitute for the
treatment of diseased or damaged tissue, and restoration of vocal function.","NIDCD","8465049","5/23/2012 12:00:00 AM","PA-07-070","3R01DC010777-03S1","3","R01","DC","010777","03","S","SHEKIM, LANA O","4/1/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Motor Function, Speech and Rehabilitation Study Section[MFSR]"," ","8654344","WELHAM, NATHAN ","Not Applicable","02","SURGERY","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","SCHOOLS OF MEDICINE","537151218","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","173","Non-SBIR/STTR","2012"," "," ","NIDCD","26578","13422"," ","40000",
"Biotechnology; Cancer; Genetics","3-Dimensional;Aftercare;Behavior;Binding;Biological Models;Breast;Cancerous;Candidate Disease Gene;Carcinoma;Categories;Cell Communication;Cells;Chromatin;Coculture Techniques;Complex;DNA;DNA Damage;DNA Methylation;Drug resistance;Ecosystem;Environment;Epithelial Cells;Escherichia coli;Event;Evolution;Fibroblasts;Genes;Genetic Transcription;Human;Instruction;Learning;Malignant Neoplasms;Mammalian Cell;Mammary gland;Mechanics;MicroRNAs;Movement;Mutate;Mutation;Mutation Fixation;Oncogenic;Outcome;Paclitaxel;Pathway interactions;Patients;Philosophy;Population;Process;Proliferating;Recruitment Activity;Recurrent disease;Resistance;Signal Transduction;Site;Stem cells;Stress;Tissues;Trans-Activators;Variant;Wound Healing;biological adaptation to stress;cell motility;cell population study;clinically relevant;driving force;epithelial to mesenchymal transition;human tissue;insight;pressure;prevent;programs;promoter;reconstruction;response;restoration;senescence;therapeutic target;transmission process;tumorigenic","MAMMALIAN CELLS AND ECOSYSTEMS","RELEVANCE (See instructions): We are learning that signals from preneoplastic cells can interact with stromal components to facilitate accelerated evolution and generate drug-resistant and metastatic cells. We hope to understand these processes and use what we are learning from the stromal environment to compose artificial selection pressures that will guide the genetically diverse cells into harmless endpoints.","NCI","8382257","8/23/2012 12:00:00 AM","RFA-CA-09-009","5U54CA143803-04","5","U54","CA","143803","04"," "," "," "," ","ZCA1-SRLB-9","7810","1863933","TLSTY, THEA D","Not Applicable","12","Unavailable","002484665","NJ1YPQXQG7U5","002484665","NJ1YPQXQG7U5","US","40.12273","-74.703461","6661401","PRINCETON UNIVERSITY","Princeton","NJ","Domestic Higher Education","085406000","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","555706","555706"," ","555706","0"," "," ",
"Cardiovascular; Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Affect;Aging;Alteplase;Biology;Blood Circulation;Bone Marrow;Cardiac;Cardiovascular system;Cell Differentiation process;Cell Proliferation;Cells;Data;Development;Ensure;Extracellular Matrix;Extramedullary Hematopoiesis;Fibroblasts;Fibrosis;Goals;Growth Factor;Heart Diseases;Hematopoietic;Hematopoietic stem cells;Impairment;Insulin Resistance;Laboratories;Ligands;Link;Matrix Metalloproteinases;Mediating;Mesenchymal;Modeling;Molecular;Mus;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Other Genetics;Pathogenesis;Patients;Plasma;Plasminogen;Plasminogen Activator Inhibitor 1;Play;Principal Investigator;Process;Proliferating;Regenerative Medicine;Role;Staging;Stem Cell Factor;Stem cells;Stimulus;Stress;Stromal Cells;System;Tissues;age related;base;biological adaptation to stress;cardiac repair;cardiovascular risk factor;cytokine;design;novel;overexpression;peripheral blood;prevent;programs;repaired;response;therapy design;vasculogenesis","Role of PAI-1 in Cardiovascular Repair and Fibrosis","n/a","NHLBI","8380883","4/30/2012 12:00:00 AM","PAR-10-285","5P01HL108795-02","5","P01","HL","108795","02"," "," "," "," ","Heart, Lung, and Blood Program Project Study Section[HLBP]","7444","6897813","LOSORDO, DOUGLAS W","Not Applicable","07","Unavailable","005436803","KG76WYENL5K1","005436803","KG76WYENL5K1","US","41.896017","-87.616602","6144650","NORTHWESTERN UNIVERSITY AT CHICAGO","CHICAGO","IL","Domestic Higher Education","606114579","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","363786","363786"," ","238548","125238"," "," ",
"Clinical Research; Osteoporosis; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Adipocytes;Age;Applications Grants;Biological Assay;Bone Development;Bone Marrow;Bone Resorption;Cell Differentiation process;Cells;Commit;Degenerative Disorder;Development;Etiology;Event;Failure;Fluorescence-Activated Cell Sorting;Fracture;G-Protein-Coupled Receptors;GTP-Binding Proteins;Goals;Green Fluorescent Proteins;Hormones;In Situ Hybridization;In Vitro;Life;Mediating;Mesenchymal;Mind;Molecular;Mus;Mutant Strains Mice;Osteoblasts;Osteocalcin;Osteoclasts;Osteogenesis;Osteoporosis;Parathyroid Hormone Receptor;Parathyroid gland;Partner in relationship;Pathway interactions;Phenotype;Play;Protein Subunits;Role;Signal Pathway;Signal Transduction;Skeletal Development;Staging;Staining method;Stains;Stromal Cells;Transgenic Mice;Woman;age related;bone;bone mass;experience;in vitro Assay;in vivo;insight;novel;osteoblast differentiation;osteogenic;osteoporosis with pathological fracture;osteoprogenitor cell;postnatal;promoter;recombinase;skeletal;transcription factor","Role of Gsalpha in Regulating Osteoblast Differentiation","n/a","NIAMS","8259195","5/4/2012 12:00:00 AM","PA-06-512","5K08AR054741-05","5","K08","AR","054741","05"," ","CHEN, FAYE H","5/1/2008 12:00:00 AM","1/6/2013 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","1900877","WU, JOY Y","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","5/1/2012 12:00:00 AM","1/6/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","64322","5146"," ","49489",
"Biotechnology; Diabetes; Genetics; Regenerative Medicine","3-Dimensional;Apical;Architecture;Area;Basal lamina;Behavior;Beta Cell;Biological;Birth;Cell Differentiation process;Cell Polarity;Cell division;Cell surface;Cells;Cellular biology;Commit;Communication;Complement;DNA Sequence Rearrangement;Data;Data Set;Development;Duct (organ) structure;Endocrine;Epithelial;Epithelial Cells;Epithelium;Event;Extracellular Matrix;Flow Cytometry;Gene Expression;Gene Expression Profile;Gene Expression Profiling;Generations;Genes;Genetic;In Vitro;Islet Cell;Learning;Light;Link;Location;Longevity;Maps;Mesenchymal;Molecular;Mono-S;Monoclonal Antibodies;Morphogenesis;Mus;Nature;Notch Signaling Pathway;Organogenesis;Pancreas;Population;Process;Proteins;Protocols documentation;RNA;RNA Interference;Reagent;Regulation;Regulator Genes;Resolution;Signal Pathway;Signal Transduction;Sorting - Cell Movement;Source;Staging;Stem cells;Stimulus;Structure;Testing;Time;Tissues;Transitional Cell;Work;cell type;computerized data processing;design;genetic pedigree;human embryonic stem cell;in vivo;insight;interest;intraepithelial;islet;member;migration;novel;novel marker;progenitor;programs;tool","Architecture and communication controlling the efficient generation of beta cells","n/a","NIDDK","8316317","8/3/2012 12:00:00 AM","RFA-DK-09-011","5U01DK089570-03","5","U01","DK","089570","03"," ","SATO, SHERYL M","9/15/2010 12:00:00 AM","6/30/2015 12:00:00 AM","ZDK1-GRB-G(M3)S"," ","1901653","WRIGHT, CHRISTOPHER V","Not Applicable","05","ANATOMY/CELL BIOLOGY","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","1125620","253249"," ","1378869",
"Asthma; Lung; Neurosciences; Pediatric","Ablation;Adult;Apoptosis;Asthma;Attention;Biological Neural Networks;Bronchial Spasm;Cells;Cellular Structures;Childhood;Chronic;Color;Congenital Disorders;Cues;Culture Techniques;Denervation;Dependence;Development;Developmental Biology;Disease;Embryo;Embryonic Development;Endothelium;Engineering;Environment;Epithelial;Epithelium;Genetic;Goals;Growth;Hypertension;Image;Injury;Intervention;Investigation;Kidney;Knowledge;Label;Lead;Life;Light;Lung;Lung diseases;Maintenance;Mammals;Measures;Medical;Mesenchymal;Mission;Morphogenesis;National Heart, Lung, and Blood Institute;Nerve;Neurons;Optical Methods;Organ;Organ Culture Techniques;Perinatal;Phenotype;Process;Public Health;Pulmonary Hypertension;Quail;Role;Signal Transduction;Smooth Muscle;Staging;Structure;Submandibular gland;System;Tissue Engineering;Tissues;Transgenic Organisms;Translating;abstracting;cell growth;fibroblast growth factor 10;in vivo;insight;lung development;lung imaging;lung repair;nerve supply;neural stimulation;neuroblast;neurodevelopment;neurogenesis;optogenetics;progenitor;pulmonary arterial hypertension;receptor;relating to nervous system;research study;two-photon;vasculogenesis","Deciphering the Dynamics of Lung Development and the Role of Neural Input","n/a","NHLBI","8332538","8/12/2012 12:00:00 AM","PA-09-232","5F30HL110723-02","5","F30","HL","110723","02"," ","COLOMBINI-HATCH, SANDRA","9/30/2011 12:00:00 AM","7/24/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F10A-S(20)L]"," ","9813689","BOWER, DANIELLE VERA","Not Applicable","27","NONE","009584210","U2JMKHNS5TG4","009584210","U2JMKHNS5TG4","US","34.134337","-118.126525","1073501","CALIFORNIA INSTITUTE OF TECHNOLOGY","PASADENA","CA","SCHOOLS OF ARTS AND SCIENCES","911250001","UNITED STATES","N","9/30/2012 12:00:00 AM","7/24/2013 12:00:00 AM","837","Training, Individual","2012"," "," ","NHLBI","32159"," "," ","32159",
"No NIH Category available","Acute;Acute Lung Injury;Address;Adult Respiratory Distress Syndrome;Area;Biological Markers;Breathing;Carbon Monoxide;Cell Culture Techniques;Clinical;Clinical Research;Communities;Critical Care;Critical Illness;Cytoprotection;Data;Development;Diagnostic;Disease;Dose;Drug Kinetics;Environmental air flow;Functional disorder;Future;Goals;Human;Incidence;Infection;Inflammation;Institutes;Instruction;Intervention Trial;Lung;Lung Inflammation;Lung diseases;Mediating;Mediator of activation protein;Mesenchymal;Mitochondria;Modality;Modeling;Molecular;Molecular Target;Morbidity - disease rate;Multiple Organ Failure;Patients;Physiological;Quality Control;Research;Research Personnel;Resolution;Respiratory Failure;Risk;Rodent;Rodent Model;Scientist;Sepsis;Stromal Cells;Syndrome;Therapeutic;Therapeutic Agents;Tidal Volume;Translating;Ursidae Family;Work;base;career;conditioning;heme oxygenase-1;human disease;lipid mediator;lung injury;metabolomics;mortality;nonhuman primate;novel;novel diagnostics;pre-clinical;programs;synergism","Carbon Monoxide: Novel Opportunities for Therapy","RELEVANCE (See instructions): 
For this Cycle I of RFA PAR-09-185: Translational Programs in Lung Diseases (P01), each project will 
integrate basic aims to determine novel mechanism(s) by which CO mediates its cytoprotection with 
translational aims focused on proof-of-concept non human primate and human studies. The synergism 
between the projects and cores will provide the groundwork to conduct Phasell/lll inhaled CO intervention 
trial in ALI at the next Cycle II of this translational P01 application.","NHLBI","8320231","8/8/2012 12:00:00 AM","PAR-09-185","5P01HL108801-02","5","P01","HL","108801","02"," ","HARABIN, ANDREA L","8/15/2011 12:00:00 AM","6/30/2016 12:00:00 AM","ZHL1-PPG-A(M1)"," ","1864413","CHOI, AUGUSTINE M","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","1875270","974839"," ","2850109",
"Aging; Autoimmune Disease; Biotechnology; Lung; Orphan Drug; Rare Diseases","Aging;Alveolar;Animal Model;Applications Grants;Bleomycin;Cells;Cerebrovascular Spasm;Characteristics;Clinical;Critical Pathways;Data;Development;Disease;Disease Progression;Drug Delivery Systems;Fibrosis;Goals;Hamman-Rich syndrome;Human;Injury;Instruction;Japan;Kidney;Lung;Maintenance;Mediating;Mesenchymal;Modeling;Molecular;Mus;Myofibroblast;NADPH Oxidase;Nature;Pathway interactions;Patients;Pharmaceutical Preparations;Pharmacotherapy;Phase;Phenotype;Physiology;Pre-Clinical Model;Process;Pulmonary Fibrosis;Regulation;Research Project Grants;Rho-associated kinase;Role;Signal Pathway;Signal Transduction;Structure of parenchyma of lung;Testing;Tissues;Translations;Validation;aged;body system;candidate identification;clinical phenotype;drug candidate;drug discovery;effective therapy;efficacy testing;fasudil;group support;human subject;in vivo;inhibitor/antagonist;innovation;lung injury;mortality;novel;novel therapeutic intervention;pre-clinical;repaired;research clinical testing;response;therapeutic target","Rho-Kinase Pathway in Pulmonary Fibrosis","RELEVANCE (See instructions): 
Idiopathic pulmonary fibrosis is a lethal disease ofthe lung with no effective therapies. This project 
evaluates the efficacy of a novel therapeutic approaches in an animal model of lung fibrosis that more 
closely resembles human IPF.","NHLBI","8262378","4/20/2012 12:00:00 AM","RFA-HL-11-015","5P50HL107181-02","5","P50","HL","107181","02"," ","EU, JERRY PC","5/1/2011 12:00:00 AM","4/30/2014 12:00:00 AM","ZHL1-CSR-D(F1)"," ","1882917","THANNICKAL, VICTOR J.","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","SCHOOLS OF MEDICINE","352940001","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","838","Research Centers","2012"," "," ","NHLBI","348051","139500"," ","439500",
"Cardiovascular; Heart Disease; Pediatric","Adult;Affect;Alleles;Anterior;Apoptosis;Behavior;Biogenesis;Blood flow;Cardiac;Cell Cycle Regulation;Cell Polarity;Cells;Cilia;Complex;Congenital Abnormality;Congenital Heart Defects;Defect;Development;Embryo;Embryonic Development;Embryonic Organizers;Endocardium;Environment;Epicardium;Epigenetic Process;Epithelial;Erinaceidae;Generations;Genetic;Genetic Models;Goals;Heart;Heart Diseases;Human;Infant;Kidney;Left;Ligands;Liquid substance;Location;Mechanics;Mediating;Membrane;Mesenchymal;Molecular;Morphogenesis;Motor;Mus;Mutation;Myocardial;Myocardium;Organ;Pancreas;Pathway interactions;Penetrance;Phenotype;Positioning Attribute;Proteins;Reporting;Role;Signal Pathway;Signal Transduction;Structure;Surface;Technology;Testing;Time;Tubular formation;Work;biliary tract;cardiogenesis;cell motility;congenital heart disorder;extracellular;fluid flow;pericardial sac;receptor;sensor;smoothened signaling pathway","Cilia in cardiac morphogenesis","
Congenital heart disease affects .8% of all liveborn infants, and is the most common major birth defect. Cilia
are antenna-like structures that extend from almost all cells to obtain and interpret information from the
extracellular environment, and abnormal cilia are known to cause some types of complex congenital heart
disease. This proposal investigates how cilia function in the developing heart to instruct normal heart
development.","NHLBI","8242065","4/9/2012 12:00:00 AM","PA-07-070","5R01HL093280-04","5","R01","HL","093280","04"," ","SCHRAMM, CHARLENE A","4/1/2009 12:00:00 AM","3/31/2014 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","1865261","BRUECKNER, MARTINA ","Not Applicable","03","PEDIATRICS","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","162113"," ","409613",
"Arthritis; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Address;Affect;Appearance;Biomedical Engineering;Cell Transplants;Cell physiology;Cells;Collagen;Data;Degenerative polyarthritis;Development;Developmental Biology;Disease;Drops;Engineering;Exhibits;Future;Glare;Hip region structure;Joint by Site;Joint repair;Joints;Knee;Knowledge;Lead;Life;Ligands;Limb structure;Maintenance;Medicine;Mesenchymal;Molecular;Multipotent Stem Cells;Mus;Mutant Strains Mice;Natural regeneration;Nuclear;Nuclear Receptors;Partner in relationship;Pathology;Pathway interactions;Pattern;Phenotype;Predisposition;Process;Quality of life;RXR;Regulation;Reporter;Retinoic Acid Receptor;Retinoids;Role;Signal Pathway;Signal Transduction;Staging;Stem cells;Tenascin;Testing;Time;Tissues;Transgenic Mice;Translations;Transplantation;Work;age related;articular cartilage;base;cellular engineering;cohort;gain of function;genetic manipulation;insight;joint function;long bone;lubricin;novel;postnatal;prenatal;prospective;reconstruction;regenerative;repaired;scleraxis;selective expression;skeletal;tool;trait","Mechanisms of Synovial Joint Formation"," Synovial joints such as those in the knee and hip are essential for function and quality of life, but are affected by common diseases including age-dependent osteoarthritis. This project will continue to clarify mechanisms by which the joints form and during prenatal and early postnatal life. It will thus generate fundamental information that can be used in the future to create novel joint repair and regeneration therapies.  
    

","NIAMS","8332340","7/20/2012 12:00:00 AM","PA-10-067","5R01AR062908-08","5","R01","AR","062908","08"," ","TYREE, BERNADETTE","7/1/2005 12:00:00 AM","8/31/2016 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1880414","PACIFICI, MAURIZIO ","ENOMOTO-IWAMOTO, MOTOMI ","03","Unavailable","073757627","G7MQPLSUX1L4","073757627","G7MQPLSUX1L4","US","39.946629","-75.196611","1499101","CHILDREN'S HOSP OF PHILADELPHIA","PHILADELPHIA","PA","Independent Hospitals","191462305","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","305642","206308"," ","511950",
"Digestive Diseases; Pediatric","Apical;Apoptosis;Area;Back;Biomedical Engineering;Cell Cycle;Cell Nucleus;Cell Polarity;Cell Shape;Cell division;Cells;Characteristics;Columnar Cell;Data;Defect;Development;Diagnosis;Epithelial;Epithelium;Event;Failure;Fetus;Fingers;Funding;Gastrocoele;Genetic;Goals;Growth;Height;Hour;Imaging Techniques;Individual;Infant;Intestines;Investigation;Knockout Mice;Length;Life;Membrane;Mesenchymal;Mitosis;Modeling;Molecular;Morphogenesis;Mus;Newborn Infant;Nuclear;Nutrient;Outcome Study;Pattern;Phase;Phenotype;Play;Positioning Attribute;Process;Production;Proteins;Pseudostratified Epithelium;Radial;Role;S Phase;Series;Shapes;Short Bowel Syndrome;Signal Transduction;Small Intestines;Staging;Surface;Testing;Therapeutic;Thick;Thinking;Time;Tissues;Tube;Villus;Work;absorption;advanced system;daughter cell;design;fetal;in utero;insight;intercalation;intestinal epithelium;mathematical model;migration;mouse model;novel;progenitor;reconstruction;research study","Morphogenesis of the fetal intestinal epithelium"," The huge surface area of the intestinal epithelium is critical for its efficient function in nutrient absorption, but little is known about how this surface area is generated in the fetus. This proposal delves deeply into the morphological and molecular processes that occur in the early mouse intestine and are required for the establishment of intestinal absorptive surface and intestinal length. The work could suggest therapeutic strategies for infants diagnosed with short bowel syndrome in utero or perinatally.  
  
    

","NIDDK","8334484","5/15/2012 12:00:00 AM","PA-10-067","5R01DK089933-02","5","R01","DK","089933","02"," ","CARRINGTON, JILL L","9/21/2011 12:00:00 AM","5/31/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-DKUS-C(03)M]"," ","1881985","GUMUCIO, DEBORAH L.","Not Applicable","12","ANATOMY/CELL BIOLOGY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","264756","142376"," ","407132",
"Stem Cell Research; Stem Cell Research - Embryonic - Human","Adult;Atherosclerosis;Blood Vessels;Blood flow;Calcium;Calcium Signaling;Cell Differentiation process;Cells;Clinical;Communication;Connexin 43;Connexins;Cytoplasmic Tail;Data;Development;Diabetes Mellitus;Disease;Elements;Endothelial Cells;Gap Junctions;Generations;Goals;Grant;Growth;Health;In Vitro;MAP Kinase Gene;Malignant Neoplasms;Matrix Metalloproteinases;Mediating;Mesenchymal;Modeling;Mus;Mutation;Pathology;Pathway interactions;Pericytes;Phosphorylation Site;Play;Process;Proteins;Recruitment Activity;Regenerative Medicine;Regulation;Research;Role;Signal Pathway;Signal Transduction;Signaling Molecule;Site;Site-Directed Mutagenesis;Smooth Muscle Myocytes;Source;Staging;Stream;System;Testing;Tissues;Undifferentiated;cell growth;extracellular;gap junction channel;human embryonic stem cell;insight;loss of function;response","Role of Gap Junctions in Blood Vessel Assembly","
Blood vessels are made up of two cell layers; endothelial cells comprise the inner luminal layer
of vessels and mural cells (pericytes and vascular smooth muscle cells) make up the
surrounding vessel wall and control blood flow and vessel stability. We are studying how
communication between endothelial cells and mural cells helps to promote vessel formation and
stability. Insights gained from our developmental studies may help to develop clinical strategies
for treating common diseases including atherosclerosis, diabetes, and cancer.","NHLBI","8452686","5/21/2012 12:00:00 AM","PA-07-070","5R01HL077675-09","5","R01","HL","077675","09"," ","GAO, YUNLING","8/1/2009 12:00:00 AM","5/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-CVS-F(02)M]"," ","7354338","HIRSCHI, KAREN KEMPER","BURT, JANIS M","03","NONE","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","313750","82448"," ","396198",
"Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Animals;Blood Vessels;Bone Development;Bone Injury;Bone Regeneration;Cell Differentiation process;Cells;Cephalic;Coculture Techniques;Communication;Coupled;Couples;Coupling;Data;Defect;Development;Distraction Osteogenesis;Elements;Endothelial Cells;Endothelium;Event;Funding;Galactosidase;Genetic;Goals;Grant;Health;Hypoxia Inducible Factor;Inflammatory;Injury;Lead;Ligase;Link;Mechanics;Mediating;Mesenchymal;Mesenchyme;Modeling;Molecular;Movement;Mus;Natural regeneration;Osteoblasts;Osteocalcin;Osteogenesis;Oxygen;Pathway interactions;Phenotype;Process;Recruitment Activity;Reporter;Research;Signal Transduction;Signaling Molecule;Site;Source;Stromal Cells;Surface;Testing;Time;VHL protein;Vascular Endothelial Growth Factors;Vascular Endothelium;Wild Type Mouse;Work;angiogenesis;bone;bone cell;bone healing;bone health;cell type;cranium;design;distraction;flat bone;hypoxia inducible factor 1;improved;long bone;mouse model;mutant;novel strategies;osteogenic;overexpression;progenitor;skeletal;stem cell niche","Oxygen Sensing and Osteogenesis","
PROJECT NARRATIVE
Our studies conducted over the last few years have identified a signaling molecule called the hypoxia-inducible
factor that controls these processes. The goal of our research is to understand the cellular and molecular
mechanisms, which couple angiogenesis in bone formation. Successful completion of this work should lead to
novel approaches for the treatment of bone development and regeneration.","NIAMS","8304141","7/16/2012 12:00:00 AM","PA-07-070","5R01AR049410-09","5","R01","AR","049410","09"," ","SHARROCK, WILLIAM J","8/1/2004 12:00:00 AM","7/31/2014 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","6799588","CLEMENS, THOMAS L","Not Applicable","07","ORTHOPEDICS","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","215551","123172"," ","338723",
"Dental/Oral and Craniofacial Disease; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Accounting;Adult;Affect;Blood Circulation;Bone Marrow;Bone Resorption;Bone remodeling;Cartilage;Cells;Chondrocytes;Cleaved cell;Commit;Connective Tissue Cells;Data;Deletion Mutation;Disease;Dwarfism;Environment;Extracellular Matrix;Fibrosis;Growth;Hematopoiesis;Hematopoietic;Hematopoietic Stem Cell Mobilization;Hematopoietic stem cells;Homeostasis;Immigration;Laboratories;MMP14 gene;MT3 gene;Maintenance;Marrow;Matrix Metalloproteinases;Mediating;Membrane;Mesenchymal;Metalloproteases;Mouse Strains;Mus;Mutation;Nature;Online Mendelian Inheritance In Man;Osteoblasts;Osteocalcin;Osteoclasts;Osteogenesis;Pattern;Pericytes;Phenocopy;Play;Process;Property;Proteolysis;Recruitment Activity;Resources;Role;Skeletal Development;Skeleton;Smooth Muscle;Staging;Syndrome;TNF gene;TNFSF11 gene;Tissues;Tumor necrosis factor receptor 11b;Work;attenuation;bone;bone loss;craniofacial;cranium;human disease;inhibitor/antagonist;long bone;member;membrane-type matrix metalloproteinase;null mutation;osteogenic;postnatal;progenitor;skeletal;skeletal disorder;trait;transcription factor","Matrix Metalloproteinases:  Remodeling of the Extracellular Matrix","n/a","NIDCR","8553335"," "," ","1ZIADE000676-17","1","ZIA","DE","000676","17"," "," "," "," "," "," ","8153931","ROBEY, PAMELA G","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIDCR"," "," "," ","1363253",
"Bioengineering; Cancer; Colo-Rectal Cancer; Digestive Diseases; Regenerative Medicine","3-Dimensional;Address;Apoptosis;Bacteria;Basement membrane;Behavior;Biological Assay;Biological Markers;Biology;Cell Differentiation process;Cell Lineage;Cell-Matrix Junction;Cells;Chemistry;Colon;Colorectal Cancer;Culture Techniques;Development;Devices;Disease;Environment;Epithelial;Epithelium;Etiology;Excision;Extracellular Matrix;Face;Fluorescence Microscopy;Future;Goals;Grant;Growth;Growth Factor;Image;Imagery;Imaging technology;In Vitro;Intestines;Lamina Propria;Lasers;Life;Maintenance;Medicine;Mesenchymal;Mitogens;Mucous Membrane;Mus;Myofibroblast;North Carolina;Nuclear;Organism;Physiological;Physiology;Plastics;Positioning Attribute;Postdoctoral Fellow;Property;Protocols documentation;Reporter Genes;Research;Research Personnel;Scanning;Side;Signal Transduction;Simulate;Site;Small Intestines;Smooth Muscle Actin Staining Method;Smooth Muscle Myocytes;Staining method;Stains;Stem cells;Structure;Surface;System;Techniques;Technology;Testing;Tissues;Transgenic Mice;Universities;Visual;base;cell growth;cell type;colonic crypt;design;gastrointestinal;in vivo;innovation;intestinal crypt;intestinal epithelium;member;morphogens;novel;polydimethylsiloxane;professor;scaffold;stem cell niche;tissue regeneration;tool","Microengineered system for ex vivo culturing of intestinal crypts"," The microengineered technology will address the specific needs of the gastrointestinal biology and disease research.  
  
    

","NIBIB","8290320","5/23/2012 12:00:00 AM","PA-10-064","5R03EB013803-02","5","R03","EB","013803","02"," ","HUNZIKER, ROSEMARIE","7/1/2011 12:00:00 AM","12/30/2013 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","10029207","WANG, YULI ","Not Applicable","04","CHEMISTRY","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF ARTS AND SCIENCES","275995023","UNITED STATES","N","7/1/2012 12:00:00 AM","12/30/2013 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","50000","24000"," ","74000",
"Asthma; Complementary and Alternative Medicine; Lung; Nutrition; Pediatric; Prevention","Adverse effects;Affect;Alveolar;Antioxidants;Asthma;Child;Childhood;Childhood Asthma;Cholecalciferol;Clinical;Data;Development;Diet;Dietary intake;Distal;Dose;Epidemiology;Epithelial;Genetic;Lactation;Lead;Link;Lipids;Lung;Mediating;Mesenchymal;Modeling;Molecular;Molecular Target;Morbidity - disease rate;Pathogenesis;Perinatal;Peroxisome Proliferator-Activated Receptors;Phenotype;Physiological;Play;Predisposition;Pregnancy;Preventive;Rattus;Receptor Signaling;Research;Role;Signal Pathway;Signal Transduction;Supplementation;Therapeutic;Time;Vitamin D;Vitamin D Analog;Vitamin D Deficiency;Vitamins;Wheezing;airway hyperresponsiveness;animal data;base;critical period;design;epidemiologic data;fetal;genetic variant;human data;insight;lung development;lung maturation;mortality;novel;offspring;paracrine;parathyroid hormone-related protein;prevent;protective effect;respiratory;respiratory smooth muscle;surfactant;tool","Molecular Basis of Childhood Asthma Following Perinatal Vitamin D Deficiency"," There are strong epidemiologic data suggesting a link between vitamin D deficiency during pregnancy and childhood asthma. However, the underlying mechanism for this association is not known. The proposed studies for the first time critically evaluate the role of vitamin D in lung maturation and are likely to provide a biologic rationale and mechanistic basis for vitamin D supplementation to prevent childhood asthma, a major contributor to childhood morbidity and mortality.  
    

","NHLBI","8298583","5/21/2012 12:00:00 AM","PA-10-069","5R21HL107118-02","5","R21","HL","107118","02"," ","NOEL, PATRICIA","7/15/2011 12:00:00 AM","11/30/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-CVRS-G(02)M]"," ","6717879","REHAN, VIRENDER K","Not Applicable","43","Unavailable","069926962","LTJVF4QSFCP9","069926962","LTJVF4QSFCP9","US","33.834898","-118.292983","2543101","LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER","TORRANCE","CA","Research Institutes","905022006","UNITED STATES","N","6/1/2012 12:00:00 AM","11/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","125000","42860"," ","167860",
"Genetics; Osteoporosis; Pediatric; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adult;Animals;Blood Vessels;Bone Marrow;Cell Communication;Cell Fate Control;Cell Lineage;Cells;Child;Clinical;Family;Family member;Fracture;Genes;Genetic;In Vitro;Injury;Knockout Mice;Life;Ligands;Limb structure;Malignant Neoplasms;Mammals;Medicine;Mesenchymal;Mesenchyme;Messenger RNA;Molecular;Mus;Musculoskeletal;Mutant Strains Mice;Notch Signaling Pathway;Organism;Osteoblasts;Osteogenesis;Osteoporosis;Pharmacy (field);Phenotype;Physiological;Play;Proteins;Research;Role;Signal Transduction;Site;Skeleton;Stem cells;Stromal Cells;Tendon structure;Testing;Tissues;Transcription Repressor/Corepressor;bone;bone cell;bone epiphysis;bone mass;cell type;design;in vivo;inhibitor/antagonist;knockout animal;member;mutant;notch protein;novel;novel strategies;novel therapeutics;osteoblast differentiation;postnatal;presenilin-1;progenitor;repaired;research study;secretase;substantia spongiosa;transcription factor","Notch Signaling and Bone Formation","
Tremendous unmet clinical needs exist in musculoskeletal medicine. Novel strategies are required to
safely promote bone formation in low turnover osteoporosis, tearing injuries at sites of bone-tendon
insertion, and bone fracture repair. This proposal is designed to understand the mechanism
responsible for controlling the number of bone cells in postnatal life. Research results from this study
will provide a molecular framework for developing novel bone-enhancing pharmaceutics.","NIAMS","8291154","6/20/2012 12:00:00 AM","PA-07-070","5R01AR055923-05","5","R01","AR","055923","05"," ","CHEN, FAYE H","9/18/2008 12:00:00 AM","9/15/2013 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","2238323","LONG, FANXIN ","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","7/1/2012 12:00:00 AM","9/15/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","209088","108726"," ","317814",
"Cardiovascular; Contraception/Reproduction; Hypertension; Infant Mortality/ (LBW); Obesity; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal Period - Conditions Originating in Perinatal Period; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human","Affect;Angiogenic Factor;Appearance;Area;Basal Plate;Basement membrane;Blood;Blood Vessels;Blood flow;CRH gene;Cell Adhesion Molecules;Cells;Characteristics;Chorionic villi;Clinical;Data;Decidua;Defect;Development;Diagnosis;Endothelial Cells;Equus caballus;Etiology;Family member;Fetal Growth;Fetal Growth Retardation;Fetus;Funding;Gene Expression;Gene Expression Profile;Gestational Age;Goals;Hormones;Immune;In Vitro;Inflammation;Invaded;Lead;Leptin;Link;Lipids;Maternal-Fetal Exchange;Mesenchymal;Molecular;Molecular Genetics;Mothers;Myometrial;Names;Nature;Obesity;Organ;Pathway interactions;Patients;Pattern;Placenta;Pre-Eclampsia;Pregnancy;Pregnancy Complications;Premature Labor;Process;Production;Regulation;Site;Specialized Epithelial Cell;Spiral Artery of the Endometrium;Stem cells;Surface;Syncytiotrophoblast;Syndrome;Techniques;Testing;Uterus;Vascular Endothelial Growth Factors;Villous;Villus;Work;base;clinical application;cytotrophoblast;fetus cell;insight;interstitial;novel;progenitor;programs;receptor;research study;therapeutic target;trophoblast","Placental Origins of Preeclampsia:  A Global Analysis of Cytrophoblast ...","n/a","NICHD","8375276","3/27/2012 12:00:00 AM"," ","5P01HD030367-18","5","P01","HD","030367","18"," "," "," ","3/31/2014 12:00:00 AM","ZHD1-DSR-L","0014","1892061","FISHER, SUSAN J.","Not Applicable","18","Unavailable","119132785","J3Z5MNJJ3FZ4","119132785","J3Z5MNJJ3FZ4","US","40.434217","-79.954766","3840801","MAGEE-WOMEN'S RES INST AND FOUNDATION","Pittsburgh","PA","Other Domestic Non-Profits","152134572","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","254579","254579"," ","208236","46343"," "," ",
"Aging; Breast Cancer; Cancer; Prevention","Aging-Related Process;Anatomy;Atypia;Atypical hyperplasia;Benign;Biological Markers;Biopsy;Breast;Breast Cancer Model;Breast Cancer Risk Assessment Tool;Breast Diseases;Calibration;Cervix Uteri;Clinic;Clinical;Clinical Management;Collaborations;Colon;Cytologic Atypia;Development;Diagnosis;Disease model;Disease susceptibility;Dissection;Early Diagnosis;Elements;Endometrium;Epidemiologic Factors;Epidemiology;Epithelial;Esophagus;Event;Extracellular Matrix;Fostering;Funding;Histologic;Histology;Immunohistochemistry;In Situ;Incidence;Individual;Institute of Medicine (U.S.);Lobular;Lobule;Malignant Neoplasms;Mammary Gland Parenchyma;Mammographic Density;Measures;Mediator of activation protein;Mesenchymal;Modeling;Molecular;Palpable;Peptide Hydrolases;Physiological Processes;Population;Postmenopause;Predisposition;Prevention;Prevention strategy;Reporting;Research;Risk;Risk Assessment;Series;Stratification;Subgroup;Techniques;Terminal Ductal Lobular Unit;Testing;Tissues;Transcript;Woman;Women&apos;s Group;Work;age related;base;cancer risk;candidate marker;carcinogenesis;case control;cohort;disorder risk;high risk;improved;insight;malignant breast neoplasm;molecular marker;normal aging;novel;surveillance strategy","Improving Breast Cancer Risk Prediction for Women with Benign Breast Disease","With the proposed work, we are testing the principle that specific histopathologic and molecular features 
present in benign breast tissue can discriminate risk of a subsequent breast cancer more accurately than 
currently used clinical and epidemiologic features. Such a risk prediction approach would facilitate 
personalized clinical management strategies for the 1 -2 million US women/year who have a benign biopsy.","NCI","8555339","10/12/2012 9:29:15 AM","PAR-10-003","5P50CA116201-07","5","P50","CA","116201","07"," "," ","9/22/2005 12:00:00 AM","8/31/2016 12:00:00 AM","ZCA1-RPRB-7(M1)","5260","1872568","INGLE, JAMES NEWELL","Not Applicable","01","Unavailable","006471700","Y2K4F9RPRRG7","006471700","Y2K4F9RPRRG7","US","44.022374","-92.465881","4976101","MAYO CLINIC ROCHESTER","ROCHESTER","MN","Other Domestic Non-Profits","559050001","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Research Centers","2012","350452","350452"," ","242614","107838"," "," ",
"Alcoholism; Chronic Liver Disease and Cirrhosis; Digestive Diseases; Liver Disease; Substance Abuse","Adult;Alcoholic Liver Diseases;Alcohols;Animals;Applications Grants;Award;Boxing;Cell Separation;Cells;Cellular biology;Cirrhosis;Collaborations;Collagen;Collagen Type I;Collection;Commit;Communication;Dimensions;Disease;Disease model;Embryo;Endothelial Cells;Ethanol;Evolution;Fluorescence;Fluorescence-Activated Cell Sorting;Funding;Genes;Genetic;Grant;Growth;Hepatic Stellate Cell;Hepatocyte;Hypoxia;Infusion procedures;Injury to Liver;Institution;Investigation;Kupffer Cells;Laboratories;Lead;Liver;Liver Cirrhosis;Liver Fibrosis;Liver diseases;Magnetism;Mesenchymal;Methods;Modality;Modeling;Molecular;Mus;Pathogenesis;Peer Review;Physiology;Play;Population Heterogeneity;Preparation;Principal Investigator;Publications;Rattus;Research;Research Personnel;Resources;Rodent;Rodent Model;Role;Science;Services;Steatohepatitis;Supporting Cell;System;Techniques;Transgenic Mice;Vitamin A;base;career development;catalyst;cell type;experience;in vivo;innovation;insight;liver hypoxia;new therapeutic target;promoter;response","Non-parenchymal Liver Cell Core","n/a","NIAAA","8260841","5/25/2012 12:00:00 AM","PAR-09-128","5R24AA012885-12","5","R24","AA","012885","12"," ","GAO, PETER","6/1/2001 12:00:00 AM","5/31/2016 12:00:00 AM","ZAA1-GG(01)"," ","2105294","TSUKAMOTO, HIDEKAZU ","Not Applicable","37","PATHOLOGY","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF MEDICINE","900894304","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","273","Other Research-Related","2012"," "," ","NIAAA","263372","168338"," ","431710",
"No NIH Category available","Ablation;Adipocytes;Age;Applications Grants;Biological Assay;Bone Development;Bone Marrow;Bone Resorption;Cell Differentiation process;Cells;Commit;Degenerative Disorder;Development;Etiology;Event;Failure;Fluorescence-Activated Cell Sorting;Fracture;G-Protein-Coupled Receptors;GTP-Binding Proteins;Goals;Green Fluorescent Proteins;Hormones;In Situ Hybridization;In Vitro;Life;Mediating;Mesenchymal;Mind;Molecular;Mus;Mutant Strains Mice;Osteoblasts;Osteocalcin;Osteoclasts;Osteogenesis;Osteoporosis;Parathyroid Hormone Receptor;Parathyroid gland;Partner in relationship;Pathway interactions;Phenotype;Play;Protein Subunits;Role;Signal Pathway;Signal Transduction;Skeletal Development;Staging;Staining method;Stains;Stromal Cells;Transgenic Mice;Woman;age related;bone;bone mass;experience;in vitro Assay;in vivo;insight;novel;osteoblast differentiation;osteogenic;osteoporosis with pathological fracture;osteoprogenitor cell;postnatal;promoter;recombinase;skeletal;transcription factor","Role of Gsalpha in Regulating Osteoblast Differentiation","n/a","NIAMS","8538221","1/7/2013 12:00:00 AM","PA-06-512","7K08AR054741-06","7","K08","AR","054741","06"," ","CHEN, FAYE H","5/1/2008 12:00:00 AM","4/30/2014 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","1900877","WU, JOY Y","Not Applicable","18","INTERNAL MEDICINE/MEDICINE","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","1/7/2013 12:00:00 AM","4/30/2014 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","29178","2334"," ","31512",
"Bioengineering; Eye Disease and Disorders of Vision; Regenerative Medicine","Architecture;Ascorbic Acid;Basic Science;Behavior;Behavior Control;Belief;Bioreactors;Cells;Chemistry;Cicatrix;Clinical Trials;Collagen;Collagen Fibril;Collagen Type III;Connective Tissue;Cornea;Corneal Injury;Corneal Stroma;Cues;Custom;Deposition;Development;Epigenetic Process;Extracellular Matrix;Fibroblasts;Goals;Growth;Human;Image;Implant;In Situ;Invaded;Investigation;Knowledge;Lead;Life;Mechanics;Mesenchymal;Natural regeneration;Neural Crest;Output;Paper;Pattern;Physiologic Intraocular Pressure;Play;Process;Production;Refractory;Reporting;Research Personnel;Resolution;Role;Series;Signal Transduction;Stretching;System;Testing;Thick;Tissue Engineering;Tissues;Weight-Bearing state;Work;Wound Healing;base;cell motility;cellular imaging;connective tissue development;crosslink;design;follow-up;insight;migration;novel strategies;prospective;regenerative;repaired;response;scaffold;self organization;success;tissue regeneration","Mechanobiology of Matrix Production by Corneal Fibroblasts"," Completion of this proposal will provide insight into the basic science of how mechanics influences cells during the production of highly-organized tissue such as the corneal stroma. The proposed work will also investigate the role of mechanical force in guiding the chemistry associated with the assembly of load-bearing tissue. Ultimately, we expect that the work will lead to better approaches to tissue engineering and a deeper understanding of the role that mechanics plays in the construction of vertebrate connective tissue.   
      

","NEI","8387865","9/3/2012 12:00:00 AM","PA-11-260","2R01EY015500-07","2","R01","EY","015500","07"," ","MCKIE, GEORGE ANN","2/1/2005 12:00:00 AM","8/31/2015 12:00:00 AM","Biology of the Visual System Study Section[BVS]"," ","7010344","RUBERTI, JEFFREY W","Not Applicable","07","ENGINEERING (ALL TYPES)","001423631","HLTMVS2JZBS6","001423631","HLTMVS2JZBS6","US","42.339503","-71.090489","6116101","NORTHEASTERN UNIVERSITY","BOSTON","MA","BIOMED ENGR/COL ENGR/ENGR STA","021155005","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","250000","138750"," ","388750",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adopted;Agonist;Behavior;Biological;Biology;Cell Communication;Cell division;Cells;Cellular biology;Cues;Development;Disease;Environment;Epithelial;Equilibrium;Failure;Goals;Growth;Hair;Hair follicle structure;Homeostasis;Image;Imaging technology;Injection of therapeutic agent;Knockout Mice;Knowledge;Laboratories;Laboratory Research;Lasers;Lead;Life;Malignant Neoplasms;Mesenchymal;Mesenchyme;Mus;Natural regeneration;Organ;Organism;Pathway interactions;Pattern;Physiological;Process;Proliferating;Regulation;Research;Role;Shapes;Signal Pathway;Signal Transduction;Skin;Stem Cell Research;Stem cells;Structure;System;Testing;Therapeutic;Time;Tissues;To specify;Wild Type Mouse;Work;cell behavior;cell motility;design;genetic manipulation;in vivo;in vivo regeneration;inhibitor/antagonist;insight;mutant;novel;novel strategies;regenerative;release factor;research study;self-renewal;skin regeneration;stem;stem cell biology;stem cell niche;stem cell population;tissue regeneration;tissue repair;treatment strategy;two-photon","Live Imaging of Skin Regeneration","  Research into stem cell holds tremendous promise to cure disease. The proposed research will utilize novel strategies that will enable us to capture aspects of biology heretofore inaccessible, and that will have broad implications for understanding mechanisms that govern stem cells during normal regeneration and disease.   
      

","NIAMS","8416828","9/7/2012 12:00:00 AM","PA-11-260","1R01AR063663-01","1","R01","AR","063663","01"," ","BAKER, CARL","9/7/2012 12:00:00 AM","8/31/2017 12:00:00 AM","Development - 1 Study Section[DEV1]"," ","10126127","GRECO, VALENTINA ","Not Applicable","03","GENETICS","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","9/7/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","148688"," ","373688",
"Bioengineering; Regenerative Medicine","3-Dimensional;Acoustics;Air;Apoptosis;Area;Basement lamina;Basement membrane;Behavior;Biocompatible Materials;Biological;Biological Assay;Biology;Biomechanics;Cell Line;Cell Proliferation;Cells;Clinical;Coculture Techniques;Complex;Development;Disease;Dysphonia;Engineering;Environment;Enzymes;Epithelial;Epithelium;Extracellular Matrix;Extracellular Matrix Proteins;Fibroblasts;Future;Gene Proteins;Goals;Histology;Immune;Immunoblotting;Immunohistochemistry;Immunologics;In Vitro;Individual;Infiltration;Kinetics;Label;Lamina Propria;Liquid substance;Measures;Membrane;Mesenchymal;Metabolic;Methodology;Modeling;Molecular and Cellular Biology;Morphogenesis;Mucous Membrane;Natural regeneration;Output;Performance;Phenotype;Physiological;Polysaccharides;Population;Production;Property;Proteomics;Refractory;Research;Series;Squamous Cell;Stem cells;Stratification;Stress;Structure;System;Techniques;Testing;Therapeutic;Tissue Engineering;Tissues;Transcriptional Regulation;Trauma;Voice;Work;base;cell behavior;cell motility;cell type;clinical application;human tissue;improved;in vitro Model;in vivo;keratinocyte;keratinocyte differentiation;novel;public health relevance;reconstitution;research study;restoration;scaffold;success;tissue regeneration;tissue repair;tool;vocal cord","Regeneration of Multi-layered Vocal Fold Mucosa","
PROJECT NARRATIVE
 The vocal fold mucosa is a complex biological structure that underpins normal voice production. The
proposed research is focused on the optimization of a multi-layered vocal fold mucosa substitute for the
treatment of diseased or damaged tissue, and restoration of vocal function.","NIDCD","8246956","3/21/2012 12:00:00 AM","PA-07-070","5R01DC010777-03","5","R01","DC","010777","03"," ","SHEKIM, LANA O","4/1/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Motor Function, Speech and Rehabilitation Study Section[MFSR]"," ","8654344","WELHAM, NATHAN ","Not Applicable","02","SURGERY","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","SCHOOLS OF MEDICINE","537151218","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","173","Non-SBIR/STTR","2012"," "," ","NIDCD","307046","148917"," ","455963",
"Cancer","Anabolic Agents;Award;Bone Diseases;Bone neoplasms;Cellular biology;Chicago;Clinical Research;Communication;Communities;Epithelial;Fostering;Foundations;Functional RNA;Generations;Grant;Imaging technology;International;Knowledge;Malignant Bone Neoplasm;Malignant Neoplasms;Mentors;Mesenchymal;Metabolism;Metastatic Neoplasm to the Bone;Michigan;MicroRNAs;Minerals;Neoplasm Metastasis;Parents;Recording of previous events;Research;Research Personnel;Resistance;Science;Scientist;Societies;Training;Translating;Travel;bone;bone cell;cancer cell;cancer complication;cancer stem cell;cancer therapy;clinical practice;design;experience;in vivo;innovation;meetings;neoplastic cell;oncology;peer;programs;skeletal;symposium;tumor","11th International Conference on Cancer-Induced Bone Disease in Chicago, IL, in p"," The 11th International Conference on Cancer-Induced Bone Disease is presented by the International Bone and Mineral Society (IBMS), with the Cancer and Bone Society (CABS), the Bone and Cancer Foundation (BCF) and its parent organization, the Paget Foundation, and will take place November 30 - December 3, 2011 at the Westin Michigan Avenue in Chicago.  The CIBD and BCF/Paget conferences have a long history of providing the most current  scientific and clinical research in metastatic bone disease, are attended by more than 300  scientists and clinicians, and continue to be the premier meetings in bone oncology, attracting  attendees from around the world.  MISSION: IBMS is the international organization that facilitates the generation and dissemination of knowledge of bone and mineral metabolism through communication, community, training, and multi-disciplinary meetings   throughout the world.  
    

","NCI","8257459","3/9/2012 12:00:00 AM","PA-10-071","1R13CA165751-01","1","R13","CA","165751","01"," ","TURNER, MICHELLE C","3/9/2012 12:00:00 AM","1/31/2013 12:00:00 AM","ZCA1-PCRB-G(P3)"," ","10340004","BALIOZIAN, KEVIN ","Not Applicable","07","Unavailable","105206978"," ","105206978"," ","US","41.88892","-87.624265","10029075","INTERNATIONAL BONE AND MINERAL SOCIETY","CHICAGO","IL","Other Domestic Non-Profits","606114255","UNITED STATES","N","3/9/2012 12:00:00 AM","1/31/2013 12:00:00 AM","396","Other Research-Related","2012"," "," ","NCI","3000"," "," ","3000",
"Cancer","Address;Adenoviruses;Affect;Antibodies;Antigens;CMV promoter;Cancer Patient;Cancer cell line;Catalytic Domain;Cell Adhesion Molecules;Cell surface;Cells;Clinical;Clinical Trials;Colorectal Cancer;Cytokeratin;DNA Tumor Viruses;Detection;Devices;Doxycycline;Early Diagnosis;Elements;Epithelial;Epithelial Cells;Evaluation;Event;FDA approved;Fibroblasts;Future;Gene Expression Regulation;Generations;Genes;Heterogeneity;Human;Image;Label;Lead;Magnetism;Malignant Neoplasms;Mesenchymal;Methods;Molecular;Monitor;Neoplasm Metastasis;Normal Cell;Patients;Principal Investigator;Procedures;Property;Recombinants;Reporting;Research;Research Personnel;Solid Neoplasm;Somatic Cell;Stem cells;System;TERT gene;Techniques;Technology;Telomerase;Testing;Tetanus Helper Peptide;Tissues;Training;Tumor Stem Cells;Viral;Work;base;cancer cell;cancer recurrence;cancer type;clinically relevant;expectation;metastatic colorectal;minimally invasive;neoplastic cell;novel;outcome forecast;peripheral blood;platform-independent;prognostic indicator;promoter;replication competent adenoviral vector;treatment response;tumor;vector","Telomerase-Specific Adenoviral Imaging Systems for Detecting and Isolating CTCs","  Circulating tumor cells are clinically relevant for early detection of primary cancers, evaluation of treatment responses, and as a prognostic indicator on primary cancer recurrence and metastasis. In this application, we plan to develop a new generation of recombinant adenoviral imaging systems for detection and isolation of telomerase-positive circulating tumor cells.   
      

","NCI","8245433","2/29/2012 12:00:00 AM","PAR-11-079","1R03CA165182-01","1","R03","CA","165182","01"," ","SORBARA, LYNN R","3/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","ZCA1-SRLB-Y(O2)"," ","6378171","ZHU, JIYUE ","Not Applicable","10","PHYSIOLOGY","129348186","TNKGNDAWB445","129348186","TNKGNDAWB445","US","40.26536","-76.625873","1524204","PENNSYLVANIA STATE UNIV HERSHEY MED CTR","HERSHEY","PA","SCHOOLS OF MEDICINE","170332360","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","50000","26500"," ","76500",
"Bioengineering; Biotechnology; Lung; Regenerative Medicine","Address;Adhesions;Animals;Architecture;Automobile Driving;Behavior;Biomedical Engineering;Bioreactors;Blocking Antibodies;Blood Vessels;Cell physiology;Cells;Cessation of life;Chronic;Chronic lung disease;Confocal Microscopy;Cues;Cystic Fibrosis;Cytoskeleton;Data;Development;Disease;Elements;Environmental air flow;Epithelial;Evaluation;Event;Experimental Models;Extracellular Matrix;Feasibility Studies;Gases;Genes;Goals;Growth;Human;Image;Imaging Device;Immunohistochemistry;Infection;Knock-out;Knowledge;Laboratories;Lung;Lung Transplantation;Lung diseases;Maintenance;Measures;Mechanical ventilation;Mechanics;Mediating;Mesenchymal;Methods;Mission;Modality;Morbidity - disease rate;Morphogenesis;Natural regeneration;Patients;Peptides;Perfusion;Phenotype;Physiological;Preparation;Principal Investigator;Process;Proliferating;Proteins;Proteomics;Pulmonary Emphysema;Pulmonary Fibrosis;Pulmonary alveolar structure;Research;Respiratory Failure;Respiratory physiology;Rodent;Slice;Staging;Structure;Structure of parenchyma of lung;Survival Rate;Symptoms;Technology;Testing;Therapeutic Intervention;Time;Tissues;Transmission Electron Microscopy;United States;Work;allograft rejection;cellular imaging;imaging modality;innovation;lung development;lung imaging;lung repair;member;mortality;novel;repaired;research study;scaffold;success;tool","Matrix and Bioreactors for Human Lung Regeneration","n/a","NHLBI","8224021","12/30/2011 12:00:00 AM","RFA-HL-12-006","1U01HL111016-01","1","U01","HL","111016","01"," ","BLAISDELL, CAROL J","1/1/2012 12:00:00 AM","12/31/2016 12:00:00 AM","ZHL1-CSR-H(O1)"," ","1869960","NIKLASON, LAURA E","WHITE, ERIC S","03","ANESTHESIOLOGY","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","563961","133088"," ","697049",
"No NIH Category available","Agonist;Biological Markers;Biometry;CU201;Cessation of life;Chemoprevention;Clinical Trials;Colorado;Early Detection Research Network;Early Diagnosis;Epidermal Growth Factor Receptor;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Family;Fibroblast Growth Factor Receptors;Goals;Growth;Growth Factor;Histology;Histone Deacetylase Inhibitor;Iloprost;Informatics;Lead;Malignant neoplasm of lung;Methylation;Mutation;Neoplasm Metastasis;Pathogenesis;Pathway interactions;Patient Selection;Population;Prevention;Prostaglandins I;Proteomics;Research Personnel;Resources;Risk;Role;Serum;Signal Pathway;Snails;Southwest Oncology Group;Tissue Banking;Tissue Banks;Translational Research;Tumor Suppressor Genes;autocrine;base;cancer risk;cancer therapy;cohort;design;epithelial to mesenchymal transition;improved;inhibitor/antagonist;lung cancer prevention;research study;rosiglitazone;slug;success;treatment strategy","SPORE in Lung Cancer","n/a","NCI","8282962","6/19/2012 12:00:00 AM","PAR-06-505","5P50CA058187-18","5","P50","CA","058187","18"," ","UJHAZY, PETER","5/20/1997 12:00:00 AM","4/30/2014 12:00:00 AM","ZCA1-GRB-I(J1)"," ","1860776","BUNN, PAUL A.","Not Applicable","06","INTERNAL MEDICINE/MEDICINE","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","397","Research Centers","2012"," "," ","NCI","1714709","720886"," ","2300000",
"Dental/Oral and Craniofacial Disease","Adhesions;Affect;Aging;Animals;Apoptosis;Apoptotic;Behavior;Biochemical;Biochemical Genetics;Biological Models;Cell Adhesion Molecules;Cell Culture Techniques;Cell Cycle Arrest;Cell physiology;Cell-Cell Adhesion;Cells;Cellular biology;Chronology;Cleaved cell;Cleft Palate;Complex;Data;Deformity;Development;E-Cadherin;Elements;Embryo;Embryonic Development;Epithelial;Event;Extracellular Matrix;Face;Failure;Family member;Fibrosis;Genes;Genetic Transcription;Goals;Grant;Heart;Individual;Kidney;Knockout Mice;Knowledge;Lead;Lung;Malignant Neoplasms;Medial;Mediating;Mesenchymal;Mesenchyme;Molecular;Mus;Outcome Study;Palate;Pathway interactions;Phase;Phenotype;Prevention;Publishing;Research;Signal Pathway;Signal Transduction;Snails;Staging;System;Tissues;Transcription Coactivator;Transforming Growth Factors;activating transcription factor;base;cell motility;cell type;craniofacial;design;developmental disease;effective therapy;in vivo;insight;knowledge base;migration;novel;novel strategies;palatal shelves;palatogenesis;protein E;response;slug;transcription factor","TGFbeta3 SIGNALING IN DEVELOPMENT OF PALATE","n/a","NIDCR","8231549","1/26/2012 12:00:00 AM","PA-07-070","5R01DE017986-05","5","R01","DE","017986","05"," ","SCHOLNICK, STEVEN","3/1/2008 12:00:00 AM","4/30/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","8442646","NAWSHAD, ALI ","Not Applicable","02","DENTISTRY","168559177","G15AG3BLLMH4","168559177","G15AG3BLLMH4","US","41.26545","-96.039767","578104","UNIVERSITY OF NEBRASKA MEDICAL CENTER","OMAHA","NE","SCHOOLS OF DENTISTRY/ORAL HYGN","681987835","UNITED STATES","N","3/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","237674","111707"," ","349381",
"Cancer; Genetics; Neurosciences; Pediatric; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","3-Dimensional;Address;Back;Behavior;Biological Markers;Biological Models;Cadherins;Cell Line;Cell Transplants;Cells;Chemotaxis;Chick Embryo;Clinical;Complex;Cues;Cutaneous Melanoma;DNA Sequence Rearrangement;Developmental Process;Diagnosis;Dorsal;Drug resistance;Embryo;Embryonic Development;Environment;Epigenetic Process;Epithelial Cells;Event;Exhibits;Focal Adhesions;Gene Expression;Gene Expression Regulation;Genes;Genetic;Goals;Health;Hour;Human;Image;Imaging Techniques;Immune system;Individual;Invaded;Label;Location;Mediating;Melanoma Cell;Metastatic Melanoma;Microscopy;Modeling;Molecular;Morphology;Neoplasm Metastasis;Neural Crest;Neural Crest Cell;Neural tube;Organ;Pathway interactions;Phase;Phenotype;Photons;Pluripotent Stem Cells;Predisposition;Primary Neoplasm;Process;Property;Research Proposals;Simulate;Site;Solid Neoplasm;Techniques;Testing;Tissues;Transplantation;cancer cell;cell motility;cell type;comparative;epithelial to mesenchymal transition;in vivo;in vivo Model;keratinocyte;melanocyte;melanoma;metastatic process;migration;neoplastic cell;novel;photoactivation;pluripotency;programs;stem;trait;tumor","Profiling Early Metastatic Melanoma in vivo using the Chick Embryo Model","PUBLIC HEALTH RELEVANCE: Malignant melanomas are consistently misdiagnosed, due in part to a lack of biomarkers specific for metastatic melanoma. This research proposal focuses on elucidating mechanisms governing early steps in melanoma metastasis, with the goal of being able to identify pre-metastatic melanoma cells in vivo.","NCI","8305952","8/27/2012 12:00:00 AM","PA-09-210","5F32CA144297-03","5","F32","CA","144297","03"," ","JAKOWLEW, SONIA B","9/1/2010 12:00:00 AM","8/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-A(20)L]"," ","9842890","BAILEY, CALEB MICHAEL","Not Applicable","05","Unavailable","614653652","KNSQZPJ3K775","614653652","KNSQZPJ3K775","US","39.036373","-94.574439","4323301","STOWERS INSTITUTE FOR MEDICAL RESEARCH","KANSAS CITY","MO","Research Institutes","641102262","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","57734"," "," ","57734",
"Contraception/Reproduction; Genetics; Infertility; Pediatric","Address;Adherence;Adhesions;Animal Model;Birth;Blastocyst Transfer;Cell Polarity;Clinical;Collaborations;Complex;Conceptions;Contraceptive Agents;Cytoskeleton;Defect;Development;E-Cadherin;Endometrium;Epithelial;Epithelial Cells;Epithelium;Estrogens;Ethics;Event;Family;Family member;Female;Female infertility;Fertility;Figs - dietary;Food;Gene Deletion;Genes;Goals;Hair follicle structure;Homeobox;Homeobox Genes;Human;Implant;Injection of therapeutic agent;Letters;Liquid substance;Mammals;Mesenchymal;Modeling;Molecular;Mus;Muscle;Pattern;Phase;Play;Powder dose form;Pregnancy;Pregnancy Rate;Pregnancy loss;Readiness;Refractory;Relative (related person);Reproduction;Role;Scientist;Seizures;Signal Pathway;Signal Transduction;Spontaneous abortion;Testing;Time;Tooth structure;Unwanted pregnancy;Uterus;Wild Type Mouse;Woman;base;blastocyst;clinically relevant;craniofacial;failure Implantation;implantation;improved;mouse model;natural Blastocyst Implantation;novel;novel strategies;placental mammal;psychologic;research study;success;transcription factor;uterine receptivity","Molecular signaling in uterine receptivity to implantation"," The underlying mechanism by which the uterus transits from the perceptive to receptive to non-receptive phases in the context of embryo implantation is not clearly understood. The proposed study will explore the role and mechanism of Msx1 and/or Msx2, two homeotic transcription factors, in this transition. The results may help developing novel strategies to improve pregnancy rates in women with poor fertility.  
    

","NICHD","8338882","6/18/2012 12:00:00 AM","PA-10-067","5R01HD068524-02","5","R01","HD","068524","02"," ","YOSHINAGA, KOJI","9/26/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Cellular, Molecular and Integrative Reproduction Study Section[CMIR]"," ","1863079","DEY, SUDHANSU K","Not Applicable","01","Unavailable","071284913","JZD1HLM2ZU83","071284913","JZD1HLM2ZU83","US","39.140882","-84.500494","615001","CINCINNATI CHILDRENS HOSP MED CTR","CINCINNATI","OH","Independent Hospitals","452293039","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","212500","112625"," ","325125",
"Autoimmune Disease; Lung; Orphan Drug; Rare Diseases","Address;Alveolar;Animal Model;Apoptosis;Breathing;Cells;Clinical;Clinical Treatment;Clinical Trials;Collection;Core Facility;Data;Development;Drug Kinetics;Epithelial;Epithelial Cells;Face;Fibrosis;Generations;Goals;Grant;Hamman-Rich syndrome;Human;Instruction;Integrins;Lead;Lung diseases;Mediating;Mesenchymal;Methods;Pathway interactions;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;Pharmacotherapy;Phase;Process;Productivity;Property;Pulmonary Fibrosis;Research Project Grants;Screening procedure;Services;Stress;Structure of parenchyma of lung;TGFB1 gene;Testing;Therapeutic Index;Transforming Growth Factor beta;Translational Research;Triage;Work;absorption;analog;cohort;design;drug candidate;drug development;effective therapy;extracellular;high throughput screening;human tissue;improved;integrin beta6;iterative design;mortality;novel;programs;tool;treatment trial","Medicinal Chemistry/Sheppard","RELEVANCE (See instructions): 
We are working to develop new and efficacious treatments for idiopathic pulmonary fibrosis. Medicinal chemistry is a critical component of these efforts. Using these methods, lead compounds are improved upon through the iterative design and testing of new analogs. In conjunction with each project, improvements in properties like potency, selectivity and drug likeness will lead to the generation of drug candidates.","NHLBI","8401283","8/9/2012 12:00:00 AM","PAR-09-185","1P01HL108794-01A1","1","P01","HL","108794","01","A"," "," "," ","ZHL1-CSR-Q(M1)","7494","9439428","BACKES, BRADLEY J","Not Applicable","12","Unavailable","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","Domestic Higher Education","941432510","UNITED STATES","N","8/9/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","365515","365515"," ","233556","131959"," "," ",
"Biotechnology; Cancer; Colo-Rectal Cancer; Digestive Diseases; Genetics; Prevention","Address;Adjuvant Chemotherapy;Area;Base Pairing;Biological Assay;Biological Markers;Blood;Blood Tests;Cancer Detection;Cancer Etiology;Cancer Patient;Carcinoembryonic Antigen;Cessation of life;Characteristics;Clinical;Colon Carcinoma;Colorectal Cancer;Complement;Coupled;Data;Data Analyses;Death Rate;Detection;Development;Disease;Disease Progression;Distant;Distant Metastasis;Early Diagnosis;Epithelial;Excision;Family;Functional RNA;Future;Gene Expression;Gene Targeting;Individual;Investigation;Localized Disease;Malignant Neoplasms;Mesenchymal;MicroRNAs;Monitor;Neoadjuvant Therapy;Neoplasm Metastasis;Patients;Performance;Pilot Projects;Plasma;Publishing;RNA;Recurrence;Reverse Transcriptase Polymerase Chain Reaction;Sampling;Screening for cancer;Staging;Stratification;Technology;Testing;Translational Repression;United States;Validation;base;chemotherapy;clinically relevant;cohort;colorectal cancer screening;density;improved;lymph nodes;member;metastatic colorectal;next generation;novel;outcome forecast;prevent;prognostic;public health relevance;response;therapy outcome","Identification of microRNAs as blood-based markers for colorectal cancer","
Project Narrative
Although the search for plasma markers for cancer is a well-established concept,
the finding of markers that are clinically useful is very infrequent. Any marker with
favorable performance characteristics would favorably impact cancer screening
and monitoring and contribute to improved survival of patients. Therefore, the
search for plasma markers for colon cancer in this proposal is critically important.","NCI","8243512","3/23/2012 12:00:00 AM","PA-08-267","5R21CA150654-02","5","R21","CA","150654","02"," ","THURIN, MAGDALENA","4/1/2011 12:00:00 AM","3/31/2013 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","1864497","ZHANG, WEI ","HAMILTON, STANLEY R.","09","PATHOLOGY","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","108750","63075"," ","171825",
"Hematology; Injury (total) Accidents/Adverse Effects","Address;Affect;Anticoagulation;Atherosclerosis;Bone Marrow;CCL21 gene;Cell Wall;Cells;Chronic;Cicatrix;Complication;Cytolysis;Cytoskeleton;Data;Deep Vein Thrombosis;Disease;Effector Cell;Environment;Fibrosis;Goals;Healed;Health;Homing;Human;In Vitro;Incidence;Inflammatory Response;Injury;Kidney;Leukocytes;Limb structure;Lung;Lymphocyte;Lymphoid;Mediating;Medical;Mesenchymal;Modeling;Mus;Organ;Pain;Patients;Peptide Hydrolases;Phenotype;Physiological Processes;Play;Postphlebitic Syndrome;Process;Production;Proteins;Resolution;Risk;Role;Secondary to;Signal Transduction;Surface Antigens;Swelling;T-Lymphocyte;Testing;Thrombosis;Thrombus;Tissues;Translations;Ulcer;Veins;Venous Thrombosis;Wound Healing;base;body system;chemokine;deep vein;disability;healing;in vivo;prevent;progenitor;public health relevance;receptor;response to injury","Vein Wall Fibrotic Injury After DVT is SLC-CCR7 Dependent","
Narrative:
This proposal will establish the role of a chemokine that mediates a circulating wound healing cell in vein wall
remodeling after deep vein thrombosis. The long term goal is to define a therapy to decrease post thrombotic
syndrome, a common and morbid complication of deep vein thrombosis.","NHLBI","8230689","2/28/2012 12:00:00 AM","PA-07-070","5R01HL092129-04","5","R01","HL","092129","04"," ","LINK, REBECCA P","4/1/2009 12:00:00 AM","2/28/2014 12:00:00 AM","Atherosclerosis and Inflammation of the Cardiovascular System Study Section[AICS]"," ","2046546","HENKE, PETER K","Not Applicable","12","SURGERY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","134888"," ","382388",
"Cancer; Clinical Research; Hematology; Lymphoma; Rare Diseases","Alteplase;Annexins;Antigen-Presenting Cells;Binding;Biochemical;Biology;Blood Vessels;Cell surface;Cells;Characteristics;Clinical;Commit;Disease;Disease Progression;Endothelial Cells;Failure;Fellowship;Generations;Hematology;Hematopoietic;Hematopoietic Neoplasms;Human;Implant;Indolent;Knockout Mice;Lymphoma;Lymphoproliferative Disorders;Matrix Metalloproteinases;Mediating;Medical center;Mentorship;Mesenchymal;Molecular;Pathogenesis;Pathologic Neovascularization;Patients;Pattern;Peptide Hydrolases;Pericytes;Phenotype;Pilot Projects;Plasmin;Plasminogen;Principal Investigator;Research Personnel;Residencies;Resources;Role;Sampling;Smooth Muscle Myocytes;Specimen;Stimulus;Stromal Cells;Structure;Surface;Therapeutic;Training;Vascular Endothelial Cell;Vascular Endothelial Growth Factor Receptor-1;Vascular Endothelial Growth Factors;abstracting;angiogenesis;base;career development;cell assembly;cell motility;clinical efficacy;design;human disease;human subject;insight;macrophage;migration;monocyte;mouse model;neovascular;novel;oncology;prognostic;programs;receptor;receptor binding;response;skills;translational medicine","Annexin 2 in Lymphoproliferative Angiogenesis","n/a","NHLBI","8215919","2/24/2012 12:00:00 AM","PA-06-512","5K08HL091517-05","5","K08","HL","091517","05"," ","SCOTT, JANE","3/1/2008 12:00:00 AM","2/28/2013 12:00:00 AM","ZHL1-CSR-X(O1)"," ","8255950","RUAN, JIA ","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","060217502","YNT8TCJH8FQ8","060217502","YNT8TCJH8FQ8","US","40.76491","-73.955055","1514803","WEILL MEDICAL COLL OF CORNELL UNIV","NEW YORK","NY","SCHOOLS OF MEDICINE","100654805","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","837","Other Research-Related","2012"," "," ","NHLBI","121750","9740"," ","131490",
"Digestive Diseases; Genetics; Pediatric; Rare Diseases; Urologic Diseases","Ablation;Animal Disease Models;Apoptosis;Birth;Bladder;Bladder Exstrophy;Cell Lineage;Cells;Cloaca Chamber;Congenital Abnormality;Coupled;Data;Defect;Development;Developmental Biology;Developmental Process;Disease;Dorsal;Embryo;Etiology;Exhibits;Future;Gastrointestinal tract structure;Gene Expression;Genes;Genetic;Genital system;Genitourinary system;Goals;Human;Hypospadias;Imperforate Anus;Incidence;Knowledge;Lead;Life;Link;Location;Lower urinary tract;Maps;Medical;Mesenchymal;Mesenchyme;Mission;Modeling;Molecular;Morphogenesis;Mus;Pathogenesis;Pathway interactions;Phenotype;Population;Process;Public Health;Publishing;Reporting;Research;Role;Signal Transduction;Testing;Time;Tissues;Tube;Urethra;Urinary tract;Urogenital Sinus;Urorectal Septum;Work;base;burden of illness;cloacal membrane;cofactor;design;disability;in vivo;innovation;interest;molecular marker;mutant;mutant mouse model;novel;rectum/anus;social;transcription factor;urinary","Functional characterizations of the Sdx1 domain during cloacal septation"," This proposal is relevant to public health because understanding basic developmental biology of lower urinary tract is the first of many steps towards a better understanding of etiology of and development of novel preventative strategies of congenital urogenital birth defects, which are among the most common in humans. The proposed research is relevant to the part of NIH's mission in pursuing fundamental knowledge to extend healthy life and to reduce the burdens of illness and disability.   
      

","NIDDK","8372803","9/17/2012 12:00:00 AM","PA-09-226","1R01DK091645-01A1","1","R01","DK","091645","01","A","HOSHIZAKI, DEBORAH K","9/18/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Kidney Molecular Biology and Genitourinary Organ Development[KMBD]"," ","2563587","LI, XUE SEAN","Not Applicable","07","Unavailable","076593722","Z1L9F1MM1RY3","076593722","Z1L9F1MM1RY3","US","42.340629","-71.094923","1504801","BOSTON CHILDREN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021155724","UNITED STATES","N","9/18/2012 12:00:00 AM","8/31/2014 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","82759","61241"," ","144000",
"Breast Cancer; Cancer; Orphan Drug; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Affect;Animal Model;Animals;Autopsy;B-Lymphocytes;Biological Assay;Breeding;Carcinoma;Cell Count;Cells;Chimerism;Collection;Colony-Forming Units Assay;Consent;Endothelial Cells;Epigenetic Process;Fatty acid glycerol esters;Fibroblasts;Genetic;Gold;Head;Hematopoietic;Human;Immunocompromised Host;Immunodeficient Mouse;Injection of therapeutic agent;Laboratories;Laboratory Animals;Malignant - descriptor;Mammary Neoplasms;Mammary gland;Measures;Mesenchymal;Modeling;Multipotent Stem Cells;Mus;Natural Killer Cells;Palliative Care;Patients;Population;Process;Qualifying;Research Design;SCID Mice;Shipping;Ships;Signal Transduction;Site;Solid Neoplasm;Sorting - Cell Movement;Specimen;Stem cells;Study models;Supporting Cell;T-Lymphocyte;Telomerase;Time;Transplantation;Tumor Bank;Tumor Stem Cells;Umbilical Cord Blood;Universities;University Hospitals;Vendor;Xenograft Model;Xenograft procedure;cancer stem cell;in vivo;leukemia;leukemic stem cell;malignant breast neoplasm;matrigel;member;neoplastic cell;programs;research study;self-renewal;stem cell population;success;therapeutic target;tumor;tumorigenic","Animal Core","n/a","NCI","8375340","5/1/2012 12:00:00 AM","RFA-CA-08-020","5P01CA139490-04","5","P01","CA","139490","04"," "," "," "," ","ZCA1-SRRB-C","5047","1866036","CLARKE, MICHAEL ","Not Applicable","18","Unavailable","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","Domestic Higher Education","943052004","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","294820","294820"," ","187948","106872"," "," ",
"Asthma; Autoimmune Disease; Lung; Rare Diseases","Alveolar;Alveolar Macrophages;Asthma;Automobile Driving;Basement membrane;Behavior;Biological Models;CD44 Antigens;CD44 gene;Cell membrane;Cell surface;Cells;Chronic;Chronic lung disease;Data;Development;Disease Progression;Epithelial;Epithelial Cells;Extracellular Matrix;Fibroblasts;Fibrosis;Generations;Glycosaminoglycans;Goals;Hamman-Rich syndrome;Human;Hyaluronan;Inflammation;Inflammatory;Injury;Instruction;Integration Host Factors;Interleukin-1;Interleukin-13;Laboratories;Lung;Lung Inflammation;Lung diseases;Mesenchymal;Modeling;Molecular;Morbidity - disease rate;Mus;Myofibroblast;Pathologic;Patients;Phenotype;Pneumonia;Principal Investigator;Pulmonary Fibrosis;Regulation;Relative (related person);Role;Signal Transduction;Smooth Muscle Actin Staining Method;Structure of parenchyma of lung;System;TLR2 gene;TLR4 gene;Testing;Tissues;Transgenes;Transgenic Mice;Work;asthmatic patient;base;extracellular;human disease;hyaluronan synthase 1;in vivo;loss of function;lung injury;macromolecule;man;mortality;mouse model;novel;programs;promoter;receptor;response;senescence;surfactant deficiency","Hyaluronan in Pulmonary Fibrosis and Asthma","n/a","NHLBI","8403438","7/19/2012 12:00:00 AM","PAR-10-285","1P01HL108793-01A1","1","P01","HL","108793","01","A"," ","8/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","ZHL1-CSR-S(M1)","7942","1895798","NOBLE, PAUL WESLEY","Not Applicable","04","Unavailable","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","Domestic Higher Education","277054673","UNITED STATES","N","8/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","351878","351878"," ","224126","127752"," "," ",
"Dental/Oral and Craniofacial Disease; Pediatric","Apoptosis;Arts;Attenuated;Bacterial Artificial Chromosomes;Cell Cycle;Cell Cycle Arrest;Cell Proliferation;Cleft Palate;Complex;Congenital Abnormality;Data;Distant;Engineering;Enhancers;Epithelial;Epithelial Cells;Epithelium;Event;Experimental Models;Failure;Funding;Gene Expression;Genes;Genetic Transcription;Genomics;Grant;Growth;Health;Human;In Vitro;LacZ Genes;Lead;MAPK14 gene;Medial;Mediating;Mesenchymal;Mesenchyme;Molecular;Morphology;Mus;Organ Culture Techniques;Pathogenesis;Pattern;Phosphotransferases;Play;Regulatory Element;Reporter;Reporting;Role;Signal Pathway;Signal Transduction;Surface;Surveys;Syndrome;Techniques;Testing;Tissues;Transforming Growth Factor beta;Transforming Growth Factors;Transgenic Mice;Transgenic Organisms;Work;base;in vivo;inhibitor/antagonist;knockout gene;mutant;notch protein;novel;palatal fusion;palatal shelves;palatogenesis;public health relevance;research study;transforming growth factor beta3","The Role of TGF-Beta3 in Palatogenesis","
Cleft palate is one of the most common congenital birth defects in humans. The proposed
studies dissect the role of a transforming growth factor-beta signaling in the pathogenesis
of cleft palate. We expect that the proposed studies will be important in understanding of
the underlying molecular mechanisms that lead to the cleft palate syndrome in humans.","NIDCR","8230752","1/26/2012 12:00:00 AM","PA-07-070","5R01DE013085-13","5","R01","DE","013085","13"," ","SCHOLNICK, STEVEN","2/1/2001 12:00:00 AM","2/28/2015 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","2740729","KAARTINEN, VESA M","Not Applicable","12","DENTISTRY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF DENTISTRY/ORAL HYGN","481091276","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","279370","136949"," ","416319",
"No NIH Category available"," ","Fibroblast Growth Factor signaling in odontogenic epithelial stem/progenitor cell","
7. Project Narrative
Stem cells derived from both epithelial and mesenchymal components are required for future
regeneration of whole teeth. The key for reconstruction from defined cellular and molecular
components and further elucidating the alterations in pathology depends on developing in vitro
systems that accurately recapitulate the in vivo functions. Although Fibroblast Growth Factors
(FGF) have been shown to play important roles in maintenance of the mouse incisor cervical
loop region where stem cells are thought to reside, the defined mechanism of FGF signaling is
not yet available for the odontogenic epithelial stem cells and surrounding microenvironment.
Our project is aimed at defining the FGF signaling pathways for the odontogenic epithelial stem
cells derived from mouse incisor cervical loops through an in vivo Fgfr2 tissue specific knockout
mouse model and developing in vitro sphere culture model.","NIDCR","8588542","12/20/2012 12:00:00 AM","PA-09-042","7K08DE020883-04","7","K08","DE","020883","04"," ","KING, LYNN M","7/1/2010 12:00:00 AM","6/30/2015 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","8803245","CHANG, JULIA YU FONG ","Not Applicable","07","DENTISTRY","605799469","HD1WMN6945W6","605799469","HD1WMN6945W6","US","47.660049","-122.31441","9087701","UNIVERSITY OF WASHINGTON","SEATTLE","WA","SCHOOLS OF DENTISTRY/ORAL HYGN","981951016","UNITED STATES","N","10/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","88443","7075"," ","95518",
"Cardiovascular; Clinical Research; Genetics; Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adult;Affect;Apolipoprotein E;Binding;Cardiac Surgery procedures;Cell Lineage;Cell Maturation;Cell Proliferation;Cells;Characteristics;Code;Comb animal structure;Congenital Abnormality;Data;Development;Dimerization;Disease;Disease Progression;Embryo;Embryonic Development;Endothelial Cells;Extracellular Matrix;Fibroblasts;Funding;Gene Expression;Gene Targeting;Generations;Goals;Heart Valves;Homo;Human;Individual;Knockout Mice;Link;Maintenance;Mesenchymal;Molecular;Morbidity - disease rate;Morphogenesis;Mus;Mutant Strains Mice;Natural regeneration;Osteogenesis;Pathogenesis;Pathology;Population;Regulation;Regulatory Pathway;Role;Sampling;Sclerosis;Signal Transduction;Source;Staging;Stem cells;Therapeutic;Transgenic Mice;United States;aged;aortic valve;aortic valve disorder;base;calcification;cell motility;dimer;fetal;heart valve replacement;in vivo;malformation;mature animal;migration;mortality;periostin;postnatal;prevent;progenitor;public health relevance;regenerative;repaired;scleraxis;stem cell population;transcription factor","Twist1 regulation of valve progenitors","
Relevance
Heart valve malformations are among the most common types of birth defects and adult valve disease is a
significant cause of morbidity and mortality in the United States. Our studies will examine the ability of the
transcription factor Twist1 to promote the formation and expansion of progenitor cells in normal valve
development. We also will determine if Twist1 functions in adult valve disease to promote cell proliferation
while inhibiting pathological calcification.","NHLBI","8268986","5/10/2012 12:00:00 AM","PA-07-070","5R01HL082716-07","5","R01","HL","082716","07"," ","SCHRAMM, CHARLENE A","7/1/2006 12:00:00 AM","5/31/2015 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","1912046","YUTZEY, KATHERINE E","Not Applicable","01","Unavailable","071284913","JZD1HLM2ZU83","071284913","JZD1HLM2ZU83","US","39.140882","-84.500494","615001","CINCINNATI CHILDRENS HOSP MED CTR","CINCINNATI","OH","Independent Hospitals","452293039","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","131175"," ","378675",
"Clinical Research; Genetics","Adaptor Signaling Protein;Adult;Affect;Anatomy;Animals;Award;Binding;Biology;Body Patterning;Body part;Cell Differentiation process;Cells;Chromatin;Clinical;Collaborations;Complex;Cultured Cells;Dermal;Dermatology;Development;Diagnosis;Disease;Distal;Embryo;Employee Strikes;Epigenetic Process;Epithelial;Ethics;Experimental Designs;Family;Feedback;Fibroblasts;Gene Activation;Gene Expression;Gene Expression Regulation;Gene Targeting;Genes;Genetic Transcription;Goals;Histone H3;Homeobox Genes;Homeostasis;Hybrids;Knowledge;Laboratories;Location;Lysine;Maintenance;Mammalian Cell;Mediating;Memory;Mentors;Mesenchymal;Methylation;Modeling;Molecular;Names;Natural regeneration;Organism;Participant;Pattern;Physicians;Positioning Attribute;Process;Proteins;Psoriasis;RNA;RNA Binding;Regulator Genes;Relative (related person);Research;Research Personnel;Resources;Role;Scientist;Scleroderma;Shapes;Site;Skin;Specificity;Structure;Time;To specify;Training;Transcriptional Activation;Transcriptional Regulation;Universities;Untranslated RNA;Work;cellular development;chromatin remodeling;clinically relevant;design;embryonic stem cell;gene repression;in vivo;insight;leukemia;novel;outcome forecast;programs;skin disorder;transcription factor;wound","Transcriptional regulation of chromatin modifying complexes by noncoding RNAs"," This proposal is focused on understanding at the molecular level how skin from different parts of the body develops unique anatomical features. Many diseases of the skin, such as psoriasis and scleroderma, have site-specific manifestations. Understanding the mechanism of why this occurs has important implications for designing the best treatment options.  
    

","NIAMS","8306126","8/14/2012 12:00:00 AM","PA-10-059","5K08AR061414-02","5","K08","AR","061414","02"," ","BAKER, CARL","9/1/2011 12:00:00 AM","9/30/2012 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","10655681","WANG, KEVIN CHUN-KAI","Not Applicable","18","DERMATOLOGY","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","9/1/2012 12:00:00 AM","9/30/2012 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","9155","732"," ","9887",
"Cancer; Digestive Diseases; Pancreatic Cancer; Rare Diseases","Address;Awareness;Behavior;Biological;Biological Assay;Biological Markers;CXCR4 gene;Cancer Cell Growth;Cancer Etiology;Cancer Patient;Cancer cell line;ChIP-on-chip;Clinical;Data;Development;Diagnosis;Diagnostic;Disease;Disease Management;Distant;Down-Regulation;Exhibits;Family;Foundations;Gene Targeting;Genes;Growth;In Vitro;Incidence;Investigation;Knowledge;Lead;Lesion;Life Expectancy;Light;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of pancreas;Molecular;Molecular Target;Neoplasm Metastasis;Normal tissue morphology;Oncogenic;Pancreas;Pathogenesis;Patients;Premalignant;Proteins;Proto-Oncogenes;RNA Interference;Reporting;Role;Sampling;Series;Site;Staging;Stratification;Testing;Time;Tumor Tissue;United States;base;c-myc Genes;cancer diagnosis;carcinogenesis;clinically relevant;effective therapy;epithelial to mesenchymal transition;in vivo;innovation;insight;migration;mortality;mouse model;myb Genes;novel;outcome forecast;overexpression;pancreatic cancer cells;pancreatic neoplasm;prognostic;therapeutic target;transcription factor;treatment strategy;tumor;tumor progression;vector","Myb, a key driver of pancreatic cancer progression and metastasis","   Pancreatic cancer is the fourth leading cause of cancer-related mortality in the United States and hence, there is a pressing need to identify novel molecular targets that could lead to the development of more effective diagnostic and treatment strategies. The proposed studies will provide novel information on the pathogenic role of Myb in pancreatic cancer growth and emphasize on its clinical potential in diagnosis, prognosis and therapy. The resulting information, in long term, will be useful for better disease management and thus enhance the life expectancy of patients diagnosed with this devastating and lethal malignancy.     
      

","NCI","8285965","3/29/2012 12:00:00 AM","PA-08-208","1R21CA167137-01","1","R21","CA","167137","01"," ","THURIN, MAGDALENA","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","8895262","SINGH, AJAY PRATAP","Not Applicable","01","NONE","172750234","QB12VPNQQFE8","172750234","QB12VPNQQFE8","US","30.694802","-88.174042","130401","UNIVERSITY OF SOUTH ALABAMA","MOBILE","AL","ORGANIZED RESEARCH UNITS","366880002","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","130500","63293"," ","193793",
"Biotechnology; Cancer; Digestive Diseases; Genetics; Pancreatic Cancer; Rare Diseases","Affect;Aftercare;Apoptosis;BMP4;Biological Assay;Blood Vessels;Cells;Cellular Morphology;Complex;Data;Development;Disease;Epithelial;Family;Genes;Goals;Growth;Immigration;In Vitro;Lead;Link;Luciferases;MADH2 gene;MADH7 gene;Malignant neoplasm of pancreas;Mesenchymal;MicroRNAs;Microprocessor;Migration Assay;Molecular Profiling;Neoplasm Metastasis;Neoplasms;Oligonucleotides;Oncogenic;Pancreatic Adenocarcinoma;Pathway interactions;Process;RNASE3L gene;Regulation;Reporter;Resistance;Role;Signal Transduction;Small Interfering RNA;Smooth Muscle Myocytes;Solid Neoplasm;Staging;TGF Beta Signaling Pathway;TIMP3 gene;Testing;Time;Transforming Growth Factor beta;Translations;Tumor Suppressor Proteins;base;cancer type;cell motility;cytokine;defined contribution;improved;inhibitor/antagonist;knock-down;maspin;migration;neoplastic cell;new therapeutic target;pancreatic cancer cells;pre-miRNA;pri-miRNA;public health relevance;receptor;research study;tumor;tumorigenesis","TGF-Beta signaling and microRNA processing: Implications for invasion and metasta","Public Health Relevance Statement 
Pancreatic adenocarcinoma is one of the most lethal types of cancer and is 
approximately 99% fatal. Better understanding of the mechanism(s) responsible for pancreatic 
cancer metastasis could lead to improved treatment options. Data acquired from this study may 
lead to the development of new therapeutics targets to treat metastatic disease.","NCI","8323105","8/16/2012 12:00:00 AM","PA-07-106","5F31CA142238-04","5","F31","CA","142238","04"," ","MCNEIL FORD, NICOLE","9/30/2009 12:00:00 AM","9/29/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-CB-N(29)L]"," ","9721399","AZEVEDO-POULY, ANA CLARA PEREIRA","Not Applicable","03","OTHER HEALTH PROFESSIONS","832127323","DLWBSLWAJWR1","832127323","DLWBSLWAJWR1","US","40.003166","-83.034278","6218701","OHIO STATE UNIVERSITY","COLUMBUS","OH","SCHOOLS OF PHARMACY","432101016","UNITED STATES","N","9/30/2012 12:00:00 AM","9/29/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","36179"," "," ","36179",
"Cancer; Genetics","Apoptosis;Area;Biochemical;Biological;Biological Assay;Cell Cycle;Cell Line;Cell Survival;Cells;Chemistry;Clinical;Collection;Communities;Data;Data Collection;Data Set;Disease;Dose;Drug resistance;Epithelial;Experimental Designs;Extensible Markup Language;Flow Cytometry;Genome;Genomics;Genotype;Goals;Growth Factor;Human;Image Cytometry;Immunoassay;Informatics;Institution;Instruction;Investigational Drugs;Libraries;Life;Ligands;Link;Malignant Neoplasms;Measures;Mesenchymal;Methodology;Methods;Molecular Profiling;Output;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;Phase;Phenotype;Process;Production;Proteins;Reporting;Resistance;Running;Sampling;Series;Signal Pathway;Signaling Protein;Software Tools;Specificity;Stem cells;Structure;System;Techniques;Time;Tumor Cell Line;base;cancer cell;cellular imaging;computer based Semantic Analysis;cytokine;drug mechanism;information processing;inhibitor/antagonist;insight;interest;kinase inhibitor;large scale production;large-scale database;malignant breast neoplasm;medical schools;meetings;neoplastic cell;novel;programs;response;senescence;small molecule;small molecule libraries","Data Production, and Informatics and Integration","RELEVANCE (See instructions): 
Plans for an HMS-based LINCS Center are directly relevant to programmatic goals of assembling 
""mechanism-based associations among the effects of disparate biological perturbations"" and insight into the 
""mechanisms of action of known drugs."" Single -cell and biochemical data generated by the HMS LINCS 
Center will be different from and complementary to existing large scale data based on genomic assays and 
transcriptional profiles. The Center's focus on clinical-grade and novel kinase inhibitors will provide data with 
high translational potential for a class of compounds that currently dominates investigational new drugs for 
cancer.","NHGRI","8382374","8/1/2012 12:00:00 AM","RFA-RM-10-003","5U54HG006097-03","5","U54","HG","006097","03"," "," "," ","7/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-CB-P]","8018","1882057","HABER, DANIEL A.","Not Applicable","07","Unavailable","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","Domestic Higher Education","021201616","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","1803000","1803000"," ","1278887","524113"," "," ",
"Acute Respiratory Distress Syndrome; Hematology; Infectious Diseases; Lung; Rare Diseases; Septicemia","Acute Lung Injury;Adult Respiratory Distress Syndrome;Animal Model;Animals;Autophagocytosis;Bacteria;Biogenesis;Breathing;Carbon Monoxide;Carboxyhemoglobin;Caring;Cataloging;Catalogs;Cell Culture System;Cells;Clinical;Clinical Research;Clinical Trials;Coagulation Process;Collaborations;Critical Care;Critical Illness;Cytoprotection;Data;Data Quality;Development;Dose;Enrollment;Ensure;Equipment;Fibrin;Gases;Goals;Good Clinical Practice;Harvest;Histopathology Facility;Hospitals;Human Resources;In Vitro;Individual;Injury;Instruction;Investigation;Ischemia;Laboratories;Ligation;Lung;Lung diseases;Measurement;Mechanics;Mediator of activation protein;Mesenchymal;Methods;Mission;Mitochondria;Modeling;Molecular Target;Monitor;Mus;Patients;Peritonitis;Phase;Physiology;Placebos;Play;Pneumonia;Proteins;Protocols documentation;Puncture procedure;Quality Control;RNA;Reperfusion Therapy;Research Personnel;Resources;Role;Safety;Sepsis;Services;Site;Staphylococcus aureus;Stromal Cells;System;Time;Tissue Harvesting;Training;Validation;Ventilator;Ventilator-induced lung injury;Woman;Work;Zymosan;cost;experience;good laboratory practice;innovation;lung injury;meetings;mortality;novel;pre-clinical;programs;research study","Carbon Monoxide Delivery in Sepsis and Acute Lung Injury","RELEVANCE (See instructions): 
Core D will provide all four Projects with standardized methods, facilities, and personnel for delivery of 
carbon monoxide (CO) gas to cells in culture, to animals during experiments, and to people as part of a 
clinical trial. By centralizing these services, Core D will coordinate and facilitate interacfions between the 
investigators of the four different Projects.","NHLBI","8380536","8/8/2012 12:00:00 AM","PAR-09-185","5P01HL108801-02","5","P01","HL","108801","02"," "," "," "," ","ZHL1-PPG-A","5945","1864413","CHOI, AUGUSTINE M","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","251354","251354"," ","154178","97176"," "," ",
"Kidney Disease; Rare Diseases; Urologic Diseases","Ablation;Acute;Address;Area;Atrophic;Beckwith-Wiedemann Syndrome;Biological;Blood Pressure;Body Water;Cell Polarity;Cell division;Cells;Chronic;Cyclin-Dependent Kinase Inhibitor;Data;Defect;Development;Disease;Duct (organ) structure;Dysplasia;Epithelium;Equilibrium;Family;Genetic;Genetic Models;Grant;Homeostasis;Hydronephrosis;Hypernatremia;Hyponatremia;Inherited;Kidney;Kidney Calculi;Knockout Mice;Knowledge;Lead;Ligands;Mediating;Mesenchymal;Modeling;Molecular;Molecular Genetics;Mus;Mutant Strains Mice;Mutate;Natural regeneration;Nephrogenic Diabetes Insipidus;Neurologic;Obstruction;Organogenesis;Pathogenesis;Pathway interactions;Physiological;Physiology;Play;Regulation;Renal function;Research;Role;Signal Transduction;Sodium Chloride;Symptoms;Tail;Testing;Tissues;Vesico-Ureteral Reflux;Water;base;cell growth regulation;interstitial;kidney medulla;nephrogenesis;paracrine;postnatal;prospective;public health relevance;repaired;response;salt balance;ureter dilatation;urinary tract obstruction;urologic","Molecular and Cellular Regulation of Mammalian Renal Medulla Development","
Project narrative
The renal medulla plays essential roles in body salt and water balance, and the regulation of
systemic blood pressure. The proposed study employs mouse genetic, molecular and cell
biological approaches to elucidate the molecular and cellular machinery guiding renal medulla
formation. The proposed research is not only critical for the mechanistic understanding of kidney
organogenesis and renal physiology, but will also provide the molecular basis for the development
of new strategies on the repair and regeneration of the disrupted/atrophic renal medulla resulted
from renal and urological anomalies.","NIDDK","8446746","3/22/2012 12:00:00 AM","PA-07-070","3R01DK085080-02S1","3","R01","DK","085080","02","S","HOSHIZAKI, DEBORAH K","6/1/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Urologic and Kidney Development and Genitourinary Diseases Study Section[UKGD]"," ","9494406","YU, JING ","Not Applicable","05","ANATOMY/CELL BIOLOGY","065391526","JJG6HU8PA4S5","065391526","JJG6HU8PA4S5","US","38.034207","-78.512346","1526402","UNIVERSITY OF VIRGINIA","CHARLOTTESVILLE","VA","SCHOOLS OF MEDICINE","229044195","UNITED STATES","N","4/1/2011 12:00:00 AM","3/31/2012 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","4500","2430"," ","6930",
"Arthritis; Genetics; Pediatric","Adolescent;Adult;Affect;American;Binding;Biochemical;Cartilage;Cartilage Diseases;Cell Proliferation;Cells;Chondrocytes;Chondrogenesis;Chromosomal Rearrangement;Clinical;Commit;Conserved Sequence;Data;Defect;Degenerative polyarthritis;Disease;Elements;Embryo;Engineering;Enhancers;Ensure;Epiphysial cartilage;Extracellular Matrix;Feedback;Genes;Genetic Transcription;Goals;Gonadal structure;Grant;Growth;Human;In Vitro;Inherited;Investigation;Joints;Knowledge;Laboratories;LacZ Genes;Lead;Maintenance;Mediating;Mesenchymal;Molecular;Mouse, Founder, Transgenic;Mutant Strains Mice;Neural Crest;Pattern;Primordium;Procedures;Regulation;Regulator Genes;Research;Research Project Grants;Rewards;Skeleton;Spinal Cord;Staging;Syndrome;Testing;Therapeutic;Tissues;Transact;Transcriptional Regulation;Transgenes;Transgenic Mice;activating transcription factor;articular cartilage;base;campomelic dysplasia;cartilage development;cis acting element;disease phenotype;effective therapy;enhancer binding protein;experience;gain of function;improved;in vivo;loss of function;malformation;mouse genome;novel;novel therapeutics;postnatal;programs;promoter;repaired;skeletal;skeletal disorder;skeletal dysplasia;spatiotemporal;therapeutic target;transcription factor;vertebrate genome","Transcriptional regulation of Sox9 in chondrogenesis"," Defects in cartilage components and regulatory factors cause many types of skeletal malformation diseases (skeletal dysplasias) and prevalent joint degeneration diseases, such as osteoarthritis. This novel study aims to identify the mechanisms that are required for Sox9 expression, a gene that is required for cartilage development. Knowledge obtained from this study will allow major progress to be made to generate functional cartilage for therapeutic strategies.   
   
      

","NIAMS","8396774","7/27/2012 12:00:00 AM","PA-11-113","1F32AR063548-01","1","F32","AR","063548","01"," ","TYREE, BERNADETTE","2/1/2013 12:00:00 AM","1/31/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-F10B-S(20)L]"," ","10940918","MEAD, TIMOTHY JOSEPH","Not Applicable","11","OTHER BASIC SCIENCES","135781701","M5QFLTCTSQN6","135781701","M5QFLTCTSQN6","US","41.479276","-81.680233","10000858","CLEVELAND CLINIC LERNER COM-CWRU","CLEVELAND","OH","SCHOOLS OF MEDICINE","441950001","UNITED STATES","N","2/1/2013 12:00:00 AM","1/31/2014 12:00:00 AM","846","Training, Individual","2012"," "," ","NIAMS","49214"," "," ","49214",
"Cardiovascular; Genetics; Heart Disease","Adult;Affect;Age;Aortic Valve Stenosis;Bicuspid;Biology;Cell physiology;ChIP-seq;Complex;Congenital Heart Defects;Data;Degenerative Disorder;Development;Diet;Disease;Embryo;Endothelial Cells;Enhancers;Essential Genes;Gender;Genes;Genetic;Goals;Homeostasis;Human;Human Characteristics;Human Genetics;Hypertension;Injury;Mediating;Mesenchymal;Modeling;Molecular;Mus;Mutation;NOTCH1 gene;Non-Insulin-Dependent Diabetes Mellitus;Notch Signaling Pathway;Outcome;Pathogenesis;Pathologic;Pathology;Pathway interactions;Patients;Population;Prevention strategy;Principal Investigator;RNA;Risk;Role;Sclerosis;Signal Transduction;Staging;Surgical Valves;Syndrome;Testing;aortic valve;bone;cardiovascular risk factor;feeding;human disease;human old age (65+);insight;interstitial cell;lipoprotein cholesterol;mouse model;mutant;novel;novel therapeutics;osteogenic;prevent;programs;semilunar valve;valve replacement","Molecular and Cellular Mechanisms of Calcific Aortic Stenosis"," The goal of this project is to study cellular and molecular mechanisms of calcific aortic valve stenosis by using newly generated mouse models of the disease. Completion of the project will provide critical information on the underlying pathogenesis of human calcific aortic valve stenosis thereby helping develop new therapeutic and preventive strategies for this devastating human disease.   
   
      

","NHLBI","8373718","8/2/2012 12:00:00 AM","PA-11-260","1R01HL111770-01A1","1","R01","HL","111770","01","A","EVANS, FRANK","8/3/2012 12:00:00 AM","6/30/2016 12:00:00 AM","Atherosclerosis and Inflammation of the Cardiovascular System Study Section[AICS]"," ","7929369","ZHOU, BIN ","Not Applicable","14","GENETICS","110521739"," ","110521739"," ","US","40.851026","-73.844361","9433501","ALBERT EINSTEIN COLLEGE OF MEDICINE","BRONX","NY","SCHOOLS OF MEDICINE","104611900","UNITED STATES","N","8/3/2012 12:00:00 AM","6/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","357851","239760"," ","597611",
"Breast Cancer; Cancer","Acinus organ component;Adhesions;Biochemical;Bioluminescence;Breast Cancer Cell;Cause of Death;Cells;E-Cadherin;Epithelial Cells;Event;Fatty acid glycerol esters;Focal Adhesion Kinase 1;Genetic;Genetic Transcription;Goals;Human;Image;Injection of therapeutic agent;Integrins;Kruppel-like transcription factors;Lung;MMP2 gene;MMP9 gene;Mammary gland;Matrix Metalloproteinases;Mediating;Modeling;Molecular;N-Cadherin;Neoplasm Metastasis;Nude Mice;Oncogenic;Pathway interactions;Patients;Phenotype;Pilot Projects;Play;Proteins;RNA;Regulation;Repression;Role;Signal Transduction;Snails;Sorting - Cell Movement;Specimen;Tail;Testing;Tumor Cell Invasion;Variant;Veins;Woman;Xenograft procedure;cancer cell;catenin p120ctn protein;design;epithelial to mesenchymal transition;human MMP14 protein;in vivo;in vivo Model;knock-down;malignant breast neoplasm;mouse model;neoplastic cell;novel;novel therapeutic intervention;novel therapeutics;overexpression;prevent;slug;tumor;tumor progression","KLF8 Regulation of EMT Tumor Metastasis","
Project narrative
Our identification of KLF8 as an inducer of EMT and invasion and a regulator of E-cadherin and MMPs is novel
and significant. Results derived from this proposal will shed new lights on mechanisms responsible for breast
cancer metastasis which may leads to new therapeutic intervention.","NCI","8256614","7/26/2012 12:00:00 AM","PA-07-070","5R01CA132977-05","5","R01","CA","132977","05"," ","WOODHOUSE, ELIZABETH","7/1/2009 12:00:00 AM","4/30/2015 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","7752181","ZHAO, JIHE ","Not Applicable","07","OTHER BASIC SCIENCES","150805653","RD7MXJV7DKT9","150805653","RD7MXJV7DKT9","US","28.587878","-81.200337","513805","UNIVERSITY OF CENTRAL FLORIDA","ORLANDO","FL","SCHOOLS OF MEDICINE","328263231","UNITED STATES","N","7/26/2012 12:00:00 AM","4/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","57212","46810"," ","104022",
"Kidney Disease; Patient Safety; Prevention; Urologic Diseases","Actins;Animal Model;Apoptosis;Area;Biochemical;Biological;Biological Assay;CYP2D6 gene;CYP3A4 gene;Cell Proliferation;Cells;Characteristics;Chemicals;Chemistry;Chronic Kidney Failure;DNA Sequence Rearrangement;Data;Development;Dose;Drug Interactions;Effectiveness;End stage renal failure;Ensure;Enzymes;Epithelial Cells;Fibrosis;Goals;High Pressure Liquid Chromatography;Human;Human Cloning;In Vitro;Isoxazoles;Kidney;Lead;Legal patent;Libraries;Life;Ligands;Lysophosphatidic Acid Receptors;Lysophospholipids;MAPK1 gene;MAPK3 gene;Minor;Modeling;Modification;Mus;Outcome;Pathway interactions;Permeability;Pharmaceutical Preparations;Phase;Phosphorylation;Preparation;Prevention;Property;Renal Replacement Therapy;Reporting;Research Design;Research Methodology;Risk;Series;Signal Transduction;Structure;System;Testing;Tubular formation;Ureteral obstruction;Work;analog;base;drug discovery;epithelial to mesenchymal transition;high throughput screening;in vitro Assay;in vitro activity;in vivo;lysophosphatidic acid;meetings;mortality;novel;novel therapeutics;phase 1 study;phase 2 study;prevent;programs;receptor;response;vzg-1 Receptor","Selective LPA1 receptor antagonists as agents in prevention of renal fibrosis"," The objective is to discover and develop new drugs for treating chronic kidney diseases that involve renal fibrosis, a significant cause of mortality.   
   
      

","NIDDK","8251867","2/21/2012 12:00:00 AM","PA-11-096","1R43DK092005-01A1","1","R43","DK","092005","01","A","MOXEY-MIMS, MARVA M","3/1/2012 12:00:00 AM","8/28/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-DKUS-L(11)B]"," ","10606082","TUCCI, FABIO COHEN","KARIHALOO, ANIL K","52","Unavailable","963248807","L1EDVCGK2327","963248807","L1EDVCGK2327","US","32.826618","-117.230223","10027024","EPIGEN BIOSCIENCES, INC.","SAN DIEGO","CA","Domestic For-Profits","921212734","UNITED STATES","N","3/1/2012 12:00:00 AM","8/28/2013 12:00:00 AM","847","SBIR/STTR","2012"," "," ","NIDDK"," "," "," ","389603",
"Cancer","Anchorage-Independent Growth;Attenuated;Biological Process;Cathepsins B;Caveolins;Cell Cycle Arrest;Cell Line;Cells;Clathrin;Cleaved cell;Complex;Coupling;Data;Development;Disabled Persons;Down-Regulation;Endocytosis;Epigenetic Process;Epithelial;Epithelial Cells;Genetic;Goals;Growth;LDL-Receptor Related Protein 1;Label;Lead;Malignant Neoplasms;Mediating;Mesenchymal;Modeling;Molecular;Mus;Outcome;Pathway interactions;Pattern Formation;Phenotype;Phosphorylation;Play;Publishing;Refractory;Regulation;Role;Route;Signal Pathway;Signal Transduction;Staging;TGFB1 gene;Testing;Therapeutic;Tumor Cell Line;Tumor Promoters;Tumor Suppressor Proteins;Tumor-Derived;Undifferentiated;Zebrafish;base;cancer cell;cell growth;cell motility;cell type;design;embryonic stem cell;in vivo;inhibitor/antagonist;insight;lipoprotein receptor-related protein 6;receptor;receptor internalization;response;therapeutic target;transdifferentiation;tumor;tumor growth;tumor progression;tumor xenograft;tumorigenesis","TGFB-Signaling Pathways"," Context-specific signaling by TGF? is of great significance to our development of anti-cancer strategies and therapeutics. Understanding how cell-type specific phenotypes are elicited by TGF? is vital to the design of therapeutics that target its tumor promoter, and not its tumor suppressor functions. The successful pursuit of the studies proposed herein will elucidate the molecular mechanism through which TGF? switches from a tumor suppressor to a tumor promoter in a context-specific manner and should provide insight aimed at modulation of its proliferative and tumor promoter function.   
      

","NCI","8355036","7/23/2012 12:00:00 AM","PA-11-260","2R01CA055536-22A1","2","R01","CA","055536","22","A","SALNIKOW, KONSTANTIN","2/1/1992 12:00:00 AM","5/31/2017 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","6449999","HOWE, PHILIP H","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","183710748","NHV3GTWSALA7","183710748","NHV3GTWSALA7","US","32.788289","-79.954891","7575301","MEDICAL UNIVERSITY OF SOUTH CAROLINA","CHARLESTON","SC","SCHOOLS OF MEDICINE","294074636","UNITED STATES","N","8/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","199455","94741"," ","294196",
"Brain Cancer; Brain Disorders; Cancer; Neurosciences; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Astrocytes;Autologous Expanded Mesenchymal Stem Cells;Behavior;Brain;Brain Neoplasms;Cells;Complex;Data;Development;Drug Design;Ecosystem;Gene Expression Profile;Generations;Genetic;Genetically Engineered Mouse;Glioma;Gliomagenesis;Growth;In Vitro;Individual;Laboratories;Maintenance;Malignant neoplasm of brain;Messenger RNA;Methodology;Microglia;Modality;Modeling;Molecular;Mus;Nature;Neuroglia;Pattern;Physicians;Platelet-Derived Growth Factor;Polyribosomes;Population;Population Growth;Radiation;Reagent;Recruitment Activity;Regulation;Research Personnel;Resistance;Role;Scientist;Senior Scientist;Signal Transduction;Sorting - Cell Movement;Staging;Stem cells;Therapeutic;Tissues;Transcript;Tumor Biology;Validation;base;cancer stem cell;cell growth;cell type;conventional therapy;improved;in vivo;mouse model;neoplastic;neoplastic cell;new therapeutic target;novel;outcome forecast;response;stem cell population;temozolomide;therapeutic target;therapy design;translational medicine;tumor;tumor initiation","Non-neoplastic cell types dictate gliomagenesis and","The grim prognosis and lack of therapeutic options for GBM highlights the urgency of developing new treatment modalities. GEM model of glioma will provide a unique opportunity to define the cells and molecular signals from the tumor microenvironment that contribute to gliomagenesis and continued growth relevant to the design of therapies aimed at eliminating the supportive niche provided by the tumor microenvironment.","NCI","8353539","9/1/2012 12:00:00 AM","PAR-11-146","1U01CA160882-01A1","1","U01","CA","160882","01","A","MOHLA, SURESH","9/1/2012 12:00:00 AM","8/31/2017 12:00:00 AM","ZCA1-SRLB-C(M1)"," ","9698692","HAMBARDZUMYAN, DOLORES ","HOLLAND, ERIC C.","11","OTHER BASIC SCIENCES","135781701","M5QFLTCTSQN6","135781701","M5QFLTCTSQN6","US","41.479276","-81.680233","10000858","CLEVELAND CLINIC LERNER COM-CWRU","CLEVELAND","OH","SCHOOLS OF MEDICINE","441950001","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","453750","137769"," ","591519",
"Kidney Disease; Neurosciences; Polycystic Kidney Disease; Rare Diseases","Address;Adult;Affect;Alleles;Architecture;Bardet-Biedl Syndrome;Basal Cell;Biochemical;Biological;Cells;Cilia;Congenital Abnormality;Cues;Defect;Detection;Development;Diffusion;Disease;Electrons;Embryo;Endothelial Cells;Engineered Gene;Epidermis;Epithelial;Epithelial Cells;Erinaceidae;Event;Family;Genes;Genetic;Homeostasis;Human;Human body;Image;Integral Membrane Protein;Joubert syndrome;Life;Link;Malignant Neoplasms;Mammalian Cell;Membrane;Mesenchymal;Microscopic;Molecular;Mus;Mutation;Nephrons;Neural tube;Pattern;Peptide Signal Sequences;Polycystic Kidney Diseases;Population;Protein translocation;Proteins;Regulation;Retinal Degeneration;Role;Shapes;Signal Transduction;Skin;Smell Perception;Somites;Staging;Surface;Syndrome;System;Testing;Time;Tissues;Vision;Work;cell type;ciliopathy;cilium biogenesis;developmental disease;human disease;in vivo;insight;mutant;novel;protein complex;protein transport;research study;response;smoothened signaling pathway;tool","Tissue-specific regulation of ciliary function by the transition zone"," Primary cilia are small projections found on many human cells involved in receiving and interpreting signals from other cells. Disruption of these ciliary signaling events contributes to birth defects, cancer, polycystic kidney disease, and other human disorders. We propose to investigate the mechanisms controlling cilium formation and protein composition to provide a molecular understanding of cilia-related diseases.)  
  
    

","NIGMS","8303407","4/23/2012 12:00:00 AM","PA-10-067","5R01GM095941-02","5","R01","GM","095941","02"," ","KRASNEWICH, DONNA M","7/18/2011 12:00:00 AM","4/30/2015 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","1952645","REITER, JEREMY F","Not Applicable","12","BIOCHEMISTRY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","188000","102460"," ","290460",
"Biotechnology; Dental/Oral and Craniofacial Disease; Genetics","Adenovirus Vector;Adenoviruses;Adult;Cell Differentiation process;Cells;Clinic;Clinical;Complement;Complementary DNA;Computer Simulation;Culture Media;Data;Dental;Development;Embryo;Engineering;Epithelial;Epithelial Cells;Exhibits;Faculty;Feathers;Felis catus;Gene Expression;Gene Targeting;Genes;Gland;Goals;Growth Factor;Hair;Impairment;In Vitro;Kidney;Knock-out;Knowledge;Lasers;Length;Lentivirus Vector;Mentors;Mesenchymal;Messenger RNA;MicroRNAs;Microscopy;Molecular;Molecular Profiling;Morphogenesis;Mus;Mutant Strains Mice;Nude Mice;Oral;Organ;Phase;Phase Transition;Phenotype;Physiological;Plant Roots;Pongidae;Proteins;Regulator Genes;Regulatory Pathway;Role;Sampling;Signal Transduction;Staging;Subfamily lentivirinae;Supernumerary Tooth;System;Technology;Testing;Tissue Engineering;Tissues;Tooth Components;Tooth Germ;Tooth Loss;Tooth structure;Transgenic Mice;Translations;Wild Type Mouse;Work;base;capsule;gain of function;gene function;in vivo;inhibitor/antagonist;insight;loss of function;mutant;oral cavity epithelium;oral tissue;programs;psychologic;small hairpin RNA;transcription factor;wisdom tooth;young adult","Wnt signaling in the induction of new tooth formation","Loss of teeth leads to great physiological and psychological impairments. I will elucidate the molecular 
mechanisms underlying the induction of tooth formation, thus paving the way for in vitro tooth engineering.","NIDCR","8197684","12/12/2011 12:00:00 AM","PA-07-297","5R00DE019871-04","5","R00","DE","019871","04"," ","LUMELSKY, NADYA L","1/2/2010 12:00:00 AM","12/31/2012 12:00:00 AM","NSS"," ","9658639","WANG, XIU-PING ","Not Applicable","07","NONE","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","SCHOOLS OF DENTISTRY/ORAL HYGN","021201616","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","137680","95688"," ","233368",
"Kidney Disease","Acute;Acute Renal Failure with Renal Papillary Necrosis;Address;Adult;Agonist;American;Angiogenic Factor;Biology;Cell Communication;Cell Culture Techniques;Cell Proliferation;Cells;Chronic;Chronic Kidney Failure;Cicatrix;Clinical;Communities;Ductal Epithelium;Epithelial;Epithelial Cells;Epithelium;Erinaceidae;Family;Fibrosis;Genetic;Health;Homeostasis;Human;Immunohistochemistry;In Situ;In Vitro;Injury;Kidney;Kidney Diseases;Kidney Failure;Ligands;Maps;Mediating;Mesenchymal;Modeling;Molecular;Mus;Myofibroblast;NCAM1 gene;Nephrons;Organ;Pathway interactions;Pattern;Pericytes;Pharmaceutical Preparations;Play;Prevalence;Process;Proliferating;Reporter;Resolution;Role;Signal Pathway;Signaling Molecule;Testing;Tissue Differentiation;Tubular formation;United States;Vimentin;aging population;cell type;cyclopamine;gain of function;in vivo;injured;injury and repair;interstitial;interstitial cell;kidney cell;kidney repair;loss of function;member;mutant;nephrogenesis;new therapeutic target;novel;novel therapeutic intervention;programs;public health relevance;purmorphamine;receptor;renal epithelium;repaired;smoothened signaling pathway;tissue regeneration;tissue repair;tool","Hedgehog Signaling in Kidney Homeostasis and Repair","
Project Narrative:
 The increasing prevalence of chronic kidney disease in our aging population represents an enormous
health burden. Because the final common pathway for most chronic nephropathies is renal fibrosis, therapies
that reverse or even slow fibrosis would have tremendous clinical impact. These studies will explore the role of
a signaling pathway called Hedgehog. Drugs are now being developed to modulate this pathway, so these
studies might identify a new use for such drugs in treating kidney fibrosis which remains a tremendous problem
in the United States and worldwide.","NIDDK","8327224","7/23/2012 12:00:00 AM","PA-07-070","5R01DK088923-03","5","R01","DK","088923","03"," ","HOSHIZAKI, DEBORAH K","7/1/2010 12:00:00 AM","6/30/2015 12:00:00 AM","Pathobiology of Kidney Disease Study Section[PBKD]"," ","1902627","HUMPHREYS, BENJAMIN D.","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","224925","176566"," ","401491",
"Acute Respiratory Distress Syndrome; Lung; Rare Diseases","Acute Lung Injury;Adenoviruses;Adhesions;Adult Respiratory Distress Syndrome;Alveolar;Animal Model;Animals;Basal lamina;Behavior;Biological Assay;Bleomycin;Cell Differentiation process;Cell Surface Receptors;Cell physiology;Cessation of life;Collagen;Connective Tissue;Data;Deposition;Development;Disease;Disease Progression;Dystroglycan;Environment;Epithelial;Epithelial Cells;Exhibits;Extracellular Matrix;Fibrosis;Future;Growth Factor;Hamman-Rich syndrome;In Situ;In Vitro;Knock-out;Knockout Mice;Laminin;Lung;Lung diseases;Mediating;Mesenchymal;Mortality Determinants;Mus;Myofibroblast;Outcome;Patients;Phenotype;Proteins;Publishing;Pulmonary Fibrosis;Resolution;Respiratory physiology;Role;Scaffolding Protein;Series;Signal Pathway;Signal Transduction;Structure of parenchyma of lung;Testing;Tissues;alveolar epithelium;base;cell behavior;cell motility;cell type;in vivo;injured;insight;lung injury;migration;mouse model;novel;plectin;public health relevance;receptor;repaired","Substrate stiffness regulates alveolar epithelial cell behavior","
In certain pulmonary diseases, lung tissue becomes fibrotic and stiffens. We propose to
assay how the stiffness of the lung regulates the function of its cellular components. Our
results will provide novel insight into the mechanisms of disease progression and has
implications for future therapies.","NHLBI","8212270","2/9/2012 12:00:00 AM","PA-07-070","5R01HL092963-04","5","R01","HL","092963","04"," ","HARABIN, ANDREA L","4/1/2009 12:00:00 AM","1/31/2014 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1863274","JONES, JONATHAN C.","BUDINGER, G R S","07","ANATOMY/CELL BIOLOGY","005436803","KG76WYENL5K1","005436803","KG76WYENL5K1","US","41.896017","-87.616602","6144650","NORTHWESTERN UNIVERSITY AT CHICAGO","CHICAGO","IL","SCHOOLS OF MEDICINE","606114579","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","129938"," ","377438",
"Cancer","Affect;Autocrine Motility Factor;Binding;Biological;Boxing;Cancer Biology;Cell Aging;Cell Surface Receptors;Cells;Complex;DNA Sequence Rearrangement;Data;Development;Diagnosis;Dissociation;Down-Regulation;Endoplasmic Reticulum;Endothelial Cells;Enzymes;Epithelial;Evolution;Fingers;Genes;Gluconeogenesis;Glycolysis;Glycoproteins;Goals;Grant;Growth;Health;Housekeeping;Housing;Hypoxia;In Vitro;Isomerase;Lead;Ligands;Ligase;Malignant Neoplasms;Mesenchymal;Mitogens;Molecular;Myofibrils;Neoplasm Metastasis;Neuroleukin;Oncogenic;Orphan;Pathway interactions;Phenotype;Play;Process;Progress Reports;Proteins;Regulation;Ring Finger Domain;Role;Serine Proteinase Inhibitors;Signal Pathway;Signal Transduction;Structure;System;Thioredoxin;Tumor Cell Invasion;Tumorigenicity;Ubiquitination;Vascular Endothelial Growth Factors;autocrine;base;biological systems;cell growth;cell motility;chemokine;chemokine receptor;cytokine;design;extracellular;in vivo;inhibitor/antagonist;migration;neoplastic cell;overexpression;prototype;receptor;therapeutic target;therapy development;tool;tumor;tumor progression;ubiquitin ligase;ubiquitin-protein ligase","Characterizaton of Motility Factor Receptor","
NARRATIVE:
The long-term objective of this proposal is to obtain a better understanding of the
molecular mechanisms governing the first step in tumor cell dissemination, namely
motility. To accomplish this we propose to define the structure-functional relationship
and mechanism of action of an autocrine motility factor (AMF) and its receptor
(AMFR/gp78). It is expected that these studies will lead to a better diagnosis, treatment
and development of rational therapy.","NCI","8265659","5/9/2012 12:00:00 AM","PA-07-070","5R01CA051714-22","5","R01","CA","051714","22"," ","WOODHOUSE, ELIZABETH","8/1/1991 12:00:00 AM","5/31/2014 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1893096","RAZ, AVRAHAM ","Not Applicable","13","PATHOLOGY","001962224","M6K6NTJ2MNE5","001962224","M6K6NTJ2MNE5","US","42.35738","-83.064737","9110501","WAYNE STATE UNIVERSITY","DETROIT","MI","SCHOOLS OF MEDICINE","482024000","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","213150","110838"," ","323988",
"Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Biological Assay;Biological Models;Bone Marrow;Brain;Cells;Dermal;Development;Embryonic Development;Epithelial;Fibroblasts;Future;Gene Expression;Gene Targeting;Genes;Genetic;Goals;Growth;Hair;Hair follicle structure;Homeostasis;Hybrids;In Vitro;Intestines;Invertebrates;Knock-out;Knowledge;Lead;Mesenchymal;Methods;Modeling;Molecular;Molecular Profiling;Morphogenesis;Mus;Natural regeneration;Patients;Process;Proliferating;Regulation;Rest;Signal Transduction;Skin;Skin Tissue;Specific qualifier value;Stem cells;Supporting Cell;Sweat Glands;Testing;Therapeutic Uses;Tissues;Transcriptional Regulation;Transplantation;Ursidae Family;Work;burn therapy;genome-wide;improved;in vivo;in vivo regeneration;knockout gene;mouse model;novel;overexpression;programs;regenerative;regenerative therapy;self-renewal;skin disorder;stem cell fate;stem cell niche;tongue papilla;tool;transcription factor","Specification of Dermal Papilla Cell Fate in the Hair Follicle Stem Cell Niche","
A thorough understanding of the regulation of stem cell (SC) activation and self-renewal by supporting niche
cells is a crucial requirement for future tissue-specific regenerative therapies. How the niche cells in
mammalian SC niches acquire their specialized status is largely unknown. We will define the transcriptional
control of niche fate specification of dermal papilla cells in the hair follicle SC niche, establishing a much
needed mammalian model, where formation and function of the SC niche can be studied. Our work will
improve our ability to create a more normal behaving skin tissue for future therapies and will also have global
relevance for other regenerative tissues, where SC niches operate to maintain tissue homeostasis.","NIAMS","8228187","3/2/2012 12:00:00 AM","PA-07-070","5R01AR059143-03","5","R01","AR","059143","03"," ","BAKER, CARL","4/1/2010 12:00:00 AM","2/28/2015 12:00:00 AM","Arthritis, Connective Tissue and Skin Study Section[ACTS]"," ","9801858","RENDL, MICHAEL ","Not Applicable","13","ANATOMY/CELL BIOLOGY","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","SCHOOLS OF MEDICINE","100296574","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","216000","147169"," ","363169",
"Bioengineering; Biotechnology; Clinical Research; Dental/Oral and Craniofacial Disease; Nanotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","3-Dimensional;Address;Anatomy;Animal Model;Animals;Apatites;Architecture;Area;Asses;Attention;Autologous;Autologous Transplantation;Behavior;Biochemical;Biocompatible Materials;Biodegradation;Biological;Biological Assay;Biological Process;Biological Sciences;Biological Testing;Biology;Biomechanics;Biomedical Engineering;Biomimetics;Bone Diseases;Bone Growth;Bone Regeneration;Bone Resorption;Bone Tissue;Bone Transplantation;Bone remodeling;Breathing;Calcified;California;Cell Adhesion;Cell Culture Techniques;Cells;Chemicals;Chemistry;Complex;Defect;Dental;Development;Devices;Dimensions;Drug Delivery Systems;Drug Formulations;Engineering;Environment;Family;Foreign-Body Reaction;Fracture;Freezing;Future;Goals;Grant;Growth Factor;Healed;Health;Hormones;Human;Hybrids;Hydrogels;Implant;In Vitro;Infection;Institution;Interdisciplinary Study;Laboratories;Laws;Lead;Length;Libraries;Mechanics;Medical;Mesenchymal Stem Cells;Metabolic;Methods;Minerals;Miniature Swine;Modeling;Monitor;Morbidity - disease rate;Multipotent Stem Cells;Mus;Nanotechnology;Natural regeneration;Nature;Nutrient;Operative Surgical Procedures;Organ;Organ Transplantation;Orthopedics;Oryctolagus cuniculus;Osteogenesis;Outcome;Parathyroid gland;Pathway interactions;Patients;Penetration;Performance;Phase;Philosophy;Physiological;Porosity;Pre-Clinical Model;Preparation;Printing;Process;Property;Protocols documentation;Quality of life;Research;Resistance;Risk;San Francisco;Science;Scientist;Series;Signal Pathway;Signaling Molecule;Site;Solubility;Structure;Supporting Cell;Surface;Suspension substance;Suspensions;System;Techniques;Testing;Time;Tissue Engineering;Tissues;United States;Universities;Vision;Weight-Bearing state;angiogenesis;base;bioresorption;bone;cell growth;chemical release;clinically relevant;combinatorial;craniofacial repair;density;design;engineering design;flexibility;functional group;healing;implant material;improved;in vivo;mineralization;multidisciplinary;nanocomposite;nanoscale;new technology;novel;osteogenic;pre-clinical;prevent;programs;response;sample fixation;scaffold;scale up;skeletal;standard of care;success;tool;wasting","Complex Nanocomposites for Bone Regeneration","The demand for biomaterials to assist or replace organ functions is rapidly increasing. Every year, more 
than one million patients in the United States with skeletal defects require bone graft procedures. This 
application will develop novel biomaterials for optimal repair of craniofacial and orthopedic skeletal defects 
that would otherwise require a bone graft from a second surgical site. Improvement of implants will result in 
improved health and quality of life for the millions of people who will need implants in the future.","NIDCR","8272456","7/13/2012 12:00:00 AM","PAR-07-352","5R01DE015633-09","5","R01","DE","015633","09"," ","LUMELSKY, NADYA L","8/4/2003 12:00:00 AM","5/31/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","6290846","TOMSIA, ANTONI P","Not Applicable","13","CHEMISTRY","078576738","ENBLDJUN4N73","078576738","ENBLDJUN4N73","US","37.866468","-122.29886","577512","UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB","BERKELEY","CA","ORGANIZED RESEARCH UNITS","947208118","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","770021","357521"," ","1127542",
"Clinical Research; Neurosciences; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Stroke","Adhesions;Aneurysm;Animal Model;Animals;Area;Award;B-Lymphocytes;Berry Aneurysm;Biological Response Modifier Therapy;Biology;Biomedical Research;Blood Vessels;Bone Marrow;Bone Marrow Transplantation;Brain;Carotid Arteries;Cell Culture Techniques;Cells;Cerebral Aneurysm;Chairperson;Chemotaxis;Commit;Complement;Complement Activation;Cytomegalovirus;Data;Development;Devices;Diagnosis;Economics;Elastases;Endothelial Cells;Engineering;Environment;Equipment;Extracellular Matrix;Florida;Functional disorder;Funding;Future;General Hospitals;Genes;Goals;Healed;Hematopoietic;Hematopoietic stem cells;Hindlimb;Histologic;Histology;Human;Immune;Immunohistochemistry;Incidence;Inflammation;Inflammatory;Inflammatory Response;Infusion procedures;Injury;Institutes;Ischemia;Knowledge;Laboratories;Leukocytes;Maps;Massachusetts;Mediating;Medical;Medical Students;Mentors;Mentorship;Mesenchymal Stem Cells;Modeling;Morbidity - disease rate;Mus;Neurosurgeon;Neurosurgical Procedures;Operative Surgical Procedures;Oral;Outcome;Personal Satisfaction;Pharmacotherapy;Polymers;Population;Process;Proteins;Public Health;Rattus;Regenerative Medicine;Regulation;Research;Research Personnel;Research Proposals;Resources;Role;Rupture;Science;Scientist;Signal Transduction;Simplexvirus;Statistical Data Interpretation;Stem cells;Stroke;Subarachnoid Hemorrhage;T-Lymphocyte;Techniques;Testing;Time;Tissues;Training;Translating;United States;United States National Institutes of Health;Universities;Vascular Graft;Vascular remodeling;Work;base;career;career development;cost;experience;healing;innovation;intravital microscopy;macrophage;matrigel;mortality;mouse model;neoplastic cell;neutrophil;novel;prevent;programs;promoter;repaired;research study;response;skills;stem cell biology;symposium;therapeutic target;vascular inflammation","Inflammation and Cerebral Aneurysm Formation: Targets for Modulation and Vascular","PROJECT NARRATIVE 
The proposed studies are of an important and under-investigated area of cerebral aneurysm pathophysiology that would directly translate into therapies that could treat cerebral aneurysms, such as 1) endovascular devices carrying signaling mechanisms that reverse the degenerative inflammatory process and promote vascular repair, and 2) medical drug therapies that arrest the degenerative inflammatory process and stabilize aneurysms from growing and progressing to rupture. The proposed research has relevance to the public health and the Nation's economic well-being because there is a significant incidence of cerebral aneurysms in the population, 3.6-6.0%; cerebral aneurysms are associated with significant morbidity and mortality; and the costs of subarachnoid hemorrhage in the United States are enormous ($5.6 billion/year).","NINDS","8303296","7/26/2012 12:00:00 AM","PA-09-042","5K08NS067058-04","5","K08","NS","067058","04"," ","KOENIG, JAMES I","9/1/2009 12:00:00 AM","8/31/2014 12:00:00 AM","NST-1 Study Section[NST-1]"," ","9729256","HOH, BRIAN LIM","Not Applicable","03","NEUROSURGERY","969663814","NNFQH1JAPEP3","969663814","NNFQH1JAPEP3","US","29.67667","-82.340932","513806","UNIVERSITY OF FLORIDA","GAINESVILLE","FL","SCHOOLS OF MEDICINE","326115500","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","853","Other Research-Related","2012"," "," ","NINDS","165166","13213"," ","178379",
"Bioengineering; Biotechnology; Regenerative Medicine","Action Potentials;Address;Adipose tissue;Alkaline Phosphatase;Area;Behavior;Biochemical;Biological Models;Bioreactors;Bone Marrow;Bone Regeneration;Bone Tissue;Calcium;Cartilage;Cell Proliferation;Cell membrane;Cells;Cellular Membrane;Chemicals;Collagen Type I;Comparative Study;Complex;Cues;Data;Defect;Deposition;Development;Developmental Biology;Differentiation and Growth;Disease model;Embryo;Engineering;Environment;Event;Fiber;Focus Groups;Genetic Transcription;Goals;Growth;Histocompatibility Testing;Human;Immigration;In Vitro;Ion Channel;Ion Transport;Ions;Laboratories;Lasers;Ligaments;Light;Limb Development;Limb structure;Link;Literature;Lower Organism;Mature Bone;Mechanics;Mediating;Membrane;Membrane Potentials;Mesenchymal Stem Cells;Modality;Modeling;Molds;Molecular;Molecular Genetics;Morphogenesis;Musculoskeletal System;Natural regeneration;Optics;Organ;Organism;Outcome;Pathway interactions;Patients;Pattern;Pattern Formation;Phase;Preclinical Drug Evaluation;Process;Rana;Reagent;Recording of previous events;Regenerative Medicine;Regulation;Research;Reverse Transcriptase Polymerase Chain Reaction;Role;Running;Scaffolding Protein;Signal Transduction;Signaling Molecule;Site;Source;Staging;Staining method;Stains;Stem cells;Structure;Support System;System;Time;Tissue Engineering;Tissue Model;Tissues;Universities;Variant;Work;Wound Healing;Zebrafish;base;bone;bone sialoprotein;cell behavior;cell type;electric field;expectation;human tissue;improved;in vivo;in vivo regeneration;insight;limb regeneration;novel;novel strategies;oil red O;photonics;programs;public health relevance;regenerative;repaired;restoration;scaffold;soft tissue;spinal cord regeneration;success;tissue regeneration;tissue repair;tool;voltage","Tissue Regeneration by Biophysical Signaling","Narrative: 
Exploitation of biophysical control of tissue regeneration is virtually unexplored territory in the field of tissue 
engineering, despite extensive studies in developmental biology that have clearly shown the importance of 
changes in membrane potential and endogenous electric fields during tisue/organ development and 
regeneration. Thus, the goal of this program is to determine the impact of membrane potential-regulated 
signaling on bone and adipose tissue regeneration, formation, and patterning. The outcome of this program 
would be an entirely new approach to tissue formation and control in vitro, with major implications for 
regeneration in vivo. Rational modulation of these powerful biophysical controls, with or without more 
traditional biochemical controls, will allow greater control of tissue development and function. Building upon 
principles from developmental biology, progress from the proposed studies will have a profound impact on the 
field of tissue engineering. Understanding the role of biophysical factors on tissue behavior will yield insight into 
fundamental control mechanisms underlying tissue growth and regeneration, offering a new perspective to the 
current tissue engineering paradigm. Such an understanding will also define a set of well-characterized 
pharmacological and molecular-genetic tools to enable novel approaches to complex tissue patterning.","NIAMS","8303026","7/30/2012 12:00:00 AM","PA-07-070","5R01AR055993-03","5","R01","AR","055993","03"," ","WANG, FEI","8/1/2010 12:00:00 AM","7/31/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","2059300","KAPLAN, DAVID L.","LEVIN, MICHAEL ","07","ENGINEERING (ALL TYPES)","073134835","WL9FLBRVPJJ7","073134835","WL9FLBRVPJJ7","US","42.423895","-71.1092","8422701","TUFTS UNIVERSITY MEDFORD","Boston","MA","BIOMED ENGR/COL ENGR/ENGR STA","021111817","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","216000","107395"," ","323395",
"Aging; Biotechnology; Cancer; Clinical Research; Digestive Diseases; Immunization; Lung; Lung Cancer; Prostate Cancer; Rare Diseases; Urologic Diseases; Vaccine Related","Acute Myelocytic Leukemia;Adenocarcinoma;Adverse effects;Agonist;Antibody Formation;Antigens;Bladder;Boxing;Brachyury protein;Breast;Breast Carcinoma;Cancer Patient;Carcinoma;Castration;Cell Line;Cessation of life;Characteristics;Clinical;Colon Carcinoma;Colorectal Cancer;Computer Simulation;Computers;Cytolysis;Cytotoxic T-Lymphocyte-Associated Protein 4;Cytotoxic T-Lymphocytes;Data;Databases;Development;Disease;Dose;Down-Regulation;Embryonic Development;Enrollment;Epidermal Growth Factor Receptor;Epithelial;Epitopes;Evaluation;Expressed Sequence Tags;Family;Fowlpox;Generations;Goals;Granulocyte-Macrophage Colony-Stimulating Factor;Hematopoietic Neoplasms;Human;Human Identifications;Immune;Immune response;Immunotherapeutic agent;In Vitro;In complete remission;Indolent;Injection Site Reaction;Kidney;Lesion;Life;Lung;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant neoplasm of prostate;Mediastinal Mass;Mediastinum;Mediating;Mesenchymal;Mesoderm;Mining;Molecular;Monitor;Monoclonal Antibodies;Mucin 1 protein;Mucin-1 Staining Method;Mucins;Multicenter Studies;Multiple Myeloma;Neoplasm Metastasis;Nomograms;Normal tissue morphology;Oncogenes;Ovarian;Ovary;Pancreas;Patients;Phase II Clinical Trials;Phosphotransferases;Primary Neoplasm;Prior Chemotherapy;Prior Therapy;Prostate;Prostate carcinoma;Prostate-Specific Antigen;Randomized;Recombinants;Regulatory T-Lymphocyte;Resistance;Reverse Transcription;Role;Serum;Small Intestinal Neoplasm;Solid Neoplasm;Squamous cell carcinoma;Stable Disease;Stomach;T cell response;T-Lymphocyte;T-Lymphocyte Epitopes;Testing;Testis;Therapeutic;Therapeutic Intervention;Thyroid Gland;Time;Tissues;Transgenes;Tumor Antigens;Tumor Cell Line;Tumor Markers;Tumor Tissue;Up-Regulation;Uterus;Vaccinated;Vaccination;Vaccine Therapy;Vaccines;Vaccinia;Vaccinium;Xenograft Model;arm;base;cancer cell;cancer immunotherapy;cancer therapy;cell motility;cohort;design;docetaxel;epithelial to mesenchymal transition;gastrointestinal;indexing;inhibitor/antagonist;lung Carcinoma;mRNA Differential Displays;malignant breast neoplasm;meetings;member;neoplastic cell;novel;overexpression;prevent;protein expression;response;selective expression;tool;transcription factor;trend;tumor;tumor progression","Identification of human tumor-associated antigens","n/a","NCI","8552906"," "," ","1ZIABC010972-05","1","ZIA","BC","010972","05"," "," "," "," "," "," ","9692339","TSANG, KWONG YOK ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","887872",
"Cardiovascular; Genetics; Heart Disease; Pediatric","3-Dimensional;Address;Adult;Affect;Alternative Splicing;Beryllium;Breeding;Cardiac;Cell Density;Cells;Childhood;Congenital Abnormality;Congenital Heart Defects;Critiques;Data;Defect;Development;Developmental Biology;EGF gene;Embryo;Embryonic Heart;Endocardium;Epidermal Growth Factor Receptor;Event;Extracellular Matrix;Eye;Failure;Funding;Gene Proteins;Genes;Genetic;Growth;Heart;Heart Septal Defects;Hyaluronan;Image;In Vitro;Knockout Mice;Length;Live Birth;Manuscripts;Mediating;Mesenchymal;Mesenchyme;Messenger RNA;Modeling;Molecular;Morphogenesis;Morphology;Mus;Mutation;Myocardial;Phenotype;Play;Preparation;Principal Investigator;Process;Proteins;Proteoglycan;Proteolysis;Proteome;Proteomics;Publishing;Pulmonary artery structure;RNA Splicing;Reagent;Reporting;Role;Shapes;Signal Pathway;Signal Transduction;Staging;Structure;Techniques;Testing;Tissues;Tube;Ventricular;Work;cardiogenesis;clinically relevant;design;in vitro Bioassay;in vivo;in vivo Model;insight;mouse model;mutant;nestin protein;novel;programs;promoter;protein expression;receptor;research study;stathmin;vector;versican","CSPG2 GENE AND CARDIAC OUTLET MORPHOGENESIS","n/a","NHLBI","8214537","2/24/2012 12:00:00 AM","PA-07-070","5R01HL066231-10","5","R01","HL","066231","10"," ","SCHRAMM, CHARLENE A","7/1/2001 12:00:00 AM","1/31/2014 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","6487196","MJAATVEDT, COREY H","Not Applicable","01","ANATOMY/CELL BIOLOGY","183710748","NHV3GTWSALA7","183710748","NHV3GTWSALA7","US","32.788289","-79.954891","7575301","MEDICAL UNIVERSITY OF SOUTH CAROLINA","CHARLESTON","SC","SCHOOLS OF MEDICINE","294074636","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","113850"," ","361350",
"Lung; Regenerative Medicine","Adaptor Signaling Protein;Alveolar Macrophages;Animal Model;Applications Grants;Asthma;Award;B-Lymphocytes;Blood;Cell physiology;Cell surface;Cells;Chronic;Chronic Obstructive Airway Disease;Cytoprotection;Data;ECM receptor;Effector Cell;Epithelial Cells;Epithelium;Event;Excision;Extracellular Matrix;Failure;Fibrosis;Funding;Gene Targeting;Glycosaminoglycans;Health;Host Defense;Hyaluronan;Immune;Immune response;Immunologic Receptors;Infection;Inflammation;Inflammatory;Inflammatory Infiltrate;Inflammatory Response;Injury;Invaded;Laboratories;Lead;Lung;Lung Inflammation;Lung diseases;Macrophage Activation;Mediating;Mediator of activation protein;Mesenchymal;Morbidity - disease rate;Mus;Natural Immunity;Outcome;Pathway interactions;Patients;Play;Polymers;Process;Production;Pulmonary Fibrosis;Resolution;Role;Signal Transduction;Site;Specificity;Structure of parenchyma of lung;T-Lymphocyte;TLR2 gene;TLR4 gene;Testing;Tissues;Toll-Like Receptor 2;Toll-like receptors;Work;adaptive immunity;alveolar homeostasis;chemokine;fibrogenesis;injured;injury and repair;lung injury;lung repair;macromolecule;macrophage;migration;molecular mass;neutrophil;novel;pathogen;repaired;response;restoration","Innate Immune Mechanisms in Non-infectious Lung Inflammation","n/a","NIAID","8237060","3/16/2012 12:00:00 AM","PA-07-070","5R01AI052201-10","5","R01","AI","052201","10"," ","DAVIDSON, WENDY F","7/1/2002 12:00:00 AM","3/31/2013 12:00:00 AM","Lung Cellular, Molecular, and Immunobiology Study Section[LCMI]"," ","1895798","NOBLE, PAUL WESLEY","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","855","Non-SBIR/STTR","2012"," "," ","NIAID","188262","105427"," ","293689",
"No NIH Category available","Address;Animal Model;Benign;Biological Models;Clinical;Clinical Research;Data;Databases;Death Rate;Development;Diagnosis;Diagnostic;Disease;Early Diagnosis;Environment;Epithelial;Evaluation;Follicular thyroid carcinoma;Genes;Genetic;Genetic Models;Genetic Predisposition to Disease;Goals;Human Genetics;In Vitro;Incidence;Individual;Inherited;Iodine;Laboratories;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of thyroid;Modeling;Molecular Abnormality;Multiple Hamartoma Syndrome;Mus;Mutation;Neoplasms;Oncogenes;Papillary;Papillary thyroid carcinoma;Pathology;Pathway interactions;Patients;Predisposition;Preventive;Progressive Disease;Public Health;Publications;Regulation;Risk;Role;Scheme;Signal Pathway;Susceptibility Gene;Syndrome;Testing;Therapeutic;Thyroid Gland;Thyroid Nodule;Tissues;Translating;Tumor Cell Invasion;United States;base;bench to bedside;carcinogenesis;cell motility;drug development;effective therapy;epithelial to mesenchymal transition;in vivo;inhibitor/antagonist;mortality;mouse model;novel;novel diagnostics;programs;response;small molecule;tumor;tumor progression;tumorigenesis;uptake","Genetic and Signaling Pathways in Epithelial Thyroid Cancer","n/a","NCI","8234155","4/19/2012 12:00:00 AM"," ","5P01CA124570-05","5","P01","CA","124570","05"," ","SNYDERWINE, ELIZABETH G","3/1/2008 12:00:00 AM","4/29/2013 12:00:00 AM","ZCA1-GRB-S(O1)"," ","6184325","RINGEL, MATTHEW D","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","832127323","DLWBSLWAJWR1","832127323","DLWBSLWAJWR1","US","40.003166","-83.034278","6218701","OHIO STATE UNIVERSITY","COLUMBUS","OH","SCHOOLS OF MEDICINE","432101016","UNITED STATES","N","3/1/2012 12:00:00 AM","4/29/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","1577278","631944"," ","2209222",
"Breast Cancer; Cancer","Address;Antineoplastic Agents;Biochemical;Biological;Breast Cancer Cell;Breast Cancer Model;Breast Cancer Treatment;Cancer Biology;Cancer Patient;Cancer cell line;Cell model;Cell physiology;Cells;Cellular Stress;Clinical;Clinical Management;Collection;Cues;Data;EGF gene;Elements;Environment;Epitopes;Family;Foundations;Future;Gene Expression;Goals;Human;Individual;Knowledge;Lead;Malignant Neoplasms;Measurable;Medicine;Mission;Modeling;Molecular Biology;Molecular Target;Outcome;Pathway interactions;Patients;Pattern;Pharmaceutical Preparations;Population Heterogeneity;Proteins;Proteomics;Public Health;Publishing;Reporting;Research;Resistance;Resistance development;Series;Signal Transduction;Signaling Protein;Specificity;Systems Biology;Techniques;Testing;Training;Trastuzumab;United States National Institutes of Health;Variant;Work;base;cancer cell;clinically relevant;computer framework;computerized tools;design;epithelial to mesenchymal transition;graduate student;improved;innovation;malignant breast neoplasm;member;neoplastic cell;new technology;novel;prognostic;protein expression;protein function;protein protein interaction;receptor;response;success;tool;tumor;undergraduate student","Noncanonical signaling and Emergent Trastuzumab Resistance in Breast Cancer"," The proposed multi-disciplinary studies are an important step towards understanding how alterations in how cancer cells process information may influence clinical response to trastuzumab in breast cancer patients. The proposed research is expected to have an important positive impact on public health, because the approach proposed will enable improved therapies that surmount de novo and acquired resistance to trastuzumab in breast cancer patients.  
    

","NCI","8232374","12/26/2011 12:00:00 AM","PA-10-070","2R15CA132124-02","2","R15","CA","132124","02"," ","FORRY, SUZANNE L","3/1/2009 12:00:00 AM","12/31/2014 12:00:00 AM","Basic Mechanisms  of Cancer Therapeutics Study Section[BMCT]"," ","8638561","KLINKE, DAVID JOHN","Not Applicable","01","ENGINEERING (ALL TYPES)","191510239","M7PNRH24BBM8","191510239","M7PNRH24BBM8","US","39.637631","-79.946405","9163701","WEST VIRGINIA UNIVERSITY","MORGANTOWN","WV","BIOMED ENGR/COL ENGR/ENGR STA","265066845","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2014 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","297642","142868"," ","440510",
"Cancer; Genetics; Lung; Lung Cancer; Rare Diseases","Address;Alleles;Animal Model;Animals;Cancer Etiology;Cell Proliferation;Cell Survival;Cell model;Cells;Cessation of life;Cytoskeleton;Data;Death Rate;Dependence;Detection;Diagnosis;Diagnostic Neoplasm Staging;Disease;Endocytosis;Epithelial Cells;Epithelium;Family;Gene Expression;Goals;Human;K-ras Gene;Knock-out;Knowledge;Light;Lung;Lung Adenocarcinoma;Lung Neoplasms;Malignant Neoplasms;Malignant neoplasm of lung;Mediating;Modeling;Molecular;Monomeric GTP-Binding Proteins;Mus;Mutant Strains Mice;Mutate;Mutation;Nature;Neoplasm Metastasis;Normal Cell;Oncogenes;Oncogenic;Outcome;Pathway interactions;Physiological;Play;Prevalence;Process;Protein Family;RNA Splicing;Regulation;Reporting;Role;Signal Pathway;Staging;System;Testing;Tissues;Toxic effect;Work;base;cell motility;epithelial to mesenchymal transition;in vivo;member;mouse model;public health relevance;rac GTP-Binding Proteins;rho;therapeutic development;tumor;tumor initiation;tumor progression;tumorigenesis;tumorigenic","The Role of RAC1 in Cancer","
Public Health Relevance Statement
 The studies proposed will shed light on the process of tumor initiation and
progression and enhance our understanding of the molecular pathways involved in lung
cancer. The finding that Rac1b might function as an oncogene and that loss of Rac1 is
""lethal"" in the context of activated K-ras raises the possibility that targeting Rac1 in Ras-
mutated tumors would be therapeutically beneficial with, perhaps, limited toxicity towards
normal cells. Given the prevalence of Ras mutations in human cancer these finds could
potentially have an impact on a broad spectrum of cancers.","NCI","8204980","12/30/2011 12:00:00 AM","PA-07-070","5R01CA124495-04","5","R01","CA","124495","04"," ","WATSON, JOANNA M","3/1/2009 12:00:00 AM","7/31/2012 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","7260889","KISSIL, JOSEPH ","Not Applicable","03","Unavailable","075524595","DW1XZMGNFBL4","075524595","DW1XZMGNFBL4","US","39.950872","-75.195321","9340401","WISTAR INSTITUTE","PHILADELPHIA","PA","Research Institutes","191044265","UNITED STATES","N","1/1/2012 12:00:00 AM","7/31/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","126275","84983"," ","211258",
"Biotechnology; Cardiovascular; Heart Disease; Pediatric","Abbreviations;Accounting;Address;Adhesions;Animal Model;BMP2 gene;Behavior;Biological;Blood flow;Cell Culture System;Cell Line;Cells;Cellular Morphology;Collagen;Complex;Congenital Heart Defects;Cues;Cultured Cells;Defect;Development;Embryo;Embryonic Heart;Extracellular Matrix;Family;Gel;Gene Silencing;Genes;Genetic;Goals;Grant;Human;Immigration;In Vitro;Infant;Knockout Mice;Knowledge;Literature;Mediating;Mesenchymal;Mesenchyme;Molecular;Morbidity - disease rate;Morphogenesis;Mus;Mutation;Myocardium;Newborn Infant;Pathologic Processes;Pathway interactions;Patients;Play;Primordium;Process;Reporting;Role;Semaphorins;Signal Pathway;Signal Transduction;Structure;Subgroup;System;Temperature;Testing;Tissues;bone morphogenic protein;cell motility;congenital heart disorder;gain of function;in vivo;loss of function;member;migration;mortality;mouse model;mutant;neuronal guidance;novel;novel diagnostics;novel therapeutics;overexpression;prevent;public health relevance;receptor;response;transdifferentiation","The Roles of Semaphorin Signaling During Mouse Valvuloseptal Development","
Malformations of cardiac valvuloseptal structures account for a large proportion of congenital
heart diseases. BMP signaling plays a critical role in atrioventricular (AV) valvuloseptal
development. We have identified Sema6D as a downstream regulatory target of BMP signaling
in AV cushions, and will apply multiple complementary approaches to explore the potentially
critical function of Sema6D in supporting normal development of AV cushions.","NHLBI","8197588","12/1/2011 12:00:00 AM","PA-07-070","5R01HL095783-03","5","R01","HL","095783","03"," ","SCHRAMM, CHARLENE A","1/1/2010 12:00:00 AM","11/30/2014 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","8457223","JIAO, KAI ","Not Applicable","07","GENETICS","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","SCHOOLS OF MEDICINE","352940001","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","115088"," ","362588",
"Bioengineering; Biotechnology; Gene Therapy; Genetics","Acquired Immunodeficiency Syndrome;Affect;Area;Back;Bacteria;Biological;Biological Preservation;Biomedical Research;Biotechnology;Buffers;Cell Culture Techniques;Cell Density;Cells;Cellular biology;Chemicals;Culture Media;Cystic Fibrosis;DNA;Development;Diabetes Mellitus;Disease;Electroporation;Epithelial;Escherichia coli;Eukaryotic Cell;Event;Freeze Drying;Future;Gene Proteins;Genes;Goals;Hour;Human;Human Virus;Laboratories;Left;Life;Ligands;Lipids;Malignant Neoplasms;Mammalian Cell;Marketing;Measurement;Mediating;Medical;Mesenchymal;Methods;Microinjections;Molecular Medicine;Muscular Dystrophies;Nucleic Acids;Nutritional;Oncogenes;Peptide antibodies;Phagocytes;Phagocytosis;Phase;Plasmids;Polymers;Process;Production;Proteins;Protocols documentation;Quality Control;RNA;RNA Interference;Reagent;Receptor Cell;Recording of previous events;Reporter;Reporter Genes;Research;Safety;Seeds;Serum;Shipping;Ships;Small Business Innovation Research Grant;Technology;Therapeutic Agents;Time;Transfection;Vaccination;Viral Vector;base;cancer cell;cell type;gene function;gene gun;gene therapy;improved;killings;nanoparticle;new technology;novel;particle;plasmid DNA;product development;protein expression;prototype;research study;success;tool;uptake;user-friendly","A Novel High-Efficiency Transfection Technology"," We propose to develop commercial products based on a novel technology that can deliver genes and other biomolecules into cells with perfect efficiency, which can greatly benefit biomedical research.   
      

","NIGMS","8314619","6/29/2012 12:00:00 AM","PA-11-096","1R43GM100587-01A1","1","R43","GM","100587","01","A","MAAS, STEFAN","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-IMST-K(14)B]"," ","6267940","CHANG, RENJIE ","TAO, LIN ","06","Unavailable","198051737"," ","198051737"," ","US","42.13392","-88.049893","4068001","LAVAX","PALATINE","IL","Domestic For-Profits","600672456","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","859","SBIR/STTR","2012"," "," ","NIGMS"," "," "," ","254578",
"Aging; Osteoporosis; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Age;Aging;American;Anabolic Agents;Attenuated;Birth;Bone Marrow;Bone Resorption;Calvaria;Childhood;Degenerative Disorder;Development;Disease;Elderly;Embryo;Employee Strikes;Fracture;Grant;Harvest;Heterotrimeric GTP-Binding Proteins;Hip Fractures;Homeostasis;Hormones;Image;Limb structure;Longevity;Malignant Neoplasms;Mediating;Mediator of activation protein;Mesenchymal;Molecular;Mus;Osteoblasts;Osteogenesis;Osteopenia;Osteoporosis;Parathyroid Hormone Receptor;Parathyroid gland;Pathway interactions;Patients;Population;Process;Recombinants;Recovery;Relative (related person);Role;Signal Pathway;Signal Transduction;Skeletal Development;Stromal Cells;Teriparatide;Testing;Up-Regulation;Work;bone mass;cost;human PTH protein;inhibitor/antagonist;insight;mortality;novel;osteoblast differentiation;osteogenic;osteoporosis with pathological fracture;osteoprogenitor cell;postnatal;progenitor;public health relevance;skeletal","Sclerostin and Gsalpha signaling in osteoblasts","
Project Narrative
Osteoporosis is a common degenerative disease of aging, and treatments available to cure this debilitating
disease are lacking. Parathyroid hormone and the Wnt signaling pathway both act to control bone formation.
This proposal seeks to understand how these two pathways interact at the molecular level, as greater insights
into the processes by which bone mass is increased may ultimately result in novel therapies for osteoporosis.","NIAMS","8296071","6/15/2012 12:00:00 AM","PAR-09-031","5R03AR059942-03","5","R03","AR","059942","03"," ","CHEN, FAYE H","8/1/2010 12:00:00 AM","1/6/2013 12:00:00 AM","ZAR1-MLB-G(M1)"," ","1900877","WU, JOY Y","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","7/1/2012 12:00:00 AM","1/6/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","6840","5267"," ","12107",
"Kidney Disease; Rare Diseases; Urologic Diseases","Ablation;Acute;Address;Area;Atrophic;Beckwith-Wiedemann Syndrome;Biological;Blood Pressure;Body Water;Cell Polarity;Cell division;Cells;Chronic;Cyclin-Dependent Kinase Inhibitor;Data;Defect;Development;Disease;Duct (organ) structure;Dysplasia;Epithelium;Equilibrium;Family;Genetic;Genetic Models;Grant;Homeostasis;Hydronephrosis;Hypernatremia;Hyponatremia;Inherited;Kidney;Kidney Calculi;Knockout Mice;Knowledge;Lead;Ligands;Mediating;Mesenchymal;Modeling;Molecular;Molecular Genetics;Mus;Mutant Strains Mice;Mutate;Natural regeneration;Nephrogenic Diabetes Insipidus;Neurologic;Obstruction;Organogenesis;Pathogenesis;Pathway interactions;Physiological;Physiology;Play;Regulation;Renal function;Research;Role;Signal Transduction;Sodium Chloride;Symptoms;Tail;Testing;Tissues;Vesico-Ureteral Reflux;Water;base;cell growth regulation;interstitial;kidney medulla;nephrogenesis;paracrine;postnatal;prospective;public health relevance;repaired;response;salt balance;ureter dilatation;urinary tract obstruction;urologic","Molecular and Cellular Regulation of Mammalian Renal Medulla Development","
Project narrative
The renal medulla plays essential roles in body salt and water balance, and the regulation of
systemic blood pressure. The proposed study employs mouse genetic, molecular and cell
biological approaches to elucidate the molecular and cellular machinery guiding renal medulla
formation. The proposed research is not only critical for the mechanistic understanding of kidney
organogenesis and renal physiology, but will also provide the molecular basis for the development
of new strategies on the repair and regeneration of the disrupted/atrophic renal medulla resulted
from renal and urological anomalies.","NIDDK","8247792","4/3/2012 12:00:00 AM","PA-07-070","5R01DK085080-03","5","R01","DK","085080","03"," ","HOSHIZAKI, DEBORAH K","6/1/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Urologic and Kidney Development and Genitourinary Diseases Study Section[UKGD]"," ","9494406","YU, JING ","Not Applicable","05","ANATOMY/CELL BIOLOGY","065391526","JJG6HU8PA4S5","065391526","JJG6HU8PA4S5","US","38.034207","-78.512346","1526402","UNIVERSITY OF VIRGINIA","CHARLOTTESVILLE","VA","SCHOOLS OF MEDICINE","229044195","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","239039","124306"," ","363345",
"Cancer; Clinical Research; Hematology; Rare Diseases","AMD3100;Adhesions;Apoptosis;Apoptotic;Biological;Blood Circulation;Bone Marrow;Bone Marrow Cells;Bone Marrow Involvement;Bortezomib;CXCR4 Receptors;CXCR4 gene;Cell Adhesion Molecules;Cells;Clinical Trials;Cytotoxic agent;Data;Diagnosis;Disease;Endothelial Cells;Future;Grant;Growth;Hematologic Neoplasms;Hematopoietic stem cells;Homing;In Vitro;Integrin alpha4beta1;Kinetics;Lead;Lymphocyte;Lytic Lesion;MMP2 gene;Maintenance Therapy;Malignant - descriptor;Marrow;Mesenchymal;Modeling;Molecular;Multiple Myeloma;Osteoclasts;Patients;Plasma;Plasma Cells;Play;Process;Property;Public Health;Regulation;Role;Signal Pathway;Signal Transduction;Staging;Stem cells;Stimulus;Stromal Cell-Derived Factor 1;Stromal Cells;Testing;Therapeutic;Therapeutic Agents;Widespread Disease;abstracting;cancer cell;cell killing;cell type;chemokine;chemokine receptor;in vivo;inhibitor/antagonist;migration;peripheral blood;prevent;receptor;response;trafficking;tumor progression","CXCR4 regulation of tumor progression in Multiple Myeloma","n/a","NCI","8247088","4/4/2012 12:00:00 AM","PA-07-070","5R01CA125690-05","5","R01","CA","125690","05"," ","MERRITT, WILLIAM D","4/14/2008 12:00:00 AM","3/30/2014 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","8436435","GHOBRIAL, IRENE M.","Not Applicable","07","Unavailable","076580745","DPMGH9MG1X67","076580745","DPMGH9MG1X67","US","42.337844","-71.108337","1464901","DANA-FARBER CANCER INST","BOSTON","MA","Independent Hospitals","022155450","UNITED STATES","N","4/1/2012 12:00:00 AM","3/30/2014 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","206694","104430"," ","311124",
"Dental/Oral and Craniofacial Disease; Genetics; Pediatric","Address;Affect;Anterior;Apical;Bone Growth;Brain;Calvaria;Cells;Complex;Congenital Abnormality;Craniosynostosis;Cues;Defect;Development;Disease;Elements;Embryo;Enhancers;Event;Eye;Frontal bone structure;Functional disorder;Gene Dosage;Genes;Genetic;Growth;Head;Health;Human;Indium;Label;Lead;Learning;Location;Meninges;Mesenchymal;Mesenchyme;Mesoderm;Molecular;Morphogenesis;Mutation;Neural Crest;Osteogenesis;Parietal;Parietal bone structure;Pathway interactions;Pattern;Pattern Formation;Population;Population Control;Positioning Attribute;Process;Property;Relative (related person);Role;Shapes;Signal Transduction;Slice;Specific qualifier value;Staging;Structure;Testing;Tooth structure;Work;base;bone;cell motility;computerized data processing;coronal suture;cranium;in vivo;interest;life history;migration;migratory population;mind control;mutant;osteogenic;osteoprogenitor cell;precursor cell;prevent;progenitor;promoter;research study;response","Cellular and Molecular Mechanisms of Patterned Growth of the Mammalian Skull","
Project Narrative
 This is a proposal to study how the skull forms and how two genes-Msx2 and Msx2-control the
shape of bones of the skull. Msx genes are of special interest because humans with mutations in MSX2 and
MSX2 have birth defects that affect their skulls and teeth. By studying how these genes work, we will learn
more about basic processes of skull development as well as how mutations in Msx1 and 2 lead to birth defects.
In the long term, this work may help to devise new treatments of such birth defects.","NIDCR","8246311","3/7/2012 12:00:00 AM","PA-07-070","5R01DE019650-04","5","R01","DE","019650","04"," ","SCHOLNICK, STEVEN","4/1/2009 12:00:00 AM","3/31/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1891907","MAXSON, ROBERT E.","Not Applicable","37","BIOCHEMISTRY","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF MEDICINE","900894304","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","232774","144320"," ","377094",
"Cancer; Neuroblastoma; Neurosciences; Orphan Drug; Pediatric; Rare Diseases","Biological Assay;Biology;Cell Communication;Cell Line;Cells;Clinical Data;Clinical Investigator;Clinical Trials;Coculture Techniques;Collaborations;Combined Modality Therapy;Cultured Tumor Cells;Data Analyses;Disease;Drug Combinations;Generations;Human;IGF1R gene;Immunocompromised Host;In Vitro;Interleukin-6;Maximum Tolerated Dose;Mesenchymal;Modeling;Multi-Drug Resistance;Mus;Natural Killer Cells;Neuroblastoma;Patients;Pharmaceutical Preparations;Pharmacodynamics;Phase I Clinical Trials;Pre-Clinical Model;Research Personnel;STAT3 gene;Schedule;Testing;Tissues;Work;Xenograft Model;aurora-A kinase;cell bank;chemotherapeutic agent;combinatorial;cytotoxicity;design;high risk;in vivo;inhibitor/antagonist;instrument;lenalidomide;monocyte;neoplastic cell;neuroblastoma cell;novel therapeutics;pre-clinical;research clinical testing;research study;subcutaneous;tumor;tumor growth;tumor xenograft","PRECLINICAL DRUG AND BIOLOGIC TESTING","Robust pre-clinical data generated through vigorous in vitro and in vivo testing will facilitate patient accrual to phase I trials, as patients most likely will enter trials with convincing experimental support. In addition, the pre-clinical modeling is crucial in establishing optimal scheduling for combination therapies, and synergistic and additive effects.","NCI","8378054","7/5/2012 12:00:00 AM","PAR-09-025","5P01CA081403-13","5","P01","CA","081403","13"," "," "," "," ","ZCA1-GRB-S","6827","6952108","KESHELAVA, NINO ","Not Applicable","28","Unavailable","052277936","DVL1CMRMWRN9","052277936","DVL1CMRMWRN9","US","34.098065","-118.29069","1520001","CHILDREN'S HOSPITAL OF LOS ANGELES","LOS ANGELES","CA","Independent Hospitals","900276062","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","91624","91624"," ","91624","0"," "," ",
"Autoimmune Disease; Clinical Research; Lung; Orphan Drug; Rare Diseases","Accounting;Address;Animal Model;Animals;Biological Markers;Biopsy;Biopsy Specimen;Bleomycin;Bronchoalveolar Lavage;Cells;Cessation of life;Cicatrix;Clinical;Clinical Trials;Collagen;DNA Methylation;Defect;Development;Dinoprostone;Disease;Disease Progression;Epoprostenol;Exhibits;Fibroblasts;Fibrosis;Future;Grant;Hamman-Rich syndrome;Heterogeneity;Human;In Vitro;Individual;Instruction;Knowledge;Link;Lung;Lung diseases;Measures;Mediator of activation protein;Mesenchymal;Methylation;Molecular;Mus;Myofibroblast;Outcome;Pathway interactions;Patients;Pattern;Plasmin;Plasminogen;Principal Investigator;Property;Prostaglandins;Prostaglandins I;Proteins;Pulmonary Fibrosis;Regimen;Reporting;Research;Resistance;Respiratory Failure;Role;Safety;Selection for Treatments;System;Testing;Therapeutic;Therapeutic Agents;Toxic effect;Transgenic Organisms;Treatment Protocols;Urokinase;active method;analog;base;cell type;effective therapy;fibrogenesis;human disease;improved;in vivo;inhibitor/antagonist;meetings;migration;mouse model;novel;pulmonary arterial hypertension;response;treatment effect","Prostanoids, Plasminogen Actication, and Personalized Therapeutics in IPF","n/a","NHLBI","8258723","5/8/2012 12:00:00 AM","RFA-HL-11-015","5P50HL107177-02","5","P50","HL","107177","02"," ","EU, JERRY PC","5/1/2011 12:00:00 AM","4/30/2014 12:00:00 AM","ZHL1-CSR-D(F1)"," ","1899275","PETERS-GOLDEN, MARC L","MARTINEZ, FERNANDO J","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","838","Research Centers","2012"," "," ","NHLBI","331800","159267"," ","446234",
"Assistive Technology; Bioengineering; Genetics; Human Genome; Infant Mortality/ (LBW); Lung; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal - Neonatal Respiratory Distress Syndrome; Perinatal Period - Conditions Originating in Perinatal Period","Affect;Agonist;Alveolar;Animal Model;Animals;Apoptosis;Bronchopulmonary Dysplasia;Cell Proliferation;Characteristics;Complex;DNA;DNA Methylation;DNA Modification Process;Data;Environmental air flow;Epigenetic Process;Equilibrium;Event;Exons;Frequencies;Genes;Genetic Transcription;Genomics;Histology;Histone Code;Histone Deacetylase Inhibitor;Histones;Human;Hypermethylation;Insulin-Like Growth Factor I;Intervention;Lung;Mechanical ventilation;Mechanics;Mesenchymal;Methylation;Modeling;Modification;Molecular;Nose;Pathogenesis;Physiological;Premature Birth;Regulation;Research;Research Design;Respiratory physiology;Site;Testing;Transcription Initiation;Transcription Initiation Site;Tretinoin;Ventilator Weaning;Vitamin A;gain of function;genome-wide;histone modification;improved;innovation;loss of function;novel;premature;prevent;respiratory gas;response","Epigenetics participate in neonatal CLD"," The mechanisms through which prematurity and MV combine to dysregulate alveolar formation are not well defined. A potential mechanism is epigenetics, which uses histone covalent modifications and DNA CpG methylation to regulate gene transcription. Our central hypothesis is that preterm birth and MV dysregulate histone covalent modifications and DNA CpG methylation in the lung compared to HFNV in a well-established animal model of neonatal CLD.    

","NHLBI","8279183","6/1/2012 12:00:00 AM","PA-10-067","5R01HL110002-02","5","R01","HL","110002","02"," ","LIN, SARA","6/15/2011 12:00:00 AM","5/31/2016 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1918378","ALBERTINE, KURT H","Not Applicable","02","PEDIATRICS","009095365","LL8GLEVH6MG3","009095365","LL8GLEVH6MG3","US","40.76776","-111.832926","514002","UNIVERSITY OF UTAH","SALT LAKE CITY","UT","SCHOOLS OF MEDICINE","841128930","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","308436","152675"," ","461111",
"Hematology; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adipocytes;Adult;Affect;Anemia;Angiogenic Factor;Applications Grants;Blood Circulation;Bone Marrow;Bone Marrow Cells;Cells;Chronic;Collagen Fiber;Collagen Type I;Development;Drosophila pros protein;Erythropoietin;Experimental Models;Fibrosis;Healed;Hematopoietic;Hematopoietic System;Homeostasis;Hyperparathyroidism;ITGAM gene;In Vitro;Knowledge;Lesion;Link;Malignant Neoplasms;Marrow;Mesenchymal;Mus;Myelofibrosis;Myofibroblast;Names;Non-Malignant;Osteoblasts;Osteoclasts;PTPRC gene;Parathyroid Hormone Receptor;Pathogenesis;Pathology;Patients;Population;Proteins;Renal Osteodystrophy;Reporting;Resistance;Site;Skeletal system;Staging;Surface Antigens;Testing;Tissues;Tumor necrosis factor receptor 11b;Work;Wound Healing;bone;cell type;cytokine;healing;in vivo;monocyte;mouse model;novel;precursor cell;progenitor;progressive myositis ossificans;research study","Identification of a novel population in the adult bone marrow","  This is a grant proposal that involves the identification, characterization and isolation of a novel cell type resident in the bone marrow. We propose that these cells could be important to maintain the homeostasis of the skeletal system and in the development of marrow fibrosis.  
  
  
    

","NIAMS","8336893","7/28/2012 12:00:00 AM","PA-10-069","5R21AR060689-02","5","R21","AR","060689","02"," ","SHARROCK, WILLIAM J","9/21/2011 12:00:00 AM","8/31/2013 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","6803498","SCHIPANI, ERNESTINA ","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","603007902","SHHBRBAPSM35","603007902","SHHBRBAPSM35","US","39.780714","-86.174977","577806","INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS","INDIANAPOLIS","IN","SCHOOLS OF MEDICINE","462022915","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","115997","59899"," ","175896",
"Biotechnology; Cooley's Anemia; Gene Therapy; Genetics; Hematology; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human; Transplantation","Adult;Autologous Transplantation;Biological Assay;CD34 gene;Cell Line;Cells;Clinical;Coculture Techniques;DNA Methylation;Dependovirus;Derivation procedure;Development;Disease;Engraftment;Epigenetic Process;Erythroid;Erythroid Cells;Excision;Fibroblasts;Funding;Gene Delivery;Gene Targeting;Genes;Genetic Recombination;Globin;Grant;Hematopoietic;Hematopoietic stem cells;Hemoglobin F Disease;Hemoglobinopathies;Hereditary Disease;Human;Hypersensitivity;Immunodeficient Mouse;In Vitro;Integrase;Kanamycin Kinase;Lentivirus Vector;Long Terminal Repeats;Mediating;Mesenchymal;Methods;Monitor;Mus;Mutation;Patients;Phenotype;Pluripotent Stem Cells;Point Mutation;Production;Proteins;Recovery;Research;Retroviral Vector;Site;Source;Spumavirus;Stem cells;Stromal Cells;Subfamily lentivirinae;Surface;System;Testing;Thalassemia;Therapeutic;Thymidine Kinase;Transgenes;Transplantation;adeno-associated viral vector;arm;base;beta Globin;cell type;design;disease-causing mutation;erythroid differentiation;fetal;fusion gene;gene correction;gene therapy;genome-wide;genotoxicity;histone modification;homologous recombination;human embryonic stem cell;improved;induced pluripotent stem cell;mutant;pluripotency;recombinase;research study;small hairpin RNA;vector","Derivation and Correction of Thalassemic Pluripotent Stem Cells","n/a","NHLBI","8378980","4/28/2012 12:00:00 AM"," ","5P01HL053750-18","5","P01","HL","053750","18"," "," "," "," ","Heart, Lung, and Blood Program Project Study Section[HLBP]","8233","1885915","RUSSELL, DAVID W","Not Applicable","07","Unavailable","605799469","HD1WMN6945W6","605799469","HD1WMN6945W6","US","47.660049","-122.31441","9087701","UNIVERSITY OF WASHINGTON","SEATTLE","WA","Domestic Higher Education","981951016","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","455111","455111"," ","322943","132168"," "," ",
"Brain Cancer; Brain Disorders; Cancer; Genetics; Neurosciences; Rare Diseases","Affect;Astrocytes;Biological Models;Biology;Blood Vessels;Brain Neoplasms;Cell surface;Cells;Collaborations;Collection;Complex;Data;Data Set;Endothelial Cells;Endothelium;Engineering;Environment;Epidermal Growth Factor Receptor;Fibroblasts;Gene Expression;Genes;Genetic Transcription;Glioblastoma;Glioma;Grant;Human;Immunohistochemistry;Implant;Inflammatory;Measures;Memorial Sloan-Kettering Cancer Center;Mesenchymal;Messenger RNA;Metastatic malignant neoplasm to brain;Microglia;Modeling;Molecular;Molecular Profiling;Mus;Neurosurgeon;Operative Surgical Procedures;Outcome;Pericytes;Phenotype;Platelet-Derived Growth Factor;Primary Brain Neoplasms;Proteins;Radiation;Reagent;Recurrence;Recurrent tumor;Resistance;Role;Sampling;Signal Pathway;Smooth Muscle Myocytes;Stem cells;Stromal Cells;Subgroup;System;Technology;The Cancer Genome Atlas;Therapeutic;Time;Translating;Tumor Bank;Tumor Biology;Tumor-Derived;Validation;base;cell stroma;cell type;clinical practice;design;in vivo;knock-down;mouse model;neoplastic cell;new technology;research study;response;standard of care;temozolomide;therapy resistant;tumor","The Proneural Perivascular Niche and Therapeutic Response","n/a","NCI","8555352","10/12/2012 2:36:39 PM","RFA-CA-10-021","5U54CA163167-02","5","U54","CA","163167","02"," "," ","9/21/2011 12:00:00 AM","6/15/2013 12:00:00 AM","ZCA1-SRLB-3(O1)","5273","2067406","HOLLAND, ERIC C.","Not Applicable","12","Unavailable","064931884","KUKXRCZ6NZC2","064931884","KUKXRCZ6NZC2","US","40.764332","-73.955697","5079202","SLOAN-KETTERING INST CAN RESEARCH","NEW YORK","NY","Research Institutes","100656007","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","236782","236782"," ","160650","76132"," "," ",
"Kidney Disease","3-Dimensional;Affinity;Amino Acids;Area;Binding;Biophysics;Cell Death;Cell physiology;Cells;Cellular biology;Chronic Kidney Failure;Collagen;Collagen Receptors;Collagen Type IV;Complex;Cytoplasmic Structures;Cytoplasmic Tail;Disease;ECM receptor;Etiology;Extracellular Domain;Extracellular Matrix;Goals;Health;Homeostasis;Individual;Induced Mutation;Integrin alpha1;Integrin beta3;Integrins;Kidney Glomerulus;Knowledge;Length;Ligand Binding;Ligands;Mammalian Cell;Mediating;Mesenchymal;Methods;Modeling;Molecular;Molecular Biology;Mutagenesis;Nephrons;Parents;Pathology;Play;Proteins;Publishing;Relative (related person);Renal glomerular disease;Resolution;Role;Scanning;Signal Transduction;Specificity;Structure;Structure-Activity Relationship;Testing;Transmembrane Domain;United States;Work;base;cell type;follow-up;glomerulosclerosis;insight;integrin alpha1beta1;intermolecular interaction;membrane model;mesangial cell;mutant;novel;public health relevance;receptor;receptor binding;role model","Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2","
Narrative
We anticipate that this study will generate novel insights into the structural basis whereby the TM and CT
domains of integrins ï¿½1ï¿½1 and ï¿½2ï¿½1 function. This knowledge is fundamental to our understanding of how
integrins transduce signals from collagens within the glomerulus in both health and disease.","NIDDK","8286378","6/28/2012 12:00:00 AM","PA-07-070","5R01DK083187-03","5","R01","DK","083187","03"," ","KETCHUM, CHRISTIAN J","7/1/2010 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BCMB-B(02)M]"," ","7040496","ZENT, ROY ","SANDERS, CHARLES R","05","INTERNAL MEDICINE/MEDICINE","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","115038"," ","320463",
"Bioengineering; Cancer","Actins;Address;Adhesions;Animals;Blood Vessels;Bulla;Cell model;Cells;Color;Complex;Computer Assisted;Computer software;Confocal Microscopy;Cytoplasmic streaming;Distant;Down-Regulation;Engineering;Environment;Event;Extracellular Matrix;Fishes;Genes;Goals;Green Fluorescent Proteins;Human;Image;Integrins;Intercellular Junctions;Invaded;Life;Locomotion;Malignant Neoplasms;Mediating;Membrane;Mesenchymal;Modeling;Molecular;Monitor;Morphology;Mutate;Mutation;Myosin Type II;Neoplasm Metastasis;Oncogenic;Optics;Organ;PTK2 gene;Pathway interactions;Patients;Phosphorylation;Physiological;Prevention;Process;Proteolysis;Receptor Activation;Reporter;Research;Research Proposals;Resolution;Rho-associated kinase;Role;Shapes;Signal Pathway;Signal Transduction;Site;Structure;System;Therapeutic;Therapeutic Agents;Tissues;Transgenic Model;Transgenic Organisms;Tumor Cell Invasion;Tyrosine;Vascular Endothelial Growth Factor Receptor;Vascular Endothelial Growth Factors;Work;Xenograft Model;Zebrafish;ameboid movement;arm;base;cadherin 5;cancer cell;cell behavior;cell motility;cell type;design;extracellular;in vivo;migration;mutant;neoplastic cell;novel;programs;reconstitution;response;src-Family Kinases;tumor progression","Imagining Human Cancer Progression in a Novel Zebrafish Model","n/a","NCI","8278051","4/30/2012 12:00:00 AM","PA-07-070","5R01CA129231-05","5","R01","CA","129231","05"," ","AULT, GRACE S","8/1/2008 12:00:00 AM","5/31/2013 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1874802","KLEMKE, RICHARD L.","Not Applicable","52","PATHOLOGY","804355790","UYTTZT6G9DT1","804355790","UYTTZT6G9DT1","US","32.881785","-117.236973","577507","UNIVERSITY OF CALIFORNIA, SAN DIEGO","LA JOLLA","CA","SCHOOLS OF MEDICINE","920930621","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","399","Non-SBIR/STTR","2012"," "," ","NCI","201275","109695"," ","310970",
"Kidney Disease","Actomyosin;Address;Adhesives;Anatomy;Animal Model;Apical;Behavior;Biology;Brain;Caenorhabditis elegans;Caliber;Cell Communication;Cell surface;Cells;Complex;Congenital Abnormality;Cytoskeletal Modeling;Defect;Development;Disease;Down-Regulation;Duct (organ) structure;EGF gene;Epithelial;Extracellular Matrix;Family;Genes;Genetic;Genetic Screening;Genetic screening method;Health;Heart Diseases;Human;Image;Integral Membrane Protein;Kidney;Kidney Diseases;Knowledge;Life;Link;Maintenance;Mammals;Mediating;Molecular;Morphogenesis;Organ;P-Cadherin;Pathway interactions;Pattern;Process;Property;Proteins;Receptor Protein-Tyrosine Kinases;Role;Shapes;Signal Transduction;Spinal Dysraphism;Stroke;Structure;System;Tertiary Protein Structure;Testing;Time;Tissues;Tube;Tubular formation;Tubulin;Vascular System;Withdrawal;Zona Pellucida;capillary bed;cell fate specification;epithelial to mesenchymal transition;in vivo;insight;kidney vascular structure;mutant;neuroblast;overexpression;prevent;programs;research study;therapy design","Ras signaling and tubulogenesis in the C. elegans excretory (renal) system"," Problems with tube development or maintenance cause birth defects such as spina bifida and many common diseases such as kidney disease, heart disease and stroke.  These studies investigate how tubes develop and are maintained, with a special emphasis on the tiniest tubes in our bodies. Understanding these mechanisms will help in the design of therapies to prevent or treat tube-related disease.      
   
      

","NIGMS","8296944","3/26/2012 12:00:00 AM","PA-10-067","2R01GM058540-10A1","2","R01","GM","058540","10","A","HOODBHOY, TANYA","4/1/2000 12:00:00 AM","12/31/2015 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","6369052","SUNDARAM, MEERA ","Not Applicable","03","GENETICS","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","4/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","210000","126000"," ","336000",
"Lung; Pediatric; Regenerative Medicine; Smoking and Health; Stem Cell Research; Stem Cell Research - Embryonic - Human; Tobacco","Affect;Amniotic Fluid;Apoptosis;Area;Asthma;Birth;Cells;Chemicals;Child;Childhood;Data;Development;Embryo;Epithelium;Exposure to;Fetal Lung;Fibroblasts;Gene Expression Profile;Growth;Human;Hypersensitivity;In Vitro;Incidence;Infant;Infant Health;Intervention;Investigation;Link;Lung;Maternal Exposure;Mesenchymal;Methods;Modeling;Morbidity - disease rate;Mothers;Mus;N-myc Gene;Newborn Infant;Nicotine;Organ;Organogenesis;Paracrine Communication;Physiological;Placenta;Pregnancy;Protocols documentation;Regulation;Respiration;Respiratory physiology;Role;Scientist;Signal Pathway;Signal Transduction;Smoking;Staging;Surface;System;Testing;Thick;Time;Translational Research;United States;cigarette smoking;embryonic stem cell;fetal tobacco exposure;human embryonic stem cell;improved;in vivo;in vivo Model;innovation;knock-down;lung development;model development;mortality;mouse model;nonhuman primate;novel;paracrine;prevent;respiratory;response;treatment effect","Nicotine Dysregulates Lung Differentiation through N-myc"," Using a novel model, this proposal will investigate the role of the N-myc gene in human lung development, and will provide a mechanism for the decreased lung function seen in infants born to smoking mothers. This can be used to guide the development of new interventions to improve the lung health of infants and children.  
    

","NHLBI","8293636","6/26/2012 12:00:00 AM","PA-10-067","5R01HL102177-03","5","R01","HL","102177","03"," ","BLAISDELL, CAROL J","4/1/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","8533138","CARLISLE, DIANE L.","Not Applicable","18","NEUROSURGERY","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","228608","36517"," ","265125",
"Hematology; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human; Stem Cell Research - Nonembryonic - Non-Human","Adult;Aorta;Biological Assay;Blood;Blood Cells;Blood Circulation;Bone Marrow;Cell Line;Cell surface;Cells;Clinical;Collection;Data;Development;Developmental Process;Disease;Dorsal;Dose;Dyes;Embryo;Endothelial Cells;Endothelium;Erinaceidae;Event;Funding;GATA2 transcription factor;Gene Transfer Techniques;Generations;Genetic Recombination;Gonadal structure;Growth;Haploidy;Hematopoiesis;Hematopoietic;Hematopoietic Cell Growth Factors;Hematopoietic System;Hematopoietic stem cells;Interleukin-3;Investigation;LacZ Genes;Lead;Life;Maps;Mesenchymal;Mesonephric structure;Methods;Molecular;Mus;Oils;Placenta;Play;Production;Research;Role;Running;Staging;System;Technology;Therapeutic;Thromboplastin;Tissues;Transgenic Mice;Transplantation;Trauma;Yolk Sac;base;bone morphogenetic protein 4;cell motility;cytokine;embryo culture;hematopoietic tissue;implantation;improved;insight;leukemia;novel;research study;transcription factor","Characterization of the first HSCs during mouse ontogeny","n/a","NIDDK","8257864","3/29/2012 12:00:00 AM"," ","5R37DK054077-15","5","R37","DK","054077","15"," ","BISHOP, TERRY ROGERS","6/1/1998 12:00:00 AM","3/31/2013 12:00:00 AM","Hematopoiesis Study Section[HP]"," ","1858072","DZIERZAK, ELAINE A","Not Applicable","n/a","Unavailable","489719798","QKXVTWJFQKA9","489719798","QKXVTWJFQKA9","NL","51.9225","4.47917","10001605","ERASMUS MEDICAL CENTER","Rotterdam"," ","Unavailable","3015 GD","NETHERLANDS","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","281259","22501"," ","303760",
"Clinical Research; Dental/Oral and Craniofacial Disease; Genetics; Pediatric","Ablation;Address;Adolescence;Affect;Anatomy;Animal Model;Belief;Binding Sites;Branchial arch structure;Cell Cycle;Cell Cycle Progression;Cell Proliferation;Cells;Centers for Disease Control and Prevention (U.S.);Cephalic;Childhood;Cleft Lip;Cleft Palate;Congenital Abnormality;Data;Defect;Development;Disabled Persons;Disease;Embryo;Epithelium;Gene Expression;Genes;Goals;Growth Factor;Homeobox Genes;Infant;Intervention;Knowledge;Laboratories;Medial;Mediating;Medical;Mesenchymal;Mesenchyme;Modality;Modeling;Modification;Molecular;Molecular Biology;Mus;Mutant Strains Mice;Mutation;Neural Crest;Neural Crest Cell;Operative Surgical Procedures;Penetrance;Phase;Phenotype;Play;Population;Process;Publications;Research;Research Design;Research Personnel;Role;Signal Transduction;Solutions;Stem cells;Testing;Therapeutic;Tissues;Transforming Growth Factor beta;Transforming Growth Factors;Work;Yang;base;craniofacial;handicapping condition;inhibitor/antagonist;malformation;medical specialties;migration;mutant;palatal fusion;palatogenesis;programs;promoter;receptor;response;skills;statistics;transcription factor","TGF-BETA SIGNALING IN PALATOGENESIS","n/a","NIDCR","8214655","1/31/2012 12:00:00 AM","PA-06-512","5K08DE017754-05","5","K08","DE","017754","05"," ","KING, LYNN M","3/1/2008 12:00:00 AM","2/28/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","8261652","URATA, MARK M","Not Applicable","37","DENTISTRY","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","900894304","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","122500","9800"," ","132300",
"Genetics; Infant Mortality/ (LBW); Lung; Nutrition; Obesity; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal Period - Conditions Originating in Perinatal Period; Prevention","Adipose tissue;Adult;Affect;Age;Attention;Chronic lung disease;Clinical;Complement;DNA;DNA Methylation;DNA Modification Process;Data;Development Plans;Diet;Dietary Intervention;Disease;Docosahexaenoic Acids;Epigenetic Process;Epithelial;Fatty Acids;Female;Fetal Growth Retardation;Funding;Future;Gender;Genes;Genetic Transcription;Goals;Individual;Intervention;Knockout Mice;Life;Lung;Maps;Mentorship;Mesenchymal;Mesenchyme;Messenger RNA;Modeling;Modification;Morbidity - disease rate;Nutrient;Nutritional;Obesity;PPAR gamma;Pattern;Perinatal;Pharmacologic Substance;Phenotype;Process;Proteins;Rattus;Regulation;Research;Research Personnel;Risk;Role;Serum;Stream;Structure of parenchyma of lung;Supplementation;Testing;Thick;Time;Tissues;Training;Transcriptional Regulation;United States National Institutes of Health;Visceral;Vocabulary;base;career;career development;histone modification;improved;in utero;in vivo;innovation;lipid biosynthesis;lung development;male;meetings;offspring;programs;response;sensor;tool;transcription factor","Epigenetic modulation of PPARgamma transcription in the IUGR rat","
Narrative
Intrauterine growth restriction is a common, biologically important condition with individuals at risk of multiple
morbidities, including chronic lung disease (CLD) and adult obesity. When inappropriately regulated, PPARg,
contributes to these IUGR related diseases. This project aims to uncover the mechanisms of inappropriate
PPARg regulation and identifies a dietary intervention that potentially improves the consequences of IUGR.
 ","NIDDK","8318233","8/21/2012 12:00:00 AM","PAR-09-060","5K01DK084036-03","5","K01","DK","084036","03"," ","HYDE, JAMES F","9/30/2010 12:00:00 AM","8/31/2013 12:00:00 AM","Diabetes, Endocrinology and Metabolic Diseases B Study Section[DDK-B]"," ","9490678","JOSS-MOORE, LISA ANNE","Not Applicable","02","PEDIATRICS","009095365","LL8GLEVH6MG3","009095365","LL8GLEVH6MG3","US","40.76776","-111.832926","514002","UNIVERSITY OF UTAH","SALT LAKE CITY","UT","SCHOOLS OF MEDICINE","841128930","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","847","Other Research-Related","2012"," "," ","NIDDK","98698","7896"," ","106594",
"Bioengineering; Biotechnology; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","15 year old;Achievement;Agonist;Alginates;Animal Model;Architecture;Autologous Transplantation;Automobile Driving;Biological Assay;Biomechanics;Bioreactors;Blast Injuries;Blood;Blood Vessels;Bone Growth;Bone Injury;Bone Lengthening;Bone Marrow;Bone Marrow Stem Cell;Bone Regeneration;Cartilage;Cell Density;Cell Differentiation process;Cell Proliferation;Cells;Cellular Morphology;Child;Chondrocytes;Complex;Culture Media;Deformity;Deposition;Development;Dextrans;Differentiation Antigens;Distraction Osteogenesis;Dorsal;Dysplasia;Engineering;Epiphysial cartilage;Erinaceidae;Ethylene Glycols;External Fixation Devices;Feedback;Filler;Fracture;Funding;Gel;Goals;Grant;Growth;Growth Factor;Healed;Housing;Human Resources;Hydrogels;Hypertrophy;Hypoxia;Image;Immunodeficient Mouse;Implant;In Vitro;Individual;Infection;Injury;Length;Limb structure;Maintenance;Marrow;Measures;Mentored Research Scientist Development Award;Mesenchymal Stem Cells;Microfluidics;Modeling;Morbidity - disease rate;Natural regeneration;Osteogenesis;Pain;Patients;Pattern;Permeability;Population;Procedures;Radial;Recruitment Activity;Reporter;Research;Research Support;Rest;Risk;Signal Pathway;Signal Transduction;Signaling Molecule;Site;Skeletal Development;Skin;Stem cells;Structure;Testing;Time;Tissue Engineering;Tissues;Training;Work;X-Ray Computed Tomography;adult stem cell;biomedical scientist;bone;bone healing;bone loss;career;career development;cartilage cell;cell type;combat;design;dextran;ethylene glycol;face bone structure;healing;in vivo;injured;limb bone;mineralization;minimally invasive;morphogens;multidisciplinary;novel;parathyroid hormone-related protein;poly(ethylene glycol)diacrylate;repaired;skeletal;skeletal disorder;skeletal dysplasia;skeletal injury;subcutaneous;tissue regeneration;tool","PTHrP/IHH Microenvironment Control for Growth Plate Tissue Engineering"," The goal of this career development grant is to establish myself as an independent biomedical scientist who develops tissue regeneration therapies through study of skeletal development and disease in engineered microenvironment models. The research focus is to create a tissue engineered growth plate model from adult stem cells using cell patterning and controlled growth factor delivery tools. With this novel model, we will be able to study cellular signaling molecules and pathways that cannot be feasibly investigated with animal models and develop treatments to repair congenital skeletal deformities and complex bone injuries that normally heal poorly.   
   
      

","NIAMS","8280645","2/24/2012 12:00:00 AM","PA-11-190","1K01AR062598-01","1","K01","AR","062598","01"," ","WANG, FEI","4/1/2012 12:00:00 AM","3/31/2017 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","10366683","TABOAS, JUAN MANUEL","Not Applicable","18","DENTISTRY","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF DENTISTRY/ORAL HYGN","152133320","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","116375","9310"," ","125685",
"Anorexia; Clinical Research; Clinical Trials; Diagnostic Radiology; Eating Disorders; Estrogen; Mental Health; Nutrition; Osteoporosis; Pediatric","Adipocytes;Adolescence;Adolescent;Adrenal Glands;Adrenal hormone preparation;Adult;Affect;Age;Anorexia Nervosa;Body Composition;Bone Density;Bone Marrow;Bone Resorption;C-telopeptide;Caring;Clinical;Clinical Trials;Data;Dehydroepiandrosterone Sulfate;Development;Dimensions;Disease;Disease Progression;Elderly;Estradiol;Estrogen Replacement Therapy;Exhibits;Fatty acid glycerol esters;Female Adolescents;Fracture;Functional disorder;Goals;Gonadal Hormones;Gonadal Steroid Hormones;Health;Height;Hematopoietic;Hormonal;Hydrocortisone;Image;Imaging Techniques;Insulin-Like Growth Factor I;Knowledge;Lead;Leptin;Life;Limb structure;Magnetic Resonance Imaging;Magnetic Resonance Spectroscopy;Maintenance;Marrow;Measurement;Measures;Mediating;Mediator of activation protein;Mesenchymal Stem Cells;Modeling;Osteoblasts;Osteogenesis;Osteoporosis;Participant;Patient Care;Patients;Peripheral;Placebos;Radial;Randomized;Randomized Controlled Trials;Red Marrow;Regimen;Research;Research Personnel;Risk;Role;Skeleton;Somatomedins;Somatotropin;Testing;Testosterone;Therapeutic;Vertebral column;Visual;Weight;X-Ray Computed Tomography;Yellow Marrow;adiponectin;adverse outcome;bone;bone health;bone loss;bone mass;bone strength;bone turnover;clinical care;critical period;dehydroepiandrosterone;double-blind placebo controlled trial;emerging adult;ghrelin;girls;improved;interest;novel;patient population;prevent;response;restoration;skeletal;subcutaneous;tibia;young woman","Effect of Adrenal and Gonadal Hormones on Bone Marrow and Appendicular BMD"," This project seeks to understand the mechanisms behind a promising new therapy, a combined regimen of dehydroepiandrosterone + estrogen replacement therapy, for adolescents with anorexia nervosa, through a randomized controlled trial. The proposal will explore effects of this combined regimen on both bone density of the peripheral skeleton and bone marrow composition, and will examine how hormonal factors mediate skeletal losses and alter marrow composition in this disease. Enhancing understanding of the mechanisms underlying skeletal losses in this young patient population will fill critical knowledge gaps that will potentially improve the care of adolescents with anorexia nervosa.  
  
    

","NIAMS","8304990","5/10/2012 12:00:00 AM","PA-10-067","5R01AR060829-02","5","R01","AR","060829","02"," ","CHEN, FAYE H","8/1/2011 12:00:00 AM","7/31/2012 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1935212","GORDON, CATHERINE M.","Not Applicable","07","Unavailable","076593722","Z1L9F1MM1RY3","076593722","Z1L9F1MM1RY3","US","42.340629","-71.094923","1504801","BOSTON CHILDREN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021155724","UNITED STATES","N","6/1/2012 12:00:00 AM","7/31/2012 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","30316","15635"," ","45951",
"Biotechnology; Cancer; Genetics","1-Phosphatidylinositol 3-Kinase;Address;Basal cell carcinoma;Biological Assay;Cell Polarity;Cell division;Cells;Cilia;Complex;Congenital Abnormality;Cutaneous;Cytoskeleton;Data;Dermal;Development;Disease;Enrollment;Epithelial;Erinaceidae;Funding;Gene Expression;Gene Targeting;Genes;Genetic;Genetic Recombination;Goals;Growth;Hair;Hair follicle structure;Human;In Vitro;Individual;Malignant Neoplasms;Mediating;Mesenchymal;Modeling;Molecular;Mutation;Natural regeneration;Neoplasm Metastasis;Organelles;Paracrine Communication;Pathway interactions;Patients;Play;Predisposition;Proteins;Recruitment Activity;Regulation;Resistance;Resources;Role;Signal Transduction;Signaling Protein;Syndrome;System;Testing;Tissues;Variant;Vesicle;autocrine;base;cancer type;cilium biogenesis;cohort;in vivo;inhibitor/antagonist;kinetosome;new therapeutic target;novel;novel therapeutics;overexpression;paracrine;skin disorder;smoothened signaling pathway;trafficking;tumor;tumorigenesis","Stromal Regulation of Basal Cell Carcinoma Formation","  Sonic hedgehog (Shh) signaling plays a crucial role in the normal development of many tissues including the hair follicle; however, inappropriate pathway activity is associated with a variety of human birth defects, and up to 25% of human cancers, including cutaneous basal cell carcinomas (BCCs). The goal of this proposal is to focus on gaps in our understanding of hedgehog signaling during regeneration and tumor formation in order to develop new therapeutic leads by determining the role of Polarity protein signaling in the hedgehog pathway, functionally dissecting the hedgehog paracrine signaling network, and by elucidating the novel mechanisms underlying invasive BCCs.   
      

","NIAMS","8317092","4/16/2012 12:00:00 AM","PA-10-067","2R01AR046786-11A1","2","R01","AR","046786","11","A","BAKER, CARL","7/1/2001 12:00:00 AM","3/31/2017 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-C(90)M]"," ","1873136","ORO, ANTHONY E","Not Applicable","18","DERMATOLOGY","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","5/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","134820"," ","359820",
"Contraception/Reproduction; Infant Mortality/ (LBW); Pediatric; Perinatal Period - Conditions Originating in Perinatal Period","1-Phosphatidylinositol 3-Kinase;Antigens;Blood Vessels;Cell Lineage;Cells;Cerebral Palsy;Derivation procedure;Development;Diagnostic;Disease;Dissection;Embryo;Ensure;Epithelial;Etiology;Event;Exhibits;Experimental Models;Extracellular Matrix;Fetal Development;Fetal Growth Retardation;Fetus;Growth Factor;Health;Hemochorial Placental Development;Human;Hypoxemia;Hypoxia;Hypoxia Inducible Factor;Hypoxia-Inducible Factor Pathway;In Vitro;Invaded;Investigation;Knowledge;Lead;MMP9 gene;Maternal-Fetal Exchange;Mesenchymal;Modification;Molecular;Nutrient;Oxygen;Pathway interactions;Physiological Processes;Placentation;Population;Pregnancy;Premature Birth;Primates;Process;Proto-Oncogene Proteins c-akt;Rattus;Regulation;Regulatory Pathway;Research;Rodent;Signal Pathway;Spiral Artery of the Endometrium;Stem cells;Therapeutic;Uterus;Vascular remodeling;base;fetus hypoxia;in vivo;in vivo Model;innovation;postnatal;trophoblast","Trophoblast Differentiation"," Disorders of hemochorial placentation are a significant human health issue. There is a paucity of knowledge regarding the regulation of trophoblast stem cells, their differentiation into invasive cells that effectively invade into the uterus and restructure uterine spiral arteries, and establish the maternal-fetal interface. Experimental dissection of fundamental mechanisms underlying the derivation of the invasive trophoblast lineage is a key to understanding the etiology of placentation-related diseases and a necessity for establishing appropriate and efficacious diagnostic and therapeutic strategies.   
      

","NICHD","8297456","7/13/2012 12:00:00 AM","PA-10-067","2R01HD020676-24","2","R01","HD","020676","24"," ","ILEKIS, JOHN V","7/1/1986 12:00:00 AM","4/30/2017 12:00:00 AM","Pregnancy and Neonatology Study Section[PN]"," ","1896310","SOARES, MICHAEL J","Not Applicable","03","PATHOLOGY","016060860","YXJGGNC5J269","016060860","YXJGGNC5J269","US","39.123452","-94.743946","1484303","UNIVERSITY OF KANSAS MEDICAL CENTER","KANSAS CITY","KS","SCHOOLS OF MEDICINE","661608500","UNITED STATES","N","7/16/2012 12:00:00 AM","4/30/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","255955","130537"," ","386492",
"Dental/Oral and Craniofacial Disease; Genetics","Affect;BMP2 gene;Binding;Biochemical;Biological Process;Categories;Cells;Cellular Membrane;Cleaved cell;Collagen;Collagen Type I;DSPP gene;Data;Defect;Dentin;Dentin Formation;Dentinogenesis;Dentinogenesis Imperfecta;Development;Disease;ENG gene;Event;Extracellular Matrix Proteins;Family;Gelatinase B;Gene Cluster;Genetic;Genetic Transcription;Goals;Hereditary Disease;Human;Inborn Genetic Diseases;Integrins;Knockout Mice;Knowledge;Lead;Length;Ligand Binding;Membrane;Mesenchymal;Molecular;Mutation;N-terminal;Natural regeneration;Nature;Odontoblasts;Osteoblasts;Osteogenesis;Pathogenesis;Pathway interactions;Pattern;Peptide Hydrolases;Play;Post-Translational Protein Processing;Process;Proteins;Proteolytic Processing;Regulation;Research;Research Personnel;Role;Series;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Site;Structure;Testing;Tooth Diseases;Tooth structure;Transcriptional Regulation;Work;base;biomineralization;bone;design;innovation;insight;member;novel;public health relevance;receptor;repaired;research study;transcription factor","DSPP signaling in dentinogenesis","
Dentin sialophosphoprotein (DSPP) protein is important for dentin formation as DSPP mutations
cause dentinogenesis imperfectas, the most common dentin genetic diseases. Here, we propose a
novel pathway for DSPP transcriptional regulation, proteolytic processing and signaling transduction
pathway for dentinogenesis. Thereafter, better understanding of the mechanisms of DSPP biological
functions will provide new avenues for repair and regeneration of teeth.","NIDCR","8268940","4/23/2012 12:00:00 AM","PA-07-070","5R01DE019802-04","5","R01","DE","019802","04"," ","SCHOLNICK, STEVEN","5/18/2009 12:00:00 AM","4/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-K(09)S]"," ","1868973","CHEN, SHUO ","Not Applicable","21","DENTISTRY","800772162","C3KXNLTAAY98","800772162","C3KXNLTAAY98","US","29.513082","-98.577731","578418","UNIVERSITY OF TEXAS HLTH SCIENCE CENTER","SAN ANTONIO","TX","SCHOOLS OF DENTISTRY/ORAL HYGN","782293901","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","196020","95070"," ","291090",
"Cancer; Colo-Rectal Cancer; Digestive Diseases; Genetics; Hematology; Rare Diseases","Acute Myelocytic Leukemia;Acute leukemia;Address;Affect;BCL6 gene;Binding Sites;Biological;Biological Assay;Biology;Cell Cycle;Cell Proliferation;Cells;Chromosomal translocation;Chromosomes, Human, Pair 8;Colorectal Cancer;DNA Binding Domain;DNA Damage;DNA Double Strand Break;DNA biosynthesis;DNA-Binding Proteins;Defect;Development;Embryo;Epithelial Cells;Erythroid;Family;Family member;Fibroblasts;Gene Family;Genes;Genome Stability;HDAC3 gene;Histones;Human;In Vitro;Intestines;Knockout Mice;Large Intestine Carcinoma;Malignant Neoplasms;Mediating;Mesenchymal;Mitosis;Mus;Mutation;Myelogenous;Oncogenes;Physiological;Play;Point Mutation;RUNX1 gene;Recruitment Activity;Role;Stem cells;TAL1 gene;TCF7L2 gene;Tissues;Work;ZNF145 gene;defined contribution;experience;genome sequencing;in vivo;leukemia;member;mouse model;progenitor;protein protein interaction;public health relevance;recombinase;t(8;21)(q22;q22);tumor","The role of MTG8 in genomic stability and colorectal cancer development","
Project narrative
The project entitled ""The role of MTG8 in genomic stability and colorectal cancer
development"" addresses the effect of MTG8 mutations on colorectal cancer (CRC).
Information from this project will help to further explain the biology of CRC and, more
importantly, describe new targets for CRC-related therapies.","NCI","8267244","4/19/2012 12:00:00 AM","PA-09-210","5F32CA150620-02","5","F32","CA","150620","02"," ","JAKOWLEW, SONIA B","11/16/2010 12:00:00 AM","4/13/2012 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-A(20)L]"," ","10120665","DEBUSK, LAURA ","Not Applicable","05","BIOCHEMISTRY","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","11/16/2011 12:00:00 AM","4/13/2012 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","23001"," "," ","23001",
"Bioengineering; Infant Mortality/ (LBW); Lung; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal Period - Conditions Originating in Perinatal Period","Adult;Alveolar;Area;Biology;Breathing;Bronchopulmonary Dysplasia;Cell Differentiation process;Cell Maturation;Cells;Cleaved cell;Clinical;Conditioned Culture Media;Development;Differentiation and Growth;Epidermal Growth Factor Receptor;Epithelial;Epithelial Cells;Extremely Low Birth Weight Infant;Fetal Lung;Goals;Growth;Growth Factor;In Vitro;Integrins;Investigation;Knockout Mice;Ligand Binding Domain;Ligands;Ligation;Liquid substance;Lung;Mechanical Stimulation;Mechanical ventilation;Mechanics;Mediating;Membrane;Mesenchymal;Modeling;Modification;Morphogenesis;Movement;Pathway interactions;Peptide Hydrolases;Phenotype;Physiological;Play;Pneumonectomy;Process;Protein Kinase;Pulmonary Surfactants;Rattus;Regulatory Pathway;Role;Signal Transduction;Signaling Protein;Simulate;Source;Stretching;Techniques;Transgenic Mice;Type II Epithelial Receptor Cell;airway remodeling;autocrine;base;extracellular;fetal;in utero;lung development;lung injury;lung maturation;neutralizing antibody;novel strategies;postnatal;pressure;receptor;research study;response","Mechanotransduction and Lung Alveolar Differentiation","n/a","NICHD","8269618","4/21/2012 12:00:00 AM","PA-07-070","5R01HD052670-05","5","R01","HD","052670","05"," ","RAJU, TONSE N","5/1/2008 12:00:00 AM","4/30/2014 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","7854103","SANCHEZ-ESTEBAN, JUAN R","Not Applicable","02","Unavailable","069851913","VUYJL5Q7YCZ3","069851913","VUYJL5Q7YCZ3","US","41.809902","-71.414278","6695601","WOMEN AND INFANTS HOSPITAL-RHODE ISLAND","PROVIDENCE","RI","Independent Hospitals","029052499","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","161568","78199"," ","239767",
"Bioengineering; Biotechnology; Breast Cancer; Cancer; Estrogen; Nanotechnology","Address;African American;Antibodies;Aromatase Inhibitors;Binding;Biodistribution;Breast Cancer Cell;Breast Cancer Treatment;CC chemokine receptor 4;CXC Chemokines;Cancer Patient;Cancer cell line;Cell surface;Chemical Engineering;Chemotaxis;Clinical Trials;Complement;Diagnosis;E-Cadherin;Endothelial Cells;Engineering;Estrogen Antagonists;Estrogen Receptors;Fibronectins;G-Protein-Coupled Receptors;Gel;Growth;Homing;Hormones;Human;In Vitro;Knowledge;Lipids;Liposomes;Lymphocyte;Malignant Neoplasms;Malignant neoplasm of lung;Methods;Molecular;Monitor;Nanotechnology;Neoplasm Metastasis;Phase;Population;RNA;Relative (related person);Roche brand of trastuzumab;Science;Surface;Survival Rate;Technology;Therapeutic;Vimentin;Woman;Work;abstracting;antibody conjugate;base;cell motility;cell type;chemokine;chemokine receptor;chromophore;cytokine;density;design;epithelial to mesenchymal transition;experience;global health;in vivo;malignant breast neoplasm;public health relevance;receptor;therapeutic target;tumor;tumor progression","Personalized therapeutics for inhibiting breast cancer metastasis","n/a","NCI","8355141","9/20/2012 12:00:00 AM","RFA-RM-11-005","1DP2CA174495-01","1","DP2","CA","174495","01"," ","WOODHOUSE, ELIZABETH","9/20/2012 12:00:00 AM","3/13/2017 12:00:00 AM","ZGM1-NDIA-C(01)X"," ","8703876","AUGUSTE, DEBRA ","Not Applicable","10","ENGINEERING (ALL TYPES)","603503991","L952KGDMSLV5","603503991","L952KGDMSLV5","US","40.818677","-73.950702","1605017","CITY COLLEGE OF NEW YORK","NEW YORK","NY","BIOMED ENGR/COL ENGR/ENGR STA","100367207","UNITED STATES","N","9/20/2012 12:00:00 AM","3/13/2017 12:00:00 AM","310","Non-SBIR/STTR","2012"," "," ","OD","1270559","654854"," ","1925413",
"Breast Cancer; Cancer; Ovarian Cancer; Rare Diseases","Agonist;Antibodies;Apoptosis;Biochemical Genetics;Breast;Breast Cancer Cell;Cancer Patient;Cancer cell line;Cell Death;Cell Death Induction;Cells;Cessation of life;Data;Death Receptor 5;ERBB2 gene;Epigenetic Process;Fenretinide;Genetic;Hormone Receptor;Induction of Apoptosis;Ligands;Malignant neoplasm of ovary;Mediating;Mesenchymal;Molecular;Patients;Protein Binding;Resistance;Retinoids;TNFRSF10A gene;TNFRSF10B gene;TNFSF10 gene;Treatment Efficacy;Tumor Necrosis Factor Receptor;Tumor Necrosis Factor-alpha;Work;base;cancer cell;chemotherapeutic agent;chemotherapy;clinically relevant;death receptor-4;functional genomics;human TNFRSF10A protein;killings;malignant breast neoplasm;member;outcome forecast;pre-clinical;receptor;triple-negative invasive breast carcinoma","TRAIL-induced Cell Death in Breast Cancer Cells","n/a","NCI","8554024"," "," ","1ZIASC007263-20","1","ZIA","SC","007263","20"," "," "," "," "," "," ","14821366","LIPKOWITZ, STANLEY ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF CLINICAL SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","238803",
"No NIH Category available","Actins;Address;Adherens Junction;Adhesions;Adhesives;Affinity;Amino Acid Motifs;Animal Experiments;Atopic Dermatitis;Cadherins;Cell-Cell Adhesion;Cells;Clinical Research;Complex;Cytoskeleton;Data;Development;Diffusion;Dimerization;Disease;Embryonic Development;Endocytosis;Epidermis;Epithelial Cells;Equilibrium;Evaluation;Event;Excision;Grant;Human;Immobilization;Individual;Infiltration;Inflammatory;Intercellular Junctions;Intervention;Lateral;Life;Lymphocyte;Mediating;Medicine;Membrane;Modeling;Molecular;Morphogenesis;Neoplasm Metastasis;Pathologic Processes;Pathology;Pathway interactions;Process;Psoriasis;Reagent;Regulation;Research;Role;Signal Transduction;Skin;Stratification;Stress;Structure;Tail;Time;Vertebrates;Work;Wound Healing;Xenopus;adhesion receptor;base;carcinogenesis;cell motility;design;dimer;epithelial to mesenchymal transition;flexibility;human tissue;in vivo;intercellular communication;keratinocyte;migration;public health relevance;research study;residence;retinal rods;skin disorder;xenopus development","Intercadherin Interactions in Epithelial Cells","
Our preliminary studies show that two processes-cadherin dimer assembly and
disassembly- control the strength and plasticity of intercellular contacts. Experiments
designed in this proposal will uncover detailed mechanisms of these two crucial
processes. The completion of this research will allow us to design animal experiments
and clinical studies aimed at understanding the role of cadherin adhesion in wound
healing and pathological morphogenesis, such as lymphocyte epidermal infiltration. The
work will make a significant impact in other fields, because cadherin adhesion is a basic
process that organizes virtually all human tissues. The study is also a critical step toward
the development of synthetic adhesion modulators and their application in medicine.","NIAMS","8310147","8/3/2012 12:00:00 AM","PA-10-067","5R01AR044016-17","5","R01","AR","044016","17"," ","BAKER, CARL","9/20/1996 12:00:00 AM","8/31/2015 12:00:00 AM","Arthritis, Connective Tissue and Skin Study Section[ACTS]"," ","1877714","TROYANOVSKY, SERGEY M","Not Applicable","07","DERMATOLOGY","005436803","KG76WYENL5K1","005436803","KG76WYENL5K1","US","41.896017","-87.616602","6144650","NORTHWESTERN UNIVERSITY AT CHICAGO","CHICAGO","IL","SCHOOLS OF MEDICINE","606114579","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","242078","127091"," ","369169",
"Kidney Disease","1-Phosphatidylinositol 3-Kinase;AXIN2 protein;Adaptor Signaling Protein;Address;Affect;Animal Model;Apoptosis;Binding;Cell Line;Cell Nucleus;Cells;Chronic;Cicatrix;Clathrin;Complex;Data;Disabled Persons;Down-Regulation;Early Endosome;End stage renal failure;Endocytosis;Epithelial;Epithelial Cells;Equilibrium;Event;Experimental Models;Exposure to;Extracellular Matrix;Fibrosis;Goals;Health;Human;In Vitro;Kidney;Kidney Diseases;Laboratories;Learning;Location;Mediating;Mediator of activation protein;Mesenchymal;Organ;Outcome;Pathway interactions;Phenotype;Play;Prevention;Production;Proteins;Receptor Activation;Receptor Signaling;Regulation;Reporting;Role;Scaffolding Protein;Signal Transduction;Signaling Molecule;Smad Proteins;Smad protein;Transcriptional Regulation;Transforming Growth Factor beta;Transforming Growth Factors;Tubular formation;Work;base;complex R;cytokine;design;fibrogenesis;glomerulosclerosis;in vitro Model;in vivo Model;interest;kidney cell;kidney epithelial cell;mesangial cell;novel;prevent;protein transport;receptor;renal scarring;response;trafficking","Adaptor Molecules in TGF-beta Signaling","n/a","NIDDK","8247833","3/30/2012 12:00:00 AM","PA-07-070","5R01DK075663-05","5","R01","DK","075663","05"," ","KETCHUM, CHRISTIAN J","4/1/2008 12:00:00 AM","3/31/2013 12:00:00 AM","Pathobiology of Kidney Disease Study Section[PBKD]"," ","7724472","SCHNAPER, H WILLIAM","Not Applicable","07","PEDIATRICS","005436803","KG76WYENL5K1","005436803","KG76WYENL5K1","US","41.896017","-87.616602","6144650","NORTHWESTERN UNIVERSITY AT CHICAGO","CHICAGO","IL","SCHOOLS OF MEDICINE","606114579","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205857","75617"," ","281474",
"Kidney Disease","Adult;Amino Acids;Apoptosis;Architecture;BMP2 gene;BMP4;BMP7 gene;Binding;Biochemical;Biological Assay;Bone Morphogenetic Proteins;Cell Culture Techniques;Cell Polarity;Cell Proliferation;Cells;Co-Immunoprecipitations;Communication;Complex;Data;Defect;Embryo;Ensure;Epithelial Cells;Epithelium;Family member;Funding;GDNF gene;Genes;Growth;Heterozygote;Human;Hypertension;In Vitro;Individual;Kidney;Kidney Failure;Knock-out;Ligand Binding;Ligands;MAPK14 gene;Mesenchymal;Mesenchyme;Metanephric Diverticulum;Metanephric structure;Molecular;Morphogenesis;Mus;Mutation;Names;Play;Process;Proteins;Regulation;Renal function;Role;Signal Transduction;Signaling Molecule;Tight Junctions;Transfection;Tubular formation;Wild Type Mouse;bone;bone morphogenetic protein receptor type II;kidney epithelial cell;nephrogenesis;overexpression;public health relevance;receptor;research study","Regulation of BMP signaling in kidney","
PROJECT NARRATIVE
 Reductions in branching morphogenesis and nephrogenesis (renal hypodysplasia)
result in abnormal renal architecture and in renal failure and adult-onset hypertension.
The cellular and molecular processes involved are poorly understood, but abundant
evidence suggests that bone morphogenetic (BMP) signaling is critically involved. We
will study the role of the BMP co-receptor Dragon in BMP signaling in kidney
development and function.","NIDDK","8329654","8/24/2012 12:00:00 AM","PA-10-067","5R01DK069533-08","5","R01","DK","069533","08"," ","HOSHIZAKI, DEBORAH K","3/1/2005 12:00:00 AM","7/31/2015 12:00:00 AM","Urologic and Kidney Development and Genitourinary Diseases Study Section[UKGD]"," ","1925053","LIN, HERBERT Y","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","155013"," ","360438",
"Dental/Oral and Craniofacial Disease; Genetics; Pediatric","Ablation;Abscess;Alopecia;Binding;Binding Sites;Biology;Branchial arch structure;Cells;Cessation of life;ChIP-seq;Characteristics;DNA Binding;DSPP gene;Defect;Dental Enamel;Dentin;Dentin Formation;Development;Developmental Process;Disease;Distal;Ectoderm;Ectodermal Dysplasia;Embryo;Embryonic Development;Epidermis;Epithelial;Epithelial Cells;Failure;Family;Gene Expression;Gene Targeting;Genes;Genetic Transcription;Goals;Hair;Hair follicle structure;Hair shaft structure;Homeobox;Homeodomain Proteins;Human;Impairment;Individual;Infection;Knock-in Mouse;Laboratories;LacZ Genes;Lead;Lesion;Link;Mesenchymal;Molecular;Morphogenesis;Mus;Mutant Strains Mice;Mutation;Neural Crest;Odontoblasts;Organ;Osteoblasts;Osteogenesis;Pathogenesis;Pathway interactions;Patients;Pattern;Placenta;Placentation;Plant Roots;Play;Positioning Attribute;Process;Production;Proteins;Pulp Chambers;Regulation;Regulatory Pathway;Reporter Genes;Reporting;Research;Role;Series;Signal Transduction;Skeletal Development;Skin;Staining method;Stains;Stratification;Structure;Syndrome;Tissues;Tooth structure;Transcription Coactivator;Transcriptional Regulation;Work;appendage;beta-Galactosidase;bone;craniofacial;early onset;homeodomain;in vivo;loss of function;member;mouse model;osteogenic;programs;promoter;transcription factor;tricho-dento-osseous syndrome","Ectodermal Dysplasias and Regulation of Ectodermal Appendage Development","n/a","NIAMS","8559308"," "," ","1ZIAAR041171-05","1","ZIA","AR","041171","05"," "," "," "," "," "," ","9691698","MORASSO, MARIA ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIAMS"," "," "," ","930237",
"Brain Cancer; Brain Disorders; Cancer; Genetics; Neurosciences; Rare Diseases","Adult;Anaplastic astrocytoma;Astrocytes;Astrocytoma;Clinic;Clinical;Clinical Data;Development;Disease;Engineering;Epidermal Growth Factor Receptor;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Erlotinib;Etiology;Event;Family member;Fluorescent in Situ Hybridization;Future;Gene Expression Profile;Genes;Genetically Engineered Mouse;Glioblastoma;Goals;Heterogeneity;Human;Immunohistochemistry;In Vitro;Malignant - descriptor;Malignant Neoplasms;Mesenchymal;Missense Mutation;Modeling;Molecular;Morphology;Mus;Mutate;Mutation;PTEN gene;Pathway Analysis;Pathway interactions;Patients;Play;Primary Brain Neoplasms;Process;Property;Proteins;Receptor Inhibition;Receptor Protein-Tyrosine Kinases;Relative (related person);Research;Resistance;Retinoblastoma Protein;Role;Signal Transduction;System;Tumor Cell Line;Tumor Suppression;Work;Yang;Yin;effective therapy;in vivo;inhibitor/antagonist;insight;mortality;mouse model;new therapeutic target;outcome forecast;overexpression;tumor;tumor progression;tumorigenesis","The study of underlying mechanism of EGFR-Ras signaling in glioblastoma","n/a","NCI","8552936"," "," ","1ZIABC011017-05","1","ZIA","BC","011017","05"," "," "," "," "," "," ","10274544","VAN DYKE, TERRY ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","652207",
"No NIH Category available","Ablation;Age;Aging;American;Anabolic Agents;Attenuated;Birth;Bone Marrow;Bone Resorption;Calvaria;Childhood;Degenerative Disorder;Development;Disease;Elderly;Embryo;Employee Strikes;Fracture;Grant;Harvest;Heterotrimeric GTP-Binding Proteins;Hip Fractures;Homeostasis;Hormones;Image;Limb structure;Longevity;Malignant Neoplasms;Mediating;Mediator of activation protein;Mesenchymal;Molecular;Mus;Osteoblasts;Osteogenesis;Osteopenia;Osteoporosis;Parathyroid Hormone Receptor;Parathyroid gland;Pathway interactions;Patients;Population;Process;Recombinants;Recovery;Relative (related person);Role;Signal Pathway;Signal Transduction;Skeletal Development;Stromal Cells;Teriparatide;Testing;Up-Regulation;Work;bone mass;cost;human PTH protein;inhibitor/antagonist;insight;mortality;novel;osteoblast differentiation;osteogenic;osteoporosis with pathological fracture;osteoprogenitor cell;postnatal;progenitor;public health relevance;skeletal","Sclerostin and Gsalpha signaling in osteoblasts","
Project Narrative
Osteoporosis is a common degenerative disease of aging, and treatments available to cure this debilitating
disease are lacking. Parathyroid hormone and the Wnt signaling pathway both act to control bone formation.
This proposal seeks to understand how these two pathways interact at the molecular level, as greater insights
into the processes by which bone mass is increased may ultimately result in novel therapies for osteoporosis.","NIAMS","8538220","1/9/2013 12:00:00 AM","PAR-09-031","7R03AR059942-04","7","R03","AR","059942","04"," ","CHEN, FAYE H","8/1/2010 12:00:00 AM","6/30/2014 12:00:00 AM","ZAR1-MLB-G(M1)"," ","1900877","WU, JOY Y","Not Applicable","18","INTERNAL MEDICINE/MEDICINE","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","1/10/2013 12:00:00 AM","6/30/2014 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","41160","23461"," ","64621",
"Cancer; Neurosciences; Pediatric; Rare Diseases","Biochemical;Biological;Biological Assay;Cartilage;Cell Communication;Cell Polarity;Cell Proliferation;Cells;Congenital Abnormality;Craniosynostosis;Development;Developmental Process;Disease;Dorsal;Ectoderm;Ectoderm Cell;Embryo;Epithelial;Face;Gene Expression;Genes;Goals;Human;Lead;Ligands;Link;Location;Malignant Neoplasms;Mass Spectrum Analysis;Mediating;Mesenchymal;Mesoderm;Molecular;Morphogenesis;Myosin Type II;Nervous system structure;Neural Crest;Neural Crest Cell;Neuroblastoma;Neuroectoderm;Pathway interactions;Pattern;Peripheral Nervous System;Play;Population;Positioning Attribute;Process;Proteins;Regulation;Research;Role;Signal Pathway;Signal Transduction;Staging;Stem cells;Syndrome;System;Testing;To specify;Transcriptional Regulation;Wnt proteins;Xenopus;base;cell fate specification;cell motility;cell type;cellular targeting;craniofacial;gene function;human JTB protein;human disease;in vivo;insight;loss of function;melanocyte;melanoma;neural plate;neurodevelopment;non-muscle myosin;novel;progenitor;prospective;receptor;research study;response;rho GTP-Binding Proteins;stem cell biology;stem cell population;tumorigenesis","Patterning of the Vertebrate Nervous System"," This application concerns molecular mechanisms leading to the development of neural crest cells. Since neural crest abnormalities are known to lead to craniosynostosis, Waardenburg and Hirschsprung's syndromes, and cancer, the proposed studies are highly relevant to human diseases associated with stem cell disorders and tumorigenesis.  
    

","NINDS","8238037","12/6/2011 12:00:00 AM","PA-10-067","2R01NS040972-11A1","2","R01","NS","040972","11","A","MORRIS, JILL A","2/1/2001 12:00:00 AM","2/29/2016 12:00:00 AM","Development - 1 Study Section[DEV1]"," ","1896269","SOKOL, SERGEI ","Not Applicable","13","ANATOMY/CELL BIOLOGY","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","SCHOOLS OF MEDICINE","100296574","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","224040","155708"," ","379748",
"Breast Cancer; Cancer","Address;Animal Model;Architecture;Basement membrane;Biological;Breast Cancer Cell;Breast Carcinoma;Cancer Patient;Cell Line;Cells;Cessation of life;Characteristics;Conditioned Culture Media;Connective Tissue;Cytoskeleton;Development;Distant;Distant Metastasis;Duct (organ) structure;Epithelium;Event;Fibroblasts;Goals;Growth;Human;Image;In Situ Lesion;Individual;Invaded;Lesion;Life;Lobule;Malignant Epithelial Cell;Mammary Ductal Carcinoma;Mammary Neoplasms;Mammary gland;MicroRNAs;Modeling;Molecular;Neoplasm Metastasis;Noninfiltrating Intraductal Carcinoma;Paracrine Communication;Pathology;Patients;Population;Resolution;Risk;Role;Sampling;Signal Pathway;Site;Staging;Stromal Cells;System;Therapeutic Intervention;Time;Tumor Cell Invasion;Tumor Pathology;Xenograft Model;cancer cell;cell behavior;cell motility;cellular imaging;clinically significant;epithelial to mesenchymal transition;genetic regulatory protein;in vivo;intercalation;loss of function;malignant breast neoplasm;neoplastic;neoplastic cell;public health relevance;transcription factor;tumor;tumor progression","Investigating Breast Cancer Collective Invasion","
Public Health Relevance
Distant metastases are responsible for nearly all breast cancer patient deaths. A critical step
leading to the development of metastases is the invasion of tumor cells into connective tissue.
We will investigate how tumor cells become invasive with the goals of more accurately
identifying which patients are at risk of developing metastases and identifying targets of
therapeutic intervention.","NCI","8230595","3/16/2012 12:00:00 AM","PA-10-067","5R01CA155241-02","5","R01","CA","155241","02"," ","WOODHOUSE, ELIZABETH","3/1/2011 12:00:00 AM","2/28/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","6156150","PEARSON, GRAY W","Not Applicable","30","PHARMACOLOGY","800771545","YZJ6DKPM4W63","800771545","YZJ6DKPM4W63","US","32.814772","-96.841146","578404","UT SOUTHWESTERN MEDICAL CENTER","DALLAS","TX","SCHOOLS OF MEDICINE","753909105","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","121907"," ","329407",
"Breast Cancer; Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adult;Apoptosis;Architecture;Binding;Biochemical;Biological Process;Bioluminescence;Blood Vessels;Bone Marrow;Bone Marrow Stem Cell;Breast Cancer Cell;Cancer cell line;Cells;Clinical;Cytology;Disseminated Malignant Neoplasm;Dissociation;Distant;Endothelial Cells;Engraftment;Excision;Extravasation;Foundations;Future;Gatekeeping;Genetic;Genetic Models;Growth;Histology;Homing;Image;Immune response;In Vitro;Indium;Invaded;Kidney;Kinetics;Liver;Location;Lung;Malignant Neoplasms;Malignant neoplasm of lung;Melanoma Cell;Mesenchymal Stem Cells;Metastatic Neoplasm to the Bone;Metastatic Neoplasm to the Liver;Modeling;Molecular;Molecular Biology;Molecular Mechanisms of Action;Mus;Neoplasm Metastasis;Organ;Osteolysis;Outcome;Pathway interactions;Patients;Pericytes;Physiological;Platelet-Derived Growth Factor;Primary Neoplasm;Property;Prostate;Quality of life;Recruitment Activity;Regulation;Research;Research Design;Research Proposals;Role;Scheme;Serum Markers;Signal Transduction;Skeleton;Specificity;Stromal Cells;Survival Rate;Testing;Therapeutic;Time;Tissues;Tyrosine Kinase Inhibitor;Work;adult stem cell;angiogenesis;base;bone;bone invasion;cancer cell;cancer therapy;circulating cancer cell;clinically relevant;improved;in vitro Assay;in vivo;in vivo Model;malignant breast neoplasm;melanoma;mortality;new therapeutic target;novel;novel therapeutics;prevent;prognostic indicator;skeletal;success;therapy design;tool;tumor;tumor growth","Bone Marrow MSCs/Pericytes: Gatekeepers Controlling Skeletal Metastasis."," The skeleton is one of the preferred organs for cancer dissemination and engraftment in various malignancies, negatively impacting patients' quality of life, therapeutic success and, thus, survival rates. We propose to understand the mechanism(s) behind the establishment of melanoma and breast cancer skeletal metastasis, based on a novel hypothesis which suggests that local adult stem cells in the bone marrow (BM- MSC), acting as pericytes, function as gatekeepers controlling cancer cell invasion to the bone, and preliminary results indicating a differential effect of those cells during intravasation (at the primary tumor)
and extravasation (at the target organ). This new hypothesis provides clinically relevant information for therapeutic strategies that innovately aim at reducing the metastasis engraftment by closing the gate through which the metastatic cancer cell transit into the normal bone, thus improving the devastating outcomes.   
      

","NCI","8373325","8/22/2012 12:00:00 AM","PA-10-067","1R01CA163562-01A1","1","R01","CA","163562","01","A","WOODHOUSE, ELIZABETH","8/22/2012 12:00:00 AM","6/30/2017 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","8291205","CAPLAN, ARNOLD IRWIN","Not Applicable","11","BIOLOGY","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","SCHOOLS OF ARTS AND SCIENCES","441061712","UNITED STATES","N","8/22/2012 12:00:00 AM","6/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","107867"," ","315367",
"Anorexia; Clinical Research; Clinical Trials; Diagnostic Radiology; Eating Disorders; Estrogen; Mental Health; Nutrition; Osteoporosis; Pediatric","Adipocytes;Adolescence;Adolescent;Adrenal Glands;Adrenal hormone preparation;Adult;Affect;Age;Anorexia Nervosa;Body Composition;Bone Density;Bone Marrow;Bone Resorption;C-telopeptide;Caring;Clinical;Clinical Trials;Data;Dehydroepiandrosterone Sulfate;Development;Dimensions;Disease;Disease Progression;Elderly;Estradiol;Estrogen Replacement Therapy;Exhibits;Fatty acid glycerol esters;Female Adolescents;Fracture;Functional disorder;Goals;Gonadal Hormones;Gonadal Steroid Hormones;Health;Height;Hematopoietic;Hormonal;Hydrocortisone;Image;Imaging Techniques;Insulin-Like Growth Factor I;Knowledge;Lead;Leptin;Life;Limb structure;Magnetic Resonance Imaging;Magnetic Resonance Spectroscopy;Maintenance;Marrow;Measurement;Measures;Mediating;Mediator of activation protein;Mesenchymal Stem Cells;Modeling;Osteoblasts;Osteogenesis;Osteoporosis;Participant;Patient Care;Patients;Peripheral;Placebos;Radial;Randomized;Randomized Controlled Trials;Red Marrow;Regimen;Research;Research Personnel;Risk;Role;Skeleton;Somatomedins;Somatotropin;Testing;Testosterone;Therapeutic;Vertebral column;Visual;Weight;X-Ray Computed Tomography;Yellow Marrow;adiponectin;adverse outcome;bone;bone health;bone loss;bone mass;bone strength;bone turnover;clinical care;critical period;dehydroepiandrosterone;double-blind placebo controlled trial;emerging adult;ghrelin;girls;improved;interest;novel;patient population;prevent;response;restoration;skeletal;subcutaneous;tibia;young woman","Effect of Adrenal and Gonadal Hormones on Bone Marrow and Appendicular BMD"," This project seeks to understand the mechanisms behind a promising new therapy, a combined regimen of dehydroepiandrosterone + estrogen replacement therapy, for adolescents with anorexia nervosa, through a randomized controlled trial. The proposal will explore effects of this combined regimen on both bone density of the peripheral skeleton and bone marrow composition, and will examine how hormonal factors mediate skeletal losses and alter marrow composition in this disease. Enhancing understanding of the mechanisms underlying skeletal losses in this young patient population will fill critical knowledge gaps that will potentially improve the care of adolescents with anorexia nervosa.  
  
    

","NIAMS","8509337","8/21/2012 12:00:00 AM","PA-10-067","7R01AR060829-03","7","R01","AR","060829","03"," ","CHEN, FAYE H","8/1/2011 12:00:00 AM","5/31/2015 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1935212","GORDON, CATHERINE M.","Not Applicable","01","Unavailable","075710996","N876TLXYGCG4","075710996","N876TLXYGCG4","US","41.820682","-71.412855","6959701","RHODE ISLAND HOSPITAL","PROVIDENCE","RI","Independent Hospitals","029034923","UNITED STATES","N","8/23/2012 12:00:00 AM","5/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","200000","96048"," ","296048",
"Bioengineering; Lung; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","3-Dimensional;Activins;Adult;Air;Alveolar;Autologous;Biology;Biomedical Engineering;Biomimetics;Bioreactors;Blood Vessels;Bone Marrow;Cell-Matrix Junction;Cells;Characteristics;Chronic;Clinic;Clinical Research;Coculture Techniques;Cues;Development;Edema;Endothelial Cells;Epithelial;Epithelial Cells;Evaluation;Extracellular Matrix;Family suidae;Fetal Lung;Fibroblast Growth Factor 2;Gases;Gel;Goals;Growth;Head;Heart;Hemorrhage;Human;Immunosuppression;Implant;Liquid substance;Lung;Lung Transplantation;Mechanics;Mesenchymal;Organ;Organ Donor;Patients;Pattern;Pericytes;Physiological;Physiology;Property;Proteins;Rattus;Research Personnel;Source;Staging;Stem cells;Stretching;Stromal Cells;Structure;Structure of parenchyma of lung;Support System;Thoracic Surgical Procedures;Trachea;Transplantation;Vascularization;abstracting;embryonic stem cell;fetal;fibroblast growth factor 10;human adult stem cell;induced pluripotent stem cell;interest;lung development;lung repair;mortality;progenitor;scaffold","Overcoming Barriers to Bioengineering 3-D Human Lung","
Project Narrative
Lung transplantation is usually the only option for patients with irreversible structural lung damage but is
hindered by two major obstacles - a lack of lung organ donors and chronic rejection after transplanatation. We
will focus on rebuilding 3-D human lungs using ventilated, decellularized (i.e. all cells are removed) whole pig
lungs as a natural 3-D matrix framework that is very similar to human lung matrix in structure and function. We
will repopulate it with human adult stem cells having the potential to grow into lung tissue and produce proteins
characteristic of healthy lung cells.","NHLBI","8527105","9/7/2012 12:00:00 AM","RFA-HL-11-025","3R01HL108627-02S1","3","R01","HL","108627","02","S","BLAISDELL, CAROL J","9/5/2011 12:00:00 AM","5/31/2013 12:00:00 AM","ZHL1-CSR-N(M1)"," ","8266063","PANOSKALTSIS-MORTARI, ANGELA ","TAYLOR, DORIS A","05","PEDIATRICS","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","SCHOOLS OF MEDICINE","554552070","UNITED STATES","N","9/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","31948","16613"," ","48561",
"Genetics; Pediatric; Urologic Diseases","Address;Androgens;Applications Grants;Area;Attention;Back;Characteristics;Congenital Abnormality;Congenital Heart Defects;Data;Defect;Development;Disease;Embryo;Embryonic Development;Endocrine Disruptors;Epithelial;Epithelium;Etiology;Event;Exposure to;FGF8 gene;Fetal Diseases;Frequencies;Gene Expression Regulation;Genetic;Genital system;Goals;Growth Factor;Health;Hormonal;Human;Hypospadias;Incidence;Knock-out;Knockout Mice;Mammals;Masculine;Mediating;Mesenchymal;Molecular;Molecular Genetics;Morphogenesis;Mus;Mutant Strains Mice;Organ;Pathway interactions;Pattern;Perinatal Exposure;Phase;Phenotype;Play;Process;Proteins;Regulation;Research Personnel;Role;Series;Sexual Development;Signal Pathway;Signal Transduction;System;Testing;Testis;Tissues;Urethra;base;external genitalia;human SMO protein;loss of function mutation;male;malformation;mutant;prepuce;reproductive;response","EXTERNAL GENITALIA DEVELOPMENT AND HYPOSPADIAS","
PROJECT NARRATIVE
This project proposes to study the function of two signaling pathways, Shh and Wnt, in both early
androgen-independent and late sexually dimorphic phases of external genitalia development.
Genital malformations including hypospadias occur at a very high rate but their etiology remains
largely unknown. Using several conditional knockout mice, this project will reveal the downstream
signaling events of these two important pathways and how they interact with each other and the
androgen signaling pathway to regulate genital morphogenesis and masculinization. Our studies
will contribute greatly to the understanding of external genitalia development and the etiology of
hypospadias.","NIEHS","8265869","2/29/2012 12:00:00 AM","PA-07-070","5R01ES016597-04","5","R01","ES","016597","04"," ","SCHUG, THADDEUS","5/1/2009 12:00:00 AM","2/28/2014 12:00:00 AM","Urologic and Kidney Development and Genitourinary Diseases Study Section[UKGD]"," ","1974052","MA, LIANG ","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","NIEHS","226402","76448"," ","302850",
"Genetics; Osteoporosis","Ablation;Acetylglucosamine;Adult;Affect;Alleles;Animal Model;Binding;Biological;Bone Development;Bone Diseases;Cell Differentiation process;Cell physiology;Cells;Chondrogenesis;Clinical;Data;Defect;Dependence;Development;Developmental Process;Diffusion;Disease;Dissection;Drug Delivery Systems;Embryo;Enzymes;Gene Mutation;Genes;Genetic;Glucuronic Acids;Goals;Growth Factor;Health;Heparin;Heparitin Sulfate;Hereditary Multiple Exostoses;Homeostasis;In Vitro;Knock-out;Knockout Mice;Lead;Life;Link;Maintenance;Masks;Mesenchymal;Metabolic;Minor;Modeling;Molecular;Molecular Profiling;Mus;Mutant Strains Mice;Orthopedics;Osteoblasts;Osteogenesis;Osteoporosis;Pathogenesis;Pathology;Patients;Pattern;Phenotype;Physical condensation;Physiological;Physiology;Play;Process;Proteins;Regulation;Right-On;Role;Signal Pathway;Signal Transduction;Skeletal Development;Skeletal system;Spatial Distribution;Specificity;Staging;Structure;System;Tamoxifen;Testing;Thromboembolism;Time;Tissues;Vascular Diseases;base;bone;bone cell;bone loss;bone mass;cell type;comparative;dosage;editorial;epimerase;human disease;improved;insight;morphogens;mutant;novel;novel therapeutics;osteoblast differentiation;research study;skeletal;skeletal disorder;skeletogenesis;sulfation","Heparan Sulfate in Skeletal Development and Diseases","n/a","NIAMS","8231467","4/4/2012 12:00:00 AM","PA-07-070","5R01AR055670-05","5","R01","AR","055670","05"," ","TYREE, BERNADETTE","7/7/2008 12:00:00 AM","3/31/2013 12:00:00 AM","Intercellular Interactions Study Section[ICI]"," ","1890939","YAMAGUCHI, YU ","Not Applicable","49","Unavailable","020520466","PHMKYKKJLQS1","020520466","PHMKYKKJLQS1","US","32.903503","-117.243803","1180101","SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE","LA JOLLA","CA","Research Institutes","920371005","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","209088","196543"," ","405631",
"Biotechnology; Dental/Oral and Craniofacial Disease; Genetics; Human Genome; Pediatric","Adolescent;Adult;Animal Model;Biological Models;Candidate Disease Gene;Chromosome Mapping;Chromosomes;Chromosomes, Human, Pair 21;Code;Competence;Complement;Congenital Abnormality;Dental;Development;Developmental Process;Diet;Dyes;Embryo;Engineering;Epithelial;Epithelium;Erinaceidae;Event;Exhibits;Family;Fishes;Fresh Water;Gasterosteidae;Gene Expression;Gene Expression Profile;Generations;Genes;Genetic;Genome;Goals;Health;Human;In Situ Hybridization;In Vitro;Induced Mutation;Knowledge;Label;Larva;Lead;Learning;Mammals;Maps;Marines;Mediating;Mesenchymal;Mesenchyme;Methods;Modeling;Molecular Genetics;Mus;Mutation;Partner in relationship;Pathway interactions;Pattern;Population;Prevention;Process;Quantitative Trait Loci;Regulation;Research;Rodent;Signal Pathway;Signal Transduction;Signaling Molecule;Staging;System;Testing;Time;Tissues;Tooth structure;Transgenic Organisms;Variant;Vertebrates;base;bone;bone morphogenetic protein 6;craniofacial;deciduous tooth;developmental genetics;genetic analysis;genetic variant;genome-wide linkage;insight;offspring;orofacial;public health relevance;research study;skeletal","Developmental genetics of tooth number variation in sticklebacks","
8. Project Narrative
PUBLIC HEALTH RELEVANCE: This research will provide fundamental knowledge of how genes control
tooth number. This knowledge will help efforts to engineer tooth formation in vitro. In addition, since changes
in tooth number are associated with common human craniofacial birth defects, this knowledge will lead to a
better understanding and prevention of human craniofacial and dental birth defects.","NIDCR","8233403","2/22/2012 12:00:00 AM","PA-10-067","5R01DE021475-02","5","R01","DE","021475","02"," ","SCHOLNICK, STEVEN","3/1/2011 12:00:00 AM","2/29/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-B(03)S]"," ","9983470","MILLER, CRAIG THOMAS","Not Applicable","13","BIOCHEMISTRY","124726725","GS3YEVSS12N6","124726725","GS3YEVSS12N6","US","37.870295","-122.268133","577502","UNIVERSITY OF CALIFORNIA BERKELEY","BERKELEY","CA","SCHOOLS OF ARTS AND SCIENCES","947101749","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","250000","133750"," ","383750",
"Aging; Breast Cancer; Cancer; Estrogen; Osteoporosis; Prevention","Anabolic Agents;Animals;Biological Models;Biology;Bone Resorption;Bone remodeling;Calcitonin;Data;Development;Disease;Dose;Endocrine;Estrogen Analogues;Estrogens;Exhibits;Fellowship;Fracture;Gene Expression;Generations;Goals;Innate Bone Remodeling;Knowledge;Laboratories;Lead;Literature;Malignant Neoplasms;Mesenchymal Differentiation;Molecular;Mus;Osteoblasts;Osteoclasts;Osteogenesis;Osteopenia;Osteoporosis;Osteoporosis prevention;Pharmaceutical Preparations;Postdoctoral Fellow;Raloxifene;Reporting;Research;Research Personnel;Risk;Selective Estrogen Receptor Modulators;Signal Transduction;Skeleton;Societies;Structure;Tamoxifen;Techniques;Testing;Therapeutic;Therapeutic Agents;Time;Training;bisphosphonate;bone;bone cell;bone health;bone loss;bone mass;bone metabolism;bone quality;bone turnover;cancer initiation;cancer therapy;career;career development;experience;in vivo;malignant breast neoplasm;mouse model;nanoindentation;novel;osteoblast differentiation;prevent;progenitor;response;skeletal;skills;spine bone structure;therapeutic development;tomography;tumor progression","Actions of Endoxifen on the Skeleton"," Osteoporosis and Breast Cancer are major burdens on society. Endoxifen is a newly identified as the primary active metabolite of Tamoxifen, one of the major therapeutic selective estrogen receptor modulators used in Breast Cancer therapy today. My preliminary studies have shown that Endoxifen is also a potent anabolic agent on the skeleton. Similar to Estrogen action on bone remodeling, my studies have indicated that Endoxifen maintains/enhances overall bone formation via enhanced remodeling. These studies have the potential to identify Endoxifen as a novel, highly beneficial, therapeutic agent for osteopenia, osteoporosis and other bone related disorders, as well as breast cancer therapy   
      

","NIAMS","8398792","7/6/2012 12:00:00 AM","PA-11-113","1F32AR063596-01","1","F32","AR","063596","01"," ","SHARROCK, WILLIAM J","7/18/2012 12:00:00 AM","7/17/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-F10B-S(20)L]"," ","10121923","GINGERY, ANNE ","Not Applicable","01","Unavailable","006471700","Y2K4F9RPRRG7","006471700","Y2K4F9RPRRG7","US","44.022374","-92.465881","4976101","MAYO CLINIC ROCHESTER","ROCHESTER","MN","Other Domestic Non-Profits","559050001","UNITED STATES","N","7/18/2012 12:00:00 AM","7/17/2013 12:00:00 AM","846","Training, Individual","2012"," "," ","NIAMS","55670"," "," ","55670",
"Bioengineering; Genetics","Algorithms;Apoptosis;Area;Behavior;Biochemical;Biochemistry;Biological;Biological Assay;Cell Cycle;Cell Line;Cell physiology;Cells;Chemistry;Clinical;Collection;Communities;Complex;Data;Data Analyses;Data Collection;Data Provenance;Data Quality;Data Set;Disease;Dose;Epithelial;Experimental Designs;Extensible Markup Language;Flow Cytometry;Genome;Genomics;Goals;Human;Image Cytometry;Immunoassay;Informatics;Institution;Instruction;Investigational Drugs;Kinetics;Knowledge;Libraries;Link;Logic;Malignant Neoplasms;Measures;Mesenchymal;Methods;Modeling;Molecular Profiling;Output;Pathway interactions;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;Phase;Phenotype;Physiology;Process;Proteins;Resolution;Series;Signal Pathway;Signal Transduction;Software Tools;Specificity;Stem cells;System;Tumor Cell Line;base;computer based Semantic Analysis;drug mechanism;flexibility;heuristics;information processing;inhibitor/antagonist;insight;kinase inhibitor;large scale production;large-scale database;mathematical model;medical schools;meetings;neoplastic cell;novel;open source;programs;response;senescence;small molecule;tool","Informatics and Integration","RELEVANCE (See instructions): 
Plans for an HMS-based LINCS Center are directly relevant to programmatic goals of assembling 
""mechanism-based associations among the effects of disparate biological perturbations"" and insight into the 
""mechanisms of action of known drugs."" Single -cell and biochemical data generated by the HMS LINCS 
Center will be different from and complementary to existing large scale data based on genomic assays and 
transcriptional profiles. The Center's focus on clinical-grade and novel kinase inhibitors will provide data with 
high translational potential for a class of compounds that currently dominates investigational new drugs for 
cancer.","NHGRI","8382376","8/1/2012 12:00:00 AM","RFA-RM-10-003","5U54HG006097-03","5","U54","HG","006097","03"," "," "," ","7/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-CB-P]","8019","8481190","STUART, JOSHUA MICHAEL","Not Applicable","07","Unavailable","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","Domestic Higher Education","021201616","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","704018","704018"," ","552560","151458"," "," ",
"Cancer; Genetics","Address;Adult;Affect;Alleles;Animals;Anterior;Apoptosis;Behavior;Biology;Bone Morphogenetic Proteins;Cell Death;Cells;Cellular biology;Collaborations;Colorectal Cancer;Data;Development;Digit structure;Disease;Distal;Down-Regulation;Effector Cell;Elements;Embryo;Embryonic Development;Excision;Experimental Genetics;Family;Fibroblast Growth Factor;Forelimb;Gastrointestinal Neoplasms;Gene Silencing;Genes;Genetic;Goals;Growth;Heart;Hindlimb;Internet;Knock-in Mouse;Lead;Learning;Ligands;Limb Bud;Limb Development;Limb structure;Link;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Mesenchymal;Mesenchyme;Metastatic Neoplasm to the Bone;Modeling;Molecular;Mus;Normal Cell;Osteogenesis;Pathway interactions;Pattern;Pelvic Girdle;Population;Positioning Attribute;Protein Family;Proteins;Role;Signal Pathway;Signal Transduction;Signaling Molecule;Skeleton;Structure;Surface Ectoderm;Testing;Work;beta catenin;bone morphogenetic protein receptors;cancer site;human DICER1 protein;insight;interest;malignant breast neoplasm;novel;progenitor;receptor;skeletal;tumor","Role of BMP and FGF signaling during limb development","n/a","NCI","8552721"," "," ","1ZIABC010518-10","1","ZIA","BC","010518","10"," "," "," "," "," "," ","8123123","LEWANDOSKI, MARK B","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","464718",
"Digestive Diseases; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adult;African;Apoptosis;Basal lamina;Binding;Biological Metamorphosis;Caco-2 Cells;Cell Culture Techniques;Cell Differentiation process;Cells;Cessation of life;Characteristics;Complement;Connective Tissue;Development;Epithelial Cells;Epithelium;Erinaceidae;Event;Extracellular Matrix;Food Processing;Gene Expression Regulation;Genes;Genetic Transcription;Goals;Human Cell Line;Intestines;Introns;Knock-out;Life;Mesenchymal;Molecular;Mus;Muscle;Nutrient;Organ;Organ Culture Techniques;Pathway interactions;Physiological;Play;Primary Cell Cultures;Process;Proliferating;Protein Synthesis Inhibitors;Protein-Arginine N-Methyltransferase;Proto-Oncogene Proteins c-myc;Rana;Regulation;Role;Series;Signal Pathway;Site;Stem Cell Development;Stem cells;Structure;Tadpoles;Tail;Thyroid Hormone Receptor;Thyroid Hormones;Tissues;Up-Regulation;Vertebrates;Xenopus;Xenopus Proteins;Xenopus laevis;Zebrafish;absorption;adult stem cell;c-myc Genes;human SMO protein;intestinal epithelium;overexpression;paracrine;promoter;research study;response;smoothened signaling pathway;sonic hedgehog receptor;spatiotemporal;stem cell division;tissue regeneration;tissue repair;toad;transcription factor","Regulation of stem cell development during tissue remodeling","n/a","NICHD","8553964"," "," ","1ZIAHD008858-05","1","ZIA","HD","008858","05"," "," "," "," "," "," ","9694107","SHI, YUN-BO ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NICHD"," "," "," ","977329",
"Cancer; Digestive Diseases; Genetics; Rare Diseases","Affect;American Cancer Society;Animals;Biological;Cells;Cessation of life;Core Facility;Diagnosis;Disease;Epidermal Growth Factor Receptor;Epithelial;Epithelial Cells;Esophageal;Esophageal Neoplasms;Esophageal Squamous Cell;Esophagus;Extracellular Matrix;Fibroblasts;Fostering;Frequencies;Genetic;Head and neck structure;Human;Lung;Malignant Neoplasms;Malignant Squamous Cell Neoplasm;Malignant neoplasm of esophagus;Mediating;Mesenchymal;Modeling;Molecular;Mutation;Neoplasm Metastasis;Paracrine Communication;Phenocopy;Phosphorylation;Property;Protein Isoforms;Protein p53;Resistance;Role;Signal Pathway;Skin Cancer;Staging;Survival Rate;Time;Tumor Cell Invasion;Tumor Suppressor Genes;United States;base;cancer cell;carcinogenesis;cell motility;cell transformation;combinatorial;erbB Genes;in vivo;in vivo Model;innovation;insight;male;migration;mutant;neoplastic cell;new therapeutic target;outcome forecast;overexpression;paracrine;tumor;tumor initiation;tumorigenesis;tumorigenic","Transformed Epithelial Cells and Activated Fibroblasts in the Esopheageal Tumor M","n/a","NCI","8380736","8/8/2012 12:00:00 AM"," ","5P01CA098101-09","5","P01","CA","098101","09"," "," ","8/15/2003 12:00:00 AM"," ","ZCA1-RPRB-O","8721","1868587","RUSTGI, ANIL K","Not Applicable","03","Unavailable","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","Domestic Higher Education","191046205","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","729773","729773"," ","512015","217758"," "," ",
"Acute Respiratory Distress Syndrome; Lung; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acute Lung Injury;Air;Alveolar;Alveolus;Apoptotic;Architecture;Biological;Cell Adhesion Molecules;Cell-Cell Adhesion;Cells;Cessation of life;Characteristics;Deposition;Disease;Epithelial;Epithelial Cells;Extracellular Matrix;Fibroblasts;Functional disorder;Genes;Intermediate Filament Proteins;Intermediate Filaments;Ion Transport;Keratin;Lead;Mediating;Mesenchymal;Modeling;Molecular;Natural regeneration;Necrosis;Pathogenesis;Pathologic Processes;Pathway interactions;Patients;Peptide Hydrolases;Phenotype;Physiological;Physiological Processes;Production;Property;Proteins;Regulation;Resolution;Role;Testing;Transforming Growth Factors;Type I Epithelial Receptor Cell;Type II Epithelial Receptor Cell;Ubiquitin;Vimentin;Wound Healing;alveolar epithelium;cell motility;in vitro Model;in vivo;induced pluripotent stem cell;injury and repair;insight;lung injury;migration;multicatalytic endopeptidase complex;novel;protein expression;reconstitution;repaired;research study;restoration;substrate-attached material;surfactant;tissue repair;transcription factor;transdifferentiation;wound","Role of intermediate filaments in alveolar epithelial wond repair","The experiments proposed for these aims will integrate studies examining the cellular and molecular
mechanisms regulating the induced expression, re-organization and/or disassembly of intermediate filaments
and the resultant alveolar epithelial cell transdifferentiation associated with ALI. Completion of the proposed
studies will provide novel insights on the role of keratin and vimentin IFs in the pathogenesis of alveolar
epithelial transdifferentiation and dysfunction, which is of biological and physiological importance in patients
with ALI.","NHLBI","8376673","3/19/2012 12:00:00 AM"," ","5P01HL071643-09","5","P01","HL","071643","09"," "," ","8/1/2003 12:00:00 AM"," ","Heart, Lung, and Blood Program Project Study Section[HLBP]","5092","2089949","RIDGE, KAREN M","Not Applicable","07","Unavailable","005436803","KG76WYENL5K1","005436803","KG76WYENL5K1","US","41.896017","-87.616602","6144650","NORTHWESTERN UNIVERSITY AT CHICAGO","CHICAGO","IL","Domestic Higher Education","606114579","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","354540","354540"," ","232485","122055"," "," ",
"Cancer; Diagnostic Radiology; Pancreatic Cancer; Rare Diseases","Biometry;Bortezomib;Clinical;Collection;Development;Ensure;Environment;Enzymes;Equipment;Extracellular Matrix;Five-Year Plans;Funding;Future;Goals;Image;Imaging technology;Kaposi Sarcoma;Lung;Magnetic Resonance Imaging;Malignant Neoplasms;Malignant neoplasm of pancreas;Mediating;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Modality;Molecular;Neoplasm Metastasis;Oncologist;Pathologist;Pathway interactions;Patients;Positron-Emission Tomography;Radiation;Renal carcinoma;Research;Research Infrastructure;Research Personnel;Resources;Scientist;Structure;Surgeon;Translating;Translations;Treatment Efficacy;Treatment outcome;base;bench to bedside;career development;effective therapy;epithelial to mesenchymal transition;hypoxia inducible factor 1;imaging modality;imaging probe;improved;in vivo Cellular and Molecular Imaging Centers;melanoma;molecular imaging;molecular oncology;oncology;optical imaging;programs;radiologist;single photon emission computed tomography;theranostics;tumor progression","Molecular Imaging in the Treatment of Kaposi's Sarcoma","The JHU ICMIC is a multi-modality multi-disciplinary molecular imaging program that incorporates MR, 
SPECT, PET, and optical imaging to investigate cancer in a bench-to-bedside approach. Our intent for the 
next five years is to translate successfully the discoveries of this program into effective treatments against 
cancer.","NCI","8566681","10/12/2012 8:17:45 AM","PAR-09-157","5P50CA103175-07","5","P50","CA","103175","07"," "," ","8/1/2012 12:00:00 AM","7/31/2016 12:00:00 AM","ZCA1-SRLB-9(M1)","6124","1942371","AMBINDER, RICHARD FREDERICK","Not Applicable","07","Unavailable","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","Domestic Higher Education","212182680","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","177940","177940"," ","113790","64150"," "," ",
"Genetics; Urologic Diseases","ATP Receptors;Advisory Committees;Affect;Afferent Neurons;Androgen Receptor;Androgens;Animal Model;Award;Benign;Benign Prostatic Hypertrophy;Bladder;Bladder Dysfunction;Capsaicin;Characteristics;Collaborations;Communities;Complex;Disease;Dose;Elderly man;Endocrinology;Epithelial;Epithelial Cells;Formalin;Formalin Tests;Functional disorder;Funding;Future;Gene Expression;Genes;Homeostasis;Human;Inflammation;Inflammatory;Injection of therapeutic agent;Interdisciplinary Study;Lead;Medical;Mesenchymal;Modeling;Molecular;Molecular Analysis;Molecular Profiling;P2X-receptor;Pathogenesis;Pathology;Pharmacology;Physiological;Prevention;Preventive;Production;Prostate;Prostatic;Prostatic Tissue;Rattus;Research;Research Personnel;Research Project Grants;Resources;Rodent;Rodent Model;Role;Signal Pathway;Societies;Specimen;TNFRSF5 gene;Testing;Testosterone;Therapeutic;Tissues;Universities;Up-Regulation;Urination;Urine;Urology;Work;aged;chemokine;clinically significant;cost;cytokine;lower urinary tract symptoms;men;multidisciplinary;novel;programs;research study;success","Molecular signatures associated with prostatic inflammation in rodent models.","Benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) is a major medical problem 
affecting most elderly men and costing society ~$4 billion annually. Success of the proposed 
multidisciplinary research will facilitate further analysis of the molecular and cellular mechanisms of BPH and 
related LUTS, which may lead to novel preventive and/or therapeutic approaches for this disease.","NIDDK","8566145","10/11/2012 2:06:07 PM","RFA-DK-12-003","2P20DK090919-03","2","P20","DK","090919","03"," "," ","9/28/2012 12:00:00 AM","8/31/2014 12:00:00 AM","ZDK1-GRB-6(O3)S","6087","1857725","WANG, ZHOU ","Not Applicable","18","Unavailable","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","Domestic Higher Education","152133320","UNITED STATES","N","9/28/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Research Centers","2012","246669","246669"," ","161750","84919"," "," ",
"Biotechnology; Cancer; Genetics","Antineoplastic Agents;Apoptosis;Area;Balbiani Body;Behavior;Biochemical;Biological;Biological Assay;Brain;Cadherins;Cancer Biology;Cancer cell line;Categories;Cell Cycle;Cell Death;Cell Lineage;Cell division;Cell-Cell Adhesion;Cellular Structures;Characteristics;Data;Development;Drosophila genus;Embryo;Epithelial;Gene Expression;Genes;Genetic;Germ;Germ Cell Cancers;Germ Cells;Goals;Immunity;Liquid Chromatography;Malignant Neoplasms;Mesenchymal;Mitochondria;Neoplasm Metastasis;Oocytes;Oogenesis;Organism;Outcome;Process;Proteins;RNA;RNA Sequence Analysis;Research;Screening procedure;Seminal;Source;Specific qualifier value;Structure;Technology;Testing;Therapeutic Intervention;To specify;Tumor Suppressor Genes;Vertebrates;Work;Xenopus;anticancer research;base;cancer stem cell;cancer therapy;drug development;expression cloning;gene function;neuronal cell body;novel;novel marker;scaffold;stem cell biology;tandem mass spectrometry;therapeutic target;tumor;tumor growth","IDENTIFYING GERMLINE GENES AS TARGETS FOR THERAPEUTIC INTERVENTION IN CANCER"," Recent progress in cancer research has highlighted a new category of targets for anti-cancer drugs: gene products expressed in the germline. Our proposed research will identify and functionally screen such high value germline targets for their ability to promote the ""hallmarks"" of cancer: uncontrolled cell division, immunity to cell death, and metastasis. Our research will discover novel candidates for the development of new anti-cancer drugs.   
   
      

","NICHD","8445954","9/27/2012 12:00:00 AM","PA-11-261","1R21HD072340-01A1","1","R21","HD","072340","01","A","RAVINDRANATH, NEELAKANTA","9/27/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","1887811","KING, MARY LOU ","Not Applicable","27","ANATOMY/CELL BIOLOGY","052780918","F8THLJQSAF93","052780918","F8THLJQSAF93","US","25.775337","-80.209809","5221250","UNIVERSITY OF MIAMI SCHOOL OF MEDICINE","CORAL GABLES","FL","SCHOOLS OF MEDICINE","331462926","UNITED STATES","N","9/27/2012 12:00:00 AM","8/31/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","100000","53000"," ","153000",
"Bioengineering; Lung; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","3-Dimensional;Activins;Adult;Air;Alveolar;Autologous;Biology;Biomedical Engineering;Biomimetics;Bioreactors;Blood Vessels;Bone Marrow;Cell-Matrix Junction;Cells;Characteristics;Chronic;Clinic;Clinical Research;Coculture Techniques;Cues;Development;Edema;Endothelial Cells;Epithelial;Epithelial Cells;Evaluation;Extracellular Matrix;Family suidae;Fetal Lung;Fibroblast Growth Factor 2;Gases;Gel;Goals;Growth;Head;Heart;Hemorrhage;Human;Immunosuppression;Implant;Liquid substance;Lung;Lung Transplantation;Mechanics;Mesenchymal;Organ;Organ Donor;Patients;Pattern;Pericytes;Physiological;Physiology;Property;Proteins;Rattus;Research Personnel;Source;Staging;Stem cells;Stretching;Stromal Cells;Structure;Structure of parenchyma of lung;Support System;Thoracic Surgical Procedures;Trachea;Transplantation;Vascularization;abstracting;embryonic stem cell;fetal;fibroblast growth factor 10;human adult stem cell;induced pluripotent stem cell;interest;lung development;lung repair;mortality;progenitor;scaffold","Overcoming Barriers to Bioengineering 3-D Human Lung","
Project Narrative
Lung transplantation is usually the only option for patients with irreversible structural lung damage but is
hindered by two major obstacles - a lack of lung organ donors and chronic rejection after transplanatation. We
will focus on rebuilding 3-D human lungs using ventilated, decellularized (i.e. all cells are removed) whole pig
lungs as a natural 3-D matrix framework that is very similar to human lung matrix in structure and function. We
will repopulate it with human adult stem cells having the potential to grow into lung tissue and produce proteins
characteristic of healthy lung cells.","NHLBI","8328582","6/1/2012 12:00:00 AM","RFA-HL-11-025","5R01HL108627-02","5","R01","HL","108627","02"," ","BLAISDELL, CAROL J","9/5/2011 12:00:00 AM","5/31/2015 12:00:00 AM","ZHL1-CSR-N(M1)"," ","8266063","PANOSKALTSIS-MORTARI, ANGELA ","TAYLOR, DORIS A","05","PEDIATRICS","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","SCHOOLS OF MEDICINE","554552070","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","650714","267159"," ","701107",
"Dental/Oral and Craniofacial Disease; Genetics; Pediatric; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Address;Adult;Alleles;Ameloblasts;Anterior;Bone Morphogenetic Proteins;Branchial arch structure;Cardiac;Cell physiology;Cervical;Cues;Data;Dental;Development;Dose;Ectoderm;Embryo;Embryonic Development;Endoderm;Environment;Epithelial;Epithelium;Family;Gene Silencing;Genes;Genetic Transcription;Goals;Growth;Health;Homeostasis;Human;Human Genetics;Hypertension;Inborn Genetic Diseases;Incisor;Investigation;Juvenile polyposis syndrome;Ligands;Lung;Mandible;Mesenchymal;Mesenchyme;Methods;Morphogenesis;Mus;Mutant Strains Mice;Mutation;Organ;Organ Size;Organogenesis;Patients;Plastics;Population;Publishing;Pulmonary artery structure;Regenerative Medicine;Regulation;Research;Rodent;Role;Signal Pathway;Signal Transduction;Site;Specific qualifier value;Staging;Stem cells;System;Testing;Therapeutic;Tissues;Tooth structure;Transgenic Organisms;Work;bone morphogenetic protein receptor type I;bone morphogenetic protein receptor type II;cell type;craniofacial;developmental genetics;embryonic stem cell;gain of function;homeodomain;human disease;in vivo;insight;mandible/maxilla;oral ectoderm;overexpression;progenitor;programs;protein function;recombinase;regenerative;research study;stem cell biology;stem cell niche;tissue culture;tissue regeneration;transcription factor","Bmp-signaling in craniofacial development","n/a","NIDCR","8286065","5/31/2012 12:00:00 AM","PA-07-070","5R01DE012324-16","5","R01","DE","012324","16"," ","SCHOLNICK, STEVEN","7/1/1997 12:00:00 AM","6/30/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1864322","MARTIN, JAMES F","Not Applicable","09","PHYSIOLOGY","051113330","FXKMA43NTV21","051113330","FXKMA43NTV21","US","29.711148","-95.39695","481201","BAYLOR COLLEGE OF MEDICINE","HOUSTON","TX","SCHOOLS OF MEDICINE","770303411","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","232774","131517"," ","364291",
"Aging; Osteoporosis; Prevention","Adipocytes;Affect;Aging;Agonist;Apoptosis;B-Cell Development;B-Lymphocytes;Bone Marrow;Cell Differentiation process;Cell physiology;Cells;Collaborations;Complex Mixtures;Data;Defect;Development;Dose;Environment;Environmental Pollution;Exposure to;Fatty acid glycerol esters;Gene Expression Profile;Goals;Heterodimerization;Homeostasis;Human;Immune;Immune response;Immune system;Impairment;In Vitro;Individual;Instruction;Intervention;Knowledge;Lead;Life;Ligands;Lymphocyte;Lymphopoiesis;Marrow;Mediating;Mediator of activation protein;Mesenchymal;Modeling;Molecular;Organ;Osteoblasts;Osteogenesis;Osteoporosis;PPAR gamma;Peroxisome Proliferator-Activated Receptors;Physiology;Prevention;RXR;Receptor Activation;Risk Assessment;Role;Signal Transduction;Site;Stromal Cells;System;Technology;Testing;Therapeutic;Toxic effect;Transgenic Model;Visceral;adipocyte differentiation;aging population;base;bone;bone loss;bone quality;immune function;improved;in vivo;lipid biosynthesis;long bone;man;mono-(2-ethylhexyl)phthalate;novel;osteoblast differentiation;osteogenic;pathogen exposure;phthalates;receptor;reproductive;small hairpin RNA;superfund chemical;toxicant","Project 4: Environmental PPARy Agonist-Mediated Toxicity in the Dev. Immune Syst","RELEVANCE (See Instructions): 
Aging is associated with an impaired immune response to infecfion, and exposure to ""environmental 
obesogens"" may mimic this phenomenon. Our data suggest that contaminant-induced fat formation in bone 
results not only in loss of bone quality but also in compromise ofthe microenvironment required to support 
immune cell development, similar to aging. Results from these studies will provide fundamental informafion 
on thfi interaction of the bone marrow environment and immune cell develoment and targets for intervention.","NIEHS","8289723","9/20/2012 12:00:00 AM","RFA-ES-10-010","2P42ES007381-16A1","2","P42","ES","007381","16","A"," "," "," ","ZES1-JAB-J(SF)","5771","11310089","SCHLEZINGER, JENNIFER ","Not Applicable","07","Unavailable","604483045","FBYMGMHW4X95","604483045","FBYMGMHW4X95","US","42.336234","-71.070647","894901","BOSTON UNIVERSITY MEDICAL CAMPUS","BOSTON","MA","Domestic Higher Education","021182841","UNITED STATES","N","9/20/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","160269","160269"," ","97907","62362"," "," ",
"Digestive Diseases","Agglutination;Area;Beryllium;Biomedical Engineering;Blood Vessels;Cell Communication;Cells;Competence;Coupling;DNA;Data;Defect;Development;Diffusion;Elements;Embryo;Enhancers;Ensure;Epithelial;Epithelium;Erinaceidae;Event;Feathers;Fingers;Gene Targeting;Generations;Genes;Genetic;Genomics;Goals;Growth;Hair follicle structure;Hour;Human;Intestines;Investigation;Length;Life;Ligands;Link;Mediating;Mesenchymal;Mesenchyme;Modeling;Molecular;Morphogenesis;Mus;Nutrient;Operative Surgical Procedures;Organ;Pathology;Pattern;Process;Reaction;Signal Pathway;Signal Transduction;Skin;Small Intestines;Software Tools;Surface;System;Time;Tissues;Vascular Endothelial Cell;Vascular Endothelial Growth Factors;Vascular System;Villus;Work;absorption;appendage;design;in utero;insight;intestinal epithelium;intestinal villi;mouse model;notch protein;novel;prevent;public health relevance;smoothened signaling pathway","Cell-Cell Interactions during intestinal development","
PROJECT NARRATIVE
The surface of the small intestine is highly convoluted by finger-like projections called villi; this extended
surface area is critical for efficient nutrient absorption. Loss of intestinal surface area either by congenital
intestinal defects or by pathological or surgical events, can be life threatening. The ability to bioengineer the
intestine from its cellular components will require not only that we elucidate the molecular signals that are
important for morphogenesis and cell fate determination, but also that we understand the rules that govern the
patterning of the functional units that comprise the organ. Currently, little is known about how villi are
generated in utero. Through the study of mouse models with perturbed villus formation and through the
analysis of a novel intestinal explant culture system, we propose to dissect the molecular processes
responsible for villus emergence. The unique focus of this investigation on signaling crosstalk in the nascent
villus unit (epithelium, mesenchyme, vasculature) will have a major impact on our understanding of how
intestinal villi are first formed in the embryo.","NIDDK","8314055","7/24/2012 12:00:00 AM","PA-10-067","5R01DK065850-08","5","R01","DK","065850","08"," ","CARRINGTON, JILL L","4/1/2005 12:00:00 AM","8/31/2014 12:00:00 AM","Clinical, Integrative and Molecular Gastroenterology Study Section[CIMG]"," ","1881985","GUMUCIO, DEBORAH L.","Not Applicable","12","ANATOMY/CELL BIOLOGY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","108205"," ","313630",
"Cancer; Genetics; Rare Diseases","Advanced Malignant Neoplasm;Amino Acids;Apoptosis;Biological Assay;Biological Markers;Blood Vessels;Cell Cycle Progression;Cells;Chemicals;Clinical;Computer Simulation;Development;Disease;Dissection;Disseminated Malignant Neoplasm;Drosophila melanogaster;Employee Strikes;Epithelial Cells;Fibroblasts;Gene Mutation;Genes;Genetic;Genomics;Hereditary Disease;Homeostasis;Homology Modeling;Human;Individual;Injury;Lobe;Loeys-Dietz Syndrome;Malignant Neoplasms;Mammalian Cell;Marfan Syndrome;Mediating;Missense Mutation;Molecular;Mutate;Mutation;NMR Spectroscopy;Pathway interactions;Patients;Phenotype;Phosphotransferases;Proteins;Receptor Gene;Research Personnel;Signal Transduction;Smooth Muscle Myocytes;Source;Syndrome;TGFBR1 gene;TGFBR2 gene;Therapeutic Effect;Thoracic Aortic Aneurysm;Tissues;Transforming Growth Factors;Tumor Escape;addiction;cancer therapy;cell motility;epithelial to mesenchymal transition;gain of function;inhibitor/antagonist;injury and repair;kinase inhibitor;malignant phenotype;mutant;novel therapeutic intervention;pre-clinical;protein folding;receptor;receptor function;repaired;response;structural biology;therapy development;tissue repair;tumor","TGFBeta Receptor Mutations in Cancer and Other Diseases","n/a","NCI","8253783","5/14/2012 12:00:00 AM"," ","5R01CA129125-06","5","R01","CA","129125","06"," ","KNOWLTON, JOHN R","7/1/2007 12:00:00 AM","6/30/2013 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","6735473","LATTIME, EDMUND C.","Not Applicable","06","INTERNAL MEDICINE/MEDICINE","617022384"," ","617022384"," ","US","40.526695","-74.470817","714203","UNIV OF MED/DENT NJ-R W JOHNSON MED SCH","PISCATAWAY","NJ","SCHOOLS OF MEDICINE","088548021","UNITED STATES","N","6/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","181116","77565"," ","258681",
"No NIH Category available","Actins;Adult;Biological Assay;Body Regions;Cell Polarity;Cells;Chemotactic Factors;Cytochalasin D;Cytoskeleton;Development;Developmental Process;Embryo;Embryonic Development;Focal Adhesions;Goals;Grant;Image;Knowledge;Label;Life;Malignant Neoplasms;Mesenchymal;Mus;Neoplasm Metastasis;Neural Crest;Neural Crest Cell;Neural tube;Neuregulin 1;Neurons;Outcomes Research;Paclitaxel;Play;Process;Research;Role;Signal Transduction;Stem cells;Stress Fibers;Techniques;Tubulin;Work;Zebrafish;cancer cell;cell motility;cofilin;in vivo;microtubule-associated protein 1B;migration;migratory population;novel;public health relevance;receptor;research study;response;tool","Mechanisms of cytoskeleton dynamics during neural crest cell chemoattraction","
Narrative
 Neural crest cell migration has been repeatedly likened to the process of metastasis and
invasion. However, although there is a wealth of research on the mechanisms that govern the
process of cell motility and invasion, we do not have much evidence showing that neural crest cells
undergo similar sub-cellular changes as those seen in cancer cells. The proposed research will
study in extensive detail the changes that trunk neural crest actin and tubulin cytoskeleton undergo
(polarizing, dynamics and leading edge formation) during chemoattraction to NRG1. The outcomes
from this research will help us understand how we may be able to harness the metastatic
aggressiveness of crest derived-cancers because it will look into the changes that allow neural
crest cells migrate throughout the embryo as it happens in adults suffering from these cancers.","NIGMS","8264740","4/2/2012 12:00:00 AM","PAR-08-028","5SC3GM096904-02","5","SC3","GM","096904","02"," ","OKITA, RICHARD T","6/1/2011 12:00:00 AM","4/30/2015 12:00:00 AM","ZGM1-MBRS-7(CG)"," ","8529324","DE BELLARD, MARIA ELENA","Not Applicable","30","BIOLOGY","055752331","LAGNHMC58DF3","055752331","LAGNHMC58DF3","US","37.215296","-119.663836","513617","CALIFORNIA STATE UNIVERSITY NORTHRIDGE","NORTHRIDGE","CA","SCHOOLS OF ARTS AND SCIENCES","913308232","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","859","Other Research-Related","2012"," "," ","NIGMS","75000","30880"," ","105880",
"Autoimmune Disease; Genetics; Lung; Rare Diseases","Actins;Adrenal Cortex Hormones;Affect;Alveolar;Apoptosis;Asthma;Autoimmune Diseases;Binding;Biological Process;CCAAT-Enhancer-Binding Proteins;Cell Differentiation process;Cell Survival;Cells;Characteristics;Chronic lung disease;Cicatrix;Collagen;Collagen Type I;Complex;DNA Methylation;Data;Deposition;Derivation procedure;Development;Diagnosis;Diagnostic;Differentiation Antigens;Disease;Ectopic Expression;Elements;Environmental Risk Factor;Epigenetic Process;Epithelial;Epithelial Cells;Extracellular Matrix;Fatal Outcome;Fibroblasts;Fibrosis;Gene Expression;Gene Targeting;Genes;Hamman-Rich syndrome;Histones;In Vitro;Indium;Inflammation;Inflammatory;Injury;Lesion;Lung;Lung diseases;Mediator of activation protein;Mesenchymal;Methylation;Myofibroblast;Pathogenesis;Pathologic;Patients;Phenotype;Prevalence;Process;Property;Protein Acetylation;Protein Isoforms;Proteins;Pulmonary Fibrosis;Regulation;Relative (related person);Respiratory Failure;Rheumatoid Arthritis;Role;Signal Pathway;Signal Transduction;Signaling Pathway Gene;Smooth Muscle Actin Staining Method;Source;Staging;Steroids;Stimulus;Testing;Transact;Transcriptional Regulation;Work;base;cytokine;effective therapy;environmental agent;gene function;improved;inhibitor/antagonist;insight;interstitial;lung injury;new therapeutic target;novel;outcome forecast;promoter;response;response to injury;therapy outcome;transcription factor","Myofibroblasts in pulmonary fibrosis","n/a","NHLBI","8236954","3/26/2012 12:00:00 AM","PA-07-070","5R01HL052285-18","5","R01","HL","052285","18"," ","EU, JERRY PC","9/30/1994 12:00:00 AM","9/30/2013 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1861132","PHAN, SEM H","Not Applicable","12","PATHOLOGY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","4/1/2012 12:00:00 AM","9/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","121747"," ","369247",
"Genetics; Lung; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","3-Phosphoinositide Dependent Protein Kinase-1;Address;Brain;Cell Death;Cell Proliferation;Cells;Data;Development;Disease;Duct (organ) structure;Embryo;Epithelial;Epithelial Cells;Future;Genes;Genetic Recombination;Goals;Hamman-Rich syndrome;Health;Homeostasis;Homologous Gene;Human;Learning;Lung;Lung diseases;Malignant Neoplasms;Mesenchymal;Mesenchyme;Molecular;Morphogenesis;Mutant Strains Mice;Names;PI3K/AKT;PTEN gene;Pathway interactions;Phenotype;Phosphoric Monoester Hydrolases;Population;Property;Proto-Oncogene Proteins c-akt;Pulmonary Fibrosis;Reagent;Reporting;Role;Signal Transduction;Stem cells;Testing;Therapeutic;Tissues;Transplantation;Tumor Suppressor Genes;Validation;base;carcinogenesis;design;interest;lung development;migration;novel;postnatal;prevent;progenitor;response;stem cell niche;stem cell population;tensin;transcription factor","Pulmonary Development: Molecular & Cellular Analysis","
Project Narrative
This is a proposal to study a gene named Pten which controls the number of
Progenitor/Stem cells in the lung. The studies address the specific role of Pten in a
serious lung condition known as Pulmonary Fibrosis for which no treatment currently
exists other than transplantation. The long-term goal of this project is to learn enough
about Pten to be able to modify its function and therefore prevent or treat lung disease.","NHLBI","8235057","3/26/2012 12:00:00 AM","PA-07-070","5R01HL056590-16","5","R01","HL","056590","16"," ","LIN, SARA","8/1/1996 12:00:00 AM","3/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-RES-B(02)M]"," ","1876418","MINOO, PARVIZ MINOO","Not Applicable","37","PEDIATRICS","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF MEDICINE","900894304","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","153450"," ","400950",
"Cancer; Clinical Research; Pediatric; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Adolescent;Adverse effects;Antibodies;Binding;Biological;Biological Assay;Bone Marrow Transplantation;Bone Tissue;Cancer Patient;Cell Count;Cell Death;Cells;Cessation of life;Characteristics;Child;Chimeric Proteins;Chromosomal translocation;Clinical;Clinical Trials;Colony-Forming Units Assay;Cytotoxic agent;Data;Development;Disease remission;Disease-Free Survival;Dose;Drug Combinations;Dyes;EWS-FLI1 fusion protein;Ewings sarcoma;Family;Gene Expression Profile;Gene Expression Profiling;Genes;Growth;Immunodeficient Mouse;Insulin-Like Growth Factor I;Lead;Malignant Bone Neoplasm;Malignant Neoplasms;Mesenchymal Stem Cells;Metastatic Ewing&apos;s Sarcoma;Molecular Target;Monoclonal Antibodies;Neoplastic Cell Transformation;Oncogenic;Pathway interactions;Patients;Pharmaceutical Preparations;Population;Procedures;Property;RNA helicase A;Recurrence;Regimen;Relapse;Reporter;Research;Resistance;Role;Signal Pathway;Signal Transduction;Stem cells;Testing;Therapeutic;Translating;Tumor Cell Line;Tumor Stem Cells;Tumorigenicity;Validation;aldehyde dehydrogenases;bone;cancer stem cell;chemotherapy;design;effective therapy;improved;inhibitor/antagonist;mRNA Expression;neoplastic cell;novel;outcome forecast;pre-clinical;programs;promoter;protein protein interaction;response;small molecule;soft tissue;stem;stem cell biology;stem cell population;transcription factor;treatment strategy;tumor;tumorigenesis;tumorigenic;young adult","Isolation and small molecule targeting of Ewing's Sarcoma stem cells","
New targeted therapies are needed for cancer patients that improve survival and
decrease side-effects of therapy. Ewing's Sarcoma Family of Tumors (ESFT) are
highly malignant tumors of bone and soft tissue that occur in children,
adolescents, and young adults. The tumors often grow in close proximity to
bone, but can occur as a soft-tissue mass. Current standard therapy for ESFT
patients is a five-drug regimen that lasts for approximately 9 months. Patients
who present with localized ESFT have approximately 70% disease-free survival.
Patients who present with metastatic ESFT have a poor prognosis (20% disease-
free survival) despite intensive therapy. These clinical response rates have
persisted for the past decade, even after dose-intensifying chemotherapy and
bone marrow transplantation. The identification of a Ewing's Sarcoma Stem Cell
(ESSC) and elucidation of its properties will be critical to advancing both novel
and effective therapies into patients with ESFT. Our identification of ESSC along
with the use of a novel inhibitor of EWS-FLI1 are directly responsive to the RFA-
CA-08-019. This project will specifically address the need for new targeted
therapies for ESFT and potentially a large number of related malignancies that
have chromosomal translocations.","NCI","8314113","8/1/2012 12:00:00 AM","RFA-CA-08-019","5R01CA138212-05","5","R01","CA","138212","05"," ","STEELE, VERNON E","9/25/2008 12:00:00 AM","7/31/2015 12:00:00 AM","ZCA1-RPRB-O(O2)"," ","6182845","TORETSKY, JEFFREY A","Not Applicable","98","INTERNAL MEDICINE/MEDICINE","049515844","TF2CMKY1HMX9","049515844","TF2CMKY1HMX9","US","38.904729","-77.016304","2869001","GEORGETOWN UNIVERSITY","WASHINGTON","DC","SCHOOLS OF MEDICINE","200570001","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2015 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","380355","77080"," ","457435",
"Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Address;Adult;Behavior;Biological Models;Cell Count;Cell Death;Cell Size;Cells;Cellularity;Characteristics;Collaborations;Dermal;Emotional;Epithelial;Epithelial Cells;Epithelium;Frequencies;Gene Expression;Genes;Graafian Follicles;Growth;Hair;Hair Part;Hair bulb structure;Hair follicle structure;Hair shaft structure;In Vitro;Individual;Maintenance;Mediating;Mesenchymal;Mesenchyme;Methods;Molds;Morphogenesis;Morphology;Mouse Strains;Mus;Natural regeneration;Organ;Organ Size;Organism;Organogenesis;Pattern Formation;Phenotype;Platelet-Derived Growth Factor;Population;Prevention;Probability;Process;Production;Property;Recruitment Activity;Regenerative Medicine;Regulation;Research;Role;Shapes;Signal Pathway;Signal Transduction;Skin;Specific qualifier value;Stem cells;Structure;System;Testing;Time;To specify;Transgenic Organisms;Wild Type Mouse;Work;adult stem cell;cell type;critical period;gain of function;gain of function mutation;in vivo;insight;keratinocyte;progenitor;psychologic;research study;restoration;stem cell biology;stem cell population;tongue papilla;tool;transcription factor","Inductive properties of the dermal papilla of the hair follicle"," The hair follicle is formed from adult stem cells under the influence of a second cell population, the dermal papilla, that directs these cells to form a hair f specific size and shape. By manipulating gene activity in the dermal papilla, we will identify the mechanisms by which the size of cell progenitor pools and their supporting niche populations are generated in the hair follicle, and how that dictates the size and shape of the hair. This research will have implications for the prevention of hair loss or restoration of defective hair follicles, and will also shed insight into the more general mechanisms that regulate organ size and shape.   
      

","NIAMS","8373369","7/31/2012 12:00:00 AM","PA-11-260","2R01AR055256-06","2","R01","AR","055256","06"," ","BAKER, CARL","8/5/2007 12:00:00 AM","7/31/2017 12:00:00 AM","Arthritis, Connective Tissue and Skin Study Section[ACTS]"," ","1903057","MORGAN, BRUCE A","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","155180"," ","380180",
"Infant Mortality/ (LBW); Lung; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal - Neonatal Respiratory Distress Syndrome; Perinatal Period - Conditions Originating in Perinatal Period","Alveolar;Amniotic Fluid;Antibodies;Area;Bronchopulmonary Dysplasia;Cells;Chemicals;Childhood;Chronic Disease;Chronic lung disease;Communication;Conditioned Culture Media;Cultured Cells;Cycloheximide;Data;Development;Disease;Endotoxins;Epithelial;Epithelium;Escherichia coli;Excision;Experimental Models;Exposure to;Fetal Lung;Gases;Gene Expression;Genes;Genetically Engineered Mouse;Goals;Growth Factor;In Vitro;Incidence;Infant;Infection of amniotic sac and membranes;Inflammation;Inflammation Mediators;Inflammatory;Intervention;Investigation;Lead;Lipopolysaccharides;Lung;Measures;Mediating;Membrane;Mesenchymal;Mesenchyme;Modeling;Molecular;Morbidity - disease rate;Morphogenesis;Mouse Strains;Mus;National Heart, Lung, and Blood Institute;Pathway interactions;Patients;Placenta;Premature Infant;Production;Protein Biosynthesis;Proteins;Reporter;Risk;Signal Transduction;Small Interfering RNA;Staging;Surface;TLR2 gene;Testing;Time;Transgenic Mice;United States;Uterus;airway epithelium;alveolar epithelium;cell type;cytokine;fetal;fibroblast growth factor 10;in vivo;in vivo Model;indexing;innovation;lung development;microbial;mouse model;mutant;novel;novel therapeutics;prenatal exposure;prevent;promoter;toll-like receptor 4;transcription factor","FGF-10 Expression in a Fetal Mouse Lung Model of Bronchopulmonary Dysplasia","n/a","NHLBI","8230585","2/8/2012 12:00:00 AM","PA-07-070","5R01HL086324-05","5","R01","HL","086324","05"," ","BLAISDELL, CAROL J","4/15/2008 12:00:00 AM","2/28/2013 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","7598551","PRINCE, LAWRENCE S","Not Applicable","05","PEDIATRICS","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","222750","119171"," ","341921",
"Biotechnology; Dental/Oral and Craniofacial Disease; Genetics; Pediatric","Affect;Alleles;Biological;Biology;Bone Development;Bone remodeling;Brain;Breathing;Cartilage;Cell Differentiation process;Cell Proliferation;Cells;Cephalic;Child;Complex;Congenital Abnormality;Craniofacial Abnormalities;Dermal;Diagnosis;Diagnostic;Dicer Enzyme;Disease;Eating;Elements;Embryo;Embryonic Development;Face;Future;Genes;Genetic;Head;Head and neck structure;Hearing;Hereditary Disease;Histocompatibility Testing;Human;In Situ Hybridization;In Vitro;Jaw;Knowledge;Lead;Learning;Limb structure;Malignant Neoplasms;Mastication;Mesenchymal;MicroRNAs;Molecular Genetics;Morphogenesis;Muscle;Osteoblasts;Osteogenesis;Phenotype;Physical condensation;Population;Prevention;Process;Role;Signaling Molecule;Skeletal Development;Skeleton;Speech;Staging;Structure;Syndrome;Testing;Tissues;bone;cancer type;craniofacial;cranium;disability;hearing impairment;human DICER1 protein;in vivo;intramembranous bone;intramembranous bone formation;malformation;novel;osteoblast differentiation;prevent;public health relevance;skeletal;skeletal abnormality;skeletal tissue;tool;transcription factor","Characterization of cranial dermal bone-specific miRNAs","
Project Narrative
Each year thousands of children are born with craniofacial diseases related to abnormal
cranial bone biology. We recently found that microRNAs, an important class of
regulatory molecules, are required for cranial bone formation. We believe that that
learning about functions of these molecules using sophisticated genetic and molecular
tools will help us understand the mechanisms governing normal cranial bone biology and
allow us to develop ways to diagnose, prevent and treat various craniofacial syndromes
in the future.","NIDCR","8230548","1/25/2012 12:00:00 AM","PA-10-069","5R21DE021535-02","5","R21","DE","021535","02"," ","LUMELSKY, NADYA L","3/1/2011 12:00:00 AM","2/28/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","8760735","ABZHANOV, ARKHAT ","Not Applicable","05","BIOLOGY","082359691","LN53LCFJFL45","082359691","LN53LCFJFL45","US","42.373148","-71.118329","3212901","HARVARD UNIVERSITY","CAMBRIDGE","MA","SCHOOLS OF ARTS AND SCIENCES","021385319","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","125000","86250"," ","211250",
"Biotechnology; Dental/Oral and Craniofacial Disease; Genetics; Pediatric; Pediatric Research Initiative","Affect;Area;Biochemical Genetics;Biological Assay;Biology;Cells;Cephalic;Chemotaxis;Cleft Lip;Cleft Palate;Collection;Congenital Abnormality;Development;Disease;Face;Gene Targeting;Genes;Genetic;Genetic Epistasis;Growth Factor;Human;In Vitro;International;Knowledge;Laboratories;Lead;Ligands;Mass Spectrum Analysis;Mediating;Mesenchymal;Mesenchyme;Molecular;Mus;Mutagenesis;Mutant Strains Mice;Mutation;Neural Crest Cell;PDGF Signaling Pathway;PDGFA gene;PDGFRB gene;PI3K/AKT;Palate;Pathway interactions;Pattern;Phenotype;Phosphorylation;Platelet-Derived Growth Factor;Platelet-Derived Growth Factor Receptor;Population;Prevention;Process;RNA Interference;Resources;Role;Signal Pathway;Signal Transduction;Tissues;Validation;cell motility;cell type;craniofacial;in vivo;insight;migration;mutant;neoplastic;novel;repository;research study;response;skeletal disorder","Growth Factor Signaling and Craniofacial Development"," Craniofacial developmental diseases including cleft lip or palate are the most prevalent birth defects in the human population worldwide. The major aims of this proposal are to identify mechanisms controlled by PDGF signaling that underlie normal development of the midface. We will investigate how PDGF controls neural crest cell migration, identify downstream intracellular signaling pathways involved in midline development, and characterize the transcriptional targets that mediate these processes.  
    

","NIDCR","8221516","11/11/2011 12:00:00 AM","PA-10-067","1R01DE022363-01","1","R01","DE","022363","01"," ","SCHOLNICK, STEVEN","12/1/2011 12:00:00 AM","11/30/2016 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1898203","SORIANO, PHILIPPE M","Not Applicable","13","ANATOMY/CELL BIOLOGY","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","SCHOOLS OF MEDICINE","100296574","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","363325","251265"," ","614590",
"Biotechnology; Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Angiogenic Factor;Apoptosis;Area;Blood Circulation;Blood Vessels;Brain Neoplasms;Cell Fraction;Cell Line;Cells;Complex;Coupled;Data;Dependency;Development;Ensure;Environment;Equilibrium;Evaluation Studies;Genomics;Goals;Growth;Heterogeneity;Homeostasis;Human;Immunofluorescence Immunologic;In Situ;In Vitro;Knowledge;Label;Maintenance;Malignant Neoplasms;Mediating;Melanoma Cell;Mesenchymal;Metabolic;Microcirculation;Microspheres;Modeling;Molecular;Morphogenesis;Neoplasm Metastasis;Nutrient;Pattern;Perfusion;Pericytes;Population;Property;Proteomics;RNA Interference;Resistance;Signal Pathway;Signal Transduction;Staging;Stem cells;Structure;Testing;Therapeutic;Time;Tissues;Treatment Failure;Up-Regulation;Validation;Vascular Endothelial Growth Factors;Virulence;Virulent;Xenograft Model;angiogenesis;autocrine;base;bone morphogenetic protein 7;cadherin 5;cancer therapy;density;gain of function;in vivo;laser capture microdissection;loss of function;melanoma;mimicry;novel;novel therapeutics;paracrine;reconstitution;self-renewal;spatial relationship;tumor;tumor growth;tumor progression","BMP7 in melanoma niche morphogenesis and homeostasis","
Narrative
Melanoma is notoriously resistant to conventional anti-cancer therapies, largely attributed to a subpopulation of
cells with stem cell-like properties known as melanoma-initiating cells (MICs). The purpose of this study is to
elucidate the mechanisms whereby MICs and their tissue environment collaborate to ensure survival and to
promote tumor growth. We believe that defining such mechanisms offers a novel opportunity to therapeutically
eliminate MICs directly or indirectly by targeting their dependency on tissue environment.","NCI","8081807","3/27/2012 12:00:00 AM","PA-07-070","5R01CA138649-03","5","R01","CA","138649","03"," ","JHAPPAN, CHAMELLI","6/4/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","8133026","HSU, MEI-YU ","Not Applicable","07","DERMATOLOGY","604483045","FBYMGMHW4X95","604483045","FBYMGMHW4X95","US","42.336234","-71.070647","894901","BOSTON UNIVERSITY MEDICAL CAMPUS","BOSTON","MA","SCHOOLS OF MEDICINE","021182841","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","128112"," ","329387",
"Biotechnology; Clinical Research; Eye Disease and Disorders of Vision; Genetics; Human Genome; Neurodegenerative; Rare Diseases","Affect;Alleles;Anterior;Axenfeld-Rieger syndrome;BMPR1A gene;Binding;Biological Assay;Brain;Candidate Disease Gene;Cell Culture Techniques;Cell Separation;Cells;Code;Collecting Cell;Confidential Information;Conserved Sequence;Data;Defect;Development;Disease;Distant;Down-Regulation;Embryo;Embryonic Eye;Enhancers;Eye;Eye Development;Failure;Fishes;Funding;Gene Chips;Gene Expression;Genes;Genetic Enhancer Element;Genome;Glaucoma;Goals;Green Fluorescent Proteins;Health;Human;Hybridization Array;In Vitro;Indium;Lead;Mediating;Mesenchymal;Mesenchyme;Microarray Analysis;Modeling;Molecular;Mutagenesis;Mutation;Nucleic Acid Regulatory Sequences;Nucleotides;Pathway interactions;Patients;Persons;Phenotype;Play;Publishing;RalDH1;Reagent;Regulation;Regulatory Element;Reporting;Research Design;Research Methodology;Resources;Role;Sampling;Site;Staging;Structure;Technology;Transcript;Transcriptional Activation;Transgenic Organisms;Undifferentiated;Vertebrates;Work;Zebrafish;Zinc Fingers;abstracting;chromatin immunoprecipitation;cohort;craniofacial;human disease;in vivo;innovation;insight;migration;migratory population;mutant;novel;nuclease;therapeutic target;transcription factor;zebrafish genome","Molecular Mechanisms of Axenfeld-Rieger Syndrome"," PITX2 is essential for normal eye development. This proposal will investigate how PITX2 is involved in eye development by identifying other genes that regulate PITX2 expression and genes that are controlled by PITX2 activities. The results of this project will provide better understanding of eye development and will likely identify new causes of human ocular conditions like glaucoma, which may lead to new treatment opportunities.  
  
    

","NEI","8306684","6/11/2012 12:00:00 AM","PA-10-067","5R01EY015518-06","5","R01","EY","015518","06"," ","CHIN, HEMIN R","12/1/2004 12:00:00 AM","6/30/2016 12:00:00 AM","Anterior Eye Disease Study Section[AED]"," ","6724798","SEMINA, ELENA V","Not Applicable","05","PEDIATRICS","937639060","E8VWJXMMUQ67","937639060","E8VWJXMMUQ67","US","43.04575","-88.020374","46001","MEDICAL COLLEGE OF WISCONSIN","MILWAUKEE","WI","SCHOOLS OF MEDICINE","532263548","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","250000","117500"," ","367500",
"Biotechnology; Cancer; Genetics; Ovarian Cancer; Rare Diseases","3&apos; Untranslated Regions;Address;Binding;Cancer Patient;Cancer cell line;Cause of Death;Cells;Cellular Morphology;Development;Diagnosis;Disease;EGF gene;Education;Educational process of instructing;Environment;Epidermal Growth Factor;Epidermal Growth Factor Receptor;Event;Faculty;Flow Cytometry;Gene Expression;Gene Expression Regulation;Gene Targeting;Genetic Transcription;Genomics;Goals;Home environment;Human;Malignant Female Reproductive System Neoplasm;Malignant Neoplasms;Malignant neoplasm of ovary;Mentorship;Messenger RNA;MicroRNAs;Microscopy;Molecular;NCI-Designated Cancer Center;Neoplasm Metastasis;New Mexico;Nucleotides;Oncogenes;Outcome;Ovarian Tissue;Pathway interactions;Patients;Positioning Attribute;RNA;Receptor Signaling;Regulation;Repression;Research;Research Personnel;Resources;Role;Scientist;Snails;Testing;Time;Tissue Sample;Translations;Tumor Cell Invasion;Universities;Woman;base;cancer cell;career;cohort;epithelial to mesenchymal transition;malignant ascites;member;neoplastic cell;new therapeutic target;novel;novel diagnostics;outcome forecast;ovarian neoplasm;overexpression;prevent;programs;receptor expression;receptor function;skills;tumor;tumor progression","Epidermal growth factor regulation of miR-125a promotes invasive ovarian cancer","n/a","NCI","8300239","7/24/2012 12:00:00 AM","PA-07-297","5R00CA133190-05","5","R00","CA","133190","05"," ","SATHYAMOORTHY, NEERAJA","9/23/2010 12:00:00 AM","8/31/2014 12:00:00 AM","NSS"," ","8666881","COWDEN DAHL, KAREN DENISE","Not Applicable","07","BIOCHEMISTRY","603007902","SHHBRBAPSM35","603007902","SHHBRBAPSM35","US","39.780714","-86.174977","577806","INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS","INDIANAPOLIS","IN","SCHOOLS OF MEDICINE","462022915","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","156837","84693"," ","241530",
"Atherosclerosis; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease","Ablation;Adipocytes;Apolipoprotein E;Arterial Fatty Streak;Atherosclerosis;Blood Vessels;Breeding;C-terminal;Cells;Chondrocytes;Data;Development;Disease;Down-Regulation;Exons;Gene Expression;Gene Expression Regulation;Genes;Growth;Hydrogen Peroxide;In Vitro;Knockout Mice;Lesion;Mediator of activation protein;Mesenchymal;Modeling;Molecular;Morbidity - disease rate;Mus;Neonatal;Osteoblasts;Osteogenesis;Oxidative Stress;PI3K/AKT;Pathogenesis;Pharmaceutical Preparations;Play;Prevention;Process;Production;Proteins;Publishing;Reactive Oxygen Species;Regulation;Role;Series;Signal Transduction;Smooth Muscle;Smooth Muscle Myocytes;Staging;System;Testing;Therapeutic Intervention;Transgenic Mice;United States;Vascular calcification;base;bone;calcification;hypercholesterolemia;in vivo;insight;mortality;mouse model;mutant;novel strategies;osteogenic;overexpression;public health relevance;response;transcription factor","Molecular Signaling in Oxidative Stress-induced Vascular Calcification","
NARRATIVE
Vascular calcification in atherosclerotic plaques is a prominent feature of atherosclerosis, a major cause of
mortality and morbidity in the United States. We have demonstrated an essential role of Runx2 in vascular
calcification in vitro. This proposal will further characterize role of Runx2 in vascular calcification in vivo and
investigate the Runx2-regulated molecular signals in oxidative stress-induced vascular calcification. These
studies will provide important molecular insights into understanding the pathogenesis of atherosclerosis, which
will leads to development of novel strategy or drugs for atherosclerosis prevention or therapy.
PHS 398/2590 (Rev. 09/04, Reissued 4/2006) Page Continuation Format Page","NHLBI","8243562","3/15/2012 12:00:00 AM","PA-07-070","5R01HL092215-04","5","R01","HL","092215","04"," ","LIU, LIJUAN","4/1/2009 12:00:00 AM","3/31/2014 12:00:00 AM","Atherosclerosis and Inflammation of the Cardiovascular System Study Section[AICS]"," ","8079676","CHEN, YABING ","Not Applicable","07","PATHOLOGY","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","SCHOOLS OF MEDICINE","352940001","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","253586","109848"," ","363434",
"No NIH Category available","Address;Adult;Apical;Architecture;Binding;Biochemical;Biological Assay;Boxing;Cartoons;Cell Polarity;Cells;Cilia;Cues;Cystic Kidney Diseases;Data;Development;Disease;Drosophila genus;Epidermis;Epithelial;Epithelial Cells;Epithelium;Event;Evolution;Extracellular Domain;Family;Genes;Genetic;Goals;Hair;Labyrinth;Ligands;Link;Logic;Maintenance;Malignant Neoplasms;Mammalian Oviducts;Mammals;Medical;Membrane;Membrane Proteins;Mesenchymal;Molecular;Morphogenesis;Mus;Mutation;Organ;Pathway interactions;Pattern;Phosphorylation;Phosphotransferases;Process;Proteins;Proto-Oncogenes;Reading;Regulation;Research;Sensory;Signal Pathway;Signal Transduction;Skin;Structure;Tissues;Tumor Suppressor Proteins;Vertebrates;Wing;base;carcinogenesis;cell growth regulation;cell motility;cell type;ciliopathy;deafness;fly;follow-up;gastrulation;genetic regulatory protein;genome wide association study;genome-wide;high risk;in vivo;insight;interest;novel;receptor;response","A Novel Signaling Pathway in Planar Cell Polarity Establishment"," Cellular polarity is a critical feature of organ development and function. The establishment and maintenance of epithelial planar cell polarity (PCP) features are linked to several diseases, ranging from cancer to ciliopathies and deafness. Whereas cellular aspects of PCP are beginning to be understood, the long-range regulation of this process remains obscure. The scope of this application is to identify the components required for long-range PCP regulation. The information acquired here is of high significance for several medical disorders.   
   
      

","NICHD","8368456","7/20/2012 12:00:00 AM","PA-10-069","1R21HD073872-01","1","R21","HD","073872","01"," ","MUKHOPADHYAY, MAHUA","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","6477169","MLODZIK, MAREK ","Not Applicable","13","ANATOMY/CELL BIOLOGY","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","SCHOOLS OF MEDICINE","100296574","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","150000","102978"," ","252978",
"Dental/Oral and Craniofacial Disease; Pediatric; Pediatric Research Initiative","Apoptosis;Arts;Attenuated;Bacterial Artificial Chromosomes;Cell Cycle;Cell Cycle Arrest;Cell Proliferation;Cleft Palate;Complex;Congenital Abnormality;Data;Distant;Engineering;Enhancers;Epithelial;Epithelial Cells;Epithelium;Event;Experimental Models;Failure;Funding;Gene Expression;Genes;Genetic Transcription;Genomics;Grant;Growth;Health;Human;In Vitro;LacZ Genes;Lead;MAPK14 gene;Medial;Mediating;Mesenchymal;Mesenchyme;Molecular;Morphology;Mus;Organ Culture Techniques;Pathogenesis;Pattern;Phosphotransferases;Play;Regulatory Element;Reporter;Reporting;Role;Signal Pathway;Signal Transduction;Surface;Surveys;Syndrome;Techniques;Testing;Tissues;Transforming Growth Factor beta;Transforming Growth Factors;Transgenic Mice;Transgenic Organisms;Work;base;in vivo;inhibitor/antagonist;knockout gene;mutant;notch protein;novel;palatal fusion;palatal shelves;palatogenesis;public health relevance;research study;transforming growth factor beta3","The Role of TGF-Beta3 in Palatogenesis","
Cleft palate is one of the most common congenital birth defects in humans. The proposed
studies dissect the role of a transforming growth factor-beta signaling in the pathogenesis
of cleft palate. We expect that the proposed studies will be important in understanding of
the underlying molecular mechanisms that lead to the cleft palate syndrome in humans.","NIDCR","8514776","7/26/2012 12:00:00 AM","PA-07-070","3R01DE013085-13S1","3","R01","DE","013085","13","S","SCHOLNICK, STEVEN","2/1/2001 12:00:00 AM","2/28/2015 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","2740729","KAARTINEN, VESA M","Not Applicable","12","DENTISTRY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF DENTISTRY/ORAL HYGN","481091276","UNITED STATES","N","9/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","118051","43013"," ","161064",
"Cancer; Genetics; Lung; Lung Cancer; Rare Diseases","Address;Alleles;Animal Model;Animals;Cancer Etiology;Cell Proliferation;Cell Survival;Cell model;Cells;Cessation of life;Cytoskeleton;Data;Death Rate;Dependence;Detection;Diagnosis;Diagnostic Neoplasm Staging;Disease;Endocytosis;Epithelial Cells;Epithelium;Family;Gene Expression;Goals;Health;Human;K-ras Gene;Knock-out;Knowledge;Light;Lung;Lung Adenocarcinoma;Lung Neoplasms;Malignant Neoplasms;Malignant neoplasm of lung;Mediating;Modeling;Molecular;Monomeric GTP-Binding Proteins;Mus;Mutant Strains Mice;Mutate;Mutation;Nature;Neoplasm Metastasis;Normal Cell;Oncogenes;Oncogenic;Outcome;Pathway interactions;Physiological;Play;Prevalence;Process;Protein Family;RNA Splicing;Regulation;Reporting;Role;Signal Pathway;Staging;System;Testing;Tissues;Toxic effect;Work;base;cell motility;epithelial to mesenchymal transition;in vivo;member;mouse model;public health relevance;rac GTP-Binding Proteins;rho;therapeutic development;tumor;tumor initiation;tumor progression;tumorigenesis;tumorigenic","The Role of RAC1 in Cancer","
Public Health Relevance Statement
 The studies proposed will shed light on the process of tumor initiation and
progression and enhance our understanding of the molecular pathways involved in lung
cancer. The finding that Rac1b might function as an oncogene and that loss of Rac1 is
""lethal"" in the context of activated K-ras raises the possibility that targeting Rac1 in Ras-
mutated tumors would be therapeutically beneficial with, perhaps, limited toxicity towards
normal cells. Given the prevalence of Ras mutations in human cancer these finds could
potentially have an impact on a broad spectrum of cancers.","NCI","8509172","7/27/2012 12:00:00 AM","PA-07-070","7R01CA124495-05","7","R01","CA","124495","05"," ","WATSON, JOANNA M","3/1/2009 12:00:00 AM","12/31/2013 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","7260889","KISSIL, JOSEPH ","Not Applicable","18","Unavailable","148230662","MGUCX773RNJ8","148230662","MGUCX773RNJ8","US","26.933813","-80.128954","10005569","SCRIPPS FLORIDA","JUPITER","FL","Research Institutes","334585284","UNITED STATES","N","8/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","75000","73500"," ","148500",
"Breast Cancer; Cancer; Colo-Rectal Cancer; Digestive Diseases; Rare Diseases","1-Phosphatidylinositol 3-Kinase;Activins;Antibodies;Binding;Biological Process;Breast Cancer Cell;CFC1 gene;Cancer cell line;Carcinoma;Cell surface;Chordata;Colon Carcinoma;Dimerization;EGF gene;Embryo;Epithelial;Epithelial Cells;Family;Genes;Germ Layers;Glypican;Human;In Vitro;Invaded;Laboratory Study;Left;MAP Kinase Gene;Maintenance;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Mammary Neoplasms;Mammary gland;Mesenchymal;Mus;Nodal;Pathogenesis;Phase I Clinical Trials;Receptor Serine/Threonine Kinase;Regulation;Research;Role;SRC gene;Signal Pathway;Signal Transduction;Tissue Microarray;Toxin Conjugates;Transforming Growth Factor beta;Transforming Growth Factor beta Receptors;Transgenes;beta catenin;design;embryonic stem cell;gastrulation;in vivo;malignant breast neoplasm;malignant stomach neoplasm;mouse development;nodal protein;overexpression;pluripotency;programs;receptor;self-renewal;transcription factor","The Role of Cripto in the Pathogenesis of Breast and Colon Cancer","n/a","NCI","8552609"," "," ","1ZIABC009003-30","1","ZIA","BC","009003","30"," "," "," "," "," "," ","6569164","SALOMON, DAVID ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","1203804",
"Cancer; Ovarian Cancer; Rare Diseases","Accounting;Adhesions;Affect;Ascites;Biochemical;Biological Assay;Biomechanics;Biophysics;Cadherins;Cancer Etiology;Cause of Death;Cell Line;Cells;Cessation of life;Collagen;Complement;Data;Development;Disease;E-Cadherin;EGF gene;Environment;Epithelial;Epithelial ovarian cancer;Epithelium;Event;Fluorescence Microscopy;Funding;Gel;Goals;Greater sac of peritoneum;Gynecologic;Human;Hybrid Cells;Hybrids;Intervention;Label;Life;Liquid substance;Lysophospholipids;Malignant Neoplasms;Measures;Mechanics;Mesenchymal;Mesothelium;Metalloproteases;Metastatic Lesion;Metastatic to;Modeling;Molecular;Mus;N-Cadherin;Neoplasm Metastasis;Newly Diagnosed;Ovarian;Ovarian Carcinoma;Patients;Peritoneal;Peritoneal Fluid;Population;Primary Neoplasm;Prognostic Factor;Proliferating;Property;Proteins;Receptor Cross-Talk;Regulation;Role;Secondary Lesion;Shapes;Signal Transduction;Stretching;Suspension substance;Suspensions;Therapeutic;Woman;base;design;implantation;improved;in vitro Assay;in vivo;intraperitoneal;lysophosphatidic acid;metastatic process;mimetics;model development;ovarian neoplasm;pressure;public health relevance;research study;shear stress;success;tumor","Receptor Cross-Talk in Early Metastatic Dissemination","
Narrative
Epithelial ovarian cancer (EOC) will affect 1 out of every 69 women born in the US today. Currently 80% of
women newly diagnosed with EOC already have metastatic disease. The long-term goal of these studies is
to gain a molecular level understanding of EOC metastasis to design strategies to more effectively target
metastatic disease.","NCI","8391939","5/25/2012 12:00:00 AM","PA-10-067","7R01CA109545-06","7","R01","CA","109545","06"," ","JHAPPAN, CHAMELLI","7/1/2006 12:00:00 AM","5/31/2016 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1898911","STACK, MARY SHARON","Not Applicable","02","CHEMISTRY","824910376","FPU6XGFXMBE9","824910376","FPU6XGFXMBE9","US","41.702007","-86.246548","6169301","UNIVERSITY OF NOTRE DAME","NOTRE DAME","IN","SCHOOLS OF ARTS AND SCIENCES","465565708","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","196085","101964"," ","298049",
"Cardiovascular; Genetics; Heart Disease; Pediatric","ADAMTS1 gene;Award;Binding;Biochemical;Biological Assay;Biology;Candidate Disease Gene;Cardiac Jelly;Cardiovascular system;Cells;Chromatin;Chromatin Remodeling Factor;Chromatin Structure;Complex;Congenital Abnormality;Congenital Heart Defects;Defect;Development;Developmental Process;Diagnostic;Embryo;Event;Extracellular Matrix;Faculty;Gene Activation;Genes;Genetic;Genetic Transcription;Goals;Heart;Heart Diseases;Human;In Situ Hybridization;Inherited;Laboratories;Laboratory Research;Manuscripts;Mediating;Medical;Memory;Mesenchymal;Modification;Molecular;Morphogenesis;Mus;Muscle;Muscle Cells;Myocardium;Nucleosomes;Oregon;Pathway interactions;Pattern;Peptide Hydrolases;Phenotype;Positioning Attribute;Proteins;Publications;Recruitment Activity;Recycling;Regulation;Repression;Research;Reverse Transcriptase Polymerase Chain Reaction;Role;Series;Signal Pathway;Signal Transduction;Specific qualifier value;Staging;Testing;Thick;Tissues;Transact;Transcript;Universities;Work;base;cardiogenesis;chromatin remodeling;derepression;embryo culture;improved;independency;mutant;novel;post-doctoral training;premature;prevent;programs;research study;response;transcription factor","Chromatin Remodeling in Cardiovascular Development","The studies will reveal novel genetic and molecular interactions controlling mammalian cardiovascular 
development. The regulatory networks to be described will include new candidate genes to be disrupted in 
human congenital heart defects. As such, this research program has medical relevance towards identifying 
improved diagnostics and eventually treatments for this most common class of birth defects.","NHLBI","8310027","7/27/2012 12:00:00 AM","PA-07-297","5R00HL087598-05","5","R00","HL","087598","05"," ","SCHRAMM, CHARLENE A","8/2/2010 12:00:00 AM","7/31/2014 12:00:00 AM","NSS"," ","8630210","STANKUNAS, KRYN ","Not Applicable","04","BIOCHEMISTRY","079289626","Z3FGN9MF92U2","079289626; 948117312","J2KGU972RXG3; Z3FGN9MF92U2","US","44.035646","-123.05255","6297005","UNIVERSITY OF OREGON","EUGENE","OR","ORGANIZED RESEARCH UNITS","974035219","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","230556","18444"," ","249000",
"Biotechnology; Clinical Research; Digestive Diseases; Genetics; Infant Mortality/ (LBW); Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal Period - Conditions Originating in Perinatal Period; Rare Diseases","Abdomen;Acute;Affect;Allergic;Appearance;Area;Bioinformatics;Biological Markers;Biological Process;Birth;Breast Feeding;Clinical;Complex;Data;Detection;Development;Developmental Gene;Diagnosis;Disease;Enrollment;Enteral Feeding;Enzymes;Feces;Feeds;Fissure in Ano;Functional disorder;Funding;Future;Gastrointestinal tract structure;Gene Expression;Gene Expression Profile;Gene Proteins;Gene Targeting;Genes;Genomics;Goals;Grant;Heme;Hour;Hypersensitivity;IgE;Immune;Infant;Inflammatory;Learning;Libraries;Mentored Clinical Scientist Development Award (K08);Mentors;Mesenchymal;Molecular Profiling;Necrotizing Enterocolitis;Neonatal;Nervous system structure;Operative Surgical Procedures;Oral;Pathologic Processes;Pathology;Pathway interactions;Pregnancy;Premature Infant;Process;Proteomics;RNA;Readiness;Research Personnel;Research Project Grants;Residual state;Resources;Risk;Saliva;Salivary;Sampling;Specialist;Staging;Testing;Time;Training and Education;Transcript;Translational Research;Universities;Up-Regulation;Writing;base;biobank;cell motility;cohort;comparative;computer science;cytokine;feeding;gastrointestinal system;interest;medical schools;meetings;neonate;neurodevelopment;novel;premature;professor;protective effect;success","Neonatal Salivary Genomic Profiles To Access Feeding Tolerance and Disease","n/a","NICHD","8294773","4/24/2012 12:00:00 AM","PA-06-512","5K08HD059819-04","5","K08","HD","059819","04"," ","GRAVE, GILMAN D","6/10/2009 12:00:00 AM","5/31/2014 12:00:00 AM","Obstetrics and Maternal-Fetal Biology Study Section[CHHD-B]"," ","9324872","MARON, JILL LAMANNA","Not Applicable","07","Unavailable","079532263","MY2ERHGDV956","079532263","MY2ERHGDV956","US","42.349496","-71.063738","130301","TUFTS MEDICAL CENTER","BOSTON","MA","Independent Hospitals","021111552","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","865","Other Research-Related","2012"," "," ","NICHD","114250","9140"," ","123390",
"Cancer; Rare Diseases","Adherent Culture;Angioinvasion;Attenuated;Cell Line;Cell physiology;Cell-Cell Adhesion;Cells;Cellular Structures;Clinical;Complement;Data;Defect;Disease;Dissociation;Down-Regulation;E-Cadherin;Employee Strikes;Environment;Epithelial;Exhibits;Genes;Guanosine Triphosphate Phosphohydrolases;Health;Human;In Vitro;Intercellular Junctions;Maintenance;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of thyroid;Molecular;Morphology;Neoplasm Metastasis;Outcome;Papillary thyroid carcinoma;Pathogenesis;Primary Neoplasm;Property;Rattus;Regulation;Role;Sampling;Signal Transduction;Specimen;Structure;Testing;Thyroid Gland;Thyroid carcinoma;Tumor Cell Line;Vimentin;base;cell motility;clinically significant;epithelial to mesenchymal transition;human tissue;lymph nodes;matrigel;neoplastic cell;outcome forecast;research study;thyroid neoplasm;tumor;tumor progression","Rap1Gap and Tumor Progression","
Narrative
This proposal investigates the contribution and clinical significance of decreased Rap1GAP
expression to the progression of human thyroid tumors. Studies in human thyroid tumor cell
lines will elucidate the mechanism through which downregulation of Rap1GAP attenuates
cell/cell adhesion and investigate whether loss of Rap1GAP enhances migratory and invasive
potential. Studies in human tumor specimens will identify the subtypes of thyroid tumors that
exhibit Rap1GAP downregulation, assess whether decreased expression of Rap1GAP is
correlated with the presence of metastatic disease at presentation, examine whether Rap1GAP
expression is further decreased in lymph node metastases compared to primary tumors and
assess whether Rap1GAP expression is correlated with the presence of angioinvasion or
lymphoinvasion, markers of poor prognosis.","NCI","8257588","5/18/2012 12:00:00 AM","PA-07-070","5R01CA127986-04","5","R01","CA","127986","04"," ","SNYDERWINE, ELIZABETH G","7/1/2009 12:00:00 AM","5/31/2014 12:00:00 AM","Molecular and Cellular Endocrinology Study Section[MCE]"," ","1939700","MEINKOTH, JUDY L","Not Applicable","03","PHARMACOLOGY","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","120765"," ","322040",
"Infant Mortality/ (LBW); Lung; Pediatric; Pediatric Research Initiative; Perinatal - Birth - Preterm (LBW); Perinatal - Neonatal Respiratory Distress Syndrome; Perinatal Period - Conditions Originating in Perinatal Period; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adult;Alveolar;Arts;Behavior;Bleomycin;Blood Vessels;Borderline Personality Disorder;Bronchopulmonary Dysplasia;Cell Proliferation;Cells;Chronic lung disease;Consensus;Data;Defect;Development;Ectopic Expression;Employee Strikes;Epithelial;Experimental Models;FGF10 gene;Fibrosis;Genetically Engineered Mouse;Growth Factor;Histologic;Human;Hyperoxia;In Vitro;Infant;Injury;Interruption;Link;Lung;Measures;Mediating;Mesenchymal;Mesenchyme;Modeling;Molecular Genetics;Morphogenesis;Mus;Neonatal;Newborn Animals;PIK3CG gene;Pathogenesis;Pathway interactions;Premature Birth;Premature Infant;Process;Pulmonary Fibrosis;Research Project Grants;Rest;Role;Severities;Signal Pathway;Signal Transduction;Signaling Molecule;Stem cells;Testing;Time;Transforming Growth Factor beta;Transgenic Mice;base;in utero;in vivo;in vivo Model;lung development;lung injury;mouse model;overexpression;receptor;research study","MECHANISMS OF BPD PATHOGENESIS"," This research project uses experimental models to elucidate how excess TGF-beta, a growth  factor, implicated in chronic lung disease in prematurely born infants causes abnormal  behavior of lung cells and hence lung injury.  
    

","NHLBI","8239005","12/30/2011 12:00:00 AM","PA-10-067","1R01HL107307-01A1","1","R01","HL","107307","01","A","LIN, SARA","1/1/2012 12:00:00 AM","11/30/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-CVRS-G(03)M]"," ","1876418","MINOO, PARVIZ MINOO","Not Applicable","37","PEDIATRICS","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF MEDICINE","900894304","UNITED STATES","N","1/1/2012 12:00:00 AM","11/30/2012 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","264346","159232"," ","423578",
"Atherosclerosis; Cardiovascular","Aging;Apolipoprotein E;Arterial Fatty Streak;Arteries;Atherosclerosis;Blood Vessels;Cartilage;Cell Lineage;Cell membrane;Cells;Chondrogenesis;Chronic Kidney Failure;Controlled Study;Cysteamine;Cysteine;Diabetes Mellitus;Disease;Enzymes;Gene Expression;Generations;Glutamate-Cysteine Ligase;Grant;Granuloma;In Situ;Inflammation;Inflammatory;Inflammatory disease of the intestine;Kidney Failure;Knock-out;Licensing;Link;Mesenchymal;Metabolism;Modeling;Molecular;Mus;Osteoblasts;Osteogenesis;Outcome;Oxidation-Reduction;Oxidative Stress;PPAR gamma;Phenotype;Physiological;Plastics;Process;Reporting;Signal Transduction;Smooth Muscle Myocytes;Stress;Sulfhydryl Compounds;Testing;Tissues;Tunica Media;Vascular calcification;abstracting;aged;autocrine;bone;calcification;chondro osseous differentiation;cytokine;feeding;in vivo;infancy;inhibitor/antagonist;inorganic phosphate;insight;macrophage;morphogens;mortality;new therapeutic target;novel;osteoblast differentiation;pantetheinase;paracrine;precursor cell;prevent;progenitor;repaired;stressor;therapeutic target;vitamin metabolism","Molecular Mechanisms in Arterial Calcification","
Lay summary
Arterial calcification is one of the potential outcomes of blood vessel repair in
atherosclerosis, diabetes, chronic kidney disease, and aging. Artery calcification
promotes mortality in these conditions and our objective is to identify new targets for
therapies. In this project, we will define and test proposed mechanisms whereby linked
changes in an enzyme (Vanin-1) involved in defense against oxidative stress, and the
gene expression regulator PPARgamma, promote arterial calcification by switching on
cartilage and bone formation in diseased arteries.","NHLBI","8291308","6/14/2012 12:00:00 AM","PA-07-070","5R01HL077360-08","5","R01","HL","077360","08"," ","FLEG, JEROME L","7/1/2004 12:00:00 AM","6/30/2014 12:00:00 AM","Atherosclerosis and Inflammation of the Cardiovascular System Study Section[AICS]"," ","8045873","TERKELTAUB, ROBERT A.","Not Applicable","52","Unavailable","933863508","E4SPG9ZLLE76","933863508","E4SPG9ZLLE76","US","32.871802","-117.231348","2908201","VETERANS MEDICAL RESEARCH FDN/SAN DIEGO","SAN DIEGO","CA","Research Institutes","921610002","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","222750","92664"," ","315414",
"No NIH Category available","Achievement;Advocate;Algorithms;Antibodies;Autoantibodies;Automobile Driving;Bioinformatics;Biological Markers;Biology;Biometry;CD44 gene;Cancer Center;Cancer Patient;Caring;Clinical;Clinical Research;Clinical Trials;Clinical Trials Design;Communities;Detection;Development;Disease;Disease Resistance;Dose;Engraftment;Faculty;Functional disorder;Funding;Goals;Grant;Human;Hypoxia;Interferons;Lead;MAP Kinase Gene;MEK inhibition;MEKs;Malignant Neoplasms;Malignant neoplasm of ovary;Measures;Mesenchymal Stem Cells;Modeling;Molecular;Morbidity - disease rate;Mus;Mutation;Normal tissue morphology;Nuclear;Ovarian Carcinoma;Ovarian Serous Adenocarcinoma;PTEN gene;Pathology;Pathway interactions;Patients;Peer Review;Performance;Pericytes;Perifosine;Phase;Philanthropic Fund;Platinum;Postmenopause;Pre-Clinical Model;Predictive Value;Proteins;Proto-Oncogene Proteins c-akt;Publications;Recruitment Activity;Recurrence;Research Infrastructure;Research Personnel;Research Project Grants;Resistance;Risk;Role;Route;Screening for Ovarian Cancer;Screening procedure;Series;Services;Signal Transduction;Small Interfering RNA;Specificity;Staging;Systems Biology;Testing;Time;Translational Research;Ultrasonography;Universities;University of Texas M D Anderson Cancer Center;VEGF Trap;Vascular Endothelial Growth Factors;Visit;WFDC2 gene;Wages;Woman;Work;Xenograft procedure;anticancer research;base;bevacizumab;cancer cell;cancer therapy;career development;docetaxel;human FRAP1 protein;imaging modality;improved;inhibitor/antagonist;innovation;interest;laboratory facility;mTOR Inhibitor;member;mortality;mutant;notch protein;operation;outcome forecast;peritoneal cancer;population based;pre-clinical;preclinical study;programs;response;translational clinical trial;tumor","The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer","n/a","NCI","8333269","9/4/2012 12:00:00 AM","PAR-08-020","5P50CA083639-13","5","P50","CA","083639","13"," ","COURTNEY, JOYANN","9/30/1999 12:00:00 AM","8/31/2015 12:00:00 AM","ZCA1-RPRB-M(M1)"," ","2717823","BAST, ROBERT C","Not Applicable","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","9/4/2012 12:00:00 AM","8/31/2013 12:00:00 AM","399","Research Centers","2012"," "," ","NCI","1521240","706036"," ","2227276",
"Cancer; Lung; Lung Cancer","A549;Antibodies;Cancer Etiology;Cancer Model;Cancer Patient;Cancer cell line;Cell Line;Cell physiology;Cells;Cessation of life;Collagen;Colon Carcinoma;Cultured Cells;Cytoskeleton;Distant;E-Cadherin;Epidermal Growth Factor;Epithelial;Epithelial Cells;Evaluation;Excision;Extracellular Matrix Proteins;Fibroblast Growth Factor 2;Fibroblasts;Fibronectins;Foundations;Gene Expression;Genes;Glass;Grant;Growth Factor;Hepatocyte Growth Factor;Immunofluorescence Immunologic;In Vitro;Insulin-Like Growth Factor II;Interleukin-1;Laminin;Lead;Libraries;Ligands;Link;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of prostate;Mediating;Mediator of activation protein;Mesenchymal;Monitor;Neoplasm Metastasis;Non-Small-Cell Lung Carcinoma;Operative Surgical Procedures;Outcome;Patients;Pharmaceutical Preparations;Phase;Physiological;Population;Primary Neoplasm;Printing;Process;Property;Proteins;Radiation therapy;Research;Research Personnel;Role;Screening for cancer;Screening procedure;Signal Transduction;Signaling Molecule;Site;Slide;Smooth Muscle Actin Staining Method;System;Technology;Therapeutic;Therapeutic Effect;Transforming Growth Factors;Tumor Cell Invasion;Validation;Vimentin;Western Blotting;base;cancer cell;cell behavior;chemotherapy;clinically relevant;connective tissue growth factor;conventional therapy;cytokine;drug discovery;extracellular;genetic analysis;in vitro Model;lung Carcinoma;lung carcinogenesis;malignant breast neoplasm;mortality;neoplastic cell;novel;novel therapeutics;tissue culture;tumor","Discovering Microenvironments Promoting Pathological EMT using Array Technology","  MicroStem will utilize a specialized cell array screening system to identify physiologically relevant microenvironments consisting of extracellular matrix proteins, growth factors, and signaling molecules that promote epithelial mesenchymal transition (EMT) of lung cancer cells. Our unique MicroMatrixTM array technology will provide a novel platform to understand the interaction between tumor cells and their microenvironment (cell-cell, cell-matrix). The results of our proposal will advance our basic understanding on tumor invasion and metastasis in lung cancer; and therefore, laying out a foundation to discover a better therapeutic effect of current chemotherapy and open a new front for novel therapeutic drugs.   
      

","NCI","8252561","8/28/2012 12:00:00 AM","PA-11-096","1R43CA165542-01","1","R43","CA","165542","01"," ","RAHBAR, AMIR M","9/1/2012 12:00:00 AM","12/28/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-OTC-H(14)B]"," ","10851749","SEROBYAN, NAIRA ","Not Applicable","49","Unavailable","831039362"," ","831039362"," ","US","32.896762","-117.221658","10023920","MICROSTEM, INC.","SAN DIEGO","CA","Domestic For-Profits","921211505","UNITED STATES","N","9/1/2012 12:00:00 AM","12/28/2013 12:00:00 AM","396","SBIR/STTR","2012"," "," ","NCI"," "," "," ","155532",
"Biotechnology; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Animal Model;Animals;Ants;Apoptotic;Bone Marrow;Bone Marrow Stem Cell;Cardiac;Cardiovascular Diseases;Cardiovascular Pathology;Cardiovascular system;Catabolism;Cell Death;Cell Differentiation process;Cell Proliferation;Cell Survival;Cell Therapy;Cells;Cessation of life;Cicatrix;Clinical Trials;Congestive Heart Failure;Coronary Arteriosclerosis;Cyclic GMP;Cyclic GMP-Dependent Protein Kinases;Cyclic Nucleotides;Cytoprotection;Data;Electron Microscopy;Electrophysiology (science);Engraftment;Environment;Enzymes;Equilibrium;Erectile dysfunction;Experimental Animal Model;Extensive Necrosis;Flow Cytometry;Gene Transfer;Growth Factor;Guanylate Cyclase;Health;Heart;Homing;Hormones;Human;Hydrolysis;Hypoxia;Image;In Vitro;Individual;Infarction;Injury;Intracellular Second Messenger;Ischemia;Ischemic Preconditioning;Lead;Lentivirus Vector;Mediating;Mediator of activation protein;Mesenchymal Stem Cells;MicroRNAs;Modality;Molecular;Molecular Biology;Morbidity - disease rate;Muscle Cells;Myocardial;Myocardial Infarction;Myocardial Ischemia;Myocardium;Natural regeneration;Neurotransmitters;Nitric Oxide;Organ;Patients;Pharmaceutical Preparations;Pharmacological Treatment;Phosphodiesterase Inhibitors;Protein Kinase;Proteomics;Pulmonary Hypertension;Resistance;Role;Safety;Second Messenger Systems;Signal Pathway;Signal Transduction;Simulate;Skeletal Muscle;Skeletal bone;Source;Stem cell transplant;Stem cells;Testing;Therapeutic;Tissues;Transplantation;Up-Regulation;Western World;alternative treatment;attenuation;base;biological systems;clinically relevant;cytokine;design;functional outcomes;heart cell;human subject;immunocytochemistry;in vivo;inhibitor/antagonist;innovation;interdisciplinary approach;novel strategies;paracrine;phosphoric diester hydrolase;prevent;protective effect;regenerative;release factor;repaired;response;second messenger;stem cell therapy;tadalafil","PDE5A  Inhibition Stimulates Stem Cell Survival & Differentiation","
LAY NARRATIVE
Myocardial infarction is the leading cause of congestive heart failure in the industrialized western world. This
proposal will study the powerful antiischemic effect of clinically approved, long acting erectile dysfunction
drug, tadalafil on stem cells for their enhanced survival and angiomyogenic differentiation after transplantation
into the infarcted heart. The proposed study using the PDE5A inhibitors may identify a potential therapeutic
role for these compounds for stem cell based de novo myocardial regeneration.","NHLBI","8197426","2/13/2012 12:00:00 AM","PA-07-070","5R01HL095375-04","5","R01","HL","095375","04"," ","SCHWARTZ, LISA","12/16/2008 12:00:00 AM","11/30/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-CVS-D(03)M]"," ","1873093","ASHRAF, MUHAMMAD ","Not Applicable","01","PATHOLOGY","041064767","DZ4YCZ3QSPR5","041064767","DZ4YCZ3QSPR5","US","39.142998","-84.503581","1523902","UNIVERSITY OF CINCINNATI","CINCINNATI","OH","SCHOOLS OF MEDICINE","452210001","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","407094","232044"," ","639138",
"Aging; Cancer; Genetics; Prostate Cancer; Urologic Diseases","Ablation;Actins;Adenocarcinoma Cell;Affect;Anabolism;Androgen Receptor;Androgen Therapy;Androgens;Animal Model;Behavior;Biological;Biological Markers;Castration;Cause of Death;Cell membrane;Characteristics;Chemoprevention;Cholesterol;Chromosomal Loss;Clinical;Code;Data;Disease;Disease Progression;Disease Resistance;Down-Regulation;EGFR gene;Elements;Epidermal Growth Factor Receptor;Evaluation;Fatty Acids;Frequencies;Genes;Goals;Hormones;Human;Infiltration;Laboratories;Link;Lipids;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Membrane;Membrane Microdomains;Mesenchymal;Metabolic;Metabolic Pathway;Metastasis Suppressor Proteins;Metastatic Prostate Cancer;Metastatic to;Modeling;Morbidity - disease rate;Neoplasm Metastasis;North America;Organ;Pain;Pathway interactions;Patients;Pattern;Phenotype;Positioning Attribute;Property;Prostate;Prostate Adenocarcinoma;Prostatic Neoplasms;Protease Inhibitor;Proteins;Publishing;RNA;Receptor Activation;Receptor Protein-Tyrosine Kinases;Resistance;Role;Series;Signal Transduction;Site;Skeleton;Solid Neoplasm;Study models;System;Testing;Therapeutic Intervention;Up-Regulation;advanced disease;base;cancer cell;cost;effective therapy;implantation;improved;in vivo;inhibitor/antagonist;insight;lipid biosynthesis;lipid metabolism;member;neoplastic cell;network models;novel;oncogene addiction;particle;prognostic;protein expression;public health relevance;research study;success;tumor;tumor growth;tumor progression","Amoeboid Membrane Dynamics in Prostate Cancer","
Project Narrative
This proposal originates from the recent discoveries by the Freeman laboratory that an actin-nucleating
protein, Diaphanous related formin-3 (DRF3), is an inhibitor of the ""amoeboid"" tumor phenotype and
that chromosomal loss at the gene encoding DRF3 occurs with high frequency in patients with
metastatic prostate cancer. DRF3 protein expression also declines with disease progression. The
mesenchymal-amoeboid transition (MAT) has recently been identified as a dynamic phenotypic
transition that can affect migration of tumor cells through matrices and reduce their sensitivity to
protease inhibitors. Our data indicate that DRF3 is positioned at a signal transduction node that controls
the MAT. Thus, DRF3 has the characteristics of a novel type of tumor- or metastasis-suppressor
protein. Our data suggest that this network is linked to anabolic lipogenesis, a feature of aggressive
tumor cells. The metabolic phenotype of tumor cells with amoeboid properties may make them
vulnerable to therapeutic interventions that target cholesterol or lipid metabolic pathways. Our goals are
to determine the biological consequences of DRF3 downregulation in prostate cancer, and to uncover
the MAT signaling network that responds to DRF3 silencing. These studies will provide new insight into
the relationship between membrane dynamics, lipid metabolism and castrate-resistant prostate cancer.
DRF3 loss and the MAT may also be functionally important in other solid tumor systems. Consequently,
these studies may provide information of more general significance to human cancer.","NCI","8206771","3/28/2012 12:00:00 AM","PA-07-070","7R01CA143777-03","7","R01","CA","143777","03"," ","MOHLA, SURESH","8/15/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","1883557","FREEMAN, MICHAEL R","Not Applicable","28","Unavailable","075307785","NCSMA19DF7E6","075307785","NCSMA19DF7E6","US","34.076546","-118.380008","1225501","CEDARS-SINAI MEDICAL CENTER","LOS ANGELES","CA","Independent Hospitals","900481804","UNITED STATES","N","3/28/2012 12:00:00 AM","1/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","237409","159064"," ","396473",
"Alcoholism; Brain Disorders; Conditions affecting unborn children; Dental/Oral and Craniofacial Disease; Fetal Alcohol Syndrome; Genetics; Mental Retardation (Intellectual and Developmental Disabilities (IDD)); Neurosciences; Pediatric; Perinatal Period - Conditions Originating in Perinatal Period; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Substance Abuse; Transplantation","Address;Adult;Affect;Age;Alcohol abuse;Alcohol consumption;Alcohol-Related Neurodevelopmental Disorder;Alcohol-related birth defects;Alcoholic Liver Diseases;Alcohols;Animal Model;Biological Process;Brain;Cardiovascular Diseases;Characteristics;Child;Clinical;DNA;DNA Methylation;Defect;Dental Pulp;Development;Disease;Dysmorphology;Embryo;Endocrine;Ensure;Epigenetic Process;Fetal Alcohol Syndrome;Fetal Growth Retardation;Functional disorder;Future;Generations;Goals;Grant;Health;Human;Immune System Diseases;Impairment;Injury;Knowledge;Maintenance;Malignant Neoplasms;Mediating;Mesenchymal Stem Cells;Modeling;Molecular;Molecular Profiling;Mus;Nervous System Trauma;Neural Crest;Neuraxis;Neuronal Differentiation;Organ;Osteoporosis;Outcome;Pancreatitis;Pathway interactions;Physiological;Play;Pregnancy;Process;Property;Regenerative Medicine;Regulation;Regulator Genes;Reporting;Research;Role;Signal Pathway;Somatic Cell;Stem cells;Study models;Systems Biology;Teenagers;Testing;Therapeutic;Undifferentiated;adult stem cell;alcohol effect;alcohol exposure;body system;cell type;chronic alcohol ingestion;clinical application;craniofacial;design;embryonic stem cell;epigenomics;fetal;human embryonic stem cell;human stem cells;improved;in vivo;induced pluripotent stem cell;innovation;novel;prevent;self-renewal;stem;stem cell biology;stem cell division;tool;transcriptomics;transdifferentiation","Alcohol-induced epigenetic alterations in human stem cells"," Alcohol abuse is known to cause abnormalities in a number of organ systems. Disorders most commonly associated with chronic alcohol consumption include alcoholic liver disease (ALD), pancreatitis, cardiovascular disease, endocrine dysfunction, osteoporosis, cancer, and immune dysfunction. It is still unanswered about what are the specific mechanisms by which alcohol induces developmental defects. This is important question to address in order for us to identify affected children at an early age and intervene to prevent or mitigate the damage. Outcomes from this proposal will significantly advance our understanding in human stem cell biology by elucidating epigenetic molecular signatures and pathways affected by alcohol exposure in human embryonic stem cells and human dental pulp stem cells. Stem cells may also prove valuable in developing therapeutic approaches for treating alcohol-induced physiological impairments and overt organ damage. Our understanding on the effect of alcohol on stem cells will be beneficial to design future clinical application of stem cells to improve human health.  
  
    

","NIAAA","8331617","6/27/2012 12:00:00 AM","RFA-ES-10-002","5R01AA021301-02","5","R01","AA","021301","02"," ","GAO, PETER","9/15/2011 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-GGG-H(50)R]"," ","6951767","KIM, YONG ","Not Applicable","33","DENTISTRY","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","900952000","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","273","Non-SBIR/STTR","2012"," "," ","NIAAA","239467","108900"," ","348367",
"Biotechnology; Gene Therapy; Genetics; Hematology; Orphan Drug; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human; Transplantation","A Mouse;Affect;Anabolism;Antibodies;Biology;Biomedical Engineering;Blood;Blood Cells;Blood Clot;Blood Coagulation Factor;Blood coagulation;Bone Marrow Transplantation;CD34 gene;Cell Lineage;Cells;Clinical;Clinical Trials;Data;Development;Disease;Drug Kinetics;Engineering;Engraftment;Factor VIII;Family suidae;Gene Mutation;Gene Transfer;Genetic;Goals;HIV;Hematopoietic;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Hemophilia A;Hemorrhage;Human;Immune Tolerance;Immune response;Immunization;Immunologic Deficiency Syndromes;Immunosuppression;In Vitro;Individual;Insertional Mutagenesis;Intravenous infusion procedures;Joints;Lentivirus Vector;Mesenchymal Stem Cells;Methods;Modeling;Modification;Morbidity - disease rate;Mus;Outcome;Pathway interactions;Patients;Performance;Phase I Clinical Trials;Plasma Proteins;Population;Procedures;Production;Property;Proteins;Protocols documentation;Reagent;Recombinants;Regimen;Reporting;Retroviral Vector;Retroviridae;SIV;Safety;Stem cell transplant;Stem cells;System;Testing;Therapeutic;Toxic effect;Transgenes;Transgenic Organisms;Translating;Transplantation;Transplantation Conditioning;Treatment Efficacy;Viral Genes;Xenograft procedure;arthropathies;base;clinically relevant;clinically significant;conditioning;cost;design;expression vector;gene therapy;gene therapy clinical trial;gene transfer vector;genetically modified cells;human F8 protein;in vivo;inhibitor/antagonist;mouse model;novel;preclinical study;promoter;protein expression;public health relevance;simian human immunodeficiency virus;stem;stem cell biology;success","Hematopoietic gene therapy for hemophilia A","
PROJECT NARRATIVE
Hemophilia A is a bleeding disorder caused by insufficiency of a blood clotting factor, designated factor VIII, for
which gene therapy offers a potential cure. However, pre-clinical studies and clinical trials showed that a major
limitation to a successful gene therapy treatment is the extremely poor expression of fVIII from the human fVIII
transgene, which we recently overcame by introducing a porcine fVIII transgene. We demonstrated that use of
the porcine transgene results in up to 100-fold greater fVIII production than the human version, and more
recently, we demonstrated that a similar differential is observed following gene transfer into blood stem cells
using recombinant retroviruses. Our current studies focus on better understanding the critical pharmacologic
parameters involved in generating curative fVIII levels with this procedure using a mouse model of hemophilia
A with the goal of understanding how this application can best be translated to clinical successes.","NHLBI","8230688","2/28/2012 12:00:00 AM","PA-07-070","5R01HL092179-04","5","R01","HL","092179","04"," ","LINK, REBECCA P","4/1/2009 12:00:00 AM","2/28/2014 12:00:00 AM","Gene and Drug Delivery Systems Study Section[GDD]"," ","2123578","DOERING, CHRISTOPHER BRADLEY","SPENCER, H TRENT","05","PEDIATRICS","066469933","S352L5PJLMP8","066469933","S352L5PJLMP8","US","33.762977","-84.42296","2384501","EMORY UNIVERSITY","ATLANTA","GA","SCHOOLS OF MEDICINE","303224250","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","137500"," ","387500",
"Biotechnology; Cancer; Gene Therapy; Genetics; Hematology; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Accounting;Adjuvant;Affect;Angiogenic Factor;Angiostatins;B lymphoid malignancy;Binding;Biology;Bone Diseases;Bone Marrow;Bone Pain;Bone Resorption;Bone remodeling;Cell Proliferation;Cell Therapy;Cells;Chemotherapy-Oncologic Procedure;Clinical Trials;Complement Factor B;Development;Disease;Disease Management;Disease Progression;Disease remission;Early treatment;Ectopic Expression;Endostatins;Engineered Gene;Engineering;Event;Gene Transfer;Genetic;Goals;Growth;Health;Hematologic Neoplasms;Homing;Human;Hypercalcemia;Infiltration;Integrins;Lead;Length;Lesion;Ligands;Limb structure;Long-Term Effects;Lytic;Marrow;Mesenchymal Stem Cells;Methods;Modality;Modification;Molecular;Morbidity - disease rate;Multiple Myeloma;Nuclear;Osteoblasts;Osteoclasts;Osteolytic;Pathological fracture;Pathology;Patients;Pelvis;Phase;Plasma Cells;Process;Proteins;Recombinant adeno-associated virus (rAAV);Recurrent disease;Relapse;Role;Skeleton;Staging;Stromal Cells;T-Lymphocyte;TNFSF10 gene;TNFSF11 gene;Testing;Therapeutic;Therapeutic Effect;Treatment Efficacy;Treatment Protocols;Tumor Angiogenesis;Tumor necrosis factor receptor 11b;Vascular Endothelial Growth Factors;Work;adeno-associated viral vector;angiogenesis;base;bone;bone loss;cell growth;chemotherapy;cranium;design;disease diagnosis;effective therapy;gene therapy;human disease;improved;in vivo;inhibitor/antagonist;long bone;mouse model;neoplastic cell;novel;osteoclastogenesis;osteogenic;osteopontin;pre-clinical;prevent;receptor;rib bone structure;spine bone structure;stem cell differentiation;stem cell therapy;tumor;tumor growth","Gene-Engineered and Targeted Stem Cell Therapy for Myeloma","
PROJECT NARRATIVE
Multiple myeloma is a B-cell malignancy characterized by the infiltration and growth of plasma cells in the
bone marrow. Patients with MM develop osteolytic bone disease permanently in the skull, ribs,
vertebrae, pelvis, and long bones of the limb, characterized by bone pain, pathologic fractures, and
hypercalcemia, making this a major cause of morbidity. Despite advances in chemotherapy regimens
used to treat patients with MM, the median length of survival after diagnosis of the disease is
approximately three years. Thus, newer therapies targeting multiple events of myeloma cell growth and
proliferation, including bone microenvironment and tumor vasculature need to be developed for
increasing patient survival. The central hypothesis of the proposed work is bone-targeted, genetically
engineered MSC therapy capable of inhibiting osteoclast activity by stable expression of OPG will be an
effective treatment for decreasing osteolytic bone lesions in MM. By combining the OPG therapy with
tumor-targeted chemotherapy and tumor vasculature-targeted anti-angiogenic gene therapy we seek to
establish a novel treatment paradigm for MM in a preclinical mouse model. Successful completion of
these studies will allow us to initiate phase-1 human clinical trials.","NCI","8247151","3/29/2012 12:00:00 AM","PA-07-070","5R01CA133737-04","5","R01","CA","133737","04"," ","YOVANDICH, JASON L","5/1/2009 12:00:00 AM","3/31/2014 12:00:00 AM","Developmental Therapeutics Study Section[DT]"," ","6379862","PONNAZHAGAN, SELVARANGAN ","Not Applicable","07","PATHOLOGY","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","SCHOOLS OF MEDICINE","352940001","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","201275","90574"," ","291849",
"Biotechnology; Cancer; Immunization; Orphan Drug; Ovarian Cancer; Rare Diseases; Vaccine Related","Abdominal Cavity;Address;Adhesions;Animal Model;Animals;Antibodies;Antigens;Antiviral Agents;Applications Grants;Attenuated Vaccines;Biometry;CA-125 Antigen;CD46 Antigen;Cancer Model;Cancer Patient;Carcinoembryonic Antigen;Catheters;Cell Line;Cell Therapy;Cell surface;Cells;Cessation of life;Clinic;Clinical;Complement;Cyclophosphamide;Diffusion;Disease;Dose;Engineering;Fox Chase Cancer Center;Gamma Cameras;Gene Expression;Genes;Giant Cells;Grant;Greater sac of peritoneum;Gynecologic;Herpesviridae;Human;Image;Immune;Immune response;Immunity;Immunology;Immunosuppressive Agents;Infection;Instruction;Intravenous;Iodine Isotopes;Isotopes;Laboratories;Letters;Malignant Female Reproductive System Neoplasm;Malignant Neoplasms;Malignant neoplasm of ovary;Measles;Measles Vaccine;Measles virus;Membrane Fusion;Mesenchymal Stem Cells;Minority;Molecular Medicine;Monitor;Morbidity - disease rate;Multiple Myeloma;Mus;Nude Mice;Oncolytic;Oncolytic viruses;Ovarian;Patients;Peptides;Peritoneal;Peritoneal Fluid;Personal Communication;Pharmaceutical Preparations;Phase;Phase I Clinical Trials;Process;Property;Radioactive Iodine;Recurrence;Recurrent disease;Research Personnel;SLC5A5 gene;Safety;Saimiri;Serum;Site;Stable Disease;Structure;Technetium;Testing;Therapeutic;Therapeutic Agents;Therapeutic Uses;Transgenes;Translating;United States;Viral;Viral Genes;Viral Proteins;Virus;Virus Receptors;Xenograft procedure;antitumor agent;cancer cell;cancer therapy;cytotoxicity;efficacy testing;gene therapy;improved;in vivo;innovation;intraperitoneal;intravenous administration;neoplastic cell;novel;novel strategies;novel therapeutics;outcome forecast;patient population;patient registry;phase 1 study;pre-clinical;programs;research clinical testing;research study;response;sample fixation;single photon emission computed tomography;sodium-iodide symporter;therapeutic transgene;tissue culture;tumor;tumor specificity","Optimizing Measles Virotherapy in the Treatment of Recurrent Ovarian Cancer","n/a","NCI","8380540","9/19/2012 12:00:00 AM","PAR-08-020","5P50CA136393-04","5","P50","CA","136393","04"," "," "," "," ","ZCA1-RPRB-M","7925","6107734","GALANIS, EVANTHIA ","PENG, KAH-WHYE ","01","Unavailable","006471700","Y2K4F9RPRRG7","006471700","Y2K4F9RPRRG7","US","44.022374","-92.465881","4976101","MAYO CLINIC ROCHESTER","ROCHESTER","MN","Other Domestic Non-Profits","559050001","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Research Centers","2012","372958","372958"," ","251920","121038"," "," ",
"Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine","Adult;Anatomy;Area;Biochemical Genetics;Cardiac;Cardiac Myocytes;Cause of Death;Cells;Cellular Structures;Cicatrix;Cytokine Gene;Development;Dilatation - action;Embryonic Heart;Epicardium;Epithelial;Epithelial Cells;Extracellular Matrix;Family;Fibroblasts;Fibrosis;Generations;Growth Factor;Heart;Heart Diseases;Heart failure;Hour;In Situ Hybridization;Infarction;Injection of therapeutic agent;Injury;Interruption;Lead;Maps;Mediating;Mediator of activation protein;Mesenchymal;Methods;Molecular;Molecular Genetics;Morbidity - disease rate;Mus;Muscle Cells;Myocardial;Myocardial Infarction;Myocardial rupture;Myocardium;Natural regeneration;Organogenesis;Pattern;Performance;Phenotype;Physiological;Play;Process;Proliferating;Proteins;Public Health;Pump;Regulation;Reporter;Role;Signal Transduction;Signaling Molecule;Site;Stress;Structure;Techniques;Technology;Therapeutic;Time;Tissues;United States;cardiac repair;cardiogenesis;cytokine;extracellular;hemodynamics;holistic approach;human SFRP4 protein;improved;injured;mortality;muscle form;novel;novel therapeutics;prevent;programs;promoter;public health relevance;repaired;research study;response;response to injury","Role of Wnts in Cardiac Repair","
PROJECT NARRATIVE
The adult heart following a heart attack does not regenerate damaged muscle but forms a non-functioning scar
in the injured region. We have identified that a developmentally important molecule known as Wnt1 contributes
to scar formation in the injured heart. In this proposal, we will determine how Wnt1 regulates scar formation in
the injured heart and aim to minimize scar formation and improve cardiac function through manipulation of Wnt
signaling.","NHLBI","8268991","5/8/2012 12:00:00 AM","PA-07-070","5R01HL102190-03","5","R01","HL","102190","03"," ","SCHWARTZ, LISA","6/15/2010 12:00:00 AM","5/31/2015 12:00:00 AM","Myocardial Ischemia and Metabolism Study Section[MIM]"," ","8670141","DEB, ARJUN ","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","118800"," ","366300",
"Biotechnology; Genetics; Human Genome; Nutrition; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Non-Human","Bioinformatics;Biological;Bone Surface;Calcitriol;Cell Count;Cell Survival;Cell physiology;Cells;Chromatin;Coupling;Custom;DNA;DNA Microarray Chip;Development;Employee Strikes;Epigenetic Process;Evaluation;Gene Chips;Gene Expression;Gene Expression Regulation;Gene Targeting;Genes;Genome;Growth;Health;Homeostasis;Hormones;Individual;Informatics;Life;Maintenance;Mediating;Medicine;Mesenchymal;Metabolic;Minerals;Modification;Molecular;Molecular Target;Nature;Osteoblasts;Osteoclasts;Output;Parathyroid gland;Pharmaceutical Preparations;Play;Process;Production;Proliferating;Property;RNA Polymerase II;Receptor Activation;Regulation;Relative (related person);Research;Role;Series;Site;Structure;Techniques;Therapeutic;Tissues;Undifferentiated;Veins;Vitamin D;Vitamin D Analog;Vitamin D3 Receptor;autocrine;base;bone;bone cell;cell growth;cell type;cellular targeting;chromatin immunoprecipitation;comparative;cytokine;density;design;genome wide association study;genome-wide;histone modification;insight;novel;osteoblast differentiation;paracrine;peptide hormone;precursor cell;receptor;skeletal;steroid hormone;tool;transcription factor","Dynamic Mechanisms of Vitamin D-Induced Gene Expression","
Narrative
Vitamin D plays significant roles both in the maintenance of mineral homeostasis and in
the control of cellular growth and function. The studies herein seek to enhance our
understanding of the mechanisms that underlie vitamin D action in bone cells such that
better and more selective medicines can be created.","NIDDK","8306852","5/31/2012 12:00:00 AM","PA-07-070","5R01DK072281-08","5","R01","DK","072281","08"," ","MARGOLIS, RONALD N","9/1/2005 12:00:00 AM","5/31/2013 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","6612277","PIKE, J WESLEY","Not Applicable","02","BIOCHEMISTRY","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","EARTH SCIENCES/RESOURCES","537151218","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","256861","117342"," ","374203",
"Genetics; Osteoporosis; Pediatric","Affect;Birth;Bone Marrow;Cartilage;Cell Differentiation process;Cells;Charcot-Marie-Tooth Disease;Chondrocytes;Collagen Type X;Commit;Complex;DNA Binding;Deformity;Demyelinations;Down-Regulation;Elements;Exhibits;FGFR2 gene;FGFR3 gene;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Genetic;Health;Human;In Situ Hybridization;Knockout Mice;Lead;MAPK1 gene;MAPK3 gene;Mediating;Mesenchymal;Mitogen-Activated Protein Kinases;Mus;Mutation;Osteoblasts;Osteocalcin;Osteogenesis;Osteopenia;Osteoporosis;Pathway interactions;Periosteal Cell;Periosteum;Peripheral Nerves;Phenotype;Play;Primary Ossification Center;Proteins;Regulation;Response Elements;Role;Signal Transduction;Skeletal Development;Syndrome;System;Testing;Time;Transgenes;Undifferentiated;base;beta catenin;bone;bone epiphysis;cartilage development;humerus;insight;neurodevelopment;novel;osteoblast differentiation;osteogenic;promoter;research study;skeletal;skeletal disorder;skeletogenesis;tibia;transcription factor","ERK Mitogen Activated Protein Kinases in Skeletogenesis","
Project Narrative
Human mutations in the molecules in the ERK MAPK pathway have been identified in a number
of skeletal syndromes. This study identifies novel regulatory mechanisms of bone formation by
ERK1 and ERK2. The identification of the regulatory mechanisms will provide much needed
information for controlling bone formation in various skeletal disorders such as osteoporosis and
genetic skeletal syndromes.","NIAMS","8289660","8/3/2012 12:00:00 AM","PA-07-070","5R01AR055556-04","5","R01","AR","055556","04"," ","TYREE, BERNADETTE","8/10/2009 12:00:00 AM","7/31/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1858783","GREENFIELD, EDWARD M.","Not Applicable","11","ORTHOPEDICS","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","SCHOOLS OF MEDICINE","441061712","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","213840","121889"," ","335729",
"Acute Respiratory Distress Syndrome; Clinical Research; Clinical Trials; Hematology; Infectious Diseases; Lung; Orphan Drug; Patient Safety; Rare Diseases; Septicemia","Academic Medical Centers;Acute Lung Injury;Adverse event;Autophagocytosis;Biogenesis;Biological Markers;Biopsy;Breathing;Carbon Monoxide;Cells;Clinical;Clinical Data;Clinical Research;Clinical Trials;Collection;Critical Illness;Cytoprotection;Data;Data Analyses;Data Coordinating Center;Databases;Drug Kinetics;Enrollment;Gene Expression;Goals;Grant;Hospitals;Human;Institutional Review Boards;Instruction;International;Intervention Trial;Lead;Lung diseases;Medical;Mesenchymal;Mitochondria;Modality;Molecular Target;Morbidity - disease rate;Muscle;Outcome;Pathway interactions;Patient Agents;Patients;Phase;Phenotype;Physiological;Placebo Control;Plasma;Play;Population;Process;Program Research Project Grants;RNA;Reporting;Research Design;Research Infrastructure;Research Personnel;Resources;Role;Safety;Sampling;Sepsis;Sepsis Syndrome;Skeletal Muscle;Specimen;Specimen Handling;Stromal Cells;Therapeutic;Time;Translational Research;Woman;base;biobank;biological systems;cohort;experience;healthy volunteer;innovation;lung injury;metabolomics;monocyte;mortality;novel;novel therapeutic intervention;novel therapeutics;peripheral blood;programs;randomized placebo controlled trial;repository;response;safety study;sample collection;translational study","Clinical Studies Coordination Core","RELEVANCE (See Instructions): 
Sepsis-induced ALI is a condition with high morbidity and mortality and with limited available treatment options. This Translational Program Project Grant proposes to advance the understanding and application of a novel therapeutic modality, inhaled carbon monoxide, in these critically ill patients. This Core will play a key role in facilitating the translational aspects of this proposal for all of the proposed projects.","NHLBI","8380533","8/8/2012 12:00:00 AM","PAR-09-185","5P01HL108801-02","5","P01","HL","108801","02"," "," "," "," ","ZHL1-PPG-A","5940","6801990","BARON, REBECCA M","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","332960","332960"," ","196481","136479"," "," ",
"Dental/Oral and Craniofacial Disease; Genetics; Osteoporosis; Rare Diseases; Regenerative Medicine","Adult;Affect;Anabolic Agents;Antibodies;Binding;Biology;Bone Marrow;Bone Regeneration;Bone Resorption;Calvaria;Cartilage;Cell Differentiation process;Cells;Chondrocytes;Cleidocranial Dysplasia;Coculture Techniques;Complex;Craniosynostosis;Defect;Development;Disease;Elements;Embryo;Embryonic Development;Exhibits;Feedback;Fellowship;Genetic Models;Genotype;Hypertrophy;In Vitro;Knock-out;Knockout Mice;Laboratories;Maintenance;Mediating;Mesenchymal Differentiation;Modeling;Molecular;Mus;Natural regeneration;Osteoblasts;Osteoclasts;Osteogenesis;Osteopenia;Phenotype;Physiological;Play;Postdoctoral Fellow;Process;Property;Relative (related person);Research;Role;Scaffolding Protein;Signal Pathway;Signal Transduction;Stromal Cells;Techniques;Testing;Tissues;Training;Tumor Suppressor Proteins;Work;X-Ray Computed Tomography;bone;bone cell;bone mass;bone strength;carcinogenesis;career;career development;density;extracellular;inhibitor/antagonist;intramembranous bone formation;long bone;macrophage;meetings;mouse development;mutant;osteoblast differentiation;postnatal;promoter;skeletal;skills;spine bone structure;substantia spongiosa;transcription factor","Runx2 and Axin2 Interactions During Bone Formation"," This project explores the molecular interactions between two crucial regulators of bone repair/regeneration and optimal bone mass accrual and maintenance: Runx2 and Axin2. The proposed project is significant because Runx2 is required for osteoblastogenesis and Axin2 is a crucial negative regulator of the Wnt-2-catenin signaling pathway, which is a target for new anabolic agents. Because Axin2 is an intracellular inhibitor of 2-catenin and Lrp5 signaling, its activity could theoretically decrease the efficiency of emerging anabolic therapies that neutralize extracellular Wnt/Lrp5/6 inhibitors (e.g., anti-Sclerostin or anti-Dkk1 antibodies). An increased understanding of the interactions between Runx2 and Axin2 will have a collective impact because Runx2 and Axin2 also contribute to chondrocyte maturation and are tumor suppressors.  
    

","NIAMS","8334718","8/7/2012 12:00:00 AM","PA-10-110","5F32AR061873-02","5","F32","AR","061873","02"," ","CHEN, FAYE H","8/4/2011 12:00:00 AM","8/3/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F10B-S(20)L]"," ","10697922","BRADLEY, ELIZABETH W","Not Applicable","01","Unavailable","006471700","Y2K4F9RPRRG7","006471700","Y2K4F9RPRRG7","US","44.022374","-92.465881","4976101","MAYO CLINIC ROCHESTER","ROCHESTER","MN","Other Domestic Non-Profits","559050001","UNITED STATES","N","8/4/2012 12:00:00 AM","8/3/2013 12:00:00 AM","846","Training, Individual","2012"," "," ","NIAMS","55670"," "," ","55670",
"Neurosciences; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Transplantation","Address;Adult;Affect;Auditory;Biological Models;Bone Marrow;Cell Line;Cell Survival;Cells;Characteristics;Cochlea;Cues;Development;Disease;Disease model;Electron Microscopy;Epithelium;Excision;Flow Cytometry;Foundations;Future;Gene Proteins;Generations;Goals;Grant;Hair Cells;Hearing;Histocytochemistry;Human;Immune;Immunohistochemistry;In Vitro;Individual;Labyrinth;Lead;Mesenchymal;Methods;Modeling;Mus;Natural regeneration;Neuraxis;Operative Surgical Procedures;Organ;Organ of Corti;Otic Placodes;Patients;Pluripotent Stem Cells;Population;Protocols documentation;Reporting;Research;Retina;Rodent;Science;Sensory;Signal Transduction;Stem Cell Development;Stem cell transplant;Stem cells;Techniques;Time;Tissues;Transplantation;Work;base;deafness;disability;embryonic stem cell;global health;hearing impairment;human embryonic stem cell;human stem cells;improved;in utero transplantation;induced pluripotent stem cell;model development;nerve stem cell;novel;otoconia;postnatal;precursor cell;progenitor;relating to nervous system;research study;stem;stem cell technology","Pluripotent Stem Cell Technology for the Study and treatment of Human hearing los"," Hearing loss is a global health concern and is caused, in most cases, by loss of the hair cells of the inner ear. These cells cannot regenerate spontaneously. Stem cells offer promise for the study and treatment of hair cell related hearing loss. This work will establish a method for the generation of inner ear hair cells from human stem cells in culture. In addition, this project will investigate the ability of stem cell-derived inner ear precrsor cells to survive and integrate into the developing mammalian inner ear upon transplantation.   
   
      

","NIDCD","8292762","2/13/2012 12:00:00 AM","PAR-10-055","1R03DC012432-01","1","R03","DC","012432","01"," ","FREEMAN, NANCY","2/15/2012 12:00:00 AM","1/31/2015 12:00:00 AM","ZDC1-SRB-L(51)"," ","9853639","GUBBELS, SAMUEL P","Not Applicable","02","SURGERY","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","SCHOOLS OF MEDICINE","537151218","UNITED STATES","N","2/15/2012 12:00:00 AM","1/31/2013 12:00:00 AM","173","Non-SBIR/STTR","2012"," "," ","NIDCD","100000","46460"," ","146460",
"Dental/Oral and Craniofacial Disease; Genetics; Pediatric; Pediatric Research Initiative; Rare Diseases","Affect;Apoptosis;BMPR1A gene;Bone Morphogenetic Proteins;Calvaria;Cells;Cephalic;Chondrocranium;Chondrocytes;Congenital abnormal Synostosis;Craniosynostosis;Defect;Deformity;Development;Developmental Process;Disease;Drosophila genus;Dysplasia;Equilibrium;Exhibits;Family;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Genes;Genetic;Growth;Health;Human;Human Development;Human Genetics;Individual;Influentials;Investigation;Jaw;Joint structure of suture of skull;Knock-out;Lead;Link;Little&apos;s Disease;MAP Kinase Gene;Mediating;Mediator of activation protein;Mesenchymal;Mesenchyme;Modeling;Monomeric GTP-Binding Proteins;Morphogenesis;Mouse Strains;Mus;Mutation;Osteoblasts;Pathogenesis;Pathway interactions;Phenotype;Population;Process;Production;Proteomics;Receptor Signaling;Regulation;Role;Signal Transduction;Signal Transduction Pathway;Skeletal Development;Skeleton;Source;Staging;Stem cells;Surgical sutures;Syndrome;Testing;Therapeutic;Wnt proteins;bone;cell type;craniofacial;cranium;design;genetic analysis;genetic element;human disease;insight;intramembranous bone formation;member;mouse model;mutant;postnatal;precursor cell;premature;receptor;skeletal;skeletal disorder;skeletogenesis;skull base;stem cell fate;stem cell population","Genetic Regulatory Network in Craniofacial Development"," This proposal investigates the basic genetic elements controlling the formation of a healthy skull during craniofacial skeletogenesis. Using genetically modified mouse strains, we elucidate the mechanism underlying the interplay of three evolutionary conserved signal transduction pathways in normal development and pathogenesis of the skull vault. The results obtained in our study are highly relevant to the health of human development in craniofacial deformities, such as craniosynostosis and cleiocranial dysplasia, and has potentials to gain insights into therapeutic strategies for human diseases.   
   
      

","NIDCR","8291784","6/5/2012 12:00:00 AM","PA-10-067","2R01DE015654-06A1","2","R01","DE","015654","06","A","SCHOLNICK, STEVEN","7/1/2006 12:00:00 AM","5/31/2017 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","7696793","HSU, WEI ","Not Applicable","25","GENETICS","041294109","F27KDXZMF9Y8","041294109","F27KDXZMF9Y8","US","43.16888","-77.615939","7047101","UNIVERSITY OF ROCHESTER","ROCHESTER","NY","SCHOOL OF MEDICINE & DENTISTRY","146270140","UNITED STATES","N","6/5/2012 12:00:00 AM","5/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","250000","136250"," ","386250",
"Dental/Oral and Craniofacial Disease","Address;Animals;Atrophic;Binding;Biomedical Engineering;Birds;Bone Morphogenetic Proteins;Branchial arch structure;Cadherins;Candidate Disease Gene;Cartilage;Cartilage injury;Cell Communication;Cell Polarity;Cell Transplantation;Cell physiology;Cells;Chondrocytes;Chondrogenesis;Cilia;Clinical;Collagen;Complement;Congenital Abnormality;Couples;Development;Diagnosis;Diagnostic;Dorsal;Elements;Embryo;Embryonic Development;Endothelin-1;Epithelium;Event;Fatty acid glycerol esters;Genetic;Goals;Growth;Growth Factor;Human;Image;Joints;Laboratories;Lead;Life;Ligands;Link;Mandible;Mesenchymal;Modeling;Molecular;Morphogenesis;Movement;Mus;Mutation;Neurodegenerative Disorders;Organ;Pathway interactions;Pattern;Phenocopy;Phenotype;Physical condensation;Population;Process;Protein Deficiency;Regulation;Relative (related person);Role;Shapes;Signal Pathway;Signal Transduction;Skeletal system;Skeleton;Source;Stem cells;Temporomandibular Joint;Testing;Time;Vertebrates;Zebrafish;cartilage development;cell type;craniofacial;fly;genetic manipulation;improved;insight;joint injury;loss of function;malformation;mutant;novel marker;overexpression;prevent;progenitor;research study;response;skeletal;skeletogenesis;transcription factor","Roles of the Fat pathway in cartilage patterning and polarity"," The proposed studies will provide some of the first evidence that the Fat pathway influences skeletogenesis. Defining molecules that control cartilage development may be of clinical importance both for improving treatments for cartilage and joint injuries and in efforts to induce cartilage from stem cells. The Fat pathway component Rere is also implicated in dentatorubral-pallido-luysian atrophy and understanding its functions could help improve diagnosis and treatments for this and related neurodegenerative diseases.   
   
      

","NIDCR","8297984","7/12/2012 12:00:00 AM","PA-10-067","2R01DE013828-11","2","R01","DE","013828","11"," ","SCHOLNICK, STEVEN","4/1/2001 12:00:00 AM","7/31/2017 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1908418","SCHILLING, THOMAS F","Not Applicable","45","ANATOMY/CELL BIOLOGY","046705849","MJC5FCYQTPE6","046705849","MJC5FCYQTPE6","US","33.678042","-117.773718","577504","UNIVERSITY OF CALIFORNIA-IRVINE","IRVINE","CA","SCHOOLS OF ARTS AND SCIENCES","926970001","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","250000","118401"," ","368401",
"Cancer","Ablation;Accounting;Address;Adjuvant;Antineoplastic Agents;Biological;Bone Marrow;Bortezomib;Breast;Cancer Vaccines;Cessation of life;Cleaved cell;Colorectal;Cytotoxic agent;Dipeptidyl Peptidases;Dose-Limiting;Drug Delivery Systems;Enzymes;Epithelial;Eragrostis;Evaluation;Exhibits;Failure;Family;Fibroblasts;Goals;Growth;Hematopoietic;Homologous Gene;Immune;Immune response;Immunity;Immunosuppression;Immunosuppressive Agents;Immunotherapeutic agent;Investigation;Knockout Mice;Knowledge;Lung;Malignant Neoplasms;Membrane Glycoproteins;Mesenchymal;Modeling;Molecular;Normal tissue morphology;Pancreas;Pear;Peptide Hydrolases;Pericytes;Pharmaceutical Preparations;Phenotype;Problem Solving;Prodrugs;Proteasome Inhibitor;Protein Inhibition;Regulation;Research;Resistance;Risk;Role;Serine Protease;Site;Solid;Staging;Stromal Neoplasm;Surface;T cell response;T-Lymphocyte;Therapeutic Index;Tissues;Toxic effect;Tumor Antigens;Tumor Immunity;Tumor Markers;Tumor Promotion;Veins;alanylproline;base;cancer cell;cancer therapy;chemotherapeutic agent;clinical efficacy;cytotoxic;design;drug discovery;fibroblast-activating factor;in vivo;inhibitor/antagonist;killings;mouse model;prevent;prolyl oligopeptidase;protein expression;response;small molecule;tumor;tumor growth;tumor progression","Using FAP to Selectively Target Epithelial Cancers","  Approved anticancer drugs are limited by toxicity and are notoriously ineffective against solid epithelial cancer (e.g. lung, colorectal, breast and pancreatic), which accounts for the majority of cancer deaths. Fibroblast activation protein (FAP) is an enzyme expressed to a far greater extent in the stromal tissue fibroblasts that promote growth of epithelial tumors than in healthy tissues. FAP and FAP-expressing fibroblasts of the tumor stroma will be investigated as drug targets in cancer in support of the goal of discovering new anticancer drugs.     
      

","NCI","8295246","8/10/2012 12:00:00 AM","PA-10-067","1R01CA163930-01A1","1","R01","CA","163930","01","A","FU, YALI","8/10/2012 12:00:00 AM","5/31/2017 12:00:00 AM","Drug Discovery and Molecular Pharmacology Study Section[DMP]"," ","1888805","BACHOVCHIN, WILLIAM W","Not Applicable","07","BIOCHEMISTRY","039318308","C1F5LNUF7W86","039318308","C1F5LNUF7W86","US","42.349907","-71.061712","8422704","TUFTS UNIVERSITY BOSTON","BOSTON","MA","SCHOOLS OF MEDICINE","021111901","UNITED STATES","N","8/10/2012 12:00:00 AM","5/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","288944","83688"," ","372632",
"Dental/Oral and Craniofacial Disease; Pediatric","Affect;Apoptosis;Biological;Cell Proliferation;Cells;Cephalic;Cleft Palate;Complex;Congenital Abnormality;DNA Binding Domain;Defect;Development;Diagnosis;Disabled Persons;Environmental Risk Factor;Epithelium;Future;Gene Targeting;Genes;Genetic;Goals;Human;Interferons;Intervention;Investigation;Lead;Live Birth;MAPK14 gene;MSX1 gene;Medial;Mediating;Mediator of activation protein;Medical;Mesenchymal;Mesenchyme;Modeling;Molecular;Morphogenesis;Mus;Mutant Strains Mice;Mutation;Neural Crest;Neural Crest Cell;Normal Cell;Palate;Population;Prevention;Research;Research Project Grants;Signal Pathway;Signal Transduction;Skin;Smad4 Protein;Testing;Transforming Growth Factor beta;Transforming Growth Factors;Van der Woude syndrome;cleft lip and palate;connective tissue growth factor;craniofacial;design;handicapping condition;loss of function mutation;malformation;method development;mutant;palatal fusion;palatal shelves;palatogenesis;programs;research study;transcription factor","TGF BETA SIGNALING AND CRANIOFACIAL MORPHOGENESIS","
Narrative
Cleft palate represents one of the most common congenital birth defects in the human population. Despite
recent advancements in medical intervention, babies born with cleft palate often suffer multiple handicaps
that significantly compromise the quality of their lives. Significantly, mutations in the Transforming Growth
Factor-ï¿½ (TGF-ï¿½) gene cause cleft palate in humans and mice. This research program is designed to
further our understanding of how aberrant TGF-ï¿½ signaling may adversely affect cell fate determination
during palatogenesis and causes cleft palate. Ultimately, this investigation will provide important
information for the future prevention and treatment of craniofacial birth defects.","NIDCR","8281349","5/31/2012 12:00:00 AM","PA-07-070","5R37DE012711-14","5","R37","DE","012711","14"," ","SCHOLNICK, STEVEN","1/1/1999 12:00:00 AM","6/30/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","6378298","CHAI, YANG ","Not Applicable","37","DENTISTRY","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","900894304","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","340025","212716"," ","552741",
"Biotechnology; Genetics; Human Genome; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Adult;Back;Biological;Biological Process;Biology;Cell Cycle;Cell physiology;Cells;Complex;Data;Degenerative Disorder;Disease;Dissection;Embryo;Epigenetic Process;Event;Evolution;Family;Feedback;Fostering;Functional RNA;Gene Combinations;Genes;Genome;Genomics;Goals;Grant;Health;Human;Individual;Knowledge;Lead;Malignant Neoplasms;Maps;Messenger RNA;Metabolism;MicroRNAs;Mission;Modeling;Molecular;Mus;Network-based;Outcome;Pathway interactions;Physiological;Physiological Processes;Process;Property;Proteins;Public Health;Research;Research Infrastructure;Role;Screening procedure;Signal Pathway;Small Interfering RNA;Somatic Cell;System;Testing;Time;Tissues;base;biological systems;cost efficient;embryonic stem cell;epithelial to mesenchymal transition;feeding;follow-up;genome wide association study;genome-wide;human disease;improved;induced pluripotent stem cell;insight;interest;member;nodal protein;novel;pluripotency;programs;protein protein interaction;research study;self-renewal;small molecule;tool","MicroRNA Based Pathway Discovery in Cellular Reprogramming"," The proposed research is relevant to public health because it develops novel means of dissecting the multiple molecular pathways involved in a biological process, which will enable more comprehensive and intelligent means of manipulating cells in the treatment of anything from degenerative disease to cancer. Furthermore, the initial focus is on induced pluripotency, which has the potential to produce replacement tissues as well as provide new and powerful tools to study human disease. Therefore the research is relevant to NIH's mission to foster fundamental creative discoveries that increase the Nation's capacity to protect and improve human health.   
   
      

","NIGMS","8273865","4/30/2012 12:00:00 AM","PA-10-067","1R01GM101180-01","1","R01","GM","101180","01"," ","HAYNES, SUSAN R","5/1/2012 12:00:00 AM","4/30/2016 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","1952829","BLELLOCH, ROBERT ","Not Applicable","12","UROLOGY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","230000","119108"," ","349108",
"No NIH Category available","Adult;Adverse effects;Affect;Aging;Agreement;Anabolism;Androgens;Antioxidants;Apoptosis;Attenuated;Cell Survival;Cells;Chemosensitization;Commit;DNA Binding;Defense Mechanisms;Dendrimers;Development;Disease;Enzymes;Equilibrium;Estradiol;Estrogen Receptors;Estrogens;Excision;Female;Generations;Genetic Transcription;Gonadal Steroid Hormones;Growth;Homeostasis;Longevity;Maintenance;Mediating;Mesenchymal;Molecular;Muramidase;Mus;NF-kappa B;Nuclear;Organ;Osteoblasts;Osteoclasts;Osteocytes;Osteoporosis;Ovarian;Ovariectomy;Oxidation-Reduction;Oxidative Stress;Pathway interactions;Phosphorylation;Production;Reactive Oxygen Species;Secondary to;Seminal Vesicles;Signal Transduction;Skeleton;Thick;Weight;Work;attenuation;base;bone;bone cell;bone loss;bone mass;cathepsin K;cell type;dentin matrix protein 1;gain of function;in vivo;male;osteoclastogenesis;overexpression;p66(ShcA) protein;prevent;progenitor;protective effect;receptor;reproductive;sex;skeletal;substantia spongiosa;transcription factor","Estrogens, androgens, aging, and bone loss in males","A deficiency of estrogens in females or both androgens and estrogens in males contributes to the development of osteoporosis in either sex. However, the mechanism(s) responsible for the adverse effects of the deficiency of either class of sex steroid on the male or female skeleton are not well understood; nor is the molecular mechanism(s) by which estrogens contribute to the maintenance of the male skeleton. The work proposed in this application will investigate how loss of androgens influences oxidative stress on bone cells and how it contributes to the development of this disease.","VA","8244288","1/19/2012 12:00:00 AM","RFA-BX-11-001","1I01BX001405-01","1","I01","BX","001405","01"," "," ","1/1/2012 12:00:00 AM","12/31/2015 12:00:00 AM","Endocrinology B[ENDB]"," ","1891756","MANOLAGAS, STAVROS C.","Not Applicable","02","Unavailable","082573742","EEMKSLSZYKJ3","082573742","EEMKSLSZYKJ3","US","34.773386","-92.289211","10006869","CENTRAL ARKANSAS VETERANS HLTHCARE SYS","NORTH LITTLE ROCK","AR","Independent Hospitals","721141709","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Complementary and Alternative Medicine; Infant Mortality/ (LBW); Lung; Nutrition; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal - Neonatal Respiratory Distress Syndrome; Perinatal Period - Conditions Originating in Perinatal Period; Prevention","Affect;Alveolar;Anti-Inflammatory Agents;Anti-inflammatory;Antioxidants;Apoptosis;Atelectasis;Blood;Bronchopulmonary Dysplasia;Cell Differentiation process;Cell Proliferation;Chronic lung disease;Curcuma longa;Curcumin;Data;Effectiveness;Environmental air flow;Epithelial;Event;Exposure to;Fibroblasts;Future;Homeostasis;Hyperoxia;Infant;Inflammation;Injury;Laboratories;Life;Lung;Mediating;Mesenchymal;Mesenchyme;Methods;Modeling;Morbidity - disease rate;Myofibroblast;Neonatal;Nuclear;Oxidants;Pathogenesis;Peroxisome Proliferator-Activated Receptors;Phenotype;Pigments;Predisposing Factor;Premature Infant;Prevalence;Prevention;Preventive Intervention;Property;Quality of life;Rattus;Respiratory physiology;Role;Severities;Signal Transduction;Spices;Structure;Therapeutic Intervention;Translations;Tumeric;Type II Epithelial Receptor Cell;Vulnerable Populations;Work;abstracting;alveolar homeostasis;effective intervention;improved;injury and repair;interstitial;lung development;lung maturation;lung repair;mortality;neonatal lung injury;preclinical study;premature;premature lungs;prevent;public health relevance;pulmonary function;transcription factor;transdifferentiation","Curcumin to Augment Neonatal Lung Injury/Repair","
Project Narrative
Up to 30% of the extremely premature infants have chronic lung disease of prematurity, called
Bronchopulmonary Dysplasia. There infants are unable to oxygenate their blood adequately, which leads to
significantly increased life-long morbidity and mortality in this vulnerable population. Though, at present, there
is no effective preventive or therapeutic intervention, the proposed studies are likely to establish the
effectiveness of curcumin, the active ingredient of the Indian spice turmeric, in effectively preventing
bronchopulmonary dysplasia.","NICHD","8206509","1/4/2012 12:00:00 AM","PA-10-064","5R03HD067319-02","5","R03","HD","067319","02"," ","RAJU, TONSE N","1/1/2011 12:00:00 AM","6/30/2013 12:00:00 AM","Pediatrics Study Section[CHHD-A]"," ","9871187","SAKURAI, REIKO ","Not Applicable","43","Unavailable","069926962","LTJVF4QSFCP9","069926962","LTJVF4QSFCP9","US","33.834898","-118.292983","2543101","LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER","TORRANCE","CA","Research Institutes","905022006","UNITED STATES","N","1/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","50000","16500"," ","66500",
"Cancer; Lung; Lung Cancer","Accounting;Address;Adhesions;Affect;Binding;Cancer Etiology;Cancer Model;Cancer Patient;Cause of Death;Cell Adhesion;Cell physiology;Cell-Cell Adhesion;Cell-Matrix Junction;Cells;Cessation of life;Cytoskeleton;Data;Diagnosis;Disease;Extracellular Matrix;Filament;Focal Adhesion Kinase 1;Focal Adhesions;Future;Goals;In Vitro;Intermediate Filament Proteins;Intermediate Filaments;Knockout Mice;Lead;Link;Lung Neoplasms;Malignant Neoplasms;Malignant neoplasm of lung;Mediating;Metastatic to;Modeling;Molecular;Neoplasm Metastasis;Non-Small-Cell Lung Carcinoma;Patients;Phosphorylation;Phosphorylation Site;Play;Primary Neoplasm;Process;Protein Dynamics;Regulation;Role;STK11 gene;Serine Phosphorylation Site;Signal Transduction;Site;Staging;Survival Rate;Testing;Time;United States;Vimentin;Western Blotting;Work;cancer cell;cancer therapy;cancer type;cell motility;epithelial to mesenchymal transition;improved;in vivo;mouse model;new therapeutic target;novel;outcome forecast;overexpression;prevent;therapeutic development;therapeutic target;tumor","The role of Vimentin in cell adhesion and lung cancer metastasis"," Lung cancer, which is frequently diagnosed during late-stages of the disease when metastasis has already occurred, is the leading cause of death due to cancer in the United States and has a 5-year survival rate of only 15-25%. This proposal seeks to understand the molecular mechanisms of metastasis with the hope of identifying future therapeutic targets that could lead to a significant improvement in the prognosis for lung cancer patients. Specifically, we will look at the role of vimentin, which is overexpressed in invasive cancer tumors, in cell adhesion to the extracellular matrix.   
      

","NCI","8314448","3/22/2012 12:00:00 AM","PA-11-113","1F32CA168112-01","1","F32","CA","168112","01"," ","JAKOWLEW, SONIA B","4/1/2012 12:00:00 AM","3/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-D(20)L]"," ","9165098","HAVEL, LAUREN SMITH","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","066469933","S352L5PJLMP8","066469933","S352L5PJLMP8","US","33.762977","-84.42296","2384501","EMORY UNIVERSITY","ATLANTA","GA","SCHOOLS OF MEDICINE","303224250","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","47114"," "," ","47114",
"Biotechnology; Genetics; Lung; Pediatric; Pediatric Research Initiative","Address;Advisory Committees;Area;Biology;Caring;Cartilage;Cell Differentiation process;Cell Lineage;Cell Therapy;Cells;Cessation of life;Chondrocytes;Chondrogenesis;Commit;Data;Development;Developmental Biology;Disease;Distal;Doctor of Philosophy;Embryo;Endothelial Cells;Environment;Epithelial;Epithelium;Etiology;Fibroblast Growth Factor;Foundations;Funding;Genes;Goals;Histology;Hospitals;In Vitro;Injury;Institutes;Knockout Mice;Knowledge;Ligands;Link;Live Birth;Lung;Mediating;Medical center;Mentors;Mesenchymal;Mesenchyme;Microscopy;Minority;Modeling;Molecular;Molecular Chaperones;Morphogenesis;Mus;Muscle;Muscle Cells;Muscle Development;Mutant Strains Mice;Neonatology;Pattern;Pediatric Hospitals;Pediatrics;Perinatal;Physical condensation;Physiology;Principal Investigator;Public Health;Publishing;Reporting;Reproduction;Research;Research Personnel;Research Training;Resources;Respiratory System;Respiratory tract structure;Role;SHH gene;Scientist;Signal Pathway;Signal Transduction;Smooth Muscle;Smooth Muscle Actin Staining Method;Source;Symptoms;Technology;Testing;Therapeutic;Trachea;Tracheal Epithelium;Tracheobronchomalacia;Training;Transcriptional Regulation;Transgenic Mice;abstracting;airway epithelium;airway obstruction;career;career development;cartilage development;cell fate specification;in vivo;infancy;insight;instructor;mutant;novel;paracrine;post-doctoral training;professor;repaired;transcription factor","Molecular mechanisms underlying upper airway patterning and tracheomalacia","
Project Narrative
The proposed research and training is relevant to public health because it addresses a poorly understood area
of pulmonary biology, namely the congenital anomalies of the upper airway. Conditions such as
tracheobronchomalacia can be so severe that may required intensive and expensive care. I will test a novel
hypothesis that paracrine Wnt signaling controls cartilage and muscle differentiation in developing conducting
airways. The findings from my proposed research will provide critical insights into the normal tracheal
development and the etiology of tracheomalacia. These studies will also provide a platform of knowledge
necessary for the development of novel therapies aimed at repairing damaged or malformed conducting
airways.","NHLBI","8367384","7/23/2012 12:00:00 AM","RFA-HL-12-030","1K01HL115447-01","1","K01","HL","115447","01"," ","COLOMBINI-HATCH, SANDRA","8/1/2012 12:00:00 AM","7/31/2017 12:00:00 AM","ZHL1-CSR-F(M1)"," ","8759127","SINNER, DEBORA ","Not Applicable","01","Unavailable","071284913","JZD1HLM2ZU83","071284913","JZD1HLM2ZU83","US","39.140882","-84.500494","615001","CINCINNATI CHILDRENS HOSP MED CTR","CINCINNATI","OH","Independent Hospitals","452293039","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","837","Other Research-Related","2012"," "," ","NHLBI","104071","8326"," ","112397",
"No NIH Category available","Age;Aging;Alveolar;Animal Model;Antibodies;Apoptosis;Biochemical;Biological Assay;Bleomycin;Cell Communication;Cells;Cicatrix;Coculture Techniques;Development;Diagnosis;Disease;Elderly;Environmental Exposure;Epithelial;Epithelial Cells;Epithelium;Exhibits;Experimental Models;Extracellular Matrix;Fibroblasts;Fibrosis;Generations;Genetic;Hamman-Rich syndrome;Hydrogen Peroxide;Immunofluorescence Immunologic;Immunohistochemistry;Incidence;Induction of Apoptosis;Injury;Investigation;Link;Lung;Lung diseases;Measurement;Mediating;Mediator of activation protein;Mesenchymal;Methods;Morphology;Mus;Muscle;Myofibroblast;NADPH Oxidase;Natural regeneration;Nature;Oxidative Stress;Pathogenesis;Pathologic;Patients;Phenotype;Physiological;Physiology;Population;Predisposition;Prevalence;Process;Pulmonary Fibrosis;Reporting;Resistance;Resolution;Respiratory Failure;Respiratory physiology;Risk;Risk Factors;Role;Severities;Site;System;Therapeutic Intervention;Time;Tissues;Tumor Necrosis Factor Ligand Superfamily Member 6;Wound Healing;age effect;age related;aged;body system;cigarette smoking;cohort;extracellular;human TGFB1 protein;in vivo;injured;injury and repair;insight;lung injury;male;novel;older patient;paracrine;pre-clinical;preclinical efficacy;progenitor;reconstitution;research clinical testing;response;response to injury;senescence;therapeutic target;tissue repair;wound","Aging, Fibroblast Senescence, and Apoptosis in Lung Fibrosis","Even in the absence of disease, aging is accompanied by changes in pulmonary physiology. These age-related changes may increase susceptibility to pulmonary disease. Idiopathic pulmonary fibrosis (IPF) is characterized by progressive scar tissue formation leading to respiratory failure, which is prevalent in the elderly population. Understanding lung injury-repair 
in the context of aging may offer novel insights for the development of therapeutic interventions aimed to treat fibrotic diseases, such as IPF.","VA","8332589","7/16/2012 12:00:00 AM","RFA-BX-11-020","1IK2BX001477-01A1","1","IK2","BX","001477","01","A"," ","6/1/2012 12:00:00 AM","5/31/2017 12:00:00 AM","Respiration[PULM]"," ","8407333","HECKER, LOUISE ","Not Applicable","07","Unavailable","082140880","QB5HA75JM9T3","082140880","QB5HA75JM9T3","US","33.512045","-86.894767","481003","BIRMINGHAM VA MEDICAL CENTER","BIRMINGHAM","AL","Independent Hospitals","352331927","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","999","Other","2012"," "," "," "," "," "," "," ",
"Breast Cancer; Cancer","Address;Affect;Aggressive behavior;Anti-Inflammatory Agents;Anti-inflammatory;Antigens;Biological Assay;Blood;Bone Marrow;Breast Cancer Cell;Breast Cancer Model;Cancer Patient;Cancer cell line;Cell Count;Cell Line;Cell surface;Cells;Coculture Techniques;Data;Epithelial;Event;Fatty acid glycerol esters;Feedback;Foundations;Generations;Genes;Growth Factor;Human;Immune system;Immunoblotting;Immunosuppressive Agents;Inflammatory;Knock-out;Knockout Mice;Lead;Macrophage Activation;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Matrigel Invasion Assay;Measures;Mediating;Mesenchymal;Modeling;Monitor;Mus;Myeloid Cells;NF-kappa B;Neoplasm Metastasis;Oncogenic;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Production;Public Health;Recruitment Activity;Reporting;Resistance;Role;Signal Pathway;Sorting - Cell Movement;Stream;Testing;Therapeutic;Time;Tissues;United States;Woman;angiogenesis;base;cancer cell;chemotherapy;cytokine;human tissue;in vivo Model;inhibitor/antagonist;knock-down;macrophage;malignant breast neoplasm;member;mouse model;neoplastic cell;outcome forecast;p65;research study;response;therapeutic target;transcription factor;tumor;tumor growth;tumorigenesis","The Role of NF-kappaB in Stromal Macrophage Influence on Breast Cancer Tumorigene"," The presence of macrophages in breast tumors can lead to increased cancer aggression, metastasis and resistance to chemotherapy. As women in the United States have a 1 in 8 chance of developing invasive breast cancer during their lifetime, this project is directly relevant to public health. Being able to reduce the influence that macrophages have on tumorigenesis will allow for better treatment options and increased breast cancer patient survival.  
  
    

","NCI","8316444","6/20/2012 12:00:00 AM","PA-10-110","5F32CA162628-02","5","F32","CA","162628","02"," ","JAKOWLEW, SONIA B","7/1/2011 12:00:00 AM","6/30/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-E(20)L]"," ","9165095","BRADFORD, JENNIFER WEBSTER","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","52190"," "," ","52190",
"Autoimmune Disease; Cancer; Genetics; Lung; Rare Diseases","3&apos; Untranslated Regions;Alveolar;Binding;Binding Proteins;Biological;Biological Markers;Blood Circulation;Cancer Biology;Cell Cycle;Cell Proliferation;Cell division;Cells;Clinical Trials;Data;Differentiation and Growth;Disease;Ectoderm;Elements;Epithelial Cells;Excision;Fibroblasts;Frequencies;Gene Expression;Gene Expression Profile;Genes;Genetically Engineered Mouse;Growth;Growth Factor;Growth Factor Receptors;Hamman-Rich syndrome;Human;Instruction;Integrins;Kinetics;Lesion;Link;Lung;Malignant Neoplasms;Malignant neoplasm of lung;Maps;Mediating;Messenger RNA;MicroRNAs;Molecular;Molecular Analysis;Molecular Target;Normal Cell;Oncogenes;Ontology;Operon;Pathway interactions;Patients;Pattern;Phenotype;Physiological;Process;Production;Property;Proteins;Publications;RNA;RNA Binding;Recruitment Activity;Refractory;Regulation;Regulatory Element;Report (document);Reporter;Ribosomes;Role;Sampling;Signal Transduction;Site;Source;Specimen;Structure of parenchyma of lung;System;Systems Biology;Testing;Tissues;Transcript;Translating;Translation Initiation;Translations;Zebrafish;base;cancer cell;epithelial to mesenchymal transition;genome-wide;insight;lung injury;malignant breast neoplasm;morphogens;prototype;response;theories","Translational control of the fibroblast phenotype in IPF","If successful, our studies will precisely identify derangements in the gene expression pathway that confer IPF 
fibroblasts with a pathological phenotype and provide insight into the role of EMT in the genesis of fibroblasts 
in the IPF lung.This information has the potential to reveal new classes of molecular targets for antifibrotic 
therapy and unveil new disease-relevant biomarkers for clinical trials.","NHLBI","8375051","3/29/2012 12:00:00 AM"," ","5P01HL091775-04","5","P01","HL","091775","04"," "," "," "," ","Heart, Lung, and Blood Program Project Study Section[HLBP]","6585","1859884","BITTERMAN, PETER B","Not Applicable","05","Unavailable","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","Domestic Higher Education","554552070","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","477894","477894"," ","350512","127382"," "," ",
"Biotechnology; Dental/Oral and Craniofacial Disease; Genetics; Neurosciences","Affect;Afferent Neurons;Binding;Biological Models;Body Regions;Cartilage;Cells;ChIP-seq;Complex;Congenital Abnormality;Cues;Defect;Destinations;Development;Disease;Down-Regulation;Ectoderm;Embryo;Environment;Face;Gene Expression;Gene Expression Regulation;Gene Targeting;Genes;Goals;Human;In Situ Hybridization;Injection of therapeutic agent;Lead;Live Birth;Messenger RNA;Microarray Analysis;Molecular;Mus;Mutagenesis;Mutation;Neural Crest;Neural Crest Cell;Neural tube;Neuroglia;Neurons;Nonsense Codon;PRDM1 gene;Paraxial Mesoderm;Phenotype;Pigments;Play;Point Mutation;Population;Proteins;RNA;Regulation;Regulator Genes;Role;SET Domain;Signal Pathway;Staging;Syndrome;Techniques;Tendon structure;Tertiary Protein Structure;Testing;Time;Tissues;To specify;Transcriptional Regulation;United States;Vertebrates;Zebrafish;bone;cleft lip and palate;craniofacial;epithelial to mesenchymal transition;interest;mutant;neural plate;novel;prolyl-serine;protein protein interaction;relating to nervous system;research study;spatiotemporal;transcription factor","Determining the molecular mechanism by which prdm1a regulates neural crest specif"," Neural crest defects are implicated in multiple human syndromes resulting in cleft lip and palate in approximately 6800 live births in the United States alone (March of Dimes, 2010). Understanding the genes involved in neural crest specification during embryological development is critical to the understanding of both normal and defective craniofacial development, as well as for expanding potential therapies and treatments for craniofacial disorders.  
    

","NIDCR","8320465","6/20/2012 12:00:00 AM","PA-10-108","5F31DE022237-02","5","F31","DE","022237","02"," ","FRIEDEN, LESLIE A","8/1/2011 12:00:00 AM","7/31/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","10748177","POWELL, DAVALYN RENEE","Not Applicable","06","DENTISTRY","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF DENTISTRY/ORAL HYGN","800452570","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","27032"," "," ","27032",
"Biotechnology; Cancer; Colo-Rectal Cancer; Digestive Diseases; Genetics; Lung; Lung Cancer; Orphan Drug; Pancreatic Cancer; Rare Diseases","Adenocarcinoma Cell;Algorithms;Antineoplastic Agents;Apoptotic;Biochemical;Bioinformatics;Biological;Biological Assay;Biology;Cancer cell line;Cell Differentiation process;Cell Line;Cell Survival;Cells;Colon;Colorectal Adenocarcinoma;Colorectal Cancer;Data;Dependency;Drug resistance;Epithelial;Frequencies;Gene Expression;Gene Expression Profile;Gene Targeting;Genes;Genome;Histocompatibility Testing;Human;Individual;K-ras mouse model;Lead;Lung;Lung Adenocarcinoma;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Maps;Mediator of activation protein;Mesenchymal;Modeling;Molecular;Molecular Profiling;Mutate;Mutation;Oncogenes;Oncogenic;Pancreas;Pancreatic Adenocarcinoma;Play;Proto-Oncogenes;Refractory;Role;Screening procedure;Signal Transduction;Solid Neoplasm;Therapeutic;Tissue Differentiation;Tissues;Tretinoin;Xenograft procedure;abstracting;addiction;base;cancer cell;efficacy testing;in vivo;inhibitor/antagonist;mortality;mutant;neoplastic cell;novel;oncogene addiction;outcome forecast;pancreatic cancer cells;pre-clinical;protein expression;ras Proteins;small molecule;therapeutic target;tumorigenesis","Defining lineage-specific determinants of K-Ras ""addiction"" in human cancers","
Project Relevance
 Kras is the most frequently mutated oncogene in solid tumors with highest
frequencies seen in lung, pancreatic and colorectal cancers. I propose to generate gene
expression signatures for lung, pancreatic and colorectal cancers in the hopes of
identifying novel therapies for each of these cancers, which are very difficult to treat with
current chemotherapeutics.","NCI","8461312","5/31/2012 12:00:00 AM","PA-09-036","4R00CA149169-03","4","R00","CA","149169","03"," ","WATSON, JOANNA M","6/8/2010 12:00:00 AM","5/31/2015 12:00:00 AM","NSS"," ","8734785","SINGH, ANURAG ","Not Applicable","07","Unavailable","604483045","FBYMGMHW4X95","604483045","FBYMGMHW4X95","US","42.336234","-71.070647","894901","BOSTON UNIVERSITY MEDICAL CAMPUS","BOSTON","MA","Domestic Higher Education","021182841","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","152123","96877"," ","249000",
"Cancer; Clinical Research; Digestive Diseases; Pancreatic Cancer; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adenocarcinoma Cell;CD44 gene;Cancer Etiology;Cells;Cessation of life;Clinical;Collagen Type I;Desmoplastic;Development;Disease;Disease Progression;Drug Metabolic Detoxication;Environment;Enzymes;Epithelial;Erinaceidae;Extracellular Matrix;Focal Adhesion Kinase 1;Gene Mutation;Genes;Genetic;Growth;Hereditary Disease;Human;In Vitro;Individual;Integrins;Laboratories;Maintenance;Malignant Neoplasms;Malignant neoplasm of pancreas;Mediating;Mesenchymal;Newly Diagnosed;Normal tissue morphology;Outcome;Pancreas;Pancreatic Adenocarcinoma;Pancreatic Ductal Adenocarcinoma;Pancreatic carcinoma;Patients;Phenotype;Play;Population;Property;Relapse;Reporting;Resistance;Role;Signal Pathway;Signal Transduction;Staging;Stem cells;Stromal Cells;Therapeutic;Validation;Work;aldehyde dehydrogenases;base;cancer stem cell;chemotherapeutic agent;clinically relevant;extracellular;gemcitabine;improved;in vivo;innovation;neoplastic cell;notch protein;novel;outcome forecast;pancreatic cancer cells;pancreatic neoplasm;prevent;self-renewal;stem cell niche;stem cell population;success;tumor;tumorigenic","Cellular diversity and clinical relevance of stem cells in pancreatic cancer"," Several groups have identified pancreatic cancer stem cells with the increased tumorigenic and metastatic potential. We will determine whether these cells differ amongst individual patients and regulated by the tumor environment. These findings may improve the treatment and survival of patients with pancreatic carcinoma.  
  
    

","NCI","8332790","7/4/2012 12:00:00 AM","PA-10-067","5R01CA150142-02","5","R01","CA","150142","02"," ","THURIN, MAGDALENA","9/14/2011 12:00:00 AM","7/31/2016 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","6354151","MATSUI, WILLIAM H","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","213079","128354"," ","341433",
"Asthma; Biotechnology; Clinical Research; Genetics; Lung","Agonist;Allergens;Allergic;Allergic inflammation;Archives;Area;Asthma;Blood Vessels;Characteristics;Chronic;Chronic lung disease;Clinical;Disease;Doctor of Philosophy;Epithelial;Epithelial Cells;Epithelium;Expenditure;Extracellular Matrix;Extrinsic asthma;Funding;Gene Expression;Gene Proteins;Genetic Transcription;Grant;Growth Factor;Growth Factor Receptor Genes;Healthcare;Immunohistochemistry;In Situ Hybridization;In Vitro;Incidence;Inflammation;Inflammation Mediators;Inflammatory;Interleukin-4;Link;Luciferases;Macaca mulatta;Mediating;Mediator of activation protein;Mentors;Mesenchymal;Modeling;Morbidity - disease rate;Obstruction;Pathology;Patient Education;Patients;Peptide Hydrolases;Phenotype;Play;Process;Proteins;Regulation;Reporter;Research;Research Personnel;Research Project Grants;Respiratory physiology;Role;Source;Symptoms;Tissues;Transcriptional Activation;Translating;Translational Research;VEGFA gene;Vascular Endothelial Growth Factor Receptor;Vascular Endothelial Growth Factors;Vascular Smooth Muscle;Vascular remodeling;airway epithelium;airway remodeling;allergic airway disease;allergic airway inflammation;cytokine;density;disease phenotype;laser capture microdissection;neovascularization;nonhuman primate;promoter;protein expression;receptor","Airway Epithelium is Major Source of VEGF in Chronic Asthma","n/a","NHLBI","8211996","12/23/2011 12:00:00 AM","PA-06-512","5K08HL090913-04","5","K08","HL","090913","04"," ","TIGNO, XENIA","1/10/2009 12:00:00 AM","12/31/2013 12:00:00 AM","ZHL1-CSR-O(O1)"," ","8914553","AVDALOVIC, MARK V","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","047120084","TX2DAGQPENZ5","047120084","TX2DAGQPENZ5","US","38.543675","-121.729989","577503","UNIVERSITY OF CALIFORNIA AT DAVIS","DAVIS","CA","SCHOOLS OF MEDICINE","956186153","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","838","Other Research-Related","2012"," "," ","NHLBI","126250","10100"," ","136350",
"Biotechnology; Genetics; Pediatric","Address;Affect;Alleles;Animals;Anterior;Automobile Driving;Behavior;Blood;Cell Polarity;Cell membrane;Cells;Chromatin;Congenital Heart Defects;Cytoskeleton;Defect;Development;Dimensions;Drosophila genus;Embryo;Embryonic Development;Enhancers;Enzymes;Epithelial;Fatty acid glycerol esters;Fishes;Gastrula;Gene Expression;Gene Expression Profiling;Genes;Genetic;Genetic screening method;Germ Layers;Glypican;Golgi Apparatus;Homologous Gene;Human;Lateral;Learning;Link;Mammals;Mammary Neoplasms;Medial;Mediating;Mesenchymal;Microtubule-Organizing Center;Microtubules;Molecular;Movement;Mus;Mutation;Neoplasm Metastasis;Neural Tube Defects;Neural tube;Organ Size;Pathway interactions;Pattern;Phenotype;Polycystic Kidney Diseases;Process;Property;Proteins;Radial;Regulation;Risk Factors;Role;SANT Domain;Shapes;Signal Transduction;Specific qualifier value;Staging;Testing;Tumor Suppressor Genes;Vertebrates;Work;Zebrafish;blastomere structure;cell behavior;cell fate specification;cell motility;chromatin remodeling;deafness;embryo tissue;gastrulation;genetic analysis;histone modification;in vivo;insight;intercalation;malformation;mutant;polarized cell;public health relevance;research study;tumor growth","GENETIC ANALYSIS OF CONVERGENT EXTENSION IN ZEBRAFISH","
Convergence and extension is a key process shaping embryonic tissues. The Wnt/PCP pathway
emerged as a universal regulator of this process. In humans, mutations in Wnt/PCP pathway genes have
been identified as a risk factor for neural tube defects. In addition, Fat genes have been implicated in
control of organ size and recently emerged as candidates for tumor suppressor genes. This work will
delineate the mechanisms via which Wnt/PCP pathway regulates cell movements during embryogenesis.","NIGMS","8204675","12/19/2011 12:00:00 AM","PA-10-067","5R01GM055101-14","5","R01","GM","055101","14"," ","HOODBHOY, TANYA","1/1/1997 12:00:00 AM","12/31/2014 12:00:00 AM","Development - 1 Study Section[DEV1]"," ","1973848","SOLNICAKREZEL, LILIANNA ","Not Applicable","01","OTHER BASIC SCIENCES","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","250001","130001"," ","380002",
"Dental/Oral and Craniofacial Disease; Pediatric; Pediatric Research Initiative","Affect;Apoptosis;Biological;Cell Proliferation;Cells;Cephalic;Cleft Palate;Complex;Congenital Abnormality;DNA Binding Domain;Defect;Development;Diagnosis;Disabled Persons;Environmental Risk Factor;Epithelium;Future;Gene Targeting;Genes;Genetic;Goals;Human;Interferons;Intervention;Investigation;Lead;Live Birth;MAPK14 gene;MSX1 gene;Medial;Mediating;Mediator of activation protein;Medical;Mesenchymal;Mesenchyme;Modeling;Molecular;Morphogenesis;Mus;Mutant Strains Mice;Mutation;Neural Crest;Neural Crest Cell;Normal Cell;Palate;Population;Prevention;Research;Research Project Grants;Signal Pathway;Signal Transduction;Skin;Smad4 Protein;Testing;Transforming Growth Factor beta;Transforming Growth Factors;Van der Woude syndrome;cleft lip and palate;connective tissue growth factor;craniofacial;design;handicapping condition;loss of function mutation;malformation;method development;mutant;palatal fusion;palatal shelves;palatogenesis;programs;public health relevance;research study;transcription factor","TGF BETA SIGNALING AND CRANIOFACIAL MORPHOGENESIS","
Narrative
Cleft palate represents one of the most common congenital birth defects in the human population. Despite
recent advancements in medical intervention, babies born with cleft palate often suffer multiple handicaps
that significantly compromise the quality of their lives. Significantly, mutations in the Transforming Growth
Factor-ï¿½ (TGF-ï¿½) gene cause cleft palate in humans and mice. This research program is designed to
further our understanding of how aberrant TGF-ï¿½ signaling may adversely affect cell fate determination
during palatogenesis and causes cleft palate. Ultimately, this investigation will provide important
information for the future prevention and treatment of craniofacial birth defects.","NIDCR","8318935","11/10/2011 12:00:00 AM","PA-07-070","3R37DE012711-13S1","3","R37","DE","012711","13","S","SCHOLNICK, STEVEN","1/1/1999 12:00:00 AM","11/30/2013 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","6378298","CHAI, YANG ","Not Applicable","37","DENTISTRY","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","900894304","UNITED STATES","N","12/1/2011 12:00:00 AM","6/30/2012 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","55416","34912"," ","90328",
"Biotechnology; Cardiovascular; Genetics; Heart Disease","Antineoplastic Agents;Apical;Behavior;Biology;Cardiac;Cardiac Myocytes;Cardiovascular Diseases;Cardiovascular system;Cell Differentiation process;Cells;Childhood;Complex;Data;Defect;Development;Disease;Disease susceptibility;Drug Delivery Systems;Embryo;Epigenetic Process;Epithelial;Genetic;Heart;Heart Atrium;Heart Injuries;Label;Lead;Learning;Left;Light;Link;Mesenchymal;Molecular;Molecular Genetics;Morbidity - disease rate;Mus;Mutation;Myocardium;Neuregulins;Pattern;Process;Reagent;Regulation;Resolution;Role;Series;Signal Pathway;Signal Transduction;System;Testing;Ventricular;Ventricular Dysfunction;Zebrafish;blood pump;constriction;design;malformation;migration;mortality;public health relevance;receptor;repaired;research study;shear stress;tool","Molecular Genetics of Cardiac Cell Differentiation","
PROJECT NARRATIVE
Cardiovascular diseases remain a leading cause of morbidity and mortality. Many of these diseases
originate at least in part from genetic defects that impact the development and maturation of the
cardiovascular system. Despite substantial progress in our understanding of cardiovascular
development and its role in disease susceptibility, much remains to be learned. The focus of this
proposal is on cardiac trabeculation, a fundamental aspect of cardiac development that modulates
cardiomyocyte mass and cardiac function. For example, defects in trabeculation have been associated
with some cases of Non-Compaction of the Left Ventricular Myocardium, a severe pediatric
malformation.
The proposed studies will help us understand cellular and molecular mechanisms of cardiac
trabeculation. Recently, Nrg/Erbb signaling has also been implicated in differentiated cardiomyocyte
proliferation and repair of heart injury (Bersell et al., 2009), and anticancer drugs targeted to the Erbb2
receptor frequently cause ventricular dysfunction (reviewed by De Keulenaer et al., 2010). Thus, by
investigating the downstream mechanisms of Erbb2 signaling in the heart, our studies should shed new
light on the action of this important signaling pathway in cardiomyocyte biology beyond trabecular
formation. Our studies will also generate new tools and reagents to investigate and manipulate
cardiomyocyte proliferation. Furthermore, they should help elucidate the critical, yet poorly understood,
role of cardiac function (via cardiomyocyte contractility and flow) in cardiac development.","NHLBI","8245686","4/9/2012 12:00:00 AM","PA-10-067","5R01HL054737-17","5","R01","HL","054737","17"," ","SCHRAMM, CHARLENE A","6/1/1996 12:00:00 AM","4/30/2016 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","1891114","STAINIER, DIDIER Y","Not Applicable","12","BIOCHEMISTRY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","5/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","128721"," ","378721",
"Biotechnology; Kidney Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute Renal Failure with Renal Papillary Necrosis;Adherence;Antibodies;Blocking Antibodies;Bone Marrow;Cadherins;Calcium;Calcium-Sensing Receptors;Cell Therapy;Cell Transplants;Cells;Cessation of life;Collagen;Conditioned Culture Media;Developmental Gene;Down-Regulation;E-Cadherin;Endocrine;Endosteum;Endothelial Cells;Epithelial;Epithelial Cells;Event;Frequencies;Gene Expression Profiling;Genes;Goals;Health;Hematopoietic;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Histone Deacetylase Inhibitor;Homing;In Vitro;Injection of therapeutic agent;Injury;Kidney;Kidney Diseases;Knockout Mice;Laboratories;Lead;Measures;Mediating;Mesenchymal;Microarray Analysis;Molecular;Morbidity - disease rate;Mus;Natural regeneration;Pathway Analysis;Pathway interactions;Proteins;Recovery;Renal function;Renal tubule structure;Sequential Treatment;Source;Stem cells;Stromal Cells;Testing;Therapeutic;Therapeutic Agents;Therapeutic Effect;Time;Transplantation;Trichostatin A;Tubular formation;base;cytokine;effective therapy;gene repression;improved;in vitro Assay;in vivo;injured;kidney cell;kidney repair;migration;mortality;novel strategies;paracrine;renotropic factor;repaired;stem;stem cell therapy","STEM CELL THERAPY FOR ACUTE KIDNEY INJURY","
Narrative
 Acute kidney injury has high morbidity and high mortality. There is no specific and effective treatment
at present time. Stem cells offer therapeutic potential for kidney disease. The goal of this application is to
develop stem cell-based therapy to treat acute kidney injury.","NIDDK","8334695","9/3/2012 12:00:00 AM","PA-07-070","5R01DK083411-05","5","R01","DK","083411","05"," ","RYS-SIKORA, KRYSTYNA E","9/24/2009 12:00:00 AM","7/31/2014 12:00:00 AM","Pathobiology of Kidney Disease Study Section[PBKD]"," ","6826278","LIN, FANGMING ","Not Applicable","13","PEDIATRICS","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","SCHOOLS OF MEDICINE","100323725","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","171517","102910"," ","274427",
"Clinical Research; Infant Mortality/ (LBW); Lung; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal - Neonatal Respiratory Distress Syndrome; Perinatal Period - Conditions Originating in Perinatal Period","Address;Adenovirus Vector;Adenoviruses;Advisory Committees;Affect;Air;Apoptosis;Attenuated;Beryllium;Biomedical Research;Blood Vessels;Bronchopulmonary Dysplasia;Cell Proliferation;Cells;Childhood;Chronic lung disease;Development;Down-Regulation;EGF gene;Embryo;Endothelial Cells;Endothelium;Epithelial;Epithelial Cells;Exhibits;Faculty;Failure;Fellowship;Fluorescence;Gene Expression;Goals;Growth;Hyperoxia;Hypoxia Inducible Factor;Individual;Infant;Infection;Injury;Instruction;Label;Laboratories;Lead;Lung;Mechanical ventilation;Medicine;Mentors;Mesenchymal;Mesenchyme;Modeling;Molecular;Monitor;Morphogenesis;Mus;Organ;Organogenesis;Oxygen;Pediatrics;Physicians;Play;Positioning Attribute;Predisposition;Premature Infant;Prevention strategy;Principal Investigator;Process;Program Development;Protein Isoforms;Recombinant Vascular Endothelial Growth Factor;Regulation;Research Personnel;Research Project Grants;Risk;Role;Scientist;Staging;Stimulus;Therapeutic;Therapeutic Intervention;Training;Training Programs;Transgenic Mice;Universities;VEGF165;Vascular Endothelial Growth Factor Receptor-1;Vascular Endothelial Growth Factors;Work;airway epithelium;angiogenesis;career;cell type;design;embryo culture;in vitro Model;infancy;injury and repair;lung development;lung injury;oxygen toxicity;pediatric department;postnatal;research study;respiratory;response;skills;success;treatment strategy","Role of VEGF in lung development and hyperoxic injury","n/a","NHLBI","8306702","7/25/2012 12:00:00 AM","PA-06-512","5K08HL089351-04","5","K08","HL","089351","04"," ","COLOMBINI-HATCH, SANDRA","8/1/2009 12:00:00 AM","7/31/2014 12:00:00 AM","ZHL1-CSR-O(O1)"," ","7586517","ESQUIBIES, AMERICO E","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","838","Other Research-Related","2012"," "," ","NHLBI","123250","9860"," ","133110",
"No NIH Category available","Bone Marrow;Calcium Binding;Calcium-Binding Proteins;Calgranulin A;Cell Surface Receptors;Cells;Chemotaxis;Cutaneous;Dermis;Disease;EF Hand Motifs;Epithelial;Family;Growth Factor;Inflammation;Inflammatory;Leukocyte L1 Antigen Complex;Leukocytes;Link;Mediating;Mediator of activation protein;Mesenchymal;Modeling;Molecular;Mus;Pathway interactions;Phenotype;Play;Poison;Production;Proteins;Psoriasis;Recruitment Activity;Regulation;Research Personnel;Role;Route;S100A8 gene;S100A9 gene;Signaling Molecule;Skin;Skin Cancer;Skin Carcinogenesis;Snails;Sunburn;Sunlight;Testing;Wound Healing;Zinc Fingers;angiogenesis;autocrine;base;carcinogenesis;cell motility;chemokine;cytokine;design;feeding;in vitro Model;in vivo;inhibitor/antagonist;keratinocyte;leukocyte activation;migration;neutrophil;novel;paracrine;prevent;receptor;response;skin disorder;slug;transcription factor;tumor progression;wound","Keratinocyte Activation by Slug-induced Calprotectin"," The skin is subject to many environmental insults, including wounds, sunlight, and toxic substances. We are studying the molecular pathways by which the skin responds to these insults with the aim of being able to enhance desirable responses like wound healing and to mitigate undesirable responses like sunburn. Our studies focus on two components of the pathway and their relationship: Slug and calprotectin, both of which enhance cell migration during wound healing, but also stimulate inflammation during sunburn.   
      

","NIAMS","8302831","2/21/2012 12:00:00 AM","PA-10-069","1R21AR061641-01A1","1","R21","AR","061641","01","A","BAKER, CARL","3/1/2012 12:00:00 AM","1/31/2014 12:00:00 AM","Arthritis, Connective Tissue and Skin Study Section[ACTS]"," ","6182419","KUSEWITT, DONNA FRANCES","Not Applicable","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","OVERALL MEDICAL","770304009","UNITED STATES","N","3/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","112500","65250"," ","177750",
"Cancer; Eye Disease and Disorders of Vision; Neurosciences; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Adhesions;Affect;Axon;Benign;Biological Models;Breast;Cancer cell line;Cell Cycle Progression;Cell Polarity;Cell-Cell Adhesion;Cell-Matrix Junction;Cells;Colon;Congenital Abnormality;Cytoplasmic Tail;Development;Embryo;Embryonic Development;Eph Family Receptors;Ephrins;Event;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Frequencies;Human;Laboratories;Ligand Binding;Ligands;Link;Malignant Neoplasms;Malignant neoplasm of gastrointestinal tract;Mediating;Membrane;Modification;Movement;Neoplasm Metastasis;Neural Crest Cell;Neuroblastoma;Pathway interactions;Pattern;Phenotype;Phosphorylation;Play;Positioning Attribute;Process;Prostate;Protein Tyrosine Kinase;Proteins;Repression;Research;Retinal;Role;Scaffolding Protein;Signal Pathway;Signal Transduction;Signaling Molecule;Staging;Stem cells;System;Tissues;Tumor Angiogenesis;Tumor Cell Invasion;Tumor Stem Cells;Tyrosine Phosphorylation;Vertebrates;Visual Fields;Xenopus;angiogenesis;cell motility;embryonic stem cell;epithelial to mesenchymal transition;hindbrain;human disease;insight;lung small cell carcinoma;melanoma;member;migration;neoplastic cell;pluripotency;retinal progenitor cell;skeletal;stem cell fate specification;tumor;tumorigenesis","Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways","n/a","NCI","8552630"," "," ","1ZIABC010006-17","1","ZIA","BC","010006","17"," "," "," "," "," "," ","9692315","DAAR, IRA ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","636508",
"Biotechnology; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human","AP 1903 reagent;Ablation;Achievement;Adult;Alkaline Phosphatase;Animals;Autologous;Behavior;Biological Assay;CD34 gene;Cell Culture Techniques;Cell Therapy;Cells;Clinical;Codon Nucleotides;Cohort Studies;DNA;Derivation procedure;Development;Ectoderm Cell;Ectopic Expression;Embryo;Endoderm Cell;Excision;Exposure to;Fibroblasts;Gene Expression;Genes;Genetic;Goals;Health;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;Hepatic;Homing;Human;Hypoxia;Immunodeficient Mouse;Implant;In Vitro;Laboratory Procedures;Left;Lentivirus Vector;Location;Macaca;Macaca mulatta;Maintenance;Marrow;Mediating;Mesenchymal;Mesoderm Cell;Methods;Modeling;Modification;Morphology;Mouse Strains;Mus;Paper;Play;Pre-Clinical Model;Proteins;Protocols documentation;Publishing;Regenerative Medicine;Resources;Retrieval;Retroviral Vector;Rodent Model;Role;Safety;Serum;Site;Skin;Somatic Cell;Specific qualifier value;Stem cells;Stromal Cells;Structure of beta Cell of islet;Suicide;TK Gene;Tacrolimus Binding Proteins;Teratoma;Tissues;Transplantation;United States National Institutes of Health;Xenograft Model;Xenograft procedure;base;caspase-9;cell type;design;gene therapy;human embryonic stem cell;immunogenic;improved;in vivo;induced pluripotent stem cell;killings;matrigel;model development;nonhuman primate;novel;osteogenic;pluripotency;prevent;programs;research study;safety testing;scale up;suicide gene;telomere;tissue regeneration;tool;transcription factor;tumor;vector","The rhesus macaque as a preclinical model for induced pluripotent stem cells","n/a","NHLBI","8558009"," "," ","1ZIAHL006062-03","1","ZIA","HL","006062","03"," "," "," "," "," "," ","2479331","DUNBAR, CYNTHIA E","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL HEART, LUNG, AND BLOOD INSTITUTE"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NHLBI"," "," "," ","386867",
"Biotechnology; Cancer; Genetics; Human Genome","Address;Allografting;Anchorage-Independent Growth;Biological;Cancer Biology;Cell Culture Techniques;Cell Proliferation;Cells;Complex;Coupled;Cultured Tumor Cells;Cytogenetics;DNA Damage;DNA Repair;DNA Repair Gene;DNA Repair Pathway;Development;Drug Delivery Systems;Epithelial;Gene Activation;Gene Expression;Gene Expression Profiling;Genetic;Genetic Induction;Genome;Genomics;Germ-Line Mutation;Goals;Growth;Health;Hereditary Disease;Hereditary Malignant Neoplasm;Human;Hypoxia;Hypoxia Inducible Factor;Immunohistochemistry;In Vitro;Lead;Link;Malignant - descriptor;Malignant Neoplasms;Mesenchymal;Molecular;Molecular Biology;Molecular Biology Techniques;Mutation;Nature;Neoplasm Metastasis;Normal Cell;Oncogene Activation;Pathway interactions;Pharmaceutical Preparations;Phosphorylation;Plant Roots;Play;Protein Isoforms;Radiation therapy;Reporting;Resistance;Role;Signal Pathway;Spectral Karyotyping;Testing;Threonine;Time;Tumor Angiogenesis;Tumor-Suppressor Gene Inactivation;Tumorigenicity;Xenograft Model;Xenograft procedure;anticancer research;base;c-myc Genes;cancer cell;cell behavior;cell killing;chemotherapy;comparative genomic hybridization;fight against;functional disability;in vivo;insight;mouse model;neoplastic cell;novel;novel strategies;novel therapeutics;protein protein interaction;response;trait;transcription factor;tumor;tumor growth;tumor progression;tumor xenograft","Mechanisms of the hypoxic response underlying tumor progression","
Project Narrative
 Cancer is, in essence, a genetic disease acquiring dynamic changes in the genome. This proposal
tackles the obscure mechanisms underlying genetic instability of cancer cells, an insurmountable problem in
the fight against cancer. We anticipate this study will help define the molecular bases for the development of
novel therapeutics.","NCI","8298649","7/10/2012 12:00:00 AM","PA-07-070","5R01CA131355-05","5","R01","CA","131355","05"," ","OKANO, PAUL","9/15/2008 12:00:00 AM","1/31/2015 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","8579931","HUANG, L. ERIC","Not Applicable","02","NEUROSURGERY","009095365","LL8GLEVH6MG3","009095365","LL8GLEVH6MG3","US","40.76776","-111.832926","514002","UNIVERSITY OF UTAH","SALT LAKE CITY","UT","SCHOOLS OF MEDICINE","841128930","UNITED STATES","N","8/1/2012 12:00:00 AM","1/31/2015 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","201275","101644"," ","302919",
"Autoimmune Disease; Bioengineering; Biotechnology; Cancer; Clinical Research; Digestive Diseases; Immunization; Inflammatory Bowel Disease; Vaccine Related","Animal Model;Autoimmune Process;Biological Assay;Biological Markers;Biology;Cell Culture Techniques;Cells;Client;Clinical;Clinical Trials;Collaborations;Communities;Consultations;Core Facility;Culture Media;Custom;Cyclic Nucleotides;Development;Disease;Eicosanoids;Enteral;Enzyme-Linked Immunosorbent Assay;Epithelial;Equipment;Event;Experimental Designs;Funding;Gastrointestinal Diseases;Goals;Growth;Growth Factor;Growth and Development function;Human;Human Resources;Immune;Immune response;Immune system;Immunoassay;Immunocompetence;Immunologic Monitoring;Immunologics;Immunosuppression;Immunosuppressive Agents;Immunotherapeutic agent;Industry;Inflammation;Inflammation Mediators;Inflammatory;Inflammatory Bowel Diseases;Intervention;Irritable Bowel Syndrome;Laboratories;Liver diseases;Malignant Neoplasms;Measurement;Measures;Mediation;Mesenchymal;Methods;Monitor;Mus;Neoplasms;Organ;Patients;Peptides;Pharmacotherapy;Phosphoproteins;Physiology;Plasma;Play;Population;Price;Procedures;Process;Protein Analysis;Proteins;Proteomics;Quality Control;Radioimmunoassay;Research;Research Personnel;Role;Safety;Second Messenger Systems;Serum;Services;Signaling Molecule;Site;System;Techniques;Technology;Therapeutic Intervention;Time;Tissue Extracts;Tissues;Training;Translational Research;Transplantation;United States National Institutes of Health;Vaccination;Vaccines;Validation;assay development;base;cancer immunotherapy;clinical efficacy;cost;cost effective;cytokine;discount;experience;gastrointestinal;gene environment interaction;immunogenicity;interest;member;neoplastic;new technology;novel;peptide hormone;prospective;reconstitution;repaired;second messenger;serological marker;symposium;technology development;tissue culture","IMMUNOTECHOLOGIES CORE","n/a","NIDDK","8374541","11/16/2011 12:00:00 AM","RFA-DK-08-002","5P30DK034987-27","5","P30","DK","034987","27"," "," "," "," ","ZDK1-GRB-8","6586","1877333","PLEVY, SCOTT E","Not Applicable","04","Unavailable","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","Domestic Higher Education","275995023","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM"," ","Research Centers","2012","132411","132411"," ","89750","42661"," "," ",
"Kidney Disease","3-Dimensional;Abbreviations;Adhesives;Annexins;Apical;Basement membrane;Binding;Canis familiaris;Cell Line;Cell membrane;Cells;Cellular biology;Charge;Collagen;Cyst;Data;Development;Enzymes;Epithelial;Epithelial Cells;Extracellular Matrix;Face;Gel;Hepatocyte Growth Factor;Image;Ions;Kidney;Life;Lipids;MDCK cell;Membrane;Mesenchymal;Microscopy;Modeling;Molecular;Molecular Models;Movement;Nephrons;Organ;PH Domain;PTEN gene;Phosphatidylinositol 4,5-Diphosphate;Phosphatidylinositols;Phospholipase D;Phosphoric Monoester Hydrolases;Phosphotransferases;Polycystic Kidney Diseases;Polymeric Immunoglobulin Receptors;Positioning Attribute;Protein Isoforms;Proteins;RNA Interference;Recruitment Activity;Role;Scaffolding Protein;Signal Transduction;Surface;Testing;Thin Layer Chromatography;Tight Junctions;Tube;Work;base;cellular imaging;inhibitor/antagonist;innovation;inorganic phosphate;inositol 4,5-bisphosphate;inositol 4-phosphate;inositol-1,4,5-trisphosphate 5-phosphatase;matrigel;molecular modeling;monolayer;phosphatidylinositol 3,4,5-triphosphate;podocalyxin;prevent;protein transport;research study;sialomucin;sialomucins;sodium-hydrogen exchanger regulatory factor;src Homology Region 2 Domain","Control of Epithelial Polarity"," Many organs consist largely of hollow tubes, lined by a layer of epithelial cells. The epithelial cells have specialized surfaces facing either the central lumen of the tube or other cells. We will analyze how the epithelial cells form these specialized surfaces and organize themselves spatially.  
    

","NIDDK","8288713","9/6/2012 12:00:00 AM","PA-10-067","5R01DK091530-02","5","R01","DK","091530","02"," ","HOSHIZAKI, DEBORAH K","7/1/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Membrane Biology and Protein Processing Study Section[MBPP]"," ","1876425","MOSTOV, KEITH E","Not Applicable","12","ANATOMY/CELL BIOLOGY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","118538"," ","336038",
"Brain Cancer; Brain Disorders; Cancer; Neurosciences; Orphan Drug; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Apoptosis;Area;Automobile Driving;Autophagocytosis;Behavior;Bioinformatics;Biometry;Cancer Cell Growth;Cells;Clinical;Data;Development;Doctor of Philosophy;Fireflies;Fostering;Genes;Glioma;Grant;Growth;Human;In Vitro;Individual;Investigational Therapies;Isoelectric Focusing;Lead;Lentivirus Vector;Malignant - descriptor;Malignant Neoplasms;Measures;Mediating;Molecular;Mutation;Names;Oncogenic;Outcome;Pathologic;Pathway interactions;Patients;Pattern;Pharmaceutical Preparations;Phase;Phosphotransferases;Play;Principal Investigator;Protein Array;Protein Isoforms;Protein-Serine-Threonine Kinases;Proteins;Quality of life;Regulation;Reporting;Research;Resistance;Role;Scientist;Signaling Molecule;Specimen;Subgroup;Systems Analysis;Techniques;Testing;Tetanus Helper Peptide;Therapeutic;Therapeutic Agents;Tissues;Toxic effect;Training;Tumor Tissue;Tumorigenicity;Work;angiogenesis;arm;cancer cell;cell growth;cell motility;conventional therapy;design;effective therapy;epithelial to mesenchymal transition;experience;glioma cell line;improved;in vivo;inhibitor/antagonist;migration;overexpression;pluripotency;programs;public health relevance;self-renewal;senescence;skills;small hairpin RNA;therapeutic target;tumor","Targeting the PI3K/Akt pathway in High Grade Glioma","
Akt is a protein that is often responsible for driving cancer cell growth, spread and
resistance to conventional and experimental therapies. Drugs that inhibit the
malignancy-associated parts of the Akt pathway may be very effective against glioma
tumors with decreased toxicity. Here we propose to identify 'arms' of the Akt pathway
that are specific to cancer cells and are ideal targets for developing effective molecular
therapies. We will also find ways to identify tumor subgroups that use different arms of
the Akt pathway and understand which proteins and pathways are active in tumor
subgroups.","NINDS","8288859","5/21/2012 12:00:00 AM","PA-09-040","5K01NS064952-03","5","K01","NS","064952","03"," ","FOUNTAIN, JANE W","5/1/2010 12:00:00 AM","4/30/2015 12:00:00 AM","ZNS1-SRB-M(72)"," ","9369086","JOY, ANNA MARGARET","Not Applicable","07","Unavailable","131606022","SKX6AXF9ZTM3","131606022","SKX6AXF9ZTM3","US","33.480398","-112.078774","2052813","ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER","PHOENIX","AZ","Independent Hospitals","850134409","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","853","Other Research-Related","2012"," "," ","NINDS","126850","4000"," ","130850",
"Biotechnology; Cancer; Ovarian Cancer; Rare Diseases","Address;Adhesions;Biological Assay;Cancer Etiology;Cause of Death;Cell Survival;Cell-Matrix Junction;Cells;Cessation of life;Collagen;Competence;Complement;Cytoplasmic Tail;Data;Development;Diagnosis;Disease;Dissociation;E-Cadherin;Epithelial;Epithelial ovarian cancer;Event;Funding;Gene Expression;Gene Targeting;Genetic Transcription;Goals;Greater sac of peritoneum;Gynecologic;In Vitro;Integrin Binding;Integrins;Life;Link;MMP14 gene;Malignant Neoplasms;Malignant neoplasm of ovary;Matrix Metalloproteinases;Mediating;Membrane;Mesenchymal;Metastatic Lesion;Metastatic to;Modeling;Modification;Molecular;Mutation;Neoplasm Metastasis;Ovarian Carcinoma;Pathway interactions;Peptide Hydrolases;Peritoneal;Phosphorylation;Phosphotransferases;Population;Post-Translational Protein Processing;Post-Translational Regulation;Primary Neoplasm;Proliferating;Proteins;Proteolysis;Regulation;Research Design;Resistance;Role;Secondary Lesion;Signal Transduction;Solid Neoplasm;Suspension substance;Suspensions;Therapeutic;Woman;chemotherapy;collagenase;design;improved;in vitro Assay;in vivo;inhibitor/antagonist;integrin-linked kinase;interstitial;intraperitoneal therapy;mimetics;model development;mortality;mutant;neoplastic cell;novel;public health relevance;research study;success;tumor progression","Regulation of Ovarian Carcinoma Proteinases","
Development of models that accurately reflect the metastatic competence of epithelial ovarian cancer
(EOC) represents a remarkable scientific challenge, because the EOC metastatic mechanism involves a
novel shedding of multi-cellular aggregates (MCAs) into a cavity (peritoneal cavity) as anchorage-
independent, chemotherapy-resistant spheroids. In this unique niche, molecular events that occur during
the transition from free-floating MCA to life-threatening peritoneally anchored metastatic lesion are poorly
understood. Understanding this transition will enable novel means of targeting intraperitoneal therapies to
appropriate multicellular populations.","NCI","8217306","3/27/2012 12:00:00 AM","PA-07-070","7R01CA086984-13","7","R01","CA","086984","13"," ","SATHYAMOORTHY, NEERAJA","7/1/2000 12:00:00 AM","3/31/2015 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1898911","STACK, MARY SHARON","Not Applicable","02","CHEMISTRY","824910376","FPU6XGFXMBE9","824910376","FPU6XGFXMBE9","US","41.702007","-86.246548","6169301","UNIVERSITY OF NOTRE DAME","NOTRE DAME","IN","SCHOOLS OF ARTS AND SCIENCES","465565708","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","194384","101080"," ","295464",
"Aging; Biotechnology; Estrogen; Genetics; Osteoporosis","Address;Affect;Androgen Receptor;Androgens;Apoptosis;Attenuated;Bacteria;Binding;Bone Diseases;Bone Resorption;Cells;Coculture Techniques;DNA Binding;Data;Development;Dominant-Negative Mutation;Drug Delivery Systems;Estradiol;Estrogen Receptors;Estrogens;Gender;Gene Expression;Gene Targeting;Genomics;Gonadal Steroid Hormones;Haplotypes;Health;Homeostasis;Hormones;Human;ICI 182780;Knockout Mice;Lead;Ligands;Light;Mammalian Cell;Mediating;Mesenchymal;Metabolism;Molecular;Mus;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis;Outcome;Pharmaceutical Preparations;Physiological;Plasmids;Play;Postmenopausal Osteoporosis;Property;Proteins;Raloxifene;Receptor Signaling;Recombinants;Recruitment Activity;Regulation;Relative (related person);Repression;Role;Selective Estrogen Receptor Modulators;Signal Transduction;Skeletal Development;Staging;System;Testing;Time;Tissues;Transcriptional Activation;Transgenic Mice;Variant;Work;base;bone;bone health;bone mass;bone metabolism;bone turnover;domain mapping;functional outcomes;improved;in vivo;insight;mouse model;mutant;novel;osteoblast differentiation;osteoclastogenesis;prevent;receptor;research study;runx proteins;skeletal;steroid hormone;steroid hormone receptor;transcription factor","Sex Steroids and Runx Signaling in Bone","
 Project Narrative
Sex Steroids and Runx Signaling in Bone
This project will unravel fundamental mechanisms of osteoporosis that occurs as sex hormones decline. It is
based on the observation that Runx proteins, which control bone metabolism, interact with receptors for both
estrogens and androgens. The proposed work can ultimately lead to the development of improved drugs to
treat postmenopausal osteoporosis.
Page 2 of 38","NIDDK","8292153","6/26/2012 12:00:00 AM","PA-07-070","5R01DK071122-06","5","R01","DK","071122","06"," ","MALOZOWSKI, SAUL N","4/1/2005 12:00:00 AM","6/30/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","6194193","FRENKEL, BARUCH ","Not Applicable","37","ORTHOPEDICS","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF MEDICINE","900894304","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","278838","145172"," ","424010",
"Aging; Eye Disease and Disorders of Vision; Injury (total) Accidents/Adverse Effects; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adult;Affect;Aging;Anterior;Area;Blindness;Carrier Proteins;Cell Differentiation process;Cell Proliferation;Cell physiology;Cells;Characteristics;Cilia;Complex;Control Animal;Cornea;Corneal Endothelium;Corneal Opacity;Cytoskeleton;Data;Defect;Descemet&apos;s membrane;Development;Disease;Endothelial Cells;Endothelium;Ensure;Epithelial;Epithelial Cells;Epithelium;Erinaceidae;Event;Eye;Genes;Glaucoma;Healed;Injury;Keratoconus;Knockout Mice;Lead;Life;Mediating;Mesenchymal;Molecular;Molecular Target;Morphogenesis;Multiple Abnormalities;Mus;Mutant Strains Mice;Nature;Neural Crest;Organelles;Pathway interactions;Patients;Pattern;Play;Process;Proteins;RNA Interference;Role;Signal Pathway;Signal Transduction;Speed;Staging;Stem cells;Structure;Surface;Syndrome;Testing;Time;Tissues;Trauma;base;cell motility;cell type;ciliopathy;corneal epithelial stem cells;corneal epithelium;corneal repair;healing;in vivo;injured;injury and repair;lentiviral-mediated;limbal;mouse development;mutant;new therapeutic target;overexpression;pathological aging;repaired;research study;smoothened signaling pathway;stem cell niche;tissue repair;wound","Role of primary cilia in corneal development and repair"," Damage of the cornea due to trauma, diseases or aging followed by ""abnormal"" repair of corneal tissues can compromise corneal transparency and lead to blindness. This study will elucidate signaling pathways required for proper corneal cell differentiation and patterning and will lead to the identification of new therapeutic targets to counteract aging, and pathological and traumatic corneal cell loss, but may also have wider implications for understanding complex morphogenetic events in other tissues.   
      

","NEI","8345547","7/16/2012 12:00:00 AM","PA-10-067","1R01EY022639-01","1","R01","EY","022639","01"," ","MCKIE, GEORGE ANN","8/1/2012 12:00:00 AM","7/31/2017 12:00:00 AM","Biology of the Visual System Study Section[BVS]"," ","9103338","IOMINI, CARLO ","Not Applicable","13","OPHTHALMOLOGY","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","SCHOOLS OF MEDICINE","100296574","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","250000","173750"," ","423750",
"Biotechnology; Cancer; Clinical Research; Genetics; Lung; Lung Cancer; Pediatric; Pediatric Research Initiative; Rare Diseases","Ablation;Address;Alleles;Cause of Death;Cells;Childhood;Complex;Coupled;Couples;Coupling;DICER1 gene;Data;Development;Diagnosis;Diagnostic;Differentiation and Growth;Disease;Disease Progression;Embryo;Embryonic Development;Epithelial;Epithelium;Etiology;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Genes;Genetic;Histology;Human;Hyperplasia;Knowledge;Life;Link;Lung;Lung diseases;Malignant Neoplasms;Malignant neoplasm of lung;Maps;Mediating;Mediator of activation protein;Mesenchymal;Mesenchyme;Mesothelium;Messenger RNA;MicroRNAs;Modeling;Molecular;Mus;Mutation;Natural regeneration;Neoplastic Cell Transformation;Pathogenesis;Pathway interactions;Phenotype;Pleuropulmonary Blastoma;Process;Processed Genes;Production;Publishing;Receptor Signaling;Regulation;Role;Signal Pathway;Signal Transduction;Signaling Molecule;Staging;Syndrome;Testing;Therapeutic;United States;design;developmental genetics;disability;feeding;fibroblast growth factor 9;in vivo;insight;interest;loss of function;loss of function mutation;lung development;lung repair;mRNA Expression;mouse model;next generation;overexpression;tumor","FGF9 REGULATION OF LUNG DEVELOPMENT AND PATHOGENESIS OF PLEUROPULMONARY BLASTOMA","  Lung disease is the fourth leading cause of death and disability in the United States. The etiology of lung disease often begins during embryonic development or early in life. To understand the pathogenesis of genetic, developmental, and acquired lung disease, to develop diagnostic criteria for these diseases, and to develop rational therapies, knowledge of the molecular, cellular and developmental mechanisms that regulate lung development is necessary. This proposal will focus on developmental mechanisms that involve Fibroblast Growth Factor 9, a signaling molecule that is essential for lung development and implicated as a pathogenic mediator of pleuropulmonary blastoma, a rare pediatric lung cancer.      

","NHLBI","8371642","8/22/2012 12:00:00 AM","PA-10-067","1R01HL111190-01A1","1","R01","HL","111190","01","A","LIN, SARA","9/1/2012 12:00:00 AM","7/31/2016 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1898903","ORNITZ, DAVID M","Not Applicable","01","OTHER BASIC SCIENCES","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","9/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","352713","168019"," ","520732",
"Biotechnology; Genetics; Kidney Disease; Regenerative Medicine","Actinin;Acute;Acute Renal Failure with Renal Papillary Necrosis;Apoptosis;Architecture;Binding;Binding Sites;Biological Assay;Boxing;Cardiac Surgery procedures;Cardiovascular system;Cell Nucleus;Cells;Co-Immunoprecipitations;Complication;Confocal Microscopy;Cytoplasm;Cytoskeleton;DNA Sequence Rearrangement;Data;E-Cadherin;Epithelial;Epithelial Cells;Focal Adhesions;Foxes;Goals;Immunofluorescence Immunologic;In Situ Nick-End Labeling;Injection of therapeutic agent;Injury;Ischemia;Kidney;Laboratories;Measures;Mesenchymal;Molecular;Monitor;Morbidity - disease rate;Morphogenesis;Mus;Mutate;Natural regeneration;Nuclear;Nuclear Export;Outcome;Patients;Phosphorylation;Phosphotransferases;Play;Process;Proliferating;Proteins;RNA Interference;Regulation;Renal function;Reperfusion Therapy;Repression;Research;Role;Serine;Simulate;Site;Small Interfering RNA;Specific qualifier value;Staining method;Stains;Transfection;Treatment Cost;Tubular formation;Up-Regulation;Vimentin;Western Blotting;cell motility;design;in vivo;injured;injury and repair;kinase inhibitor;knock-down;member;migration;mutant;nephrogenesis;overexpression;paxillin;repaired;response;skeletal;therapeutic target;transcription factor;tumor;uptake","Nuclear-Cytoplasmic Shuttling of Foxc2 via 14-3-3 Determines Proximal Tubule Cell"," Ischemia/reperfusion is a major cause of acute kidney injury (AKI) in hospitalized patients and causes complications in cardiac surgery with short-term morbidity, increased costs of treatment, and poor long-term outcome. Tubular regeneration restores normal tubular architecture and renal function following kidney injury and the mechanisms of tubular injury and repair are poorly understood. Extensive examination of the mechanisms and potential therapeutic targets will advance the understanding and potential cure for AKI in proximal tubular regeneration.   
      

","NIDDK","8398639","7/1/2012 12:00:00 AM","PA-11-113","1F32DK094589-01A1","1","F32","DK","094589","01","A","MARIC-BILKAN, CHRISTINE","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","ZDK1-GRB-G(M1)S"," ","10893413","GOLDEN, DIANA LYNNE","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Training, Individual","2012"," "," ","NIDDK","54890"," "," ","54890",
"Kidney Disease","Acute;Acute Renal Failure with Renal Papillary Necrosis;Anoikis;Apoptosis;Cell Communication;Cell Polarity;Cell Proliferation;Cell Survival;Cell membrane;Cells;Chronic;Chronic Kidney Failure;Cytoprotection;Development;EGF gene;Elements;Epidermal Growth Factor Receptor;Epithelial;Epithelial Cells;Epithelium;Extracellular Matrix;Fibrosis;Funding;Genetic;Growth;Growth Factor;Injury;Kidney;Laboratories;Lead;Ligands;Maintenance;Mediating;Membrane;Membrane Microdomains;Mesenchymal;Natural regeneration;Pathway interactions;Physiology;Play;Polycystic Kidney Diseases;Process;Receptor Activation;Receptor Inhibition;Recovery;Regulation;Renal Cell Carcinoma;Renal tubule structure;Reperfusion Injury;Role;Secondary to;Signal Transduction;Structure;Transactivation;Tubular formation;Ubiquitination;Zinc Fingers;autocrine;caveolin 1;cell motility;heparin-binding EGF-like growth factor;migration;nephrogenesis;novel;paracrine;prevent;public health relevance;receptor;response;scaffold;slug;survivin;trafficking;transcription factor","The Role of the EGF Receptor in Acute and Chronic Renal Injury","
Project)Narrative)
)
Our)studies)indicate)that)both)recovery)from)acute)kidney)injury)and))development)
of)progressive)renal)tubulointerstitial)injury)are)mediated)in)part)by)activation)of)
the)EGF)receptor))(EGFR).)The)proposed)studies)will)examine)the)mechanisms)by)
which)EGFR)is)activated)in)both)acute)and)chronic)injury)and)the)role)and)
mechanisms)in)cytoprotection)and)tubule)regeneration)with)acute)injury)and)
progressive)tubulointerstitial)damage)resulting)from)chronic)injury.))","NIDDK","8247839","5/2/2012 12:00:00 AM","PA-07-070","5R01DK051265-16","5","R01","DK","051265","16"," ","RYS-SIKORA, KRYSTYNA E","1/1/1997 12:00:00 AM","2/28/2015 12:00:00 AM","Pathobiology of Kidney Disease Study Section[PBKD]"," ","1944162","HARRIS, RAYMOND C.","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","115038"," ","320463",
"No NIH Category available","Address;Area;Behavior;Binding;Biological Assay;Biological Process;Cell Communication;Cell Culture Techniques;Cell surface;Cells;Characteristics;Cleaved cell;Complement;Complex;Data;Development;Drosophila genus;Epithelial;Erinaceidae;Extracellular Matrix;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Genes;Genetic;Glypican;HIV;Health;Heparan Sulfate Proteoglycan;Heparin Binding Growth Factor;Homeostasis;Imaging Device;In Vitro;Larva;Malignant - descriptor;Malignant Neoplasms;Mammals;Mediating;Mesenchymal;Metalloproteases;Modeling;Molecular;Molecular Biology;Morphogenesis;Neoplasm Metastasis;Nude Mice;Oncogenic;Organ;Pathology;Pattern;Peptide Hydrolases;Process;Prostate carcinoma;Proteolysis;Regulation;Research;Shapes;Signal Pathway;Signal Transduction;Signaling Molecule;Specificity;Structure;Structure-Activity Relationship;Substrate Interaction;System;Testing;Tissues;Tumor Angiogenesis;Tumor Pathology;Vascular Endothelial Growth Factors;base;clinically relevant;computerized data processing;design;enzyme substrate;extracellular;heparin proteoglycan;in vivo;inhibitor/antagonist;insight;morphogens;mutant;novel;protein function;proteoglycan core protein;public health relevance;receptor;research study;tissue regeneration;tumor;tumorigenic","Regulation of Cell-Cell Interactions by Matrix Metalloproteases","
Narrative - Health Relevance
Deregulation of Matrix metalloproteases (MMPs) and FGF signaling has been implicated in tumor-stroma
interactions, metastasis formation and tumor angiogenesis. This project will study a recently discovered
functional connection between MMP activity and FGF signaling that might be relevant in malignancy. The
potential tumor suppressive function of a specific inhibitor of FGF signaling, which is generated by MMP, will
be tested.
 ","NIGMS","8197953","12/2/2011 12:00:00 AM","PA-10-067","5R01GM095962-02","5","R01","GM","095962","02"," ","FLICKER, PAULA F","12/1/2010 12:00:00 AM","11/30/2014 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","6486092","BOHMANN, DIRK ","Not Applicable","25","GENETICS","041294109","F27KDXZMF9Y8","041294109","F27KDXZMF9Y8","US","43.16888","-77.615939","7047101","UNIVERSITY OF ROCHESTER","ROCHESTER","NY","SCHOOL OF MEDICINE & DENTISTRY","146270140","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","200000","109000"," ","309000",
"Cancer; Prostate Cancer; Urologic Diseases","ALCAM gene;Activated-Leukocyte Cell Adhesion Molecule;Adhesions;Affinity;Biochemical;Bioinformatics;Biological Assay;Blood Circulation;Cancer Patient;Cardiovascular system;Cell Extracts;Cell surface;Cell-Cell Adhesion;Cells;Cessation of life;Clinical;Communication;Complex;Data Set;Disease;Disease Progression;Distant;Epithelial;Evaluation;Extracellular Matrix;Gene Expression;Genetic;Goals;Guanosine Triphosphate Phosphohydrolases;Human;Image;Immobilization;In Vitro;Integrins;Intercellular Junctions;Intervention;Invaded;Knock-out;Left;Light;Macromolecular Complexes;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Membrane;Mesenchymal;Metastatic Prostate Cancer;Metastatic to;Modeling;Molecular;Molecular Profiling;Mus;Neoplasm Metastasis;Normal tissue morphology;Organ;PTEN gene;Patients;Prognostic Factor;Prostate;Proteins;Publishing;Recruitment Activity;Regulation;Role;Signal Transduction;Site;Solid Neoplasm;Specimen;Work;Xenograft procedure;base;bone;cell motility;genetic manipulation;human PHEMX protein;human disease;in vivo;migration;neoplastic cell;novel;patient population;prevent;public health relevance;research study;therapeutic target;tumor;tumor progression","Tetraspanin-mediated regulation of tumor cell migration and metastasis","
PROJECT NARRATIVE
 Cancer related deaths occur primarily because tumor cells spread from the site of origin to distant vital
organs using the circulatory system. In order to reach a distant organ, tumor cells have to mobilize
themselves and enter the circulation. The overall goal of proposed work is to develop mechanisms of
molecular intervention which immobilizes tumor cells and prevent tumor cell metastasis in cancer patients.","NCI","8196950","11/30/2011 12:00:00 AM","PA-07-070","5R01CA143081-03","5","R01","CA","143081","03"," ","AULT, GRACE S","12/7/2009 12:00:00 AM","11/30/2014 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","6784902","ZIJLSTRA, ANDRIES ","Not Applicable","05","PATHOLOGY","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","112714"," ","313989",
"Acute Respiratory Distress Syndrome; Biodefense; Lung; Orphan Drug; Prevention; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acute;Acute Lung Injury;Award;Biological Assay;Breathing;Bronchiolitis;Bronchiolitis Obliterans;Cell Differentiation process;Cell Proliferation;Cells;Chemicals;Chlorine;Chronic;Clinical;Clinical Trials;Collection;Data;Development;Disease;Drug Kinetics;Dyspnea;Epithelial;Epithelial Cells;FDA approved;Failure;Family suidae;Fibrosis;Functional disorder;Gene Expression;Goals;Growth Factor;Health;Human;In Vitro;Individual;Injury;Lead;Lesion;Life;Measures;Medical;Mesenchymal;Mission;Modeling;Mus;Natural regeneration;Patients;Pharmaceutical Preparations;Phase;Poison;Prevention;Production;Protein Tyrosine Kinase;Public Health;Receptor Protein-Tyrosine Kinases;Recording of previous events;Research;Safety;Signal Pathway;Signs and Symptoms;Stem cells;Symptoms;Syndrome;Testing;Therapeutic;Toxic effect;Translating;Tyrosine Kinase Inhibitor;Validation;Work;airway epithelium;angiogenesis;animal efficacy;animal rule;base;efficacy testing;high throughput screening;improved;inhibitor/antagonist;injured airway;lung injury;mouse model;novel;overexpression;phase 3 study;pre-clinical;prevent;receptor;repaired;respiratory;response;small molecule;therapeutic development","Development of therapeutics for chlorine-induced airway and lung injury"," The proposed research is relevant to public health because identifying and developing therapeutics to treat chemical-induced lung injury will markedly improve the health and well being of individuals exposed to highly toxic chemicals via accidental or intentional release. The proposed research is thus relevant to the NIH's mission of promoting the treatment of disease so that individuals can live longer and more fulfilling lives.   
      

","NIEHS","8332971","9/14/2012 12:00:00 AM","PAR-11-155","2U01ES017219-04","2","U01","ES","017219","04"," ","NADADUR, SRIKANTH","9/30/2008 12:00:00 AM","5/31/2017 12:00:00 AM","Special Emphasis Panel[ZRG1-MDCN-J(50)R]"," ","1912312","GUNN, MICHAEL D","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","9/14/2012 12:00:00 AM","5/31/2013 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","OD","588382","325940"," ","914322",
"Dental/Oral and Craniofacial Disease; Genetics; Pediatric","ATP Receptors;BMP2 gene;Basement membrane;Binding;Blood Vessels;Bone Development;Bone Marrow;Calcified;Calmodulin;Calvaria;Cartilage;Cartilage Diseases;Cartilage Matrix;Cell Line;Cell Proliferation;Cells;Chondrocytes;Chondrogenesis;Collagen;Collagen Type II;Connexins;Development;Disease;Endoplasmic Reticulum;Endothelial Cells;Epiphysial cartilage;Excision;Extracellular Matrix;Extracellular Space;Gap Junctions;Gene Mutation;Gene Targeting;Genes;Goals;Growth;Growth Factor;Growth and Development function;Heparan Sulfate Proteoglycan;Hereditary Disease;Human;Human Genetics;Invaded;Joints;Length;Limb structure;Mechanics;Mesenchymal;Mesenchyme;Metatarsal bone structure;Modeling;Molecular;Molecular Biology;Morphology;Mus;Organelles;Osteoblasts;Osteogenesis;Perinatal;Physical condensation;Play;Process;Proliferating;Protein Family;Purinoceptor;Regulation;Regulator Genes;Rest;Role;Signal Transduction;Signaling Molecule;Skeleton;Staging;Stem cells;Stimulus;Testing;Thromboplastin;Transgenes;VEGFA gene;Vascular Endothelial Cell;Vascular Endothelial Growth Factor Receptor;Vascular Endothelial Growth Factors;Vascularization;Width;aggrecan;angiogenesis;autocrine;base;bone;cartilage development;chondrodysplasia;craniofacial;extracellular;gap junction channel;intramembranous bone formation;link protein;long bone;malformation;migration;mineralization;neovascular;osteoblast differentiation;osteogenic;perlecan;skeletal;substantia spongiosa;transcription factor","Cartilage Development and Disease","n/a","NIDCR","8553323"," "," ","1ZIADE000483-24","1","ZIA","DE","000483","24"," "," "," "," "," "," ","9415015","YAMADA, YOSHIHIKO ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIDCR"," "," "," ","817936",
"Cardiovascular; Food Safety; Heart Disease; Pediatric","Address;Adult;Affect;Animals;Arsenic;Atherosclerosis;Attenuated;Biological Assay;Blood Vessels;Cardiac;Cardiovascular Diseases;Cardiovascular system;Cell Differentiation process;Chronic;Collagen;Communities;Complex;Congenital Heart Defects;Connective Tissue Diseases;Defect;Deposition;Development;Developmental Gene;Disease;Disease Outcome;Embryo;Embryonic Development;Environmental Risk Factor;Epidemiology;Etiology;Event;Exposure to;Extracellular Matrix;Fetal Development;Fibrosis;First Pregnancy Trimester;Gel;Gene Expression;Growth Factor;Hazardous Waste;Health;Heart;Heart Diseases;Heart Valves;Hyaluronan;Hypertension;In Vitro;Incidence;Ingestion;Lead;Life;Link;Maintenance;Mediating;Mesenchyme;Mitral Valve Prolapse;Molecular;Molecular Profiling;Molecular Target;Mus;Neonatal;Onset of illness;Organ;Outcome;Pathology;Perinatal Exposure;Peripheral Vascular Diseases;Population;Predisposition;Process;Production;Ptosis;Risk;Rupture;Serum;Severities;Spontaneous abortion;Structure;Surrogate Markers;System;TGFB2 gene;Testing;Tissues;Toxic effect;Translating;Vascular Diseases;attenuation;body system;carcinogenesis;critical developmental period;cytokine;drinking water;epithelial to mesenchymal transition;fetal;in utero;in vivo;malformation;mature animal;mortality;neonatal exposure;programs;remediation;toxicant;tumor progression","Project 5: As Effects On Cardiovascular Development and Disease","Chronic exposure to arsenic in drinking water has been linked recently to cardiovascular disease. These studies will determine if in utero or neonatal exposure to arsenic results in heart and vascular diseases.","NIEHS","8378309","3/28/2012 12:00:00 AM","RFA-ES-08-005","5P42ES004940-23","5","P42","ES","004940","23"," "," "," "," ","ZES1-LWJ-M","5086","3160965","CAMENISCH, TODD D","Not Applicable","03","Unavailable","806345617","ED44Y3W6P7B9","806345617","ED44Y3W6P7B9","US","32.156964","-110.877577","490201","UNIVERSITY OF ARIZONA","TUCSON","AZ","Domestic Higher Education","857210158","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","165510","165510"," ","110820","54690"," "," ",
"Genetics; Neurosciences; Regenerative Medicine","Actins;Address;Afferent Neurons;Animals;Atomic Force Microscopy;Auditory;Axon;Binding;Birds;Birth;Brain;Candidate Disease Gene;Cell Differentiation process;Cells;Cochlea;Collaborations;Complex;Data;Defect;Development;Developmental Process;Ear;Embryonic Development;Embryonic Structures;Epithelium;Event;Family member;Fascicle;Fibroblast Growth Factor;Generations;Genes;Genetic;Goals;Hair Cells;Hearing;Human;In Vitro;Individual;Insulin-Like Growth Factor Receptor;Label;Laboratories;Labyrinth;Lead;Mammals;Mechanics;Mediating;Mesenchymal;Microtubules;Molecular;Molecular Genetics;Mus;Mutant Strains Mice;Mutation;Natural regeneration;Neurons;Neuropilins;Organ;Organ of Corti;Pathway interactions;Pattern;Peripheral;Pillar Cell;Play;Population;Property;Proto-Oncogene Proteins c-akt;Radial;Role;Semaphorins;Sensory;Series;Signal Pathway;Signal Transduction;Somatomedins;Specific qualifier value;Stereotyping;Structure;Supporting Cell;Synapses;System;Testing;To specify;Transgenic Mice;Undifferentiated;Work;axon guidance;base;cell type;chromatin immunoprecipitation;deafness;ganglion cell;hair cell regeneration;hindbrain;inhibitor/antagonist;interest;mature animal;member;mutant;nerve supply;neuroblast;otoconia;prevent;promoter;protein expression;receptor expression;research study;response;restoration;sound;spiral ganglion;transcription factor","Hair Cell Development in the Mammalian Cochlea","n/a","NIDCD","8565501"," "," ","1ZIADC000059-13","1","ZIA","DC","000059","13"," "," "," "," "," "," ","9414961","KELLEY, MATTHEW ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIDCD"," "," "," ","3011488",
"Bioengineering; Biotechnology; Nanotechnology; Neurosciences; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human","Affect;Anastomosis - action;Arthritis;Biocompatible Materials;Biological Models;Bioreactors;Blood Vessels;Bypass;Caliber;Carotid Arteries;Cell Therapy;Cells;Coculture Techniques;Coronary;Demyelinating Diseases;Disease;Endocrine;Endocrine System Diseases;Ethics;Extracellular Matrix;Generations;Germ Layers;Heart failure;Immune;In Vitro;Injury;Investigation;Knowledge;Lower Extremity;Medicine;Mesenchymal;Multipotent Stem Cells;Nanostructures;Nanotechnology;Natural regeneration;Nerve;Nerve Regeneration;Neural Crest;Neurons;Operative Surgical Procedures;Osteoporosis;Patients;Peripheral Nerves;Peripheral nerve injury;Protocols documentation;Regenerative Medicine;Research;Schwann Cells;Simulate;Smooth Muscle Myocytes;Source;Spinal Dysraphism;Stem cells;Structure;System;Technology;Testing;Therapeutic;Therapeutic Effect;Tissue Differentiation;Tissue Engineering;Tissues;Trauma;Vascular Graft;Vascular remodeling;base;bone cell;cartilage cell;cell type;disability;human embryonic stem cell;in vivo;in vivo regeneration;induced pluripotent stem cell;interdisciplinary approach;melanocyte;nanofiber;nanostructured;new technology;public health relevance;relating to nervous system;repaired;response;scaffold;sciatic nerve;stem cell biology;stem cell differentiation;tissue regeneration;tissue repair","Multipotent stem cells for tissue regeneration","
Project Narrative
In this project we will explore the differentiation and therapeutic potential of induced pluripotent
stem (iPS) cells. The iPS cell-derived multipotent neural crest stem cells will be characterized
and combined with nanofibrous scaffolds for peripheral nerve and vascular repair. The
accomplishment of this project will break new grounds of using iPS cells for regenerative
medicine applications and establish novel technologies and cell sources for therapies.","NIBIB","8281546","5/14/2012 12:00:00 AM","PA-07-070","5R01EB012240-03","5","R01","EB","012240","03"," ","HUNZIKER, ROSEMARIE","8/15/2010 12:00:00 AM","5/31/2014 12:00:00 AM","Bioengineering, Technology and Surgical Sciences Study Section[BTSS]"," ","3129839","LI, SONG ","Not Applicable","13","BIOMEDICAL ENGINEERING","124726725","GS3YEVSS12N6","124726725","GS3YEVSS12N6","US","37.870295","-122.268133","577502","UNIVERSITY OF CALIFORNIA BERKELEY","BERKELEY","CA","BIOMED ENGR/COL ENGR/ENGR STA","947101749","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","323804","165360"," ","489164",
"Aging; Neurosciences; Osteoporosis","5&apos;-Nucleotidase;Address;Adenine Nucleotides;Adenosine;Adenosine A1 Receptor;Adenosine A2 Receptors;Agonist;Alkaline Phosphatase;Animal Model;Animals;Binding;Biochemical;Bone Marrow;Bone Resorption;Bone remodeling;Catabolism;Cell Culture Techniques;Cells;Child;Development;Disease;Elderly;Enzymes;Event;Family member;Fracture;G-Protein-Coupled Receptors;Generations;Giant Cells;Heart Rate;Human;Hypoxia;In Vitro;Inflammation;Inflammatory;Injury;Knock-out;Knockout Mice;Laboratories;Lead;Ligation;Liquid substance;Mediating;Mesenchymal;Modeling;Molecular;Mus;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis;Osteoporosis prevention;Parkinson Disease;Pathology;Physiological;Play;Postmenopausal Osteoporosis;Predisposition;Process;Production;Proteolysis;Public Health;Purine Nucleosides;Purinergic P1 Receptors;Regulation;Rheumatoid Arthritis;Role;Signal Transduction;Stress;TRAF6 gene;Techniques;Tissues;Ubiquitination;Vasodilation;adenosine deaminase deficiency;aging population;base;bone;bone loss;bone mass;bone metabolism;cell type;extracellular;human disease;in vivo;inhibitor/antagonist;macrophage;monocyte;neutrophil;new therapeutic target;nucleoside triphosphatase;osteoclastogenesis;peripheral blood;phosphoric diester hydrolase;prevent;pyrophosphatase;receptor;response","Purinergic Regulation of Bone Metabolism","n/a","NIAMS","8242643","3/25/2012 12:00:00 AM","PA-07-070","5R01AR054897-05","5","R01","AR","054897","05"," ","CHEN, FAYE H","7/7/2008 12:00:00 AM","8/31/2015 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1862427","CRONSTEIN, BRUCE NEIL","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","121911077","M5SZJ6VHUHN8","121911077","M5SZJ6VHUHN8","US","40.744985","-73.978118","5998304","NEW YORK UNIVERSITY SCHOOL OF MEDICINE","NEW YORK","NY","SCHOOLS OF MEDICINE","10016","UNITED STATES","N","4/1/2012 12:00:00 AM","8/31/2015 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","209088","145316"," ","354404",
"Cancer","Adhesions;Affect;Biological Models;Cancer Biology;Carcinoma;Cell Adhesion;Cell Adhesion Molecules;Cell-Matrix Junction;Data;Development;Diagnostic Neoplasm Staging;Disseminated Malignant Neoplasm;Distant;Extracellular Matrix;Genes;Growth;Human;Integrin alpha3beta1;Integrins;Laboratories;Lead;MMP9 gene;Malignant - descriptor;Malignant Neoplasms;Matrix Metalloproteinases;Mediating;Mediator of activation protein;Modeling;Molecular;Molecular Biology Techniques;Mus;Nature;Neoplasm Metastasis;Outcome;Pathway interactions;Patients;Phenotype;Play;Post-Transcriptional Regulation;Primary Neoplasm;Process;Property;Regulation;Research Project Grants;Role;Signal Pathway;Signal Transduction;Signaling Pathway Gene;Site;Squamous cell carcinoma;Staging;Transforming Growth Factor beta;Transforming Growth Factor beta Receptors;Tumor Suppressor Proteins;Tumor stage;Work;Xenograft Model;angiogenesis;cancer cell;cancer therapy;cell motility;cytokine;epithelial to mesenchymal transition;in vivo;in vivo Model;keratinocyte;malignant phenotype;metastatic process;migration;mouse model;neoplastic cell;novel;outcome forecast;prevent;promoter;public health relevance;response;transcription factor;tumor;tumor growth;tumor progression","Concerted role for integrin alpha3beta1 and TGFb signaling in cancer progression","
Project Narrative:
This research project is focused on identifying key molecules and signaling pathways involved in the a3b1-
dependent regulation of TGFb signaling leading to a pro-metastatic phenotype. These studies will contribute
towards the understanding of malignant progression and lead to the development of novel therapies against
metastatic cancer.","NCI","8194825","12/2/2011 12:00:00 AM","PA-09-210","5F32CA153976-02","5","F32","CA","153976","02"," ","JAKOWLEW, SONIA B","11/28/2010 12:00:00 AM","11/27/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-A(20)L]"," ","9512030","SUBBARAM, SITA ","Not Applicable","20","ANATOMY/CELL BIOLOGY","190592162","G6VVMPNK4Y48","190592162","G6VVMPNK4Y48","US","42.653127","-73.774154","8455007","ALBANY MEDICAL COLLEGE","ALBANY","NY","SCHOOLS OF MEDICINE","122083479","UNITED STATES","N","11/28/2011 12:00:00 AM","11/27/2012 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","53942"," "," ","53942",
"Breast Cancer; Cancer; Clinical Research; Genetics; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Affect;Alleles;Biological;Breast;Cell Adhesion;Cells;Development;Disease;Exhibits;Focal Adhesion Kinase 1;Genes;Genetic;Genomics;Goals;Growth Factor Receptors;Health;Human;Incidence;Integrins;Knock-in Mouse;Knock-out;MMP14 gene;Maintenance;Malignant Neoplasms;Mammary Neoplasms;Mammary Tumorigenesis;Mammary gland;Mediating;Modeling;Molecular;Mouse Mammary Tumor Virus;Mus;Mutant Strains Mice;Mutation;Neoplasm Metastasis;Oncogenes;Phosphorylation;Phosphotransferases;Play;Protein Tyrosine Kinase;Regulation;Role;Signal Pathway;Signal Transduction;Signaling Protein;Stem cells;Surface;Tumor Suppressor Genes;Tumorigenicity;Woman;base;cancer stem cell;cancer therapy;epithelial to mesenchymal transition;genetic analysis;in vivo;insight;malignant breast neoplasm;mammary epithelium;migration;mortality;mouse model;mutant;neoplastic cell;novel;scaffold;self-renewal;tumor;tumor growth;tumor initiation;tumor progression;tumorigenesis","Genetic Analysis of FAK kinase and scaffold functions in breast cancer"," Breast cancer is the most common malignancy among US women and a major health threat due to its high incidence and mortality from the disease. The characterization of key signaling proteins and pathways that regulate mammary tumorigenesis and progression will significantly advance our understanding of the molecular and cellular mechanisms of breast cancer that may contribute to novel and targeted therapies to eradicate breast cancer.  
    

","NCI","8218303","5/31/2012 12:00:00 AM","PA-10-067","1R01CA163493-01","1","R01","CA","163493","01"," ","WOODHOUSE, ELIZABETH","6/1/2012 12:00:00 AM","3/31/2017 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","1883065","GUAN, JUN-LIN ","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","6/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","115163"," ","322663",
"Aging; Clinical Research; Eye Disease and Disorders of Vision; Macular Degeneration; Neurodegenerative; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Actins;Adenovirus Vector;Affect;Age related macular degeneration;Aging;Animal Model;Animals;Biological Assay;Blindness;Blood;Blood Circulation;Blood Vessels;Blood capillaries;Blood flow;Bone Marrow;Bone Marrow Transplantation;Caliber;Case-Control Studies;Cells;Choroidal Neovascularization;Clinical Trials;Collagen;Complex;Data;Detection;Development;Disease;Donor person;Elderly;Endothelial Cells;Excision;Experimental Models;Exudative age-related macular degeneration;Fibrosis;Frequencies;Growth;Health;Histologic;Human;Implant;In Situ;In Vitro;Label;Lasers;Lesion;Macular degeneration;Marrow;Mediating;Mesenchymal;Mus;Myofibroblast;Operative Surgical Procedures;Pathogenesis;Pathologic;Patients;Pericytes;Peripheral;Phenotype;Process;Rattus;Relative (related person);Retina;Retinal;Rodent;Rodent Model;Severities;Smooth Muscle Actin Staining Method;Smooth Muscle Myocytes;Stem cells;Transplantation;Tube;Vascular Endothelial Growth Factor Receptor-2;Vascular Endothelial Growth Factors;Vision;Work;age related;aged;angiogenesis;base;capillary;case control;cell type;human subject;intravenous injection;matrigel;neovascularization;new growth;normal aging;peripheral blood;postnatal;pre-clinical;precursor cell;progenitor;research study;subretinal injection;vasculogenesis;von Willebrand Factor","Vascular Progenitor Cells in Neovascular AMD","n/a","NEI","8249090","3/22/2012 12:00:00 AM","PA-07-070","5R01EY018880-05","5","R01","EY","018880","05"," ","SHEN, GRACE L","4/1/2008 12:00:00 AM","3/31/2014 12:00:00 AM","Biology and Diseases of the Posterior Eye Study Section[BDPE]"," ","1893837","COUSINS, SCOTT W","Not Applicable","04","OPHTHALMOLOGY","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","240000","134400"," ","374400",
"Cancer; Digestive Diseases; Pancreatic Cancer; Rare Diseases","Ablation;Address;Adenocarcinoma;Adhesions;Amino Acid Sequence;Binding;Binding Sites;Biological;Biological Assay;Biology;Blood Vessels;Cell Proliferation;Cell Survival;Cell surface;Cells;Collagen;Collagen Receptors;Complex;Cysteine;DDR1 gene;DDR2 gene;Deposition;Diagnosis;Disease Progression;Ductal Epithelial Cell;Epigenetic Process;Extracellular Matrix;Fibrillar Collagen;Genetic;Goals;Growth Factor;In Vitro;Integrins;Malignant neoplasm of pancreas;Mediating;Neoplasm Metastasis;Pancreas;Pancreatic Ductal Adenocarcinoma;Participant;Patients;Process;Production;Proteins;Receptor Protein-Tyrosine Kinases;Receptor Signaling;Regulation;Signal Pathway;Signal Transduction;Stromal Cells;Therapeutic;Transforming Growth Factors;Tumor Biology;Tumor Cell Invasion;base;cell growth;chemotherapy;cytokine;discoidin receptor;epithelial to mesenchymal transition;improved;in vitro activity;in vivo;inhibitor/antagonist;interest;migration;neoplastic cell;novel therapeutics;pancreatic neoplasm;promoter;protein protein interaction;receptor;receptor expression;response;treatment strategy;tumor;tumor progression","SPARC as a regulator of collagen signaling in Pancreatic Cancer"," The underlying goal of this application is to further elucidate the function of collagen signaling in PDAC and demonstrate that SPARC is an endogenous inhibitor of DDR1/2 activity. We will demonstrate that a principal function of SPARC in the PDAC microenvironment is to reduce collagen-mediated signaling through DDRs. We further propose that collagen-induced activation of DDRs facilitates PDAC invasion and metastasis and our studies will provide a rationale for targeting DDR1/2 signaling as a therapeutic strategy for improving survival of patients diagnosed with PDAC.   
      

","NCI","8320629","8/29/2012 12:00:00 AM","PA-11-112","1F31CA168350-01","1","F31","CA","168350","01"," ","MCNEIL FORD, NICOLE","1/1/2013 12:00:00 AM","12/31/2017 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-D(08)L]"," ","10881725","AGUILERA, KRISTINA YOLANDA","Not Applicable","30","SURGERY","800771545","YZJ6DKPM4W63","800771545","YZJ6DKPM4W63","US","32.814772","-96.841146","578404","UT SOUTHWESTERN MEDICAL CENTER","DALLAS","TX","SCHOOLS OF MEDICINE","753909105","UNITED STATES","N","1/1/2013 12:00:00 AM","12/31/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","29597"," "," ","29597",
"Aging; Biotechnology; Eye Disease and Disorders of Vision; Prevention","ABL1 gene;Adherent Culture;Age;Animal Model;Anterior;Atopic Dermatitis;Biochemical;Biological;Biological Models;Cataract;Cataract Extraction;Cells;Complication;Development;Disease;Embryo;Epithelial Cells;Excision;Fiber;Fibrosis;Gleevec;Goals;Growth Factor;Health Sciences;Hour;Human;Imatinib mesylate;In Vitro;Intervention;Laboratories;Libraries;MAPK14 gene;Malignant Neoplasms;Mediating;Methodology;Modeling;Molecular;Myofibroblast;National Eye Institute;Oncogenic;Operative Surgical Procedures;Oregon;Pathway interactions;Patients;Pharmaceutical Preparations;Phosphotransferases;Population;Preclinical Testing;Prevention;Procedures;Process;Publishing;RNA Interference;Research;Retinitis Pigmentosa;Role;Serum;Signal Pathway;Signal Transduction;Signal Transduction Pathway;System;TGFB1 gene;Testing;Therapeutic;Therapeutic Uses;Time;Transforming Growth Factors;Trauma;Tyrosine Kinase Inhibitor;Universities;Vision;Work;base;c-abl Proto-Oncogenes;cancer therapy;capsule;combat;epithelial to mesenchymal transition;fiber cell;fusion gene;in vivo;inhibitor/antagonist;innovation;kinase inhibitor;lens;next generation;novel;novel strategies;prevent;programs;small molecule;therapeutic target","TGFB signaling as a therapeutic target in cataract and PCO"," An estimated 3 million cataract surgeries are conducted in the US annually, a rate projected to rise sharply as the population ages. The goal of our research is to target TGF2-mediated signal transduction cascades in new therapies to prevent cataract and the most common complication of cataract surgery, posterior capsule opacification. We have discovered drugs that block the deleterious effects of TGF2 in cultured lens cells, and want to understand the mechanisms of their effects and how these drugs can be used to preserve vision in humans.  
    

","NEI","8219137","4/26/2012 12:00:00 AM","PA-10-067","1R01EY022113-01","1","R01","EY","022113","01"," ","ARAJ, HOUMAM H","5/1/2012 12:00:00 AM","4/30/2015 12:00:00 AM","Anterior Eye Disease Study Section[AED]"," ","1883338","MUSIL, LINDA S","Not Applicable","03","BIOCHEMISTRY","096997515","NPSNT86JKN51","096997515","NPSNT86JKN51","US","45.499316","-122.688464","6297007","OREGON HEALTH & SCIENCE UNIVERSITY","PORTLAND","OR","SCHOOLS OF MEDICINE","972393098","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","250000","135000"," ","385000",
"Biotechnology; Cancer; Genetics; Hematology; Human Genome; Lymphoma; Neuroblastoma; Pediatric; Pediatric Research Initiative; Rare Diseases","Acute T Cell Leukemia;Address;Algorithms;Behavior;Biological Markers;Biology;Chemicals;Childhood;Collaborations;Computing Methodologies;Coupled;Custom;Data;Data Set;Dependency;Development;Dissection;Drug resistance;Elements;Epigenetic Process;Evaluation;FDA approved;Follicular Lymphoma;Funding;Future;Genes;Genetic;Glioblastoma;Glucocorticoids;Goals;Heel;Human;In Vitro;Individual;Indoles;Intervention;Lead;Libraries;Machine Learning;Malignant Neoplasms;Mediating;Mesenchymal;Methodology;Methods;Molecular Profiling;Molecular Target;Multivariate Analysis;Mutation;Neck;Neuroblastoma;Oncogenes;Output;Patients;Phenotype;Principal Investigator;Process;Property;RNA Interference;Regulator Genes;Regulatory Pathway;Research Personnel;Resistance;Sampling;Screening procedure;Signal Transduction;Staging;Structure;System;Systems Biology;Techniques;Testing;Therapeutic Intervention;Tumor Subtype;Universities;Validation;Work;anticancer research;base;document outlines;drug sensitivity;genetic profiling;genome-wide;high throughput technology;in vivo;inhibitor/antagonist;large cell Diffuse non-Hodgkin&apos;s lymphoma;malignant phenotype;novel;programs;small molecule;therapeutic development;therapeutic target;tumor;tumor progression;tumorigenesis","Systems Biology of Tumor Progression and Drug Resistance","  The identification of targets that abrogate tumorigenesis in the patient, are extensively biochemically characterized, chemically tractable, and highly penetrant constitutes one of the greatest challenges of cancer research. By interrogating multidimensional datasets characterizing genetic, epigenetic, and functional properties of large normal and tumor-related samples, it is the aim of this proposal to leverage an integrative computational and experimental pipeline for the systematic identification of novel targets that may inspire future development of therapeutic applications.   
      

","NCI","8323749","5/21/2012 12:00:00 AM","RFA-CA-11-010","1U01CA168426-01","1","U01","CA","168426","01"," ","GERHARD, DANIELA","6/1/2012 12:00:00 AM","4/30/2017 12:00:00 AM","ZCA1-SRLB-V(J1)"," ","7827402","CALIFANO, ANDREA ","Not Applicable","13","MISCELLANEOUS","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","SCHOOLS OF MEDICINE","100323725","UNITED STATES","N","6/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","797963","413630"," ","1211593",
"Genetics; Human Genome; Rare Diseases","Acyltransferase;Affect;Alleles;Animal Model;Biochemistry;Cells;Characteristics;Congenital Abnormality;Congenital Disorders;Defect;Deposition;Development;Developmental Biology;Developmental Process;Disease;Disease model;Drosophila genus;Ectoderm;Embryo;Engineering;Enzymes;Etiology;Exhibits;Experimental Designs;Eye;Family member;Fatty acid glycerol esters;Focal Dermal Hypoplasia;Genes;Genetic;Genetic Models;Goals;Hereditary Disease;Homologous Gene;Human;Human Genetics;Human Genome;Integumentary system;Knock-out;Knockout Mice;Lateral;Ligands;Link;Mammals;Maps;Mediating;Mesenchymal;Mesoderm;Mind;Modeling;Modification;Molecular;Mus;Mutant Strains Mice;Mutation;Operative Surgical Procedures;Pathology;Patients;Phenotype;Physiology;Porcupines;Production;Publishing;Rare Diseases;Research;Research Personnel;Role;Signal Pathway;Signal Transduction;Skeleton;Skin;Syndrome;Testing;Time;Tissues;Wnt proteins;Work;adipocyte differentiation;autocrine;base;clinically relevant;clinically significant;human disease;in vivo;insight;lipid biosynthesis;mouse genome;mouse model;mutant;novel;paracrine;precursor cell;prevent;programs;tissue processing;tissue/cell culture;tool","A conditional allele to dissect Porcn-dependent Wnt signaling in vivo"," Focal dermal hypoplasia (FDH) is a rare disease that affects the Wnt signaling pathway, which itself is very commonly dysregulated in additional congenital and acquired diseases. FDH is caused by mutations in the PORCN gene, for which we have generated a novel mouse genetic model. This proposal focuses on aspects of FDH that are also relevant to other diseases, and highlights the usefulness of mouse PORCN mutants to model disorders of Wnt signaling in humans.   
   
      

","OD","8309767","3/12/2012 12:00:00 AM","PA-10-138","1R21OD010559-01A1","1","R21","OD","010559","01","A","MIROCHNITCHENKO, OLEG","3/15/2012 12:00:00 AM","2/28/2014 12:00:00 AM","Development - 1 Study Section[DEV1]"," ","1938224","MURTAUGH, LEWIS C","Not Applicable","02","GENETICS","009095365","LL8GLEVH6MG3","009095365","LL8GLEVH6MG3","US","40.76776","-111.832926","514002","UNIVERSITY OF UTAH","SALT LAKE CITY","UT","SCHOOLS OF MEDICINE","841128930","UNITED STATES","N","3/15/2012 12:00:00 AM","2/28/2013 12:00:00 AM","351","Non-SBIR/STTR","2012"," "," ","OD","150000","74250"," ","224250",
"Aging; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Adipocytes;Adipose tissue;Adult;Affect;Age;Age-Months;Aging;Antibody Formation;B-Cell Development;B-Lymphocytes;Back;Birth;Blast Cell;Bone Marrow;Bone Marrow Transplantation;Cell Lineage;Common Lymphoid Progenitor;Communicable Diseases;Data;Defect;Development;Disease;Elderly;Engraftment;Environment;Feedback;Future;Gene Expression;Generations;Goals;Grant;Hematopoietic stem cells;Hormones;Human;Humoral Immunities;Immune;Immune response;Immunity;In Vitro;Individual;Infectious Agent;Injection of therapeutic agent;Lead;Left;Lymphoid;Lymphopoiesis;Mature B-Lymphocyte;Mesenchymal;Modeling;Molecular;Multipotent Stem Cells;Mus;Oryctolagus cuniculus;Osteoblasts;Osteogenesis;Parathyroid gland;Patients;Peripheral;Production;Regulation;Retrospective Studies;Serum;Signal Transduction;Staging;Stem cells;Stromal Cells;Study models;Testing;Transplant Recipients;Vaccines;adaptive immunity;age related;aged;arm;base;cost;feeding;improved;in vivo;inhibitor/antagonist;lipid biosynthesis;progenitor;research study;response;senescence;vaccine efficacy;young adult","Maintaining B cell immunity with aged B lymphocytes"," A decline in B cell immunity in the elderly as a result of a decrease in the generation of new B cells leave them with weak vaccine responses and increased vulnerability to infectious diseases. We use rabbits as a model for the loss of the generation of new B cells because rabbits stop producing B cells by a few weeks of age. Our goal is to determine the mechanism by which B cell development wanes and find a mechanism by which it can be re-initiated.   
   
      

","NIAID","8392888","7/26/2012 12:00:00 AM","PA-11-260","2R01AI068390-06A1","2","R01","AI","068390","06","A","PRABHUDAS, MERCY R","3/1/2007 12:00:00 AM","7/31/2016 12:00:00 AM","Cellular and Molecular Immunology - B Study Section[CMIB]"," ","1870646","KNIGHT, KATHERINE L.","Not Applicable","07","MICROBIOLOGY/IMMUN/VIROLOGY","791277940","RFRPFMNR8LA5","791277940","RFRPFMNR8LA5","US","41.86527","-87.833383","4689203","LOYOLA UNIVERSITY CHICAGO","MAYWOOD","IL","SCHOOLS OF MEDICINE","601533328","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","855","Non-SBIR/STTR","2012"," "," ","NIAID","250000","116561"," ","366561",
"Biotechnology; Genetics; Kidney Disease","Address;Alleles;Apical;Binding;Biological Models;Caenorhabditis elegans;Cell Adhesion;Cell Polarity;Cell-Cell Adhesion;Cells;Chronic;Chronic Kidney Failure;Complex;Cues;Cultured Cells;Defect;Development;Drosophila genus;E-Cadherin;Eating;Embryo;Epidermis;Epithelial;Epithelial Cell Junction;Epithelial Cells;Epithelium;Event;Exclusion;Fibrosis;Foundations;Future;Genetic;Goals;Homologous Gene;Human;Image;Injury;Intercellular Junctions;Kidney;Kidney Diseases;Knowledge;Lead;Learning;Life;MDCK cell;Maintenance;Mediating;Membrane;Molecular;Morphogenesis;Organ;PARD6A gene;Pathologic;Play;Process;Protein Kinase;Proteins;RNA Interference;Recruitment Activity;Renal carcinoma;Renal function;Research;Role;Scaffolding Protein;Secondary to;Signal Transduction;Site;Sterility;Structure;Surface;System;Testing;Tissues;Tube;Vitelline Membrane;base;design;epithelial to mesenchymal transition;extracellular;gene function;genome sequencing;human JTB protein;in vivo;insight;mutant;nephrogenesis;novel;prevent;research study","In vivo mechanisms for epithelial cell polarization"," Establishing epithelial cell polarity and assembling cell-cell junctions are critical steps in tissue morphogenesis and kidney development. Defects in this process can lead to loss of tissue structure, and have been shown to result in renal fibrosis secondary to chronic kidney disease. Determining the mechanisms epithelial cells use to develop polarity as they differentiate in vivo will be instrumental in learning how to prevent undesired loss of cell polarity that contributes to kidney disease and cancer.  
    

","NIDDK","8389805","5/28/2012 12:00:00 AM","PA-10-107","5F30DK093197-02","5","F30","DK","093197","02"," ","MARIC-BILKAN, CHRISTINE","6/10/2011 12:00:00 AM","6/9/2015 12:00:00 AM","ZDK1-GRB-G(M1)S"," ","10220679","ARMENTI, STEPHEN THOMAS","Not Applicable","12","ANATOMY/CELL BIOLOGY","121911077","M5SZJ6VHUHN8","121911077","M5SZJ6VHUHN8","US","40.744985","-73.978118","5998304","NEW YORK UNIVERSITY SCHOOL OF MEDICINE","NEW YORK","NY","SCHOOLS OF MEDICINE","10016","UNITED STATES","N","6/10/2012 12:00:00 AM","6/9/2013 12:00:00 AM","847","Training, Individual","2012"," "," ","NIDDK","47232"," "," ","47232",
"Biotechnology; Cancer; Colo-Rectal Cancer; Digestive Diseases; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human; Stem Cell Research - Nonembryonic - Non-Human","Address;Adult;Binding;Cells;ChIP-seq;Collaborations;Communication;DNA Binding;Data;Development;Developmental Process;Doxycycline;ES Cell Line;Embryo;Embryonic Development;Epiblast;Epithelial;Epitopes;Family;Family member;Feedback;Gastrointestinal tract structure;Gene Expression;Gene Targeting;Genes;Genetic Transcription;Genomics;Goals;Homeostasis;Human;In Situ Hybridization;Intestinal Cancer;Intestinal Neoplasms;Intestines;Knowledge;Laboratories;Lead;Malignant Neoplasms;Mediator of activation protein;Mesenchymal;Mesoderm;Microarray Analysis;Molecular;Molecular Genetics;Mus;Musculoskeletal;National Human Genome Research Institute;Nature;Neurons;Notch Signaling Pathway;Paraxial Mesoderm;Pathway interactions;Phenotype;Primitive Streaks;Publishing;Regulation;Role;Segmentation Clock Pathway;Series;Signal Pathway;Signal Transduction;Site;Spinal Cord;Stem Cell Development;Stem cells;Structure;Tail;Tissues;Transgenes;Undifferentiated;Work;Zebrafish;Zinc Fingers;adenoma;adult stem cell;beta catenin;cancer stem cell;colorectal cancer screening;embryonic stem cell;gain of function mutation;gastrulation;genome-wide;in vivo;insight;interest;member;mouse model;notch protein;null mutation;overexpression;progenitor;programs;relating to nervous system;self-renewal;somitogenesis;stem cell biology;stemness;transcription factor;tumorigenesis","The Role of Wnt Genes in Vertebrate Development and Cancer","n/a","NCI","8552675"," "," ","1ZIABC010345-13","1","ZIA","BC","010345","13"," "," "," "," "," "," ","9414492","YAMAGUCHI, TERENCE ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","1220801",
"Autoimmune Disease; Crohn's Disease; Digestive Diseases; Infectious Diseases; Inflammatory Bowel Disease","Address;Adherence;Affect;Antibiotics;B-Lymphocytes;Bacteria;Body fat;Carrier Proteins;Cell Adhesion;Chronic;Clinical;Colitis;Colorectal Cancer;Data;Defect;Development;Dextran Sulfate;Diarrhea;Disease Outcome;Disease Progression;Distal;E-Cadherin;Electrolytes;Environment;Epithelial;Epithelial Cells;Exhibits;Family;Financial compensation;Functional disorder;Future;Gastrointestinal tract structure;Genes;Helicobacter;Homeostasis;Human;Hypotension;Immune;Immune response;Immune system;Inflammation;Inflammation Mediators;Inflammatory;Inflammatory Bowel Diseases;Inflammatory disease of the intestine;Injury;Intake;Interleukin-10;Intestinal Mucosa;Intestines;Ion Transport;Laboratories;Lead;Liquid substance;Maintenance;Mediating;Mesenchymal;Metabolic acidosis;Modeling;Mucositis;Mucous Membrane;Mus;Outcome;Patients;Phenotype;Play;Predisposition;Process;Publishing;Regulatory T-Lymphocyte;Research;Role;Secondary to;Severities;Shapes;Sodium;Symptoms;Translating;Water;Work;absorption;cell motility;clinically relevant;cytokine;in vivo;microbial;microorganism interaction;mortality;novel;pathogen;prevent;response;sodium-hydrogen exchanger 3;tumor progression","Development of Intestinal Ion Transport"," NHE3 is the predominant Na+/H+ exchanger responsible for the majority of sodium and water transport across the gastrointestinal tract, and its inhibition during inflammation represents the primary mechanism of inflammation-associated diarrhea. Novel data from our laboratory suggest additional consequences resulting from NHE3 inhibition, which may lead to profound alteration of intestinal microbiota, cellular interactions, and contribute to the ultimate epithelial barrier defect. The proposed studies are of significant basic
and clinical relevance as they may not only explain the role of Na+/H+ exchange during intestinal inflammation but they may also guide future clinical approaches to a variety of inflammatory conditions of the gut.   
      

","NIDDK","8443714","9/26/2012 12:00:00 AM","PA-11-260","2R01DK041274-25","2","R01","DK","041274","25"," ","GREY, MICHAEL J","9/1/1988 12:00:00 AM","8/31/2017 12:00:00 AM","Clinical, Integrative and Molecular Gastroenterology Study Section[CIMG]"," ","1863685","GHISHAN, FAYEZ KHALAF","KIELA, PAWEL R","03","PEDIATRICS","806345617","ED44Y3W6P7B9","806345617","ED44Y3W6P7B9","US","32.156964","-110.877577","490201","UNIVERSITY OF ARIZONA","TUCSON","AZ","SCHOOLS OF MEDICINE","857210158","UNITED STATES","N","9/28/2012 12:00:00 AM","8/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","112013"," ","329513",
"Cancer; Genetics","3&apos; Untranslated Regions;Accounting;Address;Affect;Biology;C-terminal;Cancer Biology;ChIP-seq;Complex;Coupled;Cyclin D1;DNA Polymerase I;Disease;Epithelial;Equilibrium;Event;Evolution;Future;Gene Expression;Gene Expression Profile;Gene Mutation;Genes;Genetic;Genetic Translation;Genome;Human;Hypoxia;Investigation;Malignant Neoplasms;Malignant neoplasm of lung;Maps;Mesenchymal;Messenger RNA;MicroRNAs;Modeling;Molecular;Normal Cell;Outcome;Phosphorylation;Poly A;Poly(A) Tail;Polyadenylation;Polymerase;Process;Published Comment;RNA;RNA Polymerase II;RNA Sequences;RNA-Binding Proteins;Regulation;Reporting;Research;Resolution;Role;Signal Transduction;Site;Stimulus;Therapeutic;Therapeutic Agents;Transcription Coactivator;Transcription Process;Work;base;cancer cell;cell transformation;genome-wide;inhibitor/antagonist;mRNA Cleavage and Polyadenylation Factors;mRNA Precursor;mRNA Stability;malignant breast neoplasm;novel;novel therapeutics;polyadenylated messenger RNA;programs;protein expression;response;therapeutic target;tumor;tumor progression","Mis-regulation of mRNA poly (A) site selection in cancer cells (PQ11)"," This project investigates gene expression is corrupted in human cancer by misdirecting the addition of mRNA poly (A) tails. The relevance of the proposed investigations is that they could uncover new genetic drivers of tumor progression that are activated in cancer cells by the novel mechanism of altered poly (A) site choice. By understanding the mechanism underlying why 3' end formation differs between normal and cancer cells, we may be able to inform new therapeutic strategies for re- programming poly (A) site selection.   
      

","NCI","8384082","7/23/2012 12:00:00 AM","RFA-CA-11-011","1R01CA170859-01","1","R01","CA","170859","01"," ","STRASBURGER, JENNIFER","8/1/2012 12:00:00 AM","5/31/2016 12:00:00 AM","ZCA1-SRLB-9(M1)"," ","1940498","BENTLEY, DAVID L","Not Applicable","06","BIOCHEMISTRY","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","8/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","108519"," ","316019",
"Bioengineering; Cancer; Clinical Research; Nanotechnology; Prostate Cancer; Urologic Diseases","Advanced Development;Affinity;Androgens;Architecture;Bioinformatics;Biological Assay;Biological Markers;Biopsy;Blood;Blood specimen;Cancer Patient;Castration;Cell Adhesion Molecules;Cells;Clinical;DNA Sequencing Facility;Devices;Diagnostic;Differentiation Antigens;Disease-Free Survival;Epithelial;Epithelial Cells;Exhibits;Gene Expression;Gene Expression Profile;Generations;Genes;Glutamate Carboxypeptidase II;Goals;Immune;Individual;Joints;Leukocytes;Liquid substance;Malignant neoplasm of prostate;Mesenchymal;Metastatic Prostate Cancer;Microfluidics;Molecular;Molecular Profiling;Monitor;Motivation;Multiparametric Analysis;Nanostructures;Outcome;PC3 cell line;Patient Rights;Patients;Phenotype;Population;Primary Neoplasm;Proteins;Public Health;Recurrence;Research;Research Personnel;Research Proposals;Resistance;Side;Signal Transduction;Site;Source;Staging;Surface;System;TACSTD2 gene;Technology;Therapeutic Intervention;Time;Validation;Whole Blood;anti-cancer therapeutic;base;cancer cell;chemotherapy;clinical material;design;healthy volunteer;hormone refractory prostate cancer;improved;nanostructured;neoplastic cell;novel;outcome forecast;patient population;peripheral blood;response","Advanced Development of An Integrated CTC Enrichment Technology"," Relevance to Public Health The long-term objective of this research proposal is to perform advanced development and analytical validation of a technology for highly efficient enrichment of circulating tumor cells (CTCs). This new CTC-based diagnostic platform will pave the way not only for CTC enumeration to serve as a biomarker for PC to better predict clinical outcomes, but also as a source of clinical material (i.e. CTCs as a ""liquid biopsy"") for sequential molecular analyses that can be used to direct appropriate therapies for individual patients.  
    

","NCI","8332752","8/7/2012 12:00:00 AM","RFA-CA-10-004","5R33CA157396-02","5","R33","CA","157396","02"," ","TRICOLI, JAMES","9/14/2011 12:00:00 AM","8/31/2014 12:00:00 AM","ZCA1-SRLB-X(J1)"," ","8094764","TSENG, HSIAN-RONG ","Not Applicable","33","BIOCHEMISTRY","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","SCHOOLS OF MEDICINE","900952000","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","148522","80202"," ","228724",
"Dental/Oral and Craniofacial Disease; Genetics; Pediatric","Affect;Apoptosis;BHLH Protein;Binding;Biological Assay;Cell Line;Cell Proliferation;Cell Survival;Cell surface;Cells;Coupled;Couples;Coupling;DNA Binding;Data;Defect;Dental;Development;Developmental Process;Drosophila genus;Embryo;Embryonic Development;Epithelial;Epithelium;Extracellular Matrix;Family;Fibroblast Growth Factor;Fibroblast Growth Factor Receptor 2;Genes;Goals;Growth;Growth Factor;In Vitro;Interleukin-2;Joint structure of suture of skull;Laboratories;Mammals;Mediating;Mesenchymal;Mesenchyme;Mesoderm;Methods;Modality;Molecular;Molecular Genetics;Morphogenesis;Mutant Strains Mice;Natural regeneration;Nature;Odontoblasts;Organogenesis;Pathogenesis;Play;Promoter Regions;Research;Research Personnel;Research Project Grants;Role;Signal Transduction;Staging;Testing;Time;Tooth structure;Work;base;career;cell motility;chromatin immunoprecipitation;dosage;gastrulation;in vivo;innovation;insight;mutant;novel;paralogous gene;prevent;promoter;response;transcription factor;twist protein","Studies of the Roles of Twist1 and E12 in Tooth Morphogenesis"," Successful completion of the proposed studies will provide fundamental information on the molecular mechanisms that regulate tooth morphogenesis and will contribute new insights about how teeth are formed. This information is essential for understanding the pathogeneses of congenital tooth defects, establishing scientifically based treatment modalities, and for developing methods leading to tooth regeneration.  
    

","NIDCR","8328601","8/9/2012 12:00:00 AM","PAR-07-418","7R03DE021773-02","7","R03","DE","021773","02"," ","SCHOLNICK, STEVEN","9/5/2011 12:00:00 AM","8/31/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","10513660","LU, YONGBO ","Not Applicable","17","OTHER BASIC SCIENCES","835607441","HFT7XTHB6563","835607441","HFT7XTHB6563","US","30.561517","-96.274978","8266910","TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR","COLLEGE STATION","TX","SCHOOLS OF DENTISTRY/ORAL HYGN","778454375","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","75000","34500"," ","109500",
"Cancer; Dental/Oral and Craniofacial Disease; Neurosciences; Pediatric; Rare Diseases","Adopted;Afferent Neurons;Anterior;Cell Fate Control;Cell Lineage;Cells;Cephalic;Cleft Palate;Complex;Congenital Abnormality;Data;Development;Ear;Ectoderm;Embryo;Epigenetic Process;Event;Extracellular Matrix;Face;Fibroblast Growth Factor;Ganglia;Genes;Grant;Greek;Head;Heart Septal Defects;Histone Deacetylase;Lateral;Lead;Lens Placodes;Location;Malignant Neoplasms;Midbrain structure;Molecular;Movement;Multipotent Stem Cells;Nervous system structure;Neural Crest;Neural Crest Cell;Neural Fold;Neural tube;Neuroblastoma;Neuroendocrine Cell;Neurofibromatoses;Nose;Otic Placodes;Peripheral;Peripheral Nervous System;Population;Primordium;Public Health;Quail;Role;Sensory;Signal Transduction;Source;Staging;Structure;Testing;Time;To specify;Transcriptional Regulation;Trigeminal System;Vertebrates;cell type;craniofacial;epithelial to mesenchymal transition;hindbrain;knock-down;lens;loss of function;melanoma;member;nerve supply;neural plate;placodal ectoderm;prospective;public health relevance;relating to nervous system;selective expression;transcription factor","Ectodermal Placode Development into Sensory Structures","
Statement of relevance to public health
The peripheral nervous system of vertebrates arises from two sources: ectodermal placodes and neural
cres cells and the neural crest is a multipotent stem-cell-like population that migrates extensively and
gives rise to an amazingly diverse set of derivatives. Similarly, placodes migrate or invaginate, and give
rise to sensory neurons of ganglia that innervate the face. Because placodes and neural crest-derived
cells are involved in a variety of birth defects (e.g. cleft palate, cardiac septal defects) and cancers such
as neurofibromatosis, melanoma, neuroblastoma, our results on the normal mechanisms of placode
and neural crest development provide important clues regarding the mistakes that may lead to
abnormal development or loss of the differentiated state.","NIDCR","8291090","5/24/2012 12:00:00 AM","PA-07-070","5R01DE016459-12","5","R01","DE","016459","12"," ","SCHOLNICK, STEVEN","8/20/2000 12:00:00 AM","6/30/2015 12:00:00 AM","Neurogenesis and Cell Fate Study Section[NCF]"," ","1858016","BRONNER, MARIANNE ","Not Applicable","27","NONE","009584210","U2JMKHNS5TG4","009584210","U2JMKHNS5TG4","US","34.134337","-118.126525","1073501","CALIFORNIA INSTITUTE OF TECHNOLOGY","PASADENA","CA","SCHOOLS OF ARTS AND SCIENCES","911250001","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","235125","145778"," ","380903",
"Digestive Diseases; Pediatric; Rare Diseases","Address;Affect;Attention;Birth;Breathing;Cartilage;Cells;Cellular biology;Cleaved cell;Communication;Congenital Abnormality;Coupled;Data;Defect;Development;Disease;Dorsal;Embryo;Embryonic Development;Endoderm;Epithelial;Epithelium;Erinaceidae;Esophageal;Esophagus;Generations;Genetic Markers;Human;Knockout Mice;Label;Laryngeal cartilage;Larynx;Lead;Life;Literature;Malignant neoplasm of esophagus;Mesenchymal;Mesoderm;Molecular;Molecular Analysis;Morphogenesis;Mus;Neural Crest;Newborn Infant;Operative Surgical Procedures;Organ;Paracrine Communication;Pathogenesis;Pattern;Population;Primitive foregut structure;Principal Investigator;Process;Research;Research Project Grants;Role;Series;Signal Pathway;Signal Transduction;Signaling Molecule;Smooth Muscle;Specific qualifier value;Stomach;Stratification;System;Testing;Time;Tissues;Trachea;Tracheoesophageal Fistula;Transgenic Mice;Tube;Work;autocrine;base;cartilage development;feeding;genetic manipulation;insight;oral ectoderm;public health relevance;respiratory;smoothened signaling pathway;spatiotemporal;tool","Roles of hedgehog signaling in foregut development","
Proper development of embryonic foregut derivatives is essential for mammalian survival at birth. The
rostral endodermal foregut tube divides into ventral respiratory (larynx and trachea) and dorsal alimentary
(esophagus and stomach) components. These must then develop into functional organs. Little is known
about the underlying mechanisms, despite their pragmatic importance. This proposal is for a research
project to dissect the roles of the Sonic hedgehog intercellular signaling pathway in mouse foregut
development. We elucidate critical roles in the initial compartmentalization of the common foregut tube,
and in the organ-specific differentiation of endoderm and mesoderm. Our results are of direct relevance to
the mechanisms of human foregut birth defects and potentially to the pathogenesis of esophageal cancer.","NIDDK","8314058","7/23/2012 12:00:00 AM","PA-10-067","5R01DK090468-03","5","R01","DK","090468","03"," ","CARRINGTON, JILL L","9/30/2010 12:00:00 AM","8/31/2014 12:00:00 AM","Development - 1 Study Section[DEV1]"," ","1930665","KLINGENSMITH, JOHN A","Not Applicable","04","ANATOMY/CELL BIOLOGY","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","106825"," ","312250",
"Atherosclerosis; Cardiovascular; Clinical Research; Lung","Angioplasty;Apoptosis;Arteries;Atherosclerosis;Biological Assay;Blood Vessels;Boxing;Cell Differentiation process;Cell Proliferation;Cell physiology;Cells;Confocal Microscopy;Coronary artery;Development;Disease;Elements;Embryo;Endothelial Cells;Event;Functional disorder;Goals;Hypertension;In Situ Hybridization;In Vitro;Indium;Investigation;Knockout Mice;LacZ Genes;Left;Left pulmonary artery;Ligands;Light;Lung;Lymphangioleiomyomatosis;Maintenance;Maps;Mediating;Mesenchymal;Molecular;Morphogenesis;Mus;Nutrient;Pathogenesis;Pathology;Pathway interactions;Patients;Pattern;Physiological;Platelet-Derived Growth Factor;Platelet-Derived Growth Factor Receptor;Platelet-Derived Growth Factor alpha Receptor;Platelet-Derived Growth Factor beta Receptor;Play;Population;Process;Proteins;Proto-Oncogene Proteins c-sis;Pulmonary Hypertension;Pulmonary artery structure;Receptor Signaling;Reporter;Research Personnel;Rodent Model;Role;Seminal;Signal Pathway;Signal Transduction;Smooth Muscle;Smooth Muscle Myocytes;Staging;Staining method;Stains;Structure;Sum;TimeLine;Tissues;Transgenes;Transgenic Mice;Tube;Vascular Diseases;Work;cell motility;effective therapy;insight;lung development;molecular marker;programs;receptor;receptor expression;receptor-mediated signaling;research study;restenosis;transcription factor;vascular bed;vascular smooth muscle cell migration","Morphogenesis of the pulmonary artery smooth muscle layer","n/a","NHLBI","8308488","8/1/2012 12:00:00 AM","PA-06-512","5K08HL093362-06","5","K08","HL","093362","06"," ","COLOMBINI-HATCH, SANDRA","8/1/2008 12:00:00 AM","7/31/2013 12:00:00 AM","ZHL1-CSR-O(M1)"," ","8852846","GREIF, DANIEL ","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","838","Other Research-Related","2012"," "," ","NHLBI","123250","9860"," ","133110",
"Biotechnology; Dental/Oral and Craniofacial Disease; Genetics; Pediatric; Prevention","Address;Animal Model;Cell Lineage;Cell Nucleus;Cell surface;Cells;Cleft Palate;Cleft lip with or without cleft palate;Complex;Congenital Abnormality;Congenital failure of fusion;Defect;Development;Ectoderm;Ectopic Expression;Embryonic Development;Enzymes;Epithelial;Epithelium;Etiology;Event;Exhibits;Face;Future;Gene Mutation;Gene Targeting;Genes;Genetic;Goals;Growth;Hereditary Disease;High Prevalence;Human;Human Genetics;Knock-out;Knockout Mice;LDL-Receptor Related Protein 1;Lip structure;Mediating;Mesenchymal;Mesenchyme;Modeling;Molecular;Molecular Genetics;Morphogenesis;Movement;Mus;Mutant Strains Mice;Neural Crest;Newborn Infant;Oral cavity;Palate;Pathogenesis;Pathway interactions;Phenotype;Play;Prevention;Preventive;Primordium;Process;Proteins;Research;Role;Signal Pathway;Signal Transduction;Signaling Molecule;Site;Structure;Testing;Therapeutic;Tissues;Transcriptional Activation;Transcriptional Regulation;Translating;Tretinoin;United States;base;craniofacial;developmental disease;gastrulation;genetic manipulation;human disease;innovation;insight;lipoprotein receptor related protein 5;mouse model;mutant;novel;orofacial;prevent;public health relevance;receptor;research study","Wnt Signaling in Craniofacial Developmental Disorders","
PROJECT NARRATIVE
 Congenital craniofacial defects such as cleft lip with or without cleft palate (CLP) are among the
most common birth defects in humans with high prevalence and a poorly understood etiology. The
current study is targeted to uncover the mechanisms of these congenital defects through genetic
manipulation of the morphogenetic Wnt signaling pathway in mutant animal models, which may
provide a basis for future translational applications.","NIDCR","8236888","3/28/2012 12:00:00 AM","PA-10-067","5R01DE021696-02","5","R01","DE","021696","02"," ","SCHOLNICK, STEVEN","4/1/2011 12:00:00 AM","3/31/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-A(02)M]"," ","8651110","ZHOU, CHENGJI ","Not Applicable","03","ANATOMY/CELL BIOLOGY","047120084","TX2DAGQPENZ5","047120084","TX2DAGQPENZ5","US","38.543675","-121.729989","577503","UNIVERSITY OF CALIFORNIA AT DAVIS","DAVIS","CA","SCHOOLS OF MEDICINE","956186153","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","250000","134688"," ","384688",
"Cancer; Prevention","Area;Behavior;Binding;Biochemical;Biological;Biological Assay;Cancer Model;Cell Death;Cell Line;Cell surface;Cells;Cessation of life;Clinical;Cytotoxic agent;Data;Development;Dialysis procedure;Dissociation;Drug Kinetics;Encapsulated;Endocytosis;Environment;Epithelial;Equilibrium;Future;Goals;Growth;Heat-Shock Proteins 90;Homing;Human;Hypoxia;Hypoxia Inducible Factor;In Vitro;Incidence;Knowledge;Liposomes;Malignant Neoplasms;Metastatic to;MicroRNAs;Mission;Modeling;Molecular;Neoplasm Metastasis;Outcome;Oxygen;Pathway interactions;Patients;Peptide Hydrolases;Peptides;Pharmaceutical Preparations;Play;Prevention;Process;Property;Public Health;Publishing;Reagent;Reporting;Research;Resistance;Risk;Role;Solid Neoplasm;Specificity;Testing;Time;Treatment Failure;Tumor Cell Invasion;Work;ansamitocins;base;cancer cell;cancer invasiveness;cancer prevention;cancer recurrence;cancer stem cell;cancer therapy;cell killing;chemotherapy;cytotoxic;drug discovery;effective therapy;epithelial to mesenchymal transition;human MMP14 protein;improved;in vivo;innovation;metastatic process;novel;novel strategies;pre-clinical;pressure;prevent;stem;success;therapeutic target;tool;tool development;treatment strategy;tumor;tumor growth","Integrating Anti-invasive and Anti-growth Therapies Targeting Cancer Metastasis","  The proposed research will increase our understanding of the reprogramming of cancer from non-metastatic to metastatic. In addition, it will facilitate the development of tools for treatment and prevention of cancer dissemination. Thus, the proposed research is relevant to the NIH's mission that pertains to developing fundamental knowledge that will help to reduce risk of death from various cancers and will improve public health.   
      

","NCI","8275173","4/2/2012 12:00:00 AM","PA-10-067","1R01CA166936-01","1","R01","CA","166936","01"," ","FORRY, SUZANNE L","4/2/2012 12:00:00 AM","3/31/2017 12:00:00 AM","Drug Discovery and Molecular Pharmacology Study Section[DMP]"," ","8027925","CAO, JIAN ","SAMPSON, NICOLE S","01","INTERNAL MEDICINE/MEDICINE","804878247","M746VC6XMNH9","804878247","M746VC6XMNH9","US","40.907353","-73.128565","5992612","STATE UNIVERSITY NEW YORK STONY BROOK","STONY BROOK","NY","SCHOOLS OF MEDICINE","117943362","UNITED STATES","N","4/2/2012 12:00:00 AM","3/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","207500","118275"," ","325775",
"No NIH Category available","Alveolar;Alveolus;Anti-Inflammatory Agents;Anti-inflammatory;Area;Behavior;Bronchiolitis Obliterans Organizing Pneumonia;Cell Death;Cell Line;Cell Separation;Cell physiology;Cells;Cessation of life;Characteristics;Chronic;Cicatrix;Clinical;Collagen Type I;Data;Deposition;Diagnosis;Disease;Disease Progression;Educational workshop;Epithelial;Epithelial Cells;Facies;Fibroblasts;Fibrosis;Future;Genetic Transcription;Goals;Hamman-Rich syndrome;Healed;Heart;Histopathology;Individual;Inflammation;Injury;Integrins;Integumentary system;Interstitial Lung Diseases;Kidney;Knowledge;Lead;Lesion;Liver;Lung;Lung Transplantation;Lung diseases;Mind;Molecular;Myofibroblast;National Heart, Lung, and Blood Institute;Nature;Normal tissue morphology;Outcome;Pathogenesis;Pathology;Phenotype;Physiological;Process;Prognostic Factor;Progressive Disease;Proliferating;Refractory;Regulation;Research;Research Personnel;Research Project Grants;Role;Science;Scientist;Sentinel;Signal Transduction;Specimen;Staging;Tissues;Transcriptional Regulation;Translating;Translations;Work;cell injury;cytokine;effective therapy;epithelial to mesenchymal transition;healing;insight;lung repair;macromolecule;novel therapeutics;programs;response;theories;tissue repair","IPF Fibroblast Phenotype","This PPG will provide mechanistic insight into the molecular processes that make an IPF fibroblast abnormal by uncovering those components of the myofibroblast cellular machinery that result in unrelenting fibrosis in IPF. We believe the work proposed within this PPG represents some of the best science in IPF research and will advance the field and lead to novel therapeutic strategies to limit the progressive fibrosis of IPF.","NHLBI","8242760","3/29/2012 12:00:00 AM"," ","5P01HL091775-04","5","P01","HL","091775","04"," ","EU, JERRY PC","4/1/2009 12:00:00 AM","3/31/2014 12:00:00 AM","Heart, Lung, and Blood Program Project Study Section[HLBP]"," ","1903478","HENKE, CRAIG A","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","SCHOOLS OF MEDICINE","554552070","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","1273636","399441"," ","1673077",
"Breast Cancer; Cancer; Genetics","Adhesions;Adhesives;Basement membrane;Cell Adhesion Molecules;Cells;Chimera organism;Data;Disease;Enzymes;Event;Exhibits;Extravasation;FGFR1 gene;Fibroblast Growth Factor Receptors;Gelatinase B;Genes;Health;In Vitro;Intervention;Lead;Lung;MAP Kinase Gene;MAP2K1 gene;Mediating;Metalloproteases;Metastatic Neoplasm to the Lung;Metastatic to;Modeling;Mouse Mammary Tumor Virus;Mus;Mutation;N-Cadherin;Neoplasm Metastasis;Oncogenes;Outcome;Pathway interactions;Pharmaceutical Preparations;Phosphorylation;Play;Polyomavirus;Process;Production;Publishing;Reagent;Relative (related person);Role;Seeds;Signal Transduction;Site;Testing;Therapeutic;Transgenic Mice;Transgenic Organisms;Up-Regulation;Vascular Endothelium;Viral Tumor Antigens;base;cancer cell;cell motility;design;epithelial to mesenchymal transition;extracellular;improved;in vivo;inhibitor/antagonist;insight;kinase inhibitor;malignant breast neoplasm;mammary epithelium;migration;mouse model;mutant;neoplastic cell;novel;overexpression;promoter;slug;transcription factor;tumor","EMT, Extravasation and metastasis by N-Cadherin signaling","
 Project Narrative
 We found that the EMT transcription factor, Slug, is upregulated in tumors and metastases in which N-
cadherin is upregulated. We believe that N-cadherin signaling through the FGF receptor induces a cascade of
events that leads to Slug induction, extravasation and metastasis. We will rule out the role of N-cadherin
adhesion in this process. We believe these studies will broaden our understanding of mechanisms that
regulate breast cancer metastasis and will provide insights into therapeutic application.","NCI","8213685","12/30/2011 12:00:00 AM","PA-07-070","5R01CA135061-04","5","R01","CA","135061","04"," ","AULT, GRACE S","3/1/2009 12:00:00 AM","12/31/2013 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","2268252","HAZAN, RACHEL B","Not Applicable","14","PATHOLOGY","110521739"," ","110521739"," ","US","40.851026","-73.844361","9433501","ALBERT EINSTEIN COLLEGE OF MEDICINE","BRONX","NY","SCHOOLS OF MEDICINE","104611900","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","132842"," ","334117",
"Cancer; Lung; Lung Cancer; Smoking and Health; Tobacco","A549;Accounting;Adhesions;Affect;Apoptosis;Apoptotic;Arrestin Beta 1;Biochemical;Biological Assay;Blood Vessels;Butanones;Carcinogens;Cardiovascular Diseases;Cell Culture System;Cell Line;Cell Nucleus;Cell Proliferation;Cells;Colorectal Cancer;Development;Disease;Epithelial;Event;Exposure to;Functional disorder;G Protein-Coupled Receptor Signaling;Gene Expression;Gene Expression Regulation;Growth;Immigration;In Vitro;Lead;Light;Lung;Lung Neoplasms;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of lung;Mediating;Mesenchymal;Molecular;Molecular Target;Mus;N&apos;-nitrosonornicotine;Neoplasm Metastasis;Neuroglia;Nicotine;Nicotinic Receptors;Non-Small-Cell Lung Carcinoma;Nuclear Translocation;Oncogenic;Patients;Play;Process;Property;Proteins;Relative (related person);Reporting;Resistance;Role;Scaffolding Protein;Signal Transduction;Smoker;Smoking;System;Tobacco;Tobacco smoke;Tobacco use;Tobacco-Associated Carcinogen;Transcriptional Activation;Tumor Angiogenesis;Tumor Cell Invasion;Tyrosine Phosphorylation;angiogenesis;arrestin 1;base;cancer cell;chemotherapeutic agent;cigarette smoking;combat;computerized data processing;in vivo;insight;mouse model;novel;promoter;receptor;research study;response;smoking cessation;src-Family Kinases;tissue/cell culture;tumor;tumor growth;tumor progression;tumorigenesis","Role of Beta-arrestin-1 and Src in nAChR Signaling and Lung Caancer","n/a","NCI","8208242","2/27/2012 12:00:00 AM","PA-07-070","5R01CA127725-05","5","R01","CA","127725","05"," ","JHAPPAN, CHAMELLI","4/17/2008 12:00:00 AM","7/31/2013 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1868394","CHELLAPPAN, SRIKUMAR P.","Not Applicable","14","Unavailable","139301956","DVHKP4N619V9","139301956","DVHKP4N619V9","US","28.062545","-82.419587","3736101","H. LEE MOFFITT CANCER CTR & RES INST","TAMPA","FL","Research Institutes","336129497","UNITED STATES","N","2/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","134854"," ","336129",
"Autoimmune Disease; Biotechnology; Clinical Research; Genetics; Lung; Rare Diseases","Acute Lung Injury;Alveolar;Aminopeptidase;Attenuated;Bleomycin;Cell Cycle;Cell Cycle Progression;Cell Cycle Regulation;Cell Growth Processes;Cell Proliferation;Cells;Cellular biology;Chronic Disease;Cicatrix;Collagen;Critical Care;Data;Deposition;Development;Disease;Engineering;Environment;Enzymes;Epithelial Cells;Epithelium;Family;Fibroblasts;Fibrosis;Gene Expression Profiling;Genes;Goals;Growth Factor;Hamman-Rich syndrome;Hypersensitivity;Immunology;In Vitro;Interstitial Lung Diseases;Knock-out;Laboratory Research;Lung;Lung Transplantation;Lung diseases;Mediator of activation protein;Medicine;Mentors;Mesenchymal;Messenger RNA;Microarray Analysis;Microdissection;Modeling;Mus;Myofibroblast;Nuclear;Pathogenesis;Pathologic;Patients;Peptide Hydrolases;Phosphorylation;Physicians;Play;Process;Proliferating;Protocols documentation;Pulmonary Fibrosis;Relative (related person);Research;Research Personnel;Research Support;Resistance;Role;Sampling;Small Interfering RNA;Specimen;Surgeon;Symptoms;Testing;Training;Transgenic Mice;Universities;Up-Regulation;Work;Wound Healing;alveolar epithelium;career;college;effective therapy;fumagillin;indium-bleomycin;inhibitor/antagonist;injured;member;methionine aminopeptidase 2;mouse model;new therapeutic target;novel;oncoprotein p21;training project","Methionine Aminopeptidase 2 in Pulmonary Fibrosis","n/a","NHLBI","8207254","12/30/2011 12:00:00 AM","PA-06-512","5K08HL083085-06","5","K08","HL","083085","06"," ","COLOMBINI-HATCH, SANDRA","1/1/2008 12:00:00 AM","3/31/2013 12:00:00 AM","ZHL1-CSR-X(O1)"," ","2084265","KASS, DANIEL J","Not Applicable","18","INTERNAL MEDICINE/MEDICINE","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","1/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","838","Other Research-Related","2012"," "," ","NHLBI","120100","9608"," ","129708",
"Biotechnology; Breast Cancer; Cancer; Clinical Research; Genetics; Ovarian Cancer; Rare Diseases","Adipocytes;Affect;Applications Grants;Behavior;Breast Carcinoma;Carcinoma;Cataloging;Catalogs;Cells;Clinical;Connective Tissue;Connective Tissue Cells;Data;Data Set;Development;Diagnosis;Endothelial Cells;Epithelial;Fibroblasts;Future;Gene Expression;Gene Expression Profile;Gene Expression Profiling;Genes;Goals;Growth;Immunohistochemistry;In Situ Hybridization;Lead;Maintenance;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of ovary;Mediating;Mesenchymal;Molecular Profiling;Myofibroblast;Operative Surgical Procedures;Outcome;Ovarian Carcinoma;Pathologic;Pathologist;Pathway interactions;Patients;Pattern;Play;Process;Prognostic Marker;Publishing;Reaction;Research;Role;Series;Signal Transduction;Soft Tissue Neoplasms;Specimen;Stromal Cells;Stromal Neoplasm;Tissue Microarray;Tissues;Tumor Tissue;Variant;cancer cell;cancer therapy;cell type;experience;field study;follow-up;genome-wide;lymph nodes;malignant breast neoplasm;neoplastic cell;novel;novel marker;prognostic;response;sarcoma;therapeutic target;therapy resistant;tool;tumor;tumor growth;tumor progression","Discovery of Gene Expression Signatures in Cancer Stroma","
PROJECT NARRATIVE
This grant proposal aims to expand our understanding of stromal responses to cancer and, by finding new
genes and pathways involved in this response, identify new targets for tumor microenvironment-targeted
therapy. In addition to their use as prognostic markers, we believe that potential therapeutic targets may also
be discovered in the group of genes, especially those involved in ""cross-talk"" between cancer and stromal
cells. The fact that different carcinomas share expression of these targets would mean that large groups of
patients suffering from a variety of tumors could benefit.","NCI","8197004","12/6/2011 12:00:00 AM","PA-07-070","5R01CA129927-05","5","R01","CA","129927","05"," ","LIVELY, TRACY LUGO","1/10/2009 12:00:00 AM","11/30/2013 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","8748247","WEST, ROBERT B","Not Applicable","18","PATHOLOGY","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","239407","138856"," ","378263",
"Biotechnology; Genetics","Achievement;Adult;Age;Alleles;Binding;Biochemical;Biological Assay;Birth;Cartilage;Cartilage Diseases;ChIP-seq;Child;Chondrocytes;Chondrogenesis;Congenital Abnormality;Cyclic AMP-Dependent Protein Kinases;Data;Defect;Degenerative polyarthritis;Development;Disease;Elements;Enhancers;Ensure;Epiphysial cartilage;Extracellular Matrix;Gene Targeting;Genes;Genetic;Genetic Transcription;Genomics;Goals;Grant;Growth;Human;Hypertrophy;In Vitro;Knowledge;Lead;Life Expectancy;Lifting;Locus Control Region;Mediating;Mesenchymal;Molecular;Molecular Genetics;Mus;Mutation;Pain;Pathway interactions;Phosphorylation;Population;Prevalence;Proteins;RNA;Regulation;Research Design;Role;Severities;Signal Transduction;Site;Specific qualifier value;Staging;Testing;Tissues;To specify;Work;articular cartilage;base;cartilage development;chondrodysplasia;chromatin immunoprecipitation;cis acting element;high throughput screening;in vivo;insight;malformation;novel;parathyroid hormone-related protein;prevent;progenitor;programs;promoter;transcription factor","Sox9-mediated control of chondrogenesis","  This project is relevant to multiple types of cartilage malformation diseases (chondrodysplasias) and cartilage degeneration diseases (mainly osteoarthritis). Together, these diseases are highly prevalent in the human population and can have devastating consequences on life expectancy and quality from birth until senior age. Our studies are designed to increase understanding of the modes of action and regulation of Sox9, a protein with master roles in the control of genes required for cartilage development and function. We anticipate that the results of our studies will provide important new insights into mechanisms underlying cartilage diseases and will suggest novel, efficient ways to prevent and cure these diseases.   
      

","NIAMS","8334423","8/9/2012 12:00:00 AM","PA-10-067","5R01AR046249-13","5","R01","AR","046249","13"," ","TYREE, BERNADETTE","7/15/1999 12:00:00 AM","8/31/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-S(03)M]"," ","8004729","LEFEBVRE, VERONIQUE M","Not Applicable","11","OTHER BASIC SCIENCES","135781701","M5QFLTCTSQN6","135781701","M5QFLTCTSQN6","US","41.479276","-81.680233","10000858","CLEVELAND CLINIC LERNER COM-CWRU","CLEVELAND","OH","SCHOOLS OF MEDICINE","441950001","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","325131","185325"," ","510456",
"Biotechnology; Brain Cancer; Brain Disorders; Cancer; Neurosciences; Rare Diseases","Affect;Apoptosis;Biological;Cell Cycle Regulation;Cell Line;Cell Proliferation;Cell physiology;Cells;Central Nervous System Diseases;Clinical;Data;Development;Diagnostic;Disease;Down-Regulation;Employee Strikes;Event;Genetic;Genetic Transcription;Genomics;Glioblastoma;Glioma;Goals;Growth;Human;In Vitro;Knock-out;Knockout Mice;Knowledge;Laboratories;Lead;Ligands;Malignant Neoplasms;Mediating;Mesenchymal;Modality;Modeling;Molecular;Mus;Mutation;Neuraxis;Oncogene Proteins;Outcome;Pathogenesis;Pathogenicity;Pathway interactions;Patients;Phage Display;Phenotype;Phosphoric Monoester Hydrolases;Primary Neoplasm;Process;Property;Protein Dephosphorylation;Proteins;Regulation;Research;Role;Signal Transduction;Stat3 protein;Structure;System;Therapeutic;Transducers;Tumor Suppression;Tumor Suppressor Proteins;Tumor Tissue;United States;Work;Xenograft procedure;base;cell growth;human PTPRT protein;improved;in vivo;mouse model;multidisciplinary;neoplastic cell;novel;receptor;tumor;tumorigenesis","Elucidating the function of the widely inactivated phosphatase PTPRD in the molec"," Glioblastoma is a deadly disease of the central nervous system for which there is no cure. This fatal disease strikes patients in the United States and around the world. Our proposal will help illuminate the mechanisms underlying a novel, very frequently disrupted genetic pathway (the PTPRD/STAT3 pathway) in glioblastoma. Our work will significantly contribute to our understanding of the fundamental biological basis of this tumor and help identify novel targets for this devastating disease.  
  
    

","NCI","8302294","5/3/2012 12:00:00 AM","PA-10-067","5R01CA154767-02","5","R01","CA","154767","02"," ","YASSIN, RIHAB R","7/15/2011 12:00:00 AM","5/31/2016 12:00:00 AM","Cancer Molecular Pathobiology Study Section[CAMP]"," ","9306964","CHAN, TIMOTHY AN-THY","Not Applicable","12","Unavailable","064931884","KUKXRCZ6NZC2","064931884","KUKXRCZ6NZC2","US","40.764332","-73.955697","5079202","SLOAN-KETTERING INST CAN RESEARCH","NEW YORK","NY","Research Institutes","100656007","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","172018"," ","379518",
"Biotechnology; Diabetes; Genetics; Obesity","Adipocytes;Adipose tissue;Adrenergic Agents;Adult;Antibodies;Beryllium;Binding;Biogenesis;Biology;Brown Fat;CREB1 gene;Cell Line;Cells;ChIP-seq;Deletion Mutation;Development;Diabetes Mellitus;EMSA;Epidemic;Event;Fatty acid glycerol esters;Future;Gene Activation;Gene Expression;Gene Expression Profile;Gene Targeting;Genes;Genetic Transcription;Glucose;Goals;Heating;Homeostasis;In Vitro;Insulin;Knock-out;Knockout Mice;Luciferases;Mesenchymal;Metabolic Diseases;Microarray Analysis;Mitochondria;Molecular;Morphology;Mus;Non-Insulin-Dependent Diabetes Mellitus;Obesity;Obesity associated disease;Physiology;Promoter Regions;Regulatory Element;Research;Role;Signal Pathway;Testing;Therapeutic;Thermogenesis;Tissues;Transcriptional Activation;Transgenic Mice;Zinc Fingers;adipocyte differentiation;adrenergic;gene induction;genome-wide;global health;in vivo;interest;loss of function;novel;novel marker;overexpression;promoter;small hairpin RNA;transcription factor;uncoupling protein 1","Role of B2 in Brown Fat Transcription and Development"," While white adipose tissue stores fat to increase adiposity, brown adipose tissue dissipates energy as heat for thermogenesis. This research is directed toward understanding the function of a brown adipocyte transcription factor that governs brown adipose tissue gene expression and development. Understanding the mechanism and signaling pathway for the action of this transcription factor will provide us novel targets to develop strategies to control obesity and associated diseases such as diabetes.   
      

","NIDDK","8436100","9/10/2012 12:00:00 AM","PA-11-260","1R01DK095338-01A1","1","R01","DK","095338","01","A","HAFT, CAROL R","9/10/2012 12:00:00 AM","6/30/2017 12:00:00 AM","Cellular Aspects of Diabetes and Obesity Study Section[CADO]"," ","1862096","SUL, HEI SOOK ","Not Applicable","13","NUTRITION","124726725","GS3YEVSS12N6","124726725","GS3YEVSS12N6","US","37.870295","-122.268133","577502","UNIVERSITY OF CALIFORNIA BERKELEY","BERKELEY","CA","EARTH SCIENCES/RESOURCES","947101749","UNITED STATES","N","9/10/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","113478"," ","330978",
"Breast Cancer; Cancer; Genetics","Aromatic Polycyclic Hydrocarbons;Aryl Hydrocarbon Receptor;Biological Models;Carcinogens;Cell Adhesion Molecules;Cell Line;Cells;Chemosensitization;Collaborations;Colon Carcinoma;Data;Development;Disseminated Malignant Neoplasm;Dominant-Negative Mutation;Embryo;Environmental Carcinogens;Epithelial;Event;Exposure to;FVB Mouse;Funding;Genes;Genetic;Genetic Determinism;Grant;Heat-Shock Response;Human;In Vitro;Kinetics;Laboratories;Mammary Neoplasms;Mammary Tumorigenesis;Mammary gland;Modeling;Morphology;Mouse Mammary Tumor Virus;Mus;Mutation;Neoplasm Metastasis;Oncogenic;Pathway interactions;Phenotype;Phosphotransferases;Play;Process;Protein-Serine-Threonine Kinases;Proteins;Published Comment;RNA;RNA Splicing;Reagent;Regulation;Reporter;Reporting;Research Project Grants;Role;Signal Pathway;Signal Transduction;Staging;System;Techniques;Testing;Therapeutic Intervention;Transformed Cell Line;Transgenic Mice;Transgenic Organisms;Tumor Cell Invasion;Tumor Cell Line;Up-Regulation;Xenopus laevis;carcinogenesis;casein kinase II;dimethylbenzanthracene;epithelial to mesenchymal transition;in vivo;inhibitor/antagonist;interest;malignant breast neoplasm;neoplastic cell;overexpression;prevent;promoter;research study;response;snail protein;tumor;tumor progression;tumorigenesis","Research Project 2: Role of CK2 and the Wnt Signaling Pathway in the Progression","n/a","NIEHS","8376885","6/27/2012 12:00:00 AM"," ","5P01ES011624-11","5","P01","ES","011624","11"," "," "," ","6/30/2015 12:00:00 AM","ZES1-JAB-J","0005","1912829","SELDIN, DAVID C","Not Applicable","07","Unavailable","039318308","C1F5LNUF7W86","039318308","C1F5LNUF7W86","US","42.349907","-71.061712","8422704","TUFTS UNIVERSITY BOSTON","BOSTON","MA","Domestic Higher Education","021111901","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","203419","203419"," ","177506","25913"," "," ",
"Neurosciences; Pediatric","Abnormal Cell;Adhesions;Animals;Behavior;Binding;Biological Models;Biosensor;Carcinoma;Cell Adhesion;Cell physiology;Cell-Cell Adhesion;Cells;Cellular Morphology;Chimeric Proteins;Chronic;Complex;Conflict (Psychology);Cytoskeleton;Development;Developmental Process;Disease;Embryo;Embryonic Development;Environment;Epithelial;Event;F-Actin;Family;Fibrosis;GTP Binding;GTPase-Activating Proteins;Guanine Nucleotide Exchange Factors;Image;In Vitro;Individual;Inflammation;Life;Malignant Neoplasms;Mediating;Medical;Modeling;Molecular;Monomeric GTP-Binding Proteins;Neoplasm Metastasis;Neural Crest;Neural Crest Cell;Neural tube;Neuroglia;Neurons;Pathologic Processes;Pathway interactions;Peripheral;Peripheral Nervous System;Preparation;Process;Resolution;Rho-associated kinase;Role;Signal Pathway;Signal Transduction;Structure;Testing;Tissues;Zebrafish;cell behavior;cell motility;craniofacial;epithelial to mesenchymal transition;hindbrain;in vivo;in vivo Model;migration;molecular imaging;neuroepithelium;public health relevance;research study;rho;spatiotemporal;therapy design;tool;tumor progression","Analysis of RhoGTPase function in neural crest EMT in vivo","
Relevance:
EMTs are extremely important for tissue remodeling during embryonic development, and
are also central events in several pathological processes, such as fibrosis, chronic
inflammation and cancer progression and metastasis. Elucidation of the molecular
mechanisms controlling EMT is critical for understanding these developmental and
pathological events. Our experiments have potential to inform therapies designed to
treat diseases involving abnormal cell migration.","NINDS","8260498","4/24/2012 12:00:00 AM","PA-10-069","5R21NS073114-02","5","R21","NS","073114","02"," ","MORRIS, JILL A","5/1/2011 12:00:00 AM","4/30/2015 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","1926458","HALLORAN, MARY C","Not Applicable","02","ZOOLOGY","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","SCHOOLS OF ARTS AND SCIENCES","537151218","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2015 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","150000","68870"," ","218870",
"Biotechnology; Breast Cancer; Cancer; Genetics","Breast Carcinoma;Carcinoma;Cells;Clinical Trials;Collagen;Data Set;Development;Dominant-Negative Mutation;Extracellular Matrix;Funding;Gene Expression;Gene Expression Profile;Grant;Human;Immune;Immunologic Surveillance;Impairment;In Vitro;Infiltration;Inflammatory;Knock-out;Lung;Malignant Epithelial Cell;Malignant Neoplasms;Mammary gland;Matrix Metalloproteinases;Metastatic Neoplasm to the Lung;Modeling;Mouse Mammary Tumor Virus;Mutation;Myelogenous;Neoplasm Metastasis;Oncogene Activation;Oncogenes;Outcome;Pathway interactions;Pattern;Play;Polyomavirus;Primary Carcinoma;Protein-Lysine 6-Oxidase;Receptor Gene;Regulation;Role;Signal Pathway;Signal Transduction;Source;Staging;Suppressor-Effector T-Lymphocytes;Testing;Tissue Microarray;Transforming Growth Factor beta;Tumor Cell Invasion;Tumor Promotion;Tumor Suppressor Genes;Tumor Suppressor Proteins;Work;attenuation;chemokine;crosslink;cytokine;epithelial to mesenchymal transition;genetic manipulation;human tissue;in vivo;inhibitor/antagonist;malignant breast neoplasm;mouse model;outcome forecast;public health relevance;receptor;response;small molecule;tumor;tumor initiation;tumor progression;tumorigenesis","TGF-beta Suppression and Promotion of Mammary Carcinomas","
Relevance
TGF-ss signaling is a major tumor suppressor pathway in human carcinomas, but in later stages
of tumor progression, TGF-ss signaling promotes tumor progression. As systemic inhibitors of
TGF-ss signaling are in clinical trials in humans with cancer, it is important to delineate
mechanisms of both suppression and promotion of tumors by TGF-ss. We have excellent
mouse models and plans for such mechanistic studies.","NCI","8239934","5/30/2012 12:00:00 AM","PA-10-067","5R01CA085492-12","5","R01","CA","085492","12"," ","MOHLA, SURESH","5/20/2000 12:00:00 AM","2/29/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1877614","MOSES, HAROLD L","WEAVER, VALERIE MARIE","05","ANATOMY/CELL BIOLOGY","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","323261","125044"," ","448305",
"Asthma; Genetics; Lung; Nutrition; Pediatric","Address;Adult;Agonist;Appearance;Asthma;Biological Models;Blood Vessels;Bronchial Tree;Cell physiology;Cells;Child;Chromatin Remodeling Factor;Cues;DNA Methylation;Data;Development;Diet;Disease;Embryo;Environmental Risk Factor;Epigenetic Process;Epithelial;Exhibits;Exposure to;Fostering;Gene Expression;Genes;Genetic;Genetic Models;Goals;Histology;Hyperactive behavior;In Vitro;Knockout Mice;Lead;Life;Lung;Lung diseases;Maintenance;Mesenchymal;Micronutrients;Modeling;Morphology;Mus;Muscle;Nutritional;Pathway interactions;Perinatal Exposure;Pharmaceutical Preparations;Phenotype;Physiology;Predisposition;Primitive foregut structure;Primordium;Property;Regulation;Respiratory physiology;Role;Serum;Severities;Signal Transduction;Smooth Muscle;Smooth Muscle Myocytes;Stimulus;Structure;Testing;Transcription Repressor/Corepressor;Tretinoin;Up-Regulation;Visceral;Vitamin A;Vitamin A Deficiency;airway hyperresponsiveness;base;cellular development;chromatin remodeling;environmental agent;histone modification;in vivo;insight;lung development;postnatal;prenatal;progenitor;programs;pulmonary function;respiratory smooth muscle;response","RETINOIC ACID REGULATION OF LUNG DEVELOPMENT"," Studies strongly suggest that susceptibility for asthma may develop from early exposures in utero to environmental agents or nutritional changes, and that asthma severity is associated with low Vitamin A levels in children. Here we will investigate how prenatal deficiency in vitamin A influences development of the airway- associated muscle layer and how this predisposes to increased airway reactivity to spasmogenic drugs and asthmatic stimuli in adult life.  
    

","NHLBI","8238490","2/21/2012 12:00:00 AM","PA-10-067","2R01HL067129-09A1","2","R01","HL","067129","09","A","LIN, SARA","6/1/2001 12:00:00 AM","2/29/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-CVRS-G(03)M]"," ","1974562","CARDOSO, WELLINGTON V.","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","604483045","FBYMGMHW4X95","604483045","FBYMGMHW4X95","US","42.336234","-71.070647","894901","BOSTON UNIVERSITY MEDICAL CAMPUS","BOSTON","MA","SCHOOLS OF MEDICINE","021182841","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","250000","159083"," ","409083",
"Alcoholism; HIV/AIDS; Hematology; Infectious Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Substance Abuse","Acquired Immunodeficiency Syndrome;Address;Adverse effects;Affect;Agranulocytosis;Alcohol abuse;Alcohol consumption;Alcohols;Attenuated;Blood Circulation;Bone Marrow;Bone Marrow Examination;CD4 Positive T Lymphocytes;Cell Count;Cell physiology;Complex;CpG Islands;Data;Development;Disease;Dysmyelopoietic Syndromes;Environment;Equilibrium;Foundations;HIV;Hematopoietic;Hematopoietic stem cells;Highly Active Antiretroviral Therapy;Histone Acetylation;Host Defense;Immunologic Deficiency Syndromes;Individual;Infiltration;Instruction;Investigation;Knowledge;Lymphocyte;Macaca;Macaca mulatta;Mediating;Mesenchymal;Methylation;Myelogenous;Myelopoiesis;Myelosuppression;Patients;Research;Risk Factors;SIV;Sampling;Stromal Cells;Testing;Transforming Growth Factors;Virus Diseases;Virus Replication;alcohol effect;alcohol exposure;antiretroviral therapy;effective therapy;granulocyte;improved;injured;mortality;novel;precursor cell;progenitor;promoter;protective effect;research study;response;secondary infection;stem cell differentiation;transcription factor","Research Component 4","RELEVANCE (See instructions): 
This project investigates mechanisms underlying the adverse effects of alcohol on the development of myelosuppression during SIV infection with or without ART. It will greatly advance our knowledge concerning the negative impact of alcohol abuse on myelopoiesis in HIV/AIDS and will contribute to developing effective therapies to treat the complex immunodeficiencies in HIV-infected alcohol abusers.","NIAAA","8374135"," "," ","5P60AA009803-19","5","P60","AA","009803","19"," "," "," "," ","ZAA1","5162","2047512","ZHANG, PING ","Not Applicable","02","Unavailable","782627814","M7KCJ79FAVH5","782627814","M7KCJ79FAVH5","US","29.957722","-90.082903","577902","LSU HEALTH SCIENCES CENTER","NEW ORLEANS","LA","Domestic Higher Education","701127021","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM"," ","Research Centers","2012","104635","104635"," ","80994","23641"," "," ",
"Clinical Research; Hematology; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Adoptive Transfer;Animal Model;Aplastic Anemia;Biological Assay;Biological Models;Biological Process;Biology;Bone Marrow;Bone Marrow Transplantation;Cell Maintenance;Cell Survival;Cell surface;Cells;Detection;Disease;DsRed;Endothelial Cells;Engraftment;Environment;Fanconi&apos;s Anemia;Fishes;Goals;Growth;Hematopoiesis;Hematopoietic;Hematopoietic stem cells;Home environment;Homing;Imagery;In Vitro;Knowledge;Label;Learning;Maintenance;Malignant Childhood Neoplasm;Marrow;Measures;Mesenchymal;Microscopic;Modeling;Muscle;Names;Nature;Neutropenia;Organ;Osteogenesis;Pancytopenia;Patients;Pericytes;Pharmacotherapy;Play;Process;Property;Radiation;Regimen;Reporter;Risk;Role;Source;Stem cells;Stromal Cell-Derived Factor 1;Stromal Cells;Therapeutic;Thinking;Time;Tissues;Transgenic Organisms;Vertebrates;Visual;Work;Zebrafish;abstracting;cell type;chemokine;cytokine;diphtheria toxin receptor;in vivo;injury and repair;insight;lipid biosynthesis;promoter;stem;tissue repair;vasculogenesis","Perivascular Cell Characterization and Contribution to the Hematopoietic Niche"," Bone marrow transplant is the only curative measure for some pediatric cancers, but carries with it significant risk due to prolonged neutropenia associated with preparative regimen. We will learn how the hematopoietic cells home and interact with the marrow niche cells which provide their support. Understanding this process will allow us to develop new drugs and therapies to allow hematopoietic cell engraftment to occur with increased efficiency thereby decreasing time of neutropenia and ultimately increasing patient survival. Additionally, knowledge form this work may be used to better understand broader disease mechanisms in the field on bone marrow failure including aplastic anemia, Fanconi's anemia, and radiation exposure.  
    

","NHLBI","8323221","5/23/2012 12:00:00 AM","PA-10-059","5K08HL108998-02","5","K08","HL","108998","02"," ","WELNIAK, LISBETH A","9/30/2011 12:00:00 AM","6/30/2016 12:00:00 AM","ZHL1-CSR-K(M4)"," ","1894443","LUND, TROY C.","Not Applicable","05","PEDIATRICS","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","SCHOOLS OF MEDICINE","554552070","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","839","Other Research-Related","2012"," "," ","NHLBI","127000","10160"," ","137160",
"Biotechnology; Digestive Diseases; Genetics","Abbreviations;Ablation;Address;Affect;Applied Genetics;BMP4;Bone Morphogenetic Proteins;Cell Culture Techniques;Cell Death;Cells;Complex;Data;Defect;Development;Developmental Biology;Developmental Process;Dominant-Negative Mutation;Embryo;Embryonic Development;Endoderm;Epithelium;Erinaceidae;Experimental Models;Gastrointestinal Diseases;Gastrointestinal tract structure;Gene Expression;Genes;Genetic Models;Genetically Engineered Mouse;Health;Homeostasis;Human;Immunohistochemistry;In Situ Hybridization;Intestines;Knock-out;Ligands;Literature;Malignant Neoplasms;Mediating;Mesenchymal;Mesenchyme;Mesoderm;Molecular;Mus;Mutant Strains Mice;Nature;Notch Signaling Pathway;Organogenesis;Pathway interactions;Phenocopy;Play;Proteins;Relative (related person);Research;Reverse Transcription;Role;Series;Signal Pathway;Signal Transduction;Signaling Protein;Smooth Muscle;Stomach;Testing;Tissues;Transforming Growth Factors;Transgenic Mice;Work;base;bone morphogenetic protein 4;common treatment;early embryonic stage;embryo tissue;fetal;forkhead protein;gastrointestinal;improved;in vivo;meetings;mutant;notch protein;novel;prevent;research study;smoothened signaling pathway;tissue culture;tool;transcription factor","Hedgehog signaling in early development of the gastrointestinal tract","
Project Narrative: One particular surprise from the last decade of developmental biology research is
that complex developmental processes in diverse tissues depend on just a few cell signaling pathways.
The hedgehog pathway plays a vital role at many steps in development and homeostasis of the
digestive tract and is also implicated in cancers of endodermally derived tissues. The functions and
mechanisms of hedgehog signaling in gut development are poorly understood, in spite of their useful
implications and applications for human gastrointestinal disorders. This proposal seeks to apply genetic
and cell culture tools to elucidate the precise role and mechanisms of hedgehog signaling in genesis of
the mouse stomach and intestine.","NIDDK","8314081","7/24/2012 12:00:00 AM","PA-07-070","5R01DK081113-04","5","R01","DK","081113","04"," ","CARRINGTON, JILL L","9/1/2009 12:00:00 AM","8/31/2013 12:00:00 AM","Gastrointestinal Cell and Molecular Biology Study Section[GCMB]"," ","1893620","SHIVDASANI, RAMESH A","Not Applicable","07","Unavailable","076580745","DPMGH9MG1X67","076580745","DPMGH9MG1X67","US","42.337844","-71.108337","1464901","DANA-FARBER CANCER INST","BOSTON","MA","Independent Hospitals","022155450","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","213172","156041"," ","369213",
"Diabetes; Kidney Disease","Accounting;Affect;Binding;Binding Sites;Blood Glucose;Cell Culture Techniques;Cell Line;Cells;Cicatrix;Collagen;Defect;Deposition;Detergents;Development;Diabetes Mellitus;Diabetic Nephropathy;Disease;Disease Progression;End stage renal failure;Environment;Event;Exhibits;Extracellular Matrix;Extracellular Matrix Proteins;Feedback;Fibroblasts;Fibronectins;Fibrosis;Filtration;Flow Cytometry;Future;Generations;Glomerular Capillary;Glucose;Human;Immunofluorescence Immunologic;Integrin Binding;Integrins;Kidney;Kinetics;Knock-out;Lead;Measures;Mediating;Mesenchymal;Modeling;Molecular;Nature;Newly Diagnosed;Pathway interactions;Play;Post-Translational Protein Processing;Process;Production;Property;Proteins;Proteinuria;Renal glomerular disease;Role;Structure of glomerular mesangium;Surface;Testing;Therapeutic;Time;Tissues;United States;cell assembly;cell type;density;deoxycholate;dimer;fibrillogenesis;glomerular basement membrane;glomerular filtration;glomerulosclerosis;glycation;glycosylated fibronectin;insight;kidney cell;mesangial cell;neutralizing antibody;new therapeutic target;receptor;research study;sugar","Mesangial cell matrix deposition in high glucose as a model of glomerulosclerosis"," Chronically high blood sugar levels in diabetes mellitus can have devastating effects on the kidney's filtration apparatus. This apparatus depends on proper organization of a network of proteins called the extracellular matrix, which accumulate in excess and block filtration when exposed to high sugar levels. Using a kidney cell culture model, we plan to clarify the effects of high sugar levels on the filtration matrix in hopes of revealing new
targets for future therapies aimed at reversing the progression of this increasingly common and potentially deadly disease.   
      

","NIDDK","8313109","2/3/2012 12:00:00 AM","PA-11-110","1F30DK095515-01","1","F30","DK","095515","01"," ","MARIC-BILKAN, CHRISTINE","3/1/2012 12:00:00 AM","2/28/2017 12:00:00 AM","ZDK1-GRB-G(J1)S"," ","11018256","MILLER, CHARLES GRABEL","Not Applicable","12","BIOCHEMISTRY","002484665","NJ1YPQXQG7U5","002484665","NJ1YPQXQG7U5","US","40.12273","-74.703461","6661401","PRINCETON UNIVERSITY","Princeton","NJ","SCHOOLS OF ARTS AND SCIENCES","085406000","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","847","Training, Individual","2012"," "," ","NIDDK","42232"," "," ","42232",
"Dental/Oral and Craniofacial Disease; Genetics; Pediatric","Anterior;Applications Grants;Binding;Biological Assay;Bone Morphogenetic Proteins;Cell Proliferation;Cell physiology;Cleaved cell;Cleft Lip;Cleft Palate;Complex;Congenital Abnormality;Cultured Cells;Data;Defect;Development;Embryonic Development;Epithelial;Erinaceidae;Exclusion;Exhibits;Failure;Family;Fibroblast Growth Factor;Genes;Genetic;Genetic Crosses;Goals;Growth;Growth Factor;Health;Histologic;Histology;Human;Lead;Link;Mediating;Mesenchymal;Mesenchyme;Migration Assay;Molecular;Morphogenesis;Mus;Mutation;Organ;Organ Culture Techniques;Organogenesis;Orphan;Palate;Pathway interactions;Pattern;Peptides;Phenotype;Play;Population;Prevention therapy;Process;Receptor Protein-Tyrosine Kinases;Regulation;Reporter;Research;Role;Secondary Palate;Signal Transduction;Testing;Tissues;Transgenic Organisms;WNT3 gene;WNT5A gene;base;cell motility;design;developmental genetics;directional cell;insight;member;mutant;novel;palatogenesis;receptor;transcription factor","Growth Factor Signaling in Mouse Palatogensis","
Project Narrative: Cleft palate represents one of the most frequent human birth defects. This
complex birth defect is caused by both multigenic and environmental contributions. Despite the
frequent occurrence, relatively little is known about the developmental and genetic basis that
leads to a cleft palate formation. The growth factor plays vital roles in embryogenesis. Mutations
in several WNT growth factors have been associated with human cleft palate defect. This
proposal studies the role of Wnt signaling in the regulation of the palate development and
attempts to establish molecular and cellular mechanisms underlying Wnt5a and its receptors
during palatogenesis. The results obtained from this study will provide fundamental information
for our understanding of cleft palate formation in humans, and provide an insight for the genetic
prevention and therapy of the human cleft palate.","NIDCR","8310779","8/9/2012 12:00:00 AM","PA-07-070","5R01DE014044-10","5","R01","DE","014044","10"," ","SCHOLNICK, STEVEN","1/1/2002 12:00:00 AM","8/31/2014 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1888311","CHEN, YIPING ","Not Applicable","01","ANATOMY/CELL BIOLOGY","053785812","XNY5ULPU8EN6","053785812","XNY5ULPU8EN6","US","29.935453","-90.123916","8424601","TULANE UNIVERSITY OF LOUISIANA","NEW ORLEANS","LA","SCHOOLS OF ARTS AND SCIENCES","701185665","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","232774","114059"," ","346833",
"Biotechnology; Neurosciences","Amino Acid Sequence;Antibodies;Apoptosis;Apoptotic;B-Lymphocytes;Binding;Cell Culture Techniques;Cell Line;Cell Separation;Cells;Collaborations;Complex;Crystallization;Crystallography;DNA Repair;Detergents;Development;Disease;Drug abuse;Engineering;Ensure;Epithelial;Evolution;Fluorescence;Funding;Generations;Goals;In Situ;Ion Channel;Joints;Laboratories;Ligands;Lipids;Malignant Neoplasms;Mammalian Cell;Membrane Proteins;Mental Depression;Mesenchymal;Molecular Chaperones;Molecular Conformation;Mutagenesis;Mutate;Mutation;Nature;Nerve Degeneration;Neurodegenerative Disorders;Neurotensin Receptors;Neurotransmitters;Pain;Pattern;Peptide Sequence Determination;Pharmacologic Substance;Point Mutation;Process;Production;Property;Proteins;Proteolytic Processing;Publications;Receptor Protein-Tyrosine Kinases;Research;Resolution;Selection Criteria;Sodium Channel;Structure;System;Technology;Testing;Tissues;Toxic effect;Transcription factor genes;Variant;base;cellular engineering;design;directed evolution;glycosylation;improved;interest;milligram;overexpression;pressure;programs;protein expression;protein structure;receptor;serotonin transporter;structural biology;success;therapeutic development;therapeutic target;transcription factor;voltage","Evolving membrane proteins for high-level expression in modified mammalian cells","
Many of the most important therapeutics are targeted towards mammalian membrane proteins in different
tissues in the body. Our ability to develop improved pharmaceuticals for treating diseases including cancer,
neurodegeneration, depression, drug abuse, and pain will be greatly accelerated by an improved
understanding of the structural nature of complex mammalian membrane proteins. The goal of this project is
to develop the technologies that enable mammalian cells to produce high yields of biomedically important
membrane proteins needed for subsequent crystallization and structural analysis.","NIGMS","8310048","8/27/2012 12:00:00 AM","RFA-RM-09-012","5R01GM095685-03","5","R01","GM","095685","03"," ","CHIN, JEAN","9/30/2010 12:00:00 AM","7/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BCMB-S(50)R]"," ","1973881","BETENBAUGH, MICHAEL J","Not Applicable","07","ENGINEERING (ALL TYPES)","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","BIOMED ENGR/COL ENGR/ENGR STA","212182680","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","310","Non-SBIR/STTR","2012"," "," ","OD","214666","82334"," ","297000",
"Breast Cancer; Cancer","Address;Adult;Apoptosis;Apoptotic;Basement membrane;Binding;Cancer cell line;Cell Aging;Cell Differentiation process;Cell Line;Cell Proliferation;Cell Proliferation Regulation;Cell Survival;Cell physiology;Cells;Chickens;Complex;Development;Down-Regulation;Embryo;Embryonic Development;Epithelial;Epithelial Cells;Extracellular Matrix;Family;Fibroblasts;Goals;Health;Human;In Vitro;Knock-in Mouse;MCF10A cells;Malignant - descriptor;Malignant Neoplasms;Mammalian Cell;Mammary gland;Mediating;Modeling;Molecular;Mouse Strains;Mus;Oncogenes;Oncogenic;Pathway interactions;Pattern;Physiological;Play;Process;Production;Proto-Oncogenes;Publishing;Quail;RNA Interference;Regulation;Reporting;Role;Signal Pathway;Signal Transduction;Skiing;Skin;Smad Proteins;Smad protein;Specificity;Stimulus;Testing;Tissues;Transforming Growth Factor beta;Transforming Growth Factors;Tumor Suppressor Proteins;base;cancer cell;cancer therapy;cell motility;design;embryo cell;epithelial to mesenchymal transition;in vivo;member;mutant;novel;overexpression;premature;response;senescence;small hairpin RNA;tumorigenesis;tumorigenic","SnoN and TGFbeta signaling","
Project Narrative:
SnoN is a potent negative regulator of transforming growth factor-ï¿½ (TGF-ï¿½) signaling,
which play important but complex roles during mammalian tumurigenesis. It regulates
many aspects of cellular functions including proliferation, differentiation, senescence and
motility and contains both oncogenic and anti-oncogenic activities. Identification of the
signaling pathways mediating each of these activities and deciphering the specificity of
these pathways are crucial not only for understanding the mechanisms controlling
malignant progression but also for development of novel cancer therapy that specifically
targets the oncogenic activity of SnoN while preserving its anti-oncogenic activity.","NCI","8270335","4/24/2012 12:00:00 AM","PA-07-070","5R01CA087940-09","5","R01","CA","087940","09"," ","SALNIKOW, KONSTANTIN","7/1/2001 12:00:00 AM","5/31/2014 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","1897773","LUO, KUNXIN ","Not Applicable","13","BIOCHEMISTRY","124726725","GS3YEVSS12N6","124726725","GS3YEVSS12N6","US","37.870295","-122.268133","577502","UNIVERSITY OF CALIFORNIA BERKELEY","BERKELEY","CA","SCHOOLS OF ARTS AND SCIENCES","947101749","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","157358","68762"," ","226120",
"Lung; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Acute;Arterial Injury;Attenuated;B-Lymphocytes;Binding;Binding Sites;Blood Vessels;Bone Marrow Transplantation;CD4 Positive T Lymphocytes;Cell Proliferation;Cells;Cellularity;Clinical;Complex;Data;Dependence;Development;Disease;Endothelial Cells;Environment;Event;Immune;Immune response;Infiltration;Inflammation;Inflammatory;Inflammatory Response;Injury;Interleukin-6;Knock-out;Knockout Mice;Laboratories;Lesion;Lung;Maps;Mechanics;Medial;Mediating;Mesenchymal;Modeling;Monocrotaline;Mus;Natural regeneration;Pathogenesis;Pathology;Phase;Phenotype;Physiologic intraventricular pressure;Play;Process;Production;Pulmonary Hypertension;Pulmonary artery structure;RANTES;Regulation;Right Ventricular Hypertrophy;Role;STAT3 gene;Signal Pathway;Signal Transduction;Small Interfering RNA;Smooth Muscle Myocytes;Stem cells;Stenosis;Structure of jugular vein;T cell response;T-Lymphocyte;TNF gene;Time;Up-Regulation;Vascular Endothelial Cell;Vascular remodeling;Veins;Wound Healing;arteriole;cell injury;femoral artery;human disease;in vivo;lung injury;macrophage;mouse model;neointima formation;neutralizing antibody;new therapeutic target;novel;p65;prevent;programs;promoter;pulmonary arterial hypertension;research study;response to injury;small hairpin RNA","Murine models of vascular remodeling","n/a","NHLBI","8558021"," "," ","1ZIAHL006078-03","1","ZIA","HL","006078","03"," "," "," "," "," "," ","8155048","BOEHM, MANFRED ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL HEART, LUNG, AND BLOOD INSTITUTE"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NHLBI"," "," "," ","804227",
"Cancer; Clinical Research; Genetics","AREG gene;Adverse effects;Age;Attenuated;Cells;Complex;DNA;DNA Damage;Development;Drug resistance;EREG gene;Epidermal Growth Factor Receptor;Event;Feedback;Fibroblasts;Genetic Anticipation;Genotoxic Stress;Growth;Growth Factor;IL6 gene;IL8 gene;IL8RB gene;Ionizing radiation;Kinetics;Ligands;Malignant Epithelial Cell;Malignant Neoplasms;Matrix Metalloproteinases;Modeling;Neoadjuvant Therapy;Nevus;Normal Cell;Oncogenic;Outcome;Pathway interactions;Peptide Hydrolases;Pharmaceutical Preparations;Phenotype;Premalignant;Proteins;Radiation;Radiation therapy;Reaction;Recovery;Regimen;Regulatory Pathway;Resistance;Resistance development;SPINK1 gene;Signal Transduction;Solid Neoplasm;Sterile coverings;Stress;Testing;Therapeutic;Tissues;Treatment Failure;Vascular Endothelial Growth Factors;angiogenesis;autocrine;cancer therapy;cell behavior;cell growth;cell killing;cell type;chemotherapy;cytokine;design;epithelial to mesenchymal transition;extracellular;improved;migration;neoplastic cell;paracrine;programs;response;senescence;stressor;tumor;tumor growth;tumor progression;tumorigenesis","Resistance to Cancer Therapeutics Through Microenvironment Damage Responses."," The tumor microenvironment (TME) is increasingly recognized as a major contributor to the development and progression of malignant neoplasms.  We propose to evaluate the original concept that conventional cancer therapeutics, such as ionizing radiation and alkylating drugs, which exert anti-tumor effects through DNA damage, modify the TME to enhance resistance to subsequent treatments, and consequently promote adverse cancer phenotypes.   
    

","NCI","8257300","2/29/2012 12:00:00 AM","PA-10-067","1R01CA165573-01","1","R01","CA","165573","01"," ","FORRY, SUZANNE L","3/1/2012 12:00:00 AM","1/31/2017 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1901168","NELSON, PETER S","Not Applicable","07","Unavailable","078200995","HMSNCM57QNR5","078200995","HMSNCM57QNR5","US","47.628707","-122.330795","861001","FRED HUTCHINSON CANCER RESEARCH CENTER","SEATTLE","WA","Research Institutes","981094433","UNITED STATES","N","3/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","207500","157700"," ","365200",
"Biotechnology; Cancer; Colo-Rectal Cancer; Digestive Diseases; Genetics","Affect;Apoptotic;Applications Grants;Benign;Biological Markers;Cells;Cessation of life;Colon Carcinoma;Colorectal Cancer;DNA Microarray Chip;Development;Disease;Drug Delivery Systems;Early Diagnosis;Epithelial;Exhibits;Extracellular Matrix;Gene Expression Profile;General Population;Generations;Genes;Genetic;Goals;Growth;Growth Factor;Hepatic;Human;Intervention;Knowledge;Link;Malignant - descriptor;Malignant Conversion;Malignant Neoplasms;Matrix Metalloproteinases;Mediating;Metastatic Lesion;Microarray Analysis;Molecular;Monoclonal Antibodies;Mutation;Nature;Neoplasm Metastasis;Nude Mice;Oncogenic;Organ;Pathogenesis;Pathway interactions;Patients;Pattern;Peptide Hydrolases;Pharmaceutical Preparations;Phase;Phenotype;Play;Primary Neoplasm;Process;Property;Protein Tyrosine Phosphatase;Proteins;Proteomics;Public Health;RNA Splicing;Receptor Protein-Tyrosine Kinases;Role;Sampling;Signal Transduction;Signaling Protein;Small Interfering RNA;Staging;Techniques;Testing;Tissues;Variant;Western Blotting;Work;base;cancer cell;cell motility;cell transformation;clinical practice;drug development;effective therapy;epithelial to mesenchymal transition;in vivo;knock-down;malignant phenotype;metastatic colorectal;metastatic process;neoplastic cell;novel;novel strategies;overexpression;protein expression;receptor;research study;selective expression;tool;transcription factor;tumor;tumor growth;tumor initiation;tumor progression;tumorigenesis;tumorigenic","The RON Receptor in the Invasive Growth of Colon Cancer","n/a","NCI","8234137","3/27/2012 12:00:00 AM","PA-07-070","5R01CA091980-10","5","R01","CA","091980","10"," ","AULT, GRACE S","6/5/2002 12:00:00 AM","2/28/2015 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","2204874","WANG, MING-HAI ","Not Applicable","19","PHARMACOLOGY","609980727","E4Z2NUYUMHF9","609980727","E4Z2NUYUMHF9","US","33.568999","-101.884244","8285902","TEXAS TECH UNIVERSITY HEALTH SCIS CENTER","LUBBOCK","TX","SCHOOLS OF PHARMACY","794306271","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2015 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","177840","86252"," ","264092",
"Digestive Diseases; Genetics; Nutrition; Obesity; Regenerative Medicine","Apoptosis;Area;Blocking Antibodies;Blood Vessels;Body Surface Area;Cell Proliferation;Cells;Crohn&apos;s disease;Data;Diet;Disease;Electrolytes;Enterocytes;Epithelial;Epithelial Cell Proliferation;Epithelial Cells;Epithelium;Equilibrium;Erinaceidae;Etiology;Excision;Fatty Acids;Fatty acid glycerol esters;Gene Expression;Genes;Genetic Transcription;Goals;Growth;Health;Health Care Costs;Height;Immediate-Early Genes;Injury;Intestines;Ischemia;Knock-out;Lipids;Manuscripts;Mediating;Mesenchymal;Mesenchyme;Metabolic;Molecular;Morbidity - disease rate;Mus;Natural regeneration;Nutrient;Obesity;Operative Surgical Procedures;Pathway interactions;Phenotype;Process;Radiation Injuries;Regulation;Residual state;Role;Short Bowel Syndrome;Small Intestines;Surface;Transgenic Mice;Transgenic Organisms;Trauma;Triglycerides;United States;Villus;Weight;Weight Gain;absorption;cell motility;crypt cell;design;fatty acid metabolism;feeding;functional loss;gain of function;in vivo;intestinal epithelium;loss of function;male;mortality;mouse model;new growth;novel;overexpression;programs;receptor;regenerative;response;sensor;smoothened signaling pathway;uptake","MOLECULAR AND CELLULAR ANALYSIS OF INTESTINAL ADAPTATION","
Project Narrative
Short bowel syndrome is an important cause of morbidity, mortality and health care
costs in the United States. Identification of therapies that enhance residual small bowel
function and ultimately encourage growth of new intestine are needed for treatment of
short bowel syndrome, regardless of the underlying etiology (e.g. from Crohn's disease
following resection, post-trauma, or vascular injury). The significance of our proposed
studies to health is that we have identified novel pathways that regulate the ability of the
intestine to grow and absorb nutrients. We have found that pathways regulated by tis7,
a gene that regulates transcription of other genes, can promote intestinal growth and
nutrient absorption and calorie storage. These observations may provide avenues for
new therapies to enhance functional and regenerative adaptation following loss of
functional small bowel surface area","NIDDK","8291399","6/26/2012 12:00:00 AM","PA-07-010","5R01DK046122-16","5","R01","DK","046122","16"," ","CARRINGTON, JILL L","9/18/1995 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-DKUS-F(02)M]"," ","1859991","RUBIN, DEBORAH C.","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","213172","110849"," ","324021",
"Bioengineering; Genetics; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Transplantation","Accounting;Activities of Daily Living;Acute;Adult;Affect;Affinity;Allografting;Animal Model;Attenuated;Autologous;Autologous Transplantation;BMP2 gene;Behavior;Binding;Biological;Biology;Biomechanics;Biomedical Engineering;Bone Marrow;Candidate Disease Gene;Cell Density;Cells;Chemical Stimulation;Chemicals;Chronic;Clinical;Complex;Cues;Data;Data Set;Defect;Development;Developmental Biology;Diagnostic;Environment;Evaluation;Face;Failure;Fatigue;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Gene Expression;Gene Expression Profile;Generations;Genes;Genetic;Genetic Models;Genomics;Goals;Grant;Growth and Development function;Healed;Homologous Gene;Implant;In Vitro;Individual;Industry;Infection;Inferior;Injury;Institution;Joints;Knowledge;Lead;Left;Length;Ligaments;Ligands;Limb Development;Limb structure;Maps;Measures;Mechanical Stimulation;Mechanics;Medical center;Mesenchymal Stem Cells;Methodology;Modeling;Monitor;Morbidity - disease rate;Mus;Musculoskeletal;National Institute of Arthritis and Musculoskeletal and Skin Diseases;Operative Surgical Procedures;Oryctolagus cuniculus;Outcome;Pathway interactions;Patients;Pattern;Pediatric Hospitals;Postoperative Pain;Process;Property;Protein Isoforms;Proteins;Quality of life;Rattus;Recovery;Regulation;Research;Research Personnel;Risk;Rotator Cuff;Rupture;Scientist;Secondary pain;Sheep;Signal Pathway;Signal Transduction;Site;Source;Specificity;Speed;Stimulus;Surface;Tenascin;Tendon Injuries;Tendon structure;Testing;Text;Time;Tissue Engineering;Tissues;Transgenes;Transgenic Mice;Transgenic Organisms;Translating;United States National Institutes of Health;Universities;Workplace;Writing;aggrecan;base;bone;bone morphogenetic protein 2;bone morphogenetic protein 4;candidate marker;design;design and construction;experience;fibroblast growth factor receptor 2c;gene discovery;healing;improved;improved functioning;in vitro testing;in vivo;industry partner;injured;innovation;ligament injury;mRNA Expression;meetings;musculoskeletal injury;programs;protein expression;receptor;repaired;research study;response;scaffold;scleraxis;soft tissue;spatiotemporal;stem cell differentiation;success;thrombospondin 4;tissue repair;tool;transcription factor;wound","A Developmentally-Based Tissue Engineering Approach to Improve Tendon Repair","Project Narrative: 
This BRP application will use a Multi-Functional Tissue Engineering Strategy to better repair tendon injuries. 
Tendon and ligament injuries represent almost 45% of all musculoskeletal injuries and dramatically affect 
quality of life in both recreational and workplace settings. We seek to identify genes expressed during tendon 
development, and to use these data to control the generation of ""tissue engineered constructs,"" made in 
culture, with the goal of using these to repair damaged tendons in small and large animal models and in the 
longer term, to accelerate repair of tendon injuries in patients.","NIAMS","8293428","6/14/2012 12:00:00 AM","PAR-07-352","5R01AR056943-04","5","R01","AR","056943","04"," ","WANG, FEI","7/10/2009 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-L(03)M]"," ","1858171","BUTLER, DAVID L","Not Applicable","01","ENGINEERING (ALL TYPES)","041064767","DZ4YCZ3QSPR5","041064767","DZ4YCZ3QSPR5","US","39.142998","-84.503581","1523902","UNIVERSITY OF CINCINNATI","CINCINNATI","OH","BIOMED ENGR/COL ENGR/ENGR STA","452210001","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","503638","125727"," ","629365",
"Bioengineering; Biotechnology; Clinical Research; Dental/Oral and Craniofacial Disease; Pediatric; Pediatric Research Initiative; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta - Non-Human; Transplantation","8 year old;Active Learning;Address;Adolescent;Advisory Committees;Algorithms;Alveolar;Animal Model;Animals;Applications Grants;Autologous;Award;Bilateral;Biomechanics;Biomedical Engineering;Bone Marrow;Bone Transplantation;Breathing;Caring;Cell Count;Cell physiology;Cells;Characteristics;Child;Childhood;Cleaved cell;Clinical;Clinical Trials;Clupeidae;Collaborations;Committee Members;Congenital Abnormality;Congenital cerebral hernia;Consultations;Cryopreservation;Data;Defect;Deformity;Dentistry;Dermis;Development;Early treatment;Eating;Effectiveness;Environment;Ethics;Face;Family suidae;Fishes;Foundations;Funding;Future;Generations;Genome;Goals;Grant;Growth;Growth and Development function;Harvest;Healed;Human;Immune;Implant;In Vitro;Individual;Intervention;K-Series Research Career Programs;Knock-out;Knowledge;Lead;Life;Link;Live Birth;Maintenance;Mandible;Marrow;Maxilla;Measures;Mechanics;Mentors;Mesenchymal Stem Cells;Modeling;National Institute of Dental and Craniofacial Research;Natural History;Operative Surgical Procedures;Osteoblasts;Outcome;Pain;Parents;Patients;Physicians;Play;Population;Price;Procedures;Recording of previous events;Recovery;Research;Research Design;Research Personnel;Research Project Grants;Research Training;Resources;Role;School Dentistry;Schools;Scientist;Secondary to;Skeleton;Societies;Solutions;Source;Stem cells;Surface;Surgeon;Techniques;Temporomandibular Joint;Testing;Therapeutic;Thinking;Time;Tissue Engineering;Training;Translating;Translational Research;Translations;Ultrasonography;Umbilical cord structure;United States National Institutes of Health;Unnecessary Surgery;Veterinarians;Veterinary Medicine;Vision;Work;animal model development;base;bone;bone engineering;bone quality;career;career development;cleft lip and palate;clinical practice;college;comparative;craniofacial;craniofacial microsomia;demographics;experience;functional disability;healing;human subject;improved;in vivo;insight;interest;joint function;knowledge translation;medical schools;member;mineralization;next generation;novel;novel therapeutics;osteogenic;prenatal;psychosocial;reconstruction;repaired;rib bone structure;scaffold;skills;stem cell therapy;tool;treatment strategy","Large Animal Model for Novel Autologous Treatments of Alveolar Clefts"," Congenital or acquired absence of craniofacial bone in humans results in profound distortions of facial features and major functional disabilities which can cause immense hurdles to productive integration into society. The immediate goal of this research is to develop a large animal alveolar cleft model to test novel cell-based treatment for early correction of craniofacial bone defects. The long-term goal is to be able to translate these findings to children using human cells.   
   
      

","NIDCR","8425659","8/27/2012 12:00:00 AM","PA-11-193","1K08DE023124-01","1","K08","DE","023124","01"," ","KING, LYNN M","9/1/2012 12:00:00 AM","8/31/2016 12:00:00 AM","ZDE1-MH(22)"," ","9173423","VAN AALST, JOHN ANANDA","Not Applicable","04","SURGERY","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Other Research-Related","2012"," "," ","NIDCR","124792","9983"," ","134775",
"Bioengineering; Dental/Oral and Craniofacial Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Animal Model;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Apoptosis;Biological;Bone Diseases;Bone Marrow;Bone necrosis;Cell physiology;Cells;Cicatrix;Clinical;Clinical Data;Debridement;Defect;Dioxygenases;Disease;Disease model;Engraftment;Exhibits;Family suidae;Gingiva;Goals;Human;IL17 gene;IL6 gene;Immune;Immunocompromised Host;Immunology;Immunomodulators;Immunosuppression;Immunosuppressive Agents;In Vitro;Inflammation;Inflammatory;Inflammatory Response;Infusion procedures;Injury;Interleukin-10;Interleukin-17;Interleukin-6;Jaw;Knowledge;Mandible;Mediating;Mesenchymal Stem Cells;Modeling;Molecular;Mouth Diseases;Mucosal Immunity;Mus;Natural regeneration;Necrosis;Nitric Oxide;Operative Surgical Procedures;Oral;Oral cavity;Oral mucous membrane structure;Pathway interactions;Periodontal Ligament;Play;Property;Regenerative Medicine;Regulatory T-Lymphocyte;Role;Secondary to;Skin;Source;Stem Cell Research;Stem cell transplant;Stem cells;T-Lymphocyte;Testing;Therapeutic;Tissues;Tooth Socket;Tumor Necrosis Factor Ligand Superfamily Member 6;abstracting;autocrine;base;bisphosphonate;bone;chemokine;craniofacial;cytokine;graft vs host disease;immune function;immunoregulation;in vivo;indoleamine;injured;injury and repair;knock-down;medical specialties;mouse model;novel;novel therapeutic intervention;oral tissue;orofacial;paracrine;pre-clinical;prevent;reconstruction;regenerative;repaired;restoration;self-renewal;stem cell biology;stem cell population;tissue regeneration;tissue repair","GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION","
PROJECT NARRATIVE
This study will explore the use of stem cells derived from the gingiva, a specialized oral tissue, to inhibit
inflammation and its tissue destruction in order to develop an optimal approach for the repair and restoration of
the injured orofacial tissues.","NIDCR","8271275","5/4/2012 12:00:00 AM","RFA-DE-09-001","5R01DE019932-04","5","R01","DE","019932","04"," ","LUMELSKY, NADYA L","6/1/2009 12:00:00 AM","6/30/2012 12:00:00 AM","ZDE1-RW(11)"," ","6488516","LE, ANH D","SHI, SONGTAO ; SHI, YUFANG ","37","DENTISTRY","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","900894304","UNITED STATES","N","6/1/2012 12:00:00 AM","6/30/2012 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","13019","4549"," ","17568",
"Autoimmune Disease; Clinical Research; Genetics; Human Genome; Lupus; Rare Diseases; Regenerative Medicine; Stem Cell Research","Adult;Affect;Alveolar Macrophages;Anaphylaxis;Animal Model;Antigens;Autoimmune Diseases;Autoimmune Process;B-Lymphocytes;Basic Science;Behcet Syndrome;Biological Assay;Biological Markers;CD8B1 gene;Cardiac Myocytes;Cell Differentiation process;Cell Maturation;Cell Therapy;Cells;ChIP-seq;Clinical;Clinical Investigator;Clinical Trials;Collaborations;Cooperative Research and Development Agreement;DNA;DNA Damage;DNA Methylation;DNA Resequencing;DNA repair protein;Development;Disease;EP300 gene;Enhancers;Erdheim-Chester Disease;Fibroblasts;Flow Cytometry;Functional RNA;Gene Expression;Gene Expression Profile;Genes;Genetic Determinism;Genome;Genomics;Genotype;Goals;Graft Rejection;Hair;Hematopoietic;Heterotopic Ossification;Human;IgE;Immune;Immunoassay;Immunoglobulin Class Switching;Immunoglobulin Somatic Hypermutation;Immunoglobulin Switch Recombination;Immunology;Immunology procedure;Individual;Infiltration;Inflammation;Inflammatory;Injury;Instruction;Interferons;Laboratories;Lead;Lesion;Life;Maps;Measures;Mediating;Mesenchymal Stem Cells;Metabolic;Metabolism;Methods;Modeling;Molecular;Musculoskeletal Diseases;Mutation;Myogenic Regulatory Factors;National Human Genome Research Institute;National Institute of Arthritis and Musculoskeletal and Skin Diseases;National Institute of Dental and Craniofacial Research;Nucleic Acid Regulatory Sequences;Organ;Oxidative Phosphorylation;Pathogenesis;Pathway interactions;Patients;Pattern;Pharmaceutical Preparations;Phenotype;Pluripotent Stem Cells;Polycomb;Population;Predisposition;Process;Production;Proteins;RNA;RNA Polymerase II;RNA Sequences;Regulation;Regulator Genes;Reporting;Research;Research Personnel;Resources;Role;Rosa;Serum;Services;Skeletal Muscle;Skin;Source;Stem cells;Stress;Structure;System;Systemic Lupus Erythematosus;T-Cell Proliferation;T-Lymphocyte;Techniques;Testing;Translational Research;Trauma;Treatment Efficacy;Tyrosine Kinase Inhibitor;Variant;aerobic glycolysis;base;cell fate specification;clinical application;comparative genomic hybridization;cytokine;embryonic stem cell;genome-wide;histiocyte;histone modification;human disease;hydroxyurea;improved;interleukin-23;keratinocyte;mRNA Expression;macrophage;monocyte;mutant;novel;novel therapeutic intervention;particle;pluripotency;prevent;programs;receptor;repaired;response;tool;transcription factor;viral RNA","Translational Immunology research: a support for clinical immunological research","n/a","NIAMS","8559318"," "," ","1ZICAR041181-04","1","ZIC","AR","041181","04"," "," "," "," "," "," ","9691702","GADINA, MASSIMO ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIAMS"," "," "," ","4389189",
"Biotechnology; Cancer; Clinical Research; Genetics; Orphan Drug; Ovarian Cancer; Rare Diseases","Abdominal Cavity;Address;Adhesions;Antibodies;Antiviral Agents;Apoptotic;Applications Grants;CA-125 Antigen;CD46 Antigen;Cancer Model;Cancer Patient;Carcinoembryonic Antigen;Catheters;Cell Line;Cells;Cessation of life;Clinical;Complement;Cyclophosphamide;Cytolysis;Data;Diffusion;Disease;Dose;Engineering;Gamma Cameras;Gene Expression;Genes;Giant Cells;Greater sac of peritoneum;Gynecologic;Human;Human body;Image;Immune;Immune response;Immunity;Immunosuppressive Agents;Infection;Intravenous;Iodine;Iodine Isotopes;Isotopes;Malignant Female Reproductive System Neoplasm;Malignant Neoplasms;Malignant neoplasm of ovary;Measles;Measles virus;Mediating;Membrane Fusion;Mesenchymal Stem Cells;Monitor;Morbidity - disease rate;Multiple Myeloma;Mus;Nude Mice;Oncolytic;Oncolytic viruses;Ovarian;Patients;Peptides;Peritoneal;Peritoneal Fluid;Personal Communication;Pharmaceutical Preparations;Phase I Clinical Trials;Process;Property;Radioactive Iodine;Recurrence;Recurrent disease;SLC5A5 gene;Safety;Saimiri;Serum;Simplexvirus;Site;Sodium;Specificity;Stable Disease;Structure;Subgroup;Technetium;Testing;Therapeutic;Therapeutic Agents;Therapeutic Effect;Therapeutic Uses;Transgenes;Translating;Treatment Efficacy;United States;Viral;Viral Genes;Virus;Virus Receptors;Woman;Xenograft procedure;base;cancer cell;cancer therapy;efficacy testing;gene therapy;improved;in vivo;innovation;intraperitoneal;intravenous administration;neoplastic cell;novel;novel strategies;novel therapeutics;outcome forecast;ovarian neoplasm;overexpression;patient population;research clinical testing;research study;response;single photon emission computed tomography;sodium-iodide symporter;symporter;therapeutic transgene;tissue culture;tumor;tumor specificity","Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer","
PROJECT NARRATIVE
Ovarian cancer is the most common cause of gynecologic cancer death in the United States, and it is
responsible for the deaths of 16,000 women each year. Our group is developing a novel approach to treat
ovarian cancer by using measles virus strains that preferentially replicate in ovarian tumors. Based on
promising data deriving from a phase I trial of the MV-CEA measles strain in recurrent ovarian cancer patients,
in this application we seek to optimize delivery of the virus and weaken the immune response against the virus
in order to increase the efficacy of the treatment. Furthermore, we test the potential of the viral strain MV-NIS,
which allows imaging of the viral replication in the human body and use of radioactive iodine to augment the
therapeutic effect.","NCI","8249099","4/23/2012 12:00:00 AM","PA-07-070","5R01CA136547-04","5","R01","CA","136547","04"," ","SONG, MIN-KYUNG H","6/1/2009 12:00:00 AM","12/31/2014 12:00:00 AM","Developmental Therapeutics Study Section[DT]"," ","6107734","GALANIS, EVANTHIA ","PENG, KAH-WHYE ","01","Unavailable","006471700","Y2K4F9RPRRG7","006471700","Y2K4F9RPRRG7","US","44.022374","-92.465881","4976101","MAYO CLINIC ROCHESTER","ROCHESTER","MN","Other Domestic Non-Profits","559050001","UNITED STATES","N","5/1/2012 12:00:00 AM","12/31/2014 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","335573","171478"," ","507051",
"Bioengineering; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","A Mouse;Address;Age;Animal Model;Antibodies;Atomic Force Microscopy;B-Lymphocytes;Benchmarking;Biological Assay;Cardiac;Cardiac Myocytes;Cardiac Output;Cardiomyoplasty;Cause of Death;Cell Aging;Cell Culture Techniques;Cell Differentiation process;Cell Line;Cells;Cicatrix;Collagen;Competitive Binding;Congestive Heart Failure;Control Animal;Coronary artery;Cues;Detergents;Differentiation Antigens;EFRAC;Engineering;Engraftment;Ensure;Environment;Ethylmaleimide;Extracellular Matrix;Failure;Fertilization;Foreign-Body Reaction;Gel;Genes;Growth Factor;Heart;Histology;Hour;Hyaluronic Acid;Hyaluronidase;Hydrogels;Immunofluorescence Immunologic;In Vitro;Infarction;Injectable;Injection of therapeutic agent;Injury;Label;Left;Measurement;Measures;Mesenchymal Stem Cells;Metabolic;Methods;Modeling;Monitor;Muscle;Myocardial;Myocardial Infarction;Myocardium;Natural regeneration;Necrosis;Osteoblasts;Outcome;Physiologic intraventricular pressure;Polymerase Chain Reaction;Property;Rattus;Relative (related person);Sarcomeres;Shapes;Site;Sprague-Dawley Rats;Stem cells;Structure;Sulfhydryl Compounds;Supplementation;Surface;Techniques;Testing;Therapeutic;Time;Tissue Engineering;Tissues;United States;adult stem cell;angiogenesis;base;biomaterial compatibility;bone;cell age;cell behavior;cell type;crosslink;cytotoxicity;design;embryonic stem cell;functional restoration;heart function;improved;in vivo;novel;novel strategies;polyacrylamide gels;prevent;progenitor;regenerative therapy;response;scaffold;subcutaneous","Stem Cells and Dynamic Materials Improve Cardiac Function Post-mycardial Infarcti"," As a leading cause of death in the United States, congestive heart failure (CHF) post-myocardial infarction (MI) has incited the need to develop novel techniques that prevents the formation of a stiff, scarred muscle wall which impairs heart function. Over the past two decades, novel strategies using stem cell patches or injections have not been able to sufficiently remodel the tissue and restore its function, which may be in part due to their inability to address specific design criteria of the diseased niche, e.g. stiffness (denoted E); often the addition of adult stem cells into this niche results in stem cells responding to the environment rather than remodeling it, and as such, aberrant stem cell behavior occurs given that the niche is 3- to 4-fold too stiff, EInfarct, relative to healthy muscle, ECARDIO. Materials have also been proposed in conjunction with cells to treat MI, but they often do not adequately mimic native myocardial design requirements or use cells with sufficient capacity to remodel the niche. In response, we have engineering a hyaluronic acid (HA)-based material that has time-dependent crosslinking to specifically mimic how the myocardium stiffens from soft embryonic stem cells (ESCs), EESC, to the stiffer heart wall, ECARDIO; time-dependent stiffening induces cardiac progenitors to express 3-fold more mature cardiac markers versus static cultures. It also causes 85% of progenitors to form mature, contractile sarcomeres versus only 15% for static cultures. When combined with ESCs that are uniquely tuned to remodel and shape their niche as they develop, this HA- and ESC-based approach may be able to sufficiently protect ESCs as they develop, migrate into the scarred host myocardium, and subsequently remodel it to attempt to restore some level of contractile function. In this proposal, we will first study to what extent the engineered HA material enhances cardiac differentiation and matrix secretion, assembly, and remodeling in ESCs. After understanding this interaction and better, the combination will be introduced subcutaneously in a rat model to determine biocompatibility and then in used in a rat infarct model to assess its ability to improve cardiac outcome.  
  
    

","NHLBI","8296617","7/17/2012 12:00:00 AM","PA-09-248","5R21HL106529-02","5","R21","HL","106529","02"," ","SCHWARTZ, LISA","7/15/2011 12:00:00 AM","6/30/2013 12:00:00 AM","Biomaterials and Biointerfaces Study Section[BMBI]"," ","9677484","ENGLER, ADAM J","Not Applicable","52","ENGINEERING (ALL TYPES)","804355790","UYTTZT6G9DT1","804355790","UYTTZT6G9DT1","US","32.881785","-117.236973","577507","UNIVERSITY OF CALIFORNIA, SAN DIEGO","LA JOLLA","CA","SCHOOLS OF ARTS AND SCIENCES","920930621","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","125000","68750"," ","193750",
"Autoimmune Disease; Lung; Rare Diseases; Regenerative Medicine; Scleroderma","Acute;Acute Lung Injury;Alveolar;Architecture;Area;Biological Models;Biopsy;Bleomycin;CXC Chemokines;CXC chemokine receptor 3;CXCL10 gene;CXCL11 gene;CXCL12 gene;CXCL9 gene;CXCR3 gene;Cell Proliferation;Cells;Characteristics;Chronic;Collagen;Collection;Connective Tissue Diseases;Deposition;Development;Disease;Distal;Epithelial;Epithelial Cells;Evaluation;Extracellular Matrix;Fibroblasts;Fibrosis;Funding;Gases;Hamman-Rich syndrome;Host Defense;Human;Immune response;Immunity;Infiltration;Inflammation;Inflammatory;Injury;Knockout Mice;Lead;Ligands;Lung;Lung diseases;Lymphocyte;Macrophage Activation;Mesenchymal;Microscopic;Morbidity - disease rate;Mus;Nonspecific Interstitial Pneumonia;Pathologic;Patients;Pattern;Phenotype;Polymyositis;Proteoglycan;Pulmonary Fibrosis;Regulation;Resistance;Rheumatoid Arthritis;Role;Scleroderma;Site;Smooth Muscle;Source;Stem cells;System;Testing;Time;Tissues;alveolar epithelium;cell behavior;cell injury;chemokine;chemokine receptor;fibrogenesis;interstitial;lung development;lung injury;lung repair;macrophage;migration;mortality;novel;overexpression;prevent;progenitor;public health relevance;receptor;repaired;response;syndecan-4;trafficking","Regulation of Pulmonary Fibrosis by CXCR3","
This is a competitive renewal of a proposal that focuses on the role of the chemokine CXCL12 and its cognate
receptor CXCR3 in the pathobiology of lung injury, inflammation and fibrosis. We have found that CXCL10 and
CXCR3 are critical regulators of lung injury and repair in response to non-infectious lung injury through effects
on lung epithelial cell repair, fibroblast recruitment to the lung and the development of alternatively activated
macrophages. Understanding the roles of the CXCL10/CXCR3 axis in the pathobiology of lung injury and
repair could lead to new therapies for progressive pulmonary fibrosis.","NHLBI","8268397","5/17/2012 12:00:00 AM","PA-07-070","5R01HL077291-08","5","R01","HL","077291","08"," ","GAIL, DOROTHY","3/1/2005 12:00:00 AM","5/31/2013 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","11701410","LIANG, CAROL JIURONG","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","141075"," ","388575",
"Clinical Research; Hematology; Lung; Rare Diseases; Sickle Cell Disease","Adult;African American;Alveolar;Animal Model;Animals;Architecture;Attenuated;Basement membrane;Biological;Biology;Blood Circulation;Blood Pressure;Blood capillaries;Bone Marrow;CXC Chemokines;CXCL12 gene;Cells;Chronic;Cicatrix;Clinical;Data;Defect;Deposition;Development;Disease;Down-Regulation;Event;Extracellular Matrix;Extravasation;Fibrosis;Frequencies;Hamman-Rich syndrome;Hospitalization;Human;Impairment;Inborn Genetic Diseases;Injury;Interstitial Lung Diseases;Lead;Lung;Lung diseases;Mediating;Mesenchymal;Modeling;Molecular;Mus;Nature;Organ;PTPRC gene;Pathogenesis;Patient Care;Patients;Phenotype;Play;Pre-Clinical Model;Process;Pulmonary Fibrosis;Pulmonary Hypertension;Recurrence;Risk Factors;Role;Sickle Cell;Sickle Cell Anemia;Stem cells;Structure of parenchyma of lung;Testing;Time;Tissues;Transgenic Mice;Transgenic Organisms;Vascular remodeling;acute chest syndrome;attenuation;base;capillary;chemokine receptor;design;experience;improved;lung injury;lung repair;mTOR inhibition;mouse model;novel;outcome forecast;pre-clinical;public health relevance;repaired;response;trafficking","Fibrocytes in the Pathogenesis of Sickle Cell Lung Disease","
Sickle cell disease is the most common inherited disorder in African-Americans. While improved patient care in
Sickle cell disease has led to increased survival of these patients, they unfortunately experience an increase
frequency of chronic organ problems, especially related to the lung. These patients can develop a chronic lung
condition that is associated with elevated blood pressure and formation of scar tissue in their lungs. The studies in
this proposal will focus on the role of a special cell found in the circulation of patients with sickle cell disease that
may contribute to the problems we see in the lungs of these patients.","NHLBI","8322859","8/10/2012 12:00:00 AM","PA-07-070","5R01HL098526-03","5","R01","HL","098526","03"," ","GOLDSMITH, JONATHAN C","9/5/2010 12:00:00 AM","8/31/2014 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1916748","ROSE, C EDWARD","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","065391526","JJG6HU8PA4S5","065391526","JJG6HU8PA4S5","US","38.034207","-78.512346","1526402","UNIVERSITY OF VIRGINIA","CHARLOTTESVILLE","VA","SCHOOLS OF MEDICINE","229044195","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","367062","120051"," ","487113",
"Asthma; Infectious Diseases; Lung","Acute;Allergens;Allergic;Asthma;Automobile Driving;Breathing;Cell Differentiation process;Cells;Characteristics;Chronic;Clinical;Collagen;Complement;Data;Deposition;Development;Disease;Epithelial;Epithelial Cells;Epithelium;Event;Exposure to;Extracellular Matrix Proteins;Family;Family member;Fibroblasts;Fibronectins;Fibrosis;Goals;Human;Hyperplasia;Immune;Immune response;Infection;Infection prevention;Infiltration;Inflammation;Inflammatory;Instruction;Knowledge;Laminin;Lead;Leucocytic infiltrate;Ligands;Light;Link;Lung;Lung Inflammation;Lymphocyte;Mediating;Mesenchymal;Metaplasia;Modeling;Molecular;Mucous body substance;Mus;Pathogenesis;Pathway interactions;Patients;Pattern recognition receptor;Phase;Predisposition;Process;Production;Proteins;Regulation;Rhinovirus;Role;Sampling;Satellite Viruses;Severities;Signal Transduction;Smooth Muscle;Smooth Muscle Actin Staining Method;Source;Specimen;Stimulus;Surface;T-Lymphocyte;TGFB1 gene;TNFSF4 gene;Tenascin;Testing;Th2 Cells;Therapeutic Intervention;Tumor Necrosis Factor Receptor;Tumor Necrosis Factor-alpha;Virus;airborne allergen;airway inflammation;airway remodeling;angiogenesis;asthmatic patient;bronchial epithelium;cell type;eosinophil;high voltage electron microscopy;human data;lymphotoxin beta receptor;macrophage;mast cell;member;muscle form;muscle hypertrophy;novel;pathogen;receptor;thought control","Control of airway remodeling by TNFR family molecules","RELEVANCE (See instructions): 
LIGHT, OX40L, and their receptors are expressed on the surface of many immune and some non-immune cells, and are thought to regulate the ability to mount certain immune responses. There is little known about the expression and activities of these proteins in human asthma and in clinical specimens from asthmatics of varying severity. By understanding where and when LIGHT and OX40L and their partners are expressed, 
and the functional importance of these interactions, we will gain knowledge that might lead to ways to therapeutically suppress asthma and fibrotic disease.","NIAID","8381193","7/26/2012 12:00:00 AM","RFA-AI-10-013","5U19AI070535-07","5","U19","AI","070535","07"," "," ","9/1/2006 12:00:00 AM"," ","ZAI1-PA-I","8294","1864857","CROFT, MICHAEL ","Not Applicable","52","Unavailable","804355790","UYTTZT6G9DT1","804355790","UYTTZT6G9DT1","US","32.881785","-117.236973","577507","UNIVERSITY OF CALIFORNIA, SAN DIEGO","LA JOLLA","CA","Domestic Higher Education","920930621","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","455458","455458"," ","376492","78966"," "," ",
"Cancer; Digestive Diseases; Digestive Diseases - (Peptic Ulcer); Emerging Infectious Diseases; Genetics; Infectious Diseases; Rare Diseases","Age;Alleles;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Bone Morphogenetic Proteins;Canis familiaris;Cells;Chronic;Clinical Medicine;Complex;Development;Differentiation and Growth;Disease;Engineering;Epithelial Cells;Epithelium;Event;Exhibits;Family;Functional disorder;Gastric Parietal Cells;Gastric Tissue;Gastric mucosa;Gastritis;Gene Expression;Genes;Genetic Transcription;Goals;Growth Factor;H(+)-K(+)-Exchanging ATPase;Helicobacter;Helicobacter Infections;Helicobacter pylori;Homeostasis;Hormones;IL8 gene;In Vitro;Infection;Inflammation;Inflammatory;Inflammatory Response;Interferons;Knockout Mice;Lead;Lesion;MAP Kinase Gene;Mediating;Mesenchymal;Mucous body substance;Mus;Neurotransmitters;Organism;Parietal;Pathogenesis;Peptic Ulcer;Peptides;Phosphotransferases;Population;Regulation;Role;Series;Signal Transduction;Signal Transduction Pathway;Stimulus;Stomach;Structure;System;TNF gene;Testing;Tissues;Transforming Growth Factors;Transgenic Animals;Transgenic Mice;Transgenic Organisms;base;bone morphogenetic protein 2;bone morphogenetic protein 4;bone morphogenetic protein 7;clinically relevant;cytokine;gastrointestinal;in vivo;inhibitor/antagonist;insight;malignant stomach neoplasm;morphogens;mouse model;neoplastic;novel;promoter;protein expression;public health relevance;research study;response","Anti-inflammatory actions of bone morphogenetic protein signaling in the stomach","
Project Narrative
Through the proposed studies, we hope to shed new insights that will have significant
implications in clinical medicine since our findings may contribute to a better
understanding of the pathophysiology of diseases such as peptic ulcer and gastric
cancer.","NIDDK","8251117","3/26/2012 12:00:00 AM","PA-10-067","5R01DK083373-02","5","R01","DK","083373","02"," ","CARRINGTON, JILL L","4/1/2011 12:00:00 AM","3/31/2016 12:00:00 AM","Clinical, Integrative and Molecular Gastroenterology Study Section[CIMG]"," ","1888279","TODISCO, ANDREA ","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","174000","96570"," ","270570",
"Cancer; Clinical Research; Genetics; Hematology; Rare Diseases","Ascorbic Acid;BMP2 gene;Binding;Binding Sites;Bone Diseases;Bone Pain;Cell Differentiation process;Cells;Cessation of life;Clinical;Detection;Differentiation Antigens;Disease remission;Embryo;Environment;Enzymes;Epigenetic Process;Fracture;Ganciclovir;Gene Expression;Genes;Growth;Healed;Histones;In Vitro;Interleukin-6;Interleukin-7;Lesion;Lytic;Lytic Metastatic Lesion;Maintenance;Malignant Neoplasms;Mediating;Mesenchymal;Multiple Myeloma;Mus;Osteoblasts;Osteoclasts;Osteogenesis;Pathological fracture;Patients;Plasmids;Play;Production;Recruitment Activity;Reporting;Repression;Risk;Role;Skeleton;Small Interfering RNA;Stromal Cells;TNF gene;TNFSF11 gene;Testing;Thymidine Kinase;Transcription Repressor/Corepressor;Transfection;Tumor Necrosis Factor Suppression;Tumor Necrosis Factor-alpha;Up-Regulation;base;bone;cell growth;chromatin remodeling;deletion analysis;economic impact;healing;in vivo;in vivo Model;killings;lipid biosynthesis;mouse model;osteoblast differentiation;prevent;promoter;public health relevance;transcription factor","GFI-1 and Osteoblast Suppression in Multiple Myeloma","
Item 7. Project Narrative:
Multiple Myeloma (MM) is the most frequent cancer to involve the skeleton, with up to 90% of patients developing bone
lesions that can result in severe bone pain and frequent pathologic fractures. Unfortunately, these lytic bone lesions rarely
heal even when patients are in long-term complete remission because of the permanent MM-induced block of osteoblast
precursor differentiation into functional bone-forming osteoblasts. This application proposes to investigate what intrinsic
changes to the osteoblast precursor are triggered by MM cells and are responsible for the selective differentiation block.","NIAMS","8290562","6/15/2012 12:00:00 AM","PA-07-070","5R01AR059679-03","5","R01","AR","059679","03"," ","SHARROCK, WILLIAM J","7/26/2010 12:00:00 AM","6/30/2015 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","2061215","GALSON, DEBORAH LYNN","ROODMAN, GARSON DAVID","18","INTERNAL MEDICINE/MEDICINE","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","227448","50155"," ","277603",
"Cancer; Lung","70-kDa Ribosomal Protein S6 Kinases;Adult;Animal Model;Biological Markers;Childhood;Clinical Data;Clinical Oncology;Clinical Trials;Complex;Data;Deposition;Development;Diagnosis;Discipline;Disease;Disease Progression;Drug usage;Epidermal Growth Factor Receptor;Epithelial Cell Proliferation;Etiology;Event;Extracellular Matrix;Fibroblasts;Fibrosis;Future;Goals;Growth Factor;Hamman-Rich syndrome;Health;Human;In Vitro;Individual;Inflammation;Instruction;Intervention;Knockout Mice;Laboratories;Laboratory Study;Lesion;Lung;Lung diseases;MAPK Signaling Pathway Pathway;Maintenance;Malignant Neoplasms;Mechanics;Mediating;Medical;Mesenchymal;Mitogen-Activated Protein Kinase Kinases;Modality;Modeling;Molecular;Morbidity - disease rate;Mus;Myofibroblast;Pathway interactions;Patients;Pharmaceutical Preparations;Phase I Clinical Trials;Phenotype;Phosphatidylinositols;Phosphotransferases;Physiology;Platelet-Derived Growth Factor;Principal Investigator;Protein Biochemistry;Proteins;Public Health;Pulmonary Fibrosis;Pulmonary Hypertension;Receptor Activation;Receptor Signaling;Research Personnel;Ribosomal Protein S6 Kinase;Role;Sampling;Signal Pathway;Signal Transduction;Signaling Molecule;Testing;Therapeutic;Transforming Growth Factors;Transgenic Mice;Transgenic Model;Transgenic Organisms;cytokine;effective therapy;fibrogenesis;in vivo;inhibitor/antagonist;mTOR protein;mortality;mouse model;multidisciplinary;novel;oncology;pre-clinical;prevent;therapeutic target;treatment strategy","Molecular Interventions for pulmonary fibrosis","n/a","NHLBI","8259727","4/20/2012 12:00:00 AM","RFA-HL-11-015","5P50HL107159-02","5","P50","HL","107159","02"," ","EU, JERRY PC","5/1/2011 12:00:00 AM","4/30/2014 12:00:00 AM","ZHL1-CSR-D(F1)"," ","3148938","HARDIE, WILLIAM DAVID","Not Applicable","01","Unavailable","071284913","JZD1HLM2ZU83","071284913","JZD1HLM2ZU83","US","39.140882","-84.500494","615001","CINCINNATI CHILDRENS HOSP MED CTR","CINCINNATI","OH","Independent Hospitals","452293039","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","838","Research Centers","2012"," "," ","NHLBI","307738","153939"," ","461677",
"Cancer; Digestive Diseases; Gene Therapy; Genetics; Orphan Drug; Pancreatic Cancer; Rare Diseases","Address;Anatomic Models;Animal Model;Architecture;Behavior;Biological;Biology;Cancer Etiology;Cancer Model;Cell surface;Cells;Cessation of life;Clinical;Clinical Trials;Data;Development;Dimensions;Disease;Early Diagnosis;Engineering;Environment;Epithelial;Exhibits;Fiber;Generations;Hamsters;Health;Human;Image;Immune;Immunocompetent;Interferons;Laboratories;Lead;Link;Malignant Neoplasms;Malignant neoplasm of pancreas;Mesenchymal;Mesocricetus auratus;Minnesota;Modality;Modeling;Modification;Molecular;Molecular Biology;Molecular Target;Monitor;Monoclonal Antibodies;Mus;North America;Oncolytic;Outcome;Pathogenesis;Patients;Phase I Clinical Trials;Phenotype;Population;Production;Relapse;Resistance;Safety;Slice;Specificity;Stem cells;System;Telomerase;Testing;Therapeutic;Therapeutic Effect;Therapeutic Uses;Time;Tissue Slice Technology;Tissues;Toxicology;Transforming Growth Factors;Transgenes;Translating;Translations;Universities;Unresectable;Up-Regulation;Viral;Virus;Xenograft Model;base;cancer cell;cancer therapy;chemotherapeutic agent;clinically relevant;conditionally replicative adenovirus;cyclooxygenase 2;design;gemcitabine;human tissue;improved;in vivo;in vivo Model;insight;mesothelin;mouse model;next generation;novel;novel therapeutic intervention;novel therapeutics;outcome forecast;pancreatic neoplasm;promoter;receptor;research clinical testing;subcutaneous;therapeutic gene;transduction efficiency;transgene expression;tumor;vector","Enhanced CRAd for Pancreatic Cancer","
Narrative
The poor prognosis for pancreatic cancer drives our effort to develop new therapeutic modalities.
More potent and safer CRAds can be fashioned into a clinically effective therapeutics. Also,
detailed analyses of CRAd functionality in clinically relevant models will provide the crucial
information required to advance vector design. The outcome of this project will lead to a
clinically usable therapeutics for pancreatic cancer.","NCI","8258802","4/9/2012 12:00:00 AM","PA-07-070","5R01CA094084-09","5","R01","CA","094084","09"," ","ARYA, SURESH","3/1/2002 12:00:00 AM","4/30/2014 12:00:00 AM","Developmental Therapeutics Study Section[DT]"," ","7066184","YAMAMOTO, MASATO ","Not Applicable","05","SURGERY","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","SCHOOLS OF MEDICINE","554552070","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","203852","83769"," ","287621",
"Biotechnology; Cancer; Genetics","Anchorage-Independent Growth;Apoptosis;Apoptosis Regulator;Apoptotic;BIRC4 gene;Binding;Biology;Cell Adhesion;Cell Adhesion Molecules;Cell Death;Cell Death Inhibition;Cell Line;Cell Survival;Cells;Complex;Cytosol;Deposition;Disease;Dissection;Disseminated Malignant Neoplasm;Distant;Elements;Epidermal Growth Factor Receptor;Epithelial;Exhibits;Extracellular Matrix Proteins;Fibronectins;Foundations;Gene Expression;Gene Expression Regulation;Genes;Genetic Models;Global Change;Growth Factor Receptors;Human;In Vitro;Integrins;MAPK8 gene;Malignant Neoplasms;Maps;Matrix Metalloproteinases;Mediating;Mesenchymal;Mitochondria;Molecular;Molecular Analysis;Neoplasm Metastasis;Organ;Organelles;Pathway interactions;Phosphotransferases;Proteins;Receptor Signaling;Regulation;Role;Signal Transduction;Stimulus;Structure;Testing;Transgenic Mice;Transgenic Model;Tumor Cell Invasion;Up-Regulation;X-linked IAP;Xenograft Model;Xenograft procedure;design;extracellular;genetically modified cells;in vivo;in vivo Model;malignant breast neoplasm;mouse model;neoplastic cell;novel;programs;promoter;research study;response;src-Family Kinases;survivin;tumor growth;tumor progression;tumorigenesis","Control of Apoptosis in Cancer by Survivin","
PROJECT NARRATIVE
 The dissemination of tumor cells to distant organs, or metastasis, is a deadly occurrence in cancer
progression, but its underlying mechanisms are still largely obscure. The present proposal will dissect a novel
pathway of metastasis, involving interplay between regulators of cell survival and cell adhesion. The results
may open new prospects for the treatment of metastatic cancer, which is currently incurable.","NCI","8242046","3/21/2012 12:00:00 AM","PA-07-070","5R01CA078810-15","5","R01","CA","078810","15"," ","WOODHOUSE, ELIZABETH","7/1/1998 12:00:00 AM","2/28/2014 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1882783","ALTIERI, DARIO C","Not Applicable","03","Unavailable","075524595","DW1XZMGNFBL4","075524595","DW1XZMGNFBL4","US","39.950872","-75.195321","9340401","WISTAR INSTITUTE","PHILADELPHIA","PA","Research Institutes","191044265","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","178098","123600"," ","301698",
"Lung; Rare Diseases","Address;Adult;Affect;Animals;Attenuated;Bone Marrow;Calpain;Cell Proliferation;Cell physiology;Cells;Cessation of life;Chronic;Development;Disease;Embryo;Endothelial Cells;Epithelial;Exposure to;Fibroblasts;Flow Cytometry;Gene Family;Gene-Modified;Genetic;Heart failure;Hematopoietic stem cells;Hereditary Disease;Human;Hypoxia;Immunohistochemistry;Knock-out;Knockout Mice;Label;Lead;Measurement;Measures;Medial;Mediating;Mesenchymal;Modeling;Molecular;Monocrotaline;Mus;Mutation;Myofibroblast;Pathogenesis;Pathway interactions;Population;Progressive Disease;Pulmonary Hypertension;Pulmonary artery structure;Recruitment Activity;Risk;Role;Screening procedure;Signal Transduction;Smooth Muscle;Smooth Muscle Myocytes;Tamoxifen;Testing;Therapeutic Intervention;Thick;Transforming Growth Factor beta;Transforming Growth Factor beta Receptors;Transgenic Mice;Transplantation;Vascular remodeling;bone morphogenetic protein receptor type II;cell type;hemodynamics;human TGFB1 protein;inhibitor/antagonist;insight;member;neutralizing antibody;new therapeutic target;novel;pressure;prevent;promoter;pulmonary arterial hypertension;recombinase","Interrogation of the Cellular Pathogenesis of Pulmonary Hypertension","Pulmonary arterial hypertension (PAH) is a progressive disease with limited 
therapies defined as an elevation in the mean pulmonary artery pressure which 
may lead to right heart failure and death. The Transforming Growth Factor beta 
superfamily has been implicated in the disease, but the molecular mechanism by 
which alterations in this gene family result in the disease is unknown. 
Understanding the mechanism of the disease will provide the opportunity for 
developing new screening tests and therapeutic interventions.","NHLBI","8197835","12/31/2011 12:00:00 AM","PA-10-069","5R21HL096982-02","5","R21","HL","096982","02"," ","EU, JERRY PC","1/1/2011 12:00:00 AM","12/31/2013 12:00:00 AM","Respiratory Integrative Biology and Translational Research Study Section[RIBT]"," ","1882904","SHIMODA, LARISSA A.","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","150000","96000"," ","246000",
"Aging; Biotechnology; Cancer; Clinical Research; Genetics; Prostate Cancer; Urologic Diseases","7q11.2;Acetylglucosamine;Affect;African;African American;Age;American;Amino Acids;Binding;Blinded;Blood;Blood specimen;Cancer Biology;Cancer Cell Growth;Cancer Patient;Caring;Cells;Chromosomes;Collaborations;Cultured Cells;Cysteine;DNA Damage;Data;Data Set;Diagnostic Neoplasm Staging;Disease;Early Diagnosis;Endogenous Retroviruses;Endoplasmic Reticulum;Epithelial Cells;European;Evaluation;Family;Fibroblasts;Follow-Up Studies;Gagging;Gene Expression;Genes;Genetic;Genetic Predisposition to Disease;Genomics;Goals;HERVs;Human;Immune;Immunobiology;Immunohistochemistry;Incidence;Infectious Agent;Inflammation;Inflammatory;Insurance Coverage;Interferons;Investigation;Ireland;Laboratories;Link;Location;Malignant neoplasm of prostate;Medical;Medicine;Metabolism;Microarray Analysis;Molecular;Molecular Profiling;Mononuclear;Pathology;Patients;Peripheral Blood Mononuclear Cell;Pilot Projects;Population Control;Population Group;Prevalence;Prostate;Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial;Prostatic Neoplasms;Proteins;Radiation;Radiation therapy;Recruitment Activity;Relative (related person);Research;Resected;Resistance;Sample Size;Sampling;Seroprevalences;Signal Pathway;Small Interfering RNA;Stress;System;TGF Beta Signaling Pathway;Technology;Testing;Tissues;Transcript;Tumor Biology;Tumor stage;Ubiquitination;Universities;Virus Diseases;Work;Xenograft procedure;base;cancer cell;cancer health disparity;case control;chemotherapy;college;env Gene Products;epithelial to mesenchymal transition;gain of function;men;metastatic process;mortality;neoplastic cell;patient population;population based;protein complex;protein function;research study;response;tumor;tumor growth;tumor progression;yeast two hybrid system","The Molecular Profile of Prostate Tumors in African-American Men","n/a","NCI","8552753"," "," ","1ZIABC010624-09","1","ZIA","BC","010624","09"," "," "," "," "," "," ","9692197","AMBS, STEFAN ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","334423",
"Bioengineering; Cardiovascular; Diabetes; Heart Disease; Pediatric; Pediatric Research Initiative","Affect;BMP10 gene;Biological Assay;Biological Markers;Biological Models;Blood Glucose;Blood flow;Cardiac;Cardiac Myocytes;Cell Proliferation;Cell physiology;Cells;Cessation of life;Chick Embryo;Chickens;Child;Chronic;Clinical;Confocal Microscopy;Congenital Heart Defects;Data;Defect;Development;Developmental Delay Disorders;Diabetes Mellitus;Diffusion;E-Cadherin;Embryo;Embryonic Heart;Endothelial Cells;Functional disorder;Gel;Gene Expression;Gene Expression Alteration;Glucose;Heart;Heart Valves;Heat shock proteins;Human;Hyperglycemia;Image;Immunofluorescence Immunologic;Immunohistochemistry;In Vitro;Incidence;Lead;Measurement;Measures;Mechanics;Mesenchymal;Mesenchyme;Newborn Infant;Nitrates;Nitric Oxide;Optical Coherence Tomography;Oxidants;Oxidative Stress;Pattern;Peroxonitrite;Physiologic pulse;Physiological;Placenta;Population;Pregnancy;Process;Production;Proteins;Research;Risk;Role;Signal Pathway;Signal Transduction;Signaling Pathway Gene;Staging;Staining method;Stains;Structure;Superoxides;Teratogens;Testing;Time;Training;Tyrosine;Uric Acid;WNT3 gene;cardiogenesis;cell transformation;fetal;hemodynamics;in vivo;malformation;maternal diabetes;mathematical model;matrigel;mortality;nitration;prevent;protein expression;protein structure function;response;shear stress;stress protein;transdifferentiation","Effect of Hyperglycemia on Embryonic Heart Development"," The worldwide incidence of diabetes is rising worldwide, affecting 7% of pregnancies. Fluctuations in glucose affects cardiac development, specifically maternal diabetes is associated with a 3-5 fold increased risk for cardiac malformations. Research needs to be conducted on the effect of glucose on the development of cardiac malformations.   
      

","NHLBI","8397446","8/3/2012 12:00:00 AM","PA-11-113","1F32HL112546-01A1","1","F32","HL","112546","01","A","MEADOWS, TAWANNA","8/6/2012 12:00:00 AM","4/19/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-F06-T(20)L]"," ","10843769","SCOTT, DEVON ","Not Applicable","03","BIOMEDICAL ENGINEERING","096997515","NPSNT86JKN51","096997515","NPSNT86JKN51","US","45.499316","-122.688464","6297007","OREGON HEALTH & SCIENCE UNIVERSITY","PORTLAND","OR","SCHOOLS OF MEDICINE","972393098","UNITED STATES","N","8/6/2012 12:00:00 AM","4/19/2013 12:00:00 AM","837","Training, Individual","2012"," "," ","NHLBI","36744"," "," ","36744",
"Breast Cancer; Cancer; Estrogen","Affect;Alpha Cell;Animals;Biology;Blood Circulation;Blood Vessels;Bone Marrow;Bone Marrow Cells;Breast;Breast Carcinoma;Calmodulin;Cardiovascular system;Cell Differentiation process;Cells;Clinical;Collaborations;Constitution;Cyclosporine;Defect;Development;Disease;Distant;Endothelial Cells;Environmental Risk Factor;Epithelial Cells;Estrogen Antagonists;Estrogen Receptor alpha;Estrogen Receptors;Estrogen Therapy;Estrogens;Etiology;FK506;Foundations;Gene Expression Regulation;Germ Lines;Growth;Growth Factor;Hematopoietic stem cells;Home environment;Hypertension;Immune;Immune system;Immunosuppressive Agents;Inflammation;Inflammatory;Knock-out;Lymphangiogenesis;Lymphatic Endothelial Cells;Malignant Epithelial Cell;Malignant Neoplasms;Mediating;Mesenchymal;Modeling;Molecular;Mus;Myofibroblast;Neoplasm Metastasis;PECAM1 gene;PTPRC gene;Peripheral;Pharmaceutical Preparations;Physiological;Play;Process;Recruitment Activity;Regulation;Reporting;Role;Signal Pathway;Signal Transduction;Sirolimus;Site;Skeletal system;Smooth Muscle;Stem cells;Supporting Cell;System;Testing;Tube;Tumor Angiogenesis;Tumor Promotion;Work;Wound Healing;angiogenesis;cancer cell;cell type;hormone therapy;human FRAP1 protein;improved;in vivo;macrophage;malignant breast neoplasm;member;monocyte;novel;nuclear factors of activated T-cells;pre-clinical;receptor;repaired;reproductive;response;steroid hormone;transcription factor;tumor;tumor growth","Estrogen and Its Receptors in Angiogenesis","n/a","NCI","8378439","4/12/2012 12:00:00 AM"," ","5P01CA092644-09","5","P01","CA","092644","09"," "," ","6/13/2002 12:00:00 AM"," ","ZCA1-GRB-S","8207","7518381","KUPERWASSER, CHARLOTTE ","Not Applicable","07","Unavailable","071723621","C1CPANL3EWK4","071723621","C1CPANL3EWK4","US","42.346758","-71.10256","758101","BETH ISRAEL DEACONESS MEDICAL CENTER","BOSTON","MA","Independent Hospitals","022155400","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","379645","379645"," ","286065","93580"," "," ",
"Aging; Breast Cancer; Cancer; Prostate Cancer; Urologic Diseases","Adult;Adverse effects;Affect;African;African American;Area;Bone Density;Bone Resorption;Bone necrosis;Bone neoplasms;Breast Cancer Treatment;Cathepsin L;Cathepsins;Caucasians;Caucasoid Race;Cells;Cessation of life;Data;Development;Down-Regulation;E-Cadherin;Education;Epithelial;Extracellular Matrix Degradation;Felis catus;Fosamax;Hormones;Human;In Vitro;Incidence;Injury;Instruction;Jaw;Lead;Malignant neoplasm of prostate;Mediating;Mesenchymal;Metastatic Lesion;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Modeling;Neoplasm Metastasis;PC3 cell line;Pathway interactions;Patients;Process;Prostatic Neoplasms;Refractory;Role;Sampling;Services;Signal Pathway;Signal Transduction;Snails;TRANCE protein;Tumor Suppressor Proteins;Up-Regulation;Vimentin;Zoledronate;alternative treatment;anticancer research;bisphosphonate;bone;cancer cell;cell motility;hormone refractory prostate cancer;in vitro activity;in vivo;inhibitor/antagonist;malignant breast neoplasm;maspin;men;migration;osteoclastogenesis;overexpression;prevent;protein expression;receptor;transcription factor;tumor growth;tumor progression;vector","Snail Signalling in Human Prostate Cancer ","RELEVANCE (See instructions): These studies will show that Snail can regulate multiple processes (migration, bone resorption, matrix degradation, metastasis to bone) by regulating expression of proteins (cathepsin-S and L, maspin) it had not been previously associated with, especially in African American men who have a higher incidence and more aggressive prostate cancer.","NIMHD","8544046","9/26/2012 1:01:23 PM","RFA-MD-11-002","2P20MD002285-06","2","P20","MD","002285","06"," "," ","9/5/2012 12:00:00 AM","5/31/2017 12:00:00 AM","ZMD1-RN(04)","8568","8630420","ODERO-MARAH, VALERIE ","Not Applicable","05","Unavailable","065325177","JGA3E25MFDV9","065325177","JGA3E25MFDV9","US","33.748515","-84.412886","2189101","CLARK ATLANTA UNIVERSITY","ATLANTA","GA","Domestic Higher Education","303144358","UNITED STATES","N","9/5/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Research Centers","2012","169315","169315"," ","119106","50209"," "," ",
"Diabetes; Nutrition; Obesity; Patient Safety; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Acute;Address;Adipocytes;Adipose tissue;Adverse effects;Affect;Amitriptyline;Anti-Retroviral Agents;Antidepressive Agents;Antidiabetic Drugs;Antiepileptic Agents;Atazanavir;Awareness;Bone Marrow;Carbamazepine;Cardiovascular Diseases;Caring;Categories;Cell Culture Techniques;Cell Cycle Arrest;Cell Maturation;Cell Proliferation;Cell model;Cells;Cellular biology;Characteristics;Chemicals;Chronic;Clinical;Clozapine;Development;Diabetes Mellitus;Diet;Doxazosin;Drug Prescriptions;Educational process of instructing;Endothelial Cells;Enrollment;Event;Faculty;Fatty Acids;Fatty acid glycerol esters;Fibroblasts;Fostering;Foundations;Future;Gene Expression Profile;Gene Targeting;Genes;Glyburide;Glycerol;Goals;Health;Health Professional;Homeostasis;Human;Human Development;Hypertension;In Vitro;Individual;Institution;Intra-abdominal;Knowledge;Lead;Learning;Life;Life Style;Light;Link;Lipids;Lipolysis;Lopinavir;MAP Kinase Signaling Pathways;Measures;Medical;Mesenchymal Stem Cells;Mesylates;Metabolic;Microarray Analysis;Mind;Minority;Mitogen-Activated Protein Kinases;Molecular;Molecular Biology;Nonesterified Fatty Acids;Normal tissue morphology;Obesity;Osteocytes;Paroxetine;Patient Care;Patients;Pharmaceutical Preparations;Pharmacologic Substance;Physical activity;Pioglitazone;Play;Process;Productivity;Proliferating;Propranolol;Public Health;Publications;Regenerative Medicine;Regulation;Research;Risk;Risperidone;Role;Sertraline;Signal Transduction;Solutions;Stem Cell Research;Stem cells;Stimulus;Students;System;Testing;Thigh structure;Tissues;Toxic effect;Toxicity Tests;Triglycerides;United States;Valproic Acid;Visceral;Weight Gain;Work;adult stem cell;atypical antipsychotic;base;bone cell;career;cell type;drug market;drug testing;embryonic stem cell;energy balance;environmental chemical;experience;glucose uptake;improved;in vitro testing;interest;lipid biosynthesis;macrophage;molecular marker;novel;olanzapine;osteogenic;peripheral blood;prevent;prototype;public health relevance;response;safety testing;skills;stem cell biology;subcutaneous;treatment strategy","Adipogenic Toxicity Study of Obesogenic Drugs","
Proposal Narrative
This project is aimed to provide better understanding of the mechanisms underlying some common cases of
medication-induced weight gain as an undesired side effect. Findings from this proposed study will provide
useful information to the clinical and public health professionals for improved care of patients who rely on these
medications, enhance our understanding of the regulation of fat tissue homeostasis, and help establish in vitro
testing modules for predicting potential toxicity effect of a wide range of existing and future drugs as well as
environmental chemicals.","NIGMS","8274627","6/13/2012 12:00:00 AM","PAR-08-028","5SC3GM094078-03","5","SC3","GM","094078","03"," ","OKITA, RICHARD T","7/1/2010 12:00:00 AM","6/30/2014 12:00:00 AM","ZGM1-MBRS-X(GC)"," ","9789785","ZHAO, YUANXIANG ","Not Applicable","39","BIOLOGY","028929438","JMGMMM7BMBT6","028929438","JMGMMM7BMBT6","US","34.049753","-117.815696","513608","CALIFORNIA STATE POLY U POMONA","POMONA","CA","SCHOOLS OF ARTS AND SCIENCES","917682557","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","859","Other Research-Related","2012"," "," ","NIGMS","74250","31185"," ","105435",
"Asthma; Bioengineering; Lung","Acute;Acute Disease;Address;Adult Respiratory Distress Syndrome;Alveolar;Area;Asthma;Biochemical;Biological;Breathing;Cells;Chemicals;Chronic;Chronic Disease;Collagen;Collagen Fiber;Connective Tissue;Cornea;Development;Diagnosis;Diagnostic;Diffuse;Disease;Embryonic Development;Epithelial;Epithelium;Event;Extracellular Matrix;Fibrosis;Frequencies;Gel;Grant;Growth;Health;Human;Hyperplasia;In Vitro;Individual;Infection;Inflammation;Inflammatory;Inflammatory Response;Injury;Interleukin-13;Intubation;Lamina Propria;Laser Scanning Microscopy;Lead;Link;Lung;Mechanical Stress;Mechanics;Mediator of activation protein;Mesenchymal;Microscopic;Modeling;Mucous Membrane;Mucous body substance;Nature;Obstruction;Optical Coherence Tomography;Optics;Oryctolagus cuniculus;Peripheral;Pneumonia;Population;Property;Research Design;Research Methodology;Resolution;Respiratory physiology;Role;Severity of illness;Signal Pathway;Signal Transduction;Site;Skin;Smooth Muscle;Source;Staging;Structure;Structure of parenchyma of lung;Submucosa;Symptoms;Techniques;Tensile Strength;Testing;Time;Tissue Engineering;Tissues;Toxic Environmental Substances;Transforming Growth Factors;United States;Vascular System;Wound Healing;airway epithelium;airway remodeling;bronchial epithelium;crosslink;drug discovery;improved;in vivo;in vivo Model;injured airway;insight;minimally invasive;muscle form;novel;outcome forecast;protein expression;repaired;response","Linking Biological, Optical, and Mechanical Properties in the Airway Mucosa","
PROJECT NARRATIVE
 Airway injury, manifested primarily by asthma, is one of the most prevalent chronic diseases in the United
States. Diagnosis and management remain challenging due to the chronic repetitive nature of the disease that
leads to tissue remodeling. The proposal seeks to understand the link between the biological mechanisms that
trigger changes in the mechanical and optical properties in the airway mucosa. The results should provide a
platform for drug discovery and non-invasive diagnostics.","NHLBI","8300868","6/4/2012 12:00:00 AM","PA-07-070","5R01HL067954-09","5","R01","HL","067954","09"," ","NOEL, PATRICIA","8/1/2003 12:00:00 AM","7/31/2014 12:00:00 AM","Lung Cellular, Molecular, and Immunobiology Study Section[LCMI]"," ","1912012","GEORGE, STEVEN CARL","Not Applicable","45","BIOMEDICAL ENGINEERING","046705849","MJC5FCYQTPE6","046705849","MJC5FCYQTPE6","US","33.678042","-117.773718","577504","UNIVERSITY OF CALIFORNIA-IRVINE","IRVINE","CA","BIOMED ENGR/COL ENGR/ENGR STA","926970001","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","301243","142533"," ","443776",
"Hematology","Address;Antibodies;Apoptosis;B Cell Proliferation;B lymphoid malignancy;B-Cell Development;B-Lymphocyte Subsets;B-Lymphocytes;Basic Science;Bone Marrow;CSF3 gene;CXCL12 gene;Cell Count;Cell Lineage;Cell surface;Cells;Chimera organism;Clinical;Data;Development;Ectopic Expression;Employee Strikes;Endothelial Cells;Event;Flow Cytometry;Granulocyte Colony-Stimulating Factor;Granulocyte Colony-Stimulating Factor Receptors;Granulopoiesis;Hematopoietic;Immune system;Immunohistochemistry;Infection;Lentivirus Vector;Limb structure;Lymphopoiesis;Mature B-Lymphocyte;Mediating;Mesenchymal;Mus;Osteoblasts;Osteocalcin;Pharmaceutical Preparations;Play;Population;Production;Public Health;Research;Role;Signal Transduction;Signaling Molecule;Spleen;Staging;Staining method;Stains;Stromal Cell-Derived Factor 1;Stromal Cells;Testing;Tissues;Transgenic Mice;Transplantation;annexin A5;base;caspase-3;cell type;chemotherapy;cytokine;insight;leukemia;neutrophil;peripheral blood;progenitor;response","The effect of niche-specific cxcl12 production on B lymphopoiesis."," This project will benefit public health by providing insight into the development of the immune system, specifically how antibody-producing B cells develop. The project will explore how the drug granulocyte colony- stimulating factor and the signaling molecule CXCL12 regulate B cell production and number. This understanding may be useful in treating people who have leukemia derived from B cells.   
   
   
   
   
   
   
   
   
      

","NHLBI","8256110","4/1/2012 12:00:00 AM","PA-11-125","1F30HL112552-01","1","F30","HL","112552","01"," ","CHANG, HENRY","4/1/2012 12:00:00 AM","3/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-F10A-S(20)L]"," ","9194074","DAY, RYAN BRENT","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","837","Training, Individual","2012"," "," ","NHLBI","28465"," "," ","28465",
"No NIH Category available","Algorithms;Apoptosis;Area;Behavior;Biochemical;Biochemistry;Biological;Biological Assay;Cell Cycle;Cell Line;Cell Survival;Cell physiology;Cells;Chemistry;Clinical;Collection;Communities;Complex;Data;Data Analyses;Data Collection;Data Provenance;Data Quality;Data Set;Disease;Dose;Drug resistance;Epithelial;Experimental Designs;Extensible Markup Language;Flow Cytometry;Genome;Genomics;Genotype;Goals;Growth Factor;Human;Image Cytometry;Immunoassay;Informatics;Institution;Investigational Drugs;Kinetics;Knowledge;Libraries;Life;Ligands;Link;Logic;Malignant Neoplasms;Maps;Measures;Mesenchymal;Methodology;Methods;Modeling;Molecular Profiling;Normal Cell;Output;Pathway interactions;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;Phase;Phenotype;Phosphotransferases;Physiology;Process;Production;Proteins;Reporting;Resistance;Resolution;Running;Sampling;Series;Signal Pathway;Signal Transduction;Signaling Protein;Software Tools;Specificity;Stem cells;Structure;System;Techniques;Therapeutic;Time;Tumor Cell Line;base;cancer cell;cellular imaging;computer based Semantic Analysis;cytokine;drug mechanism;flexibility;heuristics;information processing;inhibitor/antagonist;insight;interest;kinase inhibitor;large scale production;large-scale database;malignant breast neoplasm;mathematical model;medical schools;meetings;movie;neoplastic cell;novel;open source;programs;public health relevance;response;senescence;small molecule;small molecule libraries;tool","Pharmaco Response Signatures and Disease Mechanism","PUBLIC HEALTH RELEVANCE: Plans for an HMS-based LINCS Center are directly relevant to programmatic goals of assembling ""mechanism-based associations among the effects of disparate biological perturbations"" and insight into the ""mechanisms of action of known drugs."" Single -cell and biochemical data generated by the HMS LINCS Center will be different from and complementary to existing large scale data based on genomic assays and transcriptional profiles. The Center's focus on clinical-grade and novel kinase inhibitors will provide data with high translational potential for a class of compounds that currently dominates investigational new drugs for cancer.","NHGRI","8332363","8/1/2012 12:00:00 AM","RFA-RM-10-003","5U54HG006097-03","5","U54","HG","006097","03"," ","PILLAI, AJAY","9/27/2010 12:00:00 AM","7/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-CB-P(52)R]"," ","1883114","SORGER, PETER KARL","MITCHISON, TIMOTHY J","07","ANATOMY/CELL BIOLOGY","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","SCHOOLS OF MEDICINE","021201616","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","310","Research Centers","2012"," "," ","OD","1831447","675571"," ","2507018",
"Bioengineering; Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human; Transplantation","3-Dimensional;Address;Adult;Angiography;Arteries;Biological Assay;Biology;Blood Circulation;Blood Vessels;Blood flow;Cardiac;Cardiac Myocytes;Cardiovascular system;Cells;Collaborations;Complement;Coronary;Coronary Circulation;Coronary artery;Development;Dichloromethylene Diphosphonate;Drug Formulations;Embryo;Endothelial Cells;Endothelium;Engraftment;Erinaceidae;Event;Fibroblasts;Goals;Growth;Heart;Heart Transplantation;Histology;Human;Infarction;Injury;Laboratories;Limb structure;Maintenance;Mesenchymal;Mesoderm;Microcirculation;Modeling;Molecular;Morphogenesis;Mus;Muscle;Muscle Cells;Myocardial;Myocardial Infarction;Myocardial tissue;Myocardium;Natural regeneration;Nude Rats;Pathway interactions;Perfusion;Peripheral;Play;Production;Resolution;Role;Screening procedure;Smooth Muscle;Smooth Muscle Myocytes;Source;Stem cells;Techniques;Testing;Time;Tissue Engineering;Tissues;Transplantation;Trees;Ultrasonography;Universities;Vascular Endothelial Growth Factor Receptor;Vascular Endothelial Growth Factor Receptor-2;Vascular blood supply;Vascularization;Work;arterial remodeling;cardiac repair;cell type;clinically relevant;cytochemistry;graft function;human embryonic stem cell;human stem cells;improved;macrophage;monocyte;novel;progenitor;repaired;research study;smoothened signaling pathway;stem","Vascularization and Growth of Human Myocardial Grafts","Stem cells offer the promise of remuscularizing the heart after injury. To date, however, stem cell-derived 
grafts are only a small fraction of the tissue originally lost. We propose that cardiac regeneration also requires 
growth of a new vascular supply. This project investigates the mechanisms through which muscle 
grafts become vascularized in the heart and uses stem cell and molecular approaches to enhance 
rpvaRriilariyatinn anri rpmiisriilariyatinn","NHLBI","8380419","6/8/2012 12:00:00 AM"," ","5P01HL094374-03","5","P01","HL","094374","03"," "," "," "," ","Heart, Lung, and Blood Program Project Study Section[HLBP]","8556","1876686","MURRY, CHARLES E","Not Applicable","07","Unavailable","605799469","HD1WMN6945W6","605799469","HD1WMN6945W6","US","47.660049","-122.31441","9087701","UNIVERSITY OF WASHINGTON","SEATTLE","WA","Domestic Higher Education","981951016","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","664941","664941"," ","400567","264374"," "," ",
"Autoimmune Disease; Biotechnology; Lung; Lupus","Address;Amphibole Asbestos;Amphiboles;Animals;Antibodies;Asbestos;Autoantibodies;Autoimmune Process;Autoimmune Responses;Autoimmunity;Binding;Biological Assay;Breathing;CCAAT-Enhancer-Binding Proteins;Cell Surface Receptors;Cessation of life;Chronic;Collagen;Complement;Complex;Country;Data;Deposition;Disease;Environmental and Occupational Exposure;Epithelial;Epithelial Cells;Etiology;Exposure to;Fibroblasts;Fibrosis;Future;Greater sac of peritoneum;Human;Immune system;Immunohistochemistry;Immunoprecipitation;Intervention;Knowledge;Laboratories;Lead;Learning;Life;Link;Lung;Lung diseases;Lupus;MADH2 gene;Mediating;Mesenchymal;Mesothelial Cell;Mesothelium;Modeling;Mus;Myofibroblast;Pathogenesis;Pathogenicity;Pathway interactions;Patients;Peritoneum;Phenotype;Platelet-Derived Growth Factor;Platelet-Derived Growth Factor Receptor;Play;Pleural;Pleural Diseases;Pleural cavity;Population;Preventive;Process;Production;Proteins;Proteomics;Pulmonary Fibrosis;Pulmonary Pathology;Reporting;Review Literature;Rheumatoid Arthritis;Risk;Role;STAT1 gene;Serum;Severities;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Smooth Muscle Actin Staining Method;Structure of parenchyma of lung;Surface;Systemic Lupus Erythematosus;Systemic Scleroderma;Testing;Therapeutic;Tissues;Toxicology;Up-Regulation;Western Blotting;cell type;cytotoxicity;human study;in vivo;inhibitor/antagonist;interstitial;mouse model;novel;receptor;systemic autoimmune disease;therapeutic development;transcription factor","Identification of Functional Targets for Asbestos Induced Autoantibodies"," This study, performed in mice, parallels a human study for translational purposes, meaning that what is learned from this study will have direct relevance to our understanding of how autoantibodies to mesothelial cells or fibroblasts can cause damage to lung tissues, and exacerbate the progression of asbestos-induced lung disease. Our ability to understand this process will guide therapeutic and preventive approaches in the future for the relentlessly progressive fibrosis that ultimately leads to death following asbestos exposure.   
      

","NIEHS","8367372","8/13/2012 12:00:00 AM","PA-10-070","1R15ES021884-01","1","R15","ES","021884","01"," ","HUMBLE, MICHAEL C","8/13/2012 12:00:00 AM","7/31/2016 12:00:00 AM","Electrical Signaling, Ion Transport, and Arrhythmias Study Section[ESTA]"," ","6770990","PFAU, JEAN COOPER","Not Applicable","02","BIOLOGY","078341468","JJC9GJJJL4M7","078341468","JJC9GJJJL4M7","US","42.86225","-112.433386","3541601","IDAHO STATE UNIVERSITY","POCATELLO","ID","SCHOOLS OF ARTS AND SCIENCES","832098046","UNITED STATES","N","8/13/2012 12:00:00 AM","7/31/2016 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","NIEHS","300000","66266"," ","366266",
"Cancer; Genetics","Algorithms;Apoptosis;Area;Behavior;Biochemical;Biochemistry;Biological;Biological Assay;Cell Cycle;Cell Line;Cell Survival;Cell physiology;Cells;Chemistry;Clinical;Collection;Communities;Complex;Data;Data Analyses;Data Collection;Data Provenance;Data Quality;Data Set;Disease;Dose;Drug resistance;Epithelial;Experimental Designs;Extensible Markup Language;Flow Cytometry;Genome;Genomics;Genotype;Goals;Growth Factor;Human;Image Cytometry;Immunoassay;Informatics;Institution;Investigational Drugs;Kinetics;Knowledge;Libraries;Life;Ligands;Link;Logic;Malignant Neoplasms;Maps;Measures;Mesenchymal;Methodology;Methods;Modeling;Molecular Profiling;Normal Cell;Output;Pathway interactions;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;Phase;Phenotype;Phosphotransferases;Physiology;Process;Production;Proteins;Reporting;Resistance;Resolution;Running;Sampling;Series;Signal Pathway;Signal Transduction;Signaling Protein;Software Tools;Specificity;Stem cells;Structure;System;Techniques;Therapeutic;Time;Tumor Cell Line;base;cancer cell;cellular imaging;computer based Semantic Analysis;cytokine;drug mechanism;flexibility;heuristics;information processing;inhibitor/antagonist;insight;interest;kinase inhibitor;large scale production;large-scale database;malignant breast neoplasm;mathematical model;medical schools;meetings;movie;neoplastic cell;novel;open source;programs;public health relevance;response;senescence;small molecule;small molecule libraries;tool","Pharmaco Response Signatures and Disease Mechanism","PUBLIC HEALTH RELEVANCE: Plans for an HMS-based LINCS Center are directly relevant to programmatic goals of assembling ""mechanism-based associations among the effects of disparate biological perturbations"" and insight into the ""mechanisms of action of known drugs."" Single -cell and biochemical data generated by the HMS LINCS Center will be different from and complementary to existing large scale data based on genomic assays and transcriptional profiles. The Center's focus on clinical-grade and novel kinase inhibitors will provide data with high translational potential for a class of compounds that currently dominates investigational new drugs for cancer.","NHGRI","8522364","9/19/2012 12:00:00 AM","RFA-RM-10-003","3U54HG006097-03S1","3","U54","HG","006097","03","S","PILLAI, AJAY","9/27/2010 12:00:00 AM","7/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-CB-P(52)R]"," ","1883114","SORGER, PETER KARL","MITCHISON, TIMOTHY J","07","ANATOMY/CELL BIOLOGY","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","SCHOOLS OF MEDICINE","021201616","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","310","Research Centers","2012"," "," ","OD","106509","73491"," ","180000",
"Genetics; Pediatric; Urologic Diseases","Address;Affect;Behavior;Biological;Birth;Cell Differentiation process;Cell Line;Cell physiology;Cells;Clinical;Congenital Abnormality;Data;Defect;Development;Distal;Embryo;Enzymes;Epithelial;Epithelium;Equilibrium;Etiology;Exhibits;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Genes;Genital system;Genitalia;Glans of clitoris;Glans penis;Goals;Hypersensitivity;Hypospadias;Image;Kidney;Knock-out;Knowledge;Lead;Life;Limb structure;Lung;MAP Kinase Gene;Measures;Mediating;Mesenchymal;Modeling;Molecular;Monitor;Morphogenesis;Mus;Mutant Strains Mice;Operative Surgical Procedures;Organ;Organogenesis;PI3K/AKT;Pathway interactions;Patients;Pattern;Phenotype;Play;Prenatal Diagnosis;Prevention;Process;Protein Tyrosine Kinase;Receptor Protein-Tyrosine Kinases;Regulation;Retinoic Acid Receptor;Role;Side;Signal Transduction;Signaling Molecule;Supplementation;Testing;Tooth structure;Tretinoin;Tube;Tubular formation;Urethra;appendage;base;constriction;external genitalia;improved;inhibitor/antagonist;innovation;insight;loss of function mutation;male;malformation;morphogens;mutant;reconstruction;research study;transcription factor","The role of Sprouty genes in development of mammalian external genitalia"," Hypospadias is one of the most common birth defects, affecting approximately 1 in every 250-300 live male births. This condition, whose molecular etiology is poorly understood, can result in severe psycho-sexual problems and voiding abnormalities in spite of the best efforts at surgical reconstruction. Thus, knowledge about the molecular pathways controlling genital development is of major clinical importance, and the experiments in this R01 application will enhance our knowledge of these pathways.   
   
      

","NIDDK","8445140","9/17/2012 12:00:00 AM","PA-11-085","1R01DK095002-01A1","1","R01","DK","095002","01","A","HOSHIZAKI, DEBORAH K","9/18/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-KMBD-C(02)S]"," ","1868802","KLEIN, OPHIR D","Not Applicable","12","DENTISTRY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","941432510","UNITED STATES","N","9/18/2012 12:00:00 AM","8/31/2014 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","95796","54204"," ","150000",
"Bioengineering; Cancer; Colo-Rectal Cancer; Digestive Diseases; Genetics","Animal Model;Architecture;Behavior;Biochemical;Blood Vessels;Breast Cancer Cell;Cancer cell line;Cell Adhesion;Cells;Chemicals;Cholesterol;Colon Carcinoma;Disease;Epithelial;Epithelial Cells;Epithelium;Gene Activation;Gene Expression;Genes;Genetic;Genetic Polymorphism;Genetic Screening;Goals;Hereditary Nonpolyposis Colorectal Neoplasms;Heterozygote;Human;In Vitro;Induced Mutation;Injury;Intestinal Cancer;Intestines;Laboratories;Larva;Link;Lipids;MYH11 gene;Malignant Neoplasms;Mechanics;Mediating;Membrane;Mesenchymal;Metalloproteases;Modeling;Molecular;Muscle Contraction;Mutagenesis;Mutation;Myosin ATPase;Myosin Heavy Chains;Neoplasm Metastasis;Organ;Oxidation-Reduction;Oxidative Stress;Pathway interactions;Patients;Peptide Hydrolases;Pharmaceutical Preparations;Phenotype;Play;Population;Production;Reactive Oxygen Species;Reporting;Role;Screening procedure;Signal Pathway;Signal Transduction;Site;Smooth Muscle;Smooth Muscle Myosins;Source;System;Tissues;Vascular remodeling;Work;Wound Healing;Zebrafish;cancer cell;cell behavior;cell motility;cell stroma;feeding;gene synthesis;in vitro Model;in vivo;intestinal epithelium;mutant;novel;regenerative;repaired;research study;response;tissue regeneration","Redox sensitive factors that regulate tissue architecture in the intestine"," The goal of this project is to understand the basic mechanisms that control tissue architecture and tissue regeneration in the intestine.  This has direct relevance for how the intestine repairs itself following injury and how intestinal cancers metastasize.        
      

","NIDDK","8547262","9/21/2012 12:00:00 AM","PA-11-260","2R56DK054942-10","2","R56","DK","054942","10"," ","CARRINGTON, JILL L","8/1/1999 12:00:00 AM","8/31/2014 12:00:00 AM","Clinical, Integrative and Molecular Gastroenterology Study Section[CIMG]"," ","1936401","PACK, MICHAEL A","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","9/25/2012 12:00:00 AM","8/31/2014 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","212500","127500"," ","340000",
"Brain Cancer; Brain Disorders; Cancer; Clinical Research; Genetics; Neurosciences; Rare Diseases","Affect;Apoptosis;Apoptotic;BCL2 gene;Brain Neoplasms;Cell Proliferation;Cell physiology;Cells;Data;Development;Disease;Event;Evolution;Family member;Gene Expression;Genes;Genetic;Glioma;Gliomagenesis;Human;Human Characteristics;Immunocompetent;Immunodeficient Mouse;Immunosuppression;Immunosuppressive Agents;Maintenance;Malignant - descriptor;Malignant Glioma;Malignant Neoplasms;Malignant neoplasm of brain;Mediating;Mesenchymal;Methods;Modeling;Molecular Abnormality;Mus;Necrosis;Normal Cell;Pathway interactions;Phenotype;Platelet-Derived Growth Factor;Play;Pre-Clinical Model;Primary Brain Neoplasms;Research;Research Proposals;Role;STAT family gene;STAT protein;STAT3 gene;Signal Pathway;Signal Transduction;Somatic Cell;Staging;Stat3 protein;Survival Rate;System;Testing;Therapeutic;Therapeutic Effect;Time;Tumor Promotion;Variant;Xenograft Model;anticancer research;cancer cell;carcinogenesis;cell growth;effective therapy;gene function;human disease;implantation;in vivo;macrophage;malignant phenotype;mouse model;neoplastic cell;novel therapeutics;overexpression;prevent;programs;reconstitution;therapeutic target;tumor;tumor growth;tumor initiation;tumor progression","Modeling Apoptotic Suppression in a Mouse Model of Brain Tumors"," Understanding the relevant genetic aberrations that contribute to brain cancer is critical for developing new therapies for this deadly disease. The signal transducers and activators of transcription (STAT) pathway is a regulator of multiple cellular processes critical to brain tumor formation. We will study the effect of STAT signaling on brain tumor initiation and progression and test novel therapeutics against this pathway with a unique mouse model that recapitulates critical features of the human disease.  
    

","NINDS","8290475","7/25/2012 12:00:00 AM","PA-10-059","5K08NS070928-02","5","K08","NS","070928","02"," ","FOUNTAIN, JANE W","7/1/2011 12:00:00 AM","6/30/2016 12:00:00 AM","NST-1 Study Section[NST-1]"," ","9896741","RAO, GANESH ","Not Applicable","09","NEUROSURGERY","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","853","Other Research-Related","2012"," "," ","NINDS","171625","13730"," ","185355",
"Genetics; Lung; Smoking and Health; Tobacco","Address;Alveolar;Amino Acids;Apoptosis;Area;Bleomycin;C-terminal;Cell Survival;Cells;Cessation of life;Collagen;Data;Disease;Distal;Dose;Drosophila pros protein;Endoplasmic Reticulum;Epithelial;Epithelial Cells;Epithelium;Exons;Exposure to;Fibroblasts;Fibrosis;Funding;Gases;Genes;Genetic;Glutamine;Hamman-Rich syndrome;Herpesviridae;Herpesviridae Infections;Human;Hyperplasia;In Vitro;Infection;Intervention;Lead;Leucine;Lung;Lung diseases;Mediating;Mesenchymal;Mitogen-Activated Protein Kinase 3;Modeling;Mus;Mutation;Particulate;Pathogenesis;Pathway interactions;Patients;Phenotype;Population;Positioning Attribute;Predisposition;Process;Protein Precursors;Proteins;Pulmonary Surfactant-Associated Protein C;Reducing Agents;Respiratory Failure;Respiratory physiology;Role;Severities;Signal Pathway;Signal Transduction;Stimulus;Structure;Structure of parenchyma of lung;Testing;Therapeutic;Time;Tobacco smoke;Transgenes;Transgenic Mice;Tunicamycin;Viral;Wild Type Mouse;Work;base;biological adaptation to stress;cell injury;cigarette smoking;endoplasmic reticulum stress;environmental agent;fibrogenesis;gammaherpesvirus;improved;lung development;mouse model;mutant;novel strategies;novel therapeutic intervention;protein folding","Epithelial-Fibroblast Interactions in Lung Fibrosis"," Progressive fibrotic lung diseases frequently lead to respiratory failure and death. Studies in this proposal are based on the idea that altered protein processing in the endoplasmic reticulum produces a vulnerable state in the lungs that predisposes to fibrotic remodeling following exposure to noxious environmental stimuli. These studies will provide a better understanding of the basic mechanisms of disease pathogenesis and suggest new treatment approaches for progressive lung fibrosis.   
   
      

","NHLBI","8294163","4/4/2012 12:00:00 AM","PA-10-067","2R01HL085317-06","2","R01","HL","085317","06"," ","EU, JERRY PC","4/10/2007 12:00:00 AM","2/28/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-CVRS-G(02)M]"," ","1916876","BLACKWELL, TIMOTHY S.","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","4/4/2012 12:00:00 AM","2/28/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","252579","141444"," ","394023",
"Breast Cancer; Cancer; Clinical Research","Acetylation;Actins;Affect;Animals;Antineoplastic Agents;Binding;Binding Proteins;Bioluminescence;Blood Vessels;Blood capillaries;Cancer Patient;Carboxypeptidase;Carcinoma;Cell Adhesion;Cell division;Cells;Chemicals;Confocal Microscopy;Cultured Cells;Cultured Tumor Cells;Cytoskeleton;Distant;Electron Microscopy;Endothelial Cells;Endothelium;Epithelial Cells;Extracellular Matrix;FDA approved;Future;Generations;Goals;Human;Image;Immunomagnetic Separation;Incidence;Invaded;Knowledge;Lead;Left;Life;Lung;Malignant Epithelial Cell;Mammary Neoplasms;Mammary gland;Measures;Microtubule Stabilization;Microtubules;Modification;Molecular;Molecular Structure;Molecular Target;Mus;Mutation;Neoadjuvant Therapy;Neoplasm Metastasis;Operative Surgical Procedures;Paclitaxel;Patients;Pharmaceutical Preparations;Psychological reinforcement;Publishing;Regulation;Research;Retinal blind spot;Risk;Role;Site;Solid Neoplasm;Speed;Structure;Surface;Testing;Tissues;Transplantation;Treatment Efficacy;Tubulin;Tumor Cell Line;Vimentin;Work;anticancer research;base;cancer imaging;capillary;cell growth;cell motility;chemotherapy;drug development;efficacy testing;epithelial to mesenchymal transition;extracellular;improved;malignant breast neoplasm;mouse model;neoplastic cell;new therapeutic target;pressure;response;restraint;success;tau Proteins;tau expression;therapeutic development;therapeutic target;tumor;tyrosyltubulin ligase","Targeting microtubule stabilization to reduce breast tumor metastasis"," This project focuses on how circulating tumor cells produce unique extensions of their surface, known as microtentacles, that were discovered in the PI's lab. These microtentacles improve the ability of circulating tumor cells to reattach in distant tissues. Microtentacles can actually be increased by cancer drugs that are aimed at cell division, so it will be important to better understand the cytoskeleton of circulating tumor cells so  that metastasis is not accidentally increased by current chemotherapies.   
      

","NCI","8372508","9/6/2012 12:00:00 AM","PA-11-260","1R01CA154624-01A1","1","R01","CA","154624","01","A","JHAPPAN, CHAMELLI","9/6/2012 12:00:00 AM","6/30/2017 12:00:00 AM","Basic Mechanisms  of Cancer Therapeutics Study Section[BMCT]"," ","6948120","MARTIN, STUART S","Not Applicable","07","PHYSIOLOGY","188435911","Z9CRZKD42ZT1","188435911","Z9CRZKD42ZT1","US","39.291412","-76.624753","820104","UNIVERSITY OF MARYLAND BALTIMORE","BALTIMORE","MD","SCHOOLS OF MEDICINE","212011508","UNITED STATES","N","9/6/2012 12:00:00 AM","6/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","111013"," ","318513",
"Clinical Research; Digestive Diseases; Infant Mortality/ (LBW); Lung; Pediatric; Perinatal Period - Conditions Originating in Perinatal Period; Rare Diseases","Abdomen;Address;Advisory Committees;Affect;Area;Arteries;Award;Back;Basic Science;Biology;Blood Vessels;Blood flow;Cells;Chest;Childhood;Clinical;Complex;Congenital Abnormality;Congenital diaphragmatic hernia;Data;Defect;Dependence;Development;Development Plans;Developmental Biology;Distal;Embryo;Environment;Epithelial;Exhibits;Extracellular Matrix;Faculty;Fetal Development;Generations;Gestational Age;Goals;Infant;Infant Mortality;Injection of therapeutic agent;Institution;K-Series Research Career Programs;Knowledge;Lead;Life;Long-Term Survivors;Lung;Measures;Mentors;Mesenchymal;Mesenchyme;Modeling;Molecular;Molecular Genetics;Morbidity - disease rate;Morphogenesis;Mus;Organogenesis;Oxygen measurement, partial pressure, arterial;Patients;Pattern;Pediatric Surgical Procedures;Perfusion;Pericytes;Platelet-Derived Growth Factor;Play;Process;Pulmonary Hypertension;Recruitment Activity;Research;Research Personnel;Respiratory Diaphragm;Respiratory distress;Respiratory physiology;Role;Secondary to;Signal Pathway;Signal Transduction;Smooth Muscle Myocytes;Structure;Surgeon;Survivors;Techniques;Time;Translating;Trees;Tube;Ultrasonography;Viscera;Work;airway epithelium;angiogenesis;career development;design;effective therapy;experience;in utero;in vivo;lung development;meetings;mortality;neonate;nitrofen;novel;postnatal;precursor cell;prenatal;progenitor;research study;symposium;tissue oxygenation;vasculogenesis","Pulmonary Blood Flow in Lung Development and Congenital Diaphragmatic Hernia"," CDH is associated with significant infant mortality and morbidity in long-term survivors. A greater understanding of the developmental mechanisms responsible for the lung defects in CDH could lead to more effective treatment options for CDH involving directed therapies, both prenatal and postnatal, toward specific mechanisms involved in airway branching and pulmonary vascular function. Also, a greater understanding of the role of early embryonic pulmonary blood flow on normal lung development may lead to a greater understanding of other lung developmental defects.  
    

","NICHD","8327856","6/7/2012 12:00:00 AM","PA-10-059","5K08HD061599-02","5","K08","HD","061599","02"," ","RAJU, TONSE N","9/10/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Pediatrics Study Section[CHHD-A]"," ","6438987","POTOKA, DOUGLAS A","Not Applicable","18","SURGERY","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","865","Other Research-Related","2012"," "," ","NICHD","116425","9074"," ","125499",
"Cancer","Address;Behavior;Binding;Binding Proteins;Binding Sites;Biochemical;Biological;Biological Assay;Biological Models;Cell Extracts;Cell Surface Receptors;Cells;Co-Immunoprecipitations;Color;Complex;Computer Simulation;Coupled;Coupling;Databases;Development;Dissociation;EGF gene;Environment;Epidermal Growth Factor Receptor;Epithelial Cells;Equation;Event;Fibroblasts;Goals;Heregulin;Human;Image;In Situ;Individual;Instruction;Knowledge;Life;Ligation;Link;Malignant Neoplasms;Maps;Mass Spectrum Analysis;Medicine;Mesenchymal;Methods;Modeling;Molecular;Monitor;Mutation;Neuronal Differentiation;Oncogenic;Outcome;Output;PC12 Cells;PDGFRB gene;PTB Domain;Pathway interactions;Patients;Pharmaceutical Preparations;Phosphopeptides;Phosphotyrosine;Play;Process;Protein Tyrosine Kinase;Proteins;Receptor Cell;Receptor Protein-Tyrosine Kinases;Receptor Signaling;Recruitment Activity;Role;Signal Transduction;Site;System;Technology;Therapeutic Intervention;Time;Tyrosine;Tyrosine Phosphorylation;Validation;base;cancer therapy;cell motility;cell type;data integration;design;human disease;imaging modality;in vivo;information processing;innovation;insight;receptor;response;single molecule;src Homology Region 2 Domain;transmission process","Dynamics and Topology of Phosphotyrosine-SH2 Interaction Networks","n/a","NCI","8294600","7/10/2012 12:00:00 AM","PAR-09-026","5U01CA154966-02","5","U01","CA","154966","02"," ","LI, JERRY","7/1/2011 12:00:00 AM","6/30/2016 12:00:00 AM","ZCA1-SRLB-1(M1)"," ","1858382","MAYER, BRUCE J.","WHITE, FOREST M","05","GENETICS","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF MEDICINE","060305335","UNITED STATES","N","7/10/2012 12:00:00 AM","6/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","385255","129665"," ","494719",
"Cardiovascular; Heart Disease; Heart Disease - Coronary Heart Disease","Address;Adhesions;Affect;Animal Model;Apical;Apical Myocardial Infarction;Area;Biomechanics;Blood;Cells;Cellular biology;Characteristics;Clinical;Clinical Research;Collagen;Complication;Cutaneous;Deposition;Developmental Process;Differentiation and Growth;Disease;Distal;Endothelial Cells;Endothelium;Event;Extracellular Matrix;Fibrosis;Financial compensation;Functional Imaging;Growth;Heart;Heart failure;Histopathology;In Vitro;Inferior Myocardial Infarction;Infiltration;Kidney;Left;Left Ventricular Remodeling;Losartan;Lung;Mechanics;Mediating;Mesenchymal;Mitral Valve;Mitral Valve Insufficiency;Modeling;Molecular;Myocardial Infarction;Myocardial Ischemia;Myofibroblast;Organ;PTPRC gene;Pathway interactions;Patients;Process;Research Personnel;Sclerosis;Sheep;Signal Transduction;Smooth Muscle Actin Staining Method;Staging;Stretching;Study models;Surface;Testing;Therapeutic;Thick;Time;Traction;Transforming Growth Factors;Translating;Vascular Cell Adhesion Molecule-1;Ventricular;Wound Healing;base;cytokine;flexibility;improved;in vitro testing;in vivo;inhibitor/antagonist;interstitial cell;mortality;neovascularization;papillary muscle;peripheral blood;physiologic model;prevent;repaired;seal","Improving Mitral Compensation in Ischemic Regurgitation"," Mitral regurgitation (MR) is a frequent, difficult to repair complication of myocardial infarction (MI) that doubles heart failure and mortality; it is caused b tethering (stretch) of the mitral valve by damaged and bulging heart walls that prevents valve closure, and is compounded by late valve stiffening. Until recently, mitral valve size has been viewed as fixed in this setting, but valve growth in adaptation to tethering could reduce this regurgitation if valve flexibility can be maintained. In this project, an interdisciplinary team wil use a new model to fill this unmet clinical need in a common disease by increasing our understanding of how adaptive valve processes can become maladaptive, and will begin to test new therapies to reduce this complication that, if corroborated, can be rapidly translated to benefit patients.   
   
      

","NHLBI","8296872","5/6/2012 12:00:00 AM","PA-10-067","1R01HL109506-01A1","1","R01","HL","109506","01","A","DESVIGNE-NICKENS, PATRICE","5/15/2012 12:00:00 AM","4/30/2016 12:00:00 AM","Clinical and Integrative Cardiovascular Sciences Study Section[CICS]"," ","1880235","LEVINE, ROBERT A","AIKAWA, ELENA ; BISCHOFF, JOYCE E.","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","5/15/2012 12:00:00 AM","4/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","665770","239910"," ","905680",
"Cancer; Clinical Research","Acute;Angiogenesis Inducing Agents;Angiogenic Factor;Angiogenic Switch;Biochemical;Blood Vessels;Bone Marrow;Bone Marrow Cells;Cells;Cessation of life;Chick Embryo;Chickens;Chronic;Endothelial Cells;Enzyme Precursors;Enzymes;Event;Gelatinase B;Goals;Human;Image;Infection;Inflammation;Inflammatory;Injury;Kinetics;Laboratories;Light;Link;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Mesenchymal;Modeling;Monitor;Mus;Myeloid Cells;Nature;Neoplasm Metastasis;Neutrophil Infiltration;Nutrient;Organ;Pathologic Neovascularization;Physiologic Neovascularization;Plasmin;Plasminogen;Population;Primary Neoplasm;Process;Production;Prostate Adenocarcinoma;Prostate carcinoma;Proteomics;Reagent;Research;Role;Route;Serine Protease;Site;Squamous cell carcinoma;Staging;Stromal Cells;Stromal Neoplasm;Testing;Time;Tissues;Transgenic Model;Transgenic Organisms;Transplantation;Tumor Angiogenesis;Tumor Tissue;Variant;angiogenesis;cell type;comparative;congenic;cytokine;feeding;fibrosarcoma;granulocyte;human disease;in vivo;in vivo Model;knock-down;macrophage;monocyte;neoplastic cell;neovascular;neutrophil;research study;response;tumor;tumor growth;tumor progression","Role of Inflammatory Neutrophils and their Unique MMP-9 in Tumor Progression","  Deaths from cancer occur mainly because tumor cells spread from the primary tumor site to other vital organs and tissues through the new angiogenic vasculature of the primary tumor. One of the non-tumor cell types of the host that can actively contribute to the induction of new angiogenic blood vessels feeding the tumor is the inflammatory neutrophil, which can import molecules that directly induce the formation of new blood vessels and do so early on in tumor progression. The goal of the proposed research is to biochemically and mechanistically examine the pro-malignant role of the unique neutrophil enzyme, MMP-9, one of the few molecules released by neutrophils that is a potent inducer of angiogenesis and likely an inducer of tumor metastasis and thus could be therapeutically targeted in cancers associated with inflammatory neutrophil infiltration.   
      

","NCI","8294290","8/24/2012 12:00:00 AM","PA-10-067","1R01CA157792-01A1","1","R01","CA","157792","01","A","SNYDERWINE, ELIZABETH G","9/1/2012 12:00:00 AM","6/30/2017 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1886517","QUIGLEY, JAMES P","Not Applicable","49","Unavailable","781613492","PHZJFZ32NKH4","781613492","PHZJFZ32NKH4","US","32.903152","-117.243436","7375802","SCRIPPS RESEARCH INSTITUTE","LA JOLLA","CA","Research Institutes","920371000","UNITED STATES","N","9/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","185713"," ","393213",
"Alcoholism; Biotechnology; Chronic Liver Disease and Cirrhosis; Digestive Diseases; Genetics; Liver Disease; Substance Abuse","Address;Adult;Alcoholic Liver Diseases;Alcohols;Animal Model;Animals;Antibodies;Candidate Disease Gene;Cause of Death;Cell Lineage;Cells;Cholesterol;Cirrhosis;Collagen Fiber;Collagen Gene;Data;Deposition;Development;Diet;Disease;Embryo;Epithelial;Fibroblasts;Fibrosis;Fluorescence-Activated Cell Sorting;Gene Expression;Gene Targeting;Generations;Genes;Genetic;Genetic Models;Hepatic Fibrogenesis;Hepatic Stellate Cell;Immunohistochemistry;Investigation;Knowledge;Label;Lead;Liver;Liver Fibrosis;Liver Regeneration;Location;Mediating;Mediator of activation protein;Mesenchymal;Mesothelial Cell;Mesothelium;Microarray Analysis;Modality;Modeling;Molecular;Mus;Myofibroblast;Pathway interactions;Patients;Plastics;Play;Population;Positioning Attribute;Process;Relative (related person);Reporter;Research;Role;Smooth Muscle Myocytes;Source;Steatohepatitis;Surface;Testing;Therapeutic Effect;Tissues;Transgenic Organisms;United States;Vitamin A;WT1 gene;Werdnig-Hoffmann Disease;alcohol abuse therapy;base;candidate marker;cell type;chronic alcohol ingestion;comparative;feeding;fibrogenesis;gain of function;gastrointestinal;in vivo;insight;loss of function;mouse model;new therapeutic target;novel;novel marker;problem drinker;promoter;saturated fat;therapeutic target","Contribution of the mesothelium to alcohol-induced liver fibrosis"," Chronic alcohol consumption causes alcoholic liver disease which is the second most common gastrointestinal cause of death in the United States. The proposed study will determine how the liver surface tissue actively participates in alcohol-induced liver fibrosis as a new mechanism. The knowledge obtained from this study will help lead to the development of novel and efficacious modalities aimed at promoting liver regeneration and suppressing liver fibrosis.  
    

","NIAAA","8323528","7/13/2012 12:00:00 AM","RFA-AA-11-002","5R01AA020753-02","5","R01","AA","020753","02"," ","OROSZ, ANDRAS","9/1/2011 12:00:00 AM","7/31/2016 12:00:00 AM","ZAA1-JJ(01)R"," ","10328808","ASAHINA, KINJI ","Not Applicable","37","PATHOLOGY","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF MEDICINE","900894304","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","273","Non-SBIR/STTR","2012"," "," ","NIAAA","212500","131750"," ","344250",
"Bioengineering; Infant Mortality/ (LBW); Lung; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal Period - Conditions Originating in Perinatal Period; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human; Transplantation","3-Dimensional;Accounting;Air Sacs;Alveolar;Applications Grants;Biomimetics;Birth;Blood Vessels;Blood capillaries;Borderline Personality Disorder;Bronchopulmonary Dysplasia;Cell Differentiation process;Cells;Childhood;Coculture Techniques;Cues;Derivation procedure;Development;Discipline of obstetrics;Distal;Embryo;Endoderm;Endoderm Cell;Endothelial Cells;Environment;Epithelial;Epithelial Cells;Event;FGF2 gene;Fibroblast Growth Factor 2;Gases;Goals;Grant;Growth Factor;Hydrogels;In Vitro;Laboratories;Low Birth Weight Infant;Lung;Lung diseases;Mesenchymal;Methods;Mus;Neonatal;Nodal;Pathologic Processes;Pathway interactions;Perinatal mortality demographics;Premature Birth;Process;Production;Proteins;Pulmonary Mass;Pulmonary Pathology;Research Personnel;Serum;Stem cells;Structure of parenchyma of lung;Supplementation;Surgeon;Time;Tissue Engineering;Training;Transplantation;Undifferentiated;United States;activin A;alveolar epithelium;capillary;embryonic stem cell;fetal;improved;in vivo;innovation;novel;premature lungs;public health relevance;scaffold;small molecule;stem cell therapy;surfactant;three dimensional structure;transcription factor","Optimal Derivation of Murine Embryonic Distal Airway Stem Cells","
Project Narrative
Preterm delivery with resultant immature lungs (pulmonary hypoplasia) is a major
problem in obstetrics and accounts for more than 70% of perinatal mortality. In 2004,
12.5% of births in the United States were preterm. These immature lungs have reduced
numbers of mature epithelial cells which results in insufficient surfactant production (a
protein used to keep the distal airways open) as well as decreased vasculature. We
propose to utilize murine embryonic stem cells to derive distal airway cells for possible
utilization in pulmonary hypoplasia. This exploratory study may help identify optimal
methods of deriving distal airway cells that can potentially be utilized for treatment of
pulmonary diseases such as pulmonary hypoplasia.","NHLBI","8289647","6/10/2012 12:00:00 AM","PA-07-070","5R01HL104258-03","5","R01","HL","104258","03"," ","BLAISDELL, CAROL J","7/1/2010 12:00:00 AM","6/30/2015 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","7749576","FINCK, CHRISTINE M","Not Applicable","05","ANATOMY/CELL BIOLOGY","022254226","H6D6JMXJXDE6","022254226","H6D6JMXJXDE6","US","41.733439","-72.797053","1506603","UNIVERSITY OF CONNECTICUT SCH OF MED/DNT","FARMINGTON","CT","SCHOOLS OF MEDICINE","060305335","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","315295","28455"," ","343750",
"Genetics; Kidney Disease; Pediatric","Accounting;Acetylation;Acute Renal Failure with Renal Papillary Necrosis;Address;Apoptosis;Binding;Biochemical;Cell Cycle;Cell Cycle Regulation;Cell Differentiation process;Cell Lineage;Cell Proliferation;Cells;Child;Chronic Kidney Failure;Clinical;Congenital Abnormality;Defect;Development;Dialysis procedure;Differentiation and Growth;Disease;Dysplasia;Epithelial;Epithelial Cells;Equilibrium;Event;Exhibits;Failure;Family;Funding;Gene Expression;Gene Expression Profile;Gene Targeting;Genes;Genetic;Goals;Grant;Growth and Development function;Health;Homologous Gene;Infant;Investigation;Kidney;Knock-in Mouse;Lysine;MAP Kinase Gene;Malignant Neoplasms;Mediating;Mesenchymal;Metanephric Diverticulum;Modeling;Molecular;Mus;Mutation;N-terminal;Nephrons;Organ Culture Techniques;Organogenesis;Pathway interactions;Phenotype;Phosphorylation;Physiological;Play;Process;Protein Isoforms;Protein p53;Recovery;Role;Serine;Signal Transduction;Stem cells;Stress;System;Testing;Transgenic Mice;Transplantation;Tumor Suppressor Proteins;Ubiquitination;Ureter;base;cell growth;clinically significant;gain of function;gene repression;in vivo;insight;kidney cell;kidney epithelial cell;malformation;member;multicatalytic endopeptidase complex;nephrogenesis;novel;prevent;programs;promoter;renal epithelium;response;senescence;spatiotemporal;transcription factor;ubiquitin-protein ligase","Terminal Differentiation of the Renal Epithelium","n/a","NIDDK","8288305","4/23/2012 12:00:00 AM","PA-07-070","5R01DK062250-09","5","R01","DK","062250","09"," ","HOSHIZAKI, DEBORAH K","8/1/2003 12:00:00 AM","4/30/2013 12:00:00 AM","Urologic and Kidney Development and Genitourinary Diseases Study Section[UKGD]"," ","1895538","EL-DAHR, SAMIR S","Not Applicable","01","PEDIATRICS","053785812","XNY5ULPU8EN6","053785812","XNY5ULPU8EN6","US","29.935453","-90.123916","8424601","TULANE UNIVERSITY OF LOUISIANA","NEW ORLEANS","LA","SCHOOLS OF MEDICINE","701185665","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","187443","91847"," ","279290",
"Breast Cancer; Cancer","Accounting;Address;Affect;African American;Age;Behavior;Behavioral;Behavioral Genetics;Biological Assay;Biological Factors;Biological Markers;Biology;Blood;Breast Cancer Epidemiology;Cancer Patient;Cancer Relapse;Catchment Area;Caucasians;Caucasoid Race;Cessation of life;Characteristics;Classification;Clinical;Clinical Oncology;Clinical Research;Clinical Treatment;Collection;Comorbidity;Complex;County;Data;Data Collection;Development;ERBB2 gene;Environmental Risk Factor;Epidemiology;Evaluation;Event;Formalin;Frequencies;Funding;Funding Agency;Gene Expression Profiling;Genes;Genetic;Genetic Risk;Genomics;Goals;Health Services Accessibility;Heterogeneity;High Prevalence;Hypoxia;Immune response;Immunohistochemistry;Incidence;Intervention;Investigation;Low Prevalence;Mesenchymal;Molecular;North Carolina;Outcome;Paint;Paper;Paraffin Embedding;Participant;Pathway interactions;Patients;Pattern;Phase;Population;Premenopause;Public Health;Race;Relapse;Research;Resources;Risk;Risk Behaviors;Risk Factors;Role;Sample Size;Sampling;Site;Socioeconomic Factors;Staging;Technology;Testing;Treatment outcome;Tumor Biology;Tumor Subtype;Universities;Woman;base;cancer health disparity;cancer risk;care delivery;clinical care;community setting;design;follow-up;insight;lifestyle factors;malignant breast neoplasm;mortality;nano-string;outcome forecast;phase 1 study;phase 3 study;population based;response;socioeconomics;tumor;wound","Carolina Breast Cancer Study","Examination of factors affecting risk, behavior, and prognosis within and across tumor subtypes, and 
between AA and non-AA women, will identify determinants of racial disparities in breast cancer risk and 
outcome.","NCI","8389741","9/14/2012 12:00:00 AM","PAR-10-003","2P50CA058223-19A1","2","P50","CA","058223","19","A"," ","8/5/1997 12:00:00 AM","8/31/2017 12:00:00 AM","ZCA1-RPRB-0(M1)","6443","2277741","MILLIKAN, ROBERT C","Not Applicable","04","Unavailable","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","Domestic Higher Education","275995023","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","854831","854831"," ","195317","659514"," "," ",
"Biotechnology; Cancer; Genetics; Prevention","Accounting;Apoptosis;Autophagocytosis;Biochemical;Biological;Biological Assay;Biological Process;Biology;Categories;Cell Aging;Cell Culture Techniques;Cell Cycle Arrest;Cell Proliferation;Cell physiology;Cells;Cellular Stress;ChIP-seq;Complement;Complex;Data;Development;Disease;Epithelial;Fibroblasts;Gene Targeting;Generations;Genes;Genetic;Genetic Recombination;Goals;Hematopoietic;Histocompatibility Testing;Human;Individual;Knock-in Mouse;Lead;Malignant Neoplasms;Malignant neoplasm of lung;Mediating;Mediator of activation protein;Medicine;Membrane;Mesenchymal;Modeling;Molecular;Molecular Mechanisms of Action;Mus;Mutant Strains Mice;Mutate;Mutation;Normal Cell;Oncogenes;Organism;Pathway interactions;Physiological;Prevention strategy;Property;Protein p53;Proteins;RNA Interference;Relative (related person);Research;Residual state;Role;Series;Signal Transduction;Stress;Therapeutic;Tissues;Transactivation;Transcription Coactivator;Transcriptional Activation;Tumor Suppression;Tumor Suppressor Proteins;base;cancer cell;cancer therapy;cell type;chemotherapy;defined contribution;gene repression;homologous recombination;in vivo;insight;interest;mitochondrial membrane;mouse model;mutant;neoplastic cell;novel;overexpression;prevent;promoter;public health relevance;research study;response;senescence;tool;treatment strategy;tumor","Mouse Models to Dissect p53 Tumor Suppressor Function","
PROJECT NARRATIVE
In the US, approximately 1 in every 2-3 individuals will develop cancer, a disease of uncontrolled cellular
proliferation that can be fatal. It is therefore very important to understand the basis of this disease in
order to be able to more effectively treat and cure it. This research aims to elucidate how p53, a gene
important for preventing cancer, acts, with the ultimate goal of devising better prevention and treatment
strategies for cancer.","NCI","8206557","1/4/2012 12:00:00 AM","PA-10-067","5R01CA140875-02","5","R01","CA","140875","02"," ","WATSON, JOANNA M","1/1/2011 12:00:00 AM","12/31/2015 12:00:00 AM","Cancer Molecular Pathobiology Study Section[CAMP]"," ","1885021","ATTARDI, LAURA D","Not Applicable","18","RADIATION-DIAGNOSTIC/ONCOLOGY","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","135490"," ","342990",
"Dental/Oral and Craniofacial Disease; Genetics; Osteogenesis Imperfecta; Rare Diseases","2-oxoglutarate 3-dioxygenase proline;Accounting;Address;Affect;Autophagosome;Biochemical;Biochemistry;Bone Tissue;COL1A1 gene;COL1A2 gene;Cartilage;Cell physiology;Cells;Characteristics;Chondrocytes;Clinical;Collagen;Collagen Type I;Complex;Connective Tissue;Contracture;Data;Defect;Dentinogenesis Imperfecta;Disease;Endoplasmic Reticulum;Extracellular Matrix;Fellowship;Fibroblasts;Genes;Goals;Golgi Apparatus;Hsp47 protein;Human;Hydroxylation;In Vitro;Inborn Genetic Diseases;Inherited;Joints;Knockout Mice;Lead;Ligaments;Link;Mesenchymal;Modification;Molecular Chaperones;Morphology;Mus;Mutant Strains Mice;Mutation;National Institute of Dental and Craniofacial Research;Null Lymphocytes;Osteoblasts;Osteogenesis Imperfecta;Osteoporosis;Pathogenesis;Pathway interactions;Patients;Phenotype;Positioning Attribute;Post-Translational Protein Processing;Procollagen;Proline;Proteins;Research;Role;Rough endoplasmic reticulum;Sclera;Severities;Signal Transduction;Skeletal system;Skeleton;Skin;Syndrome;Tacrolimus Binding Proteins;Tendon structure;Testing;Tissues;Type I Procollagen;Work;bone;bone mass;cis-trans-Isomerases;craniofacial;cranium;cyclophilin B;endoplasmic reticulum stress;hearing impairment;in vivo;insight;mouse model;new therapeutic target;novel;null mutation;protein complex;response;scoliosis;secretion process;skeletal tissue;therapeutic target;trafficking","The Role of FKBP10 in Recessive Osteogenesis Imperfecta","This project serves to elucidate the role of the loss of the gene FK506 Binding Protein 10 (FKBP10) which encodes the protein FKBP65 and complexes with Heat Shock Protein 47 (HSP47) in order to chaperone collagen in the extracellular matrix. This loss results in Bruck syndrome and progressively deforming recessive Osteogenesis Imperfecta (OI), a form of brittle bone disease. Through this research we hope to discover novel mechanisms of OI and commonalities that exist between various causes of OI, potentially leading to new targets for therapeutics.","NIDCR","8331763","7/19/2012 12:00:00 AM","PA-11-111","5F31DE022483-02","5","F31","DE","022483","02"," ","FRIEDEN, LESLIE A","9/1/2011 12:00:00 AM","8/31/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","10345636","LIETMAN, CARESSA ","Not Applicable","09","GENETICS","051113330","FXKMA43NTV21","051113330","FXKMA43NTV21","US","29.711148","-95.39695","481201","BAYLOR COLLEGE OF MEDICINE","HOUSTON","TX","SCHOOLS OF MEDICINE","770303411","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","43032"," "," ","43032",
"Cancer; Genetics","Algorithms;Apoptosis;Area;Behavior;Biochemical;Biochemistry;Biological;Biological Assay;Cell Cycle;Cell Line;Cell Survival;Cell physiology;Cells;Chemistry;Clinical;Collection;Communities;Complex;Data;Data Analyses;Data Collection;Data Provenance;Data Quality;Data Set;Disease;Dose;Drug resistance;Epithelial;Experimental Designs;Extensible Markup Language;Flow Cytometry;Genome;Genomics;Genotype;Goals;Growth Factor;Human;Image Cytometry;Immunoassay;Informatics;Institution;Investigational Drugs;Kinetics;Knowledge;Libraries;Life;Ligands;Link;Logic;Malignant Neoplasms;Maps;Measures;Mesenchymal;Methodology;Methods;Modeling;Molecular Profiling;Normal Cell;Output;Pathway interactions;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;Phase;Phenotype;Phosphotransferases;Physiology;Process;Production;Proteins;Reporting;Resistance;Resolution;Running;Sampling;Series;Signal Pathway;Signal Transduction;Signaling Protein;Software Tools;Specificity;Stem cells;Structure;System;Techniques;Therapeutic;Time;Tumor Cell Line;base;cancer cell;cellular imaging;computer based Semantic Analysis;cytokine;drug mechanism;flexibility;heuristics;information processing;inhibitor/antagonist;insight;interest;kinase inhibitor;large scale production;large-scale database;malignant breast neoplasm;mathematical model;medical schools;meetings;movie;neoplastic cell;novel;open source;programs;public health relevance;response;senescence;small molecule;small molecule libraries;tool","Pharmaco Response Signatures and Disease Mechanism","PUBLIC HEALTH RELEVANCE: Plans for an HMS-based LINCS Center are directly relevant to programmatic goals of assembling ""mechanism-based associations among the effects of disparate biological perturbations"" and insight into the ""mechanisms of action of known drugs."" Single -cell and biochemical data generated by the HMS LINCS Center will be different from and complementary to existing large scale data based on genomic assays and transcriptional profiles. The Center's focus on clinical-grade and novel kinase inhibitors will provide data with high translational potential for a class of compounds that currently dominates investigational new drugs for cancer.","NHGRI","8465336","5/17/2012 12:00:00 AM","RFA-RM-10-003","3U54HG006097-02S1","3","U54","HG","006097","02","S","PILLAI, AJAY","9/27/2010 12:00:00 AM","7/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-CB-P(52)R]"," ","1883114","SORGER, PETER KARL","MITCHISON, TIMOTHY J","07","ANATOMY/CELL BIOLOGY","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","SCHOOLS OF MEDICINE","021201616","UNITED STATES","N","8/1/2011 12:00:00 AM","7/31/2012 12:00:00 AM","310","Research Centers","2012"," "," ","OD","96730","27057"," ","123787",
"Aging; Biotechnology; Breast Cancer; Cancer; HIV/AIDS; Prevention; Prostate Cancer; Urologic Diseases","5 Alpha-Reductase Inhibitor;Address;Animal Model;Apoptosis;Area;Biochemical;Biological Markers;Body Fluids;Breast;Cancer Center;Cancer Center Support Grant;Cancer Patient;Characteristics;Clinical;Clinical Trials;Collaborations;Colorado;Complex;Detection;Development;Diagnosis;Direct Costs;Discipline;Disease;Disease Progression;Drug Delivery Systems;Endocrine system;Epidemiologist;Fertilization;Financial Support;Fish Oils;Focus Groups;Fostering;Funding;Goals;Grant;Group Meetings;Hormones;Incidence;Inflammatory;Instruction;Joints;Knowledge;Leadership;Light;Link;Malignant Female Reproductive System Neoplasm;Malignant Neoplasms;Malignant neoplasm of ovary;Malignant neoplasm of prostate;Mentors;Molecular;Nature;Neoplasm Metastasis;Newly Diagnosed;Pathway interactions;Population;Positioning Attribute;Pregnancy;Prevention;Preventive;Process;Prostate Cancer Prevention Trial;Protocols documentation;Publications;Recommendation;Refractory;Research;Research Personnel;Research Training;Resistance;Resources;Role;Schools;Scientist;Screening for Prostate Cancer;Screening procedure;Series;Southwest Oncology Group;Tissues;Training;Translating;Translations;Universities;Woman;anticancer research;base;cancer stem cell;celecoxib;clinical conference;clinical epidemiology;epithelial to mesenchymal transition;factor J;functional genomics;high throughput screening;hormone therapy;improved;interest;malignant breast neoplasm;member;mortality;new technology;novel;novel diagnostics;novel strategies;prevent;programs;prostate cancer prevention;reproductive;sample collection;small molecule;therapeutic target;treatment strategy;tumor;tumor progression","HORMONE RELATED MALIGNANCIES","RELEVANCE (See instructions): 
The Hormone Related Malignancies Program (HRM) fosters cancer-focused inter-disciplinary research among basic scientists, clinical researchers and epidemiologists who study cancers of the reproductive tract and breast The goal is to prevent, diagnose, and treat these cancers more effectively through the translation of lab-based discoveries into therapeutic targets.","NCI","8465390","10/12/2012 1:19:27 PM","PAR-11-005","2P30CA046934-24","2","P30","CA","046934","24"," "," ","8/6/1997 12:00:00 AM","1/31/2017 12:00:00 AM","Cancer Centers Study Section (A)[NCI-A]","8112","2213049","HOLT, JEFFREY P","Not Applicable","06","Unavailable","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","Domestic Higher Education","800452570","UNITED STATES","N","8/6/2012 12:00:00 AM","1/31/2013 12:00:00 AM"," ","Research Centers","2012","31086","31086"," ","20536","10550"," "," ",
"Cancer; Genetics","Algorithms;Apoptosis;Area;Behavior;Biochemical;Biochemistry;Biological;Biological Assay;Cell Cycle;Cell Line;Cell Survival;Cell physiology;Cells;Chemistry;Clinical;Collection;Communities;Complex;Data;Data Analyses;Data Collection;Data Provenance;Data Quality;Data Set;Disease;Dose;Drug resistance;Epithelial;Experimental Designs;Extensible Markup Language;Flow Cytometry;Genome;Genomics;Genotype;Goals;Growth Factor;Human;Image Cytometry;Immunoassay;Informatics;Institution;Investigational Drugs;Kinetics;Knowledge;Libraries;Life;Ligands;Link;Logic;Malignant Neoplasms;Maps;Measures;Mesenchymal;Methodology;Methods;Modeling;Molecular Profiling;Normal Cell;Output;Pathway interactions;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;Phase;Phenotype;Phosphotransferases;Physiology;Process;Production;Proteins;Reporting;Resistance;Resolution;Running;Sampling;Series;Signal Pathway;Signal Transduction;Signaling Protein;Software Tools;Specificity;Stem cells;Structure;System;Techniques;Therapeutic;Time;Tumor Cell Line;base;cancer cell;cellular imaging;computer based Semantic Analysis;cytokine;drug mechanism;flexibility;heuristics;information processing;inhibitor/antagonist;insight;interest;kinase inhibitor;large scale production;large-scale database;malignant breast neoplasm;mathematical model;medical schools;meetings;movie;neoplastic cell;novel;open source;programs;public health relevance;response;senescence;small molecule;small molecule libraries;tool","Pharmaco Response Signatures and Disease Mechanism","PUBLIC HEALTH RELEVANCE: Plans for an HMS-based LINCS Center are directly relevant to programmatic goals of assembling ""mechanism-based associations among the effects of disparate biological perturbations"" and insight into the ""mechanisms of action of known drugs."" Single -cell and biochemical data generated by the HMS LINCS Center will be different from and complementary to existing large scale data based on genomic assays and transcriptional profiles. The Center's focus on clinical-grade and novel kinase inhibitors will provide data with high translational potential for a class of compounds that currently dominates investigational new drugs for cancer.","NHGRI","8545951","9/21/2012 12:00:00 AM","RFA-RM-10-003","3U54HG006097-03S2","3","U54","HG","006097","03","S","PILLAI, AJAY","9/27/2010 12:00:00 AM","7/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-CB-P(52)R]"," ","1883114","SORGER, PETER KARL","MITCHISON, TIMOTHY J","07","ANATOMY/CELL BIOLOGY","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","SCHOOLS OF MEDICINE","021201616","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","310","Research Centers","2012"," "," ","OD","133103","91897"," ","225000",
"Bioengineering; Neurosciences; Patient Safety; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human","Adult;Algorithms;Angioblast;Animal Testing;Astrocytes;Behavioral;Blinded;Blood Vessels;Blood capillaries;Brain;Cell model;Cells;Cephalic;Cerebral cortex;Cerebrum;Clinical;Clinical Trials;Collection;Commit;Databases;Derivation procedure;Development;Drug Exposure;Drug toxicity;Endothelial Cells;Epithelium;Erinaceidae;Exposure to;Fetus;Gene Expression;Histocompatibility Testing;Human;Human body;Hydrogels;Information Systems;Laboratories;Liquid substance;Machine Learning;Mediating;Mesenchymal;Mesenchyme;Microglia;Modeling;Molecular Profiling;Myelogenous;Nature;Neural Crest;Neurons;Oligodendroglia;Organ;Pathway interactions;Peptides;Pericytes;Pharmaceutical Preparations;Physiological;Pluripotent Stem Cells;Population;RNA;RNA Sequences;Receptor Protein-Tyrosine Kinases;Recording of previous events;Robot;Rodent Model;Signal Pathway;Signal Transduction;Staging;Teratogens;Testing;Tissue Engineering;Tissues;Toxic effect;Toxicology;Toxin;Training;United States National Institutes of Health;Universities;Vascular Smooth Muscle;Washington;Yolk Sac;base;capillary;cognitive change;cost effective;drug development;embryonic stem cell;experience;improved;in vitro testing;induced pluripotent stem cell;neural plate;neurodevelopment;notch protein;precursor cell;predictive modeling;prenatal exposure;progenitor;relating to nervous system;stem cell biology;tool;toxicant","Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity"," This project will develop three-dimensional constructs of human neural tissue to better predict the neural toxicity of drugs prior to clinical trials. To accomplish this, experts in human pluripotent stem cell biology will grow the required neural components in the laboratory, experts in tissue engineers will assemble those cells into multicellular constructs, and experts in machine learning will use changes in gene expression after drug exposure to predict whether a test compound is toxic.   
      

","NCATS","8414419","7/24/2012 12:00:00 AM","RFA-RM-11-022","1UH2TR000506-01","1","UH2","TR","000506","01"," ","TAGLE, DANILO A","7/24/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BST-N(50)R]"," ","10603115","THOMSON, JAMES ALEXANDER","Not Applicable","02","Unavailable","012420082","W6Q8XJV41Z98","012420082","W6Q8XJV41Z98","US","43.072813","-89.407457","10023197","MORGRIDGE INSTITUTE FOR RESEARCH, INC.","MADISON","WI","Research Institutes","537151119","UNITED STATES","N","7/24/2012 12:00:00 AM","6/30/2013 12:00:00 AM","350","Non-SBIR/STTR","2012"," "," ","NCATS","452174","326663"," ","778837",
"Bioengineering; Neurosciences; Patient Safety; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human","Adult;Algorithms;Angioblast;Animal Testing;Astrocytes;Behavioral;Blinded;Blood Vessels;Blood capillaries;Brain;Cell model;Cells;Cephalic;Cerebral cortex;Cerebrum;Clinical;Clinical Trials;Collection;Commit;Databases;Derivation procedure;Development;Drug Exposure;Drug toxicity;Endothelial Cells;Epithelium;Erinaceidae;Exposure to;Fetus;Gene Expression;Histocompatibility Testing;Human;Human body;Hydrogels;Information Systems;Laboratories;Liquid substance;Machine Learning;Mediating;Mesenchymal;Mesenchyme;Microglia;Modeling;Molecular Profiling;Myelogenous;Nature;Neural Crest;Neurons;Oligodendroglia;Organ;Pathway interactions;Peptides;Pericytes;Pharmaceutical Preparations;Physiological;Pluripotent Stem Cells;Population;RNA;RNA Sequences;Receptor Protein-Tyrosine Kinases;Recording of previous events;Robot;Rodent Model;Signal Pathway;Signal Transduction;Staging;Teratogens;Testing;Tissue Engineering;Tissues;Toxic effect;Toxicology;Toxin;Training;United States National Institutes of Health;Universities;Vascular Smooth Muscle;Washington;Yolk Sac;base;capillary;cognitive change;cost effective;drug development;embryonic stem cell;experience;improved;in vitro testing;induced pluripotent stem cell;neural plate;neurodevelopment;notch protein;precursor cell;predictive modeling;prenatal exposure;progenitor;relating to nervous system;stem cell biology;tool;toxicant","Human iPS/ES Cell-Based Models for Predictive Neural Toxicity and Teratogenicity"," This project will develop three-dimensional constructs of human neural tissue to better predict the neural toxicity of drugs prior to clinical trials. To accomplish this, experts in human pluripotent stem cell biology will grow the required neural components in the laboratory, experts in tissue engineers will assemble those cells into multicellular constructs, and experts in machine learning will use changes in gene expression after drug exposure to predict whether a test compound is toxic.   
      

","NCATS","8414419","7/24/2012 12:00:00 AM","RFA-RM-11-022","1UH2TR000506-01","1","UH2","TR","000506","01"," ","TAGLE, DANILO A","7/24/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BST-N(50)R]"," ","10603115","THOMSON, JAMES ALEXANDER","Not Applicable","02","Unavailable","012420082","W6Q8XJV41Z98","012420082","W6Q8XJV41Z98","US","43.072813","-89.407457","10023197","MORGRIDGE INSTITUTE FOR RESEARCH, INC.","MADISON","WI","Research Institutes","537151119","UNITED STATES","N","7/24/2012 12:00:00 AM","6/30/2013 12:00:00 AM","350","Non-SBIR/STTR","2012"," "," ","OD","259622","86541"," ","346163",
"Aging; Cancer; Prostate Cancer; Urologic Diseases","Ablation;Androgens;Animal Model;Biological Models;Bone Development;Bone Marrow;Bone marrow biopsy;Bone neoplasms;Bone remodeling;Cancer Center;Cancer Etiology;Cancer Patient;Cessation of life;Clinical;Clinical Course of Disease;Clinical Research;Clinical Trials;Complex;Development;Differentiation and Growth;Disease;Disease Progression;Disease Resistance;Ectopic Expression;Embryonic Development;Epithelial;Epithelial Cells;Equilibrium;FGF9 gene;FGFR1 gene;Failure;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Foundations;Genes;Gland;Goals;Growth;Homeostasis;Human;Infiltration;Inhibitory Concentration 50;Instruction;Ligands;Malignant Neoplasms;Malignant neoplasm of prostate;Mature Bone;Mediating;Mesenchymal;Metastatic Neoplasm to the Bone;Molecular Genetics;Mus;Pathway interactions;Patient Monitoring;Pharmaceutical Preparations;Pharmacologic Substance;Phase I Clinical Trials;Principal Investigator;Prostate;Prostatic Neoplasms;Reaction;Receptor Signaling;Resistance;Safety;Signal Pathway;Signal Transduction;Site;Solid Neoplasm;Source;Stromal Neoplasm;Tyrosine Kinase Inhibitor;United States;Validation;Xenograft procedure;autocrine;base;bone;bone mass;cancer cell;candidate marker;cell growth;clinically relevant;design;kinase inhibitor;male;men;mouse model;novel therapeutics;outcome forecast;overexpression;pre-clinical;receptor;response;response marker;skeletal;tissue resource;tumor growth;tumor initiation;tumor progression","Targeting FGF Signaling in Prostate Cancer Progression","n/a","NCI","8380594","9/6/2012 12:00:00 AM","PAR-08-020","5P50CA140388-04","5","P50","CA","140388","04"," "," "," "," ","ZCA1-RPRB-7","8765","2085356","NAVONE, NORA M","Not Applicable","09","Unavailable","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","Domestic Higher Education","770304009","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Research Centers","2012","293695","293695"," ","194660","99035"," "," ",
"No NIH Category available","Astrocytes;Biology;Blood Cells;Blood Vessels;Brain;Brain Neoplasms;Breast;Carcinoma in Situ;Cell Survival;Cell surface;Cells;Coculture Techniques;Doctor of Philosophy;EGF gene;Effectiveness;Endothelial Cells;Endothelium;Engineering;Epidermal Growth Factor Receptor;Extravasation;Gene Expression;Genes;Genetic;Glioblastoma;Glioma;Growth;Human;Human Cell Line;Immunohistochemistry;Implant;In Situ;In Vitro;Infiltration;Instruction;Knock-out;Ligands;Location;Lung;Malignant Neoplasms;Mediator of activation protein;Mesenchymal;Metastatic malignant neoplasm to brain;Microglia;Modeling;Mus;Neoplasm Metastasis;Operative Surgical Procedures;Pathway interactions;Patients;Pattern;Pericytes;Phenotype;Platelet-Derived Growth Factor;Primary Neoplasm;Proteins;Radiation;Radiation therapy;Residual Tumors;Resistance;Role;Sampling;Signal Transduction;Stromal Cells;Subgroup;Therapeutic;Time;cancer cell;cell type;chemotherapy;in vivo;jagged1 protein;knock-down;monocyte;mouse model;neoplastic cell;notch protein;research study;resistance mechanism;response;small hairpin RNA;stem;temozolomide;therapy resistant;tool;tumor;tumorigenesis","Role of the Perivascular Microenvironment in Primary and Metastatic Brain Tumors","RELEVANCE (See instructions): 
Glioblastoma is one of the most deadly cancers, and metastatic tumors to the brain are equally devastating and much more common. Both tumor types are highly resistant to therapy. Evidence suggests that one of the reasons for resistance of tumors in the brain resides in the blood vessels and cells surrounding them. 
We hope to understand the role of perivascular cells in therapeutic resistance to reverse this effect.","NCI","8336840","8/27/2012 12:00:00 AM","RFA-CA-10-021","5U54CA163167-02","5","U54","CA","163167","02"," ","MOHLA, SURESH","9/21/2011 12:00:00 AM","6/15/2013 12:00:00 AM","ZCA1-SRLB-3(O1)"," ","2067406","HOLLAND, ERIC C.","Not Applicable","12","Unavailable","064931884","KUKXRCZ6NZC2","064931884","KUKXRCZ6NZC2","US","40.764332","-73.955697","5079202","SLOAN-KETTERING INST CAN RESEARCH","NEW YORK","NY","Research Institutes","100656007","UNITED STATES","N","8/1/2012 12:00:00 AM","6/15/2013 12:00:00 AM","397","Research Centers","2012"," "," ","NCI","826042","300368"," ","934192",
"Biotechnology; Brain Cancer; Brain Disorders; Cancer; Clinical Research; Neurosciences; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","1-Phosphatidylinositol 3-Kinase;Address;Antioxidants;Biological Assay;Biology;Brain Neoplasms;Brain Stem Neoplasms;Categories;Cell Culture Techniques;Cell physiology;Cells;Cellular biology;Chronic;Clinical;Clinical Research;Complication;Dependence;Dependency;Development;Functional disorder;Future;Gene Expression;Genes;Glioblastoma;Goals;Heterogeneity;In Vitro;Intervention;Knowledge;Mediating;Mesenchymal;Methodology;Microfluidics;Molecular;Molecular Analysis;Oxidative Stress;PTEN gene;Pathway interactions;Patients;Proliferating;Property;Proteins;Proto-Oncogene Proteins c-akt;Radiation;Relative (related person);Resistance;Resistance development;Role;Sampling;Sirolimus;Stem cells;Subgroup;System;Systems Analysis;Technology;Testing;The Cancer Genome Atlas;Translational Research;Treatment Failure;Tumor Stem Cells;Tumorigenicity;Xenograft procedure;base;biological adaptation to stress;cancer stem cell;chemotherapy;conventional therapy;experience;fundamental research;in vivo;inhibitor/antagonist;mTOR Inhibitor;nerve stem cell;novel;public health relevance;radiation resistance;relating to nervous system;research study;resistance mechanism;self-renewal;stem cell biology;therapeutic development;tool;treatment strategy;tumor;tumor growth;tumorigenesis","Neural Progenitor Genes and Brain Tumors","
Project Narrative
Brain tumors, especially glioblastoma multiforme (GBM) are highly lethal. This project seeks to
understand cells that are found within GBM, sometimes called cancer stem cells, and how these cells differ
from patient to patient and how they resist conventional therapies, such as radiation and chemotherapy. In
performing these studies, we hope to develop better treatment strategies for GBM.","NINDS","8240707","3/29/2012 12:00:00 AM","PA-10-067","5R01NS052563-05","5","R01","NS","052563","05"," ","FOUNTAIN, JANE W","4/27/2006 12:00:00 AM","3/31/2016 12:00:00 AM","Basic Mechanisms  of Cancer Therapeutics Study Section[BMCT]"," ","1901449","KORNBLUM, HARLEY IAN","Not Applicable","33","PSYCHIATRY","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","SCHOOLS OF MEDICINE","900952000","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","218750","118125"," ","336875",
"Aging; Eye Disease and Disorders of Vision; Genetics","Address;Adult;Adverse effects;Blindness;Cataract;Cataract Extraction;Cell Differentiation process;Cells;Chickens;Childhood;Chromatin Structure;Ciliary Muscle;Complex;Crystallins;Defect;Development;Elderly;Environment;Epigenetic Process;Epithelial;Epithelial Cells;Epithelium;Excision;Eye;Family;Fiber;Gene Activation;Gene Expression;Generations;Genes;Genetic;Genetic Transcription;Goals;Growth and Development function;HMGN Proteins;HMGN3 gene;Health;Human;Implant;Injury;Intraocular lens implant device;Investigation;Knock-out;Lens Fiber;Mesenchymal;Messenger RNA;Modeling;Molecular;Molecular Target;Mus;Natural regeneration;Operative Surgical Procedures;Outcome;Outpatients;Pathology;Patients;Pattern;Phenotype;Play;Process;Protein Family;Proteins;Regulation;Role;Staining method;Stains;Testing;Therapeutic Intervention;Tissues;Transcription Coactivator;Transcription Repressor/Corepressor;Transcriptional Regulation;Transgenic Mice;Variant;Vertebrates;Vision Disorders;Visual;Zebrafish;chromatin remodeling;cost;fiber cell;gene function;insight;lens;lens cortex;lens morphogenesis;operation;prevent;programs;promoter;response;response to injury;restoration;transcription factor","The regulation of lens fiber cell differentiation","
Project Narrative 
Cataracts are the most prevalent form of blindness worldwide.  In the USA, cataract removal is 
the most common outpatient surgical operation performed on the elderly costing over 343 
million dollars in 2005 (http://www.cms.hhs.gov/MedicareMedicaidStatSupp/).  However, 10-
20% of elderly and nearly 100% of pediatric patients treated for cataract develop posterior 
capsular opacification (PCO) which requires additional treatments and can result in reduced 
visual outcomes.  Further, much effort is being exerted towards the development of intraocular 
lens (IOLs) implants that restore the ability of the eye to accommodate (establish near focus) 
after cataract surgery.  A major impediment to long term restoration of accommodation is that 
lens epithelial cells trapped at the lens equator by the IOL often regenerate the lens cortex which 
reduces the ability of the ciliary muscles to accommodate the implanted IOL.  This proposal 
addresses unanswered questions related to the molecular mechanisms of PCO development 
and lens fiber cell differentiation with the long term goal of preventing the side effects of 
cataract surgery. ","NEI","8247062","4/9/2012 12:00:00 AM","PA-07-070","5R01EY012221-14","5","R01","EY","012221","14"," ","ARAJ, HOUMAM H","7/1/1998 12:00:00 AM","3/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BDCN-F(02)M]"," ","2189960","DUNCAN, MELINDA K","Not Applicable","At-Large","BIOLOGY","059007500","T72NHKM259N3","059007500","T72NHKM259N3","US","39.677657","-75.757204","2076701","UNIVERSITY OF DELAWARE","NEWARK","DE","SCHOOLS OF ARTS AND SCIENCES","197160099","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","213840","113335"," ","327175",
"Acute Respiratory Distress Syndrome; Injury (total) Accidents/Adverse Effects; Lung; Rare Diseases; Regenerative Medicine; Stem Cell Research","Acute;Acute Lung Injury;Address;Blood Vessels;Cell Surface Proteins;Cell Therapy;Cell physiology;Cell surface;Cells;Cessation of life;Databases;Disease;Edema;Effectiveness;Embryo;Engraftment;Fibroblasts;Fluid Balance;Hematopoietic stem cells;Human;In Situ;Infiltration;Inflammation;Inflammatory;Injury;Integrins;Intervention;Lead;Life;Ligation;Liquid substance;Lung;Lung Inflammation;Mediating;Memory;Mesenchymal;Mesoderm;Modeling;Molecular;Molecular Profiling;Mus;Natural regeneration;Population;Program Development;Proteins;Pseudomonas;Puncture procedure;Recovery;Relative (related person);Research Personnel;Role;Safety;Secondary to;Sepsis;Skin;Stem cells;Testing;Therapeutic;Time;Transplantation;Ursidae Family;Vascular Endothelial Growth Factor Receptor-2;Vascular Endothelial Growth Factors;Vascular Permeabilities;angiogenesis;base;cadherin 5;induced pluripotent stem cell;injured;innovation;lung injury;lung vascular injury;mortality;mouse model;precursor cell;prevent;progenitor;protective effect;regenerative;repaired;research study;response;restoration","iPSC-Derived Endothelial Progenitor Cell Treatment of Lung Vascular Injury"," Sepsis-induced acute lung injury (ALI) remains an intractable disease with a mortality of 50% or greater despite advanced interventions. ALI bears the hallmark of inflammatory infiltration and protein-rich edema fluid due to severe disruption of lung vascular endothelial barrier. Our studies will assess the effectiveness and mechanisms for that effectiveness of the transplantation of induced pluripotent stem cells (iPSC), derived from mouse fibroblasts, and subsequently differentiated into endothelial progenitor cells (EPCs) and hematopoietic stem cells (HSCs). These cells will be studied individually or in combination to see if they can reverse established lung microvessel injury that is induced by two sepsis mouse models and thereby re-establish normal lung fluid balance. We have generated these mouse progenitor and stem cells and found that we can readily expand them, a requirement for cell-based therapy. We hope by understanding the mechanisms of the protective effects of these easily obtainable progenitor cells to lay rigorous scientific underpinnings for the eventual use of defined iPSC-derived progenitor cells for the treatment of ALI in humans.  
  
    

","NHLBI","8282697","6/18/2012 12:00:00 AM","PA-10-067","5R01HL090152-06","5","R01","HL","090152","06"," ","BLAISDELL, CAROL J","9/28/2007 12:00:00 AM","6/30/2016 12:00:00 AM","Respiratory Integrative Biology and Translational Research Study Section[RIBT]"," ","6398229","MALIK, ASRAR B.","Not Applicable","07","PHARMACOLOGY","098987217","W8XEAJDKMXH3","098987217","W8XEAJDKMXH3","US","41.880316","-87.687597","577703","UNIVERSITY OF ILLINOIS AT CHICAGO","Chicago","IL","SCHOOLS OF MEDICINE","606124305","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","306000","175820"," ","481820",
"Genetics; Lung; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Address;Air;Anti-Bacterial Agents;Asthma;Binding;Binding Sites;Biological Assay;Biological Models;Biology;Cell Line;Cell physiology;Cells;Characteristics;Chromatin;Chronic Bronchitis;Collagen;Complex;Cystic Fibrosis;Development;Disease;Dissection;Duct (organ) structure;Ectopic Expression;Elements;Enhancers;Epithelial;Epithelial Cells;Epithelium;Ferrets;Funding;Ganciclovir;Gel;Gene Expression;Genetic;Genetic Models;Gland;Goals;Grant;Growth;HMG-Box;Human;Hyperplasia;Hypertrophy;In Vitro;Indium;Infection;Injury;Interphase;Intrinsic factor;Knock-in Mouse;Knockout Mice;Knowledge;Label;Laboratories;LacZ Genes;Link;Liquid substance;Lung;Lung diseases;Lymphoid;Maintenance;Mediating;Mesenchymal;Methods;Modeling;Molecular;Morphogenesis;Mucous body substance;Mus;Mutation;Nasal Epithelium;Natural Immunity;Pathologic;Pathway interactions;Pattern;Phenotype;Physiology;Play;Production;Regulation;Regulatory Pathway;Reporter;Repression;Role;Serous;Signal Transduction;Signaling Molecule;Small Interfering RNA;Staging;Stem cells;Surface;System;TCF7L2 gene;Testing;Time;Tracheal Epithelium;Transcriptional Activation;Transcriptional Regulation;Transgenic Animals;Transgenic Mice;Transgenic Organisms;Viral Vector;Viscosity;Wnt proteins;Xenograft procedure;airway epithelium;animal model development;base;bone morphogenetic protein 2;cell type;enhancing factor;gland development;in vivo;mouse model;novel therapeutic intervention;progenitor;promoter;reconstitution;stem cell biology;stem cell fate;stem cell niche;time use;tool;transcription factor","Biology of submucosal gland stem cells in the airway","n/a","NIDDK","8281467","6/18/2012 12:00:00 AM"," ","5R37DK047967-24","5","R37","DK","047967","24"," ","MCKEON, CATHERINE T","5/1/1990 12:00:00 AM","6/30/2015 12:00:00 AM","NSS"," ","1876393","ENGELHARDT, JOHN F","Not Applicable","02","ANATOMY/CELL BIOLOGY","062761671","Z1H9VJS8NG16","062761671","Z1H9VJS8NG16","US","41.662689","-91.547715","3972901","UNIVERSITY OF IOWA","IOWA CITY","IA","SCHOOLS OF MEDICINE","522421320","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","266587","133294"," ","399881",
"Cardiovascular; Genetics; Heart Disease","Ablation;Actins;Adherence;Adult;Animals;Aortic Diseases;Arteries;Atherosclerosis;Automobile Driving;Award;Biological;Biological Assay;Blood Vessels;Cardiac;Cardiac Myocytes;Cardiovascular system;Cell Differentiation process;Cell Lineage;Cell Nucleus;Cells;Cellular Morphology;Chemotaxis;Complement Factor B;Congenital Heart Defects;Cues;Data;Defect;Development;Embryo;Emigrations;Exhibits;Family;Genes;Genetic Transcription;Genetically Engineered Mouse;Genome;Goals;Harvest;Homeostasis;Knockout Mice;Maintenance;Maps;Mediating;Molecular;Molecular Genetics;Mus;Mutant Strains Mice;Mutation;Neural Crest;Neural Crest Cell;Neural tube;Patent Ductus Arteriosus;Pattern;Pericytes;Phenotype;Physiological;Play;Property;Reagent;Reporting;Role;Signal Pathway;Signal Transduction;Smooth Muscle Myocytes;Specificity;Stress;Syndrome;Transcription Coactivator;Translations;Undifferentiated;United States National Institutes of Health;Vascular System;Yolk Sac;angiogenesis;base;cell motility;cellular transduction;chromatin immunoprecipitation;congenital heart disorder;embryonic stem cell;epithelial to mesenchymal transition;extracellular;factor A;insight;loss of function;migration;mouse model;myocardin;null mutation;postnatal;programs;public health relevance;response;rho;transcription factor","Myocardin Related Transcription Factor Function in the Vasculature","
Compelling evidence suggests that myocardin related transcription factors (MRTFs) play
critical roles in regulating development of the cardiovascular system and maintenance of
cardiovascular homeostasis. The proposed studies examine the molecular mechanisms
regulating activity of MRTFs during embryonic and postnatal development. These
studies are directly relevant to understanding vascular proliferative syndromes including
atherosclerosis, common forms of congenital heart disease and aortic diseases.","NHLBI","8243568","3/14/2012 12:00:00 AM","PA-07-070","5R01HL102968-03","5","R01","HL","102968","03"," ","OLIVE, MICHELLE","4/19/2010 12:00:00 AM","3/31/2014 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","1961759","PARMACEK, MICHAEL S","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","279197","167518"," ","446715",
"Aging; Cancer; Prostate Cancer; Urologic Diseases","Aging;American;Androgen Receptor;Androgens;Animal Model;Antiandrogen Therapy;Attenuated;Binding Proteins;Biological Models;Cancer Cell Growth;Cancer Etiology;Cancer Model;Cells;Cessation of life;Clinical Trials;Communication;Development;Dominant Negative Receptor;Dose;Epithelial;Extracellular Matrix;Fibroblasts;Foundations;Funding;Goals;Growth;Health;Hormones;Human;Knock-out;Knowledge;Malignant Epithelial Cell;Malignant neoplasm of prostate;Mediating;Mesenchymal;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Molecular;Mus;Myofibroblast;Neoplasm Metastasis;Neoplastic Cell Transformation;Nude Mice;Organ;PC3 cell line;Participant;Patients;Pharmaceutical Preparations;Play;Production;Prostate;Prostate carcinoma;Prostatic Neoplasms;Protein Isoforms;Receptor Signaling;Recombinants;Regulation;Research;Resistance;Role;Signal Pathway;Signal Transduction;Stromal Cells;Stromal Neoplasm;System;Testing;Therapeutic;Tissues;Transforming Growth Factor beta;Transforming Growth Factor beta Receptors;Transplantation;Tumor Angiogenesis;Tumor Promoters;Tumor Suppressor Proteins;Xenograft procedure;aging population;angiogenesis;autocrine;base;cancer cell;cancer diagnosis;carcinogenesis;chemotherapeutic agent;comparative efficacy;cytokine;effective therapy;in vivo;inhibitor/antagonist;kinase inhibitor;male;men;migration;mortality;mouse model;neoplastic cell;novel;novel strategies;novel therapeutic intervention;paracrine;pre-clinical;receptor;senescence;transdifferentiation;treatment strategy;tumor;tumor growth;tumor progression;tumorigenesis","TGF beta Receptor and Tumor Progression","n/a","NCI","8242804","3/28/2012 12:00:00 AM","PA-07-070","5R01CA079683-13","5","R01","CA","079683","13"," ","MUSZYNSKI, KAREN","1/1/1999 12:00:00 AM","3/31/2014 12:00:00 AM","Basic Mechanisms  of Cancer Therapeutics Study Section[BMCT]"," ","1888627","SUN, LUZHE ","Not Applicable","21","ANATOMY/CELL BIOLOGY","800772162","C3KXNLTAAY98","800772162","C3KXNLTAAY98","US","29.513082","-98.577731","578418","UNIVERSITY OF TEXAS HLTH SCIENCE CENTER","SAN ANTONIO","TX","SCHOOLS OF MEDICINE","782293901","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","144858","70256"," ","215114",
"Cancer","Actins;Adherens Junction;Adhesions;Affect;Agar;Anchorage-Independent Growth;Aneuploid Cells;Aneuploidy;Apoptosis;Autophagocytosis;Biological;Biological Assay;Blocking Antibodies;Breast;Cadherins;Cell Adhesion;Cell Adhesion Molecules;Cell Death;Cell-Cell Adhesion;Cells;Cellular Structures;Colon;Complex;Cytokinesis;Cytoskeleton;Deltastab;Electron Microscopy;Epithelial Cells;Extracellular Matrix;Failure;Frequencies;Generations;Growth;Human;Human Cell Line;Image;In Vitro;Intercellular Junctions;Lung;Malignant Neoplasms;Mammary Neoplasms;Mediating;Mediator of activation protein;Molecular;Noninfiltrating Intraductal Carcinoma;Pathway interactions;Physiological;Ploidies;Population;Process;Production;Proteins;Reagent;Recruitment Activity;Reporting;Resistance;Role;Small Interfering RNA;Staging;Tight Junctions;Time;Tumor Cell Line;Tumor Suppression;Tumorigenicity;Vacuole;Work;cancer therapy;design;epithelial to mesenchymal transition;in vivo;inhibitor/antagonist;insight;neoplastic cell;prevent;programs;public health relevance;research study;restoration;rho GTP-Binding Proteins;small hairpin RNA;tumor;tumor growth;tumor progression;tumorigenesis;tumorigenic","The role of entosis in human cancers","
Relevance
As cell-in-cell structures are reported in a variety of cancers, such as breast, colon, and
lung, the elucidation of the entosis mechanism has the potential to uncover a previously
overlooked basic cell biological aspect of some of the most common, and deadliest
human cancers. Because the design of new cancer therapies is often tied to mechanistic
information about how cell death works in tumor cells, understanding entosis could
provide insight into new strategies for how these cancers might be treated.
)","NCI","8248174","3/15/2012 12:00:00 AM","PA-10-067","5R01CA154649-02","5","R01","CA","154649","02"," ","SALNIKOW, KONSTANTIN","4/1/2011 12:00:00 AM","3/31/2016 12:00:00 AM","Intercellular Interactions Study Section[ICI]"," ","9748632","OVERHOLTZER, MICHAEL H.","Not Applicable","12","Unavailable","064931884","KUKXRCZ6NZC2","064931884","KUKXRCZ6NZC2","US","40.764332","-73.955697","5079202","SLOAN-KETTERING INST CAN RESEARCH","NEW YORK","NY","Research Institutes","100656007","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","172018"," ","379518",
"Biotechnology; Genetics; Urologic Diseases","Ablation;Adult;Age;Alleles;Androgens;Animals;Antibodies;Benign Prostatic Hypertrophy;Binding;Binding Sites;Birth;Boxing;Chromatin;Collection;Complex;Custom;Data;Development;Differentiation and Growth;Distal;Embryo;Employee Strikes;Enhancers;Epigenetic Process;Epithelial;Epithelium;Equilibrium;Functional disorder;Gene Expression;Gene Targeting;Genes;Genetic;Genetic Enhancer Element;Genitourinary system;Genomics;Goals;Health;Heart;Immunohistochemistry;In Situ Hybridization;Laboratories;LacZ Genes;Lead;Life;Link;Maintenance;Malignant neoplasm of prostate;Maps;Mesenchymal;Mesenchyme;Modification;Molecular;Mouse Cell Line;Mus;Mutant Strains Mice;Mutation;Newborn Infant;Organ;Other Genetics;Paracrine Communication;Pattern;Phenotype;Play;Positioning Attribute;Process;Prostate;Proteins;Publishing;Regulation;Regulatory Element;Reporter;Reporter Genes;Reproductive Health;Role;Signal Pathway;Signal Transduction;Signaling Molecule;Skeleton;Small Interfering RNA;Staging;Sterility;Testing;Time;Tissues;Transcription factor genes;Transgenes;Transgenic Mice;Transgenic Organisms;Ureter;Urogenital Sinus;Work;base;cell type;chromatin immunoprecipitation;design;gland development;histone modification;in vivo;member;mutant;reproductive function;research study;response;tool;transcription factor;transcription factor USF","A role for Tbx18 in prostate development and adult prostate health","    
This project focuses on the role of the Tbx18 transcription factor gene in development and maintenance of a healthy, functioning prostate. Our preliminary data show that Tbx18 is expressed in prostate from the earliest developmental stage, and that the dysfunction of this gene leads to abnormal development of the gland. We will use a combination of mouse genetics and genomic approaches to examine this developmental function in further depth, and to provide a mechanistic context for Tbx18 function by identifying genes that interact with Tbx18 and control its expression during urogenital development.   
      

","NIDDK","8322226","3/28/2012 12:00:00 AM","PA-10-067","1R01DK095685-01","1","R01","DK","095685","01"," ","HOSHIZAKI, DEBORAH K","4/1/2012 12:00:00 AM","2/28/2016 12:00:00 AM","Genetics of Health and Disease Study Section[GHD]"," ","8602825","STUBBS, LISA ","Not Applicable","13","ANATOMY/CELL BIOLOGY","041544081","Y8CWNJRCNN91","041544081","Y8CWNJRCNN91","US","40.094458","-88.238635","577704","UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN","CHAMPAIGN","IL","SCHOOLS OF ARTS AND SCIENCES","618207473","UNITED STATES","N","4/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","113130"," ","330630",
"Breast Cancer; Cancer","Actins;Adenocarcinoma Cell;Animals;Attention;Automobile Driving;Axon;Behavior;Biological Assay;Breast;Breast Cancer Cell;Bulla;Cancer cell line;Cell Adhesion;Cell Line;Cells;Cellular Membrane;Cellular Morphology;Cellular biology;Chimeric Proteins;Clinic;Complex;Coupled;Cytoskeleton;DNA Sequence Rearrangement;Detection;Development;Diagnosis;Disease;Embryo;Energy Transfer;Exhibits;Family;Fatty acid glycerol esters;Fibroblasts;Focal Adhesions;Goals;Growth Cones;Growth Factor;Guanosine Triphosphate Phosphohydrolases;Human;Image;In Vitro;Knowledge;Life;Light;Link;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Matrix Metalloproteinase Inhibitor;Matrix Metalloproteinases;Mediating;Membrane;Mesenchymal;MicroRNAs;Microfilaments;Microscopy;Mission;Molecular;Natural regeneration;Neoplasm Metastasis;Normal Cell;Peptide Hydrolases;Physiological Processes;Play;Proteins;Regulation;Research;Role;Signal Transduction;Testing;Tetanus Helper Peptide;Time;Total Internal Reflection Fluorescent;Tumor Cell Invasion;ameboid movement;base;cancer cell;cell motility;cell type;disability;formin-2;in vivo;insight;migration;mouse model;mutant;neoplastic cell;novel;optical imaging;public health relevance;research study;rho;therapeutic target;tumor;tumor growth;tumorigenesis","Mechanisms Driving Cortical Cytoskeleton Dynamics in Cancer Cell Invasion","
A thorough understanding of cell migration and invasion is essential for progress in diagnosis and therapy of
metastasis and other disease states in which cell migration or invasion is centrally involved. Moreover,
understanding the dynamic regulation of the cortical cytoskeleton at the cell's leading edge, whether in the
context of a migrating embryonic fibroblast, an advancing growth cone in a regenerating axon or a cancer cell
spawned by metastatic malignancy, is a major goal in cell biology with widespread implications in the study of
disease and development. We anticipate that our experiments will shed light on basic and conserved
mechanisms of cytoskeletal remodeling during various behaviors in diverse cell types.","NCI","8294993","5/18/2012 12:00:00 AM","PA-07-070","5R01CA151632-03","5","R01","CA","151632","03"," ","WOODHOUSE, ELIZABETH","7/1/2010 12:00:00 AM","5/31/2015 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","7074498","EISENMANN, KATHRYN M","Not Applicable","09","BIOLOGY","807418939","M9ACC5DQCNL6","807418939","M9ACC5DQCNL6","US","41.62128","-83.615756","229501","UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS","TOLEDO","OH","SCHOOLS OF MEDICINE","436142595","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","100235"," ","301510",
"No NIH Category available","Address;Adrenal Cortex;Adrenal Gland Diseases;Adrenal Glands;Age;Alleles;Animals;Behavior;Biology;Cell Differentiation process;Cell Proliferation;Cells;Chronic;Clinical;Corticotropin;Development;Dexamethasone;Diet;Differentiation and Growth;Embryonic Development;Endocrine;Erinaceidae;Experimental Models;Gene Mutation;Genetic;Gland;Goals;Growth;Health;Homeostasis;Hormone replacement therapy;Hormones;Label;Lead;Life;Location;Logic;Maintenance;Mesenchymal;Molecular;Mus;Natural regeneration;Patients;Physiological;Physiology;Play;Population;Production;Property;Regulation;Replacement Therapy;Reporter;Role;Signal Pathway;Signal Transduction;Sodium Chloride;Sonic Hedgehog Pathway;Stem cells;Steroids;Stress;System;Tamoxifen;Testing;Time;beta catenin;capsule;cell cortex;gain of function;gene repair;improved;interest;loss of function;mouse model;novel;postnatal;progenitor;research study;response;smoothened signaling pathway;stem;stem cell population;steroid hormone;tool","Molecular Regulation of Adrenal Cortex Homeostasis and Remodeling","
The cortex, or outer region, of the adrenal gland produces steroid hormones throughout life; if hormone
production is disrupted due to genetic mutation, as occurs in about 1:15000 people, it is lethal without lifelong
daily hormone replacement therapy. This project will study the molecular mechanisms that maintain the cells
in the adrenal cortex that produce steroids. Greater understanding of these mechanisms may lead to improved
management of adrenal disorders and ultimately perhaps ways to treat patients by gene repair and cell
replacement therapy.","NIDDK","8280439","6/15/2012 12:00:00 AM","PA-07-070","5R01DK081515-04","5","R01","DK","081515","04"," ","SATO, SHERYL M","7/20/2009 12:00:00 AM","6/30/2014 12:00:00 AM","Molecular and Cellular Endocrinology Study Section[MCE]"," ","6412130","LAUFER, EDWARD ","Not Applicable","13","PATHOLOGY","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","SCHOOLS OF MEDICINE","100323725","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","213172","130035"," ","343207",
"Genetics; Human Genome; Kidney Disease; Pediatric; Prevention; Urologic Diseases","4 year old;Accounting;Animal Model;Apoptosis;Binding;Bradykinin B2 Receptor;Cells;Checkpoint kinase 1;Child;Chronic Kidney Failure;Code;Congenital Abnormality;Congenital Disorders;CpG Islands;DNA Sequence;Deacetylation;Duct (organ) structure;Dysplasia;Embryo;Environmental Exposure;Epigenetic Process;Epithelial;Excision;Gene Expression;Gene Mutation;Genetic Crosses;Genetic Transcription;HDAC1 gene;Histone Code;Histone H3;Hypermethylation;Kidney;Kidney Diseases;Lysine;Mediating;Mediator of activation protein;Mesenchyme;Metanephric Diverticulum;Methylation;Modification;Mus;Mutant Strains Mice;Mutation;Nephrons;Organ;Organogenesis;Pathway interactions;Phenotype;Phosphorylation;Physiological;Predisposition;Prevention;Preventive;Protein p53;Regulation;Reporter;Repression;Sodium Chloride;Stress;TP53 gene;Testing;Therapeutic;Transcriptional Activation;Tumor Suppressor Proteins;Urinary tract;demethylation;epithelial to mesenchymal transition;fetal;gene environment interaction;gene repression;hepatic nuclear factor 1;human HDAC1 protein;human disease;malformation;mutant;nephrogenesis;prevent;progenitor;programs;promoter;receptor;spatiotemporal;stressor;transcription factor","Inducible Dysplastic Nephropathy in B2-Deficient Mice","Congenital malformations of the kidney and urinary tract account for up to 40% of chronic kidney failure in children less than 4 years of age. In addition to mutations in the DNA sequence, abnormal kidney development may result from alterations in the ""epigenetic code"". Stable alterations in the epigenetic code resulting from transient environmental exposures can permanently disrupt the fetal gene expression 
program. Thus, understanding how a defined genetic mutation (e.g., BdkrB2-/-) interacts with a defined embryonic stressor (gestational salt) to alter the regulation of kidney development may open new avenues to the treatment or prevention of kidney and urinary tract malformations.","NIDDK","8271443","4/9/2012 12:00:00 AM","PA-07-070","5R01DK056264-12","5","R01","DK","056264","12"," ","MOXEY-MIMS, MARVA M","5/1/2000 12:00:00 AM","4/30/2015 12:00:00 AM","Urologic and Kidney Development and Genitourinary Diseases Study Section[UKGD]"," ","1895538","EL-DAHR, SAMIR S","Not Applicable","01","PEDIATRICS","053785812","XNY5ULPU8EN6","053785812","XNY5ULPU8EN6","US","29.935453","-90.123916","8424601","TULANE UNIVERSITY OF LOUISIANA","NEW ORLEANS","LA","SCHOOLS OF MEDICINE","701185665","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","184883","90593"," ","275476",
"Lung; Orphan Drug; Rare Diseases","Adult;Aerosols;Alveolar;Attenuated;Binding;Biological Assay;Biological Markers;Biopsy;Bleomycin;Blood;Breathing;Cadherins;Cell Nucleus;Cell surface;Cells;Clinical;Clinical Trials;Complex;Critical Pathways;Data;Development;Disease;Drug Delivery Systems;E-Cadherin;Enzyme-Linked Immunosorbent Assay;Epithelial;Epithelial Cells;Experimental Models;Fibrosis;Figs - dietary;Generations;Goals;Hamman-Rich syndrome;Homeostasis;Human;Instruction;Integrins;Laminin;Lead;Liquid substance;Luciferases;Lung;Lung diseases;Maps;Mesenchymal;Modeling;Mus;Myofibroblast;Nuclear;Pathway interactions;Patients;Peptides;Pharmaceutical Chemistry;Pharmaceutical Preparations;Phase;Phosphorylation;Physiological Processes;Process;Property;Proteins;Pulmonary Fibrosis;Pulmonary Surfactant-Associated Protein C;Reagent;Recombinants;Reporter;Role;Screening procedure;Signal Pathway;Signal Transduction;Site;System;TGFB1 gene;Testing;Tetracyclines;Therapeutic;Transgenic Mice;Transgenic Organisms;Translations;Tyrosine;Work;attenuation;base;cohort;drug development;drug testing;effective therapy;empowered;fibrogenesis;human tissue;in vivo;indium-bleomycin;inhibitor/antagonist;injured;interstitial;mutant;novel therapeutic intervention;novel therapeutics;research study;small molecule;small molecule libraries;tool","Inhibitors of Epithelial TGFB signaling and EMT/Sheppard","RELEVANCE (See instructions): 
There is currently little in the way of effective treatment for the most common form of adult fibrotic lung disease. Idiopathic Pulmonary Fibrosis. To date no drugs tested in these patients were developed specifically to treat pulmonary fibrosis. This application is intended to deliver promising reagents with drug like properties as new therapeutic approaches specifically developed against pathways critical to lung fibrogenesis.","NHLBI","8401277","8/9/2012 12:00:00 AM","PAR-09-185","1P01HL108794-01A1","1","P01","HL","108794","01","A"," "," "," ","ZHL1-CSR-Q(M1)","7489","1881986","CHAPMAN, HAROLD A","Not Applicable","12","Unavailable","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","Domestic Higher Education","941432510","UNITED STATES","N","8/9/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","440422","440422"," ","281420","159002"," "," ",
"Genetics; Lung; Rare Diseases","Alveolar;Apoptosis;Apoptotic;Biochemical;Biological Markers;Bleomycin;Blood specimen;Catalytic Domain;Cell Survival;Cells;Cessation of life;Chronic;Client;Clinical Trials;DNA Damage;Development;Disease;Dose;Drug Delivery Systems;Effectiveness;Endoplasmic Reticulum;Epithelial Cells;Etiology;Event;Exhibits;Fibrosis;Functional disorder;Future;Genetic;Genetic Models;Hamman-Rich syndrome;Hermanski-Pudlak Syndrome;Homeostasis;Human;In Vitro;Injury;Instruction;Integral Membrane Protein;Learning;Link;Logic;Lung;Lung diseases;Mediating;Messenger RNA;Modeling;Modification;Molecular Chaperones;Monitor;Mus;Mutation;Organelles;Output;Pathogenesis;Pathway interactions;Patients;Pharmaceutical Chemistry;Pharmaceutical Preparations;Phase;Phosphotransferases;Process;Proteins;Pulmonary Fibrosis;Pulmonary Surfactant-Associated Protein C;RNA Splicing;Ribonucleases;Screening procedure;Secretory Cell;Signal Pathway;Signal Transduction;Stress;Structure of parenchyma of lung;Testing;Therapeutic;Tissues;Translating;Tunicamycin;Validation;Work;arm;base;cohort;combat;endoplasmic reticulum stress;epithelial to mesenchymal transition;exhaust;human tissue;immortalized cell;improved;in vivo;indium-bleomycin;inhibitor/antagonist;insight;kinase inhibitor;mRNA Decay;mouse model;mutant;novel;pre-clinical;prevent;programs;protein folding;repaired;research clinical testing;response;small molecule;surfactant;theories;transcription factor","Drugs to combat ER stress-induced dysfunction of AECIIs/Sheppard","RELEVANCE (See instructions): 
We are developing drugs to treat an incurable lung disease called idiopathic pulmonary fibrosis. Our drugs are expected to work by preventing the death of special lung cells called AECs. We theorize that preventing the death of AECs in this manner may be therapeutically benficial to patients suffering from idiopathic pulmonary fibrosis.","NHLBI","8401271","8/9/2012 12:00:00 AM","PAR-09-185","1P01HL108794-01A1","1","P01","HL","108794","01","A"," ","8/9/2012 12:00:00 AM","7/31/2017 12:00:00 AM","ZHL1-CSR-Q(M1)","7485","1885698","PAPA, FEROZ R","Not Applicable","12","Unavailable","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","Domestic Higher Education","941432510","UNITED STATES","N","8/9/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","427067","427067"," ","272886","154181"," "," ",
"Hematology; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human","Address;Adopted;Adoptive Transfer;Adult;Animals;Antibodies;Autoantibodies;Autoimmune Process;Autoimmunity;B-Lymphocytes;Biological Models;Bone Marrow;CD5 Antigens;Cell Count;Cell Differentiation process;Cell physiology;Cells;Coculture Techniques;Degenerative Disorder;Development;Disease;Elderly;Engineering;Evaluation;Fostering;Foundations;Functional disorder;Future;Gene Expression;Goals;Hand;Health;Hematopoietic;Hematopoietic stem cells;Host Defense;Human;Human Characteristics;Human Identifications;Immune;Immune response;Immunocompromised Host;Immunoglobulin M;Immunoglobulins;Immunosuppressive Agents;In Vitro;Infection;Infectious Agent;Inflammatory;Interleukin-10;Knowledge;Laboratories;Lead;Lupus;Lymphocyte;Lymphopoiesis;MS4A1 gene;Malignant Neoplasms;Mesenchymal;Mus;Nature;Phenotype;Play;Population;Production;Reaction;Regulation;Role;Signal Transduction;Sorting - Cell Movement;Staging;Stem cells;System;T cell differentiation;T-Cell Proliferation;T-Lymphocyte;Therapeutic;Therapeutic Intervention;Transcript;Umbilical Cord Blood;Work;adaptive immunity;base;cytokine;design;high risk;innate immune function;meetings;microbial;novel strategies;patient population;peripheral blood;progenitor;reconstitution;therapy design","Human B1 Lymphopoiesis"," A specialized population of B lymphocytes, termed B1 cells, produces so-called ""natural"" antibodies that protect against microbial infection but are associated with autoimmunity. Although well described in animals, B1 cells were only recently identified in humans by the applicant laboratory which determined the phenotype, or address, of these immune cells. We now propose to identify the human B1 cell progenitor which is the stem cell for B1 cells and gives rise to this specialized population; identification and characterizatio of the human B1 cell progenitor will make it possible to design B1 cell-directed therapies to increase protective natural antibodies or decrease autoimmune reactions.   
   
      

","NIAID","8385892","6/25/2012 12:00:00 AM","PA-11-261","1R21AI095787-01A1","1","R21","AI","095787","01","A","NASSERI, M FARAZ","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Cellular and Molecular Immunology - B Study Section[CMIB]"," ","1871601","ROTHSTEIN, THOMAS L","Not Applicable","03","Unavailable","110565913","C5LHMPRJ9J19","110565913","C5LHMPRJ9J19","US","40.772985","-73.703245","4155008","FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH","MANHASSET","NY","Research Institutes","110303816","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","855","Non-SBIR/STTR","2012"," "," ","NIAID","125000","83750"," ","208750",
"Clinical Research; Kidney Disease; Pediatric; Polycystic Kidney Disease; Urologic Diseases","Affect;American;Anatomy;Binding;Birth;Cell Culture Techniques;Cell Line;Cell Polarity;Cell division;Cells;Cellular Structures;Child;Childhood;Collagen;Congenital Abnormality;Cyst;Cystic kidney;Cytoskeletal Proteins;Defect;Development;Developmental Gene;Developmental Process;Disease;Drosophila genus;Duct (organ) structure;Elements;Embryo;End stage renal failure;Endoderm;Engineering;Epithelial;Epithelium;Family;Gel;Gene Family;Genes;Glycoproteins;Goals;Human;Illinois;In Vitro;Intermediate Mesoderm;Kidney;Knock-out;Knockout Mice;MAPK8 gene;MDCK cell;Measurement;Mesenchymal;Mesenchyme;Messenger RNA;Metanephric Diverticulum;Metanephric structure;Modeling;Molecular Profiling;Morphogenesis;Morphology;Mus;Newborn Infant;Nuclear;Organelles;Partner in relationship;Pathway interactions;Pattern;Phenotype;Physiological;Play;Polycystic Kidney Diseases;Process;Prostate;Prostatic Tissue;Protein Family;Proteins;Renal tubule structure;Reporting;Role;Signal Pathway;Signal Transduction;Structure;System;Testing;Therapeutic Intervention;Tissues;Tubular formation;Universities;Urinary tract;Wild Type Mouse;Zebrafish;cell motility;design;directional cell;functional group;in vivo;kidney cell;member;neonate;nephrogenesis;novel;overexpression;prenatal;receptor;research study;zebrafish development","Wnt5a and Planar Cell Polarity in Kidney Development and Cyst formation"," Congenital anomalies of the kidney and urinary tract (CAKUT) constitute 20-30% of all birth defects identified in newborns, and is the cause of up to 50% of childhood end-stage kidney disease. Wnt5a is a member of the Wnt gene family, a group of very important developmental genes, and mice without Wnt5a lack kidneys. The proposed experiments are designed to determine the mechanism by which Wnt5a regulates kidney development, with the successful completion of these experiments resulting in the identification of novel candidate targets for therapeutic intervention in CAKUT, a disorder for which no treatments currently exist.      

","NIDDK","8383256","7/5/2012 12:00:00 AM","PA-11-193","1K08DK093625-01A1","1","K08","DK","093625","01","A","RANKIN, TRACY L","7/15/2012 12:00:00 AM","4/30/2017 12:00:00 AM","Kidney, Urologic and Hematologic Diseases D Study Section[DDK-D]"," ","10667775","HUANG, LIWEI ","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","7/15/2012 12:00:00 AM","4/30/2013 12:00:00 AM","847","Other Research-Related","2012"," "," ","NIDDK","143620","11490"," ","155110",
"Urologic Diseases","Accounting;Address;Adult;Affect;Androgen Receptor;Androgens;Award;Benign Prostatic Hypertrophy;Biology;Cell Differentiation process;Cell Line;Complex;Data;Development;Differentiation and Growth;Disease;Embryo;Embryonic Development;Epithelial;Epithelial Cells;Epithelium;Equilibrium;Event;Feedback;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Funding;Genetic;Growth;Growth Factor;Growth and Development function;Hormonal;Human;Human Cell Line;Image;Imaging Techniques;K-Series Research Career Programs;Knowledge;Laboratories;Malignant neoplasm of prostate;Mesenchymal;Mesenchyme;Modeling;Molecular;Morphogenesis;Mus;National Institute of Diabetes and Digestive and Kidney Diseases;Organogenesis;Output;Pathologic;Pathway interactions;Pharmaceutical Preparations;Phosphatidylinositols;Phosphotransferases;Play;Process;Prostate;Prostatic;Prostatic Diseases;Public Health;Publishing;Receptor Signaling;Regulation;Research;Role;Signal Pathway;Signal Transduction;Stromal Cells;System;Testing;Time;Tissues;Transgenic Mice;Urogenital Sinus;Work;cell motility;gain of function;in vivo;innovation;intercellular communication;interest;kidney allograft;loss of function;mTOR protein;migration;mouse model;novel;paracrine;receptor function;research study;spatial integration;stem","Role of mTORC1 In The Regulation Of  Prostatic Branching Morphogenesis"," There is increasing evidence that many of the signaling pathways that regulate prostatic growth during embryonic development are reactivated in adult diseases, such as benign prostatic hyperplasia and cancer. We have preliminary data that suggests the mTORC1 signaling pathway is important during prostatic development, and we propose to study how its activation may suppress the growth of prostatic epithelial tubules. This pathway is of particular interest because there are numerous drugs available for modulating its activity that may be useful for the treatment of human prostate diseases once we fully understand how the pathway works.      

","NIDDK","8427059","9/26/2012 12:00:00 AM","PAR-09-230","1R03DK097375-01","1","R03","DK","097375","01"," ","RANKIN, TRACY L","9/30/2012 12:00:00 AM","7/31/2014 12:00:00 AM","Kidney, Urologic and Hematologic Diseases D Study Section[DDK-D]"," ","10098443","LOTAN, TAMARA LEVIN","Not Applicable","07","PATHOLOGY","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","9/30/2012 12:00:00 AM","7/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","50000","31000"," ","81000",
"Aging; Cancer; Complementary and Alternative Medicine; Prevention; Prostate Cancer; Urologic Diseases","Actins;Adherens Junction;Animal Model;Biological Markers;Cancer Model;Cancer Patient;Cause of Death;Cells;Chronic Disease;Clinical;Clinical Trials;Colorectal Cancer;Consumption;Country;Cytoskeleton;Development;Diet;Disease;Down-Regulation;Epithelial;Experimental Models;Family;Gene Targeting;Genetic Transcription;Genistein;Head and Neck Squamous Cell Carcinoma;Healthcare;Healthcare Systems;Human;In Vitro;Incidence;Isoflavones;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Medical;Metastatic Prostate Cancer;Modeling;Molecular;Molecular Target;Neoplasm Metastasis;Neoplasms;Oncogenes;Patients;Pharmaceutical Preparations;Phenotype;Pre-Clinical Model;Prevention;Preventive;Printing;Prostate;Proteins;PubMed;Regulation;Reporting;Repression;Risk;Role;Signal Transduction;Snails;Solid Neoplasm;Staging;Surrogate Endpoint;Testing;Tumor Suppressor Proteins;United States;Xenograft Model;base;cancer cell;cost;cost effective;epithelial to mesenchymal transition;improved;in vivo;inhibitor/antagonist;link protein;lymph nodes;malignant breast neoplasm;men;mortality;novel;pre-clinical;prevent;promoter;soy;survivorship;tumor","EPLIN as a Molecular Target of Genistein in Preventing Prostate Cancer Metastasis"," EPLIN as a Molecular Target of Genistein In Preventing Prostate Cancer Metastasis Metastasis is the major cause of death from prostate cancer, the most common cancer in men in Western countries. Although several new drugs are currently available for the management of metastatic disease, these therapies can only extend the median survival by approximately 3 months at high cost, which poses a huge burden on patients, their families and the healthcare system. Given the promise of genistein as a safe, efficacious and cost-effective preventive agent that could be implemented before the development of metastasis, it is imperative to understand the molecular mechanism by which genistein inhibits prostate cancer metastasis. Our application will provide mechanistic basis and novel biomarkers for clinical investigation of genistein in the prevention of metastasis at early stages, which could significantly contribute to our efforts of reducing cancer mortality and improving healthcare in the United States and globally.   
      

","NCI","8386046","7/9/2012 12:00:00 AM","PA-10-088","1R21CA164612-01A1","1","R21","CA","164612","01","A","FU, YALI","7/9/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Chemo/Dietary Prevention Study Section[CDP]"," ","7698409","WU, DAQING ","Not Applicable","05","UROLOGY","066469933","S352L5PJLMP8","066469933","S352L5PJLMP8","US","33.762977","-84.42296","2384501","EMORY UNIVERSITY","ATLANTA","GA","SCHOOLS OF MEDICINE","303224250","UNITED STATES","N","7/9/2012 12:00:00 AM","6/30/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","130500","72863"," ","203363",
"Biotechnology; Genetics; Kidney Disease","3-Dimensional;Acids;Actins;Acute Kidney Failure;Adherens Junction;Adhesions;Adhesives;Binding;Biochemistry;Biological Assay;C-terminal;Cadherins;Caenorhabditis elegans;Calcium;Calmodulin;Calorimetry;Cell Adhesion;Cell Line;Cell Polarity;Cell model;Cell-Cell Adhesion;Cells;Cellular biology;Chimera organism;Collaborations;Collagen;Complex;Crystallography;Cultured Cells;Cyst;Development;Disease;Drosophila genus;E-Cadherin;Electrolytes;Epithelial;Epithelial Cells;Equilibrium;Event;F-Actin;Fibroblasts;Generations;Germ Cells;Goals;Health;Inflammation;Injury;Integral Membrane Protein;Kidney;Knowledge;Lateral;Ligand Binding;Link;MDCK cell;Measures;Mediating;Membrane Proteins;Mesenchymal;Modeling;Molecular;Morphogenesis;Mutate;N-terminal;Pathway interactions;Play;Positioning Attribute;Primordium;Process;Protein Binding;Protein Binding Domain;Proteins;Public Health;RNA Interference;Reagent;Recording of previous events;Regulation;Renal function;Role;SH3 Domains;Scaffolding Protein;Small Interfering RNA;Spottings;Testing;Tight Junctions;Tissues;Titrations;Transgenes;Tubular formation;Water;X-Ray Crystallography;analytical ultracentrifugation;base;crosslink;experience;human EMS1 protein;immunocytochemistry;injured;knock-down;mutant;novel;occludin;protein 4.1;protein protein interaction;repaired;research study;scaffold;sensor;solute","ZO-1 & Cytoplasmic Scaffolding of the Tight Junction","
PROJECT NARRATIVE
The proposed studies are aimed at understanding at a molecular level how the renal epithelial cell tight
junction barrier is formed. The public health significance is that loss of the barrier leads to acute renal
failure such as is common following ischemic and toxic injury. The findings will guide strategies to preserve
and restore the tubular barrier when injured.","NIDDK","8321006","8/21/2012 12:00:00 AM","PA-07-070","5R01DK061397-09","5","R01","DK","061397","09"," ","GREY, MICHAEL J","4/21/2003 12:00:00 AM","8/31/2014 12:00:00 AM","Cellular and Molecular Biology of the Kidney Study Section[CMBK]"," ","1920278","FANNING, ALAN SCOTT","Not Applicable","04","PHYSIOLOGY","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","366910","109395"," ","476305",
"Biotechnology; Digestive Diseases; Genetics; Pediatric","Actins;Address;Affect;Angioblast;Architecture;Automobile Driving;Behavior;Biological Assay;Biological Models;Birds;Blood;Blood Vessels;Cataloging;Catalogs;Cell Polarity;Cell Shape;Cells;Chickens;Childhood;Congenital Abnormality;Coupled;Cues;Cytoskeleton;Data;Development;Diagnosis;Dorsal;ES Cell Line;Embryo;Embryology;Enzymes;Exhibits;Failure;GTP-Binding Proteins;Gastrointestinal tract structure;Gel;Gene Expression;Gene Expression Regulation;Genes;Genetic;Goals;Heparan Sulfate Proteoglycan;Heparitin Sulfate;Human;Intestinal Volvulus;Intestines;Knockout Mice;Lasers;Lead;Learning;Left;Ligands;Link;Live Birth;Mediator of activation protein;Mesenchymal;Mesenteric Arteries;Mesentery;Microarray Analysis;Midgut;Modification;Molecular;Morphogenesis;Morphology;Mus;Mutant Strains Mice;Neoplasm Metastasis;Organ;Pathway interactions;Patients;Pattern;Physical condensation;Play;Positioning Attribute;Process;Property;Proteins;Publishing;Quail;Randomized;Research;Role;Rotation;Side;Signal Transduction;System;Technology;Testing;Time;Transplantation;Tube;Tubular formation;Vascular blood supply;Vascularization;angiogenesis;base;cell behavior;cellular targeting;chemokine receptor;chromatin immunoprecipitation;egg;extracellular;gene function;genetic manipulation;glypican 3;improved;in vivo;laser capture microdissection;member;molecular asymmetry;mouse model;neonate;novel;research study;rho;tissue repair;tool;transcription factor;tumor progression;vasculogenesis","Mechanisms underlying asymmetric rotation and vascular development of the midgut","  Gut malrotation is a birth defect of abnormal intestinal rotation that occurs once in approximately 500 live births. While malrotation predisposes affected babies to volvulus, a catastrophic strangulation of the intestine and its blood supply, th origin of this anomaly remains entirely unknown. We have developed the genetic tools to answer the fundamental questions surrounding proper gut rotation making use of the accessibility of the chicken egg and genetic mouse models to ultimately improve diagnosis in neonates.   
      

","NIDDK","8297300","2/28/2012 12:00:00 AM","PA-10-067","1R01DK092776-01A1","1","R01","DK","092776","01","A","CARRINGTON, JILL L","4/1/2012 12:00:00 AM","3/31/2017 12:00:00 AM","Intercellular Interactions Study Section[ICI]"," ","9815392","KURPIOS, NATASZA A","Not Applicable","23","OTHER BASIC SCIENCES","872612445","G56PUALJ3KT5","872612445","G56PUALJ3KT5","US","42.434772","-76.463216","1514802","CORNELL UNIVERSITY","ITHACA","NY","SCHOOLS OF VETERINARY MEDICINE","148502820","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","113554"," ","331054",
"Chronic Liver Disease and Cirrhosis; Digestive Diseases; Genetics; Liver Disease","5&apos; Untranslated Regions;Ablation;Address;Affect;Amyloid;Attenuated;Biology;Bone Marrow;Carbon Tetrachloride;Cells;Chronic;Cirrhosis;Clinical;Collagen;Collagen Type I;Data;Defect;Deposition;Development;Diphtheria Toxin;Dominant-Negative Mutation;Endotoxins;Enhancers;Exhibits;Extracellular Matrix Proteins;Fibrosis;Generations;Genetic;Genetic Recombination;Goals;Healthcare;Hematopoiesis;Hematopoietic;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;In Vitro;Inflammation;Inflammatory;Injury;Injury to Liver;Kidney;Ligation;Lipopolysaccharides;Liver;Liver Fibrosis;Lung;Lymphoid;Mediating;Mediation;Mediator of activation protein;Mesenchymal;Modeling;Mus;Mutation;Myelogenous;Myofibroblast;Organ;PTPRC gene;Pathogenesis;Patients;Peripheral;Phenotype;Physiological;Play;Population;Production;Property;Proteins;Proto-Oncogene Protein c-kit;Recruitment Activity;Reporter;Reporting;Role;Series;Serum;Signal Transduction;Skin;Source;Spleen;Staging;Tamoxifen;Techniques;Testing;Time;Transgenic Mice;Transplantation;Weight;Wild Type Mouse;antimicrobial;base;bile duct;care burden;cell motility;clinical application;diphtheria toxin receptor;fibrogenesis;in vivo;inhibitor/antagonist;injured;insight;mRNA Expression;migration;monocyte;mutant;novel;overexpression;prevent;progenitor;promoter;receptor;reconstitution;response;stem","The Role of Fibrocytes in Liver Fibrosis"," Hepatic fibrosis and its end stage, cirrhosis, represent an enormous health care burden worldwide. The goal of this study is to determine the role of bone marrow-derived fibrocytes, designated as Collagen Type I expressing hematopoietic cells, in the pathogenesis of liver fibrosis. Further understanding of fibrocyte biology (mechanism of migration, cellular origin, and contribution to fibrogenesis and inflammation) can make these cells an attractive target for anti-fibrotic therapy.   
      

","NIDDK","8545652","9/20/2012 12:00:00 AM","PA-11-260","1R56DK088837-01A1","1","R56","DK","088837","01","A","DOO, EDWARD","9/24/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Surgery, Anesthesiology and Trauma Study Section[SAT]"," ","10218445","KISSELEVA, TATIANA ","Not Applicable","52","INTERNAL MEDICINE/MEDICINE","804355790","UYTTZT6G9DT1","804355790","UYTTZT6G9DT1","US","32.881785","-117.236973","577507","UNIVERSITY OF CALIFORNIA, SAN DIEGO","LA JOLLA","CA","SCHOOLS OF MEDICINE","920930621","UNITED STATES","N","9/24/2012 12:00:00 AM","8/31/2014 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","125000","68750"," ","193750",
"Dental/Oral and Craniofacial Disease; Genetics; Neurosciences; Nutrition","Anterior;Automobile Driving;Back;Biological;Bone Morphogenetic Proteins;Cell Proliferation;Cells;Complex;Connective Tissue;Constitution;Development;Developmental Biology;Diet;Differentiation and Growth;Electroporation;Embryo;Environment;Epithelial;Epithelium;Equilibrium;Erinaceidae;Esthesia;Family;Food;Food Aversion;Food Preferences;Fungiform Papilla;Gene Expression;Gene Expression Profile;Gene Proteins;Genes;Genetic;Goals;Ingestion;Knockout Mice;Knowledge;Laboratories;Lead;Life;Location;Mesenchymal;Mesenchyme;Molecular;Molecular Profiling;Mus;Nerve;Nucleic Acid Regulatory Sequences;Nutrient;Organ;Organ Culture Techniques;Pathway interactions;Pattern;Physiological;Placenta;Protein Family;Regulation;Relative (related person);Reporter;Reporter Genes;Role;Sense Organs;Sensory;Sensory Receptors;Signal Transduction;Staging;Stimulus;Taste Bud Cell;Taste Buds;Taste Perception;Testing;Tissues;Tongue;Transfection;Transgenic Mice;Work;afferent nerve;base;experience;human SMO protein;insight;morphogens;neural circuit;novel strategies;progenitor;receptor;residence;response;smoothened signaling pathway;sonic hedgehog receptor;tongue papilla;transcription factor","Development of the Sense of Taste","
PROJECT NARRATIVE
The sense of taste is life-essential, in directing identification and ingestion or rejection of nutrients. Taste
buds reside, in the tongue, in taste papillae which are complex sensory organs. Thus developing papillae
contain cell and molecular information that ultimately determines taste bud formation. To understand the
developmental origins of nutrient selection, and the extent to which genetic makeup or early food
experience can determine food preferences and aversions, basic knowledge is needed about how the taste
papilla sense organs develop. It is necessary to know what periods of papilla development are rigidly
determined and what periods are vulnerable to influence from substances that cross the placenta after
maternal ingestion or access. Understanding the basic developmental biology of taste papillae also will
provide insight into formation of taste bud-sensory nerve interactions that set up the neural circuits for taste
sensation.","NIDCD","8277395","6/21/2012 12:00:00 AM","PA-07-070","5R01DC000456-24","5","R01","DC","000456","24"," ","SULLIVAN, SUSAN L","2/1/1988 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-IFCN-E(02)M]"," ","1861897","MISTRETTA, CHARLOTTE M","Not Applicable","12","DENTISTRY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF DENTISTRY/ORAL HYGN","481091276","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","173","Non-SBIR/STTR","2012"," "," ","NIDCD","203643","109875"," ","313518",
"No NIH Category available","Accounting;Acids;Advisory Committees;Alpha-glucosidase;Autologous;Biological Assay;CMV promoter;Canis familiaris;Cell Culture Techniques;Cell Therapy;Cell Transplantation;Cells;Collaborations;Complex;Core Facility;Data;Desmin;Development;Donor person;Down-Regulation;Duchenne muscular dystrophy;Dystrophin;Emery-Dreifuss Muscular Dystrophy;Engraftment;Exercise;Extracellular Matrix;Fatigue;Fibroblasts;Funding;Gene Expression;Gene Transfer;Genes;Genetic;Glycogen storage disease type II;Goals;Hematopoietic;Human;Immunodeficient Mouse;In Vitro;Individual;Injury;Kinetics;Knockout Mice;Knowledge;Laboratories;Lamin Type A;Lentivirus Vector;Lesion;Limb structure;Link;M-cadherin;MM form creatine kinase;Mesenchymal Stem Cells;Methods;MicroRNAs;Modeling;Molecular;Mononuclear;Mus;Muscle;Muscle Cells;Muscle Fibers;Muscle function;Muscle satellite cell;Muscular Dystrophies;Mutate;Mutation;Myoblasts;Myocardium;Myopathy;Natural regeneration;Nerve Degeneration;Neuroglia;Nuclear Lamin;Pericytes;Pharmaceutical Preparations;Phenotype;Population;Probability;Production;Progress Reports;Protein Isoforms;Proteins;Publications;RNA;Reagent;Regulation;Reporter;Research Design;Respiratory Diaphragm;Retinal;Retinoblastoma Protein;Role;Sarcolemma;Severities;Signal Pathway;Signal Transduction;Signaling Protein;Skeletal Muscle;Source;Stem cells;Study Subject;System;Tamoxifen;Testing;Therapeutic;Therapeutic Uses;Time;Tracer;Transgenic Mice;Transgenic Organisms;Translations;Transplantation;Utrophin;Work;Xenograft procedure;aquaporin 4;base;beta catenin;caveolin-3;cholesterol trafficking;disease phenotype;dystrobrevin;gene therapy;genetic manipulation;human ITGA7 protein;human disease;human embryonic stem cell;in vivo;interest;mdx mouse;meetings;member;migration;mouse model;muscle degeneration;muscle regeneration;myogenesis;palmitoylation;prevent;programs;public health relevance;reconstitution;research study;satellite cell;stem cell therapy;syntrophin;therapeutic protein;transduction efficiency;vector","Molecular and Cellular Therapies for Muscular Dystrophy","Public Health Relevance: Our goal is to develop methods that could be used to treat the muscular dystrophies (MDs). Stem cell therapy is a promising approach, but many limitations prevent its implementation at present. Our studies are designed to identify an accessible source of muscle stem cells that could be used for autologous stem cell therapies, and to genetically manipulate those cells to produce the protein missing in common MDs.","NINDS","8233488","3/20/2012 12:00:00 AM"," ","5P01NS046788-09","5","P01","NS","046788","09"," ","PORTER, JOHN D","4/15/2004 12:00:00 AM","3/31/2014 12:00:00 AM","Neurological Sciences and Disorders B Study Section[NSD-B]"," ","1887139","FROEHNER, STANLEY C","Not Applicable","07","PHYSIOLOGY","605799469","HD1WMN6945W6","605799469","HD1WMN6945W6","US","47.660049","-122.31441","9087701","UNIVERSITY OF WASHINGTON","SEATTLE","WA","SCHOOLS OF MEDICINE","981951016","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","877413","343785"," ","1221198",
"Arthritis; Autoimmune Disease","3-Dimensional;Adhesives;Arthralgia;Arthritis;Autoimmune Diseases;Autoimmunity;Automobile Driving;Basement membrane;Bathing;Behavior;Binding;Bone Marrow;Cadherin Domain;Cadherins;Cartilage;Cell Adhesion Molecules;Cell Line;Cell Lineage;Cell membrane;Cell physiology;Cells;Cleaved cell;Cost Measures;Cues;Cytoplasmic Protein;Degenerative polyarthritis;Desmosomes;Disease;Electrons;Epithelium;Extracellular Domain;Extracellular Matrix;Extracellular Space;Facies;Family;Fibroblasts;Functional disorder;Generations;Goals;Health;Human;Hyperplasia;Immune;Immune response;Immunoglobulins;Infiltration;Inflammation;Inflammatory;Inflammatory Response;Integral Membrane Protein;Investigation;Joints;Knockout Mice;Mediating;Mediator of activation protein;Mesenchymal;Microscopic;Modeling;Molecular;Mus;N-Cadherin;Nuclear Protein;Nutritional Support;Organ Culture Techniques;Osteoclasts;Pathogenesis;Pathologic;Pathway interactions;Patients;Perception;Physiology;Plasma;Play;Prevalence;Proteins;Publishing;Regulation;Rheumatoid Arthritis;Role;Science;Seminal;Series;Signal Transduction;Source;Structure;Swelling;Synovial Fluid;Synovial Membrane;System;Thick;Tight Junctions;Tissues;Work;abstracting;angiogenesis;bone;cadherin-11;career;extracellular;insight;joint destruction;macrophage;member;mouse model;public health relevance;research study;response;therapeutic development","Regulation of synovial fibroblast function via Cadherin-11 cleavage","
Abstract
Diarthrodial joints are lined by a highly specialized tissue called the synovium. In health, the synovial tissue is
thought to be the primary synthetic source of the viscous and lubricating synovial fluid that bathes the joint
tissues. Further, it is thought to provide nutritional support for the avascular cartilage tissue. In the context of
inflammatory arthritis, the synovial lining undergoes profound changes that include infiltration with bone
marrow derived lineages, hyperplasia and formation of a pathologic extension, termed 'pannus', that is thought
to contribute substantially to the destructive erosions evident in diseases such as rheumatoid arthritis (RA).
Despite longstanding appreciation for these synovial functions in health and disease, there exists very little
understanding of the molecular regulation of synovial tissue behavior. The PI has a primary career focus on
understanding synovial physiology in health and pathophysiology in the context of arthritis. With a goal of
gaining insight into the molecular regulation of synovial tissue, we have examined mechanisms by which a
member of the cadherin family of homophilic adhesion molecules-cadherin-11-modulates behavior of the
predominant mesenchymal lineage of synovial tissue, the synovial fibroblast (FLS). In initial collaborative
studies, the expression and function of cad11 on primary human FLS was established. In recently published
work (Science 315:1006-1010, 2007), the PI and his colleagues demonstrated that cad11 is expressed on ex
vivo primary FLS (and not on bone marrow derived lineages) and functionally modulates adhesive, migratory
and invasive capacities of these cells. He also demonstrated that healthy cad11-null mice display a
hypoplastic synovial lining thereby providing prima facie evidence for the contribution of cad11 to regulation of
FLS behavior in the synovial tissue. Examination of arthritic activity in a mouse model of inflammatory arthritis
demonstrates an ameliorated inflammatory response in cad11 null mice thus illustrating a primary involvement
of the FLS lineage in the overall pathophysiology of inflammatory arthritis. These studies also showed that
cad11 null mice are significantly protected from synovial fibroblast mediated cartilage erosion via pannus
tissue. In aggregate, these seminal analyses establish a new paradigm for our perception of the joint lining
tissue in health and disease. Now, in ongoing studies of synovial fluid from patients with RA, we have
discovered substantial quantities of soluble cad11 thereby implicating cleavage of cad11 as an active
mechanism in RA disease physiology. In a 'bedside-to-benchtop' approach, we demonstrate that cad11 is
cleaved on synovial fibroblasts to yield a secreted form as well as potentially bioactive cell-associated cad11
fragments. Guided by recently published studies of E- and N-cadherin in other tissues and cell lineages, we
hypothesize that regulated cleavage may be directly involved in the molecular pathways regulating FLS (and
by implication, synovial tissue) function. This submission proposes a series of investigations to dissect the
regulation of cad11 cleavage and functional consequences of this cleavage in primary human synovial
fibroblasts. It is anticipated that this translational activity will expand our understanding of disease
mechanisms in rheumatoid arthritis as well as provide rationale and context for development of therapeutics
directed at cad11 for patients with RA.","NIAMS","8247854","4/6/2012 12:00:00 AM","PA-07-070","5R01AR057382-03","5","R01","AR","057382","03"," ","MAO, SU-YAU","4/15/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Arthritis, Connective Tissue and Skin Study Section[ACTS]"," ","1860775","BRENNER, MICHAEL B.","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","216000","159386"," ","375386",
"Aging; Cancer; Prostate Cancer; Urologic Diseases","Affect;Animals;Biological;Biological Assay;Bone Growth;Bone Matrix;Bone Resorption;Bone remodeling;C-terminal;Cancer Patient;Cell Communication;Cell Line;Cell Proliferation;Cell Surface Receptors;Cell surface;Cleaved cell;Clinical;Clinical Trials;Complement Factor D;Data;Deposition;Diagnostic Neoplasm Staging;Event;Excision;Fibrin fragment D;Generations;Gleason Grade for Prostate Cancer;Goals;Growth;Growth Factor;Homeodomain Proteins;Human;In Vitro;Injection of therapeutic agent;LNCaP;Length;Ligands;Lytic;Malignant Epithelial Cell;Malignant neoplasm of prostate;Mediating;Mesenchymal;Metastatic Neoplasm to the Bone;Modeling;Molecular;N-terminal;Neoplasm Metastasis;Organ Culture Techniques;Osteoblasts;Osteoclasts;Osteogenesis;Osteolytic;PDGFRB gene;Phosphorylation;Platelet-Derived Growth Factor;Platelet-Derived Growth Factor Receptor;Platelet-Derived Growth Factor beta Receptor;Principal Investigator;Process;Prostate carcinoma;Prostatic Neoplasms;Proteolytic Processing;Proto-Oncogene Proteins c-sis;Reaction;Reading;Receptor Signaling;Regulation;Reporting;Research;Role;Sampling;Serine Protease;Signal Transduction;Signal Transduction Pathway;Site;Specimen;Stromal Cells;Stromal Neoplasm;Structure;Structure of base of prostate;Subcutaneous Injections;TNFSF11 gene;Tertiary Protein Structure;Testing;Therapeutic;Tumor stage;Tumor-Derived;Vascular Endothelial Growth Factors;bone;cell growth;cytokine;dimer;extracellular;in vitro Model;inhibitor/antagonist;matriptase;monomer;mouse model;neoplastic cell;novel;osteoblast differentiation;osteoclastogenesis;overexpression;paracrine;public health relevance;receptor;response;skeletal;tibia;tumor;tumor growth;tumor progression","PDGF D AND PROSTATE CANCER BONE METASTASIS","
Project Narrative
 Mesenchymal growth factors, produced by tumor cells, activate their cognate receptors expressed in
surrounding stromal cells, mediating tumor-stromal interactions. These interactions are thought to be critical
for tumor progression at both the primary and the metastatic sites. A vast majority of prostate cancer (PC)
metastases occur at skeletal sites. The mechanisms underlying the marked propensity of PC to metastasize to
bone are beginning to be understood. Although still debatable, it is believed that cell surface and secreted
factors produced by the tumor cells induce an osteoclastic response, a critical initial step for PC growth in
bones. Bone resorption by osteoclasts results in the release of growth factors and cytokines from the bone
matrix, providing a favorable microenvironment for tumor cell proliferation and invasion. Bone formation
follows or accompanies bone destruction, and these bone reactions eventually become extensive enough to be
visible on radiographs as both sclerotic and lytic reactions. Increasing evidence suggests that platelet-derived
growth factor (PDGF) mediates tumor-stromal interactions during human prostate cancer bone metastasis.
The goal of this project is to investigate the molecular mechanisms by which prostate carcinoma-produced
PDGF initiates bone remodeling, a critical event for tumor cell colonization to the bone. In this application, we
will test our hypothesis that the tumor-associated serine proteinase, matriptase, regulates the biological activity
of the newly discovered PDGF ligand, PDGF D, and that tumor-derived PDGF D regulates osteoclast
differentiation as well as osteoblast proliferation/differentiation critical for tumor cell growth.","NCI","8205007","1/4/2012 12:00:00 AM","PA-07-070","5R01CA123362-03","5","R01","CA","123362","03"," ","WOODHOUSE, ELIZABETH","1/1/2010 12:00:00 AM","12/31/2013 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1888624","KIM, HYEONG-REH CHOI","Not Applicable","13","PATHOLOGY","001962224","M6K6NTJ2MNE5","001962224","M6K6NTJ2MNE5","US","42.35738","-83.064737","9110501","WAYNE STATE UNIVERSITY","DETROIT","MI","SCHOOLS OF MEDICINE","482024000","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","104663"," ","305938",
"Bioengineering; Biotechnology; Cancer; Digestive Diseases; Pancreatic Cancer; Rare Diseases","Address;Adenocarcinoma Cell;Antimetastatic Agent;Biological Assay;Biological Markers;Biomedical Engineering;Blood Circulation;Blood Vessels;CD44 gene;Cancer Patient;Cancer cell line;Cardiovascular system;Cell Count;Cell Culture Techniques;Cell Survival;Cells;Characteristics;Chronic;Collecting Cell;Cytotoxic agent;Data;Development;Devices;Diagnosis;Disease;Disseminated Malignant Neoplasm;Early Diagnosis;Elements;Environment;Epithelial;Excision;Gases;Gel;Generations;Genetic;Harvest;Hypoxia;Implant;In Situ;In Vitro;Invaded;Laboratories;Link;Lymphatic System;MMP2 gene;Malignant Neoplasms;Malignant neoplasm of pancreas;Mesenchymal;Metabolic;Methods;Microfabrication;Microfluidics;Modeling;Molecular;Neoplasm Metastasis;Neoplasms in Vascular Tissue;Operative Surgical Procedures;Outcome;Oxidative Stress;Oxygen;Pancreas;Pancreatic Ductal Adenocarcinoma;Patients;Pattern;Play;Population;Primary Neoplasm;Proliferating;Proteomics;Resistance;Sampling;Screening procedure;Shock;Site;Staging;Stem cells;Survival Rate;System;Technology;Therapeutic;Time;Tissues;Travel;Treatment outcome;Variant;aggressive therapy;cancer stem cell;cell growth;cell motility;circulating cancer cell;clinically relevant;experience;improved;in vitro Model;in vivo;metastatic process;molecular marker;mortality;neoplastic cell;new technology;novel strategies;pancreatic neoplasm;response;stem cell therapy;therapeutic target;therapy development;therapy resistant;tumor","PDAC-on-a-Chip for Selection of Aggressive, Therapy-Resistant Tumor Cells"," The presence of hypoxia in pancreatic tumors is correlated with poor patient outcome. The proposed project focuses on the development of better in vitro models of tumor hypoxia and metastasis. This new technology will improve the screening of cytotoxic and antimetastatic agents, help find new targets for therapy and aid in the identificatio of relevant biomarkers for aggressive cancer. The overall objective is to improve treatment outcome in pancreatic cancer patients.   
      

","NCI","8384934","7/30/2012 12:00:00 AM","PA-11-298","1R03CA167471-01A1","1","R03","CA","167471","01","A","KNOWLTON, JOHN R","8/1/2012 12:00:00 AM","7/31/2014 12:00:00 AM","Instrumentation and Systems Development Study Section[ISD]"," ","1969023","GAMCSIK, MICHAEL ","Not Applicable","02","ENGINEERING (ALL TYPES)","042092122","U3NVH931QJJ3","042092122","U3NVH931QJJ3","US","35.832653","-78.645194","578204","NORTH CAROLINA STATE UNIVERSITY RALEIGH","RALEIGH","NC","BIOMED ENGR/COL ENGR/ENGR STA","276950001","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","50000","24500"," ","74500",
"Bioengineering; Biotechnology; Cancer; Genetics; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human","Antibodies;Area;Automation;Behavior;Bioinformatics;Biological;Biological Assay;Blood Vessels;CD47 gene;Cell Count;Cell Culture Techniques;Cell model;Cells;Chromatin;Chromatin Structure;Chromatin Structure Alteration;Complement;Culture Media;DNA;Data;Data Analyses;Devices;Diagnosis;Disease;Environment;Epigenetic Process;Fibroblasts;Gene Expression;Gene Expression Regulation;Genes;Genetic;Genomics;Growth;Growth Factor;Heterogeneity;Histones;Human;Human Resources;In Vitro;Individual;Investigation;Laboratories;Ligands;Malignant Neoplasms;Measurement;Mesenchymal;Methylation;Microfluidic Microchips;Microfluidics;Miniaturization;Modification;Molecular;Mus;Normal tissue morphology;Outcome;Pathway Analysis;Pathway interactions;Patients;Play;Polycomb;Population;Post-Translational Protein Processing;Proliferating;Property;Proteins;Protocols documentation;Radiopharmaceuticals;Recruitment Activity;Regulation;Regulatory Pathway;Resistance;Role;Schedule;Screening procedure;Sequence Analysis;Signal Transduction Pathway;Solid;Solid Neoplasm;Stem cells;Stratification;Stromal Cells;Support System;Supporting Cell;System;Techniques;Technology;Testing;Therapeutic;Therapeutic Agents;Time;Video Microscopy;Xenograft procedure;base;cancer cell;cancer stem cell;cancer therapy;cell behavior;cell growth;cell motility;chromatin immunoprecipitation;design;high throughput screening;in vitro Assay;in vitro testing;in vivo;insight;leukemia;malignant breast neoplasm;matrigel;neoplastic cell;new therapeutic target;research study;response;self-renewal;stem cell population;therapeutic target;time use;tool;transcription factor;tumor;tumor growth","Microfluidic Techniques for the Molecular and Functional Analysis of Gene Express","n/a","NCI","8375335","5/1/2012 12:00:00 AM","RFA-CA-08-020","5P01CA139490-04","5","P01","CA","139490","04"," "," "," "," ","ZCA1-SRRB-C","5042","2081455","QUAKE, STEPHEN R","Not Applicable","18","Unavailable","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","Domestic Higher Education","943052004","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","375144","375144"," ","239154","135990"," "," ",
"Bioengineering; Cancer; Dental/Oral and Craniofacial Disease; Nanotechnology; Rare Diseases","Behavior;Bioinformatics;Biological;Biological Markers;Biological Phenomena;Biometry;Breast Cancer Cell;Cancer Prognosis;Cell membrane;Cells;Clinic;Clinical;Color;Colorectal Cancer;Computer software;Data;Data Set;Databases;Detection;Development;Diagnostic Neoplasm Staging;Disseminated Malignant Neoplasm;E-Cadherin;Emerging Technologies;Epidermal Growth Factor Receptor;Epithelial;Flow Cytometry;Head and Neck Squamous Cell Carcinoma;Human;Image;Image Analysis;Immunohistochemistry;Literature;Lung;Machine Learning;Mesenchymal;Methodology;Methods;Modeling;NIH Program Announcements;Neoplasm Metastasis;Nomograms;Operative Surgical Procedures;Outcome;Population;Primary Neoplasm;Production;Quantum Dots;Reaction;Receiver Operating Characteristics;Research;Sampling;Sensitivity and Specificity;Signal Transduction;Site;Specificity;Specimen;Staining method;Stains;Standardization;System;Technology;Testing;Tissue Model;Tissues;Tumor Tissue;Tumor stage;Work;aldehyde dehydrogenases;anticancer research;base;cancer cell;cancer stem cell;clinical application;high risk;lymph nodes;model development;nanoparticle;neoplastic cell;novel;outcome forecast;tool;treatment planning;tumor","Developing a Platform for Prediction of Metastasis Using Multiplexed QD-imaging"," Imaging and quantifying expression and subcellular localization of multiplexed biomarkers is currently a challenge in cancer research and clinical application. This project aims to develop a platform which combines imaging and quantifying multiplexed biomarkers plus their correlation with lymph node metastasis of squamous cell carcinoma of the head and neck. This platform can be used for an assessment of LNM which is paramount for appropriate treatment planning.  
    

","NCI","8307808","7/3/2012 12:00:00 AM","PA-09-159","5R33CA161873-02","5","R33","CA","161873","02"," ","KIM, KELLY Y","7/27/2011 12:00:00 AM","6/30/2014 12:00:00 AM","Cancer Biomarkers Study Section[CBSS]"," ","1888499","CHEN, ZHUO GEORGIA","HOYT, CLIFFORD C","05","INTERNAL MEDICINE/MEDICINE","066469933","S352L5PJLMP8","066469933","S352L5PJLMP8","US","33.762977","-84.42296","2384501","EMORY UNIVERSITY","ATLANTA","GA","SCHOOLS OF MEDICINE","303224250","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","288052","66791"," ","354843",
"No NIH Category available","Adult;Alleles;Animal Model;Birth;Cell Line;Cells;Chimeric Proteins;Chromosomal translocation;DNA Binding;DNA Binding Domain;DNA Microarray Chip;Defect;Development;Down-Regulation;Doxycycline;Embryo;Ewings sarcoma;Ewings sarcoma-primitive neuroectodermal tumor;Family;Fibroblasts;Gene Targeting;Genetic;Intraperitoneal Injections;Laboratories;Medical center;Mesenchymal;Microarray Analysis;Molecular;Morbidity - disease rate;Mus;Mutant Strains Mice;Mutation;Neurons;Oncogenic;Partner in relationship;Pathogenesis;Patients;Population;Protein p53;Signal Transduction;Skeletal system;Small Interfering RNA;Specimen;Suppressor Mutations;System;Tamoxifen;Testing;Time;Tissues;Transgenes;Transgenic Mice;Tumor Suppressor Genes;Veterans;Work;cancer type;cell type;chromatin immunoprecipitation;clinically relevant;in vivo;metaplastic cell transformation;mortality;mouse model;recombinase;relating to nervous system;sarcoma;transcription factor;transgene expression;treatment strategy;tumor;tumorigenesis;tumorigenic","EWS-Fli1 fusion protein and Ewing's sarcoma","PROJECT NARRATIVE Sarcoma is a significant cause of morbidity and mortality in the veteran population. I have chosen to study Ewing's sarcoma in this application since it represents a well characterized chromosomal translocation that generates a chimeric protein resembling oncogenic fusion proteins found in other types of cancer. In my practice here at Seattle VA Medical Center I have also encountered cases in which Ewing's sarcoma is found in older veteran patients. The lack of a relevant animal model is clearly a major impediment to understanding the molecular pathogenesis of Ewing's sarcoma and has contributed to the difficulty in turning the discovery of the t(11,22) translocation into a clinically relevant, detailed understanding of the mechanism of transformation. Establishment of a mouse model for Ewing's sarcoma will help to reveal how initiation and progression of Ewing's sarcoma occurs in vivo in a defined genetic setting, thus provide a useful platform to test new treatment strategies for Ewing's sarcoma.","VA","8243798","3/6/2012 12:00:00 AM","RFA-BX-11-001","1I01BX001025-01A2","1","I01","BX","001025","01","A"," ","1/1/2012 12:00:00 AM","12/31/2014 12:00:00 AM","Oncology A[ONCA]"," ","7742996","CHANSKY, HOWARD A","Not Applicable","09","Unavailable","020232971","W6J8APWKL9J1","020232971","W6J8APWKL9J1","US","47.563294","-122.312665","481094","VA PUGET SOUND HEALTHCARE SYSTEM","SEATTLE","WA","Independent Hospitals","981081532","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Biotechnology; Cancer; Genetics; Lung; Lung Cancer; Pediatric; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Affect;Anaplasia;Breeding;Cell Lineage;Cells;Child;Childhood;Clinical;Complement;Complex;Cyst;Cystic Lesion;DICER1 gene;Data;Development;Diagnostic;Disease;Disease Progression;Distal;Employee Strikes;Epithelial;Epithelial Cells;Epithelium;Erinaceidae;Fetal Development;Fibroblast Growth Factor;Generations;Genome Stability;Goals;Growth;Growth Factor;Inherited;International;Knowledge;Lesion;Lung;Lung Neoplasms;Lung diseases;Mediating;Mesenchymal;Mesenchyme;Messenger RNA;MicroRNAs;Mixed Neoplasm;Modeling;Molecular;Morphogenesis;Mutation;Natural regeneration;Organ;Organogenesis;Outcome;Pathogenesis;Pathway interactions;Patients;Phenotype;Physical condensation;Play;Pleuropulmonary Blastoma;Pregnancy;Process;Proliferating;Proteins;Rare Diseases;Registries;Regulation;Reporting;Role;Signal Pathway;Signal Transduction;Signaling Molecule;Solid;Staging;Stem cells;Study models;Syndrome;Testing;Therapeutic;Time;Tissues;Tumor Suppressor Proteins;beta catenin;blastema;cell growth;cell type;human disease;insight;loss of function;lung development;mouse model;neonate;neoplastic;novel;overexpression;paracrine;primitive cell;progenitor;prognostic;sarcoma;smoothened signaling pathway;tissue regeneration;tumor;tumorigenesis","Mechanisms of Dicer1 Function in Lung Organogenesis and Cystic Lung Disease"," The inherited PPB syndrome represents the first described human disease with Dicer1 mutations thus making PPB a unique model for uncovering how miRNAs control development and manifest in clinical disease. Understanding Dicer1 function in lung development and PPB pathogenesis is expected to broadly impact our understanding of miRNA mediated regulation in development and disease since this syndrome manifests as neoplastic and non-neoplastic disease in multiple organs. Molecular effectors of Dicer1 function are also anticipated to have potential diagnostic, prognostic and therapeutic utility.    

","NHLBI","8279184","5/31/2012 12:00:00 AM","PA-10-067","5R01HL109265-02","5","R01","HL","109265","02"," ","LIN, SARA","6/15/2011 12:00:00 AM","5/31/2015 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","8039342","WIKENHEISER-BROKAMP, KATHRYN ANN","Not Applicable","01","Unavailable","071284913","JZD1HLM2ZU83","071284913","JZD1HLM2ZU83","US","39.140882","-84.500494","615001","CINCINNATI CHILDRENS HOSP MED CTR","CINCINNATI","OH","Independent Hospitals","452293039","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","258699","123722"," ","382421",
"Clinical Research; Neurosciences; Pediatric; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Affect;Agonist;Alleles;American;Award;Basic Science;Biological Assay;Cell Culture Techniques;Cell Differentiation process;Cell Lineage;Cell Separation;Cells;Characteristics;Child;Childhood;Cochlea;Cochlear implant procedure;Data;EGF gene;Epithelial;Epithelium;Experimental Designs;Feedback;Fibroblast Growth Factor 2;Five-Year Plans;Flow Cytometry;Genes;Goals;Grant;Hair Cells;Harvest;Hearing;Hearing Aids;Hearing problem;Homeostasis;Immunohistochemistry;In Vitro;Inner Supporting Cell;Insulin-Like Growth Factor I;Knock-in Mouse;Labyrinth;LacZ Genes;Life;Light;Maintenance;Mesenchymal;Mitogens;Modeling;Mus;Natural regeneration;Neomycin;Neonatal;Otolaryngologist;Otology;Pathology;Pathway interactions;Physicians;Pillar Cell;Play;Population;Proliferating;Proliferation Marker;Property;Protocols documentation;Regulation;Reporter;Reporting;Research;Research Personnel;Reverse Transcriptase Polymerase Chain Reaction;Role;Scientist;Sensorineural Hearing Loss;Series;Signal Transduction;Sorting - Cell Movement;Stem cells;Supporting Cell;Surgeon;System;Techniques;Testing;Training;Transgenic Mice;Writing;body system;career;cell type;clinical practice;design;equilibration disorder;experience;hearing impairment;interest;pluripotency;postnatal;progenitor;programs;public health relevance;regenerative;research study;response;restoration;self-renewal;spatiotemporal;stem;stem cell population;therapeutic target","Regulation of Inner Ear Stem Cells","
Narrative:
Hearing loss affects over 30 million Americans. Current treatment including amplication with hearing aids and
cochlear implantation do not reverse one common underlying pathology, loss of hair cells. One potential
approach to restore hearing is cell replacement using endogenous stem cells and is the topic of this project.","NIDCD","8288858","6/13/2012 12:00:00 AM","PA-09-042","5K08DC011043-03","5","K08","DC","011043","03"," ","SKLARE, DAN","7/1/2010 12:00:00 AM","6/30/2015 12:00:00 AM","ZDC1-SRB-L(49)"," ","6823286","CHENG, ALAN GI-LUN","Not Applicable","18","OTOLARYNGOLOGY","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","173","Other Research-Related","2012"," "," ","NIDCD","217130","17370"," ","234500",
"Cancer; Dental/Oral and Craniofacial Disease; Rare Diseases","1-Phosphatidylinositol 3-Kinase;Affect;Biological Markers;Catalytic Domain;Cell Line;Cell Survival;Cell physiology;Code;Cytostatics;Epithelial;Epithelial Cells;Genetically Engineered Mouse;Head and Neck Cancer;Head and Neck Squamous Cell Carcinoma;Human;Image;In Vitro;Inflammation;Lead;MAPK8 gene;Mesenchymal;Modification;Molecular;Molecular Analysis;Mouth Neoplasms;Mus;Mutation;Neoplasm Metastasis;PDPK1 gene;PIK3CA gene;Pathway interactions;Patients;Principal Investigator;Process;Proto-Oncogene Proteins c-akt;Role;Serum;Signal Transduction;Testing;Therapeutic;Tobacco;Transcription Factor AP-1;Translating;Tumor Cell Invasion;Tumor Cell Line;angiogenesis;cell growth;cell motility;clinical application;cytotoxic;head and neck cancer patient;in vivo;inhibitor/antagonist;insight;kinase inhibitor;migration;mortality;mouse model;neoplastic cell;non-invasive monitor;oral cavity epithelium;outcome forecast;overexpression;prevent;programs;public health relevance;response;therapeutic target;tumor;tumor growth;tumor progression;tumorigenesis;tumorigenic;ubiquitin-protein ligase","The Role of PI3K Pathway in Head and Neck Cancer Invasion and Metastasis","
PROJECT NARRATIVE
This proposal will use state-of-the-art mouse models and experimental approaches to identify the molecular
mechanisms underlying head and neck cancer invasion and metastasis. The proposed studies will lead to
identification of biomarkers and therapeutic targets that will be directly translated into clinical applications for
treating head and neck cancer patients.","NIDCR","8231322","12/21/2011 12:00:00 AM","PA-10-067","5R01DE021788-02","5","R01","DE","021788","02"," ","VENKATACHALAM, SUNDARESAN","2/21/2011 12:00:00 AM","1/31/2016 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","8518685","LU, SHI-LONG ","Not Applicable","06","OTOLARYNGOLOGY","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","250000","121900"," ","371900",
"Biotechnology; Cancer; Genetics; Lung; Lung Cancer","Accounting;Affect;Anchorage-Independent Growth;Appearance;Cancer Etiology;Cancer Patient;Cell Culture Techniques;Cell Line;Cell Polarity;Cells;Cessation of life;Colorectal Cancer;Development;Diagnosis;E-Cadherin;Endometrial;Epithelial Cells;Epithelium;Future;Genetic;Goals;Growth;Human;Iloprost;Immunohistochemistry;In Vitro;Knockout Mice;Lung;Lung Neoplasms;MAPK8 gene;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of prostate;Measures;Methylation;Modeling;Molecular;Mus;N-Cadherin;Neoplasm Metastasis;Non-Small-Cell Lung Carcinoma;Pathway interactions;Peroxisome Proliferator-Activated Receptors;Phenotype;Play;Predisposition;Reporting;Role;Signal Transduction;Snails;Staging;Systemic Therapy;Tumor Suppression;Tumor Suppressor Genes;Tumor Suppressor Proteins;United States;Urethane;Woman;Work;base;cancer cell;cell growth;cell transformation;design;epithelial to mesenchymal transition;in vivo;knock-down;lung carcinogenesis;malignant breast neoplasm;men;migration;mouse model;novel;prevent;promoter;public health relevance;receptor;reconstitution;small hairpin RNA;therapeutic target;tumor","Role of the noncanonical WNT pathway in non-small cell lung cancer","
PROJECT NARRATIVE
Lung cancer is the leading cause of cancer death for both men and women in the United States. In fact, more
deaths will occur this year due to lung cancer than breast, prostate, and colorectal cancers combined. The
experimental strategies outlined in this project are designed to evaluate the contribution of the non-canonical
Wnt pathway to lung cancer and to identify genetic targets of this pathway that could be used to develop
potential small molecular therapeutic targets for the treatment of lung cancer.","NCI","8337394","8/24/2012 12:00:00 AM","PA-07-070","5R01CA138528-03","5","R01","CA","138528","03"," ","WOODHOUSE, ELIZABETH","9/2/2010 12:00:00 AM","5/31/2013 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","3116287","WINN, ROBERT A.","Not Applicable","06","INTERNAL MEDICINE/MEDICINE","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","8/24/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","98528"," ","299803",
"Cancer; Genetics","Affect;Apoptosis;Apoptotic;Automobile Driving;Binding;Biochemical;Cancer cell line;Cell Death;Cell physiology;Cells;Chromosomes;Complex;DNA;Disease;Drug Delivery Systems;Gene Expression;Goals;Growth;Human;Investigation;Knowledge;Life;Maintenance;Malignant - descriptor;Malignant Neoplasms;Methods;Microfilaments;Modeling;Molecular;Morbidity - disease rate;Motion;Neoplasm Metastasis;Nuclear;Outcome;Pathway interactions;Pharmaceutical Preparations;Process;Property;Protein Isoforms;Protein Subunits;RNA Splicing;RNA-Directed DNA Polymerase;Regulation;Reliance;Research;Ribonucleoproteins;Role;Signal Pathway;Signal Transduction;Signaling Pathway Gene;System;TINF2 gene;Telomerase;Telomere Capping;Telomere Maintenance;Testing;Time;Transcript;Translating;Up-Regulation;Variant;Work;addiction;base;cancer cell;cancer stem cell;cancer therapy;cell growth;cell motility;chemotherapeutic agent;chemotherapy;computerized data processing;epithelial to mesenchymal transition;hTR RNA;human TERT protein;inhibitor/antagonist;insight;killings;knock-down;mortality;mutant;neoplastic cell;novel;novel strategies;overexpression;research study;response;stem;synergism;telomere;therapy resistant;tumor;tumor progression","Synergism of telomere maintenance and telomerase with cancer-promoting signaling"," Cancer is a major cause of morbidity and mortality, expected to increase in the coming decades, and progress in therapies will require new cancer-specific drugs targeting the multiple cellular processes in cancer cells that interact to drive tumor progression and disease. These cancer-hallmark processes include high levels of telomerase, whose enzymatic activity is known to be essential to maintain telomeres, which protect chromosome ends. The proposed research will pursue the currently emerging understanding that the roles of telomerase also extend to promoting other crucial, cancer- driving cell pathways, and is anticipated to generate new approaches for anti-cancer therapies.   
      

","NCI","8372162","8/8/2012 12:00:00 AM","PA-11-260","2R01CA096840-11","2","R01","CA","096840","11"," ","PELROY, RICHARD","9/1/2002 12:00:00 AM","6/30/2017 12:00:00 AM","Cancer Genetics Study Section[CG]"," ","1887871","BLACKBURN, ELIZABETH H","Not Applicable","12","BIOCHEMISTRY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","8/8/2012 12:00:00 AM","6/30/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","193471","96288"," ","289759",
"Clinical Research; Kidney Disease; Organ Transplantation; Transplantation","Address;Animals;Biological Markers;Biopsy;Calcineurin inhibitor;Cells;Chronic;Chronic Kidney Failure;Clinical;Clinical Research;Collagen;Confocal Microscopy;Cyclosporine;Diagnosis;Diagnostic;Disease Progression;End stage renal failure;Enzymes;Epithelial Cells;Fibrosis;Genetic Transcription;Human;Hypoxia;Imaging technology;Immunosuppression;Immunosuppressive Agents;In Vitro;Incidence;Investigation;Kidney;Kidney Failure;Knockout Mice;Laboratories;Lead;Magnetic Resonance Imaging;Measures;Mediating;Mediator of activation protein;Methods;Molecular;Monitor;Mus;NADPH Oxidase;NF-kappa B;Nephrotoxic;Organ Transplantation;Outcome;Pathway interactions;Patients;Perfusion;Phagocytes;Pharmaceutical Preparations;Pimonidazole;Prevention;Primary Cell Cultures;Protein Isoforms;Public Health;Rattus;Renal function;Respiratory Burst;Role;Solid;Staining method;Stains;Tacrolimus;Testing;Therapeutic;Therapeutic immunosuppression;Tissues;Transplant Recipients;Transplantation;Tubular formation;Vertebral column;acetovanillone;base;blood oxygen level dependent;computerized;design;digital;diphenyleneiodonium;epithelial to mesenchymal transition;fibrogenesis;improved;molecular marker;nephrotoxicity;novel diagnostics;pathogen;patient population;renal hypoxia;renal scarring;research study;success;therapy development","The role of Nox2 in CNI-induced renal fibrosis"," Chronic kidney failure from calcineurin inhibitors is an important public health concern in organ transplant recipients. We propose in vitro, animal and human studies that examine the specific role of Nox2 as a mediator of kidney fibrosis. We also propose noninvasive imaging technologies to diagnose and monitor renal scarring from these drugs. If successful these studies could lead to the development of treatment targets and diagnostic/monitoring methods for the prevention of kidney fibrosis in organ transplant recipients.  
    

","NIDDK","8334055","9/11/2012 12:00:00 AM","PA-09-181","5R01DK092454-02","5","R01","DK","092454","02"," ","ABBOTT, KEVIN C","9/20/2011 12:00:00 AM","8/31/2016 12:00:00 AM","Pathobiology of Kidney Disease Study Section[PBKD]"," ","7840646","DJAMALI, ARJANG ","Not Applicable","02","INTERNAL MEDICINE/MEDICINE","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","SCHOOLS OF MEDICINE","537151218","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","224286","103159"," ","327445",
"Brain Cancer; Brain Disorders; Cancer; Genetics; Human Genome; Neurosciences; Rare Diseases","Award;Behavior;Bioinformatics;Biological Assay;Brain Neoplasms;Cells;ChIP-seq;Chromatin;Chromatin Structure;Classification;Coupled;DNA;DNA Methylation;Data;Diagnosis;Effectiveness;Enhancers;Ensure;Epigenetic Process;Foundations;Future;Gene Activation;Gene Expression;Gene Expression Profile;Gene Silencing;Genes;Genetic;Genomics;Glioblastoma;Histones;Human;Hypermethylation;Individual;Institution;Lead;Learning;Malignant Neoplasms;Maps;Measures;Mentors;Mesenchymal;Methods;Modification;Monitor;Neoplasm Metastasis;Normal Cell;Nucleic Acid Regulatory Sequences;Nucleosomes;Paper;Patients;Pattern;Phase;Positioning Attribute;Proteins;Radiation;Regulation;Research;Resolution;Role;Scientist;Site;Staging;Structure;Techniques;Testing;The Cancer Genome Atlas;Therapeutic;Time;Tumor Suppressor Genes;Tumorigenicity;Variant;Work;arm;base;cancer cell;carcinogenesis;career;career development;chemotherapy;chromatin remodeling;demethylation;design;epigenomics;genome wide association study;genome-wide;histone modification;malignant breast neoplasm;nerve stem cell;neural precursor cell;novel;novel strategies;novel therapeutic intervention;promoter;relating to nervous system;research study;response;therapeutic target;treatment response;tumor;tumorigenesis;tumorigenic","Epigenetic alterations underlying tumorigenic potential of Glioblastoma Cells"," Glioblastoma multiforme (GBM) is a particularly aggressive and fatal tumor with limited treatment options. The experiments outlined in this proposal aim to understand the epigenetic alterations that are present in GBM and determine the effectiveness of epigenetic therapy in reversing these alterations and reducing tumorigenic potential. Epigenetic alterations can drive tumorigenesis, determine malignancy, monitor treatment response, and be used to determine therapeutic approach. However, epigenetics alterations have not been well investigated in brain tumors.  
    

","NCI","8330963","9/12/2012 12:00:00 AM","PA-10-063","5K99CA160349-02","5","K99","CA","160349","02"," ","SCHMIDT, MICHAEL K","9/9/2011 12:00:00 AM","8/31/2013 12:00:00 AM","Institutional Training and Education Study Section (F)[NCI-F]"," ","10658604","KELLY, THERESA K.","Not Applicable","37","UROLOGY","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF MEDICINE","900894304","UNITED STATES","N","9/13/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","128700","10296"," ","138996",
"No NIH Category available","Actins;Adaptor Signaling Protein;Adhesions;Affinity;Ankyrin Repeat;Architecture;Binding;Binding Proteins;Binding Sites;Biochemical;Biological;Biological Assay;Blood Platelets;Blood Vessels;Brain;C-terminal;Cardiac;Cardiovascular system;Cell Adhesion;Cell Cycle Progression;Cell Survival;Cell physiology;Cells;Chondrocytes;Competence;Complex;Cytoplasmic Protein;Cytoplasmic Tail;Data;Development;Embryonic Development;Fishes;Foundations;Goals;Growth Factor;Health;Hemostatic function;Host Defense;In Vitro;Inflammatory;Integrin Binding;Integrins;Interruption;Kidney;Kidney Diseases;LIM Domain;LIMS1 gene;Maintenance;Measures;Mediating;Molecular;Mus;Muscle;Mutagenesis;Mutation;N-terminal;Pathway interactions;Phosphotransferases;Play;Protein Kinase;Proteins;Protocols documentation;Reporting;Resolution;Roentgen Rays;Role;Sequence Analysis;Signal Pathway;Signal Transduction;Site-Directed Mutagenesis;Skin;Structure;Substrate Specificity;System;T-Lymphocyte;Tail;Testing;Therapeutic;Tissues;Tumor Angiogenesis;X-Ray Crystallography;base;cancer therapy;cell growth;cell motility;design;epithelial to mesenchymal transition;fly;genetic analysis;high throughput screening;improved;integrin-linked kinase;intermolecular interaction;migration;repaired;tumor","Structure and function of the integrin-linked kinase-PINCH-parvin complex","
Project Narrative
The project aims to enhance our molecular and functional understanding of integrin-linked kinase-PINCH-
parvin (IPP) complex. This complex is essential for embryonic development, tissue maintenance and repair,
host defense and hemostasis. We will determine crystal structures, conduct functional studies and describe
the effects of mutations in cells. The proposed studies will help us understand how the IPP complex mediates
its critical cellular roles.","NIGMS","8311685","8/1/2012 12:00:00 AM","PA-07-070","5R01GM088240-04","5","R01","GM","088240","04"," ","NIE, ZHONGZHEN","8/17/2009 12:00:00 AM","7/31/2013 12:00:00 AM","Intercellular Interactions Study Section[ICI]"," ","7345529","CALDERWOOD, DAVID A","BOGGON, TITUS JONATHON","03","PHARMACOLOGY","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","205821","134813"," ","340634",
"Cancer","Affect;Alanine;Behavior;Binding;C-terminal;Carcinoma;Caveolins;Cell Nucleus;Cell surface;Cells;Characteristics;Clathrin;Complex;Cytoplasmic Tail;Disease;Endosomes;Epithelial;Epithelial Cells;Evaluation;Event;Fibrosis;Gene Expression;Gene Targeting;Goals;Growth and Development function;Injection of therapeutic agent;Link;Lung;Lung nodule;MAP Kinase Gene;MAPK14 gene;MAPK8 gene;Malignant Neoplasms;Mammary gland;Mass Spectrum Analysis;Mediating;Mesenchymal;Metastatic to;Mitogen-Activated Protein Kinases;Modeling;Mutate;Mutation;Neoplasm Metastasis;Pathogenesis;Pathway interactions;Phosphorylation;Phosphorylation Site;Phosphotransferases;Play;Process;Receptor Protein-Tyrosine Kinases;Repression;Role;Signal Pathway;Signal Transduction;Specificity;Squamous cell carcinoma;Tail;Transforming Growth Factor beta;Transforming Growth Factor beta Receptors;Tyrosine;Tyrosine Phosphorylation;Tyrosine Phosphorylation Site;Veins;human FRAP1 protein;in vivo;insight;knock-down;mouse model;mutant;receptor;response;rho;small hairpin RNA;subcutaneous;transcription factor;tumor;tumor progression","Role of Tyrosine Phosphorylation of TbRI"," TGF-b is known to activate several signaling pathways in addition to the better known Smad pathway, and these are known to play a significant role in cancer progression. My project aims to understand the roles of phosphorylation of the TGF-b receptor on tyrosines, on the activation of these pathways by TGF-b, and how these in turn affect the response of the cell to TGF-b. A better understanding of how TGF-b regulates these pathways through the function of its receptors will enable us to better define targets for treatment of misregulated TGF-b signaling in cancer and fibrosis.   
   
      

","NCI","8320603","9/12/2012 12:00:00 AM","PA-11-112","1F31CA168460-01","1","F31","CA","168460","01"," ","MCNEIL FORD, NICOLE","9/20/2012 12:00:00 AM","9/19/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-F05-P(20)L]"," ","10719941","SAETEURN, KOY Y.","Not Applicable","12","ANATOMY/CELL BIOLOGY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","941432510","UNITED STATES","N","9/20/2012 12:00:00 AM","9/19/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","32964"," "," ","32964",
"Biotechnology; Diabetes; Obesity","Adipocytes;Adipose tissue;Adult;Area;Binding;Biochemical;Biological Assay;Biology;Blood Vessels;Cardiovascular Diseases;Cell Line;Cell Transplantation;Cells;Chronic Disease;Clinical;Commit;Dana-Farber Cancer Institute;Data;Development;Electrophoretic Mobility Shift Assay;Embryo;Epidemic;Fatty acid glycerol esters;Fibroblasts;Gene Expression Profile;Genome;Goals;Health;Homeostasis;In Situ Hybridization;In Vitro;Incidence;K-Series Research Career Programs;Knowledge;Laboratories;Location;Luciferases;Malignant Neoplasms;Mediating;Mesenchymal;Metabolic Diseases;Molecular;Mus;Non-Insulin-Dependent Diabetes Mellitus;Nude Mice;Obesity;Obesity associated disease;Property;Protein Binding;Proteins;RNA;Regulation;Regulatory Element;Research;Research Personnel;Risk Factors;System;Tertiary Protein Structure;Testing;Therapeutic;Tissues;Transgenic Mice;Transplantation;Visceral;Work;adipocyte differentiation;base;career;chromatin immunoprecipitation;experience;in vivo;molecular marker;mouse development;novel;novel therapeutics;obesity treatment;postnatal;programs;protein protein interaction;research study;subcutaneous;tool;transcription factor","Zfp423 in the Control of Preadipocyte Determination","
Project Narrative
The rising incidence of obesity has increased the urgency of understanding the fundamental systems
controlling energy homeostasis, including the formation of fat tissue. The experiments described in this
proposal will establish and utilize an important tool for studying fat cell precursors in mice, and reveal the
molecular mechanisms controlling fat cell development. This knowledge will facilitate our attempts to
manipulate fat tissue biology as a therapeutic treatment for obesity and metabolic disease.","NIDDK","8318212","8/29/2012 12:00:00 AM","PAR-09-060","7K01DK090120-03","7","K01","DK","090120","03"," ","HYDE, JAMES F","9/30/2010 12:00:00 AM","2/28/2014 12:00:00 AM","Diabetes, Endocrinology and Metabolic Diseases B Study Section[DDK-B]"," ","8835421","GUPTA, RANA K","Not Applicable","30","INTERNAL MEDICINE/MEDICINE","800771545","YZJ6DKPM4W63","800771545","YZJ6DKPM4W63","US","32.814772","-96.841146","578404","UT SOUTHWESTERN MEDICAL CENTER","DALLAS","TX","SCHOOLS OF MEDICINE","753909105","UNITED STATES","N","9/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","847","Other Research-Related","2012"," "," ","NIDDK","127434","10195"," ","137629",
"Brain Disorders; Genetics; Neurosciences; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adult;Affect;Animals;Anterior;Blood - brain barrier anatomy;Brain;Brain Diseases;Brain Stem;Brush Cell;Cajal-Retzius cells;Case Study;Cell Cycle;Cell Nucleus;Cells;Cerebellar cortex structure;Cerebellar vermis structure;Cerebellum;Cerebral cortex;Cerebrospinal Fluid;Cerebrum;Characteristics;Child;Choroid Plexus Epithelium;Clinical;Congenital Abnormality;Cytoplasmic Granules;Data;Development;Developmental Biology;Diagnosis;Dorsal;Electroporation;Embryo;Evolution;Gene Expression;Genes;Genetic;Glutamates;Goals;Grant;Heterogeneity;Hippocampus (Brain);Human;Hydrocephalus;Image;In Vitro;Lateral;Lead;Left;Life;Lip structure;Location;Maintenance;Mammals;Maps;Medial;Memory;Mesenchymal;Microarray Analysis;Molecular;Motor;Mus;Mutant Strains Mice;Nature;Neuroepithelial;Neurons;Neurosciences;Pathway interactions;Pattern;Phenotype;Population;Process;Production;Property;Regulation;Relative (related person);Role;Series;Signal Pathway;Signal Transduction;Source;Specific qualifier value;Staging;Structure of choroid plexus;System;Testing;Tissues;Unipolar Neuron;Ventricular;base;cell behavior;cell fate specification;embryonic stem cell;genetic manipulation;granule cell;homeodomain;improved;in utero;insight;malformation;mutant;neurogenesis;novel;premature;progenitor;public health relevance;research study;stem cell population;transcription factor","Dorsal midline patterning in the vertebrate CNS","
Project Narrative
 With recent advances in imaging and genetics, malformations of the human brain are more frequently
recognized. These malformations cause neurodevelopmental and motor delays in affected children, yet we
know very little regarding which processes that go awry while the brain is developing or the underlying genetic
causes. This grant uses genetic manipulations in the mouse to define the organizational principles of the
embryonic stem cell populations that reside on the dorsal midline of the brain and generate vast numbers of
neurons in the adult brain responsible for memory and motor coordination. When these stem cell populations
develop abnormally, birth defects of the brain including cerebellar and cerebral malformations and
hydrocephalus result. An improved understanding of their basic developmental biology will ultimately lead to
improved diagnosis and eventually treatment for these devastating brain disorders.","NINDS","8311069","8/22/2012 12:00:00 AM","PA-10-067","5R01NS072441-03","5","R01","NS","072441","03"," ","RIDDLE, ROBERT D","9/30/2010 12:00:00 AM","7/31/2015 12:00:00 AM","Neurogenesis and Cell Fate Study Section[NCF]"," ","7138301","MILLEN, KATHLEEN JOYCE","Not Applicable","07","Unavailable","048682157","SZ32VTCXM799","048682157","SZ32VTCXM799","US","47.663628","-122.283919","1531401","SEATTLE CHILDREN'S HOSPITAL","SEATTLE","WA","Independent Hospitals","981053901","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","245000","232750"," ","477750",
"Bioengineering; Brain Cancer; Brain Disorders; Cancer; Genetics; Networking and Information Technology R&D; Rare Diseases","Accounting;Algorithms;Blood Vessels;Brain Neoplasms;Categories;Cell Nucleus;Cell Proliferation;Cellular Morphology;Characteristics;Classification;Clinical;Computer Simulation;Computer software;Coupled;Data;Data Analyses;Data Set;Databases;Dentistry;Environment;Erinaceidae;Gene Expression;Genetic;Histology;Human;Hypoxia;Image;Image Analysis;Immunohistochemistry;Informatics;Link;Maps;Measures;Medicine;Mesenchymal;Metadata;Methodology;Methods;Methylation;Modeling;Molecular;Molecular Profiling;Morphology;Motivation;Nanotechnology;Necrosis;New Jersey;Nuclear;Oligodendroglioma-Astrocytoma;Outcome;Pathology;Pathway interactions;Patients;Pattern;Peptides;Performance;Play;Preparation;Proto-Oncogene Proteins c-akt;Quantum Dots;Regulation;Relative (related person);Research;Research Infrastructure;Research Personnel;Resolution;Resources;Scientist;Semantics;Signal Transduction Pathway;Site;Slide;Specimen;Staining method;Stains;Stem cells;Structure;Students;System;Techniques;Texture;Transcriptional Activation;Tumor-Derived;Universities;Validation;Washington;Work;base;biomedical informatics;comparative;data management;design;information model;middleware;neoplastic cell;notch protein;novel;oncology;open source;outcome forecast;protein expression;repository;response;tool;transcription factor;tumor;tumor progression;validation studies;virtual","Informatics for Integrative Brain Tumor Whole Slide Analysis","
PROJECT NARRATIVE
High-resolution image analysis of digitized pathology slides coupled with molecular data has enormous
potential to provide additional information for stratifying patients in terms of prognosis and therapy. We propose
to develop methods, analytic pipelines, and data management tools that will make it feasible to systematically
carry out large-scale comparative analyses of brain tumor histological features and of patterns of protein and
gene expression. We will deploy a data repository populated with images, features, and analytic results from
our project that will provide a publicly available resource for brain tumor research.","NLM","8294579","6/1/2012 12:00:00 AM","PA-10-067","5R01LM011119-02","5","R01","LM","011119","02"," ","YE, JANE","7/1/2011 12:00:00 AM","5/31/2015 12:00:00 AM","ZLM1-ZH-C(01)"," ","1931248","SALTZ, JOEL H.","FORAN, DAVID J","05","PATHOLOGY","066469933","S352L5PJLMP8","066469933","S352L5PJLMP8","US","33.762977","-84.42296","2384501","EMORY UNIVERSITY","ATLANTA","GA","SCHOOLS OF MEDICINE","303224250","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","879","Non-SBIR/STTR","2012"," "," ","NLM","323118","138118"," ","461236",
"No NIH Category available"," ","3D Acellular Vascular Beds: Characterization and Re-endothelialization"," As the organ wait list continues to exceed the number of donors each year, the need for alternative therapies to transplantation is becoming increasingly important. Yet, researchers have demonstrated that a vascular connection is necessary in order to maintain viability in tissues beyond 100-200 microns thick. To date, there is no effective manner in which to recreate this vascular connection. The goal of our proposed research is to develop three-dimensional vascular beds from natural tissues, which can ultimately be used in scaffolds for tissue engineering applications requiring immediate vascularization or which can be used as stand-alone grafts for necrotic tissues in the body. To create the vascular construct we will use a decellularization procedure, which we have previously developed to accurately preserve the intricate micro-architecture of peripheral nerve, to remove the immunogenic cellular components from highly vascularized lung tissue and to simultaneously preserve the microvessel extracellular matrix. The vascular bed will be subsequently re- endothelialized with human mesenchymal stem cells (MSCs) that have been transdifferentiated into an endothelial cell phenotype. MSCs offer great potential for clinical translational because they are immune- privileged or they can be isolated from the patient. In addition, decellularized tissues offer clinical opportunities; in fact, most examples of current scaffold-based regenerative therapies utilize natural, acellular tissues (e.g., SIS products from Cook Biotech, AlloDerm from LifeCell, and Avance from AxoGen; note: the Avance nerve graft is based on the PI's decellularization processes for nerve tissue).  
    

","NIBIB","8655579","5/17/2013 12:00:00 AM","PA-10-010","7R21EB013358-03","7","R21","EB","013358","03"," ","HUNZIKER, ROSEMARIE","4/1/2011 12:00:00 AM","3/31/2015 12:00:00 AM","Bioengineering, Technology and Surgical Sciences Study Section[BTSS]"," ","1921325","SCHMIDT, CHRISTINE E","Not Applicable","03","BIOMEDICAL ENGINEERING","969663814","NNFQH1JAPEP3","969663814","NNFQH1JAPEP3","US","29.67667","-82.340932","513806","UNIVERSITY OF FLORIDA","GAINESVILLE","FL","BIOMED ENGR/COL ENGR/ENGR STA","326115500","UNITED STATES","N","1/1/2013 12:00:00 AM","3/31/2015 12:00:00 AM","286","Non-SBIR/STTR","2012"," "," ","NIBIB","146510","67238"," ","213748",
"Biotechnology; Clinical Research; Genetics; Pediatric; Regenerative Medicine; Stem Cell Research; Transplantation","Address;Alleles;Allogenic;Animal Model;Area;Autologous;Autologous Transplantation;Biological Assay;Biopsy;Bone Marrow;Bulla;Caring;Cell Therapy;Cells;Cessation of life;Child;Clinic;Clinical Data;Clinical Trials;Codon Nucleotides;Collagen Type VII;Complication;Coupled;Data;Derivation procedure;Disadvantaged;Disease;Disease model;Epidermis;Epidermolysis Bullosa;Epidermolysis Bullosa Simplex;Epigenetic Process;Epithelium;Exhibits;Fibroblasts;Freezing;Gene Expression;Generations;Genes;Genetic;Genetically Engineered Mouse;Genome;Growth;Harvest;Histocompatibility;Hot Spot;Human;Immune;Immune response;Immune system;Immunocompromised Host;Infection;Inherited;Junctional Epidermolysis Bullosa;Keratin;Laminin;Lesion;Life;Local Therapy;Mediating;Mesenchymal;Methods;Modeling;Molecular Profiling;Mus;Mutation;Natural Selections;Oral cavity;Oral mucous membrane structure;PDGFRB gene;Pain;Patients;Predisposition;Process;Proteins;Protocols documentation;RNA;Recruitment Activity;Reporting;Retroviral Vector;Safety;Skin;Skin Transplantation;Skin graft;Somatic Mutation;Source;Stem cells;Stratum Basale;Systemic Therapy;Technology;Testing;Therapeutic;Therapeutic immunosuppression;Tissues;Toxic effect;Transplantation;Tumorigenicity;Variant;Zinc Fingers;adult stem cell;base;chemotherapy;conditioning;design;disability;effective therapy;exhaust;exome;gene correction;homologous recombination;induced pluripotent stem cell;injured;interest;keratin 5;keratinocyte;mouse model;mutant;novel;nuclease;pre-clinical;prevent;repaired;research study;skin disorder;stem cell population;stem cell therapy;wound","Testing the Therapeutic Potential of iPS Cells for Inherited Skin Diseases"," Epidermolysis bullosa (EB) is a group of rare inherited skin blistering diseases that result in severe blistering and scaring, and in some cases, early death. Current therapy for EB is limited to wound care. We are proposing to develop stem-cell based therapies for EB using autologous induced pluripotent stem cells (iPSC) derived from skin cells harvested from the same EB patient. If the studies outlined in this application are successful, these pre-clinical data will pave the way for approval of iPSC-based clinical trials for EB patients.   
      

","NIAMS","8440187","9/15/2012 12:00:00 AM","PA-11-260","1R01AR059947-01A1","1","R01","AR","059947","01","A","BAKER, CARL","9/17/2012 12:00:00 AM","8/31/2017 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-A(02)M]"," ","7353750","ROOP, DENNIS ","TOLAR, JAKUB ","06","DERMATOLOGY","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","9/17/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","283500","73013"," ","356513",
"Breast Cancer; Cancer; Estrogen","Accounting;Actins;Address;Adhesions;American Cancer Society;Automobile Driving;Breast Cancer Cell;Cancer Patient;Cancer cell line;Cell model;Cells;Clinical;Communication;Community Outreach;Coupling;Cytoskeletal Modeling;Development;Disease;Distant;Distant Metastasis;Drug Delivery Systems;Epidermal Growth Factor;Estrogen Antagonists;Estrogen Receptor Modulators;Exposure to;Fellowship;Female;Foundations;Guanosine Triphosphate Phosphohydrolases;Human;In Vitro;Individual;Invaded;Light;Malignant Neoplasms;Mammary Gland Parenchyma;Mammary Neoplasms;Manuscripts;Measures;Mediating;Mediator of activation protein;Mesenchymal;Molecular;Neoplasm Metastasis;Outcome;Patients;Phenotype;Preparation;Process;Proteins;Receptor Protein-Tyrosine Kinases;Research;Research Personnel;Resistance;Role;SRC gene;Scientific Advances and Accomplishments;Signal Transduction;Site;Solid;Staging;Techniques;Testing;Therapeutic;Therapeutic Intervention;Time;Tissue Microarray;Training;Training Programs;Woman;Work;anticancer research;career;cell motility;gain of function;human BCAR1 protein;improved;in vivo;infiltrating duct carcinoma;insight;loss of function;malignant breast neoplasm;meetings;member;migration;mouse model;neoplastic cell;novel;novel strategies;protein-tyrosine kinase c-src;response;rho;rho GTPase-activating protein;skills;symposium;treatment strategy;tumor;tumor progression","BCAR3 and its Role in Breast Tumor Progression, Invasion, and Metastasis","One of the major challenges in treating breast cancer patients is that the tumor cells can invade, migrate, and metastasize to distant sites within the body. Metastatic disease is largely incurable and typically results in a poor clinical outcome. The 
proposed research strives to better understand the molecular mechanisms underlying breast cancer cell migration/invasion, tumor progression and metastasis in order to develop more effective therapeutic interventions.","NCI","8254034","3/1/2012 12:00:00 AM","PA-11-111","1F31CA165703-01","1","F31","CA","165703","01"," ","SCHMIDT, MICHAEL K","3/1/2012 12:00:00 AM","2/28/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-D(20)L]"," ","10843481","WILSON, ASHLEY LAUREN","Not Applicable","05","MICROBIOLOGY/IMMUN/VIROLOGY","065391526","JJG6HU8PA4S5","065391526","JJG6HU8PA4S5","US","38.034207","-78.512346","1526402","UNIVERSITY OF VIRGINIA","CHARLOTTESVILLE","VA","SCHOOLS OF MEDICINE","229044195","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","29078"," "," ","29078",
"Lung","5&apos;-Nucleotidase;Alveolar;Animal Model;Arachidonic Acids;Architecture;Cell Adhesion;Cell Line;Cell surface;Cells;Cicatrix;Collagen;Coupled;Cyclic AMP;Cyclic AMP-Dependent Protein Kinases;Deposition;Development;Dinoprostone;Disease;Effector Cell;Extracellular Matrix;Fibrinolysis;Fibroblasts;Fibrosis;Future;GTP-Binding Proteins;Hamman-Rich syndrome;Health;Histologic;Human;Injury;Lung;Lung diseases;Mediating;Mediator of activation protein;Mesenchymal;Modeling;Mus;Myofibroblast;PTEN gene;Pathogenesis;Patients;Peptide Hydrolases;Phenotype;Phosphoric Monoester Hydrolases;Plasmin;Plasminogen;Plasminogen Activator;Plasminogen Activator Inhibitor 1;Play;Production;Prostaglandin-Endoperoxide Synthase;Prostaglandins;Proteins;Pulmonary Fibrosis;Regulation;Relative (related person);Research;Role;Signal Transduction;System;Testing;Tissues;Transforming Growth Factors;Urokinase;Urokinase Plasminogen Activator Receptor;cell type;fatty acid metabolism;guanylate;inhibitor/antagonist;injured;insight;lipid mediator;lung injury;lung repair;novel;receptor;response","Control of fibroblast function by prostaglandin E2 and plasminogen activation","
Project Narrative
The development of a serious condition known as lung scarring (pulmonary fibrosis) is opposed by
two substances produced by the body, prostaglandin E2 and urokinase plasminogen activator. This
proposal will examine how these two substances act and interact to suppress scarring responses of
the key lung cell type known as the fibroblast. These studies will enhance our understanding of how
scarring responses are regulated, and may provide insight as to whether these substances could be
administered to patients to treat this devastating condition.","NHLBI","8294649","6/29/2012 12:00:00 AM","PA-07-070","5R01HL094311-04","5","R01","HL","094311","04"," ","LINK, REBECCA P","8/11/2009 12:00:00 AM","5/31/2013 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1899275","PETERS-GOLDEN, MARC L","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","7/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","128413"," ","375913",
"Biotechnology; Cardiovascular; Gene Therapy; Genetics; Heart Disease; Heart Disease - Coronary Heart Disease; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Address;Adopted;Angiopoietin-1;Animals;Antibodies;Apoptosis;Area;Blood Circulation;Blood Vessels;Bone Marrow Cell Transplantation;Bone Marrow Cells;CXCR4 gene;Cardiac;Cardiac Myocytes;Cell Culture Techniques;Cell Cycle;Cell Death;Cell Survival;Cell Therapy;Cell Transplantation;Cell Transplants;Cells;Cicatrix;Clinical Trials;Coculture Techniques;Complex;Cultured Cells;Data;Disease;Engraftment;Ensure;Exhibits;Experimental Designs;Experimental Models;Gene Delivery;Granulocyte Colony-Stimulating Factor;Growth Factor;Heart;Hematopoietic stem cells;Human;Image;Implant;In Vitro;Infarction;Injury;Ischemia;Ischemic Preconditioning;Lead;Left ventricular structure;Mediator of activation protein;Mesenchymal Stem Cell Transplantation;Microscopy;Modality;Muscle Cells;Myeloid Progenitor Cells;Myocardial;Myocardial Infarction;Myocardial Ischemia;Myocardial Revascularization;Myocardium;Natural regeneration;Nature;Non-Viral Vector;Outcome;Pathway interactions;Peripheral;Pharmacological Treatment;Phenotype;Play;Prevention;Principal Investigator;Printing;Process;PubMed;Published Comment;Publishing;Rattus;Regional Blood Flow;Regulatory Pathway;Reporting;Research Proposals;Role;Signal Pathway;Signal Transduction;Signaling Molecule;Site;Skeletal Myoblasts;Stem Cell Factor;Stem cell transplant;Stem cells;Stromal Cell-Derived Factor 1;Therapeutic;Tissues;Transfection;Transgenes;Transplantation;Ventricular Remodeling;Viral Vector;angiogenesis;base;cardiac repair;cytokine;cytokine therapy;density;functional improvement;genetically modified cells;heart cell;heart function;hemodynamics;improved;in vivo;injured;insight;mimetics;myogenesis;outcome forecast;overexpression;oxidant stress;paracrine;preconditioning;programs;protective effect;release factor;repaired;response;therapeutic gene;transdifferentiation","Preconditioning and re-programming of stem cells for cardiac repair","n/a","NHLBI","8206537","12/22/2011 12:00:00 AM","PA-07-070","5R01HL087288-05","5","R01","HL","087288","05"," ","ADHIKARI, BISHOW B","1/18/2008 12:00:00 AM","12/31/2013 12:00:00 AM","Special Emphasis Panel[ZRG1-CVS-D(03)M]"," ","11422658","HABEEBAHMED, RAFEEQ ","HAIDER, KHAWAJA H","01","PATHOLOGY","041064767","DZ4YCZ3QSPR5","041064767","DZ4YCZ3QSPR5","US","39.142998","-84.503581","1523902","UNIVERSITY OF CINCINNATI","CINCINNATI","OH","SCHOOLS OF MEDICINE","452210001","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","138600"," ","386100",
"Dental/Oral and Craniofacial Disease; Genetics; Pain Conditions - Chronic; Pain Research; Pediatric; Temporomandibular Muscle/Joint Disorder (TMJD)","Ablation;Accounting;Adhesions;Affect;Alleles;Animal Model;Ankylosis;Applications Grants;Biological Assay;Biological Models;Breathing;Cause of Death;Cells;Cephalic;Chondrocytes;Deglutition;Deposition;Development;Disease;Dyschondrosteosis;Dysplasia;EMSA;Embryonic Development;Enzymes;Exhibits;Fibrocartilages;Genes;Genetic;Genetic Transcription;Glenoid structure;Goals;Growth;Head;Heart;Histones;Homeobox Genes;Human;Hyaline Cartilage;In Vitro;Individual;Joints;Limb structure;Link;Mandible;Mandibular Condyle;Maxilla;Mesenchymal;Modification;Molecular;Morphogenesis;Mus;Mutant Strains Mice;Mutate;Mutation;Neural Crest;Oral cavity;Osteogenesis;Pattern;Phenotype;Phosphorylation;Play;Post-Translational Protein Processing;Protein Dephosphorylation;Protein Isoforms;Proteins;Relative (related person);Reporter;Reporting;Role;Site;Stem cells;Surface;Symptoms;Syndrome;Temporal bone structure;Temporomandibular Joint;Temporomandibular Joint Disorders;Testing;Transactivation;Trauma;Turner&apos;s Syndrome;Ubiquitin;Undifferentiated;United States;Variant;Wasting Syndrome;capsule;congenital infection;feeding;in vivo;jaw movement;mutant;postnatal","Shox2 and temporomandibular joint formation","
Project Narrative: The temporomandibular joint (TMJ) ankylosis is one of the major
symptoms of TMJ disorders that occur highly frequently humans. TMJ ankylosis is
clinically characterized by the formation of bone or fibrous adhesion of the joint
components, which restricts the jaw movement and causes difficulty in feeding,
swallowing, and breathing. Congenital TMJ ankylosis have been repored, but very little
is known about the underlying genetic alteractions. A conditional inactivation of the
homeobox gene Shox2 in the TMJ cells in mice leads to abnormal formation and
ankylosis of the TMJ. Thus the conditional Shox2 mutant mice provide a unique animal
model for studying TMJ development and TMJ ankylosis. This proposal studies the role
of Shox2 in the TMJ development and its functional mechanisms using in vitro and in
vivo approaches. The results obtained from this study will provide fundamental
information for our understanding of the formation and function of this unique joint in
humans.","NIDCR","8204861","12/14/2011 12:00:00 AM","PA-07-070","5R01DE017792-04","5","R01","DE","017792","04"," ","KUSIAK, JOHN W","1/1/2009 12:00:00 AM","12/31/2013 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1888311","CHEN, YIPING ","Not Applicable","01","ANATOMY/CELL BIOLOGY","053785812","XNY5ULPU8EN6","053785812","XNY5ULPU8EN6","US","29.935453","-90.123916","8424601","TULANE UNIVERSITY OF LOUISIANA","NEW ORLEANS","LA","SCHOOLS OF ARTS AND SCIENCES","701185665","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","232774","114059"," ","346833",
"Breast Cancer; Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Affect;African American;Area;BRCA1 gene;Basal Cell;Behavior;Biological;Biological Markers;Brain;Breast;Breast Cancer Cell;Breast Cancer Treatment;CSNK1A1 gene;Cell Proliferation;Cell model;Cell physiology;Cells;Characteristics;Classification;Clinical;Clinical Trials;Cytokeratin;Detection;Development;Diagnosis;Down-Regulation;EGF gene;ERBB2 gene;Embryonic Development;Epithelial Cells;Estrogen Receptors;Estrogen receptor negative;Gene Expression;Genes;Genetic Transcription;Goals;Human;Immunohistochemistry;Lung;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Mediating;Metastatic Neoplasm to the Lung;Metastatic malignant neoplasm to brain;Modality;Molecular;Molecular Profiling;Mouse Mammary Tumor Virus;Mus;Mutation;Myoepithelial;Myoepithelial cell;NF-kappa B;Neoplasm Metastasis;Phenotype;Progesterone Receptors;Property;Proteins;Regulation;Role;Signal Transduction;Stem cells;Subgroup;Surrogate Markers;Systemic Therapy;Testing;Therapeutic;Transgenic Mice;Up-Regulation;Woman;Xenograft Model;base;cell growth;chemotherapy;epithelial to mesenchymal transition;in vivo;insight;lymph nodes;malignant breast neoplasm;migration;molecular marker;mouse model;notch protein;outcome forecast;overexpression;p65;prevent;public health relevance;self-renewal;stem;trait;transcription factor;tumor;young woman","The role of FOXC1 in basal-like breast cancer","
Project Narrative
Basal-like breast cancer is a subtype of breast cancer which has the worst prognosis and is poorly understood.
Chemotherapy is the only systemic treatment for these breast cancers. Our study will help establish a critical
molecular marker for detection and diagnosis of basal-like cancers, and also help uncover the biological basis
for the cellular traits and phenotypes of basal-like breast cancer.","NCI","8228051","3/28/2012 12:00:00 AM","PA-10-067","7R01CA151610-02","7","R01","CA","151610","02"," ","SATHYAMOORTHY, NEERAJA","2/14/2011 12:00:00 AM","1/31/2016 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","9637365","CUI, XIAOJIANG ","Not Applicable","28","Unavailable","075307785","NCSMA19DF7E6","075307785","NCSMA19DF7E6","US","34.076546","-118.380008","1225501","CEDARS-SINAI MEDICAL CENTER","LOS ANGELES","CA","Independent Hospitals","900481804","UNITED STATES","N","3/28/2012 12:00:00 AM","1/31/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","207500","139025"," ","346525",
"Aging; Biotechnology; Cancer; Complementary and Alternative Medicine; Genetics; Prostate Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Urologic Diseases","Advanced Development;African American;Algorithms;Androgens;Animal Model;Attenuated;Binding Sites;Biological;Biological Availability;Biological Markers;Cancer Etiology;Cancer Patient;Cause of Death;Cell Proliferation;Cells;Cessation of life;Characteristics;Clinical Research;Complex;Curcumin;D Cells;Disease;Dose;Down-Regulation;EZH2 gene;Family;Formalin;Gene Targeting;Genetic;Growth;Human;In Vitro;Institution;Investigation;LNCaP;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;MicroRNAs;Molecular Profiling;Neoplasm Metastasis;Normal tissue morphology;Paraffin Embedding;Patients;Phenotype;Platelet-Derived Growth Factor;Play;Point Mutation;Polycomb;Procedures;Process;Prostate;Publications;Race;Research;Resistance;Reverse Transcriptase Polymerase Chain Reaction;Role;Specimen;Stem cells;Testing;Therapeutic;Time;Tissue Microarray;Tissues;United States;analog;base;cancer cell;caucasian American;cell growth;cellular engineering;clinically relevant;deprivation;design;epithelial to mesenchymal transition;in vivo;in vivo Model;insight;men;migration;mutant;neoplastic cell;novel;novel strategies;pre-clinical;pre-miRNA;protein expression;self-renewal;stem;stemness;tumor","Mechanistic Role of miRNAs and Their Targets in Prostate Cancer Aggressiveness"," The overall objective of this application is to test the hypotheses: (i) that over-expression of Lin28B leads to the acquisition of the invasive and metastatic characteristics of prostate cancer (PCa) cells (EMT-phenotype cells) via down-regulation of miR-200b and miR-200c, resulting in increased expression of Suz12, ZEB1, and ZEB2; and (ii) that over-expression of Lin28B represses the maturation of let-7 family, leading to increased expression of EZH2, and (iii) that these processes can be attenuated by our novel synthetic analogue of curcumin [(3, 4- difluoro-benzo-curcumin); in short difluorinated-curcumin or CDF, a synthetically derived compound with greater bioavailability than curcumin]. Moreover, the aim of the study is to investigate the relevance of deregulated expression of Lin28B, EZH2, miR-200, and let-7 in archival human PCa tissue specimens to assess their roles in tumor aggressiveness in African American versus Caucasian-American patients.   
      

","NCI","8370247","8/1/2012 12:00:00 AM","PA-10-067","1R01CA164318-01A1","1","R01","CA","164318","01","A","MCKEE, TAWNYA C","8/1/2012 12:00:00 AM","7/31/2016 12:00:00 AM","Chemo/Dietary Prevention Study Section[CDP]"," ","7020611","SARKAR, FAZLUL H.","Not Applicable","13","PATHOLOGY","001962224","M6K6NTJ2MNE5","001962224","M6K6NTJ2MNE5","US","42.35738","-83.064737","9110501","WAYNE STATE UNIVERSITY","DETROIT","MI","SCHOOLS OF MEDICINE","482024000","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","207500","107900"," ","315400",
"Chronic Liver Disease and Cirrhosis; Digestive Diseases; Liver Disease; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","3-Dimensional;Ablation;Acute;Acute Liver Failure;Adult;Alagille Syndrome;Applications Grants;Autocrine Communication;Biliary;Binding;Biology;Cell Differentiation process;Cell Proliferation;Cell Survival;Cell physiology;Cell surface;Cells;Chronic;Cirrhosis;Complex;Data;Development;Diet;Equilibrium;Erinaceidae;Event;Failure;Fibroblasts;Fibrosis;Genes;Genetic;Hepatic;Hepatic Stellate Cell;In Vitro;Individual;Injury;Injury to Liver;Ligands;Ligation;Liver;Liver Fibrosis;Liver diseases;Mediating;Membrane;Mesenchymal;Mesenchyme;Modeling;Molecular;Morphogenesis;Mouse Strains;Mutate;Necrosis;Notch Signaling Pathway;Notch and Wnt Signaling Pathway;Paracrine Communication;Pathway interactions;Play;Primary carcinoma of the liver cells;Regulation;Relative (related person);Role;Signal Pathway;Signal Transduction;Source;Stem cells;System;Tamoxifen;Testing;Time;Tissues;Winged Helix;activating transcription factor;autocrine;bile duct;biliary tract;cholangiocyte;design;dietary supplements;fibrogenesis;forkhead protein;human SMO protein;in vivo;inhibitor/antagonist;injury and repair;jagged1 protein;liver repair;loss of function;mutant;notch protein;paracrine;progenitor;public health relevance;receptor;reconstruction;response;response to injury;self-renewal;smoothened signaling pathway;stem;therapeutic development;tissue repair;tool;transcription factor","Signaling pathways and the fate of hepatic progenitor cells","
Project Narrative
The studies proposed in this grant application will elucidate the signals that regulate
hepatic progenitor cells and their response to acute or chronic liver injury. Understanding
the biology of hepatic progenitor cells will have wide-ranging implications for the
development of therapeutics for acute liver failure, chronic cirrhotic liver disease and
hepatocellular carcinoma.","NIDDK","8480398","7/2/2012 12:00:00 AM","PA-07-070","3R01DK087958-03S1","3","R01","DK","087958","03","S","SERRANO, JOSE","4/1/2010 12:00:00 AM","2/28/2014 12:00:00 AM","Hepatobiliary Pathophysiology Study Section[HBPP]"," ","1888272","GREENBAUM, LINDA E","Not Applicable","03","MICROBIOLOGY/IMMUN/VIROLOGY","053284659","R8JEVL4ULGB7","053284659","R8JEVL4ULGB7","US","39.949004","-75.155569","4050801","THOMAS JEFFERSON UNIVERSITY","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191074418","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","46667","25667"," ","72334",
"Bioengineering; Cancer; Lung; Nanotechnology; Prevention","Affect;Alveolar;Animal Model;Animals;Apoptosis;Asbestos;Biological;Biological Assay;Biological Markers;Blood Tests;Blood capillaries;Blood specimen;CCL2 gene;Caliber;Cell model;Characteristics;Cicatrix;Coculture Techniques;Communication;Computer Simulation;Cultured Cells;Data;Detection;Development;Diagnostic;Dose;Early Diagnosis;Early treatment;Endothelial Cells;Environmental Health;Epithelial;Epithelial Cells;Evaluation;Exhibits;Exposure to;Fiber;Fibrosis;Future;Gases;Genes;Genomics;Health Hazards;Health protection;Human;Hyperplasia;In Vitro;Inflammation;Injury;Intercellular adhesion molecule 1;Intervention;Laboratories;Lead;Length;Lesion;Lung;Lung diseases;Malignant Neoplasms;Malignant neoplasm of lung;Measurement;Measures;Mesenchymal;Messenger RNA;MicroRNAs;Modeling;Molecular;Molecular Analysis;Molecular Profiling;Molecular Target;Mus;Mutation;Pathway interactions;Patients;Pattern;Permeability;Pharmaceutical Preparations;Phosphorylation;Pneumonia;Production;Pulmonary Fibrosis;Reaction Time;Reactive Oxygen Species;Research;Risk;Risk Assessment;Screening procedure;Shapes;Signal Pathway;Signal Transduction;Signal Transduction Alteration;Structure of parenchyma of lung;Systems Biology;Testing;Tissues;Toxic effect;Toxicology;Vascular Endothelial Growth Factors;angiogenesis;base;cancer initiation;cancer risk;capillary;carcinogenesis;cell type;chemokine;cytokine;cytotoxicity;effective therapy;genome-wide;in vitro Assay;in vivo;interdisciplinary approach;mRNA Expression;mouse model;multi walled carbon nanotube;nanoscale;novel;particle;response;treatment strategy;tumor progression","Systematic assessment of multi-walled carbon nanotubes in pulmonary disease"," Multi-walled carbon nanotubes (MWCNT) have broad industrial applications. This project will assess the risk of MWCNT exposure in humans through animal and human cell model studies, and will develop early detection and treatment strategies for MWCNT-induced lung diseases, particularly fibrosis.   
      

","NIEHS","8341498","9/18/2012 12:00:00 AM","PA-11-148","1R01ES021764-01","1","R01","ES","021764","01"," ","NADADUR, SRIKANTH","9/18/2012 12:00:00 AM","5/31/2017 12:00:00 AM","Nanotechnology Study Section[NANO]"," ","8479367","GUO, NANCY LAN","Not Applicable","01","PUBLIC HEALTH & PREV MEDICINE","191510239","M7PNRH24BBM8","191510239","M7PNRH24BBM8","US","39.637631","-79.946405","9163701","WEST VIRGINIA UNIVERSITY","MORGANTOWN","WV","SCHOOLS OF MEDICINE","265066845","UNITED STATES","N","9/18/2012 12:00:00 AM","5/31/2013 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","NIEHS","225000","108000"," ","333000",
"Cardiovascular; Clinical Research; Hypertension; Kidney Disease; Nutrition","Accounting;Acetyl Coenzyme A;Acetylcholine;Aconitate Hydratase;Acyl Coenzyme A;Applications Grants;Biogenesis;Blood Vessels;Bypass;C-terminal;Cardiovascular Abnormalities;Cardiovascular Diseases;Cells;Chronic;Chronic Kidney Failure;Citrates;Citric Acid Cycle;Clinical Trials;Coenzyme A;Collagen Type XVIII;Connexin 43;Diagnosis;Disease Progression;Disease regression;Dose;Endostatins;Endothelial Cells;Endothelium;Enoyl-CoA Hydratase;Enzymes;Evolution;Failure;Fatty Acids;Fibrosis;Functional disorder;Genetic;Glucose;Glutamine;Glycolysis;Goals;Hydroxymethylglutaryl-CoA reductase;Hypertension;Hypoxia;Impaired Renal Function;In Vitro;Individual;Investigation;Isocitrates;Kidney;Kidney Failure;LOX gene;Light;Link;Longitudinal Studies;Mesenchymal;Metabolic;Metabolism;Mitochondria;Molecular Profiling;Mus;Nitric Oxide;Oxidation-Reduction;Pathway interactions;Patients;Permeability;Peroxonitrite;Pre-Clinical Model;Process;Production;Proteomics;Staging;Stem cells;Supplementation;Testing;Therapeutic;Therapeutic Intervention;Tissues;Up-Regulation;Vascular Endothelial Growth Factors;Vascular Permeabilities;Vasodilation;Warburg Effect;base;chemokine;cytokine;glucose metabolism;glucose uptake;in vivo;isocitrate;lipid metabolism;omega-N-Methylarginine;patient population;pre-clinical;reconstitution;regenerative;stem;stem cell niche","Endothelial dysfunction, nitric oxide and renal failure"," Studies proposed in this grant application should shed light on two concepts: 1) incompetence of stem/progenitor cells in Chronic Kidney Disease (CKD) contributes to the insufficient regenerative processes thus accounting in part for progression of disease and 2) stem cell incompetence is reversible and can be pharmacologically corrected thus resulting in reduction of the rate of progression or even regression of disease. Among the potential causes of stem cell incompetence in CKD we shall focus on a) stem cell-related factors and b) stem cell niche-related factors, as well as attempt pharmacologic correction of stem cell incompetence. These studies should supplement the search for mechanisms of progression of CKD by exploring the regenerative potential and its failure in these morbid states and offering alternative therapeutic strategies.  
  
    

","NIDDK","8323909","7/27/2012 12:00:00 AM","PA-10-067","5R01DK045462-15","5","R01","DK","045462","15"," ","RYS-SIKORA, KRYSTYNA E","9/1/1995 12:00:00 AM","4/30/2015 12:00:00 AM","Pathobiology of Kidney Disease Study Section[PBKD]"," ","1877228","GOLIGORSKY, MICHAEL S","Not Applicable","17","INTERNAL MEDICINE/MEDICINE","041907486","WK63UJ11C2H7","041907486","WK63UJ11C2H7","US","41.086078","-73.784459","5948901","NEW YORK MEDICAL COLLEGE","VALHALLA","NY","SCHOOLS OF MEDICINE","105951524","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","233903","125106"," ","359009",
"Aging; Biotechnology; Nutrition; Osteoporosis; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Affect;Age;Age-Related Bone Loss;Aging;American;Amino Acids;Bone Growth;Bone Marrow;Bone Marrow Cells;Bone Marrow Stem Cell;CXCL12 gene;CXCR4 Receptors;CXCR4 gene;Cell Aging;Cell Survival;Cells;Cessation of life;Cleaved cell;Compression Fracture;Diet;Dietary Proteins;Dipeptidyl-Peptidase IV;Disease;Engraftment;Fracture;Gene Expression;Glucose;Health Care Costs;Hip Fractures;Homeostasis;Hormones;Impaired cognition;Impairment;Insulin;Insulin-Like Growth Factor I;Intake;Lectin;Leptin;Link;Mediating;Mesenchymal;MicroRNAs;Modeling;Molecular;Morbidity - disease rate;Mus;Nutrient;Osteoblasts;Osteogenesis;Osteoporosis;Pathway interactions;Peptides;Play;Population;Proteins;Public Health;Regulation;Reporting;Research;Risk;Role;Signal Transduction;Site;Small Interfering RNA;Somatomedins;Stem cell transplant;Stem cells;Stromal Cell-Derived Factor 1;Testing;Time;Transgenic Mice;Transplantation;Woman;Work;age related;aged;bone;bone loss;cell age;cell motility;chemokine;glucagon-like peptide;men;mortality;novel;osteogenic;programs;response;spine bone structure;stem cell population;tool;vector","NUTRIENT MEDIATED AGE-RELATED CHANGES IN SDF-1 RESULTS IN BONE LOSS","Aging-related osteoporosis is a major public health problem, affecting 44 million Americans. Osteoporosis is associated with significant morbidity and mortality due to fractures, in particular, vertebral compression fractures and hip fractures. Osteoporosis-associated fractures significantly increase the risk for cognitive decline and death. The estimated annual direct health-care cost for osteoporosis totaled $17 billion in 2001.","NIA","8377779","4/26/2012 12:00:00 AM"," ","5P01AG036675-02","5","P01","AG","036675","02"," "," "," "," ","ZAG1-ZIJ-8","6552","1866163","ISALES, CARLOS M.","Not Applicable","12","Unavailable","966668691","N4WWJC8T2593","809593387; 966668691","JJJNQAJY5RN6; N4WWJC8T2593","US","33.471349","-81.991385","676605","AUGUSTA UNIVERSITY","AUGUSTA","GA","Domestic Higher Education","309120004","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","269207","269207"," ","179671","89536"," "," ",
"Bioengineering; Brain Cancer; Brain Disorders; Cancer; Diagnostic Radiology; Eye Disease and Disorders of Vision; Neurosciences; Rare Diseases","3-Dimensional;Address;Affect;Anatomy;Animals;Antibodies;Atlases;Autologous Expanded Mesenchymal Stem Cells;Autoradiography;Biological;Brain;Chemicals;Colonic Neoplasms;Contrast Media;Corpus striatum structure;Data;Data Set;Development;Diffusion Magnetic Resonance Imaging;Diffusion weighted imaging;Disease;Event;Face;Generations;Glioma;Gliomagenesis;Goals;Growth;Histology;Human;Huntington Disease;Hypoxia;Image;Imaging technology;Individual;Internet;Ions;Lasers;Lipids;Magnetic Resonance Imaging;Maintenance;Maps;Mass Spectrum Analysis;Measurement;Metabolism;Microscopy;Molecular;Mus;Obsessive-Compulsive Disorder;Optic Chiasm;Optic Nerve;Optic Nerve Glioma;Organ;Parkinsonian Disorders;Pattern;Peptides;Pharmaceutical Preparations;Positron-Emission Tomography;Preparation;Proteins;Protocols documentation;Relative (related person);Relaxation;Resolution;Sampling;Spatial Distribution;Specificity;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization;Speed;Structure;Technology;Three-Dimensional Image;Three-Dimensional Imaging;Time;Tissues;Validation;Variant;Work;combinatorial;copper (II) diacetyl-di(N(4)-methylthiosemicarbazone);imaging modality;imaging probe;improved;innovation;molecular imaging;mouse model;neuropsychiatry;novel strategies;protein distribution;reconstruction;research study;small molecule;striosome;subcutaneous;tissue preparation;tool;tumor;tumor growth","Spatial Analysis of Molecules in Tissue using MALDI-MS"," 3-D Imaging Mass Spectrometry will provide an exciting new approach for mapping molecular constituents in tissue volumes in an unbiased manner (i.e., without the need for antibodies). The information obtained will allow chemical annotation, improved interpretation and validation to classical imaging technologies, i.e., MRI, PET and microscopy. A major innovative aspect of the work is that it can provide data relevant to the anatomy of the whole organ or entire animal with high spatial fidelity and unmatched molecular specificity.  
    

","NIGMS","8233645","12/12/2011 12:00:00 AM","PA-10-067","2R01GM058008-13","2","R01","GM","058008","13"," ","EDMONDS, CHARLES G","9/1/1998 12:00:00 AM","11/30/2015 12:00:00 AM","Enabling Bioanalytical and Imaging Technologies Study Section[EBIT]"," ","6691073","CAPRIOLI, RICHARD M","Not Applicable","05","BIOCHEMISTRY","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","12/15/2011 12:00:00 AM","11/30/2012 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","297454","153694"," ","451148",
"Digestive Diseases; Neurosciences; Pediatric","Address;Affect;Alleles;Animal Model;Autologous;Biological Neural Networks;Cell Count;Cell Culture Techniques;Cell Transplants;Cell physiology;Cells;Colon;Congenital Megacolon;Data;Defect;Development;Disease;Disease model;Embryo;Endothelin;Endothelin B Receptor;Endothelin Receptor;Endothelin-3;Enteral;Enteric Nervous System;Environment;Excision;Exhibits;Failure;Fetus;Fluorescence-Activated Cell Sorting;Ganglia;Gastrointestinal Motility;Gastrointestinal tract structure;Gene Proteins;Genes;Genotype;Goals;Health;Hindgut;Image;Implant;In Vitro;Individual;Intercalated Cell;Intestines;Knock-out;Label;Learning;Left;Life;Ligands;Link;Mediating;Mesenchymal;Mesenchyme;Methods;Modeling;Molecular;Motor;Motor Activity;Movement;Mus;Mutation;Myenteric Plexus;Neural Crest;Neural Crest Cell;Neural tube;Neuroglia;Neurons;Operative Surgical Procedures;Partner in relationship;Patients;Pharyngeal structure;Phenotype;Preparation;Principal Investigator;Process;Proliferating;Proteins;Relative (related person);Reporting;Research Personnel;Role;Signal Transduction;Small Intestines;Smooth Muscle Myocytes;Stem cells;Testing;Time;Tissues;Transgenic Organisms;Transplantation;Two-Dimensional Gel Electrophoresis;cell motility;cohort;implantation;in vivo;migration;motility disorder;mutant;nerve supply;neuronal circuitry;novel;novel strategies;postnatal;programs;protein expression;public health relevance;receptor","Role of Endothelin Receptor B signaling in the genesis of aganglionic megacolon","
Project Narrative:
Our goals are to elucidate the mechanisms underlying Hirschsprung's disease and to
devise a method to provide functional innervation to the region of aganglionic colon.
These studies will benefit patients with Hirchsprung's disease and other gastrointestinal
motility disorders because providing functional innervation is a superior alternative to
surgical excision, which leaves patient with lifelonggastrointestinal problems. The
information gained here will also be relevant to transplantation of other tissues including
neurons.
Public Health Relevance Statement Page 7
Principal Investigator/Program Director (Last, first, middle): EPSTEIN, MILES, L","NIDDK","8234113","2/29/2012 12:00:00 AM","PA-07-070","5R01DK081634-04","5","R01","DK","081634","04"," ","CARRINGTON, JILL L","4/1/2009 12:00:00 AM","3/31/2013 12:00:00 AM","Clinical and Integrative Gastrointestinal Pathobiology Study Section[CIGP]"," ","1896714","EPSTEIN, MILES L","Not Applicable","02","ANATOMY/CELL BIOLOGY","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","SCHOOLS OF MEDICINE","537151218","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","213172","100080"," ","313252",
"Bioengineering; Cancer; Clinical Research; Hematology; Rare Diseases","Adhesions;Affect;Aspirate substance;Biological Markers;Biopsy;Blood flow;Bone Marrow;Bone Marrow Cells;Bone marrow biopsy;Cell Adhesion;Cell Adhesion Molecules;Cell Line;Cells;Cessation of life;Clinical Trials;Coculture Techniques;Complex;Computational Technique;Computer Simulation;Data;Development;Devices;Disease;Dose;Doxorubicin;Drug Combinations;Drug Delivery Systems;Drug resistance;Elements;Environment;Evolution;Extracellular Matrix;Fibronectins;Fluorescence;Future;Grant;Growth;Heterogeneity;Hypoxia;Immune response;Immunohistochemistry;In Vitro;Individual;Integrins;Label;Life;Location;Malignant - descriptor;Malignant Neoplasms;Marrow;Mediating;Melphalan;Mesenchymal;Microfluidics;Modeling;Multiple Myeloma;Newly Diagnosed;Oxygen;Patients;Pharmaceutical Preparations;Phenotype;Plasma Cells;Proliferating;Proteins;Protocols documentation;Refractory;Relapse;Resistance;Sampling;Serum;Simulate;Staging;Stromal Cells;Structure;System;Techniques;Time;Tissue Sample;Treatment Failure;Tumor Burden;Validation;Variant;Vascular Cell Adhesion Molecule-1;chemotherapy;cytokine;density;drug efficacy;drug mechanism;host neoplasm interaction;in vivo;indexing;novel;pre-clinical;research clinical testing;research study;response;simulation;standard of care;therapy outcome","A Translational Model of Evolution of Myeloma Adhesion-Mediated Drug Resistance"," Multiple Myeloma (MM) is an incurable malignant cancer of the bone marrow (BM), and although therapy can extend survival of most patients for several years, the cancer inevitably becomes resistant, resulting in relapse and death.  There are many different drugs available for MM treatment, but due to the complexity of the disease, it is difficult for a clinician to choose the best treatment for a given patient.  We propose a novel combination of experimental and computational techniques to use information extracted from live cells and tissue samples from MM patients, to build personalized models of estimation of patient response to therapy.  
    

","NCI","8230163","7/24/2012 12:00:00 AM","PAR-09-219","1R21CA164322-01","1","R21","CA","164322","01"," ","MERRITT, WILLIAM D","7/24/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","9754239","SILVA, ARIOSTO S","Not Applicable","14","Unavailable","139301956","DVHKP4N619V9","139301956","DVHKP4N619V9","US","28.062545","-82.419587","3736101","H. LEE MOFFITT CANCER CTR & RES INST","TAMPA","FL","Research Institutes","336129497","UNITED STATES","N","7/24/2012 12:00:00 AM","6/30/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","143653","91748"," ","235401",
"No NIH Category available","Accounting;Animals;Bacterial Pneumonia;Biliverdine;Biological Process;Carbon Monoxide;Cell Proliferation;Cell Separation;Clinical Management;Communities;Community Hospitals;Data;Databases;Development;E-Cadherin;Empyema;Epithelial;Fibrosis;Figs - dietary;Freedom;Gene Expression;Heme;Home Nursing Care;Hospitalization;Hospitals;In Vitro;Infection;Inflammation;Intercellular Junctions;Intervention;Iron;Kidney;Knockout Mice;Knowledge;Link;Lung;Mediating;Membrane;Mesenchymal;MicroRNAs;Military Personnel;Modeling;Morphogenesis;Mus;Nosocomial pneumonia;Operative Surgical Procedures;Outpatients;Pathogenesis;Patients;Phenotype;Play;Pleura;Pleural;Pleural Empyema;Pleural Mesothelial Cell;Pneumonia;Population;Predisposition;Proteins;Pulmonary Fibrosis;Recruitment Activity;Regulation;Reporting;Research;Research Design;Role;Signal Transduction;Site;Spinal cord injury;Staphylococcus aureus;Therapeutic;Tissues;Transforming Growth Factors;Trauma;Veterans;abstracting;base;effective therapy;gene therapy;heme oxygenase-1;human TGFB1 protein;in vivo;innovation;instrumentation;methicillin resistant Staphylococcus aureus;mortality;mouse model;novel;operation;pathogen;prevent;public health relevance;respiratory","Mechanisms of Pleural Fibrosis in Empyema","MRSA is an emerging respiratory pathogen in both community-associated and hospital-associated infections that often leads to highly lethal empyema and pleural fibrosis. In recent years MRSA infections have become common in outpatients of army community hospitals and among military recruits, in nursing home care units of VAMC and in Operation Iraqi Freedom troop population. Furthermore, MRSA infections are a major and growing cause of hospital-associated pneumonia in patients with trauma, surgery and spinal cord injury. The clinical management of empyema is associated with prolonged hospitalization, and instrumentation of the pleural space with significant patient discomfort. Here we propose two distinct treatment approaches; 1) via HO-1 induction by pharmacological means to prevent fibrosis in pleural empyema; and 2) via targeting miR-26a by intrapleural gene therapy to prevent fibrosis in pleural empyema. Currently there are no effective treatments for pleural fibrosis therefore the findings from these studies will move towards development of potential therapeutics against empyema and help to better manage empyema patients.","VA","8198367","12/9/2011 12:00:00 AM","RFA-BX-10-001","5I01BX000971-02","5","I01","BX","000971","02"," "," ","1/1/2011 12:00:00 AM","12/31/2014 12:00:00 AM","Respiration[PULM]"," ","6858342","MOHAMMED, KAMAL A","Not Applicable","03","Unavailable","097378632","K9J8XA7VF6T7","097378632","K9J8XA7VF6T7","US","29.639112","-82.343305","481152","VETERANS HEALTH ADMINISTRATION","GAINESVILLE","FL","Independent Hospitals","326081135","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Biotechnology; Dental/Oral and Craniofacial Disease; Genetics; Pediatric; Pediatric Research Initiative; Prevention","Accounting;Adenovirus Vector;Adhesions;Affect;Alleles;Amniotic Fluid;Animal Model;Asians;Biological;Biological Assay;Birth;Blood Circulation;Breathing;Cardiovascular system;Categories;Caucasians;Caucasoid Race;Cell physiology;Cells;Child;Cleaved cell;Cleft Lip;Cleft Palate;Clinical;Congenital Abnormality;Connective Tissue;Data;Defect;Development;Diagnosis;Disease;Dose;Eating;Embryo;Engineering;Ensure;Epidermis;Epithelial Cells;Epithelium;Excision;Functional disorder;Gene Delivery;Genes;Genetic;Goals;Health;Human;Human Genetics;In Vitro;Individual;Interferons;Intervention;Knockout Mice;Laboratories;Lead;Life;Medial;Mediating;Mediator of activation protein;Medical;Mesenchymal;Minor;Molecular;Morbidity - disease rate;Mus;Musculoskeletal;Mutation;Nasal cavity;National Institute of Dental and Craniofacial Research;Neonatal;Neurologic;Oral;Oral Pathology;Oral cavity;Palate;Pathogenesis;Patients;Periderm;Phenotype;Prevalence;Prevention strategy;Process;Protocols documentation;Risk;Role;Severities;Site;Teflon;Therapeutic Intervention;Time;Tissues;Tropism;United States;Van der Woude syndrome;Weight;Work;base;body system;cancer risk;cell type;cleft lip and palate;clinically significant;craniofacial;design;drinking;feeding;in utero;in vivo;interest;keratinocyte;life time cost;mortality;mouse model;novel;palatal shelves;palatogenesis;postnatal;prevent;promoter;research study;therapy design","Role of Irf6 in palatal epithelium"," Current estimates in the United States suggest that 1/700 individuals are born with a Cleft Lip or Plate (CLP). Patients born with CLP have a greater propensity for multi-system organ dysfunction, including neurological, musculoskeletal, cardiovascular as well as a life- long increased risk of cancer and mortality, each consuming $20,0 from the economy for medical treatment. Studies of palatal development, in health and disease, can lead to rational design of therapeutic interventions and preventative strategies tailored to the patient's genetic footprint.   
      

","NIDCR","8316509","3/1/2012 12:00:00 AM","PA-11-111","1F31DE022696-01","1","F31","DE","022696","01"," ","FRIEDEN, LESLIE A","5/16/2012 12:00:00 AM","2/15/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","11041564","KOUSA, YOUSSEF A","Not Applicable","08","BIOCHEMISTRY","193247145","R28EKN92ZTZ9","193247145","R28EKN92ZTZ9","US","42.748478","-84.483276","5245901","MICHIGAN STATE UNIVERSITY","EAST LANSING","MI","SCHOOLS OF OSTEOPATHIC MEDICINE","488242600","UNITED STATES","N","5/16/2012 12:00:00 AM","5/15/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","33432"," "," ","33432",
"Cancer; Lung; Lung Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;American;Amino Acids;Anoikis;Apoptosis;Apoptotic;Binding;Biological Assay;Cancer Etiology;Cell Death;Cell Survival;Cell model;Cells;Cessation of life;Clinical;Colon Carcinoma;Complex;Cues;Cullin Proteins;Data;Diagnosis;Diagnostic Neoplasm Staging;Disease;Epithelial;Epithelial Cells;Extracellular Matrix;Frequencies;Genetic Transcription;Goals;Growth Factor;Half-Life;Human;In Vitro;Inflammation Mediators;Inflammatory;Interleukin-1;Laboratories;Ligands;Link;Lung;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Malignant neoplasm of prostate;Maps;Mediating;Mesenchymal;Microtubules;Mitochondria;Molecular;Morphology;NF-kappa B;Neoplasm Metastasis;Newly Diagnosed;Non-Small-Cell Lung Carcinoma;Nuclear;Outcome;Pathway interactions;Phenotype;Phosphorylation;Polyubiquitination;Process;Property;Proteins;Regulation;Resistance;Role;Secondary to;Site;Small Interfering RNA;Staging;Staining method;Stains;Stimulus;TNF gene;Tumor stage;Ubiquitination;United States;Up-Regulation;Withdrawal;Work;Xenograft Model;cancer cell;cancer stem cell;chemotherapy;cytochrome c;cytokine;in vitro Model;in vivo Model;lung small cell carcinoma;malignant breast neoplasm;member;mortality;multicatalytic endopeptidase complex;mutant;novel;novel strategies;outcome forecast;p65;prevent;pro-apoptotic protein;protein degradation;protein expression;receptor;research study;response;self-renewal;synaptotagmin I;transcription factor;tumor;tumor growth;ubiquitin-protein ligase","Inflammatory Cytokines Link NF-kappaB with Bim Degradation and Metastasis","n/a","NCI","8257586","4/24/2012 12:00:00 AM","RFA-CA-07-046","5R01CA132580-05","5","R01","CA","132580","05"," ","SALNIKOW, KONSTANTIN","5/1/2008 12:00:00 AM","4/30/2014 12:00:00 AM","ZCA1-SRRB-U(O1)"," ","1889852","MAYO, MARTY W","Not Applicable","05","BIOCHEMISTRY","065391526","JJG6HU8PA4S5","065391526","JJG6HU8PA4S5","US","38.034207","-78.512346","1526402","UNIVERSITY OF VIRGINIA","CHARLOTTESVILLE","VA","SCHOOLS OF MEDICINE","229044195","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","184300","91810"," ","276110",
"Breast Cancer; Cancer; Clinical Research","Address;Adult;Adverse effects;Biological Assay;Blood;Blood Vessels;Body part;Brain;Breast Cancer Model;Breast Carcinoma;Cancer Etiology;Cancer Patient;Cessation of life;Characteristics;Complex;Data;Development;Disease;Distant;Embryonic Development;Foundations;Growth;Human;Immunohistochemistry;Laboratories;Lead;Luciferases;Lung;Lymph;Lymphangiogenesis;Lymphatic;Lymphatic Endothelial Cells;Lymphatic Metastasis;Lymphatic Spread;Lymphatic System;Lymphatic vessel;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of prostate;Mammary Neoplasms;Mediating;Mediator of activation protein;Metastatic to;Modeling;Mus;Neoplasm Metastasis;Organ;Phosphoric Monoester Hydrolases;Play;Population;Primary Neoplasm;Process;Prognostic Factor;Proliferating;Publishing;Relapse;Reporter;Role;Signal Transduction;Specimen;Staging;Stem cells;Testing;Therapeutic Agents;Time;Tissues;Transgenic Organisms;Up-Regulation;Vascular Endothelial Growth Factor C;Vascular Endothelial Growth Factors;Woman;Work;Xenograft Model;Xenograft procedure;adverse outcome;bone;breast lesion;breast tumorigenesis;cancer cell;chromatin immunoprecipitation;cofactor;drug development;embryonic protein;epithelial to mesenchymal transition;in vivo;insight;lymph nodes;malignant breast neoplasm;migration;mouse model;neoplastic cell;new therapeutic target;novel;outcome forecast;overexpression;promoter;public health relevance;therapeutic target;tumor","The Six1/Eya Transcriptional complex as a mediator of lymphangiogenesis and lymph","
Project Narrative:
The vast majority of breast cancer related deaths occur due to the spread of tumor cells
to distant organs, a spread that occurs via blood vessels or, particularly important for
breast cancer, via the lymphatic system. Surprisingly, however, very little is known
about the mechanism by which tumor cells promote new lymphatic vessel development
(lymphangiogenesis) and lymphatic spread. This proposal focuses on understanding a
new mechanism of lymphangiogenesis and breast tumor metastatic spread, via control
of VEGF-C levels by the Six1/Eya2 complex, and it lays the foundation for the
development of novel, anti-metastatic therapeutic agents that would target embryonic
proteins that are re-expressed in cancers, thus conferring limited side effects while
potently inhibiting breast cancer metastasis. )","NCI","8255466","3/21/2012 12:00:00 AM","PA-10-067","5R01CA157790-02","5","R01","CA","157790","02"," ","MOHLA, SURESH","4/8/2011 12:00:00 AM","3/31/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1889696","FORD, HEIDE L.","Not Applicable","06","OBSTETRICS & GYNECOLOGY","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","243500","124266"," ","367766",
"Biotechnology","Actins;Adhesions;Antibodies;Binding;Biochemical;Biological Assay;Biological Models;Cardiovascular Diseases;Cell Adhesion;Cell physiology;Cells;Cellular Morphology;Cicatrix;Complex;Confocal Microscopy;Coupled;Cytoskeleton;Defect;Development;Disease;Embryonic Development;Environment;Exhibits;Extracellular Matrix;Family;Family member;Fibroblasts;Fibrosis;Fluorescence;Fluorescence Recovery After Photobleaching;Fluorescence Resonance Energy Transfer;Focal Adhesions;GIT2 gene;GTPase-Activating Proteins;Goals;Guanine Nucleotide Exchange Factors;Guanosine Triphosphate Phosphohydrolases;Health;Image;Immunologic Surveillance;Mediating;Mental Retardation;Microscopy;Modeling;Molecular;Movement;Myofibroblast;Neoplasm Metastasis;Neurodegenerative Disorders;PTPN12 gene;Pathway interactions;Phosphorylation;Physiological;Play;Process;Protein Tyrosine Phosphatase;Proteins;RNA Interference;Recruitment Activity;Regulation;Relative (related person);Role;Signal Transduction;Signaling Molecule;Site;Specificity;Structural Protein;Structure;System;Testing;Time;Tissues;Tumor Cell Invasion;Tyrosine Phosphorylation;Video Microscopy;Western Blotting;Work;Wound Healing;adapter protein;angiogenesis;cell motility;embryo tissue;epithelial to mesenchymal transition;genetic regulatory protein;in vivo;migration;mutant;novel;paxillin;protein expression;protein protein interaction;rho;rho GTP-Binding Proteins;scaffold;time use;tissue repair;tumor progression;two-dimensional","Structure and Function of Paxillin","
Cell movement is essential for normal processes such as embryonic development and tissue repair but it is
also a key factor in cancer progression, tissue fibrosis and several cardiovascular and neurodegenerative
disorders. Information gained from the proposed study will contribute to our understanding of how the cell
migration machinery is regulated and thereby will potentially identify novel targets for corrective therapies for
migration-associated disorders.","NIGMS","8245845","3/29/2012 12:00:00 AM","PA-07-070","5R01GM047607-21","5","R01","GM","047607","21"," ","FLICKER, PAULA F","8/5/1991 12:00:00 AM","9/29/2014 12:00:00 AM","Intercellular Interactions Study Section[ICI]"," ","1883199","TURNER, CHRISTOPHER E","Not Applicable","24","ANATOMY/CELL BIOLOGY","058889106","HYN3WD58HNN7","058889106","HYN3WD58HNN7","US","43.030473","-76.125697","5992619","UPSTATE MEDICAL UNIVERSITY","SYRACUSE","NY","SCHOOLS OF MEDICINE","132102306","UNITED STATES","N","4/1/2012 12:00:00 AM","9/29/2014 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","223571","127436"," ","351007",
"No NIH Category available","Accounting;Adipocytes;Adipose tissue;Adult;Affect;Alternative Splicing;Apoptosis;Apoptotic;Behavioral;Cardiovascular Diseases;Cause of Death;Cell Survival;Complement;Curcumin;Data;Development;Diet;Disease;Epidemic;Event;Exhibits;Expenditure;Fatty acid glycerol esters;Future;Gene Expression;General Population;Genes;Genetic;Genomics;Goals;Health;Health Care Costs;Healthcare;High Prevalence;Intervention;Knowledge;Link;Measures;Mediating;Mediator of activation protein;Medical;Mesenchymal;Metabolic syndrome;Molecular;Morbidity - disease rate;Non-Insulin-Dependent Diabetes Mellitus;Obese Mice;Obesity;Outcome;Overweight;Pathway interactions;Phenotype;Phosphotransferases;Physiological;Population;Prevalence;Prevalence Study;Preventive;Protein-Serine-Threonine Kinases;Public Health;RNA Splicing;Research;Resveratrol;Risk Factors;Role;Services;Signal Transduction;Socioeconomic Factors;Spliced Genes;Therapeutic;Therapeutic Intervention;Tissues;Transcriptional Regulation;Variant;Veterans;Weight;Weight Gain;adipocyte differentiation;base;cancer type;caspase-9;combat;design;feeding;inhibitor/antagonist;innovation;lipid biosynthesis;mouse model;obesity treatment;overexpression;precursor cell;prevent;programs;research study;therapeutic evaluation;upstream kinase","Apoptosis pathways underlying adipogenesis","The obesity epidemic is increasing at an alarming rate in USA. In the largest obesity prevalence study to date in VA, it was found that amongst veterans receiving healthcare at VA facilities overweight and obesity were at a significantly higher prevalence than the general population. In 2005, Dr. Perlin (then-acting Under Secretary of Health) announced the MOVE! (Managing weight and/or obesity for veterans everywhere) program to combat obesity and its related diseases. This program is given the highest priority as it affects current treatments and future demand for VA healthcare services. The proposed studies are expected to have important therapeutic implications as we expect to identify new targets for interventions to prevent or reverse weight gain and thereby impede the rise of obesity-related morbidities.","VA","8242899","1/18/2012 12:00:00 AM","RFA-BX-11-001","1I01BX001424-01","1","I01","BX","001424","01"," "," ","1/1/2012 12:00:00 AM","12/31/2015 12:00:00 AM","Endocriniology A[ENDA]"," ","8906064","PATEL, NIKETA A.","Not Applicable","14","Unavailable","929194256","UDPMKPKUL2D6","929194256","UDPMKPKUL2D6","US","28.065613","-82.426184","481155","JAMES A. HALEY VA MEDICAL CENTER","TAMPA","FL","Independent Hospitals","336124745","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"No NIH Category available","Address;Adverse effects;Agonist;Allergic;Asthma;Bathing;Cations;Cell Culture Techniques;Characteristics;Chemicals;Chronic;Cigarette;Communication;Complex;Contracts;Coughing;Development;Diagnosis;Disease;Disease Management;Experimental Designs;Exposure to;Faculty;Family;Fibroblasts;Functional disorder;General Population;Goals;Grant;Growth;Growth Factor;Harvest;In Vitro;Institution;Isometric Exercise;Leadership;Ligands;Lung;Lung diseases;Manuscripts;Measurement;Measures;Mediating;Mediator of activation protein;Mentors;Mesenchymal;Modeling;Mus;Muscarinics;Muscle Contraction;NGFR Protein;Nature;Nerve Growth Factor Receptors;Nerve Growth Factors;Neuroglia;Neurons;Nicotine;Nicotinic Receptors;Organ;Pathway interactions;Patient Self-Report;Patients;Pattern;Play;Population;Prevalence;Production;Productivity;Proteins;Publications;Research;Research Personnel;Research Technics;Respiratory physiology;Role;Secondary to;Signal Transduction;Small Interfering RNA;Smoke;Smoker;Smoking;Smooth Muscle Myocytes;Societies;Source;Symptoms;System;Techniques;Therapeutic;Therapeutic Intervention;Tobacco smoke;Veterans;Wheezing;Writing;airway hyperresponsiveness;cholinergic;cigarette smoking;cigarette smoking;constriction;design;experimental analysis;health care service utilization;improved;in vivo;ligand gated channel;lung carcinogenesis;lung development;meetings;methacholine;mouse model;nerve supply;neuronal growth;neurotrophic factor;novel;overexpression;paracrine;receptor;respiratory smooth muscle;response;skills;smoking prevalence","Induction of Nerve Growth Factor by Nicotine Leads to Airway Dysfunction","Cigarette smoking is more prevalent in veterans than the general population (35% vs. 21%). Exposure to tobacco smoke is also associated with airway hyperresponsiveness (AHR), a characteristic feature of asthma. Asthma is a common self reported diagnosis in veterans and contributes significantly to healthcare utilization. In asthmatics, cigarette smoke exposure is often a trigger of cough and wheezing, both manifestations of AHR. Given the increased prevalence of smoking and asthma in veterans, it is important to understand the mechanisms behind cigarette smoke associated AHR. Nicotine, the addictive component of cigarettes, may play an important role in AHR through neurogenic mechanisms. This project is relevant to the VA population because it will improve current understanding of the neurogenic pathways involved in nicotine exposure and may uncover alternative therapeutic interventions to improve disease management for asthmatic veterans, including those who continue to be exposed to cigarette smoke.","VA","8245259","1/18/2012 12:00:00 AM","RFA-BX-11-007","1IK2BX001306-01A1","1","IK2","BX","001306","01","A"," ","1/1/2012 12:00:00 AM","12/31/2014 12:00:00 AM","Respiration[PULM]"," ","1947599","WONGTRAKOOL, CHERRY P","Not Applicable","04","Unavailable","824835805","JN4QJ2LB2S13","824835805","JN4QJ2LB2S13","US","33.801554","-84.309778","481023","VETERANS HEALTH ADMINISTRATION","DECATUR","GA","Independent Hospitals","300334004","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","999","Other","2012"," "," "," "," "," "," "," ",
"Breast Cancer; Cancer; Clinical Research","Address;Adult;Adverse effects;Biological Assay;Blood;Blood Vessels;Body part;Brain;Breast Cancer Model;Breast Carcinoma;Cancer Etiology;Cancer Patient;Cessation of life;Characteristics;Complex;Data;Development;Disease;Distant;Embryonic Development;Foundations;Growth;Human;Immunohistochemistry;Laboratories;Lead;Luciferases;Lung;Lymph;Lymphangiogenesis;Lymphatic;Lymphatic Endothelial Cells;Lymphatic Metastasis;Lymphatic Spread;Lymphatic System;Lymphatic vessel;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of prostate;Mammary Neoplasms;Mediating;Mediator of activation protein;Metastatic to;Modeling;Mus;Neoplasm Metastasis;Organ;Phosphoric Monoester Hydrolases;Play;Population;Primary Neoplasm;Process;Prognostic Factor;Proliferating;Publishing;Relapse;Reporter;Role;Signal Transduction;Specimen;Staging;Stem cells;Testing;Therapeutic Agents;Time;Tissues;Transgenic Organisms;Up-Regulation;Vascular Endothelial Growth Factor C;Vascular Endothelial Growth Factors;Woman;Work;Xenograft Model;Xenograft procedure;adverse outcome;bone;breast lesion;breast tumorigenesis;cancer cell;chromatin immunoprecipitation;cofactor;drug development;embryonic protein;epithelial to mesenchymal transition;in vivo;insight;lymph nodes;malignant breast neoplasm;migration;mouse model;neoplastic cell;new therapeutic target;novel;outcome forecast;overexpression;promoter;public health relevance;therapeutic target;tumor","The Six1/Eya Transcriptional complex as a mediator of lymphangiogenesis and lymph","
Project Narrative:
The vast majority of breast cancer related deaths occur due to the spread of tumor cells
to distant organs, a spread that occurs via blood vessels or, particularly important for
breast cancer, via the lymphatic system. Surprisingly, however, very little is known
about the mechanism by which tumor cells promote new lymphatic vessel development
(lymphangiogenesis) and lymphatic spread. This proposal focuses on understanding a
new mechanism of lymphangiogenesis and breast tumor metastatic spread, via control
of VEGF-C levels by the Six1/Eya2 complex, and it lays the foundation for the
development of novel, anti-metastatic therapeutic agents that would target embryonic
proteins that are re-expressed in cancers, thus conferring limited side effects while
potently inhibiting breast cancer metastasis. )","NCI","8396724","3/22/2012 12:00:00 AM","PA-10-067","3R01CA157790-02S1","3","R01","CA","157790","02","S","OGUNBIYI, PETER","4/8/2011 12:00:00 AM","3/31/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1889696","FORD, HEIDE L.","Not Applicable","06","OBSTETRICS & GYNECOLOGY","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","33500","15370"," ","48870",
"Breast Cancer; Cancer","Animals;Anoikis;Automobile Driving;Behavior;Biochemical;Biological Assay;Biology;Breast;Breast Melanoma;Cancer Biology;Cancer Patient;Carcinoma;Cell Culture Techniques;Cell Line;Cells;Chemicals;Chemosensitization;Collaborations;Collection;Coupled;Critical Pathways;Cultured Cells;Diagnostic Neoplasm Staging;Dissection;Doxycycline;Environment;Epithelial;Epithelial Cells;Epithelium;Event;Fatty acid glycerol esters;Fibroblasts;Future;Growth;Histologic;Hyperplasia;In Vitro;Integral Membrane Protein;Lesion;Light;Lung;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of ovary;Mammary Gland Parenchyma;Mammary Neoplasms;Mammary gland;Measures;Melanoma Cell;Membrane;Mesenchymal;Methods;Modeling;Molecular;Mucins;Mus;Neoplasm Metastasis;Normal tissue morphology;Nude Mice;Operative Surgical Procedures;Outcome;Pathologist;Pathology;Patients;Phenotype;Play;Premalignant;Primary Neoplasm;Process;Property;Proteins;Relative (related person);Reporting;Role;Sampling;Series;Signal Pathway;Signal Transduction;Staging;Structure;Tetracycline Control;Tetracyclines;Therapeutic;Therapeutic Intervention;Tissue Sample;Tissues;Training;Transplantation;Tumor-Associated Process;Work;cancer cell;cell growth;cell motility;cell type;combat;drinking water;in vivo;lymph nodes;malignant breast neoplasm;malignant state;matrigel;meetings;metaplastic cell transformation;migration;mouse model;neoplastic cell;new therapeutic target;novel;overexpression;prognostic;research study;symposium;tumor;tumor growth;tumor progression","The role of the mucin Muc4 signaling in breast cancer formation and progression"," The role of the mucin Muc4 signaling in breast cancer formation and progression. The proposed studies are aimed at understanding the molecular and cellular mechanisms underlying the initiation of breast cancer and the progression of breast cancer lesions to malignancy. The successful completion of the work could shed new light on the biochemical and cellular mechanisms engaged by tumor cells to facilitate their transformation and transition to a malignant state. Ultimately, the studies could identify a novel target for therapeutic intervention.   
      

","NCI","8396313","8/2/2012 12:00:00 AM","PA-11-111","1F31CA165758-01A1","1","F31","CA","165758","01","A","SCHMIDT, MICHAEL K","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-A(21)L]"," ","10860485","HATAKEYAMA, JASON ","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","047120084","TX2DAGQPENZ5","047120084","TX2DAGQPENZ5","US","38.543675","-121.729989","577503","UNIVERSITY OF CALIFORNIA AT DAVIS","DAVIS","CA","SCHOOLS OF MEDICINE","956186153","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","34567"," "," ","34567",
"Genetics; Lung; Rare Diseases","Affect;Back;Biochemical;Blood Vessels;Blood flow;Boxing;Cell Nucleus;Cellular biology;Cicatrix;Coagulation Process;Collagen Type I;Complex;Consensus;DNA;DNA-Binding Proteins;DNA-Protein Interaction;Diagnosis;Disease;Disease Progression;Enzyme-Linked Immunosorbent Assay;Epigenetic Process;Epithelial;Epithelial Cells;Etiology;Fibroblasts;Fibrosis;Fostering;Functional disorder;Future;Gene Activation;Gene Expression;Genes;Heart failure;Individual;Infarction;Infection;Knowledge;Lead;Lung;Lung Transplantation;MAP2K1 gene;Mediating;Mesenchymal;Metabolic;Methods;Molecular;Muscle;Myofibroblast;Obstruction;Organ Transplantation;Output;Patients;Perfusion;Phase;Phosphotransferases;Process;Protein Biochemistry;Proteins;Pulmonary Hypertension;Pulmonary artery structure;Research;Serum Response Factor;Side;Signal Transduction;Site;Smad Proteins;Smad protein;Smooth Muscle Actin Staining Method;Solid;Specimen;Staging;Stroke;Sudden Death;Syndrome;Testing;Tissues;Trans-Activators;Transcription Coactivator;Transcription Repressor/Corepressor;Transcriptional Activation;Trauma;Tunica Media;Vascular Diseases;Vascular remodeling;Wound Healing;actin 2;arm;arterial remodeling;arteriole;base;blood pump;cardiopulmonary system;design;feeding;heart function;immunocytochemistry;improved;lung injury;new therapeutic target;novel;promoter;protein complex;pulmonary arterial hypertension;response;tissue repair;tool;treatment strategy","Peri-arteriolar Myofibroblast Differentiation in the Pathobiology of IPAH","
NARRATIVE
Gene activation in the blood vessel wall is controlled by protein:protein and protein:DNA complexes that are
necessary for rapid wound healing and tissue repair after infection or physical trauma. When these processes
become inoperative or dysfunctional in the cardiopulmonary system, excess scar tissue can accumulate and
stiffen very small blood vessels that eventually slows normal blood flow leading to clot formation, stroke, tissue
infarction (degradation), and sudden death. Protein complexes that control wound healing in the lung may be
faulty in patients with pulmonary hypertension which if untreated will eventually damage the right side of the
heart that functions as the blood pump to the lung. The proposed research will examine the protein
constituents of these regulatory complexes and determine if they are different in normal individuals compared
to patients diagnosed with end-stage pulmonary hypertension. The proposed research may lead to the design
of new treatment strategies for this devastating lung vascular disease that has no cure and only treatable by
performing lung transplantation surgery.","NHLBI","8335478","7/19/2012 12:00:00 AM","RFA-HL-11-032","5R03HL110802-02","5","R03","HL","110802","02"," ","MOORE, TIMOTHY M","9/23/2011 12:00:00 AM","1/31/2014 12:00:00 AM","ZHL1-CSR-Q(S1)"," ","1922551","STRAUCH, ARTHUR ROGER","Not Applicable","03","PHYSIOLOGY","832127323","DLWBSLWAJWR1","832127323","DLWBSLWAJWR1","US","40.003166","-83.034278","6218701","OHIO STATE UNIVERSITY","COLUMBUS","OH","SCHOOLS OF MEDICINE","432101016","UNITED STATES","N","8/1/2012 12:00:00 AM","1/31/2014 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","50000","26250"," ","76250",
"Breast Cancer; Cancer","Acinus organ component;Address;Animal Model;Award;Benign;Binding;Biological Assay;Biological Markers;Biology;Breast;Breast Cancer Cell;Cancer Etiology;Carcinoma;Cause of Death;Cells;Cessation of life;Characteristics;Clinical;Complex;Data;Development;Diagnosis;Differentiation and Growth;Distant Metastasis;Down-Regulation;Drug Delivery Systems;Ductal Carcinoma;E-Cadherin;ERBB2 gene;Epithelial;Epithelial Cells;Epithelium;Estrogen Receptor Status;Estrogen receptor positive;Exhibits;Family;Funding;Genes;Goals;Growth;Histologic;In Vitro;Insulin-Like Growth Factor I;Invaded;Investigation;Knockout Mice;Knowledge;Laboratories;Learning;Lesion;Maintenance;Malignant - descriptor;Malignant Conversion;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Mediating;Metastatic Neoplasm to the Breast;Molecular;Mus;Neoplasm Metastasis;Nodal;Noninfiltrating Intraductal Carcinoma;Outcome;Pathogenesis;Pathway interactions;Patients;Play;Premalignant;Prevention;Process;Proteins;Repression;Role;Sampling;Signal Pathway;Signal Transduction;Signaling Protein;Therapeutic Intervention;Tissue Sample;Transgenic Mice;Translating;Tumor Suppressor Proteins;Woman;Women&apos;s Health;base;breast tumorigenesis;cancer cell;cohort;epithelial to mesenchymal transition;follow-up;human tissue;improved;in vivo;in vivo Model;inflammatory breast cancer;loss of function;malignant breast neoplasm;mammary epithelium;member;mouse model;mutant;novel;outcome forecast;overexpression;prevent;research study;tissue resource;tumor;tumor growth;tumor progression","Role of CCN6 (WISP3) in the progression and metastasis of breast cancer","n/a","NCI","8305594","8/1/2012 12:00:00 AM","PA-07-070","5R01CA125577-05","5","R01","CA","125577","05"," ","WOODHOUSE, ELIZABETH","9/1/2008 12:00:00 AM","7/31/2013 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","7753298","KLEER, CELINA G","Not Applicable","12","PATHOLOGY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","92300"," ","293575",
"Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","ACVR1 gene;Address;Adenoviruses;Adoptive Transfer;Adrenal Cortex Hormones;Affect;Attenuated;Autoimmune Diseases;Biochemical;Birth;Blood Vessels;Bone Marrow;Bone Morphogenetic Proteins;Burn injury;Cells;Complement;Complication;Connective Tissue;Dendritic Cells;Development;Disease;Engraftment;Fracture;Gene Expression;Genetic;Grant;Heart Diseases;Heterotopic Ossification;Human;Immune;Individual;Infection;Inflammation;Inflammatory;Injury;Joints;Kinetics;Lead;Lesion;Ligaments;Ligands;Mediating;Mesenchymal;Modeling;Molecular;Molecular Target;Morbidity - disease rate;Mus;Muscle;Mutation;Myositis;Natural Immunity;Natural regeneration;Operative Surgical Procedures;Osteogenesis;Pain;Pathogenesis;Pericytes;Phosphotransferases;Population;Premature Mortality;Process;Proteins;Rare Diseases;Receptor Signaling;Recruitment Activity;Replacement Arthroplasty;Role;Signal Pathway;Signal Transduction;Skeletal Muscle;Skeletal Muscle Satellite Cells;Stem cells;Stimulus;Syndrome;Techniques;Testing;Tissues;Toll-like receptors;Transgenes;Transgenic Organisms;Trauma;Vascular Diseases;Viral;base;bone;bone morphogenetic protein receptor type I;calcification;cell type;cellular targeting;effective therapy;falls;gain of function;human disease;injury and repair;insight;macrophage;mouse model;mutant;novel;novel strategies;osteogenic;osteoprogenitor cell;postnatal;progenitor;programs;progressive myositis ossificans;receptor;receptor-mediated signaling;recombinase;reconstitution;repaired;response;skeletal abnormality;small molecule;soft tissue","Molecular and cellular mechanisms of heterotopic ossification","PROJECT NARRATIVE 
This proposal asks how bone morphogenetic protein signals, which normally regulate the activity of 
progenitor cells involved in the repair of muscle, blood vessels, connective tissues, and bone, may 
become dysregulated to cause inappropriate bone formation in the human diseases of heterotopic 
ossification and fibrodysplasia ossificans progressiva. In addition to providing insights into the 
mechanism of these poorly understood processes, these studies may identify much needed novel 
approaches for their management. These mechanisms have relevance to a broader set of conditions 
in which inflammation and injury appear to lead to abnormal ossification in autoimmune, cardiac, and 
vascular disease.","NIAMS","8538700","9/10/2012 12:00:00 AM","PA-07-070","3R01AR057374-03S1","3","R01","AR","057374","03","S","SHARROCK, WILLIAM J","8/1/2010 12:00:00 AM","6/30/2015 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1860889","YU, PAUL B","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","9/10/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","33720","26117"," ","59837",
"Breast Cancer; Cancer; Genetics","Address;Adjuvant Therapy;Aftercare;Animal Model;Biology;Breast;Cancer Patient;Cancer Survivor;Cell Cycle;Cell Survival;Cell physiology;Cells;Cessation of life;Clinical;Development;Diagnosis;Disease;Down-Regulation;Doxycycline;ERBB2 gene;Epithelial;Genetically Engineered Mouse;Goals;Growth;Human;Integrins;Knowledge;Light;Malignant Neoplasms;Mammary Neoplasms;Mediating;Mesenchymal;Micrometastasis;Modeling;Molecular;Mus;Neoplasm Metastasis;Oncogenes;Operative Surgical Procedures;Outcome;PTK2 gene;Pathway interactions;Patients;Play;Primary Neoplasm;Process;Radiosurgery;Recurrence;Recurrent tumor;Residual Neoplasm;Residual Tumors;Residual state;Resistance;Risk;Role;Series;Signal Transduction;Snails;Testing;Therapeutic;Transcription Repressor/Corepressor;Transgenic Mice;Trastuzumab;Up-Regulation;Woman;anticancer research;base;cancer recurrence;effective therapy;in vivo;malignant breast neoplasm;mouse model;neoplastic cell;overexpression;public health relevance;research clinical testing;research study;transcription factor;tumor;tumor progression;tumorigenesis","In Vivo Oncogene-induced Tumorigenesis and Escape","
The tendency of breast cancers to recur following treatment is the most important determinant of clinical
outcome, since recurrent breast cancer is typically an incurable disease. In this regard, a cardinal feature of
human breast cancers is the survival and persistence of residual tumor cells in a dormant state for many years
after successful treatment of the primary tumor. Since recurrent breast cancers invariably arise from
disseminated tumor cells, understanding their biology and identifying the molecular pathways responsible for
recurrence is an essential goal in breast cancer research. Achieving this goal will permit more effective
therapeutic approaches to be developed for the millions of breast cancer survivors at risk for recurrence.","NCI","8215925","3/16/2012 12:00:00 AM","PA-07-070","5R01CA098371-08","5","R01","CA","098371","08"," ","MOHLA, SURESH","4/18/2003 12:00:00 AM","1/31/2015 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","1882180","CHODOSH, LEWIS A","Not Applicable","03","BIOLOGY","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","210780","126468"," ","337248",
"Dental/Oral and Craniofacial Disease; Pediatric; Regenerative Medicine","Affect;Attention;BMP2 gene;Binding;Binding Proteins;Biological;Biological Assay;Biological Availability;Biomedical Engineering;Bone Morphogenetic Proteins;Calvaria;Cartilage;Cell Culture Techniques;Cell Differentiation process;Cell surface;Cells;Child;Childhood;Chondrocytes;Chondrogenesis;Deformity;Degenerative polyarthritis;Disease;Doctor of Philosophy;EXT1 gene;EXT2 gene;Elements;Embryo;Enzymes;Epiphysial cartilage;Erinaceidae;Exostoses;Extracellular Matrix;Family;Fibroblast Growth Factor;Fracture;Future;Genes;Grant;Growth;Growth Factor Interaction;Healed;Heparitin Sulfate;Hereditary Multiple Exostoses;Impairment;In Vitro;Indium;Knowledge;Lead;Limb structure;Link;Location;Mandible;Mandibular Condyle;Measures;Mesenchymal;Mus;Mutation;National Research Service Awards;Natural regeneration;Partner in relationship;Pathology;Pathway interactions;Patients;Penetrance;Phenotype;Physical condensation;Physiological;Process;Proteins;Proteoglycan;Quality of life;Regulation;Research;Rest;Role;Signal Transduction;Skeletal Development;Skeleton;Small Interfering RNA;Structure;System;Testing;Therapeutic;Time;Tissues;Transforming Growth Factors;Work;bone;bone morphogenetic protein 2;chronic pain;craniofacial;early onset;functional restoration;glycosyltransferase;healing;heparanase;in vivo;insight;intramembranous bone formation;long bone;loss of function;loss of function mutation;member;mouse model;mutant;novel;repaired;rib bone structure;skeletal;skeletogenesis;skull base;spine bone structure;translational medicine","Heparan sulfate-dependent mechanisms of skeletogenesis"," Skeletal development and growth are fundamental processes that when defective, can cause major pathologies in the craniofacial, trunk and limb skeleton and can lead to impairment of body function and quality of life. This grant will allow me to complete my Ph.D. thesis work on physiologic skeletogenesis and an abnormal form of it called Hereditary Multiple Exostoses. The project will provide novel insights into mechanisms and will thus suggest possible therapeutic ways to repair and regenerate defective skeletal elements and restore function.  
    

","NIDCR","8328009","7/13/2012 12:00:00 AM","PA-10-108","5F31DE022204-02","5","F31","DE","022204","02"," ","FRIEDEN, LESLIE A","9/1/2011 12:00:00 AM","8/31/2013 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","9609065","HUEGEL, JULIANNE ","Not Applicable","03","ORTHOPEDICS","053284659","R8JEVL4ULGB7","053284659","R8JEVL4ULGB7","US","39.949004","-75.155569","4050801","THOMAS JEFFERSON UNIVERSITY","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191074418","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","43032"," "," ","43032",
"Biodefense; Biotechnology; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Accidents;Acute;Animal Model;Animals;Annexins;Apoptosis;Area;Attention;Biological Assay;Biological Monitoring;Biopsy;Blood Cells;Blunt Trauma;Bromodeoxyuridine;Burn Trauma;Burn injury;Cell Therapy;Cells;Characteristics;Chronic;Clinical;Collagen;Complex;Confocal Microscopy;Custom;Data;Deposition;Dose;Ear;Event;Exposure to;Fibroblasts;Goals;Green Fluorescent Proteins;Growth Factor;Hematopoietic;Histology;Hour;Imaging Techniques;Immune system;Immunobiology;Impaired wound healing;In Situ Nick-End Labeling;Individual;Infection;Infiltration;Inflammatory;Inflammatory Response;Injection of therapeutic agent;Injury;Interleukin-6;Investigation;Kinetics;Label;Lead;Life;Low Dose Radiation;Lymphocyte;Lymphocyte Count;Marrow;Measures;Medical;Mesenchymal Stem Cell Transplantation;Methods;Microscopy;Modeling;Molecular;Mouse Strains;Mus;Natural regeneration;Nuclear;Outcome;Phase;Plasma;Play;Population;Process;Proteins;Publishing;Radiation;Radiation Injuries;Radiation Syndromes;Recovery;Relative (related person);Rest;Role;Sampling;Site;Skin;Staining method;Stains;Stem cell transplant;Stem cells;Stromal Cells;Syndrome;Techniques;Technology;Testing;Therapeutic Intervention;Thick;Time;Tissues;Transplantation;Trauma;Umbilical Cord Blood;Vascular Endothelial Growth Factors;Wound Healing;base;cellular development;cytokine;design;dosimetry;effective therapy;efficacy testing;experience;heat injury;high throughput screening;improved;in vivo;injured;intravenous injection;irradiation;macrophage;mortality;mouse model;neovascularization;neutrophil;novel;novel strategies;progenitor;radiation effect;repaired;research study;response;trait;two-photon;wound","Skin Stem Cells in Combined Radiation Injury","n/a","NIAID","8305028","7/16/2012 12:00:00 AM"," ","5R33AI080525-05","5","R33","AI","080525","05"," ","DICARLO-COHEN, ANDREA L","7/18/2008 12:00:00 AM","7/31/2013 12:00:00 AM","NSS"," ","1867786","CHAO, NELSON J.","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","855","Non-SBIR/STTR","2012"," "," ","OD","236628","134878"," ","371506",
"Genetics; Infectious Diseases; Kidney Disease; Pediatric; Urologic Diseases","Accounting;Adult;Alleles;Antibodies;Atrophic;Axon;Birth;Bladder;Blood Pressure;Cell Proliferation;Cells;Child;Childhood;Chromosomal translocation;Cicatrix;Confocal Microscopy;Congenital Abnormality;Data;Defect;Development;Developmental Process;Disease;Electron Microscopy;Employee Strikes;End stage renal failure;Endowment;Epithelial Cells;Etiology;Exhibits;Family;Focal Segmental Glomerulosclerosis;Focal glomerulosclerosis;Gene Dosage;Goals;Growth;Health;Hereditary Disease;Homozygote;Human;Hypertension;Hypertrophy;Incidence;Infant;Infection;Injury;Integral Membrane Protein;Kidney;Kidney Diseases;Kidney Failure;Knock-out;Knockout Mice;Knowledge;Lead;Life;Ligands;Location;Maintenance;Measures;Mediating;Mesenchymal;Mesenchyme;Metanephric Diverticulum;Modeling;Molecular;Morbidity - disease rate;Morphogenesis;Morphology;Mus;Mutant Strains Mice;Mutate;Mutation;Nature;Nephrons;Nerve Fibers;Newborn Infant;Obstruction;Online Mendelian Inheritance In Man;Pathogenesis;Pathology;Patients;Pattern;Peristalsis;Phenotype;Play;Point Mutation;Population;Population Genetics;Positioning Attribute;Predisposition;Proteinuria;Recurrence;Reflux;Renal function;Renal pelvis;Risk;Role;Shapes;Signal Transduction;Staging;Staining method;Stains;Stream;Stress;Structure;Sum;Testing;Therapeutic Intervention;Tissues;Tubular formation;Ureter;Urinary tract;Urinary tract infection;Urine;Vesico-Ureteral Reflux;axon guidance;base;cell type;fetal;glomerulosclerosis;in vivo;insight;kidney cortex;knowledge base;mouse model;mutant;nephrogenesis;nerve supply;neurodevelopment;novel;novel strategies;novel therapeutics;podocyte;postnatal;pressure;research study;urinary;urinary tract pressure","Molecular Pathogenesis of Vesicoureteral Reflux","n/a","NIDDK","8294937","6/7/2012 12:00:00 AM","PA-07-059","5R01DK078226-05","5","R01","DK","078226","05"," ","HOSHIZAKI, DEBORAH K","8/1/2008 12:00:00 AM","2/28/2015 12:00:00 AM","Urologic and Kidney Development and Genitourinary Diseases Study Section[UKGD]"," ","8230238","LU, WEINING ","Not Applicable","07","Unavailable","005492160","JZ8RQC4EMDZ5","005492160","JZ8RQC4EMDZ5","US","42.337865","-71.070685","3617301","BOSTON MEDICAL CENTER","BOSTON","MA","Independent Hospitals","021182908","UNITED STATES","N","6/1/2012 12:00:00 AM","2/28/2015 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","196020","135254"," ","331274",
"Autism; Brain Disorders; Clinical Research; Genetics; Mental Health; Mental Retardation (Intellectual and Developmental Disabilities (IDD)); Neurosciences; Pediatric","Affect;Animal Model;Autistic Disorder;Bioinformatics;Biological;Biological Models;Biological Process;Birth;Brain;Brain Stem;Candidate Disease Gene;Centers for Disease Control and Prevention (U.S.);Cerebellar malformation;Cerebellar vermis structure;Cerebellum;Code;Complex;Computer Analysis;Congenital cerebellar hypoplasia;Counseling;Dandy-Walker Syndrome;Data;Data Linkages;Databases;Development;Diagnosis;Diffuse;Disease;Disease Association;Embryo;Epilepsy;Family;Finding by Cause;Frequencies;Functional RNA;Future;Gene Proteins;Genes;Genetic;Genome;Goals;Grant;Human;In Vitro;Individual;Joubert syndrome;Lead;Maps;Mental Retardation;Mesenchymal;Mesenchyme;Methods;Midbrain structure;Modeling;Molar tooth;Molecular;Molecular Genetics;Mus;Mutant Strains Mice;Network-based;Pathway interactions;Patients;Phenotype;Posterior Fossa;Recruitment Activity;Reporting;Resolution;Resources;Seeds;Signal Transduction;Structure;Syndrome;Testing;Time;Transgenic Mice;Validation;Variant;Work;base;cisterna magna;cohort;developmental disease;gene discovery;genetic linkage analysis;genome-wide linkage;hindbrain;human subject;improved;in vitro Assay;infancy;insight;malformation;mouse model;mutant;network models;novel;overexpression;programs;public health relevance","The Genetic Basis of Mid-Hindbrain Malformations","
Project Narrative
Developmental disorders of the brainstem and cerebellum - which are derived from the embryonic midbrain
and hindbrain - are a collectively important class of disorders that affect a minimum of 2.4 per 1000 resident
births based on data from the CDC. The true frequency is likely much higher. This large class of disorders
co-occurs with more common developmental disorders such as autism, mental retardation and some forms of
infantile epilepsy, and shares some of the same causes. We propose to find the causes of several different
types of brainstem and cerebellar malformations, which will contribute to more accurate diagnosis and
counseling in the short term, and to specific treatments for some of these disorders in the long term.","NINDS","8277226","7/4/2012 12:00:00 AM","PA-07-070","5R01NS050375-08","5","R01","NS","050375","08"," ","RIDDLE, ROBERT D","9/15/2005 12:00:00 AM","5/31/2015 12:00:00 AM","Developmental Brain Disorders Study Section[DBD]"," ","6096072","DOBYNS, WILLIAM B.","Not Applicable","07","Unavailable","048682157","SZ32VTCXM799","048682157","SZ32VTCXM799","US","47.663628","-122.283919","1531401","SEATTLE CHILDREN'S HOSPITAL","SEATTLE","WA","Independent Hospitals","981053901","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","788287","306059"," ","798866",
"Cardiovascular; Genetics; Heart Disease; Lung; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Ablation;Adult;Agreement;Alveolus;Architecture;Biological Models;Biology;Bleomycin;Blood;Bromodeoxyuridine;Cardiac;Cardiac Myocytes;Cardiovascular Diseases;Cardiovascular system;Cell Fate Control;Cell Line;Cell physiology;Cells;Cellular biology;Chemicals;Collaborations;Collection;Color;Commit;Complex;Cues;Data;Disease;Education;Engraftment;Ensure;Fibrosis;Functional disorder;Gene Expression;Gene Mutation;Gene Targeting;Genes;Goals;Growth;Healthcare;Heart;Human;Human Resources;Immunohistochemistry;In Vitro;Injury;Isoxazoles;Knock-out;Knowledge;Label;Lung;Lung diseases;Maps;Mediating;Mesenchymal;Messenger RNA;MicroRNAs;Mission;Modeling;Molecular Profiling;Mus;Mutant Strains Mice;Myocardial;Myocardial Infarction;Naphthalene;National Heart, Lung, and Blood Institute;Natural regeneration;Organ;Pathway interactions;Pericardial body location;Plants;Positioning Attribute;Principal Investigator;Process;Proteins;RNA;Reagent;Recombinant Growth Factor;Recruitment Activity;Regenerative Medicine;Reporter;Science;Scientist;Signal Transduction;Signaling Molecule;Site;Solid;Specialist;Specific qualifier value;Staging;Stem cells;Stress;Technology;Therapeutic;Tissue Model;Transgenic Organisms;Ultrasonography;Virus;Work;base;diphtheria toxin fragment A;drug development;frontier;in vivo;induced pluripotent stem cell;injured;innovation;lung injury;member;mutant;next generation;pressure;prevent;progenitor;programs;repaired;research facility;research study;response;small molecule;stem;tool;transcription factor","Microenvironmental control of progenitors in organ dysfunction and repair","n/a","NHLBI","8266329","6/25/2012 12:00:00 AM","RFA-HL-09-004","5U01HL100401-04","5","U01","HL","100401","04"," ","TOLUNAY, ESER","9/30/2009 12:00:00 AM","4/30/2016 12:00:00 AM","ZHL1-CSR-J(S1)"," ","1930355","SCHNEIDER, JAY W","OLSON, ERIC N","30","INTERNAL MEDICINE/MEDICINE","800771545","YZJ6DKPM4W63","800771545","YZJ6DKPM4W63","US","32.814772","-96.841146","578404","UT SOUTHWESTERN MEDICAL CENTER","DALLAS","TX","SCHOOLS OF MEDICINE","753909105","UNITED STATES","N","6/25/2012 12:00:00 AM","4/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","815760","379665"," ","1195425",
"Cancer","Acute;Address;Adenovirus Vector;Adult;Angiogenic Factor;Applications Grants;Avastin;Biological Assay;Blood Vessels;Calcineurin;Cancer Control;Cells;Characteristics;Chronic;Collaborations;DNA Sequence Rearrangement;Data;Daughter;Defect;Discontinuous Capillary;Endothelial Cells;Engineering;Event;Exhibits;Exposure to;Extravasation;Fibroblast Growth Factor 2;Genes;Growth;Growth Factor;Head;Histamine;Histone Deacetylase;Human;Inflammation;Inflammatory;Intervention;Knockout Mice;Laboratories;Lead;Learning;Literature;Malignant Neoplasms;Mediating;Mesenchymal;Microvascular Proliferation;Modeling;Molecular;Mothers;Mus;NR4A1 gene;Neoplasms in Vascular Tissue;Nuclear;Orphan;Pathologic Neovascularization;Pathway interactions;Pericytes;Permeability;Phase;Phosphoric Monoester Hydrolases;Phosphorylation;Physiological;Plasma;Plasma Proteins;Platelet-Derived Growth Factor;Play;Process;Property;Protein Dephosphorylation;Public Health;Publications;Rattus;Regulation;Rest;Role;Serotonin;Signal Pathway;Signal Transduction;Structure;System;Technology;Terminology;Testing;Tissues;Transgenic Mice;Transgenic Organisms;Tumor Angiogenesis;Vascular Endothelial Growth Factor Receptor;Vascular Endothelial Growth Factor Receptor-1;Vascular Endothelial Growth Factor Receptor-2;Vascular Endothelial Growth Factors;Vascular Endothelium;Vascular Permeabilities;Work;Wound Healing;analog;angiogenesis;in vivo;macromolecule;matrigel;orphan nuclear receptor TR3;overexpression;promoter;research study;tool;transcription factor;tumor;venule","Akt Signaling Pathways in VEGF-A-induced Angiogenesis","n/a","NCI","8378435","4/12/2012 12:00:00 AM"," ","5P01CA092644-09","5","P01","CA","092644","09"," "," ","6/13/2002 12:00:00 AM"," ","ZCA1-GRB-S","8203","1920790","BENJAMIN, LAURA E","Not Applicable","07","Unavailable","071723621","C1CPANL3EWK4","071723621","C1CPANL3EWK4","US","42.346758","-71.10256","758101","BETH ISRAEL DEACONESS MEDICAL CENTER","BOSTON","MA","Independent Hospitals","022155400","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","292351","292351"," ","198771","93580"," "," ",
"Cardiovascular; Pediatric; Rare Diseases","Accounting;Address;Affect;Age-Months;Angiotensin II;Angiotensin II Type 1 Receptor Blockers;Aorta;Aortic Diseases;Appearance;Architecture;Area;Binding;Binding Proteins;Binding Sites;Blood Vessels;Caring;Cartoons;Cell Culture Techniques;Cell physiology;Child;Collaborations;Complement;Complex;Data;Defect;Development;Dilatation - action;Disease;Environment;Epithelial;Equilibrium;Event;Extracellular Matrix;FBN1;Fetal Development;Functional disorder;Funding;Future;Goals;Growth Factor;Homeostasis;Individual;Investigation;Knowledge;Lead;Losartan;MAPK14 gene;Marfan Syndrome;Mediating;Mesenchymal;Microfibrils;Modeling;Molecular;Morphology;Mus;Mutant Strains Mice;Mutation;Organ;Outcome;Pathogenesis;Pathway interactions;Phenotype;Plant Roots;Protocols documentation;Reagent;Receptor Signaling;Research;Reverse Transcriptase Polymerase Chain Reaction;Role;Signal Transduction;Site;Skeletal Development;Smooth Muscle;Smooth Muscle Myocytes;Specific qualifier value;TGFB1 gene;Testing;Therapeutic;Therapy Clinical Trials;Time;Transforming Growth Factor beta;Translational Research;Work;base;biological adaptation to stress;bone morphogenetic protein 7;cell behavior;cellular targeting;design;in vivo;interest;latent TGF-beta binding protein;mouse model;mutant;mutant mouse model;novel;postnatal;prenatal;prevent;programs;receptor expression;repaired;response;skeletal disorder","Homeostasis and Repair in the Marfan Aorta","These investigations will identify novel mechanisms and pathways involved in aortic disease, will test
candidate molecules that may perform significant roles in aortic disease, will specify the contribution of
smooth muscle cells to aortic disease, and will determine whether or not aortic disease in MFS is inifiated
postnatally. These studies will suggest new targets for future therapies and will also contribute to strategies
for targeting cellular compartments in the aorta or for optimal timing of future therapies for MFS.","NIAMS","8379272","8/9/2012 12:00:00 AM"," ","5P01AR049698-09","5","P01","AR","049698","09"," "," ","7/1/2004 12:00:00 AM"," ","ZAR1-MLB-F","7051","1978988","SAKAI, LYNN Y","Not Applicable","13","Unavailable","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","Domestic Higher Education","100296574","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","325309","325309"," ","286196","39113"," "," ",
"Cancer; Clinical Research; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adult;Affect;Apoptosis;Binding;Biological Assay;Cell Culture Techniques;Cell Lineage;Cell Proliferation;Cell Separation;Cells;Chromatin;Complex;Coupled;DNA Binding;DNA-Binding Proteins;Data;Defect;Development;Differentiation and Growth;Embryo;Engineering;Engraftment;Epidermis;Epigenetic Process;Epithelial;Equilibrium;Family;Family member;Funding;Gene Targeting;Genes;Genetic;Genetic Transcription;Goals;Grant;Growth;Hair;Hair follicle structure;Histones;Homeostasis;Human;In Vitro;Infection;Injury;Keratin;Knowledge;Lead;Link;Malignant Neoplasms;Maps;Mediating;Mesenchymal;Methodology;Modeling;Morphogenesis;Mus;Mutant Strains Mice;Natural regeneration;Nuclear;Nude Mice;Pharmacologic Substance;Physiological;Play;Population;Predisposition;Process;Proliferating;Property;Regenerative Medicine;Regulation;Relative (related person);Reporter;Repression;Research;Rest;Role;Signal Pathway;Signal Transduction;Skin;Skin Cancer;Source;Specific qualifier value;Stem cells;Stimulus;System;Tamoxifen;Technology;Testing;Tetracyclines;Tissues;Transcriptional Regulation;Transgenic Organisms;Work;adult stem cell;anti-cancer therapeutic;appendage;cell behavior;chromatin immunoprecipitation;chromatin remodeling;comparative;embryonic stem cell;gene therapy;in utero;in vivo;innovation;keratinocyte;lentiviral-mediated;new growth;pluripotency;postnatal;promoter;public health relevance;repaired;small hairpin RNA;stem cell biology;stemness;tool;transcription factor;tumor;tumorigenesis","Regulation of Epidermal Development and Differentiation","
Project Narrative
Wnt signaling plays a central role in development and in regulating the properties of stem cells. This research
focuses on deciphering the key target genes that change in hair follicle stem cells as they receive signals from
their surroundings, begin to proliferate and generate new hair growth. Gone awry, these mechanisms lead to
skin cancers. By unearthing the direct genes and mechanisms involved in normal stem cell activation, we are
likely to uncover new targets for the development of anti-cancer therapeutics.","NIAMS","8227956","5/18/2012 12:00:00 AM","PA-10-067","5R01AR031737-30","5","R01","AR","031737","30"," ","BAKER, CARL","1/1/1983 12:00:00 AM","5/31/2016 12:00:00 AM","Development - 2 Study Section[DEV2]"," ","1864075","FUCHS, ELAINE ","Not Applicable","12","BIOLOGY","071037113","LHGDNJMZ64Y1","071037113","LHGDNJMZ64Y1","US","40.762898","-73.95652","7056601","ROCKEFELLER UNIVERSITY","NEW YORK","NY","GRADUATE SCHOOLS","100656399","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","353518","243927"," ","597445",
"Bioengineering","Actins;Active Sites;Address;Amino Acids;Animals;Area;Biology;Biosensor;CCI-779;Catalytic Domain;Cell Communication;Cells;Cellular biology;Collaborations;Communities;Cyclic AMP-Dependent Protein Kinases;Data;Development;Developmental Biology;Disease;Engineering;Epithelial;Epithelial Cells;Fishes;Focal Adhesion Kinase 1;Generations;Goals;Guanosine Triphosphate Phosphohydrolases;HRAS gene;Health;Heterodimerization;Image;Kinetics;Laboratories;Leukocytes;Life;Light;Long-Term Effects;MAP Kinase Gene;MAPK1 gene;MEKs;Mammalian Cell;Membrane;Molecular Models;Movement;Mutation;Myosin Light Chain Kinase;Oncogenic;Optics;Organ;Oxygen;Pathogenesis;Peptides;Phosphorylation;Phosphotransferases;Physiological;Physiology;Protein Dynamics;Protein-Serine-Threonine Kinases;Proteins;Reporting;Research;Research Personnel;Resolution;Route;Signal Transduction;Sirolimus;Specificity;System;Techniques;Tertiary Protein Structure;Testing;Tissues;Translating;Tyrosine;Universities;Wisconsin;Work;Zebrafish;analog;base;cell motility;cell type;design;epithelial to mesenchymal transition;in vivo;insight;instrumentation;molecular modeling;new technology;novel;novel strategies;optogenetics;small molecule;src-Family Kinases;success;tool;voltage;zebrafish development","A toolkit for imaging and photo-manipulation of signaling in zebrafish"," Dynamic cell signaling contributes to normal health and disease. There has been recent progress in developing tools to image and manipulate cell signaling, however, there has been a gap in translating these tools for use in live animals. The goal of the proposed research is to provide new tools to quantify and manipulate signaling in living zebrafish thereby enabling application to broad areas of developmental biology and disease pathogenesis.   
      

","NIGMS","8332584","7/12/2012 12:00:00 AM","PAR-11-131","1R01GM102924-01","1","R01","GM","102924","01"," ","DEATHERAGE, JAMES F","8/1/2012 12:00:00 AM","5/31/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-CB-Z(56)R]"," ","1881003","HUTTENLOCHER, ANNA ","HAHN, KLAUS M.","02","MICROBIOLOGY/IMMUN/VIROLOGY","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","SCHOOLS OF MEDICINE","537151218","UNITED STATES","N","8/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","528371","114904"," ","643275",
"Kidney Disease","1-Phosphatidylinositol 3-Kinase;Abbreviations;Acute Renal Failure with Renal Papillary Necrosis;Apical;Apoptosis;Area;Biological Models;Canis familiaris;Cell Culture Techniques;Cell Shape;Cell membrane;Cells;Complex;Confocal Microscopy;Contact Inhibition;Cyst;Disabled Persons;Dominant-Negative Mutation;Enzymes;Epithelial;Epithelial Cells;Epithelium;Extracellular Matrix;Extracellular Signal Regulated Kinases;Failure;Focal Adhesions;Gel;Goals;Grant;Guanine Nucleotide Exchange Factors;Height;Hepatocyte Growth Factor;Human;Incidence;Injury;Kidney;Kinetics;Left;Life;MEKs;Medical;Mesenchymal;Modeling;Molecular;PH Domain;Patients;Pharmacotherapy;Phosphatidylinositol 4,5-Diphosphate;Phosphatidylinositols;Phospholipase D;Phosphoric Monoester Hydrolases;Phosphotransferases;Play;Polycystic Kidney Diseases;Positioning Attribute;Process;Proliferating;Protein Isoforms;Proximal Kidney Tubules;RNA Interference;Ras/Raf;Recovery;Renal tubule structure;Reperfusion Injury;Resolution;Role;Shapes;Signal Pathway;Specimen;Supportive care;System;Telomerase;Testing;Thick;Thin Layer Chromatography;Tight Junctions;Tubular formation;Wound Healing;base;cellular imaging;effective therapy;handicapping condition;improved;in vivo Model;inhibitor/antagonist;injured;innovation;inorganic phosphate;interest;knock-down;migration;monolayer;mortality;p21 activated kinase;phosphatidylinositol 3,4,5-triphosphate;repaired","Recovery from acute kidney injury"," Acute kidney injury is an enormous medical problem, for which there is no therapy. The absence of therapy is a result of our lack of understanding of how the kidney recovers from injury. We have developed an innovative cell culture model system to study the cellular and molecular mechanisms of recovery from acute kidney injury.  
    

","NIDDK","8331430","8/22/2012 12:00:00 AM","PA-10-067","5R01DK074398-06","5","R01","DK","074398","06"," ","HOSHIZAKI, DEBORAH K","1/1/2007 12:00:00 AM","5/31/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-DKUS-G(03)M]"," ","1876425","MOSTOV, KEITH E","Not Applicable","12","ANATOMY/CELL BIOLOGY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","118538"," ","336038",
"Biotechnology; Cancer; Genetics; HIV/AIDS; Hematology; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Adipocytes;Antibodies;B-Lymphocytes;Binding;Binding Proteins;Binding Sites;Biological Assay;Birth;Blood Cells;Bone Marrow Cells;Cell Cycle;Cell Differentiation process;Cell Line;Cell Lineage;Cells;Cellularity;ChIP-seq;Chondrocytes;Co-Immunoprecipitations;Complex;Complex Mixtures;Consensus;DNA;Data Set;Defect;Development;Developmental Process;Differentiation Inhibitor;Endothelial Cells;Epigenetic Process;Erythroid;Erythroid Cells;Event;Family member;Fetal Liver;Future;Gene Expression;Gene Expression Profile;Gene Targeting;Genes;Genetic Transcription;Goals;Growth;Helix-Turn-Helix Motifs;Hematopoiesis;Hematopoietic;Hematopoietic Neoplasms;Hematopoietic stem cells;Hepatocyte;Histone-Lysine N-Methyltransferase;Histones;Hour;In Vitro;Knockout Mice;Leukemic Cell;Life;Luciferases;Lymphoid Cell;Lysine;Mass Spectrum Analysis;Mediating;Mediator of activation protein;Membrane;Mesenchymal;Microarray Analysis;Molecular;Mouse Strains;Mus;Mutate;Myelogenous;Myeloid Cells;Myeloproliferative disease;Osteoblasts;Patients;Phenotype;Physiological;Population;Process;Proteomics;Recruitment Activity;Regulation;Reporter;Repression;Role;SCID Mice;Sampling;Signal Transduction;Site;Smooth Muscle;Staging;Stem Cell Development;Stem cells;Stromal Cells;T-Lymphocyte;TCF3 gene;Testing;Tissues;Transgenic Mice;Transplantation;Undifferentiated;Zinc Fingers;cell growth;fetal;in vivo;knock-down;leukemia;leukemia/lymphoma;mouse model;novel;progenitor;programs;promoter;receptor;recombinase;reconstitution;research study;self-renewal;stem;stem cell biology;therapeutic target;transcription factor","MolecularCellular Regulation of Hematopoiesis","n/a","NCI","8552629"," "," ","1ZIABC010001-17","1","ZIA","BC","010001","17"," "," "," "," "," "," ","6569266","KELLER, JONATHAN R","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","1020550",
"Aging; Biotechnology; Breast Cancer; Cancer; Genetics; Prostate Cancer; Urologic Diseases","African American;Apoptosis;Architecture;BMI1 gene;BRCA1 gene;Behavior;Biology;Breast Cancer Cell;Breast Cancer Model;CHES1 gene;Caucasians;Caucasoid Race;Chromosomes;Clinical Trials;Combined Modality Therapy;Custom;DNA Repair;DNA biosynthesis;DNA copy number;Data Set;Development;Differentiation Therapy;Estrogen Receptors;Etiology;Event;Exhibits;Frequencies;GATA3 transcription factor;Gene Expression;Gene Mutation;Genes;Genetic;Genomics;Goals;Growth;Histologic;Human;In Vitro;Informatics;Knowledge;Lead;Libraries;Maintenance;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of prostate;Mammary Neoplasms;Medicine;MicroRNAs;Modeling;Molecular;Molecular Evolution;Mouse Mammary Tumor Virus;Neoplasm Metastasis;Oncogenes;Oncogenic;Pattern;Phenotype;Ploidies;Polycomb;Pre-Clinical Model;Prevention;Process;Progesterone Receptors;Property;Protein-Lysine 6-Oxidase;RRM1 gene;RRM2 gene;Signal Transduction;Small Interfering RNA;Specificity;Technology;Testing;Therapeutic;Transgenic Model;Woman;Work;base;cancer therapy;chemotherapy;clinical care;epithelial to mesenchymal transition;gemcitabine;hormone therapy;improved;in vivo;inhibitor/antagonist;insight;mRNA Expression;malignant breast neoplasm;mouse model;novel;novel strategies;optimism;outcome forecast;overexpression;research clinical testing;transcription factor;triple-negative invasive breast carcinoma;tumor;tumorigenesis","Transgenic Models for Prostate and Breast Cancer","n/a","NCI","8552587"," "," ","1ZIABC005740-20","1","ZIA","BC","005740","20"," "," "," "," "," "," ","6569020","GREEN, JEFFREY E","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","1120018",
"Eye Disease and Disorders of Vision; Regenerative Medicine","Adverse effects;Aging-Related Process;Autoimmune Diseases;Binding;Biological;Biological Process;Cell Differentiation process;Cell Proliferation;Chronic;Climate;Data;Development;Developmental Biology;Diffusion;Disease;Dry Eye Syndromes;Epithelial;Epithelial Cells;Extracellular Matrix;Eye;FGF10 gene;FGF3 gene;FGF7 gene;Family;Fibroblast Growth Factor;Functional disorder;Gene Expression;Gene Expression Regulation;Gene Family;Genes;Goals;Harderian Gland;Heparitin Sulfate;Hospitals;Laboratories;Lacrimal gland structure;Lead;Letters;Los Angeles;Lubrication;Mediating;Mediator of activation protein;Medical center;Mesenchymal;Mitogen-Activated Protein Kinase 3;Mitogen-Activated Protein Kinases;Modeling;Modification;Molecular Structure;Morphogenesis;Mutation;Natural regeneration;Organ;Pathway interactions;Patients;Pharmaceutical Preparations;Pollution;Process;Property;Publications;Reagent;Regulation;Salivary Glands;Signal Pathway;Signal Transduction;Signaling Molecule;Sjogren&apos;s Syndrome;Specificity;Structure;Syndrome;System;Time;Tissues;Translating;Work;alternative treatment;base;cell motility;computerized data processing;design;digital;eye dryness;fibroblast growth factor 10;fibroblast growth factor receptor 2b;fibroblast growth factor receptor 2c;gland development;homeodomain;member;migration;novel therapeutic intervention;proto-oncogene protein kfgf;public health relevance;repaired;research study;transcription factor","Regulation of lacrimal gland development and regeneration","
PROJECT NARRATIVE
In this application we will focus on understanding the regulatory mechanisms that control
lacrimal gland branching and repair. Our long-term goal is to define these mechanisms
and to create a comprehensive model of lacrimal gland development that could be
critical for designing alternative treatments for patients with lacrimal gland disorders.)
)","NEI","8217219","2/6/2012 12:00:00 AM","PA-10-069","5R21EY021292-02","5","R21","EY","021292","02"," ","MCKIE, GEORGE ANN","2/1/2011 12:00:00 AM","1/31/2014 12:00:00 AM","Anterior Eye Disease Study Section[AED]"," ","9506759","MAKARENKOVA, HELEN P","Not Applicable","49","Unavailable","781613492","PHZJFZ32NKH4","781613492","PHZJFZ32NKH4","US","32.903152","-117.243436","7375802","SCRIPPS RESEARCH INSTITUTE","LA JOLLA","CA","Research Institutes","920371000","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2014 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","125000","112375"," ","237375",
"Biotechnology; Brain Disorders; Eye Disease and Disorders of Vision; Genetics; Pediatric; Rare Diseases","Actins;Address;Affect;Amblyopia;Animal Model;Ankle;Antibodies;Binding;Biological Assay;Birth;Blepharophimosis;Boxing;Cell Culture Techniques;Cell Line;Cells;Code;Complex;Congenital Disorders;Data;Defect;Dermis;Development;Differentiation Antigens;Down-Regulation;Doxycycline;ES01;Embryo;Enhancers;Epidemiologic Studies;Epidermis;Exhibits;Eye;Eyelid Diseases;Eyelid structure;Fetus;Gene Expression;Gene Expression Regulation;Gene Mutation;Gene Structure;Gene Targeting;Genes;Genetic;Genetic Recombination;Genetic Transcription;Goals;Hereditary Disease;Homologous Gene;Human;Hyperopia;Immunoglobulin binding proteins;Impairment;Infertility;Instruction;Knowledge;Lazy Eyes;Lead;Luciferases;Mammals;Manganese Superoxide Dismutase;Mediating;Mesenchymal;Molecular;Morphogenesis;Mouse Strains;Movement;Mus;Muscle;Muscle Development;Mutation;Myopia;Neural Crest;Outcome;Outcome Study;Ovarian;Ovary;Oxidative Stress;Pathogenesis;Pathway interactions;Phenotype;Physiologic pulse;Play;Premature Ovarian Failure;Principal Investigator;Process;Protein Region;Proteins;Ptosis;Regulation;Research;Risk;Role;Signal Transduction;Smooth Muscle;Staging;Strabismus;Stress;Stromal Cells;Structure;Syndrome;Testing;Transfection;Transgenic Mice;Vision;Visual system structure;Woman;calponin;chromatin immunoprecipitation;craniofacial;forkhead protein;gender preference;granulose;loss of function;malformation;meibomian gland;mouse model;notch protein;novel;ocular surface;programs;promoter;protein expression;vector","Mouse model for eyelid disease: Congenital blepharophimosis"," The goal of the proposed research is to understand the normal eyelid morphogenesis and the pathogenesis of human congenital blephrophimosis syndrome (BPES). Specifically, we plan to use transgenic mice and cell cultures to investigate the mechanism of how the Notch1 activation may serve as the upstream control of expression of FoxL2 by periocular mesenchyma, which are destined for Mï¿½eller smooth muscle development of the eyelids. Furthermore, the new knowledge will help us unravel signaling mechanisms of the Notch pathway in regulating FoxL2 gene expression governing levator Mï¿½eller smooth muscle differentiation during eyelid morphogenesis.   
    

","NEI","8323433","8/16/2012 12:00:00 AM","PA-10-067","5R01EY021501-02","5","R01","EY","021501","02"," ","MCKIE, GEORGE ANN","9/1/2011 12:00:00 AM","8/31/2016 12:00:00 AM","Anterior Eye Disease Study Section[AED]"," ","2878366","LIU, CHIA-YANG ","Not Applicable","01","OPHTHALMOLOGY","041064767","DZ4YCZ3QSPR5","041064767","DZ4YCZ3QSPR5","US","39.142998","-84.503581","1523902","UNIVERSITY OF CINCINNATI","CINCINNATI","OH","SCHOOLS OF MEDICINE","452210001","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","250000","142500"," ","392500",
"Aging; Cancer; Prostate Cancer; Urologic Diseases","Actins;Adhesions;Aging;Androgen Receptor;Androgens;Apoptosis;Apoptosis Promoter;Apoptotic;Benign;Benign Prostatic Hypertrophy;Bypass;Cells;Complex;Cytoskeleton;Defect;Development;Disseminated Malignant Neoplasm;Dominant-Negative Mutation;Embryonic Development;Epithelial;Epithelial Cell Proliferation;Epithelial Cells;Event;Extracellular Matrix;Family;Fibroblasts;Genetic Transcription;Goals;Growth;Growth Factor;Human;In Vitro;Induction of Apoptosis;Inhibition of Apoptosis;Knockout Mice;LNCaP;Laboratories;Ligands;Link;MAP Kinase Gene;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Mediator of activation protein;Modeling;Molecular;Neoplasm Metastasis;Outcome;Pathway interactions;Phosphotransferases;Physiological;Physiological Processes;Premalignant;Prostate;Prostatic Neoplasms;Proteins;Proteomics;Reading;Receptor Signaling;Regulation;Research;Resistance;Role;Signal Pathway;Signal Transduction;Testing;Tissues;Transforming Growth Factor beta;Transforming Growth Factors;Transgenic Mice;Transgenic Organisms;Tumor Promoters;Tumor Suppressor Proteins;Tumorigenicity;Work;base;cancer cell;cell growth;cell motility;cofilin;epithelial to mesenchymal transition;evidence base;in vivo;insight;malignant phenotype;migration;mouse model;novel;overexpression;programs;prohibitin;promoter;public health relevance;receptor;response;tissue repair;trafficking;tumor;tumor initiation;tumor progression;tumorigenesis;tumorigenic","TGF-Beta Signaling Effectors in Prostate Growth Regulation/Tumor Progression","
NARRATIVE
The long term objective of the application is to characterize the functional
interplay between the TGF-ï¿½1 and androgen signaling pathways that
independently of Smad effectors and in the context of tissue microenvironment
contribute to deregulation of TGFï¿½1 mediated effects on prostate growth during
tumor initiation and progression. The application will also pursue the mechanism
converting TGF-ï¿½ from a tumor suppressor in normal and benign prostate
growth, to a tumor promoter in advanced metastatic cancer.","NIDDK","8322333","8/9/2012 12:00:00 AM","PA-07-070","5R01DK083761-03","5","R01","DK","083761","03"," ","RANKIN, TRACY L","8/15/2010 12:00:00 AM","7/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-DKUS-B(03)M]"," ","7875447","KYPRIANOU, NATASHA ","Not Applicable","06","SURGERY","939017877","H1HYA8Z1NTM5","939017877","H1HYA8Z1NTM5","US","38.042307","-84.458748","2793601","UNIVERSITY OF KENTUCKY","LEXINGTON","KY","SCHOOLS OF MEDICINE","405260001","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","95168"," ","300593",
"Brain Cancer; Brain Disorders; Cancer; Neurosciences; Rare Diseases","Address;Affect;Animals;Binding;Blood Vessels;Brain;Cell Survival;Cells;Cisplatin;Clinical;Combined Modality Therapy;Dissociation;EGF gene;Epidermal Growth Factor Receptor;Genes;Glioblastoma;Glioma;Goals;Growth;Human;In Vitro;Infiltration;Injury;Magnetic Resonance Imaging;Malignant - descriptor;Malignant Glioma;Malignant Neoplasms;Malignant neoplasm of lung;Mesenchymal;Modeling;Mus;Names;Neuropilins;Oncogenic;Patients;Phosphorylation;Proteins;Recurrence;Research;Resistance;Role;Signal Pathway;Signal Transduction;Smooth Muscle Myocytes;Specimen;TRAF6 gene;Testing;Therapeutic;Treatment Efficacy;Tyrosine;Tyrosine Phosphorylation;Work;Xenograft procedure;base;celecoxib;cell growth;chemotherapeutic agent;chemotherapy;clinically significant;epidermal growth factor receptor VIII;innovation;malignant breast neoplasm;neuro-oncology;novel;outcome forecast;overexpression;pre-clinical;rapid growth;temozolomide;therapy resistant;tumor;tumor xenograft;tumorigenesis","Modulation of Oncogenic Signaling in Glioblastomas"," Modulation of Oncogenic Signaling in Glioblastomas  Human glioblastomas are characterized with malignant growth, rapid progression and intrinsic invasiveness, rendering these tumors virtually resistant to existing therapies, and the great propensity for tumor recurrence. In this application, we propose to investigate a novel mechanism by which oncogenic EGFRvIII and EGFR promote glioblastoma malignancy and resistant to therapies through activation of ESDN- TRAF6/CrkII signaling. The proposed work holds promise to elucidate the glioblastoma malignancy and to overcome the tumor resistance to combination therapies.  
    

","NCI","8257239","8/28/2012 12:00:00 AM","PA-10-067","1R01CA159811-01A1","1","R01","CA","159811","01","A","SNYDERWINE, ELIZABETH G","9/1/2012 12:00:00 AM","6/30/2017 12:00:00 AM","Special Emphasis Panel[ZRG1-OBT-A(02)S]"," ","1887509","CHENG, SHI-YUAN ","Not Applicable","07","NEUROLOGY","005436803","KG76WYENL5K1","005436803","KG76WYENL5K1","US","41.896017","-87.616602","6144650","NORTHWESTERN UNIVERSITY AT CHICAGO","CHICAGO","IL","SCHOOLS OF MEDICINE","606114579","UNITED STATES","N","9/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","113088"," ","320588",
"Biotechnology; Gene Therapy; Genetics; HIV/AIDS; Pediatric; Pediatric AIDS; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","AMD3100;Address;Adherence;Adult;Bone Marrow;CD34 gene;CSF3 gene;Cell Lineage;Cells;Clinical Research;Clonality;Collection;Dependovirus;Differentiation and Growth;Dinoprostone;Drug resistance;Erythrocytes;Erythropoietin;Fibronectins;Future;Gene Expression;Gene Transfer;Generations;Genes;Genetic;Goals;HIV-1;Hematopoietic;Hematopoietic Cell Growth Factors;Hematopoietic stem cells;Human;In Vitro;Interleukin-6;Lentivirus Vector;Ligands;Macaca mulatta;Megakaryocytes;Mesenchymal;Methodology;Modeling;Molecular;Monoclonal Antibodies;Nature;Organ;Organogenesis;Population;Primates;Publications;Recombinants;Recovery;Regulatory T-Lymphocyte;Reporter Genes;Retroviral Vector;Safety;Serum;Serum-Free Culture Media;Stem Cell Factor;Stem cells;Technology;Therapeutic;Thrombopoietin;Tissues;Transplantation;Vascular Endothelial Growth Factor Receptor-1;Viral Vector;adeno-associated viral vector;base;bicyclam;cell type;cytokine;enhanced green fluorescent protein;human subject;improved;in vivo;neutralizing antibody;neutrophil;nonhuman primate;novel;primitive cell;programs;protein expression;reconstitution;repaired;retroviral-mediated;small molecule;stem;success;suicide gene;therapeutic gene;transduction efficiency;vector;vesicular stomatitis virus G protein","Retroviral Mediated Gene Transfer Into Primate Hematopoietic Cells","n/a","NHLBI","8558130"," "," ","1ZICHL002338-15","1","ZIC","HL","002338","15"," "," "," "," "," "," ","2479331","DUNBAR, CYNTHIA E","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL HEART, LUNG, AND BLOOD INSTITUTE"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NHLBI"," "," "," ","2624810",
"Genetics; Kidney Disease; Urologic Diseases","Affect;Alleles;Animals;Binding Proteins;Biological Process;Biology;Cell Line;Cell Polarity;Cell Proliferation;Cells;Complex;Cytoskeleton;Data;Defect;Development;Drosophila And protein;Drosophila genus;Embryo;Employee Strikes;Epithelial;Epithelial Cells;Epithelium;Event;Exhibits;Eyelid structure;Family;Family member;Female;Fibroblasts;Gene Expression;Genes;Genetic;Genitourinary system;Golgi Apparatus;Guanylate kinase;Health;Homologous Gene;Human;Hydronephrosis;Immigration;Immunofluorescence Immunologic;In Vitro;Kidney;Kidney Diseases;Knock-out;Knockout Mice;Life;MAPK14 gene;Mammalian Cell;Mediating;Mesenchymal;Mesenchyme;Metanephric Diverticulum;Methods;Microtubule-Organizing Center;Molecular;Molecular Profiling;Morphogenesis;Morphology;Motion;Mus;Muscle;Mutagenesis;Mutant Strains Mice;Mutate;Mutation;Nature;Palate;Pattern;Peristalsis;Phenotype;Phosphotransferases;Play;Population;Prevention;Protein Binding Domain;Protein Family;Proteins;Regulation;Reporter;Research;Role;SH3 Domains;Scaffolding Protein;Seminal Vesicles;Signal Transduction;Site;Smooth Muscle;Smooth Muscle Myocytes;Staging;Sternum;Stromal Cells;Structure;Structure of mesonephric duct;Suppressor-Effector T-Lymphocytes;Synapses;System;Testing;Time;Tissues;Transfection;Transgenes;Transgenic Mice;Tumor Suppressor Proteins;Ureter;Urinary tract;Urine;Urothelial Cell;Urothelium;Vagina;Work;Wound Healing;base;cell motility;cell type;fly;glycogen synthase kinase 3 beta;human DLG1 protein;imaginal disc;in vivo;male;member;membrane-associated guanylate kinase;migration;mouse model;mutant;novel;null mutation;postsynaptic density protein;reproductive;research study;synaptic function;urinary tract obstruction","DLGH1 AND UROGENITAL DEVELOPMENT","n/a","NIDDK","8288317","5/17/2012 12:00:00 AM","PA-07-059","5R01DK081156-05","5","R01","DK","081156","05"," ","HOSHIZAKI, DEBORAH K","8/14/2008 12:00:00 AM","5/31/2014 12:00:00 AM","Urologic and Kidney Development and Genitourinary Diseases Study Section[UKGD]"," ","3102492","MINER, JEFFREY H","SWAT, WOJCIECH A","01","INTERNAL MEDICINE/MEDICINE","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","208271","108301"," ","316572",
"Biotechnology; Breast Cancer; Cancer; Clinical Research; Genetics; Orphan Drug; Rare Diseases; Transplantation","Adopted;African American;Archives;Automobile Driving;BRCA1 gene;Biological;Biological Assay;Biological Markers;Biology;Breast;Cancer Etiology;Cancer and Leukemia Group B;Carboplatin;Cessation of life;Clinical;Clinical Trials;Collaborations;Companions;Comparative Biology;DNA Damage;DNA Microarray Chip;DNA Repair;DNA Repair Disorder;DNA Repair Gene;DNA copy number;Data;Defect;Development;Diagnostic;Drug Combinations;Drug Delivery Systems;ERBB2 gene;Formalin;Freezing;Future;Gene Expression;Gene Expression Profiling;Genes;Genetically Engineered Mouse;Genomics;Growth Factor;Human;Immune;Knowledge;MEKs;Malignant Neoplasms;Mammary Neoplasms;Marker Discovery;Messenger RNA;Modeling;Molecular;Mus;Neoadjuvant Therapy;Outcome;Paclitaxel;Paraffin Embedding;Pathway interactions;Patients;Pharmaceutical Preparations;Platinum;Pre-Clinical Model;Prevalence;Property;RNA;RNA Sequences;Randomized;Regimen;Resistance;Sampling;Signal Pathway;Subgroup;Technology;Testing;Therapeutic;Training;Treatment Efficacy;Validation;Woman;Xenograft procedure;base;chemotherapy;chromosome 5q loss;comparative;efficacy testing;epithelial to mesenchymal transition;genome-wide;improved;in vivo;inhibitor/antagonist;malignant breast neoplasm;mortality;mouse model;nano-string;outcome forecast;pre-clinical;response;triple-negative invasive breast carcinoma;tumor;tumor xenograft","Development and Validation of Biomarkers and Targets in Triple Negative Breast Ca","Breast cancer is the second most common cause of cancer deaths in women in the US each year, with Triple Negative Breast Cancers being overrepresented within these deaths and are among the most clinically challenging because of their paucity of treatment options. Therefore, it is imperative to understand the driving biology of TNBC, and then to target this with the right drugs so that improved outcomes can be achieved.","NCI","8389743","9/14/2012 12:00:00 AM","PAR-10-003","2P50CA058223-19A1","2","P50","CA","058223","19","A"," ","8/5/1997 12:00:00 AM","8/31/2017 12:00:00 AM","ZCA1-RPRB-0(M1)","6445","1902907","PEROU, CHARLES M.","Not Applicable","04","Unavailable","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","Domestic Higher Education","275995023","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Research Centers","2012","182329","182329"," ","182329","0"," "," ",
"Cancer; Kidney Disease; Pediatric; Rare Diseases; Urologic Diseases","Affect;Animal Model;Apoptotic;Benign;Binding;Binding Proteins;Biological Assay;Brachyury protein;Calcineurin;Calcium;Calcium Signaling;Caricatures;Cell Count;Cell Culture Techniques;Cell Polarity;Cell Survival;Cells;Cephalic;Collaborations;Computer Simulation;Defect;Development;Disease;Duct (organ) structure;Embryo;Employee Strikes;Epithelial;Epithelium;Family;Family member;Genitourinary system;Goals;Intermediate Mesoderm;Invaded;Kidney;Lead;Ligands;Maintenance;Malignant Childhood Neoplasm;Mediating;Mesenchymal;Mesenchyme;Mesoderm;Metanephric Diverticulum;Metanephric structure;Modeling;Molecular Target;Morphogenesis;Movement;Mus;Neoplasms;Nephroblastoma;Nephrogenic Cord;Nephrons;Normal tissue morphology;Organogenesis;Pathogenesis;Pathway interactions;Pediatric Neoplasm;Phenotype;Phosphorylation;Population;Preclinical Drug Evaluation;Process;Proteins;Regulation;Reporting;Rho-associated kinase;Role;STAT3 gene;STAT5A gene;Signal Transduction;Site;Skeletal system;Stem cells;Structure;Structure of mesonephric duct;Study Section;System;Tamoxifen;Time;Tissues;Transcription Factor AP-2 Alpha;Twin Multiple Birth;Ureter;Xenograft procedure;activating transcription factor;bone;bone loss;cytokine;drug development;inhibitor/antagonist;interest;kinase inhibitor;leukemia inhibitory factor;loss of function;male;mineralization;mouse model;mutant;neoplastic;neoplastic cell;nephrogenesis;novel;overexpression;prevent;progenitor;promoter;reproductive;response;small molecule;substantia spongiosa;tissue culture;tool;tumor;tumorigenesis;tumorigenic","GrowthDifferentiation Factors in Organogenesis","n/a","NCI","8552564"," "," ","1ZIABC005093-34","1","ZIA","BC","005093","34"," "," "," "," "," "," ","6568865","PERANTONI, ALAN ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","1194902",
"Chronic Liver Disease and Cirrhosis; Digestive Diseases; Injury (total) Accidents/Adverse Effects; Liver Disease; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human","Acute;Address;Affect;Automobile Driving;Biliary;Binding;Biochemical;Biological;CD44 gene;Carbon Tetrachloride;Cell Adhesion;Cell Differentiation process;Cell Proliferation;Cell membrane;Cells;Chronic;Cicatrix;Cirrhosis;Cleaved cell;Clinical;Collagen;Common bile duct structure;Data;Deposition;Development;Disease;Disease Progression;Epithelial;Epithelial Cells;Event;Fibrillar Collagen;Fibroblasts;Fibrosis;Goals;Hepatic Stellate Cell;Hepatitis C;Hepatocyte;Impaired wound healing;In Vitro;Incidence;Inflammation;Injection of therapeutic agent;Injury;Injury to Liver;Integrin Binding;Kupffer Cells;Laboratories;Ligation;Link;Liver;Liver Fibrosis;Mediating;Membrane Proteins;Mesenchymal;Messenger RNA;Modeling;Molecular;Mus;Myofibroblast;Necrosis;Neoplasm Metastasis;Oxidative Stress;Pathogenesis;Patients;Pattern;Peptide Hydrolases;Phosphotransferases;Physiological;Play;Primary carcinoma of the liver cells;Process;Proteins;Reaction;Reactive Oxygen Species;Reading;Recombinants;Role;Signal Pathway;Signal Transduction;Signaling Molecule;Staging;Stress;Testing;Thioacetamide;Time;Up-Regulation;Wild Type Mouse;Work;Wound Healing;base;chronic liver disease;collagenase 3;cytokine;feeding;fibrillogenesis;fibrogenesis;in vivo;in vivo Model;insight;novel;osteopontin;oval cell;prevent;public health relevance;research study;response;sensor;stellate cell;therapy design","Osteopontin and the fibrogenic response to liver injury","PROJECT NARRATIVE 
We have recently identified osteopontin as a key protein involved in the pathogenesis of liver fibrosis. The work 
proposed herein will clarify the mechanism whereby osteopontin modulates oval cell expansion, ductular 
reaction, and collagen I increase; thus, contributing to design treatments to prevent liver fibrosis, a disease 
affecting many people worldwide.","NIDDK","8518941","8/13/2012 12:00:00 AM","PA-07-070","3R56DK069286-06S1","3","R56","DK","069286","06","S","SERRANO, JOSE","8/1/2010 12:00:00 AM","6/30/2013 12:00:00 AM","Hepatobiliary Pathophysiology Study Section[HBPP]"," ","7028562","NIETO, NATALIA ","Not Applicable","13","INTERNAL MEDICINE/MEDICINE","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","SCHOOLS OF MEDICINE","100296574","UNITED STATES","N","8/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","71000","49345"," ","120345",
"Bioengineering; Biotechnology; Cancer","Address;Angiogenic Factor;Behavior;Blood;Blood Circulation;Blood Vessels;Blood capillaries;Cell Adhesion Molecules;Cell Line;Cells;Clinical;Coculture Techniques;Colon Adenocarcinoma;Data Reporting;Development;Devices;Diffusion;Disease;Disease Management;Down-Regulation;E-Cadherin;Endothelial Cells;Environment;Epithelial;Equilibrium;Fellowship;Fibroblasts;Genome;Goals;Growth;Growth Factor;Human;In Vitro;Inflammation;Lead;Leukocytes;Ligands;Macrophage Colony-Stimulating Factor;Malignant Neoplasms;Mesenchymal;Microfluidics;Modeling;Neoplasm Metastasis;Normal Cell;Nutrient;Outcome;Oxygen;Phenotype;Physiologic Neovascularization;Physiological;Physiology;Play;Preclinical Drug Evaluation;Process;Recruitment Activity;Relative (related person);Reporting;Reproduction;Research Training;Role;Site;System;Technology;Therapeutic;Tissue Engineering;Tissue Model;Tumor Cell Invasion;Tumor Necrosis Factor-alpha;Tumor-Associated Process;Work;Wound Healing;Xenograft Model;Xenograft procedure;angiogenesis;beta-Chemokines;cancer cell;cancer therapy;capillary;capillary bed;cell motility;chemokine;density;design;human TNF protein;in vitro Model;in vivo;interest;macrophage;monocyte;neoplastic cell;research study;three-dimensional modeling;tumor;tumor growth;tumor progression","Creating a 3D dynamic in vitro model of the tumor microenvironment to characteriz"," Treatments for cancer remain elusive due, in large part, to the dynamic and unstable genome of most cancer cells. This research training proposal will lead to a better understanding of the behavior of normal cells within the tumor microenvironment (e.g. endothelial cells, fibroblast, and leukocytes), which may be selectively targeted as an effective alternative or complimentary approach in the overall management of the disease. The impact of creating an in vitro 3D metastasis model with perfused human capillary bed could significantly enhance high- throughput anti-metastatic drug screening.  
  
    

","NCI","8514928","9/19/2012 12:00:00 AM","PA-10-109","5F31CA163049-02","5","F31","CA","163049","02"," ","MCNEIL FORD, NICOLE","9/1/2011 12:00:00 AM","8/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-E(20)L]"," ","10756038","ALONZO, LUIS FERNANDO","Not Applicable","45","BIOMEDICAL ENGINEERING","046705849","MJC5FCYQTPE6","046705849","MJC5FCYQTPE6","US","33.678042","-117.773718","577504","UNIVERSITY OF CALIFORNIA-IRVINE","IRVINE","CA","BIOMED ENGR/COL ENGR/ENGR STA","926970001","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","35736"," "," ","35736",
"Cardiovascular; HIV/AIDS; Hypertension; Kidney Disease","70-kDa Ribosomal Protein S6 Kinases;AIDS-Associated Nephropathy;African;African American;Aldosterone;Aldosterone Antagonists;Angiotensin-Converting Enzyme Inhibitors;Angiotensinogen;Animal Model;Attenuated;Data;Development;Dilatation - action;Disease;Disease model;End stage renal failure;Environmental Risk Factor;Enzyme Inhibition;Epithelial;Epithelial Cells;Focal glomerulosclerosis;Gene Expression;Generations;Genes;Genetic;Goals;HIV-1;Hospitalization;Human;In Situ;Individual;Infection;Injury;Integration Host Factors;Kidney;Kidney Diseases;Lesion;Mediating;Mesenchymal;Modeling;Molecular;Mouse Strains;Mus;Pathogenesis;Pathway interactions;Patients;Peptidyl-Dipeptidase A;Pharmacologic Substance;Phenotype;Play;Population;Production;Rattus;Renal Tissue;Renin;Renin-Angiotensin-Aldosterone System;Reporting;Research;Research Personnel;Role;System;Testing;Transgenic Mice;Tubular formation;Variant;aliskiren;base;cell injury;eplerenone;experience;human FRAP1 protein;inhibitor/antagonist;kidney cell;mRNA Expression;podocyte;prevent;public health relevance;receptor;transdifferentiation;vpr Genes","Renin Angioensin Aldosterone System in Drub Abuse and HIV-associated Nephropathy","
7. Project Narrative
Patients infected with HIV-1 are prone to develop a rapidly progressing kidney disease
termed HIV-associated nephropathy (HIVAN). HIVAN is the third leading cause of End-
stage renal disease among individuals with African American background, and is
associated with the highest rates of hospitalizations in this population. At present, there is
no specific treatment to cure this disease. Since activation of Renin-Angiotensin-
Aldosterone System plays an important role in the progression of renal diseases in
general, we intend to evaluate the effect of its inhibition in HIVAN. Our long term
research goal is to develop strategies to slow down the progression as well as find a
cure of this devastating kidney disease.","NIDDK","8304380","8/9/2012 12:00:00 AM","PA-07-070","5R01DK084910-03","5","R01","DK","084910","03"," ","KIMMEL, PAUL","8/1/2010 12:00:00 AM","7/31/2015 12:00:00 AM","NeuroAIDS and other End-Organ Diseases Study Section[NAED]"," ","1863819","SINGHAL, PRAVIN C","Not Applicable","03","Unavailable","110565913","C5LHMPRJ9J19","110565913","C5LHMPRJ9J19","US","40.772985","-73.703245","4155008","FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH","MANHASSET","NY","Research Institutes","110303816","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","194901","128635"," ","323536",
"Brain Cancer; Brain Disorders; Cancer; Kidney Disease; Orphan Drug; Polycystic Kidney Disease; Rare Diseases; Tuberous Sclerosis","Address;Adult;Age;Angiomyolipoma;Autophagocytosis;Benign;Bioenergetics;Brain;Brain Neoplasms;Cell Survival;Cells;Child;Clinical;Collaborations;Complex;Cyst;Cystadenoma;Cystic kidney;Defect;Detection;Development;Disease;Down-Regulation;Epithelial;FDA approved;Genes;Genetic;Genus Hippocampus;Glucose;Glutamine;Goals;Growth;Heart;Human;Institutes;Interleukin-6;Kidney;Kidney Diseases;Kidney Neoplasms;Lead;Lesion;Life;Loss of Heterozygosity;Mediating;Mesenchymal;Metabolic;Metabolism;Modeling;Monitor;Mus;Null Lymphocytes;Operative Surgical Procedures;Pathogenesis;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Play;Polycystic Kidney Diseases;Preclinical Drug Evaluation;Production;Reagent;Regulation;Renal Angiomyolipoma;Role;Signal Transduction;Sirolimus;Skin;Starvation;System;TSC2 gene;Technology;Testing;Time;Tuberous sclerosis protein complex;Work;Xenograft Model;cell growth;cytokine;human FRAP1 protein;human TSC2 protein;human disease;in vivo;in vivo Model;inhibition of autophagy;inhibitor/antagonist;innovation;mTOR protein;metabolomics;mouse model;novel;novel therapeutics;response;small hairpin RNA;therapeutic target;tumor;tumor xenograft","Roles of autophagy-mediated pathways in the pathogenesis and treatment of TSC"," Novel therapeutic paradigms are urgently needed for children and adults with TSC, for whom the only non- surgical treatment option is continuous, perhaps life-long, treatment with TORC1 inhibitors. We will identify the central mechanisms through which autophagy-dependent signaling networks impact the pathogenesis and targeted therapy of TSC, leading to new therapeutic paradigms for TSC and the many other human diseases in which the TORC1 signaling axis is dysregulated.   
      

","NIDDK","8369983","9/3/2012 12:00:00 AM","PA-11-260","1R01DK096556-01A1","1","R01","DK","096556","01","A","RASOOLY, REBEKAH S","9/3/2012 12:00:00 AM","5/31/2017 12:00:00 AM","Kidney Molecular Biology and Genitourinary Organ Development[KMBD]"," ","1877083","HENSKE, ELIZABETH P","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","9/3/2012 12:00:00 AM","5/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","146786"," ","364286",
"No NIH Category available","Adhesiveness;Animals;Apoptosis;Apoptotic;Automobile Driving;Basement membrane;Beds;Blood Platelets;Blood Vessels;CXC Chemokines;CXCL10 gene;CXCL11 gene;CXCL9 gene;CXCR3 gene;Calpain;Cell Count;Cell Death;Cell Proliferation;Cell Transplantation;Cells;Cellularity;Chronic;Cicatrix;Clinical;Coagulation Process;Collagen;Communication;Cyclic AMP-Dependent Protein Kinases;Defect;Derivation procedure;Dermal;Dermis;Diabetes Mellitus;Diabetic ulcer;Elements;Endothelial Cells;Enzymes;Epidermis;Epithelial;Equilibrium;Failure;Fibroblasts;Figs - dietary;Funding;G-Protein-Coupled Receptors;Goals;Growth Factor;Healed;Health;In Vitro;Individual;Inflammatory;Internet;Investigation;Knockout Mice;Lead;Ligands;Link;Mediating;Mesenchymal;Modeling;Molecular;Morbidity - disease rate;Mus;Natural regeneration;Neuropathy;Organogenesis;Oxygen;Patients;Peptides;Phase;Phenotype;Plasmin;Play;Process;Production;Recruitment Activity;Resolution;Role;Series;Signal Pathway;Signal Transduction;Skin;Skin Ulcer;Staging;Stromal Cells;Testing;Thick;Time;Tissues;Trauma;Tube;Vascular Endothelial Growth Factors;Wound Healing;base;cell motility;cell type;chemokine;extracellular;healing;in vivo;keratinocyte;mortality;mouse model;neovascular;neovascularization;neovasculature;normal aging;prevent;regenerative;repaired;research study;response;small molecule;stressor;therapy design;vessel regression;wound","Dermal-Epidermal Communication during Wound Healing","
NARRATIVE
Failure to properly heal wounds results in significant morbidity and mortality in many patients, particularly
those with diabetes, neuropathies, trauma and even those just advanced in years. Incomplete wound
resolution predisposes to ulcers and skin disruption, while excessive repair results in scarring which impairs
use and function. These investigations will define key extracellular and intracellular molecules that are
potential targets for rationally designed interventions to promote normal wound healing and limit scarring.","NIGMS","8319496","8/24/2012 12:00:00 AM","PA-07-070","5R01GM063569-08","5","R01","GM","063569","08"," ","SOMERS, SCOTT D","7/1/2003 12:00:00 AM","8/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-SBIB-E(02)M]"," ","1887605","WELLS, ALAN ","Not Applicable","18","PATHOLOGY","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","220523","113569"," ","334092",
"Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","ACVR1 gene;Address;Adenoviruses;Adoptive Transfer;Adrenal Cortex Hormones;Affect;Attenuated;Autoimmune Diseases;Biochemical;Birth;Blood Vessels;Bone Marrow;Bone Morphogenetic Proteins;Burn injury;Cells;Complement;Complication;Connective Tissue;Dendritic Cells;Development;Disease;Engraftment;Fracture;Gene Expression;Genetic;Grant;Heart Diseases;Heterotopic Ossification;Human;Immune;Individual;Infection;Inflammation;Inflammatory;Injury;Joints;Kinetics;Lead;Lesion;Ligaments;Ligands;Mediating;Mesenchymal;Modeling;Molecular;Molecular Target;Morbidity - disease rate;Mus;Muscle;Mutation;Myositis;Natural Immunity;Natural regeneration;Operative Surgical Procedures;Osteogenesis;Pain;Pathogenesis;Pericytes;Phosphotransferases;Population;Premature Mortality;Process;Proteins;Rare Diseases;Receptor Signaling;Recruitment Activity;Replacement Arthroplasty;Role;Signal Pathway;Signal Transduction;Skeletal Muscle;Skeletal Muscle Satellite Cells;Stem cells;Stimulus;Syndrome;Techniques;Testing;Tissues;Toll-like receptors;Transgenes;Transgenic Organisms;Trauma;Vascular Diseases;Viral;base;bone;bone morphogenetic protein receptor type I;calcification;cell type;cellular targeting;effective therapy;falls;gain of function;human disease;injury and repair;insight;macrophage;mouse model;mutant;novel;novel strategies;osteogenic;osteoprogenitor cell;postnatal;progenitor;programs;progressive myositis ossificans;receptor;receptor-mediated signaling;recombinase;reconstitution;repaired;response;skeletal abnormality;small molecule;soft tissue","Molecular and cellular mechanisms of heterotopic ossification","PROJECT NARRATIVE 
This proposal asks how bone morphogenetic protein signals, which normally regulate the activity of 
progenitor cells involved in the repair of muscle, blood vessels, connective tissues, and bone, may 
become dysregulated to cause inappropriate bone formation in the human diseases of heterotopic 
ossification and fibrodysplasia ossificans progressiva. In addition to providing insights into the 
mechanism of these poorly understood processes, these studies may identify much needed novel 
approaches for their management. These mechanisms have relevance to a broader set of conditions 
in which inflammation and injury appear to lead to abnormal ossification in autoimmune, cardiac, and 
vascular disease.","NIAMS","8325423","6/28/2012 12:00:00 AM","PA-07-070","5R01AR057374-03","5","R01","AR","057374","03"," ","SHARROCK, WILLIAM J","8/1/2010 12:00:00 AM","6/30/2015 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1860889","YU, PAUL B","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","216000","169560"," ","385560",
"Biotechnology; Cancer; Clinical Research; Genetics; Lung; Lung Cancer; Rare Diseases","Adenocarcinoma Cell;Alleles;Area;Binding;Biomedical Engineering;Biopsy Specimen;Blood Coagulation Factor VII;Breast Cancer Model;Cancer Etiology;Cancer Patient;Cause of Death;Cell Shape;Cells;Cellular biology;Cessation of life;Clinical Trials;Country;Disease;Early treatment;Epithelial;Event;Family;Family member;Gene Expression Profile;Genes;Genetic;Genetic Transcription;Goals;Helper-Inducer T-Lymphocyte;Human;Individual;Injection of therapeutic agent;Investigation;Ligands;Link;Lung;Lung Adenocarcinoma;Lung Neoplasms;Malignant neoplasm of lung;Mediating;Mediator of activation protein;Metastasis Suppression;MicroRNAs;Modeling;Mus;Neoplasm Metastasis;Oncogenic;Patients;Pattern;Pharmaceutical Preparations;Phenotype;Play;Prevention;Primary Neoplasm;Process;Property;Public Health;Recurrence;Regulation;Reporting;Resected;Role;Signal Transduction;Small RNA;Staging;Techniques;Transcription Repressor/Corepressor;Transfection;Transforming Growth Factors;Tumor Cell Line;Tumor Suppressor Proteins;Tumorigenicity;base;cancer cell;epithelial to mesenchymal transition;expression vector;extracellular;high risk;inhibitor/antagonist;innovation;matrigel;mouse model;mutant;neoplastic cell;notch protein;novel strategies;prevent;promoter;public health relevance;response;secretase;small hairpin RNA;transcription factor;tumor;tumorigenesis","Regulation of Lung Cancer Metastasis by miR-200","
PROJECT NARRATIVE
Lung cancer is the primary cause of cancer-related death in western countries, and metastasis is the primary
cause of death from lung cancer, which demonstrates a crucial need to better understand the biologic
underpinnings of metastasis. On the basis of the findings presented here, we postulate that tumor cells bind to
each other in a lock-and-key fashion through a receptor (Notch) that binds to its ligand (jagged2) on adjacent
tumor cells; Notch then suppresses the levels of a small RNA called miR-200, inducing a change in cell shape
and detachment from neighboring cells, an early event in metastasis. If proven true, these findings would
warrant studies to determine whether drugs that inhibit Notch receptors, which are currently in clinical trials,
prevent lung cancer metastasis and do so most effectively for tumors that have high levels of jagged2 and
Notch.","NCI","8241956","3/16/2012 12:00:00 AM","PA-10-067","5R01CA157450-02","5","R01","CA","157450","02"," ","KIM, KELLY Y","3/14/2011 12:00:00 AM","2/28/2016 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1869259","KURIE, JONATHAN M","Not Applicable","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","237294","87435"," ","324729",
"Dental/Oral and Craniofacial Disease","Actins;Adhesions;Adhesives;Affinity;Alveolar;Amino Acids;Aspartic Acid;Binding;Biological Process;Bone Matrix;Calcium;Calmodulin;Cell Proliferation;Cell Survival;Cell membrane;Cell physiology;Cells;Charge;Collagen;Collagen Fiber;Collagen Fibril;Complex;Crystal Formation;Cytoskeleton;Dentin;Dentin Formation;Dentinogenesis;Deposition;Development;Embryo;Event;Exhibits;Extracellular Matrix;Gel;Gene Expression;Gene Proteins;Gene Targeting;Genes;Genetic Transcription;Goals;Growth;Growth and Development function;Human;Hydroxyapatites;In Vitro;Inorganic Chemicals;Integrin Binding;Integrins;Ions;Kidney;Knowledge;Lead;Life;Ligation;Location;Lung;Mechanics;Mediating;Mesenchymal;Minerals;Mitogen-Activated Protein Kinases;Molecular;Morphology;Mus;Musculoskeletal;Natural regeneration;Neural Crest;Neural Crest Cell;Nuclear Translocation;Odontoblasts;Organism;Phase;Phosphoproteins;Phosphorylation;Phosphotransferases;Physiologic calcification;Play;Precipitation;Process;Production;Property;Protein Biosynthesis;Proteins;RGD (sequence);Reporting;Role;Second Messenger Systems;Serine;Shapes;Signal Pathway;Signal Transduction;Signaling Molecule;Site;Staging;Stem cells;Structure;Temperature;Testing;Time;Tissues;Tooth structure;Vertebrates;biomineralization;bone;calcium phosphate;calmodulin-dependent protein kinase II;cell type;demineralization;extracellular;in vivo;insight;interest;macromolecule;mineralization;phosphophoryn;pressure;public health relevance;receptor;response;scaffold;second messenger","Intracellular and Extracellular function of dentin phosphophoryn","
PROJECT NARRATIVE
During tooth development, the preodontoblasts polarize and elongate as they
mature to the secretory form and secrete collagen and a variety of
noncollagenous proteins. The major acidic phosphoprotein synthesized by the
odontoblasts is ""dentin phosphophoryn"" DPP. DPP is a highly acidic protein and
has been implicated to function as a regulator of mineral deposition during dentin
formation. In this proposal we intend to identify the mechanism by which DPP
functions in the extracellular matrix as a regulator of mineralization and
intracellularly as a cell signaling molecule. DPP mediated signaling can regulate
odontoblast proliferation and differentiation. Results from this study should help
us define the various functions of DPP, and its potential use in dentin
regeneration.","NIDCR","8269568","5/2/2012 12:00:00 AM","PA-07-070","5R01DE019633-03","5","R01","DE","019633","03"," ","LUMELSKY, NADYA L","7/1/2010 12:00:00 AM","5/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-MOSS-B(02)]"," ","1867555","GEORGE, ANNE ","Not Applicable","07","DENTISTRY","098987217","W8XEAJDKMXH3","098987217","W8XEAJDKMXH3","US","41.880316","-87.687597","577703","UNIVERSITY OF ILLINOIS AT CHICAGO","Chicago","IL","SCHOOLS OF DENTISTRY/ORAL HYGN","606124305","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","247500","141075"," ","388575",
"Cancer; Digestive Diseases; Emerging Infectious Diseases; Infectious Diseases; Prevention; Rare Diseases","Acids;Adoptive Transfer;Adult;Animals;Apical;Atrophic;Atrophic Gastritis;Bacterial Infections;Biological Assay;Biological Markers;Biology;Cancer Diagnostics;Cancer Etiology;Cancerous;Cell Culture Techniques;Cell Differentiation process;Cell Lineage;Cell physiology;Cell-Cell Adhesion;Cells;Cessation of life;Chronic;Data;Development;Diagnosis;Differentiation and Growth;Disease;Embryonic Development;Epithelial;Epithelial Cells;Epithelium;Erinaceidae;Event;Gastric Parietal Cells;Gastric Tissue;Gastritis;Gastrointestinal tract structure;Gland;Goals;Healed;Health;Helicobacter Infections;Helicobacter pylori;Homeostasis;Immune;Immune response;In Vitro;Inflammation;Inflammatory;Inflammatory Response;Knowledge;Laboratories;Left;Lesion;Link;Maintenance;Malignant Neoplasms;Metaplasia;Metaplastic;Molecular;Morphology;Mucous body substance;Mus;Natural regeneration;Neoplasms;Normal Cell;Organ;Outcome;Parietal;Pathogenesis;Patients;Pattern;Play;Prevention;Process;Production;Public Health;Publishing;Research;Role;Sonic hedgehog protein;Splenocyte;Staging;Stomach;T-Lymphocyte;Tamoxifen;Tars;Testing;Therapeutic Intervention;Tight Junctions;Time;Tissues;Tube;Ulcer;Work;base;carcinogenesis;chemokine;cytokine;epithelial to mesenchymal transition;gastric cancer prevention;healing;in vivo;innovation;malignant stomach neoplasm;morphogens;mouse model;mutant;neoplastic;novel;novel strategies;prevent;prognostic;public health relevance;response;smoothened signaling pathway;therapeutic target","The role of Hedgehog Signaling in gastric tissue homeostasis and disease","
PROJECT NARRATIVE
The proposed research has relevance to public health because gastric cancer continues to be the second
leading cause of cancer-related death worldwide. The successful completion of this proposal will have a
positive impact on our current knowledge of gastric biology, especially the aspects that are important in
understanding the pathogenesis of gastric cancer. In addition, identifying the role of Hedgehog signaling
in the development of neoplasia will allow for the therapeutic intervention to target the treatment or pre-
vention of gastric cancer.","NIDDK","8212337","2/8/2012 12:00:00 AM","PA-10-067","5R01DK083402-02","5","R01","DK","083402","02"," ","HAMILTON, FRANK A","2/1/2011 12:00:00 AM","1/31/2016 12:00:00 AM","Gastrointestinal Mucosal Pathobiology Study Section[GMPB]"," ","8036512","ZAVROS, YANA ","Not Applicable","01","PHYSIOLOGY","041064767","DZ4YCZ3QSPR5","041064767","DZ4YCZ3QSPR5","US","39.142998","-84.503581","1523902","UNIVERSITY OF CINCINNATI","CINCINNATI","OH","SCHOOLS OF MEDICINE","452210001","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","217500","112132"," ","329632",
"Cancer; Clinical Research; Genetic Testing; Genetics; Human Genome; Pediatric; Rare Diseases","14q31;6 year old;Address;Affect;Alleles;Anatomy;Animal Model;Autoimmune Process;Cancer Family;Candidate Disease Gene;Caring;Cell physiology;Cells;Child;Chromosomes;Cleaved cell;Clinical;Consent;Counseling;Cyst;DICER1 gene;Data;Defect;Detection;Development;Disease;Early Diagnosis;Embryo;Epithelial;Epithelial cyst;Epithelium;Evaluation;Extended Family;Familial disease;Family;Family Study;Family history of;Family member;Fetal Lung;Foundations;Frequencies;Future;Gene Expression;Genes;Genetic;Genetic Heterogeneity;Germ-Line Mutation;Heritability;Human;Immunohistochemistry;Individual;Inherited;Investigation;Knock-out;Lead;Learning;Light;Lung;Malignant Neoplasms;Maps;Measures;Medical;Medical History;Medical Records;Mesenchymal;Mesenchyme;MicroRNAs;Modeling;Molecular;Molecular Profiling;Mus;Mutation;Mutation Analysis;Neoplasms;Neoplastic Cell Transformation;Nephroblastoma;Parents;Pathogenesis;Pathway interactions;Patients;Pediatric Neoplasm;Penetrance;Phenotype;Play;Pleuropulmonary Blastoma;Predisposition;Pregnancy Histories;Processed Genes;Proteins;Questionnaire Designs;RNASE3L gene;Recording of previous events;Research;Rhabdomyosarcoma;Ribonuclease III;Risk;Role;Screening procedure;Siblings;Solid;Somatic Mutation;Staging;Syndrome;Testing;Tissues;Work;base;cohort;exportin 5;genetic linkage analysis;grandparent;human disease;loss of function;lung development;lung sarcoma;member;novel;proband;public health relevance;research study;sarcoma;tumor;tumor initiation;tumorigenesis","DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome","
This work will shed light on the role genetics plays in a new pediatric tumor syndrome and could ultimately lead
to new strategies to the detection and treatment of PPB and related tumors such as rhabdomyosarcoma and
Wilms tumor.","NCI","8207988","12/30/2011 12:00:00 AM","PA-07-070","5R01CA143167-03","5","R01","CA","143167","03"," ","SEMINARA, DANIELA","1/1/2010 12:00:00 AM","12/31/2014 12:00:00 AM","Cancer Genetics Study Section[CG]"," ","8309409","HILL, DANA ASHLEY","Not Applicable","98","Unavailable","143983562","M3KHEEYRM1S6","143983562","M3KHEEYRM1S6","US","38.92636","-77.012376","1518602","CHILDREN'S RESEARCH INSTITUTE","WASHINGTON","DC","Research Institutes","200102916","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","239607","91843"," ","331450",
"Chronic Liver Disease and Cirrhosis; Digestive Diseases; Kidney Disease; Liver Disease; Polycystic Kidney Disease; Regenerative Medicine; Transplantation","Accounting;Address;Adult;Affect;Angiogenesis Inhibitors;Angiopoietin-1;Angiopoietins;Animals;Autosomal Dominant Polycystic Kidney;Autosomal Recessive Polycystic Kidney;Biliary;Cell Differentiation process;Cell Line;Cells;Child;Childhood;Chronic;Cilia;Cyst;Cystic kidney;Defect;Development;Disease;Disease Progression;Disease model;Epithelial;Epithelial Cells;Epithelium;Etiology;Functional disorder;Genetic;Goals;Growth;Growth Factor;Hemorrhage;Hepatic Cyst;Hepatocyte;In Vitro;Infection;Inflammatory;Inherited;Kidney;Kidney Failure;Liver;Liver Fibrosis;Liver Regeneration;Liver diseases;Mediating;Medical;Mesenchymal;Morbidity - disease rate;Morphogenesis;Mus;Mutate;Mutation;Natural regeneration;Organ Transplantation;PKD2 protein;Pathogenesis;Pathway interactions;Patients;Physiological;Play;Population;Property;Proteins;Reaction;Regulation;Role;Role Concepts;Rupture;Signal Pathway;Signal Transduction;Syndrome;Testing;Therapeutic;Up-Regulation;Variant;Vascular Endothelial Growth Factor Receptor-2;Vascular Endothelial Growth Factors;autocrine;base;bile duct;biliary tract;cholangiocyte;cytokine;density;functional disability;improved;in vivo;interest;intrahepatic;liver function;liver repair;liver transplantation;mouse model;overexpression;paracrine;polycystic kidney disease 1 protein;polycystic liver disease;prevent;protein function;public health relevance;receptor;repaired;response;young adult","Epithelial Angiogenic Signaling in Polycystic Diseases of the Liver","n/a","NIDDK","8228110","2/21/2012 12:00:00 AM","PA-07-293","5R01DK079005-05","5","R01","DK","079005","05"," ","DOO, EDWARD","4/1/2008 12:00:00 AM","4/30/2013 12:00:00 AM","Hepatobiliary Pathophysiology Study Section[HBPP]"," ","8772820","STRAZZABOSCO, MARIO ","Not Applicable","03","INTERNAL MEDICINE/MEDICINE","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","3/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","196020","128393"," ","324413",
"Clinical Research; Infant Mortality/ (LBW); Lung; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal - Neonatal Respiratory Distress Syndrome; Perinatal Period - Conditions Originating in Perinatal Period","Affect;Agonist;Alveolar;Alveolitis;Birth;Bronchopulmonary Dysplasia;Cell Communication;Cells;Child;Chronic lung disease;Clinical;Clinical Data;Complication;Data;Dichloromethylene Diphosphonate;Disease;Effector Cell;Epithelial;Exposure to;Fetal Lung;Genetic;Health;Immune;Immune response;Immune system;Impairment;In Vitro;Individual;Infant;Infection;Infection of amniotic sac and membranes;Inflammation;Inflammatory;Injection of therapeutic agent;Injury;Interleukin-1;Interleukin-12;Knockout Mice;Lead;Life;Link;Lipopolysaccharides;Lung;Lung Inflammation;Measures;Mechanical ventilation;Mediating;Mesenchymal;Mesenchyme;Morphogenesis;Mus;NF-kappa B;NFKB Signaling Pathway;Natural Immunity;Newborn Infant;Outcome;Pathogenesis;Pathway interactions;Patients;Perinatal;Perinatal Exposure;Phenotype;Population;Premature Birth;Premature Infant;Process;Production;Recurrence;Regulation;Risk;Role;Signal Pathway;Signal Transduction;Staging;Stimulus;TLR4 gene;TNF gene;Testing;Toll-like receptors;Transgenic Mice;Transgenic Model;Tumor Necrosis Factor Receptor;United States;Weaning;Wild Type Mouse;abstracting;cell type;cytokine;fetal;fibroblast growth factor 10;human disease;immune activation;immune function;improved;in utero;lung development;macrophage;mouse model;novel;oxygen toxicity;prenatal;prenatal exposure;prevent;pup;response","Role of Fetal Lung Macrophages in Bronchopulmonary Dysplasia","
Narrative
This proposal will test novel mechanisms of disease explaining how infection and inflammation disrupt normal
lung development and immune function in preterm infants. These processes contribute to the pathogenesis of
bronchopulmonary dysplasia, a chronic lung disease that affects up to 10,000 former preterm children each
year in the United States.","NHLBI","8304371","7/31/2012 12:00:00 AM","RFA-HL-08-009","5R01HL097195-04","5","R01","HL","097195","04"," ","BLAISDELL, CAROL J","9/14/2009 12:00:00 AM","1/31/2013 12:00:00 AM","ZHL1-CSR-H(M2)"," ","7598551","PRINCE, LAWRENCE S","BLACKWELL, TIMOTHY S.","05","PEDIATRICS","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","8/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","330745","185217"," ","515962",
"Arthritis; Bioengineering; Injury (total) Accidents/Adverse Effects; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute;Address;Adult;Allogenic;Allografting;Animal Model;Anterior Cruciate Ligament;Autologous Transplantation;Behavior;Biology;Biomechanics;Bone Marrow;Bone Tissue;Cadaver;Caring;Cells;Characteristics;Child;Childhood;Chromosome Painting;Collaborations;Connective Tissue;Data;Degenerative polyarthritis;Development;Embryonic Development;Engineering;Ensure;Exhibits;Female;Generations;Goals;Growth Factor;Healthcare;Human;Implant;Injury;Innovative Therapy;Joints;Knee Injuries;Laboratories;Lead;Life;Ligaments;Malignant Neoplasms;Mammals;Maps;Mesenchymal;Molecular;Musculoskeletal;Natural regeneration;Operative Surgical Procedures;Organ Transplantation;Outcome;Pathway interactions;Patients;Population;Procedures;Process;Quality of life;Replacement Therapy;Research;Risk;Safety;Sheep;Signal Transduction;Stem cells;Stromal Cells;Technology;Tendon structure;Time;Tissue Differentiation;Tissue Engineering;Tissues;Translating;Transplantation;Transplanted tissue;Treatment Efficacy;Undifferentiated;Work;Y Chromosome;anterior cruciate ligament reconstruction;base;bone;bone engineering;cell motility;cost;early onset;hamstring;high risk;implantation;improved;in vivo;in vivo regeneration;injured;innovation;ligament injury;male;molecular marker;musculoskeletal injury;new technology;novel;precursor cell;regenerative;regenerative therapy;repaired;response;scaffold;spatiotemporal;stem;success;young adult","Using BMSC-derived Bone-Ligament-Bone Tissue as a Live Template for ACL Regenerat"," Billions of dollars are spent each year on anterior cruciate ligament (ACL) reconstructions after acute knee injury and more than half of patients who undergo this procedure develop early- onset osteoarthritis. New technology developed by this research team uses bone marrow stromal cell-derived, living bone-ligament-bone templates to replace the injured ACL. Transplanted tissue does not survive long-term in the recipient (patient), but induces the regeneration of a new ligament made entirely of the patient's own cells! The regenerating ACL integrates into bone and forms a viable and mechanically appropriate replacement ligament. If these preliminary results are confirmed, we will be one large step closer to translating these results into a vastly improved human therapy. Further, understanding the mechanisms by which this regeneration occurs will open new avenues in the regeneration of musculoskeletal tissue.   
      

","NIAMS","8383131","6/15/2012 12:00:00 AM","PA-10-010","1R21AR063444-01","1","R21","AR","063444","01"," ","WANG, FEI","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","1889947","WELLIK, DENEEN M","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","135000","74925"," ","209925",
"Brain Cancer; Brain Disorders; Cancer; Neurosciences; Rare Diseases","Abbreviations;Affect;Biological;Biological Assay;Brain Neoplasms;Carmustine;Cell Cycle Arrest;Cell Death;Cell Line;Cell Proliferation;Cells;Chromosomes, Human, Pair 10;Clinic;Clinical;Cyclin-Dependent Kinase Inhibitor;DNA Repair;Data;Epidermal Growth Factor Receptor;Esters;Fibroblasts;Foundations;Galactosidase;Glioblastoma;Glioma;Goals;Heart Neoplasms;Heterochromatin;Homologous Gene;Immunocompromised Host;Immunofluorescence Microscopy;Laboratories;MGMT gene;Mesenchymal;Modeling;Mus;Mutate;Notch Signaling Pathway;O(6)-Methylguanine-DNA Methyltransferase;Operative Surgical Procedures;PTEN gene;Pathway interactions;Pharmaceutical Preparations;Phosphoric Monoester Hydrolases;Play;Radiation therapy;Reporting;Resistance;Role;Series;Signal Transduction;Staining method;Stains;Survival Rate;Testing;Translating;Treatment Protocols;base;cancer stem cell;cancer therapy;chemotherapy;epidermal growth factor receptor VIII;fetal bovine serum;gamma secretase;in vivo;inhibitor/antagonist;neoplastic cell;neurosurgery;notch protein;novel;outcome forecast;prevent;public health relevance;research study;response;secretase;senescence;sound;temozolomide;tensin;tumor","Enhancing glioma chemotherapy by suppressing Notch signaling","
PROJECT NARRATIVE
Glioblastoma multiforme is the highest-grade brain tumor and is a tremendously difficult
clinical problem. The current therapy is a combination of surgery, radiotherapy and
chemotherapy with temozolomide, resulting in a 5% 5-year survival rate. We recently
discovered that inhibitors of the Notch signaling pathway enhance temozolomide
treatment of glioblastoma cell in culture. Our goal is to understand the underlying
mechanism, identity markers for responsive glioblastomas and translate these
observations to the clinic.","NINDS","8269695","5/17/2012 12:00:00 AM","PA-07-070","5R01NS021716-27","5","R01","NS","021716","27"," ","FOUNTAIN, JANE W","3/1/1988 12:00:00 AM","5/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-BDCN-W(03)M]"," ","1865029","ROSS, ALONZO H","Not Applicable","02","BIOCHEMISTRY","603847393","MQE2JHHJW9Q8","603847393","MQE2JHHJW9Q8","US","42.277722","-71.759339","850903","UNIV OF MASSACHUSETTS MED SCH WORCESTER","WORCESTER","MA","SCHOOLS OF MEDICINE","016550002","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","853","Non-SBIR/STTR","2012"," "," ","NINDS","214375","138272"," ","352647",
"Autoimmune Disease; Lung; Rare Diseases","Alveolar;Alveolar wall;Apoptosis;Applications Grants;Architecture;Area;Behavior;Bleomycin;Bone Marrow;Cells;Chronic;Collagen;Collagen Type I;Complex;Defect;Deposition;Disease;Extracellular Matrix;Facies;Feedback;Fibroblasts;Fibronectins;Fibrosis;Goals;Growth;Hamman-Rich syndrome;Healed;Health;In Vitro;Inflammation;Inflammatory;Injury;Integrins;Interstitial Lung Diseases;Knockout Mice;Knowledge;Left;Lesion;Ligation;Lipids;Lung;Lung diseases;Membrane;Mesenchymal;Methodology;Molecular;Mus;Myofibroblast;Nature;Normal tissue morphology;PTEN gene;Pathologic;Pathway interactions;Phenotype;Phosphoric Monoester Hydrolases;Phosphotransferases;Physiological;Process;Proliferating;Protein Biosynthesis;Protein Phosphatase 2A Regulatory Subunit PR53;Proteins;Pulmonary Fibrosis;Regulation;Role;Seminal;Sentinel;Signal Pathway;Signal Transduction;Staging;Structure of parenchyma of lung;Testing;Tissues;Tumor Suppressor Proteins;Validation;Wild Type Mouse;base;caveolin 1;effective therapy;fibrogenesis;healing;in vivo;lung development;lung injury;lung repair;mRNA Expression;mTOR Inhibitor;member;protein expression;repaired;response;restraint;therapeutic target;tissue repair;transcription factor","Integrin-collagen signaling and control of fibroblast proliferation","
Idiopathic pulmonary fibrosis (IPF) is a chronic, lethal interstitial lung disease. The sentinel morphological
lesion is the fibroblastic focus, which is composed of fibroblasts embedded in a type I collagen rich matrix.
Seminal studies have demonstrated that polymerized type I collagen acts as a negative regulator of fibroblast
proliferation. We have discovered that IPF fibroblasts have escaped this restraint. Our mechanistic studies of
this phenomenon point to aberrant proliferation signaling through the ï¿½1 integrin, involving the downstream
phosphoinositol 3-kinase/Akt - PTEN axis. The objective of this grant application is to characterize the
molecular mechanism by which ï¿½1 integrin-collagen interaction results in abnormal proliferative signaling in IPF
fibroblasts. It is our goal to uncover those components of the myofibroblast cellular machinery that result in
unrelenting fibrosis in IPF, and in proper tissue healing under normal circumstances. Identifying key regulatory
nodes controlling the pathologic behavior of IPF fibroblasts may provide molecular therapeutic targets to limit
the progressive fibrosis that characterizes IPF.","NHLBI","8269781","5/23/2012 12:00:00 AM","PA-07-070","5R01HL089228-04","5","R01","HL","089228","04"," ","EU, JERRY PC","9/4/2009 12:00:00 AM","5/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-RES-B(02)M]"," ","1903478","HENKE, CRAIG A","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","SCHOOLS OF MEDICINE","554552070","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","107330","54738"," ","162068",
"Chronic Liver Disease and Cirrhosis; Digestive Diseases; Liver Disease; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","3-Dimensional;Ablation;Acute;Acute Liver Failure;Adult;Alagille Syndrome;Applications Grants;Autocrine Communication;Biliary;Binding;Biology;Cell Differentiation process;Cell Proliferation;Cell Survival;Cell physiology;Cell surface;Cells;Chronic;Cirrhosis;Complex;Data;Development;Diet;Equilibrium;Erinaceidae;Event;Failure;Fibroblasts;Fibrosis;Genes;Genetic;Hepatic;Hepatic Stellate Cell;In Vitro;Individual;Injury;Injury to Liver;Ligands;Ligation;Liver;Liver Fibrosis;Liver diseases;Mediating;Membrane;Mesenchymal;Mesenchyme;Modeling;Molecular;Morphogenesis;Mouse Strains;Mutate;Necrosis;Notch Signaling Pathway;Notch and Wnt Signaling Pathway;Paracrine Communication;Pathway interactions;Play;Primary carcinoma of the liver cells;Regulation;Relative (related person);Role;Signal Pathway;Signal Transduction;Source;Stem cells;System;Tamoxifen;Testing;Time;Tissues;Winged Helix;activating transcription factor;autocrine;bile duct;biliary tract;cholangiocyte;design;dietary supplements;fibrogenesis;forkhead protein;human SMO protein;in vivo;inhibitor/antagonist;injury and repair;jagged1 protein;liver repair;loss of function;mutant;notch protein;paracrine;progenitor;public health relevance;receptor;reconstruction;response;response to injury;self-renewal;smoothened signaling pathway;stem;therapeutic development;tissue repair;tool;transcription factor","Signaling pathways and the fate of hepatic progenitor cells","
Project Narrative
The studies proposed in this grant application will elucidate the signals that regulate
hepatic progenitor cells and their response to acute or chronic liver injury. Understanding
the biology of hepatic progenitor cells will have wide-ranging implications for the
development of therapeutics for acute liver failure, chronic cirrhotic liver disease and
hepatocellular carcinoma.","NIDDK","8265850","2/27/2012 12:00:00 AM","PA-07-070","5R01DK087958-03","5","R01","DK","087958","03"," ","SERRANO, JOSE","4/1/2010 12:00:00 AM","2/28/2014 12:00:00 AM","Hepatobiliary Pathophysiology Study Section[HBPP]"," ","1888272","GREENBAUM, LINDA E","Not Applicable","03","MICROBIOLOGY/IMMUN/VIROLOGY","053284659","R8JEVL4ULGB7","053284659","R8JEVL4ULGB7","US","39.949004","-75.155569","4050801","THOMAS JEFFERSON UNIVERSITY","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191074418","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","112984"," ","318409",
"Breast Cancer; Cancer","Adhesives;Amino Acids;Area;Atlas of Cancer Mortality in the United States;Behavior;Biological Assay;Brain;Breast;Breast Cancer Cell;Cadherin Domain;Cadherins;Carcinoma;Carcinoma in Situ;Cell Line;Cells;Characteristics;Chimeric Proteins;Clinical;Complement;Data;Down-Regulation;Ductal Carcinoma;E-Cadherin;Epithelial;Epithelium;Genes;Health;In Vitro;Kidney;Light;Link;Lung;Malignant - descriptor;Mammary Neoplasms;Mammary gland;Maps;Mediating;Mesenchymal;Methylation;Molecular;Morphogenesis;Muscle;N-Cadherin;Neoplasm Metastasis;Nodal;Noninfiltrating Intraductal Carcinoma;Outcome;Pancreas;Patients;Phenotype;Play;Primary Neoplasm;Prognostic Factor;R-cadherin;Retina;Risk;Role;Series;Signal Pathway;Signal Transduction;Specific qualifier value;Specimen;Testing;Therapeutic;Tissues;Tumor Cell Invasion;Tumor Suppression;base;cell motility;cell type;clinically relevant;design;follow-up;in vitro activity;in vivo;in vivo Model;infiltrating duct carcinoma;insight;lymph nodes;malignant breast neoplasm;neoplastic cell;outcome forecast;overexpression;tumor;tumor progression;tumorigenesis","R-Cadherin in Breast Cancer Suppression","
 Project Narrative
 We found that R-cadherin is substantially downregulated in breast cancer. We have established a
series of in vitro and in vivo models to test tumor suppression by R-cadherin. Interestingly, R-cadherin and N-
cadherin are structurally very similar, yet display opposite effects on tumor progression. We have designed a
series of studies to study the role of R-cadherin loss in breast cancer progression and map the molecular
determinants that mediate its suppressive function as opposed to those that mediate tumor invasion by N-
cadherin. We believe these studies have the potential to broaden our understanding of mechanisms that
regulate breast cancer progression and have thus the potential to provide insights into therapeutic application.","NCI","8288276","5/31/2012 12:00:00 AM","PA-07-070","5R01CA136854-04","5","R01","CA","136854","04"," ","LIVELY, TRACY LUGO","7/22/2009 12:00:00 AM","5/31/2014 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","2268252","HAZAN, RACHEL B","Not Applicable","14","PATHOLOGY","110521739"," ","110521739"," ","US","40.851026","-73.844361","9433501","ALBERT EINSTEIN COLLEGE OF MEDICINE","BRONX","NY","SCHOOLS OF MEDICINE","104611900","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","201275","132842"," ","334117",
"Genetics; Prevention","4-ethoxymethylene-2-phenyl-2-oxazoline-5-one;Abbreviations;Address;Affect;Amino Acid Motifs;Amino Acids;Amphiregulin;Binding;Biochemical;Biological;Biology;Carrier Proteins;Cell Nucleus;Cell membrane;Cells;Cicatrix;Complex;Cytoplasmic Tail;Data;Defect;Destinations;Disease;Disintegrins;Documentation;Dominant-Negative Mutation;Drosophila genus;Dynamin;Endocytosis;Epidermal Growth Factor;Epiregulin;Epithelial;Epithelial Cells;Family;Family member;Fibrosis;Genetic Transcription;Growth;Growth Factor;Health;Heparin Binding;Homeostasis;Human;Immunoprecipitation;In Vitro;Indium;Intervention;Kidney;Language;Length;Ligands;Locales;Malignant Neoplasms;Mediating;Mediator of activation protein;Membrane;Mesenchymal;Metalloproteases;Modeling;Normal tissue morphology;Nuclear;Organ;Orthologous Gene;Pathologic Processes;Phenotype;Phosphorylation;Platelet-Derived Growth Factor;Population;Prevention;Proteins;Public Health;Publishing;Rattus;Regulation;Research Design;Role;Signal Transduction;Sorting - Cell Movement;Surface;T2R taste receptors;Tail;Testing;Tissues;Trans-Activators;Transcriptional Regulation;Transforming Growth Factor beta;Transforming Growth Factor beta Receptors;Transforming Growth Factors;Tropism;Ureteral obstruction;Vacuolar Protein Sorting;Wing;Work;Wound Healing;basolateral membrane;betacellulin;cell growth;connective tissue growth factor;epigen;granulocyte;heparin-binding EGF-like growth factor;member;monocyte colony stimulating factor;nexin;paracrine;prevent;protein transport;public health relevance;receptor;receptor binding;response;trafficking","TGF Beta Receptor Dynamics","
Relevance to public health (lay language): TGF-ï¿½ is a protein which can be either helpful or harmful to human
health. While its ability to stimulate cell growth is important for normal wound healing, when unchecked the
function of many organs can be disrupted by scar (i.e., fibrosis) formation. Conversely, the growth inhibitory
actions of TGF-ï¿½ are critical in preventing cancer. The proposed studies will identify/characterize targets which
can be used to either increase or decrease these responses.","NIGMS","8260318","4/27/2012 12:00:00 AM","PA-07-070","5R37GM055816-16","5","R37","GM","055816","16"," ","MARINO, PAMELA","5/1/1997 12:00:00 AM","4/30/2014 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","1893649","LEOF, EDWARD B","Not Applicable","01","Unavailable","006471700","Y2K4F9RPRRG7","006471700","Y2K4F9RPRRG7","US","44.022374","-92.465881","4976101","MAYO CLINIC ROCHESTER","ROCHESTER","MN","Other Domestic Non-Profits","559050001","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","225423","115191"," ","340614",
"No NIH Category available","Animals;Award;Biometry;Bortezomib;Brain imaging;Cancer Center;Clinical;Clinical Research;Collection;Comprehensive Cancer Center;Development;Disease;Ensure;Environment;Enzymes;Equipment;Extracellular Matrix;Five-Year Plans;Functional Imaging;Funding;Future;Goals;Grant;Guidelines;Human;Image;Imaging technology;Kaposi Sarcoma;Lung;Magnetic Resonance;Magnetic Resonance Imaging;Malignant Neoplasms;Malignant neoplasm of pancreas;Mediating;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Modality;Molecular;Molecular Biology;Molecular Medicine;Nanotechnology;Neoplasm Metastasis;Oncologist;Optics;Pathologist;Pathway interactions;Patients;Play;Positron-Emission Tomography;Radiation;Renal carcinoma;Research;Research Infrastructure;Research Personnel;Resources;Role;Scientist;Services;Structure;Surgeon;System;Techniques;Training;Translating;Translations;Treatment Efficacy;Treatment outcome;Ultrasonography;United States National Institutes of Health;X-Ray Computed Tomography;base;bench to bedside;cancer imaging;career development;cost;effective therapy;epithelial to mesenchymal transition;hypoxia inducible factor 1;imaging modality;imaging probe;improved;in vivo Cellular and Molecular Imaging Centers;melanoma;molecular imaging;molecular oncology;novel;oncology;optical imaging;pre-clinical;pre-clinical research;programs;radiologist;ranpirnase;research clinical testing;single photon emission computed tomography;theranostics;tumor progression","JHU ICMIC Program","The JHU ICMIC is a multi-modality multi-disciplinary molecular imaging program that incorporates MR, 
SPECT, PET, and optical imaging to investigate cancer in a bench-to-bedside approach. Our intent for the 
next five years is to translate successfully the discoveries of this program into effective treatments against 
cancer.","NCI","8337288","9/5/2012 12:00:00 AM","PAR-09-157","5P50CA103175-07","5","P50","CA","103175","07"," ","MENKENS, ANNE E","8/10/2003 12:00:00 AM","7/31/2016 12:00:00 AM","ZCA1-SRLB-9(M1)"," ","1878950","BHUJWALLA, ZAVER M.","Not Applicable","07","RADIATION-DIAGNOSTIC/ONCOLOGY","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","399","Research Centers","2012"," "," ","NCI","1025480","583903"," ","1442883",
"Aging; Arthritis; Autoimmune Disease","American;Antibodies;Antigen Presentation;Area;Arthritis;Atherosclerosis;Attention;Autoimmune Diseases;Autoimmunity;B-Cell Activation;B-Cell Development;B-Lymphocytes;Basic Science;Behavior;Biology;Biotechnology;Blood Vessels;Bone remodeling;Cartilage;Cell Count;Cells;Cellular Stress Response;Cellular biology;Clinical;Clinical Investigator;Clinical Research;Clinical Trials;Complex;Congresses;Connective Tissue;Consensus;Dendritic Cells;Development;Developmental Biology;Disease;Education;Engineering;Environment;Evolution;Extracellular Matrix;Face;Fibrosis;Fostering;Functional RNA;Functional disorder;Gays;Genes;Genetic;Genome;Genomics;Goals;Health;Health Policy;Health Status;Homeostasis;Human;Immune;Immune Tolerance;Immune response;Immune system;Immunobiology;Immunology;Indium;Inflammation;Inflammatory;Investigation;Knowledge;Lead;Lymphocyte;Massachusetts;Mediating;Medical;Medical Research;Medical center;Medicine;Mentors;Mesenchymal;Methods;Molecular;Musculoskeletal;Musculoskeletal Diseases;Natural Immunity;Natural regeneration;Osteitis;Osteogenesis;Pathogenesis;Pathology;Patient Care;Patients;Policy Maker;Predisposition;Principal Investigator;Process;Proteins;Public Health;Recruitment Activity;Regulation;Research;Research Personnel;Rheumatism;Rheumatology;Robin bird;Role;Salmon;Schedule;Science;Scientist;Senior Scientist;Series;Site;T-Lymphocyte;Therapeutic;Thrombosis;Tissues;Training;Translating;Tumor Biology;United States National Institutes of Health;Universities;Variant;Virginia;abstracting;adaptive immunity;adverse outcome;angiogenesis;base;bone;college;human disease;immunoregulation;improved;insight;interest;joint destruction;lectures;lipid mediator;meetings;migration;novel strategies;posters;prevent;professor;programs;research study;socioeconomics;symposium;trafficking","ACR Basic Research Conference","
To foster understanding of disease and development of new therapies for patients with rheumatic diseases,
this conference seeks to (1) assemble rheumatology clinicians and researchers in a scientific forum to discuss
advances in the disease (2) strategize on research related to new treatments of rheumatic diseases and (3)
foster mentoring of young investigators and fellows-in-training.","NIAMS","8326544","6/28/2012 12:00:00 AM","PA-08-149","5R13AR048234-11","5","R13","AR","048234","11"," ","MANCINI, MARIE","7/1/2002 12:00:00 AM","6/30/2015 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","1862427","CRONSTEIN, BRUCE NEIL","Not Applicable","06","Unavailable","154038590","JX1ASDAR5VN7","154038590","JX1ASDAR5VN7","US","33.848318","-84.312005","3994301","AMERICAN COLLEGE OF RHEUMATOLOGY","ATLANTA","GA","Domestic For-Profits","303195310","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIAMS","50000","0"," ","50000",
"Aging; Arthritis; Autoimmune Disease","American;Antibodies;Antigen Presentation;Area;Arthritis;Atherosclerosis;Attention;Autoimmune Diseases;Autoimmunity;B-Cell Activation;B-Cell Development;B-Lymphocytes;Basic Science;Behavior;Biology;Biotechnology;Blood Vessels;Bone remodeling;Cartilage;Cell Count;Cells;Cellular Stress Response;Cellular biology;Clinical;Clinical Investigator;Clinical Research;Clinical Trials;Complex;Congresses;Connective Tissue;Consensus;Dendritic Cells;Development;Developmental Biology;Disease;Education;Engineering;Environment;Evolution;Extracellular Matrix;Face;Fibrosis;Fostering;Functional RNA;Functional disorder;Gays;Genes;Genetic;Genome;Genomics;Goals;Health;Health Policy;Health Status;Homeostasis;Human;Immune;Immune Tolerance;Immune response;Immune system;Immunobiology;Immunology;Indium;Inflammation;Inflammatory;Investigation;Knowledge;Lead;Lymphocyte;Massachusetts;Mediating;Medical;Medical Research;Medical center;Medicine;Mentors;Mesenchymal;Methods;Molecular;Musculoskeletal;Musculoskeletal Diseases;Natural Immunity;Natural regeneration;Osteitis;Osteogenesis;Pathogenesis;Pathology;Patient Care;Patients;Policy Maker;Predisposition;Principal Investigator;Process;Proteins;Public Health;Recruitment Activity;Regulation;Research;Research Personnel;Rheumatism;Rheumatology;Robin bird;Role;Salmon;Schedule;Science;Scientist;Senior Scientist;Series;Site;T-Lymphocyte;Therapeutic;Thrombosis;Tissues;Training;Translating;Tumor Biology;United States National Institutes of Health;Universities;Variant;Virginia;abstracting;adaptive immunity;adverse outcome;angiogenesis;base;bone;college;human disease;immunoregulation;improved;insight;interest;joint destruction;lectures;lipid mediator;meetings;migration;novel strategies;posters;prevent;professor;programs;research study;socioeconomics;symposium;trafficking","ACR Basic Research Conference","
To foster understanding of disease and development of new therapies for patients with rheumatic diseases,
this conference seeks to (1) assemble rheumatology clinicians and researchers in a scientific forum to discuss
advances in the disease (2) strategize on research related to new treatments of rheumatic diseases and (3)
foster mentoring of young investigators and fellows-in-training.","NIAMS","8326544","6/28/2012 12:00:00 AM","PA-08-149","5R13AR048234-11","5","R13","AR","048234","11"," ","MANCINI, MARIE","7/1/2002 12:00:00 AM","6/30/2015 12:00:00 AM","Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]"," ","1862427","CRONSTEIN, BRUCE NEIL","Not Applicable","06","Unavailable","154038590","JX1ASDAR5VN7","154038590","JX1ASDAR5VN7","US","33.848318","-84.312005","3994301","AMERICAN COLLEGE OF RHEUMATOLOGY","ATLANTA","GA","Domestic For-Profits","303195310","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","846","Other Research-Related","2012"," "," ","NIA","3000","0"," ","3000",
"Cancer; Immunization; Lung; Lung Cancer; Rare Diseases; Vaccine Related","Adenocarcinoma;Adult;Animal Model;B lymphoid malignancy;Boxing;Brachyury protein;CD8B1 gene;Cancer Etiology;Cancer Patient;Cancer Vaccines;Cancer cell line;Carcinoma;Cessation of life;Colorectal Cancer;Cytolysis;Development;Disease;Epidermal Growth Factor Receptor;Epithelial;Goals;Hematopoietic Neoplasms;Human;IL8 gene;Immunohistochemistry;Immunotherapeutic agent;In Vitro;Intervention;Lead;Lung;Lung Neoplasms;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of ovary;Malignant neoplasm of prostate;Mediating;Mesenchymal;Modality;Modeling;Neoplasm Metastasis;Normal tissue morphology;Pattern;Phenotype;Phosphotransferases;Process;Radiation;Research;Resistance;Role;Signal Transduction;Source;Squamous cell carcinoma;T-Lymphocyte;T-Lymphocyte Epitopes;Testis;Therapeutic;Therapeutic Intervention;Thyroid Gland;Tissues;Tumor Cell Line;Tumor Tissue;Vaccine Therapy;base;cancer immunotherapy;cancer therapy;cell motility;chemokine;chemotherapy;combinatorial;human tissue;lung Carcinoma;malignant breast neoplasm;neoplastic cell;novel;novel therapeutic intervention;novel vaccines;peripheral blood;prevent;protein expression;receptor;resistance mechanism;small molecule;transcription factor;tumor;tumor progression","Novel Targets for Vaccine Therapy","n/a","NCI","8554084"," "," ","1ZICBC010937-05","1","ZIC","BC","010937","05"," "," "," "," "," "," ","10270286","PALENA, CLAUDIA ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","848816",
"Contraception/Reproduction; Diethylstilbestrol (DES); Estrogen; Genetics; Infertility; Pediatric; Perinatal Period - Conditions Originating in Perinatal Period; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Urologic Diseases","Activins;Adrenal Cortex;Adrenal Glands;Adult;Affect;Androgens;Arsenic;Birth;Bisexual;Cell Lineage;Cells;Decision Making;Defect;Development;Developmental Biology;Diethylstilbestrol;Dose;Ductal Epithelium;Embryo;Embryology;Embryonic Development;Endocrine Disruptors;Environment;Environmental Risk Factor;Epididymis;Epithelium;Erinaceidae;Estrogen Receptor alpha;Estrogen Receptors;Exhibits;Exposure to;Female;Fertility;Gene Expression;Gene Mutation;Genetic;Genital system;Goals;Gonadal structure;Growth;Histology;Human;In Vitro;Infertility;Knock-out;Lead;Maintenance;Malignant neoplasm of testis;Mesenchymal;Mesenchyme;Mesonephric structure;Microarray Analysis;Modeling;Molecular;Morphogenesis;Mus;Mutant Strains Mice;Oocytes;Organ;Ovarian;Ovarian Follicle;Ovary;Pathway interactions;Pattern;Perinatal Exposure;Phenotype;Play;Postdoctoral Fellow;Primordium;Process;Production;Proliferating;Prostate;Recruitment Activity;Regulation;Research;Resistance;Rodent;Role;Somatic Cell;Sonic Hedgehog Pathway;Source;Sperm Count Procedure;Stem cells;Structure of mesonephric duct;Testicular Dysgenesis Syndrome;Testing;Testis;Time;Tissues;Vas deferens structure;Visit;Yasmin;activin A;bisphenol A;capsule;cell type;design;estrogenic endocrine disruptor;fetal;gene environment interaction;granulosa cell;granulose;in utero;in vivo;insight;interest;male;mature animal;novel;paracrine;pre-doctoral;progenitor;receptor;regenerative;reproductive;research study;sex;sperm cell;stem cell population;theca cell","Impacts of Genetic and Environmental Factors on Reproductive Organ Development","n/a","NIEHS","8553809"," "," ","1ZIAES102965-02","1","ZIA","ES","102965","02"," "," "," "," "," "," ","11118954","YAO, HUNG CHANG ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIEHS"," "," "," ","1406984",
"Biotechnology; Dental/Oral and Craniofacial Disease; Digestive Diseases; Infectious Diseases","AIDS/HIV problem;Affect;Antifungal Agents;Candida;Candida albicans;Cell Line;Cells;Clinical;Complication;Defect;Defensins;Development;Disease;Enzyme-Linked Immunosorbent Assay;Epithelial Cells;Epithelium;Etiology;Family;Family member;Fibroblasts;Gene Targeting;Genes;Host Defense;Human;Immune;Immune system;Immunity;Immunoblotting;Immunocompromised Host;Industrial fungicide;Infection;Inflammation;Inflammatory;Interleukin-17;Job&apos;s Syndrome;Ligands;Measures;Mediating;Mesenchymal;Methodology;Modeling;Modification;Molecular;Monitor;Mus;Mutation;Opportunistic Infections;Oral;Oral candidiasis;Oral mucous membrane structure;Outcome;Patients;Phosphorylation;Play;Population;Process;Production;Proteins;Regulation;Reverse Transcriptase Polymerase Chain Reaction;Role;Saliva;Salivary;Salivary Glands;Signal Pathway;Signal Transduction;Signaling Molecule;Small Interfering RNA;Syndrome;System;TNF gene;TRAF6 gene;Techniques;Time;Tissues;Tumor Necrosis Factor-Beta;Ubiquitination;Xerostomia;antimicrobial;antimicrobial peptide;aquaporin 5;cell type;chemokine;cytokine;fungus;histidine-rich proteins;interleukin-17C;interleukin-17E;knock-down;matrigel;mouse model;neutrophil;oral cavity epithelium;oral infection;oropharyngeal thrush;protein expression;receptor;response;salivary cell;therapeutic target;ubiquitin ligase","Salivary Gland IL-17R Signaling in Oral Candidiasis"," Candida albicans causes the disease oral candidiasis in patients with immune system defects. Both the oral mucosal epithelium and salivary gland are involved in host protection to Candida albicans, but the exact mechanisms are not well understood. This application will study the mechanism of IL-17R signaling in the salivary gland, and how this contributes to protection against disease.   
   
      

","NIDCR","8452958","8/7/2012 12:00:00 AM","PA-11-113","1F32DE023293-01","1","F32","DE","023293","01"," ","FRIEDEN, LESLIE A","12/1/2012 12:00:00 AM","11/30/2015 12:00:00 AM","ZDE1-MH(22)"," ","10968273","CONTI, HEATHER RAQUEL","Not Applicable","18","INTERNAL MEDICINE/MEDICINE","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","12/1/2012 12:00:00 AM","11/30/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","52990"," "," ","52990",
"Biotechnology; Genetics; Neurosciences; Pediatric; Rare Diseases; Spina Bifida","Actins;Affect;Apical;Bardet-Biedl Syndrome;Biochemical Genetics;Biological Assay;Biological Models;Birds;Cell Communication;Cell Polarity;Cells;Cilia;Communication;Complementary DNA;Congenital Abnormality;Cytoskeleton;DNA Sequence Rearrangement;Data;Defect;Development;Dimerization;Dominant-Negative Mutation;Drosophila genome;Drosophila genus;Electrophoretic Mobility Shift Assay;Epithelial;Epithelium;Eye;Family;Feathers;Fishes;Generations;Genes;Genetic;Hair;Health;Human;In Vitro;Knowledge;Labyrinth;Lead;Leukocytes;Ligands;Link;Literature;Lung;Mammals;Mediating;Mesenchymal;Microfilaments;Movement;Mucous body substance;Mutation;Nephronophthisis;Neural Tube Closure;Neural Tube Defects;Neural tube;Nuclear;Oncogenes;Organ;Organism;Pathway interactions;Phosphorylation;Photoreceptors;Physiological;Positioning Attribute;Process;Protein Family;Proteins;RNA Interference;Regulation;Research;Rho-associated kinase;Role;Rotation;Signal Transduction;Spinal Dysraphism;Stereocilium;Structure;System;Testing;Vertebrates;Wing;Work;Xenopus;Zebrafish;ascidian;base;cell determination;cell motility;ciliopathy;fibrosarcoma;fly;gastrulation;genetic analysis;genome wide association study;genome-wide;in vivo;intercalation;knock-down;member;migration;mutant;novel;receptor;response;rho;sound;transcription factor","Planar Cell Polarity and the Cytoskeleton","
Project narrative
The mechanism of communicaiton between cells of the fruitfly Drosophila and humans is
well conserved and very similar. We make use of Drosophila to study how cell
communication affects cell movement. Lack of such communication can lead to severe
birth defects such as open neural tubes (e.g. spina bifida).","NIGMS","8306159","7/16/2012 12:00:00 AM","PA-07-070","5R01GM088202-04","5","R01","GM","088202","04"," ","HOODBHOY, TANYA","9/30/2009 12:00:00 AM","7/31/2014 12:00:00 AM","Development - 1 Study Section[DEV1]"," ","7896676","JENNY, ANDREAS ","Not Applicable","14","ANATOMY/CELL BIOLOGY","110521739"," ","110521739"," ","US","40.851026","-73.844361","9433501","ALBERT EINSTEIN COLLEGE OF MEDICINE","BRONX","NY","SCHOOLS OF MEDICINE","104611900","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","196020","129373"," ","325393",
"Biotechnology; Breast Cancer; Cancer; Genetics","Algorithms;BRCA1 gene;Biological Assay;Biological Markers;Bioluminescence;Biomedical Engineering;Blood Circulation;Breast;Breast Cancer Cell;Breast Cancer Model;Bypass;Cancer Patient;Cancer cell line;Cause of Death;Cell physiology;Cells;Chemistry;Chicago;Chromatin;Clinical;Clinical Medicine;Correlation Studies;Data;Detection;Drug Compounding;Drug resistance;EZH2 gene;Electrophoretic Mobility Shift Assay;Epithelial;Family;Fatty acid glycerol esters;Future;Gene Targeting;Genes;Genetic;Goals;Human;Image;In Vitro;Knowledge;Length;Lentivirus Vector;Luciferases;Lung;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Medicine;Mentors;Mesenchymal;Messenger RNA;MicroRNAs;Microarray Analysis;Modeling;Molecular;Monitor;Mus;Mutation;Neoplasm Metastasis;Nucleotides;Optical reporter;Patients;Phase;Property;Protocols documentation;Regulation;Reporting;Research Personnel;Research Training;Resistance;Small RNA;Specimen;Stem cells;Technology;Therapeutic;Toxic effect;Transcriptional Regulation;Translating;Transplantation;Tumor-Derived;United States;Universities;Western Blotting;Xenograft Model;base;breast cancer diagnosis;cancer cell;cancer initiation;cancer therapy;clinical application;improved;in vivo;innovation;lymph nodes;malignant breast neoplasm;mortality;neoplastic cell;novel;overexpression;post-doctoral training;pre-clinical;preclinical study;prevent;promoter;therapeutic target;tumor;tumor growth;tumor initiation;tumor progression","Identifying a network of microRNAs and genes that regulate breast tumor metastasi"," Using patient tumor-derived human breast cancer models, this project aims to identify a novel network of microRNAs and their target genes critical for breast cancer initiation and/or metastasis. Newly identified microRNAs are promising candidates for novel biomarkers and therapeutics for cancer medicine.    
   
I am a permanent resident in the United States. I am in my 5th year of postdoctoral training at The University of Chicago, and am ready to make a timely transition to an independent investigator upon completing the one-year mentored phase. This application proposes a 1-year mentored phase (100% effort) and a 3-year independent phase (80% effort) to complete the research and training goals.   
      

","NCI","8300449","9/19/2012 12:00:00 AM","PA-11-197","1K99CA160638-01A1","1","K99","CA","160638","01","A","SCHMIDT, MICHAEL K","9/19/2012 12:00:00 AM","11/30/2013 12:00:00 AM","Institutional Training and Education Study Section (F)[NCI-F]"," ","8968196","LIU, HUIPING ","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","005421136","ZUE9HKT2CLC9","005421136","ZUE9HKT2CLC9","US","41.789554","-87.601172","1413601","UNIVERSITY OF CHICAGO","CHICAGO","IL","SCHOOLS OF MEDICINE","606372612","UNITED STATES","N","9/19/2012 12:00:00 AM","11/30/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","123818","9905"," ","133723",
"Bioengineering; Biotechnology; Dental/Oral and Craniofacial Disease; Digestive Diseases; Genetics; Pediatric; Regenerative Medicine","Address;Adenovirus Vector;Adhesives;Architecture;Area;Atlases;BMP4;BMP5 gene;Basement membrane;Bioinformatics;Biological Assay;Biological Models;Biomedical Engineering;Cattle;Cell Culture Techniques;Cell surface;Cells;Cephalic;Cleaved cell;Communities;Complex;Connective Tissue;Cultured Cells;DNA Sequence Rearrangement;Data Set;Databases;Defect;Dependovirus;Development;Duct (organ) structure;Ectoderm;Embryo;Embryonic Development;Emigrations;Employee Strikes;Epithelial;Epithelial Cells;Epithelium;Equilibrium;Extracellular Matrix;Extracellular Matrix Proteins;FGF8 gene;Face;Fibroblast Growth Factor;Fibronectins;Gene Expression;Gene Expression Profiling;Gene Targeting;Gene Transfer;Generations;Genes;Genome;Gland;Goals;Growth Factor;Immunofluorescence Immunologic;Infection;Kidney;Knowledge;Lasers;Lung;Mammary gland;Mandible;Maxilla;Mediating;Mediator of activation protein;Mesenchymal;Methods;Microdissection;Microinjections;Microscopy;Morphogenesis;Mus;Natural regeneration;Neural Crest;Neural Crest Cell;Oligonucleotides;Oral cavity;Organ;Organ Culture Techniques;Pathway interactions;Play;Population;Process;Protein Overexpression;Proteins;RNA Interference;Regulation;Reporter;Research;Role;Salivary;Salivary Glands;Screening procedure;Signal Transduction;Specificity;Stem cells;Structure;Subfamily lentivirinae;Surface;System;Systems Analysis;Techniques;Time;Tissue Engineering;Tissues;Tooth structure;Validation;Viral Genes;Virus;WNT Signaling Pathway;bone;cell motility;cell type;craniofacial;data acquisition;embryo culture;embryo tissue;genetic manipulation;genetic regulatory protein;gland development;high risk;in vivo;keratinocyte growth factor;migration;novel;protein expression;receptor function;reconstitution;relating to nervous system;self assembly;serial analysis of gene expression;transcription factor;vector","Craniofacial Developmental Dynamics","n/a","NIDCR","8553327"," "," ","1ZIADE000525-22","1","ZIA","DE","000525","22"," "," "," "," "," "," ","9415013","YAMADA, KENNETH ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIDCR"," "," "," ","804710",
"Aging; Autoimmune Disease; Cancer; Osteogenesis Imperfecta; Rare Diseases; Scleroderma","Affect;Age-Related Bone Loss;Aging;Anabolism;Animals;Bone Marrow Transplantation;Bone Matrix;Calvaria;Carcinoma;Cells;Clinical;Collagen;Collagen Type I;Connective Tissue;Cyclic AMP;Cyclic AMP-Dependent Protein Kinases;Degenerative polyarthritis;Dermal;Development;Diagnostic;Diet;Disease;Down-Regulation;Duodenum;Ehlers-Danlos Syndrome;Endoplasmic Reticulum;Enzymes;Fiber;Fibroblasts;Fibrosis;Gene Expression;Genetic Transcription;Glycine;Goals;Homeostasis;Image;Immunofluorescence Immunologic;In Vitro;Interstitial Collagenase;Investigation;Ligand Binding;Light;Location;Malignant Neoplasms;Maps;Matrix Metalloproteinases;McCune-Albright Syndrome;Mesenchymal;Modeling;Molecular;Molecular Chaperones;Mus;Mutation;Organ;Osteoblasts;Osteoclasts;Osteogenesis;Osteogenesis Imperfecta;Osteoporosis;Pathology;Patients;Pharmacological Treatment;Phenotype;Procollagen;Protein Isoforms;Proteins;Recruitment Activity;Research;Resistance;Role;Scleroderma;Serotonin;Severities;Signal Pathway;Signal Transduction;Site;Stromal Cells;Structure;Technology;Testing;Tissues;Translating;Triplet Multiple Birth;Undifferentiated;Uterine Fibroids;Variant;Vertebrates;base;biological adaptation to stress;bone;cancer cell;cell motility;cell transformation;collagenase;endoplasmic reticulum stress;glomerulosclerosis;human tissue;in vivo;interest;migration;mineralization;molecular pathology;novel;novel strategies;protein misfolding;response;skeletal abnormality;skeletal disorder;skin lesion;spectroscopic imaging;spine bone structure;therapeutic target;triple helix;tumor;tumor growth;type I collagen alpha 1","Collagen-related diseases","n/a","NICHD","8553831"," "," ","1ZIAHD000256-15","1","ZIA","HD","000256","15"," "," "," "," "," "," ","9416136","LEIKIN, SERGEY ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NICHD"," "," "," ","792684",
"Bioengineering; Biotechnology; Clinical Research; Dental/Oral and Craniofacial Disease; Genetics; Regenerative Medicine","Address;Adipose tissue;Adult;Age;Bioinformatics;Biomedical Engineering;Bone Marrow;Bone Tissue;Caliber;Calvaria;Case Study;Cell Separation;Cell Surface Receptors;Cell surface;Cells;Cellular biology;Cephalic;Child;Clinical Research;Clinical Trials;Complementary DNA;Complex;Computer Analysis;Data;Defect;Developmental Biology;Disease;Effectiveness;Etiology;Future;Gene Expression;Gene Expression Profile;Gene Targeting;Genes;Genetic Transcription;Growth;Harvest;Healed;Heterogeneity;Human;In Vitro;Incidence;Individual;Infection;Injury;Laboratories;Life;Mesenchymal;Methods;Microfluidics;Molecular Profiling;Mus;Musculoskeletal System;Operative Surgical Procedures;Organogenesis;Osteogenesis;Parietal bone structure;Patients;Pilot Projects;Population;Population Heterogeneity;Procedures;Reaction;Reagent;Regenerative Medicine;Resolution;Reverse Transcriptase Polymerase Chain Reaction;Risk;Science;Stem cells;Stromal Cells;Subgroup;Suction Lipectomy;Surface Antigens;Surgeon;Techniques;Therapeutic;Tissue Engineering;Tissues;base;bone;clinical application;cost;craniofacial;cranium;healing;immature animal;improved;in vivo;innovation;interest;mandible/maxilla;mature animal;novel;osteogenic;osteoprogenitor cell;prospective;reconstruction;regenerative;repaired;response;scaffold;skeletal;skeletal regeneration;stem;stem cell biology;tissue regeneration;tissue repair","Osteogenic Enrichment of Adipose Derived Stromal Cells"," Successful re-ossification of craniofacial defects is more robust in immature animals and young children. Conversely, skeletally mature animals and adult humans demonstrate an impaired ability to heal skull defects. While a plethora of strategies have been developed over the past century for treating adult calvarial defects, the myriad of methods currently available reflects the inadequacies of each therapeutic technique. By combining advances in developmental biology, organogenesis, stem cell biology, bioengineering, and material sciences, however, a new paradigm for calvarial bone tissue engineering has emerged - Regenerative Medicine. Despite accumulating evidence demonstrating the utility of human adipose derived stromal cells (hASCs) in regenerative applications, little is known about the heterogeneity that exists within the hASC population. By applying an information theoretic approach to cluster individual cells based on similar transcriptional profiles, it becomes possible it systematically interrogate a heterogeneous group of cells, such as hASCs, for functionally distinct subpopulations such as an osteoprogenitor population. This enriched population would be ideal to use for cell-based strategies for craniofacial skeletal regenerative medicine.  
  
    

","NIDCR","8235490","9/3/2012 12:00:00 AM","PA-10-067","1R01DE021683-01A1","1","R01","DE","021683","01","A","LUMELSKY, NADYA L","9/3/2012 12:00:00 AM","8/31/2017 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1923715","LONGAKER, MICHAEL T","GURTNER, GEOFFREY C","18","SURGERY","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","9/3/2012 12:00:00 AM","8/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","250000","144649"," ","394649",
"Bioengineering; Biotechnology; Dental/Oral and Craniofacial Disease; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human","Adult;Area;Ascorbic Acid;Autologous;Biology;Blood Vessels;Bone Development;Bone Diseases;Bone Marrow;Bone Regeneration;Cell Therapy;Cells;Clinical;Complex;Defect;Development;Developmental Biology;Developmental Gene;Dexamethasone;Environment;Fracture;Fracture Healing;Gene Expression;Genetic;Growth;Healed;Histology;Human;Implant;Injury;Mediating;Mesenchymal;Mesoderm;Modeling;Morbidity - disease rate;Musculoskeletal;Musculoskeletal Diseases;Orthopedic Surgery procedures;Orthopedics;Osteoblasts;Osteogenesis;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Pluripotent Stem Cells;Population;Production;Proteins;RNA;Regenerative Medicine;Reporter;Research;Rodent;Signal Pathway;Signal Transduction;Sirolimus;Site;Source;Stem Cell Development;Stem cells;Stimulus;Stromal Cells;Surface;System;Testing;Time;Transcript;Translating;Translations;Trauma;Undifferentiated;adult stem cell;base;biomechanical engineering;bone;clinical practice;design;healing;high throughput screening;human embryonic stem cell;human embryonic stem cell line;human stem cells;implantation;improved;in vitro Assay;in vivo;induced pluripotent stem cell;innovation;insight;meetings;novel;novel strategies;novel therapeutic intervention;osteogenic;osteoprogenitor cell;promoter;recombinant human bone morphogenetic protein-2;repaired;scaffold;stem;stem cell biology;stem cell population;subcutaneous;therapeutic development;tissue regeneration","Osteogenic Repair from Human Pluripotent Stem Cells"," These studies will have important impact in the rapidly growing area of regenerative medicine. Better understanding of osteogenic development from hESCs and iPSCs will translate to novel source of cells to treat complex and non-healing orthopedic injuries. Additionally, the RUNX2 promoter-reporter system can advance to a high-throughput screening system to identify new compounds to promote osteogeneis without use of exogenous cells.  
    

","NIDCR","8293086","6/15/2012 12:00:00 AM","PA-10-067","5R01DE022556-02","5","R01","DE","022556","02"," ","LUMELSKY, NADYA L","7/1/2011 12:00:00 AM","6/30/2015 12:00:00 AM","Musculoskeletal Tissue Engineering Study Section[MTE]"," ","6156043","KAUFMAN, DAN S","Not Applicable","05","INTERNAL MEDICINE/MEDICINE","555917996","KABJZBBJ4B54","555917996","KABJZBBJ4B54","US","44.974119","-93.227014","1450402","UNIVERSITY OF MINNESOTA","MINNEAPOLIS","MN","SCHOOLS OF MEDICINE","554552070","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","269282","97613"," ","366895",
"Bioengineering; Clinical Research; Dental/Oral and Craniofacial Disease; Emerging Infectious Diseases; Genetics; Hematology; Infectious Diseases; Osteoporosis; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human; Transplantation","Acute;Acute Graft Versus Host Disease;Address;Adipocytes;Adolescent;Affect;Animals;Ascorbic Acid;Autologous Transplantation;Binding;Biological;Biology;Blood;Bone Marrow;Bone Regeneration;Bone Tissue;Cardiovascular Diseases;Cartilage;Cell Culture Techniques;Cell Proliferation;Cell Transplantation;Cell physiology;Cells;Chimera organism;Clinical Trials;Code;Colony-forming units;Complex;Connective Tissue;Connective Tissue Cells;Cyclic AMP;Cyclic AMP-Dependent Protein Kinases;Data;Data Analyses;Defect;Dental Cementum;Dental Pulp;Development;Dexamethasone;Disease;Erythroid;Erythropoiesis;Excision;Exhibits;Fibroblasts;G(q) Alpha;G-Protein-Coupled Receptors;G-substrate;GNAS gene;GTP-Binding Protein alpha Subunits, Gs;GTP-Binding Proteins;Generations;Genes;Goals;Growth Factor;Hajdu-Cheney Syndrome;Health;Hematopoiesis;Hematopoietic;Hereditary Disease;Homeostasis;Human;Human G(i) Alpha Proteins;In Vitro;Infection;Inflammation;Injury;Interleukin-6;Intrinsic factor;Iron;Knowledge;Laboratories;Lentivirus Vector;MCAM gene;Mainstreaming;Marrow;McCune-Albright Syndrome;Mediating;Mediator of activation protein;Mesenchymal Stem Cells;Mesoderm;Metabolism;Missense Mutation;Molecular Profiling;Mus;Mutation;Myelogenous;Natural regeneration;Neuroectoderm;Organ;Osteitis Fibrosa Disseminata;Osteoblasts;Osteoclasts;Osteogenesis;Osteoporosis;Output;Pathway interactions;Patients;Periodontal Ligament;Phenotype;Play;Population;Preparation;Process;Property;Protein Family;Proteins;Regenerative Medicine;Reporting;Role;Sampling;Signal Pathway;Signal Transduction;Skeletal Development;Skeleton;Skin;Sorting - Cell Movement;Source;Spleen;Staging;Stem cells;Stromal Cells;Study Section;Techniques;Tissue Engineering;Tissues;Toxoplasmosis;Transplant Recipients;Transplantation;United States National Institutes of Health;Vascular Cell Adhesion Molecule-1;Work;base;beta catenin;bone;bone loss;bone resorbing activity;c-Myc Staining Method;calponin;cell type;craniofacial;cytokine;gnatho-diaphyseal dysplasia;granulocyte;hepcidin;human SFRP4 protein;human embryonic stem cell;improved;in vivo;induced pluripotent stem cell;inorganic phosphate;interest;macrophage;mutant;osteogenic;peripheral blood;preclinical study;progenitor;receptor;reconstruction;response;skeletal;skeletal abnormality;skeletal disorder","The role of post-natal skeletal stem cells in health and disease","n/a","NIDCR","8553319"," "," ","1ZIADE000380-29","1","ZIA","DE","000380","29"," "," "," "," "," "," ","8153931","ROBEY, PAMELA G","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIDCR"," "," "," ","1363253",
"Behavioral and Social Science; Biotechnology; Brain Disorders; Depression; Genetics; Huntington's Disease; Mental Health; Neurodegenerative; Neurosciences; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Stroke","Acetylation;Acute;Aging;Amyloid beta-Protein;Animal Model;Anti-Inflammatory Agents;Anti-inflammatory;Anticonvulsants;Antidepressive Agents;Antimanic Agents;Anxiety;Area;Astrocytes;Atrophic;Behavior;Behavioral;Behavioral Symptoms;Bipolar Disorder;Blood - brain barrier anatomy;Brain;Brain Diseases;Brain imaging;Brain region;Brain-Derived Neurotrophic Factor;CXC Chemokines;Carbamazepine;Cardiovascular Diseases;Cell Density;Cell Proliferation;Central Nervous System Diseases;Cerebral Ischemia;Cerebrovascular Circulation;Chronic;Clinical Trials;Cultured Cells;Development;Diabetes Mellitus;Diet;Disease;Dose;Drug usage;Endothelial Cells;Epigenetic Process;Etiology;Event;Exhibits;Exons;Experimental Animal Model;Experimental Models;Future;Gelatinase A;Gelatinase B;Gene Expression;Gene Targeting;Generations;Genetic;Glutamates;Glycogen Synthase Kinase 3;Goals;Heat-Shock Proteins 70;Hippocampus (Brain);Histone H3;Histones;Huntington Disease;Hyperactive behavior;Hypoxia Inducible Factor;Image;In Vitro;Infarction;Inflammation;Inherited;Injection of therapeutic agent;Ipsilateral;Ischemia;Ischemic Stroke;Knowledge;Lesion;Life;Lithium;Locomotion;Longevity;Manic;Medial;Mediating;Memory;Mental Depression;Mental disorders;Mesenchymal Stem Cells;Messenger RNA;Methylation;MicroRNAs;Middle Cerebral Artery Occlusion;Modeling;Molecular;Molecular Target;Mono-S;Mood stabilizers;Moods;Mus;N-acetylaspartate;Nerve Degeneration;Neurobiology;Neurons;Neurosciences;Obesity;Outcome;Patients;Performance;Pharmaceutical Preparations;Phenotype;Prefrontal Cortex;Process;Property;Psychiatry;Psychotropic Drugs;Rattus;Recurrence;Regulation;Relative (related person);Reporting;Research;Role;Signal Pathway;Signal Transduction;Signaling Pathway Gene;Site;Sodium Butyrate;Staging;Stem cells;Stress;Structure;Suicide attempt;Symptoms;Synaptic plasticity;Tail;Therapeutic;Therapeutic Effect;Third ventricle structure;Thyroid Diseases;Tight Junctions;Time;Transgenic Mice;Traumatic Brain Injury;Valproic Acid;Vascular Endothelial Growth Factors;Veins;Ventral Striatum;Work;analog;angiogenesis;beta secretase;brain cell;brain volume;cell motility;chemokine receptor;clinical efficacy;density;dentate gyrus;depressive symptoms;excitotoxicity;fibroblast growth factor 21;functional disability;glycogen synthase kinase 3 beta;gray matter;human Huntingtin protein;improved;in vivo;insight;lamotrigine;lymphoblastoid cell line;meetings;mortality;motor skill learning;mouse model;mutant;nervous system disorder;neurogenesis;neuroinflammation;neuron loss;neuropsychiatry;novel;overexpression;pre-clinical;promoter;prophylactic;resilience;small hairpin RNA;tau Proteins;treatment response","Mechanisms Of Action Of Psychoactive Drugs","n/a","NIMH","8556906"," "," ","1ZIAMH002468-25","1","ZIA","MH","002468","25"," "," "," "," "," "," ","6571807","CHUANG, DE-MAW ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF MENTAL HEALTH"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIMH"," "," "," ","1527360",
"Aging; Alzheimer's Disease; Behavioral and Social Science; Brain Disorders; Neurodegenerative; Neurosciences","Adverse event;Age;Agonist;Alzheimer&apos;s Disease;Amyloid beta-Protein;Amyloid deposition;Animal Model;Anti-Inflammatory Agents;Anti-inflammatory;Antibodies;Antigen-Antibody Complex;Archives;Astrocytes;Attenuated;Autopsy;Behavior;Binding;Blood - brain barrier anatomy;Blood Vessels;Bone Marrow;C5a anaphylatoxin receptor;CD14 gene;Caymans;Cell Adhesion Molecules;Cell Culture Techniques;Cells;Cerebral hemisphere hemorrhage;Cerebrovascular system;Cerebrum;Chemicals;Chronic;Collaborations;Complement;Complement 3a;Complement 5a;Complement Activation;Complex;Dementia;Deposition;Down Syndrome;Elderly;Elements;Endothelial Cells;Event;Exposure to;Functional disorder;Growth Factor;Head;Health;Hemorrhage;Human;Immune system;Immunotherapy;Impaired cognition;Incidence;Inflammation;Inflammatory;Inflammatory Response;Injection of therapeutic agent;Insulin;Insulin Resistance;Insulin-Like Growth Factor I;Interleukin-16;Interleukin-6;Knockout Mice;Learning;Lesion;Life;Maps;Measures;Mediating;Memory impairment;Mesenchymal Stem Cells;Minocycline;Modeling;Molecular Conformation;Monitor;Monozygotic twins;Mus;Neurodegenerative Disorders;Neuroglia;Neuronal Dysfunction;Neuronal Plasticity;Non-Insulin-Dependent Diabetes Mellitus;Pathogenesis;Pathology;Periodontal Diseases;Peripheral;Peroxisome Proliferator-Activated Receptors;Pharmaceutical Preparations;Phenotype;Play;Preparation;Principal Investigator;Proteins;Relative (related person);Reporter;Reporting;Risk;Risk Factors;Role;Series;Signal Transduction;Site;Smooth Muscle Myocytes;Specimen;System;TNF gene;Teenagers;Testing;Tg2576;Therapeutic;Tissues;Trophic Factor Receptor;Vascular Dementia;Vascular Endothelial Cell;abeta accumulation;age related;aged;anakinra;behavior test;cerebrovascular;clinical phenotype;cognitive function;cyclooxygenase 2;cytokine;improved;inflammatory marker;insulin sensitivity;interest;macrophage;mild neurocognitive impairment;modifiable risk;mouse model;mouse toll-like receptor 4;neuropathology;neurovascular unit;novel;programs;receptor;receptor-mediated signaling;research study;rosiglitazone;toll-like receptor 4;vascular inflammation","OLIGOMERIC AB AND INFLAMMATION IN NEUROVASCULAR PATHOGENESIS IN AD","n/a","NIA","8376749","3/19/2012 12:00:00 AM"," ","5P01AG000538-33","5","P01","AG","000538","33"," "," "," ","3/31/2014 12:00:00 AM","ZAG1-ZIJ-3","0026","2061103","CRIBBS, DAVID HASTINGS","Not Applicable","45","Unavailable","046705849","MJC5FCYQTPE6","046705849","MJC5FCYQTPE6","US","33.678042","-117.773718","577504","UNIVERSITY OF CALIFORNIA-IRVINE","IRVINE","CA","Domestic Higher Education","926970001","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","256418","256418"," ","170478","85940"," "," ",
"Cancer","Advanced Malignant Neoplasm;Adverse effects;Breast;Cancer Biology;Cancer cell line;Clinical;Clinical Trials;Combined Modality Therapy;Complex;Critical Pathways;Development;Diagnostic;Diagnostic Neoplasm Staging;Disease;Disease Marker;Disease Progression;Disease Resistance;Distant Metastasis;Endocrine;Endometrial;Enrollment;Genetic;Genetic Models;Goals;Human;In Vitro;Incidence;Interleukin-8;Lead;Malignant Neoplasms;Malignant neoplasm of thyroid;Mediating;Mediator of activation protein;Modeling;Mus;NF-kappa B;Neoplasm Metastasis;Parathyroid gland;Pathway interactions;Patient Monitoring;Patients;Physiology;Plasma;Process;Prostate;Proteins;Proteomics;Radiation;Resistance;Role;Signal Transduction;Solid Neoplasm;Systemic Therapy;Taxane Compound;Testing;Tissues;Translational Research;Treatment Efficacy;Tumor Angiogenesis;Tumor Cell Invasion;Tumor Markers;Tumor Tissue;Tumor stage;angiogenesis;base;cancer cell;cancer therapy;chemotherapy;comparative;conventional therapy;effective therapy;epithelial to mesenchymal transition;immune function;improved;in vivo Model;inhibitor/antagonist;innovation;lymph nodes;molecular marker;mouse model;neutralizing antibody;new therapeutic target;novel;novel marker;overexpression;pre-clinical;preclinical study;taxane;therapeutic target;thyroid neoplasm;tool;tumor;tumor growth;tumor progression","The NFkB-dependent Secretome and Invasion/Angiogenesis in Thyroid Cancer"," Approximately 1,700 patients with thyroid cancer die each year in the U.S. and many others suffer from progressive, symptomatic disease with no effective therapies. A better understanding of critical pathways in cancer development and progression will lead to discovery of new markers of tumor growth and metastases as well as development of novel directed therapies. Successful completion of the proposed studies will define the role of an important pathway in thyroid cancer (NFkB), and identify new proteins associated with this active pathway that can likely be used as markers of disease progression and novel therapeutic targets.  
    

","NCI","8311654","5/22/2012 12:00:00 AM","PA-10-067","5R01CA155512-02","5","R01","CA","155512","02"," ","SNYDERWINE, ELIZABETH G","8/3/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Integrative and Clinical Endocrinology and Reproduction Study Section[ICER]"," ","1935062","HAUGEN, BRYAN R.","Not Applicable","06","INTERNAL MEDICINE/MEDICINE","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","101969"," ","309469",
"Atherosclerosis; Cardiovascular; Diabetes; Heart Disease; Heart Disease - Coronary Heart Disease; Nutrition","Aging;Amputation;Anti-Inflammatory Agents;Anti-inflammatory;Apolipoprotein E;Apoptotic;Arteries;Arteriosclerosis;Atherosclerosis;Autocrine Communication;Biogenesis;Biology;Blood Vessels;Blood flow;Calcified;Calcium;Cardiac;Cell Adhesion Molecules;Cells;Characteristics;Complex;Data;Deposition;Diabetes Mellitus;Diabetic Angiopathies;Diabetic macrovascular disease;Diet;Disease;Disease Progression;Disease model;Distal;Dyslipidemias;Elastin;Epitopes;Exhibits;Fatty acid glycerol esters;Financial cost;Functional disorder;Funding;Goals;Health;Hormones;Inflammation;Inflammatory;Knockout Mice;Lead;Lower Extremity;MMP9 gene;Medial;Mesenchymal;Metabolic;Modification;Molecular;Mus;Myocardial;Myocardial Infarction;Myofibroblast;Non-Insulin-Dependent Diabetes Mellitus;Osteogenesis;Outcome;Oxidation-Reduction;Oxidative Stress;Paracrine Communication;Parathyroid gland;Patients;Peptide Hydrolases;Perfusion;Phase;Physiology;Process;Reactive Oxygen Species;Recruitment Activity;Regulation;Reporting;Research;Risk;Role;Signal Transduction;Smooth Muscle Myocytes;Staging;Stream;Stress;Structure;Study models;Teriparatide;Testing;Thrombin;Tissues;Uremia;Vascular Smooth Muscle;Vascular calcification;Workload;angiogenesis;aortic valve;arterial remodeling;beta catenin;biomineralization;bone;calcification;cell type;cytokine;diabetic;extracellular;feeding;foot;improved;in vivo;indexing;inhibitor/antagonist;inorganic phosphate;macrophage;male;mineralization;monocyte;osteogenic;osteopontin;promoter;response;scavenger receptor;systolic hypertension;vascular inflammation","OSTEOGENIC REGULATION OF VASCULAR CALCIFICATION","
Project Lay Narrative:
Arterial hardening in diabetes increases the risk for heart attacks & foot amputation. This
occurs in part via metabolic & inflammatory signals that induce bone-like calcification in
large arteries. We test whether regulation of these signals reduces arterial hardening,
decreases cardiac workload, and improves blood flow to the foot.","NHLBI","8309172","7/5/2012 12:00:00 AM","PA-07-070","5R01HL069229-12","5","R01","HL","069229","12"," ","SRINIVAS, POTHUR R","9/30/2001 12:00:00 AM","11/30/2012 12:00:00 AM","Atherosclerosis and Inflammation of the Cardiovascular System Study Section[AICS]"," ","1879402","TOWLER, DWIGHT A.","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","8/1/2012 12:00:00 AM","11/30/2012 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","122346","63619"," ","185965",
"Breast Cancer; Cancer; Clinical Research; Genetics; Human Genome; Prevention","Address;Biological Assay;Biological Markers;Biological Models;CDKN2A gene;Cancer Prognosis;Carcinoma;Cells;Clinical assessments;Coculture Techniques;CpG Islands;Cyclin D1;Cyclin-Dependent Kinase Inhibitor 2A;DNA;DNA Methylation;DNMT3a;Data;Disease;Down-Regulation;E-Cadherin;E2F Transcription Factor 1;EZH2 gene;Early Diagnosis;Epigenetic Process;Epithelial;Epithelial Cells;Epithelial-Stromal Communication;Event;Fatty acid glycerol esters;Fibroblasts;Gene Expression;Genes;Genetic Transcription;Genomic Instability;Genomics;Growth;HOXA9 gene;Histology;Human;Hypermethylation;Immunocompromised Host;In Vitro;Individual;Kinetics;Malignant - descriptor;Mammary Neoplasms;Mammary gland;Methylation;Monitor;Mus;Myoepithelial;Pathway interactions;Phenocopy;Phenotype;Plastics;Play;Polycomb;Population;Predisposition;Prevention strategy;Prevention therapy;Process;Promoter Regions;Proteins;Regulation;Repression;Retinoblastoma Protein;Role;Signal Transduction;Site;Stem cells;Stromal Cells;Testing;Tumor Subtype;Tumorigenicity;Up-Regulation;Woman;abstracting;cell motility;cell type;chromatin remodeling;clinically relevant;disorder risk;epithelial to mesenchymal transition;in vitro Model;in vivo;malignant breast neoplasm;member;neoplastic cell;progenitor;programs;promoter;protein expression;tumor;tumor progression;tumorigenesis","Regulation of Genomic Instability in Early Breast Cancer","
Project Narrative
While the role of acquired DNA methylation in gene expression changes is of obvious importance,
methylation events can play additional roles in the clinical assessment of tumors, providing potential
biomarkers to assess the onset and progression of disease, risk states, monitor prevention strategies,
provide early diagnosis and to track the prognosis of cancer. Our new observations in the regulation of
epigenetic changes provide potential markers for assessing susceptibility to malignant transformation in
individuals, as well as, potential targets for prevention and therapy.","NCI","8244511","3/21/2012 12:00:00 AM","PA-07-070","5R01CA097214-09","5","R01","CA","097214","09"," ","OKANO, PAUL","6/1/2003 12:00:00 AM","4/30/2014 12:00:00 AM","Cancer Genetics Study Section[CG]"," ","1863933","TLSTY, THEA D","Not Applicable","12","PATHOLOGY","094878337","KMH5K9V7S518","094878337","KMH5K9V7S518","US","37.78689","-122.448998","577508","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO","SAN FRANCISCO","CA","SCHOOLS OF MEDICINE","941432510","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","168624","85855"," ","254479",
"Aging; Biotechnology; Cancer; Prostate Cancer; Urologic Diseases","Address;Affect;Aging;Androgen Receptor;Androgens;Animal Model;Animals;Apoptosis;Area;Attention;Benign Prostatic Hypertrophy;Biological Assay;Biological Models;Breeding;Cancer Etiology;Cancer Model;Cancerous;Cell Culture Techniques;Cell Line;Cell physiology;Cells;Cessation of life;ChIP-seq;Choristoma;Coculture Techniques;Data;Development;Disease;Disease Progression;Elderly;Elderly man;Endocrine system;Epithelial;Epithelial Cells;Epithelium;Etiology;Fibroblasts;Frequencies;Future;Gene Targeting;Generations;Genetic Recombination;Growth;Homeostasis;Human;Image;Immune;In Vitro;Incidence;Investigation;Knock-out;Knockout Mice;Lead;Lesion by Stage;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Mesenchymal;Modeling;Molecular;Mus;PTEN gene;Pathway interactions;Phenotype;Physiological;Play;Prolactin;Prostate;Prostatic Diseases;Prostatic hypertrophy;Publications;Rattus;Receptor Signaling;Recombinants;Reporting;Research;Rodent;Role;SCID Mice;Signal Transduction;Smooth Muscle;Stream;Stromal Cells;Structure;Symptoms;System;Therapeutic;Tissues;Transgenic Mice;Urination;alternative treatment;cancer cell;cancer initiation;carcinogenesis;cell stroma;cell type;implantation;in vivo;in vivo Model;insight;intraepithelial;men;mouse model;nephrogenesis;novel;pre-clinical;probasin;promoter;prostate carcinogenesis;public health relevance;receptor function;response;tumor progression;tumorigenesis;urinary","Stromal AR Roles in Prostate Hyperplasia and Cancer","
Narrative
To date, the epithelial androgen receptor (AR) has drawn a lot of attention in prostate carcinogenesis and
there are thousands of publications focused on addressing the role of epithelial AR in prostate cancer. For
the stromal AR, there is still a lack of an in vivo model to investigate its impact on the BPH and prostate
carcinogenesis. The accomplishment of the studies could help to (i) uncover new insights about the cellular
functions of stromal AR, (ii) explore and understand the critical roles of the stromal AR in BPH and prostate
cancer initiation and progression, and (iii) could help to formulate new and alternative therapeutic strategies
by selectively targeting stromal AR and its downstream pathways to battle those two important prostate
diseases.","NCI","8213431","4/12/2012 12:00:00 AM","PA-10-067","5R01CA156700-02","5","R01","CA","156700","02"," ","MOHLA, SURESH","4/1/2011 12:00:00 AM","3/30/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","7684977","CHANG, CHAWNSHANG ","YEH, SHUYUAN ","25","PATHOLOGY","041294109","F27KDXZMF9Y8","041294109","F27KDXZMF9Y8","US","43.16888","-77.615939","7047101","UNIVERSITY OF ROCHESTER","ROCHESTER","NY","SCHOOL OF MEDICINE & DENTISTRY","146270140","UNITED STATES","N","4/1/2012 12:00:00 AM","3/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","113088"," ","320588",
"Cancer; Lung; Lung Cancer","Address;Autocrine Communication;Binding;Cancer cell line;Cell Line;Cells;Clinical;Data;Disease;Dominant-Negative Mutation;EGF gene;Endothelial Cells;Epidermal Growth Factor Receptor;Epithelial;Epithelial Cells;Erlotinib;Exhibits;Extracellular Signal Regulated Kinases;FGFR1 gene;FGFR2 gene;Family;Fibroblast Growth Factor;Fibroblast Growth Factor 2;Fibroblast Growth Factor Receptor 2;Fibroblast Growth Factor Receptors;Gefitinib;Growth;Growth Factor;Growth Factor Receptors;Heterogeneity;Human;Institutional Review Boards;Laboratories;Ligands;Lung;Malignant neoplasm of lung;Measurement;Measures;Mediating;Mesenchymal;Neoplasm Metastasis;Non-Small-Cell Lung Carcinoma;Pathologist;Pathway interactions;Patients;Phosphorylation;Play;Primary Neoplasm;Principal Investigator;Protein Isoforms;Receptor Protein-Tyrosine Kinases;Receptor Signaling;Regulation;Resistance;Role;Sampling;Sampling Studies;Signal Pathway;Signal Transduction;Source;Stromal Cells;Testing;Tissue Sample;Tumor Angiogenesis;Tyrosine Kinase Inhibitor;autocrine;base;cancer cell;cancer therapy;cell type;fibroblast growth factor receptor 2c;inhibitor/antagonist;interest;neoplastic cell;paracrine;programs;protein expression;receptor;research study;response;small hairpin RNA;success;therapeutic target;tumor;tumor progression","FGF-2 Autocrine Signaling in Lung Cancer","n/a","NCI","8197119","11/15/2011 12:00:00 AM","PA-07-070","5R01CA127105-05","5","R01","CA","127105","05"," ","SALNIKOW, KONSTANTIN","12/1/2007 12:00:00 AM","11/30/2013 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","1883178","HEASLEY, LYNN E","Not Applicable","06","INTERNAL MEDICINE/MEDICINE","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","102409"," ","303684",
"Biotechnology; Cancer; Genetics","Accounting;Adult;Affect;Alleles;Anterior;Apoptosis;Apoptotic;Brain;Cancer Biology;Cell Adhesion;Cell Cycle;Cell Death;Cell Lineage;Cell Proliferation;Cell Survival;Cell physiology;Cells;Cessation of life;Child;Communities;Complex;Development;Developmental Biology;Differentiation and Growth;Digit structure;Embryo;Ensure;Erinaceidae;Family member;Fibroblast Growth Factor;Fingers;G1 Arrest;Gene Expression Regulation;Gene Targeting;Genes;Genetic;Genomics;Goals;Growth;Hereditary Disease;Holoprosencephaly;Human;Image;Infant;Intercept;Joints;Knock-out;Lead;Learning;Length;Limb Development;Limb structure;Link;Malignant Neoplasms;Mediator of activation protein;Mesenchymal;Mesoderm;Mission;Mitogens;Modeling;Morbidity - disease rate;Morphogenesis;Mus;Mutant Strains Mice;Mutate;Mutation;Nature;Neoplasm Metastasis;Neoplasms;Neural Crest;Normal tissue morphology;Organ;Pallister-Hall syndrome;Pancreas;Pathology;Pathway interactions;Pattern;Phalanx;Phase;Physical condensation;Physiological Processes;Play;Process;Prostate;Proteomics;Regulation;Research;Role;Shapes;Signal Pathway;Signal Transduction;Skeleton;Skin;Sonic Hedgehog Pathway;Specific qualifier value;Staging;Stomach;Structure;Study models;System;Systems Biology;Tamoxifen;Testing;Thumb structure;Time;Tissues;Transgenes;Tumor Biology;Vertebrates;Work;cancer type;cell behavior;cell motility;cellular targeting;design;developmental genetics;genome wide association study;morphogens;mortality;mutant;neoplastic cell;programs;promoter;recombinase;research study;selective expression;smoothened signaling pathway;tool;transcription factor;tumorigenesis","Role of Shh in developmental patterning and proliferation of digit skeleton","n/a","NCI","8552993"," "," ","1ZIABC011118-05","1","ZIA","BC","011118","05"," "," "," "," "," "," ","9692609","MACKEM, SUSAN ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","372029",
"Contraception/Reproduction; Digestive Diseases; Genetics","Adherence;Administrative Supplement;Advisory Committees;Animal Experimentation;Animal Experiments;Animal Model;Animals;Antigens;Artificial Insemination;Back;Bacteria;Bacterial Genes;Biology;Biomedical Research;Biotechnology;Bone Marrow;Breeding;Cells;Chronic;Collaborations;Communities;Control Animal;Core Facility;Country;Crying;Cryopreservation;Custom;Dendritic Cells;Derivation procedure;Detection;Development;Diet;Digestive System Disorders;Direct Costs;Disease;Doctor of Medicine;Doctor of Philosophy;Embryo;Embryo Transfer;Engineering;Ensure;Environment;Epithelial;Equipment;Film;Funding;Gene Expression;Generations;Genes;Genetic;Germ-Free;Gnotobiotic;Goals;Grant;Housing;Human Resources;Immune;Immune response;Immunologist;Individual;Inflammatory;Inflammatory Bowel Diseases;Inflammatory disease of the intestine;Institution;Interleukin-10;International;Intestines;Knock-out;Knockout Mice;Laboratory Animals;Leadership;Life;Link;Location;London;Maintenance;Marines;Medicine;Mesenchymal;Methods;Microbiology;Molds;Molecular;Monitor;Mouse Strains;Mus;Mutant Strains Mice;Mutation;NIH Mouse;National Center for Research Resources;National Institute of Diabetes and Digestive and Kidney Diseases;North Carolina;Operative Surgical Procedures;Organ;Ovary;Parasites;Pathogenesis;Phenotype;Physiologic pulse;Physiological;Physiological Processes;Postdoctoral Fellow;Process;Production;Publishing;Quality Control;Rattus;Recombinants;Recovery;Regulation;Research;Research Personnel;Research Project Grants;Resources;Retirement;Retroviridae;Rodent;Role;Series;Services;Source;Specific Pathogen Frees;Sterility;Surrogate Mothers;System;T-Lymphocyte;Technical Expertise;Techniques;Time;Training;Transgenic Mice;Transgenic Organisms;Transplantation;United States National Institutes of Health;Universities;Veterinary Medicine;Virus;Washington;Wisconsin;Work;Yeasts;Zebrafish;animal resource;base;college;commensal microbes;comparative;cost;design;experience;flexibility;fungus;gastrointestinal;gene environment interaction;germ free condition;gut microbiota;in vivo;innovation;interest;male;medical schools;member;microbial;multidisciplinary;neoplastic;novel;response;sperm cell","GNOTOBIOTIC CORE","n/a","NIDDK","8374538","11/16/2011 12:00:00 AM","RFA-DK-08-002","5P30DK034987-27","5","P30","DK","034987","27"," "," "," "," ","ZDK1-GRB-8","6584","1932757","TONKONOGY, SUSAN L","Not Applicable","04","Unavailable","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","Domestic Higher Education","275995023","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM"," ","Research Centers","2012","148724","148724"," ","100773","47951"," "," ",
"Genetics","Ablation;Address;Affinity;Anatomy;Animals;BMP2 gene;Biochemical;Biological;Biological Process;Biology;Bone Diseases;Bone Matrix;Bone Morphogenetic Proteins;Bone Regeneration;Bone Tissue;Cartilage;Cartilage Diseases;Cell Differentiation process;Cell Maturation;Cell model;Cells;Chondrocytes;Cleidocranial Dysplasia;Complex;Cues;DNA Binding;DNA Binding Domain;Data;Deposition;Development;Differentiation and Growth;Embryo;Erinaceidae;Event;Failure;Family;Functional disorder;Gene Deletion;Gene Expression;Gene Expression Profile;Gene Targeting;Genes;Genetic;Genetic Transcription;Goals;Growth;Human;In Situ Hybridization;Inherited;Innovative Therapy;Intervention;Knockout Mice;Knowledge;MAP Kinase Gene;Maintenance;Mammals;Mediating;Mesenchymal;Metabolic Bone Diseases;Modeling;Modification;Molecular;Molecular Biology;Monitor;Mus;Mutagenesis;Mutation;Null Lymphocytes;Osteoblasts;Osteogenesis;Pathway interactions;Pattern;Phenotype;Process;Protein Biochemistry;Proteins;RNA;Regulation;Research;Role;Runx2 protein;Signal Transduction;Skeleton;Specific qualifier value;Specificity;Subgroup;Testing;Tissues;To specify;Ubiquitin;Ubiquitination;Vertebrates;Work;Zinc Fingers;base;bone;bone cell;improved;in vivo;insight;interdisciplinary approach;intramembranous bone formation;mineralization;morphogens;multicatalytic endopeptidase complex;mutant;novel;osteoblast differentiation;osteogenic;osteoprogenitor cell;prevent;protein function;reconstitution;repaired;skeletal;skeletal disorder;skeletal tissue;skeletogenesis;stable cell line;transcription factor;ubiquitin ligase","Sp7 Mediated Control of Runx2 Function for Osteoblast Differentiation"," Crucial understanding of molecular mechanism involved in the regulation of bone cell maturation has significant potential for developing interventional therapies in growth anomalies and metabolic bone disorders. Findings from this study will help us in understanding the pathophysiology of skeletal tissues and cartilage and bone disorders.  
    

","NIAMS","8220442","2/15/2012 12:00:00 AM","PA-10-067","1R01AR062091-01","1","R01","AR","062091","01"," ","CHEN, FAYE H","3/1/2012 12:00:00 AM","2/28/2017 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","7626905","JAVED, AMJAD ","Not Applicable","07","DENTISTRY","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","SCHOOLS OF DENTISTRY/ORAL HYGN","352940001","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","225000","96877"," ","321877",
"Aging; Breast Cancer; Cancer; Estrogen; Genetics; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","6q21;Address;Antigens;Attention;Binding;Bioinformatics;Biometry;Breast Cancer Cell;Breast Cancer Epidemiology;CD44 Antigens;CD44 gene;Cancer cell line;Cell Line;Cells;Clinical;Complex;DNA;DNA Methylation;Data;Databases;Distant Metastasis;Endocrine;Epidemiologic Studies;Epidemiology;Epigenetic Process;Epithelial;Epithelial Cells;Estrogen Antagonists;Estrogen Receptor Modulators;Estrogen Receptor Status;Estrogen Receptor alpha;Estrogen receptor positive;Estrogens;Event;Frequencies;Future;Gene Targeting;Genes;Genetic Transcription;Growth;High Prevalence;Hormonal;Hormone Receptor;Hormones;Human;Hypermethylation;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Mediating;Mesenchymal;Methylation;Neoplasm Metastasis;Normal tissue morphology;Outcome;Patients;Phenotype;Pilot Projects;Premenopause;Prevalence;Primary Neoplasm;Proteins;Publications;Publishing;Recurrence;Recurrent disease;Regulation;Resistance;Resistance development;Response Elements;Role;Signal Transduction;Stem cells;Tamoxifen;Therapeutic;Tissues;Tumor Promoters;Woman;Work;Y Chromosome;abstracting;advanced disease;anticancer research;bisulfite;cancer stem cell;clinically significant;deprivation;epidemiologic data;hormone regulation;hormone therapy;malignant breast neoplasm;mortality;promoter;public health relevance;tumor;tumor initiation;tumor progression;tumorigenic","Prevalence of CD24 epigenetic silencing in breast tumors and ERalpha status","
Project Narrative
Endocrine therapy like Tamoxifen treatment remains important in premenopausal women with hormone
receptor positive breast cancer as it work best in women whose tumors are positive for estrogen receptor
(ERï¿½) and unfortunately it is estimated that one third of women treated with Tamoxifen for 5 years will have a
recurrence within 15 years suggesting these are endocrine resistant tumors which represents about one-fourth
of all breast cancers. Silencing of hormone regulated genes in tumors are known to cause this resistance and
this pilot project will focus on the prevalence of the silencing of one of the hormone target genes (CD24) in
breast tumors compared to the surrounding normal tissues and its correlation to hormone receptor status.
Results from this pilot study will provide important data to plan future larger studies to better understand the
role of this silencing in therapeutic resistance and clinical outcome.","NCI","8212012","12/30/2011 12:00:00 AM","PAR-08-237","5R03CA150027-02","5","R03","CA","150027","02"," ","MARTIN, DAMALI","1/7/2011 12:00:00 AM","12/31/2013 12:00:00 AM","ZCA1-SRLB-D(O1)"," ","10027528","KAIPPARETTU, BENNY ABRAHAM","Not Applicable","09","INTERNAL MEDICINE/MEDICINE","051113330","FXKMA43NTV21","051113330","FXKMA43NTV21","US","29.711148","-95.39695","481201","BAYLOR COLLEGE OF MEDICINE","HOUSTON","TX","SCHOOLS OF MEDICINE","770303411","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","50000","28250"," ","78250",
"Breast Cancer; Cancer","3-Dimensional;Accounting;Adherens Junction;Affect;Apical;Basement membrane;Binding;Biological Assay;Biological Models;Breast Cancer Cell;Breast Cancer Prognostic Factor;Cancer Patient;Cell physiology;Cell-Cell Adhesion;Cells;Cessation of life;Characteristics;Chickens;Collagen;Collagen Receptors;DDR1 gene;Data;Dimerization;Distant;Duct (organ) structure;Ductal;E-Cadherin;Epithelial;Epithelial Cells;Epithelium;Future;Gel;Gene Mutation;Genes;Hour;Human;Hyperplasia;Immune;Invaded;Laboratories;Libraries;Lobular;Lobule;MAP Kinase Gene;MAPK1 gene;Malignant Neoplasms;Mammary Gland Parenchyma;Mammary Neoplasms;Mammary gland;Measures;Mediating;Mesenchymal;Messenger RNA;Molecular;Mus;Neoplasm Metastasis;Noninfiltrating Intraductal Carcinoma;Organ;Phosphorylation;Play;Post-Translational Regulation;Primary Neoplasm;Process;Prognostic Marker;Proteins;RNA Interference;Receptor Protein-Tyrosine Kinases;Regulation;Research;Role;Sampling;Scientist;Signal Transduction;Site;Staging;Staining method;Stains;Testing;Therapeutic;Tumor Cell Invasion;Xenograft Model;base;cancer cell;cell motility;cell type;chorioallantoic membrane;discoidin domain receptor 2;high throughput screening;improved;in vivo;malignant breast neoplasm;neoplastic cell;novel;overexpression;transcription factor","Regulation of Snail1 in cancer metastasis","Cancer begins with genetic mutations and molecular signals that cause cells to grow abnormally quickly and develop into a primary tumor. Some of these tumor cells acquire the ability to invade away from the primary tumor and migrate to distant organs, and this spread causes the majority of cancer-related deaths. Understanding the molecular signals that contribute to tumor cell invasion is essential for developing better therapies to treat cancer patients and reduce the number of cancer-related deaths.","NCI","8313089","3/21/2012 12:00:00 AM","PA-11-111","1F31CA165729-01A1","1","F31","CA","165729","01","A","SCHMIDT, MICHAEL K","9/1/2012 12:00:00 AM","8/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-D(08)L]"," ","10742871","CORSA, CALLIE ANN SPRUNGER","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","34855"," "," ","34855",
"Biotechnology; Cancer; Food Safety; Genetics; Lung; Lung Cancer; Prevention","A/J Mouse;Affect;Anchorage-Independent Growth;Arsenic;Binding;Boxing;Cancer Etiology;Carcinogens;Cell Line;Country;Down-Regulation;E-Cadherin;Ectopic Expression;Environmental Exposure;Environmental Health;Environmental Pollutants;Epigenetic Process;Epithelial Cells;Exhibits;Exposure to;Family member;Functional RNA;Gene Expression;Gene Targeting;Goals;Homeobox;Human;Knock-out;Knockout Mice;Lead;Luciferases;Lung Adenocarcinoma;Lung Neoplasms;Malignant Neoplasms;Malignant neoplasm of liver;Malignant neoplasm of lung;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Mediating;MicroRNAs;Modeling;Molecular Profiling;Molecular Target;Mus;Nude Mice;Phenotype;Play;Process;Production;Protein p53;Rattus;Recombinant Transforming Growth Factor;Reporter;Reporting;Repression;Resistance;Risk;Role;Signal Pathway;Signal Transduction;Skin;Skin Cancer;Small Interfering RNA;Source;Testing;Time;Tissues;Transcription Repressor/Corepressor;Transforming Growth Factor beta;Transforming Growth Factors;Tumor Promoters;United States;Zinc Fingers;base;cancer prevention;carcinogenesis;cell transformation;chemical carcinogenesis;cytokine;drinking water;epidemiology study;epithelial to mesenchymal transition;exposed human population;fetal;gain of function;knock-down;loss of function;lung carcinogenesis;lung tumorigenesis;matrigel;metaplastic cell transformation;novel;overexpression;promoter;public health relevance;small hairpin RNA;subcutaneous;tumor;tumor progression;tumorigenesis;vector control","The Epigenetic Mechanism of Arsenic Lung Carcinogenesis - Role of MicroRNAs","
Arsenic (As) is one of the most common environmental pollutants and exposure to As
through drinking water is a major environmental health concern, affectsing millions of
people in the United States and many other countries. The goal of this study is to
determine the mechanism by which As exposure causes cancers and identify molecular
targets for the treatment and prevention of cancers resulting from As exposure.","NIEHS","8249919","3/28/2012 12:00:00 AM","PA-07-070","5R01ES017777-03","5","R01","ES","017777","03"," ","TYSON, FREDERICK L","4/8/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Cancer Etiology Study Section[CE]"," ","9719630","YANG, CHENGFENG ","Not Applicable","08","PHYSIOLOGY","193247145","R28EKN92ZTZ9","193247145","R28EKN92ZTZ9","US","42.748478","-84.483276","5245901","MICHIGAN STATE UNIVERSITY","EAST LANSING","MI","SCHOOLS OF VETERINARY MEDICINE","488242600","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","NIEHS","234779","104247"," ","339026",
"Aging; Atherosclerosis; Cardiovascular; Clinical Research; Heart Disease; Heart Disease - Coronary Heart Disease; Osteoporosis; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Nonembryonic - Non-Human","Affect;Aging;Alkaline Phosphatase;Animal Model;Antibodies;Atherosclerosis;Binding;Biology;Blood Vessels;Bone Marrow;Bone Surface;CD34 gene;Calcified;Cardiac Catheterization Procedures;Cardiology;Cardiovascular system;Cells;Clinical Research;Collagen;Control Animal;Coronary;Coronary Arteriosclerosis;Coronary Circulation;Coupled;Development;Diffuse;Disease;Elderly woman;Endocrinology;Event;Flow Cytometry;Functional disorder;Genes;Heart Diseases;In Vitro;Individual;Injury;Ligands;Link;Mesenchymal;Methods;Modeling;Mus;Myocardial Infarction;Nodule;Osteoblasts;Osteocalcin;Osteogenesis;Osteoporosis;Pathway interactions;Patients;Phenotype;Play;Prevention;Process;Proteins;Public Health;Research Personnel;Risk;Role;Rupture;Smooth Muscle Myocytes;Sorting - Cell Movement;Staining method;Stains;Stem cells;Stroke;Structure;TNFSF11 gene;Testing;Therapeutic Intervention;Tumor necrosis factor receptor 11b;Ultrasonography;Vascular Diseases;Vascular Endothelial Growth Factor Receptor-2;Vascular calcification;Work;animal data;base;bone;bone metabolism;bone turnover;calcification;human data;in vivo;interdisciplinary approach;mRNA Expression;mineralization;mortality;novel;novel marker;osteogenic;public health relevance;receptor;repaired;response;subcutaneous;therapy design","Role of Endothelial Progenitor Cells in vascular Aging and Calcification","
 Project Narrative
Aging is associated with osteoporosis and with vascular (blood vessel) disease. In
addition, patients with osteoporosis (who have reduced bone) have an increased risk of
vascular calcification, which is associated with formation of bone-like structures in blood
vessels and with heart attacks and strokes. The proposed work focuses on the role of
circulating cells which likely arise from the bone marrow in initiating vascular calcification
as opposed to normal repair. These studies should help us better understand how
vascular calcification occurs, and perhaps ways of modifying the process into a more
normal repair process, which would have important implications for the prevention and
treatment of heart disease with aging.
Public Health","NIA","8242709","3/2/2012 12:00:00 AM","PA-07-070","5R01AG031750-03","5","R01","AG","031750","03"," ","KOHANSKI, RONALD A","4/15/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Aging Systems and Geriatrics Study Section[ASG]"," ","1901040","LERMAN, AMIR ","KHOSLA, SUNDEEP ","01","Unavailable","006471700","Y2K4F9RPRRG7","006471700","Y2K4F9RPRRG7","US","44.022374","-92.465881","4976101","MAYO CLINIC ROCHESTER","ROCHESTER","MN","Other Domestic Non-Profits","559050001","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","866","Non-SBIR/STTR","2012"," "," ","NIA","272198","139093"," ","411291",
"Breast Cancer; Cancer; Complementary and Alternative Medicine; Genetics; Nutrition","Adverse effects;American;Anthracenes;Aromatic Polycyclic Hydrocarbons;Benzo(a)pyrene;Binding;Breast Cancer Cell;Breast Diseases;Cancer cell line;Carcinogenesis Mechanism;Carcinogens;Cause of Death;Cell Proliferation;Cell Survival;Cells;Clinic;Collaborations;Complex;Cytoplasm;Dietary Factors;Disease Progression;Drug resistance;ERBB2 gene;Environmental Carcinogens;Environmental Risk Factor;Epigallocatechin Gallate;Epigenetic Process;Event;Exposure to;Family;Funding;Gene Activation;Genes;Genetic;Green tea;Growth;Heavy Metals;Human;In Vitro;Incidence;Malignant - descriptor;Mammary Neoplasms;Mammary Tumorigenesis;Mammary gland;Mediating;Modeling;Mouse Mammary Tumor Virus;Mus;NF-kappa B;Neoplastic Cell Transformation;Oncogenes;Pathway interactions;Patients;Phenotype;Phosphotransferases;Play;Pleural effusion disorder;Process;Progress Reports;Rattus;Reporting;Research Project Grants;Resistance;Roche brand of trastuzumab;Role;Signal Pathway;Signal Transduction;Solid Neoplasm;Specimen;Staging;TANK-binding kinase 1;TNFRSF5 gene;Testing;Tissues;Transactivation;Translating;Trastuzumab;Tumor Cell Line;Woman;Xenograft Model;carcinogenesis;casein kinase II;cigarette smoking;combinatorial;dimethylbenzanthracene;early onset;efficacy testing;epithelial to mesenchymal transition;gallocatechol;in vivo;inhibitor/antagonist;malignant breast neoplasm;mammary gland development;member;mouse model;neoplastic cell;novel;polyphenol;pre-clinical;programs;promoter;research clinical testing;slug;transcription factor;tumor;tumorigenesis","Research Project 3: Role of the NF-kB/Rel in Mammary Carcinogenesis","n/a","NIEHS","8376881","6/27/2012 12:00:00 AM"," ","5P01ES011624-11","5","P01","ES","011624","11"," "," "," ","6/30/2015 12:00:00 AM","ZES1-JAB-J","0003","1896578","SONENSHEIN, GAIL E.","Not Applicable","07","Unavailable","039318308","C1F5LNUF7W86","039318308","C1F5LNUF7W86","US","42.349907","-71.061712","8422704","TUFTS UNIVERSITY BOSTON","BOSTON","MA","Domestic Higher Education","021111901","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","127137","127137"," ","101224","25913"," "," ",
"Biotechnology; Cancer; Lung; Lung Cancer","3p21.3;Affect;Antibodies;Binding;Biological Markers;Cancer Patient;Cancer cell line;Cell Line;Clinical Trials;Dasatinib;Data;Development;Disease;Down-Regulation;E-Cadherin;E-Cadherin Staining Method;EPHA2 gene;EPHB2 gene;Endothelial Cells;Engineering;Ephrin-B3;Epidermal Growth Factor Receptor;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Epithelial;Erlotinib;Family;Fibroblast Growth Factor;Fibroblast Growth Factor Receptors;Frequencies;Gefitinib;Gene Targeting;Genes;Goals;Growth Factor;Histone Deacetylase Inhibitor;Human;In Vitro;Integrins;Knowledge;Lesion;Malignant Neoplasms;Malignant neoplasm of lung;Mesenchymal;Molecular;Nature;Neoplasm Metastasis;Neuropilin-1;Neuropilins;Outcome;Pathogenesis;Pathway interactions;Patients;Premalignant;Preparation;Proteins;Proto-Oncogene Proteins c-akt;Recurrence;Reporting;Resistance;Sampling;Semaphorins;Signal Pathway;Signal Transduction;Snails;Staging;Testing;Tetanus Helper Peptide;Therapeutic;Therapeutic Agents;Time;Tissue Banking;Tissue Banks;Tumor Suppressor Genes;VAV3 gene;Vascular Endothelial Cell;Vascular Endothelial Growth Factor Receptor;Vascular Endothelial Growth Factors;Vorinostat;Work;Xenograft Model;antibody inhibitor;base;cancer therapy;celecoxib;clinically relevant;design;gene discovery;in vivo;inhibitor/antagonist;integrin-linked kinase;mutant;neoplastic;neoplastic cell;plexin;pre-clinical;receptor;research study;small hairpin RNA;small molecule;tumor;vector control","SEMA3F and ZEB1 in Lung Cancer: Therapy and Target Gene Discovery","n/a","NCI","8376652","6/19/2012 12:00:00 AM","PAR-06-505","5P50CA058187-18","5","P50","CA","058187","18"," "," "," ","4/30/2014 12:00:00 AM","ZCA1-GRB-I","0018","1885652","DRABKIN, HARRY A.","Not Applicable","06","Unavailable","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","Domestic Higher Education","800452570","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM"," ","Research Centers","2012","337498","337498"," ","238151","99347"," "," ",
"Alcoholism; Biotechnology; Chronic Liver Disease and Cirrhosis; Digestive Diseases; Genetics; Liver Disease; Substance Abuse","3&apos; Untranslated Regions;Accounting;Affect;Alcohols;Autoimmune Process;Automobile Driving;Binding;Biogenesis;Biology;Cause of Death;Cell Cycle Progression;Cell Proliferation;Cells;Cellular biology;Cessation of life;Chronic;Cicatrix;Collagen;Deposition;Development;Disease;E-Box Elements;Elements;Epithelial;Ethanol;Exposure to;FDA approved;Fibrillar Collagen;Fibrosis;Functional RNA;Gene Targeting;Genes;Genetic;Genetic Transcription;Goals;Health;Heart;Hepatic Stellate Cell;Hepatocyte;Human;Immigration;Individual;Injury;Introns;Kidney;Knowledge;Lead;Light;Liposomes;Liver;Liver Cirrhosis;Liver Fibrosis;Liver diseases;Lung;Malignant neoplasm of liver;Medical;Mesenchymal;Metabolism;MicroRNAs;Mus;Organ;Outcome Study;Pancreas;Pathology;Pathway interactions;Pattern;Play;Post-Transcriptional Regulation;Process;Production;Public Health;RNA;Regulation;Research;Role;Signal Transduction;Skin;Smooth Muscle Actin Staining Method;Testing;Therapeutic;Therapeutic Intervention;Tissues;Toxin;Transcript;Transforming Growth Factors;United States National Institutes of Health;alcohol response;base;cell type;clay;connective tissue growth factor;effective therapy;fibrogenesis;improved;in vivo;in vivo Model;liver function;mRNA Expression;nanoscale;nanosized;novel;novel therapeutics;promoter;response;stemness","MicroRNA regulation of CTGF in hepatic stellate cells"," Fibrosis of internal organs is a significant contributing factor in about 45% of the deaths in the USA yet there are currently no FDA-approved anti-fibrotic therapeutics. Chronic fibrosis most commonly affects the liver, lung, kidney, heart, pancreas and skin and is the result of diverse causes such as autoimmune, genetic, idiopathic, or toxins (e.g. alcohol in hepatic fibrosis). These studies will determine the role of connective tissue growth factor (CTGF) in controlling the pro-fibrogenic functions of hepatic stellate cells, which are the principal fibrogenic cell type in the liver. This proposal focuses on identifying the mechanisms by
which CTGF production is regulated by small naturally occurring RNA molecules called microRNA. The relevance of these studies is that they will identify key steps in the pathways that lead to hepatic fibrosis and will define points of therapeutic intervention that exploit the central role played by connective tissue growth factor (CTGF) in driving fibrotic pathology.   
      

","NIAAA","8275273","3/5/2012 12:00:00 AM","PA-10-067","1R01AA021276-01","1","R01","AA","021276","01"," ","RADAEVA, SVETLANA","3/5/2012 12:00:00 AM","2/28/2017 12:00:00 AM","Hepatobiliary Pathophysiology Study Section[HBPP]"," ","1880770","BRIGSTOCK, DAVID R","Not Applicable","03","Unavailable","147212963","EYMJXLN2MFB4","147212963","EYMJXLN2MFB4","US","39.952467","-82.979099","1495302","RESEARCH INST NATIONWIDE CHILDREN'S HOSP","COLUMBUS","OH","Research Institutes","432052664","UNITED STATES","N","3/5/2012 12:00:00 AM","2/28/2013 12:00:00 AM","273","Non-SBIR/STTR","2012"," "," ","NIAAA","225000","100800"," ","325800",
"Autoimmune Disease; Biotechnology; Genetics; Human Genome; Lung; Prevention; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Acetylation;Affect;Age;Alveolar;American;Asphyxia;Automobile Driving;Biological Models;Cause of Death;Cell Differentiation process;Cells;Cessation of life;Chromatin Remodeling Factor;Chromatin Structure;Chromosomes;Cicatrix;Complex;Cuboidal Cell;DNA Methylation;Data;Deposition;Development;Developmental Biology;Diagnosis;Differentiation and Growth;Disease;Dissection;Distal;Effector Cell;Epigenetic Process;Epithelial;Epithelial Cells;Etiology;Event;Fibroblasts;Fibrosis;Functional RNA;Gases;Gene Expression;Gene Expression Profile;Gene Expression Regulation;Genes;Genetic Transcription;Genomics;Goals;Growth Factor;Hamman-Rich syndrome;Health;Human;Immunofluorescence Immunologic;Immunohistochemistry;In Vitro;Injury;Knowledge;Location;Lung;Lung diseases;Maps;Mediating;Messenger RNA;Methylation;MicroRNAs;Modeling;Modification;Monitor;Morphology;Normal Cell;Pathogenesis;Patients;Pattern;Peripheral;Phenotype;Play;Polycomb;Population;Prevention;Prevention strategy;Process;Proliferating;Property;Public Health;Pulmonary Surfactants;Pulmonology;RNA Polymerase II;Regenerative Medicine;Regulation;Regulatory Pathway;Resolution;Respiratory Failure;Reverse Transcriptase Polymerase Chain Reaction;SMARCA4 gene;Serum;Source;System;Time;Tissues;Transcriptional Regulation;Transforming Growth Factor beta;Transplantation;United States;Validation;Woman;alveolar epithelium;base;bisulfite;cell type;chromatin immunoprecipitation;data integration;disorder prevention;epigenomics;epithelial to mesenchymal transition;genome-wide;histone modification;in vivo;insight;lung repair;men;prevent;progenitor;programs;response;response to injury;restoration;self-renewal;spatial relationship;transcription factor;treatment strategy","Epigenetic profiling of human alveolar epithelial cells in health and disease","
RELEVANCE TO PUBLIC HEALTH
Nobody knows why each year up to 34,000 Americans develop idiopathic pulmonary
fibrosis, ""IPF"", a lethal disease in which the lungs are slowly destroyed by scar tissue,
ultimately resulting in suffocation. Evidence suggests that in patients with IPF, certain
lung cells differentiate into scar tissue instead of growing normally. Using a unique
system of cultured human lung cells, we will examine how the information that is layered
on top of the genes (""epigenetic"" information) makes lung cells grow in normal as well as
abnormal ways, with the objective to develop new treatment and prevention strategies
for IPF and other lung diseases.","NHLBI","8336907","7/4/2012 12:00:00 AM","RFA-ES-10-002","5R01HL114094-02","5","R01","HL","114094","02"," ","GAN, WEINIU","9/23/2011 12:00:00 AM","6/30/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-GGG-M(50)R]"," ","2194061","OFFRINGA, ITE A","BOROK, ZEA ","37","SURGERY","072933393","G88KLJR3KYT5","072933393","G88KLJR3KYT5","US","34.065915","-118.196446","7636101","UNIVERSITY OF SOUTHERN CALIFORNIA","Los Angeles","CA","SCHOOLS OF MEDICINE","900894304","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","409428","262034"," ","671462",
"Cancer","Actins;Actomyosin;Address;Adhesions;Antibodies;Automobile Driving;BRAF gene;Basic Science;Biochemical;Cancer Etiology;Cancer cell line;Carcinoma;Cell Line;Cell model;Cells;Cellular biology;Chemicals;Complex;Computer software;Computing Methodologies;Cytoskeleton;Data;Dissection;Disseminated Malignant Neoplasm;Distant;Doctor of Philosophy;Epithelial;Epithelial Cells;Exhibits;Fluorescence Microscopy;Future;Genetic;Genetic Transcription;Goals;Image;In Vitro;KRAS2 gene;Label;Location;MAP Kinase Gene;Malignant Neoplasms;Malignant neoplasm of pancreas;Manuscripts;Mechanics;Mentors;Microscopy;Mitogen-Activated Protein Kinases;Modeling;Molecular;Morbidity - disease rate;Morphology;Movement;Mutation;Myosin Light Chains;Neoplasm Metastasis;Normal Cell;Oncogenic;Organ;Pathway interactions;Patients;Phosphorylation;Phosphotransferases;Production;Publishing;RPS6KA gene;Receptor Protein-Tyrosine Kinases;Regulation;Research;Ribosomal Protein S6 Kinase;Role;Science;Scientist;Signal Pathway;Signal Transduction;Site;Speed;Stratification;Techniques;Testing;Therapeutic;Time;Tissue Microarray;Tissue Sample;Tissues;Training;Training Programs;ZYX gene;anticancer research;base;cancer cell;cancer type;career;cell motility;cell transformation;epithelial to mesenchymal transition;improved;malignant breast neoplasm;medical schools;melanoma;migration;mortality;mutant;myosin phosphatase;neoplastic cell;new therapeutic target;novel;particle;paxillin;polymerization;prevent;professor;programs;spatiotemporal;treatment strategy","Regulation of Cell Motility by the Oncogenic ERK-MAPK Pathway","Cancer mortality is primarily due to the effects of invasive cancer spreading to other organs. We have identified, and propose to further investigate, a role for the oncogenic ERK/RSK signaling pathway in driving cancer cell migration and invasion. My goals are to understand the molecular basis of how mutations that activate the ERK/RSK pathway regulate the actomyosin cytoskeleton to induce cancer cell motility. Our findings will inform upon treatments strategies aimed at preventing cancer's metastatic spread.","NCI","8351580","8/20/2012 12:00:00 AM","PAR-09-052","1K01CA168850-01","1","K01","CA","168850","01"," ","SOYOMBO-SHOOLA, ABIGAIL A","9/1/2012 12:00:00 AM","8/31/2017 12:00:00 AM","Transition to Independence Study Section (I)[NCI-I]"," ","10312449","MENDOZA, MICHELLE CHRISTINE","Not Applicable","07","ANATOMY/CELL BIOLOGY","047006379","JDLVAVGYJQ21","047006379","JDLVAVGYJQ21","US","42.335814","-71.105033","3212902","HARVARD MEDICAL SCHOOL","BOSTON","MA","SCHOOLS OF MEDICINE","021201616","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","112875","9030"," ","121905",
"Autoimmune Disease; Diabetes; Digestive Diseases; Inflammatory Bowel Disease; Nutrition; Obesity; Pediatric; Perinatal Period - Conditions Originating in Perinatal Period","5&apos;-AMP-activated protein kinase;Academy;Adult;Affect;Age;Age-Years;Allergic Disease;American;Animals;Antidiabetic Drugs;Antigens;Asthma;Autoimmune Diseases;Autoimmune Process;Bacteria;Biomedical Research;Catalytic Domain;Cell Culture Techniques;Cell Differentiation process;Cells;Child;Country;Data;Development;Developmental Biology;Diabetes Mellitus;Disease;Disease Association;Elderly;Energy Metabolism;Epidemic;Epithelial;Epithelial Cells;Epithelium;Fetal Development;Food Hypersensitivity;Funding;Gastrointestinal Diseases;General Population;Health;Hypersensitivity;Immune system;Immunology;Impairment;In Vitro;Incidence;Inflammation;Inflammatory Bowel Diseases;Inflammatory disease of the intestine;Institution;Insulin-Dependent Diabetes Mellitus;Intervention;Knockout Mice;Knowledge;Laboratories;Link;Long-Term Effects;Mediating;Mesenchymal;Metformin;Methodology;Mineral Waters;Mothers;Movement;Neonatal;Nutrient;Obese Mice;Obesity;Patients;Permeability;Pharmaceutical Preparations;Play;Predisposing Factor;Pregnancy;Pregnant Women;Prevalence;Protein Isoforms;Proteins;Research Infrastructure;Resources;Role;Science;Signal Pathway;Signal Transduction;Staging;Stream;Stress;Students;Systems Development;Testing;Tissues;Training;United States;United States National Institutes of Health;Universities;Virus;Woman;Work;Wyoming;autoimmune inflammatory bowel disease;biomedical scientist;child bearing;clinical application;experience;fetal;graduate student;improved;interest;mRNA Expression;macromolecule;mouse model;next generation;novel;offspring;statistics;transmission process;undergraduate student","Maternal Obesity, AMPK and Development of Fetal and Neonatal Gut"," The United States is experiencing an obesity epidemic with increasing obesity rates in both general population as well as women of child bearing years, while the diseases associated with enhanced gut permeability, such as incidence of autoimmune diseases, food allergy and inflammatory bowel diseases, are also becoming much more common. Impairment in fetal gut development is linked to adult diseases. Proposed studies will test the notion that maternal obesity impairs fetal gut development via AMP-activated protein kinase (AMPK), which will make it possible to use numerous available anti-diabetic drugs, known activators of AMPK, to improve offspring gut function of obese mothers.   
      

","NICHD","8367647","7/11/2012 12:00:00 AM","PA-10-070","1R15HD073864-01","1","R15","HD","073864","01"," ","GRAVE, GILMAN D","7/11/2012 12:00:00 AM","9/30/2012 12:00:00 AM","Special Emphasis Panel[ZRG1-EMNR-E(90)A]"," ","8826973","ZHU, MEIJUN ","Not Applicable","At-Large","VETERINARY SCIENCES","069690956","FDR5YF2K32X5","069690956","FDR5YF2K32X5","US","41.309221","-105.610491","9412601","UNIVERSITY OF WYOMING","LARAMIE","WY","EARTH SCIENCES/RESOURCES","820712000","UNITED STATES","N","7/11/2012 12:00:00 AM","9/30/2012 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","1","0"," ","1",
"Bioengineering; Biotechnology; Breast Cancer; Cancer; Contraception/Reproduction; Genetic Testing; Genetics; Human Genome","Affect;Area;Benign;Biological Assay;Biological Markers;Biomedical Engineering;Blood;Breast;Breast Cancer Cell;Cancer Patient;Carcinoma;Cell Count;Cell Cycle Stage;Cell Line;Cell Nucleus;Cells;Chromatin;Chromosome abnormality;Chromosomes, Human, Pair 12;Classification;Clinical;Clinical Research;Competence;Conceptus;Cytogenetic Analysis;Cytogenetics;Cytoplasm;Cytosol;DNA;DNA Probes;DNA Sequence Rearrangement;Detection;Development;Devices;Diagnosis;Diagnostic;Differential Diagnosis;Disease;Embryo;Epigenetic Process;Feasibility Studies;Fertilization in Vitro;Fine-needle biopsy;Fluorescent in Situ Hybridization;Freezing;Gene Amplification;Gene Deletion;Gene Expression;Gene Expression Profiling;Gene Rearrangement;Generations;Genes;Genetic;Genome;Glass;Harvest;Human;In Situ;Individual;Interphase Cell;Investigation;Karyotype;Label;Lesion;Live Birth;Location;Longevity;Malignant - descriptor;Malignant neoplasm of thyroid;Measures;Mesenchymal;Metaphase;Methodology;Methods;MicroRNAs;Microfluidics;Molecular Profiling;Numerical Chromosomal Abnormality;Oocytes;Patients;Phenotype;Placenta;Positioning Attribute;Post-Translational Protein Processing;Prediction of Response to Therapy;Pregnancy;Premalignant;Proto-Oncogenes;Protocols documentation;Puncture biopsy;Radiation;Reproduction;Research;Research Personnel;Resolution;Sampling;Slide;Specimen;Stretching;Structural Chromosomal Abnormality;Supporting Cell;Techniques;Technology;Testing;Thick;Thyroid Adenoma;Time;Tissue Sample;Tissues;Transcript;Work;anticancer research;base;cancer diagnosis;cancer therapy;clinical practice;design;disease diagnosis;experience;granulosa cell;innovation;malignant breast neoplasm;meetings;multidisciplinary;neoplastic cell;novel;point of care;prototype;technology development;tool;tumor","Microfluidic Chip for Genome Analysis"," For accurate diagnosis, many situations require the assessment of not just one, but a combination of several different types of disease biomarkers. This multidisciplinary bioengineering project seeks to develop an inexpensive, versatile technology platform to detect and quantitate multiple biomarkers such as a combination of chromosomal alterations and aberrant gene expression in clinical samples.   
      

","NCI","8401300","8/7/2012 12:00:00 AM","PA-10-010","1R21CA168345-01A1","1","R21","CA","168345","01","A","TRICOLI, JAMES","8/7/2012 12:00:00 AM","7/31/2014 12:00:00 AM","Instrumentation and Systems Development Study Section[ISD]"," ","1974254","WEIER, HEINZ-ULRICH GUENTER","Not Applicable","13","BIOLOGY","078576738","ENBLDJUN4N73","078576738","ENBLDJUN4N73","US","37.866468","-122.29886","577512","UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB","BERKELEY","CA","ORGANIZED RESEARCH UNITS","947208118","UNITED STATES","N","8/7/2012 12:00:00 AM","7/31/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","130500","104453"," ","234953",
"Arthritis; Autoimmune Disease; Clinical Research; Genetics","Abbreviations;Affect;Animal Model;Animals;Arthritis;Autoimmune Diseases;Binding;Bone Marrow;Bovine Serum Albumin;C57BL/6 Mouse;Cartilage;Cell Lineage;Cells;Chondrocytes;Chromosomes;Chymase;Coculture Techniques;Collection;Complement 5a;Complex;Connective Tissue;Deacetylase;Degenerative polyarthritis;Development;Disease;Enzyme-Linked Immunosorbent Assay;Extracellular Matrix;Family;Fibroblasts;Genes;Genetic Transcription;Green Fluorescent Proteins;Heparin;Human;Hyaluronan;Immature Mast Cell;Immune;In Vitro;Inbred Mouse;Inbreeding;Inflammation;Interleukins;Joints;Life;Mass Spectrum Analysis;Matrix Metalloproteinases;Mediator of activation protein;Mesenchymal;Messenger RNA;Modeling;Molecular;Mouse Strains;Mus;Orthologous Gene;Pathway interactions;Patients;Peptide Hydrolases;Phenotype;Phosphate Buffer;Physiology;Platelet-Derived Growth Factor;Play;Polyacrylamide Gel Electrophoresis;Polymerase Chain Reaction;Progress Reports;Proteins;Proteoglycan;Rattus;Reagent;Recombinants;Research;Rheumatoid Arthritis;Role;Saline;Secretory Vesicles;Serine Protease;Sodium Dodecyl Sulfate-PAGE;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization;Staging;Stem Cell Factor;Synovial Fluid;Synovial Membrane;TNF gene;Time;Tissue Inhibitor of Metalloproteinases;Tissues;Transcript;Transforming Growth Factors;Transgenic Mice;Transgenic Organisms;Tryptase;Tumor Necrosis Factor-alpha;Untranslated Regions;Work;aggrecan;cytokine;gel electrophoresis;in vivo;inhibitor/antagonist;insight;joint injury;mast cell;mast cell protease 6;member;mouse model;novel;public health relevance;release factor;serglycin;sulfotransferase","Synovial mast cells in inflammatory arthritis","
Project Narrative
 We have discovered that a cell lineage called the mast cell can contribute to
inflammation in rheumatoid arthritis (RA) by studying mouse models of disease. Now,
we have found that a protein made by mast cells, called tryptase, is among the means by
which mast cells impact disease. We are working out the mechanisms that tryptase
impacts to understand better how to target this novel pathway in treating people with RA.","NIAID","8277927","5/4/2012 12:00:00 AM","PA-07-070","5R01AI059746-08","5","R01","AI","059746","08"," ","PEYMAN, JOHN A","4/1/2004 12:00:00 AM","5/31/2014 12:00:00 AM","Hypersensitivity, Autoimmune, and Immune-mediated Diseases Study Section[HAI]"," ","1876609","STEVENS, RICHARD L","Not Applicable","07","Unavailable","030811269","QN6MS4VN7BD1","030811269","QN6MS4VN7BD1","US","42.334978","-71.105987","1080401","BRIGHAM AND WOMEN'S HOSPITAL","BOSTON","MA","Independent Hospitals","021156110","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","855","Non-SBIR/STTR","2012"," "," ","NIAID","247500","174859"," ","422359",
"Cardiovascular; Hypertension; Infant Mortality/ (LBW); Lung; Pediatric; Perinatal - Birth - Preterm (LBW); Perinatal - Neonatal Respiratory Distress Syndrome; Perinatal Period - Conditions Originating in Perinatal Period; Prevention","Accounting;Adult;Alveolar;Angiogenesis Inhibition;Animal Model;Biological Preservation;Blood Vessels;Breathing;Bronchopulmonary Dysplasia;Cells;Chronic lung disease;Clinical;Clinical Trials;Complication;Consensus;Data;Development;Dysplasia;Educational workshop;Embryonic Development;Employee Strikes;Epithelial;Exercise;Experimental Models;Extremely Low Birth Weight Infant;Failure;Growth;Hepatocyte Growth Factor;Hospitalization;Hyperoxia;Hypertension;Infant;Late Effects;Lead;Lung;Lung diseases;Maintenance;Mediating;Mediator of activation protein;Mesenchymal;Mitogens;Molecular;Morbidity - disease rate;National Heart, Lung, and Blood Institute;National Institute of Child Health and Human Development;Neonatal;Nitric Oxide;Pathogenesis;Pathway interactions;Patient Selection;Perinatal;Perinatal Care;Physiological;Premature Birth;Premature Infant;Prevention;Prevention strategy;Production;Public Health;Pulmonary Hypertension;Randomized Clinical Trials;Recurrence;Research Design;Respiratory physiology;Role;Series;Signal Pathway;Signal Transduction;Steroids;Stream;Structure;Structure of respiratory epithelium;Survivors;Testing;Therapeutic;Tretinoin;Vascular Endothelial Growth Factors;Vascular Endothelium;Ventilator;airway epithelium;angiogenesis;autocrine;base;improved;inhaled nitric oxide;insight;lung development;mortality;neonate;novel;novel therapeutics;prevent;receptor;respiratory;surfactant;symposium","Role of VEGF in Perinatal Hypertension"," Broncho-pulmonary dysplasia (BPD), the chronic lung disease that follows premature birth, is a major public health problem that is associated with significant mortality and morbidity. Despite improvements in perinatal care, BPD persists as a major complication, occurring in nearly 10,000 infants per year in the USA alone. This project proposes to determine mechanisms through which vascular and alveolar growth are impaired in experimental models of BPD, which may lead to the development of new therapeutic strategies for its prevention or treatment.   
   
      

","NHLBI","8372775","8/22/2012 12:00:00 AM","PA-10-067","2R01HL068702-09A1","2","R01","HL","068702","09","A","LIN, SARA","6/20/2001 12:00:00 AM","7/31/2016 12:00:00 AM","Respiratory Integrative Biology and Translational Research Study Section[RIBT]"," ","1898075","ABMAN, STEVEN HERBERT","Not Applicable","06","PEDIATRICS","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","9/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","322896","97759"," ","420655",
"Aging; Breast Cancer; Cancer; Complementary and Alternative Medicine; Nutrition; Prevention; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adverse effects;American;Animal Model;Animals;Apoptosis;Aromatase Inhibitors;Automobile Driving;Autophagocytosis;Biological Markers;Breast Cancer Cell;Breast Cancer Prevention;Cancer Etiology;Cells;Cessation of life;Chemoprevention;Chemopreventive Agent;Clinical;Clinical Management;Clinical Trials;Clinical Trials Design;Development;Diet;Dietary Phytochemical;Disease;Down-Regulation;Epithelial;Experimental Designs;Funding;Future;Genetic;Genetic Predisposition to Disease;Grant;In Vitro;Incidence;Induction of Apoptosis;Inhibition of Cell Proliferation;Investigation;Lead;Malignant Neoplasms;Mammary Neoplasms;Mediating;Mesenchymal;Metastatic Neoplasm to the Lung;Modeling;Molecular;Mouse Mammary Tumor Virus;Mus;Pharmacology;Plasma;Publications;Publishing;RNA Interference;Regimen;Research;Research Design;Research Project Grants;Risk Factors;Role;Selective Estrogen Receptor Modulators;Signal Transduction;System;Testing;Time;Toxic effect;Transgenic Mice;Translations;Tumor Tissue;Urokinase;Validation;Woman;Xenograft Model;base;benzyl isothiocyanate;cancer chemoprevention;cancer stem cell;cruciferous vegetable;design;experience;in vivo;inhibitor/antagonist;innovation;malignant breast neoplasm;migration;mouse model;notch protein;novel;novel strategies;overexpression;pre-clinical;receptor;research study;response;secretase;self-renewal;stemness;therapy resistant;tumor;vector","Breast Cancer Prevention by Dietary Phytochemicals"," Breast cancer is a leading cause of cancer-related death in women worldwide. Novel approaches for chemoprevention of breast cancer are clinically attractive. Long-term objective of this research project is to develop a safe and inexpensive but effective regimen for chemoprevention of breast cancer using cruciferous vegetable constituent benzyl isothiocyanate (BITC). Research conducted in the previous funding period provided preclinical evidence for efficacy of BITC against breast cancer, but efficient translation of these
observations into a clinical setting depends on full appreciation of the molecular pharmacology of BITC. Clinical trial design without a full appreciation of the molecular pharmacology of BITC may be sub-optimal. Defining innovation of the current application includes translational merit of the proposed research as well as novel research directions.   
      

","NCI","8368331","7/6/2012 12:00:00 AM","PA-11-260","2R01CA129347-06","2","R01","CA","129347","06"," ","EMENAKER, NANCY J","9/7/2007 12:00:00 AM","5/31/2017 12:00:00 AM","Chemo/Dietary Prevention Study Section[CDP]"," ","1880969","SINGH, SHIVENDRA ","Not Applicable","18","PHARMACOLOGY","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","8/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","184300","95468"," ","279768",
"Breast Cancer; Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Actins;Address;Affect;Autophagocytosis;Blood Circulation;Brain;CD44 gene;CDKN2A gene;Cancer Patient;Catabolic Process;Cell Cycle Arrest;Cell Survival;Cells;Characteristics;Chloroquine;Clinical;Collagen;Complex;Dependence;Development;Disease;Disease Progression;Distant;Drug resistance;Exposure to;Fatty acid glycerol esters;Focal Adhesions;Genome Stability;Goals;Growth;Human;Hypoxia;Implant;In Vitro;Incidence;Lead;Link;Liver;Lung;Malignant Neoplasms;Mammary Neoplasms;Mammary Tumorigenesis;Mammary gland;Metastatic Neoplasm to the Bone;Modeling;Molecular;Mouse Mammary Tumor Virus;Mus;NOD/SCID mouse;Nature;Neoplasm Metastasis;Nutrient;Organ;Organelles;Palpable;Pharmaceutical Preparations;Phenotype;Play;Primary Neoplasm;Process;Property;Recurrence;Role;Secondary to;Seeds;Site;Solid Neoplasm;Sorting - Cell Movement;Staging;Stem cells;Stress;Stress Fibers;Survival Rate;System;Testing;Time;Tissue Microarray;Transgenic Organisms;Transplantation;Tumor Cell Invasion;Tumor Stem Cells;Woman;Work;Xenograft procedure;aldehyde dehydrogenase 1;base;cancer recurrence;cancer stem cell;cell motility;chemotherapy;clinically relevant;deprivation;epithelial to mesenchymal transition;exposed human population;improved;in vivo;inhibition of autophagy;malignant breast neoplasm;migration;mortality;mouse model;neoplastic cell;novel;prevent;protein aggregate;response;self-renewal;stem;tumor;tumor progression;tumorigenesis","Autophagy in Tumor Progression and Metastasis","   The importance of understanding the mechanistic basis of how tumor cells escape the primary tumor and spread to distant organs where they survive in a dormant or stem-like state before growing out to form overt metastases is highlighted by the emergence of recurrent and/or metastatic disease in breast cancer patients that were treated for their primary cancer years earlier. We will test the role of autophagy, an adaptive response to nutrient deprivation, in breast cancer metastasis with the goal of providing a novel understanding of the factors that determine how and when tumor cells become invasive, disseminate, remain dormant or grow out as overt metastases.   
      

","NCI","8311298","8/13/2012 12:00:00 AM","PA-10-067","1R01CA162405-01A1","1","R01","CA","162405","01","A","WOODHOUSE, ELIZABETH","8/13/2012 12:00:00 AM","6/30/2017 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","7375165","MACLEOD, KAY F","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","005421136","ZUE9HKT2CLC9","005421136","ZUE9HKT2CLC9","US","41.789554","-87.601172","1413601","UNIVERSITY OF CHICAGO","CHICAGO","IL","SCHOOLS OF MEDICINE","606372612","UNITED STATES","N","8/13/2012 12:00:00 AM","6/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","115729"," ","323229",
"Bioengineering; Biotechnology; Nanotechnology; Regenerative Medicine; Transplantation","Actins;Adhesions;American;Analysis of Variance;Angiopoietin-1;Animal Model;Area;Arginine;Artificial Organs;Aspartic Acid;Biocompatible Materials;Biology;Bioreactors;Blood Vessels;Cell Culture Techniques;Cell physiology;Cell-Matrix Junction;Cells;Chi-Square Tests;Chimeric Proteins;Clinic;Clinical;Coculture Techniques;Computer Analysis;Cytoplasmic Tail;Cytoskeletal Modeling;DNA;Data;Development;Elastin;Endothelial Cells;Engineering;Enzyme-Linked Immunosorbent Assay;Extracellular Matrix;Faculty;Failure;Fibronectins;Fluorescence Microscopy;Focal Adhesion Kinase 1;Glean;Glycine;Growth Factor;Human;Image Analysis;Implant;In Vitro;Integrins;Lead;Left;Length;Life;Ligands;Measures;Mechanical Stimulation;Mediating;Medical;Mentors;Mesenchymal;Metabolic;Molecular;Organ;Organ Transplantation;Oxygen;Patients;Peptide Hydrolases;Perfusion;Phosphorylation;Process;Protein Engineering;Proteins;Radial;Recombinants;Regenerative Medicine;Regression Analysis;Research;Reverse Transcriptase Polymerase Chain Reaction;Signal Transduction;Specific qualifier value;Speed;Staining method;Stains;Stem cells;Structure;Surface;Talin;Technology;Testing;Thick;Tissue Engineering;Tissues;Training;Translating;Translations;Transplantation;Vascular Endothelial Growth Factors;Vascularization;Work;base;blebbistatin;cell growth;cell motility;cellular engineering;clinically relevant;implantation;improved;in vivo;meetings;monolayer;nano;nanofiber;nanopattern;nanoscale;novel;polymerization;prevent;professor;receptor;regenerative therapy;scaffold;two-dimensional;vector","NANO-PATTERNING OF BIOMATERIALS FOR BLOOD-VESSEL FORMATION IN ARTIFICIAL TISSUES"," There are 112,000 Americans waiting for donated organs, and, in 2008, 9% of those on the waitlist died before a transplant became available. As an alternative to donated organs, artificial tissue has yet to become clinically useful because we cannot meet the perfusion needs of bulk constructs post-implantation. Induction of blood-vessels within artificial tissues, which we propose to achieve using a novel biomaterials strategy, will overcome this deficiency by forming a perfusion-ready network and by enabling swift vascular integration upon implantation.   
   
      

","NHLBI","8318495","4/3/2012 12:00:00 AM","PA-11-112","1F31HL114315-01","1","F31","HL","114315","01"," ","MEADOWS, TAWANNA","6/25/2012 12:00:00 AM","6/24/2017 12:00:00 AM","Special Emphasis Panel[ZRG1-F04-A(20)L]"," ","10997671","BENITEZ, PATRICK ","Not Applicable","18","BIOMEDICAL ENGINEERING","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","6/25/2012 12:00:00 AM","6/24/2013 12:00:00 AM","837","Training, Individual","2012"," "," ","NHLBI","31892"," "," ","31892",
"Biotechnology; Cancer; Clinical Research; Genetic Testing; Genetics; Human Genome; Lung; Lung Cancer; Prevention","3&apos; Untranslated Regions;Address;Affect;American College of Radiology Imaging Network;Back;Biological Assay;Biological Markers;Cancer Burden;Cancer Detection;Cancer Etiology;Cancer Patient;Case-Control Studies;Cell Line;Cessation of life;Chromosomal Breaks;Chronic;Chronic Obstructive Airway Disease;Classification;Clinical;Code;Cohort Studies;Colorado;Copy Number Polymorphism;Cytosine;DNA Damage;DNA Methyltransferase;DNA Modification Methylases;DNA Repair;DNA Resequencing;Detection;Development;Double Strand Break Repair;Early identification;Epigenetic Process;Epithelial;Epithelial Cells;Etiology;Gene Expression;Gene Silencing;Gene Targeting;Genes;Genetic Determinism;Genetic Transcription;Genetic Variation;Genome;Genotype;Goals;Grant;Haplotypes;Health;High-Risk Cancer;Hypermethylation;In Vitro;Inherited;Intervention;Laboratories;Lead;Link;Linkage Disequilibrium;Lung;Lung Neoplasms;Lymphocyte;Malignant Neoplasms;Malignant neoplasm of lung;Methylation;MicroRNAs;Mission;Modeling;Nested Case-Control Study;Not Hispanic or Latino;Oncogenes;Pathway interactions;Persons;Predictive Value;Prevalence;Promoter Regions;Regulation;Risk;Risk Assessment;Risk Factors;Risk Marker;Role;SNP genotyping;Screening procedure;Sensitivity and Specificity;Smoker;Sputum;Staging;Structure of respiratory epithelium;Testing;Thoracic Radiography;Tobacco-Associated Carcinogen;Translating;Tumor Suppressor Genes;Tumor-Derived;Variant;cancer diagnosis;cancer risk;chromatin remodeling;cohort;design;epithelial to mesenchymal transition;follow-up;genome wide association study;histone modification;improved;indexing;innovation;lung cancer screening;member;neoplasm registry;population based;promoter;prospective;public health relevance;translational study","Factors for Epigenetic Silencing of Lung Cancer Genes","
Project Narrative
Studies in this application could lead to the development of a comprehensive model using clinical risk factors,
genetic variation, and gene methylation in sputum for early lung cancer detection.
 ","NCI","8292971","5/25/2012 12:00:00 AM","PA-07-070","5R01CA097356-08","5","R01","CA","097356","08"," ","KAGAN, JACOB","9/23/2004 12:00:00 AM","5/31/2015 12:00:00 AM","Cancer Biomarkers Study Section[CBSS]"," ","1880971","BELINSKY, STEVEN A","Not Applicable","01","Unavailable","045911138","N1UBCLRAPNG6","045911138","N1UBCLRAPNG6","US","35.055893","-106.579286","679302","LOVELACE BIOMEDICAL & ENVIRONMENTAL RES","Albuquerque","NM","Research Institutes","871085127","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","498504","469698"," ","968202",
"Biotechnology; Cancer; Genetics; Orphan Drug; Pediatric; Rare Diseases","Address;Affect;Applications Grants;Appointment;Award;Behavior;Bioinformatics;Boston;Cancer Center;Categories;Child;Classification;Classification Scheme;Clinical;Clinical Pathways;Clinical Trials;Computational Biology;Computing Methodologies;Dana-Farber Cancer Institute;Data;Data Set;Databases;Development;Diagnostic;Differential Diagnosis;Disease;Environment;Freezing;Functional RNA;Future;Gastrointestinal Stromal Tumors;Gene Expression;Gene Expression Profiling;Genes;Genetic Transcription;Genome;Genomics;Goals;Growth Factor;Heterogeneity;Histologic;Histology;Human;Incidence;Individual;Informatics;Institution;Investigation;Israel;K22 Award;Laboratories;Lead;Malignant Fibrous Histiocytoma;Malignant Neoplasms;Malignant Peripheral Nerve Sheath Tumor;Medical;Medical center;Mentors;Mesenchymal;Messenger RNA;MicroRNAs;Modeling;Molecular;Molecular Abnormality;Molecular Profiling;Natural History;Neoplasm Metastasis;New York;Oncogenic;Operative Surgical Procedures;Outcome;Paraffin;Paraffin Tissue;Pathway interactions;Patients;Pattern;Pediatric Hospitals;Philosophy;Population;Productivity;Proto-Oncogene Protein c-kit;Publishing;Qualifying;RNA;Relative (related person);Reporting;Research;Research Personnel;Sampling;Series;Solid;Special Hospitals;Specific qualifier value;Specimen;Subgroup;Systems Biology;Testing;Therapeutic;Time;Tissues;Training;Translations;United States National Institutes of Health;Validation;Work;anticancer research;base;cancer genomics;career;chemotherapeutic agent;chemotherapy;clinical application;cohort;diagnostic accuracy;drug development;improved;inhibitor/antagonist;innovation;insight;medical schools;novel;osteosarcoma;post-doctoral training;prognostic;programs;public health relevance;response;sarcoma;soft tissue;therapeutic target;tissue resource;tool;tumor;years of life lost;young adult","Dissecting sarcoma complexity via innovative microRNA and informatics approaches","
Sarcomas are cancers with almost unparalleled clinical, biologic and molecular diversity
that disproportionately affect young adults or children. Despite their complexity,
classification and therapeutic approaches, with rare exceptions, have not advanced in
almost 20 years. This grant proposal will utilize cutting-edge tools of tumor genomic
analysis to dissect their molecular complexity so that novel personalized therapies can
be developed.","NCI","8307004","8/14/2012 12:00:00 AM","PAR-09-089","5K22CA138716-03","5","K22","CA","138716","03"," ","JAKOWLEW, SONIA B","9/1/2010 12:00:00 AM","8/31/2014 12:00:00 AM","Transition to Independence Study Section (I)[NCI-I]"," ","9501963","SPENTZOS, DIMITRIOS ","Not Applicable","07","Unavailable","071723621","C1CPANL3EWK4","071723621","C1CPANL3EWK4","US","42.346758","-71.10256","758101","BETH ISRAEL DEACONESS MEDICAL CENTER","BOSTON","MA","Independent Hospitals","022155400","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","177000","14160"," ","191160",
"Biotechnology; Genetics; HIV/AIDS; Kidney Disease","AIDS-Associated Nephropathy;Accounting;African American;Animal Model;Apoptosis;Bioinformatics;Cells;Chronic Kidney Failure;Computational Biology;Consensus;DNA;DNA-Protein Interaction;Data;Data Analyses;Databases;Development;Disease;End stage renal failure;Epithelial;Epithelial Cells;Epithelium;Fibrosis;Gene Expression;Gene Expression Profiling;Genes;Graph;HIV;HIV-1;Human;In Vitro;Infection;Injury;Kidney;Kidney Diseases;Knock-out;Knockout Mice;Knowledge;Link;Links List;Mediating;Mesenchymal;Messenger RNA;Modeling;Molecular Profiling;Mus;Online Systems;Pathogenesis;Pathway Analysis;Pathway interactions;Pattern;Phosphorylation;Phosphotransferases;Protein Kinase;Protein Microchips;Proteins;Regulation;Relative (related person);Role;Seeds;Signal Pathway;Signal Transduction;Signaling Molecule;Stream;System;Systems Biology;Testing;Therapeutic;Transcription factor genes;Transforming Growth Factors;Transgenic Mice;Tubular formation;Ureteral obstruction;analytical tool;base;clinically relevant;homeodomain;in vivo;interstitial;mRNA Expression;mouse model;new therapeutic target;notch protein;novel;novel strategies;programs;protein expression;protein protein interaction;public health relevance;research study;theories;tool;transcription factor;upstream kinase;vpr Genes","Role of HIPK2 in Kidney Tubulointerstitial Injury","
NARRATIVE
 HIPK2 could be a novel upstream kinase activating multiple downstream pathways leading to
tubulo-interstitial injury, which is a final common pathway in the progression of chronic kidney
disease. HIPK2 could be a potential new therapeutic target for the treatment of HIV-associated
nephropathy as well as other kidney diseases. Our studies will also provide a novel approach to link
upstream signaling pathways to data from gene expression microarray, which could help us to identify
key upstream kinases responsible for kidney injury in HIVAN, as well as in other diseases.","NIDDK","8320387","7/17/2012 12:00:00 AM","PA-07-367","5R01DK088541-03","5","R01","DK","088541","03"," ","RYS-SIKORA, KRYSTYNA E","7/1/2010 12:00:00 AM","6/30/2015 12:00:00 AM","NeuroAIDS and other End-Organ Diseases Study Section[NAED]"," ","7529577","HE, JOHN CIJIANG","MA'AYAN, AVI ","13","INTERNAL MEDICINE/MEDICINE","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","SCHOOLS OF MEDICINE","100296574","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","139915"," ","345340",
"Aging; Cardiovascular; Diabetes; Heart Disease; Heart Disease - Coronary Heart Disease; Nutrition","Aging;Amputation;Apoptosis;Arteries;Arterioloscleroses;Arteriosclerosis;Atherosclerosis;BMP2 gene;Blood Vessels;Blood flow;Calcified;Calcium;Cardiac;Cardiovascular system;Cells;Chondrocytes;Chronic Disease;Collagen Type I;Data;Diabetes Mellitus;Diabetic mouse;Diet;Distal;Down-Regulation;Elasticity;Elderly;Embryo;Fatty acid glycerol esters;Fibrosis;Funding;Genes;Genetic;Genetic Transcription;Health;Human;Hypertension;Inflammatory;Lead;Life;Lower Extremity;Mediating;Mediator of activation protein;Mesenchymal;Metabolic;Modeling;Monkeberg&apos;s Medial Calcific Sclerosis;Mus;Myocardial;Myocardial Infarction;Myofibroblast;Non-Insulin-Dependent Diabetes Mellitus;Osteoblasts;Outcome;Oxidative Stress;Parathyroid Hormone Receptor;Perfusion;Phenotype;Physiological;Physiology;Population;Process;Property;Proteins;Reactive Oxygen Species;Regulation;Risk;Role;Signal Pathway;Signal Transduction;Smooth Muscle Myocytes;Stream;Study models;TNF gene;Technology;Testing;Therapeutic;Tissues;Transgenic Mice;Up-Regulation;Uremia;Validation;Vascular Smooth Muscle;Vascular calcification;Vesicle;WNT Signaling Pathway;Work;Workload;bone;burden of illness;calcification;crosslink;cytokine;diabetic;feeding;foot;impaired glucose tolerance;improved;in vivo;interstitial;male;mineralization;mouse model;osteogenic;paracrine;progenitor;programs;response;transcription factor","MSX2-WNT SIGNALING IN CARDIOVASCULAR CALCIFICATION","
Project Lay Narrative:
Arterial hardening in diabetes increases the risk for heart attacks & foot amputation. This
occurs in part via metabolic & inflammatory signals that induce bone-like calcification in
large arteries. We have identified that two proteins, LRP6 and ï¿½-catenin, are activated
with calcification, fibrosis, and hardening of the arteries in diabetic mice. We test
whether regulation of these proteins reduces arterial hardening, decreases cardiac
workload, and improves blood flow to the foot.","NHLBI","8290230","5/31/2012 12:00:00 AM","PA-07-070","5R01HL081138-08","5","R01","HL","081138","08"," ","SRINIVAS, POTHUR R","9/30/2005 12:00:00 AM","11/30/2012 12:00:00 AM","Atherosclerosis and Inflammation of the Cardiovascular System Study Section[AICS]"," ","1879402","TOWLER, DWIGHT A.","Not Applicable","01","INTERNAL MEDICINE/MEDICINE","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","6/1/2012 12:00:00 AM","11/30/2012 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","147925","76921"," ","224846",
"Cancer; Clinical Research; Organ Transplantation; Transplantation","Achievement;Azathioprine;Basement membrane;Basic Science;Biological Models;Blood Circulation;Carcinoma;Caring;Cells;Clinic;Clinical;Coculture Techniques;Connecticut;Cutaneous;Cyclosporine;DNA Microarray Chip;Dermatology;Development;Distant;Doctor of Philosophy;Elements;Enrollment;Epithelial;Etiology;Gene Expression Profile;General Population;Genes;Goals;Head and Neck Squamous Cell Carcinoma;Human;Immune system;Immunobiology;Immunologic Deficiency Syndromes;Immunologic Monitoring;Immunosuppression;Immunosuppressive Agents;In Vitro;Incidence;Invaded;K-Series Research Career Programs;Location;Lymphatic;Macrophage-Activating Factors;Malignant Neoplasms;Mentors;Mentorship;Mesenchymal;Microarray Analysis;Micrometastasis;Molecular;Molecular Profiling;Mus;Mycophenolic Acid;Natural Immunity;Neoplasm Metastasis;Organ Transplantation;Pathway interactions;Phagocytosis;Phenotype;Physicians;Play;Postoperative Period;Prednisone;Research;Research Personnel;Resources;Role;Scientist;Screening procedure;Sirolimus;Site;Skin;Skin Cancer;Solid;Squamous cell carcinoma;Structural Protein;Sum;T-Cell Activation;Tacrolimus;Therapeutic immunosuppression;Time;Transplant Recipients;Transplantation;Tumor-Derived;United States;Universities;base;cancer cell;career;cell motility;chemokine receptor;cytokine;density;design;interest;keratinocyte;macrophage;metastatic process;molecular phenotype;neoplastic cell;outcome forecast;pathogen;prevent;professor;programs;repository;research study;skin squamous cell carcinoma;stem;transcription factor;transdifferentiation;tumor;tumor immunology;tumor progression;tumorigenesis","Defining the role of macrophages in the progression of human cutaneous squamous c"," Narrative Increased density of tumor-associated macrophages, cells of the innate immune system, within tumors correlates with a poor prognosis in most types of tumors. To date, few studies have characterized the mechanistic role of macrophages in the progression of cutaneous squamous cell carcinomas. Our objectives are to identify and characterize tumor-promoting factors produced by tumor-associated macrophages isolated from squamous cell carcinomas with the long-term goal of abrogating these factors to prevent tumor progression.   
      

","NCI","8424372","9/11/2012 12:00:00 AM","PAR-12-051","1K08CA172580-01","1","K08","CA","172580","01"," ","OJEIFO, JOHN O","9/11/2012 12:00:00 AM","8/31/2016 12:00:00 AM","ZCA1-RTRB-Z(O1)"," ","9042574","COLEGIO, OSCAR RENE","Not Applicable","03","DERMATOLOGY","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","9/11/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","137493","10999"," ","148492",
"Infectious Diseases; Vector-Borne Diseases","Antibodies;Antigen-Presenting Cells;Architecture;Behavior;CD4 Positive T Lymphocytes;Cell Adhesion Molecules;Cell physiology;Cells;Chronic;Data;Dendritic Cells;Dermis;Disease;Effector Cell;Environment;Event;Extracellular Matrix;Feedback;Foundations;Genetic;Goals;Helper-Inducer T-Lymphocyte;Image;Immune;Immune response;Immunology;In Vitro;Infection;Inflammation;Integrins;Interleukin-13;Interleukin-4;Interleukin-5;Laboratories;Leishmania;Leishmania major;Leukocytes;Life;Location;Lymphocyte;Lymphoid Tissue;Mediating;Mesenchymal;Microscopy;Modeling;Molecular;Movement;Mus;Myosin Type II;Nature;Parasites;Parasitic infection;Pathology;Pathway interactions;Pattern;Peripheral;Phenotype;Photons;Population;Research Training;Residencies;Selectins;Signal Transduction;Site;Small Interfering RNA;Solid;Stream;Surface;System;T-Cell Activation;T-Lymphocyte;T-Lymphocyte Subsets;Testing;Th1 Cells;Th2 Cells;Therapeutic;Tissues;Tumor Necrosis Factor-Beta;Work;antibody inhibitor;base;cell motility;chemokine;cytokine;design;in vivo;interstitial;intravital microscopy;lymph nodes;novel;pathogen;public health relevance;receptor;response;small molecule;therapeutic target;tumor","Defining modes of helper T cell motility within inflamed tissues","
PROJECT NARRATIVE
Using a system of intravital microscopy to image live T cells within the inflamed dermis of a mouse, we have
observed two unique crawling phenotypes that were displayed by functionally distinct CD4+ T cell populations.
In the current research training plan, we will test whether the different crawling phenotypes observed utilize
unique molecular mechanisms in vivo. An understanding of mechanisms employed by functionally distinct
effector T cells could present means of preferentially manipulating subsets of tissue-resident effector cells,
potentially offering great therapeutic potential for many disease states.","NIAID","8261449","2/2/2012 12:00:00 AM","PA-10-110","5F32AI089079-02","5","F32","AI","089079","02"," ","PROGRAIS, LAWRENCE J","2/14/2011 12:00:00 AM","7/20/2012 12:00:00 AM","Special Emphasis Panel[ZRG1-F07-C(20)L]"," ","9896927","OVERSTREET, MICHAEL GLEN","Not Applicable","25","MICROBIOLOGY/IMMUN/VIROLOGY","041294109","F27KDXZMF9Y8","041294109","F27KDXZMF9Y8","US","43.16888","-77.615939","7047101","UNIVERSITY OF ROCHESTER","ROCHESTER","NY","SCHOOL OF MEDICINE & DENTISTRY","146270140","UNITED STATES","N","2/14/2012 12:00:00 AM","7/20/2012 12:00:00 AM","855","Training, Individual","2012"," "," ","NIAID","27187"," "," ","27187",
"Aging; Cancer; Uterine Cancer","Adjuvant Therapy;Adopted;Autophagocytosis;Binding Proteins;Biological Assay;Biological Markers;Biology;Biopsy;Cancer Center;Cancer Patient;Carcinoma;Caring;Clinic;Clinical;Clinical Management;Comorbidity;Data Set;Decision Making;Diabetes Mellitus;Diagnosis;Diagnostic;Diagnostic Neoplasm Staging;Disease;Doctor of Medicine;Endometrial;Endometrial Carcinoma;Endometrial Endometrioid Adenocarcinoma;Endometrioid Carcinoma;Endometrium;Estrogen receptor positive;Estrogens;Evaluation;Fingerprint;Formalin;Fostering;Funding;Gene Expression;Genes;Genomics;Goals;Growth;Guidelines;Gynecologic;High Risk Woman;Hypertension;Hysterectomy;In Vitro;Incidence;Insulin-Like Growth Factor I;Knowledge;Light;Lymph node excision;Malignant Neoplasms;Mesenchymal;Methodology;Modeling;Molecular;Obesity;Oncologist;Operative Surgical Procedures;Paraffin Embedding;Pathway interactions;Patient Care;Patients;Pelvis;Phase;Physicians;Positive Lymph Node;Postoperative Period;Protein Binding;Proteins;Quantitative Reverse Transcriptase PCR;Radiation therapy;Receiver Operating Characteristics;Recurrence;Research;Risk;Sampling;Series;Site;Specimen;Staging;Surgical Management;Techniques;Technology;Testing;Tissue Sample;Tissues;Translational Research;Tretinoin;Universities;University of Texas M D Anderson Cancer Center;Uterine Cancer;Vagina;Validation;Vent;Washington;Woman;Work;base;cancer recurrence;chemotherapy;clinical care;clinical practice;follow-up;high risk;improved;innovation;kidney vascular structure;leukemia;malignant breast neoplasm;molecular marker;mortality;novel;outcome forecast;prevent;programs;protein degradation;repository;routine care;standard of care;tissue fixing;tool;tumor","Strategy for the Incorporation of Tissue Biomarkers in the Clinical Management of","Currently, we cannot reliably identify pre-operatively the endometrial cancer patients who would benefit most 
from extensive surgical staging. In addition, we cannot reliably predict the women with low stage 
endometrioid-type endometrial cancer who will suffer recurrence. We propose here to validate and augment a biomarker panel that can help to better individualize endometrial cancer patient care.","NCI","8382321","8/1/2012 12:00:00 AM","PAR-08-020","5P50CA098258-08","5","P50","CA","098258","08"," "," "," "," ","ZCA1-RPRB-M","7829","7111071","BROADDUS, RUSSELL R","Not Applicable","09","Unavailable","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","Domestic Higher Education","770304009","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Research Centers","2012","185897","185897"," ","185897","0"," "," ",
"Organ Transplantation; Rare Diseases; Regenerative Medicine; Transplantation","Address;Allografting;Anatomy;Antigens;Apoptosis;Apoptotic;Blood Circulation;Blood Vessels;Blood flow;Brain Hypoxia-Ischemia;Bronchiolitis Obliterans;CD8-Positive T-Lymphocytes;CD8B1 gene;CSF1R gene;CXCR4 gene;Cell Hypoxia;Cells;Chronic;Cicatrix;DDR1 gene;Development;Endothelial Cells;Fibrosis;Genes;Genetic;Graft Rejection;Heterozygote;Homozygote;Human;Hypoxia;Immunity;Immunotherapy;Infiltration;Inflammatory;Injury;Investigation;Kinetics;Knockout Mice;Knowledge;Label;Leukocytes;Lung;Lung Transplantation;Lung diseases;Mediating;Mesenchymal;Microcirculation;Modeling;Mus;Natural regeneration;Operative Surgical Procedures;Organ Transplantation;PECAM1 gene;Patients;Plant Roots;Procedures;Process;Recovery;Relative (related person);Reporter;Resistance;Role;Signal Transduction;Solid;Staging;Staining method;Stains;Stem cells;Syndrome;T-Lymphocyte;T-Lymphocyte Subsets;Tamoxifen;Testing;Time;Tissues;Transplant Recipients;Transplantation;Ubiquitin;Up-Regulation;Vascular Endothelial Growth Factor Receptor-2;caspase-3;cell motility;cell type;cytokine;fibrogenesis;hypoxia inducible factor 1;injured airway;loss of function;lung allograft;migration;mouse Cre recombinase;novel;novel therapeutics;prevent;promoter;public health relevance;recombinase;repaired;research study;response;restoration;vector","A Critical Role for the Microvasculature in Airway Transplantation","
PROJECT NARRATIVE
While lung transplantation is a cure for end-stage pulmonary disease, the majority of patients undergoing this
procedure will eventually die from scarring of the airways. This may happen, in part, because of a temporary
loss of airway blood flow. The proposed studies will investigate how the body's normal reparative processes
resupply airways with blood vessels and how this process might be utilized to prevent airway injury.","NHLBI","8235020","3/16/2012 12:00:00 AM","PA-07-070","5R01HL095686-03","5","R01","HL","095686","03"," ","MOORE, TIMOTHY M","4/1/2010 12:00:00 AM","3/31/2014 12:00:00 AM","Lung Cellular, Molecular, and Immunobiology Study Section[LCMI]"," ","8432204","NICOLLS, MARK ROBERT","Not Applicable","18","Unavailable","624218814","H58TR2D7DNE3","624218814","H58TR2D7DNE3","US","37.40457","-122.145003","2357101","PALO ALTO VETERANS INSTIT FOR RESEARCH","PALO ALTO","CA","Research Institutes","943041207","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","254508","101874"," ","356382",
"Cancer; Colo-Rectal Cancer; Digestive Diseases","Accounting;Adherence;Anchorage-Independent Growth;Award;Carcinoma;Carcinoma in Situ;Cell Proliferation;Cell Proliferation Regulation;Colon Carcinoma;Colonic Neoplasms;Colorectal;Colorectal Cancer;Colorectal Neoplasms;Complex;Cyclin D1;Data;Disease;Disseminated Malignant Neoplasm;Down-Regulation;E-Cadherin;Epigenetic Process;Epithelium;Fibronectins;Frequencies;Gene Expression;Growth;Health;Human;Large Intestine Carcinoma;Lead;MAPK8 gene;MMP9 gene;Matrix Metalloproteinases;Metastatic Neoplasm to the Liver;Modeling;Molecular;Mutation;Neoplasm Metastasis;Oncogenic;Pathway interactions;Play;Protein Binding;Protein-Serine-Threonine Kinases;Regulation;Reporting;Resistance;Role;Signal Transduction;Testing;Transducers;Transforming Growth Factors;Tumor Suppressor Proteins;Tumorigenicity;Up-Regulation;WD Repeat;WT1 gene;base;cancer cell;carcinogenesis;cell growth;cell motility;claudin-1 protein;clinically relevant;drug development;epithelial to mesenchymal transition;improved;malignant phenotype;metastatic colorectal;migration;novel;protein E;receptor;receptor expression;response;serine-threonine kinase receptor-associated protein;transcription factor;tumor;tumor progression","STRAP and Smad 7 Signaling in Colorectal Carcinomas","
Narrative
The loss of transforming growth factor-ss (TGF-ss)-induced tumor suppressor function in tumors plays a pivotal
role in the transition from normal colorectal epithelium, to in situ carcinoma, and finally invasive and metastatic
cancers. We will investigate the mechanism of function of oncogenic STRAP and its crosstalk with Smad7 in
colorectal cancer progression and metastasis. A better understanding of these mechanisms will help to
improve drug development and treatment of this lethal disease.","NCI","8214603","2/24/2012 12:00:00 AM","PA-07-070","5R01CA095195-09","5","R01","CA","095195","09"," ","AULT, GRACE S","5/1/2003 12:00:00 AM","7/31/2012 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","6875894","DATTA, PRAN K","Not Applicable","05","SURGERY","965717143","GTNBNWXJ12D5","965717143","GTNBNWXJ12D5","US","36.140134","-86.796274","8721001","VANDERBILT UNIVERSITY","Nashville","TN","SCHOOLS OF MEDICINE","372032408","UNITED STATES","N","2/1/2012 12:00:00 AM","7/31/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","157493","88196"," ","245689",
"Digestive Diseases","Acute;Adult;Affect;Animals;Anti-Inflammatory Agents;Anti-inflammatory;Antigen-Presenting Cells;Apical;Autoimmune Process;Automobile Driving;Biological Assay;Bone Marrow;Celiac Disease;Cell physiology;Cells;Chronic;Complex;Data;Dendritic Cells;Development;Disease;Environment;Enzyme-Linked Immunosorbent Assay;Epithelial;Epithelial Cells;Epithelium;Equilibrium;Erinaceidae;Event;Exhibits;Exposure to;Gastrointestinal tract structure;Goals;Health;Homeostasis;Hyperplasia;ITGAM gene;Immune;Immune Tolerance;Immune response;Immune system;Immunity;In Vitro;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Inflammatory Response;Interleukin-6;Intestines;Knock-out;LacZ Genes;Lamina Propria;Life;Ligands;Link;Mesenchymal;Mesenchyme;Mononuclear;Mucosal Immunity;Myelogenous;Myeloid Cells;Myofibroblast;Organ;Output;Phenotype;Play;Population;Publishing;Regulatory T-Lymphocyte;Reporter;Reverse Transcriptase Polymerase Chain Reaction;Rheumatoid Arthritis;Role;Signal Transduction;System;T-Cell Activation;T-Lymphocyte;Testing;Time;Tissues;Tretinoin;Villus;Work;autoimmune pancreatitis;cell type;cellular targeting;conditioning;cytokine;hedgehog signal transduction;human TSLP protein;immune function;improved;in vivo;intestinal epithelium;macrophage;monocyte;mouse model;paracrine;paralogous gene;receptor expression;smoothened signaling pathway","Hedgehog Signaling in Intestinal Tolerance and Inflammation"," Hedgehog (Hh) signals are critical for multiple events during intestinal development and are downregulated, but still present in adult life in some organs, including the GI tract. In the adult intestine, myofibroblasts and myeloid cells are direct cellular targets of Hh signaling. These cells can modulate the inflammatory milieu and communicate with T-cells and are thus important integrators of inflammatory signaling. Indeed, preliminary studies indicate that Hh signals promote a tolerogenic phenotype in these cells. The goal of this work is to determine how Hh affects functional inflammatory signaling in myeloid cells and myofibroblasts. These studies will increase our understanding of how Hh influences intestinal immune responses, information that may be highly relevant to inflammatory bowel disease.  
    

","NIDDK","8255779","5/4/2012 12:00:00 AM","PA-11-113","1F32DK094574-01","1","F32","DK","094574","01"," ","PODSKALNY, JUDITH M,","7/1/2012 12:00:00 AM","6/30/2014 12:00:00 AM","ZDK1-GRB-2(O1)S"," ","10844868","MUZA-MOONS, MICHELLE M","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Training, Individual","2012"," "," ","NIDDK","59626"," "," ","59626",
"Breast Cancer; Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Achievement;Affect;Area;Back;Binding;Biological Assay;Biology;Bone Marrow;Breast;Breast Cancer Model;Cancer Patient;Cell Communication;Cells;Coculture Techniques;Core Facility;Environment;Epigenetic Process;Fatty acid glycerol esters;Fluorescence Microscopy;Fluorescence-Activated Cell Sorting;Gene Expression;Genes;Genetic;Goals;Growth;Growth Factor;Hematopoietic;Human;Image;Imaging Techniques;Immune system;In Vitro;Individual;Injury;Institution;Integrins;Isogenic transplantation;Knockout Mice;Lead;Life;Ligands;Malignant Neoplasms;Mammals;Mammary gland;Medicine;Mesenchymal;Microarray Analysis;Modeling;Molecular Biology;Molecular and Cellular Biology;Monitor;Mus;Neoplasm Metastasis;Neoplasm Transplantation;Normal tissue morphology;Pathway interactions;Play;Property;Radiation;Relapse;Reporter;Reporting;Research;Research Personnel;Resistance;Role;Scientist;Signal Pathway;Signal Transduction;Solid;Staging;Stem cells;Subfamily lentivirinae;System;Technology;Testing;Tissues;Tomatoes;Training;Training Programs;Transplantation;Tumor Stem Cells;Tumor-Derived;Wnt proteins;Xenograft Model;Xenograft procedure;abstracting;anticancer research;base;cancer stem cell;cell type;chemokine;college;cytokine;drug development;in vitro Assay;in vivo;insight;knock-down;malignant breast neoplasm;mouse model;neoplastic cell;new therapeutic target;planetary Atmosphere;prevent;regenerative;research study;self-renewal;skills;small hairpin RNA;stem cell niche;tumor;tumor growth;tumor initiation;tumor progression","Defining the role of the tumor-initiating cell niche in breast cancer","
Narrative
The functional interaction between the cancer stem cells (tumor-initiating cells, TICs), and their
microenvironment, the ""niche"" will be investigated using a p53 null syngeneic transplantation mouse model, as
well as an established human breast cancer patient-derived xenograft model. Both in vivo and in vitro assays
will be applied in studying how the components of the niche microenvironment affect stem cells, and how the
deregulation of these interactions via genetic or epigenetic alterations may lead to tumor initiation. Insights into
niche-TIC interactions may provide new therapeutic targets for drug development with the goal of both
preventing breast cancer and reducing metastasis.","NCI","8528268","9/26/2012 12:00:00 AM","PA-09-036","4R00CA142898-03","4","R00","CA","142898","03"," ","WOODHOUSE, ELIZABETH","9/1/2010 12:00:00 AM","8/31/2015 12:00:00 AM","NSS"," ","9610336","ZHANG, MEI ","Not Applicable","18","ANATOMY/CELL BIOLOGY","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","9/26/2012 12:00:00 AM","8/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","189325","59674"," ","248999",
"Aging; Cancer; Prostate Cancer; Urologic Diseases","3-Dimensional;Androgen Receptor;Animal Model;Antibodies;Apoptosis;Automobile Driving;Biological Markers;Biology;Bone Tissue;CREB1 gene;Cancer Cell Growth;Cancer Model;Cancer Patient;Catalytic RNA;Cell Line;Cell Survival;Cells;Clinical;Custom;Detection;Development;Diagnosis;Diagnostic;Diagnostic Factor;Epithelial;Epithelial Cells;Essential Genes;Fluorescence;Funding;Gastrula;Gene Activation;Gene Expression;Genes;Goals;Growth;Growth Factor;Human;Inflammatory;Instruction;Laboratories;Lead;Ligands;Luciferases;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of prostate;Mediating;Metastatic Neoplasm to the Bone;Metastatic Prostate Cancer;Modeling;Molecular;Molecular Profiling;Morbidity - disease rate;Mus;Myeloid Cells;NF-kappa B;Nanotechnology;Neoplasm Metastasis;Neuropilins;Normal Cell;Organ;PC3 cell line;PO-1;Patients;Principal Investigator;Prostate;Quantum Dots;Reagent;Regulation;Renal carcinoma;Research Personnel;Role;Serum;Signal Pathway;Signal Transduction;Signaling Molecule;Specimen;Stromal Cells;TNFSF11 gene;Technology;Testing;Tetanus Helper Peptide;Therapeutic Agents;Tissues;Translations;Tumor Biology;Vascular Endothelial Growth Factor Receptor;Vascular Endothelial Growth Factors;Visceral;Zebrafish;beta-2 Microglobulin;bone;bone turnover;cancer cell;cell behavior;cell growth;cell killing;cell stroma;clinical material;clinically relevant;effective therapy;epithelial to mesenchymal transition;genetically modified cells;improved;in vivo;interest;leukemia;malignant breast neoplasm;migration;mortality;novel;osteoclastogenesis;outcome forecast;prognostic;programs;receptor expression;soft tissue;survivin;therapeutic target;tumor;tumor progression;zebrafish development;zinc-binding protein","Biology of Tumor-Stroma Interaction","n/a","NCI","8382406","8/9/2012 12:00:00 AM"," ","5P01CA098912-09","5","P01","CA","098912","09"," "," ","9/17/2003 12:00:00 AM"," ","ZCA1-GRB-S","8182","1877206","CHUNG, LELAND W.K.","Not Applicable","28","Unavailable","075307785","NCSMA19DF7E6","075307785","NCSMA19DF7E6","US","34.076546","-118.380008","1225501","CEDARS-SINAI MEDICAL CENTER","LOS ANGELES","CA","Independent Hospitals","900481804","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","289128","289128"," ","246735","42393"," "," ",
"Digestive Diseases; Neurosciences; Stem Cell Research; Stem Cell Research - Embryonic - Human","3-Dimensional;Activities of Daily Living;Affect;Animals;Anterior;Cell Proliferation;Cells;Cephalic;Chickens;Congenital Megacolon;Cues;Development;Diet;Embryo;Embryonic Development;Endoderm;Endothelin;Engraftment;Enteral;Enteric Nervous System;Enterocytes;Enteroendocrine Cell;Environment;Enzymes;Epithelial;Epithelium;Excision;Fecal Incontinence;Fibroblast Growth Factor;Fibroblasts;Food;Functional Imaging;Functional disorder;GDNF gene;Gastrointestinal Diseases;Gastrointestinal Motility;Gastrointestinal tract structure;Gene Expression;Genetic;Germ Layers;Goblet Cells;HOI;Human;In Vitro;Intestinal Diseases;Intestinal Motility;Intestines;Irritable Bowel Syndrome;Mesenchymal;Mesenchyme;Mesoderm;Methods;Molecular;Movement;Muscle Contraction;Myofibroblast;Nerve;Nervous System Physiology;Neural Crest;Neural Crest Cell;Neuroglia;Neurons;Organoids;Paneth Cells;Pathway interactions;Patients;Pattern;Peristalsis;Pharmaceutical Preparations;Plastics;Population;Process;Protocols documentation;Research;Screening procedure;Signal Pathway;Signal Transduction;Smooth Muscle;Smooth Muscle Actin Staining Method;Somites;Specific qualifier value;Staging;Stem cells;Structure;Study models;System;Testing;Tissues;Tretinoin;Villus;base;body system;cell motility;cell type;gastrointestinal epithelium;hindbrain;improved;induced pluripotent stem cell;migration;motility disorder;nervous system development;notch protein;progenitor;response;stem cell differentiation;three dimensional structure;tool;treatment planning","Generating Human Intestinal Organoids with an ENS."," Gastrointestinal (GI) motility/functional disorders affect up to 25% of the US population. Common intestinal motility disorders include Irritable Bowel Syndrome and Fecal Incontinence, whereas more rare forms such as Hirschsprung's Disease have a genetic basis and are associated with absence or paucity of enteric nerves. Current treatment plans for GI motility/functional disorders range from changes in diet to bowel resection, however there are very few drugs available that target the primary deficiencies in controlled peristalsis. One barrier to research of GI disease is that it has largely relied on in vvo animal studies, which are intrinsically low throughput. This proposal aims to generate human intestinal organoids containing functional epithelium, surrounded by smooth muscle that is innervated by enteric nerves. This research tool would allow for unprecedented studies of the cellular and molecular basis of gut motility in humans and be an ideal screening platform for drugs that regulate gut motility.   
      

","NCATS","8415736","7/24/2012 12:00:00 AM","RFA-RM-12-001","1U18TR000546-01","1","U18","TR","000546","01"," ","TAGLE, DANILO A","7/24/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BST-N(50)R]"," ","1924383","WELLS, JAMES M","Not Applicable","01","Unavailable","071284913","JZD1HLM2ZU83","071284913","JZD1HLM2ZU83","US","39.140882","-84.500494","615001","CINCINNATI CHILDRENS HOSP MED CTR","CINCINNATI","OH","Independent Hospitals","452293039","UNITED STATES","N","7/24/2012 12:00:00 AM","6/30/2013 12:00:00 AM","350","Other Research-Related","2012"," "," ","OD","115152","0"," ","115152",
"Digestive Diseases; Neurosciences; Stem Cell Research; Stem Cell Research - Embryonic - Human","3-Dimensional;Activities of Daily Living;Affect;Animals;Anterior;Cell Proliferation;Cells;Cephalic;Chickens;Congenital Megacolon;Cues;Development;Diet;Embryo;Embryonic Development;Endoderm;Endothelin;Engraftment;Enteral;Enteric Nervous System;Enterocytes;Enteroendocrine Cell;Environment;Enzymes;Epithelial;Epithelium;Excision;Fecal Incontinence;Fibroblast Growth Factor;Fibroblasts;Food;Functional Imaging;Functional disorder;GDNF gene;Gastrointestinal Diseases;Gastrointestinal Motility;Gastrointestinal tract structure;Gene Expression;Genetic;Germ Layers;Goblet Cells;HOI;Human;In Vitro;Intestinal Diseases;Intestinal Motility;Intestines;Irritable Bowel Syndrome;Mesenchymal;Mesenchyme;Mesoderm;Methods;Molecular;Movement;Muscle Contraction;Myofibroblast;Nerve;Nervous System Physiology;Neural Crest;Neural Crest Cell;Neuroglia;Neurons;Organoids;Paneth Cells;Pathway interactions;Patients;Pattern;Peristalsis;Pharmaceutical Preparations;Plastics;Population;Process;Protocols documentation;Research;Screening procedure;Signal Pathway;Signal Transduction;Smooth Muscle;Smooth Muscle Actin Staining Method;Somites;Specific qualifier value;Staging;Stem cells;Structure;Study models;System;Testing;Tissues;Tretinoin;Villus;base;body system;cell motility;cell type;gastrointestinal epithelium;hindbrain;improved;induced pluripotent stem cell;migration;motility disorder;nervous system development;notch protein;progenitor;response;stem cell differentiation;three dimensional structure;tool;treatment planning","Generating Human Intestinal Organoids with an ENS."," Gastrointestinal (GI) motility/functional disorders affect up to 25% of the US population. Common intestinal motility disorders include Irritable Bowel Syndrome and Fecal Incontinence, whereas more rare forms such as Hirschsprung's Disease have a genetic basis and are associated with absence or paucity of enteric nerves. Current treatment plans for GI motility/functional disorders range from changes in diet to bowel resection, however there are very few drugs available that target the primary deficiencies in controlled peristalsis. One barrier to research of GI disease is that it has largely relied on in vvo animal studies, which are intrinsically low throughput. This proposal aims to generate human intestinal organoids containing functional epithelium, surrounded by smooth muscle that is innervated by enteric nerves. This research tool would allow for unprecedented studies of the cellular and molecular basis of gut motility in humans and be an ideal screening platform for drugs that regulate gut motility.   
      

","NCATS","8415736","7/24/2012 12:00:00 AM","RFA-RM-12-001","1U18TR000546-01","1","U18","TR","000546","01"," ","TAGLE, DANILO A","7/24/2012 12:00:00 AM","6/30/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BST-N(50)R]"," ","1924383","WELLS, JAMES M","Not Applicable","01","Unavailable","071284913","JZD1HLM2ZU83","071284913","JZD1HLM2ZU83","US","39.140882","-84.500494","615001","CINCINNATI CHILDRENS HOSP MED CTR","CINCINNATI","OH","Independent Hospitals","452293039","UNITED STATES","N","7/24/2012 12:00:00 AM","6/30/2013 12:00:00 AM","350","Other Research-Related","2012"," "," ","NCATS","109848","119250"," ","229098",
"Dental/Oral and Craniofacial Disease; Genetics; Pediatric; Prevention; Rare Diseases","Accounting;Animal Model;Apoptosis;Apoptotic;Budgets;Cartilage;Cell Death;Cell Maintenance;Cells;Centers for Disease Control and Prevention (U.S.);Child;Cleft Lip;Cleft Palate;Congenital Abnormality;Connective Tissue;Counseling;Craniofacial Abnormalities;Craniosynostosis;Data;Defect;Dental Care;Destinations;Development;Disease;Embryo;Embryonic Development;Employee Strikes;Esthetics;Etiology;Event;Exhibits;Face;Future;Gene Proteins;Genes;Genetic;Genotype;Head;Healthcare;Human;Individual;Infant Mortality;Knockout Mice;Maintenance;Mandibulofacial Dysostosis;Maps;Modeling;Mus;Names;Nerve Tissue;Neural Crest;Neural Crest Cell;Nuclear Orphan Receptor;Operative Surgical Procedures;Parents;Pathogenesis;Pattern;Peripheral Nervous System;Play;Population;Prevention;Process;Rehabilitation therapy;Robin bird;Role;Severities;Shapes;Stem cells;Syndrome;Therapeutic;Tissues;Waardenburg syndrome;X Chromosome;bone;chromatin immunoprecipitation;clinical application;cost;craniofacial;disorder prevention;epithelial to mesenchymal transition;life time cost;loss of function;malformation;migration;mouse model;mutant;nerve stem cell;neural plate;novel;novel therapeutics;pluripotency;prevent;psychologic;public health relevance;social;stable cell line;stem","Craniofacial Development and Disease","
 Craniofacial abnormalities account for approximately one third of all birth defects
in new born kids, are a major cause of infant mortality and dramatically impact upon
national health care budgets. Disorders such as Treacher Collins, Pierre Robin and
Waardenburg syndromes, along with holoposencephaly and craniosynostosis to name a
few, have serious lifetime functional, esthetic and social consequences that are
devastating to children and parents alike. Comprehensive surgery, dental care,
psychological counseling and rehabilitation help ameliorate the problems, but at a great
cost over many years. The Center for Disease Control estimates that the lifetime cost of
treating the children born each year with cleft lip and/or cleft palate alone to be $697
million. Post-natal treatment of malformation syndromes such as Treacher Collins
through comprehensive, well-coordinated and integrated strategies can provide
satisfactory management of each condition. However, the results are often variable and
rarely fully corrective, hence considerable effort needs to be invested into developing
therapeutic avenues of prevention. This can only come from a deep appreciation of the
precise etiology and pathogenesis of individual malformation syndromes, which is built
upon a thorough understanding of the normal events that regulate neural crest cell
patterning and craniofacial development.","NIDCR","8291876","6/11/2012 12:00:00 AM","PA-07-070","5R01DE016082-08","5","R01","DE","016082","08"," ","SCHOLNICK, STEVEN","7/1/2004 12:00:00 AM","6/30/2015 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","7840241","TRAINOR, PAUL ","Not Applicable","05","Unavailable","614653652","KNSQZPJ3K775","614653652","KNSQZPJ3K775","US","39.036373","-94.574439","4323301","STOWERS INSTITUTE FOR MEDICAL RESEARCH","KANSAS CITY","MO","Research Institutes","641102262","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","247500","146025"," ","393525",
"Aging; Arthritis","Ablation;Adult;Affect;American;Animals;Appearance;Arthritis;CCL2 gene;Cartilage;Cells;Chemicals;Chondrocytes;Clinical;Controlled Environment;Data;Degenerative polyarthritis;Developed Countries;Development;Disease;Dominant-Negative Mutation;Down-Regulation;Environment;Epiphysial cartilage;Equilibrium;Event;Excision;Failure;Functional disorder;Future;Genes;Goals;Growth Factor;Homeostasis;Human;Hyperostosis;Image;Inflammation;Joints;Lead;Lesion;Life;Limb structure;Location;Loeys-Dietz Syndrome;Maintenance;Mechanical Stress;Mechanics;Medial meniscus structure;Mediator of activation protein;Medical;Mesenchymal;Modeling;Monocyte Chemoattractant Proteins;Mus;Mutation;Natural regeneration;Nature;Online Mendelian Inheritance In Man;Pathogenesis;Pathway interactions;Patients;Pharmaceutical Preparations;Population;Process;Public Health;Regulation;Reporter;Reporting;Research;Rodent Model;Role;Severities;Signal Transduction;Site;Stem cells;Stream;Symptoms;Syndrome;System;Tamoxifen;Testing;Therapeutic;Tissues;Transforming Growth Factor alpha;Transforming Growth Factor beta;Transgenic Mice;Transgenic Organisms;arthropathies;base;cartilage metabolism;chemokine;cytokine;disability;early onset;fetal;in vivo;innovation;insight;joint function;monocyte chemoattractant protein 1 receptor;novel;operation;overexpression;palliative;postnatal;prevent;promoter;receptor;regenerative","MCP5 as key mediator of TGFbeta signaling in joint maintenance and osteoarthritis"," The proposed research is relevant to public health because it will provide new targets to advance therapies for the treatment of osteoarthritis (OA). Osteoarthritis (OA) is the most common cause of disability in industrialized countries and affects more than 46 million Americans. All present therapies for OA are targeted at symptoms, and none exists that can alter the degenerative course of the disease. Our study, by connecting joint development with OA degeneration, provides a novel perspective to study OA pathophysiology in which joints are not the passive ""victims"" of the degenerative force of inflammation but, rather make their own contribution to OA pathogenesis by a failure of an active cell joint population to maintain a controlled cytokine environment (such as MCP-5/MCP-1). The information derived from our studies has major medical relevance and implications as will provide critical insights into the chain of events that lead to OA and will point the research's direction to novel therapies
to restore joint function in OA.   
      

","NIAMS","8365371","7/29/2012 12:00:00 AM","PAR-09-031","1R03AR063232-01","1","R03","AR","063232","01"," ","TYREE, BERNADETTE","8/1/2012 12:00:00 AM","7/31/2015 12:00:00 AM","ZAR1-EHB(M1)"," ","10810453","LONGOBARDI, LARA ","Not Applicable","04","PEDIATRICS","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","50000","24000"," ","74000",
"Breast Cancer; Cancer","Actins;Adaptor Signaling Protein;Address;Adhesions;Affect;Affinity;Amino Acids;Apical;Appointment;Area;Award;Binding;Biological;Biological Assay;Biometry;Breast Cancer Model;Cancer Biology;Cancer Center;Cancerous;Cell Count;Cell Polarity;Cell Proliferation;Cell membrane;Cells;Cellular Assay;Cellular Membrane;Cellular biology;Characteristics;Chemical Engineering;Cholesterol;Circular Dichroism;Collaborations;Complex;Core Facility;DNA Sequence Rearrangement;Development;Diagnosis;Differentiation and Growth;Dimensions;Discipline;Disease remission;Docking;Ductal Carcinoma;Ductal Epithelial Cell;E-Cadherin;Educational workshop;Elements;Endosomes;Energy Transfer;Environment;Epithelial;Epithelial Cells;Equilibrium;Event;Faculty;Family;Family member;Fluorescence;Goals;Grant;Growth;Hand;Head;Hyperplasia;Image;In Vitro;Individual;Isoenzymes;Knowledge;Laboratories;Life;Link;Lipid Binding;Lipids;Liposomes;MAP Kinase Gene;Malignant Neoplasms;Mammary gland;Measurement;Measures;Membrane;Mentors;Mesenchymal;Microscopy;Mission;Modeling;Molecular;Molecular Biology;Monitor;Morphology;N-Cadherin;Outcome;Phase;Play;Prevention;Proliferating;Property;Protein Dynamics;Protein Isoforms;Proteins;Public Health;Publications;Regulation;Relative (related person);Research;Research Ethics;Research Personnel;Research Training;Resources;Role;Signal Transduction;Site-Directed Mutagenesis;Sorting - Cell Movement;Specificity;Structure;Surface;Techniques;Testing;Time;Training;Tryptophan;Tyrosine;United States;United States National Institutes of Health;Woman;Work;Writing;active method;apical membrane;assay development;base;cell growth;cell motility;density;design;innovation;insight;malignant breast neoplasm;migration;mutant;novel;outcome forecast;prevent;programs;protein transport;responsible research conduct;scaffold;study characteristics;therapeutic target;tissue culture;tumor;tumorigenesis","Defining the role of Amot lipid binding in cellular proliferation and migration","The proposed work is relevant to public health because over 2.5 million women in the United States are affected by breast cancer, either living with the diagnosis, in active treatment, or in remission. Specifically, the work is directed toward understanding the biophysical mechanisms involved in the arrangement of cancer related proteins mammary cell membrane. Thus the proposed research is relevant to the part of NIH-NCI's mission that pertains to developing knowledge to diagnose and give a prognosis for breast cancer.","NCI","8354099","9/1/2012 12:00:00 AM","PAR-09-052","1K01CA169078-01","1","K01","CA","169078","01"," ","SOYOMBO-SHOOLA, ABIGAIL A","9/1/2012 12:00:00 AM","8/31/2017 12:00:00 AM","Transition to Independence Study Section (I)[NCI-I]"," ","10343402","KIMBLE-HILL, ANN CAROL","Not Applicable","07","BIOCHEMISTRY","603007902","SHHBRBAPSM35","603007902","SHHBRBAPSM35","US","39.780714","-86.174977","577806","INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS","INDIANAPOLIS","IN","SCHOOLS OF MEDICINE","462022915","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","89059","7125"," ","96184",
"Kidney Disease; Urologic Diseases","Adult;Agonist;Animal Model;Anti-Inflammatory Agents;Anti-inflammatory;Apoptosis;Apoptotic;Binding;Binding Sites;Caspase-1;Cell Death;Cells;Child;Chronic;Chronic Kidney Failure;Clinical;Colitis;Cytokine Inducible SH2-Containing Protein;Data;Deletion Mutagenesis;Development;Disease;Elements;Epithelial;Epithelial Cells;Extracellular Matrix;Family;Feedback;Fibrosis;Gene Expression;Genes;Genetic Transcription;Human;Hyperglycemia;Immunologics;In Vitro;Infiltration;Inflammation Mediators;Inflammatory;Injury;Interferons;Interleukin-1;Interleukin-18;Investigation;Kidney;Kidney Diseases;Kidney Failure;Liver;Mediating;Mediator of activation protein;Mesenchymal;Modeling;Mus;Obstruction;Patients;Process;Production;Property;Recombinant Interleukin-18;Role;STAT3 gene;Signal Pathway;Signal Transduction;Small Interfering RNA;Source;TNF gene;Testing;Therapeutic;Transcription Factor AP-1;Transplantation;Tubular formation;Ureteral obstruction;Urinary tract;cell injury;clinically relevant;cytokine;in vivo;inhibitor/antagonist;insight;interleukin-18 receptor;macrophage;mutant;novel;prevent;promoter;public health relevance;receptor;receptor expression;response;toll-like receptor 4;treatment strategy;urinary","IL-18 Mediates Obstruction-Induced Renal Injury via TLR4 Signaling","
PROJECT NARRATIVE
 Obstruction of the kidney is a major clinical problem in both children and adults that results in progressive
and ultimately irreversible kidney damage. While increased expression of the inflammatory mediator,
interleukin 18 (IL-18), has been demonstrated in a wide range of kidney diseases, the role of IL-18 in
obstruction-induced kidney injury remains unknown. This investigation would provide novel insight into IL-18's
signaling mechanisms and its role in the development of obstruction-induced kidney damage, and in turn,
provide potentially clinically relevant therapeutic strategies to limit or prevent the kidney damage associated
with obstruction.","NIDDK","8250012","9/6/2012 12:00:00 AM","PA-07-070","5R01DK081695-04","5","R01","DK","081695","04"," ","MULLINS, CHRISTOPHER V","4/1/2010 12:00:00 AM","3/31/2015 12:00:00 AM","Pathobiology of Kidney Disease Study Section[PBKD]"," ","7566367","MELDRUM, KIRSTAN K","Not Applicable","03","UROLOGY","969663814","NNFQH1JAPEP3","969663814","NNFQH1JAPEP3","US","29.67667","-82.340932","513806","UNIVERSITY OF FLORIDA","GAINESVILLE","FL","SCHOOLS OF MEDICINE","326115500","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","212850","102967"," ","313567",
"Biotechnology; Cancer; Digestive Diseases; Pancreatic Cancer; Rare Diseases","Adult;Agar;Amino Acids;Anoikis;Basic Science;Binding;Cancer Etiology;Cancer Patient;Cancer cell line;Cell Culture Techniques;Cell Line;Cells;Clinical;Cytoplasm;Development;Diagnosis;Disease;Dissociation;Dominant-Negative Mutation;Ductal Epithelial Cell;Epithelial;Family;Family member;Genes;Goals;Growth;Guanine Nucleotide Dissociation Inhibitors;Guanosine Triphosphate;Health;Human;Malignant neoplasm of pancreas;Mediating;Mesenchymal;Metastatic Neoplasm to the Liver;Modeling;Molecular;Molecular Genetics;Mus;Mutation;Neoplasm Metastasis;Nonmetastatic;Nude Mice;Operative Surgical Procedures;Outcome;Pancreas;Pancreatic Adenocarcinoma;Patients;Peritoneal;Phenotype;Phosphotransferases;Play;Protein Tyrosine Kinase;Publications;Receptor Protein-Tyrosine Kinases;Research;Resistance;Retroperitoneal Space;Role;Signal Pathway;Signal Transduction;Specimen;Staging;Survival Rate;Testing;Therapeutic;Translational Research;Tropomyosin;Tumor Cell Line;United States;Variant;Xenograft procedure;anticancer research;base;chemotherapy;design;effective therapy;genetic profiling;in vivo;kinase inhibitor;knock-down;member;mortality;mouse model;mutant;novel;novel therapeutic intervention;overexpression;pancreatic cancer cells;pancreatic neoplasm;pancreatic tumorigenesis;perineural;public health relevance;rho;rhoB p20 GDI;small hairpin RNA;therapy resistant;treatment strategy","Mechanisms of Overexpressed TrkB in Inducing Pancreatic Cancer Metastasis","
Pancreatic cancer remains an unsolved health problem in the United States and throughout the world.
Only through basic and translational research aimed at understanding molecular basis of pancreatic
cancer and identifying novel targets for designing therapeutic approaches will the outcome change for
the over 42,470 people in the United States who develop this disease each year. The proposed study
will fill in the gaps in our understanding of the molecular mechanisms of human pancreatic cancer
metastasis by studying the novel signaling pathways mediated by TrkBT1 overexpression.","NCI","8265693","5/1/2012 12:00:00 AM","PA-07-070","5R01CA142674-03","5","R01","CA","142674","03"," ","AULT, GRACE S","7/6/2010 12:00:00 AM","5/31/2015 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1880458","CHIAO, PAUL J","Not Applicable","09","MICROBIOLOGY/IMMUN/VIROLOGY","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","116740"," ","318015",
"Cancer; Digestive Diseases; Orphan Drug; Pancreatic Cancer; Rare Diseases","Address;Adult;Affect;Appearance;Basal cell carcinoma;Binding;Biology;Cancer Etiology;Cells;Cessation of life;Clinic;Clinical;Colon;Data;Development;Diagnosis;Disease;Employee Strikes;Epithelial;Epithelial Cells;Epithelium;Erinaceidae;Event;Family;Feedback;Fibroblasts;Figs - dietary;Gastrointestinal tract structure;Gene Targeting;Goals;Inflammation;Inflammatory;Inflammatory Response;Integral Membrane Protein;Interleukin-6;Intestines;Lesion;Ligands;Link;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Malignant neoplasm of prostate;Mammals;Mediating;Mediator of activation protein;Mesenchymal;Modeling;Mutation;Nature;Neoplasms;Organ;Outcome;Pancreas;Pancreatic Diseases;Pancreatic Ductal Adenocarcinoma;Pancreatic Intraepithelial Neoplasia;Pancreatitis;Pathway interactions;Patients;Pharmaceutical Preparations;Phase I Clinical Trials;Play;Process;Public Health;Relapse;Reporting;Role;Scheme;Shapes;Source;Syndrome;Testing;Tissues;Treatment Efficacy;autocrine;cancer therapy;carcinogenesis;chemotherapy;colon carcinogenesis;cytokine;human SMO protein;human disease;inhibitor/antagonist;insight;interest;medulloblastoma;mortality;mouse model;mutant;neoplastic cell;new therapeutic target;novel therapeutics;outcome forecast;paracrine;pre-clinical;public health relevance;receptor;response;smoothened signaling pathway;therapeutic target;tissue repair;transcription factor;tumor;tumor growth;tumorigenesis","Gli Activity in the Pancreas:  Inflammation, Tissue Repair and Cancer","
Narrative (relevance to public health).
Pancreatic cancer is a horrific disease with a very dismal prognosis. It constitutes the fourth leading
cause of cancer death in the US, and its yearly mortality equals the diagnosis rate. Novel therapeutic
options for this disease are sorely needed, and they are likely to result from new insights on the biology of
this disease. The Hedgehog signaling pathway involved in cancer of several organs, including the
pancreas. Inhibitors of the pathway are currently in clinical therapy for basal cell carcinoma. Although
several studies have addressed different aspects of Hedgehog signaling in pancreatic carcinogenesis,
we do not, at this point, know whether activation of this pathway is a limiting and required event in
pancreatic carcinogenesis. Our studies aim at understanding how the Hedgehog signaling pathway
promotes pancreatic carcinogenesis, and whether it would constitute a promising therapeutic target for
this disease.","NCI","8259535","4/24/2012 12:00:00 AM","PA-07-070","5R01CA151588-03","5","R01","CA","151588","03"," ","MIETZ, JUDY","7/1/2010 12:00:00 AM","4/30/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-DKUS-C(02)M]"," ","9699074","PASCA DI MAGLIANO, MARINA ","Not Applicable","12","SURGERY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","102226"," ","303501",
"Breast Cancer; Cancer","Adult;Affect;Animal Model;Animals;Architecture;Behavior;Biological Assay;Biology;Breast;Breast Cancer Cell;Breast Carcinoma;Cancer Cell Growth;Carcinoma;Cell Adhesion;Cell surface;Cells;Complex;Connective Tissue;Data;Development;Ductal;Elements;Employee Strikes;Endothelial Cells;Epithelial Cells;Event;Extracellular Matrix;Fiber;Fibroblasts;Fibronectins;Gene Expression;Generations;Goals;Growth;Growth Factor;Head;Health;Homeostasis;Human;Imaging Device;Immune system;In Situ Lesion;In Vitro;Individual;Integrins;Invaded;Knowledge;Lead;Link;Malignant Epithelial Cell;Malignant Neoplasms;Mammary gland;Measures;Mechanics;Mesenchymal;Molecular;Morphogenesis;Morphology;Movement;Neoplasm Metastasis;Newly Diagnosed;Noninfiltrating Intraductal Carcinoma;Normal tissue morphology;Outcome;Pathway interactions;Patients;Pattern;Phase;Play;Primary Carcinoma;Production;Property;Proteoglycan;Regulation;Research;Research Personnel;Role;Sampling;Signal Transduction;Stromal Cells;Structure;Techniques;Testing;Therapeutic;Therapeutic Agents;Tissue Microarray;Tissues;Woman;Work;Xenograft Model;adhesion receptor;base;body system;cancer cell;cell motility;cell type;design;disease natural history;fibrillogenesis;gain of function;improved;in vivo;inhibitor/antagonist;innovation;loss of function;malignant breast neoplasm;molecular domain;neoplastic cell;novel;novel therapeutics;outcome forecast;paracrine;prevent;prototype;public health relevance;receptor;research study;scaffold;syndecan;tissue support frame;tool;tumor;tumor progression;tumorigenesis","Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas","
PUBLIC HEALTH RELEVANCE STATEMENT
With approximately 200,000 newly diagnosed cases in the US per year, breast cancer is and remains a major
health issue. Even with the advanced treatment options available, 40,000 women die annually. Our project
aims at understanding how the architecture of the connective tissue scaffold in breast cancer is regulated and
how it affects cancer invasion and spread. The knowledge generated with this work may lead to novel
therapies that target the structure of this scaffold and prevent the escape of cancer cells.","NCI","8208079","3/16/2012 12:00:00 AM","PA-07-070","5R01CA107012-08","5","R01","CA","107012","08"," ","SATHYAMOORTHY, NEERAJA","3/1/2005 12:00:00 AM","1/31/2015 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","6380864","FRIEDL, ANDREAS ","Not Applicable","02","PATHOLOGY","161202122","LCLSJAGTNZQ7","161202122","LCLSJAGTNZQ7","US","43.068377","-89.40086","578503","UNIVERSITY OF WISCONSIN-MADISON","MADISON","WI","SCHOOLS OF MEDICINE","537151218","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","194203","94188"," ","288391",
"Biotechnology; Clinical Research; Genetics; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Adult;Affect;Alleles;Anterior Pituitary Gland;Brain;Candidate Disease Gene;Cataloging;Catalogs;Cell Culture Techniques;Cell Cycle;Cell Lineage;Cell-Cell Adhesion;Cells;Cessation of life;Child;Collection;Congenital Abnormality;Cyclin E;DNA Sequence;Defect;Delayed Puberty;Dependence;Development;Diagnosis;Embryonic Development;Etiology;Exons;Eye;Failure;Fertility;Fibroblast Growth Factor;Functional disorder;Gene Expression;Gene Expression Profile;Gene Targeting;Generations;Genes;Genetic;Genetic Variation;Genetically Engineered Mouse;Gland;Goals;Grant;Growth;Homeobox Genes;Hormones;Human;Hypogonadism;Hypophyseal diverticulum;Hypopituitarism;Hypothalamic structure;Intracranial Neoplasms;Introns;Knock-out;Lead;Lesion;Life;Medical;Molecular;Molecular Diagnosis;Molecular Profiling;Monitor;Multipotent Stem Cells;Mus;Mutate;Mutation;Organ;Organogenesis;Panhypopituitarism;Patients;Phenotype;Pituitary Gland;Pituitary Gland Adenoma;Pituitary Hormones;Pituitary Hypoplasia;Primordium;Process;Production;Regulation;Repression;Research;Risk;Role;Sampling;Sequence Analysis;Signal Transduction;Somatotropin;Stem cells;Testing;Therapeutic;Transgenic Mice;Trauma;Variant;WNT Signaling Pathway;Work;Zebrafish;adenoma;base;biological adaptation to stress;cell growth;cell motility;cell type;chromatin immunoprecipitation;craniofacial;density;diencephalon;embryonic stem cell;epithelial to mesenchymal transition;exome;follow-up;gain of function;genetic pedigree;hormone deficiency;improved;insight;loss of function;mutant;notch protein;novel;pituitary gland development;precursor cell;proband;progenitor;transcription factor;tumorigenesis","A Panhypopituitary Mouse Mutation"," One in 4000 babies are born with a defect in pituitary development that affects growth and other bodily functions. We seek to identify the basis for these birth defects by studying patients and genetically engineered mice with hypopituitarism. This work will lead to better diagnoses in the short term and better therapy in the long term.   
      

","NICHD","8372721","8/17/2012 12:00:00 AM","PA-11-260","2R01HD030428-20","2","R01","HD","030428","20"," ","JAVOIS, LORETTE CLAIRE","4/1/1993 12:00:00 AM","4/30/2017 12:00:00 AM","Genetics of Health and Disease Study Section[GHD]"," ","1896127","CAMPER, SALLY A.","Not Applicable","12","GENETICS","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF MEDICINE","481091276","UNITED STATES","N","8/17/2012 12:00:00 AM","4/30/2013 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","254496","136718"," ","391214",
"Cancer; Genetics; Lung; Lung Cancer","Adhesions;Alleles;Apoptosis;Biological Markers;CXCR4 gene;Cancer Etiology;Cancer cell line;Cells;Cellular Stress;Cessation of life;Data;Data Set;Development;Disease;Down-Regulation;Embryo;Extracellular Matrix Degradation;FDA approved;Family member;Fibroblasts;Gene Targeting;Genes;Genetic;Genomics;Histologic;Histology;Human;Hypoxia;Hypoxia Inducible Factor;Hypoxia-Inducible Factor Pathway;In Vitro;LOX gene;Lesion;Ligation;Lung Adenocarcinoma;Lung Neoplasms;Maintenance;Malignant Neoplasms;Malignant neoplasm of lung;Matrix Metalloproteinases;Mediating;Mediator of activation protein;Messenger RNA;Molecular Analysis;Mus;Mutation;Neoplasm Metastasis;Non-Small-Cell Lung Carcinoma;Nutrient;Oncogene Activation;Oncogenes;Oncogenic;Pathway interactions;Patients;Phenotype;Platelet-Derived Growth Factor;Play;Process;Protein-Serine-Threonine Kinases;Proteins;Renal Cell Carcinoma;Role;STK11 gene;Signal Pathway;Signal Transduction;Sirolimus;Somatic Mutation;Squamous Cell;Squamous Differentiation;Staining method;Stains;Stromal Cell-Derived Factor 1;Therapeutic;Thrombospondin 1;Tissue Microarray;Tuberous sclerosis protein complex;Tumor Suppressor Genes;Tumor-Suppressor Gene Inactivation;Up-Regulation;Variant;Vascular Endothelial Growth Factors;Woman;cancer cell;epithelial to mesenchymal transition;in vivo;in vivo Model;inhibitor/antagonist;knock-down;lung Carcinoma;lung tumorigenesis;mTOR protein;men;metastatic process;migration;mortality;mouse model;mutant;pre-clinical;public health relevance;response;restoration;therapeutic target;tumor;tumorigenesis","Characterization and therapeutic targeting of HIF in LKB1 - deficient lung cancer","
Narrative
We will investigate the role of HIF2 in the tumorigenesis of LKB1-defective lung tumors. HIF2 has been shown
to be a bona fide oncogene in renal cell carcinoma (RCC) and downstream mediators of HIF2 signaling are the
relevant therapeutic targets that have resulted in positive impact for RCC patients. Defining HIF2 as a critical
oncogenic mediator of LKB1-defective tumors will not only define an important deregulated signaling pathway
in the setting of LKB1 loss but also give strong preclinical rationale to the use of HIF inhibitors in LKB1-
defective lung tumors.","NCI","8225390","3/15/2012 12:00:00 AM","PA-07-070","5R01CA142794-03","5","R01","CA","142794","03"," ","SALNIKOW, KONSTANTIN","3/1/2010 12:00:00 AM","2/28/2015 12:00:00 AM","Cancer Genetics Study Section[CG]"," ","6772358","KIM, WILLIAM Y.","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","95315"," ","296590",
"Cardiovascular; Genetics; Rare Diseases","AGTR2 gene;Abnormal Cell;Adult;Agonist;Alleles;Aneurysm;Angiotensin II;Angiotensins;Animals;Aorta;Aortic Aneurysm;Attenuated;Automobile Driving;BMP7 gene;Behavior;Biological Availability;Blood Vessels;Cardiac;Cells;Cessation of life;Clinical;Clinical Trials;Collaborations;Complement;Complex;Data;Developed Countries;Development;Disease;Disease Progression;Endothelial Cells;Environment;Enzymes;Event;Exhibits;FBN1;Family;Fibrosis;Future;Genes;Genetic;Genotype;Growth Factor;Heart;Homeostasis;Individual;Integrins;Knowledge;Lead;Life;Ligands;Light;Losartan;Lung;MAP2K1 gene;MAPK14 gene;MAPK3 gene;Marfan Syndrome;Matrix Metalloproteinases;Medial;Mediating;Mediator of activation protein;Mesenchymal;Modeling;Mus;Muscle;Mutation;Myofibroblast;Myopathy;Neonatal;Neural Crest;Normal Cell;PECAM1 gene;Pathogenesis;Pathologic;Pathway interactions;Performance;Phenotype;Process;Production;Property;Proteins;Pulmonary Emphysema;Recombinants;Reporter;Sampling;Series;Severities;Signal Transduction;Skeletal Muscle;Skeleton;Smooth Muscle;Sorting - Cell Movement;Stratification;Surveys;System;TGFB1 gene;Testing;Therapeutic;Therapeutic Agents;Therapeutic Effect;Thinking;Thrombospondin 1;Time;Tissues;Transforming Growth Factor beta;Translational Research;Type 2 Angiotensin II Receptor;U-0126;Vascular Diseases;Work;ascending aorta;autocrine;base;extracellular;fasudil;human disease;inhibitor/antagonist;insight;meetings;mouse model;mutant;neutralizing antibody;novel;paracrine;postnatal;prevent;receptor;response;rho GTP-Binding Proteins;therapeutic target","Developmental Basis of Aneurysm in Marfan Syndrome and Therapeutic Implication","This work will explore the basic mechanisms driving aortic aneurysm, a condifion responsible for the death of
1-2% of individuals in industrialized countries. There is high potenfial that this work will derive novel
therapeufic strategies for Marfan syndrome, and that these insights will prove relevant to other presentafions of aortic aneurysm.","NIAMS","8379269","8/9/2012 12:00:00 AM"," ","5P01AR049698-09","5","P01","AR","049698","09"," "," ","7/1/2004 12:00:00 AM"," ","ZAR1-MLB-F","7049","1864063","DIETZ, HARRY C., III","Not Applicable","13","Unavailable","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","Domestic Higher Education","100296574","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","483128","483128"," ","444016","39112"," "," ",
"Anthrax; Breast Cancer; Cancer; Emerging Infectious Diseases; Infectious Diseases; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Affinity;Archives;Basal Cell;Binding;Biological Assay;Biological Markers;Breast;Breast Cancer Cell;CD44 gene;Cancer cell line;Cancerous;Cell division;Cell surface;Cells;Cleaved cell;Collagen;Data Set;Disease;Drug resistance;Dyes;Endothelial Cells;Epithelial;Epithelial Cells;Estrogen Antagonists;Extracellular Domain;Future;Gene Expression;Genes;Heterogeneity;Immunohistochemistry;In Vitro;Ligands;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Matrix Metalloproteinases;Measures;Mediating;Molecular Profiling;NOD/SCID mouse;Neoplasm Metastasis;Nodal;Normal Cell;Nuclear;Nuclear Receptors;Outcome;PKH 26;Pathway interactions;Patients;Pharmaceutical Preparations;Phenotype;Phosphorylation;Play;Property;Radiation;Recurrence;Reporting;Resistance;Role;Signal Transduction;Solid Neoplasm;Stem cells;TACSTD2 gene;Testing;Tumorigenicity;Up-Regulation;Urokinase;aldehyde dehydrogenase 1;aldehyde dehydrogenases;anthrax lethal factor;anthrax protective factor;anthrax toxin;anthrax toxin receptors;base;cancer cell;cancer stem cell;cell transformation;cell type;chemotherapy;cohort;conventional therapy;cytotoxic;docetaxel;epithelial to mesenchymal transition;hormone therapy;in vivo;inhibitor/antagonist;lipoprotein receptor-related protein 6;malignant breast neoplasm;multicatalytic endopeptidase complex;mutant;neoplastic cell;overexpression;progenitor;public health relevance;radiation resistance;response;self-renewal;small hairpin RNA;small molecule;stem;stemness;stromelysin 3;therapeutic target;therapy development;tumor;v-src Oncogenes","Anthrax Toxin Receptor as a marker and target of breast cancer stem cells","
Project Narrative
This proposal will determine the role of anthrax toxin receptor 1 (ANTXR1) in breast cancer stem cells.
ANTXR1 is expressed at a higher level in breast cancer stem cells compared to mature cells and may control
the function of Wnt pathway in cancer stem cells. Inhibitors of ANTXR1, such as mutant protective antigen of
anthrax or soluble ANTXR1, may inhibit ANTXR1 activity and sensitize cancer stem cells to chemotherapy.","NCI","8244440","4/10/2012 12:00:00 AM","PA-08-165","5R21CA152536-02","5","R21","CA","152536","02"," ","ARYA, SURESH","3/17/2011 12:00:00 AM","2/28/2014 12:00:00 AM","Basic Mechanisms  of Cancer Therapeutics Study Section[BMCT]"," ","1868604","NAKSHATRI, HARIKRISHNA ","Not Applicable","07","SURGERY","603007902","SHHBRBAPSM35","603007902","SHHBRBAPSM35","US","39.780714","-86.174977","577806","INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS","INDIANAPOLIS","IN","SCHOOLS OF MEDICINE","462022915","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2014 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","108750","58725"," ","167475",
"Biotechnology; Brain Cancer; Brain Disorders; Cancer; Neurosciences; Rare Diseases","Affect;Apoptotic;Behavior;Biochemical;Biological Assay;Biological Process;Cell Proliferation;Clinical;Clinical Trials;Foundations;Gene Expression;Genetic;Glioblastoma;Glioma;Gliomagenesis;Growth;Human;Immunoblotting;Immunocompetent;In Situ;Injection of therapeutic agent;Interleukin-6;JAK2 gene;Janus kinase 1;Lead;Ligation;Maintenance;Malignant Glioma;Malignant Neoplasms;Mesenchymal;Modeling;Molecular Profiling;Neuraxis;Normal Cell;Nude Mice;Pathway interactions;Patients;Phenotype;Pre-Clinical Model;Principal Investigator;Prognostic Factor;Protein Kinase;Protein Tyrosine Kinase;Protein-Serine-Threonine Kinases;Proteins;Radiation;Radiation Tolerance;Reporting;Role;Signal Pathway;Signal Transduction;Stat3 protein;Stem cells;Survival Analysis;Survival Rate;Techniques;Testing;The Cancer Genome Atlas;Therapeutic Intervention;Time;Tissue Sample;Tissues;Tyrosine Phosphorylation;Xenograft procedure;angiogenesis;cytokine;human PIAS3 protein;human data;in vivo;inhibitor/antagonist;innovation;interest;new therapeutic target;novel;programs;protein expression;protein inhibitors of activated STAT;relating to nervous system;response;temozolomide;transcription factor;tumor;tumor growth;upstream kinase","Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma"," One critically important signaling pathway gaining interest in the context of GBMs is the JAK/STAT-3 pathway, and we hypothesize that JAKs are novel therapeutic targets in GBMs. We will test for the first time the potent JAK1/JAK2 inhibitor AZD1480: by inhibiting the upstream kinases JAK1 and JAK2, AZD1480 treatment will lead to inhibition of STAT-3 activation, gene expression, and the biological functions that promote and sustain gliomagenesis. Collectively, the results from this proposal will provide a compelling rationale for the use of JAK/STAT-3 inhibitors in clinical trials for patients with GBMs.  
  
    

","NCI","8237478","2/28/2012 12:00:00 AM","PA-10-067","1R01CA158534-01A1","1","R01","CA","158534","01","A","ARYA, SURESH","3/1/2012 12:00:00 AM","2/28/2017 12:00:00 AM","Clinical Neuroimmunology and Brain Tumors Study Section[CNBT]"," ","1893276","BENVENISTE, ETTY N","Not Applicable","07","ANATOMY/CELL BIOLOGY","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","SCHOOLS OF MEDICINE","352940001","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","207500","96488"," ","303988",
"Aging; Biotechnology; Breast Cancer; Cancer; Genetics; Prevention","Age;Age-Years;Aging-Related Process;Anatomy;Benign;Biological Markers;Biopsy;Breast;Breast Cancer Cell;Breast Diseases;Cell Culture Techniques;Cell Line;Cells;Characteristics;Clinic;Clinical;Data;Diagnosis;Diagnostic;Disease susceptibility;Duct (organ) structure;Epidemiologic Studies;Epithelial;Epithelial Cells;Evaluation;Exhibits;Failure;Freezing;General Population;Genetic Polymorphism;Goals;Histologic;Human;Human Characteristics;Incidence;Individual;Lesion;Link;Lobular;Lobule;Malignant Neoplasms;Mammary Gland Parenchyma;Mammary gland;Measures;Menopause;Mesenchymal;Methods;MicroRNAs;Molecular;Operative Surgical Procedures;Pathologist;Patients;Phenotype;Pilot Projects;Population;Postmenopause;Premalignant;Preparation;Prevention strategy;Probability;Procedures;Process;Property;Protocols documentation;RNA Sequence Analysis;RNA Sequences;Retrospective Studies;Risk;Risk Assessment;Role;Sampling;Screening procedure;Small RNA;Staging;Structure;Techniques;Technology;Terminal Ductal Lobular Unit;Testing;Time;Tissues;United States;Woman;Work;age related;cancer risk;cohort;cost;disorder risk;experience;high risk;improved;insight;malignant breast neoplasm;malignant state;molecular marker;next generation;normal aging;overexpression;surveillance strategy;tool;tumor progression","MicroRNAs in lobular involution and breast cancer"," About 2 million women are diagnosed with benign breast disease (BBD) each year in the United States. Although these women are at significantly increased risk for developing breast cancer, the connections between BBD and breast cancer progression have been largely understudied. Our colleagues have recently determined that failure to undergo normal, age-related breast involution is a significant factor in progression from BBD to breast cancer. In fact, all of the increased risk among women with BBD is associated with individuals who have failed to undergo a process known as lobular involution (LI). Evaluation of LI status is therefore a very important aspect of risk assessment among BBD patients. However, it is very difficult to quantify LI status using conventional pathological techniques, which involve counting the number of terminal duct lobules and scoring them for the extent of involution. This procedure is very subjective and requires a highly skilled pathologist with a lot of experience in assessing breast tissue structure. What are needed at this time are good molecular markers that can be used to quantify the LI status in women with BBD. Our objective is to identify small RNAs (microRNAs) that can be used to this end. We will initially use state of the art high throughput small RNA sequencing technology to identify and count all of the microRNAs in cells from involuted and non-involuted breasts. We will determine if there are microRNAs that are differentially expressed in such cells and tissues. We will determine if any of these microRNAs are functionally linked to the more cancer-like properties of cells from non-involuted breast tissues. In this manner we will identify microRNAs that can be used as quantitative markers of LI status and which may be mechanistically linked to breast cancer risk in BBD patients.  
    

","NCI","8338876","8/14/2012 12:00:00 AM","PA-09-200","5R21CA155129-02","5","R21","CA","155129","02"," ","WANG, WENDY","9/26/2011 12:00:00 AM","8/31/2013 12:00:00 AM","Cancer Genetics Study Section[CG]"," ","1891524","THOMPSON, E. AUBREY","NECELA, BRIAN M","04","Unavailable","153223151","GKPBCFV1QMM3","153223151","GKPBCFV1QMM3","US","30.265046","-81.437603","4976105","MAYO CLINIC  JACKSONVILLE","JACKSONVILLE","FL","Other Domestic Non-Profits","322241865","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","394","Non-SBIR/STTR","2012"," "," ","NCI","108750","59813"," ","168563",
"No NIH Category available","Acute;Acute Lung Injury;Allergens;Allergic inflammation;Animals;Asthma;Bacteria;Biochemical;Biological Response Modifiers;Biology;Biopsy;Breathing;Bronchoalveolar Lavage;Bronchoscopy;CD44 Antigens;Cell Surface Receptors;Cell surface;Cells;Chronic;Chronic lung disease;Data;Development;Disease;Endogenous Factors;Environment;Epithelial Cells;Extracellular Matrix;Fibroblasts;Fibrosis;Flow Cytometry;Foundations;Generations;Genetic Models;Glycosaminoglycans;Growth Factor;Hamman-Rich syndrome;Host Defense;Human;Human Biology;Hyaluronan;Immune;Immune response;Immunohistochemistry;Individual;Inflammation;Inflammatory;Inflammatory Response;Integration Host Factors;Interleukin-13;Invaded;Investigation;Lead;Lung;Lung Inflammation;Lung diseases;Maintenance;Mediating;Mediator of activation protein;Mesenchymal;Modeling;Molecular;Morbidity - disease rate;Mus;Myofibroblast;Nature;Operative Surgical Procedures;Pathway interactions;Patients;Pattern;Phenotype;Physiological;Play;Polymers;Population;Process;Production;Program Research Project Grants;Property;Proteins;Pulmonary Fibrosis;Pulmonary Surfactant-Associated Protein A;Pulmonary Surfactant-Associated Protein D;Recruitment Activity;Refractory;Regulation;Research;Respiratory physiology;Role;Sampling;Second Messenger Systems;Signal Transduction;Source;Structure of parenchyma of lung;System;Talents;Testing;Therapeutic;Tissue Sample;Tissues;Toll-like receptors;Toxic Environmental Substances;Transforming Growth Factor beta;Translational Research;Virus;airway inflammation;airway remodeling;asthmatic airway;asthmatic patient;chemokine;cytokine;hyaluronan synthase 1;injured;insight;interstitial;lung injury;man;mortality;novel;pollutant;programs;receptor;response;restoration;second messenger;surfactant","Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease","RELEVANCE: There are no effective therapeutic approaches to limit airway remodeling and interstitial fibrosis. Our proposal brings together experts in surfactant biology, interstitial fibosis and translational asthma research and will provide mechanistic insights into how endogenous host factors regulate chronic inflammation, airway remodeling and interstitial fibrosis in mouse and man with the potential to provide new therapies for these severe diseases.","NHLBI","8337988","7/19/2012 12:00:00 AM","PAR-10-285","1P01HL108793-01A1","1","P01","HL","108793","01","A","GAIL, DOROTHY","8/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","ZHL1-CSR-S(M1)"," ","1882936","KRAFT, MONICA ","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","8/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","838","Non-SBIR/STTR","2012"," "," ","NHLBI","1575616","433669"," ","2009285",
"Biotechnology; Cancer; Clinical Research; Pediatric; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Stem Cell Research - Umbilical Cord Blood/ Placenta; Stem Cell Research - Umbilical Cord Blood/ Placenta - Human","Adjuvant;Adult;Aging-Related Process;Area;Bioinformatics;Biological;Biological Assay;Biological Markers;Biological Models;Blood;Blood Vessels;Blood specimen;Bone Marrow;Bone Marrow Neoplasms;CD34 gene;Cells;Childhood;Chronic Disease;Clinical Trials;Collaborations;Colony-Forming Units Assay;DNA;Development;Disease;Disease Progression;Disseminated Malignant Neoplasm;Distant;Drug Delivery Systems;Effectiveness;Epigenetic Process;Evaluation;Ewings sarcoma;Excision;Flow Cytometry;Functional RNA;Genes;Growth and Development function;Heart Diseases;Hematopoietic;High-Risk Cancer;Human;Immunofluorescence Immunologic;Inflammatory;Institutional Review Boards;Investigation;Li-Fraumeni Syndrome;Longevity;Longitudinal Studies;Malignant Neoplasms;Measures;Mediator of activation protein;Mesenchymal;Microarray Analysis;Monitor;Mus;Mutation;Myeloid Cells;Nature;Neoplasm Metastasis;Normal tissue morphology;Nutrient;Operative Surgical Procedures;Organ Transplantation;Patients;Phase I Clinical Trials;Population;Pre-Clinical Model;Predisposition;Primary Neoplasm;Process;Prognostic Marker;Protein p53;Recruitment Activity;Recurrence;Relapse;Risk;Role;Site;Solid Neoplasm;Stem cells;Stromal Cells;Supporting Cell;Syndrome;Testing;Time;Tissues;Translational Research;Tumor Burden;Tumor Cell Line;Tumor-Derived;Vascular Diseases;Work;Wound Healing;Xenograft procedure;angiogenesis;base;bone circulation;improved;indexing;inhibitor/antagonist;monocyte;novel;pre-clinical;preclinical study;progenitor;prognostic;repository;response;sarcoma;standard care;therapeutic target;therapy design;therapy development;tissue regeneration;tool;tumor;tumor progression;tumorigenesis","Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis","n/a","NCI","8553112"," "," ","1ZIABC011334-03","1","ZIA","BC","011334","03"," "," "," "," "," "," ","10712506","KAPLAN, ROSANDRA ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","488066",
"Breast Cancer; Cancer","3-Dimensional;Address;Adhesives;Architecture;Basement membrane;Biochemical;Biological Assay;Biological Models;Breast;Breast Cancer Cell;Breast Cancer Model;Breast Carcinoma;Cancer Control;Cancer Patient;Cancer cell line;Cancerous;Carcinoma;Cells;Cleaved cell;Collagen;Collagen Receptors;DDR1 gene;DDR2 gene;Data;Development;Diagnostic;Distant Metastasis;Down-Regulation;Engineering;Enzymes;Epithelial;Epithelial Cells;Epithelium;Experimental Models;Extracellular Matrix;Family;Funding;Human;In Situ;In Vitro;Invaded;Knowledge;Ligands;Light;MMP14 gene;MT3 gene;Maintenance;Malignant - descriptor;Malignant Neoplasms;Mammary Gland Parenchyma;Mammary gland;Matrix Metalloproteinases;Mediating;Mediator of activation protein;Membrane;Mesenchymal;Modeling;Molecular;Morphogenesis;Mus;Neoplasm Metastasis;Outcome;Patients;Phenotype;Phosphotransferases;Play;Process;Proteolysis;Receptor Activation;Receptor Cross-Talk;Receptor Protein-Tyrosine Kinases;Regulation;Reporting;Role;Signal Transduction;Structure-Activity Relationship;Supporting Cell;System;Testing;Therapeutic;Time;Tissues;base;breast cancer diagnosis;cancer cell;cell behavior;cell motility;cohort;design;discoidin receptor;human MMP14 protein;human tissue;improved;in vivo;information gathering;insight;malignant breast neoplasm;malignant phenotype;member;membrane-type matrix metalloproteinase;neoplastic cell;novel;programs;public health relevance;receptor;response;therapeutic target;tumor;tumor progression","MT-MMP/DDR cross talk at the tumor cell-matrix interface and cancer progression","
Public Health Relevance
The development of tumor metastasis continues to be the major limitation in our ability to control cancer and
improve survival. Metastasis depends on specific interactions between the cancer cells and the tissue barriers
they have to invade during dissemination. We have identified a unique interaction between enzymes that
degrades tissue barriers and a group of receptors that serves cells to attach. These receptors belong to the
family of receptor kinases that are potential therapeutic targets in cancer. Our studies unveiled a novel
functional relationship between the tissue-breaking enzymes and the kinase receptor that may regulate the
migratory and invasive activities of cancer cells. The studies of this application will focus on understanding this
relationship in normal and malignant breast cancer cells and in breast cancer tissues of human patients. We
expect that the information gathered from this application will contribute to the diagnosis of breast cancer and
to the design of new therapies aimed at controlling cancer dissemination.","NCI","8293054","4/4/2012 12:00:00 AM","PA-10-067","5R01CA061986-17","5","R01","CA","061986","17"," ","SNYDERWINE, ELIZABETH G","7/6/1995 12:00:00 AM","4/30/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1885137","FRIDMAN, RAFAEL A.","Not Applicable","13","PATHOLOGY","001962224","M6K6NTJ2MNE5","001962224","M6K6NTJ2MNE5","US","42.35738","-83.064737","9110501","WAYNE STATE UNIVERSITY","DETROIT","MI","SCHOOLS OF MEDICINE","482024000","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","171284","89068"," ","260352",
"Cancer; Clinical Research; Colo-Rectal Cancer; Digestive Diseases","ABL1 gene;Adenomatous Polyposis Coli;Affinity Chromatography;Attenuated;Binding;Carcinoma;Cell membrane;Cell surface;Cells;Chemotactic Factors;Colon Carcinoma;Complex;Cues;Data;Diagnosis;Diagnostic;Down-Regulation;Drosophila sli protein;E-Cadherin;Endothelial Cells;Enzyme-Linked Immunosorbent Assay;Epithelial;Family;Glycogen Synthase Kinases;Growth;Health;Human;Integral Membrane Protein;Islets of Langerhans;Laminin Receptor;Large Intestine Carcinoma;Leukocyte Chemotaxis;Link;Lymphangiogenesis;Lymphatic;Lymphatic Endothelial Cells;Lymphatic Metastasis;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Mesenchymal;Mesentery;Molecular;Molecular Target;Mus;Neoplasm Metastasis;Neurons;Nuclear;Oncogenes;Pathogenesis;Peptides;Phosphorylation;Play;Primary Neoplasm;Process;Prognostic Marker;Proteins;Reporting;Role;Serum;Signal Transduction;Small Interfering RNA;Staining method;Stains;TCF Transcription Factor;Testing;Therapeutic;Tissues;Transgenic Mice;Tube;Tumor Angiogenesis;Tyrosine;Vascular Endothelial Cell;Xenograft Model;adenoma;angiogenesis;autocrine;axon guidance;c-abl Proto-Oncogenes;cancer cell;cancer therapy;carcinogenesis;cell type;design;inhibitor/antagonist;insulinoma;knock-down;lymph nodes;melanoma;migration;mouse model;neoplastic;neutralizing monoclonal antibodies;novel;overexpression;prognostic;promoter;receptor;tool;tumor;tumor growth;tumorigenesis","Slit-Robo Signaling in Tumor Growth and Metastasis","
PROJECT NARRATIVE
Our study on Slit-Robo signaling in tumor growth and metastasis will not only deepen our understanding of the
molecular mechanisms involved in tumor growth and metastasis, but also facilitate the use of Slit2 and Robo1
as the novel molecular targets for diagnosis and treatment of cancers.","NCI","7996017","7/23/2012 12:00:00 AM","PA-07-070","5R01CA126897-04","5","R01","CA","126897","04"," ","WOODHOUSE, ELIZABETH","1/1/2009 12:00:00 AM","11/30/2013 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","7736701","GENG, JIAN-GUO ","Not Applicable","12","DENTISTRY","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","SCHOOLS OF DENTISTRY/ORAL HYGN","481091276","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","105825"," ","313325",
"No NIH Category available","Acute Lymphocytic Leukemia;Acute Myelocytic Leukemia;Adenoviruses;Adoptive Immunotherapy;Adoptive Transfer;Adult;Affinity;Allogenic;Antigen Receptors;Antigens;B lymphoid malignancy;B-Lymphocytes;Blood;Blood Cells;Bone Marrow;Bone Marrow Transplantation;CD19 Antigens;CD19 gene;Cancer Immunology Science;Cancer Patient;Carbohydrates;Caucasians;Caucasoid Race;Cause of Death;Cell Line;Cell surface;Cells;Child;Clinical;Clinical Trials;Commit;Cost Analysis;Cytomegalovirus;Cytotoxic T-Lymphocytes;Data;Disadvantaged;Disease;Dose;Effectiveness;Engraftment;Enrollment;Epitopes;Family;Fucosyltransferase;Generations;Goals;HLA Antigens;Hematologic Neoplasms;Hematopoietic;Hematopoietic stem cells;Homing;Hospitalization;Human Herpesvirus 4;Immune;Immunity;Immunology;Incidence;Infection;Infusion procedures;Institutional Review Boards;Instruction;Investigation;Laboratory Finding;Lymphocyte;Malignant - descriptor;Malignant Childhood Neoplasm;Malignant Neoplasms;Marrow;Medical;Memory;Mesenchymal;Minority;Minority Groups;Myeloid Leukemia;Outcome;Patients;Phenotype;Population;Procedures;Records;Recurrence;Relapse;Research;Research Personnel;Research Project Grants;Residual Tumors;Selectins;Services;Source;Specificity;Stem cell transplant;Stem cells;Stromal Cells;Surface;T cell therapy;T-Lymphocyte;Testing;Therapeutic;Time;Translating;Transplantation;Tumor Antigens;Umbilical Cord Blood;Umbilical Cord Blood Transplantation;Viral;Virus;Virus Diseases;Work;allotransplant;design;graft failure;graft vs host disease;immunosuppressed;improved;leukemia;multidisciplinary;neoplastic cell;novel;patient population;progenitor;programs;receptor;reconstitution;stem;stem cell biology;success;transplantation typing;tumor","IMPROVING CORD BLOOD TRANSPLANTATION","RELEVANCE (See instructions): Cord blood transplantation is a potentially useful treatment for leukemias and other hematologic malignancies, but its effectiveness has been limited by delayed engraftment, poor immune reconstitution, viral infections and relapse of the primary disease. The studies proposed in this application are designed to improve the outcome of this procedure so that it can be used more widely in cancer patients without other therapeutic options.","NCI","8337300","9/17/2012 12:00:00 AM","PAR-09-025","5P01CA148600-02","5","P01","CA","148600","02"," ","MERRITT, WILLIAM D","9/22/2011 12:00:00 AM","8/31/2016 12:00:00 AM","ZCA1-RPRB-J(J1)"," ","1866037","SHPALL, ELIZABETH J","BOLLARD, CATHERINE M.","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","9/17/2012 12:00:00 AM","8/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","1983050","509547"," ","2492597",
"Cancer; Pancreatic Cancer; Rare Diseases","1-Phosphatidylinositol 3-Kinase;Address;Affinity;Anchorage-Independent Growth;Binding;Biological;Cancer Patient;Cell Line;Cells;Clinic;Clinical;Complex;Complication;Dependence;Dependency;Development;Disease;Dissection;Drug Industry;Epithelial;GTP Binding;Gene Expression Regulation;Goals;Growth;Guanosine Triphosphate;Guanosine Triphosphate Phosphohydrolases;KRAS2 gene;Lead;Link;MEKs;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of pancreas;Mediating;Mesenchymal;Mitogen-Activated Protein Kinases;Mutation;Neoplasm Metastasis;Oncogenes;Outcome;Pathway Analysis;Pathway interactions;Patients;Pharmaceutical Preparations;Phase;Phenotype;Positioning Attribute;Property;Protein Isoforms;Protein Kinase;Proto-Oncogene Proteins c-akt;Publishing;Ras Inhibitor;Role;Sequence Analysis;Signal Pathway;Signal Transduction;Tumorigenicity;cancer therapy;design;effective therapy;genome-wide;human FRAP1 protein;human STK6 protein;in vivo;inhibitor/antagonist;mouse model;mutant;novel;optimism;overexpression;prevent;protein geranylgeranyltransferase;public health relevance;ras Oncogene;ras Proteins;small molecule;success;tumor;tumor growth;tumorigenesis;tumorigenic","Biological Activity of Ras Oncogenes","
PROJECT NARRATIVE
The essentially 100% occurrence of RAS oncogene mutations in pancreatic cancer argues that anti-Ras
inhibitors will be effective anti-cancer therapies for this deadline disease. In our studies we have identified a
key signaling pathway that is crucial for pancreatic cancer tumor growth, invasion and metastasis. Therefore,
we believe that our studies to better understand how this pathway, the RalGEF-Ral pathway, promotes Ras-
driven cancer growth will lead to our identification of novel drugs for the effective treatment of pancreatic
cancer.","NCI","8213560","3/15/2012 12:00:00 AM","PA-07-070","5R01CA042978-26","5","R01","CA","042978","26"," ","JHAPPAN, CHAMELLI","7/1/1986 12:00:00 AM","1/31/2015 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","1860326","DER, CHANNING J.","Not Applicable","04","PHARMACOLOGY","608195277","D3LHU66KBLD5","608195277","D3LHU66KBLD5","US","35.926939","-79.038605","578206","UNIV OF NORTH CAROLINA CHAPEL HILL","CHAPEL HILL","NC","SCHOOLS OF MEDICINE","275995023","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","242097","114794"," ","356891",
"No NIH Category available","Address;Adherens Junction;Adult;Alveolar;Alveolar Cell;Animal Model;Apoptosis;Area;Attenuated;Basement membrane;Birth;Blood Cells;Blood Vessels;Blood capillaries;Blood flow;Brain;Bronchopulmonary Dysplasia;Cadherins;Cell Adhesion Molecules;Cell Communication;Cell Maintenance;Cell surface;Cells;Characteristics;Chronic Kidney Insufficiency;Chronic Obstructive Airway Disease;Defect;Development;Diabetes Mellitus;Diffusion;Disease;Disease Progression;Endothelial Cells;Endothelium;Ensure;Epithelial Cells;Extravasation;Fibroblasts;Fibrosis;Filtration;Fostering;Gap Junctions;Gases;Goals;Growth;Health Care Costs;Healthcare;Hospitalization;Human;In Vitro;Integrins;Kidney;LacZ Genes;Laminin;Laser Scanning Confocal Microscopy;Learning;Liver;Longevity;Lung;Mediating;Mesenchymal;Microcirculatory Bed;Microscopic;Molecular;Mus;Myofibroblast;Newborn Infant;Nuclear;Organ;Outcome;PDGF Signaling Pathway;Pathogenesis;Pericytes;Permeability;Phosphotransferases;Plasma;Platelet-Derived Growth Factor;Platelet-Derived Growth Factor alpha Receptor;Population;Pulmonary Circulation;Pulmonary Emphysema;Pulmonary Gas Exchange;Pulmonary Hypertension;Regulation;Signal Pathway;Signal Transduction;Smooth Muscle Myocytes;Stroke;Structure;Supporting Cell;Surface;Symptoms;Therapeutic;Tight Junctions;Time;Tube;Vascular Diseases;Vascular Endothelial Growth Factors;Veterans;angiogenesis;arteriole;capillary;capillary bed;cell motility;cost;improved;interstitial;intimate behavior;mesangial cell;migration;mixed cell culture;nectin;neutrophil;novel;platelet-derived growth factor A;prevent;public health relevance;repaired;restoration;smoking prevalence;stellate cell;tumor;venule","Regulation of mural cells during pulmonary capillary formation","PROJECT NARRATIVE: Although the prevalence of smoking has declined, chronic obstructive 
pulmonary disease (COPD) and its attendant pathological pulmonary abnormality, emphysema, 
are common and disproportionately contribute to hospitalizations and health care costs among 
veterans. Because most of the currently available therapies only address symptoms, 
identification of strategies that limit disease progression remains an important goal. This 
proposal will investigate mechanisms that regulate how supporting structural cells associate 
with and modify lung capillaries, to improve gas exchange, increase blood flow, and provide 
vascular stability. These studies are relevant to other vascular diseases including stroke, 
diabetes, and chronic renal insufficiency, which are also common among veterans.","VA","8195607","12/8/2011 12:00:00 AM","RFA-BX-09-001","5I01BX000508-03","5","I01","BX","000508","03"," "," ","10/1/2009 12:00:00 AM","12/31/2013 12:00:00 AM","Respiration[PULM]"," ","1918351","MCGOWAN, STEPHEN E","Not Applicable","02","Unavailable","028084333","EJXSLDWM2BP6","028084333","EJXSLDWM2BP6","US","41.65248","-91.540398","481031","IOWA CITY VA MEDICAL CENTER","IOWA CITY","IA","Independent Hospitals","522462208","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"No NIH Category available","Abdomen;Address;Adherens Junction;Affect;Behavior;Binding;Blood Vessels;CREB1 gene;Cause of Death;Cell Survival;Cell-Matrix Junction;Cells;Cellular Structures;Complex;Cyclic AMP Response Element;Cytoskeleton;Down-Regulation;E-Cadherin;E-Cadherin Staining Method;Enzymes;Epithelial;Extracellular Matrix;Failure;Focal Adhesion Kinase 1;Funding;Gelatinase A;Genetic Transcription;Goals;Grant;Health;Healthcare;Hospitals;Integrins;Laboratories;Left;Link;Malignant Neoplasms;Malignant neoplasm of ovary;Measures;Mediating;Mediator of activation protein;Membrane Proteins;Modeling;NF-kappa B;Neoplasm Metastasis;Nude Mice;Oncogenic;Organ;Ovarian;Pathway interactions;Patients;Peritoneal;Phenotype;Phosphorylation;Play;Population;Post-Translational Protein Processing;Primary Neoplasm;Process;Proteins;Proto-Oncogene Proteins c-akt;Reporting;Resistance;Role;Signal Transduction;Site;Stem cells;Testing;Time;Tissues;Transforming Growth Factors;Transglutaminases;Tumorigenicity;Veterans;Woman;Work;abstracting;arm;base;beta catenin;cancer cell;cancer recurrence;cancer stem cell;cellular engineering;chemotherapy;crosslink;epithelial to mesenchymal transition;intraperitoneal;knock-down;malignant breast neoplasm;mortality;neoplastic cell;ovarian neoplasm;overexpression;public health relevance;response;standard care;tumor;tumor progression","Role of Tissue Transglutaminase in Ovarian Cancer","Relevance to Veterans Health and Health Care Issues: Ovarian cancer is the most fatal gynecological malignancy, metastasis to abdominal organs being the most common cause of mortality. Given the increasing numbers of women in the US Armed Forces and the VA, the devastating complications of OC and limited treatment options, the issue of developing better therapies is highly relevant to the health of our veterans. The number of women in the US Armed Forces has increased from 2% to 15% and 7.4% of the veterans served by VA Hospitals are women. This proposal will investigate the role of tissue transglutaminase in metastasis and the survival of ovarian cancer stem cells. It is likely that the persistence of these stem cells is responsible for the failure of chemotherapy to eliminate cancer. It is therefore important to VA patients to better understand the key molecules that regulate these cells, which give rise to metastases, treatment resistance and cancer recurrence.","VA","8196339","12/1/2011 12:00:00 AM","RFA-BX-09-008","5I01BX000792-02","5","I01","BX","000792","02"," "," ","10/1/2010 12:00:00 AM","9/30/2014 12:00:00 AM","Oncology A[ONCA]"," ","6681816","MATEI, DANIELA E","Not Applicable","07","Unavailable","608434697","FF27EX32BTZ1","608434697","FF27EX32BTZ1","US","39.77973","-86.187563","481029","RLR VA MEDICAL CENTER","INDIANAPOLIS","IN","Independent Hospitals","462022803","UNITED STATES","N","10/1/2011 12:00:00 AM","9/30/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Biotechnology; Cancer; Genetics; Kidney Disease; Prevention; Rare Diseases","Accounting;Adaptor Signaling Protein;Adult;Biological Assay;Cancer Biology;Cancer Model;Cell Culture Techniques;Cells;Cessation of life;Characteristics;Clear Cell;Complex;Conditioned Culture Media;Defect;Development;Disease;Disseminated Malignant Neoplasm;Drosophila genus;Early Diagnosis;Epigenetic Process;Erythropoietin;Event;Excision;Familial Polycythemia;Fibrosis;Funding;Gene Expression Profile;Gene Expression Profiling;Genes;Genetic;Genetic Epistasis;Genetic Markers;Genetic Models;Germ Lines;Glucose;Glycolysis;Human;Hypoxia Inducible Factor;In Vitro;Incidence;Inflammation;Injury;Kidney;Knock-out;Knockout Mice;Lasers;Lesion;Loss of Heterozygosity;Malignant Epithelial Cell;Malignant Neoplasms;Metabolic;Metabolic Pathway;Metastatic to;Modeling;Molecular;Molecular Profiling;Mus;Mutation;Names;Operative Surgical Procedures;Pathway interactions;Patients;Premalignant;Preventive;Primary Lesion;Process;Procollagen-Proline Dioxygenase;Proteins;Radiation;Relapse;Renal Cell Carcinoma;Renal carcinoma;Renal tubule structure;Reporter Genes;Role;Signal Transduction;Somatic Mutation;Survival Rate;Symptoms;System;Therapeutic;Time;Tissues;Tumor Suppressor Genes;Uncertainty;United States;VHL gene;VHL mutation;Vascular Endothelial Growth Factors;Von Hippel-Lindau Syndrome;attributable mortality;cancer cell;cancer type;cell type;chemokine;cytokine;design;epithelial to mesenchymal transition;expectation;in vivo;kidney cell;mouse model;mutant;mutant mouse model;novel;protein degradation;public health relevance;statistics;tumor;tumor initiation;tumor progression;tumorigenesis;tumorigenic;ubiquitin-protein ligase","VHL tumor suppressor gene and the initiation of renal cell carcinoma","
Relevance: Mutations in VHL tumor suppressor gene are the cause of a majority of kidney cancers, but the
exact tumorigenic mechanism of this deadly disease is still unknown. We recently developed a VHL mutant
mouse model that for the first time, generated kidney cancer and suggested an intriguing possibility of
inflammation prior to tumor development. Our proposed study should shed lights on the process of kidney
cancer formation and point to preventive and curative strategies.","NCI","8494112","8/2/2012 12:00:00 AM","PA-10-067","3R01CA109860-08S1","3","R01","CA","109860","08","S","OGUNBIYI, PETER","7/1/2004 12:00:00 AM","3/31/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1921964","HSU, TIEN ","Not Applicable","07","Unavailable","005492160","JZ8RQC4EMDZ5","005492160","JZ8RQC4EMDZ5","US","42.337865","-71.070685","3617301","BOSTON MEDICAL CENTER","BOSTON","MA","Independent Hospitals","021182908","UNITED STATES","N","8/2/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","44684","30832"," ","75516",
"Diabetes; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Embryonic - Non-Human; Stem Cell Research - Nonembryonic - Non-Human","Acinar Cell;Address;Adult;Apoptosis;Area;Autoimmune Process;Beta Cell;Binding;Biological Process;Bone Marrow;CDKN2A gene;Cell Cycle;Cell Differentiation process;Cell Lineage;Cell Proliferation;Cell division;Cell physiology;Cells;Cellular biology;Chemical Warfare;Clinical;Complex;Cyclin D1;Cyclin-Dependent Kinase 4;Cyclin-Dependent Kinases;DNA;Development;Diabetes Mellitus;Diagnostic;Disease;Ductal;Ductal Epithelial Cell;Ductal Epithelium;E2F Transcription Factor 1;E2F1 gene;Embryo;Endocrine;Epithelial;Epithelium;Exhibits;Gene Targeting;Generations;Genes;Glucose;Goals;Growth;Growth and Development function;Hour;Hyperplasia;Inherited;Injury;Insulin;Investigation;Islets of Langerhans;Kinetics;Knockout Mice;Lead;Location;Maintenance;Mammalian Cell;Mediating;Mesenchymal;Mesenchyme;Modeling;Morphogenesis;Mus;Mutant Strains Mice;Natural regeneration;Obesity;Organ;Organogenesis;Pancreas;Pancreatectomy;Pancreatic duct;Pathogenesis;Pathway interactions;Phosphotransferases;Physiological;Play;Pluripotent Stem Cells;Point Mutation;Primary Cell Cultures;Process;Property;Recruitment Activity;Regulation;Relative (related person);Reporting;Research;Retinoblastoma Protein;Role;Source;Specific qualifier value;Splenocyte;Stem cells;Sum;Therapeutic;Tissues;Toxin;Translating;analog;base;cell growth;clinical application;cyclin D2;diabetes management;diabetes mellitus therapy;embryonic stem cell;established cell line;human CDK2 protein;in vivo;inhibitor/antagonist;islet;mathematical model;mortality;mouse model;novel;pancreas development;precursor cell;progenitor;programs;promoter;reconstitution;regenerative;response;transcription factor;transdifferentiation;treatment strategy","Cell Cycle Regulators in Pancreatic Development and Disease","n/a","NIDDK","8553541"," "," ","1ZIADK055105-06","1","ZIA","DK","055105","06"," "," "," "," "," "," ","9415529","RANE, SUSHIL ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIDDK"," "," "," ","346331",
"Cancer; Dental/Oral and Craniofacial Disease; Genetics; Human Genome; Rare Diseases","4-Hydroxy-Tamoxifen;Abbreviations;Alcohols;Anthracenes;Benign;Binding;Biological Markers;Biology;Cancer Prognosis;Cells;Chronic;Collagen;Country;Data;Defect;Development;Down-Regulation;Elements;Environmental Carcinogens;Epithelial;Epithelial Cells;Epithelium;Event;Experimental Models;Family member;Fanconi&apos;s Anemia;Fibroblasts;Funding;Gene Targeting;Genes;Genetically Engineered Mouse;Genomic Instability;Goals;HRAS gene;Head and Neck Cancer;Head and Neck Squamous Cell Carcinoma;Head and neck structure;Human;Immunohistochemistry;Inflammation;Lead;Loss of Heterozygosity;Malignant Conversion;Malignant Neoplasms;Matrix Metalloproteinases;Mediating;Mesenchymal;Microarray Analysis;Molecular;Molecular Target;Mouth Neoplasms;Mus;Mutation;Oncogenic;Pathway Analysis;Pathway interactions;Patients;Play;Poly(ADP-ribose) Polymerases;Production;Role;Signal Pathway;Signal Transduction;Squamous cell carcinoma;System;Testing;Therapeutic;Tissues;Tobacco;Transforming Growth Factor beta;Transforming Growth Factors;Up-Regulation;Vascular Endothelial Growth Factors;angiogenesis;base;cancer therapy;cancer type;carcinogenesis;chemical carcinogen;chromatin immunoprecipitation;comparative genomic hybridization;cytokine;dimethylbenzanthracene;genome wide association study;genome-wide;improved;laser capture microdissection;macrophage stimulating protein;member;mouse model;novel therapeutic intervention;oral fibroblast;oral tissue;outcome forecast;overexpression;paracrine;promoter;public health relevance;receptor;tumor","Role of TGFbeta signaling in HNSCC progression","
Project Narrative
The application will use state-of-the-art experimental models and approaches to identify
molecular mechanisms that cause head & neck cancer formation and progression. The
proposed studies will lead to the identification of biomarkers that can be used to improve cancer
prognosis and therapy.","NIDCR","8208190","12/28/2011 12:00:00 AM","PA-07-070","5R01DE015953-09","5","R01","DE","015953","09"," ","VENKATACHALAM, SUNDARESAN","3/1/2004 12:00:00 AM","1/31/2015 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","7838047","WANG, XIAO-JING ","Not Applicable","06","PATHOLOGY","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","273077","123965"," ","397042",
"Cancer; Genetics; Prostate Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Urologic Diseases","Address;Aftercare;American;Androgens;Award;Benign;Biological Markers;CSF1 gene;CSF1R gene;Cancer Etiology;Cell Cycle;Cell Maintenance;Cell Proliferation;Cell Survival;Cells;Cessation of life;Characteristics;Chronic;Collaborations;Culture Techniques;Cytotoxic agent;DNA Damage;Development;Dinoprostone;Disease;Epigenetic Process;Epithelium;Etiology;Event;Family;Fibroblasts;Fred Hutchinson Cancer Research Center;Genitourinary system;Growth;Growth Factor;HMGA2 gene;Homeostasis;Immune;Immune System and Related Disorders;Immune Tolerance;Immune system;Immunotherapy;In Vitro;Infection;Inflammation;Inflammatory;Instruction;Joints;Laboratories;Light;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of prostate;Mesenchymal;Mesenchyme;Molecular;Mus;Natural regeneration;Oncogenes;Oncogenic;Organ;Organogenesis;Outcome;Pathogenesis;Pathway interactions;Phenotype;Property;Prostate;Prostatic Neoplasms;Proteins;Radiation;Regulation;Regulatory Pathway;Research;Resistance;Resistance development;Role;Signal Transduction;Stem cells;System;Therapeutic;Therapeutic Intervention;Tissues;Tumor Expansion;Tumor Stem Cells;Tumor Tissue;Universities;Washington;advanced disease;base;cancer cell;cancer prevention;cancer stem cell;cancer therapy;cell behavior;cell transformation;cell type;chemotherapy;cytokine;design;genetic technology;improved;inhibitor/antagonist;male health;man;member;men;neoplastic;neoplastic cell;novel;novel therapeutics;paracrine;progenitor;programs;response;self-renewal;stem;stem cell therapy;therapy resistant;tissue regeneration;tumor;tumor progression;tumorigenesis;tumorigenic","Influences of the Microenvironment on Cancer Stem Cells","RELEVANCE (See instructions): 
Despite its enormous impact on male health, the molecular mechanisms underlying the pathogenesis of 
prostate cancer remain unsolved. A central focus of this application is to investigate whether cells, molecule 
and regulatory pathways surrounding the prostate stem cells can alter stem cell properties and contribute to 
prostate cancer development and resistance to therapies. This will help in understanding the origin of the 
disease and provide rationales for novel, stem cell-targeted treatment.","NCI","8333391","8/28/2012 12:00:00 AM","PAR-09-026","5U01CA164188-02","5","U01","CA","164188","02"," ","MOHLA, SURESH","9/15/2011 12:00:00 AM","8/31/2016 12:00:00 AM","ZCA1-SRLB-V(O1)"," ","7748029","WU, HONG ","NELSON, PETER S; WITTE, OWEN N.","33","PHARMACOLOGY","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","SCHOOLS OF MEDICINE","900952000","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","466981","133296"," ","600277",
"Aging; Atherosclerosis; Biotechnology; Cardiovascular; Clinical Research","Address;Adult;Age;Aorta;Apolipoprotein E;Arterial Fatty Streak;Arterial Injury;Atherosclerosis;Biology;Blood Vessels;Bone Marrow Cells;Bone Marrow Transplantation;Bromodeoxyuridine;Candidate Disease Gene;Cardiovascular Diseases;Cardiovascular system;Cell Count;Cells;Cessation of life;Clinical;Clinical Medicine;Clinical Research;Contractile Proteins;Coupled;Data;Development;Endothelial Cells;Endothelium;Epidemic;Event;Failure;Fibroblasts;Flow Cytometry;Fluorescence Microscopy;Fostering;Future;Gene Chips;Gene Expression Profile;Genes;Goals;Harvest;Homeostasis;Immunofluorescence Microscopy;In Vitro;Inflammation;Injury;Kinetics;Label;Location;Maintenance;Maps;Mediating;Mentors;Mesenchymal;Modeling;Molecular;Morbidity - disease rate;Mus;Myocardial Infarction;Myofibroblast;Necrosis;Osteoblasts;Pathway interactions;Phenotype;Play;Prevention;Process;Proliferating;Proteins;Public Health;Research;Research Project Grants;Resolution;Role;Rupture;Seeds;Senile Plaques;Shoulder;Signal Transduction;Smooth Muscle Myocytes;Societies;Speed;Stroke;Structure;System;Tamoxifen;Techniques;Thick;Thrombosis;Time;Tissues;Training;Transgenic Mice;Tunica Adventitia;Vascular Diseases;Viral Vector;Wound Healing;arterial remodeling;atherothrombosis;base;career;career development;cell type;defined contribution;design;femoral artery;fighting;in vivo;injury and repair;insight;interest;intima media;laser capture microdissection;migration;mortality;mouse model;neutralizing antibody;normal aging;novel;pre-clinical;programs;promoter;receptor;repaired;research study;skills;small hairpin RNA;vector","Cellular and molecular mechanisms of endothelial repair and atherosclerosis","  This proposal seeks to characterize the contribution of endothelial cells to arterial homeostasis, arterial repair and atherosclerosis. Using unique mouse models we will define the function of endothelial cells in these processes and also investigate the ability of endothelial cells to change their phenotype to become smooth muscle cells, fibroblasts or other cells that drive atherosclerosis. These experiments are highly relevant to public health as they are designed to identify novel molecular pathways, with the ultimate aim of creating new treatments to fight cardiovascular disease.   
      

","NHLBI","8225629","12/12/2011 12:00:00 AM","PA-10-059","1K08HL111330-01","1","K08","HL","111330","01"," ","SCOTT, JANE","12/12/2011 12:00:00 AM","11/30/2016 12:00:00 AM","ZHL1-CSR-K(O1)"," ","10714317","KOVACIC, JASON CIRIL","Not Applicable","13","INTERNAL MEDICINE/MEDICINE","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","SCHOOLS OF MEDICINE","100296574","UNITED STATES","N","12/12/2011 12:00:00 AM","11/30/2012 12:00:00 AM","837","Other Research-Related","2012"," "," ","NHLBI","119875","9590"," ","129465",
"Aging; Cancer; Genetics; Prostate Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Urologic Diseases","Affect;Animal Model;Animals;Apoptosis;BMP4;Cancer Model;Cells;Cellular biology;Characteristics;Chromosomes;Clinical;Crowding;Cues;DNA;Data;Diagnosis;Differentiation and Growth;Disease;Epithelial;Epithelial Cells;Epithelium;Family;Fibrous capsule of kidney;Freezing;Gene Amplification;Gene Deletion;Gene Dosage;Genes;Genetic;Genitourinary system;Gleason Grade for Prostate Cancer;Growth;Health;Heterozygote;Human Genome;Hyperplasia;In Vitro;Interleukin-1;Knockout Mice;Lead;Luciferases;Lymph Node Involvement;MAP kinase kinase kinase 7;MAP3K7 gene;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Mesenchymal;Methylation;Missense Mutation;Mitogen-Activated Protein Kinases;Modeling;Mutation;Neoplasm Metastasis;Normal tissue morphology;Nuclear Atypia;Nude Mice;Oncogenes;PTEN gene;Pathway interactions;Penetration;Phenotype;Phosphotransferases;Population Study;Prevalence;Prognostic Marker;Proliferating;Proliferation Marker;Prostate;Prostatic Intraepithelial Neoplasias;Prostatic Neoplasms;Protein-Serine-Threonine Kinases;Proteins;Radical Prostatectomy;Recombinants;Role;Sampling;Seminal Vesicles;Serine;Signal Transduction;Signal Transduction Pathway;Signaling Molecule;Stem cells;Stromal Cells;TNF gene;Testing;Time;Tissue Grafts;Tissue Recombination;Tissues;Tumor Suppressor Genes;Tumor Suppressor Proteins;Tumor Tissue;Universities;Weight;cohort;density;fetal;forest;gene interaction;human MAP3K7 protein;in vivo;interdisciplinary approach;male;medical schools;member;men;monolayer;mouse model;neoplastic cell;novel;novel strategies;overexpression;progenitor;promoter;response;stem cell differentiation;therapeutic target;tumor;tumor progression;tumorigenesis","Tak1, a novel prostate cancer tumor suppressor","
Prostate cancer is a deadly disease that affects one in six men in the US. We have
identified a potential prostate cancer tumor suppressor gene located on chromosome
6q15, the MAP3K7 gene. Our studies will test if this gene is a prostate cancer tumor
suppressor and interrogate its downstream targets.","NCI","8239454","3/28/2012 12:00:00 AM","PA-07-070","5R01CA129418-05","5","R01","CA","129418","05"," ","SNYDERWINE, ELIZABETH G","7/1/2009 12:00:00 AM","4/30/2014 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","1968849","CRAMER, SCOTT D","Not Applicable","06","PHARMACOLOGY","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","206075","100994"," ","307069",
"No NIH Category available","Adenocarcinoma Cell;Alkaloids;Animals;Biology;Cancer Etiology;Cancer Patient;Caring;Cell Line;Cells;Cessation of life;Clinical Treatment;Culture Setup;Cysteine;Data;Diagnosis;Disease;Disease Resistance;Distant;Drug resistance;Early Diagnosis;Erinaceidae;Etiology;Event;Exhibits;Genes;Genetically Engineered Mouse;Growth;Growth Factor;Heparin Binding;Human;In Vitro;Integrins;Knowledge;Laboratories;Lead;Lesion;Ligands;Link;Longevity;Maintenance;Malignant neoplasm of pancreas;Mediating;Mediator of activation protein;Modeling;Molecular;Molecular Target;Neoplasm Metastasis;Organ;Outcome Study;Palliative Care;Pancreas;Pancreatic Adenocarcinoma;Pancreatic Ductal Adenocarcinoma;Pathogenesis;Pathway interactions;Patients;Phenotype;Physiologic Neovascularization;Play;Pre-Clinical Model;Proteins;Regulation;Resistance;Role;Sampling;Signal Pathway;Signal Transduction;Solid Neoplasm;Sonic Hedgehog Pathway;Stem cells;Stream;Survival Rate;Systemic Therapy;Teratogens;Testing;Therapeutic;Time;Translating;United States;Up-Regulation;Work;Xenograft Model;Xenograft procedure;cancer stem cell;cancer therapy;carcinogenesis;cell motility;chemotherapy;clinical practice;cyclopamine;epithelial to mesenchymal transition;gemcitabine;human SMO protein;improved;in vivo;inhibitor/antagonist;insight;migration;mouse model;notch protein;novel;outcome forecast;pancreatic cancer cells;prevent;public health relevance;receptor;research study;response;small molecule;smoothened signaling pathway;tissue culture;tumor;tumor growth;tumor progression;tumor xenograft","The Role of Cyr61 in Patho-Biology and Therapeutics of Pancreatic Cancer","Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths in the United States. A patient with PDAC has the worst survival rate of any solid tumor due to its late detection, early metastasis, and resistance to conventional chemotherapy. We have suggested that Cyr61 may be an early and late mediator of PDAC. This insight is developed from our recent findings which indicate that Cyr61 regulates Sonic Hedgehog (SHh) expression. Cyr61 promotes multiple crucial events associated with the progression of the disease and resistance to chemotherapy. The objectives of this project are to evaluate the mechanism whereby Cyr61 regulates SHh expression in pancreatic cancer, as well as uncover the mechanisms by which Cyr61 promotes tumor progression and metastatic growth to the distant organs. The role of Cyr61 in resistance to chemotherapy will also be evaluated. We are anticipating that the outcome of these studies will propose that targeting Cyr61 can provide a new treatment option for patients with pancreatic cancer.","VA","8242631","12/9/2011 12:00:00 AM","RFA-BX-10-001","5I01BX001002-02","5","I01","BX","001002","02"," "," ","1/1/2011 12:00:00 AM","12/31/2014 12:00:00 AM","Oncology A[ONCA]"," ","7835883","BANERJEE, SNIGDHA ","Not Applicable","05","Unavailable","844272125","K2Q8HL5K1ZF2","844272125","K2Q8HL5K1ZF2","US","39.067164","-94.527526","481049","KANSAS CITY VA MEDICAL CENTER","KANSAS CITY","MO","Independent Hospitals","641282226","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Biotechnology; Cancer; Genetics; Hematology; Rare Diseases","Affect;African American;BCL9 gene;Biological Assay;Biological Models;Bone Marrow;Bone Marrow Cells;Caucasians;Caucasoid Race;Cell Line;Cell Proliferation;Cell Survival;Cells;Colon Carcinoma;Complex;Data;Development;Disease;Disease Progression;Early Diagnosis;Elderly;Epithelial;Event;Gene Expression Profiling;Gene Targeting;Gene Transfer;Genes;Genetic;Genetic Transcription;Goals;Health;Hematologic Neoplasms;Heterogeneity;High-Dose Chemotherapy with Autologous Stem Cell Transplant;Homeostasis;Human;Immunoblot Analysis;In Vitro;Individual;Investigation;Laboratories;Lead;Ligands;Maintenance;Malignant Neoplasms;Mediating;Medicine;Mesenchymal;Mining;Modeling;Molecular;Molecular Genetics;Molecular Target;Multiple Myeloma;Mutation;Non-Hodgkin&apos;s Lymphoma;Oncogenes;Pathogenesis;Pathway interactions;Patients;Peptides;Play;Pre-Clinical Model;Property;Proteins;Public Health;RNA Interference;Reporter;Role;Signal Transduction;Small Interfering RNA;Technology;Testing;Therapeutic;Therapeutic Intervention;Tropism;Tumor Suppressor Proteins;Validation;Work;alpha helix;base;beta catenin;chromatin immunoprecipitation;cytokine;effective therapy;extracellular;gain of function;improved;in vivo;in vivo Model;inhibitor/antagonist;loss of function;loss of function mutation;model design;nanoparticle;neoplastic cell;new therapeutic target;novel;overexpression;protein complex;response;small hairpin RNA;small molecule;therapeutic development;therapeutic target;therapy resistant;tool;tumor;tumor growth;tumor progression","Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics","PUBLIC HEALTH RELEVANCE: Multiple Myeloma (MM) is the second most frequent hematological cancer in the US after non-Hodgkin's lymphoma with about 20,000 individuals succumbing to this dreaded disease each year in the US alone. MM primarily affects older adults and it is more common in black populations than in Caucasians. Despite high- dose chemotherapy with stem cell support, MM remains incurable. Therefore, there is a significant need for continual efforts directed towards the development of novel and effective rational-based therapeutics for MM. Here, we propose to functionally characterize and validate as therapeutic target the BCL9 oncogene, a recently discovered transcriptional regulator protein that we have found to play important roles in the pathogenesis and progression of MM and colon carcinoma. The studies proposed in this RO1 are significant to Public Health in that they may lead to the development of novel pharmacologic strategies to treat MM and other cancers associated with deregulated Wnt signaling.","NCI","8260868","4/27/2012 12:00:00 AM","PA-07-070","5R01CA151391-03","5","R01","CA","151391","03"," ","HOWCROFT, THOMAS K","7/1/2010 12:00:00 AM","5/31/2015 12:00:00 AM","Cancer Molecular Pathobiology Study Section[CAMP]"," ","6410805","CARRASCO, RUBEN D","Not Applicable","07","Unavailable","076580745","DPMGH9MG1X67","076580745","DPMGH9MG1X67","US","42.337844","-71.108337","1464901","DANA-FARBER CANCER INST","BOSTON","MA","Independent Hospitals","022155450","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","144918"," ","346193",
"Biotechnology; Cancer; Genetics; Kidney Disease; Prevention; Rare Diseases","Accounting;Adaptor Signaling Protein;Adult;Biological Assay;Cancer Biology;Cancer Model;Cell Culture Techniques;Cells;Cessation of life;Characteristics;Clear Cell;Complex;Conditioned Culture Media;Defect;Development;Disease;Disseminated Malignant Neoplasm;Drosophila genus;Early Diagnosis;Epigenetic Process;Erythropoietin;Event;Excision;Familial Polycythemia;Fibrosis;Funding;Gene Expression Profile;Gene Expression Profiling;Genes;Genetic;Genetic Epistasis;Genetic Markers;Genetic Models;Germ Lines;Glucose;Glycolysis;Human;Hypoxia Inducible Factor;In Vitro;Incidence;Inflammation;Injury;Kidney;Knock-out;Knockout Mice;Lasers;Lesion;Loss of Heterozygosity;Malignant Epithelial Cell;Malignant Neoplasms;Metabolic;Metabolic Pathway;Metastatic to;Modeling;Molecular;Molecular Profiling;Mus;Mutation;Names;Operative Surgical Procedures;Pathway interactions;Patients;Premalignant;Preventive;Primary Lesion;Process;Procollagen-Proline Dioxygenase;Proteins;Radiation;Relapse;Renal Cell Carcinoma;Renal carcinoma;Renal tubule structure;Reporter Genes;Role;Signal Transduction;Somatic Mutation;Survival Rate;Symptoms;System;Therapeutic;Time;Tissues;Tumor Suppressor Genes;Uncertainty;United States;VHL gene;VHL mutation;Vascular Endothelial Growth Factors;Von Hippel-Lindau Syndrome;attributable mortality;cancer cell;cancer type;cell type;chemokine;cytokine;design;epithelial to mesenchymal transition;expectation;in vivo;kidney cell;mouse model;mutant;mutant mouse model;novel;protein degradation;public health relevance;statistics;tumor;tumor initiation;tumor progression;tumorigenesis;tumorigenic;ubiquitin-protein ligase","VHL tumor suppressor gene and the initiation of renal cell carcinoma","
Relevance: Mutations in VHL tumor suppressor gene are the cause of a majority of kidney cancers, but the
exact tumorigenic mechanism of this deadly disease is still unknown. We recently developed a VHL mutant
mouse model that for the first time, generated kidney cancer and suggested an intriguing possibility of
inflammation prior to tumor development. Our proposed study should shed lights on the process of kidney
cancer formation and point to preventive and curative strategies.","NCI","8248192","4/6/2012 12:00:00 AM","PA-10-067","5R01CA109860-08","5","R01","CA","109860","08"," ","AULT, GRACE S","7/1/2004 12:00:00 AM","3/31/2016 12:00:00 AM","Tumor Microenvironment Study Section[TME]"," ","1921964","HSU, TIEN ","Not Applicable","07","Unavailable","005492160","JZ8RQC4EMDZ5","005492160","JZ8RQC4EMDZ5","US","42.337865","-71.070685","3617301","BOSTON MEDICAL CENTER","BOSTON","MA","Independent Hospitals","021182908","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","194378","134121"," ","328499",
"No NIH Category available","1-Phosphatidylinositol 3-Kinase;ABL1 gene;ATF2 gene;Abbreviations;Address;Amino Acids;Binding;Biochemical Genetics;Biology;Cell Nucleus;Cell Proliferation;Cell membrane;Cell surface;Cells;Cicatrix;Clathrin;Colony-Stimulating Factor Receptors;Complex;Couples;Data;Dominant-Negative Mutation;Down-Regulation;Endocytosis;Endoplasmic Reticulum;Environment;Epidermal Growth Factor;Epidermal Growth Factor Receptor;Epithelial;Epithelial Cells;Fibroblasts;Fibrosis;Fluorescence Resonance Energy Transfer;Focal Adhesion Kinase 1;Golgi Apparatus;Growth;Growth Factor;Health;Human;Immunoprecipitation;Intervention;Language;Length;Ligands;Locales;Malignant Neoplasms;Mediating;Membrane;Mesenchymal;Modeling;Nuclear;Nuclear Import;Nuclear Pore Complex;Nuclear Receptors;Organ;PAK2 kinase;Pathway interactions;Phosphorylation;Phosphotransferases;Platelet-Derived Growth Factor;Proteins;Public Health;Publishing;Receptor Cell;Recycling;Reporting;Role;Route;Signal Transduction;Site;T1R receptor;Testing;Therapeutic;Transforming Growth Factor beta;Transforming Growth Factor beta Receptors;Transforming Growth Factors;Treatment Efficacy;Wound Healing;c-abl Proto-Oncogenes;cell growth;cell type;granulocyte;human FRAP1 protein;inhibitor/antagonist;monocyte colony stimulating factor;nucleocytoplasmic transport;prevent;public health relevance;receptor;response;scaffold;trafficking;transcription factor","TGF beta Receptors and Cell Proliferation","
Relevance to public health (lay language): TGF-ï¿½ is a protein which can be either helpful or harmful to human
health. While its ability to stimulate cell growth is important for normal wound healing, when unchecked the
function of many organs can be disrupted by scar (i.e., fibrosis) formation. Conversely, the growth inhibitory
actions of TGF-ï¿½ are critical in preventing cancer. The proposed studies will identify/characterize targets which
direct these different activities and can be used to either increase or decrease the response.","NIGMS","8247728","4/13/2012 12:00:00 AM","PA-10-067","5R01GM054200-17","5","R01","GM","054200","17"," ","MAAS, STEFAN","5/1/1996 12:00:00 AM","4/30/2015 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","1893649","LEOF, EDWARD B","Not Applicable","01","Unavailable","006471700","Y2K4F9RPRRG7","006471700","Y2K4F9RPRRG7","US","44.022374","-92.465881","4976101","MAYO CLINIC ROCHESTER","ROCHESTER","MN","Other Domestic Non-Profits","559050001","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","225000","129825"," ","354825",
"No NIH Category available","Address;Adhesions;Affect;Aggressive behavior;Area;Behavior;Binding;Biochemical;Biological;Biological Markers;Biology;Biopsy;Blood Circulation;Bone Marrow;Bone Marrow Cells;Breast Cancer Model;Cancer Model;Cell model;Cell physiology;Cells;Cellular biology;Chest;Clinical;Clinical Data;Collaborations;Collection;Complex;Data;Development;Diagnostic;Distant;Doctor of Philosophy;Endocrine;Epithelial;Etiology;Exhibits;Extracellular Matrix;Extracellular Matrix Proteins;Extramedullary;Extravasation;Fibroblasts;Funding;General Hospitals;Generations;Genes;Genetically Engineered Mouse;Goals;Growth Factor;Hematopoietic;Human;Individual;Inflammatory;Institutes;Instruction;Integrins;Invaded;Investigation;Laboratories;Link;Lung Adenocarcinoma;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of lung;Mass Spectrum Analysis;Massachusetts;Medicine;Mesenchymal;Methods;Modeling;Molecular;Mus;Myeloid Cells;Myofibroblast;Nature;Neoplasm Metastasis;Neoplastic Epithelial Cell;Neoplastic Stromal Cell;Non-Small-Cell Lung Carcinoma;Normal Cell;Oncologist;Organ;Paracrine Communication;Pathogenesis;Patients;Phenotype;Physiological;Play;Primary Neoplasm;Process;Property;Proteins;Proteomics;Reagent;Recording of previous events;Recruitment Activity;Research;Research Project Grants;Role;Sampling;Signal Transduction;Site;Spleen;Splenomegaly;Stem cells;Stromal Cells;System;Systems Biology;Tenascin;Testing;Therapeutic Intervention;Tissue Microarray;Tissue Sample;Tissues;Tumor Bank;Tumor Tissue;Work;base;behavior influence;cancer cell;cell type;college;cytokine;extracellular;granulocyte;host neoplasm interaction;human tissue;imaging modality;in vivo;innovation;loss of function;macrophage;malignant breast neoplasm;migration;monocyte;mouse model;neoplastic cell;neutrophil;novel;overexpression;pre-clinical;precursor cell;prognostic;prognostic indicator;programs;release factor;response;stem;trafficking;trait;tumor;tumor progression;working group","Impact of Cellular and Extracellular Host Components on Tumor Progression","RELEVANCE (See instructions): 
Tumor cells are strongly influenced by their surroundings, the so-called microenvironment, which contains multiple normal cell types from the local tissue and recruited from distant sites in the body as well an extracellular matrix of proteins. These components interact with tumor cells in both protumorigenic and antitumorigenic ways. This application seeks to identify the roles of many of these microenvironmental 
influence in cancer.","NCI","8337799","9/7/2012 12:00:00 AM","RFA-CA-10-021","5U54CA163109-02","5","U54","CA","163109","02"," ","MOHLA, SURESH","9/23/2011 12:00:00 AM","7/31/2016 12:00:00 AM","ZCA1-SRLB-3(O1)"," ","1894213","HYNES, RICHARD O","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","001425594","E2NYLCDML6V1","001425594","E2NYLCDML6V1","US","42.359476","-71.093853","4911501","MASSACHUSETTS INSTITUTE OF TECHNOLOGY","CAMBRIDGE","MA","SCHOOLS OF ARTS AND SCIENCES","021421029","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","397","Research Centers","2012"," "," ","NCI","576150","206246"," ","734206",
"Biotechnology; Cancer; Genetics; Orphan Drug; Ovarian Cancer; Rare Diseases","Apoptosis;Behavior;Cancer Patient;Cancerous;Cause of Death;Cell Culture Techniques;Cell Proliferation;Cell Survival;Cell physiology;Characteristics;Clinical;Data;Death Rate;Development;Diagnosis;Diagnostic;Disease;Down-Regulation;Early Diagnosis;Ectopic Expression;Epithelial Cells;Gene Targeting;Genes;Goals;Growth;Human;Intervention;Intra-abdominal;Lead;Lysophospholipids;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of ovary;Messenger RNA;Metastatic Malignant Neoplasm to the Ovary;MicroRNAs;Molecular Profiling;Neoplasm Metastasis;Normal Cell;Nucleotides;Oncogenes;Oncogenic;Operative Surgical Procedures;Ovarian;Ovarian Carcinoma;Ovary;Patients;Phenotype;Plasma;Platinum;Play;Primary Neoplasm;Process;Prognostic Marker;Receptor Gene;Regulation;Relapse;Resistance;Role;Scheme;Screening for Ovarian Cancer;Serum;Simian virus 40;Small RNA;Staging;Surface;Survival Rate;Testing;Tissues;Transcriptional Regulation;Transgenic Mice;Treatment Failure;Tumor Debulking;Tumor Markers;Tumor Suppressor Genes;Up-Regulation;Western World;Xenograft procedure;angiogenesis;base;cancer cell;cancer therapy;carcinogenesis;cell motility;chemotherapy;epithelial to mesenchymal transition;gain of function;loss of function;lysophosphatidic acid;malignant phenotype;mouse model;mullerian-inhibiting hormone;neoplastic;novel;outcome forecast;overexpression;promoter;response;standard care;therapeutic target;tumorigenesis","MicroRNAs in Human Ovarian Cancer","
Project Narrative MicroRNA in Human Ovarian Cancer
Ovarian carcinoma is the leading cause of death from gynecological malignancies. Its high death rate is a result
of the fact that most patients (~75%) are diagnosed at an advanced stage of disease. Despite an initial response
rate of 65%-80% to first-line chemotherapy, most ovarian carcinomas relapse. Acquired resistance to further
chemotherapy is generally responsible for treatment failure, resulting in an overall 5-year survival rate of only
about 25% for late-stage ovarian cancer. Thus, there is urgent need to develop tumor markers for early detection
and identify novel molecules that are responsible for chemoresistance and ovarian cancer development, and thus
lead to new targeted therapy. We have recently identified frequent alterations of a class small nucleotides,
called microRNAs, in human ovarian cancer. Some of these microRNAs are involved in chemoresistance and
drive ""normal"" cells to malignant behavior. We also detected microRNA in human ovarian cancer plasma.
Based on these preliminary results, we will investigate if the microRNAs could be diagnostic/prognostic markers,
therapeutic targets and causal factors in human ovarian cancer. These studies will have significant impact on
ovarian cancer detection and treatment.","NCI","8257530","4/9/2012 12:00:00 AM","PA-07-070","5R01CA137041-04","5","R01","CA","137041","04"," ","ARYA, SURESH","6/1/2009 12:00:00 AM","4/30/2014 12:00:00 AM","Basic Mechanisms  of Cancer Therapeutics Study Section[BMCT]"," ","2083857","CHENG, JIN Q","Not Applicable","14","Unavailable","139301956","DVHKP4N619V9","139301956","DVHKP4N619V9","US","28.062545","-82.419587","3736101","H. LEE MOFFITT CANCER CTR & RES INST","TAMPA","FL","Research Institutes","336129497","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","201275","134854"," ","336129",
"Breast Cancer; Cancer; Estrogen; Pediatric","Adult;Adverse effects;Agonist;American;Animals;Apoptosis;Atomic Force Microscopy;Biochemical;Biomechanics;Brain region;Breast;Breast Cancer Risk Factor;Carcinoma in Situ;Complex;Data;Daughter;Development;Diethylstilbestrol;Distal;Dose;Ductal;Endocrine Disruptors;Environment;Epithelium;Estrogen Receptors;Estrogens;Estrus;Evaluation;Exposure to;Extracellular Matrix;Fatty acid glycerol esters;Fetal Development;Gene Expression;Gland;Goals;Gonadotropins;Health;Health Policy;Hormonal;Hormones;Human;Hyperplasia;Hypothalamic structure;In Vitro;Incidence;Infertility;Intraductal Hyperplasia;Knowledge;Lactation;Lead;Lesion;Life;Link;Malignant Neoplasms;Mammary gland;Mediating;Mesenchymal;Mesenchyme;Methods;Modeling;Molecular;Morphogenesis;Mus;Neoplasms;Neoplastic Cell Transformation;Noninfiltrating Intraductal Carcinoma;Obesity;Organogenesis;Outcome;Ovarian hormone;Pathology;Perinatal;Perinatal Exposure;Periodicity;Phenotype;Pituitary Gland;Population;Pregnancy;Premalignant;Prevalence;Process;Property;Public Health;Research;Rodent;Role;Signal Transduction;Testing;Time;Tissues;Toxic effect;Transplantation;Woman;Work;anticancer research;bisphenol A;brain behavior;carcinogenicity;exposed human population;fetal;fetus cell;hypothalamic pituitary ovarian axis;innovation;lipid biosynthesis;malignant breast neoplasm;mammary gland development;neoplastic;physical property;programs;reproductive;reproductive success;research study;scaffold;success;tool;toxicant;tumor progression;xenoestrogen","Mechanism of developmental toxicity of Bisphenol-A"," Perinatal exposure to xenoestrogens, such as BPA, induce deleterious health effects such as obesity, infertility and mammary neoplasias in rodents. During the last fifty years, the prevalence of these pathologies also increased in human populations, suggesting a link between BPA exposure and these outcomes. We observed that animals exposed perinatally to low doses of BPA developed mammary precancerous lesions. The proposed study aims at characterizing the mechanisms underlying this effect. This is of utmost relevance to the evaluation of BPA, a widespread contaminant found in 92% of the tested American population, and therefore it has the potential to greatly impact public health and public health policy. Additionally, this research promises to develop a method to assess the potential breast carcinogenicity of other toxicants.  
    

","NIEHS","8325046","5/23/2012 12:00:00 AM","PA-10-067","5R01ES008314-16","5","R01","ES","008314","16"," ","HEINDEL, JERROLD","9/1/1996 12:00:00 AM","4/30/2016 12:00:00 AM","Special Emphasis Panel[ZRG1-EMNR-Q(02)M]"," ","1968948","SOTO, ANA ","Not Applicable","07","ANATOMY/CELL BIOLOGY","039318308","C1F5LNUF7W86","039318308","C1F5LNUF7W86","US","42.349907","-71.061712","8422704","TUFTS UNIVERSITY BOSTON","BOSTON","MA","SCHOOLS OF MEDICINE","021111901","UNITED STATES","N","6/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","113","Non-SBIR/STTR","2012"," "," ","NIEHS","386386","206653"," ","593039",
"Cancer; Rare Diseases","Adenoviruses;Adipose tissue;Adult;Age;Animal Model;Animals;Apoptosis;Apoptosis Regulator;Biochemistry;Boxing;Breast;CDKN2A gene;Cartilage;Cell Line;Cell Proliferation;Cell Survival;Cell physiology;Cells;Cellular biology;Characteristics;Clear Cell;Clinical;Colon;Colonic Neoplasms;Connective Tissue;Development;Diagnosis;Disease;Distant;Extracellular Matrix;Gelatinase A;Gelatinase B;Genes;Genetic;Goals;Hepatic;Human;Hypoxia;Hypoxia Inducible Factor;Hypoxia-Inducible Factor Pathway;Immunodeficient Mouse;Immunohistochemistry;In Vitro;Integrins;Intramuscular Injections;Kidney;Lung;Lung Neoplasms;Malignant - descriptor;Malignant Fibrous Histiocytoma;Malignant Neoplasms;Mammary Neoplasms;Mediating;Mesenchymal;Metastatic Malignant Fibrous Histiocytoma;Metastatic Neoplasm to the Lung;Methods;Microarray Analysis;Molecular;Mus;Muscle;Muscle Cells;Mutate;Mutation;Neoplasm Metastasis;Outcome;Oxidative Stress;Oxygen;Pathway interactions;Patients;Play;Process;Radiosurgery;Regulation;Research Proposals;Role;Signal Transduction;Site;Solid Neoplasm;Staging;Survival Rate;Tissues;Tumor-Derived;Undifferentiated;Vascularization;Xenograft Model;Xenograft procedure;base;biological adaptation to stress;c-myc Genes;catalase;cell motility;chemotherapy;hypoxia inducible factor 1;in vivo;migration;mouse model;new therapeutic target;overexpression;p19ARF;programs;recombinase;response;sarcoma;senescence;soft tissue;therapeutic target;transcription factor;tumor;tumor xenograft;tumorigenesis","Hypoxia and HIF in Sarcomagenesis"," MFH is the most commonly diagnosed type of sarcoma in adults ages 50 -70. It is also the most aggressive type of sarcoma and has a five-year survival rate of only 24%. The current treatments for sarcoma are surgery, radiation, and chemotherapy. However, targeted treatments for this disease are limited because it is poorly characterized at the molecular level. There are also no treatments that specifically target metastatic sarcoma cells. Therefore, I propose to investigate the mechanisms of sarcoma formation and progression in order to facilitate the development of targeted therapeutics.   
    

","NCI","8326371","8/27/2012 12:00:00 AM","PA-10-110","5F32CA156979-02","5","F32","CA","156979","02"," ","JAKOWLEW, SONIA B","9/1/2011 12:00:00 AM","12/31/2012 12:00:00 AM","Special Emphasis Panel[ZRG1-F09-E(20)L]"," ","8065318","EISINGER, TZIPORA SARAH KARIN","Not Applicable","03","ANATOMY/CELL BIOLOGY","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","9/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","398","Training, Individual","2012"," "," ","NCI","18705"," "," ","18705",
"Bioengineering; Biotechnology; Eye Disease and Disorders of Vision; Genetics; Regenerative Medicine; Transplantation","Affect;Aging;Animal Experiments;Aqueous Humor;Basement membrane;Binding;Biological Models;Bromodeoxyuridine;Bullous Keratopathy;Cadaver;Caliber;Cell Culture Techniques;Cell Density;Cell Line;Cell Nucleus;Cell Proliferation;Cells;Contact Inhibition;Cornea;Corneal Endothelium;Data;Descemet&apos;s membrane;Disease;Dose;E-Cadherin;Edetic Acid;Endothelial Cells;Engineering;Excision;Eye;Fibroblast Growth Factor 2;Functional disorder;Future;Gene Targeting;Human;Human Engineering;Injury;Intercellular Junctions;Keratoplasty;Label;Mediating;Membrane;Mesenchymal;Metaplasia;Methods;Microtubules;Mitotic;N-Cadherin;Na(+)-K(+)-Exchanging ATPase;Natural regeneration;Nocodazole;Normal Cell;Nuclear;Nuclear Translocation;Operative Surgical Procedures;Patients;Pattern;Phase;Phenotype;Play;Procedures;Proteins;RNA Interference;Receptor Protein-Tyrosine Kinases;Regenerative Medicine;Regimen;Reporting;Risk;Role;Running;Shapes;Signal Pathway;Signal Transduction;Small Interfering RNA;Solutions;Structure of retinal pigment epithelium;Technology;Therapeutic;Tissue Engineering;Tissues;Transcript;Transplantation;Trypsin;Vision;Withdrawal;adherent junction;base;catenin p120ctn protein;density;gene repression;improved;in vitro Model;in vivo;monolayer;new technology;novel;novel strategies;pre-clinical;response;restoration;src-Family Kinases;trend","Engineering of Human Corneal Endothelial Grafts"," This Phase I application proposes to develop a novel strategy of engineering human corneal endothelium based on selective activation of p120ctn/Kaiso signaling using interference RNA technology targeted at p120-catenin. Using our reported in vitro model system, we have provided strong preliminary data supporting the plausibility of further expanding human corneal endothelial monolayers by additional Kaiso siRNA knockdown with or without nocodazole. By switching on and off p120/Kaiso signaling, our novel engineering strategy may control cellular proliferation without disrupting their intercellular junctions, hence
avoiding both the use of enzymatically dissociated single cells and the risk of losing the normal cell phenotype to fibrous metaplasia. Such engineered grafts may one day be used to improve the surgical procedure of endothelial keratoplasty for restoring sight in patients suffering from bullous keratopathy due to dysfunctional human corneal endothelium. Furthermore, the said technology may also be applied to engineer other similar tissues, such as the retinal pigment epithelium, in the future.   
   
      

","NEI","8309737","5/28/2012 12:00:00 AM","PA-11-096","1R43EY022502-01","1","R43","EY","022502","01"," ","WUJEK, JEROME R","6/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-ETTN-E(12)B]"," ","11043250","ZHU, YING TING ","Not Applicable","25","Unavailable","167232888","C4GJA1DTK7L1","167232888","C4GJA1DTK7L1","US","25.703399","-80.350307","4464601","TISSUETECH, INC.","Miami","FL","Domestic For-Profits","33126","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2014 12:00:00 AM","867","SBIR/STTR","2012"," "," ","NEI"," "," "," ","210593",
"Chronic Liver Disease and Cirrhosis; Clinical Research; Clinical Trials; Digestive Diseases; Hepatitis; Liver Disease","Address;Adult;Affect;American;Ancillary Study;Attention;Biological Markers;Burn injury;Cardiovascular Diseases;Cardiovascular system;Child;Childhood;Cirrhosis;Clinical;Clinical Research;Clinical Trials;Clinical Trials Database;Collection;Control Groups;Cross-Sectional Studies;Data;Data Coordinating Center;Data Set;Databases;Development;Diabetes Mellitus;Diagnosis;Disease;Disease Progression;Double-Blind Method;Elements;Enrollment;Erinaceidae;Fatty Liver;Feasibility Studies;Fibrosis;Funding;Genetic;Goals;Health;Histology;Hospitals;Incidence;Intervention;Length;Liver;Liver diseases;Longitudinal Studies;Metformin;Methods;Modification;National Institute of Diabetes and Digestive and Kidney Diseases;Natural History;North America;Pathogenesis;Pathway interactions;Patients;Performance;Phenotype;Pilot Projects;Pioglitazone;Placebos;Prevention;Proteomics;Protocols documentation;Publications;Randomized;Randomized Clinical Trials;Reporting;Research;Risk;Risk Factors;Sampling;Serum;Severity of illness;Site;Specificity;Staging;Systems Biology;Therapeutic;Therapeutic Intervention;Therapeutic Studies;Therapy Clinical Trials;Tissue Sample;Tissues;United States;United States Dept. of Health and Human Services;United States National Institutes of Health;Universities;Vitamin D;Vitamin E;Work;base;chronic liver disease;clinical material;cytokine;disease natural history;effective therapy;epithelial to mesenchymal transition;follow-up;genome wide association study;insulin sensitizing drugs;interest;liver biopsy;meetings;member;metabolomics;non-alcoholic fatty liver;non-diabetic;nonalcoholic steatohepatitis;novel;prospective;public health relevance;response;smoothened signaling pathway;sobriety;success;therapeutic target;tool","NASH Clinical Research Network","Public Health Relevance: (provided by the applicant): NAFLD and NASH are important health problems and their incidence is expected to increase. During the initial funding period, the CRN has made important contributions to the field of NAFLD and NASH, however there remain numerous unanswered questions. During the next funding period, the CRN will continue to investigate risk factors, clinical aspects, natural history and optimal treatment for NASH and associated conditions ","NIDDK","8301751","7/27/2012 12:00:00 AM","RFA-DK-08-505","5U01DK061713-11","5","U01","DK","061713","11"," ","DOO, EDWARD","5/1/2002 12:00:00 AM","4/30/2014 12:00:00 AM","ZDK1-GRB-7(M1)S"," ","1868904","DIEHL, ANNA MAE ELIZABETH","Not Applicable","04","INTERNAL MEDICINE/MEDICINE","044387793","TP7EK8DZV6N5","044387793","TP7EK8DZV6N5","US","36.006824","-78.924579","2221101","DUKE UNIVERSITY","DURHAM","NC","SCHOOLS OF MEDICINE","277054673","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","416581","118877"," ","511429",
"Cancer; Genetics; Lung; Lung Cancer; Rare Diseases","Adenocarcinoma Cell;Alleles;Cancer Etiology;Cancer Patient;Cause of Death;Cell Communication;Cell Line;Cell Polarity;Cell-Cell Adhesion;Cells;Cessation of life;Clinical Research;Deposition;Development;Disease;Distant;Doxycycline;Epithelial;Event;Exhibits;Gene Expression;Genes;Guanosine Triphosphate Phosphohydrolases;Human;In Vitro;Inflammatory;Invaded;Lung;Lung Adenocarcinoma;Lung Neoplasms;MAP2K4 gene;MAP3K4 gene;Malignant neoplasm of lung;Mediating;Membrane;Metalloproteases;Modeling;Mus;Mutate;Mutation;Myelogenous;Neoplasm Metastasis;Non-Small-Cell Lung Carcinoma;Oncogenic;Other Genetics;Patients;Penetrance;Phosphotransferases;Prevention;Proliferating;Property;Recruitment Activity;Recurrence;Regulatory T-Lymphocyte;Reporting;Signal Transduction;Site;Somatic Mutation;Specimen;Stem cells;Stress;Subcutaneous Injections;Suppressor-Effector T-Lymphocytes;Testing;Transcription Repressor/Corepressor;Tumor Cell Invasion;Tumor Immunity;United States;abstracting;base;bronchial epithelium;cancer cell;cancer type;chemokine;cytokine;epithelial to mesenchymal transition;high risk;in vitro Assay;loss of function;loss of function mutation;lung tumorigenesis;matrigel;mouse model;mutant;novel strategies;prevent;promoter;skills;subcutaneous;tumor","Kinase Signaling in Lung Tumorigenesis","
Project Narrative
Lung cancer is the most common cause of cancer-related death in the United States, and metastasis is the
most common cause of death in lung cancer patients. New approaches are needed for the prevention of
metastasis in patients with lung cancer. Studies have shown that K-ras mutations are common in human lung
adenocarcinomas and are sufficient to initiate the development of lung adenocarcinomas in mice, but other
genetic events are required for the subsequent metastasis of these tumors. In this project, we will test the
hypothesis that inactivating mutations in MKK4, a gene that is frequently mutated in a variety of human cancer
types including lung cancer, promote the metastasis of K-ras-mutant lung cancer cells. We will examine
whether MKK4 inactivation causes these cells to develop the ""skills"" to metastasize, including the ability to
recruit inflammatory cells that promote cancer cell invasion and dissemination. If our findings support this
hypothesis, then clinical studies would be warranted to examine whether the presence of mutations in K-ras
and MKK4 together identify a subset of patients who are at high risk for metastasis and would benefit from
additional therapy to prevent disease recurrence.","NCI","8254442","4/5/2012 12:00:00 AM","PA-07-070","5R01CA105155-09","5","R01","CA","105155","09"," ","SALNIKOW, KONSTANTIN","2/1/2004 12:00:00 AM","4/30/2014 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","1869259","KURIE, JONATHAN M","Not Applicable","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","158379","85525"," ","243904",
"Autoimmune Disease; Cancer; Chronic Liver Disease and Cirrhosis; Clinical Research; Colo-Rectal Cancer; Crohn's Disease; Dental/Oral and Craniofacial Disease; Digestive Diseases; Inflammatory Bowel Disease; Liver Disease; Pediatric; Regenerative Medicine","Adolescent;Adult;Antigens;Asthma;Atopic Dermatitis;Biochemistry;Biology;Birth;Blood capillaries;CAP1;Cell Proliferation;Cell Surface Receptors;Cell surface;Cells;Cesarean section;Chronic;Cicatrix;Colitis;Collaborations;Collagen;Colon Adenocarcinoma;Colorectal Cancer;Complex;Congenital Abnormality;Connective Tissue;Crohn&apos;s disease;Cues;Data;Defect;Degradation Pathway;Deposition;Development;Diffuse;Disease;Ectoderm;Eczema;Embryo;Embryonic Development;Endocytosis;Environment;Epithelial;Event;Failure;Family;Female;Fetus;Fibromatoses;Fibrosis;Fostering;Foundations;Gastrointestinal tract structure;Genetic;Growth Factor;Healed;Hepatic;Hepatic Stellate Cell;Homeostasis;Human;Immune;Immune System Diseases;Immune system;Impairment;Individual;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Injury;Intestines;Ion Channel;Kidney;Labyrinth;Link;Liver;Liver Cirrhosis;Liver Fibrosis;Maintenance;Malignant - descriptor;Malignant Neoplasms;Maryland;Membrane;Mesenchymal;Messenger RNA;Morphogenesis;Mouth Diseases;Mucous Membrane;Mus;Mutation;Myofibroblast;Myometrial;Natural regeneration;Neural tube;Organ;Osteogenesis;PRSS8 gene;Pathology;Pathway interactions;Peptide Hydrolases;Permeability;Physiology;Population;Pregnancy;Protease Inhibitor;Proteins;Proteolysis;Receptor Activation;Research;Role;ST14 gene;Series;Serine Protease;Serine Proteinase Inhibitors;Signal Pathway;Signal Transduction;Smooth Muscle Myocytes;Staging;Study Section;Syndrome;Tissues;Ulcerative Colitis;Universities;Up-Regulation;Uterus;Washington;bone;capillary;carcinogenesis;cytokine;extracellular;healing;hepatocyte growth factor activator;hepatocyte growth factor activator-inhibitor 1;human PRSS8 protein;improved;infancy;inhibitor/antagonist;macrophage;male;matriptase;migration;monolayer;myometrium;novel;offspring;oral tissue;pregnant;pup;receptor;tissue repair","Cell surface serine proteases in development, tissue repair, and malignancy","n/a","NIDCR","8553338"," "," ","1ZIADE000699-13","1","ZIA","DE","000699","13"," "," "," "," "," "," ","6790860","BUGGE, THOMAS H","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIDCR"," "," "," ","1967547",
"Biotechnology; Cancer; Genetics; HIV/AIDS; Prevention; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Affect;Animal Model;Apoptosis;Area;Autophagocytosis;Biological Markers;Biological Models;Biological Process;Budgets;Cancer Center Support Grant;Cancer Control;Cancer Patient;Cancer Vaccine Related Development;Cancerous;Cell Cycle;Cell Cycle Regulation;Cell Death;Cell Differentiation process;Cell division;Cell physiology;Cells;Cellular Immunity;Cellular biology;Chemopreventive Agent;Clinical Trials;Collaborations;Colorado;Cutaneous Melanoma;DNA biosynthesis;Defect;Development;Direct Costs;Drug Delivery Systems;Epigenetic Process;Epithelial;Focus Groups;Funding;Future;Genetic;Gifts;Goals;Grant;Growth and Development function;Head and Neck Cancer;Health;Histone H3;Immune response;Immune system;Immunity;Inflammation;Inflammatory Response;Instruction;Knowledge;Life;Maintenance;Malignant Neoplasms;Malignant neoplasm of lung;Mediating;Mesenchymal;Mitosis;Modification;Molecular;Neoplasm Metastasis;Normal Cell;Oncogenes;Paper;Pathway interactions;Peer Review;Pharmaceutical Preparations;Physicians;Preclinical Drug Evaluation;Prevention strategy;Process;Production;Proteins;Publications;Publishing;Rana;Recruitment Activity;Regenerative Medicine;Regulation;Research;Research Personnel;Resources;Role;Schools;Scientist;Screening for cancer;Signal Transduction;Skin;Skin Carcinoma;Stem Cell Development;Stem cells;Technology;Testing;Therapeutic;Tissues;Translating;Universities;Work;adult stem cell;anticancer research;cancer cell;cancer chemoprevention;cancer stem cell;cancer therapy;cancer type;cell behavior;cell growth;cytokine;follower of religion Jewish;frontier;functional genomics;gain of function mutation;improved;malignant phenotype;man;melanoma;member;migration;neoplastic cell;new technology;novel;novel diagnostics;novel strategies;novel therapeutics;outcome forecast;prevent;programs;response to injury;silibinin;stem cell biology;therapeutic target;tumor;tumor progression","CANCER CELL BIOLOGY","RELEVANCE (See instructions): 
The Cancer Cell Biology Program organizes UCCC researchers who study how cellular processes function in the development and progression of cancer. Understanding how cancer changes the way cells function can help biomedical researchers discover new ways to prevent and treat it.","NCI","8465399","10/12/2012 1:19:28 PM","PAR-11-005","2P30CA046934-24","2","P30","CA","046934","24"," "," ","8/6/1997 12:00:00 AM","1/31/2017 12:00:00 AM","Cancer Centers Study Section (A)[NCI-A]","8121","1887801","SCLAFANI, ROBERT A","Not Applicable","06","Unavailable","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","Domestic Higher Education","800452570","UNITED STATES","N","8/6/2012 12:00:00 AM","1/31/2013 12:00:00 AM"," ","Research Centers","2012","34438","34438"," ","22750","11688"," "," ",
"Cardiovascular; Genetics; Heart Disease; Neurofibromatosis; Neurosciences; Rare Diseases","Accounting;Adult;Affect;Awareness;Benign;Biological Assay;Blood Vessels;Cafe-au-lait macules with pulmonary stenosis;Calcineurin;Cardiac;Cardiac Myocytes;Cardiovascular Abnormalities;Cardiovascular Diseases;Cardiovascular Pathology;Cardiovascular Physiology;Cardiovascular system;Cell physiology;Chemicals;Congenital Heart Defects;Data;Defect;Development;Disease;Embryo;Embryonic Development;Endothelial Cells;Epithelial;Etiology;Exhibits;Funding;Gene Silencing;Genes;Genetic Epistasis;Grant;Health;Heart;Heart Hypertrophy;Heart Valves;Heart failure;Hereditary Disease;Human;Human Genetics;Hypertension;Hypertrophy;Knock-out;Knockout Mice;Knowledge;Malignant Neoplasms;Mesenchymal;Mesenchyme;Modeling;Mus;Muscle Cells;Mutate;Mutation;Myocardium;NF1 gene;Neural Crest;Neural Crest Cell;Neurofibromatoses;Neurofibromatosis 1;Neurofibromatosis Type 1 Protein;Noonan Syndrome;Pathogenesis;Pathway interactions;Patients;Phenotype;Play;Protein phosphatase;Ras Inhibitor;Regulation;Role;Signal Pathway;Signal Transduction;Smooth Muscle;Testing;Tissues;Vascular Endothelium;Vascular Smooth Muscle;Work;angiogenesis;base;cardiogenesis;congenital heart disorder;design;effective therapy;hypertensive heart disease;in vitro Assay;in vivo;loss of function;mouse model;novel;ras GTPase-Activating Proteins;research study;response to injury","Neurofibromin, Neural Crest and Cardiac Development","
Project Narrative:
This is a competing renewal request for a project focused on identifying the role of Nf1 in
cardiovascular development and function. Our lab has shown that the gene causing
Neurofibromatosis, Nf1, functions in vascular endothelium and smooth muscle; and preliminary
data indicates that Nf1 is important in cardiac myocytes as well. We propose experiments to
elucidate the mechanism of Nf1 function in the cardiovascular system with implications for the
treatment of cardiovascular disorders in Neurofibromatosis, and for understanding of common
diseases such as hypertension and heart failure.","NHLBI","8242042","3/21/2012 12:00:00 AM","PA-07-070","5R01HL062974-13","5","R01","HL","062974","13"," ","SCHRAMM, CHARLENE A","7/8/1999 12:00:00 AM","3/31/2014 12:00:00 AM","Cardiovascular Differentiation and Development Study Section[CDD]"," ","1876674","EPSTEIN, JONATHAN A.","Not Applicable","03","ANATOMY/CELL BIOLOGY","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2014 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","142313"," ","389813",
"Breast Cancer; Cancer; Diagnostic Radiology; Genetics","Accounting;Animals;Area;Autopsy;BHLH Protein;Biochemical;Biochemistry;Biogenesis;Biological;Biological Markers;Blood Vessels;Breast;Breast Cancer Cell;Breast Cancer Model;Cancer Patient;Carcinoma;Cause of Death;Cell Line;Cell physiology;Cells;Characteristics;Choline;Choline Kinase;Data;Destinations;Development;Disease;Down-Regulation;Environment;Epithelial;Epithelium;Exhibits;Functional Imaging;Functional Magnetic Resonance Imaging;Generations;Genes;Goals;Growth;Image;Imaging Techniques;Investigation;Label;Laboratories;Lactate Dehydrogenase;Lead;Life;Longitudinal Studies;Lung;Lysine;MCF7 cell;Magnetic Resonance Imaging;Magnetic Resonance Spectroscopy;Malignant - descriptor;Malignant Neoplasms;Mammary Neoplasms;Measurement;Mesenchymal;Metabolic;Molecular;Mutation;Neoplasm Metastasis;Oncogenic;Optical reporter;Organ;Pathology;Pathway interactions;Patients;Pattern;Permeability;Pharmaceutical Preparations;Phenotype;Phosphorylcholine;Physiological;Polyethyleneimine;Population;Pre-Clinical Model;Process;Regulation;Reporter Genes;Research Design;Research Proposals;Role;Sampling;Small Interfering RNA;Spectrum Analysis;Staging;Surface;Survival Rate;System;Therapeutic Agents;Tomatoes;Transgenic Organisms;Tumor Cell Invasion;Tumor Volume;Vascular Endothelial Growth Factors;Visceral;Xenograft Model;Xenograft procedure;angiogenesis;base;breast cancer diagnosis;cell motility;design;extracellular;in vivo;insight;knock-down;malignant breast neoplasm;novel;novel diagnostics;novel therapeutics;optical imaging;pre-clinical;programs;promoter;research study;small hairpin RNA;transcription factor;tumor;tumor growth;tumor progression;tumor xenograft;tumorigenesis","Functional Imaging of Twist induced breast cancer","
Metastatic disease is the principle cause of death from breast cancer. Molecular characterization of
this process is crucial to the development of novel diagnostic and therapeutic agents that will
alleviate patient suffering and increase the survival rate. In this research proposal, we will use
functional magnetic resonance imaging to identify the molecular changes that influence the
phenotypic characteristics of breast tumors, such as, changes in choline containing compound
levels, lactate levels, extracellular pHe, vascular volume and permeability surface area product in
Twist over-expressing breast cancer cells. Finally, the gene signature patterns of metastatic
progression identified using Twist over-expressing breast cancer cells in preclinical model will be
applied to patient samples in order to identify potential markers of breast cancer progression.","NCI","8207919","12/30/2011 12:00:00 AM","PA-07-070","5R01CA140226-03","5","R01","CA","140226","03"," ","JHAPPAN, CHAMELLI","3/10/2010 12:00:00 AM","12/31/2014 12:00:00 AM","Clinical Molecular Imaging and Probe Development[CMIP]"," ","6983512","RAMAN, VENU ","Not Applicable","07","RADIATION-DIAGNOSTIC/ONCOLOGY","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","128816"," ","330091",
"Regenerative Medicine","Abnormal Cell;Adult;Affect;Amputation;Apoptosis;Area;Axon;B-Lymphocytes;Barbus;Behavior;Biological;Biological Assay;Biological Models;Biomedical Research;Blood Vessels;Blood capillaries;Caliber;Candidate Disease Gene;Cell Death;Cell Proliferation;Cell division;Cell physiology;Cells;Cessation of life;Cicatrix;Collaborations;Connective Tissue;Data;Deposition;Development;Electroporation;Embryo;Environment;Epithelial;Esthesia;Extracellular Matrix;Eye;Face;Fertilization;Fishes;Fluid Balance;Funding;Genes;Genetic;Gland;Glypican;Goals;Growth;Health;Heart;Heat-Shock Response;Histocompatibility Testing;Histocytochemistry;Human;Hypertrophic Cicatrix;Image;In Situ Hybridization;Injection of therapeutic agent;Injury;Institution;Investigation;Keloid;Knowledge;Label;Life;Ligands;Longevity;Lymph;Lymphangiogenesis;Lymphatic;Maintenance;Maps;Maxilla;Mediating;Mesenchymal;Methods;Molecular;Molecular and Cellular Biology;Natural regeneration;Nature;Neoplasm Metastasis;Nerve;Nerve Regeneration;Nose;Organ;Pathology;Pathway interactions;Pattern;Peripheral;Peripheral Nerves;Physiological;Pigments;Positioning Attribute;Process;Protocols documentation;Regulation;Research;Resolution;Reverse Transcriptase Polymerase Chain Reaction;Rodent;Role;Sensory;Signal Pathway;Signal Transduction;Signaling Molecule;Skin;Structure;Surveys;System;Tadpoles;Tail;Taste Buds;Techniques;Testing;Tissues;Training;Training Programs;Transgenic Organisms;Trauma;United States National Institutes of Health;Vertebrates;Vibrissae;Wound Healing;Xenopus;Zebrafish;afferent nerve;appendage;base;blastema;capillary;cell behavior;cell type;functional restoration;in vivo;in vivo Model;innovation;light microscopy;melanocyte;migration;mutant;next generation;novel;novel strategies;receptor;repaired;research study;response;response to injury;senescence;skills;tumor","Development and regeneration of the zebrafish maxillary barbel"," This study will establish the biological potential of a novel, easily accessible and relatively non-intrusive system for studying skin appendage development and regeneration in the zebrafish, Danio rerio. Because all vertebrates share many genes in common, findings from this project are expected to relate to the cellular mechanisms of wound healing/scarring, revascularization and nerve regeneration in the adult tissues of other species, such as rodents or humans. The 3-year project will provide undergraduates at our institution with a comprehensive training program in zebrafish genetics, molecular biology and cellular regeneration, all vital skills for the next generation of biomedical professionals.    
    

","NICHD","8460604","8/3/2012 12:00:00 AM","PA-10-070","3R15HD064169-01A1S1","3","R15","HD","064169","01","A1S","MUKHOPADHYAY, MAHUA","3/1/2011 12:00:00 AM","11/28/2014 12:00:00 AM","Development - 1 Study Section[DEV1]"," ","2096941","LECLAIR, ELIZABETH E","Not Applicable","07","BIOLOGY","045694130","MNZ8KMRWTDB6","045694130","MNZ8KMRWTDB6","US","41.878094","-87.627654","2052001","DE PAUL UNIVERSITY","CHICAGO","IL","SCHOOLS OF ARTS AND SCIENCES","606042201","UNITED STATES","N","6/1/2012 12:00:00 AM","11/28/2014 12:00:00 AM","865","Non-SBIR/STTR","2012"," "," ","NICHD","15063","7004"," ","22067",
"Cancer","Address;Adenocarcinoma Cell;Affinity;Amino Acids;Animals;Antineoplastic Agents;Binding;Biological;Biological Availability;Biology;Bioluminescence;Biotin;CCR;Cause of Death;Cell Cycle Progression;Cell Line;Cell Proliferation;Cell Shape;Cell Survival;Cells;Chemicals;Collaborations;Conditioned Culture Media;Cultured Cells;Development;Docking;Dose;Drug Delivery Systems;Drug Formulations;Drug Kinetics;Drug effect disorder;Epithelial;Event;Fluorescent Dyes;Focal Adhesions;Future;Gene Expression;Goals;Growth Factor;Growth Factor Interaction;Half-Life;Human;Image;Implant;In Vitro;Integrins;Investigation;Laboratories;Link;Malignant Neoplasms;Malignant neoplasm of prostate;Malignant neoplasm of urinary bladder;Mass Spectrum Analysis;Mediating;Melanoma Cell;Mesenchymal;Microfilaments;Modeling;Modification;Molecular;Molecular Conformation;Molecular Profiling;Molecular Target;Molecular Weight;Mus;Mutation;N-Cadherin;Neoplasm Metastasis;Normal Cell;Oncogenic;PC3 cell line;PTK2 gene;Pathway interactions;Peptide Signal Sequences;Pharmaceutical Preparations;Pharmacodynamics;Plasma;Process;Proline;Prostate Adenocarcinoma;Protein Tyrosine Phosphatase;Proteins;Reagent;Relative (related person);Reporting;Research;Role;Route;Sampling;Signal Pathway;Signal Transduction;Site;Solid Neoplasm;Src homology 2 domain-containing, transforming protein 1;Streptavidin;System;Technology;Therapeutic Agents;Therapeutic Effect;Time;Toxic effect;Toxicology;Tumor Angiogenesis;Tumor Cell Line;Tumor-Derived;Tyrosine;Work;adapter protein;angiogenesis;anti-cancer therapeutic;base;cell motility;cell transformation;design;drug efficacy;effective therapy;extracellular;growth factor receptor-bound protein 2;implantation;improved;in vivo;inhibitor/antagonist;innovation;meetings;mimetics;mouse model;nanoparticle;neoplastic cell;novel;osmotic minipump;p21 activated kinase;pre-clinical;prevent;protein protein interaction;prototype;receptor;small molecule;therapeutic target;three dimensional structure;tool;tumor;tumorigenesis;urinary","Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics","n/a","NCI","8552998"," "," ","1ZIABC011123-05","1","ZIA","BC","011123","05"," "," "," "," "," "," ","9887952","BOTTARO, DONALD ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","98228",
"Cardiovascular; Clinical Research; Genetics","Accounting;Actins;Aneurysm;Aorta;Aortic Aneurysm;Apoptosis;Atherosclerosis;Binding;Binding Sites;Biological Assay;Birth;Blood Vessels;Bone Marrow;Bone Marrow Cells;Bone Marrow Transplantation;CCL2 gene;Caliber;Cause of Death;Cell Proliferation;Cells;Collagen;Consensus;Data;Disease;Disease Progression;Down-Regulation;Elastases;Elastin;Elements;Embryo;Endothelial Cells;Enzymes;Epigenetic Process;Exhibits;Extracellular Matrix;GKLF protein;Gene Activation;Gene Expression;Genes;Growth;Health;Histone H4;Histones;Human;Immunohistochemistry;In Vitro;Infiltration;Inflammatory;Injury;Knock-out;Knockout Mice;Laboratories;Lesion;Leukocytes;Ligation;MMP3 gene;Maintenance;Manuscripts;Marrow;Matrix Metalloproteinases;Medial;Mediating;Medical;Mentors;Mesenchymal;Methods;Methylation;Modeling;Modification;Molecular;Mus;Mutation;Nucleic Acid Regulatory Sequences;Operative Surgical Procedures;Pathogenesis;Pattern;Perfusion;Phenotype;Phospholipids;Play;Preparation;Principal Investigator;Production;Promoter Regions;Proteins;Regulation;Relative (related person);Repression;Resolution;Role;SWI1;Serum Response Factor;Smooth Muscle Myocytes;Somatic Cell;T-Lymphocyte;Tamoxifen;Testing;Thick;Tissues;Transcriptional Activation;Transgenic Organisms;Up-Regulation;Vascular Cell Adhesion Molecule-1;Wild Type Mouse;cell determination;cell type;chromatin immunoprecipitation;cytokine;embryonic stem cell;histone modification;in vivo;interest;macrophage;neointima formation;novel;pluripotency;prevent;programs;promoter;receptor;reconstitution;repaired;response;stem;therapeutic target;transcription factor","The Effects of KLF4 in experimental aortic aneurysm formation","
 Program Director/Principal Investigator (Last, First, Middle): Ailawadi, Gorav
Project Narrative/ Relevance
There are no proven medical treatments to alter progression of aneurysm disease. KLF4 delays SMC
phenotypic switching to an inflammatory state in models of vascular injury. Furthermore, KLF4 is highly
upregulated in AA. Loss of KLF4 studies will allow us to determine the effect of KLF4 and SMC phenotype in
the progression of disease and determine if this is a potential therapeutic target to slow AA progression.
PHS 398/2590 (Rev. 11/07) Page Continuation Format Page","NHLBI","8204609","12/30/2011 12:00:00 AM","PA-09-042","5K08HL098560-03","5","K08","HL","098560","03"," ","SCOTT, JANE","2/10/2010 12:00:00 AM","11/30/2014 12:00:00 AM","ZHL1-CSR-U(O1)"," ","9776548","AILAWADI, GORAV ","Not Applicable","05","SURGERY","065391526","JJG6HU8PA4S5","065391526","JJG6HU8PA4S5","US","38.034207","-78.512346","1526402","UNIVERSITY OF VIRGINIA","CHARLOTTESVILLE","VA","SCHOOLS OF MEDICINE","229044195","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","837","Other Research-Related","2012"," "," ","NHLBI","121450","9716"," ","131166",
"Biotechnology; Breast Cancer; Cancer","Address;Affect;Animal Model;Antineoplastic Agents;Behavior;Binding;Binding Sites;Biological Assay;Blood;Breast;Breast Adenocarcinoma;Breast Cancer Cell;Breast Cancer Model;Breast Cancer Treatment;Breast Melanoma;Cell Culture Techniques;Cell Line;Cell Proliferation;Cells;Complex;Data;Deacetylation;Development;Diagnosis;Diagnostic Neoplasm Staging;Disease;Disseminated Malignant Neoplasm;Drug Delivery Systems;Enhancers;Event;Extracellular Matrix;F-Actin;Genes;Glioblastoma;Goals;HDAC6 gene;Histone Deacetylase;Homing;Human;Imaging technology;In Vitro;Invaded;Knowledge;Link;Malignant Epithelial Cell;Malignant Neoplasms;Mammary Neoplasms;Measures;Mediating;Membrane;Mesenchymal;Metastatic Melanoma;Metastatic to;Molecular;Mus;Neoplasm Metastasis;Pathway interactions;Patients;Phase II Clinical Trials;Phosphorylation;Phosphotransferases;Play;Predisposition;Primary Neoplasm;Process;Proteins;Regulation;Regulatory Pathway;Reporting;Research;Role;Series;Signal Transduction;Site;Small Interfering RNA;Stream;Testing;Therapeutic Intervention;Tissue Survival;Tissues;Tumor stage;Ubiquitin;Ubiquitination;Up-Regulation;Work;Xenograft Model;aurora-A kinase;base;cancer cell;cancer therapy;cell motility;clinically relevant;human EMS1 protein;human disease;human subject;improved;in vivo;inhibitor/antagonist;innovation;insight;kinase inhibitor;knockout gene;malignant breast neoplasm;melanoma;multicatalytic endopeptidase complex;neoplastic cell;novel;overexpression;prevent;protein expression;public health relevance;research study;response;small molecule;therapeutic target;tumor;tumor growth;tumor progression;tumor xenograft","The role of HEF1 protein in division and invasion of metastatic breast cancer","
Project Narrative
Changes in HEF1 protein expression drive metastasis in more than 30% of human melanomas, and
have been linked to metastatic behavior in breast cancer. The proposed work will elucidate the action
of HEF1 in metastatic cancer progression, and reveal points of cancer cell vulnerability that can be
therapeutically exploited. Further, the proposed work will directly test existing, clinically validated
drugs targeting AurA and HDAC6 for effects on metastases formation, and may thus provide basis
for using these agents as new anti-invasive measures prior to tumor metastasis.","NCI","8215921","4/11/2012 12:00:00 AM","PA-07-070","5R01CA148671-03","5","R01","CA","148671","03"," ","JHAPPAN, CHAMELLI","4/1/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","9349618","PUGACHEVA, ELENA NIKOLAEVNA","Not Applicable","01","BIOCHEMISTRY","191510239","M7PNRH24BBM8","191510239","M7PNRH24BBM8","US","39.637631","-79.946405","9163701","WEST VIRGINIA UNIVERSITY","MORGANTOWN","WV","SCHOOLS OF MEDICINE","265066845","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","201275","93593"," ","294868",
"No NIH Category available","Afghanistan;African American;Aging;Animal Model;Area;Autocrine Communication;Award;Back;Behavior;Behavioral Model;Biological;Biological Models;Bioreactors;Breast Carcinoma;Carcinoma;Cell Adhesion Molecules;Cell Cycle;Cell Death;Cell Survival;Cell physiology;Cell-Cell Adhesion;Cells;Cessation of life;Clinical;Communication;Complex;Cues;Data;Disease;Disseminated Malignant Neoplasm;Distant Metastasis;Down-Regulation;E-Cadherin;Elderly;Environment;Epidermal Growth Factor Receptor;Epithelial;Event;Extracapsular;Future;Grant;Growth;Image;Inflammation;Intervention;Investigation;Iraq;Knowledge;Korean War;Label;Life;Light;Liver;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of prostate;Mesenchymal;Metastatic Prostate Cancer;Methylation;Micrometastasis;Modeling;Molecular;Molecular Probes;Molecular Profiling;Morbidity - disease rate;Neoplasm Metastasis;Organ;Organ Culture Techniques;Phase;Phenotype;Population;Primary Lesion;Primary Neoplasm;Prostate;Prostate carcinoma;Receptor Signaling;Refractory;Regimen;Regulation;Research;Resistance;Secondary to;Services;Signal Transduction;Site;Soil;Staging;Starvation;System;Systemic Therapy;Techniques;Testing;Therapeutic;Thinking;Tissues;Translations;Tumor Biology;Up-Regulation;Validation;Veterans;Vietnam;World War II;base;cadherin 10;cadherin 8;cancer cell;cell behavior;cell killing;chemotherapy;cohort;design;improved;in vivo;innovation;insight;killings;male;men;migration;mortality;neoplastic cell;novel;novel diagnostics;novel therapeutic intervention;promoter;research study;tool;tumor;tumor progression;two-dimensional","Molecular Regulation of Cancer Progression","Prostate cancer is common among aging Veterans, presenting in significant numbers during and after the fifth decade of life. This cohort consists of World War II, Korean War, Vietnam era, and now Gulf and Iraq/Afghanistan Veterans, many of whom are still actively employed and in service. Prostate cancer is so devastating that the VA has labeled this a Designated Research Area on multiple occasions. Prostate cancer is more prevalent and aggressive among African-Americans, a group over-represented in the Veteran population. Our proposal will test two, distinct but complementary, aspects of tumor dissemination and survival. Even partial support of our hypothesis would suggest new diagnostic and therapeutic approaches to disseminated cancer, and novel insights to treat cryptic disseminated disease even attacking dormant cells. Longer term, new targets would be defined. )","VA","8244856","1/18/2012 12:00:00 AM","RFA-BX-11-001","1I01BX001017-01A2","1","I01","BX","001017","01","A"," ","10/1/2011 12:00:00 AM","9/30/2015 12:00:00 AM","Oncology A[ONCA]"," ","1887605","WELLS, ALAN ","Not Applicable","18","Unavailable","033127569","EWCNKHWFNJN8","033127569","EWCNKHWFNJN8","US","40.479754","-79.90176","481080","VETERANS HEALTH ADMINISTRATION","PITTSBURGH","PA","Independent Hospitals","152401003","UNITED STATES","N","10/1/2011 12:00:00 AM","9/30/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Aging; Eye Disease and Disorders of Vision; Macular Degeneration; Neurodegenerative; Neurosciences; Prevention","Acetylcysteine;Affect;Age;Age related macular degeneration;Age-Months;Animal Model;Animals;Antioxidants;Apoptosis;Apoptotic;Blindness;C57BL/6 Mouse;Caspase;Cataract;Cataract Extraction;Cell Death;Cell Survival;Cells;Cellular Stress;Characteristics;Chemotactic Factors;Crystalline Lens;Crystallins;Cysteine;Data;Deposition;Disease;Drug Formulations;Drusen;Early treatment;Effectiveness;Electroretinography;Enzymes;Epithelial Cells;Event;Eye;Eye diseases;Eyedrops;Functional disorder;Glutathione;Goals;Health Care Costs;Human;Injection of therapeutic agent;Lipid Peroxidation;Macular degeneration;Measurement;Measures;Mediating;Medical;Metabolic;Mitochondria;Modeling;Molecular Weight;Mus;N-Acetylcysteinamide;Nuclear;Ophthalmology;Out-Migrations;Oxidative Stress;PTEN gene;Pathogenesis;Pathology;Pathway interactions;Pharmaceutical Preparations;Pharmacologic Substance;Photoreceptors;Physiological;Play;Postpartum Period;Prevention;Protein Binding;Proteins;Publishing;Quality of life;Rattus;Reactive Oxygen Species;Research;Retina;Retinal;Retinal Degeneration;Retinitis Pigmentosa;Role;Selenite;Senile Cataract;Services;Site;Solubility;Staging;Study models;Sulfhydryl Compounds;Testing;Therapeutic;Therapeutic Effect;Tissues;United States;Vertebrate Photoreceptors;Visual;Wistar Rats;Work;age related;analog;base;combat;cost;cytochrome c;density;epithelial to mesenchymal transition;improved;in vivo Model;indexing;intraperitoneal;lens;macrophage;macula;male;novel;oxidation;oxidative damage;polyunsaturated fat;prevent;prophylactic;protective effect;pup;research study;sodium iodate;stressor","Therapeutic Effect of a Novel Antioxidant on Degenerative Eye Disorders"," The loss of vision from age-related eye diseases now affects over 30 million people in the United States-a number that is expected to double in the coming decades. Diseases such as cataracts and age-related macular degeneration significantly affect quality of life and represent sizable medical costs. The annual total outlay for cataract surgery each year in the U.S. is over $9 billion while the total costs of all services related to such visin problems is over $20 billion. Several experiments show that an antioxidant called N-acetylcysteine amide (NACA) may delay the onset or halt the progression of these types of diseases. This research will test whether NACA in eye drop form can prevent and treat eye diseases such as cataracts and macular degeneration in animal models. Successful results from this study will support the advance of this medication into human use. NACA eye drops would represent an alternative to costly cataract surgery, reduce health care costs related to age-related eye diseases and greatly improve the quality of life of people affected by these diseases.     
      

","NEI","8367557","7/16/2012 12:00:00 AM","PA-10-070","1R15EY022218-01A1","1","R15","EY","022218","01","A","SHEN, GRACE L","8/1/2012 12:00:00 AM","7/31/2015 12:00:00 AM","Special Emphasis Panel[ZRG1-MDCN-E(96)A]"," ","1880370","ERCAL, NURAN ","Not Applicable","08","CHEMISTRY","804883767","Y6MGH342N169","804883767","Y6MGH342N169","US","37.953045","-91.7654","578005","MISSOURI UNIVERSITY OF SCIENCE & TECHNOLOGY","ROLLA","MO","SCHOOLS OF ARTS AND SCIENCES","654096506","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2015 12:00:00 AM","390","Non-SBIR/STTR","2012"," "," ","NEI","250000","128750"," ","378750",
"Cancer; Rare Diseases","Affect;Age;Apoptosis;Blood Vessels;Bromodeoxyuridine;Cancer Model;Cancer Patient;Cell Cycle Progression;Cell Proliferation;Cells;Cleaved cell;Cyclin D1;Development;Disease;Distant;Distant Metastasis;Down-Regulation;Endocrine Gland Neoplasms;Epithelial;Epithelial Cells;Event;Exhibits;Follicular thyroid carcinoma;Gelatinase A;Growth;Human;Incidence;Label;Lead;Lung;Malignant Neoplasms;Malignant neoplasm of thyroid;Mediating;Mediator of activation protein;Membrane;Mesenchymal;Mitogen-Activated Protein Kinases;Molecular;Molecular Genetics;Mus;Mutant Strains Mice;Mutate;Mutation;Neoplasm Metastasis;Nuclear;Oral;Organ;Outcome;PTTG1 gene;Papillary;Papillary thyroid carcinoma;Pathway interactions;Patients;Pharmaceutical Preparations;Phosphotransferases;Pre-Clinical Model;Production;Propylthiouracil;Proteins;Proto-Oncogene Proteins c-akt;Refractory;Role;SKI gene;Serum;Signal Pathway;Signal Transduction;Staining method;Stains;Testing;Therapeutic Agents;Thyroid Gland;Thyroid Hormone Receptor Beta;Thyroid Hormone Resistance Syndrome;Thyroid Hormones;Thyroid carcinoma;Thyrotropin;Tumor Biology;Tumor Cell Invasion;Tumor Promoters;Variant;attenuation;beta catenin;cancer cell;carcinogenesis;caspase-3;cyclin D2;inhibitor/antagonist;mortality;mouse model;neoplastic cell;outcome forecast;pre-clinical;prevent;response;therapeutic target;thyroid neoplasm;treatment strategy;tumor;tumor growth;tumor progression;tumorigenesis","Preclinical Mouse Model of Thyroid Carcinogenesis","n/a","NCI","8553031"," "," ","1ZIABC011191-04","1","ZIA","BC","011191","04"," "," "," "," "," "," ","6569140","CHENG, SHEUE-YANN ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","716979",
"Osteoporosis","1-Phosphatidylinositol 3-Kinase;Address;Adult;Affect;Age;Amino Acids;Binding;Biological Assay;Bone Growth;Bone Marrow;Bone remodeling;Calvaria;Carrier Proteins;Cell Differentiation process;Cell Proliferation;Cell Surface Proteins;Cell Surface Receptors;Cells;Co-Immunoprecipitations;Complex;DEFB1 gene;Defect;Development;Dual-Energy X-Ray Absorptiometry;Family;Future;Gene Expression;Genetically Engineered Mouse;Goals;Growth;Hematopoietic;Hematopoietic stem cells;Heparin Binding;In Vitro;Inbreeding;Insulin-Like Growth Factor Binding Protein 3;Insulin-Like Growth Factor I;Insulin-Like Growth Factor II;Insulin-Like Growth Factor Receptor;Insulin-Like Growth-Factor-Binding Proteins;Interdisciplinary Study;Laboratories;Lead;Length;Ligands;Magnetic Resonance Imaging;Maintenance;Marrow;Mediating;Membrane;Mesenchymal;Metabolic Bone Diseases;Metatarsal bone structure;Molecular;Molecular Profiling;Mus;Myelogenous;Nuclear;Osteoblasts;Osteoclasts;Osteogenesis;PTEN gene;Pathway interactions;Peptide Hydrolases;Peptides;Phenotype;Phosphorylation;Physiologic calcification;Production;Proto-Oncogene Proteins c-akt;Public Health;Relative (related person);Role;Serine;Signal Pathway;Signal Transduction;Skeleton;Somatomedins;Staging;Stromal Cells;Sum;System;Testing;Transcript;Transplantation;Tyrosine Phosphorylation;Work;bone;bone cell;bone mass;bone turnover;congenic;human IGFBP2 protein;in vivo;indexing;insight;lipid biosynthesis;mineralization;mutant;novel;osteoblast differentiation;osteoclastogenesis;osteogenic;pleiotrophin;receptor;reconstitution;research study;skeletal;small molecule;substantia spongiosa","Determination of the Mechanisms by which IGFBP-2 Stimulates Bone Remodeling"," This proposal has significant public health implications since it will help delineate the role of the IGF regulatory system in bone. Importantly, studies of the heparin binding domain will determine whether this small molecule can be used for the treatment of metabolic bone disorders.  
  
  
  
  
    

","NIAMS","8306113","8/9/2012 12:00:00 AM","PA-10-067","5R01AR061164-02","5","R01","AR","061164","02"," ","CHEN, FAYE H","8/1/2011 12:00:00 AM","7/31/2016 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","1971652","ROSEN, CLIFFORD JAMES","CLEMMONS, DAVID ROBERT","01","Unavailable","071732663","MAYKB1LWD5U9","071732663","MAYKB1LWD5U9","US","43.652614","-70.27474","4757601","MAINEHEALTH","PORTLAND","ME","Independent Hospitals","041023175","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","383788","76140"," ","459928",
"Clinical Research; Genetics; Kidney Disease; Organ Transplantation; Transplantation","Abbreviations;Acute Kidney Tubular Necrosis;Address;Allografting;Applications Grants;Area;Award;Binding;Biochemical;Biochemistry;Biological;Biology;Blood Urea Nitrogen;Blood Vessels;Cardiac;Cardiovascular Diseases;Cardiovascular Surgical Procedures;Cells;Cerebral Ischemia;Chemicals;Clinical;Complex;Cytoplasm;Data;Deacetylase;Deacetylation;Development;Disease;Environment;Epigenetic Process;Epithelial;Family;Functional disorder;Goals;Heat shock proteins;Heat-Shock Response;Histone Deacetylase;Histone Deacetylase Inhibitor;Histones;Human;Immunologic Memory;Immunology;Impairment;Individual;Inflammation;Inflammatory;Inflammatory Response;Institutes;Investigation;Kidney;Kidney Transplantation;Knockout Mice;Knowledge;Laboratories;Lead;Life;Mentored Clinical Scientist Development Award (K08);Mentors;Mentorship;Mesenchymal;Methods;Mission;Modeling;Mus;Myocardial Infarction;Operative Surgical Procedures;Organ;Organ Donor;Organ Transplantation;Outcome;Patients;Pediatric Hospitals;Pennsylvania;Performance;Perfusion;Philadelphia;Physiological Processes;Play;Polymerase Chain Reaction;Process;Proteins;Regulatory T-Lymphocyte;Renal function;Reperfusion Injury;Research;Research Project Grants;Research Proposals;Research Training;Role;Scientist;Signal Pathway;Signal Transduction;Site;Specificity;Stroke;T-Lymphocyte;Therapeutic;Therapeutic Agents;Tissues;Transcriptional Regulation;Transplant Recipients;Transplant Surgeon;Transplantation;Transplantation Immunology;Trichostatin A;Universities;University Hospitals;Ursidae Family;Vorinostat;Warm Ischemia;Work;base;career;career development;clinical practice;clinically relevant;histone acetyltransferase;improved;inhibitor/antagonist;innovation;insight;knowledge base;member;molecular array;novel;prevent;renal ischemia;response;response to injury;restoration;small molecule;stem;success","Histone/Protein Deacetylase Inhibitors Minimize Renal Ischemia-Reperfusion Injury"," This mentored research project describes an investigation of the role that histone deacetylase (HDAC) activity plays in responses to ischemia-reperfusion injury (IRI) and the potential benefit of HDAC manipulation in mitigating IRI. This work will utilize pan-HDAC, HDAC class, and individual HDAC small molecule inhibitors as well as mice genetically deficient in a variety of HDAC molecules to explore renal function after IRI in a murine renal ischemia model. Specifically, the proposed research will 1) define the HDAC class or individual HDAC molecule that participates in renal IRI, 2) determine the improvement in renal IRI tolerance that can be attained through selective and unselective HDAC inhibition, and 3) determine if the improvement in renal IRI tolerance brought about by HDAC inhibition acts on the renal parenchyma, the inflammatory response to IRI, or both. This knowledge has the potential to identify relevant targets for improving IRI responses that would have significant applicable benefit to human patients in organ transplantation, cardiac and cerebral ischemia, and cardiovascular surgery where IRI has significant clinical impact.    

","NIDDK","8299953","4/30/2012 12:00:00 AM","PA-10-059","5K08DK092282-02","5","K08","DK","092282","02"," ","RANKIN, TRACY L","7/15/2011 12:00:00 AM","4/30/2016 12:00:00 AM","Kidney, Urologic and Hematologic Diseases D Study Section[DDK-D]"," ","1880657","LEVINE, MATTHEW HOWARD","Not Applicable","03","SURGERY","042250712","GM1XX56LEP58","042250712","GM1XX56LEP58","US","39.952982","-75.192768","6463801","UNIVERSITY OF PENNSYLVANIA","PHILADELPHIA","PA","SCHOOLS OF MEDICINE","191046205","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","847","Other Research-Related","2012"," "," ","NIDDK","142501","11400"," ","153901",
"Arthritis; Autoimmune Disease; Biotechnology; Brain Cancer; Brain Disorders; Breast Cancer; Cancer; Rare Diseases","Animals;Anti-Anxiety Agents;Anti-Inflammatory Agents;Anti-inflammatory;Antibodies;Antineoplastic Agents;Arthritis;Brain Neoplasms;Breast;Breast Cancer Cell;CCL2 gene;Cancer Biology;Cancer Prognosis;Carcinoma;Cell Adhesion Molecules;Cells;Central Nervous System Neoplasms;Clinic;Clinical Trials;Computer Simulation;Computing Methodologies;Crystallization;Data;Disease;Drug Discovery Groups;ERBB2 gene;Epithelium;Event;FDA approved;Fibroblast Growth Factor Receptors;Gene Expression;Genes;Glioblastoma;Growth;Housing;Human;In Vitro;Incidence;Inflammation Mediators;Inflammatory;Ligands;Link;Malignant Neoplasms;Mediating;Mesenchymal;Methods;Molecular;Mus;Neoplasm Metastasis;Noninfiltrating Intraductal Carcinoma;PDGFRB gene;Pathway interactions;Pharmaceutical Preparations;Protein Tyrosine Kinase;Receptor Protein-Tyrosine Kinases;Recombinants;Regulatory Pathway;Rheumatoid Arthritis;Rheumatology;Role;Screening procedure;Series;Shapes;Signal Transduction;Signaling Molecule;Structure;Surface Plasmon Resonance;System;TIMP3 gene;Testing;Work;Xenograft procedure;antibody inhibitor;attenuation;cadherin-11;cancer cell;cancer therapy;celecoxib;chemical property;chemokine;effective therapy;human ESR1 protein;humanized monoclonal antibodies;inhibitor/antagonist;malignant breast neoplasm;migration;mortality;novel;outcome forecast;pre-clinical;receptor;small molecule;structural biology;therapeutic target;tumor;tumorigenesis","Cadherin11 in cancer & rheumatoid arthritis: Common target, common therapies? (5)"," Basal-like breast cancers and brain tumors of the glioblastoma type are among the poorest prognosis cancers with no effective treatments. This proposal links a molecular pathway elevated in these tumors to a similar pathway important in the inflammatory disease rheumatoid arthritis. We propose that drugs currently in use for arthritis as well as drugs repurposed to inhibit the common pathway will be useful as novel cancer therapies.   
      

","NCI","8384229","8/2/2012 12:00:00 AM","RFA-CA-11-011","1R01CA170653-01","1","R01","CA","170653","01"," ","WOODHOUSE, ELIZABETH","9/1/2012 12:00:00 AM","6/30/2016 12:00:00 AM","ZCA1-SRLB-9(M1)"," ","1865396","BYERS, STEPHEN W","Not Applicable","98","INTERNAL MEDICINE/MEDICINE","049515844","TF2CMKY1HMX9","049515844","TF2CMKY1HMX9","US","38.904729","-77.016304","2869001","GEORGETOWN UNIVERSITY","WASHINGTON","DC","SCHOOLS OF MEDICINE","200570001","UNITED STATES","N","9/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","478199","137091"," ","615290",
"Cancer; Clinical Research; Immunization; Vaccine Related","Activated Natural Killer Cell;Address;Aftercare;Antibodies;Antigen Presentation;Antigen-Presenting Cells;Apoptosis;Apoptotic;Autoimmune Process;Autologous;B-Lymphocytes;Binding Proteins;Biochemical;Biopsy;Blocking Antibodies;Blood;Blood specimen;CCL22 gene;CD8B1 gene;Cancer Immunology Science;Cancer Patient;Cancer Vaccines;Cells;Clinical;Clinical Trials;Competence;Complement;Cytotoxic T-Lymphocyte-Associated Protein 4;Defect;Dendritic Cells;Development;Disease;Distant Metastasis;Dominant-Negative Mutation;EGF gene;Elements;Enhancing Antibodies;Equilibrium;Fibrosis;Foundations;Frequencies;Future;Genetic;Granulocyte-Macrophage Colony-Stimulating Factor;Growth;Homeostasis;Human;ITGAM gene;Immune;Immune response;Immunity;Immunization;Immunologic Surveillance;Immunosuppression;Immunotherapy;In Vitro;Integrins;Investigation;Ligands;Lymphocyte;Lymphocyte Subset;MHC Class II Genes;Maintenance;Mediating;Melanoma Cell;Melanoma Vaccine;Metastatic Melanoma;Modeling;Mus;Mutate;Myelogenous;Necrosis;Neoplasm Metastasis;Pathologic;Pathway interactions;Patients;Peripheral;Phagocytes;Phase I Clinical Trials;Phosphatidylserines;Pre-Clinical Model;Proteins;Reaction;Regulation;Regulatory T-Lymphocyte;Resected;Resistance;Role;Sampling;Scheme;Signal Transduction;Skin Cancer;Staging;Stress;T-Lymphocyte;Techniques;Therapeutic;Toxic effect;Tumor Antigens;Tumor Escape;Tumor Immunity;Vaccination;Vaccines;Vertical Growth Phase;Wild Type Mouse;Work;angiogenesis;cancer immunotherapy;cellular engineering;clinically significant;cytokine;cytotoxic;design;epithelial to mesenchymal transition;granulocyte;improved;in vivo;killings;melanoma;milk fat globule;mouse model;mutant;neoplastic cell;novel therapeutic intervention;promoter;public health relevance;response;tumor;uptake","Targeting MFG-E8 as Melanoma Immunotherapy","
Project Narrative
This project explores a new therapeutic approach for malignant melanoma (the most
lethal form of skin cancer) that involves targeting a protein called MFG-E8. We have
shown that MFG-E8 functions to promote the growth of melanoma cells and to inhibit
protective immune responses against melanoma. Blocking the actions of MFG-E8 in
mouse models results in melanoma destruction. Work in this project will clarify the ways
in which MFG-E8 blockade accomplishes melanoma killing, which in turn should support
the development of MFG-E8 targeted treatments for melanoma patients.","NCI","8196804","11/30/2011 12:00:00 AM","PA-07-070","5R01CA143083-03","5","R01","CA","143083","03"," ","MCCARTHY, SUSAN A","1/1/2010 12:00:00 AM","11/30/2014 12:00:00 AM","Transplantation, Tolerance, and Tumor Immunology Study Section[TTT]"," ","1885415","DRANOFF, GLENN ","Not Applicable","07","Unavailable","076580745","DPMGH9MG1X67","076580745","DPMGH9MG1X67","US","42.337844","-71.108337","1464901","DANA-FARBER CANCER INST","BOSTON","MA","Independent Hospitals","022155450","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","201275","114727"," ","316002",
"Breast Cancer; Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","ABCC1 gene;Autopsy;BHLH Protein;Benign;Biogenesis;Biological Markers;Biological Process;Breast;Breast Cancer Cell;Breast Carcinoma;CD44 gene;Cancer cell line;Cataloging;Catalogs;Cell Cycle Regulation;Cell Line;Cells;Choline;Choline Kinase;Clinical;Development;Epithelial;Epithelial Cells;Epithelium;Exhibits;Fatty acid glycerol esters;Gene Expression;Genetic;Goals;Growth;Human;Image;Implant;In Vitro;Knowledge;Lead;Link;Longitudinal Studies;Loss of E-cadherin Expression;MCF7 cell;Magnetic Resonance Imaging;Magnetic Resonance Spectroscopy;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Mesenchymal;Metabolic;Metastatic Lesion;Modeling;Molecular;Mucin 1 protein;Myoepithelial;Neoplasm Metastasis;Neoplastic Cell Transformation;Noninfiltrating Intraductal Carcinoma;Oncogenic;Organ;Outcome;Pathogenesis;Pathway interactions;Patients;Permeability;Pharmaceutical Preparations;Phenotype;Population;Pre-Clinical Model;Property;Protein p53;Regulation;Research;Research Design;Research Project Grants;Research Proposals;Rhodamine 123;Role;SCID Mice;Sampling;Sorting - Cell Movement;Staging;Stem cells;Technology;Testing;Time;Tissue Sample;Transcriptional Regulation;Treatment outcome;Tumor Cell Invasion;Visceral;Work;Xenograft procedure;advanced disease;aldehyde dehydrogenases;angiogenesis;base;breast tumorigenesis;cancer cell;clinical application;improved;in vivo;insight;malignant breast neoplasm;metabolomics;novel;optical imaging;progenitor;programs;radiation resistance;research study;therapy resistant;tumor;tumor progression;tumorigenesis","The role of Twist in inducing breast cancer initiating cells and metastasis"," The project will help define the role of Twist in inducing cancer initiating cells and in metastasis during the pathogenesis of breast cancer. The clinical translatability of these findings will be confirmed in human breast cancer tissue samples such as pure DCIS and that obtained from the rapid autopsy program at Johns Hopkins. We anticipate that the clinical applications derived from the insights and knowledge provided by the successful completion of this research project will lead to molecular approaches to identify and target this lethal subpopulation of cells, which will improve treatment outcomes. In the long term, these studies will help characterize breast cancer initiating cells and provide insights that will contribute to the development of novel imaging markers and chemotherapeutic drugs for breast cancer.  
  
    

","NCI","8332787","7/30/2012 12:00:00 AM","PA-10-067","5R01CA131250-02","5","R01","CA","131250","02"," ","AULT, GRACE S","9/14/2011 12:00:00 AM","7/31/2016 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","6983512","RAMAN, VENU ","Not Applicable","07","RADIATION-DIAGNOSTIC/ONCOLOGY","001910777","FTMTDMBR29C7","001910777","FTMTDMBR29C7","US","39.329164","-76.617855","4134401","JOHNS HOPKINS UNIVERSITY","BALTIMORE","MD","SCHOOLS OF MEDICINE","212182680","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","147748","91604"," ","239352",
"Biodefense; Biotechnology; Emerging Infectious Diseases; HIV/AIDS; Hematology; Infectious Diseases; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation","Adenosine;Adenosine A2A Receptor;Adult;Affect;Agonist;Allogenic;Area;Ascaridil;Asthma;Autologous;B-Lymphocytes;Basic Science;Biological;Biological Sciences;Biology;Blood;Blood Cells;Blood donor;Bone Marrow;C-terminal;CD34 gene;CXCR4 Receptors;CXCR4 gene;Cell Therapy;Cell model;Cells;Characteristics;Chronic Granulomatous Disease;Chronic Obstructive Airway Disease;Clinic;Clinical;Clinical Trials;Communities;Conduct Clinical Trials;Defect;Development;Dipeptidyl-Peptidase IV;Disease;Donor person;Engraftment;Functional disorder;Future;Gene Transfer;General Population;Goals;Hematopoietic;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Human;Hydrogen Peroxide;Hyperactive behavior;Hypersensitivity;Immune;Immune System Diseases;Immune system;Immunity;Infection;Inflammation;Lead;Leukocytes;Ligands;Link;Lymphocyte;Marrow;Mesenchymal;Methods;Modeling;Mutation;National Institute of Allergy and Infectious Disease;Natural Immunity;Neutropenia;Oxidases;Paper;Patients;Peptides;Peripheral Blood Stem Cell;Phase;Prevention;Process;Production;Program Development;Property;Publications;Publishing;Regulation;Regulatory Element;Reporting;Role;SCID Mice;Siblings;Signal Transduction;Somatic Cell;Source;Stem cell transplant;Stem cells;Stream;Stromal Cell-Derived Factor 1;Syndrome;System;T-Lymphocyte;Therapeutic;Time;Transfusion;Transplantation;Umbilical Cord Blood;Universities;Work;cell type;design;disease phenotype;gene correction;gene repair;gene therapy;graft vs host disease;granulocyte;human adult stem cell;human stem cells;improved;in vitro Model;in vivo;induced pluripotent stem cell;inhibitor/antagonist;innate immune function;interest;microbicide;monocyte;neutrophil;novel;prevent;protease IV;receptor;reconstitution;response;self-renewal;small molecule;stem cell population;success;trafficking","Basic Research on Hematopoietic Human Stem Cells","n/a","NIAID","8555915"," "," ","1ZIAAI000988-06","1","ZIA","AI","000988","06"," "," "," "," "," "," ","9413709","MALECH, HARRY L","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIAID"," "," "," ","425190",
"Biotechnology; Cancer; Colo-Rectal Cancer; Digestive Diseases; Genetics; Prevention","American Cancer Society;Anatomy;Appointment;Area;Asians;Awareness;Basic Science;Biochemistry;Biological Markers;Biology;Biometry;Cancer Biology;Cancer Center;Cancer Control;Caring;Cell Cycle;Cell Cycle Regulation;Cellular biology;Clinic;Clinical;Clinical Investigator;Clinical Pharmacology;Clinical Research;Clinical Sciences;Clinical Trials;Collaborations;Colon Carcinoma;Colorectal;Colorectal Cancer;Communities;Complement;Country;Delaware;Detection;Development;Devices;Diagnostic;Diagnostic Neoplasm Staging;Disease;Disease Management;Early Diagnosis;Education;Endocrine;Ensure;Epigenetic Process;Epithelial;Epithelial Cells;Equilibrium;Evidence based practice;Faculty;Family Practice;Fertilization;Foundations;Functional disorder;Funding;Gastrointestinal tract structure;Gene Expression;Genetic;Genetic Programming;Genomics;Goals;Guidelines;Health;Healthcare Systems;Hepatic;Hepatitis;Hepatitis C virus;Hepatitis Viruses;Hormonal;Hormones;Hospitals;Image;Imaging Techniques;Immunologics;Immunology;Immunotherapeutic agent;In Vitro;Individual;Inherited;Internal Medicine;Intervention;Intervention Trial;Intestinal Cancer;Intestines;Investigation;Laboratories;Maintenance;Malignant Neoplasms;Malignant neoplasm of gastrointestinal tract;Mediating;Mediation;Medical Oncology;Mesenchymal;Metabolic;Minority;Modality;Molecular;Molecular Biology;Molecular Genetics;Molecular Target;Nanostructures;National Surgical Adjuvant Breast and Bowel Project;Neoadjuvant Therapy;Neoplasm Metastasis;Neoplastic Cell Transformation;Oncogenes;Operative Surgical Procedures;Organ;Pancreas;Pathology;Patients;Peer Review;Pharmacology;Physicians;Population;Postoperative Period;Prevention;Primary Health Care;Primary carcinoma of the liver cells;Process;Protein Tyrosine Phosphatase;Provider;Publications;Radiation;Radiology Specialty;Recruitment Activity;Rectal Cancer;Research;Research Activity;Research Personnel;Resources;Risk;Role;Screening procedure;Signal Transduction;Societies;Stem cells;Stratification;Surgical Oncology;Therapeutic;Tissues;Training and Education;Translating;Translational Research;Translations;United States National Institutes of Health;Vaccines;Vitamin K;Work;angiogenesis;base;bench to bedside;cancer cell;cancer prevention;clinical application;clinical practice;disease diagnosis;disorder risk;follow-up;gastrointestinal;gene therapy;improved;in vivo;inhibitor/antagonist;innovation;interest;medical schools;member;molecular imaging;multidisciplinary;novel;novel vaccines;outcome forecast;paracrine;patient population;programs;protein expression;therapeutic target;tool;tumor;tumorigenesis","Gastro Intestinal Cancer","n/a","NCI","8378870","8/28/2012 12:00:00 AM"," ","5P30CA056036-13","5","P30","CA","056036","13"," "," "," "," ","Cancer Centers Study Section (A)[NCI-A]","9016","1858112","WALDMAN, SCOTT A","Not Applicable","03","Unavailable","053284659","R8JEVL4ULGB7","053284659","R8JEVL4ULGB7","US","39.949004","-75.155569","4050801","THOMAS JEFFERSON UNIVERSITY","PHILADELPHIA","PA","Domestic Higher Education","191074418","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Research Centers","2012","30359","30359"," ","19722","10637"," "," ",
"Biotechnology; Breast Cancer; Cancer; Estrogen; Genetics; Human Genome","Affect;African American;Agonist;Amino Acids;Animal Model;Binding;Biological;Biological Markers;Breast;Breast Cancer Cell;Breast Cancer Model;Breast Cancer Treatment;CDH1 gene;Cancer cell line;Cell Death;Cell Line;Cells;Chemicals;Chromatin;Clinical;Complex;Contact Inhibition;DNA;DNA Methylation;Data;Development;Differentiation and Growth;Disease;Dissection;E-Cadherin;E-Cadherin Staining Method;ESR1 gene;Epigenetic Process;Epithelial;Essential Genes;Estrogen Antagonists;Estrogen Receptors;Estrogens;FVB Mouse;Gene Silencing;Gene Targeting;Genes;Genetic Transcription;Genomics;Histone Deacetylase;Histone Deacetylase Inhibitor;Histone H3;Human;Hypermethylation;IGFBP2 gene;In Vitro;KDM5B gene;Lead;Lysine;Malignant Neoplasms;Mediating;Mesenchymal;Modeling;Morphogenesis;Mouse Mammary Tumor Virus;Mus;Neoplasm Metastasis;PLU-1 gene;Pathway interactions;Pattern;Peptides;Pharmaceutical Preparations;Phenotype;Proteins;Recruitment Activity;Regulation;Repression;Research;Retinoic Acid Receptor;Role;Scaffolding Protein;Screening procedure;Specificity;Structure;Tamoxifen;Techniques;Tertiary Protein Structure;Testing;Therapeutic;Therapeutic Effect;Transcription Repressor/Corepressor;Transfection;Transgenic Model;Tretinoin;Woman;Work;cationic antimicrobial protein CAP 37;chemotherapeutic agent;combinatorial;design;genome-wide;improved;in vivo;inhibitor/antagonist;insight;malignant breast neoplasm;neoplastic cell;new therapeutic target;novel;novel strategies;outcome forecast;pre-clinical;programs;public health relevance;response;restoration;scaffold;small molecule;transcription factor;treatment effect;treatment response;treatment strategy;triple-negative invasive breast carcinoma;tumor;tumor growth;vector","Targeted epigenetic therapy of triple-negative breast cancer","
We have used a decoy (SID) to disrupt a specific epigenetic target which induces human triple negative breast
cancer cell, morphogenesis, loss of invasion, differentiation, growth inhibition in vivo and restores sensitivity to
anti-estrogen. Dissecting the mechanisms and consequences of SID decoy disruption will be studied in depth
and should offer new insights in understanding epigenetic regulation of the basal phenotype and insight into
breast cancer development. Successful SID decoy development offers other therapeutic options for triple
negative breast cancer and also novel drugable targets.","NCI","8248214","3/23/2012 12:00:00 AM","PA-10-067","5R01CA158121-02","5","R01","CA","158121","02"," ","ARYA, SURESH","4/1/2011 12:00:00 AM","3/31/2016 12:00:00 AM","Basic Mechanisms  of Cancer Therapeutics Study Section[BMCT]"," ","1878958","WAXMAN, SAMUEL ","Not Applicable","13","INTERNAL MEDICINE/MEDICINE","078861598","C8H9CNG1VBD9","078861598","C8H9CNG1VBD9","US","40.790525","-73.953788","3839801","ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI","NEW YORK","NY","SCHOOLS OF MEDICINE","100296574","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","210820","115370"," ","326190",
"No NIH Category available","Activities of Daily Living;Address;Adipose tissue;Adverse effects;Advocate;Allografting;Animal Model;Animals;Anterior Cruciate Ligament;Area;Attention;Autologous;Autologous Transplantation;Biochemical;Biological;Biological Models;Biomechanics;Bioreactors;Blood;Bone Marrow;Bone Marrow Cells;Cadaver;Canis familiaris;Carbon;Cartilage;Categories;Cattle;Cell Therapy;Cells;Characteristics;Chondroitin Sulfates;Chronic;Clinical;Clinical Research;Collagen;Collagen Fiber;Connective Tissue;Contracture;Data;Data Analyses;Deposition;Devices;Disadvantaged;Disease;Dose;Embryo;Engineering;Equipment;Ethics;Exhibits;Extracellular Matrix;Extracellular Matrix Protein Gene;Extracellular Matrix Proteins;Failure;Family suidae;Fascia;Female;Fiber;Fibroblast Growth Factor 2;Fibroblasts;Fibronectins;Fracture;Frequencies;Funding;Gel Chromatography;Gene Expression;Germ Cells;Glutaral;Goals;Gold;Golf;Growth;Growth Factor;HIV;Harvest;Healed;Healthcare;Hepatitis B;Hepatitis C;Human;Hydrogels;Immunohistochemistry;Implant;In Vitro;Inflammation;Inflammatory Response;Injury;Institution;Investigation;Knee;Knee bone;Knee joint;Lactic acid;Laminin;Left;Life;Ligaments;Location;Maintenance;Measurable;Measures;Mechanical Stimulation;Mechanics;Medical;Meniscus structure of joint;Mesenchymal Stem Cells;Methods;Modification;Monitor;Morbidity - disease rate;Natural regeneration;Necrosis;Normal tissue morphology;Operative Surgical Procedures;Outcome;Outcome Study;Pain;Particulate;Pathway interactions;Patients;Phase;Phenotype;Physical activity;Platelet Factor 4;Polymers;Polytetrafluoroethylene;Primates;Process;Production;Property;Prosthesis;Protein Biosynthesis;Proteins;Proteoglycan;Quality of life;Recurrence;Rehabilitation therapy;Relative (related person);Reporting;Research;Resistance;Risk;Rotator Cuff;Rupture;Services;Sheep;Shoulder;Site;Skin;Softball;Solutions;Source;Specimen;Sports;Staging;Staining method;Stains;Stem cells;Stimulus;Stress;Structure;Surgeon;Synovitis;Techniques;Tenascin;Tendinitis;Tendon structure;Testing;Time;TimeLine;Tissue Engineering;Tissues;Toes;United States;United States Food and Drug Administration;United States National Institutes of Health;Veterans;Walking;Xenograft procedure;abstracting;adult stem cell;anterior cruciate ligament reconstruction;anterior cruciate ligament rupture;articular cartilage;base;bone;caprolactone;carbon fiber;cohort;copolymer;dacron;data acquisition;decorin;design and construction;disease transmission;graft failure;hamstring;healing;human TGFB1 protein;human adult stem cell;implantation;improved;in vivo;injured;ligament injury;meetings;novel;novel strategies;patient population;poly(lactic acid);prevent;progenitor;programs;protein expression;public health relevance;quadriceps muscle;reconstruction;repaired;research study;response;scaffold;stem cell population;success;transmission process;two-dimensional","Use Of Adipose Derived Stem Cells For Engineering Of Ligament Tissue","Project Narrative 
 
Potential Impact on Veterans Health Care: Because knee ligament injuries which require surgical 
reconstruction are common in the VA patient population, this proposal has the potential to directly 
influence the lives of veterans and thereby enhance the quality of services provided by the VA. 
Although current methods for ACL reconstruction are successful at restoring stability to the knee, 
there are many side effects and risks to surgical reconstruction due primarily to the use of a graft 
which is needed to rebuild the injured ligament. In fact, many veterans with this injury are denied 
surgery for this problem and thus must decrease their physical activity level because the risk of 
morbidity from the graft harvest is not justified and there are not enough allografts currently 
available for everyone with this problem. At our VA institution alone, over 150 ACL reconstructions 
have been performed over the last 6 years. Thus, this proposal can improve the management of ACL 
injuries in veterans. In addition, basic methods of ligament and tendon tissue engineering developed 
in this study could be directly applied to other common clinical problems in which tendon or 
ligament tissue is absent or deficient. These problems include shoulder (rotator cuff) and knee 
(quadriceps and patellar) tendon ruptures, which are also common in the VA patient population. 
Furthermore, the results of this research could be applied to engineering of other connective tissues 
including other tendons, fascia, and skin. Thus, this proposal could ultimately result in substantial 
improvements in the quality of life of veterans.","VA","8195938","11/30/2011 12:00:00 AM","RFA-BX-08-001","5I01BX000126-03","5","I01","BX","000126","03"," "," ","4/1/2009 12:00:00 AM","9/30/2012 12:00:00 AM","Surgery[SURG]"," ","9443104","MCALLISTER, DAVID ","Not Applicable","33","Unavailable","066689118","DL46AKJ5YD48","066689118","DL46AKJ5YD48","US","34.104809","-118.41105","481012","VA GREATER LOS ANGELES HEALTHCARE SYSTEM","LOS ANGELES","CA","Independent Hospitals","900731003","UNITED STATES","N","10/1/2011 12:00:00 AM","9/30/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Aging; Genetics; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adipose tissue;Adult;Affect;Aging;Aging-Related Process;American;Animal Model;Attenuated;Behavioral Research;Binding;Binding Sites;Biological Assay;Body Weight decreased;Boxing;Bromodeoxyuridine;CDKN2A gene;Cell Aging;Cell Cycle;Cell Cycle Arrest;Cell Cycle Progression;Cell Survival;Cells;Cellular Stress;Consensus;Cyclin-Dependent Kinase Inhibitor 2A;Cyclin-Dependent Kinases;DNA biosynthesis;Data;Development;E-Box Elements;Electrophoretic Mobility Shift Assay;Embryo;Epithelial;Event;Fibroblasts;Foundations;Genetic;Genetic Transcription;Genetically Modified Animals;Goals;Growth;HMGA2 gene;Health;Hematopoietic;Hematopoietic stem cells;Human;In Vitro;Intervention;Knock-out;Kyphosis deformity of spine;Laboratories;Learning;Link;Luciferases;Mesenchymal;Methods;Mission;Modeling;Molecular;Mus;Muscle satellite cell;Oncogene Activation;Osteoporosis;Outcome;Pathway interactions;Personal Satisfaction;Phenotype;Premature aging syndrome;Process;Promoter Regions;Public Health;Regulation;Reporter;Research;Research Project Grants;Role;Series;Site;Skeletal Muscle;Stem cells;Technology;Testing;Therapeutic;Therapeutic Intervention;Tissues;United States National Institutes of Health;Work;Zinc Fingers;adult stem cell;anti aging;chromatin immunoprecipitation;combat;derepression;improved;in vivo;inhibitor/antagonist;innovation;insight;method development;novel;overexpression;oxidative damage;p19ARF;prevent;promoter;regenerative;research study;self-renewal;senescence;slug;small hairpin RNA;social;stem;tissue regeneration;transcription factor","Regulatory Role of Transcription Factor Slug in Aging"," This research project is relevant to public health because aging is a common denominator of declining health. The overriding objective is to gain new insight into the mechanisms underlying mammalian aging, and thus molecular foundation for the development of methods to enhance tissue regeneration, thereby attenuating some effects of the aging process. Thus, this project will contribute to the NIH mission: improve the health and well-being of older Americans through biomedical, social, and behavioral research.  
    

","NIA","8309141","7/9/2012 12:00:00 AM","PA-10-067","5R01AG040182-03","5","R01","AG","040182","03"," ","VELAZQUEZ, JOSE M","8/1/2011 12:00:00 AM","7/31/2013 12:00:00 AM","Cellular Mechanisms in Aging and Development Study Section[CMAD]"," ","7549949","WU, WEN-SHU ","Not Applicable","13","Unavailable","076536184","PMDEB5ZPQQN3","076536184","PMDEB5ZPQQN3","US","37.837291","-122.26762","1514301","CHILDREN'S HOSPITAL & RES CTR AT OAKLAND","OAKLAND","CA","Independent Hospitals","946091609","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","866","Non-SBIR/STTR","2012"," "," ","NIA","205000","127100"," ","332100",
"Biotechnology; Cardiovascular; Clinical Research; Dental/Oral and Craniofacial Disease; Genetics; Heart Disease; Human Genome; Neurosciences; Pediatric; Rare Diseases; Stem Cell Research; Stem Cell Research - Embryonic - Human; Stem Cell Research - Nonembryonic - Human","Accounting;Address;Binding;Biochemical;Biological Assay;Blindness;CHARGE syndrome;Cardiac;Cartilage;Cell Line;Cells;ChIP-seq;Characteristics;Chromatin;Cleft Lip;Clinical;Complement;Complex;Congenital Abnormality;Congenital Heart Defects;Congenital Megacolon;Data;Defect;Development;Diagnosis;Disease;Disease model;Distal;Distal Enhancer Elements;Dominant-Negative Mutation;Down-Regulation;Drosophila genus;E1A-associated p300 protein;Ear;Elements;Embryo;Embryology;Enhancers;Epigenetic Process;Etiology;Event;Eye;Family;Fetal Alcohol Syndrome;Functional disorder;Gene Expression;Gene Expression Profile;Gene Targeting;Genes;Genetic Enhancer Element;Genomics;Genotype;Hearing Impaired Persons;Heart;Hereditary Disease;Homologous Gene;Human;In Vitro;Intervention;Lead;Lesion;Libraries;Link;Mandibulofacial Dysostosis;Mesenchymal;Mesoderm;Modeling;Molecular;Mutation;Neural Crest;Neural Crest Cell;Palate;Patients;Penetrance;Peripheral Nervous System;Pigmentation physiologic function;Population;Predisposition;Pregnancy;Process;Proteins;Rana;Regulatory Element;Research;Resources;Role;SMARCA4 gene;Series;Severities;Structure;Syndrome;Testing;Undifferentiated;Variant;Work;Xenopus;base;bone;cell type;chromatin remodeling;congenital heart disorder;craniofacial;genome wide association study;genome-wide analysis;histone modification;human disease;human embryonic stem cell;improved;in vivo;induced pluripotent stem cell;insight;malformation;member;mutant;nerve stem cell;novel;overexpression;public health relevance;tool;trait","Chromatin remodeling in multipotent neural crest formation and CHARGE syndrome","
Reseach proposed here will uncover molecular and cellular mechanisms underlying
CHARGE syndrome, a leading cause of deaf-blindness, congenital heart disease and
craniofacial malformations. Our work will advance understanding and diagnosis of this
multisystemic syndrome and may lead to improved clinical interventions in patients. In
addition, we will identify a set of candidate genomic sequences whose mutations may
confer susceptibility to some of the most common birth defects, such as craniofacial
dysmorphisms including cleft lip and/or palate, heart malformations and peripheral
nervous system defects.","NIGMS","8320428","8/27/2012 12:00:00 AM","PA-10-067","5R01GM095555-03","5","R01","GM","095555","03"," ","KRASNEWICH, DONNA M","9/30/2010 12:00:00 AM","8/31/2015 12:00:00 AM","Molecular Genetics B Study Section[MGB]"," ","8954849","WYSOCKA, JOANNA ","Not Applicable","18","PHARMACOLOGY","009214214","HJD6G4D6TJY5","009214214","HJD6G4D6TJY5","US","37.429038","-122.178178","8046501","STANFORD UNIVERSITY","STANFORD","CA","SCHOOLS OF MEDICINE","943052004","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","859","Non-SBIR/STTR","2012"," "," ","NIGMS","193050","112376"," ","305426",
"Biotechnology; Brain Cancer; Brain Disorders; Cancer; Gene Therapy; Genetics; Neurosciences; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Adult;Animals;Astrocytes;Biological Process;Blood Tests;Blood Vessels;Brain;Brain Neoplasms;Brain region;CD31 Antigens;CD34 gene;Cell Extracts;Cell Line;Cells;Commit;Data;Deferoxamine;Development;Disease;Disease Progression;Endothelial Cells;Epidermal Growth Factor Receptor;Event;Gene Combinations;Gene Expression Profile;Gene Mutation;Generations;Genes;Genomics;Glial Fibrillary Acidic Protein;Glioblastoma;Glioma;HRAS gene;Harvest;Heterogeneity;Hippocampus (Brain);Human;Hypoxia;Immune;In Vitro;Injection of therapeutic agent;Lentivirus Vector;Location;Maintenance;Malignant Neoplasms;Mesenchymal;Methodology;Methods;Microarray Analysis;Modeling;Molecular;Mus;Mutate;Mutation;Neoplasms in Vascular Tissue;Neuraxis;Neuroglia;Neurons;Oligodendroglia;Oligonucleotides;Oncogenic;PTEN gene;Pathology;Pathway interactions;Phosphotransferases;Plants;Procollagen-Proline Dioxygenase;Proto-Oncogene Proteins c-akt;RNA;Recombinants;Seminal;Small Interfering RNA;Sorting - Cell Movement;Stem cells;Suspension substance;Suspensions;Synapsins;Testing;Therapeutic;Therapeutic Intervention;Time;Tissues;Transgenic Mice;Transplantation;Tumor Markers;VWF gene;base;cell type;cellular transduction;mouse model;mutant;neoplastic cell;nerve stem cell;nestin protein;novel;precursor cell;recombinant virus;research study;self-renewal;therapeutic target;transdifferentiation;tumor;tumor progression;vector;vector-induced;von Willebrand Factor","Lentiviral Vectors to Model Human Gliomas in Mice"," Glioblastoma multiforme (GBM) is a deadly brain tumor with few therapeutic options. We are proposing to generate mouse models of this disease and use them to understand the molecular mechanisms involved in the progression of the disease and develop targets for therapy.  
    

","NHLBI","8277324","5/18/2012 12:00:00 AM","PA-10-067","5R01HL053670-16","5","R01","HL","053670","16"," ","LINK, REBECCA P","9/30/1994 12:00:00 AM","3/31/2015 12:00:00 AM","Molecular Oncogenesis Study Section[MONC]"," ","1876512","VERMA, INDER MOHAN","Not Applicable","49","Unavailable","078731668","NNJ6BMBTFGN5","078731668","NNJ6BMBTFGN5","US","32.886474","-117.243921","7210001","SALK INSTITUTE FOR BIOLOGICAL STUDIES","La Jolla","CA","Research Institutes","920371002","UNITED STATES","N","6/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","839","Non-SBIR/STTR","2012"," "," ","NHLBI","349670","316451"," ","666121",
"Chronic Liver Disease and Cirrhosis; Digestive Diseases; Eye Disease and Disorders of Vision; Genetics; Infectious Diseases; Liver Disease; Macular Degeneration; Neurodegenerative; Neurosciences","Acquired Immunodeficiency Syndrome;Acute Retinal Necrosis Syndrome;Address;Adolescent;Affect;Age;Age related macular degeneration;Animal Model;BMP2 gene;BMP4;BMP6 gene;Blindness;Blood-Retinal Barrier;Bone Morphogenetic Proteins;Brain;Cataract;Caucasians;Caucasoid Race;Cell Differentiation process;Cell Proliferation;Cell Surface Proteins;Cell physiology;Cells;Ceruloplasmin;Characteristics;Code;Complement Factor H;Cytomegalovirus;Cytomegalovirus Infections;Data;Dependence;Development;Disease;Down-Regulation;Drusen;E-Cadherin;Enzymes;Epithelial;Event;Exhibits;FarGo;Frequencies;Functional disorder;Gene Expression;Genes;Glaucoma;Goals;HLA Antigens;Health;Hereditary Disease;Hereditary hemochromatosis;Herpesvirus 1;Homeostasis;Human;In Vitro;Infection;Injury;Iron;Iron Metabolism Disorders;Iron Overload;Iron-Regulatory Proteins;Kidney;Laboratories;Link;Liver;Maintenance;Mediating;Molecular;Morphology;Muller&apos;s cell;Mus;Mutate;Mutation;Neural Retina;Nutrient;Organ;Oxidative Stress;Pancreas;Pathogenesis;Pathology;Patients;Phenotype;Photoreceptors;Play;Proliferative Vitreoretinopathy;Proteins;RPE65 protein;Regulation;Regulator Genes;Reporting;Retina;Retinal;Retinal Degeneration;Retinal Diseases;Retinal Ganglion Cells;Retinitis;Role;Signal Transduction;Stem cells;Structure;Testing;Time;Tissues;Toxic effect;Transgenic Mice;Transplant Recipients;Up-Regulation;Virus;Virus Diseases;Wild Type Mouse;age related;base;design;epithelial to mesenchymal transition;ganglion cell;hepcidin;in vivo;insight;interest;metal transporting protein 1;mouse model;novel;oxidative damage;pluripotency;public health relevance;receptor;transcription factor;transferrin receptor 2","Retinal Iron Homeostasis in Health and Disease","
Hereditary hemochromatosis (HHC) is the most prevalent genetic disease characterized by excessive iron
accumulation in various systemic organs, but whether the iron status in the retina is affected in this disease
is not known. It is known however, that excessive iron accumulation in the retina causes oxidative damage
and retinal degeneration. Studies proposed in this project will investigate the HHC-associated changes in
the iron status, structure, and morphology of the retina and the functional consequences using transgenic
mouse models of HHC, and assess the involvement of various iron-regulatory proteins in RPE and the
retina during infection with cytomegalovirus and herpes simplex virus-1.","NEI","8231427","2/7/2012 12:00:00 AM","PA-07-070","5R01EY019672-03","5","R01","EY","019672","03"," ","MCKIE, GEORGE ANN","3/1/2010 12:00:00 AM","2/28/2014 12:00:00 AM","Biology and Diseases of the Posterior Eye Study Section[BDPE]"," ","1861006","GANAPATHY, VADIVEL ","Not Applicable","12","BIOCHEMISTRY","966668691","N4WWJC8T2593","809593387; 966668691","JJJNQAJY5RN6; N4WWJC8T2593","US","33.471349","-81.991385","676605","AUGUSTA UNIVERSITY","AUGUSTA","GA","SCHOOLS OF MEDICINE","309120004","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","867","Non-SBIR/STTR","2012"," "," ","NEI","255766","99800"," ","355566",
"Biotechnology; Cancer; Immunization; Ovarian Cancer; Rare Diseases; Vaccine Related","Adenoviruses;Affect;Animal Model;Ascites;Atvogen;CA-15-3 Antigen;Cancer Model;Cancer Vaccine Related Development;Cell Line;Cell Survival;Cell-Cell Adhesion;Cells;Dendritic Cell Vaccine;Development;Dinoprostone;Disease;Disease Resistance;Disease-Free Survival;Dose;Drug Combinations;Environment;Epithelium;Future;Glycopeptides;Glycoproteins;Gold;Greater sac of peritoneum;Histology;Human;Immune;Immunobiology;Immunosuppression;Immunotherapy;In Vitro;Inflammation;Inflammatory;Injection of therapeutic agent;Learning;Link;Malignant neoplasm of ovary;Modeling;Mucin 1 protein;Mucin-1 Staining Method;Mus;Mutation;Myelogenous;NF-kappa B;Neoplasm Metastasis;Normal Cell;Oncogene Proteins;Oncogenes;Oncogenic;Operative Surgical Procedures;Ovarian;Ovarian Surface Epithelial-Stromal Tumor;Ovary;PTGS2 gene;Pathogenesis;Pathway interactions;Patients;Platinum;Play;Pre-Clinical Model;Regulatory T-Lymphocyte;Reporting;Role;Signal Pathway;Site;Specificity;Suppressor-Effector T-Lymphocytes;Surface;T-Lymphocyte;Taxane Compound;Testing;Therapeutic;Transgenes;Transgenic Animals;Transgenic Mice;Transgenic Organisms;Tumor Antigens;Tumor-Derived;Up-Regulation;Vaccinated;Vaccines;Vascular Endothelial Growth Factors;WT1 gene;Weight;Women&apos;s Health;Work;base;celecoxib;cell growth;cell motility;chemotherapy;effective therapy;efficacy testing;epithelial to mesenchymal transition;glycosylation;human disease;immunogenicity;in vivo;inhibitor/antagonist;macrophage;mortality;mouse model;novel;novel vaccines;ovarian neoplasm;overexpression;pre-clinical;response;taxane;therapeutic target;therapy development;translational study;tumor;tumor growth;tumor initiation;vaccine development","MUC1 Roles in ovarian cancer pathogenesis and immune therapy"," The five year survival in ovarian cancer is very low, mostly because the disease is usually detected late, when the tumors have spread outside of the ovaries, in the peritoneal cavity. Despite improvements in current treatments, which typically combine surgery and chemotherapy, the tumor invariably recurs and the patients succumb to loco-regional metastases. We focus here on an ovarian tumor-associated antigen and oncoprotein called mucin 1 (MUC1) and will test the hypothesis that MUC1 plays a key role in tumor metastasis and that MUC1-based vaccines may provide therapeutic benefit in ovarian cancer.  
    

","NCI","8217560","2/29/2012 12:00:00 AM","PA-10-067","1R01CA163462-01","1","R01","CA","163462","01"," ","YOVANDICH, JASON L","3/1/2012 12:00:00 AM","1/31/2017 12:00:00 AM","Cancer Immunopathology and Immunotherapy Study Section[CII]"," ","8575534","VLAD, ANDA M","Not Applicable","18","Unavailable","119132785","J3Z5MNJJ3FZ4","119132785","J3Z5MNJJ3FZ4","US","40.434217","-79.954766","3840801","MAGEE-WOMEN'S RES INST AND FOUNDATION","Pittsburgh","PA","Other Domestic Non-Profits","152134572","UNITED STATES","N","3/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","242624","60922"," ","303546",
"Autoimmune Disease; Clinical Research; Crohn's Disease; Digestive Diseases; Inflammatory Bowel Disease","Abbreviations;Affect;Antigens;Attention;B-Lymphocytes;Benzene;Blood;Blood Circulation;Blood Vessels;Body part;Cell Adhesion Molecules;Cell physiology;Cells;Charge;Colitis;Crohn&apos;s disease;Dendritic Cells;Disease;Drainage procedure;Effector Cell;Elements;Endothelial Cells;Epithelial;Erythrocytes;Excision;Fibroblasts;Fluid Balance;Fostering;Funding;Generations;Granulomatous;Growth;Helper-Inducer T-Lymphocyte;High Endothelial Venule;Homeostasis;Human;Immune;Immune response;Immune system;Immunologic Surveillance;Inflammation;Inflammation Mediators;Inflammatory;Inflammatory Bowel Diseases;Inflammatory Response;Inflammatory disease of the intestine;Injury;Interferons;Interleukins;Intervention;Intestines;Investigation;Knowledge;Laboratories;Lamina Propria;Leukocytes;Lymph;Lymphangiogenesis;Lymphangitis;Lymphatic;Lymphatic Abnormalities;Lymphatic Endothelial Cells;Lymphatic System;Lymphatic vessel;Lymphedema;Lymphoid;Lymphoid Follicle;Lymphoid Tissue;Maintenance;Mediating;Mediator of activation protein;Mesenchymal;Mesentery;Microbial Genetics;Mononuclear;Mucous Membrane;Mus;Nerve;Nutrient;Obstruction;Organ;Oxygen;Pathogenesis;Pathologist;Patients;Peripheral Blood Mononuclear Cell;Permeability;Phase;Play;Process;Proteins;Reporting;Resolution;Role;Series;Site;Sodium Dextran Sulfate;Source;Sulfonic Acids;System;T-Lymphocyte;TNF gene;Testing;Therapeutic Effect;Tight Junctions;Time;Tissues;Toll-like receptors;Tumor Necrosis Factor-Beta;Tumor Necrosis Factor-alpha;Ulcerative Colitis;Vascular Endothelial Growth Factors;Vascular System;Work;angiogenesis;cell type;density;follow-up;improved;in vivo;junctional adhesion molecule;lymph nodes;macrophage;novel;novel therapeutic intervention;receptor;research study;tool;trafficking","The Role of Lymphangiogenesis in IBD Pathogenesis"," The proposed studies aim at understanding the function of the lymphatic system in patients with inflammatory bowel disease (IBD). The lymphatic vessels are similar to blood vessels but, instead of carrying red blood cells, white blood cells, oxygen and nutrients throughout the body, they carry the bulk of the immune cells responsible for the body's defense. Therefore, the function of the intestinal lymphatic system is closely related to the function of the gut immune system, and any abnormality of lymphatic function may impair the local immune response and cause gut inflammation. There are reasons to believe that the gut lymphatic system is overly extended in IBD patients, but its capacity to carry immune cells away from sites of inflammation is deficient. If so, an excessive accumulation of immune cells occurs in the tissue causing inflammation to linger, as typically seen in IBD patients. A series of experiments are therefore propose to understand why the lymphatic system fails to work efficiently in the gut affected by IBD, and what can be done to restore its normal function and eliminate inflammation.  
    

","NIDDK","8322037","6/25/2012 12:00:00 AM","PA-10-067","5R01DK069854-07","5","R01","DK","069854","07"," ","HAMILTON, FRANK A","9/15/2005 12:00:00 AM","6/30/2015 12:00:00 AM","Gastrointestinal Mucosal Pathobiology Study Section[GMPB]"," ","1877095","FIOCCHI, CLAUDIO ","DANESE, SILVIO ","11","OTHER BASIC SCIENCES","135781701","M5QFLTCTSQN6","135781701","M5QFLTCTSQN6","US","41.479276","-81.680233","10000858","CLEVELAND CLINIC LERNER COM-CWRU","CLEVELAND","OH","SCHOOLS OF MEDICINE","441950001","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","225555","66579"," ","292134",
"Biotechnology; Brain Disorders; Dental/Oral and Craniofacial Disease; Genetics; Pediatric; Rare Diseases","Accounting;Affect;Alanine;Animal Model;Animals;Apert syndrome;Apert-Crouzon syndrome;Binding Sites;Biochemical;Biological Models;Birth;Brain;Breeding;Cells;Cephalic;Chotzen Syndrome;Cleft Palate;Coculture Techniques;Color;Congenital Abnormality;Craniofacial Abnormalities;Craniosynostosis;Data;Defect;Development;Disease;Docking;Dysplasia;Engineering;EphA4 Receptor;Ephrin-A2;Equilibrium;FGFR2 gene;Fibroblast Growth Factor;Fibroblast Growth Factor Receptor 2;Fibroblast Growth Factor Receptors;Fluorescence-Activated Cell Sorting;Functional disorder;Gene Expression;Gene Targeting;Genetic;Genetically Engineered Mouse;Germ Lines;Goals;Growth;Growth Factor Receptors;Histology;Human;In Situ Hybridization;In Vitro;Intervention;Joint structure of suture of skull;Joints;Knock-in Mouse;Life;Link;Mediating;Mediator of activation protein;Mesenchymal;Mesenchyme;Mesoderm Cell;Methods;Molecular;Molecular Analysis;Morphogenesis;Mus;Mutant Strains Mice;Mutate;Mutation;Neural Crest;Neural Crest Cell;Osteoblasts;Pathway interactions;Pattern;Pfeiffer Syndrome;Phenotype;Phosphorylation;Phosphotransferases;Population;Prevalence;Proliferating;Protein Isoforms;Protein Tyrosine Phosphatase;Proteins;Recombinants;Recruitment Activity;Reporter;Role;Signal Pathway;Signal Transduction;Signaling Molecule;Site;Specificity;Staging;Staining method;Stains;Stem cells;Surgical sutures;Syndrome;System;Testing;Tyrosine;Work;base;bone;coronal suture;craniofacial;cranium;design;face bone structure;fibroblast growth factor receptor 2c;gain of function;gain of function mutation;genome-wide;loss of function;mRNA Expression;mutant;mutant mouse model;neuronal cell body;novel;osteogenic;osteoprogenitor cell;premature;public health relevance;receptor;research study;response;stem;suture fusion","Mechanisms of FGFR2 Signaling in Craniofacial Development","
7. PROJECT NARRATIVE
 Dominant gain of function mutations in FGFR2 accounts for majority of the human craniosynostosis
syndromes including Crouzon, Pfeiffer and Apert syndrome which are characterized by the premature fusion of
cranial sutures before the completion of brain growth. The goal of this proposal is to obtain a comprehensive
molecular picture of the signaling pathways that are activated in response to FGFR2 stimulation, which govern
craniofacial development. It is anticipated that the findings will enable the design of novel pharmacological
interventions for craniofacial disorders that are caused by dysfunction in FGFRs.
 ","NIDCR","8232100","1/26/2012 12:00:00 AM","PA-07-070","5R01DE020823-03","5","R01","DE","020823","03"," ","SCHOLNICK, STEVEN","3/3/2010 12:00:00 AM","2/28/2015 12:00:00 AM","Skeletal Biology Development and Disease Study Section[SBDD]"," ","8244567","ESWARAKUMAR, JACOB V.P.","Not Applicable","03","ORTHOPEDICS","043207562","FL6GV84CKN57","043207562","FL6GV84CKN57","US","41.303164","-72.931644","9420201","YALE UNIVERSITY","NEW HAVEN","CT","SCHOOLS OF MEDICINE","065208327","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","252379","156083"," ","408462",
"Biotechnology; Brain Cancer; Brain Disorders; Cancer; Digestive Diseases; Genetics; Pancreatic Cancer; Rare Diseases","Ablation;Adrenal Glands;Adult;Affect;Alleles;Angiogenic Factor;Angiogenic Peptides;Antineoplastic Agents;Basal Cell;Basal Cell Nevus Syndrome;Basal cell carcinoma;Behavior;Binding;Biology;Cell Communication;Cell Proliferation;Cells;ChIP-seq;Clinical;Clinical Trials;Colorectal Cancer;Data;Desmoplastic;Development;Disease;Drug Delivery Systems;Ductal;Endothelial Cells;Epithelial;Epithelial Cells;Epitopes;Erinaceidae;Extracellular Matrix;Fibroblasts;Future;Gene Expression;Gene Targeting;Genes;Genetic;Genetically Engineered Mouse;Glioblastoma;Goals;Immunofluorescence Immunologic;In Vitro;Inherited;Large Intestine Carcinoma;Learning;Ligands;Lung;Maintenance;Malignant Neoplasms;Malignant neoplasm of esophagus;Malignant neoplasm of pancreas;Malignant neoplasm of prostate;Mediating;Mediator of activation protein;Mesenchymal;Mesenchyme;Molecular;Molecular Biology;Mutation;Neoplastic Epithelial Cell;Organ;Ovarian Carcinoma;Pancreatic Ductal Adenocarcinoma;Pancreatic carcinoma;Paracrine Communication;Pathway interactions;Pattern;Pharmaceutical Preparations;Play;Predisposition;Process;Reporter;Resolution;Role;Signal Transduction;Source;Stromal Cells;System;Testing;Therapeutic;Tissues;Tumor Tissue;Variant;Vascular Endothelial Growth Factors;Vascularization;Work;Wound Healing;angiogenesis;autocrine;cancer genetics;cancer type;cell type;chemotherapy;design;human SMO protein;in vivo;inhibitor/antagonist;insight;loss of function mutation;lung small cell carcinoma;malignant breast neoplasm;malignant stomach neoplasm;medulloblastoma;melanoma;mouse model;neoplastic cell;overexpression;pancreatic neoplasm;paracrine;pre-clinical;preclinical study;promoter;prostate carcinogenesis;public health relevance;research study;response;restoration;smoothened signaling pathway;transcription factor;tumor;tumorigenesis","Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer","
Relevance
The goal of this proposal is to learn how a new class of anticancer agent works at the molecular level.
""Smoothened inhibitors"" have recently entered clinical trials for 9 different types of cancer, including pancreatic
cancer. This proposal uses preclinical trials in pancreatic cancer to better understand the effects of
Smoothened inhibitors.","NCI","8232091","12/30/2011 12:00:00 AM","PA-10-067","5R01CA157980-02","5","R01","CA","157980","02"," ","MOHLA, SURESH","3/1/2011 12:00:00 AM","12/31/2015 12:00:00 AM","Basic Mechanisms  of Cancer Therapeutics Study Section[BMCT]"," ","3127300","OLIVE, KENNETH P","Not Applicable","13","INTERNAL MEDICINE/MEDICINE","621889815","QHF5ZZ114M72","621889815","QHF5ZZ114M72","US","40.841253","-73.940404","1833205","COLUMBIA UNIVERSITY HEALTH SCIENCES","NEW YORK","NY","SCHOOLS OF MEDICINE","100323725","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","207500","126575"," ","334075",
"Dental/Oral and Craniofacial Disease; Genetics","Address;Age;Binding Sites;Biochemical;Biological Assay;Biological Process;Bone Marrow;Bone Matrix;C-terminal;Cell Proliferation;Cells;Collagen;Collagen Type I;DSPP gene;Dental;Dental Papilla;Dental Pulp;Dental Pulp Calcification;Dental caries;Dentin;Dentin Formation;Dentinogenesis;Dentition;Development;Disease;Doctor of Philosophy;Elements;Enamel Organ;Epithelium;Event;Extracellular Matrix;Extracellular Matrix Proteins;Family;Family member;Fellowship;Fibrosis;Foundations;Functional disorder;Gene Expression;Gene Expression Regulation;Genetic;Glycoproteins;Growth Factor;Health;Hormones;Human;In Vitro;Individual;Inherited;Integrin Binding;Laboratories;Lead;Ligands;Limb structure;Link;Literature;Mammals;Mediating;Mesenchymal;Minerals;Modeling;Molecular;Morphology;Mus;Muscle Weakness;Mutation;Odontoblasts;Online Mendelian Inheritance In Man;Oral;Osteoblasts;Pain;Patients;Pattern;Peptides;Phenotype;Physiologic calcification;Play;Point Mutation;Process;Progressive Diaphyseal Dysplasia;Property;Proteins;Regulation;Reporting;Research;Research Training;Role;School Dentistry;Scientist;Sexual Development;Signal Transduction;Skeleton;Specimen;Staging;Stem cells;Syndrome;System;TGFB1 gene;Tertiary Protein Structure;Testing;Therapeutic;Tissues;Tooth structure;Transforming Growth Factors;Transgenic Mice;Transgenic Model;Transgenic Organisms;Up-Regulation;Work;bone;bone morphogenetic protein 2;bone sialoprotein;cellular pathology;cranium;cytokine;density;dentin matrix protein 1;dentinal phosphophoryn;enhancing factor;human TGFB1 protein;inorganic phosphate;kidney vascular structure;long bone;member;mineralization;molecular pathology;mouse model;novel;novel diagnostics;novel therapeutics;osteopontin;overexpression;pre-doctoral;programs;promoter;protein expression;skeletal;skeletal disorder;skeletogenesis;soft tissue;tomography;tool","Individual Predoctoral Dental Scientist Fellowship","  The proposed research for my graduate thesis work in the UAB DMD/PhD (Molecular and Cellular Pathology) program at UAB School of Dentistry will focus on dentin mineralization, particularly, the function of matrix extracellular phosphoglycoprotein (MEPE), a protein found especially in bones and teeth, as regulated by a common component in most tissues, transforming growth factor-21 (TGF21). These studies will contribute to our knowledge of how mineralization occurs normally in bones and teeth, which factors enhance or reduce the mineralization process specifically in the dentin layer of teeth, and which molecular events disrupt bone and tooth formation in human mineralization disorders. This work has potential to lead to the development of novel therapeutics for individuals with genetic or non-hereditary tissue mineralization disorders (e.g. excessive thickening of long bones, abnormal dental pulp calcification or tooth development).  
    

","NIDCR","8386819","7/13/2012 12:00:00 AM","PA-10-107","5F30DE021945-02","5","F30","DE","021945","02"," ","FRIEDEN, LESLIE A","8/1/2011 12:00:00 AM","7/31/2014 12:00:00 AM","NIDCR Special Grants Review Committee[DSR]"," ","9541329","GULLARD, ANGELA ","Not Applicable","07","PATHOLOGY","063690705","YND4PLMC9AN7","063690705","YND4PLMC9AN7","US","33.506935","-86.809252","1288803","UNIVERSITY OF ALABAMA AT BIRMINGHAM","BIRMINGHAM","AL","SCHOOLS OF MEDICINE","352940001","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","121","Training, Individual","2012"," "," ","NIDCR","48032"," "," ","48032",
"Cancer; Digestive Diseases; Pancreatic Cancer; Rare Diseases","Anti-Inflammatory Agents;Anti-inflammatory;Apoptosis;Boxing;Cancer Patient;Cancer cell line;Cells;Characteristics;Cyclin-Dependent Kinase Inhibitor;Desmoplastic;Development;Dinoprostone;Disease;Disease Outcome;E-Cadherin;Epidemiology;Epithelial;Epithelial Cells;Event;Family;Generations;Glucocorticoids;Goals;Growth;Human;IL8 gene;Immigration;Immune;In Vitro;Inflammation;Inflammatory;Inflammatory Response;Inherited;Interleukin-6;Investigation;Lesion;MAPK1 gene;MAPK3 gene;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of liver;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Mediating;Messenger RNA;MicroRNAs;Migration Inhibitory Factor;Mitogen-Activated Protein Kinases;Molecular;NF-kappa B;Natural Immunity;Neoplasm Metastasis;Nitric Oxide;Nitrogen;Outcome;Oxygen;PTGS2 gene;Pancreas;Pancreatitis;Pathway interactions;Patients;Phenotype;Phospholipase A2;Phosphorylation;Play;Prevention therapy;Production;Property;Proteins;Regulation;Resected;Resistance;Risk;Role;Serum;Signal Pathway;TNF gene;Testing;Therapeutic;Tumor Biology;Tumor Necrosis Factor-alpha;Vasodilation;Vimentin;Xenograft procedure;cytokine;design;epithelial to mesenchymal transition;human NOS2A protein;human NOS3 protein;human TNF protein;improved;mRNA Expression;member;mouse model;novel strategies;overexpression;pancreatic cancer cells;pancreatic neoplasm;phenylpyruvate tautomerase;small hairpin RNA;therapeutic target;toll-like receptor 4;transcription factor;tumor;tumor growth;tumor progression;tumorigenesis","Role of Inflammation in the Development and Progression of Pancreatic Cancer","n/a","NCI","8553025"," "," ","1ZIABC011185-04","1","ZIA","BC","011185","04"," "," "," "," "," "," ","10270577","HUSSAIN, SYED ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","304907",
"Biotechnology; Cancer; Clinical Research; Dental/Oral and Craniofacial Disease; Genetics; Rare Diseases","Affect;Anoikis;Apoptosis;Apoptotic;Binding;Biological Assay;Biological Models;Cancer Cell Growth;Caspase;Cell Proliferation;Cell Survival;Cells;Chemicals;Clinical Trials;Co-Immunoprecipitations;Complex;Developed Countries;Dissociation;Distant;Distant Metastasis;Epidemiology;Epigenetic Process;Epithelial;FOS gene;Family member;Funding;Gene Expression;Gene Targeting;Genes;Genetic Determinism;Genetic Transcription;Growth;Growth Factor;Head and Neck Cancer;Head and Neck Squamous Cell Carcinoma;Head and neck structure;Hepatocyte Growth Factor;Histones;Human;Immunohistochemistry;In Vitro;Invaded;JUN gene;Left;Location;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of prostate;Mesenchymal;Methylation;Microarray Analysis;Mitogen-Activated Protein Kinases;Molecular;Molecular Genetics;Monitor;Morbidity - disease rate;Movement;Neoplasm Metastasis;Normal Cell;Nude Mice;Oncogenic;Oral cavity;Organ;Patients;Pattern;Play;Process;Protein Family;Proteins;Public Health;Recruitment Activity;Resistance;Role;Sampling;Signal Pathway;Signal Transduction;Site;Squamous cell carcinoma;Therapeutic;Tissue Microarray;Tissues;Transcription Factor AP-1;Tumor Cell Invasion;Western Blotting;cancer cell;chromatin immunoprecipitation;chromatin remodeling;cytokine;inhibitor/antagonist;knock-down;lymph nodes;malignant breast neoplasm;matrigel;meetings;migration;mouse model;novel;novel strategies;outcome forecast;promoter;public health relevance;small hairpin RNA;transcription factor;tumor","Molecular and Genetic Determinants of Invasion in HNSCC","
Relevance to Public Health
Squamous cell carcinoma (SCC) is the most common cancer of the head and neck.
Advanced SCC with metastasis is often incurable and possesses poor prognosis.
Hepatoctye growth factor (HGF) has been found to play an important role in SCC
metastasis by stimulating the invasive growth of SCC cells. The long-term objectives of
this application are to understand why head and neck SCC and other malignant cancers
frequently leave their original site and spread to local and distant organs. In this
application, we will examine how HGF stimulates invasion and survival of SCC cells by
inducing new gene expression. We will determine whether HGF target genes are
abnormally expressed in human SCC tumors and are associated with metastasis. New
findings from this study will help us to develop novel strategies for treating SCC and
other human cancers.","NIDCR","8269541","1/27/2012 12:00:00 AM","PA-07-070","5R01DE015964-09","5","R01","DE","015964","09"," ","VENKATACHALAM, SUNDARESAN","4/1/2004 12:00:00 AM","2/28/2015 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","2234578","WANG, CUN-YU ","Not Applicable","33","DENTISTRY","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","SCHOOLS OF DENTISTRY/ORAL HYGN","900952000","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","121","Non-SBIR/STTR","2012"," "," ","NIDCR","343846","114324"," ","458170",
"Cancer; Genetics; Human Genome; Ovarian Cancer; Prevention; Rare Diseases","Address;Amino Acids;Apoptosis;Biological Assay;Blood;Cancer Center;Cancer Etiology;Candidate Disease Gene;Cell Differentiation process;Cell physiology;Cells;Characteristics;Clinic;Code;Collection;Custom;DNA;DNA Sequence;Data;Data Set;Disease;Elements;Ensure;Epidemiology;Epithelial;Epithelial ovarian cancer;Etiology;Formalin;Freezing;Frequencies;Funding;Genes;Genetic;Genetic Models;Genetic Research;Genome;Genomics;Genotype;Haplogroup;Haplotypes;Health;Histologic;Housing;Individual;Inherited;Investigation;Joints;Logistic Regressions;Malignant Female Reproductive System Neoplasm;Malignant Neoplasms;Malignant neoplasm of ovary;Maps;Mesenchymal;Mitochondria;Mitochondrial DNA;Mutation;NIH Program Announcements;National Cancer Institute;Nuclear;Oxidative Phosphorylation;Paraffin Embedding;Pathway interactions;Play;Population Study;Production;Progress Review Group;Protein Biosynthesis;Proteins;Publications;Reactive Oxygen Species;Research;Research Design;Resources;Risk;Risk Factors;Role;Running;Screening procedure;Signal Transduction;Single Nucleotide Polymorphism;Specimen;Staging;Tissues;Translating;Tumor Subtype;Tumor Tissue;Variant;Woman;Work;base;cancer cell;cancer genetics;cancer genome;cancer risk;case control;cell growth;design;follow-up;gene environment interaction;genetic risk factor;genetic variant;genome wide association study;genome-wide;interest;mitochondrial DNA mutation;mitochondrial genome;mortality;non-genetic;novel;ovarian neoplasm;skills;sound;tumor","The Mitochondrial Genome and Ovarian Cancer Risk","PUBLIC HEALTH RELEVANCE: Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality in women in the US but little is known of the genetic basis of this disease. Mitochondria participate in a number of essential functions in the cell including energy production, protein and amino acid synthesis and programmed cell death (apoptosis). The mitochondrial genome consists of a circular mitochondrial DNA (mtDNA) of 16.5 kilobases which codes for 37 genes. There are also approximately 1500 mitochondrial genes in the nuclear DNA, involved in a myriad of essential cellular functions such as signaling, cell growth and differentiation and apoptosis. Germline and somatic mitochondrial genome variants and mutations have been identified in a number of different cancers. However, very few studies have investigated the mitochondrial genome in EOC. We have previously performed a study looking at genetic variants around the whole genome in women with ovarian cancer compared to those who do not have the disease. Some of the most significant associations with ovarian cancer are in mitochondria-related genes. Furthermore we have previously looked at some genes related to the mitochondria and found some associations with ovarian cancer. The GOAL of the proposed study is to more comprehensively investigate mitochondrial genome variation in ovarian cancer. We will look both in the germline and tumor DNA. Nuclear mitochondrial gene variation, mtDNA haplotype analysis and correlative somatic mtDNA studies will be performed. These studies will enable us to fully evaluate the HYPOTHESIS that inherited variation in the mitochondrial genome as well as the nuclear genome should be considered as factors for risk of epithelial ovarian cancer. We have the following specific aims: 1) Stage 1 - To investigate SNPs in nuclear mitochondrial-related and mtDNA genes Approach: We will look at the results of the nuclear mitochondrial-related and mtDNA genes from the oxidative phosphorylation, epithelial-mesenchymal transition, protein synthesis and apoptosis pathways. Then for those genes that are significantly associated with ovarian cancer we will expand the coverage on genes in our chosen pathways in a study population of 2000 EOC cases and 2000 controls. Additional mtDNA SNPs will be included to ensure identification of the most common mtDNA haplogroups. We will use statistical analysis to look for SNP associations within major histologic subtypes and tumor characteristics. 2) Stage 2 - To validate the top hits in nuclear mitochondrial-related genes and mtDNA genes in an independent case-control collection Approach: We will validate the SNPs showing the most statistically significant associations with ovarian cancer (approximately 40 SNPs) in a collection of up to 10000 ovarian cancer cases and 10000 frequency matched controls from the Ovarian Cancer Association Consortium (OCAC). Furthermore we will include mtDNA SNPs that define the most common mtDNA haplogroups. We will then use logistic regression to investigate the association of mtDNA haplogroups and histologic subtype and perform exploratory gene-environment interactions with non-genetic risk factors. 3) To identify mtDNA mutations and variants in EOC Approach: We will undertake mtDNA sequencing in ovarian tumor tissue in a subset of 400 ovarian cancer cases from the above panel. Sequencing will be performed using the Affymetrix MitoChip v2.0. Variants and mutations will be investigated in germline DNA of the same individual . We will investigate if particular mtDNA haplotypes are correlated with somatic variants or mutations in ovarian tumor tissue or particular variants are associated with tumor-specific characteristics. In this unique and powerful study we will investigate the impact of variation in the mitochondrial genome and variation of the nuclear genome on ovarian cancer risk. The preliminary data for this study comes from two ovarian cancer GWASes in over 8000 individuals which provides an immense resource upon which to build this study so as to make strides in ovarian cancer genetic research. The epidemiologic and genotype datasets are readily available, and are currently housed at the Moffitt Cancer Center which proves the feasibility of the proposed research. The blood DNAs and tumor specimens/blocks are also readily available for this study. The proposed work is scientifically sound, highly significant and novel. Our research team is highly skilled and has been working together successfully for many years in ovarian cancer SNP association studies as is evidenced by our joint publications and funding record. We will address several priorities established by the National Cancer Institute-convened Gynecologic Cancers Progress Review Group including (1) application of novel study designs to elucidate the genomics of ovarian cancer, and (2) systematic screening of germline genetic targets with translational impact. Finally, this study will address a number of the questions on the role of mitochondria in cancer that were posed in the program announcement (PA-08-143).","NCI","8212214","2/24/2012 12:00:00 AM","PA-08-143","5R01CA149429-03","5","R01","CA","149429","03"," ","VERMA, MUKESH","4/1/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Epidemiology of Cancer Study Section[EPIC]"," ","8218685","PHELAN, CATHERINE ","Not Applicable","14","Unavailable","139301956","DVHKP4N619V9","139301956","DVHKP4N619V9","US","28.062545","-82.419587","3736101","H. LEE MOFFITT CANCER CTR & RES INST","TAMPA","FL","Research Institutes","336129497","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","399207","205417"," ","604624",
"Aging; Biotechnology; Cancer; Prostate Cancer; Urologic Diseases","Address;Affect;Androgen Receptor;Androgens;Antibodies;Apoptosis;Biological;Biology;Bone Tissue;Cancer Cell Growth;Cancer Patient;Cell Death;Cell Line;Cell Survival;Cells;Cellular Stress;Clinical;Clinical Protocols;Complex;DNA Damage;DNA Repair Enzymes;Development;Effectiveness;Exhibits;Experimental Models;Future;Gene Targeting;Genes;Gleason Grade for Prostate Cancer;Growth;Growth Factor;Health;Hereditary hemochromatosis;Histocompatibility Antigens Class I;Hormones;Human;Immune;Immunity;Ionizing radiation;Iron;LNCaP;Laboratories;Liquid substance;Major Histocompatibility Complex;Malignant Bone Neoplasm;Malignant Neoplasms;Malignant neoplasm of prostate;Marrow;Mediating;Metastatic Neoplasm to the Bone;MicroRNAs;Molecular;Monoclonal Antibodies;Morbidity - disease rate;Multiple Myeloma;Mus;Normal Cell;Oxidation-Reduction;Pathway interactions;Production;Prostate-Specific Antigen;Prostatic Neoplasms;Proteins;Radiation;Reactive Oxygen Species;Recommendation;Recycling;Refractory;Regimen;Regulation;Renal Cell Carcinoma;Reporting;Role;Safety;Series;Serum;Signal Pathway;Signal Transduction;Signaling Molecule;Skeleton;Solid;Specimen;Stromal Cells;TFRC gene;Testing;Therapeutic;Therapeutic Agents;Therapeutic antibodies;Tissues;Toxic effect;Transferrin;Transferrin Receptor;Transgenic Mice;Translations;Work;Xenograft procedure;base;bench to bedside;beta-2 Microglobulin;biological adaptation to stress;bone;cancer cell;combinatorial;cytotoxicity;epithelial to mesenchymal transition;fascinate;improved;mortality;mouse model;multiple myeloma M Protein;neoplastic cell;new therapeutic target;novel;novel strategies;novel therapeutic intervention;preclinical study;protocol development;receptor;response;soft tissue;survivin;synergism;tumor;tumor xenograft;uptake;urinary","Beta 2-Microglobulin signaling and targeting in bone metastasis","
PROJECT NARRATIVE
Prostate cancer bone metastasis contributes to mortality and morbidity of prostate cancer patients. We have
developed a new therapeutic approach by using a novel anti-ï¿½2-Microglobulin antibody plus radiation, which
has been shown to completely abolish the growth of human tumors in mice. This project focuses on defining
the molecular mechanism of this synergism and the appropriate preclinical studies to move these discoveries
from bench to the bedside.","NCI","8301006","7/13/2012 12:00:00 AM","PA-07-070","5R01CA122602-04","5","R01","CA","122602","04"," ","MOHLA, SURESH","9/29/2009 12:00:00 AM","7/31/2014 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1877206","CHUNG, LELAND W.K.","Not Applicable","28","Unavailable","075307785","NCSMA19DF7E6","075307785","NCSMA19DF7E6","US","34.076546","-118.380008","1225501","CEDARS-SINAI MEDICAL CENTER","LOS ANGELES","CA","Independent Hospitals","900481804","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","181148","113218"," ","294366",
"Cancer; Neuroblastoma; Neurosciences; Pediatric; Rare Diseases","Ablation;Apoptosis;Apoptotic;Binding Proteins;Biology;Bone Marrow;Bone marrow biopsy;Cell Line;Cell Proliferation;Cells;Child;Clinical Trials;Collaborations;DNA;Data;Databases;Diagnosis;Disease;Drug resistance;Drug toxicity;Etoposide;Galectin 3;Genetic;Goals;Human;Infiltration;Inflammation;Inflammatory;Interleukin 6 Receptor;Interleukin-6;Knowledge;MAPK3 gene;MEKs;MYCN gene;Mediating;Mesenchymal;Metastatic Neoplasm to the Bone;Mitogen-Activated Protein Kinases;Modeling;Molecular;Monoclonal Antibodies;Mus;Mutation;NF-kappa B;Neoplasm Metastasis;Neuroblastoma;Osteoclasts;Paper;Pathway interactions;Patients;Pharmaceutical Preparations;Phase;Play;Pre-Clinical Model;Primary Neoplasm;Production;Protein Binding;Proteins;Publishing;Ras/Raf;Recurrence;Role;Series;Signal Pathway;Signal Transduction;Site;Source;Specimen;Staging;Stat3 protein;Testing;Therapeutic;Therapeutic Intervention;Time;Transcriptional Activation;Transgenic Organisms;Tyrosine 3-Monooxygenase;bone;bone invasion;cancer initiation;chemokine;chemotherapeutic agent;chemotherapy;cytokine;cytotoxic;drug sensitivity;high risk;human BIRC4 protein;inhibitor/antagonist;kinase inhibitor;loss of function;macrophage;monocyte;mouse model;neoplastic cell;neuroblastoma cell;pre-clinical;preclinical study;promoter;protein expression;receptor;receptor expression;small molecule;survivin;tumor;tumor progression;tumorigenesis","BONE MARROW MICROENVIRONMENT AND NEUROBLASTOMA PROGRESSION","The bone marrow provides a sanctuary for tumor cells and is a frequent site of metastasis in neuroblastoma. The goals of this project are 1. to acquire a fundamental understanding of how the interactions between neuroblastoma cells and the bone marrow microenvironment contribute to cancer progression, 2. to rapidly use this knowledge to test in preclinical models agents interfering with these interactions, and 3. to identify those agents that are the most likely to be of therapeutic benefit in children with high risk neuroblastoma.","NCI","8378040","7/5/2012 12:00:00 AM","PAR-09-025","5P01CA081403-13","5","P01","CA","081403","13"," "," "," "," ","ZCA1-GRB-S","6820","10616176","DECLERCK, YVES ","Not Applicable","28","Unavailable","052277936","DVL1CMRMWRN9","052277936","DVL1CMRMWRN9","US","34.098065","-118.29069","1520001","CHILDREN'S HOSPITAL OF LOS ANGELES","LOS ANGELES","CA","Independent Hospitals","900276062","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","732590","732590"," ","179818","552772"," "," ",
"Aging; Atherosclerosis; Cardiovascular; Genetics; Heart Disease; Heart Disease - Coronary Heart Disease; Prevention","ACVR1 gene;ATP-Binding Cassette Transporters;Address;Affect;Alkaline Phosphatase;Animals;Ankylosis;Arterial Fatty Streak;Arteries;Atherosclerosis;Back;Binding;Blood Vessels;Bone Morphogenetic Proteins;Breeding;Calcified;Calcium;Calcium Binding;Cardiovascular system;Cell Differentiation process;Cell Line;Cell Proliferation;Cells;Complement;Complement Factor B;Complex;Critiques;Data;Development;Disease;Dominant Negative Receptor;Dose;Dystrophic Calcification;Elastic Fiber;Feedback;Gene Targeting;Genes;Genetic;Genomics;Glutamates;Grant;Heart Diseases;Hepatic;Hereditary hemorrhagic telangiectasia;Human;In Vitro;Inflammation Mediators;Inflammatory;Kidney;Knockout Mice;Lesion;Ligands;Link;Lipids;Lipoproteins;Liver;Medial;Mediating;Mediator of activation protein;Membrane Transport Proteins;Mesenchymal;Metabolism;Minerals;Modeling;Molecular;Mus;Muscle Cells;Mutate;Mutation;Myocardial;Nature;Organ;Pathway interactions;Poorly Differentiated Lesion;Precipitation;Prevention;Principal Investigator;Proline;Protein Binding;Proteins;Pseudoxanthoma Elasticum;Published Comment;Quantitative Trait Loci;Receptor Signaling;Regulatory Pathway;Reporting;Research Personnel;Role;Severities;Signal Pathway;Signal Transduction;Site;Small Interfering RNA;Smooth Muscle Myocytes;Techniques;Testing;Transforming Growth Factors;Vascular Diseases;Vascular Endothelial Cell;Vascular Endothelial Growth Factors;Vascular Endothelium;Vascular calcification;Work;activin receptor-like kinase 1;atherogenesis;base;bone morphogenetic protein 2;bone morphogenetic protein 4;bone morphogenetic protein 9;bone morphogenetic protein receptor type II;bone morphogenetic protein receptors;calcification;carboxylate;cell type;chelation;data modeling;design;extracellular;feeding;homologous recombination;in vivo;inhibitor/antagonist;matrix Gla protein;mineralization;molecular site;mouse model;osteogenic;osteopontin;overexpression;phosphoric diester hydrolase;prevent;programs;protective effect;pyrophosphatase;receptor;receptor expression;research study;segregation;therapy development","Molecular Mechanisms of Vascular Calcification","Our studies are relevant to the prevention of vascular calcification, so-called ""hardening of the arteries"",
which contributes to the severity of heart disease. Information gained from our studies may aid in the design
of new treatments for vascular calcification.","NHLBI","8378583","3/19/2012 12:00:00 AM"," ","5P01HL030568-29","5","P01","HL","030568","29"," "," "," "," ","Heart, Lung, and Blood Program Project Study Section[HLBP]","8180","6184443","BOSTROM, KRISTINA I","Not Applicable","33","Unavailable","092530369","RN64EPNH8JC6","092530369","RN64EPNH8JC6","US","34.104809","-118.41105","577505","UNIVERSITY OF CALIFORNIA LOS ANGELES","LOS ANGELES","CA","Domestic Higher Education","900952000","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","360476","360476"," ","234075","126401"," "," ",
"Aging; Bioengineering; Biotechnology; Cancer; Diagnostic Radiology; Nanotechnology; Prevention; Prostate Cancer; Urologic Diseases","Adopted;Adverse effects;Anatomy;Animals;Apoptosis;Area;Attention;Basal Cell;Biocompatible;Biotechnology;Cancer Etiology;Cell Line;Cell Nucleus;Cells;Cellular Stress;Cessation of life;Chelating Agents;Collaborations;Data;Dendrimers;Development;Diagnostic;Diagnostic Imaging;Disease;Down-Regulation;Drug Delivery Systems;Drug Kinetics;Drug Monitoring;Epithelial;Epithelium;Future;GTPase-Activating Proteins;Genes;Goals;Growth Factor;Hormones;Human;Human body;Image;Imaging Techniques;Imaging technology;Impotence;In Vitro;Incontinence;Investigational Therapies;Knock-out;Knowledge;Laboratories;Lead;Lesion;Location;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of prostate;Medicine;Membrane;Metastatic Prostate Cancer;Metastatic to;Molecular;Molecular Medicine;Molecular Target;Monitor;Nanotechnology;Neoplasm Metastasis;Non-Malignant;One-Step dentin bonding system;Organ;Outcome Study;PC3 cell line;PSA screening;Pathologic;Patients;Peptides;Permeability;Pharmaceutical Preparations;Phenotype;Population;Positron-Emission Tomography;Pre-Clinical Model;Predictive Value;Progression-Free Survivals;Prostate;Protein Biochemistry;Proteins;Publications;Quality of life;Radiation;Reporting;Research;Risk;Screening procedure;Sensitivity and Specificity;Signal Pathway;Signal Transduction;Signaling Protein;Single Nucleotide Polymorphism;Site;Staging;Stimulus;Survival Rate;System;Tertiary Protein Structure;Testing;The Sun;Therapeutic;Therapeutic Agents;Therapeutic Index;Time;Tissues;Toxic effect;Tracer;Translating;Treatment Efficacy;Tumorigenicity;Ursidae Family;Work;base;cancer cell;cancer diagnosis;cancer imaging;cancer surgery;cancer therapy;cell growth;chemotherapy;clinical application;cytotoxicity;design;drug development;early onset;epithelial to mesenchymal transition;extracellular;flexibility;hormone therapy;imaging probe;improved;in vivo;insight;lymph nodes;men;molecular imaging;mortality;nanocarrier;nanomedicine;nanoparticle;neoplastic cell;novel;particle;prevent;response;small molecule;success;synthetic peptide;targeted delivery;theranostics;tumor","Targeting aggressive prostate cancer with novel theranostic nanomedicine"," Today, nanotechnology has produced many unique drug delivery platforms that can be integrated into a ""theranostic"" agent. Non-invasive molecular imaging techniques have advantages over anatomic imaging techniques to better define the location and extent of disease and to better assess the response of target tissue or organ to drugs in a real-time manner. By teaming up experts from various areas, the goal of this project is to invent mechanism-specific targeting agents using dendrimer then test their translational ability into future clinical application, which has many potentials to spin off a new biotechnology entity and further revolutionize current cancer therapy.  
    

","NCI","8336823","7/11/2012 12:00:00 AM","PA-10-067","5R01CA159144-02","5","R01","CA","159144","02"," ","FU, YALI","9/21/2011 12:00:00 AM","7/31/2016 12:00:00 AM","Developmental Therapeutics Study Section[DT]"," ","1879580","HSIEH, JER-TSONG ","Not Applicable","30","UROLOGY","800771545","YZJ6DKPM4W63","800771545","YZJ6DKPM4W63","US","32.814772","-96.841146","578404","UT SOUTHWESTERN MEDICAL CENTER","DALLAS","TX","SCHOOLS OF MEDICINE","753909105","UNITED STATES","N","8/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","230551","93111"," ","323662",
"Brain Cancer; Brain Disorders; Cancer; Clinical Research; Clinical Trials; Genetics; Neurosciences; Orphan Drug; Rare Diseases","19q;Aggressive course;Angiogenesis Inhibitors;Angiogenic Proteins;Apoptosis;Area;Basic Science;Biological Markers;Biological Process;Biology;Blood Volume;Brain Neoplasms;Bypass;Cancer Center;Cell Death;Cell Differentiation process;Cerebrovascular Circulation;Chromatin;Clinical;Clinical Research;Clinical Trials;Clinical Trials Design;Collaborations;Critical Pathways;DNA;DNA Structure;Data;Development;Diffusion;Disease;Endothelial Cells;Epigenetic Process;Faculty;Fellowship Program;Funding;Gene Expression;Glioblastoma;Glioma;Goals;Grant;Growth Factor Inhibition;Histone Deacetylase Inhibitor;Human;Incidence;Investigation;Laboratories;Laboratory Research;Laboratory Study;MGMT gene;MRI Scans;Magnetic Resonance Imaging;Malignant - descriptor;Malignant Glioma;Malignant Neoplasms;Measurement;Measures;Mentors;Mentorship;Mesenchymal;Methods;Methylation;Molecular;Morbidity - disease rate;Mutation;Neurologic;Neurology;Oncologist;Outcome;Pathway interactions;Patients;Perfusion;Physicians;Platelet-Derived Growth Factor;Prediction of Response to Therapy;Primary Brain Neoplasms;Principal Investigator;Process;Progression-Free Survivals;Randomized;Recurrence;Regulation;Relative (related person);Research;Research Personnel;Research Training;Resistance;Resistance development;Resources;Role;Route;Scientist;Screening procedure;Serum;Structure;Testing;Therapeutic;Time;Tissues;Training;Translational Research;Translations;Treatment Failure;Treatment outcome;Tumor Biology;Vascular Endothelial Growth Factors;Vorinostat;angiogenesis;arm;base;bevacizumab;career;clinical care;conventional therapy;design;experience;humanized antibody;improved;insight;interest;member;mortality;neuro-oncology;novel;novel strategies;novel therapeutics;oligodendroglioma;oncology;outcome forecast;overexpression;patient oriented;patient oriented research;pre-clinical;preclinical study;prevent;programs;promoter;research study;response;translational study;treatment response;tumor","Patient Oriented Research Program in Neuro-oncology"," Primary brain tumors are among the worst in prognosis among human malignancies. Efficient development of novel therapies against primary malignant gliomas require rapid translation of results from promising laboratory studies to well designed clinical trials; this will allow rapid screening of new therapies in order to channel the most promising of these to large confirmatory trials. This Mid-Career Investigator grant will allow Dr. Puduvalli, the principal investigator of this project, to design and deploy novel therapeutic strategies that targets ""epigenetics"" of brain tumors, which is essential for regulation of the tumors biological processes and treatment response; in addition, it will allow Dr. Puduvalli to develop a new program in brain tumor epigenetics and provide opportunities for mentorship of neuro-oncology fellows and junior faculty.   
      

","NCI","8300649","4/13/2012 12:00:00 AM","PA-11-195","1K24CA160777-01A1","1","K24","CA","160777","01","A","LIM, SUSAN E","4/13/2012 12:00:00 AM","12/31/2012 12:00:00 AM","Education Study Section (G)[NCI-G]"," ","7017702","PUDUVALLI, VINAY K","Not Applicable","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","4/13/2012 12:00:00 AM","12/31/2012 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","151594","12128"," ","163722",
"Biotechnology; Brain Disorders; Injury (total) Accidents/Adverse Effects; Injury - Trauma - (Head and Spine); Injury - Traumatic brain injury; Neurosciences; Patient Safety; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Acute;Address;Adult;Affect;Age;Agreement;American;Anatomy;Animals;Autopsy;Biodistribution;Biotechnology;Blood - brain barrier anatomy;Bone Marrow;Brain Injuries;Cardiovascular Diseases;Catheters;Cell Line;Cell Survival;Cell Therapy;Cells;Cerebral Edema;Cerebrum;Child;Childhood;Choristoma;Clinical Data;Clinical Trials;Critiques;Data;Development;Direct Costs;Disease;Dose;Elderly man;Elderly woman;Environment;Evaluation;Facilities and Administrative Costs;Goals;Healthcare Systems;Hypoxia;Immune response;In Vitro;Inflammation;Inflammatory;Inflammatory Bowel Diseases;Infusion procedures;Injury;Institutional Review Boards;Intracranial Hypertension;Intracranial Pressure;Intravenous;Investigational Drugs;Ischemic Stroke;Legal patent;Licensing;Life;Link;Literature;Medical;Mesenchymal;Military Personnel;Modeling;Mononuclear;Morbidity - disease rate;National Institute of Neurological Disorders and Stroke;Nervous System Trauma;Organ;Osmolar Concentration;Outcome;Outcome Measure;Pathology;Patients;Perfusion;Permeability;Pharmacology and Toxicology;Phase;Population;Pre-Clinical Model;Protocols documentation;Publishing;Relative (related person);Research;Research Project Grants;Research Proposals;Rodent;Rodent Model;Safety;Scheme;Secondary to;Signal Transduction;Small Business Innovation Research Grant;Spinal cord injury;Stem cells;Stroke;Supportive care;System;TBI Patients;Texas;Tissues;Toxic effect;Translating;Traumatic Brain Injury;Treatment Protocols;United States;Universities;Walkers;aged;base;cGMP production;cell type;central nervous system injury;clinically relevant;combat;effective therapy;efficacy testing;graft vs host disease;in vivo;injured;male;medical schools;mortality;nervous system disorder;novel therapeutic intervention;pre-clinical;prevent;primary outcome;regenerative;relating to nervous system;response;response to injury;safety study;scale up;secondary outcome;web site","Cell Based Therapy for Treatment of Traumatic Brain Injury","The treatment of traumatic brain injury (TBI) is an unmet medical need of significance in the United States, especially for children under the age of 5, young male adults aged 15-25, elderly men and women aged 75 and older and military personnel in active combat zones (NINDS Website). According to the National Institutes of Neurological Disorders and Stroke there are currently more than 5 million Americans living with permanent deficits resulting from TBI that require daily help or assistance, with a resulting burden in direct and indirect costs to the United States health care system of $56 Billion annually. Although cell-based therapies have emerged as experimental treatments for a number of other neurological and cardiovascular disorders, there is currently no treatment for TBI other than post-injury supportive care. The specific objective of this research project is to develop an optimized cellular therapy regimen for treatment of patients suffering TBI.","NINDS","8252522","1/31/2012 12:00:00 AM","PAR-08-235","1U44NS077511-01","1","U44","NS","077511","01"," ","HICKS, RAMONA R","2/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","Neurological Sciences and Disorders A Study Section[NSD-A]"," ","1861362","MAYS, ROBERT WILLIAM","COX, CHARLES S","11","Unavailable","839321403","MYE4CDGEMAY9","839321403","MYE4CDGEMAY9","US","41.500165","-81.665744","3428101","ATHERSYS, INC.","CLEVELAND","OH","Domestic For-Profits","441152634","UNITED STATES","N","2/1/2012 12:00:00 AM","7/31/2013 12:00:00 AM","853","SBIR/STTR","2012"," "," ","NINDS"," "," "," ","299999",
"Aging; Cancer; Genetics; Prostate Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Urologic Diseases","Ablation;Adult;Aggressive behavior;Androgens;Apoptotic;Behavior;Bicalutamide;CWR22Rv1;Cancer Etiology;Cancer Patient;Caring;Castration;Cell Fraction;Cell Line;Cell model;Cells;Cessation of life;Clinical;Clinical Treatment;Development;Diagnosis;Disease Progression;Disease Resistance;Distant;Drug resistance;EGF gene;Early Diagnosis;Elements;Epidermal Growth Factor Receptor;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Epigenetic Process;Epithelial;Epithelial Cells;Erinaceidae;Etiology;GLI-1;Gefitinib;Gene Expression;Genes;Genetic;Goals;Growth;Hormones;Human;In Vitro;Investigation;Lead;MEKs;Malignant - descriptor;Malignant neoplasm of prostate;Mesenchymal;Methods;Molecular;Neoplasm Metastasis;Non-Malignant;Oncogenic;Organ;PC3 cell line;Pathway interactions;Patient Care;Patients;Pharmaceutical Preparations;Phenotype;Phospholipase;Phosphorylation;Prostate carcinoma;Prostatic;Prostatic Tissue;Proteins;Radiation therapy;Radical Prostatectomy;Recurrent disease;Refractory;Relapse;Research;Resistance;Second Primary Neoplasms;Signal Transduction;Sonic Hedgehog Pathway;Specimen;Staging;Stem cells;Techniques;Testing;Therapeutic;Tissues;Up-Regulation;Validation;androgen independent prostate cancer;base;cancer cell;cancer initiation;cell motility;chemotherapy;clinically relevant;cyclopamine;docetaxel;high risk;hormone therapy;human FRAP1 protein;human SMO protein;improved;in vivo;inhibitor/antagonist;interest;malignant phenotype;men;new therapeutic target;novel;palliative;prevent;programs;prostate carcinogenesis;self-renewal;small hairpin RNA;smoothened signaling pathway;stem;therapeutic target;tumor;tumor progression;tumorigenic","Novel deregulated genes in the etiology and progression of human prostate cancer","
Description of research program
The research program aims to establish the implications of EGFR and hedgehog cascades and other
interacting pathways in the malignant transformation of PC stem/progenitor cells and their progenies
and treatment resistance and validate novel therapeutic targets for improving current therapies and
preventing disease relapse and the death of PC patients. The studies will consist to delineate the gene
products modulated through the EGFR and hedgehog pathways that can cooperate in PC progression and
treatment resistance and validate novel therapeutic targets for eradicating total PC cell mass by using human
PC cell models and prostatic tissue specimens from patients relevant to prostate carcinogenesis.","NCI","8494115","9/14/2012 12:00:00 AM","PA-07-070","3R01CA138791-03S1","3","R01","CA","138791","03","S","OGUNBIYI, PETER","5/1/2010 12:00:00 AM","2/28/2015 12:00:00 AM","Cancer Etiology Study Section[CE]"," ","7239627","BATRA, SURINDER K.","Not Applicable","02","BIOCHEMISTRY","168559177","G15AG3BLLMH4","168559177","G15AG3BLLMH4","US","41.26545","-96.039767","578104","UNIVERSITY OF NEBRASKA MEDICAL CENTER","OMAHA","NE","SCHOOLS OF MEDICINE","681987835","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","25329","12285"," ","37614",
"Biotechnology; Cancer; Digestive Diseases; Genetics; Human Genome; Liver Cancer; Liver Disease; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","ABCG2 gene;Address;Adult;Antibodies;Biological Assay;Blood Vessels;Bone Marrow Stem Cell;Brain;Breast;CD44 gene;Cancer Biology;Cancer Model;Cancer Patient;Cancer cell line;Cell Density;Cell Line;Cell Lineage;Cell Separation;Cell model;Cells;Classification;Clinical;DNA;DNA Methylation;DNA Methyltransferase;DNA Modification Methylases;Data;Diagnosis;Employee Strikes;Epidermal Growth Factor Receptor;Epigenetic Process;Epithelial;Epithelial Cells;Evaluation;Event;Exhibits;Exposure to;Frequencies;Gene Expression;Gene Expression Profile;Gene Targeting;Generations;Genes;Genetic;Genomics;Glioblastoma;Goals;HRAS gene;Hepatic;Hepatocyte;Heterogeneity;Human;Hypoxia;In Vitro;Incidence;Individual;Injection of therapeutic agent;Liver;Liver neoplasms;Lung;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of liver;Membrane Transport Proteins;Mesenchymal;Methylcellulose;MicroRNAs;Minor;Modeling;Mutation;NOD/SCID mouse;Neoplasm Metastasis;Oncogenes;Oncogenic;Organ;Outcome;Pathway interactions;Penetrance;Pharmaceutical Preparations;Play;Population;Proliferating;Property;Prostate;Proteins;Proteomics;Pump;Radio;Regulation;Reporting;Research Personnel;Resistance;Rest;Role;Serum;Serum-Free Culture Media;Side;Signal Pathway;Simian virus 40;Site;Solid;Staging;Stem cells;Subgroup;TACSTD2 gene;Target Populations;Testing;Therapeutic;Thyroid Gland;Tissues;Translations;Transplantation;Tumor-Derived;Tumorigenicity;United States;Western Europe;Zebularine;adult stem cell;beta catenin;c-myc Genes;cancer cell;cancer stem cell;cell transformation;cell type;clinically relevant;density;established cell line;genome sequencing;hepatoma cell;in vitro Assay;in vivo;inhibitor/antagonist;interest;mouse model;new therapeutic target;novel;outcome forecast;overexpression;pluripotency;prospective;research study;response;self renewing cell;self-renewal;small hairpin RNA;stem;stem cell biology;stem cell population;stemness;theories;tool;trait;transcriptomics;transdifferentiation;tumor;tumor initiation;tumorigenesis;vasculogenesis","Cancer stem cells and human liver cancer","n/a","NCI","8552944"," "," ","1ZIABC011031-05","1","ZIA","BC","011031","05"," "," "," "," "," "," ","9692443","THORGEIRSSON, SNORRI ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","635990",
"Biotechnology; Brain Cancer; Brain Disorders; Cancer; Genetics; Kidney Disease; Neuroblastoma; Neurosciences; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","Address;Aerobic;Antineoplastic Agents;Apoptotic;Attenuated;BNIP3L gene;Binding;Binding Sites;Biological;Biological Assay;Cell Line;Cell model;Cells;Chemicals;Collection;Complement;Data;Development;Dimethyl Sulfoxide;Epidermal Growth Factor Receptor;Epithelial;Gene Targeting;Genes;Genomics;Glioblastoma;Goals;Growth;Hour;Hypoxia;Hypoxia Inducible Factor;Hypoxia-Responsive Elements;In Vitro;Laboratories;Lead;Libraries;Link;Luciferases;Maintenance;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of brain;Mediator of activation protein;Messenger RNA;Minority;Modeling;Morbidity - disease rate;Neoplasm Metastasis;Neuroblastoma;Non-Small-Cell Lung Carcinoma;Oncogene Proteins;Operative Surgical Procedures;Pathway interactions;Patients;Pharmaceutical Preparations;Population;Process;Prognostic Factor;Protein Isoforms;Radiation therapy;Reading;Recurrence;Regulation;Renal Cell Carcinoma;Renal carcinoma;Reporter;Role;Screening procedure;Signal Transduction;Small Interfering RNA;Solid Neoplasm;Stem cells;Tandem Repeat Sequences;Testing;Therapeutic;Time;United States National Institutes of Health;Validation;Vascular Endothelial Growth Factors;Work;base;c-myc Genes;cancer stem cell;cancer therapy;computerized data processing;counterscreen;epithelial to mesenchymal transition;experience;functional outcomes;genome-wide;high throughput screening;hypoxia inducible factor 1;in vivo;inhibitor/antagonist;insight;neoplastic;neoplastic cell;novel;novel strategies;outcome forecast;promoter;response;self-renewal;small molecule;stem cell differentiation;stem cell population;therapy resistant;tissue culture;transcription factor;tumor;tumor initiation;tumor progression","High-throughput screen for specific small-molecule inhibitors of HIF-2A activity","
NARRATIVE
HIF-2ï¿½ increases the growth and aggressiveness of specific tumor types such as kidney and brain cancers.
HIF-2ï¿½ is also required for the survival of cancer stem cells, which allow a tumor to reappear after it has been
treated by chemo/radiotherapy or surgery. We propose to screen the NIH compound library for drugs that
specifically inhibit HIF-2ï¿½ activity by using our cell lines which contain a HIF-2ï¿½ reporter and whose activity will
be blocked by potential HIF-2ï¿½ inhibitors. To evaluate whether these inhibitors may become useful anti-cancer
drugs, we will also test their ability to inhibit tumor progression in other cell-based models.","NIDA","8262506","1/31/2012 12:00:00 AM","PAR-09-129","1R03DA033980-01A1","1","R03","DA","033980","01","A","SINGH, HARI","2/1/2012 12:00:00 AM","1/31/2014 12:00:00 AM","Special Emphasis Panel[ZRG1-BST-F(50)R]"," ","10775792","KOH, MEI YEE ","Not Applicable","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","279","Non-SBIR/STTR","2012"," "," ","OD","25000","14500"," ","39500",
"Bioengineering; Biotechnology; Breast Cancer; Cancer; Genetics; Prevention; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Adjuvant Chemotherapy;Africa;African American;Aggressive behavior;Appointment;Area;Automobile Driving;Basic Science;Bioinformatics;Biological;Biological Factors;Biological Sciences;Biomechanics;Biomedical Engineering;Biometry;Blue Cross;Blue Shield;Breast;Breast Cancer Genetics;Breast Cancer Treatment;Cancer Center;Cancer Center Support Grant;Cancer Survivorship;Cells;Cessation of life;Clinical;Clinical Research;Clinical Trials;Collaborations;Communities;Complex;Computational Biology;Continuance of life;Coupled;DNA Repair;DNA Sequence;DNA Sequencing Facility;Data;Development;Developmental Therapeutics Program;Devices;Diagnosis;Diagnostic;Doctor of Medicine;Drosophila chb protein;Drug Kinetics;Engineering;Ensure;Epithelial;Evaluation;Event;Faculty;Flow Cytometry;Foundations;Free Energy;Fund Raising;Funding;Future;Generations;Genes;Ghana;Goals;Grant;Health;Health Services Research;Hematology;Hospitals;Informatics;Institute of Medicine (U.S.);Institutes;International Agencies;Joints;Laboratories;Lead;Leadership;Malignant - descriptor;Malignant Neoplasms;Mammary Gland Parenchyma;Mechanics;Mediation;Medicine;Mesenchymal;Metabolism;Methods;Michigan;Middle East;Modeling;Molecular;Molecular Genetics;Monitor;Nanotechnology;Neoplasm Metastasis;Outcome;Outcomes and Health Services Research;Pathway interactions;Patients;Peer Review;Pharmacogenetics;Phase;Phase I Clinical Trials;Population;Positioning Attribute;Prevention;Prevention strategy;Process;Proteins;Publications;Quality of life;Recruitment Activity;Regulation;Research;Research Personnel;Research Project Grants;Resistance;Risk Assessment;Risk Management;Role;Schools;Science;Sister;Site;Teaching Hospitals;Text;Therapeutic;Training Activity;Transcriptional Regulation;Translational Research;Universities;University of Michigan Comprehensive Cancer Center;Woman;Work;Xenograft procedure;anticancer research;cancer cell;cancer education;cancer stem cell;cell motility;chemokine;chemotherapy;college;community setting;drug development;drug discovery;frontier;gamma secretase;genetic epidemiology;global health;improved;inhibitor-of-apoptosis protein;inhibitor/antagonist;malignant breast neoplasm;medical schools;meetings;member;model development;molecular imaging;neoplastic cell;new therapeutic target;next generation;novel;novel diagnostics;novel therapeutics;oncology;oncology program;outcome forecast;pre-clinical;preclinical study;programs;stem;stem cell population;survivorship;tool development;triple-negative invasive breast carcinoma;tumor;tumorigenesis;working group","Breast Oncology","The Breast Oncology Program is dedicated to research on the prevention, diagnosis, treatment and survivorship of breast cancer.","NCI","8300277","10/4/2012 10:47:58 AM","PAR-11-005","2P30CA046592-24","2","P30","CA","046592","24"," "," ","6/1/2012 12:00:00 AM","5/31/2017 12:00:00 AM","Cancer Centers Study Section (A)[NCI-A]","6461","1872561","WICHA, MAX S.","Not Applicable","12","Unavailable","073133571","GNJ7BBP73WE9","073133571","GNJ7BBP73WE9","US","42.244005","-83.73915","1506502","UNIVERSITY OF MICHIGAN AT ANN ARBOR","ANN ARBOR","MI","Domestic Higher Education","481091276","UNITED STATES","N","9/21/2012 12:00:00 AM","5/31/2013 12:00:00 AM"," ","Research Centers","2012","105068","105068"," ","67610","37458"," "," ",
"No NIH Category available","Accounting;Adverse effects;Affect;Affinity;Amino Acid Substitution;Amino Acids;Apatites;Attenuated;Binding;Binding Proteins;Biochemical;Biological;Biological Assay;Bone Growth;Bone Matrix;Bone Morphogenetic Proteins;Bone Transplantation;C-terminal;Cartilage;Cell Proliferation;Cells;Characteristics;Charge;Chemicals;Chondrocytes;Chondrogenesis;Clinical;Collagen;Complex;Cyclic Peptides;Defect;Development;Diffusion;Dose;Embryonic Development;Engineering;Equilibrium;Exhibits;Extracellular Matrix Proteins;Family;Fracture;Fracture Healing;Gene Expression;Gene Expression Regulation;Growth Factor;Healed;Histology;Human;Immobilization;Implant;Individual;Inflammation;Joints;Kinetics;Lead;Length;Ligands;MAP Kinase Gene;MAPK14 gene;MAPK8 gene;Mediating;Mesenchymal;Minerals;Modification;Mutation;Nuclear Translocation;Orthopedic Surgery procedures;Orthopedics;Osteoblasts;Osteocalcin;Osteogenesis;Outcome;Pathway interactions;Peptides;Phospho-Specific Antibodies;Phosphorylation;Phosphotransferases;Play;Proliferating;Property;Protein Binding;Proteins;Proteoglycan;Proteolysis;Receptor Signaling;Recombinants;Regulation;Relative (related person);Reporting;Research;Rodent Model;Role;Scanning;Signal Transduction;Site;Skeleton;Spinal Canal;Spinal Fusion;Stream;Surface Plasmon Resonance;Testing;Therapeutic;Therapeutic Agents;Time;Tissues;Transforming Growth Factor Beta 2;Transforming Growth Factor beta;Transforming Growth Factors;Translating;Trauma;Veterans;Water;attenuation;base;bone;bone growth factor;bone healing;bone metabolism;bone morphogenetic protein 2;bone morphogenetic protein 7;cancer surgery;carcinogenesis;casein kinase II;cathelicidin;cell growth;clinically relevant;combat;cost;cytokine;design;disulfide bond;extracellular;healing;human TGFB1 protein;improved;injured;insight;intramembranous bone formation;long bone;member;neoplastic cell;novel;osteogenic;public health relevance;receptor;receptor binding;reconstruction;release factor;secreted phosphoprotein 24;skeletal;synthetic peptide;theories","BBP (Bone Morphogenetic Protein Binding Peptide) and Bone Healing","The clinical relevance of this project is direct because the object is to produce materials that can be translated into therapeutics. Complex fractures, non-unions, and large bone defects due to trauma or cancer surgery that require extensive reconstruction are common problems among both veterans and combat injured individuals. Our long-term objective is to develop less expensive, more effective synthetic bone graft substitutes for use in orthopedic applications. We hope to develop a family of bone growth factor or BMP/TGF-b (bone morphogenetic protein/transforming growth factor-beta)-binding materials that can be employed in clinical situations where there is a need to retain the growth factors at the skeletal site where they are implanted in order to enhance their activity and promote bone growth and the successful integration of bone grafts or artificial joints into the skeleton. We will also determine how the native bone protein spp24 (secreted phosphoprotein-24 kDa) inhibits BMP/TGF-b-dependent tumor cell growth.","VA","8242608","12/1/2011 12:00:00 AM","RFA-BX-10-001","5I01BX000511-02","5","I01","BX","000511","02"," "," ","10/1/2010 12:00:00 AM","9/30/2014 12:00:00 AM","Endocrinology B[ENDB]"," ","1889377","MURRAY, SAMUEL SCOTT","Not Applicable","33","Unavailable","066689118","DL46AKJ5YD48","066689118","DL46AKJ5YD48","US","34.104809","-118.41105","481012","VA GREATER LOS ANGELES HEALTHCARE SYSTEM","LOS ANGELES","CA","Independent Hospitals","900731003","UNITED STATES","N","10/1/2011 12:00:00 AM","9/30/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Breast Cancer; Cancer; Clinical Research; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Applications Grants;Area;Automobile Driving;Award;Biological Assay;Breast;Breast Cancer Prevention;Cell Count;Cell Proliferation;Cell Separation;Cell surface;Cells;Clinical;Clinical Investigator;Conditioned Culture Media;Conflict (Psychology);Data;Development;Diagnosis;Duct (organ) structure;Ductal Epithelial Cell;ERBB2 gene;Epithelial;Estradiol;Faculty;Fluorescence;Focus Groups;Foundations;Funding;Funding Opportunities;Future;Genes;Genetic Heterogeneity;Goals;Growth;Heterogeneity;Histopathology;Hormonal;Hormones;Human;Human Resources;Immunoassay;Immunodeficient Mouse;In Situ Lesion;In Vitro;K-Series Research Career Programs;Laboratory mice;Lead;Leadership;Left;Lesion;Longitudinal Studies;Malignant - descriptor;Malignant Neoplasms;Mammary gland;Mastectomy;Mentors;Mesenchymal;Methods;Modeling;Molecular;Molecular Profiling;Mus;Neoplasm Metastasis;Non-Invasive Lesion;Noninfiltrating Intraductal Carcinoma;Ovarian Steroid Hormone;Paracrine Communication;Pathway interactions;Patient Care;Patients;Phenotype;Population;Positioning Attribute;Premalignant;Prevention strategy;Progesterone;Property;Public Health;Radiation;Research;Research Personnel;Research Training;Risk;Risk Assessment;Role;Sampling;Scientist;Secure;Series;Signal Pathway;Signal Transduction;Solid;Sorting - Cell Movement;Specimen;Staging;Stem cells;Surface;TACSTD2 gene;Techniques;Testing;Therapeutic;Time;Training;Translational Research;Variant;Woman;Xenograft Model;Xenograft procedure;anticancer research;base;breast lesion;breast lumpectomy;cancer stem cell;carcinogenesis;cell growth;design;human disease;human stem cells;improved;in vitro Assay;in vivo;malignant breast neoplasm;meetings;novel;paracrine;progenitor;programs;research study;response;self-renewal;skills;stem;stem cell division;stem cell population;steroid hormone;therapeutic target;tumor;tumor progression;working group","Stem cells and their aberrant self-renewal pathways in DCIS malignant progression","Almost 50,000 women are diagnosed with the early, non-invasive stage of breast cancer known as ductal carcinoma in situ (DCIS) every year. Because we are currently unable to predict which DCIS lesions will become invasive, these non-invasive cancers are always treated as though they will progress by mastectomy or lumpectomy followed by radiation, and thus in some instances may be over-treated. This proposal seeks to identify the subset of cells that are responsible for the variation in invasive potential among DCIS cases. This may help identify patients at risk for invasive breast cancer and provide potential therapeutic targets for breast cancer prevention.","NCI","8384295","9/25/2012 12:00:00 AM","PAR-09-069","1K22CA160587-01A1","1","K22","CA","160587","01","A","OJEIFO, JOHN O","9/25/2012 12:00:00 AM","8/31/2015 12:00:00 AM","Transition to Independence Study Section (I)[NCI-I]"," ","6430486","VALDEZ, KELLI E","Not Applicable","03","PATHOLOGY","016060860","YXJGGNC5J269","016060860","YXJGGNC5J269","US","39.123452","-94.743946","1484303","UNIVERSITY OF KANSAS MEDICAL CENTER","KANSAS CITY","KS","SCHOOLS OF MEDICINE","661608500","UNITED STATES","N","9/25/2012 12:00:00 AM","8/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","116924","9354"," ","126278",
"Aging; Autoimmune Disease; Bioengineering; Biotechnology; Genetics; Immunization; Infectious Diseases; Lupus; Prevention; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Transplantation; Vaccine Related","Adult;Affect;Age;Aging;Algorithms;Amino Acid Sequence;Antibodies;Atrophic;Autoimmune Diseases;Autoimmunity;Autologous;Biological;Biology;Bone Marrow Transplantation;Castration;Cell Separation;Communicable Diseases;Complex;Computational Technique;Computer Simulation;Computing Methodologies;Coupled;Data;Databases;Development;Disease;Elderly;Epithelial;Expressed Sequence Tags;Future;Gene Chips;Gene Expression;Gene Expression Profile;Genes;Goals;Grant;Growth;Health;Health Care Costs;Hematopoietic Stem Cell Transplantation;Hematopoietic stem cells;Human;Immune response;Immunity;Immunofluorescence Immunologic;Immunohistochemistry;In Situ;In Situ Hybridization;Incidence;Infection;Informatics;Intervention;Knock-out;Laboratories;Lasers;Life;Link;Location;Lupus Erythematosus;Lymphocyte;Lymphoid;Lymphopenia;Maintenance;Measures;Mesenchymal;Messenger RNA;Metabolic Pathway;Methodology;Methods;Microdissection;Modeling;Multiple Sclerosis;Natural regeneration;Online Systems;Outcome;Output;Pathway interactions;Pattern;Peptide Sequence Determination;Peripheral;Phase;Policies;Postdoctoral Fellow;Predisposition;Process;Production;Protein Binding Domain;Proteins;Puberty;Public Domains;Quality of life;RNA;Research;Research Design;Risk;Sampling;Scientist;Severities;Signal Pathway;Signal Transduction;Source;Stem cell transplant;Stimulus;Stromal Cells;System;Systemic Lupus Erythematosus;T-Cell Immunodeficiency;T-Lymphocyte;Techniques;Testing;Therapeutic;Thymus Gland;Time;Tissues;Training;Transgenic Organisms;United States National Institutes of Health;Update;Vaccination;Vaccines;Validation;age related;aging population;analytical method;base;cDNA Arrays;cancer therapy;computerized data processing;density;follow-up;interest;leukemia;new therapeutic target;normal aging;novel;novel strategies;prevent;receptor;research study;response;skills;sound;success;tool;tumor","Identification of stromal responses during castration-induced thymic regrowth.","Project Narrative
Decreases in T cell immunity are a direct consequence of age-related thymic degeneration, and
are linked to a host of undesirable conditions, including increased risk of infection, increased
severity of infection, decreased response to vaccinations, decreased tumor surveillance,
increased autoimmunity, and so on. Regenerating the thymus is therefore of significant interest
to human health. This application proposes a novel approach to understanding the biology of
regrowth of the atrophied thymus. In addition to an in-depth understanding of the regrowth
process, this project is expected to ultimately reveal potential new targets for thymic
regeneration therapy.","NIA","8220866","2/6/2012 12:00:00 AM","PA-07-070","5R01AG031576-04","5","R01","AG","031576","04"," ","FULDNER, REBECCA A","2/1/2009 12:00:00 AM","1/31/2014 12:00:00 AM","Cellular Mechanisms in Aging and Development Study Section[CMAD]"," ","1877910","PETRIE, HOWARD T.","Not Applicable","49","Unavailable","781613492","PHZJFZ32NKH4","781613492","PHZJFZ32NKH4","US","32.903152","-117.243436","7375802","SCRIPPS RESEARCH INSTITUTE","LA JOLLA","CA","Research Institutes","920371000","UNITED STATES","N","2/15/2012 12:00:00 AM","1/31/2013 12:00:00 AM","866","Non-SBIR/STTR","2012"," "," ","NIA","195076","191174"," ","386250",
"Brain Disorders; Cancer; Contraception/Reproduction; Estrogen; Fibroid Tumors (Uterine); Genetics; Lung; Rare Diseases; Tuberous Sclerosis","Accounting;Adenomatous Polyposis Coli;Affect;Alleles;Biological Models;Blood Circulation;Blood Vessels;Breeding;Candidate Disease Gene;Cells;Cephalic;Cervix Uteri;Chronic;Contraceptive Usage;Critical Pathways;Desmin;Detection;Development;Diffuse;Disease;Disease Progression;Embryo;Estradiol;Estrogens;Etiology;Female;Female of child bearing age;Fibroid Tumor;Fibrosis;Fluorescence;Foundations;Functional disorder;Future;Genes;Genetic;Hemorrhage;Hormone Responsive;Hormones;Human;Human Characteristics;Hypertrophic Cicatrix;Immunofluorescence Immunologic;Incidence;Infiltration;Injection of therapeutic agent;Investigation;Lead;Leiomyoma;Lesion;Lung;Lung Lymphangioleiomyomatosis;Lung Transplantation;Lymphangioleiomyomatosis;Malignant Neoplasms;Mammalian Oviducts;Menarche;Menopause;Mesenchymal;Mesenchyme;Modeling;Modification;Mus;Mutant Strains Mice;Mutation;Natural regeneration;Neoplasm Metastasis;Organ;Ovarian Steroid Hormone;Pathology;Pathway interactions;Patient observation;Patients;Process;Progesterone;Progestins;Proliferating;Pulmonary Fibrosis;Rare Diseases;Regulation;Reporter;Research;Respiratory Failure;Signal Pathway;Site;Smooth Muscle;Smooth Muscle Myocytes;Source;Specificity;Stromal Cells;Structure;Structure of paramesonephric duct;Structure of parenchyma of lung;Tail;Testing;Therapeutic Intervention;Tissues;Tuberous Sclerosis;Tuberous sclerosis protein complex;Uterine Fibroids;Uterine Lesion;Uterine hemorrhage;Uterus;Vagina;Veins;Wound Healing;base;cohort;hormone regulation;human TSC1 protein;human TSC2 protein;in vivo Model;interstitial;male;mouse model;mutant;peripheral blood;pill;preclinical study;repaired;reproductive;research study;therapeutic target","Uterine-specific genetic modification and lymphangioleiomyomatosis"," One of the major unknowns in lymphangioleiomyomatosis (LAM) research is the cell or tissue of origin for the smooth muscle cells that infiltrate the lung to form the fibrotic lesions. We have generated mice with defective wound healing in uteri, which results in hemorrhaging, hypertrophic scarring and fibroids. Our preliminary results investigating the lungs suggest that circulating post-traumatic uterine cells might be the cells that cause LAM. The proposed studies will investigate whether the uterine cells are the source of fibrotic cells found in LAM, whether the LAM lung lesions are hormonally responsive, and whether these mutant mice will be a needed model system for investing the mechanisms and pathways involved in the infiltration of the lungs with fibrotic cells and for preclinical studies of possible therapeutic intervention.    

","NHLBI","8306053","5/29/2012 12:00:00 AM","PAS-10-226","5R21HL109935-02","5","R21","HL","109935","02"," ","PEAVY, HANNAH H","8/1/2011 12:00:00 AM","5/31/2013 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1863028","TEIXEIRA, JOSE M.","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","OD","28373","21627"," ","50000",
"Brain Disorders; Cancer; Contraception/Reproduction; Estrogen; Fibroid Tumors (Uterine); Genetics; Lung; Rare Diseases; Tuberous Sclerosis","Accounting;Adenomatous Polyposis Coli;Affect;Alleles;Biological Models;Blood Circulation;Blood Vessels;Breeding;Candidate Disease Gene;Cells;Cephalic;Cervix Uteri;Chronic;Contraceptive Usage;Critical Pathways;Desmin;Detection;Development;Diffuse;Disease;Disease Progression;Embryo;Estradiol;Estrogens;Etiology;Female;Female of child bearing age;Fibroid Tumor;Fibrosis;Fluorescence;Foundations;Functional disorder;Future;Genes;Genetic;Hemorrhage;Hormone Responsive;Hormones;Human;Human Characteristics;Hypertrophic Cicatrix;Immunofluorescence Immunologic;Incidence;Infiltration;Injection of therapeutic agent;Investigation;Lead;Leiomyoma;Lesion;Lung;Lung Lymphangioleiomyomatosis;Lung Transplantation;Lymphangioleiomyomatosis;Malignant Neoplasms;Mammalian Oviducts;Menarche;Menopause;Mesenchymal;Mesenchyme;Modeling;Modification;Mus;Mutant Strains Mice;Mutation;Natural regeneration;Neoplasm Metastasis;Organ;Ovarian Steroid Hormone;Pathology;Pathway interactions;Patient observation;Patients;Process;Progesterone;Progestins;Proliferating;Pulmonary Fibrosis;Rare Diseases;Regulation;Reporter;Research;Respiratory Failure;Signal Pathway;Site;Smooth Muscle;Smooth Muscle Myocytes;Source;Specificity;Stromal Cells;Structure;Structure of paramesonephric duct;Structure of parenchyma of lung;Tail;Testing;Therapeutic Intervention;Tissues;Tuberous Sclerosis;Tuberous sclerosis protein complex;Uterine Fibroids;Uterine Lesion;Uterine hemorrhage;Uterus;Vagina;Veins;Wound Healing;base;cohort;hormone regulation;human TSC1 protein;human TSC2 protein;in vivo Model;interstitial;male;mouse model;mutant;peripheral blood;pill;preclinical study;repaired;reproductive;research study;therapeutic target","Uterine-specific genetic modification and lymphangioleiomyomatosis"," One of the major unknowns in lymphangioleiomyomatosis (LAM) research is the cell or tissue of origin for the smooth muscle cells that infiltrate the lung to form the fibrotic lesions. We have generated mice with defective wound healing in uteri, which results in hemorrhaging, hypertrophic scarring and fibroids. Our preliminary results investigating the lungs suggest that circulating post-traumatic uterine cells might be the cells that cause LAM. The proposed studies will investigate whether the uterine cells are the source of fibrotic cells found in LAM, whether the LAM lung lesions are hormonally responsive, and whether these mutant mice will be a needed model system for investing the mechanisms and pathways involved in the infiltration of the lungs with fibrotic cells and for preclinical studies of possible therapeutic intervention.    

","NHLBI","8306053","5/29/2012 12:00:00 AM","PAS-10-226","5R21HL109935-02","5","R21","HL","109935","02"," ","PEAVY, HANNAH H","8/1/2011 12:00:00 AM","5/31/2013 12:00:00 AM","Lung Injury, Repair, and Remodeling Study Section[LIRR]"," ","1863028","TEIXEIRA, JOSE M.","Not Applicable","08","Unavailable","073130411","FLJ7DQKLL226","073130411","FLJ7DQKLL226","US","42.347465","-71.082058","4907701","MASSACHUSETTS GENERAL HOSPITAL","BOSTON","MA","Independent Hospitals","021142621","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","96627","57909"," ","154536",
"Bioengineering; Cancer; Diagnostic Radiology; HIV/AIDS; Networking and Information Technology R&D","Address;Agreement;Algorithms;Animal Model;Applied Research;Area;Artificial Intelligence;Automated Pattern Recognition;Automation;Biological Markers;Biological Models;Biopsy;Blood Vessels;CD8B1 gene;CLIC4 gene;Cancer Diagnostics;Cancer Model;Cell Culture Techniques;Cells;Chloride Channels;Collaborations;Combined Modality Therapy;Complex;Comprehension;Computer Assisted;Computer-Assisted Image Analysis;Cytoskeleton;DNA Sequence Analysis;Dendritic Cells;Development;Diagnosis;Diagnostic;Diagnostic Neoplasm Staging;Disease;Disease remission;Disseminated Malignant Neoplasm;Equipment;Evaluation;Genetic Engineering;Growth;Harvest;Hematopoietic Neoplasms;Heterogeneity;Histologic;Histopathology;Human;Image;Image Analysis;Immunological Diagnosis;Immunotherapeutic agent;In Vitro;Interleukin-15;Investigation;Knowledge;Laboratories;Lesion;Lung;Lymphoma;Magnetic Resonance Imaging;Malignant Neoplasms;Manuals;Mass Spectrum Analysis;Measurement;Mediating;Medical;Medicine;Mesenchymal;Methods;Microdissection;Modality;Modeling;Molecular;Molecular Analysis;Mus;Nuclear;Oncogene Activation;Optical Instrument;Oxidation-Reduction;Pathologic;Pathologist;Pathology;Pattern Recognition;Phenotype;Protein Family;Reagent;Regimen;Relative (related person);Reproducibility;Research;Research Design;Research Personnel;Research Project Grants;Resistance;Resources;Role;Scanning;Signal Transduction;Slide;Source;Specimen;Structure of parenchyma of lung;T-Lymphocyte;TNFRSF5 gene;Techniques;Technology;Teratoma;Tissue Preservation;Tissue Procurements;Tissues;Training;Transforming Growth Factor beta;Translational Research;Treatment Efficacy;Tumor Burden;Tumor Tissue;Ultrasonography;Variant;Work;X-Ray Computed Tomography;biobank;cancer cell;cancer therapy;cell type;data acquisition;design;digital;experience;human CLIC4 protein;human disease;image processing;imaging Segmentation;improved;in vivo;insight;instrument;interest;melanoma;member;molecular imaging;molecular pathology;neoplastic cell;optical imaging;osteosarcoma;pluripotency;pre-clinical;quality assurance;ras Oncogene;residence;sarcoma;soft tissue;systems research;technology development;tool;trend;tumor","Molecular Pathology Research for Cancer Diagnostics and Biomarkers","n/a","NCI","8554087"," "," ","1ZICBC010953-05","1","ZIC","BC","010953","05"," "," "," "," "," "," ","9692305","SIMPSON, ROBERT ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","1239425",
"Aging; Cancer; Genetics; Prostate Cancer; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human; Urologic Diseases","Ablation;Adult;Aggressive behavior;Androgens;Apoptotic;Behavior;Bicalutamide;CWR22Rv1;Cancer Etiology;Cancer Patient;Caring;Castration;Cell Fraction;Cell Line;Cell model;Cells;Cessation of life;Clinical;Clinical Treatment;Development;Diagnosis;Disease Progression;Disease Resistance;Distant;Drug resistance;EGF gene;Early Diagnosis;Elements;Epidermal Growth Factor Receptor;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Epigenetic Process;Epithelial;Epithelial Cells;Erinaceidae;Etiology;GLI-1;Gefitinib;Gene Expression;Genes;Genetic;Goals;Growth;Hormones;Human;In Vitro;Investigation;Lead;MEKs;Malignant - descriptor;Malignant neoplasm of prostate;Mesenchymal;Methods;Molecular;Neoplasm Metastasis;Non-Malignant;Oncogenic;Organ;PC3 cell line;Pathway interactions;Patient Care;Patients;Pharmaceutical Preparations;Phenotype;Phospholipase;Phosphorylation;Prostate carcinoma;Prostatic;Prostatic Tissue;Proteins;Radiation therapy;Radical Prostatectomy;Recurrent disease;Refractory;Relapse;Research;Resistance;Second Primary Neoplasms;Signal Transduction;Sonic Hedgehog Pathway;Specimen;Staging;Stem cells;Techniques;Testing;Therapeutic;Tissues;Up-Regulation;Validation;androgen independent prostate cancer;base;cancer cell;cancer initiation;cell motility;chemotherapy;clinically relevant;cyclopamine;docetaxel;high risk;hormone therapy;human FRAP1 protein;human SMO protein;improved;in vivo;inhibitor/antagonist;interest;malignant phenotype;men;new therapeutic target;novel;palliative;prevent;programs;prostate carcinogenesis;self-renewal;small hairpin RNA;smoothened signaling pathway;stem;therapeutic target;tumor;tumor progression;tumorigenic","Novel deregulated genes in the etiology and progression of human prostate cancer","
Description of research program
The research program aims to establish the implications of EGFR and hedgehog cascades and other
interacting pathways in the malignant transformation of PC stem/progenitor cells and their progenies
and treatment resistance and validate novel therapeutic targets for improving current therapies and
preventing disease relapse and the death of PC patients. The studies will consist to delineate the gene
products modulated through the EGFR and hedgehog pathways that can cooperate in PC progression and
treatment resistance and validate novel therapeutic targets for eradicating total PC cell mass by using human
PC cell models and prostatic tissue specimens from patients relevant to prostate carcinogenesis.","NCI","8233916","4/12/2012 12:00:00 AM","PA-07-070","5R01CA138791-03","5","R01","CA","138791","03"," ","SATHYAMOORTHY, NEERAJA","5/1/2010 12:00:00 AM","2/28/2015 12:00:00 AM","Cancer Etiology Study Section[CE]"," ","7239627","BATRA, SURINDER K.","Not Applicable","02","BIOCHEMISTRY","168559177","G15AG3BLLMH4","168559177","G15AG3BLLMH4","US","41.26545","-96.039767","578104","UNIVERSITY OF NEBRASKA MEDICAL CENTER","OMAHA","NE","SCHOOLS OF MEDICINE","681987835","UNITED STATES","N","3/1/2012 12:00:00 AM","2/28/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","241530","116712"," ","358242",
"Biotechnology; Breast Cancer; Cancer","Address;Adhesions;Affect;Agar;American;American Association of Cancer Research;Anchorage-Independent Growth;Animals;Area;Aromatic Polycyclic Hydrocarbons;Aryl Hydrocarbon Receptor;Authorship;BHLH Protein;Biochemistry;Biological Markers;Bioluminescence;Biomedical Research;Breast Carcinoma;Cancer Biology;Carcinoma;Cell Cycle;Cell Line;Cell Survival;Cells;Clinical Markers;Complement;Comprehensive Cancer Center;Core Facility;Critiques;DNA Damage;Data;Development;Disease;Doctor of Philosophy;Educational workshop;Environment;Enzymes;Epithelial Cells;Estrogens;Exhibits;Faculty;Feedback;Funding;Future;Gene Expression;Gene Family;Generations;Genes;Genetic Transcription;Genome;Goals;Grant;Group Meetings;Growth;Guns;HIV;Human;Image;Implant;In Vitro;Journals;Kentucky;Laboratories;Lead;Ligands;Link;Mainstreaming;Maintenance;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Mammary Neoplasms;Mammary gland;Manuscripts;Matrigel Invasion Assay;Measures;Mediating;Medical center;Medicine;Mentors;Minority;Modification;Molecular;Molecular Toxicology;Monitor;National Institute of General Medical Sciences;Neoplasm Metastasis;Oligonucleotide Microarrays;Parents;Pathway interactions;Patients;Peer Review;Pharmacology;Phosphotyrosine;Population;Preventive Intervention;Prognostic Factor;Protein Kinase;Proteomics;Publications;Publishing;Records;Regulation;Reporting;Research;Research Personnel;Research Proposals;Resource Sharing;Role;SCID Mice;Series;Signal Pathway;Signal Transduction;Signaling Pathway Gene;Small Interfering RNA;Societies;Specimen;Staging;Structure;Students;Technology;Testing;Therapeutic;Therapeutic Intervention;Time;Tissue Microarray;Toxicology;Training;Tyrosine;United States National Institutes of Health;Universities;Wisconsin;Work;Writing;Xenograft Model;activating transcription factor;base;cancer initiation;carcinogenesis;career;cell motility;cell transformation;chemical carcinogenesis;density;design;epithelial to mesenchymal transition;graduate student;health disparity;improved;in vivo;inhibitor/antagonist;malignant breast neoplasm;malignant phenotype;medical schools;medical specialties;meetings;member;migration;neoplastic cell;novel;oncology;overexpression;professor;prognostic;programs;public health relevance;receptor;receptor expression;research study;symposium;transcription factor;tumor;tumor progression;tumorigenic","The Aryl Hydrocarbon Receptor and Breast Cancer","
 Narrative
The proposed research in this application is designed to address and define the causal role of
AhR in invasive breast cancer progression. Results from these studies will help identify the AhR
as one of the breast cancer metastatic determinants; thus establishing it as an independent
survival prognostic factor for breast cancer. The studies will also lead to a better understanding
of the molecular action of AhR and its ligand-independent activation in advanced breast cancer,
thus providing a unique target for the design of novel selective inhibitors for therapeutic
intervention of metastatic breast cancer.
.","NCI","8294832","5/17/2012 12:00:00 AM","PAR-08-026","5SC1CA153326-03","5","SC1","CA","153326","03"," ","CHUNG, DAVYD W","6/1/2010 12:00:00 AM","5/31/2015 12:00:00 AM","ZGM1-MBRS-7(GC)"," ","8822404","ELTOM, SAKINA E.","Not Applicable","05","BIOCHEMISTRY","041438185","DLTJBDQBGBC9","041438185","DLTJBDQBGBC9","US","36.177472","-86.807838","5050201","MEHARRY MEDICAL COLLEGE","NASHVILLE","TN","SCHOOLS OF MEDICINE","372083501","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","393","Other Research-Related","2012"," "," ","NIGMS","247500","115088"," ","362588",
"Biotechnology; Clinical Research; Genetics; Kidney Disease; Organ Transplantation; Transplantation","Accounting;Acute;Adult;Affect;Albuminuria;Algorithms;Allografting;Atrophic;Award;Biological Assay;Biological Markers;Biological Response Modifiers;Biopsy;Blood Cells;CXC chemokine IP-10;CXCR3 gene;Calcineurin inhibitor;Cardiovascular system;Cells;Cessation of life;Chronic rejection of renal transplant;Clinical;Clinical Sciences;Clinical Trials;Clinical and Translational Science Awards;Cohort Studies;Complementary DNA;Core Biopsy;Data;Data Analyses;Deterioration;Development;Diagnosis;Diagnostic;Diagnostic tests;Dose;E-Cadherin;Enrollment;Epithelial;Exhibits;Fibrosis;Foundations;Functional RNA;Functional disorder;Funding;Gene Expression;Gene Expression Profile;Genes;Genetic Transcription;Glomerular Filtration Rate;Goals;Growth;Human;IL2RA gene;Immunosuppression;Immunosuppressive Agents;Incidence;Industry;Infection;Interferon Type II;Interleukin-10;Interleukin-2;Kidney;Kidney Diseases;Lead;Letters;MS4A1 gene;Malignant Neoplasms;Measurement;Measures;Mesenchymal;Messenger RNA;Metabolic;Methods;MicroRNAs;Modeling;Modification;Molecular;Molecular Profiling;Needles;Nucleotides;Organ Transplantation;Outcome;Patients;Pattern;Performance;Pharmaceutical Preparations;Protease Inhibitor;Proteins;Protocols documentation;RNA;RNA, Ribosomal, 18S;Randomized;Randomized Controlled Trials;Regimen;Renal tubule structure;Request for Applications;Research;Reverse Transcription;Risk;Sensitivity and Specificity;Specific qualifier value;Specificity;Specimen;Tacrolimus;Testing;Therapeutic immunosuppression;Time;Translational Research;Translations;Transplantation;Tubular formation;United States National Institutes of Health;Urinary tract infection;Urine;Validation;base;bone morphogenetic protein 7;clinical care;cost;experience;granzyme B;improved;interstitial;kidney allograft;perforin;peripheral blood;prognostic;programs;public health relevance;stem;symporter;trial comparing;urinary","Biomolecular Markers for Safe Minimization of Immunosuppression","PUBLIC HEALTH RELEVANCE: The use of immunosuppressive drugs is associated with an excess of infections, malignancy and cardiovascular and metabolic aberrations in organ graft recipients. Thus, immunosuppression minimization is a major goal in organ transplantation. We propose to develop gene-based diagnostic tests for guiding the minimization of immunosuppressive therapy in organ graft recipients.","NIAID","8299151","5/30/2012 12:00:00 AM","PA-07-070","5R37AI051652-09","5","R37","AI","051652","09"," ","HAYES, DEBORAH","2/15/2002 12:00:00 AM","6/30/2014 12:00:00 AM","Transplantation, Tolerance, and Tumor Immunology Study Section[TTT]"," ","1966582","SUTHANTHIRAN, MANIKKAM ","Not Applicable","12","INTERNAL MEDICINE/MEDICINE","060217502","YNT8TCJH8FQ8","060217502","YNT8TCJH8FQ8","US","40.76491","-73.955055","1514803","WEILL MEDICAL COLL OF CORNELL UNIV","NEW YORK","NY","SCHOOLS OF MEDICINE","100654805","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","855","Non-SBIR/STTR","2012"," "," ","NIAID","245025","169067"," ","414092",
"Brain Cancer; Brain Disorders; Cancer; Neurosciences; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Address;Adjuvant Therapy;Affect;Animal Model;Animals;Award;Behavior;Belief;Binding;Biochemical;Biological Markers;Biology;Blood;Blood - brain barrier anatomy;Brain;Cell physiology;Cells;Characteristics;Chromosomes;Clinical;Coupled;Cues;Defect;Dependence;Development;Diagnosis;Diet;Diffuse;Disease;Doctor of Medicine;Doctor of Philosophy;Employee Strikes;Environment;Etiology;Extracellular Space;Extravasation;Faculty;Genetic;Genetic Heterogeneity;Genotype;Glioblastoma;Glioma;Goals;Growth;Heterogeneity;Histology;Human;Image;Imaging Techniques;In Vitro;Infection;Infiltration;Intracranial Neoplasms;Invaded;Label;Laboratories;Laboratory Study;Large-Scale Sequencing;Lead;Leucine;Magnetic Resonance Imaging;Malignant Neoplasms;Measures;Mediating;Medical Genetics;Mentors;Mentorship;Mesenchymal;Methodology;Methods;Molecular Biology;Monitor;Morbidity - disease rate;Nerve Degeneration;Neurodegenerative Disorders;Neurosurgical Procedures;Operative Surgical Procedures;Outcome;Pathologic;Pathway interactions;Patients;Permeability;Phenotype;Physicians;Physics;Positioning Attribute;Postdoctoral Fellow;Primary Brain Neoplasms;Proteins;Proteomics;Rattus;Recurrence;Research;Research Proposals;Residencies;Residual state;Resistance;Resources;Role;Scientific Advances and Accomplishments;Scientist;Sensitivity and Specificity;Serum;Serum Proteins;Signal Transduction;Site;Stem cells;Stroke;Surgeon;TWIST1 gene;Techniques;Technology;Testing;Therapeutic;Time;Tissues;Transfusion;Trauma;Tumor-Derived;Universities;Vascular Endothelial Growth Factors;Washington;Work;anticancer research;bevacizumab;brain tissue;cell motility;design;experience;extracellular;improved;in vivo;inhibitor/antagonist;innovation;interest;mortality;multidisciplinary;neoplastic cell;neurological pathology;new therapeutic target;novel;overexpression;post-doctoral training;pre-doctoral;prevent;protein profiling;repaired;skills;transcription factor;tumor;tumor growth","Effects of Extravasated Serum Proteins on Human Glioblastoma Invasion","    
   
Glioblastoma multiforme (GBM) is the most common and the most lethal primary brain tumor. Despite advances in a variety of therapies, survival has remained largely unchanged for more than 30 years. The invasion of GBM into healthy brain tissues is the main reason for disease intractability. It is unclear why GBM tumor cells invade. However, there is compelling evidence that suggests the accumulation of specific serum proteins in the extracellular space due to disruption of the blood-brain-barrier may make GBM tumor cells more invasive. Serum proteins have not previously been recognized as modulators of invasion. The identification of specific serum proteins that actuate GBM cell migration would establish new therapeutic targets directed at preventing the spread of GBM tumor cells throughout the brain. By stopping the migratory behavior of GBM, therapies directed at bulk tumor growth may prove more effective and survival from this devastating disease may improve for the first time in many decades.   
      

","NCI","8353237","8/2/2012 12:00:00 AM","PA-11-197","1K99CA168943-01","1","K99","CA","168943","01"," ","SCHMIDT, MICHAEL K","8/2/2012 12:00:00 AM","7/31/2014 12:00:00 AM","Institutional Training and Education Study Section (F)[NCI-F]"," ","10761209","UNDERHILL, HUNTER REEVE","Not Applicable","07","NEUROSURGERY","605799469","HD1WMN6945W6","605799469","HD1WMN6945W6","US","47.660049","-122.31441","9087701","UNIVERSITY OF WASHINGTON","SEATTLE","WA","SCHOOLS OF MEDICINE","981951016","UNITED STATES","N","8/2/2012 12:00:00 AM","7/31/2013 12:00:00 AM","398","Other Research-Related","2012"," "," ","NCI","102430","8194"," ","110624",
"Biodefense; Chronic Liver Disease and Cirrhosis; Clinical Research; Digestive Diseases; Emerging Infectious Diseases; Genetics; Hepatitis; Hepatitis - C; Infectious Diseases; Liver Disease; Lung; Pediatric","4-ethoxymethylene-2-phenyl-2-oxazoline-5-one;Affect;Agonist;Anabolism;Animal Model;Antioxidants;Apical;Apoptosis;Arachidonic Acids;Asthma;Bacterial Infections;Biochemical;Blood Vessels;Breast;Cell Aging;Cell Differentiation process;Cell model;Cells;Chronic;Chronic Granulomatous Disease;Cirrhosis;Colitis;Cretinism;Cystic Fibrosis;Data;Defect;Development;Disease;Dominant-Negative Mutation;Enzymes;Epithelial;Epithelial Cells;Exhibits;Exocrine Glands;Extracellular Matrix;Family;Fibronectins;Fibrosis;Gastrointestinal tract structure;Generations;Genetic Polymorphism;Goals;Growth Factor;Heart;Hepatitis C;Hepatitis C virus;Hepatocyte;Hormones;Host Defense;Human;Hydrogen Peroxide;Immune;Infection;Inflammatory;Inflammatory Response;Isoenzymes;Kidney;Lead;Link;Liver;Liver Fibrosis;Lung;Lung diseases;MADH3 gene;Mammary gland;Mediating;Membrane;Messenger RNA;Molecular;Mus;Mutation;NADPH Oxidase;Natural Immunity;Neoplasm Metastasis;Nox enzyme;Oxidants;Oxidases;Oxidation-Reduction;Oxidative Stress;Oxygen;Patients;Pattern;Pattern Recognition;Peroxidases;Phagocytes;Phospholipase A2;Play;Predisposition;Process;Production;Proteins;Pseudomonas Infections;Pseudomonas aeruginosa;Pyocyanine;Reactive Oxygen Species;Role;Salivary;Signal Transduction;Single Nucleotide Polymorphism;Source;Stimulus;Surface;Surveys;System;TGF-beta type I receptor;Therapeutic Intervention;Thyroid Gland;Tissues;Toxin;Transcriptional Regulation;Transforming Growth Factor beta;Viral;Virus Diseases;Wound Healing;antimicrobial;arachidonate;autocrine;base;cell motility;cellular targeting;cytokine;epithelial to mesenchymal transition;feeding;glutathione peroxidase;inhibitor/antagonist;insight;interest;microbial;microbicide;migration;neutrophil cytosol factor 40K;pathogen;patient population;peroxiredoxin;programs;promoter;reconstitution;research study;response;small hairpin RNA;tissue/cell culture;tumor;tumor progression","Nox family NADPH oxidases: roles in innate immunity and inflammatory disease","n/a","NIAID","8555786"," "," ","1ZIAAI000614-22","1","ZIA","AI","000614","22"," "," "," "," "," "," ","6568505","LETO, THOMAS ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NIAID"," "," "," ","843127",
"Biotechnology; Cancer; Colo-Rectal Cancer; Digestive Diseases; Genetics; Human Genome; Rare Diseases","13q;18q;20p;20q;Address;Affect;Aneuploidy;Architecture;Biopsy;Bypass;C57BL/6 Mouse;Cancer cell line;Carcinoma;Cell Line;Cell Nucleus;Cell model;Cells;Chromosome Arm;Chromosome Mapping;Chromosome Positioning;Chromosome Territory;Chromosome Transfer;Chromosome abnormality;Chromosomes;Chromosomes, Human, Pair 18;Chromosomes, Human, Pair 19;Chromosomes, Human, Pair 20;Chromosomes, Human, Pair 7;Code;Colon;Colon Carcinoma;Colonic Neoplasms;Colorectal Cancer;Complement;Coupled;Cultured Cells;Cytogenetics;DNA copy number;Data;Diploidy;Disease;Down-Regulation;Epithelial;Epithelial Cells;Eukaryota;Event;Evolution;Exhibits;Gene Amplification;Gene Deletion;Gene Expression;Gene Expression Profile;Gene Expression Profiling;Genes;Genetic;Genome;Genomic Instability;Genomics;Goals;HMGA1 gene;Homologous Gene;Human;Human Chromosomes;Hybrids;Immune response;Immunologic Surveillance;Individual;International Union Against Cancer;Interphase;Laboratories;Large Intestine;Laser Scanning Confocal Microscopy;Lesion;Maintenance;Malignant Neoplasms;Maps;Mediating;Mesenchymal;Methods;Modeling;Modification;Molecular Cytogenetics;Molecular Profiling;Mucous Membrane;Mus;Mutation;Nature;Normal Cell;Nuclear;Nuclear Structure;Nude Mouse Assay;Oligonucleotide Microarrays;Oncogenes;PTGS2 gene;Pathway interactions;Pattern;Peripheral;Phenotype;Play;Positioning Attribute;Primary Carcinoma;Primary Neoplasm;Rectal Adenocarcinoma;Rectal Cancer;Recurrence;Relative (related person);Renal Cell Carcinoma;Reporting;Reverse Transcriptase Polymerase Chain Reaction;Role;Sampling;Series;Serum;Signal Transduction;Solid Neoplasm;Staging;Structure-Activity Relationship;System;TGFB1 gene;Techniques;Time;Tissues;Trisomy;Tumor Biology;Tumor Cell Line;Tumor Suppressor Genes;Tumor-Derived;Tumorigenicity;Up-Regulation;Validation;Vascular Endothelial Growth Factors;WNT1 gene;base;cancer cell;carcinogenesis;cell type;colon cancer cell line;comparative genomic hybridization;density;design;established cell line;lymph nodes;mouse model;novel;pre-clinical;rectal;research study;therapeutic target;tumor;tumorigenesis","Consequences of Genomic Instability and Aneuploidy on the Colorectal Cancer Tran","n/a","NCI","8552854"," "," ","1ZIABC010835-06","1","ZIA","BC","010835","06"," "," "," "," "," "," ","9414484","RIED, THOMAS ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF BASIC SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","1076682",
"Cancer; Clinical Research; Immunization; Infectious Diseases; Orphan Drug; Patient Safety; Prevention; Rare Diseases; Regenerative Medicine; Stem Cell Research; Stem Cell Research - Nonembryonic - Human; Transplantation; Vaccine Related","10 year old;Acute Graft Versus Host Disease;Address;Adenoviruses;Adverse effects;Affect;Age;Age-Years;Allogenic;Allografting;Antibodies;B-Lymphocytes;BK Virus;Biopsy Specimen;CD19 gene;CD3 Antigens;CD34 gene;CD4 Positive T Lymphocytes;CSF3 gene;Cardiovascular system;Cell Count;Cell Therapy;Cells;Cellular Immunity;Cessation of life;Characteristics;Clinic;Clinical Trials;Collaborations;Cyclophosphamide;Cystitis;Cytomegalovirus;Defect;Disease-Free Survival;Donor person;Dose;Engraftment;Event;Failure;Female;Frequencies;Goals;Growth Factor;Harvest;Hematologic Neoplasms;Hepatic;Homing;Human Papilloma Virus Vaccine;Human Papillomavirus;Immune;Immunity;Immunobiology;Immunodominant Antigens;Immunosuppression;Infection;Infectious Agent;Infusion procedures;Interleukin-15;Interleukin-2;Kinetics;Laboratory Finding;Lead;Lesion;Long-Term Survivors;Lung;Lymphocyte;Lymphocyte Count;Lymphokines;Magnetism;Malignant Neoplasms;Marrow;Measures;Mesenchymal;Methods;National Institute of Child Health and Human Development;Natural Killer Cells;Normal Range;Oncogenic;Organ;Osteopenia;Outcome;PTPRC gene;Patients;Pattern;Peripheral Blood Stem Cell;Phase;Phenotype;Plasma;Population;Premalignant;Prevention;Probability;Prophylactic treatment;Protocols documentation;Quality of life;Recovery;Regimen;Regulatory T-Lymphocyte;Relapse;Reporting;Research Personnel;Risk;Safety;Schedule;Screening procedure;Second Primary Neoplasms;Series;Siblings;Spermatogenesis;Squamous Cell;Stem cell transplant;Stem cells;Steroid Resistance;Stromal Cells;Survivors;System;T-Cell Depletion;T-Lymphocyte;Techniques;Therapeutic;Thyroid Gland;Tissues;Toxic effect;Translating;Translational Research;Transplantation;United States National Institutes of Health;Vaccines;Virus;Virus Diseases;Volunteer Group;Whole-Body Irradiation;Work;cardiovascular risk factor;chronic graft versus host disease;college;conditioning;cytokine;experience;fludarabine;follow-up;graft failure;graft vs host disease;healthy volunteer;immune function;improved;in vivo;leukemia;male;mortality;older patient;prevent;progenitor;programs;pulmonary function;reconstitution;research clinical testing;response;restoration;safety study;scale up;success","improving outcomes after stem cell transplantation","n/a","NHLBI","8558044"," "," ","1ZIAHL006105-02","1","ZIA","HL","006105","02"," "," "," "," "," "," ","8154841","BARRETT, AUSTIN JOHN","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL HEART, LUNG, AND BLOOD INSTITUTE"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NHLBI"," "," "," ","1966744",
"Genetics; Human Genome; Neurosciences; Pediatric; Prevention; Rare Diseases; Spina Bifida","AXIN2 protein;Actins;Address;Affect;Age;Alanine;Alleles;Anencephaly;Animal Model;Animals;Antioxidants;Apical;Apolipoproteins B;Apoptosis;Autistic Disorder;BMP5 gene;Basic Science;Biochemical;Biological;Biological Assay;CNTNAP1 gene;Carbon;Categories;Cell Death;Cell Polarity;Cell Proliferation;Cells;Child;Clinical;Clinical Research;Complex;Computer Simulation;Custom;DNA;DNA Methylation;DNA Resequencing;Data;Defect;Detection;Development;Disease;Dorsal;Dose;Embryo;Embryonic Development;Emulsions;Environmental Exposure;Environmental Risk Factor;Enzymes;Event;Exons;Failure;Family;Female of child bearing age;Fetus;Fibroblast Growth Factor Receptor 1;Folate;Folic Acid;Frequencies;Gene Expression;Gene Transfer;Generations;Genes;Genetic;Genetic Polymorphism;Genetic Variation;Genomics;Genotype;Guns;Hereditary Disease;Homocysteine;Homocystine;Hour;Human;Human Cell Line;Hydrogen Peroxide;In Vitro;Individual;Inflammation;Inositol;Instruction;Intake;Intervention;Knowledge;Laboratories;Lead;MTHFR gene;Mediation;Mesenchymal;Metabolic Pathway;Metabolism;Methodology;Methylation;Microfilaments;Modeling;Molecular;Molecular Target;Mouse Cell Line;Mus;Mutate;Mutation;Nanotechnology;Nature;Neural Fold;Neural Tube Closure;Neural Tube Defects;Neural tube;Neurons;Nitrogen;Nutrient;Oxidative Stress;Oxygen;Pathogenesis;Pathway Analysis;Pathway interactions;Patients;Pattern;Peroxonitrite;Phenotype;Phosphotransferases;Population;Predictive Value;Pregnancy;Prevention;Proteins;Reaction;Reactive Oxygen Species;Regimen;Risk;Role;Running;Sampling;Schizophrenia;Screening procedure;Shapes;Signal Transduction;Signaling Molecule;Single Nucleotide Polymorphism;Sonic Hedgehog Pathway;Spinal Dysraphism;Strabismus;Superoxides;Supplementation;System;Tail;Testing;Text;Time;Translating;Validation;Variant;Vinculin;Woman;Work;advanced system;analytical tool;animal data;base;cardiovascular disorder risk;caspase-9;chromatin remodeling;clinical practice;combinatorial;deprivation;design;epigenomics;extracellular;folic acid metabolism;gain of function;gene environment interaction;gene interaction;grasp;high throughput screening;in vitro testing;in vivo;knock-down;milligram;mouse model;mutant;nitration;nitrosative stress;overexpression;prenatal;prevent;profilin;programs;receptor;repository;reproductive;single molecule;sonic hedgehog receptor;transcription factor","PROJECT 1: Gene Variants & Their Interactions Defining Human NTD Risk","n/a","NICHD","8379335","6/1/2012 12:00:00 AM","PAR-10-245","5P01HD067244-02","5","P01","HD","067244","02"," "," "," "," ","ZHD1-DSR-N","8746","2075379","ROSS, MARGARET ELIZABETH","Not Applicable","12","Unavailable","060217502","YNT8TCJH8FQ8","060217502","YNT8TCJH8FQ8","US","40.76491","-73.955055","1514803","WEILL MEDICAL COLL OF CORNELL UNIV","NEW YORK","NY","Domestic Higher Education","100654805","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM"," ","Non-SBIR/STTR","2012","474806","474806"," ","402084","72722"," "," ",
"Aging; Cancer; Genetics; Prostate Cancer; Urologic Diseases","1-Phosphatidylinositol 3-Kinase;8-Oxoguanine DNA Glycosylase;Abbreviations;Ablation;Accounting;Androgen Antagonists;Androgen Receptor;Androgens;Applications Grants;Automobile Driving;Base Excision Repairs;CDH1 gene;Cancer Etiology;Cancer Patient;Castration;Cells;Cessation of life;Charcoal;Cholesterol;Chronic progressive external ophthalmoplegia;CpG Islands;DNA;DNA-Directed DNA Polymerase;Data;Development;Diagnosis;Disease;Down-Regulation;E-Cadherin;Endothelin B Receptor;Event;GTPase-Activating Proteins;Gleason Grade for Prostate Cancer;Goals;Grant;Growth;Guanine Nucleotide Exchange Factors;Homidium Bromide;Hormones;Human;Hypermethylation;In Vitro;Investigation;LNCaP;Lead;Link;Lovastatin;MAPK8 gene;MGMT gene;Malignant Neoplasms;Malignant neoplasm of prostate;Mitochondria;Mitochondrial DNA;Mitogen-Activated Protein Kinases;Molecular;Morbidity - disease rate;Mus;NF-kappa B;Neoplasm Metastasis;Nuclear;O(6)-Methylguanine-DNA Methyltransferase;OGG1 gene;PC3 cell line;Pathway interactions;Phase;Phenotype;Phosphatidylinositols;Ploidies;Population;Prevention;Process;Progress Reports;Prostate;Prostate Cancer therapy;Prostate-Specific Antigen;Prostatic Neoplasms;Proto-Oncogene Proteins c-akt;Reactive Oxygen Species;Reagent;Recurrence;Refractory;Reporting;Research;Resistance;Respiratory Chain;Role;Serum;Somatotropin;Specimen;Staining method;Stains;Tissue Sample;Tissues;Transferase;Transforming Growth Factor beta;Tumor Suppressor Genes;United States;Up-Regulation;Variant;Work;Xenograft Model;Xenograft procedure;androgen independent prostate cancer;cancer cell;epithelial to mesenchymal transition;hormone therapy;hydroethidine;in vivo;men;mevalonate;mortality;novel;novel strategies;overexpression;prevent;public health relevance;response;stressor;tumor growth;tumor progression","Prostate tumor progression by mitochondrial DNA change","
Project Narrative
Our results indicate that reduction of mitochondrial DNA content regulate prostate cancer
progression. Confirmation of our hypothesis and an understanding of the underlying
mechanisms will lead to development of high impact strategies for new diagnosis, novel
approaches to targeted prevention and/or therapy for prostate cancer.","NCI","8256624","4/20/2012 12:00:00 AM","PA-07-070","5R01CA100846-09","5","R01","CA","100846","09"," ","WOODHOUSE, ELIZABETH","9/30/2003 12:00:00 AM","4/30/2014 12:00:00 AM","Tumor Cell Biology Study Section[TCB]"," ","2199501","HIGUCHI, MASAHIRO ","Not Applicable","02","BIOCHEMISTRY","122452563","VDFYLZPJEAV6","122452563","VDFYLZPJEAV6","US","34.751472","-92.320637","1471106","UNIV OF ARKANSAS FOR MED SCIS","LITTLE ROCK","AR","SCHOOLS OF MEDICINE","722057101","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","160551","72249"," ","232800",
"No NIH Category available","Actinin;Anchorage-Independent Growth;Anti-Inflammatory Agents;Anti-inflammatory;Apoptosis;Appearance;Asbestos;Biological;Biological Assay;Breast Melanoma;Cancer Etiology;Carcinogens;Caring;Cell Culture Techniques;Cell Line;Cell Polarity;Cell Proliferation;Cells;Cessation of life;Chemopreventive Agent;Colon;Colorectal Cancer;Development;Disease;Distal;E-Cadherin;Early Diagnosis;Eicosanoids;Epithelium;Epoprostenol;Exposure to;Future;Goals;Human;Iloprost;Immunohistochemistry;In Vitro;Investigation;Knockout Mice;Laboratories;Lead;Lung;Lung Neoplasms;MAPK8 gene;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of prostate;Medical;Medical Research;Methylation;Military Personnel;Mission;Modification;Molecular;Molecular Target;Mus;Mutation;N-Cadherin;Neoplasm Metastasis;Non-Small-Cell Lung Carcinoma;Oral;PPAR gamma;Pathway interactions;Patient Care;Patients;Phase II Clinical Trials;Phenotype;Play;Population;Predisposition;Property;Prostacyclin synthase;Prostaglandins I;Research;Research Priority;Role;Screening procedure;Services;Signal Pathway;Signal Transduction;Smoke;Smoker;Smoking Prevention;Snails;Staging;Supplementation;Survival Rate;Tail;Testing;Therapeutic;Tobacco Dependence;Troponin I;Troponin T;Tumor Suppressor Genes;Tumor Suppressor Proteins;United States;Urethane;Veins;Veterans;Woman;Work;abstracting;agent orange;analog;base;beta catenin;cancer therapy;cell growth;cell transformation;chemical carcinogen;cigarette smoking;connectin;epithelial to mesenchymal transition;genetic regulatory protein;high risk;improved;in vivo;lung Carcinoma;lung carcinogenesis;malignant breast neoplasm;member;men;migration;overexpression;plakoglobin;prevent;promoter;receptor;response;restoration;small hairpin RNA;smoking cessation;success;therapeutic target;tobacco abuse;tumor;tumorigenic","The Wnt and Prostacyclin pathways act in concert to inhibit NSCLC cell growth","Investigations into molecular cancer therapy of lung cancer are directly relevant to the Department of Veterans' Affairs patient care mission, as lung cancer is a Veterans' Affairs medical research priority. Lung cancer is the leading cause of cancer death in the veteran population. While tobacco abuse is currently discouraged by the military, there still exists a very large percentage of high-risk current and former smokers cared for by the VA that might benefit from advances in therapeutic molecular targeting in lung cancer. Agent Orange and asbestos exposure, well-established lung carcinogens, are service-connected disorders and have strongly been associated with lung cancer. Research investigating the mechanisms and strategies for lung cancer molecular therapeutic therapy has tremendous potential benefit to veterans, many of whom no longer smoke, yet remain at high risk for lung cancer.","VA","8289263","12/9/2011 12:00:00 AM","RFA-BX-10-001","5I01BX001004-02","5","I01","BX","001004","02"," "," ","4/1/2011 12:00:00 AM","3/31/2015 12:00:00 AM","Oncology A[ONCA]"," ","3116287","WINN, ROBERT A.","Not Applicable","06","Unavailable","003252830","HK7TZB6FX583","003252830","HK7TZB6FX583","US","39.732591","-104.935144","481018","VA EASTERN COLORADO HEALTH CARE SYSTEM","Aurora","CO","Independent Hospitals","800457211","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Clinical Research; Stem Cell Research; Stem Cell Research - Nonembryonic - Non-Human","AHR gene;Ablation;Address;Affect;Agonist;Alopecia;Alopecia Areata;Animal Model;Aryl Hydrocarbon Receptor;Biological Assay;Biological Markers;Biological Process;Biopsy;COL1A1 gene;CYP1A1 gene;Cell Cycle Kinetics;Cell Proliferation;Cell physiology;Cells;Chronic;Cicatrix;Classification;Clinical;Complex;Cutaneous;Data;Dermis;Development;Dioxins;Disease;Disease Progression;Epidermal Growth Factor Receptor;Epidermis;Epithelial;Epithelial Cells;Event;Extracellular Matrix;Fibroblasts;Fibrosis;Folliculitis;Functional disorder;Gene Targeting;Genes;Goals;Growth;Growth Factor;Hair;Hair follicle structure;Healed;Health;Histologic;Homeostasis;Immunofluorescence Immunologic;Immunohistochemistry;In Vitro;Inflammation;Inflammatory;Injury;Integrins;Knockout Mice;LHX2 gene;Lead;Lichen planopilaris;Link;Literature;Lymphocyte;Mediating;Medical;Mesenchymal;Messenger RNA;Molecular;Monitor;Mus;Myofibroblast;Natural regeneration;Normal Cell;Normalcy;Nuclear Receptors;Organ;PPAR gamma;Pathogenesis;Pathology;Peptide Hydrolases;Peroxisome Proliferator-Activated Receptors;Phenocopy;Phenotype;Physiological Processes;Plant Roots;Play;Preventive;Principal Investigator;Process;Proteins;Receptor Activation;Receptor Cross-Talk;Receptor Signaling;Regulation;Reporter Genes;Repression;Response Elements;Role;Sampling;Scalp structure;Sebaceous Glands;Seborrheic dermatitis;Signal Pathway;Signal Transduction;Signal Transduction Pathway;Staining method;Stains;Stem cells;TCF3 gene;TNF gene;Testing;Therapeutic;Therapeutic Intervention;Time;Tissues;Toxic effect;Transgenic Mice;Western Blotting;Wound Healing;Xenobiotics;aryl hydrocarbon receptor ligand;base;cdc Genes;cell motility;chromatin immunoprecipitation;cytokine;fibrogenesis;healing;human tissue;immune activation;improved;in vitro Assay;in vivo;inhibitor/antagonist;insight;lipid metabolism;mRNA Expression;migration;mouse model;neutrophil;novel;novel diagnostics;novel therapeutics;osteopontin;prevent;programs;promoter;protein expression;receptor;receptor expression;repaired;research study;response","PPAR-gamma Signaling in Normal Pilosebaceous Units and in Scarring Alopecia","Program Director/Principal Investigator (Last, First, Middle): Karnik, Pratima 
Project Narrative 
This proposal will determine if the loss of activity of the nuclear receptor, PPAR, is the cause of permanent 
hair loss in scarring alopecia. It will also determine whether the xenobiotic response receptor, AhR, has a role 
in inhibiting PPAR. PPAR has broad-range effects in controlling inflammation and regulating lipid 
metabolism. Because this nuclear receptor is important for normal hair follicle health, understanding its 
regulatory mechanisms and target effectors provides a basis for targeted therapy in hair and cutaneous 
diseases. 
PHS 398/2590 (Rev. 11/07) Page Continuation Format Page","NIAMS","8315907","8/9/2012 12:00:00 AM","PA-07-070","5R01AR056245-04","5","R01","AR","056245","04"," ","CIBOTTI, RICARDO","9/28/2009 12:00:00 AM","8/31/2014 12:00:00 AM","Arthritis, Connective Tissue and Skin Study Section[ACTS]"," ","8462466","KARNIK, PRATIMA ","Not Applicable","11","DERMATOLOGY","077758407","HJMKEF7EJW69","077758407","HJMKEF7EJW69","US","41.505076","-81.609998","218601","CASE WESTERN RESERVE UNIVERSITY","CLEVELAND","OH","SCHOOLS OF MEDICINE","441061712","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","213840","121889"," ","335729",
"Breast Cancer; Cancer; Genetics","1-Phosphatidylinositol 3-Kinase;Affect;African American;Agar;Alleles;American;Anabolism;Anchorage-Independent Growth;Anthracenes;Aromatic Polycyclic Hydrocarbons;Bioluminescence;Boston;Breast Cancer Cell;Cancer Etiology;Cancer cell line;Carcinogen exposure;Carcinoma;Case-Control Studies;Cell Line;Cell Proliferation;Cells;Cessation of life;Co-Immunoprecipitations;Collagen;Data;Databases;Deposition;Development;Disease Progression;E-Cadherin;ERBB2 gene;Effectiveness;Elastin;Environment;Enzymes;Estrogen Receptors;Estrogen receptor negative;Exposure to;Extracellular Matrix;Fatty acid glycerol esters;Fibroblasts;Frequencies;Gene Expression;Genes;Glutamine;Growth;HRAS gene;Heat shock proteins;Hypoxia;Image;In Vitro;Investigation;Knock-in Mouse;Lead;Length;MEKs;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of pancreas;Mammary gland;Mass Spectrum Analysis;Mediating;Minor;Modeling;Mutation;NIH 3T3 Cells;Neoplasm Metastasis;Normal Cell;Nude Mice;Oncogenic;Oxidases;Pancreatic carcinoma;Participant;Pathway Analysis;Pathway interactions;Phenotype;Pilot Projects;Protein Tyrosine Phosphatase;Protein-Lysine 6-Oxidase;Proteins;Proteolytic Processing;Ras Inhibitor;Risk;Risk Assessment;Risk Factors;Role;Screening procedure;Signal Pathway;Signal Transduction;Single Nucleotide Polymorphism;Snails;TP53 gene;Testing;Tissues;Treatment Protocols;Tumor Suppressor Proteins;United States National Institutes of Health;Universities;Up-Regulation;Variant;Vimentin;Woman;Women&apos;s Health;Work;Xenograft Model;Yeasts;cancer cell;cohort;crosslink;dimethylbenzanthracene;effective therapy;epithelial to mesenchymal transition;extracellular;in vivo;inhibitor/antagonist;lung Carcinoma;malignant breast neoplasm;malignant phenotype;matrigel;migration;mouse model;mutant;novel;pancreatic cancer cells;protein function;public health relevance;ras Oncogene;receptor;research clinical testing;tool;transcription factor;tumor;tumor progression;tumorigenic;yeast two hybrid system","Lysyl Oxidase Propeptide: Breast Cancer Inhibitor","
Project Narrative
Overall, these studies represent pre-clinical testing of the LOX-PP protein, a novel suppressor of Ras
signaling, in breast cancer. The rs1800449 single nucleotide polymorphism (SNP) results in an Arg-to-Gln
variant in LOX-PP and in substantially reduced Ras suppressing activity and increased risk of ERï¿½ negative
breast cancer in African-American women. Our proposed work will delineate the mechanism of LOX-PP
activity, the changes that result from the Gln variant and prepare a knock-in mouse model that allows for
testing of the potential use of SNP in assessment of risk for breast cancer.","NCI","8211091","3/20/2012 12:00:00 AM","PA-07-070","5R01CA143108-03","5","R01","CA","143108","03"," ","SATHYAMOORTHY, NEERAJA","4/12/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Tumor Progression and Metastasis Study Section[TPM]"," ","1896578","SONENSHEIN, GAIL E.","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","039318308","C1F5LNUF7W86","039318308","C1F5LNUF7W86","US","42.349907","-71.061712","8422704","TUFTS UNIVERSITY BOSTON","BOSTON","MA","SCHOOLS OF MEDICINE","021111901","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","395339","110290"," ","505629",
"No NIH Category available","Address;Adenomatous Polyps;Adherens Junction;Adhesions;Adhesives;Affect;Anchorage-Independent Growth;Attenuated;BCAR3 gene;Binding;Biological Assay;Biological Markers;Biology;Blood Vessels;Breast;CDK4 gene;Cancer Control;Cancer Etiology;Cancer cell line;Cell Adhesion Molecules;Cell Culture Techniques;Cell Cycle;Cell Line;Cell Proliferation;Cell membrane;Cell-Cell Adhesion;Cells;Clinical;Colon;Colon Carcinoma;Colorectal Cancer;Complex;CpG Islands;Cyclin D1;Cytokeratin;Data;Decitabine;Development;Diagnosis;Diagnostic;Disease;Dominant-Negative Mutation;Dysmyelopoietic Syndromes;E-Cadherin;E-Cadherin Staining Method;Epigenetic Process;Epithelial;Epithelial Cells;Event;FDA approved;Functional disorder;Gene Activation;Genetic;Growth;Health Personnel;Healthcare Systems;Human;Hybrids;Hypermethylation;Incidence;Inflammatory;Large Intestine Carcinoma;Link;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of ovary;Maps;Mechanics;Mediating;Membrane;Mesenchymal;Methylation;Modeling;Molecular;Morphology;Mus;Myosin ATPase;Neoplasm Metastasis;Nuclear;Nude Mice;Ovarian;Pathology;Pathway interactions;Phenotype;Play;Process;Proteins;Proto-Oncogenes;RHOA gene;Regulator Genes;Regulatory Pathway;Reporter;Repression;Resistance;Role;Sampling;Screening procedure;Signal Pathway;Signal Transduction;Small Interfering RNA;Staging;Structure;Surveys;Testing;Tight Junctions;Transcriptional Activation;Treatment Efficacy;Tumor Biology;Tumor Suppressor Proteins;United States;United States Department of Veterans Affairs;Veterans;Vimentin;WNT Signaling Pathway;Wound Healing;Xenograft procedure;Yeasts;attenuation;base;blood vessel restoration;burden of illness;cancer cell;cancer diagnosis;carcinogenesis;cell motility;claudin 3;colorectal cancer prevention;corneal epithelium;design;in vivo;insight;knock-down;malignant phenotype;malignant stomach neoplasm;migration;monolayer;mortality;new therapeutic target;novel;novel diagnostics;overexpression;programs;promoter;rho;splenic capsule;therapeutic target;tumor;tumor growth;tumorigenesis;tumorigenic","Modulation of junctional signaling by BVES in colorectal carcinoma","The VA healthcare system is one of the largest healthcare providers in the United States, with over million veterans subscribed in 2009. Colorectal cancer remains the second leading cause of cancer related mortality within the United States. Because of the burden of disease associated with colorectal cancer, the VHA has issued specific directives (VHA Directive 2007-004) describing colorectal cancer prevention and control best practices for the VA. Despite these aggressive screening programs, which are clearly intended to identify disease at treatable stages, colorectal cancer is diagnosed in 4500 veterans and 650 of these are stage IV disease. We have identified a tight junction associated protein that appears to suppress cancer function. We are just barely beginning to understand the biology of this protein. Understanding its function may illuminate unrealized aspects of tumor biology. We hope to develop this protein as a diagnostic marker or druggable target in colorectal cancer, and possibly other tumor types.","VA","8332389","7/12/2012 12:00:00 AM","RFA-BX-11-014","1I01BX001426-01A1","1","I01","BX","001426","01","A"," ","7/1/2012 12:00:00 AM","6/30/2016 12:00:00 AM","Oncology A[ONCA]"," ","7056252","WILLIAMS, CHRISTOPHER S.","Not Applicable","05","Unavailable","156385783","M4CNTUL3N9L7","156385783","M4CNTUL3N9L7","US","36.142612","-86.804682","481084","VETERANS HEALTH ADMINISTRATION","NASHVILLE","TN","Independent Hospitals","372122637","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Biotechnology; Cancer; Emerging Infectious Diseases; Genetics; HIV/AIDS; Infectious Diseases; Lymphoma; Rare Diseases","AIDS related cancer;Acquired Immunodeficiency Syndrome;Adhesions;Amino Acids;Angiogenic Factor;Area;Attenuated;Binding;Biochemical;Biological Assay;Blood Vessels;C-terminal;CXCL10 gene;CXCL11 gene;CXCL12 gene;CXCR4 Receptors;CXCR4 gene;Cause of Death;Cell Line;Cell Proliferation;Cells;Cessation of life;Characteristics;Clinical Trials;Collaborations;Complex;Contracts;Dermal;Development;Disease;Drug Delivery Systems;Effector Cell;Endothelial Cells;Exhibits;FADD protein;Fibrosis;Frequencies;G-Protein-Coupled Receptors;Gene Expression Microarray Analysis;Gene Expression Regulation;Gene Proteins;Genes;Goals;HIV;HIV Infections;Hepatomegaly;High Dose Chemotherapy;Hodgkin Disease;Human;Human Herpesvirus 8;Immunity;Immunodeficient Mouse;In Vitro;Individual;Infection;Inflammatory;Integral Membrane Protein;Interferons;Interleukin-6;Kaposi Sarcoma;Lesion;Ligands;Link;Lymphangiogenesis;Lymphatic Diseases;Lymphoma;Lytic;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of lung;Mesenchymal;Molecular;Morbidity - disease rate;Morphology;Multicentric Angiofollicular Lymphoid Hyperplasia;Mus;NF-kappa B;Natural History;Notch Signaling Pathway;Nuclear;Organ;Pathogenesis;Pathway interactions;Patients;Phenotype;Phosphotransferases;Plasma Cells;Play;Process;Property;Proteins;Reporter;Reporting;Research;Resistance;Role;STAT3 gene;Serum;Signal Pathway;Signal Transduction;Sirolimus;Spleen;Splenomegaly;T-Lymphocyte;TGF Beta Signaling Pathway;Testing;Tissues;Transgenes;Transgenic Mice;Tumor Angiogenesis;Tumorigenicity;Uncertainty;Viral;Work;angiogenesis;base;cancer type;cardiogenesis;cell growth;cell type;chemokine;chemokine receptor;cytokine;effusion;genetic regulatory protein;global health;in vivo;interest;lymph nodes;mTOR protein;mortality;neoplastic cell;notch protein;novel;overexpression;programs;receptor;research study;response;slug;success;therapeutic target;trait;transcription factor;tumor;tumor progression;tumorigenic","A Role for KSHV in the Pathogenesis of Malignancies","n/a","NCI","8554046"," "," ","1ZIASC010356-13","1","ZIA","SC","010356","13"," "," "," "," "," "," ","9414375","TOSATO, GIOVANNA ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF CLINICAL SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","488185",
"No NIH Category available","3-Dimensional;Acute;Address;Adipocytes;Adipose tissue;Affect;Aging;Allogenic;Animals;Apoptosis;Apoptotic;Autologous;Biological Models;Blood Vessels;Blood flow;Cell Proliferation;Cell Survival;Cell Therapy;Cells;Cellular Structures;Cerebral Ischemia;Characteristics;Chondrocytes;Coupled;Cutaneous;Data;Devices;Diabetes Mellitus;Diabetic Angiopathies;Diabetic mouse;Disease;Effectiveness;Elderly;Endothelial Cells;Environment;Evaluation;Exhibits;Fatty acid glycerol esters;Functional disorder;Genes;Genetic;Goals;Growth Factor;Health Care Costs;Hematopoietic;Hepatocyte Growth Factor;Hindlimb;Human;Hyperglycemia;Hypoxia;Hypoxia Inducible Factor;Hypoxia-Inducible Factor Pathway;Immunocompromised Host;Impairment;Implant;In Vitro;Individual;Insulin-Dependent Diabetes Mellitus;Investigation;Ischemia;Islets of Langerhans;Islets of Langerhans Transplantation;Laboratories;Lead;Mediating;Mesenchymal;Metabolic Diseases;Methods;Modeling;Modification;Molecular;Mus;Muscle Fibers;Myocardial;Neurons;Non-Insulin-Dependent Diabetes Mellitus;Osteoblasts;Oxygen;Pathway interactions;Patients;Perfusion;Pericytes;Physiological;Play;Population;Process;Property;Proteins;Publishing;Relative (related person);Role;Signal Pathway;Signal Transduction;Site-Directed Mutagenesis;Skeletal Muscle;Source;Specific qualifier value;Stem cells;Stromal Cells;Structure;Suction Lipectomy;Supplementation;System;Testing;Therapeutic;Tissue Survival;Tissues;Transplantation;United States Department of Veterans Affairs;Vascular Endothelial Growth Factors;Vascular blood supply;Vascularization;Veterans;Work;Wound Healing;aged;cell preparation;diabetic;diabetic patient;functional disability;human subject;implantation;improved;in vivo;insight;irradiation;islet;network models;novel;pancreatic islet function;paracrine;postnatal;public health relevance;research study;response;stem;subcutaneous;two-dimensional;vasculogenesis","Adipose Stromal Cells and Vasculogenesis: Tissue Perfusion and Islet Survival","Our study will provide insight into how to use the stem cells located in fat tissue to assist in creating blood vessel structures to help provide blood supply to tissues that require it, and in particular to islets that are transplanted. Since we are working with cell preparation devices / methods that are appropriate for human use, the insights developed in this study will be directly translatable to Veterans. Specifically, we anticipate that the approaches we are studying will apply to Veterans that have problems due to poor blood flow; such as poor wound healing; and to diabetic Veterans who may be able to benefit from islet transplantation to treat or actually cure their diabetes. The findings from this study will point the way to optimized methods for transplanting islets along with cells that can assemble vascular structures; and will also determine whether cells from all patients can be used, or whether cells from younger or healthier patients must be explored, and why. Successful work to treat diabetes and diabetic vascular disease will markedly improve the effectiveness, and may indeed decrease longterm costs of healthcare in the Veterans Administration system.","VA","8196346","12/1/2011 12:00:00 AM","RFA-BX-09-008","5I01BX000860-02","5","I01","BX","000860","02"," "," ","10/1/2010 12:00:00 AM","9/30/2014 12:00:00 AM","Cardiovascular Studies A[CARA]"," ","1865058","MARCH, KEITH LEONARD","Not Applicable","07","Unavailable","608434697","FF27EX32BTZ1","608434697","FF27EX32BTZ1","US","39.77973","-86.187563","481029","RLR VA MEDICAL CENTER","INDIANAPOLIS","IN","Independent Hospitals","462022803","UNITED STATES","N","10/1/2011 12:00:00 AM","9/30/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Cardiovascular; Genetics; Human Genome; Hypertension; Kidney Disease; Rare Diseases","1q21;Accounting;Albumins;Alleles;Animals;Biological Assay;Blood Glucose;Blood Pressure;Breeding;Candidate Disease Gene;Cardiovascular system;Cell Line;Cells;Chromosomes, Human, Pair 2;Code;Complex;Complex Genetic Trait;Congenic Strain;Development;Diabetes Mellitus;Dialysis procedure;Diploidy;Disease;Disease Progression;Disease model;End stage renal failure;Epithelial;Evaluation;Event;Exhibits;Expenditure;Fibrosis;Filtration;Focal Segmental Glomerulosclerosis;Functional disorder;Gene Expression;Gene Expression Profile;Genes;Genetic;Genetic Techniques;Genetic Variation;Genome;Genome Scan;Genomics;Glomerular Capillary;Goals;Haplotypes;Health;Human;Human Chromosomes;Human Genetics;Human Genome;Hypertension;In Vitro;Inbred SHR Rats;Inbred Strains Rats;Inbreeding;Incidence;Inflammation;Injury;Insurance;Kidney;Kidney Diseases;Kidney Failure;Knowledge;Link;Measurement;Measures;Mediating;Medicare;Mesenchymal;Modeling;Mutation;Nephrotic Syndrome;Organ;Pathway interactions;Patients;Permeability;Phase;Physiological;Play;Population;Preparation;Primary Cell Cultures;Production;Proteins;Proteinuria;Quantitative Trait Loci;Rattus;Recombinants;Renal Blood Flow;Renal function;Research;Resistance;Rodent Model;Role;Sequence Analysis;Signal Transduction;Staging;Structure;Subfamily lentivirinae;Susceptibility Gene;System;Testing;Time;Transcript;Transplantation;Tubular formation;United States;Validation;Variant;Western Blotting;Work;abstracting;arteriole;base;blood pressure regulation;comparative;congenic;cost;design;economic impact;effective therapy;genetic analysis;genetic linkage analysis;genetic variant;glomerular filtration;glomerular function;hemodynamics;human disease;in vitro testing;in vivo;interest;interstitial;kidney cell;lentiviral-mediated;overexpression;podocyte;population based;pressure;prevent;protein expression;research study;response;salt sensitive;success;trait;transmission process;uptake","Genetics of Renal End Organ Damage in Hypertension","
Project Narrative
 High blood pressure is major contributor to end-stage renal disease (ESRD). The number of ESRD
patients treated by either dialysis or transplantation has more than doubled in the period from 1991 to 2004
from 209,000 to 472,000. In the next 20 years, the numbers of ESRD patients are expected to increase to
over 2 million. Additionally, the economic impact is substantial, burdening the Medicare system (costing
$20.1 billion or 7% percent of total Medicare expenditures), and the private insurance sector (estimated at
$12.1 billion). The unfortunate reality is that treatment options are limited and only slow the progression of
the disease. The focus of the proposed work is to identify genes that predispose the Dahl salt-sensitive (S)
rat to develop hypertension-induced kidney disease. Previous genetic analysis using the S rat identified
several chromosomal regions linked to kidney disease. In particular, a region on rat chromosome 2 was
found to play a significant role in the kidney injury observed in the S rat. The homologous region on human
chromosome 1q21 has also been linked to kidney disease in multiple studies. This underlies the importance
in identifying the gene in the rat because the findings may be readily applied to human kidney disease. In
summary, it is the goal of this proposal to utilize a rodent model of human disease and advanced genetic
techniques to expedite the identification of a gene involved in kidney disease. The application of knowledge
gained from this research will contribute to a better understanding of the how and why of the disease and
ultimately provide earlier and more effective treatments of the disease before kidney failure is reached.","NHLBI","8289584","5/31/2012 12:00:00 AM","PA-07-070","5R01HL094446-04","5","R01","HL","094446","04"," ","OH, YOUNGSUK","8/1/2009 12:00:00 AM","6/30/2014 12:00:00 AM","Hypertension and Microcirculation Study Section[HM]"," ","7888323","GARRETT, MICHAEL R","Not Applicable","03","PHARMACOLOGY","928824473","X59NJBFL8BJ3","928824473","X59NJBFL8BJ3","US","32.328724","-90.175537","5390304","UNIVERSITY OF MISSISSIPPI MED CTR","JACKSON","MS","SCHOOLS OF MEDICINE","392164500","UNITED STATES","N","7/1/2012 12:00:00 AM","6/30/2013 12:00:00 AM","837","Non-SBIR/STTR","2012"," "," ","NHLBI","247500","122513"," ","370013",
"Cancer; Lung; Lung Cancer","3-Dimensional;A549;Amino Acid Sequence;Amino Acids;Antibodies;Apoptotic;Basement membrane;Behavior;Binding;Biochemical;Biological;Biological Response Modifier Therapy;Biology;Breast Cancer Cell;Cancer cell line;Cell Differentiation process;Cell Line;Cell Surface Receptors;Cells;Chemicals;Chronic Disease;Complex;Cues;Development;EGF gene;Elements;Endothelial Cells;Epidermal Growth Factor Receptor;Evolution;Excision;Extracellular Matrix;Family;Fibroblast Growth Factor;Fibroblast Growth Factor 2;Fibroblasts;Future;Gene Expression;Genes;Goals;Growth;Growth Factor;Growth Factor Receptors;Homeostasis;Human;Immune response;In Vitro;Infiltration;Inflammation;Inhibition of Matrix Metalloproteinases Pathway;Injection of therapeutic agent;Integrin Binding;Integrin alpha3beta1;Integrins;Kaposi Sarcoma;Laboratories;Lead;Malignant - descriptor;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of lung;Matrix Metalloproteinases;Mediating;Mus;Mutation;Myelogenous;N-terminal;Neoplasm Metastasis;Non-Malignant;Normal Cell;Normal tissue morphology;Oncogenes;Organ;Organism;Pathway interactions;Peptides;Phenotype;Phosphorylation;Play;Primary Neoplasm;Process;Property;Protein Tyrosine Phosphatase;Proteins;Proto-Oncogene Proteins c-akt;Reagent;Receptor Activation;Receptor Protein-Tyrosine Kinases;Receptor Signaling;Recombinants;Regulation;Relative (related person);Role;Signaling Molecule;Site;Solvents;Stimulation of Cell Proliferation;Structure;Suppressor-Effector T-Lymphocytes;Teratocarcinoma;Therapeutic;Tissue Inhibitor of Metalloproteinase-1;Tissue Inhibitor of Metalloproteinases;Tissues;Tumor Angiogenesis;Tumor Cell Invasion;Tumor Suppression;Tumor Suppressor Genes;Tumor Suppressor Proteins;Vascular Endothelial Growth Factor Receptor-2;Vascular Endothelial Growth Factors;Work;Xenograft Model;Xenograft procedure;angiogenesis;base;blastocyst;cancer cell;cancer site;cancer therapy;cell behavior;cell growth;cell type;cytokine;epithelial to mesenchymal transition;extracellular;fibrosarcoma;flexibility;human tissue;in vivo;in vivo Model;lung Carcinoma;melanoma;member;metastatic process;mouse model;neoplastic cell;new therapeutic target;novel;novel therapeutics;overexpression;pre-clinical;precursor cell;pressure;protein aminoacid sequence;receptor;research study;response;synthetic peptide;tumor;tumor growth;tumor progression;tumorigenic","The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis","n/a","NCI","8554031"," "," ","1ZIASC009179-24","1","ZIA","SC","009179","24"," "," "," "," "," "," ","9414468","STETLER-STEVENSON, WILLIAM ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","DIVISION OF CLINICAL SCIENCES - NCI"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NCI"," "," "," ","752082",
"Aging; Arthritis; Biotechnology; Genetics; Regenerative Medicine","Actins;Adenoviruses;Adipose tissue;Adult;Affect;American;Animal Model;Apoptosis;Area;Awareness;Binding;Biological;Biological Models;Biology;Blood Vessels;Bone Development;Bone Marrow;Boxing;Calcified;Candidate Disease Gene;Cartilage;Cartilage injury;Cattle;Cell Culture Techniques;Cell Cycle;Cell Cycle Progression;Cell Differentiation process;Cells;ChIP-on-chip;Characteristics;Chondrocytes;Chondrogenesis;Collaborations;Collagen;Collagen Type II;Collagen Type X;Data;Degenerative Disorder;Degenerative polyarthritis;Development;Disease;Down-Regulation;Dwarfism;EGF gene;EWS/FLI 1 Type 1 antisense oligonucleotide;Enzymes;Epigenetic Process;Epiphysial cartilage;Event;Excision;Extracellular Matrix;Fibroblast Growth Factor;Funding;Gene Expression;Gene Expression Regulation;Genes;Genetic Transcription;Glyceraldehyde-3-Phosphate Dehydrogenases;Goals;Grant;Growth Factor;HMGA Proteins;HMGA1 gene;HMGA2 gene;Health;Human;Hypertrophy;In Vitro;Intervention;Knee;Knock-out;Knowledge;Mesenchymal Differentiation;Messenger RNA;Methods;Microarray Analysis;Mitogen-Activated Protein Kinases;Modeling;Mus;Oligonucleotide Microarrays;Osteogenesis;Pathway Analysis;Pathway interactions;Patients;Phenotype;Play;Procedures;Process;Production;Protein Family;Proteins;Proto-Oncogenes;Publications;Publishing;RNA;RNA Splicing;Regulation;Replacement Arthroplasty;Reverse Transcriptase Polymerase Chain Reaction;Role;Screening procedure;Signal Pathway;Signal Transduction;Skeletal Development;Staging;Stem cells;Stromal Cells;Study models;System;Systems Biology;Techniques;Tissue Engineering;Tissues;Transcript;Transcription factor genes;Transcriptional Regulation;Trypsin;USF1 gene;USF2 gene;Universities;Up-Regulation;Variant;Washington;adapter protein;aggrecan;aggrecanase;angiogenesis;articular cartilage;base;bone;cartilage development;cartilage repair;collagenase;design;factor C;genome-wide;in vitro Model;in vivo;injury and repair;link protein;lipid biosynthesis;malformation;mammalian COMP;mutant;novel;overexpression;prevent;programs;promoter;repaired;research study;response;response to injury;skeletal;skeletal disorder;stem cell differentiation;tissue repair;tool;transcription factor;vpr Genes","Function and Regulation of CD-RAP","Project Narrative 
Osteoarthritis will affect 50 million Americans by 2020. The disease process is 
characterized by the aberrant gene expression and the inability of cartilage chondrocytes 
to repair the extracellular matrix leading to cartilage degeneration. CD-RAP is a small 
cartilage-characteristic protein that is co-expressed in cartilage with type II collagen and 
aggrecan. The current proposal will focus on analyses to define transcriptional 
regulatory networks that predominantly operate in and define cartilage development (as 
opposed to the growth plate which results in bone formation), cartilage repair, and 
osteoarthritis. As new transcription factors arise, specific mechanism of activity will be 
deciphered using our CD-RAP and COL2A1 gene models.","NIAMS","8310868","7/19/2012 12:00:00 AM","PA-07-070","5R01AR045550-14","5","R01","AR","045550","14"," ","TYREE, BERNADETTE","3/1/1998 12:00:00 AM","8/31/2014 12:00:00 AM","Skeletal Biology Structure and Regeneration Study Section[SBSR]"," ","1882196","SANDELL, LINDA J","Not Applicable","01","ORTHOPEDICS","068552207","L6NFUM28LQM5","068552207","L6NFUM28LQM5","US","38.647241","-90.300814","9083901","WASHINGTON UNIVERSITY","SAINT LOUIS","MO","SCHOOLS OF MEDICINE","631304862","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","271953","141416"," ","413369",
"Biotechnology; Cancer; Clinical Research; Genetics; Pancreatic Cancer; Rare Diseases","Ablation;Acetylation;Address;Affect;Animals;Apoptosis;Attenuated;Biochemical;Biological;Biological Assay;Biopsy;Bortezomib;Cancer cell line;Cell Death;Cell Line;Cells;Cellular Stress;Chemicals;Chromatin;Clinical Trials;Collaborations;Combination Drug Therapy;Combined Modality Therapy;Data;Defect;Development;Dominant-Negative Mutation;Drug Delivery Systems;Drug resistance;Drug-sensitive;Enrollment;Epithelial Cells;Exposure to;FDA approved;Gene Expression;Gene Expression Profile;Gene Silencing;Genes;Goals;Golgi Apparatus;Growth;HDAC6 gene;Heat-Shock Proteins 70;Heterogeneity;Histone Deacetylase;Histone Deacetylase Inhibitor;Histone deacetylase inhibition;Histones;Human;Immunohistochemistry;In Vitro;Inflammation;Laboratories;Ligands;Link;MAPK8 gene;Malignant Neoplasms;Malignant neoplasm of pancreas;Measures;Mediating;Medicine;Methods;Molecular;Molecular Profiling;Mus;Noxae;Nuclear;Nutrient;Pancreas;Pathway interactions;Patients;Peripheral Blood Mononuclear Cell;Pharmaceutical Preparations;Pharmacodynamics;Phase II Clinical Trials;Phenotype;Phosphorylation;Physiological;Play;Pre-Clinical Model;Process;Production;Proteasome Inhibition;Proteasome Inhibitor;Protein Biosynthesis;Protein Kinase;Proteins;Publishing;Regimen;Relative (related person);Research;Resistance;Role;Serum;Small Interfering RNA;Solid;Stress;Structure;TNFSF10 gene;Techniques;Testing;Therapeutic Intervention;Toxic effect;Translations;Transmission Electron Microscopy;Tubulin;Tumor Necrosis Factor-alpha;Tumor-Derived;Vorinostat;Work;Xenograft procedure;angiogenesis;arm;base;cancer cell;cancer therapy;carcinogenesis;cell killing;chronic pancreatitis;clinical application;cytotoxic;epithelial to mesenchymal transition;gemcitabine;human CASP4 protein;inhibitor/antagonist;interest;killings;mRNA Expression;multicatalytic endopeptidase complex;neoplastic cell;novel;pancreatic cancer cells;peripheral blood;pre-clinical;prevent;prospective;protein expression;protein misfolding;research study;response;synthetic protein;therapy resistant;transcription factor;tubacin;tumor;tumor progression;tumor xenograft","Proteasome Inhibition and ER Stress","
PROJECT NARRATIVE/RELEVANCE
Clinical trials have demonstrated that the effects of conventional and investigational cancer therapies are
remarkably heterogeneous, and efforts are currently underway to match therapies to the specific molecular
features associated with responsiveness to them in an effort to better exploit their effects (""personalized
medicine""). The overall goal of the research proposed here is to better understand the mechanisms involved in
cell killing induced by two promising classes of investigational cancer therapies (proteasome inhibitors and
histone deacetylase inhibitors) so that the promising effects of these drugs that have been noted in preclinical
models can be best exploited in patients. We will be directly comparing the effects of two proteasome inhibitors
and three HDAC inhibitors that are either already FDA-approved, being evaluated in clinical trials, or being
developed for clinical application in humans, and in our third Specific Aim we will develop and apply
pharmacodynamic assays to measure drug-target interactions and the biological consequences of effective
drug targeting within the context of a Phase II clinical trial in patients.","NCI","8204790","11/23/2011 12:00:00 AM","PA-07-070","5R01CA127494-04","5","R01","CA","127494","04"," ","SALNIKOW, KONSTANTIN","1/1/2009 12:00:00 AM","11/30/2013 12:00:00 AM","Basic Mechanisms  of Cancer Therapeutics Study Section[BMCT]"," ","1862151","MCCONKEY, DAVID J","Not Applicable","09","UROLOGY","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","12/1/2011 12:00:00 AM","11/30/2012 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","161020","86951"," ","247971",
"Cancer; Genetics; Infectious Diseases; Lung; Lung Cancer; Pneumonia; Pneumonia & Influenza; Smoking and Health; Tobacco","Acceleration;Alveolar;Alveolar Macrophages;Anti-Inflammatory Agents;Anti-inflammatory;Apoptosis;Apoptotic;Architecture;Aromatic Polycyclic Hydrocarbons;Benzo(a)pyrene;Bone Marrow;Breathing;Butanones;Cancer Etiology;Cancer cell line;Carcinogen exposure;Carcinogens;Catalytic Domain;Cell Death;Cell Survival;Cells;Cessation of life;Chemicals;Chronic;Chronic Gastritis;Chronic Obstructive Airway Disease;Cigarette Smoker;Colon;Complex;Cytokine Gene;DNA Adduction;Dependence;Development;Diethylnitrosamine;Disease;Dose;Enzymes;Epithelial;Epithelial Cells;Epithelium;Etiology;Evaluation;Exposure to;Family;Fibroblasts;Fibrosis;Foundations;Free Radicals;Gases;Genes;Genetic;Goals;Growth;Hypoxia;Immune system;Individual;Infection;Inflammation;Inflammatory;Inflammatory Response;Injection of therapeutic agent;Injury;Interleukin-1;Interleukin-6;Lesion;Lewis Lung Carcinoma;Link;Liver;Lung;Lung Inflammation;Lung Neoplasms;Lung diseases;Mainstreaming;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of lung;Mediating;Mesenchymal;Metastatic Neoplasm to the Lung;Modeling;Molecular Genetics;Monitor;Mouse Strains;Mus;Mutagenesis;Mutagens;Mutation;Myeloid Cells;Natural Immunity;Nature;Necrosis;Neoplasm Metastasis;Nitrogen;Nitrosamines;Normal tissue morphology;Oncogenes;Oxidative Stress;Oxygen;PTGS2 gene;Pathogenesis;Pathway interactions;Personal Communication;Phase;Phosphotransferases;Play;Pneumonia;Premalignant Cell;Prevention;Process;Production;Proto-Oncogenes;Pulmonary Fibrosis;Ras/Raf;Recruitment Activity;Recurrence;Risk;Risk Factors;Role;Signal Transduction;Site;Smoker;Smoking;Stomach;TNF gene;Testing;Tissues;Tobacco;Tobacco smoke;Tobacco smoking;Transcription Factor AP-1;Transgenes;Transgenic Mice;Transgenic Model;Transplantation;Tumor Promoters;Tumor Suppressor Proteins;Variant;Work;bactericide;base;cancer cell;cancer initiation;carcinogenesis;cell type;chemical carcinogen;cytokine;enhancing factor;eosinophil;improved;lung carcinogenesis;macrophage;mast cell;member;metastatic process;mortality;mouse model;neutrophil;novel;overexpression;oxidative DNA damage;particle;release factor;repaired;response;transcription factor;tumor;tumor growth;tumor progression","Pulmonary inflammation and lung cancer development and progression","n/a","NCI","8247107","3/14/2012 12:00:00 AM","RFA-CA-07-046","5R01CA132586-05","5","R01","CA","132586","05"," ","HOWCROFT, THOMAS K","5/5/2008 12:00:00 AM","4/30/2014 12:00:00 AM","ZCA1-SRRB-U(O1)"," ","1861927","KARIN, MICHAEL ","Not Applicable","52","PHARMACOLOGY","804355790","UYTTZT6G9DT1","804355790","UYTTZT6G9DT1","US","32.881785","-117.236973","577507","UNIVERSITY OF CALIFORNIA, SAN DIEGO","LA JOLLA","CA","SCHOOLS OF MEDICINE","920930621","UNITED STATES","N","5/1/2012 12:00:00 AM","4/30/2014 12:00:00 AM","396","Non-SBIR/STTR","2012"," "," ","NCI","211777","115418"," ","327195",
"Biotechnology; Brain Cancer; Brain Disorders; Cancer; Clinical Research; Genetics; Neurosciences; Rare Diseases","Acids;Address;Adult;Adverse effects;Affect;Amino Acid Sequence;Animal Model;Animals;Antibodies;Binding;Biology;Blood Island;Blood capillaries;Brain;Brain Neoplasms;Categories;Cell Culture Techniques;Cell Differentiation process;Cell Proliferation;Cell-Mediated Cytolysis;Cells;Chemicals;Ciliary Neurotrophic Factor Receptor;Clinical Trials;Complex;Conventional (Clear Cell) Renal Cell Carcinoma;Cooperative Research and Development Agreement;Culture Media;Cytoplasmic and Nuclear Receptors;Data;Defect;Development;Developmental Biology;Diagnosis;Diagnostic;Disease;Drug Combinations;Drug Formulations;EPOR gene;Epigenetic Process;Erythroblasts;Erythrocytes;Erythropoietin;Erythropoietin Receptor;Gene Mutation;Gene Targeting;Genetic;Genetic Heterogeneity;Genetic Transcription;Glial Fibrillary Acidic Protein;Glioblastoma;Glioma;Growth;Heterogeneity;Histone Deacetylase Inhibitor;Human;Image;Inherited;Investigation;Isoelectric Focusing;Lead;Liquid Chromatography;Loss of Heterozygosity;Maintenance;Materials Testing;Mediator of activation protein;Membrane;Mesenchymal;Microdissection;Modeling;Molecular;Mus;Mutation;Neoplasms;Neuraxis;Nuclear;Nuclear Receptors;Okadaic Acid;Oligodendroglioma-Astrocytoma;Organ;Pathogenesis;Pathologic;Pathology;Pathway interactions;Patients;Pattern;Peptide Sequence Determination;Peptides;Pharmaceutical Preparations;Phase;Population;Primary Neoplasm;Proteins;Proteome;Proteomics;Protocols documentation;Radiation;Radiation enhancer;Retinoic Acid Receptor;Retinoids;Secondary to;Series;Stem cells;Syndrome;Techniques;Testing;Therapeutic;Therapeutic Uses;Thyroid Hormone Receptor;Time;Tissues;Toxic effect;Tretinoin;Tumor Cell Line;Tumor Suppressor Genes;Tumor-Derived;Von Hippel-Lindau Syndrome;Work;Xeno;analog;angiogenesis;antibody-dependent cell cytotoxicity;autocrine;base;capillary;cell growth;endolymphatic sac;gel electrophoresis;gene function;genetic analysis;hemangioblastoma;histogenesis;histone deacetylase 3;in vitro testing;inhibitor/antagonist;insight;molecular imaging;nano;neoplastic cell;new technology;novel therapeutics;overexpression;phosphatase inhibitor;programs;receptor;receptor expression;small molecule;therapeutic target;tool;tumor;tumor growth;tumor progression;tumorigenesis;two-dimensional","Molecular Pathogenesis of Neoplasia","n/a","NINDS","8557070"," "," ","1ZIANS003052-05","1","ZIA","NS","003052","05"," "," "," "," "," "," ","9694687","LONSER, RUSSELL ","Not Applicable","n/a","Unavailable"," "," "," "," "," "," "," "," ","NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE"," "," ","Other Domestic Non-Profits"," ","UNITED STATES","N"," "," "," ","Intramural Research","2012"," "," ","NINDS"," "," "," ","930329",
"Biotechnology; Cancer; Cervical Cancer; Clinical Research; Dental/Oral and Craniofacial Disease; Genetics; Infectious Diseases; Rare Diseases; Sexually Transmitted Diseases/Herpes","Acute;Advanced Malignant Neoplasm;Affect;Atlas of Cancer Mortality in the United States;Benign;Binding;Biological Assay;Biological Models;Cancer Patient;Cause of Death;Cell Proliferation;Cell Survival;Cell model;Cells;Cessation of life;Chemosensitization;Chromatin;DEK gene;Data;Development;Diagnosis;Diagnostic;Diagnostic Neoplasm Staging;Disease;Epithelial;Epithelium;Funding;Future;Growth;HPV E7;Head and Neck Cancer;Head and Neck Squamous Cell Carcinoma;Human;Human Papillomavirus;Human body;Human papillomavirus 16;Hyperplasia;Immunodeficient Mouse;Knockout Mice;Left;Ligands;Link;Malignant Epithelial Cell;Malignant Neoplasms;Malignant neoplasm of cervix uteri;Maps;Mass Spectrum Analysis;Mediating;Mesenchymal;Messenger RNA;Modeling;Molecular;Mus;Mutagens;Normal Cell;Nuclear;Oncogenes;Oncogenic;Outcome;Pathway interactions;Phenotype;Play;Pre-Clinical Model;Preparation;Production;Proteins;Proto-Oncogenes;Publishing;Regulation;Reporting;Research Project Grants;Resistance;Retinoblastoma;Role;Signal Pathway;Signal Transduction;Skin Papilloma;Squamous Epithelium;Squamous cell carcinoma;Structure;Tertiary Protein Structure;Testing;Therapeutic;Transgenic Mice;Tumor Pathology;Tumor Suppressor Proteins;Up-Regulation;Validation;Work;Xenograft procedure;base;cancer cell;cancer stem cell;cancer type;carcinogenesis;cell growth;cell type;chemotherapy;combat;gain of function;high risk;human Dek protein;human NUP214 protein;improved;in vivo;keratin 5;keratinocyte;leukemia;mouse model;mutant;neoplastic cell;novel strategies;overexpression;promoter;research study;retinoblastoma tumor suppressor;self-renewal;stem cell population;therapeutic target;time use;tumor;tumor growth;tumorigenesis","Role and Regulaton of the Human DEK Proto-Oncogene"," DEK upregulation has been clinically noted for many human tumor types, and DEK has thus been widely referred to as an oncogene. We have published that DEK supports the initial stages of cancer development, and generated the first preclinical model systems in which therapeutic DEK targeting approaches can now be tested. These models include organotypic epithelial rafts, human xenografts and DEK knockout mice. DEK inhibition selectively targeted epithelial tumor cells: acute DEK depletion caused the death and chemosensitization of cancer cells. However, DEK depletion did not affect normal cells to the same extent, and left differentiated cells which comprise the majority of human epithelium unaffected. HNC is a devastating disease with poor survival, and new approaches to diagnose and treat this disease are urgently needed. Preliminary data herein support critical roles for DEK in HNC growth, and also invasion and thus cancer cell dissemination. Thus DEK might be targeted in advanced cancers which are responsible for the great majority of HNC-related deaths. The application determines the role of DEK in the activation of b-catenin signaling pathways which we believe are a major contributor to HNC growth and spread in the human body. We anticipate that the results of the proposed studies in HNC will have broad implications for all cancers in which DEK is overexpressed. Based upon our preliminary and published findings, we postulate that DEK will be a useful diagnostic marker, and that its targeting - perhaps in conjunction with conventional chemotherapies - will improve therapeutic outcomes at both early and late cancer stages.   
      

","NCI","8387662","9/5/2012 12:00:00 AM","PA-10-067","2R01CA116316-06A1","2","R01","CA","116316","06","A","READ-CONNOLE, ELIZABETH LEE","4/1/2006 12:00:00 AM","6/30/2017 12:00:00 AM","Cancer Etiology Study Section[CE]"," ","6436782","WELLS, SUSANNE I","Not Applicable","01","Unavailable","071284913","JZD1HLM2ZU83","071284913","JZD1HLM2ZU83","US","39.140882","-84.500494","615001","CINCINNATI CHILDRENS HOSP MED CTR","CINCINNATI","OH","Independent Hospitals","452293039","UNITED STATES","N","9/5/2012 12:00:00 AM","6/30/2013 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","174318","92389"," ","266707",
"No NIH Category available","Animal Model;Apoptosis;Attention;Biological;Biological Assay;Biological Markers;Biopsy;Cancer Patient;Cancer and Leukemia Group B;Cancer cell line;Cell Adhesion Molecules;Cell Polarity;Cell Proliferation;Cell Surface Proteins;Cessation of life;Characteristics;Clinical;Clinical Research;Clinical Trials;Colon Carcinoma;Combined Modality Therapy;Correlative Study;Coxibs;Data;Development;Dinoprostone;Disease;Disease-Free Survival;Dose;Down-Regulation;Drug resistance;E-Cadherin;Eicosanoids;Enzyme-Linked Immunosorbent Assay;Epidermal Growth Factor Receptor;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Epithelial;Epithelial Cells;Erlotinib;Evaluation;Event;Failure;Funding;Future;Gene Expression;Genes;Goals;Growth;Health;Human;Inflammation;Inflammatory;Interleukin-1;Investigation;Laboratories;Laboratory Finding;Lead;Link;MAP Kinase Gene;Malignant Neoplasms;Malignant neoplasm of lung;Malignant neoplasm of prostate;Measurement;Mediating;Mesenchymal;Molecular;Molecular Profiling;Multivariate Analysis;New Agents;Non-Small-Cell Lung Carcinoma;Outcome;PTGS2 gene;Pathogenesis;Pathway Analysis;Pathway interactions;Patient Selection;Patients;Pharmaceutical Preparations;Phase I Clinical Trials;Phase II Clinical Trials;Phenotype;Plasma;Plasma Proteins;Play;Prognostic Marker;Prostaglandin E Receptor;Protein Isoforms;Protein Kinase C;Proteins;Publishing;Randomized;Receptor Activation;Receptor Inhibition;Recurrence;Regulation;Reporting;Research Support;Resistance;Resources;Role;Sampling;Signal Pathway;Signal Transduction;Specimen;Testing;Tissue Stains;Tissues;Toxic effect;United States;Urine;Veterans;abstracting;angiogenesis;arm;autocrine;base;cancer cell;celecoxib;cell motility;chemotherapy;cyclooxygenase 2;effective therapy;hazard;improved;inhibitor/antagonist;malignant breast neoplasm;malignant phenotype;neoplastic cell;novel;overexpression;paracrine;phase 1 study;pre-clinical;protein expression;protein function;public health relevance;receptor;resistance mechanism;response;response marker;therapeutic target;translational study;tumor;tumor growth;tumor progression","Inflammation in the pathogenesis of lung cancer","Relevance to Veterans Health. Successful therapy for lung cancer remains an unattained goal for many of our 
VA patients. Each year lung cancer exacts a devastating toll in terms of lives lost and resources expended. It is 
expected that this VA supported research will ultimately lead to improvement in disease-free survival for 
veterans with lung cancer.","VA","8195934","12/1/2011 12:00:00 AM","RFA-BX-08-001","5I01BX000359-03","5","I01","BX","000359","03"," "," ","4/1/2009 12:00:00 AM","9/30/2013 12:00:00 AM","Oncology A[ONCA]"," ","1914919","DUBINETT, STEVEN M.","Not Applicable","33","Unavailable","066689118","DL46AKJ5YD48","066689118","DL46AKJ5YD48","US","34.104809","-118.41105","481012","VA GREATER LOS ANGELES HEALTHCARE SYSTEM","LOS ANGELES","CA","Independent Hospitals","900731003","UNITED STATES","N","10/1/2011 12:00:00 AM","9/30/2012 12:00:00 AM","999","Non-SBIR/STTR","2012"," "," "," "," "," "," "," ",
"Biotechnology; Cancer; Immunization; Prevention; Vaccine Related","Adverse effects;Angiogenic Factor;Animals;Antigen Targeting;Antigen-Presenting Cells;Antigens;Autoimmune Process;Blood;Blood - brain barrier anatomy;Blood Vessels;CD8B1 gene;Carboplatin;Cell Death;Cells;Chronic;Clinical;Collaborations;Complex;Cross-Priming;Cues;Data;Development;Diagnostic Neoplasm Staging;Disease;Disease model;Dose;Drug Kinetics;Effector Cell;Epitopes;Excision;Fertility;Genetic;HLA-A2 Antigen;Hematopoietic;Hemorrhage;Histologic;Human;Hypoxia;Imaging Techniques;Immune;Immune system;Immunotherapy;Infiltration;Inflammation;Intercellular Fluid;Large Intestine Carcinoma;Lesion;Leukocytes;Maintenance;Malignant Neoplasms;Mediating;Mesenchymal;Modality;Modeling;Monitor;Mus;Neoplasm Metastasis;Neoplasms in Vascular Tissue;Normal tissue morphology;Organ;Pathologic;Pathology;Patients;Peptides;Pericytes;Peripheral;Pharmaceutical Preparations;Pharmacodynamics;Platelet-Derived Growth Factor;Population;Primary Neoplasm;Process;Recruitment Activity;Reporting;Retina;Safety;Secondary Immunization;Site;Staging;Stromal Cells;Structure;T cell response;T-Lymphocyte;Testing;Therapeutic;Therapeutic Agents;Time;Treatment Efficacy;Tube;Tumor stage;Vaccinated;Vaccine Design;Vaccines;Variant;Vascular Endothelial Cell;Vascular Endothelial Growth Factors;Vascular Permeabilities;Vascularization;Work;Wound Healing;antibody inhibitor;base;cancer cell;cell type;chemotherapeutic agent;chemotherapy;expectation;improved;in vivo;inhibitor/antagonist;irinotecan;melanoma;mouse model;neoplastic cell;neovascularization;novel;oxaliplatin;pre-clinical;pressure;prevent;prophylactic;public health relevance;research clinical testing;small molecule;temozolomide;therapeutic target;therapeutic vaccine;tumor;tumor growth;tumor vascular supply;vaccine efficacy","Vaccines to promote Tc-1-based targeting of tumor stroma","
NARRATIVE
Progressively growing tumors are supported by additional cell types that are collectively called the
stroma. Stromal cells include vascular endothelial cells and pericytes that are required for the
construction and maintenance of the tumor blood supply. Since stromal cells are normal and not subject
to the genetic instability common to cancer cells, they provide a static target for the development of
therapeutic agents. Over the past decade, therapeutic targeting of the tumor vasculature has become
increasingly attractive, leading to the development of small molecule and antibody inhibitors. Clinically,
these agents normalize the tumor vasculature and when applied alone or in combination with other
drugs, such as chemotherapy, they have resulted in anti-tumor effects in patients with cancer.
Unfortunately, as these drugs are applied systemically, there are substantial side effects in patients that
preclude their chronic administration. An alternative to these modalities are vaccines designed to elicit
specific T cell responses against antigens expressed by cells making up the tumor vasculature. Based
on our preliminary data, such vaccines provide potent anti-tumor protection and do not target normal
tissue vasculature, making them both effective and safe. Since such T cells may be renewed periodically
by booster vaccination, they may provide novel and potent inhibitors of tumor growth. The studies we
propose will assess the safety and efficacy of this modality in a mouse model that approximates the
human immune system. These results may provide the translational inertia to develop vaccine and
combinational therapies targeting the tumor stroma that can be applied to patients harboring any type of
vascularized cancer.","NCI","8213498","2/24/2012 12:00:00 AM","PA-07-070","5R01CA140375-03","5","R01","CA","140375","03"," ","MUSZYNSKI, KAREN","4/1/2010 12:00:00 AM","1/31/2015 12:00:00 AM","Cancer Immunopathology and Immunotherapy Study Section[CII]"," ","1942504","STORKUS, WALTER J.","Not Applicable","18","DERMATOLOGY","004514360","MKAGLD59JRL1","004514360","MKAGLD59JRL1","US","40.444001","-79.956102","2059802","UNIVERSITY OF PITTSBURGH AT PITTSBURGH","PITTSBURGH","PA","SCHOOLS OF MEDICINE","152133320","UNITED STATES","N","2/1/2012 12:00:00 AM","1/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","201275","95165"," ","296440",
"Cancer; Clinical Research; Dental/Oral and Craniofacial Disease; Orphan Drug; Rare Diseases; Stem Cell Research; Stem Cell Research - Nonembryonic - Human","Aftercare;Animal Model;Applications Grants;Biological Preservation;Biopsy;Cancer Etiology;Cell Count;Cells;Cessation of life;Cetuximab;Clinic;Clinical Research;Clinical Trials;Colon Carcinoma;Dose;Dose-Limiting;Epidermal Growth Factor Receptor;Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor;Erinaceidae;Event;Fine needle aspiration biopsy;Flow Cytometry;GLI gene;Gene Expression;Goals;Growth;Head and Neck Cancer;Head and Neck Squamous Cell Carcinoma;Head and neck structure;Human;Implant;Laboratories;Lead;Malignant Squamous Cell Neoplasm;Malignant neoplasm of brain;Malignant neoplasm of pancreas;Maximum Tolerated Dose;Modeling;Molecular;Mus;Outcome;Pathway interactions;Patients;Pharmaceutical Preparations;Pharmacodynamics;Phase;Phase I Clinical Trials;Phenotype;Population;Positioning Attribute;Principal Investigator;Proliferating;Receptor Inhibition;Recurrence;Refractory;Relapse;Research Personnel;Resistance;Reverse Transcriptase Polymerase Chain Reaction;Sampling;Signal Transduction;Solid Neoplasm;Stem cells;Testing;Therapeutic;Tissues;Toxic effect;Transducers;Translating;Translational Research;Translations;Tumor-Derived;Uncertainty;Variant;Work;Xenograft procedure;aldehyde dehydrogenases;base;cancer stem cell;cancer therapy;chemotherapy;conventional therapy;drug development;epithelial to mesenchymal transition;experience;head and neck cancer patient;human study;improved;in vitro Model;in vivo;in vivo Model;inhibitor/antagonist;innovation;malignant breast neoplasm;melanoma;novel;open label;outcome forecast;phase 1 study;pre-clinical;precursor cell;prevent;promoter;prospective;receptor;response;smoothened signaling pathway;stem cell population;tumor;tumor initiation;tumorigenesis","Rational combination of EGFR and Hedgehog inhibitors in head and neck cancer"," Our goal is to conduct a translational Phase 1 study combining EGFR and Hedgehog inhibitors in patients with head and neck cancer. We propose to investigate the molecular events in sequential biopsies taken from these patients, which will elucidate the variations induced by therapy in proliferating and cancer stem cells. This project is based on preclinical work conducted in the applicant's laboratory that identified cancer stem cells as responsible for resistance to anti-EGFR therapy. For this he utilized a novel direct patient tumor model he has devised implanting patient head and neck cancers in mice. These stem cells were then characterized molecularly and compared to non-progenitor cells, which led to the identification of the Hedgehog pathway as 500-fold more expressed in these progenitor cells. A combination containing a drug inhibiting this pathway (IPI- 926) achieved tumor cures and a reduction in the number of precursor cells in animal models. This supports translating these findings to the clinic. The first unique feature of this proposal is the utilization of a direct patient tumor model that allows the preservation of all the compartments that constitute a tumor. The second is the integration of laboratory observations and clinical research, since the applicant works with IPI-926 in his laboratory as well as leading the first-in-human Phase 1 study of IPI-926 in patients with solid tumors. It is that integration that permits an efficient translation such as this cancer stem cell-specific therapy. This proposed clinical trial represents truly hypothesis-driven drug development and applied translational science.  
    

","NCI","8330247","8/24/2012 12:00:00 AM","PAR-08-025","5R21CA156114-02","5","R21","CA","156114","02"," ","TIMMER, WILLIAM C","9/8/2011 12:00:00 AM","8/31/2014 12:00:00 AM","Clinical Oncology Study Section[CONC]"," ","8665415","JIMENO, ANTONIO ","Not Applicable","06","INTERNAL MEDICINE/MEDICINE","041096314","MW8JHK6ZYEX8","041096314","MW8JHK6ZYEX8","US","39.708143","-104.724958","1199905","UNIVERSITY OF COLORADO DENVER","Aurora","CO","SCHOOLS OF MEDICINE","800452570","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2014 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","207500","109975"," ","317475",
"No NIH Category available","Accounting;Address;Adult;Age;Age-Months;Antibodies;Binding;Binding Proteins;Biological Assay;Biological Markers;Biological Response Modifier Therapy;Biology;Blood;Blood specimen;Bone Marrow;Bone Marrow Neoplasms;Canada;Cell Line;Cells;Cellular biology;Cephalic;Child;Childhood Solid Neoplasm;Clinical;Clinical Research;Clinical Trials;Collaborations;Consolidation Therapy;Critical Pathways;Cytotoxic Chemotherapy;Cytotoxic agent;Data;Developmental Biology;Developmental Therapeutics Program;Diagnosis;Disease;Dose;Drug Delivery Systems;Drug resistance;FDA approved;Femur;Genes;Goals;Granulocyte-Macrophage Colony-Stimulating Factor;Growth;Guanidines;Human;Image;Imaging technology;Immune system;Immunosuppressive Agents;Immunotherapy;In Vitro;Institution;Interleukin-12;Interleukin-2;Interleukin-6;Laboratories;Lead;MYCN gene;Malignant Neoplasms;Mesenchymal;Metastatic Neoplasm to the Bone;Modeling;Molecular and Cellular Biology;Monoclonal Antibody Ch14.18;Mouse Cell Line;Mus;Myeloid Cells;N-Myc Protein;NOD/SCID mouse;Natural Killer Cells;Neoadjuvant Therapy;Neoplasm Metastasis;Neuroblastoma;Newly Diagnosed;North America;Operative Surgical Procedures;Osteoclasts;Outcome;PIK3CG gene;Pathway interactions;Patients;Pediatric Oncology;Pharmaceutical Preparations;Pharmacodynamics;Pharmacology;Phase;Phase I/II Trial;Primary Neoplasm;Principal Investigator;Proteins;Recurrence;Recurrent disease;Refractory;Refractory Disease;Research;Research Personnel;Residual Neoplasm;Residual state;Resistance;Role;STAT3 gene;Schedule;Series;Sirolimus;Site;Staging;Subgroup;Testing;Therapeutic Human Experimentation;Transgenic Mice;Transgenic Model;Xenograft Model;antibody-dependent cell cytotoxicity;aurora-A kinase;base;bone;cell growth;chemokine;chemotherapy;clinical remission;combinatorial;cytokine;cytotoxic;cytotoxicity;density;drug testing;high risk;human STK6 protein;improved;in vivo;in vivo Model;inhibitor/antagonist;lenalidomide;mTOR Inhibitor;macrophage;monocyte;mutant;neoplastic cell;neuroblastoma cell;noradrenaline transporter;novel;novel strategies;pre-clinical;pre-clinical research;programs;radiation effect;research study;response;small molecule;therapeutic target;tumor","Biology and Therapy of High Risk Neuroblastoma","n/a","NCI","8270606","7/5/2012 12:00:00 AM","PAR-09-025","5P01CA081403-13","5","P01","CA","081403","13"," ","TIMMER, WILLIAM C","7/6/2000 12:00:00 AM","5/31/2015 12:00:00 AM","ZCA1-GRB-S(J1)"," ","1873132","SEEGER, ROBERT CHARLES","Not Applicable","28","Unavailable","052277936","DVL1CMRMWRN9","052277936","DVL1CMRMWRN9","US","34.098065","-118.29069","1520001","CHILDREN'S HOSPITAL OF LOS ANGELES","LOS ANGELES","CA","Independent Hospitals","900276062","UNITED STATES","N","6/1/2012 12:00:00 AM","5/31/2013 12:00:00 AM","395","Non-SBIR/STTR","2012"," "," ","NCI","1453608","552772"," ","2006380",
"Biotechnology; Cancer; Clinical Research; Hematology; Rare Diseases","Affect;American;Antibodies;Apoptosis;Apoptotic;B lymphoid malignancy;B-Lymphocytes;Blood Cells;Bone Diseases;Bone Marrow;Bone Resorption;CD34 gene;Cancer Patient;Cell Death;Cell Line;Cell secretion;Cells;Coculture Techniques;Cytostatics;Development;Dexamethasone;Disease;Dose;Epidermal Growth Factor Receptor;Epithelial;Goals;Growth;HLA-A2 Antigen;Hematologic Neoplasms;Hematopoiesis;Hematopoietic;Histocompatibility Antigens Class I;Hour;Human;Hypercalcemia;Implant;In Vitro;Interleukin-6;Lead;Ligands;Lytic Lesion;MAPK8 gene;MHC Class I Genes;Malignant - descriptor;Malignant Neoplasms;Malignant neoplasm of prostate;Mediating;Membrane Proteins;Mesenchymal;Methods;Mitochondria;Modeling;Monoclonal Antibodies;Multiple Myeloma;Mus;NOD/SCID mouse;Neurons;Normal Cell;Nuclear;Organ;Osteoclasts;Osteoporosis;Pathological fracture;Patients;Pharmaceutical Preparations;Phosphotransferases;Plasma Cells;Protein Binding;Proteins;Publications;Recurrent disease;Renal Cell Carcinoma;Renal function;Reporting;Role;SCID-hu Mice;Safety;Series;Signal Pathway;Stem cells;Surface;T-Lymphocyte;TNF gene;TNFSF11 gene;Testing;Therapeutic;Therapeutic Agents;Therapeutic Monoclonal Antibodies;Tissues;Transgenic Organisms;Xenograft procedure;bone;cancer cell;caspase-9;cell transformation;chemotherapy;cytochrome c;cytokine;fetal;in vivo;innovation;killings;leukemia/lymphoma;mouse model;neoplastic cell;novel;osteoblast differentiation;outcome forecast;prevent;receptor;research study;response;small molecule;spinal cord compression;tumor","Targeting surface b2M for myeloma and bone therapy","Project Narrative 
The current studies will examine the therapeutic potential of anti-ï¿½2-microglobulin (ï¿½2M) monoclonal antibodies 
(mAbs) in myeloma. We recently made a novel and exciting discovery that anti-ï¿½2M mAbs had strong apoptotic 
activity in myeloma cells, and were also active and therapeutic in vivo in xenograft mouse models of myeloma. 
The mAbs selectively target and kill myeloma cells in coculture with normal hematopoietic cells without 
damaging normal blood cells. Moreover, our preliminary studies showed that anti-ï¿½2M mAbs may also be able 
to inhibit myeloma-mediated bone destruction in patients. Thus, we hypothesize that anti-ï¿½2M mAbs may be 
used as therapeutic agents to treat patients with myeloma. We propose a series of experiments to examine the 
mechanisms of mAb-induced apoptosis in myeloma cells, to elucidate the mechanisms of anti-ï¿½2M mAb- 
mediated protection of myeloma bone disease, and to develop strategies to enhance the efficacy of the mAbs 
to kill myeloma cells. These novel studies will lead to a better understanding of the role of anti-ï¿½2M mAbs in 
myeloma and may provide another avenue for augmenting currently available therapies for treating myeloma 
and potentially other hematological malignancies.","NCI","8192944","1/4/2012 12:00:00 AM","PA-07-070","4R01CA138402-03","4","R01","CA","138402","03"," ","WELCH, ANTHONY R","7/1/2009 12:00:00 AM","12/31/2013 12:00:00 AM","Cancer Immunopathology and Immunotherapy Study Section[CII]"," ","3123599","YI, QING ","Not Applicable","09","INTERNAL MEDICINE/MEDICINE","800772139","S3GMKS8ELA16","800772139","S3GMKS8ELA16","US","29.706319","-95.397195","578407","UNIVERSITY OF TX MD ANDERSON CAN CTR","HOUSTON","TX","HOSPITALS","770304009","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","393","Non-SBIR/STTR","2012"," "," ","NCI","205485","110963"," ","316448",
"Arthritis; Autoimmune Disease; Clinical Research; Pain Conditions - Chronic; Pain Research","9-deoxy-delta-9-prostaglandin D2;Acute;Alprostadil;Anabolism;Aneurysm;Anti-Inflammatory Agents;Anti-inflammatory;Antibodies;Antigen Presentation;Arachidonic Acids;Arthritis;Autoimmune Process;Autoimmunity;Back;Biology;Blood Platelets;Blood Vessels;Bone Marrow;CD4 Positive T Lymphocytes;Cardiovascular system;Cell Surface Receptors;Cell physiology;Cell surface;Cells;Chimera organism;Clinical;Clinical Data;Clinical Trials;Collagen;Collagen Arthritis;Collagen Type II;Coxibs;Cytokine Signaling;Data;Dendritic Cells;Development;Dinoprostone;Disease;Effectiveness;Effector Cell;Eicosanoids;Embryo;Enzymes;Epoprostenol;Equilibrium;Event;Exhibits;Failure;Fever;Fibroblasts;Generations;Genetic;Goals;Hematopoietic;Homeostasis;Human;Immune;Immune response;Immunity;Inflammation;Inflammatory;Inflammatory Response;Interleukin-12;Interleukin-17;K/BxN model;Knockout Mice;Lead;Learning;Leukotriene B4;Lipids;Literature;Lymphocyte;Matrix Metalloproteinases;Mediator of activation protein;Mesenchymal;Modeling;Mus;Pain;Peroxisome Proliferator-Activated Receptors;Pharmaceutical Preparations;Phenotype;Phospholipase A2;Phospholipids;Play;Process;Production;Property;Prostaglandin D2;Prostaglandin H2;Prostaglandin Production;Prostaglandin-Endoperoxide Synthase;Prostaglandins;Protein Isoforms;Regulatory T-Lymphocyte;Resistance;Resolution;Rheumatoid Arthritis;Risk;Role;Serum;Shunt Device;Small Interfering RNA;Stimulus;Swelling;Synovial Membrane;T-Cell Receptor;T-Lymphocyte;Therapeutic;Therapeutic Intervention;Tissues;Toxic effect;Transgenic Mice;Translating;Up-Regulation;Work;analog;base;cell type;cyclooxygenase 1;cyclooxygenase 2;cytokine;expectation;gastrointestinal;human NOS2A protein;immunoregulation;inhibitor/antagonist;insight;mouse PGE synthase 1;peripheral blood;pre-clinical;prostaglandin E synthase;public health relevance;research study;response;therapeutic target","Microsomal Prostaglandin E Synthase in Rheumatoid Arthritis","
PROJECT NARRATIVE
The discovery of COX-2 and subsequent development of specific COX-2 inhibitors
represented an enormous conceptual advance in eicosanoid biology and opened new
possibilities for pharmacologic treatment of inflammation and pain. It is clear, however,
that COX-2-specific NSAIDs have their own toxicities. The finding of a PGE synthase
isoform induced during inflammation and required for high level PGE2 production
represents a conceptual advance of similar magnitude. In view of the existence of
multiple PGES enzymes and other PG subclasses, the specific role of mPGES-1-derived
PGE2 in inflammation and autoimmunity remains uncertain. Furthermore, information on
the biology that will inform the development of mPGES-1 as a therapeutic target remains
incomplete. It is our expectation that our work will yield new insights into the role of PGs
in the functioning of eicosanoids during initiation and resolution of inflammation and the
transition from the innate to the acquired immune response.","NIAMS","8209253","2/7/2012 12:00:00 AM","PA-07-070","5R01AR049010-08","5","R01","AR","049010","08"," ","MAO, SU-YAU","9/29/2004 12:00:00 AM","12/31/2014 12:00:00 AM","Arthritis, Connective Tissue and Skin Study Section[ACTS]"," ","1888793","CROFFORD, LESLIE J","Not Applicable","06","INTERNAL MEDICINE/MEDICINE","939017877","H1HYA8Z1NTM5","939017877","H1HYA8Z1NTM5","US","38.042307","-84.458748","2793601","UNIVERSITY OF KENTUCKY","LEXINGTON","KY","SCHOOLS OF MEDICINE","405260001","UNITED STATES","N","1/1/2012 12:00:00 AM","12/31/2012 12:00:00 AM","846","Non-SBIR/STTR","2012"," "," ","NIAMS","216000","104760"," ","320760",
"Biotechnology; Cancer; Chronic Liver Disease and Cirrhosis; Digestive Diseases; Genetics; Hepatitis; Hepatitis - B; Infectious Diseases; Liver Cancer; Liver Disease; Nutrition; Orphan Drug; Prevention; Rare Diseases","Adult;Aflatoxin B1;Age;Alcohols;Animal Model;Antineoplastic Agents;Apoptosis;Aromatic Amines;Aromatic Polycyclic Hydrocarbons;Biological Process;Cancer Detection;Cancer Etiology;Cancer Patient;Carcinogens;Carcinoma;Case Study;Cell physiology;Cells;Cessation of life;Chronic;Cirrhosis;Complex;Data;Death Rate;Development;Diabetes Mellitus;Diagnostic Neoplasm Staging;Diet;Diethylnitrosamine;Disease;Disease Progression;Down-Regulation;Ectopic Expression;Endothelial Cells;Environmental Pollutants;Epigenetic Process;Etiology;Excision;Exposure to;Fatty Liver;Fibrosis;Functional disorder;Future;Genes;Goals;Grant;Growth;Growth Factor;Heavy Drinking;Hemochromatosis;Hepatic;Hepatitis;Hepatitis B;Hepatitis B Virus;Hepatitis C virus;Hepatocarcinogenesis;Hepatocyte;Human;IGF2 gene;In Vitro;Incidence;Infection;Infiltration;Inflammation;Inflammatory;Injury;Institutes;Interleukin-6;Knock-out;Knockout Mice;Life;Liposomes;Liver;Liver Dysfunction;Liver diseases;Liver neoplasms;Magnetic Resonance Imaging;Malignant Neoplasms;Malignant neoplasm of liver;MicroRNAs;Mission;Modeling;Molecular;Monitor;Mus;Mutation;Neoplasm Metastasis;Nitrosamines;Nodule;Nude Mice;Obesity;Oncogenic;Operative Surgical Procedures;Oral Contraceptives;Patients;Physiology;Play;Poison;Predisposition;Prevention;Primary carcinoma of the liver cells;Process;Property;Publishing;RNA;Radiation;Recurrence;Risk Factors;Rodent;Role;Staging;Testing;Therapeutic;Therapeutic Agents;Tissues;Treatment Efficacy;Treatment Protocols;Tumor Suppressor Proteins;Tumor stage;United States;Vinyl Chloride;Virus;Work;abstracting;adenoma;alpha-Fetoproteins;base;cancer cell;cancer therapy;chemical carcinogen;chemotherapeutic agent;chemotherapy;choline deficient diet;cytokine;epithelial to mesenchymal transition;feeding;in vivo;inhibitor/antagonist;liver function;liver transplantation;loss of function;men;migration;mimetics;mortality;mouse model;nanoparticle;non-alcoholic fatty liver;nonalcoholic steatohepatitis;novel;outcome forecast;preclinical study;public health relevance;response;tumor;tumor growth;tumorigenic","Role of microRNA-122 in hepatocarcinogenesis using conditional knock out mice","
Layman's Abstract
The urgent need for new treatments for hepatocellular cancer (HCC) is warranted
because incidence of HCC is increasing considerably in the United States, their dismal
prognosis and the poor response of this cancer to treatment regimen currently available.
This project focuses on the role of the loss of function of miR-122 in the development
and progression of hepatocellular carcinoma (HCC), one of the most common human
malignancies. Our previous studies have shown downregulation of miR-122 in HCCs of
both human and rodent origin. Now we intend to show that the loss of function of this
liver specific miR plays a causal role in the initiation and progression of HCC. If this is
the case, these studies will open the way to the development of novel miR-122 therapy
for this incurable disease. Thus, establishing role of miR-122 mimetic in an animal
model (in preclinical trial) would be a major milestone in the treatment of this deadly
disease in the near future.","NIDDK","8240491","3/19/2012 12:00:00 AM","PA-08-243","5R01DK088076-03","5","R01","DK","088076","03"," ","SHERKER, AVERELL H","5/17/2010 12:00:00 AM","3/31/2014 12:00:00 AM","Cancer Etiology Study Section[CE]"," ","8254551","GHOSHAL, KALPANA ","Not Applicable","03","PATHOLOGY","832127323","DLWBSLWAJWR1","832127323","DLWBSLWAJWR1","US","40.003166","-83.034278","6218701","OHIO STATE UNIVERSITY","COLUMBUS","OH","SCHOOLS OF MEDICINE","432101016","UNITED STATES","N","4/1/2012 12:00:00 AM","3/31/2013 12:00:00 AM","847","Non-SBIR/STTR","2012"," "," ","NIDDK","205425","107848"," ","313273",
"No NIH Category available","Accounting;Acids;Acute;Address;Affinity;Allogenic;Alveolar;Animals;Antibodies;Anticol;Antigen-Presenting Cells;Antigens;Apical;Arterial Fatty Streak;Atherosclerosis;Autoantigens;Autoimmune Diseases;Autoimmune Process;Autoimmune Responses;Autoimmunity;Automobile Driving;B-Lymphocytes;Binding;Biochemistry;Blood Vessels;Bronchiolitis;Bronchiolitis Obliterans;CD4 Positive T Lymphocytes;Cause of Death;Cell physiology;Cells;Cellular Immunity;Chronic;Clinical;Collaborations;Collagen;Collagen Receptors;Collagen Type I;Collagen Type II;Collagen Type V;Complex;Connective Tissue;Coronary;Coronary Vessels;Cytoskeleton;DDR1 gene;DDR2 gene;Data;Dendritic Cells;Deposition;Development;Disease;Down-Regulation;Employee Strikes;Environment;Epithelial Cells;Epithelium;Epitopes;Equilibrium;Event;Exposure to;Extracellular Matrix;Fibrillar Collagen;Goals;Graft Rejection;HLA-DR Antigens;Heart;Heart Diseases;Heart Transplantation;Helper-Inducer T-Lymphocyte;Human;Humoral Immunities;Immune;Immune response;Immune system;Immunity;Immunoglobulins;Immunology;Inflammation;Inflammatory;Injury;Integral Membrane Protein;Interleukin-17;Interleukin-4;Interleukin-6;Ischemia;Isogenic transplantation;Knock-out;Lead;Learning;Lesion;Leukocytes;Life;Ligands;Link;Lung;Lung Transplantation;Lung diseases;MHC Class II Genes;Macrophage Activation;Mediating;Mediator of activation protein;Mesenchymal;Metalloproteases;Methods;Minor;Modeling;Molecular Biology;Mononuclear;Mus;Normal tissue morphology;Organ;Organ Transplantation;Pathogenesis;Pathologic;Pathology;Pathway interactions;Patients;Peptide Hydrolases;Play;Process;Production;Proliferating;Property;Rattus;Regulatory T-Lymphocyte;Reperfusion Injury;Reperfusion Therapy;Reporting;Research;Research Personnel;Risk Factors;Role;Science;Signal Transduction;Smooth Muscle Myocytes;Solid;Source;Staging;Staining method;Stains;Surface;Syndrome;T cell response;T-Lymphocyte;TGFB1 gene;TNF gene;Techniques;Testing;Tetanus;Therapeutic Intervention;Tissue Sample;Tissues;Transgenic Organisms;Transplant Recipients;Transplantation;Vascular Diseases;Virus;Weight;allograft rejection;base;chemokine;cytokine;discoidin receptor;heart allograft;immunogenic;in vivo;interdisciplinary approach;interstitial;isoimmunity;lung allograft;macrophage;microbial;monocyte;novel;novel strategies;overexpression;pathogen;programs;receptor;receptor binding;receptor expression;research study;response;tool;translational approach;transplantation medicine;vascular bed","TH17 Autoimmunity to Type V Collagen in Heart and Lung Transplant","The Studies in this application are directly relevant to the identification of targets for therapeutic intervention to prolong the life of lung and heart transplant recipients as well as those suffering from atherosclerotic heart disease.","NIAID","8317659","8/6/2012 12:00:00 AM"," ","5P01AI084853-03","5","P01","AI","084853","03"," ","ODIM, JONAH","9/15/2010 12:00:00 AM","8/31/2015 12:00:00 AM","ZAI1-QV-I(S1)"," ","1882930","WILKES, DAVID S","Not Applicable","07","INTERNAL MEDICINE/MEDICINE","603007902","SHHBRBAPSM35","603007902","SHHBRBAPSM35","US","39.780714","-86.174977","577806","INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS","INDIANAPOLIS","IN","SCHOOLS OF MEDICINE","462022915","UNITED STATES","N","9/1/2012 12:00:00 AM","8/31/2013 12:00:00 AM","855","Non-SBIR/STTR","2012"," "," ","NIAID","1388959","144231"," ","1533190",
